PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Blazer, A; Wang, BH; Simpson, D; Kirchhoff, T; Heffron, S; Clancy, RM; Heguy, A; Ray, K; Snuderl, M; Buyon, JP				Blazer, Ashira; Wang, Binhuan; Simpson, Danny; Kirchhoff, Tomas; Heffron, Sean; Clancy, Robert M.; Heguy, Adriana; Ray, Karina; Snuderl, Matija; Buyon, Jill P.			Apolipoprotein L1 risk variants associate with prevalent atherosclerotic disease in African American systemic lupus erythematosus patients	PLOS ONE			English	Article							INTERNATIONAL COLLABORATING CLINICS; CARDIOVASCULAR-DISEASE; KIDNEY-DISEASE; APOL1; CYTOTOXICITY; NEPHROPATHY; PROTEIN; CLASSIFICATION; LOCALIZATION; RECEPTOR	Objective Atherosclerosis is exaggerated in African American (AA) systemic lupus erythematosus (SLE) patients, with doubled cardiovascular disease (CVD) risk compared to White patients. The extent to which common Apolipoprotein L1 (APOL1) risk alleles (RA) contribute to this trend is unknown. This retrospective cohort study assessed prevalent atherosclerotic disease across APOL1 genotypes in AA SLE patients. Methods One hundred thirteen AA SLE subjects were APOL1-genotyped and stratified as having: zero risk alleles, one risk allele, or two risk alleles. Chart review assessed CVD manifestations including abdominal aortic aneurysm, angina, carotid artery disease, coronary artery disease, myocardial infarction, peripheral vascular disease, stroke, and vascular calcifications. Associations between the genotypes and a composite endpoint defined as one or more CVD manifestations were calculated using logistic regression. Symptomatic atherosclerotic disease, excluding incidental vascular calcifications, was also assessed. Results The 0-risk-allele, 1-risk-allele and 2-risk-allele groups, respectively, comprised 34%, 53%, and 13% of the cohort. Respectively, 13.2%, 41.7%, and 60.0% of the 0-risk allele, 1-risk-allele, and 2-risk-allele groups met the composite endpoint of atherosclerotic CVD (p = 0.001). Adjusting for risk factors-including smoking, ESRD, BMI > 25 and hypertension-we observed an association between carrying one or more RA and atherosclerotic CVD (OR = 7.1; p = 0.002). For symptomatic disease, the OR was 3.5 (p = 0.02). In a time-to-event analysis, the proportion of subjects free from the composite primary endpoint, symptomatic atherosclerotic CVD, was higher in the 0-risk-allele group compared to the 1-risk-allele and 2-risk-allele groups (chi(2) = 6.5; p = 0.04). Conclusions Taken together, the APOL1 RAs associate with prevalent atherosclerotic CVD in this cohort of AA SLE patients, perhaps reflecting a potentiating effect of SLE on APOL1-related cardiovascular phenotypes.	[Blazer, Ashira; Clancy, Robert M.; Buyon, Jill P.] NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10003 USA; [Wang, Binhuan] NYU, Sch Med, Dept Populat Hlth, Div Biostat, New York, NY USA; [Simpson, Danny; Kirchhoff, Tomas] NYU, Sch Med, Dept Populat Hlth, Div Genom, New York, NY USA; [Heffron, Sean] NYU, Sch Med, Dept Med, Leon H Charney Div Cardiol, New York, NY USA; [Heguy, Adriana; Ray, Karina] NYU, Sch Med, Genome Technol Ctr, New York, NY USA; [Snuderl, Matija] NYU, Sch Med, Dept Pathol & Neurol, New York, NY USA	New York University; New York University; New York University; New York University; New York University; New York University	Blazer, A (corresponding author), NYU, Sch Med, Dept Med, Div Rheumatol, New York, NY 10003 USA.	ashira.blazer@nyumc.org	Heguy, Adriana/GPP-3907-2022	Buyon, Jill/0000-0002-3852-7129; Heffron, Sean/0000-0002-2692-5189; Snuderl, Matija/0000-0003-0752-0917; Blazer, Ashira/0000-0002-0386-5259; Kirchhoff, Tomas/0000-0002-9055-2364; Simpson, Danny/0000-0001-9690-3527; Wang, Binhuan/0000-0002-3435-3424	Rheumatology Research Foundation [14-A0-00-003545-01]; Rheumatology Research Foundation; NYU CTSA from the National Center for the Advancement of Translational Science (NCATS), NIH; Colton Center at New York University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001445] Funding Source: NIH RePORTER	Rheumatology Research Foundation; Rheumatology Research Foundation; NYU CTSA from the National Center for the Advancement of Translational Science (NCATS), NIH; Colton Center at New York University School of Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The corresponding author, Dr. Ashira Blazer, received a Scientist Development Award (grant number: 14-A0-00-003545-01) through the Rheumatology Research Foundation (https://www.rheumresearch.org/) for the completion of this work. Funding for this project was provided by the Rheumatology Research Foundation Scientist Development Award. This work was supported in part by the NYU CTSA grant 1UL1TR001445 from the National Center for the Advancement of Translational Science (NCATS), NIH, and The Colton Center at New York University School of Medicine. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.; The authors thank Janet Nwaukoni, study coordinator, for her contributions in populating the SLE SAMPLE database and enrolling study participants. The genotyping experiment using The Infinium QC-Array-24v1.0 was performed at the New York University Cancer Institute Genomics Facility. Funding for this project was provided by the Rheumatology Research Foundation Scientist Development Award. This work was supported in part by the NYU CTSA grant 1UL1TR001445 from the National Center for the Advancement of Translational Science (NCATS), NIH, and The Colton Center at New York University School of Medicine.	Agarwal Surabhi, 2009, Curr Rheumatol Rep, V11, P241; Alenghat FJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep20303; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Baran Y, 2013, AM J HUM GENET, V92, P882, DOI 10.1016/j.ajhg.2013.04.023; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Buyon JP, 2005, ANN INTERN MED, V142, P953, DOI 10.7326/0003-4819-142-12_Part_1-200506210-00004; Cheng DM, 2015, J LIPID RES, V56, P1583, DOI 10.1194/jlr.M059733; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Estrella MM, 2015, CLIN INFECT DIS, V60, P646, DOI 10.1093/cid/ciu765; Freedman BI, 2014, ARTHRITIS RHEUMATOL, V66, P390, DOI 10.1002/art.38220; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Garcia MA, 2014, RHEUMATOLOGY, V53, P1431, DOI 10.1093/rheumatology/keu011; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Ines L, 2015, ARTHRIT CARE RES, V67, P1180, DOI 10.1002/acr.22539; Ito K, 2014, CIRC RES, V114, P845, DOI 10.1161/CIRCRESAHA.114.302347; Kasembeli AN, 2015, J AM SOC NEPHROL, V26, P2882, DOI 10.1681/ASN.2014050469; Khatua AK, 2015, AM J PHYSIOL-CELL PH, V309, pC22, DOI 10.1152/ajpcell.00384.2014; Kopp JB, 2015, J AM SOC NEPHROL, V26, P1443, DOI 10.1681/ASN.2013111242; Kopp JB, 2011, J AM SOC NEPHROL, V22, P2129, DOI 10.1681/ASN.2011040388; Lan XQ, 2015, EXP MOL PATHOL, V98, P491, DOI 10.1016/j.yexmp.2015.03.020; Langefeld CD, 2015, KIDNEY INT, V87, P169, DOI 10.1038/ki.2014.254; Larsen CP, 2013, J AM SOC NEPHROL, V24, P722, DOI 10.1681/ASN.2012121180; Limou S, 2014, ADV CHRONIC KIDNEY D, V21, P426, DOI 10.1053/j.ackd.2014.06.005; Lipkowitz MS, 2015, KIDNEY INT, V87, P14, DOI 10.1038/ki.2014.319; Ma LJ, 2017, J AM SOC NEPHROL, V28, P1093, DOI 10.1681/ASN.2016050567; Ma LJ, 2015, J AM SOC NEPHROL, V26, P339, DOI 10.1681/ASN.2013091017; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Mukamal KJ, 2016, ARTERIOSCL THROM VAS, V36, P398, DOI 10.1161/ATVBAHA.115.305970; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Nieves CEF, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0571-2; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Parsa A, 2013, NEW ENGL J MED, V369, P2183, DOI 10.1056/NEJMoa1310345; Petri M, 1999, J RHEUMATOL, V26, P502; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose-John S, 2015, BEST PRACT RES CL EN, V29, P787, DOI 10.1016/j.beem.2015.07.001; Sampson MG, 2016, J AM SOC NEPHROL, V27, P814, DOI 10.1681/ASN.2014111131; Sesin CA, 2005, KIDNEY INT, V68, P110, DOI 10.1111/j.1523-1755.2005.00385.x; Vanhollebeke B, 2006, CELL MOL LIFE SCI, V63, P1937, DOI 10.1007/s00018-006-6091-x; Wilson WA, 1999, ARTHRITIS RHEUM, V42, P1309, DOI 10.1002/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F	40	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182483	10.1371/journal.pone.0182483	http://dx.doi.org/10.1371/journal.pone.0182483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850570	Green Published, gold, Green Submitted			2022-12-27	WOS:000408544200003
J	Lavia, C; Dallorto, L; Maule, M; Ceccarelli, M; Fea, AM				Lavia, Carlo; Dallorto, Laura; Maule, Milena; Ceccarelli, Manuela; Fea, Antonio Maria			Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis	PLOS ONE			English	Review							TRABECULAR MICROBYPASS STENTS; EXCIMER-LASER TRABECULOTOMY; MICRO-BYPASS STENT; AB-INTERNO; INTRAOCULAR-PRESSURE; CATARACT-SURGERY; MEDICATION ADHERENCE; PHACOEMULSIFICATION; IMPLANTATION; OUTCOMES	Background MIGS have been developed as a surgical alternative for glaucomatous patients. Purpose To analyze the change in intraocular pressure (IOP) and glaucoma medications using different MIGS devices (Trabectome, iStent, Excimer Laser Trabeculotomy (ELT), iStent Supra, CyPass, XEN, Hydrus, Fugo Blade, Ab interno canaloplasty, Goniscopy-assisted transluminal trabeculotomy) as a solo procedure or in association with phacoemulsification. Methods Randomized control trials (RCT) and non-RCT (non randomized comparative studies, NRS, and before-after studies) were included. Studies with at least one year of follow-up in patients affected by primary open angle glaucoma, pseudoexfoliative glaucoma or pigmentary glaucoma were considered. Risk of Bias assessment was performed using the Cochrane Risk of Bias and the ROBINS-I tools. The main outcome was the effect of MIGS devices compared to medical therapy, cataract surgery, other glaucoma surgeries and other MIGS on both IOP and use of glaucoma medications 12 months after surgery. Outcomes measures were the mean difference in the change of IOP and glaucoma medication compared to baseline at one and two years and all ocular adverse events. The current meta-analysis is registered on PROSPERO (reference n degrees CRD42016037280). Results Over a total of 3,069 studies, nine RCT and 21 case series with a total of 2.928 eyes were included. Main concerns about risk of bias in RCTs were lack of blinding, allocation concealment and attrition bias while in non-RCTs they were represented by patients' selection, masking of participants and co-intervention management. Limited evidence was found based on both RCTs and non RCTs that compared MIGS surgery with medical therapy or other MIGS. In before-after series, MIGS surgery seemed effective in lowering both IOP and glaucoma drug use. MIGS showed a good safety profile: IOP spikes were the most frequent complications and no cases of infection or BCVA loss due to glaucoma were reported. Conclusions Although MIGS seem efficient in the reduction of the IOP and glaucoma medication and show good safety profile, this evidence is mainly derived from non-comparative studies and further, good quality RCTs are warranted.	[Lavia, Carlo; Dallorto, Laura; Fea, Antonio Maria] Univ Turin, Dept Surg Sci, Eye Clin, Turin, Italy; [Maule, Milena] Univ Turin, Dept Med Sci, Turin, Italy; [Maule, Milena] AOU Citta Salute & Sci Torino, CPO Piemonte, Turin, Italy; [Ceccarelli, Manuela] AOU Citta Salute & Sci Torino, CPO Piemonte, SCDU Epidemiol Tumori, Turin, Italy	University of Turin; University of Turin; A.O.U. Citta della Salute e della Scienza di Torino; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte; A.O.U. Citta della Salute e della Scienza di Torino; Centro di Riferimento per Epidemiologia e la Prevenzione Oncologica in Piemonte	Fea, AM (corresponding author), Univ Turin, Dept Surg Sci, Eye Clin, Turin, Italy.	antoniomfea@gmail.com	Maule, Milena M/K-3858-2018	Maule, Milena M/0000-0003-2142-1288				Ahmed IIK, 2014, J CATARACT REFR SURG, V40, P1295, DOI 10.1016/j.jcrs.2014.07.004; Alba AC, 2016, J CLIN EPIDEMIOL, V70, P129, DOI 10.1016/j.jclinepi.2015.09.005; Arriola-Villalobos P, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/1056573; Arriola-Villalobos P, 2013, BRIT J OPHTHALMOL, V97, P1250, DOI 10.1136/bjophthalmol-2012-302394; Arriola-Villalobos P, 2012, BRIT J OPHTHALMOL, V96, P645, DOI 10.1136/bjophthalmol-2011-300218; Babighian S, 2010, EYE, V24, P632, DOI 10.1038/eye.2009.172; Babighian S, 2006, OPHTHALMOLOGICA, V220, P285, DOI 10.1159/000094616; Baudouin C, 2010, PROG RETIN EYE RES, V29, P312, DOI 10.1016/j.preteyeres.2010.03.001; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Belovay GW, 2012, J CATARACT REFR SURG, V38, P1911, DOI 10.1016/j.jcrs.2012.07.017; Brandao LM, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/705915; Caprioli J, 2015, OPHTHALMOLOGY, V122, P1795, DOI 10.1016/j.ophtha.2015.02.029; Craven ER, 2012, J CATARACT REFR SURG, V38, P1339, DOI 10.1016/j.jcrs.2012.03.025; Donnenfeld ED, 2015, CLIN OPHTHALMOL, V9, P2057, DOI 10.2147/OPTH.S91732; Dreer LE, 2012, J GLAUCOMA, V21, P234, DOI 10.1097/IJG.0b013e31821dac86; European Glaucoma Society, 2014, TERM GUID GLAUC; Fea AM, 2008, TECH OPHTHALMOL, V6, P45, DOI 10.1097/ito.0b013e31817dcba2; Fea AM, 2017, CLIN EXP OPHTHALMOL, V45, P120, DOI 10.1111/ceo.12805; Fea AM, 2014, CLIN OPHTHALMOL, V8, P875, DOI 10.2147/OPTH.S59932; Fea AM, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/795357; Fernandez-Barrientos Y, 2010, INVEST OPHTH VIS SCI, V51, P3327, DOI 10.1167/iovs.09-3972; Fogagnolo P, 2012, OPHTHALMOLOGICA, V228, P154, DOI 10.1159/000337838; Francis BA, 2011, OPHTHALMOLOGY, V118, P1466, DOI 10.1016/j.ophtha.2011.03.028; Friedrich JO, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-32; Gandolfi SA, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/3410469; Garciia-Feijoo J, 2015, AM J OPHTHALMOL, V159, P1075, DOI 10.1016/j.ajo.2015.02.018; Gedde SJ, 2012, AM J OPHTHALMOL, V153, P789, DOI 10.1016/j.ajo.2011.10.026; Gedde SJ, 2012, CURR OPIN OPHTHALMOL, V23, P118, DOI 10.1097/ICU.0b013e32834ff2d1; Gonnermann J, 2017, GRAEF ARCH CLIN EXP, V255, P359, DOI 10.1007/s00417-016-3514-8; HIGGINS JPT, 2011, COCHRANE HDB SYSTEMA, V0001; Higgins JPT, 2008, STAT MED, V27, P6072, DOI 10.1002/sim.3427; Katz LJ, 2015, CLIN OPHTHALMOL, V9, P2313, DOI 10.2147/OPTH.S96695; Khan M, 2015, J CATARACT REFR SURG, V41, P1716, DOI 10.1016/j.jcrs.2014.12.061; Klamann MKJ, 2013, GRAEF ARCH CLIN EXP, V251, P2195, DOI 10.1007/s00417-013-2408-2; Kurji K, 2017, CAN J OPHTHALMOL, V52, P99, DOI 10.1016/j.jcjo.2016.06.018; Lindstrom R, 2016, ADV THER, V33, P2082, DOI 10.1007/s12325-016-0420-8; Manasses DT, 2016, OPHTHALMOL THER, V5, P135, DOI 10.1007/s40123-016-0054-6; Melancia D, 2015, OPHTHALMIC RES, V53, P141, DOI 10.1159/000377635; Newman-Casey PA, 2015, OPHTHALMOLOGY, V122, P1308, DOI 10.1016/j.ophtha.2015.03.026; Pahlitzsch M, 2015, KLIN MONATSBL AUGENH, V232, P1198, DOI 10.1055/s-0041-105941; Pahlitzsch M, 2017, CAN J OPHTHALMOL, V52, P92, DOI 10.1016/j.jcjo.2016.07.011; Parrish RK, 2003, AM J OPHTHALMOL, V135, P688, DOI 10.1016/S0002-9394(03)00098-9; Perez-Torregrosa V T, 2016, Arch Soc Esp Oftalmol, V91, P415, DOI 10.1016/j.oftal.2016.02.006; Pfeiffer N, 2015, OPHTHALMOLOGY, V122, P1283, DOI 10.1016/j.ophtha.2015.03.031; Poley BJ, 2009, J CATARACT REFR SURG, V35, P1946, DOI 10.1016/j.jcrs.2009.05.061; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Richter GM, 2016, CLIN OPHTHALMOL, V10, P189, DOI 10.2147/OPTH.S80490; Saheb H, 2012, CURR OPIN OPHTHALMOL, V23, P96, DOI 10.1097/ICU.0b013e32834ff1e7; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Schuman JS, 2000, CLIN THER, V22, P167, DOI 10.1016/S0149-2918(00)88478-7; Schwartz GR, 2008, SURV OPHTHALMOL, V53, pS57, DOI 10.1016/j.survophthal.2008.08.002; Shrivastava A, 2010, CURR OPIN OPHTHALMOL, V21, P118, DOI 10.1097/ICU.0b013e3283360ac3; Spiegel D, 2009, EUR J OPHTHALMOL, V19, P393, DOI 10.1177/112067210901900311; Sterne JAC, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i4919; Ting JLM, 2012, J CATARACT REFR SURG, V38, P315, DOI 10.1016/j.jcrs.2011.08.043; Toteberg-Harms M, 2013, BMC OPHTHALMOL, V13, DOI 10.1186/1471-2415-13-24; Vold S, 2016, OPHTHALMOLOGY, V123, P2103, DOI 10.1016/j.ophtha.2016.06.032; Vold SD, 2016, OPHTHALMOL THER, V5, P161, DOI 10.1007/s40123-016-0065-3; Voskanyan L, 2014, ADV THER, V31, P189, DOI 10.1007/s12325-014-0095-y	59	197	198	6	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183142	10.1371/journal.pone.0183142	http://dx.doi.org/10.1371/journal.pone.0183142			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850575	Green Submitted, Green Published, gold			2022-12-27	WOS:000408544200010
J	Pullicin, AJ; Penner, MH; Lim, J				Pullicin, Alexa J.; Penner, Michael H.; Lim, Juyun			Human taste detection of glucose oligomers with low degree of polymerization	PLOS ONE			English	Article							ALPHA-AMYLASE; SWEET TASTE; POLYCOSE; RECEPTOR; STARCH; T1R3; RAT; POLYSACCHARIDE; CHROMATOGRAPHY; MALTODEXTRINS	Studies have reported that some animals, including humans, can taste mixtures of glucose oligomers (i.e., maltooligosaccharides, MOS) and that their detection is independent of the known T1R2/T1R3 sweet taste receptor. In an effort to understand potential mechanisms underlying the taste perception of glucose oligomers in humans, this study was designed to investigate: 1) the variability of taste sensitivity to MOS with low degree-of-polymerization (DP), and 2) the potential role of hT1R2/T1R3 in the MOS taste detection. To address these objectives, a series of food grade, narrow-DP-range MOS were first prepared (DP 3, 3-4, 5-6, and 6-7) by fractionating disperse saccharide mixtures. Subjects were then asked to discriminate these MOS stimuli as well as glucose (DP 1) and maltose (DP 2) from blanks after the stimuli were swabbed on the tongue. All stimuli were presented at 75 mM with and without a sweet taste inhibitor (lactisole). An a-glucosidase inhibitor (acarbose) was added to all test stimuli to prevent oral digestion of glucose oligomers. Results showed that all six stimuli were detected with similar discriminability in normal tasting conditions. When the sweet receptor was inhibited, DP 1, 2, and 3 were not discriminated from blanks. In contrast, three higher-DP paired MOS stimuli (DP 3-4, 5-6, and 6-7) were discriminated from blanks at a similar degree. Overall, these results support the presence of a sweet-independent taste perception mechanism that is stimulated by MOS greater than three units.	[Pullicin, Alexa J.; Penner, Michael H.; Lim, Juyun] Oregon State Univ, Dept Food Sci & Technol, Corvallis, OR 97331 USA	Oregon State University	Lim, J (corresponding author), Oregon State Univ, Dept Food Sci & Technol, Corvallis, OR 97331 USA.	juyun.lim@oregonstate.edu	Lim, Juyun/AAR-4637-2020	Lim, Juyun/0000-0002-1781-8912				Balto AS, 2016, FOOD CHEM, V197, P872, DOI 10.1016/j.foodchem.2015.10.120; BROOKS JR, 1987, CEREAL CHEM, V64, P253; Ennis D.M., 1993, J SENSORY STUDIES, V8, P353; Galindo-Cuspinera V, 2006, NATURE, V441, P354, DOI 10.1038/nature04765; Glendinning JI, 2017, AM J PHYSIOL-REG I; Glendinning JI, 2015, AM J PHYSIOL-REG I, V309, pR552, DOI 10.1152/ajpregu.00056.2015; Green B, CHEM SENSES, V38, P655; Jiang PH, 2005, J BIOL CHEM, V280, P15238, DOI 10.1074/jbc.M414287200; Lapis TJ, CHEM SENSES; Lapis TJ, 2016, CHEM SENSES, V41, P755, DOI 10.1093/chemse/bjw088; Lapis TJ, 2014, CHEM SENSES, V39, P737, DOI 10.1093/chemse/bju031; Laska M, 2001, J CHEM ECOL, V27, P1997, DOI 10.1023/A:1012286719241; Lawless H. T., 2010, SENSORY EVALUATION F; Nilsson GS, 1996, STARCH-STARKE, V48, P352, DOI 10.1002/star.19960481003; NISSENBAUM JW, 1987, NEUROSCI BIOBEHAV R, V11, P187, DOI 10.1016/S0149-7634(87)80025-8; PANGBORN RM, 1961, NATURE, V191, P810, DOI 10.1038/191810a0; ROBYT JF, 1994, CARBOHYD RES, V251, P187, DOI 10.1016/0008-6215(94)84285-X; ROBYT JF, 1970, J BIOL CHEM, V245, P3917; Sclafani A, 2004, APPETITE, V43, P1, DOI 10.1016/j.appet.2004.03.007; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P253, DOI 10.1016/S0149-7634(87)80033-7; SCLAFANI A, 1987, NEUROSCI BIOBEHAV R, V11, P197, DOI 10.1016/S0149-7634(87)80026-X; Spector AC, 2016, BEHAV EVIDENCE SELEC; Sukumaran SK, 2016, P NATL ACAD SCI USA, V113, P6035, DOI 10.1073/pnas.1520843113; Treesukosol Y, 2011, J NEUROSCI, V31, P13527, DOI 10.1523/JNEUROSCI.2179-11.2011; Treesukosol Y, 2009, AM J PHYSIOL-REG I, V296, pR855, DOI 10.1152/ajpregu.90869.2008; van der Maarel MJEC, 2002, J BIOTECHNOL, V94, P137, DOI 10.1016/S0168-1656(01)00407-2; VIGORITO M, 1987, NEUROSCI BIOBEHAV R, V11, P201, DOI 10.1016/S0149-7634(87)80027-1; WHELAN WJ, 1952, NATURE, V170, P748, DOI 10.1038/170748a0; Yee KK, 2011, P NATL ACAD SCI USA, V108, P5431, DOI 10.1073/pnas.1100495108; Zukerman S, 2009, AM J PHYSIOL-REG I, V296, pR866, DOI 10.1152/ajpregu.90870.2008	31	23	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183008	10.1371/journal.pone.0183008	http://dx.doi.org/10.1371/journal.pone.0183008			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850567	Green Published, Green Submitted, gold			2022-12-27	WOS:000408544200007
J	Abdelmaksoud, AA; Girerd, PH; Garcia, EM; Brooks, JP; Leftwich, LM; Sheth, NU; Bradley, SP; Serrano, MG; Fettweis, JM; Huang, B; Strauss, JF; Buck, GA; Jefferson, KK				Abdelmaksoud, Abdallah A.; Girerd, Philippe H.; Garcia, Erin M.; Brooks, J. Paul; Leftwich, Lauren M.; Sheth, Nihar U.; Bradley, Steven P.; Serrano, Myrna G.; Fettweis, Jennifer M.; Huang, Bernice; Strauss, Jerome F., III; Buck, Gregory A.; Jefferson, Kimberly K.			Association between statin use, the vaginal microbiome, and Gardnerella vaginalis vaginolysin-mediated cytotoxicity	PLOS ONE			English	Article							BACTERIAL-VAGINOSIS; HAEMOPHILUS VAGINALIS; RACIAL DISPARITIES; PRETERM BIRTH; HIV-INFECTION; CHOLESTEROL; LACTOBACILLI; ATORVASTATIN; ACQUISITION; WOMEN	Background Bacterial vaginosis (BV) is the leading dysbiosis of the vaginal microbiome. The pathways leading towards the development of BV are not well understood. Gardnerella vaginalis is frequently associated with BV. G. vaginalis produces the cholesterol-dependent cytolysin (CDC), vaginolysin, which can lyse a variety of human cells and is thought to play a role in pathogenesis. Because membrane cholesterol is required for vaginolysin to function, and because HMG-CoA reductase inhibitors (statins) affect not only serum levels of cholesterol but membrane levels as well, we hypothesized that statins might affect the vaginal microbiome. Methods To investigate the relationship between use of the statins and the vaginal microbiome, we analyzed 16S rRNA gene taxonomic surveys performed on vaginal samples from 133 women who participated in the Vaginal Human Microbiome Project and who were taking statins at the time of sampling, 152 women who reported high cholesterol levels but were not taking statins, and 316 women who did not report high cholesterol. To examine the effect of statins on the cytolytic effect of vaginolysin, the cholesterol-dependent cytolysin (CDC) produced by Gardnerella vaginalis, we assessed the effect of simvastatin pretreatment of VK2E6/E7 vaginal epithelial cells on vaginolysin-mediated cytotoxicity. Results The mean proportion of G. vaginalis among women taking statins was significantly lower relative to women not using statins. Women using statins had higher mean proportions of Lactobacillus crispatus relative to women with normal cholesterol levels, and higher levels of Lactobacillus jensenii relative to women with high cholesterol but not taking statins. In vitro, vaginal epithelial cells pretreated with simvastatin were relatively resistant to vaginolysin and this effect was inhibited by cholesterol. Conclusions In this cross-sectional study, statin use was associated with reduced proportions of G. vaginalis and greater proportions of beneficial lactobacilli within the vaginal microbiome. The negative association between statin use and G. vaginalis may be related to inhibition of vaginolysin function.	[Abdelmaksoud, Abdallah A.; Garcia, Erin M.; Leftwich, Lauren M.; Sheth, Nihar U.; Bradley, Steven P.; Serrano, Myrna G.; Fettweis, Jennifer M.; Huang, Bernice; Buck, Gregory A.; Jefferson, Kimberly K.] Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA; [Girerd, Philippe H.; Strauss, Jerome F., III] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA USA; [Brooks, J. Paul] Virginia Commonwealth Univ, Ctr Study Biol Complex, Richmond, VA USA; [Sheth, Nihar U.] DNAnexus Inc, Mountain View, CA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Jefferson, KK (corresponding author), Virginia Commonwealth Univ, Dept Microbiol & Immunol, Richmond, VA 23298 USA.	kimberly.jefferson@vcuhealth.org			National Institutes of Health [4UH3A1083263, P60 MD002256, U54 DE023786-01]; National Institute on Minority Health and Health Disparities [P60MD002256] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by National Institutes of Health (www.nih.gov) [grants 4UH3A1083263, "The Vaginal Microbiome: Disease, Genetics and the Environment", P60 MD002256, the "VCU NIMHD Comprehensive Center of Excellence", and U54 DE023786-01 "A Multi-'omic Analysis of the Vaginal Microbiome during Pregnancy"].	Ahmed A, 2012, J BACTERIOL, V194, P3922, DOI 10.1128/JB.00056-12; Alcendor DJ, 2016, AM J REPROD IMMUNOL, V76, P99, DOI 10.1111/aji.12497; Amaya Rene A, 2002, J Perinatol, V22, P585, DOI 10.1038/sj.jp.7210757; Brotman RM, 2014, MENOPAUSE, V21, P450, DOI 10.1097/GME.0b013e3182a4690b; Castro J, 2013, INT J MED SCI, V10, P1193, DOI 10.7150/ijms.6304; Cheng HH, 2014, EUR REV MED PHARMACO, V18, P2294; Cherpes TL, 2003, CLIN INFECT DIS, V37, P319, DOI 10.1086/375819; Cohen J, 2016, SCIENCE, V354, P157, DOI 10.1126/science.354.6309.157; Cohn JA, 2005, JAIDS-J ACQ IMM DEF, V39, P340, DOI 10.1097/01.qai.0000146599.47925.e0; COSSART P, 1989, INFECT IMMUN, V57, P3629, DOI 10.1128/IAI.57.11.3629-3636.1989; CRISWELL BS, 1969, OBSTET GYNECOL, V33, P195; Farage MA., 2010, TXB AGING SKIN, DOI [10. 1007/978-3-540-89656-2, DOI 10.1007/978-3-540-89656-2, 10.1007/978-3-540-89656-2]; Fettweis JM, 2014, MICROBIOL-SGM, V160, P2272, DOI 10.1099/mic.0.081034-0; Fettweis JM, 2011, NAT PRECED; FETTWEIS JM, 2012, BMC GENOMICS S8, V13; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fiscella K, 1996, PUBLIC HEALTH REP, V111, P104; GARDNER HL, 1955, AM J OBSTET GYNECOL, V69, P962, DOI 10.1016/0002-9378(55)90095-8; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Goldenberg RL, 1998, AM J PUBLIC HEALTH, V88, P233, DOI 10.2105/AJPH.88.2.233; Gosmann C, 2017, IMMUNITY, V46, P29, DOI 10.1016/j.immuni.2016.12.013; Graham S, 2009, J MED MICROBIOL, V58, P1382, DOI 10.1099/jmm.0.007781-0; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; HILLIER SL, 1993, CLIN INFECT DIS, V16, pS273, DOI 10.1093/clinids/16.Supplement_4.S273; Hotomi M, 2016, FOLIA MICROBIOL, V61, P375, DOI 10.1007/s12223-016-0445-z; Huett Pirje, 2016, Microbial Ecology in Health and Disease, V27, P30484, DOI 10.3402/mehd.v27.30484; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Klebanoff MA, 2005, AM J OBSTET GYNECOL, V192, P470, DOI 10.1016/j.ajog.2004.07.017; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; Kramer MR, 2009, EPIDEMIOL REV, V31, P84, DOI 10.1093/ajerev/mxp003; Lagace-Wiens PRS, 2008, J CLIN MICROBIOL, V46, P804, DOI 10.1128/JCM.01545-07; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mendling W, 2016, ADV EXP MED BIOL, V902, P83, DOI 10.1007/978-3-319-31248-4_6; Mirmonsef P, 2015, MENOPAUSE, V22, P702, DOI 10.1097/GME.0000000000000397; Mowla K, 2016, J CLIN DIAGN RES, V10, pOC32, DOI 10.7860/JCDR/2016/16538.7814; Myer L, 2005, LANCET INFECT DIS, V5, P786, DOI 10.1016/S1473-3099(05)70298-X; Myer L, 2005, J INFECT DIS, V192, P1372, DOI 10.1086/462427; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; O'Hanlon DE, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-200; Patterson JL, 2010, MICROBIOL-SGM, V156, P392, DOI 10.1099/mic.0.034280-0; POGUE DH, 1995, J PHARMACOL EXP THER, V273, P863; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; REIMER LG, 1984, OBSTET GYNECOL, V64, P170; Tralhao AFR, 2014, POSTGRAD MED, V126, DOI 10.3810/pgm.2014.11.2832; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; SHEAR CL, 1992, CIRCULATION, V85, P1293, DOI 10.1161/01.CIR.85.4.1293; Simon JA, 2006, AM J CARDIOL, V97, P843, DOI 10.1016/j.amjcard.2005.09.134; Sparrow CP, 2001, ARTERIOSCL THROM VAS, V21, P115, DOI 10.1161/01.ATV.21.1.115; Statt S, 2015, AM J RESP CELL MOL, V53, P689, DOI 10.1165/rcmb.2014-0391OC; Swidsinski A, 2005, OBSTET GYNECOL, V106, P1013, DOI 10.1097/01.AOG.0000183594.45524.d2; Swidsinski A, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.06.039; Swidsinski A, 2011, FEMS IMMUNOL MED MIC, V61, P41, DOI 10.1111/j.1574-695X.2010.00743.x; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Verstraelen H, 2009, BMC MICROBIOL, V9; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Youssef S, 2002, NATURE, V420, P78, DOI 10.1038/nature01158	57	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183765	10.1371/journal.pone.0183765	http://dx.doi.org/10.1371/journal.pone.0183765			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846702	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600050
J	Hanna, M; Dumas, I; Orain, M; Jacob, S; Tetu, B; Sanschagrin, F; Bureau, A; Poirier, B; Diorio, C				Hanna, Mirette; Dumas, Isabelle; Orain, Michele; Jacob, Simon; Tetu, Bernard; Sanschagrin, Francois; Bureau, Alexandre; Poirier, Brigitte; Diorio, Caroline			Association between local inflammation and breast tissue age-related lobular involution among premenopausal and postmenopausal breast cancer patients	PLOS ONE			English	Article							TRANSFORMING GROWTH-FACTOR-BETA-1; GROWTH-FACTOR; RISK; EXPRESSION; CYTOKINES; ADIPOKINES; DISEASE; PLASMA; CELLS; TUMOR	Increased levels of pro-inflammatory markers and decreased levels of anti-inflammatory markers in the breast tissue can result in local inflammation. We aimed to investigate whether local inflammation in the breast tissue is associated with age-related lobular involution, a process inversely related to breast cancer risk. Levels of eleven pro-and anti-inflammatory markers were assessed by immunohistochemistry in normal breast tissue obtained from 164 pre- and postmenopausal breast cancer patients. Involution status of the breast (degree of lobular involution and the predominant lobule type) was microscopically assessed in normal breast tissue on hematoxylin-eosin stained mastectomy slides. Multivariate generalized linear models were used to assess the associations. In age-adjusted analyses, higher levels of pro-inflammatory markers IL-6, TNF-alpha, CRP, COX-2, leptin, SAA1 and IL-8; and anti-inflammatory marker IL-10, were inversely associated with the prevalence of complete lobular involution (all P <= 0.04). Higher levels of the pro-inflammatory marker COX-2 were also associated with lower prevalence of predominant type 1/no type 3 lobules in the breast, an indicator of complete involution, in age-adjusted analysis (P = 0.017). Higher tissue levels of inflammatory markers, mainly the pro-inflammatory ones, are associated with less involuted breasts and may consequently be associated with an increased risk of developing breast cancer.	[Hanna, Mirette; Dumas, Isabelle; Orain, Michele; Jacob, Simon; Tetu, Bernard; Sanschagrin, Francois; Poirier, Brigitte; Diorio, Caroline] Univ Laval, Oncol Res Unit, CHU Quebec Res Ctr, Quebec City, PQ, Canada; [Hanna, Mirette; Bureau, Alexandre; Diorio, Caroline] Univ Laval, Canc Res Ctr, Dept Social & Prevent Med, Quebec City, PQ, Canada; [Jacob, Simon; Tetu, Bernard] Univ Laval, Dept Mol Biol Med Chem & Pathol, Canc Res Ctr, Quebec City, PQ, Canada; [Jacob, Simon; Tetu, Bernard] Univ Laval, CHU Quebec, Serv Mol Biol Med Chem & Pathol, Hop St Sacrement, Quebec City, PQ, Canada; [Jacob, Simon; Tetu, Bernard; Sanschagrin, Francois; Poirier, Brigitte; Diorio, Caroline] Hop St Sacrement, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada; [Bureau, Alexandre] Univ Laval, Inst Univ Sante Mentale Quebec, Ctr Rech, Quebec City, PQ, Canada; [Poirier, Brigitte] Univ Laval, Canc Res Ctr, Dept Surg, Quebec City, PQ, Canada	Laval University; Laval University; Laval University; Laval University; Laval University; Laval University; Laval University	Diorio, C (corresponding author), Univ Laval, Oncol Res Unit, CHU Quebec Res Ctr, Quebec City, PQ, Canada.; Diorio, C (corresponding author), Univ Laval, Canc Res Ctr, Dept Social & Prevent Med, Quebec City, PQ, Canada.; Diorio, C (corresponding author), Hop St Sacrement, Ctr Malad Sein Deschenes Fabia, Quebec City, PQ, Canada.	Caroline.Diorio@crchudequebec.ulaval.ca		Diorio, Caroline/0000-0001-5355-7345	Canadian Breast Cancer Research Alliance [20462]; Fondation du cancer du sein du Quebec; Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award [703003]; FRQS Research Scholar; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec Sante (FRQS); Canadian Tumor Repository Network (CTRNet)	Canadian Breast Cancer Research Alliance; Fondation du cancer du sein du Quebec; Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award; FRQS Research Scholar; Banque de tissus et donnees of the Reseau de recherche sur le cancer of the Fond de recherche du Quebec Sante (FRQS); Canadian Tumor Repository Network (CTRNet)	This research was supported by grants from the Canadian Breast Cancer Research Alliance (grant #20462), the Fondation du cancer du sein du Quebec and the "Banque de tissus et donnees of the Reseau de recherche sur le cancer" of the "Fond de recherche du Quebec Sante (FRQS)", associated with the Canadian Tumor Repository Network (CTRNet). CD is a recipient of The Canadian Breast Cancer Foundation-Canadian Cancer Society Capacity Development award (award #703003) and the FRQS Research Scholar.	Baer HJ, 2009, CANCER, V115, P1404, DOI 10.1002/cncr.24167; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Barcellos-Hoff MH, 2000, BREAST CANCER RES, V2, P92, DOI 10.1186/bcr40; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; Degnim AC, 2014, BREAST CANCER RES TR, V144, P539, DOI 10.1007/s10549-014-2896-8; Figueroa JD, 2016, BREAST CANCER RES TR, V159, P163, DOI 10.1007/s10549-016-3908-7; Figueroa JD, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju286; Ghosh K, 2010, JNCI-J NATL CANCER I, V102, P1716, DOI 10.1093/jnci/djq414; Giancotti V, 2006, CANCER LETT, V243, P145, DOI 10.1016/j.canlet.2006.01.035; Gierach GL, 2016, CANCER PREV RES, V9, P149, DOI 10.1158/1940-6207.CAPR-15-0282; Hamidullah, 2012, BREAST CANCER RES TR, V133, P11, DOI 10.1007/s10549-011-1855-x; Hanna M, 2016, MENOPAUSE J N AM MEN, V24; Hanna M, 2015, MENOPAUSE, V22, P964, DOI 10.1097/GME.0000000000000433; Henson DE, 2006, JNCI-J NATL CANCER I, V98, P1589, DOI 10.1093/jnci/djj454; Horne HN, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0678-4; Hugo HJ, 2015, J MAMMARY GLAND BIOL, V20, P109, DOI 10.1007/s10911-015-9333-4; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Kemp WL, 2008, HIGH ED SCI ENG; Lithgow D, 2005, BIOL RES NURS, V7, P118, DOI 10.1177/1099800405280823; Llanos AA, 2012, CANCER EPIDEM BIOMAR, V21, P1745, DOI 10.1158/1055-9965.EPI-12-0016; Maccio A, 2011, THESCIENTIFICWORLDJO, V11, P2020, DOI 10.1100/2011/806787; Mantovani A, 2008, LANCET, V371, P771, DOI 10.1016/S0140-6736(08)60241-X; McKian KP, 2009, J CLIN ONCOL, V27, P5893, DOI 10.1200/JCO.2008.21.5079; Miettinen PJ, 1994, J CELL BIOL 2, V127; Milanese TR, 2006, J NATL CANCER I, V98, P1600, DOI 10.1093/jnci/djj439; Miller JA, 2013, BIOMARK RES, V1, DOI 10.1186/2050-7771-1-18; Nicolini A, 2006, CYTOKINE GROWTH F R, V17, P325, DOI 10.1016/j.cytogfr.2006.07.002; Oh H, 2016, HORM CANCER-US, V7, P305, DOI 10.1007/s12672-016-0265-2; Purohit A, 2002, BREAST CANCER RES, V4, P65, DOI 10.1186/bcr425; Radisky DC, 2016, BREAST CANCER RES TR, V155, P423, DOI 10.1007/s10549-016-3691-5; Radisky DC, 2009, J MAMMARY GLAND BIOL, V14, P181, DOI 10.1007/s10911-009-9123-y; Ramakrishnan R, 2004, BREAST CANCER RES TR, V86, P259, DOI 10.1023/B:BREA.0000036899.97114.b3; Reed JR, 2010, J MAMMARY GLAND BIOL, V15, P329, DOI 10.1007/s10911-010-9188-7; RUSSO J, 1988, CANCER RES, V48, P2837; RUSSO J, 1994, CANCER EPIDEM BIOMAR, V3, P353; RUSSO J, 1989, IN VITRO CELL DEV B, V25, P643; SILBERSTEIN GB, 1990, J CELL BIOL, V110, P2209, DOI 10.1083/jcb.110.6.2209; Toomey D, 1999, IMMUNOL INVEST, V28, P29, DOI 10.3109/08820139909022721; Vierkant RA, 2009, BREAST CANCER RES TR, V117, P193, DOI 10.1007/s10549-008-0082-6; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Yang XHR, 2013, BREAST CANCER RES TR, V137, P837, DOI 10.1007/s10549-012-2380-2	42	12	12	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183579	10.1371/journal.pone.0183579	http://dx.doi.org/10.1371/journal.pone.0183579			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846716	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600039
J	Xu, FL; Ding, M; Yao, J; Shi, ZS; Wu, X; Zhang, JJ; Pang, H; Xing, JX; Xuan, JF; Wang, BJ				Xu, Feng-ling; Ding, Mei; Yao, Jun; Shi, Zhang-sen; Wu, Xue; Zhang, Jing-jing; Pang, Hao; Xing, Jia-xin; Xuan, Jin-feng; Wang, Bao-jie			Association between mitochondrial DNA variations and schizophrenia in the northern Chinese Han population	PLOS ONE			English	Article							NO EVIDENCE; RISK; SUSCEPTIBILITY; POLYMORPHISMS; HAPLOGROUPS; VARIANTS; GENETICS; SEQUENCE; GENOME; HV	To determine whether mitochondrial DNA (mtDNA) variations are associated with schizophrenia, 313 patients with schizophrenia and 326 unaffected participants of the northern Chinese Han population were included in a prospective study. Single-nucleotide polymor-phisms (SNPs) including C5178A, A10398G, G13708A, and C13928G were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Hypervariable regions I and II (HVSI and HVSII) were analyzed by sequencing. The results showed that the 4 SNPs and 11 haplotypes, composed of the 4 SNPs, did not differ significantly between patient and control groups. No significant association between haplogroups and the risk of schizophrenia was ascertained after Bonferroni correction. Drawing a conclusion, there was no evidence of an association between mtDNA (the 4 SNPs and the control region) and schizophrenia in the northern Chinese Han population.	[Xu, Feng-ling; Ding, Mei; Yao, Jun; Shi, Zhang-sen; Wu, Xue; Zhang, Jing-jing; Pang, Hao; Xing, Jia-xin; Xuan, Jin-feng; Wang, Bao-jie] China Med Univ, Sch Forens Med, Shenyang, Peoples R China	China Medical University	Wang, BJ (corresponding author), China Med Univ, Sch Forens Med, Shenyang, Peoples R China.	wangbj77@163.com	wang, jie/GRS-0942-2022; WANG, JINGYI/GSJ-1241-2022		National Natural Science Foundation of China [81373244]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (No. 81373244). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All the participants are worthy of being thanked in the study. This study was supported by National Natural Science Foundation of China(No. 81373244).	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Amar S, 2007, SCHIZOPHR RES, V94, P354, DOI 10.1016/j.schres.2007.04.020; Amberger JS, 2015, NUCLEIC ACIDS RES, V43, pD789, DOI 10.1093/nar/gku1205; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Bamne MN, 2008, SCHIZOPHRENIA BULL, V34, P458, DOI 10.1093/schbul/sbm100; Ben-Shachar D, 1999, INT J NEUROPSYCHOPH, V2, P245, DOI 10.1017/S1461145799001649; Ben-Shachar D, 2004, INT REV NEUROBIOL, V59, P273; Brown MD, 1996, AM J MED GENET, V61, P283, DOI 10.1002/(SICI)1096-8628(19960122)61:3<283::AID-AJMG15>3.0.CO;2-P; Chen F, 2015, ELECTROPHORESIS, V36, P930, DOI 10.1002/elps.201400493; Chu QH, 2015, SCI REP-UK, V5, DOI 10.1038/srep17170; Dimauro S, 2005, ANN MED, V37, P222, DOI 10.1080/07853890510007368; Diop AG, 2003, ACTA TROP, V87, P149, DOI 10.1016/S0001-706X(03)00038-X; Dupont WD, 1998, CONTROL CLIN TRIALS, V19, P589, DOI 10.1016/S0197-2456(98)00037-3; Fachal L, 2015, AM J MED GENET B, V168, P54, DOI 10.1002/ajmg.b.32276; Fan L, 2013, MITOCHONDRION, V13, P360, DOI 10.1016/j.mito.2013.04.011; GOLDSTEIN JM, 1992, SCHIZOPHR RES, V7, P135, DOI 10.1016/0920-9964(92)90043-5; Guan FL, 2016, SCI REP-UK, V6, DOI 10.1038/srep38048; Ingman M, 2006, NUCLEIC ACIDS RES, V34, pD749, DOI 10.1093/nar/gkj010; Ishikawa K, 2008, MITOCHONDRION, V8, P339, DOI 10.1016/j.mito.2008.07.006; Jiang HG, 2014, CANCER SCI, V105, P639, DOI 10.1111/cas.12412; Kato T, 2001, J AFFECT DISORDERS, V62, P151, DOI 10.1016/S0165-0327(99)00173-1; Kato T, 2000, AM J MED GENET, V96, P182, DOI 10.1002/(SICI)1096-8628(20000403)96:2<182::AID-AJMG12>3.3.CO;2-H; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Liou CW, 2012, DIABETES, V61, P2642, DOI 10.2337/db11-1369; LOBO A, 1986, PSYCHOL MED, V16, P135, DOI 10.1017/S0033291700002579; Lott Marie T, 2013, Curr Protoc Bioinformatics, V44, DOI 10.1002/0471250953.bi0123s44; Mosquera-Miguel A, 2012, AM J MED GENET B, V159B, P414, DOI 10.1002/ajmg.b.32044; Nijiati M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081806; Pereira J, 2012, FORENSIC SCI INT-GEN, V6, P228, DOI 10.1016/j.fsigen.2011.05.005; Pezzotti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005356; Pietka Grzegorz, 2008, Otolaryngol Pol, V62, P158, DOI 10.1016/S0030-6657(08)70233-6; Roig B, 2007, MOL PSYCHIATR, V12, P833, DOI 10.1038/sj.mp.4001995; Rollins B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004913; Sullivan PF, 2005, PLOS MED, V2, P614, DOI 10.1371/journal.pmed.0020212; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Takagi K, 2004, ATHEROSCLEROSIS, V175, P281, DOI 10.1016/j.atherosclerosis.2004.03.008; Torrell H, 2014, AM J MED GENET B, V165, P607, DOI 10.1002/ajmg.b.32264; Ueno H, 2009, MITOCHONDRION, V9, P385, DOI 10.1016/j.mito.2009.06.003; Wang GX, 2013, PSYCHIAT RES, V209, P279, DOI 10.1016/j.psychres.2013.01.001; Xu FL, 2017, MITOCHONDRIAL DNA PA, P1; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999; Zhang W, 2014, J GENET GENOMICS, V41, P397, DOI 10.1016/j.jgg.2014.05.004; Zhou HY, 2014, GENET MOL RES, V13, P616, DOI 10.4238/2014.January.28.7; Zsurka G, 1998, BIOL PSYCHIAT, V44, P371, DOI 10.1016/S0006-3223(97)00461-7	44	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182769	10.1371/journal.pone.0182769	http://dx.doi.org/10.1371/journal.pone.0182769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846698	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600014
J	Mutahar, M; O'Toole, S; Carpenter, G; Bartlett, D; Andiappan, M; Moazzez, R				Mutahar, Mahdi; O'Toole, Saoirse; Carpenter, Guy; Bartlett, David; Andiappan, Manoharan; Moazzez, Rebecca			Reduced statherin in acquired enamel pellicle on eroded teeth compared to healthy teeth in the same subjects: An in-vivo study	PLOS ONE			English	Article							HUMAN PAROTID-SALIVA; DENTAL EROSION; TOOTH SURFACES; VITRO; DEMINERALIZATION; HYDROXYAPATITE; PEPTIDE; WEAR; SUSCEPTIBILITY; PROTECTION	The aim of this in-vivo study was to compare total protein and four key salivary proteins present in the acquired enamel pellicle (AEP) on eroded and non-eroded surfaces in participants with erosive tooth wear. Participants with erosive tooth wear of dietary non-intrinsic origin, present on the occlusal surfaces of the lower first molars and an unaffected posterior occlusal surface in the same quadrant were recruited from restorative dental clinics at King's College London Dental Institute (n = 29, REC ref 14/EM/1171). Following removal of the salivary film, AEP samples were collected from the eroded occlusal surfaces (EP, n = 29) and the non-eroded occlusal surfaces (NP, n = 29) using 0.5% sodium dodecyl sulfate (SDS) soaked filter papers. Total protein concentration was analysed using bicinchoninic acid assay (BCA). Protein fractions were separated using SDS-PAGE and immunoblotted against: mucin5b, albumin, carbonic anhydrase VI (CA VI) and statherin antibodies. Amounts were quantified using ImageLab software against purified protein standards of known concentration. ANOVA followed by paired t-test and Wilcoxon's matched-pair signed-rank test were used to test statistical significance. The difference was considered to be significant at a P value < 0.05. The total protein on eroded surfaces was significantly lower compared to the total protein on non-eroded surfaces [0.41mg/mL (0.04) and 0.61 mg/mL (0.11)] respectively (p< 0.05). The median (min, max) amount of statherin was also significantly lower on eroded occlusal surfaces [84.1 (20.0, 221.8) ng] compared to AEP from non-eroded teeth in the same subjects [97.1(30.0, 755.6) ng] (p = 0.002). No statistical differences were observed for mucin 5b, albumin or CA VI. The total protein and statherin in the in-vivo AEP were different between eroded and non-eroded tooth surfaces of the same patient.	[Mutahar, Mahdi; Carpenter, Guy; Moazzez, Rebecca] Kings Coll London, Mucosal & Salivary Biol, Inst Dent, London, England; [O'Toole, Saoirse; Bartlett, David] Kings Coll London, Inst Dent, Tissue Engn & Biophoton, London, England; [Andiappan, Manoharan] Kings Coll London, Inst Dent, Biostat & Res Methods Ctr, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London	Mutahar, M (corresponding author), Kings Coll London, Mucosal & Salivary Biol, Inst Dent, London, England.	Mahdi.mutahar@kcl.ac.uk		Moazzez, Rebecca/0000-0002-3673-2604; Carpenter, Guy/0000-0003-3084-3415; Mutahar, Mahdi/0000-0002-4036-5931; O'Toole, Saoirse/0000-0002-2144-1847				Amaechi BT, 1999, J ORAL REHABIL, V26, P97, DOI 10.1046/j.1365-2842.1999.00349.x; AMERONGEN AVN, 1987, CARIES RES, V21, P297; Bartlett D, 2008, CLIN ORAL INVEST, V12, pS65, DOI 10.1007/s00784-007-0181-5; Bartlett DW, 2005, INT DENT J, V55, P277; Carlen A, 1998, CARIES RES, V32, P447, DOI 10.1159/000016486; Carpenter G, 2014, CARIES RES, V48, P361, DOI 10.1159/000356973; Carvalho TS, 2015, CARIES RES, V49, P109, DOI 10.1159/000369104; Carvalho TS, 2016, CLIN ORAL INVESTIGAT; Casas EBL, 2008, TRIBOL INT, V41, P1232, DOI 10.1016/j.triboint.2008.03.008; Daly Blanaid, 2011, Prim Dent Care, V18, P31, DOI 10.1308/135576111794065793; Ganss C, 2000, ARCH ORAL BIOL, V45, P897, DOI 10.1016/S0003-9969(00)00041-8; Ganss C, 2001, COMMUNITY DENT ORAL, V29, P264, DOI 10.1034/j.1600-0528.2001.290405.x; Gibbins HL, 2014, COLLOID SURFACE B, V120, P184, DOI 10.1016/j.colsurfb.2014.05.020; Hannig C, 2008, ARCH ORAL BIOL, V53, P416, DOI 10.1016/j.archoralbio.2007.12.003; Hannig C, 2009, CLIN ORAL INVEST, V13, P123, DOI 10.1007/s00784-008-0243-3; Hannig M, 2006, MG ORAL SCI, V19, P29, DOI 10.1159/000090585; Hannig M, 2004, ARCH ORAL BIOL, V49, P903, DOI 10.1016/j.archoralbio.2004.05.008; Harvey NM, 2011, BIOFOULING, V27, P823, DOI 10.1080/08927014.2011.603412; HAY DI, 1973, ARCH ORAL BIOL, V18, P1531, DOI 10.1016/0003-9969(73)90128-3; Hellwig E, 2013, CARIES RES, V47, P553, DOI 10.1159/000351634; Hemingway CA, 2008, CARIES RES, V42, P348, DOI 10.1159/000151440; Jaeggi T, 2014, MONOGR ORAL SCI, V25, P55, DOI 10.1159/000360973; JENSEN JL, 1992, J DENT RES, V71, P1569, DOI 10.1177/00220345920710090501; Kosoric J, 2007, INT J PEPT RES THER, V13, P497, DOI 10.1007/s10989-007-9085-0; Leinonen J, 1999, CARIES RES, V33, P185, DOI 10.1159/000016515; Li J, 2004, ARCH ORAL BIOL, V49, P379, DOI 10.1016/j.archoralbio.2004.01.002; Lindh L, 2001, SWEDISH DENT J S, P1; Lussi A, 2008, CLIN ORAL INVEST, V12, pS5, DOI 10.1007/s00784-007-0179-z; Piangprach T, 2009, J AM DENT ASSOC, V140, P1137, DOI 10.14219/jada.archive.2009.0341; Proctor GB, 2005, BIOCHEM J, V389, P111, DOI 10.1042/BJ20042012; Buzalaf MAR, 2012, J APPL ORAL SCI, V20, P493, DOI 10.1590/S1678-77572012000500001; Siqueira WL, 2007, ANN NY ACAD SCI, V1098, P504, DOI 10.1196/annals.1384.023; Siqueira WL, 2012, J DENT RES, V91, P1110, DOI 10.1177/0022034512462578; Siqueira WL, 2009, ARCH ORAL BIOL, V54, P437, DOI 10.1016/j.archoralbio.2009.01.011; Sreebny LM, 2000, INT DENT J, V50, P140, DOI 10.1111/j.1875-595X.2000.tb00554.x; Svendsen IE, 2009, BIOFOULING, V25, P255, DOI 10.1080/08927010802712861; Svendsen IE, 2008, BIOFOULING, V24, P227, DOI 10.1080/08927010802018277; Vitorino R, 2008, J SEP SCI, V31, P523, DOI 10.1002/jssc.200700486; Vukosavljevic D, 2014, ARCH ORAL BIOL, V59, P631, DOI 10.1016/j.archoralbio.2014.02.002; Wetton S, 2006, CARIES RES, V40, P213, DOI 10.1159/000092228; Yao Y, 2001, ARCH ORAL BIOL, V46, P293, DOI 10.1016/S0003-9969(00)00134-5; Zimmerman JN, 2013, INT J MOL SCI, V14, P920, DOI 10.3390/ijms14010920	42	18	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183660	10.1371/journal.pone.0183660	http://dx.doi.org/10.1371/journal.pone.0183660			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837608	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000096
J	Pinheiro, DS; Santos, RD; de Brito, RB; Cruz, AHD; Ghedini, PC; Reis, AAS				Pinheiro, Denise S.; Santos, Rodrigo da S.; de Brito, Rodrigo B.; Cruz, Aline Helena da S.; Ghedini, Paulo C.; Reis, Angela A. S.			GSTM1/GSTT1 double-null genotype increases risk of treatment-resistant schizophrenia: A genetic association study in Brazilian patients	PLOS ONE			English	Article							GLUTATHIONE TRANSFERASES; ANTIOXIDANT ENZYMES; LIPID-PEROXIDATION; POLYMORPHISMS; GSTT1; GSTM1; SUSCEPTIBILITY; ANTIPSYCHOTICS; DETOXICATION; CATALYZE	Background The role of oxidative stress in schizophrenia has been demonstrated, particularly in subjects with treatment-resistant schizophrenia (TRS). In such patients, the decreased levels of antioxidants in conjunction with the increased generation of reactive oxygen species in the brain exposes the neurons to a higher risk of damage. Methods and findings We evaluated the association of deletion polymorphisms of two genes of the antioxidant Glutathione S-Transferase family, GSTT1 and GSTM1, with susceptibility to TRS. A total of 54 TRS patients (mean age 38.7 years) and 78 healthy control subjects (mean age 39.0 years) were enrolled in this study. The subjects were matched by sex, age, and smoking and alcohol consumption habits. In the case group, the frequencies of GSTT1-null and GSTM1-null genotypes were 24.1 and 51.9%, respectively, whereas for the control group, the frequencies were 12.8 and 46.2%, respectively. Analysis performed with respect to the risk of developing TRS associated with the GSTT1 and GSTM1 deletion polymorphisms, resulted in odds ratio (OR) values of 2.1 and 1.2, respectively. However, the association was not found to be significant (p = 0.1229 and p = 0.5916, respectively). The analysis performed with respect to the combined genotypes of GSTT1 and GSTM1 revealed that the double-null genotype confers a 4.6-fold increased risk of developing TRS (p = 0.0412). Conclusion The results of the present study indicate that a combination of GST deficiencies may play a role in enhanced susceptibility to TRS, and the present genotype of one of these genes may buffer the deficiency caused by the lack (null genotype) of the other. The results suggest that combined deletion polymorphisms of GSTT1 and GSTM1 can have implications in the prediction of the clinical course of the disease.	[Pinheiro, Denise S.; Santos, Rodrigo da S.; Cruz, Aline Helena da S.; Reis, Angela A. S.] Univ Fed Goias, Dept Biochem & Mol Biol, Inst Biol Sci ICB 2, Goiania, Go, Brazil; [Santos, Rodrigo da S.] Univ Fed Goias, Dept Nat Sci LEdoC, Special Acad Unit Human Sci, Goiania, Go, Brazil; [de Brito, Rodrigo B.] Bueno Med Ctr, Inst Brain, Goiania, Go, Brazil; [de Brito, Rodrigo B.; Ghedini, Paulo C.] Univ Fed Goias, Dept Pharmacol, Inst Biol Sci ICB 2, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Reis, AAS (corresponding author), Univ Fed Goias, Dept Biochem & Mol Biol, Inst Biol Sci ICB 2, Goiania, Go, Brazil.	angeladamski@gmail.com	DA SILVA, ANGELA ADAMSKI/AAJ-1403-2021; da Silva Pinheiro, Denise/Y-9276-2019	DA SILVA, ANGELA ADAMSKI/0000-0002-8281-7334; da Silva Pinheiro, Denise/0000-0001-7405-6822; Reis, AlessanRSS/0000-0001-8486-7469; da Silva Santos, Rodrigo/0000-0002-9480-4362	Fundacao de Amparo a Pesquisa do estado de Goias (FAPEG) [201310267000014]	Fundacao de Amparo a Pesquisa do estado de Goias (FAPEG)	This work was supported by grant (number: 201310267000014) from the Fundacao de Amparo a Pesquisa do estado de Goias (FAPEG - URL: http://www.fapeg.go.gov.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NC, 2008, NAT GENET, V40, P827, DOI 10.1038/ng.171; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P915; Baez S, 1997, BIOCHEM J, V324, P25, DOI 10.1042/bj3240025; Boskovic M, 2011, CURR NEUROPHARMACOL, V9, P301, DOI 10.2174/157015911795596595; Burim RV, 2004, MUTAGENESIS, V19, P291, DOI 10.1093/mutage/geh034; Caspi Asaf, 2004, Dialogues Clin Neurosci, V6, P61; Colombo J, 2004, WORLD J GASTROENTERO, V10, P1240; Dringen R, 2000, PROG NEUROBIOL, V62, P649, DOI 10.1016/S0301-0082(99)00060-X; Gravina P, 2011, PSYCHIAT RES, V187, P454, DOI 10.1016/j.psychres.2010.10.008; Harada S, 2003, PSYCHIAT GENET, P13; Hayes JD, 2000, PHARMACOLOGY, V61, P154, DOI 10.1159/000028396; Joober R, 2002, J PSYCHIATR NEUROSCI, V27, P336; Kim SK, 2015, INT J MOL SCI, V16, P19602, DOI 10.3390/ijms160819602; Marin F, 2010, J MOL DIAGN, V12, P300, DOI 10.2353/jmoldx.2010.090076; Medina-Hernandez V, 2007, J PSYCHIATR RES, V41, P652, DOI 10.1016/j.jpsychires.2006.02.010; Mukherjee S, 1996, SCHIZOPHR RES, V19, P19, DOI 10.1016/0920-9964(95)00048-8; Nakajima S, 2015, SCHIZOPHR RES, V161, P429, DOI 10.1016/j.schres.2014.12.024; Parikh V, 2003, J PSYCHIATR RES, V37, P43, DOI 10.1016/S0022-3956(02)00048-1; Pazvantoglu O, 2009, PSYCHIAT CLIN NEUROS, V63, P693, DOI 10.1111/j.1440-1819.2009.02015.x; PEMBLE S, 1994, BIOCHEM J, V300, P271, DOI 10.1042/bj3000271; Pinheiro DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076262; Raffa M, 2013, GENE, V512, P282, DOI 10.1016/j.gene.2012.10.031; Ranjekar PK, 2003, PSYCHIAT RES, V121, P109, DOI 10.1016/S0165-1781(03)00220-8; Reddy R, 2003, SCHIZOPHR RES, V62, P205, DOI 10.1016/S0920-9964(02)00407-3; Saadat M, 2007, PSYCHIAT RES, V153, P87, DOI 10.1016/j.psychres.2006.03.024; Saha S, 2005, SYSTEMATIC REV PREVA, DOI [10.1371/journal.pmed.0020141, DOI 10.1371/JOURNAL.PMED.0020141]; Salnikova LE, 2010, ASS STUDY XENOBIOTIC, V2; SeguraAguilar J, 1997, J BIOL CHEM, V272, P5727, DOI 10.1074/jbc.272.9.5727; Smythies JR, 1997, SCHIZOPHR RES, V24, P357, DOI 10.1016/S0920-9964(97)00005-4; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Teo C, 2012, PHARMACOGENET GENOM, V22, P807, DOI 10.1097/FPC.0b013e3283586c04; Yao JK, 1998, SCHIZOPHR RES	32	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183812	10.1371/journal.pone.0183812	http://dx.doi.org/10.1371/journal.pone.0183812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837637	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000127
J	Ravel, A; Hurst, M; Petrica, N; David, J; Mutschall, SK; Pintar, K; Taboada, EN; Pollari, F				Ravel, Andre; Hurst, Matt; Petrica, Nicoleta; David, Julie; Mutschall, Steven K.; Pintar, Katarina; Taboada, Eduardo N.; Pollari, Frank			Source attribution of human campylobacteriosis at the point of exposure by combining comparative exposure assessment and subtype comparison based on comparative genomic fingerprinting	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; EXPERT ELICITATION; HUMAN SALMONELLOSIS; GENETIC DIVERSITY; ANIMAL CONTACT; HUMAN-DISEASE; FOOD-SOURCES; RIVER WATER; JEJUNI; FOODBORNE	Human campylobacteriosis is a common zoonosis with a significant burden in many countries. Its prevention is difficult because humans can be exposed to Campylobacter through various exposures: foodborne, waterborne or by contact with animals. This study aimed at attributing campylobacteriosis to sources at the point of exposure. It combined comparative exposure assessment and microbial subtype comparison with subtypes defined by comparative genomic fingerprinting (CGF). It used isolates from clinical cases and from eight potential exposure sources (chicken, cattle and pig manure, retail chicken, beef, pork and turkey meat, and surface water) collected within a single sentinel site of an integrated surveillance system for enteric pathogens in Canada. Overall, 1518 non-human isolates and 250 isolates from domestically-acquired human cases were subtyped and their subtype profiles analyzed for source attribution using two attribution models modified to include exposure. Exposure values were obtained from a concurrent comparative exposure assessment study undertaken in the same area. Based on CGF profiles, attribution was possible for 198 (79%) human cases. Both models provide comparable figures: chicken meat was the most important source (65-69% of attributable cases) whereas exposure to cattle (manure) ranked second (14-19% of attributable cases), the other sources being minor (including beef meat). In comparison with other attributions conducted at the point of production, the study highlights the fact that Campylobacter transmission from cattle to humans is rarely meat borne, calling for a closer look at local transmission from cattle to prevent campylobacteriosis, in addition to increasing safety along the chicken supply chain.	[Ravel, Andre; Petrica, Nicoleta; David, Julie] Univ Montreal, Grp Rech Epidemiol Zoonoses & Sante Publ, Fac Med Vet, St Hyacinthe, PQ, Canada; [Ravel, Andre] Univ Montreal, Dept Pathol & Microbiol, Fac Med Vet, St Hyacinthe, PQ, Canada; [Hurst, Matt; Pintar, Katarina; Pollari, Frank] Publ Hlth Agcy Canada, Ctr Food Borne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Mutschall, Steven K.; Taboada, Eduardo N.] Publ Hlth Agcy Canada, Natl Microbiol Lab Lethbridge, Lethbridge, AB, Canada; [Petrica, Nicoleta] Inst Natl Stat & Etud Econ, Direct Stat Entreprises, Paris, France; [David, Julie] Agence Natl Securite Sanit Alimentat Environm, Lab Ploufragan Plouzane, Ploufragan, France	Universite de Montreal; Universite de Montreal; Public Health Agency of Canada; Public Health Agency of Canada; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ploufragan-Plouzane Niort Laboratory	Ravel, A (corresponding author), Univ Montreal, Grp Rech Epidemiol Zoonoses & Sante Publ, Fac Med Vet, St Hyacinthe, PQ, Canada.; Ravel, A (corresponding author), Univ Montreal, Dept Pathol & Microbiol, Fac Med Vet, St Hyacinthe, PQ, Canada.	andre.ravel@umontreal.ca	Taboada, Eduardo N/Y-4854-2018	Taboada, Eduardo N/0000-0001-8373-3653				Anonymous, 2005, REGION WATERLOO FOOD; Barco L, 2013, INT J FOOD MICROBIOL, V163, P193, DOI 10.1016/j.ijfoodmicro.2013.03.005; Bessell PR, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-80; Boysen L, 2014, EPIDEMIOL INFECT, V142, P1599, DOI 10.1017/S0950268813002719; Butler AJ, 2016, FOODBORNE PATHOG DIS, V13, P57, DOI 10.1089/fpd.2015.1957; Butler AJ, 2015, FOODBORNE PATHOG DIS, V12, P335, DOI 10.1089/fpd.2014.1856; Carter PE, 2009, APPL ENVIRON MICROB, V75, P6038, DOI 10.1128/AEM.01039-09; Cha W, 2016, EPIDEMIOL INFECT, V144, P3316, DOI 10.1017/S095026881600159X; Cody AJ, 2015, ENV MICROBIOL REP, V7, P782, DOI 10.1111/1758-2229.12314; David JM, 2014, EPIDEMIOL INFECT, V142, P28, DOI 10.1017/S0950268813000770; David JM, 2013, PREV VET MED, V110, P12, DOI 10.1016/j.prevetmed.2013.02.002; David JM, 2013, RISK ANAL, V33, P397, DOI 10.1111/j.1539-6924.2012.01877.x; Davidson VJ, 2011, FOODBORNE PATHOG DIS, V8, P983, DOI 10.1089/fpd.2010.0786; Deckert AE, 2014, FOODBORNE PATHOG DIS, V11, P150, DOI 10.1089/fpd.2013.1610; Di Giannatale E, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00887; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Domingues AR, 2012, EPIDEMIOL INFECT, V140, P970, DOI 10.1017/S0950268811002676; *EFSA, 2008, EFSA J, V6; Evers E. G., 2008, International Journal of Risk Assessment & Management, V8, P174, DOI 10.1504/IJRAM.2008.016151; FoodNet Canada, 2014, 2010 ANN REP, P102; Galanis E, 2014, EPIDEMIOL INFECT, V142, P2075, DOI 10.1017/S095026881400123X; Gilpin BJ, 2013, EPIDEMIOL INFECT, V141, P1253, DOI 10.1017/S0950268812001719; Gras LM, 2013, EPIDEMIOL INFECT, V141, P2526, DOI 10.1017/S0950268813000356; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Griekspoor P, 2015, VET MICROBIOL, V178, P94, DOI 10.1016/j.vetmic.2015.04.025; Guo CF, 2011, FOODBORNE PATHOG DIS, V8, P509, DOI 10.1089/fpd.2010.0714; Hald T, 2004, RISK ANAL, V24, P255, DOI 10.1111/j.0272-4332.2004.00427.x; Hauri AM, 2013, DEUT MED WOCHENSCHR, V138, P357, DOI 10.1055/s-0032-1332884; Kemp R, 2005, APPL ENVIRON MICROB, V71, P1876, DOI 10.1128/AEM.71.4.1876-1882.2005; Kittl S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081796; Levesque S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083731; Longenberger AH, 2013, CLIN INFECT DIS, V57, P263, DOI 10.1093/cid/cit231; Mossong J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20939; Mullner P, 2010, APPL ENVIRON MICROB, V76, P2145, DOI 10.1128/AEM.00862-09; Mughini-Gras L, 2016, WATER RES, V101, P36, DOI 10.1016/j.watres.2016.05.069; Mughini-Gras L, 2014, INFECT GENET EVOL, V28, P251, DOI 10.1016/j.meegid.2014.10.003; Mughini-Gras L, 2014, INT J FOOD MICROBIOL, V191, P109, DOI 10.1016/j.ijfoodmicro.2014.09.010; Mullner P, 2010, EPIDEMIOL INFECT, V138, P1372, DOI 10.1017/S0950268809991579; Mullner P, 2009, INFECT GENET EVOL, V9, P1311, DOI 10.1016/j.meegid.2009.09.003; Mullner P, 2009, RISK ANAL, V29, P970, DOI 10.1111/j.1539-6924.2009.01224.x; Murphy HM, 2016, EPIDEMIOL INFECT, V144, P1355, DOI 10.1017/S0950268815002071; Pintar K, 2016, RISK ANAL; Pires SM, 2009, FOODBORNE PATHOG DIS, V6, P417, DOI 10.1089/fpd.2008.0208; Ravel A, 2009, J FOOD PROTECT, V72, P1963, DOI 10.4315/0362-028X-72.9.1963; Ravel A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3679-4; Ravel A, 2010, FOODBORNE PATHOG DIS, V7, P1463, DOI 10.1089/fpd.2010.0582; ROSEF O, 1985, APPL ENVIRON MICROB, V49, P1507, DOI 10.1128/AEM.49.6.1507-1510.1985; Roux F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064504; Sheppard SK, 2009, CLIN INFECT DIS, V48, P1072, DOI 10.1086/597402; Smid JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055029; Strachan NJC, 2009, J INFECT DIS, V199, P1205, DOI 10.1086/597417; Taboada EN, 2013, J MICROBIOL METH, V95, P24, DOI 10.1016/j.mimet.2013.07.007; Taboada EN, 2012, J CLIN MICROBIOL, V50, P788, DOI 10.1128/JCM.00669-11; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; Van Dyke MI, 2010, J APPL MICROBIOL, V109, P1053, DOI 10.1111/j.1365-2672.2010.04730.x; van Pelt W., 1999, INFECT B, V10, P240; Wahlstrom H, 2011, EPIDEMIOL INFECT, V139, P1246, DOI 10.1017/S0950268810002293; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203	58	39	39	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183790	10.1371/journal.pone.0183790	http://dx.doi.org/10.1371/journal.pone.0183790			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837643	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000121
J	Uppu, DSSM; Konai, MM; Sarkar, P; Samaddar, S; Fensterseifer, ICM; Farias, C; Krishnamoorthy, P; Shome, BR; Franco, OL; Haldar, J				Uppu, Divakara S. S. M.; Konai, Mohini M.; Sarkar, Paramita; Samaddar, Sandip; Fensterseifer, Isabel C. M.; Farias-Junior, Celio; Krishnamoorthy, Paramanandam; Shome, Bibek R.; Franco, Octavio L.; Haldar, Jayanta			Membrane-active macromolecules kill antibiotic-tolerant bacteria and potentiate antibiotics towards Gram-negative bacteria	PLOS ONE			English	Article							CATIONIC-AMPHIPHILIC POLYMERS; RESISTANCE EFFLUX PUMPS; PSEUDOMONAS-AERUGINOSA; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; ANTIBACTERIAL AGENTS; PERSISTENT INFECTIONS; MOLECULAR-MECHANISMS; BIOFILM FORMATION	Chronic bacterial biofilms place a massive burden on healthcare due to the presence of antibiotic-tolerant dormant bacteria. Some of the conventional antibiotics such as erythromycin, vancomycin, linezolid, rifampicin etc. are inherently ineffective against Gram-negative bacteria, particularly in their biofilms. Here, we report membrane-active macromolecules that kill slow dividing stationary-phase and antibiotic tolerant cells of Gram-negative bacteria. More importantly, these molecules potentiate antibiotics (erythromycin and rifampicin) to biofilms of Gram-negative bacteria. These molecules eliminate planktonic bacteria that are liberated after dispersion of biofilms (dispersed cells). The membrane-active mechanism of these molecules forms the key for potentiating the established antibiotics. Further, we demonstrate that the combination of macromolecules and antibiotics significantly reduces bacterial burden in mouse burn and surgical wound infection models caused by Acinetobacter baumannii and Carbapenemase producing Klebsiella pneumoniae (KPC) clinical isolate respectively. Colistin, a well-known antibiotic targeting the lipopolysaccharide (LPS) of Gram-negative bacteria fails to kill antibiotic tolerant cells and dispersed cells (from biofilms) and bacteria develop resistance to it. On the contrary, these macromolecules prevent or delay the development of bacterial resistance to known antibiotics. Our findings emphasize the potential of targeting the bacterial membrane in antibiotic potentiation for disruption of biofilms and suggest a promising strategy towards developing therapies for topical treatment of Gram-negative infections.	[Uppu, Divakara S. S. M.; Konai, Mohini M.; Sarkar, Paramita; Samaddar, Sandip; Haldar, Jayanta] JNCASR, New Chem Unit, Chem Biol & Med Chem Lab, Bangalore, Karnataka, India; [Fensterseifer, Isabel C. M.; Franco, Octavio L.] Ctr Anal Proteom & Bioquim, Posgrad Ciencias Genom & Biotecnol UC, Brasilia, DF, Brazil; [Fensterseifer, Isabel C. M.; Franco, Octavio L.] Univ Brasilia, Mol Pathol Postgrad Program, Brasilia, DF, Brazil; [Farias-Junior, Celio] Lacen, Lab Cent, Brasilia, DF, Brazil; [Krishnamoorthy, Paramanandam; Shome, Bibek R.] ICAR Natl Inst Vet Epidemiol & Dis Informat NIVED, Bengaluru, Karnataka, India; [Franco, Octavio L.] Univ Catolica Dom Bosco, Posgrad Biotecnol, S Inova Biotech, Campo Grande, Brazil; [Uppu, Divakara S. S. M.] SMART, ID IRG, Singapore, Singapore	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Universidade de Brasilia; Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics; Universidade Catolica Dom Bosco (UCDB); Singapore-MIT Alliance for Research & Technology Centre (SMART)	Haldar, J (corresponding author), JNCASR, New Chem Unit, Chem Biol & Med Chem Lab, Bangalore, Karnataka, India.	jayanta@jncasr.ac.in	Krishnamoorthy, Paramanandham/ABC-3793-2021; Franco, Octavio L/T-3020-2017; Uppu, Divakara SSM/U-1848-2019	Krishnamoorthy, Paramanandham/0000-0001-7495-1333; Uppu, Divakara SSM/0000-0002-7271-9538; Sarkar, Paramita/0000-0001-6917-3493; Samaddar, Sandip/0000-0002-2653-9050; Franco, Octavio/0000-0001-9546-0525; Shome, Bibek/0000-0003-4741-7076	Sheikh Saqr laboratory at JNCASR; CNPQ; CAPES; FAPDF; FUNDECT	Sheikh Saqr laboratory at JNCASR; CNPQ(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPDF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	SS is funded by the Sheikh Saqr laboratory at JNCASR for post-doctoral fellowship. Brazillian group was granted by CNPQ, CAPES, FAPDF and FUNDECT. The funders had no role in study design, data collection, decision to publish, or preparation of the manuscript.	Allison KR, 2011, NATURE, V473, P216, DOI 10.1038/nature10069; Amato SM, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00070; Balaban NQ, 2013, NAT REV MICROBIOL, V11, P587, DOI 10.1038/nrmicro3076; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Barraud N, 2012, ANGEW CHEM INT EDIT, V51, P9057, DOI 10.1002/anie.201202414; Baugh S, 2012, J ANTIMICROB CHEMOTH, V67, P2409, DOI 10.1093/jac/dks228; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Blair JMA, 2015, NAT REV MICROBIOL, V13, P42, DOI 10.1038/nrmicro3380; Brauner A, 2016, NAT REV MICROBIOL, V14, P320, DOI 10.1038/nrmicro.2016.34; Cameron A, 2014, BIOPOLYMERS, V102, P88, DOI 10.1002/bip.22423; Chua SL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5462; Conlon BP, 2013, NATURE, V503, P365, DOI 10.1038/nature12790; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Cox G, 2014, J ANTIMICROB CHEMOTH, V69, P1844, DOI 10.1093/jac/dku057; de la Fuente-Nunez C, 2015, CHEM BIOL, V22, P196, DOI 10.1016/j.chembiol.2015.01.002; Dhal PK, 2009, ADV DRUG DELIVER REV, V61, P1121, DOI 10.1016/j.addr.2009.05.004; Eckert R, 2006, ANTIMICROB AGENTS CH, V50, P3833, DOI 10.1128/AAC.00509-06; Fensterseifer ICM, 2015, PEPTIDES, V63, P38, DOI 10.1016/j.peptides.2014.10.019; Flemming K, 2009, J ANTIMICROB CHEMOTH, V63, P136, DOI 10.1093/jac/dkn464; Ganewatta MS, 2015, POLYMER, V63, pA1, DOI 10.1016/j.polymer.2015.03.007; Giano MC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5095; Gill EE, 2015, CHEM BIOL DRUG DES, V85, P56, DOI 10.1111/cbdd.12478; Goldberg K, 2013, FASEB J, V27, P3818, DOI 10.1096/fj.13-227942; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Harris TL, 2014, ACS CHEM BIOL, V9, P122, DOI 10.1021/cb400490k; Hoque J, 2015, CHEM COMMUN, V51, P13670, DOI 10.1039/c5cc05159b; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Jennings MC, 2014, CHEMBIOCHEM, V15, P2211, DOI 10.1002/cbic.201402254; Kaneti G, 2015, BIOCH BIOPHYS ACTA; Kazemzadeh-Narbat M, 2013, BIOMATERIALS, V34, P5969, DOI 10.1016/j.biomaterials.2013.04.036; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Kim W, 2016, FUTURE MED CHEM, V8, P257, DOI 10.4155/fmc.15.189; Konai MM, 2015, BIOCONJUGATE CHEM, V26, P2442, DOI 10.1021/acs.bioconjchem.5b00494; Lebeaux D, 2013, PATHOGENS, V2, P288, DOI 10.3390/pathogens2020288; Lewis K, 2010, ANNU REV MICROBIOL, V64, P357, DOI 10.1146/annurev.micro.112408.134306; Li J, 2015, J CONTROL RELEASE; Li Y, 2013, ANGEW CHEM INT EDIT, V52, P674, DOI 10.1002/anie.201206053; LIPNICK RL, 1995, FOOD CHEM TOXICOL, V33, P223, DOI 10.1016/0278-6915(94)00136-C; Liu RH, 2015, J AM CHEM SOC, V137, P2183, DOI 10.1021/ja512567y; Maisonneuve E, 2014, CELL, V157, P539, DOI 10.1016/j.cell.2014.02.050; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; McConnell MJ, 2013, FEMS MICROBIOL REV, V37, P130, DOI 10.1111/j.1574-6976.2012.00344.x; McGrath DM, 2013, P NATL ACAD SCI USA, V110, P3477, DOI 10.1073/pnas.1221924110; McLeod GI, 1996, J BACTERIOL, V178, P3683, DOI 10.1128/jb.178.13.3683-3688.1996; Mohammad H, 2015, J ANTIBIOT, V68, P259, DOI 10.1038/ja.2014.142; Niu YH, 2012, J MED CHEM, V55, P4003, DOI 10.1021/jm300274p; O'Loughlin CT, 2013, P NATL ACAD SCI USA, V110, P17981, DOI 10.1073/pnas.1316981110; O'Shea MK, 2012, INT J ANTIMICROB AG, V39, P363, DOI 10.1016/j.ijantimicag.2012.01.018; O'Toole G, 2000, ANNU REV MICROBIOL, V54, P49, DOI 10.1146/annurev.micro.54.1.49; Ooi N, 2010, J ANTIMICROB CHEMOTH, V65, P72, DOI 10.1093/jac/dkp409; Pamp SJ, 2008, MOL MICROBIOL, V68, P223, DOI 10.1111/j.1365-2958.2008.06152.x; Pan JC, 2013, BIOORG MED CHEM LETT, V23, P4648, DOI 10.1016/j.bmcl.2013.06.011; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Pieri C, 2014, J MED CHEM, V57, P4263, DOI 10.1021/jm500194e; Pu YY, 2017, DRUG RESIST UPDATE, V30, P7, DOI 10.1016/j.drup.2016.11.002; Pu YY, 2016, MOL CELL, V62, P284, DOI 10.1016/j.molcel.2016.03.035; Rahim NA, 2015, J ANTIMICROB CHEMOTH, V70, P2589, DOI 10.1093/jac/dkv135; Ribeiro SM, 2015, ANTIMICROB AGENTS CH, V59, P3906, DOI 10.1128/AAC.00092-15; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Schmidt NW, 2014, ACS NANO, V8, P8786, DOI 10.1021/nn502201a; Sgolastra F, 2013, ACCOUNTS CHEM RES, V46, P2977, DOI 10.1021/ar400066v; Sharma A, 2015, CHEM-EUR J, V21, P3540, DOI 10.1002/chem.201404650; Soon RL, 2011, J ANTIMICROB CHEMOTH, V66, P126, DOI 10.1093/jac/dkq422; Takahashi H, 2013, MACROMOL BIOSCI, V13, P1285, DOI 10.1002/mabi.201300126; Uppu DSSM, 2016, CHEM COMMUN, V52, P4644, DOI 10.1039/c5cc09930g; Uppu DSSM, 2016, BIOMACROMOLECULES, V17, P862, DOI 10.1021/acs.biomac.5b01567; Uppu DSSM, 2016, BIOMATERIALS, V74, P131, DOI 10.1016/j.biomaterials.2015.09.042; Uppu DSSM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119422; Uppu DSSM, 2013, CHEM COMMUN, V49, P9389, DOI 10.1039/c3cc43751e; Vaara M, 2010, ANTIMICROB AGENTS CH, V54, P3341, DOI 10.1128/AAC.01439-09; Xiong M, 2015, P NATL ACAD SCI USA, V112, P13155, DOI 10.1073/pnas.1507893112; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001	73	25	25	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183263	10.1371/journal.pone.0183263	http://dx.doi.org/10.1371/journal.pone.0183263			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837596	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000055
J	Cho, S; Tripathi, A; Chlipala, G; Green, S; Lee, H; Chang, EB; Jeong, H				Cho, Sungjoon; Tripathi, Ashutosh; Chlipala, George; Green, Stefan; Lee, Hyunwoo; Chang, Eugene B.; Jeong, Hyunyoung			Fructose diet alleviates acetaminophen-induced hepatotoxicity in mice	PLOS ONE			English	Article							INDUCED LIVER-INJURY; GLUTATHIONE METABOLISM; AMINO-ACID; TOXICITY; CYP2E1; MICROBIOTA; PROTECTION; FAILURE; SYSTEM; GENE	Acetaminophen (APAP) is a commonly used analgesic and antipyretic that can cause hepatotoxicity due to production of toxic metabolites via cytochrome P450 (Cyp) 1a2 and Cyp2e1. Previous studies have shown conflicting effects of fructose (the major component in Western diet) on the susceptibility to APAP-induced hepatotoxicity. To evaluate the role of fructose-supplemented diet in modulating the extent of APAP-induced liver injury, male C57BL/6J mice were given 30% (w/v) fructose in water (or regular water) for 8 weeks, followed by oral administration of APAP. APAP-induced liver injury (determined by serum levels of liver enzymes) was decreased by two-fold in mice pretreated with fructose. Fructose-treated mice exhibited (similar to 1.5 fold) higher basal glutathione levels and (similar to 2 fold) lower basal (mRNA and activity) levels of Cyp1a2 and Cyp2e1, suggesting decreased bioactivation of APAP and increased detoxification of toxic metabolite in fructose-fed mice. Hepatic mRNA expression of heat shock protein 70 was also found increased in fructose-fed mice. Analysis of bacterial 16S rRNA gene amplicons from the cecal samples of vehicle groups showed that the fructose diet altered gut bacterial community, leading to increased a-diversity. The abundance of several bacterial taxa including the genus Anaerostipes was found to be significantly correlated with the levels of hepatic Cyp2e1, Cyp1a2 mRNA, and glutathione. Together, these results suggest that the fructose-supplemented diet decreases APAP-induced liver injury in mice, in part by reducing metabolic activation of APAP and inducing detoxification of toxic metabolites, potentially through altered composition of gut microbiota.	[Cho, Sungjoon; Tripathi, Ashutosh; Lee, Hyunwoo; Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL USA; [Chlipala, George; Green, Stefan] Univ Illinois, Res Resources Ctr, Chicago, IL USA; [Chang, Eugene B.] Univ Chicago, Gastroenterol Sect, Knapp Ctr Biomed Discovery, Chicago, IL USA; [Jeong, Hyunyoung] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Jeong, H (corresponding author), Univ Illinois, Coll Pharm, Dept Biopharmaceut Sci, Chicago, IL USA.; Jeong, H (corresponding author), Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL 60607 USA.	yjeong@uic.edu		Jeong, Hyunyoung/0000-0001-7769-7676; Green, Stefan/0000-0003-2781-359X; Chlipala, George/0000-0003-0203-3191	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health [DK47722, DK42086]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK042086] Funding Source: NIH RePORTER	Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the Chicago Biomedical Consortium with support from the Searle Funds at The Chicago Community Trust to Hyunyoung Jeong and Eugene Chang (http://www.chicagabiomedicalconsortium.org/awards/funded_awards), as well as National Institutes of Health (DK47722 and DK42086 to Eugene Chang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMSON GM, 1989, BIOCHEM PHARMACOL, V38, P3323, DOI 10.1016/0006-2952(89)90630-8; Allen-Vercoe E, 2012, ANAEROBE, V18, P523, DOI 10.1016/j.anaerobe.2012.09.002; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bergheim I, 2008, J HEPATOL, V48, P983, DOI 10.1016/j.jhep.2008.01.035; Botta D, 2006, J BIOL CHEM, V281, P28865, DOI 10.1074/jbc.M605143200; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Circu ML, 2008, FREE RADICAL RES, V42, P689, DOI 10.1080/10715760802317663; Cover C, 2006, TOXICOL APPL PHARM, V216, P98, DOI 10.1016/j.taap.2006.04.010; Di Luccia B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134893; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ericsson AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116704; Felmlee MA, 2008, DRUG METAB DISPOS, V36, P435, DOI 10.1124/dmd.107.018838; Fisher FM, 2017, MOL METAB, V6, P14, DOI 10.1016/j.molmet.2016.11.008; Fisher JE, 2013, J SURG RES, V180, P147, DOI 10.1016/j.jss.2012.11.051; Green SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128122; Gregory B, 2010, J INVEST MED, V58, P707, DOI 10.231/JIM.0b013e3181db8764; HENDRICK JP, 1993, ANNU REV BIOCHEM, V62, P349, DOI 10.1146/annurev.bi.62.070193.002025; Hojo I, 2000, XENOBIOTICA, V30, P933, DOI 10.1080/004982500433345; HUANG CS, 1993, J BIOL CHEM, V268, P20578; Iizuka K, 2017, NUTRIENTS, V9, DOI 10.3390/nu9020181; Ishida K, 1995, EXP TOXICOL PATHOL, V47, P509, DOI 10.1016/S0940-2993(11)80338-6; Jena PK, 2014, APPL BIOCHEM BIOTECH, V172, P3810, DOI 10.1007/s12010-014-0772-y; Kennedy K, 2014, APPL ENVIRON MICROB, V80, P5717, DOI 10.1128/AEM.01451-14; Krasniak AE, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00314; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Lee WM, 2004, HEPATOLOGY, V40, P6, DOI 10.1002/hep.20293; LIU SY, 1995, DNA CELL BIOL, V14, P285, DOI 10.1089/dna.1995.14.285; Liu ZX, 2004, GASTROENTEROLOGY, V127, P1760, DOI 10.1053/j.gastro.2004.08.053; Lu SC, 2013, BBA-GEN SUBJECTS, V1830, P3143, DOI 10.1016/j.bbagen.2012.09.008; Mardinoglu A, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156487; McConnachie LA, 2007, TOXICOL SCI, V99, P628, DOI 10.1093/toxsci/kfm165; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; MEISTER A, 1988, J BIOL CHEM, V263, P17205; MITCHELL JR, 1973, J PHARMACOL EXP THER, V187, P211; Moonsamy PV, 2013, TISSUE ANTIGENS, V81, P141, DOI 10.1111/tan.12071; MOURELLE M, 1991, BIOCHEM PHARMACOL, V41, P1831, DOI 10.1016/0006-2952(91)90121-K; Nourjah P, 2006, PHARMACOEPIDEM DR S, V15, P398, DOI 10.1002/pds.1191; PATTEN CJ, 1993, CHEM RES TOXICOL, V6, P511, DOI 10.1021/tx00034a019; Payne AN, 2012, OBES REV, V13, P799, DOI 10.1111/j.1467-789X.2012.01009.x; PRESCOTT LF, 1981, BRIT J CLIN PHARMACO, V12, P149; Saito C, 2010, TOXICOL APPL PHARM, V246, P8, DOI 10.1016/j.taap.2010.04.015; Salminen WF, 1998, J PHARMACOL EXP THER, V286, P519; Schirmer M, 2016, CELL, V167, P1125, DOI 10.1016/j.cell.2016.10.020; Schmidt LE, 2002, HEPATOLOGY, V35, P876, DOI 10.1053/jhep.2002.32148; Schwiertz A, 2002, SYST APPL MICROBIOL, V25, P46, DOI 10.1078/0723-2020-00096; Selwyn FP, 2015, TOXICOL SCI, V147, P84, DOI 10.1093/toxsci/kfv110; Sener G, 2005, J APPL TOXICOL, V25, P20, DOI 10.1002/jat.1012; Shayiq RM, 1999, HEPATOLOGY, V29, P451, DOI 10.1002/hep.510290241; Softic S, 2016, DIGEST DIS SCI, V61, P1282, DOI 10.1007/s10620-016-4054-0; Su GL, 2005, HEPATOLOGY, V41, P187, DOI 10.1002/hep.20533; Tillman EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107206; Tolson JK, 2006, TOXICOL APPL PHARM, V210, P157, DOI 10.1016/j.taap.2005.10.001; WALKER RM, 1982, CAN J PHYSIOL PHARM, V60, P399, DOI 10.1139/y82-058; Welch KD, 2006, CHEM RES TOXICOL, V19, P223, DOI 10.1021/tx050285z; Wolf KK, 2007, DRUG METAB DISPOS, V35, P1223, DOI 10.1124/dmd.107.014738; Xu JJ, 2008, FEBS LETT, V582, P1276, DOI 10.1016/j.febslet.2008.01.063; Ye DW, 2014, HEPATOLOGY, V60, P977, DOI 10.1002/hep.27060; Zaher H, 1998, TOXICOL APPL PHARM, V152, P193, DOI 10.1006/taap.1998.8501; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou SF, 2009, CURR DRUG METAB, V10, P713, DOI 10.2174/138920009789895552	61	8	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182977	10.1371/journal.pone.0182977	http://dx.doi.org/10.1371/journal.pone.0182977			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832650	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800039
J	Hasan, A; Chung, PC; Hayes, W				Hasan, Adib; Chung, Po-Chien; Hayes, Wayne			Graphettes: Constant-time determination of graphlet and orbit identity including (possibly disconnected) graphlets up to size 8	PLOS ONE			English	Article							NETWORK ALIGNMENT; COMPLEX NETWORKS	Graphlets are small connected induced subgraphs of a larger graph G. Graphlets are now commonly used to quantify local and global topology of networks in the field. Methods exist to exhaustively enumerate all graphlets (and their orbits) in large networks as efficiently as possible using orbit counting equations. However, the number of graphlets in G is exponential in both the number of nodes and edges in G. Enumerating them all is already unacceptably expensive on existing large networks, and the problem will only get worse as networks continue to grow in size and density. Here we introduce an efficient method designed to aid statistical sampling of graphlets up to size k = 8 from a large network. We define graphettes as the generalization of graphlets allowing for disconnected graphlets. Given a particular (undirected) graphette g, we introduce the idea of the canonical graphette K(g) as a representative member of the isomorphism group Iso(g) of g. We compute the mapping K, in the form of a lookup table, from all 2 (k(k -1)/2) undirected graphettes g of size k <= 8 to their canonical representatives K(g), as well as the permutation that transforms g to K(g). We also compute all automorphism orbits for each canonical graphette. Thus, given any k <= 8 nodes in a graph G, we can in constant time infer which graphette it is, as well as which orbit each of the k nodes belongs to. Sampling a large number N of such k-sets of nodes provides an approximation of both the distribution of graphlets and orbits across G, and the orbit degree vector at each node.	[Hasan, Adib] Ananda Mohan Coll, Mymensingh, Bangladesh; [Chung, Po-Chien; Hayes, Wayne] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Hayes, W (corresponding author), Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA.	whayes@uci.edu		Hayes, Wayne B./0000-0002-3310-6042				Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chatr-aryamontri A, 2013, NUCLEIC ACIDS RES, V41, pD816, DOI 10.1093/nar/gks1158; Codenotti P, 2013, TOOLS ARTIFICIAL INT; Cook S. A., 1971, Proceedings of the 3rd annual ACM symposium on theory of computing, P151; Dehmer M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094985; Emmert-Streib F, 2016, INFORM SCIENCES, V346, P180, DOI 10.1016/j.ins.2016.01.074; Gross JL, GRAPH THEORY LECT A; Hocevar T, 2014, BIOINFORMATICS, V30, P559, DOI 10.1093/bioinformatics/btt717; Kuchaiev O, 2010, J R SOC INTERFACE, V7, P1341, DOI 10.1098/rsif.2010.0063; Malod-Dognin N., 2015, BIOINFORMATICS; Mamano N, 2017, BIOINFORMATICS, P8; Mckay B. D, 2010, NAUTY; Melckenbeeck I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147078; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman M., 2010, HIST SEXUALITY, P1; Pillich RT, 2017, METHODS MOL BIOL, V1558, P271, DOI 10.1007/978-1-4939-6783-4_13; Przulj N, 2006, BIOINFORMATICS, V22, P974, DOI 10.1093/bioinformatics/btl030; Przulj N, 2004, BIOINFORMATICS, V20, P3508, DOI 10.1093/bioinformatics/bth436; Przulj N, 2007, BIOINFORMATICS, V23, pE177, DOI 10.1093/bioinformatics/btl301; Rahman M, 2014, IEEE T KNOWL DATA EN, V26, P2466, DOI 10.1109/TKDE.2013.2297929; Saraph V, 2014, BIOINFORMATICS, V30, P2931, DOI 10.1093/bioinformatics/btu409; Sloane N. J. A., ONLINE ENCY INTEGER; Thorne T, 2012, J ROYAL SOC INTERFAC; Wilson RC, 2008, PATTERN RECOGN, V41, P2833, DOI 10.1016/j.patcog.2008.03.011; Yaveroglu ON, 2014, SCI REP-UK, V4, DOI 10.1038/srep04547	25	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181570	10.1371/journal.pone.0181570	http://dx.doi.org/10.1371/journal.pone.0181570			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832661	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800006
J	Lanning, DK; Esteves, PJ; Knight, KL				Lanning, Dennis K.; Esteves, Pedro J.; Knight, Katherine L.			The remnant of the European rabbit (Oryctolagus cuniculus) IgD gene	PLOS ONE			English	Article							HEAVY-CHAIN LOCUS; IMMUNOGLOBULIN-D; C-MU; SURFACE-IMMUNOGLOBULIN; SEQUENCE-ANALYSIS; LIGHT-CHAIN; IDENTIFICATION; EVOLUTION; REVEALS; REGION	Although IgD first appeared, along with IgM, in the cartilaginous fishes and has been retained throughout subsequent vertebrate evolution, it has been lost in a diverse group of vertebrate species. We previously showed that, unlike vertebrates that express IgD, the rabbit lacks an IgD (Cd) gene within 13.5 kb downstream of the IgM gene. We report here that, by conducting BLAST searches of rabbit Ig heavy chain genomic DNA with known mammalian IgD exons, we identified the remnant of the rabbit Cd gene approximately 21 kb downstream of the IgM gene. The remnant Cd locus lacks the delta CH1 and hinge exons, but contains truncated delta CH2 and delta CH3 exons, as well as largely intact, but non-functional, secretory and transmembrane exons. In addition, we report that the Cd gene probably became non-functional in leporids at least prior to the divergence of rabbits and hares similar to 12 million years ago.	[Lanning, Dennis K.; Knight, Katherine L.] Loyola Univ Chicago, Stritch Sch Med, Ctr Translat Res & Educ, Dept Microbiol & Immunol, Maywood, IL 60660 USA; [Esteves, Pedro J.] Univ Porto, InBIO Res Network Biodivers & Evolutionary Biol, CIBIO, Campus Vairao,Campus Agr Vairao, Vairao, Portugal; [Esteves, Pedro J.] Univ Porto, Fac Ciencias, Dept Biol, Porto, Portugal; [Esteves, Pedro J.] CESPU, CITS, Gandra, Portugal	Loyola University Chicago; Universidade do Porto; Universidade do Porto	Lanning, DK (corresponding author), Loyola Univ Chicago, Stritch Sch Med, Ctr Translat Res & Educ, Dept Microbiol & Immunol, Maywood, IL 60660 USA.	dlannin@luc.edu	Esteves, Pedro/A-7537-2010	Esteves, Pedro/0000-0002-6055-8298	National Institutes of Health; Portuguese Foundation for Science and Technology;  [A150260];  [IF/00376/2015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institutes of Health - KLK, Portuguese Foundation for Science and Technology - PJE, and R01 Grant A150260 for Dr. Katherine L. Knight; IF/00376/2015 for Dr. Pedro J Esteves. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABNEY ER, 1974, NATURE, V252, P600, DOI 10.1038/252600a0; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Arpin C, 1998, J EXP MED, V187, P1169, DOI 10.1084/jem.187.8.1169; Benton MJ, 2007, MOL BIOL EVOL, V24, P26, DOI 10.1093/molbev/msl150; BLATTNER FR, 1984, NATURE, V307, P417, DOI 10.1038/307417a0; Burwinkel B, 1998, J MOL BIOL, V277, P513, DOI 10.1006/jmbi.1998.1641; Butler JE, 1997, SCAND J IMMUNOL, V45, P455, DOI 10.1046/j.1365-3083.1997.d01-423.x; Butler JE, 1996, INT IMMUNOL, V8, P1897, DOI 10.1093/intimm/8.12.1897; Butler JE, 2011, DEV COMP IMMUNOL, V35, P273, DOI 10.1016/j.dci.2010.08.011; Chen K, 2009, NAT IMMUNOL, V10, P889, DOI 10.1038/ni.1748; de Matos AL, 2014, IMMUNOGENETICS, V66, P43, DOI 10.1007/s00251-013-0740-7; de Sousa-Pereira P, 2016, IMMUNOGENETICS, V68, P477, DOI 10.1007/s00251-016-0909-y; ESKINAZI DP, 1979, J IMMUNOL, V122, P469; FROHMAN MA, 1993, METHOD ENZYMOL, V218, P340; Fu S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025648; Gilbert N, 2002, CELL, V110, P315, DOI 10.1016/S0092-8674(02)00828-0; Guo Y, 2012, PLOS ONE, V7; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han BY, 2016, J IMMUNOL, V196, P5138, DOI 10.4049/jimmunol.1600307; Han KD, 2005, NUCLEIC ACIDS RES, V33, P4040, DOI 10.1093/nar/gki718; Hordvik I, 1999, SCAND J IMMUNOL, V50, P202; Huchon D, 2002, MOL BIOL EVOL, V19, P1053, DOI 10.1093/oxfordjournals.molbev.a004164; Kluin PM, 1995, EUR J IMMUNOL, V25, P3504, DOI 10.1002/eji.1830251244; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; KRANE DE, 1991, MOL BIOL EVOL, V8, P1; Kriegs JO, 2007, TRENDS GENET, V23, P158, DOI 10.1016/j.tig.2007.02.002; Lanning DK, 2003, GENE, V309, P135, DOI 10.1016/S0378-1119(03)00500-6; Lundqvist ML, 2001, J BIOL CHEM, V276, P46729, DOI 10.1074/jbc.M106221200; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; MARTIN LN, 1976, INT ARCH ALLER A IMM, V51, P320, DOI 10.1159/000231606; Matthee CA, 2004, SYST BIOL, V53, P433, DOI 10.1080/10635150490445715; MELCHER U, 1974, J EXP MED, V140, P1427, DOI 10.1084/jem.140.5.1427; MILSTEIN CP, 1984, NUCLEIC ACIDS RES, V12, P6523, DOI 10.1093/nar/12.16.6523; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; Neves F, 2016, INNATE IMMUN-LONDON, V22, P336, DOI 10.1177/1753425916647471; Neves F, 2015, INNATE IMMUN-LONDON, V21, P787, DOI 10.1177/1753425915606209; Ohta Y, 2006, P NATL ACAD SCI USA, V103, P10723, DOI 10.1073/pnas.0601407103; Pinheiro A, 2016, IMMUNOGENETICS, V68, P83, DOI 10.1007/s00251-015-0868-8; Pinheiro A, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.140088; Pinheiro A, 2013, IMMUNOGENETICS, V65, P777, DOI 10.1007/s00251-013-0728-3; Rogers KA, 2006, IMMUNOLOGY, V118, P88, DOI 10.1111/j.1365-2567.2006.02345.x; Ros F, 2004, GENE, V330, P49, DOI 10.1016/j.gene.2003.12.037; Rouaud P, 2014, J EXP MED, V211, P975, DOI 10.1084/jem.20131385; ROWE DS, 1965, J EXP MED, V121, P171, DOI 10.1084/jem.121.1.171; ROWE DS, 1965, J EXP MED, V121, P185, DOI 10.1084/jem.121.1.185; RUDDICK JH, 1977, J IMMUNOL, V118, P1025; Sabouri Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13381; SIRE J, 1979, EUR J IMMUNOL, V9, P13, DOI 10.1002/eji.1830090104; SIRE J, 1982, GENE, V20, P377, DOI 10.1016/0378-1119(82)90206-2; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Stenvik J, 2000, IMMUNOGENETICS, V51, P452, DOI 10.1007/s002510050644; Sun JS, 1997, IMMUNOGENETICS, V46, P452, DOI 10.1007/s002510050305; Symer DE, 2002, CELL, V110, P327, DOI 10.1016/S0092-8674(02)00839-5; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; TUCKER PW, 1980, SCIENCE, V209, P1353, DOI 10.1126/science.6968091; Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141; van der Loo W, 2009, J VIROL, V83, P2386, DOI 10.1128/JVI.01116-08; Wagner B, 2004, J IMMUNOL, V173, P3230, DOI 10.4049/jimmunol.173.5.3230; Wang XX, 2009, IMMUNOGENETICS, V61, P581, DOI 10.1007/s00251-009-0385-8; WILDER RL, 1979, J IMMUNOL, V122, P464; Wilson M, 1997, P NATL ACAD SCI USA, V94, P4593, DOI 10.1073/pnas.94.9.4593; Zhao Y, 2000, IMMUNOLOGY, V101, P348, DOI 10.1046/j.1365-2567.2000.00106.x; Zhao YF, 2009, J IMMUNOL, V183, P3285, DOI 10.4049/jimmunol.0900469; Zhao YF, 2002, J IMMUNOL, V169, P4408, DOI 10.4049/jimmunol.169.8.4408; Zhu L, 2014, DEV COMP IMMUNOL, V42, P138, DOI 10.1016/j.dci.2013.08.020	66	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182029	10.1371/journal.pone.0182029	http://dx.doi.org/10.1371/journal.pone.0182029			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832642	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800009
J	Penndorf, D; Tadic, V; Witte, OW; Grosskreutz, J; Kretz, A				Penndorf, Diane; Tadic, Vedrana; Witte, Otto W.; Grosskreutz, Julian; Kretz, Alexandra			DNA strand breaks and TDP-43 mislocation are absent in the murine hSOD1(G93A) model of amyotrophic lateral sclerosis in vivo and in vitro	PLOS ONE			English	Article							CELL NUCLEAR ANTIGEN; INCREASED OXIDATIVE DAMAGE; MOTOR-NEURON DEGENERATION; L1 RETROTRANSPOSITION; TRANSPOSABLE ELEMENTS; H2AX PHOSPHORYLATION; TRANSGENIC MICE; COMET ASSAY; REPAIR; SOD1	Mutations in the human Cu/Zn superoxide dismutase type-1 (hSOD1) gene are common in familial amyotrophic lateral sclerosis (fALS). The pathophysiology has been linked to, e.g., organelle dysfunction, RNA metabolism and oxidative DNA damage conferred by SOD1 malfunction. However, apart from metabolically evoked DNA oxidation, it is unclear whether severe genotoxicity including DNA single-strand breaks (SSBs) and double-strand breaks (DSBs), originates from loss of function of nuclear SOD1 enzyme. Factors that endogenously interfere with DNA integrity and repair complexes in hSOD1-mediated fALS remain similarly unexplored. In this regard, uncontrolled activation of transposable elements (TEs) might contribute to DNA disintegration and neurodegeneration. The aim of this study was to elucidate the role of the fALS-causing hSOD1 G93A mutation in the generation of severe DNA damage beyond well-characterized DNA base oxidation. Therefore, DNA damage was assessed in spinal tissue of hSOD1 G93A. overexpressing mice and in corresponding motor neuron-enriched cell cultures in vitro. Overexpression of the hSOD1 G93A locus did not change the threshold for severe DNA damage per se. We found that levels of SSBs and DSBs were unaltered between hSOD1 G93A and control conditions, as demonstrated in postmitotic motor neurons and in astrocytes susceptible to replication-dependent DNA breakage. Analogously, parameters indicative of DNA damage response processes were not activated in vivo or in vitro. Evidence for a mutation-related elevation in TE activation was not detected, in accordance with the absence of TAR DNA binding protein 43 (TDP-43) proteinopathy in terms of cytoplasmic mislocation or nuclear loss, as nuclear TDP-43 is supposed to silence TEs physiologically. Conclusively, the superoxide dismutase function of SOD1 might not be required to preserve DNA integrity in motor neurons, at least when the function of TDP-43 is unaltered. Our data establish a foundation for further investigations addressing functional TDP-43 interaction with ALS-relevant genetic mutations.	[Penndorf, Diane; Tadic, Vedrana; Witte, Otto W.; Grosskreutz, Julian; Kretz, Alexandra] Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Thuringia, Germany	Friedrich Schiller University of Jena	Kretz, A (corresponding author), Jena Univ Hosp, Hans Berger Dept Neurol, Jena, Thuringia, Germany.	alexandra.kretz@med.uni-jena.de	Grosskreutz, Julian/G-2293-2010; Kretz, Alexandra/AAW-6687-2020; Witte, Otto/P-4127-2018	Grosskreutz, Julian/0000-0001-9525-1424; Witte, Otto/0000-0003-2101-4105	Ministry for Economics, Sciences and Digital Society of Thuringia (TMWWDG) [RegenerAging-FSU-I-03/14]; Interdisciplinary Center for Clinical Research (IZKF) Jena [FF01]; BMBF (Bundesministerium fur Bildung and Forschung); European Union; German Association for Neuromuscular Diseases (DGM e.V.)	Ministry for Economics, Sciences and Digital Society of Thuringia (TMWWDG); Interdisciplinary Center for Clinical Research (IZKF) Jena; BMBF (Bundesministerium fur Bildung and Forschung)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); German Association for Neuromuscular Diseases (DGM e.V.)	This work was supported by the Ministry for Economics, Sciences and Digital Society of Thuringia (TMWWDG), in the framework of the ProExcellence Initiative RegenerAging (RegenerAging-FSU-I-03/14 to AK), and by the Interdisciplinary Center for Clinical Research (IZKF) Jena (Project FF01 to AK). JG received funding from a BMBF (the Bundesministerium fur Bildung and Forschung) grant in the framework of the E-RARE program (PYRAMID), JPND (OnWebDUALS and SOPHIA) of the European Union and the German Association for Neuromuscular Diseases (DGM e.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre N, 2005, FREE RADICAL RES, V39, P383, DOI 10.1080/10715760400027979; Ahmed MS, 2000, J NEUROL SCI, V176, P88, DOI 10.1016/S0022-510X(00)00317-8; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Baple EL, 2014, J CLIN INVEST, V124, P3137, DOI 10.1172/JCI74593; Barbosa LF, 2010, BBA-MOL BASIS DIS, V1802, P462, DOI 10.1016/j.bbadis.2010.01.011; Carroll J, 2015, HUM MOL GENET, V24, P828, DOI 10.1093/hmg/ddu500; Chiang SC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602506; Collins AR, 2004, MOL BIOTECHNOL, V26, P249, DOI 10.1385/MB:26:3:249; Coufal NG, 2009, NATURE, V460, P1127, DOI 10.1038/nature08248; Douville R, 2011, ANN NEUROL, V69, P141, DOI 10.1002/ana.22149; Farg MA, 2017, HUM MOL GENET; Ferrante RJ, 1997, J NEUROCHEM, V69, P2064; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; Gary R, 1997, J BIOL CHEM, V272, P24522, DOI 10.1074/jbc.272.39.24522; Gasior SL, 2006, J MOL BIOL, V357, P1383, DOI 10.1016/j.jmb.2006.01.089; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hoelz DJ, 2006, PROTEOMICS, V6, P4808, DOI 10.1002/pmic.200600142; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kee N, 2002, J NEUROSCI METH, V115, P97, DOI 10.1016/S0165-0270(02)00007-9; Konca K, 2003, MUTAT RES-GEN TOX EN, V534, P15, DOI 10.1016/S1383-5718(02)00251-6; Li HF, 2016, TRANSL NEURODEGENER, V5, DOI 10.1186/s40035-016-0050-8; Li WH, 2013, NAT NEUROSCI, V16, P529, DOI 10.1038/nn.3368; Li WH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044099; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Lukas C, 2011, NAT CELL BIOL, V13, P243, DOI 10.1038/ncb2201; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Margulies EH, 2005, P NATL ACAD SCI USA, V102, P3354, DOI 10.1073/pnas.0408539102; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Morgan S, 2016, BRIT MED BULL, V119, P87, DOI 10.1093/bmb/ldw026; Muotri AR, 2010, NATURE, V468, P443, DOI 10.1038/nature09544; Muratai T, 2008, FREE RADICAL RES, V42, P221, DOI 10.1080/10715760701877262; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Reilly MT, 2013, J NEUROSCI, V33, P17577, DOI 10.1523/JNEUROSCI.3369-13.2013; Reuter M, 2011, NATURE, V480, P264, DOI 10.1038/nature10672; Riballo E, 2004, MOL CELL, V16, P715, DOI 10.1016/j.molcel.2004.10.029; Rizzardini M, 2005, J NEUROL SCI, V232, P95, DOI 10.1016/j.jns.2005.02.004; Robertson J, 2007, NEUROSCI LETT, V420, P128, DOI 10.1016/j.neulet.2007.03.066; Sabatelli M, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.02.009; Sau D, 2007, HUM MOL GENET, V16, P1604, DOI 10.1093/hmg/ddm110; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Scotter EL, 2015, NEUROTHERAPEUTICS, V12, P515, DOI 10.1007/s13311-015-0351-0; Shan XY, 2009, NEUROSCI LETT, V458, P70, DOI 10.1016/j.neulet.2009.04.031; Sieber MW, 2010, NEUROBIOL AGING, V31, P654, DOI 10.1016/j.neurobiolaging.2008.05.023; Tan CF, 2007, ACTA NEUROPATHOL, V113, P535, DOI 10.1007/s00401-007-0206-9; Taneja N, 2004, J BIOL CHEM, V279, P2273, DOI 10.1074/jbc.M310030200; TorresRamos CA, 1996, P NATL ACAD SCI USA, V93, P9676, DOI 10.1073/pnas.93.18.9676; Umar A, 1996, CELL, V87, P65, DOI 10.1016/S0092-8674(00)81323-9; Van Damme P, 2003, J NEUROSCI, V23, P4942; Van Den Bosch L, 2000, J NEUROL SCI, V180, P29, DOI 10.1016/S0022-510X(00)00414-7; Wang HY, 2005, J CELL PHYSIOL, V202, P492, DOI 10.1002/jcp.20141; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Wate R, 2005, J RADIAT RES, V46, P67, DOI 10.1269/jrr.46.67; Wechsler T, 2004, P NATL ACAD SCI USA, V101, P1247, DOI 10.1073/pnas.0307765100; Williams KL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11253; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yuce O, 2013, MOL CELL BIOL, V33, P406, DOI 10.1128/MCB.01195-12	60	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183684	10.1371/journal.pone.0183684	http://dx.doi.org/10.1371/journal.pone.0183684			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832631	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800079
J	Askitas, N				Askitas, Nikolaos			Explaining opinion polarisation with opinion copulas	PLOS ONE			English	Article								An empirically founded and widely established driving force in opinion dynamics is homophily i.e. the tendency of "birds of a feather" to "flock together". The closer our opinions are the more likely it is that we will interact and converge. Models using these assumptions are called bounded confidence models (BCM) as they assume a tolerance threshold after which interaction is unlikely. They are known to produce one or more clusters, depending on the size of the bound, with more than one cluster being possible only in the deterministic case. Introducing noise, as is likely to happen in a stochastic world, causes BCM to produce consensus which leaves us with the open problem of explaining the emergence and sustainance of opinion clusters and polarisation. We investigate the role of heterogeneous priors in opinion formation, introduce the concept of opinion copulas, argue that it is well supported by findings in Social Psychology and use it to show that the stochastic BCM does indeed produce opinion clustering without the need for extra assumptions.	[Askitas, Nikolaos] IZA Inst Labor Econ, Schaumburg Lippe Str 5-9, D-53113 Bonn, Germany	IZA Institute Labor Economics	Askitas, N (corresponding author), IZA Inst Labor Econ, Schaumburg Lippe Str 5-9, D-53113 Bonn, Germany.	askitas@iza.org	Askitas, Nikolaos/O-1065-2019; Askitas, Nikolaos/L-8362-2016	Askitas, Nikolaos/0000-0002-3134-6616; Askitas, Nikolaos/0000-0002-3134-6616				Blume L, 2015, J ECON THEORY, V156, P1, DOI 10.1016/j.jet.2014.11.002; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Cucker F, 2007, IEEE T AUTOMAT CONTR, V52, P852, DOI 10.1109/TAC.2007.895842; Del Vicario M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40391; Del Vicario M, 2016, P NATL ACAD SCI USA, V113, P554, DOI 10.1073/pnas.1517441113; Einstein A, 1906, ANN PHYS-BERLIN, V19, P371; Hartley EL, 1950, PUBLIC OPIN QUART, V14, P668; Hegselmann R, 2002, JASSS-J ARTIF SOC S, V5; Lorenz J, 2007, INT J MOD PHYS C, V18, P1819, DOI 10.1142/S0129183107011789; Mas M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000959; Neau D., 2000, REVISIONS CROYANCES; Nelsen RB, 2006, INTRO STAT; SCHELLING TC, 1969, AM ECON REV, V59, P488; Shiller RJ, 2015, IRRATIONAL EXUBERANC; Wang X., 2005, MATH MAG, V78, P390, DOI [10.2307/30044198, DOI 10.2307/30044198]	15	4	4	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183277	10.1371/journal.pone.0183277	http://dx.doi.org/10.1371/journal.pone.0183277			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829802	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100034
J	Jimenez, C; Andreou, V; Evriviadou, M; Munkes, B; Hadjioannou, L; Petrou, A; Abu Alhaija, R				Jimenez, Carlos; Andreou, Vasilis; Evriviadou, Marina; Munkes, Britta; Hadjioannou, Louis; Petrou, Antonis; Abu Alhaija, Rana			Epibenthic communities associated with unintentional artificial reefs (modern shipwrecks) under contrasting regimes of nutrients in the Levantine Sea (Cyprus and Lebanon)	PLOS ONE			English	Article							FOULING COMMUNITIES; FISH ASSEMBLAGES; MARINE; CORAL; TEMPERATURE; RECRUITMENT; SETTLEMENT	Artificial reefs, in the Eastern Mediterranean (Cyprus,) became a popular and frequently used tool, in fisheries and biodiversity conservation management. Even though evaluation studies about the efficacy of artificial reefs are plentiful in the rest of the Mediterranean (Central and Western), in the Eastern Basin they are largely absent. As the Eastern part of the Mediterranean Sea is characterised by unique physical parameters, the necessity to study artificial reefs under these contrasting regimes increases. The epibenthic communities of two unintentional artificial reefs (modern shipwrecks) in Cyprus (Zenobia) and Lebanon (Alice-B) were evaluated in 2010. Both shipwrecks are at similar depth, type of sea bottom, made of the same material (steel) and were sunk approximately the same period of time. However, Alice-B shipwreck off the coast of Lebanon is constantly exposed to higher levels of nutrients than Zenobia in Cyprus. Significant dissimilarities were observed in the composition, percentage of benthic cover of predominant taxonomic groups and development of the epibenthic communities. Differences in physical and chemical parameters between sides lay mainly in the nutrient and thermal regimes affecting the shipwrecks and most likely bring about the differences in the observed community structure. The results of this study suggest that epibenthic communities could be highly impacted by eutrophication caused by anthropogenic activities, leading to less biodiverse	[Jimenez, Carlos; Andreou, Vasilis; Hadjioannou, Louis; Petrou, Antonis; Abu Alhaija, Rana] Enalia Physis Environm Res Ctr ENALIA, Acropoleos 2, Nicosia, Cyprus; [Jimenez, Carlos; Evriviadou, Marina; Abu Alhaija, Rana] Cyprus Inst, Energy Environm & Water Res Ctr, Nicosia, Cyprus; [Munkes, Britta] Helmholtz Ctr Ocean Res GEOMAR, Expt Ecol Dept, Dusternbrooker Weg 20, Kiel, Germany	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel	Jimenez, C (corresponding author), Enalia Physis Environm Res Ctr ENALIA, Acropoleos 2, Nicosia, Cyprus.; Jimenez, C (corresponding author), Cyprus Inst, Energy Environm & Water Res Ctr, Nicosia, Cyprus.	c.jimenez@enaliaphysis.org.cy	Jimenez, Carlos/AAJ-7275-2020; Hadjioannou, Louis/F-3272-2018	Jimenez, Carlos/0000-0003-3413-6662; Hadjioannou, Louis/0000-0001-5864-5467	AP Marine Environmental Consultancy Ltd.; TEMPUS (Germany-Lebanon)	AP Marine Environmental Consultancy Ltd.; TEMPUS (Germany-Lebanon)	This study was funded in part by AP Marine Environmental Consultancy Ltd., TEMPUS Program (Germany-Lebanon), and Mr. Nick Galea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARDIZZONE GD, 1989, B MAR SCI, V44, P592; Arnott J, 2014, BIOFOULING, V30, P1045, DOI 10.1080/08927014.2014.967687; Baird AH, 2003, MAR ECOL PROG SER, V252, P289, DOI 10.3354/meps252289; Barnard A, 2015, NY TIMES; BAYNES TW, 1989, B MAR SCI, V44, P545; Borum J, 1996, OIKOS, V76, P406, DOI 10.2307/3546213; Boynton W.R., 1982, ESTUARINE COMP, P69, DOI DOI 10.1016/B978-0-12-404070-0.50011-9; Burt J, 2009, J EXP MAR BIOL ECOL, V373, P72, DOI 10.1016/j.jembe.2009.03.009; Canning-Clode J, 2008, MAR ECOL-EVOL PERSP, V29, P115, DOI 10.1111/j.1439-0485.2007.00210.x; Cheminee A, 2013, J EXP MAR BIOL ECOL, V442, P70, DOI 10.1016/j.jembe.2013.02.003; Colella S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155756; CONNELL JH, 1977, AM NAT, V111, P1119, DOI 10.1086/283241; Consoli P, 2015, J MAR BIOL ASSOC UK, V95, P17, DOI 10.1017/S0025315414000940; Dobretsov S, 2009, BIOFOULING, V25, P413, DOI 10.1080/08927010902853516; Fabi G, 2011, BRAZ J OCEANOGR, V59, P155, DOI 10.1590/S1679-87592011000300017; Fernandez-Marquez D, 2010, 16 S IB EST BIOL MAR, P6; Fowler AM, 2012, MAR BIOL, V159, P2787, DOI 10.1007/s00227-012-2039-x; Gamfeldt L, 2015, OIKOS, V124, P252, DOI 10.1111/oik.01549; Haines-Young J., 2016, AL ARABIYA ENGLISH; Harrison P.L., 2000, 9 INT COR REEF S, V1, P409; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Humanes A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161616; Jennings S, 1997, MAR ECOL PROG SER, V146, P109, DOI 10.3354/meps146109; Jensen A, 2002, ICES J MAR SCI, V59, pS3, DOI 10.1006/jmsc.2002.1298; Jimenez C, 2016, REG ENVIRON CHANGE, V16, P1963, DOI 10.1007/s10113-014-0729-2; Jimenez C, 2017, WATER-SUI, V9, DOI 10.3390/w9010011; JOKIEL PL, 1977, MAR BIOL, V43, P201, DOI 10.1007/BF00402312; Kersting DK, 2015, SCI REP-UK, V5, DOI 10.1038/srep18635; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Malak A. D., 2011, OVERVIEW CONSERVATIO; Moreno I, 2004, JOURNAL OF COASTAL R, V39, P1843; Nozawa Y, 2007, MAR BIOL, V152, P1181, DOI 10.1007/s00227-007-0765-2; Park SR, 2011, ESTUAR COAST SHELF S, V91, P163, DOI 10.1016/j.ecss.2010.10.013; Perkol-Finkel S, 2007, J EXP MAR BIOL ECOL, V340, P25, DOI 10.1016/j.jembe.2006.08.008; Perkol-Finkel S, 2006, MAR ENVIRON RES, V61, P121, DOI 10.1016/j.marenvres.2005.08.001; Perkol-Finkel S, 2005, MAR ENVIRON RES, V59, P79, DOI 10.1016/j.marenvres.2004.03.122; Pickering H, 1997, FISH RES, V31, P39, DOI 10.1016/S0165-7836(97)00019-2; Relini G, 2000, ARTIFICIAL REEFS IN EUROPEAN SEAS, P129; Sala E, 2005, AQUATIC FOOD WEBS: AN ECOSYSTEM APPROACH, P170; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Santos LN, 2011, ECOL APPL, V21, P251, DOI 10.1890/09-1283.1; Walker SJ, 2007, MAR ECOL-EVOL PERSP, V28, P435, DOI 10.1111/j.1439-0485.2007.00193.x; Zenetos A, 2002, MEDITERRANEAN SEA	43	9	9	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182486	10.1371/journal.pone.0182486	http://dx.doi.org/10.1371/journal.pone.0182486			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850572	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000408544200004
J	Maruko, I; Koizumi, H; Hasegawa, T; Arakawa, H; Iida, T				Maruko, Ichiro; Koizumi, Hideki; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro			Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy	PLOS ONE			English	Article							TERM-FOLLOW-UP; PHOTODYNAMIC THERAPY; PHOTOCOAGULATION	Purpose To compare the efficacy of the subthreshold micropulse laser (SML) to conventional laser (CL) in treating focal leakages of the retinal pigment epithelium (RPE) in the eyes with central serous chorioretinopathy (CSC). Methods Twenty-nine eyes of 28 patients with CSC and typical focal leakage were treated with CL or SML. Both treatments were made with a 577 nm yellow laser (CL: NIDEK MC-500, SML: IRIDEX IQ577). The percentage of eyes with a complete resolution, the distance of the laser burns from the fovea, and injury of the RPE after treatment were studied. Results A complete resolution was seen in 10 of 15 eyes (66.7%) after CL and 9 of 14 eyes (64.3%) after SML (P = 0.89). The average distance from the foveal center to the leakage point was 1282 +/- 596 mu m for eyes treated with CL and 1271 +/- 993 mu m for eyes treated with SML (P = 0.4). Only three eyes treated with SML had treatment sites within 500 ae m of the fovea. RPE damage determined by fundus autofluorescence was found in all eyes treated with CL and only one eye treated with SML (P <.01). Conclusions SML achieved equivalent therapeutic effects as CL but without RPE damage in eyes with CSC.	[Maruko, Ichiro; Koizumi, Hideki; Hasegawa, Taiji; Arakawa, Hisaya; Iida, Tomohiro] Tokyo Womens Med Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan	Tokyo Women's Medical University	Maruko, I (corresponding author), Tokyo Womens Med Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Tokyo, Japan.	imaruko@twmu.ac.jp	Hasegawa, Taiji/ABG-8260-2021; Maruko, Ichiro/AFP-1311-2022	Maruko, Ichiro/0000-0001-5647-6372	JSPS KAKENHI [JP16K11274]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Dr. Maruko reports grants from JSPS KAKENHI (Grant Number JP16K11274), grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work. Dr. Koizumi reports grants and personal fees from Novartis Pharma K.K., personal fees from Bayer Yakuhin, Ltd., personal fees from Santen Pharmaceutical Inc., personal fees from Alcon Japan, Ltd., personal fees from Topcon Co., Ltd., personal fees from Senju Pharmaceutical Co., Ltd., personal fees from HOYA Corp., personal fees from Canon Inc., personal fees from Wakamoto Pharmaceutical Co., Ltd., personal fees from NIDEK Co., Ltd., outside the submitted work;. Dr. Hasegawa has nothing to disclose. Dr. Arakawa has nothing to disclose. Dr. lida reports grants and personal fees from Novartis Pharma K.K. (Japan), personal fees from Bayer Yakuhin, Ltd. (Japan), grants and personal fees from Santen Pharmaceutical Co., Ltd. (japan), grants from Nidek, research support from Chuosangyo (Japan), outside the submitted work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Elhamid AH, 2015, CLIN OPHTHALMOL, V9, P2277, DOI 10.2147/OPTH.S87499; Chan WM, 2008, OPHTHALMOLOGY, V115, P1756, DOI 10.1016/j.ophtha.2008.04.014; Chan WM, 2008, RETINA-J RET VIT DIS, V28, P85, DOI 10.1097/IAE.0b013e318156777f; Chen SN, 2008, OPHTHALMOLOGY, V115, P2229, DOI 10.1016/j.ophtha.2008.08.026; FICKER L, 1988, BRIT J OPHTHALMOL, V72, P829, DOI 10.1136/bjo.72.11.829; GARTNER J, 1987, DOC OPHTHALMOL, V66, P19, DOI 10.1007/BF00144736; Gass J., 1967, AM J OPHTHALMOL, V63, P1; Inagaki K, 2015, JPN J OPHTHALMOL, V59, P21, DOI 10.1007/s10384-014-0361-1; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Klais CM, 2006, RETINA, V2, P1135, DOI DOI 10.1016/B978-0-323-02598-0.50069-02-S2.0-84917282576; Koss MJ, 2012, EYE, V26, P307, DOI 10.1038/eye.2011.282; Lanzetta P, 2008, EUR J OPHTHALMOL, V18, P934, DOI 10.1177/112067210801800613; Lim JI, 1999, SURV OPHTHALMOL, V44, P95, DOI 10.1016/S0039-6257(99)00077-6; Ozmert E, 2016, J OPHTHALMOL, V2016, DOI 10.1155/2016/3513794; Piccolino FC, 2003, RETINA-J RET VIT DIS, V23, P752, DOI 10.1097/00006982-200312000-00002; ROBERTSON DM, 1983, AM J OPHTHALMOL, V95, P457, DOI 10.1016/0002-9394(83)90265-9; Salehi M, 2015, COCHRANE DATABASE SY; Scholz P, 2016, EYE, V30, P1371, DOI 10.1038/eye.2016.142; Scholz P, 2017, ADV THER, V34, P1528, DOI 10.1007/s12325-017-0559-y; Yadav NK, 2015, EYE, V29, P258, DOI 10.1038/eye.2014.315; Yannuzzi LA, 2003, RETINA-J RET VIT DIS, V23, P288, DOI 10.1097/00006982-200306000-00002; Yap EY, 1996, ARCH OPHTHALMOL-CHIC, V114, P689, DOI 10.1001/archopht.1996.01100130681007	22	26	27	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0184112	10.1371/journal.pone.0184112	http://dx.doi.org/10.1371/journal.pone.0184112			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850595	Green Submitted, gold, Green Published			2022-12-27	WOS:000408544200058
J	Aguilar, C; Chossat, P; Krupa, M; Lavigne, F				Aguilar, Carlos; Chossat, Pascal; Krupa, Martin; Lavigne, Frederic			Latching dynamics in neural networks with synaptic depression	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; LONG-TERM-MEMORY; MONKEY INFEROTEMPORAL CORTEX; SEMANTIC PRIMING SHIFT; PREFRONTAL CORTEX; ASSOCIATIVE MEMORY; PYRAMIDAL NEURONS; CORTICAL NETWORK; WORKING-MEMORY; ABSTRACT RULES	Prediction is the ability of the brain to quickly activate a target concept in response to a related stimulus (prime). Experiments point to the existence of an overlap between the populations of the neurons coding for different stimuli, and other experiments show that prime-target relations arise in the process of long term memory formation. The classical modelling paradigm is that long term memories correspond to stable steady states of a Hopfield network with Hebbian connectivity. Experiments show that short term synaptic depression plays an important role in the processing of memories. This leads naturally to a computational model of priming, called latching dynamics; a stable state (prime) can become unstable and the system may converge to another transiently stable steady state (target). Hopfield network models of latching dynamics have been studied by means of numerical simulation, however the conditions for the existence of this dynamics have not been elucidated. In this work we use a combination of analytic and numerical approaches to confirm that latching dynamics can exist in the context of a symmetric Hebbian learning rule, however lacks robustness and imposes a number of biologically unrealistic restrictions on the model. In particular our work shows that the symmetry of the Hebbian rule is not an obstruction to the existence of latching dynamics, however fine tuning of the parameters of the model is needed.	[Aguilar, Carlos; Lavigne, Frederic] Univ Nice Sophia Antipolis, CNRS, UMR 7320, F-06357 Nice, France; [Chossat, Pascal; Krupa, Martin] Univ Nice Sophia Antipolis, UMR CNRS UNS 7351, Lab JA Dieudonne, F-06108 Nice, France; [Chossat, Pascal; Krupa, Martin] Inria Sophia Antipolis, MathNeuro Team, F-06902 Valbonne, France; [Krupa, Martin] Univ Coll Cork, Dept Appl Math, Cork, Ireland	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; University College Cork	Krupa, M (corresponding author), Univ Nice Sophia Antipolis, UMR CNRS UNS 7351, Lab JA Dieudonne, F-06108 Nice, France.; Krupa, M (corresponding author), Inria Sophia Antipolis, MathNeuro Team, F-06902 Valbonne, France.; Krupa, M (corresponding author), Univ Coll Cork, Dept Appl Math, Cork, Ireland.	maciej.krupa@inria.fr		Krupa, Maciej (Martin)/0000-0001-9330-4705	European Research Council [227747]	European Research Council(European Research Council (ERC)European Commission)	Our work was funded in part by European Research Council Advanced Grant NerVi number 227747, https://erc.europa.eu/advanced-grants. There was no additional external funding received for this study.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Amit DJ, 2003, CEREB CORTEX, V13, P435, DOI 10.1093/cercor/13.5.435; AMIT DJ, 1994, J NEUROSCI, V14, P6435; Bick C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.218101; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brothers T, 2015, COGNITION, V136, P135, DOI 10.1016/j.cognition.2014.10.017; Brunel N, 1996, NEURAL COMPUT, V8, P1677, DOI 10.1162/neco.1996.8.8.1677; Brunel N, 2004, NEURON, V43, P745, DOI 10.1016/j.neuron.2004.08.023; Brunel N, 2016, NAT NEUROSCI, V19, P749, DOI 10.1038/nn.4286; Brunel N, 2009, J COGNITIVE NEUROSCI, V21, P2300, DOI 10.1162/jocn.2008.21156; BUHMANN J, 1989, PHYS REV A, V39, P2689, DOI 10.1103/PhysRevA.39.2689; Bunge SA, 2003, J NEUROPHYSIOL, V90, P3419, DOI 10.1152/jn.00910.2002; Chapeton J, 2012, P NATL ACAD SCI USA, V109, pE3614, DOI 10.1073/pnas.1211467109; Chaudhuri R, 2016, NAT NEUROSCI, V19, P394, DOI 10.1038/nn.4237; Chossat P., 2016, J NONLINEAR SCI, V28, P471; Clopath C, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002919; Clopath C, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002448; Cortes JM, 2006, NEURAL COMPUT, V18, P614, DOI 10.1162/089976606775623342; Cree GS, 2003, J EXP PSYCHOL GEN, V132, P163, DOI 10.1037/0096-3445.132.2.163; DARK VJ, 1988, MEM COGNITION, V16, P299, DOI 10.3758/BF03197040; DeLong KA, 2005, NAT NEUROSCI, V8, P1117, DOI 10.1038/nn1504; DeLong KA, 2014, LANG LINGUIST COMPAS, V8, P631, DOI 10.1111/lnc3.12093; DeLong KA, 2014, NEUROPSYCHOLOGIA, V61, P150, DOI 10.1016/j.neuropsychologia.2014.06.016; Ding N, 2016, NAT NEUROSCI, V19, P158, DOI 10.1038/nn.4186; Erickson CA, 1999, J NEUROSCI, V19, P10404; Fiete I, 2014, BINARY HOPFIELD NETW; Fujimichi R, 2010, EUR J NEUROSCI, V32, P659, DOI 10.1111/j.1460-9568.2010.07320.x; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; GOCHIN PM, 1994, J NEUROPHYSIOL, V71, P2325, DOI 10.1152/jn.1994.71.6.2325; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; HERRMANN M, 1993, BIOL CYBERN, V68, P455, DOI 10.1007/BF00198778; Hofbauer J, 1998, EVOLUTIONARY GAMES P; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; HORN D, 1989, PHYS REV A, V40, P1036, DOI 10.1103/PhysRevA.40.1036; Huber DE, 2003, COGNITIVE SCI, V27, P403, DOI 10.1016/S0364-0213(03)00012-0; Hung CP, 2005, SCIENCE, V310, P863, DOI 10.1126/science.1117593; Hutchison KA, 2003, PSYCHON B REV, V10, P785, DOI 10.3758/BF03196544; Hutchison KA, 2014, J EXP PSYCHOL LEARN, V40, P844, DOI 10.1037/a0035781; Ison MJ, 2015, NEURON, V87, P220, DOI 10.1016/j.neuron.2015.06.016; Johnson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050276; KAWAMOTO AH, 1985, ACTA PSYCHOL, V59, P35, DOI 10.1016/0001-6918(85)90041-1; KIRKWOOD A, 1994, J NEUROSCI, V14, P3404; Kreiman G, 2006, NEURON, V49, P433, DOI 10.1016/j.neuron.2005.12.019; Kropff Emilio, 2007, Natural Computing, V6, P169, DOI 10.1007/s11047-006-9019-3; Krupa M, 1997, NONLINEAR SCI, V7, P129; Kutas M., 2011, PREDICTIONBRAIN US, P190, DOI DOI 10.1093/ACPROF:OSO/9780195395518.003.0065; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lavigne F, 2000, ACTA PSYCHOL, V104, P191, DOI 10.1016/S0001-6918(00)00020-2; Lavigne F, 2008, NEUROPSYCHOLOGIA, V46, P3074, DOI 10.1016/j.neuropsychologia.2008.06.019; Lavigne F, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00842; Lavigne F, 2013, ADV COGN PSYCHOL, V9, P1, DOI 10.2478/v10053-008-0126-9; Lavigne F, 2012, COGN NEURODYNAMICS, V6, P467, DOI 10.1007/s11571-012-9206-0; Lavigne F, 2011, J COGNITIVE NEUROSCI, V23, P1447, DOI 10.1162/jocn.2010.21504; Lefort S, 2009, NEURON, V61, P301, DOI 10.1016/j.neuron.2008.12.020; Lerner I, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00314; Lerner I, 2012, COGNITIVE SCI, V36, P1339, DOI 10.1111/cogs.12007; Lerner I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040663; Luka BJ, 2014, BRAIN LANG, V135, P115, DOI 10.1016/j.bandl.2014.06.001; Markram H, 1997, J PHYSIOL-LONDON, V500, P409, DOI 10.1113/jphysiol.1997.sp022031; Marro J, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/02/P02017; Marro J, 2007, NEURAL NETWORKS, V20, P230, DOI 10.1016/j.neunet.2006.11.005; MASON A, 1991, J NEUROSCI, V11, P72; MASSON MEJ, 1995, J EXP PSYCHOL LEARN, V21, P3, DOI 10.1037/0278-7393.21.1.3; Masson MEJ, 1991, DISTRIBUTED MEMORY M; McDonald SA, 2003, PSYCHOL SCI, V14, P648, DOI 10.1046/j.0956-7976.2003.psci_1480.x; McRae K, 2005, BEHAV RES METHODS, V37, P547, DOI 10.3758/BF03192726; Messinger A, 2001, P NATL ACAD SCI USA, V98, P12239, DOI 10.1073/pnas.211431098; Meyer DE, 2014, SCIENCE, V345, P523, DOI 10.1126/science.345.6196.523-b; MEYER DE, 1971, J EXP PSYCHOL, V90, P227, DOI 10.1037/h0031564; Miller EK, 1999, NEURON, V22, P15, DOI 10.1016/S0896-6273(00)80673-X; Miller P, 2006, CHAOS, V16, DOI 10.1063/1.2208923; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; MIYASHITA Y, 1988, NATURE, V335, P817, DOI 10.1038/335817a0; Mongillo G, 2003, EUR J NEUROSCI, V18, P2011, DOI 10.1046/j.1460-9568.2003.02908.x; Moss H. E., 1994, Connection Science, V6, P413, DOI 10.1080/09540099408915732; Muhammad R, 2006, J COGNITIVE NEUROSCI, V18, P974, DOI 10.1162/jocn.2006.18.6.974; Naya Y, 2003, EUR J NEUROSCI, V18, P2915, DOI 10.1111/j.1460-9568.2003.03020.x; Naya Y, 2003, J NEUROSCI, V23, P2861; Naya Y, 2001, SCIENCE, V291, P661, DOI 10.1126/science.291.5504.661; Neely J. H., 1991, BASIC PROCESSES READ, P264; Pantic L, 2002, NEURAL COMPUT, V14, P2903, DOI 10.1162/089976602760805331; Plaut D.C., 1995, P 17 ANN C COGN SCI, P37; Plaut DC, 2000, PSYCHOL REV, V107, P786, DOI 10.1037//0033-295X.107.4.786; Quiroga R. Quian, 2010, PSYCHOL REV, V117, P291, DOI [10.1037/a0016917, DOI 10.1037/A0016917]; Quiroga RQ, 2016, NEUROPSYCHOLOGIA, V83, P227, DOI 10.1016/j.neuropsychologia.2015.12.016; Quiroga RQ, 2012, NAT REV NEUROSCI, V13, P587, DOI 10.1038/nrn3251; Rabinovich MI, 2012, PHYS LIFE REV, V9, P51, DOI 10.1016/j.plrev.2011.11.002; Rainer G, 1999, J NEUROSCI, V19, P5493; Ranganath C, 2005, CURR OPIN NEUROBIOL, V15, P175, DOI 10.1016/j.conb.2005.03.017; Roitman JD, 2002, J NEUROSCI, V22, P9475; Rolls E.T., 2010, NOISY BRAIN STOCHAST; Rolls ET, 2008, NAT REV NEUROSCI, V9, P696, DOI 10.1038/nrn2462; ROLLS ET, 1995, J NEUROPHYSIOL, V73, P713, DOI 10.1152/jn.1995.73.2.713; Russo E, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/1/015008; SAKAI K, 1991, NATURE, V354, P152, DOI 10.1038/354152a0; Shadlen MN, 1998, J NEUROSCI, V18, P3870; SIK A, 1995, J NEUROSCI, V15, P6651; Sjostrom PJ, 2001, NEURON, V32, P1149, DOI 10.1016/S0896-6273(01)00542-6; SOFTKY WR, 1993, J NEUROSCI, V13, P334; SPENCE DP, 1990, J PSYCHOLINGUIST RES, V19, P317, DOI 10.1007/BF01074363; Tamura H, 2001, CEREB CORTEX, V11, P384, DOI 10.1093/cercor/11.5.384; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Torres JJ, 2007, NEURAL COMPUT, V19, P2739, DOI 10.1162/neco.2007.19.10.2739; Torres JJ, 2008, NEURAL NETWORKS, V21, P1272, DOI 10.1016/j.neunet.2008.07.002; Treves A, 2005, COGN NEUROPSYCHOL, V22, P276, DOI 10.1080/02643290442000329; Tsao DY, 2006, SCIENCE, V311, P670, DOI 10.1126/science.1119983; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Tsodyks M. V., 1990, Modern Physics Letters B, V4, P259, DOI 10.1142/S0217984990000325; Tsodyks MV, 1997, P NATL ACAD SCI USA, V94, P719, DOI 10.1073/pnas.94.2.719; Van Petten C, 2014, INT J PSYCHOPHYSIOL, V94, P407, DOI 10.1016/j.ijpsycho.2014.10.012; Wallis JD, 2001, NATURE, V411, P953, DOI 10.1038/35082081; Wallis JD, 2003, J NEUROPHYSIOL, V90, P1790, DOI 10.1152/jn.00086.2003; Wang XJ, 2002, NEURON, V36, P955, DOI 10.1016/S0896-6273(02)01092-9; Weinberger NM, 1998, NEUROBIOL LEARN MEM, V70, P226, DOI 10.1006/nlme.1998.3850; Willems R. M., 2015, CEREB CORTEX; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Yakovlev V, 1998, NAT NEUROSCI, V1, P310, DOI 10.1038/1131; Yoshida M, 2003, P NATL ACAD SCI USA, V100, P4257, DOI 10.1073/pnas.0736457100; YOUNG MP, 1992, SCIENCE, V256, P1327, DOI 10.1126/science.1598577	122	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183710	10.1371/journal.pone.0183710	http://dx.doi.org/10.1371/journal.pone.0183710			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846727	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600047
J	Ivanicova, Z; Valarik, M; Pankova, K; Travnivkova, M; Dolezel, J; Safar, J; Milec, Z				Ivanicova, Zuzana; Valarik, Miroslav; Pankova, Katerina; Travnivkova, Martina; Dolezel, Jaroslav; Safar, Jans; Milec, Zbynek			Heritable heading time variation in wheat lines with the same number of Ppd-B1 gene copies	PLOS ONE			English	Article							COPY NUMBER; DNA METHYLATION; FLOWERING TIME; SE GENE; VERNALIZATION; EARLINESS; REGION; LOCUS; PARAMUTATION; SEQUENCE	The ability of plants to identify an optimal flowering time is critical for ensuring the production of viable seeds. The main environmental factors that influence the flowering time include the ambient temperature and day length. In wheat, the ability to assess the day length is controlled by photoperiod (Ppd) genes. Due to its allohexaploid nature, bread wheat carries the following three Ppd-1 genes: Ppd-A1, Ppd-B1 and Ppd-D1. While photoperiod (in) sensitivity controlled by Ppd-A1 and Ppd-D1 is mainly determined by sequence changes in the promoter region, the impact of the Ppd-B1 alleles on the heading time has been linked to changes in the copy numbers (and possibly their methylation status) and sequence changes in the promoter region. Here, we report that plants with the same number of Ppd-B1 copies may have different heading times. Differences were observed among F-7 lines derived from crossing two spring hexaploid wheat varieties. Several lines carrying three copies of Ppd-B1 headed 16 days later than other plants in the population with the same number of gene copies. This effect was associated with changes in the gene expression level and methylation of the Ppd-B1 gene.	[Ivanicova, Zuzana; Valarik, Miroslav; Dolezel, Jaroslav; Safar, Jans; Milec, Zbynek] Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 31, Olomouc, Czech Republic; [Pankova, Katerina; Travnivkova, Martina] Crop Res Inst, Drnovska 507, Prague, Czech Republic; [Travnivkova, Martina] Czech Univ Life Sci Prague, Kamycka 129, Prague 6, Czech Republic	Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Czech Crop Research Institute (CRI); Czech University of Life Sciences Prague	Milec, Z (corresponding author), Inst Expt Bot, Ctr Reg Hana Biotechnol & Agr Res, Slechtitelu 31, Olomouc, Czech Republic.	milec@ueb.cas.cz	Dolezel, Jaroslav/B-7716-2008; Safar, Jan/G-1038-2014; Milec, Zbynek/F-8655-2014; Valárik, Miroslav/F-6129-2014	Dolezel, Jaroslav/0000-0002-6263-0492; Valárik, Miroslav/0000-0003-0143-6853; Milec, Zbynek/0000-0003-4724-9519	Ministry of Education, Youth and Sports of the Czech Republic [L01204]; Czech Science Foundation [P501-12-G090]; Ministry of Agriculture of the Czech Republic [MZE OR R00417]	Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Agriculture of the Czech Republic(Ministry of Agriculture, Czech Republic)	This work was supported by the Ministry of Education, Youth and Sports of the Czech Republic (award L01204 from the National Program of Sustainability I), Czech Science Foundation (grant no. P501-12-G090) and supported by Ministry of Agriculture of the Czech Republic, Project No. MZE OR R00417. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Beales J, 2007, THEOR APPL GENET, V115, P721, DOI 10.1007/s00122-007-0603-4; BIRD A, 1992, CELL, V70, P5, DOI 10.1016/0092-8674(92)90526-I; Bullrich L, 2002, THEOR APPL GENET, V105, P585, DOI 10.1007/s00122-002-0982-5; Cane K, 2013, CROP PASTURE SCI, V64, P100, DOI 10.1071/CP13086; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Della Vedova CB, 2004, PLANT CELL, V16, P1358, DOI 10.1105/tpc.160630; Diallo AO, 2012, MOL GENET GENOMICS, V287, P575, DOI 10.1007/s00438-012-0701-0; Diaz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033234; Dumas M, 2008, J DRUGS DERMATOLOG S, V6, P20; EHRLICH M, 1982, NUCLEIC ACIDS RES, V10, P2709, DOI 10.1093/nar/10.8.2709; Finnegan EJ, 2007, CURR BIOL, V17, P1978, DOI 10.1016/j.cub.2007.10.026; Force A, 1999, AM ZOOL, V39, p78A; Francia E, 2016, PLANT MOL BIOL, V92, P161, DOI 10.1007/s11103-016-0505-4; Giorgi D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057994; Henderson IR, 2010, EPIGENETICS-US, V5, P47, DOI 10.4161/epi.5.1.10560; Herman JJ, 2014, EVOLUTION, V68, P632, DOI 10.1111/evo.12324; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Ivanicova Z, 2016, NEW BIOTECHNOL, V33, P718, DOI 10.1016/j.nbt.2016.01.008; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; Kiss T, 2014, MOL BREEDING, V34, P297, DOI 10.1007/s11032-014-0034-2; Lewis S, 2008, J EXP BOT, V59, P3595, DOI 10.1093/jxb/ern209; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; Milec Z, 2012, MOL BREEDING, V30, P317, DOI 10.1007/s11032-011-9621-7; Newell-Price J, 2000, TRENDS ENDOCRIN MET, V11, P142, DOI 10.1016/S1043-2760(00)00248-4; Nishida H, 2013, MOL BREEDING, V31, P27, DOI 10.1007/s11032-012-9765-0; Nitcher R, 2013, MOL GENET GENOMICS, V288, P261, DOI 10.1007/s00438-013-0746-8; Piepho HP, 2000, GENETICS, V156, P2043; Pilu R, 2015, SEMIN CELL DEV BIOL, V44, P2, DOI 10.1016/j.semcdb.2015.08.015; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Saintenac C, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-r88; Simkova H, 2008, BMC GENOMICS, V9, DOI [10.1186/1471-2164-9-237, 10.1186/1471-2164-9-294]; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sun H, 2014, NEW PHYTOL, V204, P682, DOI 10.1111/nph.12948; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Valarik M, 2006, THEOR APPL GENET, V112, P945, DOI 10.1007/s00122-005-0198-6; Wurschum T, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0258-0; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang X, 2015, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2015/05/P05014; Zmienko A, 2014, THEOR APPL GENET, V127, P1, DOI 10.1007/s00122-013-2177-7	41	3	3	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183745	10.1371/journal.pone.0183745	http://dx.doi.org/10.1371/journal.pone.0183745			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846721	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600048
J	Hylkema, TH; Stevens, M; Van Beveren, J; Rijk, PC; van Jonbergen, HP; Brouwer, RW; Bulstra, SK; Brouwer, S				Hylkema, Tjerk H.; Stevens, Martin; Van Beveren, Jan; Rijk, Paul C.; van Jonbergen, Hans Peter; Brouwer, Reinoud W.; Bulstra, Sjoerd K.; Brouwer, Sandra			Preoperative characteristics of working-age patients undergoing total knee arthroplasty	PLOS ONE			English	Article							PHYSICAL-ACTIVITY QUESTIONNAIRE; QUALITY-OF-LIFE; TOTAL HIP; YOUNGER PATIENTS; HEALTH-STATUS; WOMAC OSTEOARTHRITIS; WESTERN-ONTARIO; OBESE-PATIENTS; COHORT KNEE; REPLACEMENT	Objective Total Knee Arthroplasty (TKA) is performed more in working-age (<65 years) patients. Until now, research in this patient population has been conducted mainly among retired (>= 65 years) patients. Aim of this study was therefore to describe demographic, physical, psychological and social characteristics of working TKA patients and to subsequently compare these characteristics with retired TKA patients and the general population. Methods A cross-sectional analysis. Preoperative data of 152 working TKA patients was used. These data were compared with existing data of retired TKA patients in hospital registers and with normative values from literature on the general population. Demographic, physical, psychological and social (including work) characteristics were analyzed. Results The majority (83.8%) of working TKA patients was overweight (42.6%) or obese (41.2%), a majority (72.4%) was dealing with two or more comorbidities, and most (90%) had few depressive symptoms. Mean physical activity level was 2950 minutes per week. Compared to the retired TKA population, working TKA patients perceived significantly more stiffness and better physical functioning and vitality, were more physically active, and perceived better mental health. Compared to the general population working TKA patients perceived worse physical functioning, worse physical health and better mental health, and worked fewer hours. Conclusion This study shows that a majority of working TKA patients are overweight/obese, have multiple comorbidities, but are highly active in light-intensity activities and have few depressive symptoms. Working patients scored overall better on preoperative characteristics than retired patients, and except for physical activity scored overall worse than the general population.	[Hylkema, Tjerk H.; Stevens, Martin; Bulstra, Sjoerd K.] Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands; [Hylkema, Tjerk H.; Brouwer, Sandra] Univ Groningen, Univ Med Ctr Groningen, Div Community & Occupat Med, Dept Hlth Sci, Groningen, Netherlands; [Van Beveren, Jan] Ropcke Zweers Hosp Hardenberg, Dept Orthoped, Hardenberg, Netherlands; [Rijk, Paul C.] Med Ctr Leeuwarden, Dept Orthoped, Leeuwarden, Netherlands; [van Jonbergen, Hans Peter] Deventer Hosp, Dept Orthoped, Deventer, Netherlands; [Brouwer, Reinoud W.] Martini Hosp Groningen, Dept Orthoped, Groningen, Netherlands	University of Groningen; University of Groningen; Medical Center Leeuwarden; Deventer Hospital; Martini Hospital	Hylkema, TH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Orthoped, Groningen, Netherlands.; Hylkema, TH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Div Community & Occupat Med, Dept Hlth Sci, Groningen, Netherlands.	t.h.hylkema@umcg.nl	Brouwer, Sandra/AAH-3182-2020; Stevens, Martin/A-5196-2013	Stevens, Martin/0000-0001-8183-6894				Aaronson NK, 1998, J CLIN EPIDEMIOL, V51, P1055, DOI 10.1016/S0895-4356(98)00097-3; Anema JR, 2009, J OCCUP REHABIL, V19, P419, DOI 10.1007/s10926-009-9202-3; Arden N, 2006, BEST PRACT RES CL RH, V20, P3, DOI 10.1016/j.berh.2005.09.007; Bauman A, 2009, J PHYS ACT HEALTH, V6, pS5, DOI 10.1123/jpah.6.s1.s5; Bedair H, 2014, J BONE JOINT SURG AM, V96A, P119, DOI 10.2106/JBJS.L.01736; Bellamy N, 2011, SEMIN ARTHRITIS RHEU, V41, P139, DOI 10.1016/j.semarthrit.2011.03.002; Bieleman HJ, 2010, ARTHRIT CARE RES, V62, P683, DOI 10.1002/acr.20112; Bliddal H, 2011, ANN RHEUM DIS, V70, P1798, DOI 10.1136/ard.2010.142018; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Culliford DJ, 2010, J BONE JOINT SURG BR, V92B, P130, DOI 10.1302/0301-620X.92B1.22654; Dauty M, 2007, Ann Readapt Med Phys, V50, P462, DOI 10.1016/j.annrmp.2007.04.012; De Filippis LG, 2004, INT J CLIN PHARM RES, V24, P103; Diduch DR, 1997, J BONE JOINT SURG AM, V79A, P575, DOI 10.2106/00004623-199704000-00015; Ethgen O, 2004, J BONE JOINT SURG AM, V86A, P963, DOI 10.2106/00004623-200405000-00012; Ethgen O, 2004, QUAL LIFE RES, V13, P321, DOI 10.1023/B:QURE.0000018492.40262.d1; Felson DT, 2000, ANN INTERN MED, V133, P635, DOI 10.7326/0003-4819-133-8-200010170-00016; Friedman RJ, 2013, CLIN ORTHOP RELAT R, V471, P3358, DOI 10.1007/s11999-013-3049-9; Gandhi R, 2010, KNEE, V17, P15, DOI 10.1016/j.knee.2009.06.003; Health Council of the Netherlands (RIVM), MAN PEOPL HAV OV; Heck DA, 1998, CLIN ORTHOP RELAT R, P93, DOI 10.1097/00003086-199811000-00015; Hermans J, 2012, ARTHRIT CARE RES, V64, P853, DOI 10.1002/acr.21617; Hoogeboom TJ, 2010, CLIN REHABIL, V24, P901, DOI 10.1177/0269215510371427; Jarvenpaa J, 2010, SCAND J SURG, V99, P45; Keeney JA, 2014, CLIN ORTHOP RELAT R, V472, P1210, DOI 10.1007/s11999-013-3376-x; Kemper HGC, 2000, TIJDSCHR SOC GEZONDH, V78, P180; Khatod M, 2008, ACTA ORTHOP, V79, P812, DOI 10.1080/17453670810016902; Kiebzak GM, 2002, AM J MANAG CARE, V8, P463; Kim S., 2008, ARTHRITIS RHEUM, V59, P481; Kim SH, 2012, J ARTHROPLASTY, V27, P1777, DOI 10.1016/j.arth.2012.06.017; Klit J, 2014, J ARTHROPLASTY, V29, P912, DOI 10.1016/j.arth.2013.09.035; Kocalevent RD, 2013, GEN HOSP PSYCHIAT, V35, P551, DOI 10.1016/j.genhosppsych.2013.04.006; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kurtz SM, 2009, CLIN ORTHOP RELAT R, V467, P2606, DOI 10.1007/s11999-009-0834-6; Leskinen J, 2012, ARTHRITIS RHEUM-US, V64, P423, DOI 10.1002/art.33367; Long WJ, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01259; Lutzner C, 2014, CLIN ORTHOP RELAT R, V472, P3933, DOI 10.1007/s11999-014-3813-5; Mathew J, 2013, INT J SPINE SURG, V7, DOI 10.1016/j.ijsp.2013.02.001; McConnell S, 2001, ARTHRIT RHEUM-ARTHR, V45, P453, DOI 10.1002/1529-0131(200110)45:5<453::AID-ART365>3.0.CO;2-W; Neogi T, 2013, RHEUM DIS CLIN N AM, V39, P1, DOI 10.1016/j.rdc.2012.10.004; Odum SM, 2013, J ARTHROPLASTY, V28, P148, DOI 10.1016/j.arth.2013.02.036; Otten Renee, 2010, Ned Tijdschr Geneeskd, V154, pA1534; PATE RR, 1995, JAMA-J AM MED ASSOC, V273, P402, DOI 10.1001/jama.273.5.402; Poos MJJC, 2009, HOE VAAK KOMT ARTROS; Ravi B, 2012, BEST PRACT RES CLIN, V26, P637, DOI DOI 10.1016/J.BERH.2012.07.014; Roorda LD, 2004, ANN RHEUM DIS, V63, P36, DOI 10.1136/ard.2002.001784; Roos EM, 1999, SCAND J RHEUMATOL, V28, P210; RUBIN DB, 1991, STAT MED, V10, P585, DOI 10.1002/sim.4780100410; Rubin DB, 2009, MULTIPLE IMPUTATION, V307; Scuderi GR, 2004, J ARTHROPLASTY, V19, P17, DOI 10.1016/j.arth.2004.02.014; Singh JA, 2014, ARTHRIT CARE RES, V66, P897, DOI 10.1002/acr.22233; Statistics Netherlands, 1989, HLTH QUEST 1989; Statistics Netherlands, LIF EXP ACC SEX; Statistics Netherlands, WERKL WERKZ BER MAAN; Statistics Netherlands, TOEN OND NED; Statistics Netherlands, GEM ARB AFG JAR NAUW; Stevenson JD, 2012, J ORTHOP SURG RES, V7, DOI 10.1186/1749-799X-7-15; Sutton PM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-14; Van der Zee KI, 1993, METEN ALGEMENE GEZON; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; W-Dahl A, 2010, ACTA ORTHOP, V81, P161, DOI 10.3109/17453670903413186; Wagenmakers R, 2008, PHYS THER, V88, P1039, DOI 10.2522/ptj.20070375; Wagenmakers R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-141; Wendel-Vos GCW, 2003, J CLIN EPIDEMIOL, V56, P1163, DOI 10.1016/S0895-4356(03)00220-8; Wesseling J, 2013, RHEUMATOLOGY, V52, P180, DOI 10.1093/rheumatology/kes288; Zambon S, 2016, ARTHRIT CARE RES, V68, P801, DOI 10.1002/acr.22755; Zhang W, 2010, J RHEUMATOL, V37, P1805, DOI 10.3899/jrheum.100123	66	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183550	10.1371/journal.pone.0183550	http://dx.doi.org/10.1371/journal.pone.0183550			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841709	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700041
J	Lu, YD; Jones, DJ; Sharara, N; Kaltenbach, T; Laine, L; McQuaid, K; Soetikno, R; Subramanian, V; Barkun, A				Lu, Yidan; Jones, Derek J.; Sharara, Nour; Kaltenbach, Tonya; Laine, Loren; McQuaid, Kenneth; Soetikno, Roy; Subramanian, Venkataraman; Barkun, Alan			Transparency ethics in practice: Revisiting financial conflicts of interest disclosure forms in clinical practice guidelines	PLOS ONE			English	Article							BOUNDED ETHICALITY; MANAGEMENT; RECOMMENDATIONS	Background Authors of clinical practice guidelines (CPGs) disclose financial conflicts of interest (FCOIs) to promote transparency ethics. Typically, they do so on standard declaration forms containing generic open-ended questions on FCOIs. Yet, the literature is scant on the format and effect of alternative disclosure forms. Does supplementing a standard form with subsequent detailed disclosure forms tailored to the context of the CPG improve the yield or accuracy of FCOIs declarations? Methods For an international CPG in gastroenterology on the endoscopic surveillance for colorectal neoplasia in inflammatory bowel disease, we compared the use of a standard FCOIs disclosure form with a contextual FCOIs disclosure form that detailed commercial relations related to the CPG topic. This included manufacturers of endoscopes, endoscopy equipment and accessories. Participants completed the generic form early, and the supplementary contextual form six months later. We then compared the FCOI disclosures obtained. Findings 26 participants provided FCOIs disclosures using both disclosure forms. We found discrepancies regarding (1) the disclosure of FCOIs (presence/absence), and (2) the listing of financial entities. While the number of participants who disclosed a FCOI remained the same (30.8%) using the two forms, disclosures were not from the same individuals: two additional participants disclosed a FCOI, whereas two participants withdrew previous disclosures. Among those who reported a FCOI in either form, we noted inconsistencies in disclosures for 70% of the participants. This included changes in FCOIs disclosure status or modifications of "their commercial relations". Discussion Accurate reporting of FCOIs advances the transparency and ethical integrity of CPGs. Our experience suggests that a contextual FCOIs disclosure form tailored to content of the CPG with narrow, detailed questions provides supplementary, more complete FCOIs declarations than generic forms alone. The finding raises challenges on how forms are best written and formatted, optimally timed, and more effectively processed with sensitivity to professional behaviour, so as to heighten transparency.	[Lu, Yidan; Sharara, Nour; Barkun, Alan] McGill Univ, Div Gastroenterol, Ctr Hlth, Montreal, PQ, Canada; [Jones, Derek J.] McGill Univ, Fac Law, Montreal, PQ, Canada; [Jones, Derek J.] Paris Sch Econ, Hospinn, Paris, France; [Jones, Derek J.] Publ Hosp Paris, Hospinn, Paris, France; [Kaltenbach, Tonya; McQuaid, Kenneth] San Francisco VA Med Ctr, Div Gastroenterol, San Francisco, CA USA; [Kaltenbach, Tonya; McQuaid, Kenneth] Univ Calif San Francisco, Div Gastroenterol, San Francisco, CA 94143 USA; [Laine, Loren] Yale Sch Med, Sect Digest Dis, New Haven, CT USA; [Laine, Loren] Vet Affairs Connecticut Healthcare Syst, Div Gastroenterol, West Haven, CT USA; [Soetikno, Roy] Vet Affairs Palo Alto Healthcare Syst, Div Gastroenterol, Palo Alto, CA USA; [Soetikno, Roy] Stanford Univ, Sch Med, Div Gastroenterol, Palo Alto, CA 94304 USA; [Subramanian, Venkataraman] Univ Leeds, Div Gastroenterol, Leeds, W Yorkshire, England; [Barkun, Alan] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; McGill University; Paris School of Economics; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; University of California System; University of California San Francisco; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; University of Leeds; McGill University	Barkun, A (corresponding author), McGill Univ, Div Gastroenterol, Ctr Hlth, Montreal, PQ, Canada.; Barkun, A (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	alan.barkun@muhc.mcgill.ca			Maxine and Jack Zarrow Family Foundation; William K Warren Foundations	Maxine and Jack Zarrow Family Foundation; William K Warren Foundations	The study and the writing of the manuscript were not supported by any funding source. However, the SCENIC guidelines process was supported by the Maxine and Jack Zarrow Family Foundation and William K Warren Foundations who had no involvement in the study.	Accreditation Council for Continuing Medical Education, 2011, STAND COMM SUPP STAN; Accreditation Council for Continuing Medical Education, 2012, STAND COMM SUPP STAN; Baethge C, 2013, PEERJ, V1, DOI 10.7717/peerj.128; Barkun AN, 2010, ANN INTERN MED, V152, P101, DOI 10.7326/0003-4819-152-2-201001190-00009; Bindslev JBB, 2013, BMC MED ETHICS, V14, DOI 10.1186/1472-6939-14-19; Cain DM, 2005, J LEGAL STUD, V34, P1, DOI 10.1086/426699; Canadian Association of Gastroenterology, 2008, POL APPL IMPL CLIN P; Classen DC, 2015, JAMA-J AM MED ASSOC, V314, P871, DOI 10.1001/jama.2015.7462; Cosgrove L, 2013, J EVAL CLIN PRACT, V19, P674, DOI 10.1111/jep.12016; Drazen JM, 2009, LANCET, V374, P1395, DOI 10.1016/S0140-6736(09)61796-7; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Fallone CA, 2016, TORONTO CONSENSUS TR; Graham R, 2011, CLINICAL PRACTICE GUIDELINES WE CAN TRUST, P1; Guidelines International Network, 2017, INT GUID LIBR; Jones DJ, 2012, ANN INTERN MED, V156, P809, DOI 10.7326/0003-4819-156-11-201206050-00008; Kern MC, 2009, PSYCHOL SCI, V20, P378, DOI 10.1111/j.1467-9280.2009.02296.x; Kredo T, 2016, INT J QUAL HEALTH C, V28, P122, DOI 10.1093/intqhc/mzv115; Laine L, 2015, GASTROENTEROLOGY, V148, P639, DOI 10.1053/j.gastro.2015.01.031; Lenzer J, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5535; Lo B, 2009, CONFLICT INTEREST ME, p[64, 71]; Lo B, 2009, CONFLICT INTEREST ME, P189; Loewenstein G, 2012, JAMA-J AM MED ASSOC, V307, P669, DOI 10.1001/jama.2012.154; National Institues of Health. Responsibility of Applicants for Promoting Objectivity in Research for Which Public Health Service Funding Is Sought and Responsible Prospective Contractors, 2011, FED REGISTER, V76, p53256 ; National Institute for Health and Care Excellence, 2014, POL CONFL INT; Norris SL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025153; Pham-Kanter G, 2014, MILBANK Q, V92, P446, DOI 10.1111/1468-0009.12073; Schunemann HJ, 2015, ANN INTERN MED, V163, P548, DOI 10.7326/M14-1885; Shu LL, 2012, P NATL ACAD SCI USA, V109, P15197, DOI 10.1073/pnas.1209746109; Singh H, 2014, CAN J GASTROENTEROL, V28, P473, DOI 10.1155/2014/680829; Stelfox HT, 1998, NEW ENGL J MED, V338, P101, DOI 10.1056/NEJM199801083380206; Woolf SH, 1999, BRIT MED J, V318, P527, DOI 10.1136/bmj.318.7182.527; Zhang T, 2015, ORGAN DYN, V44, P310, DOI 10.1016/j.orgdyn.2015.09.009	32	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182856	10.1371/journal.pone.0182856	http://dx.doi.org/10.1371/journal.pone.0182856			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841650	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700012
J	Zhang, SQ; Zeng, N; Alowayed, N; Singh, Y; Cheng, AC; Lang, F; Salker, MS				Zhang, Shaqiu; Zeng, Ni; Alowayed, Nour; Singh, Yogesh; Cheng, Anchun; Lang, Florian; Salker, Madhuri S.			Downregulation of endometrial mesenchymal marker SUSD2 causes cell senescence and cell death in endometrial carcinoma cells	PLOS ONE			English	Article							DOMAIN-CONTAINING 2; STEM-CELLS; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; STEM/STROMAL CELLS; PROTEIN MODULE; CANCER-CELLS; GALECTIN-1; EXPRESSION; TUMORIGENESIS	The cause of death among the majority of endometrial cancer patients involves migration of cancer cells within the peritoneal cavity and subsequent implantation of cancer spheroids into neighbouring organs. It is, thereby, important to identify factors that mediate metastasis. Cell adhesion and migration are modified by the mesenchymal stem cell (MSC) marker Sushi domain containing 2 (SUSD2), a type I transmembrane protein that participates in the orchestration of cell adhesion and migration through interaction with its partner Galactosidase-binding soluble-1 (LGALS1). MSCs have emerged as attractive targets in cancer therapy. Human endometrial adenocarcinoma (Ishikawa) cells were treated with TGF beta (10 ng/ml) for 72h. SUSD2, LGALS1 and MKI67 transcript levels were quantified using qRT-PCR. The proportion of SUSD2 positive (SUSD2+) cells and SMAD2/3 abundance were quantified by FACS and Western blotting, respectively. Senescent cells were identified with beta-galactosidase staining; cell cycle and cell death were quantified using Propidium Iodide staining. Treatment of endometrial cancer cells (Ishikawa cells) with TGF beta (10 ng/ml) significantly decreased SUSD2 transcript levels and the proportion of SUSD2 positive cells. Silencing of SUSD2 using siRNA resulted in senescence and cell death of Ishikawa cells via activation of SMAD2/3. These findings suggest that SUSD2 counteracts senescence and cell death and is thus a potential chemotherapeutic target in human endometrial cancer.	[Zhang, Shaqiu; Cheng, Anchun] Sichuan Agr Univ, Inst Prevent Vet Med, Chengdu, Sichuan, Peoples R China; [Zhang, Shaqiu; Zeng, Ni; Alowayed, Nour; Singh, Yogesh] Tubingen Univ, Dept Internal Med 3, Tubingen, Germany; [Singh, Yogesh] Tubingen Univ, Inst Med Genet & Appl Genom, Tubingen, Germany; [Lang, Florian; Salker, Madhuri S.] Tubingen Univ, Dept Physiol 1, Tubingen, Germany; [Salker, Madhuri S.] Univ Hosp Tubingen, Res Inst Womens Hlth, Tubingen, Germany	Sichuan Agricultural University; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Lang, F (corresponding author), Tubingen Univ, Dept Physiol 1, Tubingen, Germany.	florian.lang@uni-tuebingen.de	; Singh, Yogesh/T-8230-2017	Salker, Madhuri Sonal/0000-0002-7939-289X; Singh, Yogesh/0000-0001-6919-6273				Acosta JC, 2013, NAT CELL BIOL, V15, P978, DOI 10.1038/ncb2784; Braig M, 2005, NATURE, V436, P660, DOI 10.1038/nature03841; Burke W. M., 2014, GYNECOL ONCOL, V134, P385, DOI DOI 10.1016/J.YGYN0.2014.05.018; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cheng YY, 2016, TUMOR BIOL, V37, P9919, DOI 10.1007/s13277-015-4734-y; Ciccarelli FD, 2002, TRENDS BIOCHEM SCI, V27, P113, DOI 10.1016/S0968-0004(01)02049-7; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; COLOMBATTI A, 1993, MATRIX, V13, P297, DOI 10.1016/S0934-8832(11)80025-9; Coppe JP, 2006, J BIOL CHEM, V281, P29568, DOI 10.1074/jbc.M603307200; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; Di Cristofano A, 2007, ANNU REV PATHOL-MECH, V2, P57, DOI 10.1146/annurev.pathol.2.010506.091905; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Duraisamy S, 2006, GENE, V373, P28, DOI 10.1016/j.gene.2005.12.021; Gargett CE, 2016, HUM REPROD UPDATE, V22, P137, DOI 10.1093/humupd/dmv051; Gurung S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15042; Horbelt D, 2012, INT J BIOCHEM CELL B, V44, P469, DOI 10.1016/j.biocel.2011.12.013; Ikushima H, 2010, NAT REV CANCER, V10, P415, DOI 10.1038/nrc2853; Itoh S, 2000, NUCLEIC ACIDS RES, V28, P4291, DOI 10.1093/nar/28.21.4291; Jeschke U, 2009, J HISTOCHEM CYTOCHEM, V57, P871, DOI 10.1369/jhc.2009.952085; Kadoya T, 2005, CURR DRUG TARGETS, V6, P375, DOI 10.2174/1389450054022007; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Lama VN, 2007, J CLIN INVEST, V117, P989, DOI 10.1172/JCI29713; Letouzey V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127531; Liu XR, 2016, CANCER CELL INT, V16, DOI 10.1186/s12935-016-0286-5; Luo K., 2017, COLD SPRING HARBOR P, V9; Masuda H, 2012, CELL TRANSPLANT, V21, P2201, DOI 10.3727/096368911X637362; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Murakami K, 2014, ENDOCRINOLOGY, V155, P4542, DOI 10.1210/en.2014-1370; NORMAN DG, 1991, J MOL BIOL, V219, P717, DOI 10.1016/0022-2836(91)90666-T; Pan W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06812; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rajaraman G, 2013, TISSUE ENG PART C-ME, V19, DOI 10.1089/ten.tec.2011.0718; Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834; Sarugaser R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006498; Senturk S, 2010, HEPATOLOGY, V52, P966, DOI 10.1002/hep.23769; Shany S, 2016, ANTICANCER RES, V36, P6225, DOI 10.21873/anticanres.11216; Sheets JN, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.64; Sivasubramaniyan K, 2013, STEM CELLS DEV, V22, P1944, DOI 10.1089/scd.2012.0584; Su K, 2014, ACTA BIOMATER, V10, P5012, DOI 10.1016/j.actbio.2014.08.031; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; Sugahara T, 2007, CANCER SCI, V98, P909, DOI 10.1111/j.1349-7006.2007.00467.x; Tian H, 2016, ONCOL REP, V36, P1361, DOI 10.3892/or.2016.4942; Ulrich D, 2014, HUM REPROD, V29, P1895, DOI 10.1093/humrep/deu159; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Wu JF, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-21; Wu SQ, 2009, EXP CELL RES, V315, P3099, DOI 10.1016/j.yexcr.2009.09.009; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Yagi Hiroshi, 2013, Frontiers in Genetics, V4, P261, DOI 10.3389/fgene.2013.00261; Yu AL, 2010, INVEST OPHTH VIS SCI, V51, P5718, DOI 10.1167/iovs.10-5679	52	15	15	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183681	10.1371/journal.pone.0183681	http://dx.doi.org/10.1371/journal.pone.0183681			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841682	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700050
J	Bennani, A; El-Kettani, A; Hancali, A; El-Rhilani, H; Alami, K; Youbi, M; Rowley, J; Abu-Raddad, L; Smolak, A; Taylor, M; Mahiane, G; Stover, J; Korenromp, EL				Bennani, Aziza; El-Kettani, Amina; Hancali, Amina; El-Rhilani, Houssine; Alami, Kamal; Youbi, Mohamed; Rowley, Jane; Abu-Raddad, Laith; Smolak, Alex; Taylor, Melanie; Mahiane, Guy; Stover, John; Korenromp, Eline L.			The prevalence and incidence of active syphilis in women in Morocco, 1995-2016: Model-based estimation and implications for STI surveillance	PLOS ONE			English	Article								Background Evolving health priorities and resource constraints mean that countries require data on trends in sexually transmitted infections (STI) burden, to inform program planning and resource allocation. We applied the Spectrum STI estimation tool to estimate the prevalence and incidence of active syphilis in adult women in Morocco over 1995 to 2016. The results from the analysis are being used to inform Morocco's national HIV/STI strategy, target setting and program evaluation. Methods Syphilis prevalence levels and trends were fitted through logistic regression to data from surveys in antenatal clinics, women attending family planning clinics and other general adult populations, as available post-1995. Prevalence data were adjusted for diagnostic test performance, and for the contribution of higher-risk populations not sampled in surveys. Incidence was inferred from prevalence by adjusting for the average duration of infection with active syphilis. Results In 2016, active syphilis prevalence was estimated to be 0.56% in women 15 to 49 years of age (95% confidence interval, CI: 0.3%-1.0%), and around 21,675 (10,612 +/- 37,198) new syphilis infections have occurred. The analysis shows a steady decline in prevalence from 1995, when the prevalence was estimated to be 1.8% (1.0 +/- 3.5%). The decline was consistent with decreasing prevalences observed in TB patients, fishermen and prisoners followed over 2000-2012 through sentinel surveillance, and with a decline since 2003 in national HIV incidence estimated earlier through independent modelling. Conclusions Periodic population-based surveys allowed Morocco to estimate syphilis prevalence and incidence trends. This first-ever undertaking engaged and focused national stakeholders, and confirmed the still considerable syphilis burden. The latest survey was done in 2012 and so the trends are relatively uncertain after 2012. From 2017 Morocco plans to implement a system to record data from routine antenatal programmatic screening, which should help update and re-calibrate next trend estimations.	[Bennani, Aziza; El-Kettani, Amina; Youbi, Mohamed] Minist Hlth, Directorate Epidemiol & Dis Control, Rabat, Morocco; [Hancali, Amina] Natl Inst Hyg, Dept Bacteriol, STIs Lab, Rabat, Morocco; [El-Rhilani, Houssine; Alami, Kamal] UNAIDS Morocco Country Off, Rabat, Morocco; [Abu-Raddad, Laith; Smolak, Alex] Cornell Univ, Weill Cornell Med Coll Qatar, Doha, Qatar; [Taylor, Melanie] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Taylor, Melanie] Ctr Dis Control & Prevent, Div STD Prevent, Atlanta, GA USA; [Mahiane, Guy; Stover, John; Korenromp, Eline L.] Avenir Hlth, Glastonbury, CT 06033 USA	Qatar Foundation (QF); Weill Cornell Medical College Qatar; World Health Organization; Centers for Disease Control & Prevention - USA	Korenromp, EL (corresponding author), Avenir Hlth, Glastonbury, CT 06033 USA.	ekorenromp@avenirhealth.org	Abu-Raddad, Laith J/AAY-1441-2020	Abu-Raddad, Laith J/0000-0003-0790-0506	World Health Organization, Department of Reproductive Health and Research, STI program; Qatar National Research Fund [NPRP 9-040-3-008]	World Health Organization, Department of Reproductive Health and Research, STI program; Qatar National Research Fund(Qatar National Research Fund (QNRF))	The project was funded by the World Health Organization, Department of Reproductive Health and Research, STI program. LAR and AS acknowledge the support of Qatar National Research Fund (NPRP 9-040-3-008) that provided funding for collating data and analyses provided to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami K, 2002, East Mediterr Health J, V8, P794; Avenir Health, 2011, GOALS MAN MOD EST EF; Centers for Disease Control USA ICAP project at Columbia University Zimbabwe National AIDS Coun-cil (NAC), 2016, ZIMB POP BAS HIV IMP; El Kettani A, SEX TRANSM IN PRESS; El Kettani A, 2016, 17 IUSTI WORLD C MAR; Gerbase AC, 1998, SEX TRANSM INFECT, V74, pS12; Ham D Cal, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS10, DOI 10.1016/j.ijgo.2015.04.012; Hancali A, 2013, SEX TRANSM INFECT, V89, P24, DOI 10.1136/sextrans-2013-051166; Johnston LG, 2015, EPIDEMIOLOGY, V26, P846, DOI 10.1097/EDE.0000000000000362; Korenromp EL, 2001, SEX TRANSM DIS, V28, P613, DOI 10.1097/00007435-200111000-00001; Korenromp EL, 2017, SEX TRANSM INFECT; Korenromp EL, 2016, SPECTRUM MODEL ESTIM; Kouyoumjian SP, 2013, INT J STD AIDS, V24, P507, DOI 10.1177/0956462413477971; Kouyoumjian SP, 2014, NATL SOUSS MASSA DRA; Ministere de la sante A du Maroc, 2013, ETUD COMP ATT PRAT J; Ministere de la Sante A du Maroc, 2005, SURV SENT VIH SYPH; Ministere de la sante A du Maroc, 2007, ETUD COMP ATT PRAT J; Ministere de la Sante A du Maroc, 2016, EST NAT VIH SID 2016; Ministere de la Sante A [Maroc] ORC Macro Ligue desE A tats Arabes. Enquete sur la Population et la Sante A Familiale (EPSF) 2003-2004. Calverton Maryland USA Ministere de la Sante A et ORC Macro, 2005, ET PREV IST CHEZ FEM; Mumtaz G, 2010, NATL SOUSS MASSA DRA; Mumtaz GR, 2013, SEX TRANSM INFECT, V89, P49, DOI 10.1136/sextrans-2012-050844; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Newman L, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001396; Programme national de lutte contre les IST/ SIDA de la sante A du Maroc Direction de l'Epide-miologie et de Lutte contre les Maladies, 1999, SANT MAR DIR EP LUTT; Royaume du Maroc Programme National de lutte contre les IST/ SIDA Direction de l'e A pide A miologie et des luttes contre les maladies du de la Sante A, 2012, DIR EP LUTT MAL MIN; Royaume du Maroc Programme National de lutte contre les IST/ SIDA Direction de l'e A pide A miologie et des luttes contre les maladies du Ministere de la Sante A, 2001, DIR EP LUTT MAL MIN; South Africa Ministry of Health. National HIV and Syphilis Sero-Prevalence Survey of women attending, 2000, NAT HIV SYPH SER PRE; Stover J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154893; WHO, 2012, GLOB INC PREV SEL CU; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organisation,, 2016, GLOB HLTH SECT STRAT; World Health Organization, 2012, BAS REP GLOB SEX TRA; World Health Organization, 2015, TOOL STRENGTH STI SU; World Health Organization, 2007, GLOB EL CONG SYPH RA; World Health Organization, 2014, REP GLOB SEX TRANSM	35	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181498	10.1371/journal.pone.0181498	http://dx.doi.org/10.1371/journal.pone.0181498			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837558	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000008
J	Tsai, SB; Zhou, J; Gao, Y; Wang, JT; Li, GD; Zheng, YX; Ren, P; Xu, W				Tsai, Sang-Bing; Zhou, Jie; Gao, Yang; Wang, Jiangtao; Li, Guodong; Zheng, Yuxiang; Ren, Peng; Xu, Wei			Combining FMEA with DEMATEL models to solve production process problems	PLOS ONE			English	Article							FAILURE MODE; RISK-EVALUATION; GROWTH TRENDS; SUPPLIERS	Failure mode and effects analysis (FMEA) is an analysis tool for identifying and preventing flaws or defects in products during the design and process planning stage, preventing the repeated occurrence of problems, reducing the effects of these problems, enhancing product quality and reliability, saving costs, and improving competitiveness. However, FMEA can only analyze one influence factor according to its priority, rendering this method ineffective for systems containing multiple FMs whose effects are simultaneous or interact with one another. Accordingly, when FMEA fails to identify the influence factors and the factors being influenced, the most crucial problems may be placed in lower priority or remain unresolved. Decision-Making Trial and Evaluation Laboratory (DEMATEL) facilitates the determination of cause and effect factors; by identifying the causal factors that should be prioritized, prompt and effective solutions to core problems can be derived, thereby enhancing performance. Using the photovoltaic cell manufacturing industry in China as the research target, the present study combined FMEA with DEMATEL to amend the flaws of FMEA and enhance its effectiveness. First, FMEA was used to identify items requiring improvement. Then, DEMATEL was employed to examine the interactive effects and causal relationships of these items. Finally, the solutions to the problems were prioritized. The proposed method effectively combined the advantages of FMEA and DEMATEL to facilitate the identification of core problems and prioritization of solutions in the Chinese photovoltaic cell industry.	[Tsai, Sang-Bing; Wang, Jiangtao] Univ Elect Sci & Technol China, Zhongshan Inst, Guangzhou, Guangdong, Peoples R China; [Tsai, Sang-Bing; Li, Guodong] Civil Aviat Univ China, Econ & Management Coll, Tianjin, Peoples R China; [Tsai, Sang-Bing] Foshan Univ, Business & Law Sch, Foshan, Guangdong, Peoples R China; [Tsai, Sang-Bing; Zheng, Yuxiang] Shanghai Maritime Univ, Sch Econ & Management, Shanghai, Peoples R China; [Zhou, Jie] Nankai Univ, Coll Tourism & Serv Management, Tianjin, Peoples R China; [Gao, Yang] Dalian Univ Technol, Sch Business, Panjin, Peoples R China; [Ren, Peng; Xu, Wei] Nankai Univ, Sch Business, Tianjin, Peoples R China	University of Electronic Science & Technology of China; Civil Aviation University of China; Foshan University; Shanghai Maritime University; Nankai University; Dalian University of Technology; Nankai University	Tsai, SB (corresponding author), Univ Elect Sci & Technol China, Zhongshan Inst, Guangzhou, Guangdong, Peoples R China.; Tsai, SB; Li, GD (corresponding author), Civil Aviat Univ China, Econ & Management Coll, Tianjin, Peoples R China.; Tsai, SB (corresponding author), Foshan Univ, Business & Law Sch, Foshan, Guangdong, Peoples R China.; Tsai, SB; Zheng, YX (corresponding author), Shanghai Maritime Univ, Sch Econ & Management, Shanghai, Peoples R China.; Zhou, J (corresponding author), Nankai Univ, Coll Tourism & Serv Management, Tianjin, Peoples R China.; Ren, P; Xu, W (corresponding author), Nankai Univ, Sch Business, Tianjin, Peoples R China.	sangbing@hotmail.com; zhoujie_1980@126.com; 369890684@qq.com; yxzheng@shmtu.edu.cn; renptj@163.com; glxyl2017@163.com	Tsai, Sang-Bing/C-2978-2014	Tsai, Sang-Bing/0000-0001-6988-5829	National Social Science Fund of China [12BYJ125]; Provincial Nature Science Foundation of Guangdong [2015A030310271, 2015A030313679]; Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute [415YKQ08]; Tianjin philosophy and social science planning project [TJGL13-028]; Fundamental Research Funds for the Central Universities [ZXH2012N002]; Social Science Foundation of Tianjin [TJGL16-005]; Zhongshan City Science and Technology Bureau project	National Social Science Fund of China; Provincial Nature Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute; Tianjin philosophy and social science planning project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Social Science Foundation of Tianjin; Zhongshan City Science and Technology Bureau project	This work was supported by National Social Science Fund of China (No. 12BYJ125); Provincial Nature Science Foundation of Guangdong (No. 2015A030310271 and 2015A030313679); Academic Scientific Research Foundation for High-level Researcher, University of Electronic Science Technology of China, Zhongshan Institute (No. 415YKQ08); Tianjin philosophy and social science planning project (No. TJGL13-028); The Fundamental Research Funds for the Central Universities (No. ZXH2012N002); The Social Science Foundation of Tianjin (No. TJGL16-005); Zhongshan City Science and Technology Bureau project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arabian-Hoseynabadi H, 2010, INT J ELEC POWER, V32, P817, DOI 10.1016/j.ijepes.2010.01.019; Automotive Industry Action Group (AIAG), 1995, REF MAN POT FAIL MOD; Chang KH, 2014, J INTELL MANUF, V25, P1413, DOI 10.1007/s10845-013-0747-9; Chen HM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3746-4; Chen LH, 2010, EUR J OPER RES, V201, P619, DOI 10.1016/j.ejor.2009.03.010; Chen PS, 2013, COMPUT IND ENG, V66, P634, DOI 10.1016/j.cie.2013.09.018; Datas A, 2017, RENEW SUST ENERG REV, V73, P477, DOI 10.1016/j.rser.2017.01.071; Deng XY, 2014, EXPERT SYST APPL, V41, P635, DOI 10.1016/j.eswa.2013.07.088; Fontela E., 1976, DEMATEL 1976 REPORT; Gabus A., 1973, PERCEPTIONS WORLD PR; Geum Y, 2011, MATH COMPUT MODEL, V54, P3126, DOI 10.1016/j.mcm.2011.07.042; Guimaraes ACF, 2004, PROG NUCL ENERG, V44, P191, DOI 10.1016/j.pnucene.2003.12.001; Guo JJ, 2015, S AFR J IND ENG, V26, P56, DOI 10.7166/26-2-956; Huen P, 2017, RENEW SUST ENERG REV, V72, P1295, DOI 10.1016/j.rser.2016.10.042; Lee YC, 2014, PENSEE, V76, P190; Lee YC, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016641011; Liu HC, 2015, APPL SOFT COMPUT, V28, P579, DOI 10.1016/j.asoc.2014.11.036; Liu HC, 2014, EXPERT SYST APPL, V41, P4670, DOI 10.1016/j.eswa.2014.01.031; Liu HC, 2012, EXPERT SYST APPL, V39, P12926, DOI 10.1016/j.eswa.2012.05.031; Luthra S, 2016, RENEW SUST ENERG REV, V63, P379, DOI 10.1016/j.rser.2016.04.041; Qu Q, 2015, USING HYBRID MODEL E, DOI [10.1155/2015/361275, DOI 10.1155/2015/361275]; Sathe TM, 2017, RENEW SUST ENERG REV, V76, P645, DOI 10.1016/j.rser.2017.03.075; Shahin Arash, 2004, INT J QUALITY RELIAB, DOI DOI 10.1108/02656710410549082; SU JM, 2016, SPRINGERPLUS, V5; Tsai S. B., 2016, RENEWABLE SUSTAINAB; Tsai SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167710; Tsai SB, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-3774-0; Tsai SB, 2016, ENVIRON PLANN B, V43, P941, DOI 10.1177/0265813515600897; Tsai SB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154071; Tsai SB, 2016, CLEAN TECHNOL ENVIR, V18, P563, DOI 10.1007/s10098-015-1017-7; Tsai SB, 2014, P I MECH ENG B-J ENG, V228, P931, DOI 10.1177/0954405413509079; Sampaio PGV, 2017, RENEW SUST ENERG REV, V74, P590, DOI 10.1016/j.rser.2017.02.081; Xue JL, 2017, RENEW SUST ENERG REV, V73, P1, DOI 10.1016/j.rser.2017.01.098; Yang JP, 2011, ENG FAIL ANAL, V18, P2084, DOI 10.1016/j.engfailanal.2011.06.014; Zhang K.L., 2014, THESIS; Zhang KY, 2016, RESOUR POLICY, V47, P87, DOI 10.1016/j.resourpol.2016.01.005; Zhang XZ, 2013, INT J PROD RES, V51, P7405, DOI 10.1080/00207543.2012.757669; Zhou J., 2016, IEEE T SYSTEMS MAN C	38	51	52	3	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183634	10.1371/journal.pone.0183634	http://dx.doi.org/10.1371/journal.pone.0183634			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837663	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000092
J	Graham, AL; Zhao, K; Papandonatos, GD; Erar, B; Wang, X; Amato, MS; Cha, S; Cohn, AM; Pearson, JL				Graham, Amanda L.; Zhao, Kang; Papandonatos, George D.; Erar, Bahar; Wang, Xi; Amato, Michael S.; Cha, Sarah; Cohn, Amy M.; Pearson, Jennifer L.			A prospective examination of online social network dynamics and smoking cessation	PLOS ONE			English	Article							PARTNER SUPPORT; QUIT SMOKING; INTERVENTION; INTERNET; ABSTINENCE; COMMUNITY; HEALTH; TRIAL; RELAPSE; ADHERENCE	Introduction Use of online social networks for smoking cessation has been associated with abstinence. Little is known about the mechanisms through which the formation of social ties in an online network may influence smoking behavior. Using dynamic social network analysis, we investigated how temporal changes of an individual's number of social network ties are prospectively related to abstinence in an online social network for cessation. In a network where quitting is normative and is the focus of communications among members, we predicted that an increasing number of ties would be positively associated with abstinence. Method Participants were N = 2,657 adult smokers recruited to a randomized cessation treatment trial following enrollment on BecomeAnEX. org, a longstanding Internet cessation program with a large and mature online social network. At 3-months post-randomization, 30-day point prevalence abstinence was assessed and website engagement metrics were extracted. The social network was constructed with clickstream data to capture the flow of information among members. Two network centrality metrics were calculated at weekly intervals over 3 months: 1) indegree, defined as the number of members whose posts a participant read; and 2) out-degreeaware, defined as the number of members who read a participant's post and commented, which was subsequently viewed by the participant. Three groups of users were identified based on social network engagement patterns: non-users (N = 1,362), passive users (N = 812), and active users (N = 483). Logistic regression modeled 3-month abstinence by group as a function of baseline variables, website utilization, and network centrality metrics. Results Abstinence rates varied by group (non-users = 7.7%, passive users = 10.7%, active users = 20.7%). Significant baseline predictors of abstinence were age, nicotine dependence, confidence to quit, and smoking temptations in social situations among passive users (ps < .05); age and confidence to quit among active users. Among centrality metrics, positive associations with abstinence were observed for in-degree increases from Week 2 to Week 12 among passive and active users, and for out-degree-aware increases from Week 2 to Week 12 among active users (ps < .05). Conclusions This study is the first to demonstrate that increased tie formation among members of an online social network for smoking cessation is prospectively associated with abstinence. It also highlights the value of using individuals' activities in online social networks to predict their offline health behaviors.	[Graham, Amanda L.; Amato, Michael S.; Cha, Sarah; Cohn, Amy M.; Pearson, Jennifer L.] Truth Initiat, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA; [Graham, Amanda L.; Cohn, Amy M.] Georgetown Univ, Med Ctr, Dept Oncol, Canc Prevent & Control Program,Lombardi Comprehen, Washington, DC 20007 USA; [Zhao, Kang; Wang, Xi] Univ Iowa, Tippie Coll Business, Iowa City, IA USA; [Papandonatos, George D.; Erar, Bahar] Brown Univ, Ctr Stat Sci, Providence, RI 02912 USA; [Pearson, Jennifer L.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD USA	Georgetown University; University of Iowa; Brown University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Graham, AL (corresponding author), Truth Initiat, Schroeder Inst Tobacco Res & Policy Studies, Washington, DC USA.; Graham, AL (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Canc Prevent & Control Program,Lombardi Comprehen, Washington, DC 20007 USA.	agraham@truthinitiative.org	Pearson, Jennifer L/AAZ-9398-2020; Papandonatos, George D/J-2328-2014; Wang, Xi/AAJ-8100-2020	Pearson, Jennifer L/0000-0002-1400-5932; Papandonatos, George D/0000-0001-6770-932X; Wang, Xi/0000-0002-7568-0851; Zhao, Kang/0000-0002-8321-2804; Graham, Amanda/0000-0003-3036-9653; Amato, Michael/0000-0002-9769-957X; Cha, Sarah/0000-0003-3505-3164	National Cancer Institute of the National Institutes of Health as part of a trans-NIH initiative known as Collaborative Research on Addiction (GRAN) [R01 CM 92345]; NATIONAL CANCER INSTITUTE [R01CA192345] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health as part of a trans-NIH initiative known as Collaborative Research on Addiction (GRAN); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was funded by grant #R01 CM 92345 (ALG, KZ) from the National Cancer Institute of the National Institutes of Health (https://www.cancer.gov/) as part of a trans-NIH initiative known as Collaborative Research on Addiction (GRAN). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed OH, 2010, DISABIL REHABIL, V32, P1877, DOI 10.3109/09638281003734409; An LC, 2006, NICOTINE TOB RES, V8, pS7, DOI 10.1080/14622200601039881; [Anonymous], 2021, LANG ENV STAT COMP; Bandura A., 1986, SOCIAL FDN THOUGHT A; Bondy SJ, 2013, INT J ENV RES PUB HE, V10, P623, DOI 10.3390/ijerph10020623; Braha D, 2006, COMPLEXITY, V12, P59, DOI 10.1002/cplx.20156; Brandt CL, 2013, SCAND J PUBLIC HEALT, V41, P655, DOI 10.1177/1403494813489602; Burri M, 2006, NICOTINE TOB RES, V8, pS13, DOI 10.1080/14622200601042513; Centola D, 2010, SCIENCE, V329, P1194, DOI 10.1126/science.1185231; Cha S, 2016, ANN BEHAV MED; Christakis NA, 2008, BRIT MED J, V336, P1468, DOI 10.1136/bmj.a452; Christakis NA, 2008, NEW ENGL J MED, V358, P2249, DOI 10.1056/NEJMsa0706154; Chuang KY, 2012, J MED INTERNET RES, V14, P349, DOI 10.2196/jmir.1824; CLARKSON DB, 1993, ACM T MATH SOFTWARE, V19, P484, DOI 10.1145/168173.168412; Cobb Nathan K., 2013, Journal of the National Cancer Institute Monographs, P224, DOI 10.1093/jncimonographs/lgt020; Cobb NK, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.1911; Cobb NK, 2010, AM J PUBLIC HEALTH, V100, P1282, DOI 10.2105/AJPH.2009.165449; COHEN S, 1990, J CONSULT CLIN PSYCH, V58, P304, DOI 10.1037/0022-006X.58.3.304; Cohen S, 1988, MARSHALING SOCIAL SU; Cohen S, 2009, PERSPECT PSYCHOL SCI, V4, P375, DOI 10.1111/j.1745-6924.2009.01141.x; COPPOTELLI HC, 1985, J CONSULT CLIN PSYCH, V53, P455, DOI 10.1037/0022-006X.53.4.455; Coulson NS, 2013, J SUBST USE, P1; Cunningham JA, 2008, PATIENT EDUC COUNS, V70, P193, DOI 10.1016/j.pec.2007.10.003; Eckmann JP, 2004, P NATL ACAD SCI USA, V101, P14333, DOI 10.1073/pnas.0405728101; Eichhorn KC, 2008, J COMPUT-MEDIAT COMM, V14, P67, DOI 10.1111/j.1083-6101.2008.01431.x; Eysenbach G, 2005, J MED INTERNET RES, V7, DOI 10.2196/jmir.7.1.e11; Fiore MC, 2008, TREATING TOBACCO USE; FRIEDKIN NE, 1993, AM SOCIOL REV, V58, P861, DOI 10.2307/2095955; Gosling SD, 2003, J RES PERS, V37, P504, DOI 10.1016/S0092-6566(03)00046-1; Graham AL, 2017, TRANSL BEHAV MED; Graham AL, 2006, NICOTINE TOB RES, V8, pS49, DOI 10.1080/14622200601045367; Graham AL, 2017, NICOTINE TOB RES, V19, P324, DOI 10.1093/ntr/ntw282; Graham AL, 2015, HEALTH PSYCHOL, V34, P1286, DOI 10.1037/hea0000278; Graham AL, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-48; Graham AL, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.987; GRUDER CL, 1993, J CONSULT CLIN PSYCH, V61, P113, DOI 10.1037/0022-006X.61.1.113; Healey B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106603; HEATHERTON TF, 1991, BRIT J ADDICT, V86, P1119; Hennrikus D, 2010, PREV MED, V50, P134, DOI 10.1016/j.ypmed.2010.01.003; Japuntich SJ, 2006, NICOTINE TOB RES, V8, pS59, DOI 10.1080/14622200601047900; Kviz FJ, 2016, J AGING HEALTH, V6, P229, DOI [10.1177/089826439400600206, DOI 10.1177/089826439400600206]; Lakon CM, 2016, AM J PUBLIC HEALTH, V106, P1374, DOI 10.2105/AJPH.2016.303256; Laranjo L, 2015, J AM MED INFORM ASSN, V22, P243, DOI 10.1136/amiajnl-2014-002841; Lerman K, 2010, P 8 WORKSH MIN LEARN; LICHTENSTEIN E, 1986, BEHAV THER, V17, P607, DOI 10.1016/S0005-7894(86)80098-3; Maher CA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2952; Mao WJ, 2011, IEEE INTELL SYST, V26, P19, DOI 10.1109/MIS.2011.105; May S, 2000, TOB CONTROL, V9, P415, DOI 10.1136/tc.9.4.415; May S, 2006, PATIENT EDUC COUNS, V64, P235, DOI 10.1016/j.pec.2006.02.008; McBride CM, 2004, AM J PREV MED, V27, P232, DOI 10.1016/j.amepre.2004.06.005; McCausland KL, 2011, CASES PUBLIC HLTH CO, V5, P3, DOI DOI 10.2196/JMIR.2277; McClure JB, 2014, NICOTINE TOBACCO RES; MEHTA CR, 1986, ACM T MATH SOFTWARE, V12, P154, DOI 10.1145/6497.214326; MERMELSTEIN R, 1986, J CONSULT CLIN PSYCH, V54, P447, DOI 10.1037/0022-006X.54.4.447; MERMELSTEIN R, 1983, J CONSULT CLIN PSYCH, V51, P465, DOI 10.1037/0022-006X.51.3.465; Millington R, 2014, FEVERBEE; Munoz RF, 2009, NICOTINE TOB RES, V11, P1025, DOI 10.1093/ntr/ntp090; Myneni S, 2015, AM J PUBLIC HEALTH, pe1; Myneni S, 2013, STUD HEALTH TECHNOL, V192, P807, DOI 10.3233/978-1-61499-289-9-807; NYBORG KF, 1986, BEHAV THER, V17, P620, DOI 10.1016/S0005-7894(86)80099-5; ORLEANS CT, 1991, J CONSULT CLIN PSYCH, V59, P439, DOI 10.1037/0022-006X.59.3.439; Papandonatos GD, 2016, J CONSULT CLIN PSYCH, V84, P633, DOI 10.1037/ccp0000099; PARK EW, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD002928.PUB2; Patten CA, 2004, AM J PREV MED, V26, P386, DOI 10.1016/j.amepre.2004.02.008; Perrin A., 2015, SOCIAL NETWORKING US; Pew Research Center, INT US TIM 2014; Preece J, 2004, COMPUT HUM BEHAV, V20, P201, DOI 10.1016/j.chb.2003.10.015; Qiu B, 2010, P 2010 IEEE INT C SO; Richardson A, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2277; Saul JE, 2007, J MED INTERNET RES, V9, DOI 10.2196/jmir.9.4.e28; Schwarzer R, 2012, PREV MED; Selby P, 2010, J MED INTERNET RES, V12, DOI 10.2196/jmir.1340; Sillence E, 2012, HLTH EXPECTATIONS IN; Sillence E, 2013, CYBERPSYCH BEH SOC N, V16, P480, DOI 10.1089/cyber.2013.1512; Solomon LJ, 2005, PREV MED, V40, P306, DOI 10.1016/j.ypmed.2004.06.005; Tantipathananandh C, 2007, P 13 ACM SIGKDD INT; Valente TW, 1996, SOC NETWORKS, V18, P69, DOI 10.1016/0378-8733(95)00256-1; Vallone DM, 2009, AM J PUBLIC HEALTH, V101, P302; van Mierlo T, 2012, J MED INTERNET RES, V14, P45, DOI 10.2196/jmir.1854; VELICER WF, 1990, ADDICT BEHAV, V15, P271, DOI 10.1016/0306-4603(90)90070-E; WALDRON I, 1989, AM J PREV MED, V5, P136, DOI 10.1016/S0749-3797(18)31094-8; Westmaas JL, 2010, NICOTINE TOB RES, V12, P695, DOI 10.1093/ntr/ntq077; Zhang M, 2013, 2013 IEEE INT C HEAL; Zhao K, 2014, JAMIA; Zhao K, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5985	85	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183655	10.1371/journal.pone.0183655	http://dx.doi.org/10.1371/journal.pone.0183655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832621	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800077
J	Ostergren, O; Lundberg, O; Artnik, B; Bopp, M; Borrell, C; Kalediene, R; Leinsalu, M; Martikainen, P; Regidor, E; Rodriguez-Sanz, M; de Gelder, R; Mackenbach, JP				Ostergren, Olof; Lundberg, Olle; Artnik, Barbara; Bopp, Matthias; Borrell, Carme; Kalediene, Ramune; Leinsalu, Mall; Martikainen, Pekka; Regidor, Enrique; Rodriguez-Sanz, Maica; de Gelder, Rianne; Mackenbach, Johan P.			Educational expansion and inequalities in mortality-A fixed-effects analysis using longitudinal data from 18 European populations	PLOS ONE			English	Article							LIFE EXPECTANCY; LABOR-MARKET; HEALTH; TRENDS	Objective The aim of this paper is to empirically evaluate whether widening educational inequalities in mortality are related to the substantive shifts that have occurred in the educational distribution. Materials and methods Data on education and mortality from 18 European populations across several decades were collected and harmonized as part of the Demetriq project. Using a fixed-effects approach to account for time trends and national variation in mortality, we formally test whether the magnitude of relative inequalities in mortality by education is associated with the gender and age-group specific proportion of high and low educated respectively. Results The results suggest that in populations with larger proportions of high educated and smaller proportions of low educated, the excess mortality among intermediate and low educated is larger, all other things being equal. Conclusion We conclude that the widening educational inequalities in mortality being observed in recent decades may in part be attributed to educational expansion.	[Ostergren, Olof; Lundberg, Olle] Stockholm Univ, Ctr Hlth Equ Studies CHESS, Karolinska Inst, Stockholm, Sweden; [Artnik, Barbara] Univ Ljubljana, Dept Publ Hlth, Fac Med, Ljubljana, Slovenia; [Bopp, Matthias] Univ Zurich, Epidemiol Biostat & Prevent Inst, Zurich, Switzerland; [Borrell, Carme; Rodriguez-Sanz, Maica] Agencia Salut Publ Barcelona, Barcelona, Spain; [Kalediene, Ramune] Lithuanian Univ Hlth Sci, Kaunas, Lithuania; [Leinsalu, Mall] Sodertorn Univ, Stockholm Ctr Hlth & Social Change, Huddinge, Sweden; [Leinsalu, Mall] Natl Inst Hlth Dev, Dept Epidemiol & Biostat, Tallinn, Estonia; [Martikainen, Pekka] Univ Helsinki, Dept Sociol, Helsinki, Finland; [Regidor, Enrique] Univ Complutense Madrid, Dept Prevent Med & Publ Hlth, Madrid, Spain; [de Gelder, Rianne; Mackenbach, Johan P.] Erasmus MC, Dept Publ Hlth, Erasmus MC, Rotterdam, Netherlands	Karolinska Institutet; Stockholm University; University of Ljubljana; University of Zurich; Public Health Agency of Barcelona; Lithuanian University of Health Sciences; Sodertorn University; National Institute for Health Development - Estonia; University of Helsinki; Complutense University of Madrid; Erasmus University Rotterdam; Erasmus MC	Ostergren, O (corresponding author), Stockholm Univ, Ctr Hlth Equ Studies CHESS, Karolinska Inst, Stockholm, Sweden.	olof.ostergren@chess.su.se	Leinsalu, Mall/I-3768-2018	Leinsalu, Mall/0000-0003-4453-4760; Ostergren, Olof/0000-0002-7156-3260; Bopp, Matthias/0000-0003-0766-3723; Martikainen, Pekka/0000-0001-9374-1438	European Commission Research and Innovation Directorate General, Developing methodologies to reduce inequalities in the determinants of health (DEMETRIQ) project [278511]	European Commission Research and Innovation Directorate General, Developing methodologies to reduce inequalities in the determinants of health (DEMETRIQ) project	This work was supported by a grant (FP7-CP-FP grant no. 278511) from the European Commission Research and Innovation Directorate General, as part of the Developing methodologies to reduce inequalities in the determinants of health (DEMETRIQ) project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison PD, 2002, SOCIOL METHODOL, V32, P247, DOI 10.1111/1467-9531.00117; ARRIAGA EE, 1984, DEMOGRAPHY, V21, P83, DOI 10.2307/2061029; Bambra C., 2011, J EPIDEMIOLOGY COMMU; Bernardi F, 2012, RES SOC STRAT MOBIL, V30, P159, DOI 10.1016/j.rssm.2011.05.005; Bol T., 2015, ACTA SOCIOL; Bradley K, 2000, SOCIOL EDUC, V73, P1, DOI 10.2307/2673196; Case A, 2005, J HEALTH ECON, V24, P365, DOI 10.1016/j.jhealeco.2004.09.008; Cipollone A, 2014, IZA J EUR LABOR STUD, V3, DOI 10.1186/2193-9012-3-18; Cutler DM, 2006, ED HLTH EVALUATING T; Galobardes B, 2004, EPIDEMIOL REV, V26, P7, DOI 10.1093/epirev/mxh008; Gesthuizen M, 2011, EUR SOCIOL REV, V27, P264, DOI 10.1093/esr/jcq006; Goldthorpe J., 2013, BARNETT PAPERS SOCIA; Goldthorpe John H., 2013, BARNETT PAPERS SOCIA; Hallerod B, 2011, SOC SCI MED, V72, P116, DOI 10.1016/j.socscimed.2010.09.036; Hertz T, 2007, BE J ECON ANAL POLI, V7, DOI 10.2202/1935-1682.1775; Kunst A.E., 2004, DEMOGR RES S, V2, P229, DOI [10.4054/demres.2004.s2.9, 10.4054/DemRes.2004.S2.9]; Leon DA, 2011, INT J EPIDEMIOL, V40, P271, DOI 10.1093/ije/dyr061; Ljungdahl S., 2015, EUROPEAN J PUBLIC HL; Lohmann H., 2014, ED POVERTY COMP PERS; Maas C.J.M., 2005, METHODOLOGY, V1, P86, DOI [10.1027/1614-2241.1.3.86, DOI 10.1027/1614-2241.1.3.86]; Mackenbach JP, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1732; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Mackenbach JP, 1997, SOC SCI MED, V44, P757, DOI 10.1016/S0277-9536(96)00073-1; Meschi E., 2013, EMPIR ECON, P1; Mirowsky J., 2003, ED SOCIAL STATUS HLT; Mohring K., 2012, CRAFTING CROSS NATL, P1; Montez JK, 2014, DEMOGRAPHY, V51, P413, DOI 10.1007/s13524-013-0261-x; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Shkolnikov V.M., 2011, J EPIDEMIOLOGY COMMU; Solga H, 2002, EUR SOCIOL REV, V18, P159, DOI 10.1093/esr/18.2.159; Wolbers MHJ, 2001, ACTA SOCIOL, V44, P5, DOI 10.1177/000169930104400102	31	16	16	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182526	10.1371/journal.pone.0182526	http://dx.doi.org/10.1371/journal.pone.0182526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832601	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800027
J	Rashidi, M; Novy, RG; Wallis, CM; Rashed, A				Rashidi, Mahnaz; Novy, Richard G.; Wallis, Christopher M.; Rashed, Arash			Characterization of host plant resistance to zebra chip disease from species-derived potato genotypes and the identification of new sources of zebra chip resistance	PLOS ONE			English	Article							CANDIDATUS LIBERIBACTER SOLANACEARUM; COCKERELLI HEMIPTERA TRIOZIDAE; PSYLLID BACTERICERA-COCKERELLI; SYSTEMIC ACQUIRED-RESISTANCE; TRANSMISSION EFFICIENCY; VECTOR TRANSMISSION; UNITED-STATES; SUSCEPTIBILITY; INFECTION; GERMPLASM	Candidatus Liberibacter solanacearum' (Lso), an uncultivable phloem-limited phytopathogenic bacteria, is known to be associated with Zebra Chip disease (ZC), which represents a major threat to potato production in the US and elsewhere. This pathogen is transmitted by the phloem-feeding potato psyllid, Bactericera cockerelli Sulc (Hem. Triozidae). Currently, there are no reports of resistance to ZC in cultivated potatoes. This greenhouse study was conducted to evaluate Lso transmission success and the susceptibility of 11 potato breeding clones, representing diverge genetic background, to ZC, in relation to a susceptible commercial cultivar, Russet Burbank. Individual plants were exposed to two Lso-positive potato psyllids for 48 hours. The percentage of successful Lso transmission varied across the evaluated genotypes ranging between 7 and 57%. Freshly-cut and fried tubers showed significant variation in ZC symptom severity among the breeding clones, with several genotypes expressing relative tolerance when compared to Russet Burbank. None of the evaluated clones showed statistically lower Lso titers than Russet Burbank with the exception of one genotype in the second year of the study. However, the presence of a non-significant relationship between average symptom severity and Lso titer indicated variations in phenotypic responses (i.e. tolerance) to Lso existed among evaluated breeding lines. Breeding clones A07781-3LB, A07781-4LB and A07781-10LB had relatively lower Lso titer (low susceptibility) and tuber symptom expression (high tolerance) among the tested genotypes. As these three clones represent full siblings, the observed effects could be indicative of the presence of a genetic basis for resistance/tolerance to ZC. Findings provide a better understanding of resistance/tolerance to ZC, and contribute to continued efforts in breeding for resistance to this disease.	[Rashidi, Mahnaz; Rashed, Arash] Univ Idaho, Aberdeen Res & Extens Ctr, Dept Entomol Plant Pathol & Nematol, Aberdeen, ID 83210 USA; [Rashidi, Mahnaz] Univ Florida, Citrus Res & Educ Ctr, Dept Entomol, Lake Alfred, FL USA; [Novy, Richard G.] USDA ARS, Small Grains & Potato Germplasm Res Unit, Aberdeen, ID 20250 USA; [Wallis, Christopher M.] USDA ARS, Crop Dis Pests & Genet Res Unit, Parlier, CA USA	Idaho; University of Idaho; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); United States Department of Agriculture (USDA)	Rashed, A (corresponding author), Univ Idaho, Aberdeen Res & Extens Ctr, Dept Entomol Plant Pathol & Nematol, Aberdeen, ID 83210 USA.	arashed@uidaho.edu	Wallis, Christopher/AFO-9404-2022	Wallis, Christopher/0000-0003-3855-8256	United States Department of Agriculture- National Institute of Food and Agriculture [2014-67014-22408]; United States Department of Agriculture- National Institute of Food and Agriculture, Hatch project [IDA01506]; United States Department of Agriculture-ARS-State Partnership Potato Grant [58-5366-4-008]	United States Department of Agriculture- National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); United States Department of Agriculture- National Institute of Food and Agriculture, Hatch project; United States Department of Agriculture-ARS-State Partnership Potato Grant	This work was supported by the United States Department of Agriculture- National Institute of Food and Agriculture (2014-67014-22408); United States Department of Agriculture- National Institute of Food and Agriculture, Hatch project IDA01506 to AR; United States Department of Agriculture-ARS-State Partnership Potato Grant (Agreement #58-5366-4-008) to RGN and AR.; We would like to thank F. Aguilar, B. Schneider, R. K. Cruzado, A. Silva, C. Lowder, L. Paetzold, and A. Gonzalez for their help with different aspects of this project. This work was supported by the USDA-National Institute of Food and Agriculture, Hatch/Rashed project IDA01506, USDA- National Institute of Food and Agriculture project 2014-67014-22408, and USDA-ARS-State Partnership Potato Grant, Agreement #58-5366-4-008. Mention of trade names or commercial products in this publication is solely for the purpose of providing specific information and does not imply recommendation or endorsement by the U.S. Department of Agriculture. USDA is an equal opportunity provider and employer.	Agrios NG, 1977, GENETIC PLANT DIS, P115; Anderson JAD, 2013, AM J POTATO RES, V90, P58, DOI 10.1007/s12230-012-9276-x; Bragard C, 2013, ANNU REV PHYTOPATHOL, V51, P177, DOI 10.1146/annurev-phyto-082712-102346; Buchman JL, 2011, J ECON ENTOMOL, V104, P1486, DOI 10.1603/EC11123; Butler CD, 2011, CROP PROT, V30, P1233, DOI 10.1016/j.cropro.2011.05.006; Casteel CL, 2014, PLANT J, V77, P653, DOI 10.1111/tpj.12417; Cooper WR, 2016, AM J POTATO RES, V93, P386, DOI 10.1007/s12230-016-9512-x; Cooper WR, 2014, AM J POTATO RES, V91, P532, DOI 10.1007/s12230-014-9384-x; Crosslin JM, 2012, PLANT DIS, V96, P452, DOI 10.1094/PDIS-10-11-0894; Diaz-Montano J, 2014, AM J POTATO RES, V91, P363, DOI 10.1007/s12230-013-9356-6; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; Hansen AK, 2008, APPL ENVIRON MICROB, V74, P5862, DOI 10.1128/AEM.01268-08; Levy J, 2014, J ECON ENTOMOL, V107, P1187, DOI 10.1603/EC13295; Levy JG, 2015, AM J POTATO RES, V92, P417, DOI 10.1007/s12230-015-9452-x; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Li WB, 2009, J MICROBIOL METH, V78, P59, DOI 10.1016/j.mimet.2009.04.009; Liu D, 2007, ENTOMOL EXP APPL, V123, P35, DOI 10.1111/j.1570-7458.2007.00521.x; Lopes SA, 2009, PLANT DIS, V93, P257, DOI 10.1094/PDIS-93-3-0257; Marzachi C, 1998, ANN APPL BIOL, V133, P45, DOI 10.1111/j.1744-7348.1998.tb05801.x; Miles GP, 2010, AM J POTATO RES, V87, P337, DOI 10.1007/s12230-010-9140-9; Munyaneza JE, 2007, J ECON ENTOMOL, V100, P656, DOI 10.1603/0022-0493(2007)100[656:AOBCHP]2.0.CO;2; Munyaneza JE, 2012, AM J POTATO RES, V89, P329, DOI 10.1007/s12230-012-9262-3; Munyaneza JE, 2012, PLANT DIS, V96, P18, DOI 10.1094/PDIS-03-11-0185; Munyaneza JE, 2011, AM J POTATO RES, V88, P435, DOI 10.1007/s12230-011-9209-0; Prager SM, 2015, ENVIRON ENTOMOL, V44, P1065, DOI 10.1093/ee/nvv081; Prager SM, 2013, CROP PROT, V54, P84, DOI 10.1016/j.cropro.2013.08.001; Rashed A, 2013, PHYTOPATHOLOGY, V103, P419, DOI 10.1094/PHYTO-09-12-0244-R; Rashed A, 2012, PHYTOPATHOLOGY, V102, P1079, DOI 10.1094/PHYTO-04-12-0094-R; Rashed A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055326; Ryals JA, 1996, PLANT CELL, V8, P1809, DOI 10.1105/tpc.8.10.1809; Secor GA, 2009, PLANT DIS, V93, P574, DOI 10.1094/PDIS-93-6-0574; Stout MJ, 2006, ANNU REV ENTOMOL, V51, P663, DOI 10.1146/annurev.ento.51.110104.151117; Swisher KD, 2012, ENVIRON ENTOMOL, V41, P1019, DOI 10.1603/EN12066; Wallis CM, 2015, PHYTOPATHOLOGY, V105, P1573, DOI 10.1094/PHYTO-02-15-0040-R; Wen A., 2012, P 11 ANN SCRI ZEBR C, P74; Zeilinger AR, 2014, OIKOS, V123, P613, DOI 10.1111/j.1600-0706.2013.01074.x	36	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183283	10.1371/journal.pone.0183283	http://dx.doi.org/10.1371/journal.pone.0183283			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832618	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800054
J	Zetterberg, C; Forsman, M; Richter, HO				Zetterberg, Camilla; Forsman, Mikael; Richter, Hans O.			Neck/shoulder discomfort due to visually demanding experimental near work is influenced by previous neck pain, task duration, astigmatism, internal eye discomfort and accommodation	PLOS ONE			English	Article							GENERALIZED ESTIMATING EQUATIONS; COMPUTER VISION SYNDROME; TRAPEZIUS MUSCLE; MUSCULOSKELETAL DISORDERS; SHOULDER SYMPTOMS; UPPER EXTREMITY; RISK-FACTORS; INTERVENTIONS; POWERREFRACTOR; PERFORMANCE	Visually demanding near work can cause eye discomfort, and eye and neck/shoulder discomfort during, e.g., computer work are associated. To investigate direct effects of experimental near work on eye and neck/shoulder discomfort, 33 individuals with chronic neck pain and 33 healthy control subjects performed a visual task four times using four different trial lenses (referred to as four different viewing conditions), and they rated eye and neck/shoulder discomfort at baseline and after each task. Since symptoms of eye discomfort may differ depending on the underlying cause, two categories were used; internal eye discomfort, such as ache and strain, that may be caused by accommodative or vergence stress; and external eye discomfort, such as burning and smarting, that may be caused by dry-eye disorders. The cumulative performance time (reflected in the temporal order of the tasks), astigmatism, accommodation response and concurrent symptoms of internal eye discomfort all aggravated neck/shoulder discomfort, but there was no significant effect of external eye discomfort. There was also an interaction effect between the temporal order and internal eye discomfort: participants with a greater mean increase in internal eye discomfort also developed more neck/shoulder discomfort with time. Since moderate musculoskeletal symptoms are a risk factor for more severe symptoms, it is important to ensure a good visual environment in occupations involving visually demanding near work.	[Zetterberg, Camilla; Richter, Hans O.] Univ Gavle, Fac Hlth & Occupat Studies, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden; [Forsman, Mikael] Karolinska Inst, Inst Environm Med, Stockholm, Sweden	University of Gavle; Karolinska Institutet	Zetterberg, C (corresponding author), Univ Gavle, Fac Hlth & Occupat Studies, Dept Occupat & Publ Hlth Sci, Ctr Musculoskeletal Res, Gavle, Sweden.	camilla.zetterberg@hig.se	Forsman, Mikael/AAE-5119-2020	Zetterberg, Camilla/0000-0002-2919-3921; Forsman, Mikael/0000-0001-5777-4232	University of Gavle; Swedish Research Council for Health, Working Life and Welfare [2005-0488, 2009-1761]	University of Gavle; Swedish Research Council for Health, Working Life and Welfare(Swedish Research CouncilSwedish Research Council for Health Working Life & Welfare (Forte))	This study was funded by internal funds from the University of Gavle and by external funds from the Swedish Research Council for Health, Working Life and Welfare (reference number 2005-0488 and 2009-1761). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anshel J., 2005, VISUAL ERGONOMICS HD; Babyak MA, 2004, PSYCHOSOM MED, V66, P411, DOI 10.1097/01.psy.0000127692.23278.a9; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; BERGQVIST U, 1995, ERGONOMICS, V38, P754, DOI 10.1080/00140139508925147; Blade PJ, 2006, OPTOMETRY VISION SCI, V83, P346, DOI 10.1097/01.opx.0000221402.35099.fb; Blehm C, 2005, SURV OPHTHALMOL, V50, P253, DOI 10.1016/j.survophthal.2005.02.008; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Brewer S, 2006, J OCCUP REHABIL, V16, P325, DOI 10.1007/s10926-006-9031-6; Cagnie B, 2007, EUR SPINE J, V16, P679, DOI 10.1007/s00586-006-0269-7; Camm AJ, 1996, EUR HEART J, V17, P354; Cote P, 2008, SPINE, V33, pS60, DOI 10.1097/BRS.0b013e3181643ee4; Fitzmaurice G, 2011, APPL LONGITUDINAL AN, V2nd; Garcia-Munoz Angel, 2014, J Optom, V7, P178, DOI 10.1016/j.optom.2014.06.005; Gerr F, 2005, OCCUP ENVIRON MED, V62, P478, DOI 10.1136/oem.2004.015792; Ghisletta P, 2004, J EDUC BEHAV STAT, V29, P421, DOI 10.3102/10769986029004421; Hanley JA, 2003, AM J EPIDEMIOL, V157, P364, DOI 10.1093/aje/kwf215; Hemphala H, 2012, WORK, V41, P3433, DOI 10.3233/WOR-2012-0620-3433; Hemphala H, 2012, APPL ERGON, V43, P217, DOI 10.1016/j.apergo.2011.05.006; Hunt OA, 2003, BRIT J OPHTHALMOL, V87, P1504, DOI 10.1136/bjo.87.12.1504; Huysmans MA, 2012, INT ARCH OCC ENV HEA, V85, P651, DOI 10.1007/s00420-011-0717-5; JONSSON B, 1982, Journal of Human Ergology, V11, P73; Lavrich JB, 2010, CURR OPIN OPHTHALMOL, V21, P356, DOI 10.1097/ICU.0b013e32833cf03a; LIE I, 1987, EUR J APPL PHYSIOL, V56, P151, DOI 10.1007/BF00640638; Madeleine P, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-226; Mathiassen SE, 1995, J ELECTROMYOGR KINES, V5, P197, DOI 10.1016/1050-6411(94)00014-X; Nordlund A, 2004, OCCUP ENVIRON MED, V61, DOI 10.1136/oem.2002.005249; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Portello JK, 2012, OPHTHAL PHYSL OPT, V32, P375, DOI 10.1111/j.1475-1313.2012.00925.x; Punnett L., 1997, VISUAL DISPLAY UNIT; Richter HO, 2007, OPHTHAL PHYSL OPT, V27, P361, DOI 10.1111/j.1475-1313.2007.00494.x; Richter HO, 2011, EUR J APPL PHYSIOL, V111, P29, DOI 10.1007/s00421-010-1629-x; Richter HO, 2011, WORK, V39, P67, DOI 10.3233/WOR-2011-1152; Robertson MM, 2013, APPL ERGON, V44, P73, DOI 10.1016/j.apergo.2012.05.001; Rosenfield M, 2012, OPHTHAL PHYSL OPT, V32, P142, DOI 10.1111/j.1475-1313.2011.00887.x; Rosenfield M, 2011, OPHTHAL PHYSL OPT, V31, P502, DOI 10.1111/j.1475-1313.2011.00834.x; ROSSIGNOL AM, 1987, J OCCUP ENVIRON MED, V29, P112; Sheedy JE, 2003, OPTOMETRY VISION SCI, V80, P732, DOI 10.1097/00006324-200311000-00008; Thorn S, 2007, J ELECTROMYOGR KINES, V17, P420, DOI 10.1016/j.jelekin.2006.04.010; Toomingas A, 2014, WORK, V47, P291, DOI 10.3233/WOR-131778; Visser B, 2006, J ELECTROMYOGR KINES, V16, P1, DOI 10.1016/j.jelekin.2005.06.005; Waersted M, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-79; WIDROW B, 1975, P IEEE, V63, P1692, DOI 10.1109/PROC.1975.10036; Wiggins N P, 1992, J Am Optom Assoc, V63, P177; Wiggins N P, 1991, J Am Optom Assoc, V62, P680; Wiholm C, 2007, SCAND J WORK ENV HEA, P54; Wolffsohn JS, 2002, OPHTHAL PHYSL OPT, V22, P380, DOI 10.1046/j.1475-1313.2002.00050.x; Woods V, 2005, OCCUP MED-OXFORD, V55, P121, DOI 10.1093/occmed/kqi029; Zetterberg C, 2013, J ELECTROMYOGR KINES, V23, P1190, DOI 10.1016/j.jelekin.2013.06.003	49	18	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182439	10.1371/journal.pone.0182439	http://dx.doi.org/10.1371/journal.pone.0182439			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832612	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800023
J	Butt, ZA; Shrestha, N; Wong, S; Kuo, M; Gesink, D; Gilbert, M; Wong, J; Yu, A; Alvarez, M; Samji, H; Buxton, JA; Johnston, JC; Cook, VJ; Rothe, D; Consolacion, T; Murti, M; Hottes, TS; Ogilvie, G; Balshaw, R; Tyndall, MW; Krajden, M; Janjua, NZ				Butt, Zahid Ahmad; Shrestha, Nabin; Wong, Stanley; Kuo, Margot; Gesink, Dionne; Gilbert, Mark; Wong, Jason; Yu, Amanda; Alvarez, Maria; Samji, Hasina; Buxton, Jane A.; Johnston, James C.; Cook, Victoria J.; Rothe, David; Consolacion, Theodora; Murti, Michelle; Hottes, Travis S.; Ogilvie, Gina; Balshaw, Robert; Tyndall, Mark W.; Krajden, Mel; Janjua, Naveed Z.		BC Hepatitis Testers Cohort	A syndemic approach to assess the effect of substance use and social disparities on the evolution of HIV/HCV infections in British Columbia	PLOS ONE			English	Article							HEPATITIS-C VIRUS; ILLICIT DRUG-USE; HIV; CANADA; COINFECTION; POPULATION; DISEASE; COMORBIDITIES; TUBERCULOSIS; MORTALITY	Background Co-occurrence of social conditions and infections may affect HIV/HCV disease risk and progression. We examined the changes in relationship of these social conditions and infections on HIV and hepatitis C virus (HCV) infections over time in British Columbia during 1990-2013. Methods The BC Hepatitis Testers Cohort (BC-HTC) includes similar to 1.5 million individuals tested for HIV or HCV, or reported as a case of HCV, HIV, HBV, or tuberculosis linked to administrative health-care databases. We classified HCV and HIV infection status into five combinations: HIV-/HCV-, HIV+monoinfected, HIV-/HCV+seroconverters, HIV-/HCV+prevalent, and HIV+/HCV+. Results Of 1.37 million eligible individuals, 4.1% were HIV-/HCV+ prevalent, 0.5% HIV+ monoinfected, 0.3% HIV+/HCV+ co-infected and 0.5% HIV-/HCV+seroconverters. Overall, HIV+ monoinfected individuals lived in urban areas (92%), had low injection drug use (IDU) (4%), problematic alcohol use (4%) and were materially more privileged than other groups. HIV +/HCV+ co-infected and HIV-/HCV+ seroconverters were materially most deprived (37%, 32%), had higher IDU (28%, 49%), problematic alcohol use (14%, 17%) and major mental illnesses (12%, 21%). IDU, opioid substitution therapy, and material deprivation increased in HIV-/HCV+ seroconverters over time. In multivariable multinomial regression models, over time, the odds of IDU declined among HIV-/HCV+ prevalent and HIV+monoinfected individuals but not in HIV-/HCV+seroconverters. Declines in odds of problematic alcohol use were observed in HIV-/HCV+seroconverters and coinfected individuals over time. Conclusions These results highlight need for designing prevention, care and support services for HIV and HCV infected populations based on the evolving syndemics of infections and social conditions which vary across groups.	[Butt, Zahid Ahmad; Shrestha, Nabin; Wong, Jason; Buxton, Jane A.; Johnston, James C.; Cook, Victoria J.; Murti, Michelle; Ogilvie, Gina; Tyndall, Mark W.; Krajden, Mel; Janjua, Naveed Z.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Wong, Stanley; Kuo, Margot; Gilbert, Mark; Wong, Jason; Yu, Amanda; Alvarez, Maria; Samji, Hasina; Buxton, Jane A.; Johnston, James C.; Cook, Victoria J.; Rothe, David; Consolacion, Theodora; Ogilvie, Gina; Balshaw, Robert; Tyndall, Mark W.; Krajden, Mel; Janjua, Naveed Z.] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Gesink, Dionne] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hottes, Travis S.; Krajden, Mel] BCCDC Publ Hlth Lab, Vancouver, BC, Canada; [Murti, Michelle] Fraser Hlth, Surrey, BC, Canada	University of British Columbia; University of Toronto	Butt, ZA (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	zahid.butt@bccdc.ca	Alvarez, Maria/GZH-1345-2022; Zafar, Naveed/A-2712-2008; Butt, Zahid Ahmad/W-4292-2017	Zafar, Naveed/0000-0001-5681-719X; Butt, Zahid Ahmad/0000-0002-2486-4781; Tyndall, Mark/0000-0003-4450-5679; Ogilvie, Gina/0000-0001-5783-4493; Samji, Hasina/0000-0002-4555-7609; Salway, Travis/0000-0002-5699-5444	BC Centre for Disease Control; Canadian Institutes of Health Research [201503NHC-348216-NHC-ADWY-62134, 201410PHE-337680-PHECAAA-179547]	BC Centre for Disease Control; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by BC Centre for Disease Control and Agencies contributing data to the study and the Canadian Institutes of Health Research [Grant # 201503NHC-348216-NHC-ADWY-62134 & 201410PHE-337680-PHECAAA-179547]. The funder provided support in the form of salaries for authors (ZAB NS SW MK MG JW AY MA HS JAB JCJ VJC DR TC RB MWT MK NZJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, Can Commun Dis Rep, V21 Suppl 2, P1; Audet CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070326; Belani Hrishikesh, 2012, Morbidity and Mortality Weekly Report, V61, P1; Braitstein P, 2005, AIDS CARE, V17, P505, DOI 10.1080/09540120412331291733; Britton A, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0273-z; Butt ZA, 2014, EPIDEMIOL INFECT, V142, P2131, DOI 10.1017/S0950268813003038; Butt ZA, 2017, C RETR OPP INF BOST; Centers for Disease Control and Prevention, COMM CRIS IS THER GE; Durham DP, 2016, CLIN INFECT DIS, V62, P298, DOI 10.1093/cid/civ894; Fernandez-Montero JV, 2016, J VIRAL HEPATITIS, V23, P47, DOI 10.1111/jvh.12447; Friedland G, 2010, JAIDS-J ACQ IMM DEF, V55, pS37, DOI 10.1097/QAI.0b013e3181f9c0b6; Goulet JL, 2005, AIDS, V19, pS99, DOI 10.1097/01.aids.0000192077.11067.e5; Graham CS, 2001, CLIN INFECT DIS, V33, P562, DOI 10.1086/321909; Hall W, 1998, AUSTRALASIAN J AGEIN, V17; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Huckans MS, 2005, AIDS, V19, pS106, DOI 10.1097/01.aids.0000192078.49185.b0; Islam N., 2016, LANCET GASTROENTEROL; Janjua NZ, 2016, EBIOMEDICINE, V12, P189, DOI 10.1016/j.ebiom.2016.08.035; Janjua NZ, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1683-z; Janjua NZ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150176; Kendall CE, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-161; Khan K, 2011, EMERG INFECT DIS, V17, P357, DOI 10.3201/eid1703.100833; Klein MB, 2014, AIDS, V28, P1957, DOI 10.1097/QAD.0000000000000377; Knight R, 2017, ADDICTION; Kuo M, 2015, AM J PUBLIC HEALTH, V105, P1604, DOI 10.2105/AJPH.2015.302591; Lima VD, 2015, LANCET HIV, V2, pE92, DOI 10.1016/S2352-3018(15)00017-X; Lima VD, 2010, CAN J PUBLIC HEALTH, V101, P44, DOI 10.1007/BF03405561; lvsins A, 2010, DRUG USE TRENDS VICT; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Maalouf NM, 2013, J BONE MINER RES, V28, P2577, DOI 10.1002/jbmr.1988; Mocroft A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040245; Morano JP, 2013, PLOS ONE, V8; Pampalon R, 2012, CAN J PUBLIC HEALTH, V103, pS17, DOI 10.1007/BF03403824; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Public Health Agency of Canada, 2015, SUMM EST HIV INC PRE; Rourke Sean B, 2011, Open Med, V5, pe120; Simon D, 2014, EPIDEMIOL INFECT, V142, P2616, DOI 10.1017/S0950268814000041; Sulkowski MS, 2005, AIDS, V19, pS8, DOI 10.1097/01.aids.0000192064.09281.48; UNAIDS, FACT SHEET LAT STAT; WHO, 2017, WHO PUBLISHES LIST B	40	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183609	10.1371/journal.pone.0183609	http://dx.doi.org/10.1371/journal.pone.0183609			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829824	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100059
J	Kacar, G; Wang, XG; Biondi, A; Daane, KM				Kacar, Gulay; Wang, Xin-Geng; Biondi, Antonio; Daane, Kent M.			Linear functional response by two pupal Drosophila parasitoids foraging within single or multiple patch environments	PLOS ONE			English	Article							SPOTTED WING DROSOPHILA; SUZUKII DIPTERA DROSOPHILIDAE; BIOLOGICAL-CONTROL; HYMENOPTERA-BRACONIDAE; BEMISIA-ARGENTIFOLII; POPULATION-DYNAMICS; LARVAL PARASITOIDS; FRUIT PRODUCTION; HOST; DENSITY	Functional response describes the number of prey or hosts attacked by a predator or parasitoid as a function of prey or host density. Using three different experimental designs, we found a linear functional response by two insect parasitoids (the pteromalid Pachycrepoideus vindemiae and the diapriid Trichopria drosophilae) to their hosts (the drosophilids Drosophila suzukii and D. melanogaster). A linear function response is considered unusual for insect parasitoids. The first design was a 'fixed time within patch experiment' where individual parasitoids were exposed to a range of host densities for 24 h; the second two designs were a 'variable time functional response' and a 'selective functional response' experiments where individual parasitoids were presented with a range of host patches and allowed to freely select and explore only one patch (variable time) or forage for 24 h (selective). In all experimental designs, the number of hosts parasitized increased linearly until reaching an upper limit. Under the laboratory conditions used, the functional response of P. vindemiae was limited by its egg supply and time (host handling time) whereas T. drosophilae was limited by time only. The linear functional response by both parasitoids likely resulted from a constant attack rate and an incremental foraging strategy where the parasitoids left a poor (low density) host patch or remained in a higher quality host patch when there was successful oviposition and adequate host density.	[Kacar, Gulay; Wang, Xin-Geng; Biondi, Antonio; Daane, Kent M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Kacar, Gulay] Abant Izzet Baysal Univ, Fac Agr & Nat Sci, Bolu, Turkey; [Biondi, Antonio] Univ Catania, Dept Agr Food & Environm, Catania, Italy	University of California System; University of California Berkeley; Abant Izzet Baysal University; University of Catania	Daane, KM (corresponding author), Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA.	kdaane@ucanr.edu	BIONDI, Antonio/I-6381-2012; Kacar, Gulay GK/D-9407-2015	BIONDI, Antonio/0000-0002-1982-7716; Daane, Kent/0000-0001-8052-1954	National Institute of Food and Agriculture, USDA Specialty Crops Research Initiative [2015-51181-24252]; California Cherry Board; University of California's ANR Competitive Grants Program [15-3726]; Scientific and Technological Research Council of Turkey; People Programme of the European Union's Seventh Framework Programme FP7 [318246]; Italian Ministry of Education, University and Research (PRIN project GEISCA) [2010CXXHJE_004]	National Institute of Food and Agriculture, USDA Specialty Crops Research Initiative; California Cherry Board; University of California's ANR Competitive Grants Program(French National Research Agency (ANR)); Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); People Programme of the European Union's Seventh Framework Programme FP7; Italian Ministry of Education, University and Research (PRIN project GEISCA)	Funding was supported by the National Institute of Food and Agriculture, USDA Specialty Crops Research Initiative under Agreement No. 2015-51181-24252, the California Cherry Board, and the University of California's ANR Competitive Grants Program Project No. 15-3726. Gulay Kagar was supported by a visiting scholar grant from the Scientific and Technological Research Council of Turkey. Antonio Biondi received funding from the People Programme of the European Union's Seventh Framework Programme FP7/2007-2013/Agreement 318246 and from the Italian Ministry of Education, University and Research (PRIN project GEISCA, 2010CXXHJE_004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asplen MK, 2015, J PEST SCI, V88, P469, DOI 10.1007/s10340-015-0681-z; BEDDINGTON JR, 1978, NATURE, V273, P513, DOI 10.1038/273513a0; Chabert S, 2012, BIOL CONTROL, V63, P40, DOI 10.1016/j.biocontrol.2012.05.005; COLLINS MD, 1981, J ANIM ECOL, V50, P479, DOI 10.2307/4069; Cressman R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088773; Daane KM, 2016, J PEST SCI, V89, P823, DOI 10.1007/s10340-016-0740-0; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; DRIESSEN G, 1995, J ANIM ECOL, V64, P117, DOI 10.2307/5832; Fernandez-Arhex V, 2003, BIOCONTROL SCI TECHN, V13, P403, DOI 10.1080/0958315031000104523; Gabarra R, 2015, BIOCONTROL, V60, P331, DOI 10.1007/s10526-014-9646-z; Gutierrez AP, 2008, J APPL ECOL, V45, P524, DOI 10.1111/j.1365-2664.2007.01356.x; Haye T, 2016, J PEST SCI, V89, P643, DOI 10.1007/s10340-016-0737-8; HERTLEIN MB, 1987, ENVIRON ENTOMOL, V16, P593, DOI 10.1093/ee/16.3.593; Hoddle MS, 1998, ENTOMOL EXP APPL, V87, P15, DOI 10.1023/A:1003124627628; Hoffmann MP, 2002, BIOL CONTROL, V25, P249, DOI 10.1016/S1049-9644(02)00105-6; Holling C. S., 1959, Canadian Entomologist, V91, P385; HOPPER KR, 1986, ENVIRON ENTOMOL, V15, P476, DOI 10.1093/ee/15.3.476; Irvin N, 2009, ENVIRON ENTOMOL, V38, P1634, DOI 10.1603/022.038.0616; Ives AR, 1999, AM NAT, V154, P652, DOI 10.1086/303269; Jeschke JM, 2002, ECOL MONOGR, V72, P95, DOI 10.1890/0012-9615(2002)072[0095:PFRDBH]2.0.CO;2; Jones WA, 1999, BIOCONTROL, V44, P13, DOI 10.1023/A:1009992421012; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; LESSELLS CM, 1985, J ANIM ECOL, V54, P27, DOI 10.2307/4618; Luna MG, 2007, ENVIRON ENTOMOL, V36, P887, DOI 10.1603/0046-225X(2007)36[887:POTALG]2.0.CO;2; Martinou AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144413; Mazzetto F, 2016, J PEST SCI, V89, P837, DOI 10.1007/s10340-016-0746-7; Miller B, 2015, B INSECTOL, V68, P255; Mills NJ, 2004, ECOL ENTOMOL, V29, P208, DOI 10.1111/j.0307-6946.2004.00584.x; Mitsui H, 2006, POPUL ECOL, V48, P233, DOI 10.1007/s10144-006-0260-5; Nachman G, 2006, J ANIM ECOL, V75, P948, DOI 10.1111/j.1365-2656.2006.01114.x; Nunez-Campero SR, 2016, ANN ENTOMOL SOC AM, V109, P730, DOI 10.1093/aesa/saw045; Poyet M, 2013, PHYSIOL ENTOMOL, V38, P45, DOI 10.1111/phen.12002; Smout S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010761; Stacconi MVR, 2015, BIOL CONTROL, V84, P28, DOI 10.1016/j.biocontrol.2015.02.003; Stewart TJ, 2014, J ECON ENTOMOL, V107, P1771, DOI 10.1603/EC14197; Tochen S, 2014, ENVIRON ENTOMOL, V43, P501, DOI 10.1603/EN13200; TREXLER JC, 1988, OECOLOGIA, V76, P206, DOI 10.1007/BF00379954; VANLENTEREN JC, 1978, NETH J ZOOL, V28, P213; Varone L, 2007, BIOCONTROL SCI TECHN, V17, P945, DOI 10.1080/09583150701596289; WAAGE JK, 1979, J ANIM ECOL, V48, P353, DOI 10.2307/4166; WAAGE JK, 1983, ECOL ENTOMOL, V8, P447, DOI 10.1111/j.1365-2311.1983.tb00523.x; WALDE SJ, 1988, ANNU REV ENTOMOL, V33, P441, DOI 10.1146/annurev.en.33.010188.002301; Wang XG, 2004, BIOL CONTROL, V31, P227, DOI 10.1016/j.biocontrol.2004.04.019; Wang XG, 2002, ECOL ENTOMOL, V27, P105, DOI 10.1046/j.1365-2311.2002.0374a.x; Wang XG, 2016, J PEST SCI, V89, P701, DOI 10.1007/s10340-016-0747-6; Wang XG, 2016, BIOCONTROL, V61, P387, DOI 10.1007/s10526-016-9720-9; Wang XG, 2016, BIOL CONTROL, V96, P64, DOI 10.1016/j.biocontrol.2016.02.004; Yazdani M, 2016, BIOL CONTROL, V97, P63, DOI 10.1016/j.biocontrol.2015.05.004	48	37	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183525	10.1371/journal.pone.0183525	http://dx.doi.org/10.1371/journal.pone.0183525			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829796	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100053
J	Howing, T; Dann, M; Hoefle, C; Huckelhoven, R; Gietl, C				Hoewing, Timo; Dann, Marcel; Hoefle, Caroline; Hueckelhoven, Ralph; Gietl, Christine			Involvement of Arabidopsis thaliana endoplasmic reticulum KDEL-tailed cysteine endopeptidase 1 (AtCEP1) in powdery mildew-induced and AtCPR5-controlled cell death	PLOS ONE			English	Article							CASTOR BEAN ENDOSPERM; TRIGGERED IMMUNITY; SALICYLIC-ACID; RESISTANCE; CPR5; DEFENSE; RICINOSOMES; EXPRESSION; PROTEASES; RESPONSES	Programmed cell death (PCD) is a prerequisite for successful development and it limits the spread of biotrophic pathogens in a rapid hypersensitive response at the site of infection. KDEL-tailed cysteine endopeptidases (KDEL CysEP) are a subgroup of papain-type cysteine endopeptidases expressed in tissues undergoing PCD. In Arabidopsis, three KDEL CysEPs (AtCEP1, AtCEP2, and AtCEP3) are expressed. We have previously shown that AtCEP1 is a factor of basal resistance to powdery mildew caused by the biotrophic ascomycete Erysiphe cruciferarum, and is expressed in spatiotemporal association with the late fungal development on Arabidopsis leaves. The endoplasmic reticulum-localized proenzyme of AtCEP1 was further visualized at the haustorial complex encased with callose. The AtCPR5 gene (CONSTITUTIVE EXPRESSION OF PR GENES 5) is a regulator of expression of pathogenesis related genes. Loss of AtCPR5 leads to spontaneous expression of chlorotic lesions which was associated with enhanced expression of AtCEP1. We used the atcpr5-2 mutant plants and the atcep1 atcpr5-2 double mutants harboring a non-functional reporter (PCEP1:: pre-pro-3xHA-EGFP-KDEL) for visualization of AtCEP1 promoter activity. We found the specific up-regulation of AtCEP1 in direct neighborhood of spreading leaf lesions thus likely representing cells undergoing PCD. Furthermore, we found a strong resistance of atcpr5 mutant plants against infection with E. cruciferarum. Loss of AtCEP1 had no obvious influence on the strong resistance of atcpr5-2 mutant plants against infection with E. cruciferarum. However, the area of necrotic leaf lesions associated with E. cruciferarum colonies was significantly larger in atcpr5-2 as compared to atcep1 atcpr5-2 double mutant plants. The presence of AtCEP1 thus contributes to AtCPR5-controlled PCD at the sites of powdery mildew infection.	[Hoewing, Timo; Dann, Marcel; Gietl, Christine] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Bot, Freising Weihenstephan, Germany; [Hoefle, Caroline; Hueckelhoven, Ralph] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Phytopathol, Freising Weihenstephan, Germany; [Dann, Marcel] Ludwig Maximilians Univ Munchen, Dept Biol 1, Lehrstuh Bot Mol Biol Pflanzen, Planegg Martinsried, Germany	Technical University of Munich; Technical University of Munich; University of Munich	Gietl, C (corresponding author), Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Lehrstuhl Bot, Freising Weihenstephan, Germany.	christine.gietl@wzw.tum.de	Huckelhoven, Ralph/H-6676-2013	Huckelhoven, Ralph/0000-0001-5632-5451	Deutsche Forschungsgemeinschaft [SFB924]; Technische Universitat Munchen within the funding programme Open Access Publishing	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Technische Universitat Munchen within the funding programme Open Access Publishing	This work was supported by grants from the Deutsche Forschungsgemeinschaft [SFB924 to CG (A07) and RH (B08)] and by the Technische Universitat Munchen within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beers EP, 2004, PHYTOCHEMISTRY, V65, P43, DOI 10.1016/j.phytochem.2003.09.005; Boch J, 1998, MOL PLANT MICROBE IN, V11, P1196, DOI 10.1094/MPMI.1998.11.12.1196; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Bowling SA, 1994, MUTATION ARABIDOPSIS; Brininstool G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-58; Clarke JD, 2001, PLANT J, V26, P409, DOI 10.1046/j.1365-313X.2001.2641041.x; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; Dickman MB, 2013, ANNU REV PHYTOPATHOL, V51, P543, DOI 10.1146/annurev-phyto-081211-173027; Eichmann R, 2008, J PLANT PHYSIOL, V165, P5, DOI 10.1016/j.jplph.2007.05.004; Eichmann R, 2006, MOL PLANT PATHOL, V7, P543, DOI 10.1111/j.1364-3703.2006.00359.X; Fendrych M, 2014, CURR BIOL, V24, P931, DOI 10.1016/j.cub.2014.03.025; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Helm M, 2008, AM J BOT, V95, P1049, DOI 10.3732/ajb.2007404; Hierl G, 2014, PLANT MOL BIOL, V84, P605, DOI 10.1007/s11103-013-0157-6; Hierl G, 2012, PHYSIOL PLANTARUM, V145, P103, DOI 10.1111/j.1399-3054.2012.01580.x; Howing T, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00058; Kirik V, 2001, CURR BIOL, V11, P1891, DOI 10.1016/S0960-9822(01)00590-5; Koh S, 2005, PLANT J, V44, P516, DOI 10.1111/j.1365-313X.2005.02545.x; LECKIE CP, 1995, NEW PHYTOL, V131, P211, DOI 10.1111/j.1469-8137.1995.tb05722.x; Maekawa T, 2012, P NATL ACAD SCI USA, V109, P20119, DOI 10.1073/pnas.1218059109; Micali CO, 2011, CELL MICROBIOL, V13, P210, DOI 10.1111/j.1462-5822.2010.01530.x; Misas-Villamil JC, 2016, NEW PHYTOL, V212, P902, DOI 10.1111/nph.14117; Nakano RT, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00073; Orjuela J, 2013, MOL PLANT MICROBE IN, V26, P1455, DOI 10.1094/MPMI-05-13-0127-R; Lopez-Fernandez MP, 2015, J INTEGR PLANT BIOL, V57, P996, DOI 10.1111/jipb.12367; Rasband, 2018, IMAGE J; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; Schmid M, 1999, P NATL ACAD SCI USA, V96, P14159, DOI 10.1073/pnas.96.24.14159; Schmid M, 1998, PLANTA, V206, P466, DOI 10.1007/s004250050423; Schmid M, 2001, P NATL ACAD SCI USA, V98, P5353, DOI 10.1073/pnas.061038298; Senatore A, 2009, PLANT PHYSIOL, V149, P775, DOI 10.1104/pp.108.132720; Than ME, 2004, J MOL BIOL, V336, P1103, DOI 10.1016/j.jmb.2003.12.075; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Wang S, 2014, CELL HOST MICROBE, V16, P787, DOI 10.1016/j.chom.2014.10.005; Xiao SY, 2001, SCIENCE, V291, P118, DOI 10.1126/science.291.5501.118; Zhang DD, 2014, PLANT CELL, V26, P2939, DOI 10.1105/tpc.114.127282; Zhou LZ, 2016, PLANT REPROD, V29, P265, DOI 10.1007/s00497-016-0288-4; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	38	12	12	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183870	10.1371/journal.pone.0183870	http://dx.doi.org/10.1371/journal.pone.0183870			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846731	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600053
J	Su, JB; Yang, XH; Zhang, XL; Cai, HL; Huang, HY; Zhao, LH; Xu, F; Chen, T; Cheng, XB; Wang, XQ; Lu, Y				Su, Jian-bin; Yang, Xiao-hua; Zhang, Xiu-lin; Cai, Hong-li; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Chen, Tong; Cheng, Xing-bo; Wang, Xue-qin; Lu, Yan			The association of long-term glycaemic variability versus sustained chronic hyperglycaemia with heart rate-corrected QT interval in patients with type 2 diabetes	PLOS ONE			English	Article							ACUTE GLUCOSE FLUCTUATIONS; OXIDATIVE STRESS; RISK-FACTORS; DISPERSION; MORTALITY; DURATION; DISEASE; CARDIOMYOPATHY; POPULATION; PREVALENCE	Objectives Prolonged heart rate-corrected QT(QTc) interval is related to ventricular arrhythmia and cardiovascular mortality, with considerably high prevalence of type 2 diabetes. Additionally, long-term glycaemic variability could be a significant risk factor for diabetic complications in addition to chronic hyperglycaemia. We compared the associations of long-term glycaemic variability versus sustained chronic hyperglycaemia with the QTc interval among type 2 diabetes patients. Methods In this cross-sectional study, 2904 type 2 diabetes patients were recruited who had undergone at least four fasting plasma glucose (FPG) and 2-hour postprandial plasma glucose (PPG) measurements (at least once for every 3 months, respectively) during the preceding year. Long-term glycaemic variabilities of FPG and 2-hour PPG were assessed by their standard deviations (SD-FPG and SD-PPG, respectively), and chronic fasting and postprandial hyperglycaemia were assessed by their means (M-FPG and M-PPG, respectively). HbA1c was also determined upon enrolment to assess current overall glycaemic control. QTc interval was estimated from resting 12-lead electrocardiograms, and more than 440 ms was considered abnormally prolonged. Results Patients with prolonged QTc interval (>= 440 ms) had greater M-FPG, M-PPG, SD-PPG and HbA1c than those with normal QTc interval but comparable SD-FPG. QTc interval was correlated with M-FPG, M-PPG, SD-PPG and HbA1c (r = 0.133, 0.153, 0.245 and 0.207, respectively, p = 0.000) but not with SD-FPG (r = 0.024, p = 0.189). After adjusting for metabolic risk factors via multiple linear regression analysis, SD-PPG, M-PPG and HbA1c (t = 12.16, 2.69 and 10.16, respectively, p = 0.000) were the major independent contributors to the increased QTc interval. The proportion of prolonged QTc interval increased significantly from 10.9% to 14.2% to 26.6% for the first (T1) to second (T2) to third (T3) tertiles of SD-PPG. After adjusting via multiple logistic regression analysis, the odd ratios of prolonged QTc interval of the T2 and T3 versus the T1 of SD-PPG were 1.15 (95% CI, 0.821.60) and 2.62 (1.923.57), respectively. Conclusions Increased long-term variability of PPG is a strong independent risk factor for prolonged QTc interval in type 2 diabetes patients, in addition to long-term postprandial hyperglycaemia and current HbA1c.	[Su, Jian-bin; Yang, Xiao-hua; Cheng, Xing-bo; Lu, Yan] Soochow Univ, Dept Endocrinol, Affiliated Hosp 1, Suzhou, Peoples R China; [Su, Jian-bin; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Wang, Xue-qin] Nantong Univ, Dept Endocrinol, Affiliated Hosp 2, Nantong, Peoples R China; [Yang, Xiao-hua] Nantong Univ, Dept Endocrinol, Affiliated Haian Hosp, Nantong, Haian, Peoples R China; [Zhang, Xiu-lin; Chen, Tong] Nantong Univ, Dept Clin Lab, Affiliated Hosp 2, Nantong, Peoples R China; [Cai, Hong-li] Nantong Univ, Dept Geriatr, Affiliated Hosp 2, Nantong, Peoples R China	Soochow University - China; Nantong University; Nantong University; Nantong University; Nantong University	Cheng, XB; Lu, Y (corresponding author), Soochow Univ, Dept Endocrinol, Affiliated Hosp 1, Suzhou, Peoples R China.; Wang, XQ (corresponding author), Nantong Univ, Dept Endocrinol, Affiliated Hosp 2, Nantong, Peoples R China.	xingbo1107@sohu.com; wangxueqin@medmail.com.cn; lucia1817@163.com	Su, Jian-bin/R-9181-2017	Su, Jian-bin/0000-0002-2138-0263	Scientific Research Program of Nantong [MS22015065]; Scientific Research Program of Health and Planning Commission of Jiangsu [H201553]; Scientific and Educational Program for Health Care Prosperity of Jiangsu (Young Medical Talents Project) [QNRC2016408]	Scientific Research Program of Nantong; Scientific Research Program of Health and Planning Commission of Jiangsu; Scientific and Educational Program for Health Care Prosperity of Jiangsu (Young Medical Talents Project)	The study was funded by the Scientific Research Program of Nantong (MS22015065), http://www.ntkj.gov.cn/; the Scientific Research Program of Health and Planning Commission of Jiangsu (H201553), http://www.jswst.gov.cn/jsswshjhsywyh/index.html;and the Scientific and Educational Program for Health Care Prosperity of Jiangsu (Young Medical Talents Project: QNRC2016408), http://www.jswst.gov.cn/jsswshjhsywyh/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aneja A, 2008, AM J MED, V121, P748, DOI 10.1016/j.amjmed.2008.03.046; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Cardoso C, 2001, INT J CARDIOL, V79, P253, DOI 10.1016/S0167-5273(01)00443-0; Cavalot F, 2011, DIABETES CARE, V34, P2237, DOI 10.2337/dc10-2414; Ceriello A, 2010, DIABETIC MED, V27, P862, DOI 10.1111/j.1464-5491.2010.02967.x; Chang CM, 2012, ACTA DIABETOL, V49, pS171, DOI 10.1007/s00592-012-0398-x; Colette C, 2007, HORM METAB RES, V39, P683, DOI 10.1055/s-2007-985157; Cox AJ, 2014, DIABETES CARE, V37, P1454, DOI 10.2337/dc13-1257; Festa A, 2000, AM J CARDIOL, V86, P1117, DOI 10.1016/S0002-9149(00)01170-X; Gao X, 2012, CHINESE MED J-PEKING, V125, P4167, DOI 10.3760/cma.j.issn.0366-6999.2012.23.002; Gastaldelli A, 2000, AM J PHYSIOL-REG I, V279, pR2022, DOI 10.1152/ajpregu.2000.279.6.R2022; Guo XF, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005568; Jun JE, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0233-0; Klonoff DC, 2011, J CLIN ENDOCR METAB, V96, P2968, DOI 10.1210/jc.2010-2756; Lin CC, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0165-7; Lin CC, 2013, AM J MED, V126, DOI 10.1016/j.amjmed.2013.04.015; Lin CC, 2012, AM J MED, V125, DOI 10.1016/j.amjmed.2011.07.027; Lin YC, 2012, AM J PHYSIOL-HEART C, V302, pH1013, DOI 10.1152/ajpheart.00837.2011; Marfella R, 2000, DIABETOLOGIA, V43, P571, DOI 10.1007/s001250051345; Meek S, 2002, BRIT MED J, V324, P415, DOI 10.1136/bmj.324.7334.415; Mizamtsidi M, 2016, EUR J CLIN INVEST, V46, P947, DOI 10.1111/eci.12673; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Monnier L, 2015, DIABETES METAB, V41, pS9; Monnier L, 2009, DIABETES-METAB RES, V25, P393, DOI 10.1002/dmrr.962; Ninkovic VM, 2016, ACTA DIABETOL, V53, P737, DOI 10.1007/s00592-016-0864-y; Ohara M, 2016, DIABETES RES CLIN PR, V122, P62, DOI 10.1016/j.diabres.2016.09.025; Omran J, 2016, OBES REV, V17, P520, DOI 10.1111/obr.12390; Pickham D, 2014, J CARDIOVASC NURS, V29, P264, DOI 10.1097/JCN.0b013e31827f174c; Sartore G, 2013, ACTA DIABETOL, V50, P437, DOI 10.1007/s00592-013-0459-9; Shah MS, 2016, CIRC RES, V118, P1808, DOI 10.1161/CIRCRESAHA.116.306923; Stettler C, 2007, DIABETOLOGIA, V50, P186, DOI 10.1007/s00125-006-0483-1; Strohmer B, 2005, J INTERN MED, V257, P238, DOI 10.1111/j.1365-2796.2004.01436.x; Su G, 2013, DIABETES CARE, V36, P1026, DOI 10.2337/dc12-0925; Su G, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-19; Subbalakshmi NK, 2010, DIABETES RES CLIN PR, V88, P265, DOI 10.1016/j.diabres.2010.03.001; Szabo Z, 2005, CAN J CARDIOL, V21, P847; Takao T, 2011, DIABETES RES CLIN PR, V91, pE40, DOI 10.1016/j.diabres.2010.10.009; Tanaka K, 2014, HEART VESSELS, V29, P256, DOI 10.1007/s00380-013-0356-8; Targher G, 2014, NUTR METAB CARDIOVAS, V24, P663, DOI 10.1016/j.numecd.2014.01.005; Tarquini R, 2011, ACTA DIABETOL, V48, P173, DOI 10.1007/s00592-010-0180-x; Thomakos P, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/329189; Torimoto K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-1; Veglio M, 2002, J INTERN MED, V251, P317, DOI 10.1046/j.1365-2796.2002.00955.x; Xu F, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-139	45	12	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183055	10.1371/journal.pone.0183055	http://dx.doi.org/10.1371/journal.pone.0183055			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846720	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600022
J	Benhalevy, D; Biran, I; Bochkareva, ES; Sorek, R; Bibi, E				Benhalevy, Daniel; Biran, Ido; Bochkareva, Elena S.; Sorek, Rotem; Bibi, Eitan			Evidence for a cytoplasmic pool of ribosome-free mRNAs encoding inner membrane proteins in Escherichia coli	PLOS ONE			English	Article							SIGNAL RECOGNITION PARTICLE; SINGLE STRANDS BIND; LARGE GENE LISTS; SHOCK PROTEIN; SUBCELLULAR-LOCALIZATION; ENDOPLASMIC-RETICULUM; CSPA-FAMILY; RECEPTOR; TRANSLATION; CHAPERONES	Translation-independent mRNA localization represents an emerging concept in cell biology. In Escherichia coli, mRNAs encoding integral membrane proteins (MPRs) are targeted to the membrane where they are translated by membrane associated ribosomes and the produced proteins are inserted into the membrane co-translationally. In order to better understand aspects of the biogenesis and localization of MPRs, we investigated their subcellular distribution using cell fractionation, RNA-seq and qPCR. The results show that MPRs are overrepresented in the membrane fraction, as expected, and depletion of the signal recognition particle-receptor, FtsY reduced the amounts of all mRNAs on the membrane. Surprisingly, however, MPRs were also found relatively abundant in the soluble ribosome-free fraction and their amount in this fraction is increased upon overexpression of CspE, which was recently shown to interact with MPRs. CspE also conferred a positive effect on the membrane-expression of integral membrane proteins. We discuss the possibility that the effects of CspE overexpression may link the intriguing subcellular localization of MPRs to the cytosolic ribosome-free fraction with their translation into membrane proteins and that the ribosome-free pool of MPRs may represent a stage during their targeting to the membrane, which precedes translation.	[Benhalevy, Daniel; Biran, Ido; Bochkareva, Elena S.; Bibi, Eitan] Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel; [Sorek, Rotem] Weizmann Inst Sci, Dept Mol Genet, Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Bibi, E (corresponding author), Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel.	e.bibi@weizmann.ac.il	Benhalevy, Daniel/AGG-5321-2022	Benhalevy, Daniel/0000-0001-6998-1933; Bibi, Eitan/0000-0003-3700-2707	Israel Science Foundation [541/15]; Minerva Foundation; Pasteur-Weizmann center; Federal German Ministry for Education and Research	Israel Science Foundation(Israel Science Foundation); Minerva Foundation; Pasteur-Weizmann center; Federal German Ministry for Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by the Israel Science Foundation research grant (541/15), the Minerva Foundation with funding from the Federal German Ministry for Education and Research and by the Pasteur-Weizmann center to EB.; We thank Dr. Shlomi Dagan for writing Matlab scripts and Dr. Ester Feldmesser from the Bioinformatics and Biological Computing Unit at the Weizmann Institute of Science, for help in the clustering analysis. We also thank Drs. Hajime Tokuda and Hans-Georg Koch for sharing antibodies. This work was supported by the Israel Science Foundation research grant (541/15), the Minerva Foundation with funding from the Federal German Ministry for Education and Research and by the Pasteur-Weizmann center for non-coding RNA research. E.B. holds the Jerome A., Freda, and Edward M. Siegel professorial Chair.	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bae WH, 2000, P NATL ACAD SCI USA, V97, P7784, DOI 10.1073/pnas.97.14.7784; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Becker AH, 2013, NAT PROTOC, V8, P2212, DOI 10.1038/nprot.2013.133; Benhalevy D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134413; Bercovich-Kinori A, 2015, J CELL SCI, V128, P1444, DOI 10.1242/jcs.166116; Bibi E, 2012, TRENDS BIOCHEM SCI, V37, P1, DOI 10.1016/j.tibs.2011.09.004; Bibi E, 2011, BBA-BIOMEMBRANES, V1808, P841, DOI 10.1016/j.bbamem.2010.07.025; Blaha G, 2002, BIOPHYS CHEM, V96, P153, DOI 10.1016/S0301-4622(02)00021-2; Burk J, 2009, J BACTERIOL, V191, P7017, DOI 10.1128/JB.00208-09; Carpousis AJ, 2009, PROG MOL BIOL TRANSL, V85, P91, DOI 10.1016/S0079-6603(08)00803-9; Cui XYA, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001336; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; du Plessis DJ, 2010, BIOCHIM BIOPHYS ACTA, DOI [10.1074/ibc.M109.081935, DOI 10.1074/ibc.M109.081935]; Elvekrog MM, 2015, CURR OPIN CHEM BIOL, V29, P79, DOI 10.1016/j.cbpa.2015.09.016; Erez E, 2010, J BIOL CHEM, V285, P40508, DOI 10.1074/jbc.M110.140921; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerst JE, 2008, TRENDS CELL BIOL, V18, P68, DOI 10.1016/j.tcb.2007.11.005; Herskovits AA, 2000, P NATL ACAD SCI USA, V97, P4621, DOI 10.1073/pnas.080077197; Herskovits AA, 2002, J CELL BIOL, V159, P403, DOI 10.1083/jcb.200204144; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Horn G, 2007, CELL MOL LIFE SCI, V64, P1457, DOI 10.1007/s00018-007-6388-4; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jansen RP, 2014, TRENDS GENET, V30, P408, DOI 10.1016/j.tig.2014.07.002; Jiang WN, 1997, J BIOL CHEM, V272, P196; Kraut-Cohen J, 2013, MOL BIOL CELL, V24, P3069, DOI 10.1091/mbc.E13-01-0038; Lange C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168143; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Lyabin DN, 2014, WIRES RNA, V5, P95, DOI 10.1002/wrna.1200; Max KEA, 2006, J MOL BIOL, V360, P702, DOI 10.1016/j.jmb.2006.05.044; Moffitt JR, 2016, ELIFE, V5, DOI 10.7554/eLife.13065; Morgan HP, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm040; Muller C, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5020019; Nevo-Dinur K, 2011, SCIENCE, V331, P1081, DOI 10.1126/science.1195691; Nyathi Y, 2013, BBA-MOL CELL RES, V1833, P2392, DOI 10.1016/j.bbamcr.2013.02.021; Pesole G, 2001, GENE, V276, P73, DOI 10.1016/S0378-1119(01)00674-6; Phadtare S, 1999, MOL MICROBIOL, V33, P1004, DOI 10.1046/j.1365-2958.1999.01541.x; Phadtare S, 2001, J BACTERIOL, V183, P1205, DOI 10.1128/JB.183.4.1205-1214.2001; Phadtare S, 2005, NUCLEIC ACIDS RES, V33, P5583, DOI 10.1093/nar/gki859; Phadtare S, 2010, RNA BIOL, V7, P788, DOI 10.4161/rna.7.6.13482; Prilusky J, 2009, P NATL ACAD SCI USA, V106, P6662, DOI 10.1073/pnas.0902029106; Prinz A, 2000, EMBO J, V19, P1900, DOI 10.1093/emboj/19.8.1900; Rey S, 2005, NUCLEIC ACIDS RES, V33, pD164, DOI 10.1093/nar/gki027; Rodnina MV, 2016, J MOL BIOL, V428, P2165, DOI 10.1016/j.jmb.2016.03.022; Sachs R, 2012, RNA, V18, P65, DOI 10.1261/rna.02809212; Schuwirth BS, 2006, NAT STRUCT MOL BIOL, V13, P879, DOI 10.1038/nsmb1150; Seluanov A, 1997, J BIOL CHEM, V272, P2053; Shenhar Y, 2012, ENV MICROBIOL REP, V4, P532, DOI 10.1111/j.1758-2229.2012.00358.x; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Von Konig K., 2003, THESIS; Wickstrom D, 2011, J BIOL CHEM, V286, P4598, DOI 10.1074/jbc.M109.081935; Wild K, 2016, J MOL BIOL; Yosef I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009130	55	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183862	10.1371/journal.pone.0183862	http://dx.doi.org/10.1371/journal.pone.0183862			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841711	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700064
J	Lopez-Pascual, J; Page, A; Serra-Ano, P				Lopez-Pascual, Juan; Page, Alvaro; Serra-Ano, Pilar			Dynamic thoracohumeral kinematics are dependent upon the etiology of the shoulder injury	PLOS ONE			English	Article							ROTATOR CUFF TEARS; MOTOR VARIABILITY; MUSCLE-ACTIVITY; PAIN; IMPINGEMENT; RHYTHM; ARTHROPLASTY; RELIABILITY; DISORDERS; SYMPTOMS	Obtaining kinematic patterns that depend on the shoulder injury may be important when planning rehabilitation. The main goal of this study is to explore whether the kinematic patterns of continuous and repetitive shoulder elevation motions are different according to the type of shoulder injury in question, specifically tendinopathy or rotator cuff tear, and to analyze the influence of the load handled during its assessment. For this purpose, 19 individuals with tendinopathy and 9 with rotator cuff tear performed a repetitive scaption movement that was assessed with stereophotogrammetry. Furthermore, static range of motion (ROM) and isometric strength were evaluated with a goniometer and a dynamometer, respectively. Dynamic measurements of maximum elevation (Emax), variablility of the maximum angle (VMA), maximum angular velocity (Velmax), and time to maximum velocity (tmaxvel) were found to be significantly different between the tendinopathy group (TG) and the rotator cuff tear group (RTCG). No differences were found in the ROM assessed with goniometry and the isometric strength. The effect of increasing the load placed in the hand during the scaption movement led to significant differences in Emax, VMA, tmaxvel and repeatability. Therefore, only the dynamic variables showed sufficient capability of detecting differences in functional performance associated with structural shoulder injury. The differences observed in the kinematic variables between patients with tendinopathy and rotator cuff tear seem to be related to alterations in thoracohumeral rhythm and neuromuscular control. Kinematic analysis may contribute to a better understanding of the functional impact of shoulder injuries, which would help in the assessment and treatment of shoulder pain.	[Lopez-Pascual, Juan] Univ Politecn Valencia, Inst Biomecan Valencia, Valencia, Spain; [Page, Alvaro] Univ Politecn Valencia, Dept Fis Aplicada, Valencia, Spain; [Page, Alvaro] CIBER BBN, Grp Tecnol Sanitaria, IBV, Valencia, Spain; [Serra-Ano, Pilar] Univ Valencia, Dept Fisioterapia, Valencia, Spain	Instituto de Biomecanica de Valencia (IBV); Universitat Politecnica de Valencia; Universitat Politecnica de Valencia; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; University of Valencia	Serra-Ano, P (corresponding author), Univ Valencia, Dept Fisioterapia, Valencia, Spain.	pilar.serra@uv.es	Serra-Añó, Pilar/L-6085-2014	Serra-Añó, Pilar/0000-0002-0743-3445; Lopez Pascual, Juan/0000-0002-6641-0200	Spanish Government; Secretaria de Estado de Investigacion, Desarrollo e Innovacion; EU FEDER funds [DPI2013-44227-R]	Spanish Government(Spanish GovernmentEuropean Commission); Secretaria de Estado de Investigacion, Desarrollo e Innovacion; EU FEDER funds(European Commission)	This work was funded by the Spanish Government, Secretaria de Estado de Investigacion, Desarrollo e Innovacion, and co-financed by EU FEDER funds (Grant DPI2013-44227-R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allom R, 2009, J BONE JOINT SURG BR, V91B, P367, DOI 10.1302/0301-620X.91B3.20714; Bergsma A, 2014, ARCH PHYS MED REHAB, V95, P1731, DOI 10.1016/j.apmr.2014.03.033; Brown LE, 2001, J EXERC PHYSL ONLINE, V4, DOI DOI 10.4236/JEP.2013.46A001; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; CLARK JE, 1993, CHILD DEV, V64, P1143, DOI 10.1111/j.1467-8624.1993.tb04192.x; Dabholkar A, 2015, INT J HLTH SCI RES I, V5, P232; Reyes-Guzman ADL, 2014, CLIN BIOMECH, V29, P719, DOI 10.1016/j.clinbiomech.2014.06.013; de Toledo JM, 2012, CLIN BIOMECH, V27, P793, DOI 10.1016/j.clinbiomech.2012.04.009; Duhamel A, 2004, GAIT POSTURE, V20, P204, DOI 10.1016/j.gaitpost.2003.09.010; Dunn WR, 2014, SHOULDER ARTHROSCOPY, P585; Garofalo P, 2009, MED BIOL ENG COMPUT, V47, P475, DOI 10.1007/s11517-009-0454-z; Gates DH, 2016, AM J OCCUP THER, V70, DOI 10.5014/ajot.2016.015487; Gausden EB, 2017, J SHOULDER ELB SURG, V26, P331, DOI 10.1016/j.jse.2016.07.013; Hebert LJ, 2002, ARCH PHYS MED REHAB, V83, P60, DOI 10.1053/apmr.2002.27471; Jaspers E, 2011, GAIT POSTURE, V33, P279, DOI 10.1016/j.gaitpost.2010.11.021; KANEKO K, 1995, CLIN IMAG, V19, P8, DOI 10.1016/0899-7071(94)00024-7; Karduna AR, 2001, J BIOMECH ENG-T ASME, V123, P184, DOI 10.1115/1.1351892; Kwon YW, 2012, J SHOULDER ELB SURG, V21, P1184, DOI 10.1016/j.jse.2011.07.031; Laudner KG, 2006, J ORTHOP SPORT PHYS, V36, P485, DOI 10.2519/jospt.2006.2146; Li XT, 2016, J BIOMECH, V49, P2806, DOI 10.1016/j.jbiomech.2016.06.018; Lopez-Pascual J, 2016, J BIOMECH, V49, P502, DOI 10.1016/j.jbiomech.2015.12.045; Lowe CJM, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-228; Ludewig PM, 2003, OCCUP ENVIRON MED, V60, P841, DOI 10.1136/oem.60.11.841; Ludewig PM, 2000, PHYS THER, V80, P276, DOI 10.1093/ptj/80.3.276; Madeleine P, 2008, EXP BRAIN RES, V185, P689, DOI 10.1007/s00221-007-1199-2; Meana-Riera M., 2008, BIOMECANICA BASES NE, P489; Mell AG, 2005, J SHOULDER ELB SURG, V14, p58S, DOI 10.1016/j.jse.2004.09.018; Page A, 2006, MED BIOL ENG COMPUT, V44, P1113, DOI 10.1007/s11517-006-0124-3; Page A, 2006, J BIOMECH, V39, P2526, DOI 10.1016/j.jbiomech.2005.07.032; PATTE D, 1990, CLIN ORTHOP RELAT R, P81; Pribicevic M., 2012, EPIDEMIOLOGY SHOULDE; Reese N., 2016, JOINT RANGE MOTION M; Rice IM, 2014, ARCH PHYS MED REHAB, V95, P699, DOI 10.1016/j.apmr.2013.11.005; Robert-Lachaine X, 2015, COMPUT METHOD BIOMEC, V18, P249, DOI 10.1080/10255842.2013.792810; Scibek JS, 2008, J SHOULDER ELB SURG, V17, P172, DOI 10.1016/j.jse.2007.05.010; Scibek Jason S., 2010, Journal of Musculoskeletal Research, V13, P23, DOI 10.1142/S0218957710002429; Scibek JS, 2009, J ATHL TRAINING, V44, P148, DOI 10.4085/1062-6050-44.2.148; Srinivasan D, 2012, CLIN BIOMECH, V27, P979, DOI 10.1016/j.clinbiomech.2012.08.007; Struyf F, 2014, J ELECTROMYOGR KINES, V24, P277, DOI 10.1016/j.jelekin.2013.12.002; van Andel CJ, 2008, GAIT POSTURE, V27, P120, DOI 10.1016/j.gaitpost.2007.03.002; van der Heijden GJMG, 1999, BEST PRACT RES CL RH, V13, P287, DOI 10.1053/berh.1999.0021; VANDERHELM FCT, 1995, J BIOMECH ENG-T ASME, V117, P27, DOI 10.1115/1.2792267; Vidt ME, 2016, J BIOMECH, V49, P611, DOI 10.1016/j.jbiomech.2016.01.029; Walton MJ, 2007, J SHOULDER ELB SURG, V16, P285, DOI 10.1016/j.jse.2006.08.002; Wickham J, 2010, J ELECTROMYOGR KINES, V20, P212, DOI 10.1016/j.jelekin.2009.06.004	45	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183954	10.1371/journal.pone.0183954	http://dx.doi.org/10.1371/journal.pone.0183954			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841697	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700071
J	Martinez-Granados, L; Serrano, M; Gonzalez-Utor, A; Ortiz, N; Badajoz, V; Olaya, E; Prados, N; Boada, M; Castilla, JA				Martinez-Granados, Luis; Serrano, Maria; Gonzalez-Utor, Antonio; Ortiz, Nereyda; Badajoz, Vicente; Olaya, Enrique; Prados, Nicolas; Boada, Montse; Castilla, Jose A.		Special Interest Grp Quality	Inter-laboratory agreement on embryo classification and clinical decision: Conventional morphological assessment vs. time lapse	PLOS ONE			English	Article							EXTERNAL QUALITY-CONTROL; IMPLANTATION; MORPHOKINETICS; SELECTION; MODEL; PREDICTION; ALGORITHM	The aim of this study is to determine inter-laboratory variability on embryo assessment using time-lapse platform and conventional morphological assessment. This study compares the data obtained from a pilot study of external quality control (EQC) of time lapse, performed in 2014, with the classical EQC of the Spanish Society for the Study of Reproductive Biology (ASEBIR) performed in 2013 and 2014. In total, 24 laboratories (8 using EmbryoScope (TM), 15 using Primo Vision (TM) and one with both platforms) took part in the pilot study. The clinics that used EmbryoScope (TM) analysed 31 embryos and those using Primo Vision (TM) analysed 35. The classical EQC was implemented by 39 clinics, based on an analysis of 25 embryos per year. Both groups were required to evaluate various qualitative morphological variables (cell fragmentation, the presence of vacuoles, blastomere asymmetry and multinucleation), to classify the embryos in accordance with ASEBIR criteria and to stipulate the clinical decision taken. In the EQC time-lapse pilot study, the groups were asked to determine, as well as the above characteristics, the embryo development times, the number, opposition and size of pronuclei, the direct division of 1 into 3 cells and/or of 3 into 5 cells and false divisions. The degree of agreement was determined by calculating the intra-class correlation coefficients and the coefficient of variation for the quantitative variables and the Gwet index for the qualitative variables. For both EmbryoScope (TM) and Primo Vision (TM), two periods of greater inter-laboratory variability were observed in the times of embryo development events. One peak of variability was recorded among the laboratories addressing the first embryo events (extrusion of the second polar body and the appearance of pronuclei); the second peak took place between the times corresponding to the 8-cell and morula stages. In most of the qualitative variables analysed regarding embryo development, there was almost-perfect inter-laboratory agreement among conventional morphological assessment (CMA), EmbryoScope (TM) and Primo Vision (TM), except for false divisions, vacuoles and asymmetry (users of all methods) and multinucleation (users of Primo Vision (TM)), where the degree of agreement was lower. The inter-laboratory agreement on embryo classification according to the ASEBIR criteria was moderate-substantial (Gwet 0.41-0.80) for the laboratories using CMA and EmbryoScope (TM), and fair-moderate (Gwet 0.21-0.60) for those using Primo Vision (TM). The inter-laboratory agreement for clinical decision was moderate (Gwet 0.41-0.60) on day 5 for CMA users and almost perfect (Gwet 0.81-1) for time-lapse users. In conclusion, time-lapse technology does not improve inter-laboratory agreement on embryo classification or the analysis of each morphological variable. Moreover, depending on the time-lapse platform used, inter-laboratory agreement may be lower than that obtained by CMA. However, inter-laboratory agreement on clinical decisions is improved with the use of time lapse, regardless of the platform used.	[Martinez-Granados, Luis; Castilla, Jose A.] Hosp Univ Virgen Nieves, IIBG, UGC Lab Clin, U Reprod, Granada, Spain; [Martinez-Granados, Luis; Castilla, Jose A.] Hosp Univ Virgen Nieves, IIBG, UGC Obstetricia & Ginecol, U Reprod, Granada, Spain; [Serrano, Maria] Clin IFEM, Cordoba, Spain; [Gonzalez-Utor, Antonio] Ctr MasVida Reprod, Seville, Spain; [Ortiz, Nereyda] Inst Europeo Fertilidad, Madrid, Spain; [Badajoz, Vicente] Ginefiv, Madrid, Spain; [Olaya, Enrique] Clin Tambre, Madrid, Spain; [Prados, Nicolas] IVI, Seville, Spain; [Boada, Montse] Womens Hlth Dexeus, Barcelona, Spain; [Castilla, Jose A.] CEIFER Biobanco, Granada, Spain; [Castilla, Jose A.] Univ Granada, Fac Med, Dept Anat & Embriol Humana, Granada, Spain	Hospital Universitario Virgen de las Nieves; Hospital Universitario Virgen de las Nieves; University of Granada	Martinez-Granados, L (corresponding author), Hosp Univ Virgen Nieves, IIBG, UGC Lab Clin, U Reprod, Granada, Spain.; Martinez-Granados, L (corresponding author), Hosp Univ Virgen Nieves, IIBG, UGC Obstetricia & Ginecol, U Reprod, Granada, Spain.	Luismargra@gmail.com	Castilla, jose antonio/ABF-8754-2021; Prados, Nicolas/P-1554-2016	Castilla, jose antonio/0000-0003-2185-565X; Prados, Nicolas/0000-0002-7888-2125				Ahlstrom A, 2016, REPROD BIOMED ONLINE, V33, P61, DOI 10.1016/j.rbmo.2016.03.008; Castilla JA, 2010, REPROD BIOMED ONLINE, V20, P68, DOI 10.1016/j.rbmo.2009.09.033; Aparicio-Ruiz B, 2016, FERTIL STERIL, V106, P1379, DOI 10.1016/j.fertnstert.2016.07.1117; Arce JC, 2006, HUM REPROD, V21, P2141, DOI 10.1093/humrep/del106; ASEBIR, 2008, CUAD EMBR CLIN 2 CRI; Basile N, 2015, HUM REPROD, V30, P276, DOI 10.1093/humrep/deu331; Chavez SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2249; Ciray HN, 2014, HUM REPROD, V29, P2650, DOI 10.1093/humrep/deu278; Conaghan J, 2013, FERTIL STERIL, V100, P412, DOI 10.1016/j.fertnstert.2013.04.021; de los Santos MJ, 2013, FERTIL STERIL, V100, P402, DOI 10.1016/j.fertnstert.2013.03.044; De los Santos MJ, 2016, HUM REPROD, V31, P685, DOI 10.1093/humrep/dew016; Diamond MP, 2015, J ASSIST REPROD GEN, V32, P61, DOI 10.1007/s10815-014-0366-1; Gardner DK, 2016, MOL HUM REPROD, V22, P704, DOI 10.1093/molehr/gaw057; Hardarson T, 2002, Reprod Biomed Online, V5, P36; Harper J, 2012, HUM REPROD, V27, P303, DOI 10.1093/humrep/der414; Kieslinger DC, 2016, HUM REPROD, V31, P2450, DOI 10.1093/humrep/dew207; Kirkegaard K, 2015, FERTIL STERIL, V103, P323, DOI 10.1016/j.fertnstert.2014.11.003; Kirkegaard K, 2014, REPROD BIOMED ONLINE, V29, P156, DOI 10.1016/j.rbmo.2014.04.011; Kirkegaard K, 2013, FERTIL STERIL, V99, P738, DOI 10.1016/j.fertnstert.2012.11.028; Kirkegaard K, 2012, HUM REPROD, V27, P1277, DOI 10.1093/humrep/des079; Liu YH, 2016, FERTIL STERIL, V105, P656, DOI 10.1016/j.fertnstert.2015.11.003; Lundin K, 2015, REPROD BIOMED ONLINE, V31, P459, DOI 10.1016/j.rbmo.2015.06.026; Mastenbroek S, 2011, HUM REPROD, V26, P964, DOI 10.1093/humrep/der050; Meseguer M, 2011, HUM REPROD, V26, P2658, DOI 10.1093/humrep/der256; Milewski R, 2015, J ASSIST REPROD GEN, V32, P571, DOI 10.1007/s10815-015-0440-3; Molder A, 2015, CYTOM PART A, V87A, P119, DOI 10.1002/cyto.a.22611; Petersen BM, 2016, HUM REPROD, V31, P2231, DOI 10.1093/humrep/dew188; Rubio I, 2012, FERTIL STERIL, V98, P1458, DOI 10.1016/j.fertnstert.2012.07.1135; de Assin RR, 2009, REPROD BIOMED ONLINE, V19, P824, DOI 10.1016/j.rbmo.2009.09.026; Sundvall L, 2013, HUM REPROD, V28, P3215, DOI 10.1093/humrep/det366; VerMilyea MD, 2014, REPROD BIOMED ONLINE, V29, P729, DOI 10.1016/j.rbmo.2014.09.005; Wirka KA, 2014, FERTIL STERIL, V101, P1637, DOI 10.1016/j.fertnstert.2014.02.050	32	12	12	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183328	10.1371/journal.pone.0183328	http://dx.doi.org/10.1371/journal.pone.0183328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841654	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700024
J	Akshaya, KM; Shivalli, S				Akshaya, Kibballi Madhukeshwar; Shivalli, Siddharudha			Birth preparedness and complication readiness among the women beneficiaries of selected rural primary health centers of Dakshina Kannada district, Karnataka, India	PLOS ONE			English	Article							NEPAL	Introduction Birth preparedness and complication readiness (BPCR) is a strategy to promote timely use of skilled maternal and neonatal care during childbirth. According to World Health Organization, BPCR should be a key component of focused antenatal care. Dakshina Kannada, a coastal district of Karnataka state, is categorized as a high-performing district (institutional delivery rate > 25%) under the National Rural Health Mission. However, a substantial proportion of women in the district experience complications during pregnancy (58.3%), childbirth (45.7%), and postnatal (17.4%) period. There is a paucity of data on BPCR practice and the factors associated with it in the district. Exploring this would be of great use in the evidence-based fine-tuning of ongoing maternal and child health interventions. Objective To assess BPCR practice and the factors associated with it among the beneficiaries of two rural Primary Health Centers (PHCs) of Dakshina Kannada district, Karnataka, India. Methods A facility-based cross-sectional study was conducted among 217 pregnant (> 28 weeks of gestation) and recently delivered (in the last 6 months) women in two randomly selected PHCs from June - September 2013. Exit interviews were conducted using a pre-designed semi-structured interview schedule. Information regarding socio-demographic profile, obstetric variables, and knowledge of key danger signs was collected. BPCR included information on five key components: identified the place of delivery, saved money to pay for expenses, mode of transport identified, identified a birth companion, and arranged a blood donor if the need arises. In this study, a woman who recalled at least two key danger signs in each of the three phases, i.e., pregnancy, childbirth, and postpartum (total six) was considered as knowledgeable on key danger signs. Optimal BPCR practice was defined as following at least three out of five key components of BPCR. Outcome measures Proportion, Odds ratio, and adjusted Odds ratio (adj OR) for optimal BPCR practice. Results A total of 184 women completed the exit interview (mean age: 26.9 +/- 3.9 years). Optimal BPCR practice was observed in 79.3% (95% CI: 73.5-85.2%) of the women. Multivariate logistic regression revealed that age > 26 years (adj OR = 2.97; 95% CI: 1.15-7.7), economic status of above poverty line (adj OR = 4.3; 95% CI: 1.12-16.5), awareness of minimum two key danger signs in each of the three phases, i.e., pregnancy, childbirth, and postpartum (adj OR = 3.98; 95% CI: 1.4-11.1), preference to private health sector for antenatal care/delivery (adj OR = 2.9; 95% CI: 1.1-8.01), and woman's discussion about the BPCR with her family members (adj OR = 3.4; 95% CI: 1.1-10.4) as the significant factors associated with optimal BPCR practice. Conclusion In this study population, BPCR practice was better than other studies reported from India. Healthcare workers at the grassroots should be encouraged to involve women's family members while explaining BPCR and key danger signs with a special emphasis on young (<26 years) and economically poor women. Ensuring a reinforcing discussion between woman and her family members may further enhance the BPCR practice.	[Akshaya, Kibballi Madhukeshwar] Yenepoya Univ, Yenepoya Med Coll, Dept Community Med, Mangaluru, Karnataka, India; [Shivalli, Siddharudha] Yenepoya Univ, Yenepoya Med Coll, Dept Publ Hlth, Mangaluru, Karnataka, India; [Shivalli, Siddharudha] TEPHINET, Southeast Asia Reg Off SEARO, Decatur, GA USA	Yenepoya (Deemed to be University); Yenepoya (Deemed to be University)	Shivalli, S (corresponding author), Yenepoya Univ, Yenepoya Med Coll, Dept Publ Hlth, Mangaluru, Karnataka, India.; Shivalli, S (corresponding author), TEPHINET, Southeast Asia Reg Off SEARO, Decatur, GA USA.	shivalli.bhu@gmail.com	Shivalli, Siddharudha/AAU-3907-2020; Akshaya, Kibballi Madhukeshwar/AAE-3352-2021	Shivalli, Siddharudha/0000-0003-1454-7114				Acharya Anita Shankar, 2015, Indian J Community Med, V40, P127, DOI 10.4103/0970-0218.153881; Acsadi GT, 1991, SOCIAL CULTURAL FACT, P73; Agarwal S, 2010, J HEALTH POPUL NUTR, V28, P383; August F, 2015, GLOBAL HEALTH ACTION, V8, P1, DOI 10.3402/gha.v8.26922; Bintabara D, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0041-8; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Debelew GT, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.272.4244; Ekabua John E, 2011, ISRN Obstet Gynecol, V2011, P560641, DOI 10.5402/2011/560641; Govt. of India (Sample Registration System), MAT MORT IND 1997 20; Hailu M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021432; JHPIEGO, 2004, MAT NEON HLTH MON BI; Karkee R, 2013, MIDWIFERY, V29, P1206, DOI 10.1016/j.midw.2013.05.002; Kaso M, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-55; Lwanga SK., 1991, SAMPLE SIZE DETERMIN, P25; Malik Geeta, 2009, Nurs J India, V100, P88; Markos D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-282; Mazumdar R, AL AMEEN J MED SCI, V7, P52; Mukhopadhyay Dipta Kanti, 2013, Indian J Public Health, V57, P147, DOI 10.4103/0019-557X.119827; Mullany BC, 2007, HEALTH EDUC RES, V22, P166, DOI 10.1093/her/cyl060; Mutiso S M, 2008, East Afr Med J, V85, P275; Nandan D, 2009, STUDY ASSESSING BIRT; Nawal D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060957; Odimegwu Clifford, 2005, Afr J Reprod Health, V9, P59; Pembe AB, 2009, BMC PREGNANCY CHILDB, V9, DOI 10.1186/1471-2393-9-12; Shetty N., DAKSHINA KANNADA DIS; Sookhoo D., 2009, SOCIAL CONTEXT BIRTH, P85; Soubeiga D, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-129; stergren P-O, 2011, REPROD HLTH, V8, P33; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Timsa L, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.23969; World Health Organization, 2010, WORK IND FAM COMM IM; World Health Organization, 2015, WORLD REP AG HLTH, P3; Wylie KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0027735	33	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183739	10.1371/journal.pone.0183739	http://dx.doi.org/10.1371/journal.pone.0183739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837683	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000408365000108
J	Doyle, AM; Plummer, ML; Weiss, HA; Changalucha, J; Watson-Jones, D; Hayes, RJ; Ross, DA				Doyle, Aoife M.; Plummer, Mary L.; Weiss, Helen A.; Changalucha, John; Watson-Jones, Deborah; Hayes, Richard J.; Ross, David A.			Concurrency and other sexual partnership patterns reported in a survey of young people in rural Northern Tanzania	PLOS ONE			English	Article							HIV-INFECTION; CAPE-TOWN; PREVALENCE; TRANSMISSION; BEHAVIOR; POPULATION; LEVEL; RAKAI; RISK; MEN	African adolescents and young adults remain at substantial risk of infection with HIV and other sexually transmitted infections (STIs), and AIDS is the leading cause of death among African adolescents (10-19 years). Sexual partnership patterns influence transmission risk of sexually transmitted infections. We describe patterns reported by youth (15-30y) in a community-based survey in Tanzania. Among participants reporting multiple partners, we investigated factors associated with reported concurrency. Female (N = 6513) and male (N = 7301) participants had median ages of 21 and 22 years, respectively. Most participants (92%) reported having previously been sexually active, of whom 15% of males and <1% of females reported >= 4 partners in the past year. The point prevalence of concurrency was 2.3% (95% CI 1.9-2.9) for females and 10.6% (95% CI 9.3-12.1) for males. High levels of multiple and concurrent partnerships were reported by those previously married. Females were more likely than males to report having spousal/regular partners and longer partnership lengths. Compared to males, the partnerships reported by females were less likely to be new partnerships, and more likely to be defined by the respondent as still 'ongoing'. Females reporting younger sexual debut were more likely to report concurrent sexual partners. Far fewer young women reported multiple and concurrent partnerships, but we cannot definitively conclude that concurrency was uncommon for women, because stigma towards women's multiple sexual partnerships might contribute to substantial under-reporting, as was found in extensive qualitative research in the study population. This study provides one of the most comprehensive quantitative descriptions of partnership patterns of young people in an African setting. Interventions addressing sexual risk among youth should involve male partners, empower women to protect themselves within different types of partnerships, and encourage a greater openness about young people's sexual relationships.	[Doyle, Aoife M.; Weiss, Helen A.; Hayes, Richard J.] London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England; [Changalucha, John] Natl Inst Med Res, Mwanza, Tanzania; [Watson-Jones, Deborah] London Sch Hyg & Trop Med, Dept Clin Res, London, England; [Ross, David A.] WHO, Geneva, Switzerland	University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research; University of London; London School of Hygiene & Tropical Medicine; World Health Organization	Doyle, AM (corresponding author), London Sch Hyg & Trop Med, MRC Trop Epidemiol Grp, London, England.	aoife.doyle@lshtm.ac.uk	Doyle, Aoife/AAX-3525-2020; weiss, helen/ABC-7823-2021	Doyle, Aoife/0000-0002-3305-7738; weiss, helen/0000-0003-3547-7936; Hayes, Richard/0000-0002-1729-9892; Plummer, Mary Louisa/0000-0002-6816-8235	European Commission; UK Department for International Development; Irish Aid; Medical Research Council of Great Britain; United Nations Joint Programme on HIV/AIDS (UNAIDS); UK Medical Research Council [G0902121]; MRC [G0902121] Funding Source: UKRI; Medical Research Council [G0902121, MR/K012126/1] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); UK Department for International Development; Irish Aid(CGIAR); Medical Research Council of Great Britain(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); United Nations Joint Programme on HIV/AIDS (UNAIDS); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The MEMA kwa Vijana Trial was a collaboration between the London School of Hygiene & Tropical Medicine (LSHTM), the Tanzanian National Institute for Medical Research (NIMR), the African Medical and Research Foundation (AMREF), and the Ministries of Health and Social Welfare and of Education and Vocational Training of the Government of Tanzania. It was supported by grants from the European Commission, the UK Department for International Development, and Irish Aid, with additional funding support from the Medical Research Council of Great Britain and The United Nations Joint Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AMD was funded by the UK Medical Research Council (G0902121).	Baumgartner JN, 2010, AIDS CARE, V22, P1153, DOI 10.1080/09540121003615095; Beauclair R, 2015, J INT AIDS SOC, V18, DOI 10.7448/IAS.18.1.19372; Beguy D, 2009, J ADOLESCENT HEALTH, V45, P595, DOI 10.1016/j.jadohealth.2009.03.014; Doherty IA, 2006, SEX TRANSM DIS, V33, P368, DOI 10.1097/01.olq.0000194586.66409.7a; Doyle AM, 2013, 10 INT ASS AD HLTH W, P43; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Fund UNCs, 2016, EV CHILD END AIDS 7; Gersovitz M, 1998, J AM STAT ASSOC, V93, P875, DOI 10.2307/2669826; Glynn JR, 2012, AIDS, V26, P977, DOI 10.1097/QAD.0b013e328350fc1f; Gorbach PM, 2005, SEX TRANSM DIS, V32, P7, DOI 10.1097/01.olq.0000148302.81575.fc; Gorbach PM, 2003, J URBAN HEALTH, V80, P15; Gourvenec D., 2007, MULTIPLE CONCURRENT; Harrison A, 2008, STUD FAMILY PLANN, V39, P295, DOI 10.1111/j.1728-4465.2008.00176.x; Harrison A, 2010, AIDS BEHAV, V14, P991, DOI 10.1007/s10461-010-9687-y; Hattori MK, 2007, SOC SCI MED, V64, P1067, DOI 10.1016/j.socscimed.2006.10.005; Hayes R, 2004, 15 M INT SOC SEX TRA; Hewett PC, 2004, SEX TRANSM INFECT, V80, P43, DOI 10.1136/sti.2004.013250; Jana M, 2008, ONE LOVE MULTIPLE CO; Kenyon C, 2010, SAHARA J-J SOC ASP H, V7, P35, DOI 10.1080/17290376.2010.9724967; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Mah TL, 2010, SEX TRANSM DIS, V37, P105, DOI 10.1097/OLQ.0b013e3181bcdf75; Manhart LE, 2002, SEX TRANSM DIS, V29, P133, DOI 10.1097/00007435-200203000-00003; Mathur S, 2015, JAIDS-J ACQ IMM DEF, V69, P75, DOI 10.1097/QAI.0000000000000539; Maughan-Brown B, 2012, SEX TRANSM DIS, V39, P537, DOI 10.1097/OLQ.0b013e31824cc0c1; Maughan-Brown B, 2011, AIDS, V25, P1549, DOI 10.1097/QAD.0b013e32834905c4; Mayone Stycos J., 2000, SOCIAL RES DEV COUNT, P53; Morris M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014092; Nnko S, 2004, SOC SCI MED, V59, P299, DOI 10.1016/j.socscimed.2003.10.031; Nnko S, 1997, HLTH TRANSIT REV S3, V7, P6; Pettifor AE, 2004, AIDS, V18, P1435, DOI 10.1097/01.aids.0000131338.61042.b8; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Plummer M.L., 2012, PROMOTING ABSTINENCE; Plummer ML, 2004, SEX TRANSM INFECT, V80, P49, DOI 10.1136/sti.2004.011924; Plummer ML, 2011, YOUNG PEOPLES LIVES; Powers KA, 2011, SEX TRANSM DIS, V38, P657, DOI 10.1097/OLQ.0b013e31820cb223; Sawers L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17431; Steffenson AE, 2011, SEX TRANSM DIS; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; UNAIDS (United National Programme on AIDS), 2009, CONS CONC SEX PARTN; UNDAIDS, 2010, UNAIDS1011EJC1958E; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Westercamp N, 2013, AIDS BEHAV, V17, P3124, DOI 10.1007/s10461-013-0457-5; White R, 2000, AIDS, V14, P2323, DOI 10.1097/00002030-200010200-00013; WHO, 2014, HLTH WORLDS AD 2 CHA; Wight D, 2006, SOC SCI MED, V62, P987, DOI 10.1016/j.socscimed.2005.06.052	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182567	10.1371/journal.pone.0182567	http://dx.doi.org/10.1371/journal.pone.0182567			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837686	Green Accepted, Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000021
J	Gao, LY; Chen, B; Li, JH; Yang, F; Cen, XC; Liao, ZB; Long, X				Gao, Liyang; Chen, Bing; Li, Jinhong; Yang, Fan; Cen, Xuecheng; Liao, Zhuangbing; Long, Xiao'ao			Wnt/beta-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms	PLOS ONE			English	Article							BETA-CATENIN; WNT; EXPRESSION; GROWTH; INVASION; TARGET; ANGIOGENESIS; FIBRONECTIN; LAMININ; MARKER	The Wnt signaling pathway is necessary for the development of the central nervous system and is associated with tumorigenesis in various cancers. However, the mechanism of the Wnt signaling pathway in glioma cells has yet to be elucidated. Small-molecule Wnt modulators such as ICG-001 and AZD2858 were used to inhibit and stimulate the Wnt/beta-catenin signaling pathway. Techniques including cell proliferation assay, colony formation assay, Matrigel cell invasion assay, cell cycle assay and Genechip microarray were used. Gene Ontology Enrichment Analysis and Gene Set Enrichment Analysis have enriched many biological processes and signaling pathways. Both the inhibiting and stimulating Wnt/beta-catenin signaling pathways could influence the cell cycle, moreover, reduce the proliferation and survival of U87 glioma cells. However, Affymetrix expression microarray indicated that biological processes and networks of signaling pathways between stimulating and inhibiting the Wnt/beta-catenin signaling pathway largely differ. We propose that Wnt/beta-catenin signaling pathway might prove to be a valuable therapeutic target for glioma.	[Gao, Liyang] Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China; [Gao, Liyang] Guangdong Med Univ, Affiliated Hosptial, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang, Peoples R China; [Chen, Bing; Li, Jinhong; Yang, Fan; Cen, Xuecheng; Liao, Zhuangbing; Long, Xiao'ao] Guangdong Med Univ, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China	Ningxia University; Guangdong Medical University; Guangdong Medical University	Gao, LY (corresponding author), Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China.; Gao, LY (corresponding author), Guangdong Med Univ, Affiliated Hosptial, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang, Peoples R China.; Chen, B (corresponding author), Guangdong Med Univ, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China.	pandarun@aliyun.com; 13702878900@139.com			Major Innovation Projects of Building First-class Universities in China's Western Region [ZKZD2017001]	Major Innovation Projects of Building First-class Universities in China's Western Region	This study was supported by the Major Innovation Projects of Building First-class Universities in China's Western Region (ZKZD2017001). This funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6853; An SM, 2013, ACTA PHARMACOL SIN, V34, P777, DOI 10.1038/aps.2013.64; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Cao P, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1495-3; Chen DF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087281; Duan R, 2015, ONCOTARGET, V6, P27778, DOI 10.18632/oncotarget.4813; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Evans DGR, 2009, GENET MED, V11, P599, DOI 10.1097/GIM.0b013e3181ac9a27; Fenstermaker RA, 2016, CANCER IMMUNOL IMMUN, V65, P1339, DOI 10.1007/s00262-016-1890-x; Gao J, 2015, INT J CLIN EXP PATHO, V8, P10130; Gu XF, 2014, NEURO-ONCOLOGY, V16, P217, DOI 10.1093/neuonc/not194; Guo Y, 2011, HISTOPATHOLOGY, V59, P763, DOI 10.1111/j.1365-2559.2011.03993.x; Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9; Herbst Andreas, 2007, Methods Mol Biol, V361, P63; Hu JX, 2010, J AM STAT ASSOC, V105, P1215, DOI 10.1198/jasa.2010.tm09329; Huijbers IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009808; Iacopino F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105166; Katz LH, 2013, EXPERT OPIN THER TAR, V17, P743, DOI 10.1517/14728222.2013.782287; KAVINSKY CJ, 1979, J SUPRAMOL STR CELL, V11, P269, DOI 10.1002/jss.400110216; Kingdom U, 2008, OCT4 SPLICED VARIANT, P3068; Kingsmore KM, 2016, INTEGR BIOL; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li QF, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-302; LIESI P, 1984, MED BIOL, V62, P163; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Ma Q, 2015, ONCOTARGET, V6, P35851, DOI 10.18632/oncotarget.5323; Maguschak K, 2012, J NEUROIMMUNE PHARM; Maiese K, 2008, PHARMACOL THERAPEUT, V118, P58, DOI 10.1016/j.pharmthera.2008.01.004; Mulligan KA, 2012, J NEUROIMMUNE PHARM, V7, P774, DOI 10.1007/s11481-012-9404-x; Nagaraj AB, 2015, ONCOTARGET, V6, P23720, DOI 10.18632/oncotarget.4690; Nagaraj NS, 2010, EXPERT OPIN INV DRUG, V19, P77, DOI 10.1517/13543780903382609; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; ORourke NA, 1997, DEVELOPMENT, V124, P997; OSADA T, 1995, BRAIN RES, V683, P254, DOI 10.1016/0006-8993(95)00336-O; Payne LS, 2013, MOL CANCER RES, V11, P1129, DOI 10.1158/1541-7786.MCR-13-0236; Pu P, 2009, CANCER GENE THER, V16, P351, DOI 10.1038/cgt.2008.78; Qiu B, 2012, INT J MOL SCI, V13, P9142, DOI 10.3390/ijms13079142; RAMPAZZO E, 2013, CELL DEATH DIS, V4; Reis M, 2012, J EXP MED, V209, P1611, DOI 10.1084/jem.20111580; Seidel C, 2007, MOL CARCINOGEN, V46, P865, DOI 10.1002/mc.20317; Thacker PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120045; Wang DY, 2015, ONCOL LETT, V9, P2603, DOI 10.3892/ol.2015.3079; Wang HD, 2016, ONCOL LETT, V11, P678, DOI 10.3892/ol.2015.3917; Wang K, 2013, NEURO-ONCOLOGY, V15, P578, DOI 10.1093/neuonc/not004; Wang Lei, 2016, Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi, V32, P789; Wiranowska M, 2010, INT J CANCER, V127, P532, DOI 10.1002/ijc.25085; XU TA, 1995, DEVELOPMENT, V121, P1053; Zhang N, 2011, CANCER CELL, V20, P427, DOI 10.1016/j.ccr.2011.08.016; Zhao P, 2015, ONCOTARGET, V6, P31901, DOI 10.18632/oncotarget.5043	50	51	51	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181346	10.1371/journal.pone.0181346	http://dx.doi.org/10.1371/journal.pone.0181346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837560	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000006
J	Hohloch, L; Eberbach, H; Wagner, FC; Strohm, PC; Reising, K; Sudkamp, NP; Zwingmann, J				Hohloch, Lisa; Eberbach, Helge; Wagner, Ferdinand C.; Strohm, Peter C.; Reising, Kilian; Suedkamp, Norbert P.; Zwingmann, Joern			Age- and severity-adjusted treatment of proximal humerus fractures in children and adolescents - A systematical review and meta-analysis	PLOS ONE			English	Review							TITANIUM ELASTIC NAILS; EPIPHYSEAL FRACTURES; MANAGEMENT; REDUCTION; FIXATION	Background Fractures of the proximal humerus in patients under the age of 18 years show a low incidence; existing clinical studies only comprise small patient numbers. Different treatment methods are mentioned in the literature but a comparison of the outcome of these methods is rarely made. Up to now, no evidence-based algorithm for conservative and operative treatment is available. The aim of this systematic review with meta-analysis was therefore to gather the best evidence of different treatment methods and their associated functional outcome, complication rates, rates of limb length discrepancies and radiological outcome. Methods and findings The OVID database was systematically searched on September 30th in 2016 in order to find all published clinical studies on the subject of proximal humerus fractures of patients <= 18 years. Exclusion criteria were previously defined. The Coleman Methodology Score was used to evaluate the quality of the single studies. 886 studies have been identified by the search strategy. 19 studies with a total of 643 children (mean age: 11.8 years) were included into the meta-analysis with a mean Coleman Methodology Score of 71 +/- 7.4 points. 18 of the 19 studies eligible for inclusion were retrospective ones, of the best quality available (mean follow-up >= 1 year, mean follow-up rate >= 65%). 56% of the patients were male. Proximal humerus fractures were treated conservatively in 41% and surgically in 59% of the cases (Elastic Stable Intramedullary Nailing (ESIN): 31%; K-wires: 20%; 8% other methods, e.g. plate osteosynthesis, olecranon traction). The overall success rate (good/excellent outcome) for all treatment methods was 93%. The success rate of ESIN (98%) and of K-wire fixation (95%) was significantly higher (p = 0.01) than the success rate of conservative treatment options (91%). A subgroup analysis of severely displaced fractures (Neer grade III/IV, angulation >= 20 degrees) resulted in a change of success rates, to the disadvantage of conservative treatment methods (conservative treatment 82%, ESIN 98%, K-wires 95%; p < 0.001). Complication rates did not differ to a significant extent. 9% of the complications occurred in the patients treated by K-wire fixation, 8% if a conservative treatment option was chosen and 7% in the fractures that were stabilized by ESIN. A change from a one-nail technique to a two-nail technique reduced the complication rate of ESIN significantly. Follow-up X-rays without residual deformity could be found in 96% of the patients treated by ESIN, a rate which was higher than in the patients treated conservatively (93%) or by K-wire fixation (88%). The rate of arm length discrepancies at final follow-up was lower if the fractures were stabilized by ESIN (4%) than if they were treated conservatively (9%) or by K-wires (19%). An evaluation of age-dependent treatment options was performed. Conclusions By performing this meta-analysis an evidence-based treatment algorithm could be introduced to treat the fractures according to the severity of displacement and according to the patient's age. For severely displaced fractures ESIN is the method of choice, with the best clinical and radiological outcome.	[Hohloch, Lisa; Eberbach, Helge; Wagner, Ferdinand C.; Reising, Kilian; Suedkamp, Norbert P.; Zwingmann, Joern] Albert Ludwigs Univ Freiburg, Fac Med, Med Ctr, Dept Orthoped & Trauma Surg, Freiburg, Germany; [Strohm, Peter C.] Klinikum Bamberg, Clin Orthoped & Trauma Surg, Bamberg, Germany	University of Freiburg	Hohloch, L (corresponding author), Albert Ludwigs Univ Freiburg, Fac Med, Med Ctr, Dept Orthoped & Trauma Surg, Freiburg, Germany.	lisa.hohloch@uniklinik-freiburg.de	Reising, Kilian/ABB-4931-2021; Suedkamp, Norbert/AAF-2931-2019	Bode, Lisa/0000-0002-1112-8291; Sudkamp, Norbert/0000-0002-5913-624X; Zwingmann, Jorn/0000-0001-8755-6383	German Research Foundation (DFG); University of Freiburg	German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	The article processing charge is funded by the German Research Foundation (DFG) and the University of Freiburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften, 2016, PROX HUM BEIM KIND; Bahrs C, 2009, J PEDIATR ORTHOPED, V29, P238, DOI 10.1097/BPO.0b013e31819bd9a7; BAXTER MP, 1986, J BONE JOINT SURG BR, V68, P570, DOI 10.1302/0301-620X.68B4.3733832; Beaty J H, 1992, Instr Course Lect, V41, P369; Bishop JY, 2005, CLIN ORTHOP RELAT R, P41, DOI 10.1097/01.blo.0000156004.01503.43; BURGOSFLORES J, 1993, INT ORTHOP, V17, P16; Canavese F, 2014, J PEDIATR ORTHOP B, V23, P144, DOI 10.1097/BPB.0000000000000009; Caviglia H, 2005, CLIN ORTHOP RELAT R, P49, DOI 10.1097/01.blo.0000156452.91271.fb; Chaus GW, 2015, J PEDIATR ORTHOPED, V35, P234, DOI 10.1097/BPO.0000000000000265; Chee Y, 2006, J PEDIATR ORTHOP B, V15, P45, DOI 10.1097/01202412-200601000-00010; Coleman BD, 2000, SCAND J MED SCI SPOR, V10, P2, DOI 10.1034/j.1600-0838.2000.010001002.x; DAMERON TB, 1969, J BONE JOINT SURG AM, VA 51, P289, DOI 10.2106/00004623-196951020-00008; Dobbs MB, 2003, J PEDIATR ORTHOPED, V23, P208, DOI 10.1097/00004694-200303000-00015; Fernandez FF, 2008, INJURY, V39, P1453, DOI 10.1016/j.injury.2008.04.001; FREY C, 1989, Z KINDERCHIR, V44, P280; GIEBEL G, 1983, CHIRURG, V54, P406; Karatosun V, 2003, J ORTHOP TRAUMA, V17, P578, DOI 10.1097/00005131-200309000-00007; Khan A, 2014, Eur J Orthop Surg Traumatol, V24, P165, DOI 10.1007/s00590-013-1177-2; Kraus T, 2014, J SHOULDER ELB SURG, V23, P1462, DOI 10.1016/j.jse.2014.01.015; LARSEN CF, 1990, ACTA ORTHOP SCAND, V61, P255, DOI 10.3109/17453679008993512; LIGIER JN, 1983, CHIR PEDIATR, V24, P383; METAIZEAU JP, 1984, J CHIR-PARIS, V121, P527; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Neer C S 2nd, 1965, Clin Orthop Relat Res, V41, P24; Nilsson S, 1965, Acta Chir Scand, V130, P433; Pahlavan S, 2011, J CHILD ORTHOP, V5, P187, DOI 10.1007/s11832-011-0328-4; Popkin CA, 2015, J AM ACAD ORTHOP SUR, V23, P77, DOI 10.5435/JAAOS-D-14-00033; Schwendenwein E, 2004, EUR J PEDIATR SURG, V14, P51, DOI 10.1055/s-2004-815781; Wang XL, 2014, INT ORTHOP, V38, P107, DOI 10.1007/s00264-013-2122-z; Xie F, 2011, J PEDIATR ORTHOPED, V31, P839, DOI 10.1097/BPO.0b013e3182306860; Zwingmann J, 2013, INJURY, V44, P1540, DOI 10.1016/j.injury.2013.04.003; Zwingmann J, 2013, ARCH ORTHOP TRAUM SU, V133, P1257, DOI 10.1007/s00402-013-1788-4	32	16	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183157	10.1371/journal.pone.0183157	http://dx.doi.org/10.1371/journal.pone.0183157			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837601	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000049
J	Hull, WW; Bourdeau, PE				Hull, Wesley W.; Bourdeau, Paul E.			Can crabs kill like a keystone predator? A field-test of the effects of crab predation on mussel mortality on a northeast Pacific rocky shore	PLOS ONE			English	Article							COMMUNITY STATES; MYTILUS-EDULIS; WAVE-EXPOSURE; SIZE; COMPLEXITY; PATTERNS; STRESS; LEVEL; GULF	Predation can strongly influence community structure and ecosystem function, so the loss of key predators can have dramatic ecological consequences, unless other predatory species in the system are capable of playing similar ecological roles. In light of the recent outbreak of sea star wasting disease (SSWD) and subsequent depletion of west coast sea star populations, including those of the keystone predator Pisaster ochraceus, we examined whether large mobile crabs could play a role as predators on mussels (Mytilus californianus) on a rocky shore in Northern California. Using a combination of sea star removal and predator exclusion cages we found that mussel mortality was 43-294 times greater in uncaged treatments versus caged treatments. Mortality on uncaged mussels at low tidal elevations was due to predation by large mobile crabs (Cancer productus and Romaleon antennarium); confirmed by the presence of mussel shell fragments and documented attacks on wax snail replicas. Laboratory feeding assays indicated that crabs, on a per unit biomass basis, can consume almost twenty-five times as many mussels per day than sea stars, which together with the results of our field experiment, suggest that large predatory crabs could play an important role in maintaining ecosystem function through their predation on mussels on rocky shores where P. ochraceus are rare, absent, or have been depleted by SSWD.	[Hull, Wesley W.; Bourdeau, Paul E.] Humboldt State Univ, Telonicher Marine Lab, Trinidad, CA 95570 USA; [Hull, Wesley W.; Bourdeau, Paul E.] Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA	California State University System; California State Polytechnic University, Humboldt; California State University System; California State Polytechnic University, Humboldt	Bourdeau, PE (corresponding author), Humboldt State Univ, Telonicher Marine Lab, Trinidad, CA 95570 USA.; Bourdeau, PE (corresponding author), Humboldt State Univ, Dept Biol Sci, Arcata, CA 95521 USA.	peb112@humboldt.edu	Bourdeau, Paul/AAA-3551-2019	Bourdeau, Paul/0000-0002-8927-1899	Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award; Humboldt State University Research, Scholarly, and Creative Activities Research Grant; Humboldt State University; California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program	Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award; Humboldt State University Research, Scholarly, and Creative Activities Research Grant; Humboldt State University; California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program	Funding was provided by a Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award to WWH and by a Humboldt State University Research, Scholarly, and Creative Activities Research Grant to PEB. Additional funding was provided by a Humboldt State University Sponsored Programs Foundation Incentives Program Grant to PEB. PEB acknowledges support from The California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the director and staff of the Humboldt State University Telonicher Marine Laboratory for logistical support, as well as volunteers from the Phenotype Environment Biodiversity Lab who helped with field work. We thank both T. Flagor and J. Paulsen for field and lab assistance. We also thank T. McClure for his assistance in creating our map. Mussels, crabs, and sea stars were collected by the authors under scientific collecting permit # SCP 10571 issued to PEB from the California Department of Fish and Wildlife. Two anonymous reviewers provided constructive criticism on earlier versions of this manuscript. Funding was provided by a Humboldt Marine and Coastal Sciences Institute Undergraduate Student Research Award to WWH and by a Humboldt State University Research, Scholarly, and Creative Activities Research Grant to PEB. Additional funding was provided by a Humboldt State University Sponsored Programs Foundation Incentives Program Grant to PEB. PEB acknowledges support from The California State University Council on Ocean Affairs, Science & Technology (CSU-COAST) Grant Development Program. This work conforms to the legal requirements of the country in which it was carried out and to accepted international ethical standards, including those relating to conservation and animal welfare. This is a contribution of the Humboldt State University Telonicher Marine Laboratory and the Humboldt Marine and Coastal Sciences Institute. This manuscript is dedicated to the memory of Lynn K. Hull.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bertness MD, 2002, ECOLOGY, V83, P3434, DOI 10.1890/0012-9658(2002)083[3434:DASCSE]2.0.CO;2; Bertness MD, 2004, ECOLOGY, V85, P1321, DOI 10.1890/02-0636; Boulding EG, 1999, J EXP MAR BIOL ECOL, V232, P217, DOI 10.1016/S0022-0981(98)00117-8; Bourdeau PE, 2009, ECOLOGY, V90, P1659, DOI 10.1890/08-1653.1; BRETT JR, 1979, CAN J ZOOL, V57, P658, DOI 10.1139/z79-078; Carroll JC, 1989, US FISH WILD1 SERV B, V82; Coverdale TC, 2013, FRONT ECOL ENVIRON, V11, P69, DOI 10.1890/120130; Denny MW, 2011, J EXP MAR BIOL ECOL, V400, P175, DOI 10.1016/j.jembe.2011.02.006; DENNY MW, 1983, LIMNOL OCEANOGR, V28, P1269, DOI 10.4319/lo.1983.28.6.1269; EBLING FJ, 1964, J ANIM ECOL, V33, P73, DOI 10.2307/2349; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Errington PL, 1967, PREDATION LIFE; Estes JA, 1998, SCIENCE, V282, P473, DOI 10.1126/science.282.5388.473; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; HALDORSON L, 1979, COPEIA, P567; Harley CDG, 2003, LIMNOL OCEANOGR, V48, P1498, DOI 10.4319/lo.2003.48.4.1498; Helmuth BST, 2001, BIOL BULL-US, V201, P374, DOI 10.2307/1543615; Hewson I, 2014, P NATL ACAD SCI USA, V111, P17278, DOI 10.1073/pnas.1416625111; Hoey AS, 2009, ECOSYSTEMS, V12, P1316, DOI 10.1007/s10021-009-9291-z; Jenkinson RS, 2017, BASELINE MONITORING; Jurgens LJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep37573; KITCHING JA, 1959, J ANIM ECOL, V28, P331, DOI 10.2307/2087; Krenz C, 2007, THESIS; Mazerolle MJ, 2016, AICCMODAVG MODEL SEL; Menge BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153994; MILLER B, 1994, CONSERV BIOL, V8, P677, DOI 10.1046/j.1523-1739.1994.08030677.x; Miller LP, 2007, J EXP MAR BIOL ECOL, V344, P215, DOI 10.1016/j.jembe.2007.01.005; Navarrete SA, 1996, ECOL MONOGR, V66, P409, DOI 10.2307/2963488; Nummi P, 2014, AQUAT CONSERV, V24, P623, DOI 10.1002/aqc.2437; Opermanis O, 2005, ACTA U LATVIENSIS, V691, P17; Oug Eivind, 2011, Marine Biodiversity, V41, P467, DOI 10.1007/s12526-010-0068-6; PAINE RT, 1969, AM NAT, V103, P91, DOI 10.1086/282586; PAINE RT, 1966, AM NAT, V100, P65, DOI 10.1086/282400; PAINE RT, 1976, ECOLOGY, V57, P858, DOI 10.2307/1941053; PALUMBI SR, 1984, J EXP MAR BIOL ECOL, V81, P171, DOI 10.1016/0022-0981(84)90004-2; Robinson EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021025; ROBLES C, 1989, J NAT HIST, V23, P1041, DOI 10.1080/00222938900770951; ROBLES C, 1990, ECOLOGY, V71, P1564, DOI 10.2307/1938292; Rogers TL, 2013, MAR BIOL, V160, P853, DOI 10.1007/s00227-012-2139-7; SCHMITT RJ, 1984, OECOLOGIA, V63, P6, DOI 10.1007/BF00379778; SEED R, 1969, OECOLOGIA, V3, P317, DOI 10.1007/BF00390381; SPIGHT TM, 1974, ECOLOGY, V55, P712, DOI 10.2307/1934409; SUCHANEK TH, 1981, OECOLOGIA, V50, P143, DOI 10.1007/BF00348028; Tyler Cl, 2014, J MAR BIOL ASSOC UK, V95, P361, DOI DOI 10.1017/S0025315414001210; Walker B. H., 1992, Conservation Biology, V6, P18, DOI 10.1046/j.1523-1739.1992.610018.x; Yamada SB, 1996, J EXP MAR BIOL ECOL, V204, P59, DOI 10.1016/0022-0981(96)02579-8	48	9	9	1	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183064	10.1371/journal.pone.0183064	http://dx.doi.org/10.1371/journal.pone.0183064			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837597	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000045
J	Mazur, M; Gladkowski, W; Srcek, VG; Radosevic, K; Maciejewska, G; Wawrzenczyk, C				Mazur, Marcelina; Gladkowski, Witold; Srcek, Visnja Gaurina; Radosevic, Kristina; Maciejewska, Gabriela; Wawrzenczyk, Czeslaw			Regio- and enantioselective microbial hydroxylation and evaluation of cytotoxic activity of beta-cyclocitral-derived halolactones	PLOS ONE			English	Article							BICYCLIC GAMMA-LACTONES; CYCLOHEXANE SYSTEM; ABSIDIA-COERULEA; FUNGAL STRAINS; TRANSFORMATION; BIOTRANSFORMATION; RING; OXIDATION; CULTURES	Three beta-cyclocitral-derived halolactones, which exhibit antifeedant activity towards storage product pests, were subjected to microbial transformation processes. Among the thirty tested strains of filamentous fungi and yeast, the most effective biocatalysts were Absidia cylindrospora AM336, Mortierella isabellina AM212 and Mortierella vinaceae AM149. As a result of regio- and enantioselective hydroxylation four new oxygenated derivatives were obtained. Regardless of the biocatalyst applied, the alpha-iodo- and delta-bromo-gamma-lactones were hydroxylated in an inactivated position C-5 of cyclohexane ring. The analogous transformation of chlorolactone was observed in Mortierella isabellina AM212 culture but in the case of two other biocatalysts the hydroxy group was introduced at C-3 position. All obtained hydroxylactones were enantiomerically pure (ee = 100%) or enriched (ee = 50%). The highest enantioselectivity of hydroxylation was observed for M. isabellina AM212. The cytotoxic activity of halolactones was also examined by WST-1 assay wherein tested compounds did not exhibit significant effect on the viability of tumor HeLa and normal CHO-K1 cells.	[Mazur, Marcelina; Gladkowski, Witold; Wawrzenczyk, Czeslaw] Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland; [Srcek, Visnja Gaurina; Radosevic, Kristina] Univ Zagreb, Fac Food Technol & Biotechnol, Zagreb, Croatia; [Maciejewska, Gabriela] Wroclaw Univ Technol, Cent Lab Instrumental Anal, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; University of Zagreb; Wroclaw University of Science & Technology	Mazur, M (corresponding author), Wroclaw Univ Environm & Life Sci, Dept Chem, Wroclaw, Poland.	marcelina.mazur@upwr.edu.pl	Gładkowski, Witold/A-5750-2017; Srcek, Visnja Gaurina/ABB-6821-2020; Radošević, Kristina/AAE-7909-2021; Mazur, Marcelina/AAC-4794-2020	Gładkowski, Witold/0000-0002-3271-779X; Srcek, Visnja Gaurina/0000-0001-6591-3810; Mazur, Marcelina/0000-0002-6192-5248; Radosevic, Kristina/0000-0001-5156-1893	Ministry of Science and Higher Education, Poland [B010/00031/16]; Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW)	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland); Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW)	This work was financially supported by Ministry of Science and Higher Education, Poland (grant number B010/00031/16). Publication supported by Wroclaw Centre of Biotechnology, programme the Leading National Research Centre (KNOW) for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnoch RC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0114945; Borges KB, 2009, TETRAHEDRON-ASYMMETR, V20, P385, DOI 10.1016/j.tetasy.2009.02.009; Chen GT, 2016, J MOL CATAL B-ENZYM, V123, P154, DOI 10.1016/j.molcatb.2015.11.015; Chen XL, 2014, ENZYME MICROB TECH, V66, P28, DOI 10.1016/j.enzmictec.2014.08.002; Dai JG, 2003, TETRAHEDRON LETT, V44, P1091, DOI 10.1016/S0040-4039(02)02714-4; Dai SY, 2010, TETRAHEDRON, V66, P6919, DOI 10.1016/j.tet.2010.06.039; Gadkowski W, 2013, TETRAHEDRON, V69, P10414, DOI DOI 10.1016/j.tet.2013.09.094; Gladkowski W, 2006, J MOL CATAL B-ENZYM, V39, P31, DOI 10.1016/j.molcatb.2006.01.023; Gladkowski W, 2004, J MOL CATAL B-ENZYM, V29, P13, DOI 10.1016/j.molcarb.2003.10.012; Gladkowski W, 2007, J MOL CATAL B-ENZYM, V49, P79, DOI 10.1016/j.molcatb.2007.08.006; Gladkowski W, 2015, EUR J ORG CHEM, V2015, P605, DOI 10.1002/ejoc.201403343; Gladkowski W, 2011, ENZYME MICROB TECH, V48, P326, DOI 10.1016/j.enzmictec.2010.12.007; Gliszczynska A, 2016, CATAL COMMUN, V80, P39, DOI 10.1016/j.catcom.2016.03.018; Gnitka R, 2015, PHYTOCHEM LETT, V13, P41; Grabarczyk M, 2014, J MOL CATAL B-ENZYM, V102, P195, DOI 10.1016/j.molcatb.2014.02.012; Grabarczyk M, 2012, MOLECULES, V17, P9741, DOI 10.3390/molecules17089741; Grotowska AK, 2002, J MOL CATAL B-ENZYM, V19, P203, DOI 10.1016/S1381-1177(02)00168-6; Grudniewska A, 2013, MOLECULES, V18, P2778, DOI 10.3390/molecules18032778; Han F, 2016, PHYTOCHEM LETT, V18, P136, DOI 10.1016/j.phytol.2016.10.002; Heidary M, 2016, J MOL CATAL B-ENZYM, V126, P32, DOI 10.1016/j.molcatb.2016.01.007; Janeczko T, 2014, J MOL CATAL B-ENZYM, V109, P47, DOI 10.1016/j.molcatb.2014.08.006; Khan N, 2014, ORIENT J CHEM, V30, P941; Mao S, J MOL CATAL B; Martinez A, 2015, PHYTOCHEMISTRY, V117, P500, DOI 10.1016/j.phytochem.2015.07.020; Mazur M, 2015, J BIOSCI BIOENG, V119, P72, DOI 10.1016/j.jbiosc.2014.06.007; Mazur M, 2014, PEST MANAG SCI, V70, P286, DOI 10.1002/ps.3557; Milecka-Tronina N, 2014, BIOORGAN MED CHEM, V22, P883, DOI 10.1016/j.bmc.2013.11.050; Pawlak A, 2017, CHEM-BIOL INTERACT, V261, P18, DOI 10.1016/j.cbi.2016.11.013; Qiao LR, 2014, TETRAHEDRON, V70, P3560, DOI 10.1016/j.tet.2014.04.011; Rivero CW, 2015, PROCESS BIOCHEM, V50, P935, DOI 10.1016/j.procbio.2015.03.015; Roiban GD, 2013, TETRAHEDRON, V69, P5306, DOI 10.1016/j.tet.2013.04.132; Siddiqui M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171476; Solano DM, 2012, BIORESOURCE TECHNOL, V115, P196, DOI 10.1016/j.biortech.2011.11.131; Winska K, J SAUDI CHEM SOC; Yi-Qing W, 2016, CHIN J NAT MED, V14, P939; Zhang BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037641; Zhang RZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083586	37	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183429	10.1371/journal.pone.0183429	http://dx.doi.org/10.1371/journal.pone.0183429			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837605	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000066
J	Chana-Munoz, A; Jendroszek, A; Sonnichsen, M; Kristiansen, R; Jensen, JK; Andreasen, PA; Bendixen, C; Panitz, F				Chana-Munoz, Andres; Jendroszek, Agnieszka; Sonnichsen, Malene; Kristiansen, Rune; Jensen, Jan K.; Andreasen, Peter A.; Bendixen, Christian; Panitz, Frank			Multi-tissue RNA-seq and transcriptome characterisation of the spiny dogfish shark (Squalus acanthias) provides a molecular tool for biological research and reveals new genes involved in osmoregulation	PLOS ONE			English	Article							FISH CALLORHINCHUS-MILII; ORNITHINE UREA CYCLE; SKATE LEUCORAJA-ERINACEA; RECTAL GLAND; GLUTAMINE-SYNTHETASE; CARTILAGINOUS FISH; CHOROID-PLEXUS; FUNCTIONAL-CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; SEQUENCE ALIGNMENT	The spiny dogfish shark (Squalus acanthias) is one of the most commonly used cartilaginous fishes in biological research, especially in the fields of nitrogen metabolism, ion transporters and osmoregulation. Nonetheless, transcriptomic data for this organism is scarce. In the present study, a multi-tissue RNA-seq experiment and de novo transcriptome assembly was performed in four different spiny dogfish tissues (brain, liver, kidney and ovary), providing an annotated sequence resource. The characterization of the transcriptome greatly increases the scarce sequence information for shark species. Reads were assembled with the Trinity de novo assembler both within each tissue and across all tissues combined resulting in 362,690 transcripts in the combined assembly which represent 289,515 Trinity genes. BUSCO analysis determined a level of 87% completeness for the combined transcriptome. In total, 123,110 proteins were predicted of which 78,679 and 83,164 had significant hits against the SwissProt and Uniref90 protein databases, respectively. Additionally, 61,215 proteins aligned to known protein domains, 7,208 carried a signal peptide and 15,971 possessed at least one transmembrane region. Based on the annotation, 81,582 transcripts were assigned to gene ontology terms and 42,078 belong to known clusters of orthologous groups (eggNOG). To demonstrate the value of our molecular resource, we show that the improved transcriptome data enhances the current possibilities of osmoregulation research in spiny dogfish by utilizing the novel gene and protein annotations to investigate a set of genes involved in urea synthesis and urea, ammonia and water transport, all of them crucial in osmoregulation. We describe the presence of different gene copies and isoforms of key enzymes involved in this process, including arginases and transporters of urea and ammonia, for which sequence information is currently absent in the databases for this model species. The transcriptome assemblies and the derived annotations generated in this study will support the ongoing research for this particular animal model and provides a new molecular tool to assist biological research in cartilaginous fishes.	[Chana-Munoz, Andres; Bendixen, Christian; Panitz, Frank] Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark; [Jendroszek, Agnieszka; Sonnichsen, Malene; Jensen, Jan K.; Andreasen, Peter A.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Kristiansen, Rune] Kattegatcentret, Grenaa, Denmark; [Jendroszek, Agnieszka] Aarhus Univ, Inst Biosci Zoophysiol, Aarhus, Denmark; [Sonnichsen, Malene] Aarhus Univ, Interdisciplinary Nanosci Ctr INANO MBG, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Panitz, F (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Tjele, Denmark.	frank.panitz@mbg.au.dk	Panitz, Frank/A-3281-2017	Panitz, Frank/0000-0002-6909-5162	Danish Council for Independent Research \ Natural Sciences [0602-02216B]	Danish Council for Independent Research \ Natural Sciences(Det Frie Forskningsrad (DFF))	This study was funded by the Danish Council for Independent Research vertical bar Natural Sciences [http://ufm.diVeniresearch-and-innovation/camels-and-commissionsithe-danishcouncil-for-independent-research/the-council/thedanish-council-for-independent-research-natural-sciences] under the grant number 0602-02216B to P.A. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson Paul M., 2001, Fish Physiology, V20, P239; ANDERSON PM, 1980, SCIENCE, V208, P291, DOI 10.1126/science.6245445; Anderson WG, 2005, J EXP ZOOL PART A, V303A, P917, DOI 10.1002/jez.a.199; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baehr CH, 2006, AM J PHYSIOL-REG I, V291, pR464, DOI 10.1152/ajpregu.00814.2005; Barnes DW, 2012, J FISH BIOL, V80, P2089, DOI 10.1111/j.1095-8649.2011.03205.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOYLAN JW, 1972, COMP BIOCHEM PHYSIOL, V42, P27, DOI 10.1016/0300-9629(72)90361-1; BURGER JW, 1960, SCIENCE, V131, P670, DOI 10.1126/science.131.3401.670; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; CASEY CA, 1982, J BIOL CHEM, V257, P8449; Claiborne JB, 2008, AM J PHYSIOL-REG I, V294, pR1092, DOI 10.1152/ajpregu.00718.2007; Cutler CP, 2012, FRONT PHYSIOL, V2, pCP4, DOI 10.3389/fphys.2011.00107; Deck CA, 2016, COMP BIOCHEM PHYS A, V193, P29, DOI 10.1016/j.cbpa.2015.12.004; Deck CA, 2013, COMP BIOCHEM PHYS D, V8, P334, DOI 10.1016/j.cbd.2013.09.003; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; EPSTEIN FH, 1979, YALE J BIOL MED, V52, P517; EVANS DH, 2010, FRONT PHYSIOL, V1; Finn RN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113686; Forest D, 2007, P NATL ACAD SCI USA, V104, P1224, DOI 10.1073/pnas.0610350104; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gopalan TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100018; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hamlett WC, 1999, ANN ANAT, V181, P159, DOI 10.1016/S0940-9602(99)80003-X; Hazon N, 2003, COMP BIOCHEM PHYS B, V136, P685, DOI 10.1016/S1096-4959(03)00280-X; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Hyodo S, 2014, AM J PHYSIOL-REG I, V307, pR1381, DOI 10.1152/ajpregu.00033.2014; Janech MG, 2003, AM J PHYSIOL-RENAL, V284, pF996, DOI 10.1152/ajprenal.00174.2002; Janech MG, 2006, AM J PHYSIOL-REG I, V291, pR844, DOI 10.1152/ajpregu.00739.2005; Kajimura M, 2006, PHYSIOL BIOCHEM ZOOL, V79, P602, DOI 10.1086/501060; Kakumura K, 2015, CELL TISSUE RES, V362, P677, DOI 10.1007/s00441-015-2234-4; Kakumura K, 2009, COMP BIOCHEM PHYS B, V154, P239, DOI 10.1016/j.cbpb.2009.06.009; King BL, 2011, SCIENCE, V334, P1517, DOI 10.1126/science.1210912; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lehrich RW, 1998, J CLIN INVEST, V101, P737, DOI 10.1172/JCI803; LeMoine CMR, 2015, J EXP BIOL, V218, P1936, DOI 10.1242/jeb.114223; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li Chunling, 2014, Subcell Biochem, V73, P227, DOI 10.1007/978-94-017-9343-8_14; Li D, 2002, ONCOGENE, V21, P2805, DOI 10.1038/sj.onc.1205410; Li RG, 2013, FISH SHELLFISH IMMUN, V34, P1404, DOI 10.1016/j.fsi.2013.02.015; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Litman Thomas, 2009, Handb Exp Pharmacol, P327, DOI 10.1007/978-3-540-79885-9_17; Matthews GD, 2005, FEBS LETT, V579, P5527, DOI 10.1016/j.febslet.2005.08.082; MOORE KS, 1993, P NATL ACAD SCI USA, V90, P1354, DOI 10.1073/pnas.90.4.1354; Mulley JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1074; Nakada T, 2010, J BIOL CHEM, V285, P2653, DOI 10.1074/jbc.M109.052068; Nawata CM, 2015, J EXP BIOL, V218, P238, DOI 10.1242/jeb.114967; Oliveros J. C., VENNY INTERACTIVE TO; Part P, 1998, COMP BIOCHEM PHYS A, V119, P117, DOI 10.1016/S1095-6433(97)00400-5; Parton A, 2007, COMP BIOCHEM PHYS C, V145, P111, DOI 10.1016/j.cbpc.2006.07.003; Parton A, 2010, COMP BIOCHEM PHYS D, V5, P199, DOI 10.1016/j.cbd.2010.04.004; Perni M, 2017, P NATL ACAD SCI USA, V114, pE1009, DOI 10.1073/pnas.1610586114; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Rao MN, 2000, J NAT PROD, V63, P631, DOI 10.1021/np990514f; Reichel V, 2008, AM J PHYSIOL-REG I, V295, pR1311, DOI 10.1152/ajpregu.90373.2008; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards VP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-697; RIORDAN JR, 1994, J EXP BIOL, V196, P405; SCHMIDTNIELSEN B, 1972, COMP BIOCHEM PHYSIOL, V42, P13, DOI 10.1016/0300-9629(72)90360-X; SCHOOLER JM, 1966, COMP BIOCHEM PHYSIOL, V18, P271, DOI 10.1016/0010-406X(66)90186-1; Sills AK, 1998, CANCER RES, V58, P2784; Silva P, 1996, KIDNEY INT, V49, P1552, DOI 10.1038/ki.1996.223; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith CP, 1999, AM J PHYSIOL-REG I, V276, pR622, DOI 10.1152/ajpregu.1999.276.2.R622; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steele SL, 2005, PHYSIOL BIOCHEM ZOOL, V78, P216, DOI 10.1086/427052; Takagi W, 2014, J EXP BIOL, V217, P1353, DOI 10.1242/jeb.094649; Takagi W, 2012, COMP BIOCHEM PHYS B, V161, P331, DOI 10.1016/j.cbpb.2011.12.006; Venkatesh B, 2014, NATURE, V505, P174, DOI 10.1038/nature12826; Villalobos ARA, 2002, AM J PHYSIOL-REG I, V282, pR1308, DOI 10.1152/ajpregu.00677.2001; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; WEBB JT, 1980, SCIENCE, V208, P293, DOI 10.1126/science.6102799; Wood CM, 2013, PEERJ, V1, DOI 10.7717/peerj.33; Wood CM, 2010, COMP BIOCHEM PHYS A, V155, P435, DOI 10.1016/j.cbpa.2009.09.006; Wright PA, 2009, J EXP BIOL, V212, P2303, DOI 10.1242/jeb.023085	83	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182756	10.1371/journal.pone.0182756	http://dx.doi.org/10.1371/journal.pone.0182756			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832628	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800032
J	Hussey, EK; Christianson, K; Treiman, DM; Smith, KA; Steinmetz, PN				Hussey, Erika K.; Christianson, Kiel; Treiman, David M.; Smith, Kris A.; Steinmetz, Peter N.			Single neuron recordings of bilinguals performing in a continuous recognition memory task	PLOS ONE			English	Article							HEMODYNAMIC SIGNALS; FMRI EVIDENCE; TIME-COURSE; LANGUAGE; BRAIN; TRANSLATION; CORTEX; REPRESENTATION; INFORMATION; VARIABILITY	We report the results of a bilingual continuous recognition memory task during which single-and multi-neuron activity was recorded in human subjects with intracranial microwire implants. Subjects (n = 5) were right-handed Spanish-English bilinguals who were undergoing evaluation prior to surgery for severe epilepsy. Subjects were presented with Spanish and English words and the task was to determine whether any given word had been seen earlier in the testing session, irrespective of the language in which it had appeared. Recordings in the left and right hippocampus revealed notable laterality, whereby both Spanish and English items that had been seen previously in the other language (switch trials) triggered increased neural firing in the left hippocampus. Items that had been seen previously in the same language (repeat trials) triggered increased neural firings in the right hippocampus. These results are consistent with theories that propose roles of both the left-and right-hemisphere in real-time linguistic processing. Importantly, this experiment presents the first instance of intracranial recordings in bilinguals performing a task with switching demands.	[Hussey, Erika K.] US Army, Natick Soldier Res Dev & Engn Ctr, Cognit Sci Team, Natick, MA 01760 USA; [Hussey, Erika K.] Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA; [Hussey, Erika K.; Christianson, Kiel] Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA; [Christianson, Kiel] Univ Illinois, Dept Educ Psychol, Champaign, IL 61820 USA; [Treiman, David M.; Steinmetz, Peter N.] Barrow Neurol Inst, Dept Neurol, Phoenix, AZ 85013 USA; [Smith, Kris A.; Steinmetz, Peter N.] Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Steinmetz, Peter N.] Nakamoto Brain Res Inst, Tempe, AZ USA	United States Department of Defense; US Army Research, Development & Engineering Command (RDECOM); University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Barrow Neurological Institute; Barrow Neurological Institute	Hussey, EK (corresponding author), US Army, Natick Soldier Res Dev & Engn Ctr, Cognit Sci Team, Natick, MA 01760 USA.; Hussey, EK (corresponding author), Ctr Appl Brain & Cognit Sci, Medford, MA 02155 USA.; Hussey, EK (corresponding author), Univ Illinois, Beckman Inst Adv Sci & Technol, Urbana, IL 61801 USA.	erikahussey@gmail.com			National Institutes of Health grant [T32 HD055272]; Barrow Neurological Foundation; Barrow Neurological Institute	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Barrow Neurological Foundation; Barrow Neurological Institute	National Institutes of Health grant #T32 HD055272 supported EH. The Barrow Neurological Foundation (https://www.supportbarrovy.org/) supported PS, KS, DT, and this research project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is dedicated to the memory of Donald B. Steinmetz, an outstanding linguist who originally suggested this collaboration. The authors would like to thank all the patients who participated in this study. We also thank Gary Dell for insightful feedback on this work, Michael Blasingame and Rebecca Foote for their assistance with stimulus selection and norming, Gayle Kiyota for administrative assistance, and Kent Home and Elaine Cabrales for technical assistance with the recordings. A portion of this work was presented at the 21st Annual Conference on Architectures and Mechanisms for Language Processing (Valletta, Malta) and the 45th Annual Meeting of the Society for Neuroscience (Chicago, Illinois). We thank the attendees for their helpful comments and suggestions. The corresponding author's (EKH) current affiliation is US Army NSRDEC, but the reported research was conducted while at the University of Illinois and thus, was not supported by US Army funding. Funding was provided by the Barrow Neurological Institute.	Abutalebi J, 2008, LANG COGNITIVE PROC, V23, P557, DOI 10.1080/01690960801920602; Abutalebi J, 2007, J NEUROSCI, V27, P13762, DOI 10.1523/JNEUROSCI.3294-07.2007; Abutalebi J, 2012, CEREB CORTEX, V22, P2076, DOI 10.1093/cercor/bhr287; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BEAUVILLAIN C, 1987, J MEM LANG, V26, P658, DOI 10.1016/0749-596X(87)90108-2; Bentin S, 1999, J COGNITIVE NEUROSCI, V11, P235, DOI 10.1162/089892999563373; Bialystok E, 2010, CURR DIR PSYCHOL SCI, V19, P19, DOI 10.1177/0963721409358571; Blank IA, 2016, EXPANDING LANGUAGE N; Blank SC, 2002, BRAIN, V125, P1829, DOI 10.1093/brain/awf191; Borovsky A, 2013, NEUROPSYCHOLOGIA, V51, P825, DOI 10.1016/j.neuropsychologia.2013.01.027; Boynton GM, 2011, J VISION, V11, DOI 10.1167/11.5.12; Bradley M., 1999, TECHNICAL REPORT, DOI DOI 10.1109/MIC.2008.114; Broca P., 1861, B SOC ANAT PARIS, V6, P330, DOI DOI 10.1093/ACPROF:OSO/9780195177640.003.0018; Cardoso MMB, 2012, NAT NEUROSCI, V15, P1298, DOI 10.1038/nn.3170; CELEUX G, 1995, PATTERN RECOGN, V28, P781, DOI 10.1016/0031-3203(94)00125-6; Christianson K, 2017, ACTA PSYCHOL, V178, P73, DOI 10.1016/j.actpsy.2017.05.012; Coderre EL, 2016, BILING-LANG COGN, V19, P471, DOI 10.1017/S1366728915000188; Conner CR, 2011, J NEUROSCI, V31, P12855, DOI 10.1523/JNEUROSCI.1457-11.2011; Costa A, 2014, COGNITION, V130, P236, DOI 10.1016/j.cognition.2013.11.010; Coulson S, 2005, J EXP PSYCHOL LEARN, V31, P129, DOI 10.1037/0278-7393.31.1.129; Davenport T, 2013, NEUROPSYCHOLOGIA, V51, P907, DOI 10.1016/j.neuropsychologia.2013.01.018; Davies M., 2008, CORPUS CONT AM ENGLI; Demonet JF, 2005, PHYSIOL REV, V85, P49, DOI 10.1152/physrev.00049.2003; Duff MC, 2006, NAT NEUROSCI, V9, P140, DOI 10.1038/nn1601; Duff MC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00069; Dymond A M, 1972, Biomed Sci Instrum, V9, P1; Eickenbaum H, 2001, CONDITIONING CONSCIO; Fabiani M, 2000, J COGNITIVE NEUROSCI, V12, P941, DOI 10.1162/08989290051137486; Federmeier KD, 2007, PSYCHOPHYSIOLOGY, V44, P491, DOI 10.1111/j.1469-8986.2007.00531.x; Fedorenko E, 2014, TRENDS COGN SCI, V18, P120, DOI 10.1016/j.tics.2013.12.006; Feng L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110896; Fried I, 1999, J NEUROSURG, V91, P697, DOI 10.3171/jns.1999.91.4.0697; Friederici AD, 2011, PHYSIOL REV, V91, P1357, DOI 10.1152/physrev.00006.2011; FRIEDMAN D, 1990, BIOL PSYCHOL, V30, P61, DOI 10.1016/0301-0511(90)90091-A; Halsband U, 2002, BEHAV BRAIN RES, V132, P47, DOI 10.1016/S0166-4328(01)00386-2; Handwerker DA, 2011, NEUROIMAGE, V55, P1409, DOI 10.1016/j.neuroimage.2010.04.037; HANNAY HJ, 1989, J CLIN EXP NEUROPSYC, V11, P444, DOI 10.1080/01688638908400905; Hasegawa M, 2002, NEUROIMAGE, V15, P647, DOI 10.1006/nimg.2001.1001; Hernandez AE, 2001, NEUROIMAGE, V14, P510, DOI 10.1006/nimg.2001.0810; Hernandez AE, 2009, BRAIN LANG, V109, P133, DOI 10.1016/j.bandl.2008.12.005; Hull R, 2007, NEUROPSYCHOLOGIA, V45, P1987, DOI 10.1016/j.neuropsychologia.2007.03.002; Huo BX, 2014, J NEUROSCI, V34, P10975, DOI 10.1523/JNEUROSCI.1369-14.2014; Hussey EK, 2015, PLOS ONE; Jiang N, 2001, J MEM LANG, V44, P32, DOI 10.1006/jmla.2000.2737; Jung-Beeman M, 2005, TRENDS COGN SCI, V9, P512, DOI 10.1016/j.tics.2005.09.009; Kadir SN, 2014, NEURAL COMPUT, V26, P2379, DOI 10.1162/NECO_a_00661; Keysar B, 2012, PSYCHOL SCI, V23, P661, DOI 10.1177/0956797611432178; Kleinfeld David, 2011, Front Neuroenergetics, V3, P1, DOI 10.3389/fnene.2011.00001; KROLL JF, 1994, J MEM LANG, V33, P149, DOI 10.1006/jmla.1994.1008; Kroll JF, 2010, BILING, V13, P378; Kutas M, 2011, ANNU REV PSYCHOL, V62, P621, DOI 10.1146/annurev.psych.093008.131123; Lehtonen MH, 2005, NEUROREPORT, V16, P607, DOI 10.1097/00001756-200504250-00018; Lei MM, 2014, BRAIN LANG, V138, P12, DOI 10.1016/j.bandl.2014.08.009; Lieberman P, 2002, YEARB PHYS ANTHROPOL, V45, P36, DOI 10.1002/ajpa.10171; Lima B, 2014, J NEUROSCI, V34, P13878, DOI 10.1523/JNEUROSCI.1595-14.2014; Mahendra N, 2003, NEUROREPORT, V14, P1225, DOI 10.1097/00001756-200307010-00007; Marian V, 2003, BRAIN LANG, V86, P70, DOI 10.1016/S0093-934X(02)00535-7; Martin C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI [10.3389/fnins.2014.00211, 10.3389/fnana.2014.00007]; Mehta AD, 2005, J NEUROSURG, V102, P1040, DOI 10.3171/jns.2005.102.6.1040; METCALFE J, 1995, PSYCHOL SCI, V6, P157, DOI 10.1111/j.1467-9280.1995.tb00325.x; Meuter RFI, 1999, J MEM LANG, V40, P25, DOI 10.1006/jmla.1998.2602; Meyer M, 2000, COGNITIVE BRAIN RES, V9, P19, DOI 10.1016/S0926-6410(99)00039-7; MIDDLETON FA, 1994, SCIENCE, V266, P458, DOI 10.1126/science.7939688; Moritz-Gasser S, 2009, NEUROREPORT, V20, P1577, DOI 10.1097/WNR.0b013e328333907e; Niendam TA, 2012, COGN AFFECT BEHAV NE, V12, P241, DOI 10.3758/s13415-011-0083-5; Ousdal OT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096146; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Papanicolaou AC, 1999, J NEUROSURG, V90, P85, DOI 10.3171/jns.1999.90.1.0085; Perani D, 1998, BRAIN, V121, P1841, DOI 10.1093/brain/121.10.1841; PETERSEN SE, 1988, NATURE, V331, P585, DOI 10.1038/331585a0; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Price CJ, 1999, BRAIN, V122, P2221, DOI 10.1093/brain/122.12.2221; Pulvermuller F, 2005, NAT REV NEUROSCI, V6, P576, DOI 10.1038/nrn1706; Pylkkanen L, 2003, TRENDS COGN SCI, V7, P187, DOI 10.1016/S1364-6613(03)00092-5; R Core Team, 2021, R LANGUAGE ENV STAT; Redondo J, 2007, BEHAV RES METHODS, V39, P600, DOI 10.3758/BF03193031; Rubin RD, 2011, PSYCHOL SCI, V22, P1574, DOI 10.1177/0956797611418245; Ruschemeyer SA, 2005, HUM BRAIN MAPP, V25, P266, DOI 10.1002/hbm.20098; Rutishauser U, 2015, NAT NEUROSCI, V18, P1041, DOI 10.1038/nn.4041; Sammler D, 2010, BRAIN, V133, P2643, DOI 10.1093/brain/awq231; Scott GG, 2012, J EXP PSYCHOL LEARN, V38, P783, DOI 10.1037/a0027209; Scott GG, 2009, BIOL PSYCHOL, V80, P95, DOI 10.1016/j.biopsycho.2008.03.010; Sebastian N., 2000, LEXESP LEXICO INFORM; SHOLL A, 1995, PSYCHOL SCI, V6, P45, DOI 10.1111/j.1467-9280.1995.tb00303.x; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Squire LR, MEDIAL TEMPORAL REGI; Stocco A, 2014, BRAIN LANG, V137, P50, DOI 10.1016/j.bandl.2014.07.005; Thomas MSC, 2000, J MEM LANG, V43, P44, DOI 10.1006/jmla.1999.2700; Tzourio-Mazoyer N, 2016, CORTEX; Valdez AB, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/1/016001; Van Petten C, 2006, BRAIN LANG, V97, P279, DOI 10.1016/j.bandl.2005.11.003; Warriner AB, 2013, BEHAV RES METHODS, V45, P1191, DOI 10.3758/s13428-012-0314-x; Weierich MR, 2010, NEUROIMAGE, V49, P2871, DOI 10.1016/j.neuroimage.2009.09.047; Wernicke C., 1874, APHASISCHE SYMPTOMEN; Whatmough C, 2007, BEHAV BRAIN RES, V181, P262, DOI 10.1016/j.bbr.2007.04.017; Wixted JT, 2014, P NATL ACAD SCI USA, V111, P9621, DOI 10.1073/pnas.1408365111; Wurm LH, 2014, J MEM LANG, V72, P37, DOI 10.1016/j.jml.2013.12.003; Yang Y, 2017, CORTEX, V92, P304, DOI 10.1016/j.cortex.2017.04.021	101	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181850	10.1371/journal.pone.0181850	http://dx.doi.org/10.1371/journal.pone.0181850			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832639	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800007
J	Malay, AD; Arakawa, K; Numata, K				Malay, Ali D.; Arakawa, Kazuharu; Numata, Keiji			Analysis of repetitive amino acid motifs reveals the essential features of spider dragline silk proteins	PLOS ONE			English	Article							MAJOR AMPULLATE SILK; SOLID-STATE NMR; MECHANICAL-PROPERTIES; NEPHILA-CLAVIPES; EVOLUTION; FIBROIN; BEHAVIOR; FIBERS; SEQUENCE; SUPERCONTRACTION	The extraordinary mechanical properties of spider dragline silk are dependent on the highly repetitive sequences of the component proteins, major ampullate spidroin 1 and 2 (MaSp2 and MaSp2). MaSp sequences are dominated by repetitive modules composed of short amino acid motifs; however, the patterns of motif conservation through evolution and their relevance to silk characteristics are not well understood. We performed a systematic analysis of MaSp sequences encompassing infraorder Araneomorphae based on the conservation of explicitly defined motifs, with the aim of elucidating the essential elements of MaSp1 and MaSp2. The results show that the GGY motif is nearly ubiquitous in the two types of MaSp, while MaSp2 is invariably associated with GP and di-glutamine (QQ) motifs. Further analysis revealed an extended MaSp2 consensus sequence in family Araneidae, with implications for the classification of the archetypal spidroins ADF3 and ADF4. Additionally, the analysis of RNA-seq data showed the expression of a set of distinct MaSp-like variants in genus Tetragnatha. Finally, an apparent association was uncovered between web architecture and the abundance of GP, QQ, and GGY motifs in MaSp2, which suggests a co-expansion of these motifs in response to the evolution of spiders' prey capture strategy.	[Malay, Ali D.; Numata, Keiji] RIKEN, Ctr Sustainable Resource Sci, Enzyme Res Team, Wako, Saitama, Japan; [Arakawa, Kazuharu] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan	RIKEN; Keio University	Malay, AD; Numata, K (corresponding author), RIKEN, Ctr Sustainable Resource Sci, Enzyme Res Team, Wako, Saitama, Japan.	a.malay@riken.jp; keiji.numata@riken.jp	Numata, Keiji/H-9751-2012	Numata, Keiji/0000-0003-2199-7420; Arakawa, Kazuharu/0000-0002-2893-4919	Japan Science and Technology Agency (JST); Impulsing Paradigm Change through Disruptive Technologies Program (ImPACT)	Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST)); Impulsing Paradigm Change through Disruptive Technologies Program (ImPACT)	This work was supported by Japan Science and Technology Agency (JST), grant: Impulsing Paradigm Change through Disruptive Technologies Program (ImPACT) (http://www.jst.go.jp/impact/en/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	dos Santos-Pinto JRA, 2014, J PROTEOMICS, V105, P174, DOI 10.1016/j.jprot.2014.01.002; Asakura T, 2004, MAGN RESON CHEM, V42, P258, DOI 10.1002/mrc.1337; Askarieh G, 2010, NATURE, V465, P236, DOI 10.1038/nature08962; Ayoub NA, 2008, MOL BIOL EVOL, V25, P277, DOI 10.1093/molbev/msm246; Babb PL, 2017, NAT GENET, V49, P895, DOI 10.1038/ng.3852; Beckwitt R, 1998, INSECT BIOCHEM MOLEC, V28, P121, DOI 10.1016/S0965-1748(97)00083-0; Belton PS, 1999, J CEREAL SCI, V29, P103, DOI 10.1006/jcrs.1998.0227; Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00833; Blackledge TA, 2012, SCI REP-UK, V2, DOI 10.1038/srep00782; Bond JE, 2014, CURR BIOL, V24, P1765, DOI 10.1016/j.cub.2014.06.034; Boutry C, 2010, J EXP BIOL, V213, P3505, DOI 10.1242/jeb.046110; Brooks AE, 2005, BIOMACROMOLECULES, V6, P3095, DOI 10.1021/bm050421e; Chang Z, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0596-2; Correa-Garhwal SM, 2014, BIOMACROMOLECULES, V15, P4598, DOI 10.1021/bm501409n; Cranford SW, 2012, NATURE, V482, P72, DOI 10.1038/nature10739; Eickbush TH, 2007, GENETICS, V175, P477, DOI 10.1534/genetics.107.071399; Elices M, 2009, BIOMACROMOLECULES, V10, P1904, DOI 10.1021/bm900312c; Fernandez R, 2014, CURR BIOL, V24, P1772, DOI 10.1016/j.cub.2014.06.035; Gaines WA, 2008, INSECT MOL BIOL, V17, P465, DOI 10.1111/j.1365-2583.2008.00828.x; Gao ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056142; Garb JE, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-243; Gatesy J, 2001, SCIENCE, V291, P2603, DOI 10.1126/science.1057561; Geurts P, 2010, BIOMACROMOLECULES, V11, P3495, DOI 10.1021/bm101002w; GOSLINE JM, 1984, NATURE, V309, P551, DOI 10.1038/309551a0; GOSLINE JM, 1986, ENDEAVOUR, V10, P37, DOI 10.1016/0160-9327(86)90049-9; Gosline JM, 1999, J EXP BIOL, V202, P3295; Guehrs KH, 2008, INSECT MOL BIOL, V17, P553, DOI 10.1111/j.1365-2583.2008.00826.x; Guerette PA, 1996, SCIENCE, V272, P112, DOI 10.1126/science.272.5258.112; Hagn F, 2010, NATURE, V465, P239, DOI 10.1038/nature08936; Hayashi CY, 1999, INT J BIOL MACROMOL, V24, P271, DOI 10.1016/S0141-8130(98)00089-0; Hayashi CY, 2000, SCIENCE, V287, P1477, DOI 10.1126/science.287.5457.1477; Hayashi CY, 1998, J MOL BIOL, V275, P773, DOI 10.1006/jmbi.1997.1478; HINMAN MB, 1992, J BIOL CHEM, V267, P19320; Holland GP, 2008, J AM CHEM SOC, V130, P9871, DOI 10.1021/ja8021208; Huemmerich D, 2004, CURR BIOL, V14, P2070, DOI 10.1016/j.cub.2004.11.005; Jenkins JE, 2010, CHEM COMMUN, V46, P6714, DOI 10.1039/c0cc00829j; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kummerlen J, 1996, MACROMOLECULES, V29, P2920, DOI 10.1021/ma951098i; Lawrence BA, 2004, BIOMACROMOLECULES, V5, P689, DOI 10.1021/bm0342640; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; LI SFY, 1994, BIOPHYS J, V66, P1209, DOI 10.1016/S0006-3495(94)80903-8; Lin TY, 2017, BIOMACROMOLECULES; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Malay AD, 2016, SCI REP-UK, V6, DOI 10.1038/srep27573; Marhabaie M, 2014, BIOMACROMOLECULES, V15, P20, DOI 10.1021/bm401110b; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Partlow BP, 2016, BIOMACROMOLECULES, V17, P3570, DOI 10.1021/acs.biomac.6b01086; Perez-Rigueiro J, 2010, INT J BIOL MACROMOL, V46, P555, DOI 10.1016/j.ijbiomac.2010.03.013; Perry DJ, 2010, BIOMACROMOLECULES, V11, P3000, DOI 10.1021/bm1007585; Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4; Rising A, 2007, INSECT MOL BIOL, V16, P551, DOI 10.1111/j.1365-2583.2007.00749.x; Rising A, 2015, NAT CHEM BIOL, V11, P309, DOI [10.1038/nchembio.1789, 10.1038/NCHEMBIO.1789]; Sanggaard KW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4765; Savage KN, 2008, J EXP BIOL, V211, P1948, DOI 10.1242/jeb.014225; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Schwarze S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3815; Shewry PR, 2002, PHILOS T R SOC B, V357, P133, DOI 10.1098/rstb.2001.1024; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simmons AH, 1996, SCIENCE, V271, P84, DOI 10.1126/science.271.5245.84; Sponner A, 2005, NAT MATER, V4, P772, DOI 10.1038/nmat1493; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Starrett J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038084; TERMONIA Y, 1994, MACROMOLECULES, V27, P7378, DOI 10.1021/ma00103a018; Thiel BL, 1997, BIOPOLYMERS, V41, P703, DOI 10.1002/(SICI)1097-0282(199706)41:7<703::AID-BIP1>3.0.CO;2-T; van Beek JD, 2002, P NATL ACAD SCI USA, V99, P10266, DOI 10.1073/pnas.152162299; VanDijk AA, 1997, PROTEIN SCI, V6, P637; Vollrath F, 1999, INT J BIOL MACROMOL, V24, P243, DOI 10.1016/S0141-8130(98)00095-6; Vollrath F, 1996, P ROY SOC B-BIOL SCI, V263, P147, DOI 10.1098/rspb.1996.0023; Vollrath F, 2007, ANNU REV ECOL EVOL S, V38, P819, DOI 10.1146/annurev.ecolsys.37.091305.110221; Vollrath F, 2016, BIOCHEM SOC T, V44, P1151, DOI 10.1042/BST20160058; WORK RW, 1977, TEXT RES J, V47, P650, DOI 10.1177/004051757704701003; XU M, 1990, P NATL ACAD SCI USA, V87, P7120, DOI 10.1073/pnas.87.18.7120; Yim KM, 2014, J HERED, V105, P771, DOI 10.1093/jhered/esu043; Zhang Y, 2013, COMP BIOCHEM PHYS B, V164, P151, DOI 10.1016/j.cbpb.2012.12.002	74	35	38	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183397	10.1371/journal.pone.0183397	http://dx.doi.org/10.1371/journal.pone.0183397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832627	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800057
J	Soto-Rojas, C; Suazo-Ortuno, I; Laos, JAM; Alvarado-Diaz, J				Soto-Rojas, Carlos; Suazo-Ortuno, Ireri; Montoya Laos, Jose Arturo; Alvarado-Diaz, Javier			Habitat quality affects the incidence of morphological abnormalities in the endangered salamander Ambystoma ordinarium	PLOS ONE			English	Article							AMPHIBIAN MALFORMATIONS; ULTRAVIOLET-RADIATION; LIFE-HISTORY; RANA-PIPIENS; INFECTION; RISK; HEALTH; INJURY; FROGS; ORGANISMS	Identification of early warning signals previous to the occurrence of population decline or extinction is a major challenge for the conservation of animal species. Prevalence of morphological abnormalities in a population can be one of these signals. We registered morphological abnormalities in the salamander Ambystoma ordinarium. We also evaluated the relation between habitat quality and the prevalence of abnormalities in this species. We used scores from rapid bioassessment protocols (RBPs) to assess the habitat quality of streams inhabited by A. ordinarium. A preliminary survey indicated that of 29 streams where this species has been historically registered, 13 might have few or no A. ordinarium. The association between habitat quality and the incidence of morphological abnormalities was evaluated in these 16 streams. Of 502 sampled individuals, 224 (44.62%) had at least one body abnormality. Of the 224 individuals with body abnormalities, 84 (37.5%) presented more than one abnormality. Of a total of 5,522 evaluated morphological characters, 344 (6.74%) were abnormal. Partial loss of gills and missing digits were the most frequent abnormalities. Results of a binomial logistic regression indicated that the probability of a character of an individual to be abnormal was significantly associated with habitat quality; as the levels of the quality of the habitat increased, the prevalence of morphological abnormalities decreased. These results suggest that RBPs are a quick and useful method for assessing the habitat quality of streams inhabited by A. ordinarium. Given that RBPs provide rapid and cost-effective assessments of the ecological health of aquatic ecosystems, it will be important to test if the RBPs protocols can be used to rapidly assess habitat quality for other species of stream amphibians. The negative association between habitat quality and the prevalence of morpohological abnormalities that we found indicates that habitat condition plays an important role in the high number of abnormalities registered in A. ordinarium. Therefore, our results suggest that one of the several negative effects of habitat degradation on amphibians is an increase in the frequency of morphological abnormalities with marked consequences for the survival and general fitness of aquatic amphibians.	[Soto-Rojas, Carlos; Suazo-Ortuno, Ireri; Alvarado-Diaz, Javier] Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico; [Montoya Laos, Jose Arturo] Univ Sonora, Dept Matemat, Col Ctr, Hermosillo, Sonora, Mexico	Universidad Michoacana de San Nicolas de Hidalgo; Universidad de Sonora	Suazo-Ortuno, I (corresponding author), Univ Michoacana, Inst Invest Recursos Nat, Morelia, Michoacan, Mexico.	ireri.suazo@gmail.com	Suazo-Ortuño, Ireri/AAO-9826-2020		Programa Nacional de Becas del Consejo Nacional de Ciencia y Tecnologia [239254]; Secretaria de Educacion Kiblica/Consejo Nacional de Ciencia y Tecnologia Ciencia Basica [2015-259173]	Programa Nacional de Becas del Consejo Nacional de Ciencia y Tecnologia; Secretaria de Educacion Kiblica/Consejo Nacional de Ciencia y Tecnologia Ciencia Basica	This study was part of the project "Efecto de la calidad del agua sobre parametros poblacionales, fisiologicos y morfologicos de la salamandra de montana (Ambystoma ordinarium)" Secretaria de Educacion Kiblica/Consejo Nacional de Ciencia y Tecnologia Ciencia Basica 2015-259173. The results of this study are part of the Ph.D. thesis of the principal author, under the direction of ISO. CSR thanks the financial support of Programa Nacional de Becas del Consejo Nacional de Ciencia y Tecnologia No. 239254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON J D, 1971, Herpetologica, V27, P165; Andrews K. M., 2006, US DEP TRANSPORTATIO; Ankley GT, 2000, CAN J ZOOL, V78, P1092, DOI 10.1139/cjz-78-6-1092; Ankley GT, 2004, ECOTOX ENVIRON SAFE, V58, P7, DOI 10.1016/j.ecoenv.2004.01.004; Ankley GT, 2002, ENVIRON SCI TECHNOL, V36, P2853, DOI 10.1021/es011195t; [Anonymous], 1999, RAPID BIOASSESSMENT; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Bendik NF, 2013, J ZOOL, V290, P35, DOI 10.1111/jzo.12009; Blaustein AR, 2003, FRONT ECOL ENVIRON, V1, P87, DOI 10.1890/1540-9295(2003)001[0087:TCODA]2.0.CO;2; Bowerman J, 2010, ECOLOGY, V91, P242, DOI 10.1890/08-1687.1; Burggren Warren W., 1992, P467; Burkhart JG, 2000, ENVIRON HEALTH PERSP, V108, P83, DOI 10.2307/3454299; Eaton BR, 2004, J HERPETOL, V38, P283, DOI 10.1670/95-03N; Garcia-Garrido Pedro, 2016, Mesoamerican Herpetology, V3, P461; Gardiner DM, 1999, J EXP ZOOL, V284, P207, DOI 10.1002/(SICI)1097-010X(19990701)284:2<207::AID-JEZ10>3.0.CO;2-B; Gibbons JW, 2000, BIOSCIENCE, V50, P653, DOI 10.1641/0006-3568(2000)050[0653:TGDORD]2.0.CO;2; Harding J.S., 2009, STREAM HABITAT ASSES; HARRIS RN, 1989, AM NAT, V134, P835, DOI 10.1086/285016; Hoppe David M., 2000, Journal of the Iowa Academy of Science, V107, P86; Johnson PTJ, 2005, AMPHIBIAN DECLINES: THE CONSERVATION STATUS OF UNITED STATES SPECIES, P124; Johnson PTJ, 2006, ECOLOGY, V87, P2227, DOI 10.1890/0012-9658(2006)87[2227:AITISE]2.0.CO;2; Johnson PTJ, 2012, ECOL LETT, V15, P235, DOI 10.1111/j.1461-0248.2011.01730.x; Johnson PTJ, 1999, SCIENCE, V284, P802, DOI 10.1126/science.284.5415.802; Johnson PTJ, 2004, ADV PARASIT, V57, P191, DOI 10.1016/S0065-308X(04)57003-3; Johnson PTJ, 2002, ECOL MONOGR, V72, P151, DOI 10.1890/0012-9615(2002)072[0151:PROILT]2.0.CO;2; Johnson PTJ, 2001, HERPETOLOGICA, V57, P336; Johnstone CP, 2010, J MAMMAL, V91, P1332, DOI 10.1644/10-MAMM-A-034.1; Kaczmarski M, 2016, ENVIRON SCI POLLUT R, V23, P21940, DOI 10.1007/s11356-016-7297-6; Kang Changku, 2016, Journal of Ecology and Environment, V39, P11, DOI 10.5141/ecoenv.2016.002; Kie JG, 1988, PSW106 USDA FOR SERV; Martinez-Silvestre Albert, 2014, Herpetology Notes, V7, P277; MEYERROCHOW VB, 1988, ZOOL ANZ, V221, P70; Ousterhout BH, 2015, J ANIM ECOL, V84, P914, DOI 10.1111/1365-2656.12344; Pinto HA, 2013, J PARASITOL, V99, P914, DOI 10.1645/GE-3214.1; Pokhrel LR, 2013, ETHOL ECOL EVOL, V25, P214, DOI 10.1080/03949370.2013.767858; R Core Team, R LANG ENV STAT COMP; Reeves MK, 2008, ENVIRON HEALTH PERSP, V116, P1009, DOI 10.1289/ehp.10963; Reeves MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077467; Ruiz-Martinez L, 2014, SALAMANDRA, V50, P63; Schotthoefer AM, 2003, J PARASITOL, V89, P475, DOI 10.1645/0022-3395(2003)089[0475:ROTSTL]2.0.CO;2; SEMLITSCH RD, 1989, OECOLOGIA, V81, P100, DOI 10.1007/BF00377017; SESSIONS SK, 1990, J EXP ZOOL, V254, P38, DOI 10.1002/jez.1402540107; SHAFFER HB, 1993, SYST BIOL, V42, P508, DOI 10.2307/2992486; Shulse CD, 2014, HYDROBIOLOGIA, V723, P131, DOI 10.1007/s10750-013-1502-0; Soto RC, 2012, THESIS; Taylor B, 2005, ENVIRON HEALTH PERSP, V113, P1497, DOI 10.1289/ehp.7585; Thompson S, 2014, REGENERATION, V1, P27, DOI 10.1002/reg2.17; Weisrock DW, 2006, MOL ECOL, V15, P2489, DOI 10.1111/j.1365-294X.2006.02961.x; Wells KD, 2007, COMPETITION PREDATIO, P776; Winandy L, 2011, BEHAV RES METHODS, V43, P568, DOI 10.3758/s13428-011-0058-z; Wu W, 2014, ENVIRON MONIT ASSESS, V186, P3701, DOI 10.1007/s10661-014-3651-7	51	11	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183573	10.1371/journal.pone.0183573	http://dx.doi.org/10.1371/journal.pone.0183573			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846723	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600038
J	Bailly, C; Leforestier, R; Campion, L; Thebaud, E; Moreau, A; Kraeber-Bodere, F; Carlier, T; Bodet-Milin, C				Bailly, Clement; Leforestier, Rodolphe; Campion, Loic; Thebaud, Estelle; Moreau, Anne; Kraeber-Bodere, Francoise; Carlier, Thomas; Bodet-Milin, Caroline			Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma	PLOS ONE			English	Article							F-18-FDG PET/CT; BONE SARCOMAS; TUMOR VOLUME; SOLID TUMORS; SURVIVAL; CHILDREN; CRITERIA; RECIST; MRI	Purpose The objective of this retrospective work was to evaluate the prognostic value on histological response and survival of quantitative indices derived from FDG-PET performed before and after chemotherapy (CHT), in a homogeneous pediatric Ewing sarcoma (EWS) and Osteosarcoma (OST) population. Methods Thirty-one patients with EWS and 31 with OST were included. All patients were treated with neoadjuvant CHT, and underwent surgery for local control. All patients had FDG-PET at diagnosis and after CHT, prior to surgery. Several parameters were evaluated: SUVmax, SUVpeak, SUVmean, metabolic tumor volume, total lesion glycolysis, 7 textural features and 3 shape features (SF). The segmentation was performed using an adaptive approach. Results were compared to histopathological regression of the resected tumor and to clinical follow-up for survival evaluation. Results For EWS, univariate analysis did not highlight any prognostic value on histological response, or survival regardless of all the considered metrics. For OST, only one of the SF, namely elongation, was significantly associated with PFS and OS on both univariate and multivariate analysis (PFS: p = 0.019, HR = 5.583; OS: p = 0.0062, HR = 7.113). Conclusion Only elongation determined on initial FDG-PET has a potential interest as a prognostic factor of PFS and OS in pediatric OST patients. Unlike recent studies of the literature realized in adult population, all the metrics reveal limited additional prognostic value in pediatric EWS patients. This seems to reinforce the question of whether children experience different sub-types of the same pathologies than older patients, with different outcomes.	[Bailly, Clement; Leforestier, Rodolphe; Kraeber-Bodere, Francoise; Carlier, Thomas; Bodet-Milin, Caroline] Univ Hosp, Dept Nucl Med, Nantes, France; [Bailly, Clement; Kraeber-Bodere, Francoise; Carlier, Thomas; Bodet-Milin, Caroline] Univ Nantes, Nantes Angers Canc Res Ctr CRCNA, CNRS,INSERM, UMR892,UMR6299, Nantes, France; [Campion, Loic] ICO Rene Gauducheau Canc Ctr, Biometr Dept, St Herblain, France; [Thebaud, Estelle] Univ Hosp, Dept Pediat Oncol, Nantes, France; [Moreau, Anne] Univ Hosp, Dept Pathol, Nantes, France	Nantes Universite; CHU de Nantes; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; UNICANCER; Institut de Cancerologie de l'Ouest (ICO); Nantes Universite; CHU de Nantes; Nantes Universite; CHU de Nantes	Bodet-Milin, C (corresponding author), Univ Hosp, Dept Nucl Med, Nantes, France.; Bodet-Milin, C (corresponding author), Univ Nantes, Nantes Angers Canc Res Ctr CRCNA, CNRS,INSERM, UMR892,UMR6299, Nantes, France.	caroline.milin@chu-nantes.fr	Campion, Loic/K-4726-2015; Leforestier, Rodolphe/C-1321-2018; Bodet-Milin, Caroline/F-7721-2013; Bailly, Clément/AAX-9022-2020; Carlier, Thomas/L-2924-2015; Kraeber-Bodéré, Françoise/F-7143-2013; Leforestier, Rodolphe/AAC-5304-2022	Campion, Loic/0000-0003-4903-0908; Leforestier, Rodolphe/0000-0001-7492-0537; Bodet-Milin, Caroline/0000-0002-8219-3592; Bailly, Clément/0000-0001-8313-3287; Kraeber-Bodéré, Françoise/0000-0002-3417-0759; Leforestier, Rodolphe/0000-0001-7492-0537	French National Agency for Research [ANR-11-LABX-0018-01]	French National Agency for Research(French National Research Agency (ANR))	This work was supported by a grant from the French National Agency for Research called Investissementsd' Avenir no ANR-11-LABX-0018-01. The funders had no role in study design,data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the French National Agency for Research called Investissementsd' Avenir no ANR-11-LABX-0018-01.	Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bailly C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159984; Bielack S, 2013, MINERVA PEDIATR, V65, P125; Byun BH, 2014, EUR J NUCL MED MOL I, V41, P1553, DOI 10.1007/s00259-014-2746-2; Byun BH, 2013, J NUCL MED, V54, P1725, DOI 10.2967/jnumed.112.117697; Carlier T, 2015, FRONT MED, V2, DOI 10.3389/fmed.2015.00018; Costelloe CM, 2009, J NUCL MED, V50, P340, DOI 10.2967/jnumed.108.058461; Cotterill SJ, 2000, J CLIN ONCOL, V18, P3108, DOI 10.1200/JCO.2000.18.17.3108; Denecke T, 2010, EUR J NUCL MED MOL I, V37, P1842, DOI 10.1007/s00259-010-1484-3; Duchman KR, 2015, CANCER EPIDEMIOL, V39, P189, DOI 10.1016/j.canep.2014.12.012; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Franzius C, 2002, J NUCL MED, V43, P1012; Gaston LL, 2011, SKELETAL RADIOL, V40, P1007, DOI 10.1007/s00256-011-1096-4; Guimarães Júlio Brandão, 2015, Radiol Bras, V48, P175, DOI 10.1590/0100-3984.2013.1887; HaDuong JH, 2015, PEDIATR CLIN N AM, V62, P179, DOI 10.1016/j.pcl.2014.09.012; Hatt M, 2015, J NUCL MED, V56, P38, DOI 10.2967/jnumed.114.144055; Hawkins DS, 2002, CANCER, V94, P3277, DOI 10.1002/cncr.10599; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Kolb EA, 2003, J CLIN ONCOL, V21, P3423, DOI 10.1200/JCO.2003.10.033; Leavey PJ, 2014, PEDIATR BLOOD CANCER, V61, P2149, DOI 10.1002/pbc.25214; Li HT, 2012, SURG ONCOL, V21, pE165, DOI 10.1016/j.suronc.2012.07.002; Guerra JLL, 2012, CLIN TRANSL ONCOL, V14, P294, DOI 10.1007/s12094-012-0798-y; Luetke A, 2014, CANCER TREAT REV, V40, P523, DOI 10.1016/j.ctrv.2013.11.006; Meyer JS, 2008, PEDIATR BLOOD CANCER, V51, P163, DOI 10.1002/pbc.21596; Nair, 2000, Clin Positron Imaging, V3, P79, DOI 10.1016/S1095-0397(00)00037-6; O'Sullivan F, 2011, IEEE T MED IMAGING, V30, P2059, DOI 10.1109/TMI.2011.2160984; Ozaki T, 2015, J ORTHOP SCI, V20, P250, DOI 10.1007/s00776-014-0687-z; Palmerini E, 2016, EUR J NUCL MED MOL I; Quartuccio N, 2015, AM J ROENTGENOL, V204, P153, DOI 10.2214/AJR.14.12932; Raciborska A, 2016, CLIN TRANSL ONCOL, V18, P189, DOI 10.1007/s12094-015-1351-6; SALZERKUNTSCHIK M, 1983, J CANCER RES CLIN, V106, P21, DOI 10.1007/BF00625047; Vauclin S, 2009, PHYS MED BIOL, V54, P6901, DOI 10.1088/0031-9155/54/22/010; Wahl RL, 2009, J NUCL MED, V50, p122S, DOI 10.2967/jnumed.108.057307; Williams RF, 2016, SURG CLIN N AM, V96, P1107, DOI 10.1016/j.suc.2016.05.012	34	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183841	10.1371/journal.pone.0183841	http://dx.doi.org/10.1371/journal.pone.0183841			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841702	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700061
J	Garas, G; Cingolani, I; Panzarasa, P; Darzi, A; Athanasiou, T				Garas, George; Cingolani, Isabella; Panzarasa, Pietro; Darzi, Ara; Athanasiou, Thanos			Network analysis of surgical innovation: Measuring value and the virality of diffusion in robotic surgery	PLOS ONE			English	Article							EMERGING TECHNOLOGIES; MENTORING PERCEPTION; PERSPECTIVE; PERFORMANCE; DEVICES	Background Existing surgical innovation frameworks suffer from a unifying limitation, their qualitative nature. A rigorous approach to measuring surgical innovation is needed that extends beyond detecting simply publication, citation, and patent counts and instead uncovers an implementation-based value from the structure of the entire adoption cascades produced over time by diffusion processes. Based on the principles of evidence-based medicine and existing surgical regulatory frameworks, the surgical innovation funnel is described. This illustrates the different stages through which innovation in surgery typically progresses. The aim is to propose a novel and quantitative network-based framework that will permit modeling and visualizing innovation diffusion cascades in surgery and measuring virality and value of innovations. Materials and methods Network analysis of constructed citation networks of all articles concerned with robotic surgery (n = 13,240, Scopus (R)) was performed (1974-2014). The virality of each cascade was measured as was innovation value (measured by the innovation index) derived from the evidence-based stage occupied by the corresponding seed article in the surgical innovation funnel. The network-based surgical innovation metrics were also validated against real world big data (National Inpatient Sample-NIS (R)). Results Rankings of surgical innovation across specialties by cascade size and structural virality (structural depth and width) were found to correlate closely with the ranking by innovation value (Spearman's rank correlation coefficient = 0.758 (p = 0.01), 0.782 (p = 0.008), 0.624 (p = 0.05), respectively) which in turn matches the ranking based on real world big data from the NIS (R) (Spearman's coefficient = 0.673; p = 0.033). Conclusion Network analysis offers unique new opportunities for understanding, modeling and measuring surgical innovation, and ultimately for assessing and comparing generative value between different specialties. The novel surgical innovation metrics developed may prove valuable especially in guiding policy makers, funding bodies, surgeons, and healthcare providers in the current climate of competing national priorities for investment.	[Garas, George; Darzi, Ara; Athanasiou, Thanos] Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Surg Innovat Ctr, London, England; [Garas, George; Darzi, Ara; Athanasiou, Thanos] Royal Coll Surgeons England, Dept Surg Res & Innovat, London, England; [Cingolani, Isabella] Imperial Coll London, St Marys Hosp, Big Data & Analyt Unit, London, England; [Panzarasa, Pietro] Queen Mary Univ London, Sch Business & Management, London, England	Imperial College London; Royal College of Surgeons of England; Imperial College London; University of London; Queen Mary University London	Garas, G (corresponding author), Imperial Coll London, St Marys Hosp, Dept Surg & Canc, Surg Innovat Ctr, London, England.; Garas, G (corresponding author), Royal Coll Surgeons England, Dept Surg Res & Innovat, London, England.	g.garas@imperial.ac.uk	Garas, George/AAC-1968-2019	Garas, George/0000-0001-7468-3287; Cingolani, Isabella/0000-0002-1792-0124	Royal College of Surgeons of England Doctoral Research Fellowship [GG 1037600/2017-2018]; Imperial College London [CID 337755/2015-2018]; Alexander S. Onassis Public Benefit Foundation [F ZM 014-1/2016-2017]	Royal College of Surgeons of England Doctoral Research Fellowship; Imperial College London(General Electric); Alexander S. Onassis Public Benefit Foundation	Dr. George Garas, MD, FRCS holds a Royal College of Surgeons of England Doctoral Research Fellowship (Grant number GG 1037600/2017-2018) and is also supported by Imperial College London (Grant number CID 337755/2015-2018) and the Alexander S. Onassis Public Benefit Foundation (Grant number F ZM 014-1/2016-2017). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Healthcare Research and Quality (AHRQ), 2016, DESCR LEV EV GRAD RE; [Anonymous], P 9 ACM SIGKDD INT C; Apuzzo MLJ, 2008, NEUROSURGERY, V63, P1035, DOI 10.1227/01.NEU.0000335789.61773.C5; Arora A, 2016, INT J SURG, V27, P110, DOI 10.1016/j.ijsu.2016.01.071; Athanasiou T, 2016, POSTGRAD MED J, V92, P581, DOI 10.1136/postgradmedj-2016-134313; Athanasiou T, 2016, POSTGRAD MED J, V92, P597, DOI 10.1136/postgradmedj-2015-133542; Ciotti V, 2016, EPJ DATA SCI, V5, DOI 10.1140/epjds/s13688-016-0068-2; Dawkins Richard, 1976, SELFISH GENE; Dow P.A., 2013, ICWSM; Dunphy SM, 1996, TECHNOL FORECAST SOC, V53, P279, DOI 10.1016/S0040-1625(96)00098-4; Garas G, 2013, THYROID, V23, P1138, DOI 10.1089/thy.2012.0588; Garas G, 2012, WORLD J SURG, V36, P1723, DOI 10.1007/s00268-012-1597-x; Goel S, 2016, MANAGE SCI, V62, P180, DOI 10.1287/mnsc.2015.2158; Goldstein KM, 2017, HEALTHC; Hansen MT, 2007, HARVARD BUS REV, V85, P121; Healthcare Cost and Utilization Project (HCUP), 2012, NAT NAT INP SAMPL NI; Hughes-Hallett A, 2014, ANN SURG, V260, P205, DOI 10.1097/SLA.0000000000000662; Janda M, 2009, J BONE JOINT SURG AM, V91A, P17, DOI 10.2106/JBJS.H.01337; Lambiotte R, 2009, J INFORMETR, V3, P180, DOI 10.1016/j.joi.2009.03.007; MCCULLOCH P, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F3012; Najafzadeh M, 2017, NEW ENGL J MED, V376, P1203, DOI 10.1056/NEJMp1614720; Newman MEJ., 2010, NETWORKS INTRO, P168, DOI 10.1093/acprof:oso/9780199206650.001.0001; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Riskin DJ, 2006, ANN SURG, V244, P686, DOI 10.1097/01.sla.0000242706.91771.ce; Sherman RE, 2016, NEW ENGL J MED, V375, P2293, DOI 10.1056/NEJMsb1609216; Stafinski T, 2010, CAN J SURG, V53, P86; Taalbi J, 2017, J EVOL ECON, V27, P461, DOI 10.1007/s00191-017-0491-y; Trehan A, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7470; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Wong KA, 2016, INTERACT CARDIOV TH, V23, P940, DOI 10.1093/icvts/ivw257	31	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183332	10.1371/journal.pone.0183332	http://dx.doi.org/10.1371/journal.pone.0183332			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841648	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700025
J	Campos, SDG; Vieira, MLO; de Sousa, FB				Gomes Campos, Samara de Azevedo; Oliveira Vieira, Maria Lucia; de Sousa, Frederico Barbosa			Correlation between ICDAS and histology: Differences between stereomicroscopy and microradiography with contrast solution as histological techniques	PLOS ONE			English	Article							CARIES; DENTIN; LIGHT; REPRODUCIBILITY; ACCURACY; LESIONS; SYSTEM; LAYER	Detection of occlusal caries with visual examination using ICDAS correlates strongly with histology under stereomicroscopy (SM), but dentin aspects under SM are ambiguous regarding mineral content. Thus, our aim was to test two null hypotheses: SM and microradiography result in similar correlations between ICDAS and histology; SM and microradiography result in similar positive (PPV) and negative predictive values (NPV) of ICDAS cut-off 1-2 (scores 0-2 as sound) with histological threshold D3 (demineralization in the inner third of dentin). Occlusal surfaces of extracted permanent teeth (n = 115) were scored using ICDAS. Undemineralized ground sections were histologically scored using both SM without contrast solution and microradiography after immersion in Thoulet's solution 1.47 for 24 h (MRC). Correlation between ICDAS and histology differed from SM (0.782) to MRC (0.511) (p = 0.0002), with a large effect size "q" of 0.49 (95% CI: 0.638/0.338). For ICDAS cut-off 1-2 and D3, PPV from MRC (0.56) was higher than that from SM (0.28) (p < 0.00001; effect size h = 0.81), and NPV from MRC (0.72) was lower than that from SM (1,00) (p < 0.00001; effect size h = 1.58). In conclusion, SM overestimated the correlation between ICDAS and lesion depth, and underestimated the number of occlusal surfaces with ICDAS cut-off 1-2 and deep dentin demineralization.	[Gomes Campos, Samara de Azevedo; de Sousa, Frederico Barbosa] Univ Fed Paraiba, Master Program Dent, Ctr Ciencias Saude, Cidade Univ, Joao Pessoa, Paraiba, Brazil; [Oliveira Vieira, Maria Lucia; de Sousa, Frederico Barbosa] Univ Fed Paraiba, Lab Microscopy & Biol Image, Ctr Ciencias Saude, Cidade Univ, Joao Pessoa, Paraiba, Brazil; [de Sousa, Frederico Barbosa] Univ Fed Paraiba, Dept Morphol, Ctr Ciencias Saude, Cidade Univ, Joao Pessoa, Paraiba, Brazil	Universidade Federal da Paraiba; Universidade Federal da Paraiba; Universidade Federal da Paraiba	de Sousa, FB (corresponding author), Univ Fed Paraiba, Master Program Dent, Ctr Ciencias Saude, Cidade Univ, Joao Pessoa, Paraiba, Brazil.; de Sousa, FB (corresponding author), Univ Fed Paraiba, Lab Microscopy & Biol Image, Ctr Ciencias Saude, Cidade Univ, Joao Pessoa, Paraiba, Brazil.; de Sousa, FB (corresponding author), Univ Fed Paraiba, Dept Morphol, Ctr Ciencias Saude, Cidade Univ, Joao Pessoa, Paraiba, Brazil.	fredericosousa@hotmail.com	De Sousa, Frederico Barbosa/B-8772-2008	De Sousa, Frederico Barbosa/0000-0002-9158-8342	CNPQ (Brazilian Ministry of Science, Technology and Innovation)	CNPQ (Brazilian Ministry of Science, Technology and Innovation)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The research scholarship given by CNPQ (Brazilian Ministry of Science, Technology and Innovation) to MLOV is greatly acknowledged.; The research scholarship given by CNPQ (Brazilian Ministry of Science, Technology and Innovation) to MLOV is greatly acknowledged.	APPLEBAUM E., 1935, Dental Cosmos, V77, P931; Applebaum E, 1933, DENT COSMOS, V75, P1097; ARENDS J, 1995, CARIES RES, V29, P118, DOI 10.1159/000262052; Arends J, 1997, Adv Dent Res, V11, P403; Bjorndal L, 1998, CARIES RES, V32, P59, DOI 10.1159/000016431; Boving TB, 2001, J CONTAM HYDROL, V53, P85, DOI 10.1016/S0169-7722(01)00138-3; Braga MM, 2009, CARIES RES, V43, P405, DOI 10.1159/000239755; Cohen J.E., 1988, STAT POWER ANAL BEHA; de Sousa FB, 2017, EUR J ORAL SCI, V125, P229, DOI 10.1111/eos.12350; Diniz MB, 2009, COMMUNITY DENT ORAL, V37, P399, DOI 10.1111/j.1600-0528.2009.00487.x; EKSTRAND KR, 1995, CARIES RES, V29, P243, DOI 10.1159/000262076; Ekstrand KR, 1997, CARIES RES, V31; Elliott JC, 1997, CIBA F SYMP, V205, P54; GARBEROGLIO R, 1976, ARCH ORAL BIOL, V21, P355, DOI 10.1016/S0003-9969(76)80003-9; Gottlieb B, 1946, AM J ORTHOD ORAL SUR, V32; Gottlieb B, 1946, CLIN ASPECTS PROPHYL; Zou GY, 2007, PSYCHOL METHODS, V12, P399, DOI 10.1037/1082-989X.12.4.399; Ismail AI, 2007, COMMUNITY DENT ORAL, V35, P170, DOI 10.1111/j.1600-0528.2007.00347.x; Jablonski-Momeni A, 2008, CARIES RES, V42, P79, DOI 10.1159/000113160; Kienle A, 2003, PHYS MED BIOL, V48, pN7, DOI 10.1088/0031-9155/48/2/401; OGAWA K, 1983, J DENT RES, V62, P7, DOI 10.1177/00220345830620011701; Pugach MK, 2009, J DENT RES, V88, P71, DOI 10.1177/0022034508327552; Shellis R. P., 2000, TOOTH WEAR SENSITIVI, P19; SHIMIZU C, 1981, J DENT RES, V60, P1826, DOI 10.1177/00220345810600110101; Silva Priscila Florentino, 2014, F1000Res, V3, P13, DOI 10.12688/f1000research.3-13.v1; Meira KRS, 2015, ARCH ORAL BIOL, V60, P883, DOI 10.1016/j.archoralbio.2015.03.001; Soviero VM, 2012, J DENT, V40, P35, DOI 10.1016/j.jdent.2011.09.002; Suplee C, 2009, XRAY MASS ATENUATION; TENBOSCH JJ, 1991, J DENT RES, V70, P2, DOI 10.1177/00220345910700010301; Zandona AF, 2012, J DENT RES, V91, P841, DOI 10.1177/0022034512455030; ZIJP JR, 1993, APPL OPTICS, V32, P411, DOI 10.1364/AO.32.000411	31	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183432	10.1371/journal.pone.0183432	http://dx.doi.org/10.1371/journal.pone.0183432			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841688	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700031
J	Lee, SY; Shin, YR; Park, HJ; Rho, MH; Chung, EC				Lee, So-Yeon; Shin, Yu Ri; Park, Hee Jin; Rho, Myung Ho; Chung, Eun Chul			Usefulness of multiecho fast field echo MRI in the evaluation of ossification of the posterior longitudinal ligament and dural ossification of the cervical spine	PLOS ONE			English	Article								Objectives The diagnosis of ossification of the posterior longitudinal ligament (OPLL) on magnetic resonance imaging (MRI) is challenging. The purpose of this study is to evaluate the usefulness of the multiecho fast field echo (mFFE) MRI in the detection of ossification of the posterior longitudinal ligament and dural ossification (DO) of the cervical spine. Methods Sixty-three patients who underwent MRI with mFFE and CT for cervical spine were retrospectively evaluated. The presence of OPLL and DO on MR images was assessed by two independent readers. The sensitivity, specificity, and accuracy of MRI for detecting OPLL and DO were determined using CT as a reference standard. Image contrast ratios were obtained between the OPLL and perilesional structures on each sequence. Results There were 31 patients with OPLL and 13 DO lesions. The mean sensitivity, specificity, and accuracy of both readers were 94%, 81%, 88% for OPLL and 92%, 81%, 86% for DO, respectively. The contrast ratios for OPLL and intervertebral disc, spinal cord and cerebrospinal fluid were significantly superior on mFFE images, whereas those for OPLL and bone marrow were significantly inferior on mFFE images than those of T1-and T2-weighted images (p <= 0.016). Conclusions MRI with mFFE may be sufficient for the assessment of OPLL and DO, with good contrasts between OPLL and intervertebral disc, spinal cord, and cerebrospinal fluid.	[Lee, So-Yeon; Park, Hee Jin; Rho, Myung Ho; Chung, Eun Chul] Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea; [Shin, Yu Ri] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiol, Coll Med, Incheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Park, HJ (corresponding author), Sungkyunkwan Univ, Sch Med, Kangbuk Samsung Hosp, Dept Radiol, Seoul, South Korea.	radiology12@paran.com		Lee, So-Yeon/0000-0002-0109-0998				Chang H, 2010, CLIN ORTHOP SURG, V2, P8, DOI 10.4055/cios.2010.2.1.8; Dorenbeck U, 2004, NEURORADIOLOGY, V46, P306, DOI 10.1007/s00234-004-1175-5; Held P, 2001, EUR J RADIOL, V38, P64, DOI 10.1016/S0720-048X(00)00253-9; Hida Kazutoshi, 1997, Neurologia Medico-Chirurgica, V37, P173, DOI 10.2176/nmc.37.173; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lee SY, 2008, AM J ROENTGENOL, V191, P81, DOI 10.2214/AJR.07.2945; Li H, 2011, SPINE J, V11, P1049, DOI 10.1016/j.spinee.2011.09.008; Min JH, 2007, J NEUROSURG-SPINE, V6, P309, DOI 10.3171/spi.2007.6.4.4; Mizuno J, 2005, J NEUROSURG-SPINE, V2, P425, DOI 10.3171/spi.2005.2.4.0425; OTAKE S, 1992, AM J NEURORADIOL, V13, P1059; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; YAMASHITA Y, 1990, RADIOLOGY, V175, P843, DOI 10.1148/radiology.175.3.2111569	12	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183744	10.1371/journal.pone.0183744	http://dx.doi.org/10.1371/journal.pone.0183744			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841680	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700055
J	Saravo, B; Netzel, J; Kiesewetter, J				Saravo, Barbara; Netzel, Janine; Kiesewetter, Jan			The need for strong clinical leaders - Transformational and transactional leadership as a framework for resident leadership training	PLOS ONE			English	Article							IMPACT; HEALTH; HOSPITALS; PROGRAMS; SAFETY	Background For the purpose of providing excellent patient care, residents need to be strong, effective leaders. The lack of clinical leadership is alarming given the detrimental effects on patient safety. The objective of the study was to assess whether a leadership training addressing transactional and transformational leadership enhances leadership skills in residents. Methods A volunteer sample of 57 residents from postgraduate year one to four was recruited across a range of medical specialties. The residents took part in an interventional controlled trial. The four-week IMPACT leadership training provided specific strategies for leadership in the clinical environment, addressing transactional (e.g. active control, contingent reward) and transformational leadership skills (e.g. appreciation, inspirational motivation). Transactional and transformational leadership skill performance was rated (1) on the Performance Scale by an external evaluator blinded to the study design and (2) self-assessed transformational and transactional leadership skills. Both measures contained items of the Multifactor Leadership Questionnaire, with higher scores indicating greater leadership skills. Results Both scores were significantly different between the IMPACT group and the control group. In the IMPACT group, the Performance Scale increased 15% in transactional leadership skill performance (2.10 to 2.86) (intervention effect, 0.76; 95% CI, 0.40 to 1.13; p < .001, eta(2) = 0.31) and 14% in transformational leadership skill performance (2.26 to 2.94) (intervention effect, 0.68; 95% CI, 0.27 to 1.09; p < .001, eta(2) = 0.22). The self-assessed transactional skills revealed a 4% increase (3.83 to 4.03) (intervention effect, 0.20; 95% CI, 0.08 to 0.33; p < .001, eta 2 = 0.18) and a 6% increase in transformational leadership skills (3.54 to 3.86) (intervention effect, 0.31; 95% CI, 0.02 to 0.40; p < .001, eta(2) = 0.53). Discussion and conclusions These findings support the use of the transactional and transformational leadership framework for graduate leadership training. Future studies should incorporate time-latent posttests, evaluating the stability of the behavioral performance increase.	[Saravo, Barbara; Kiesewetter, Jan] Klinikum Ludwig Maximilians Univ Munchen, Inst Didakt & Ausbildungsforsch Med, Munich, Bavaria, Germany; [Netzel, Janine] Ludwig Maximilians Univ Munchen, Ctr Leadership & People Management, Munich, Bavaria, Germany	University of Munich; University of Munich	Kiesewetter, J (corresponding author), Klinikum Ludwig Maximilians Univ Munchen, Inst Didakt & Ausbildungsforsch Med, Munich, Bavaria, Germany.	jan.kiesewetter@med.lmu.de	Kiesewetter, Jan/AFQ-5216-2022	Kiesewetter, Jan/0000-0001-8165-402X	Forderprogramm fur Forschung und Lehre (FoFoLe)	Forderprogramm fur Forschung und Lehre (FoFoLe)	This work was funded by the Forderprogramm fur Forschung und Lehre (FoFoLe) to JK by a grant to the Klinikum of the Ludwig-Maximilians-Universitat Munich. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrell C, 2011, Z PERSONALFORSCH, V25, P205, DOI 10.1688/1862-0000_ZfP_2011_03_Abrell; Al-Mailam Faten Fahad, 2004, Qual Manag Health Care, V13, P278; Angood P, 2015, ACAD MED, V90, P1290, DOI 10.1097/ACM.0000000000000880; Arbeit Bf, 2011, ARBEITSMARKTBERICHTE; Avolio B. J., 1991, FULL RANGE LEADERSHI; Awad SS, 2004, AM J SURG, V188, P481, DOI 10.1016/j.amjsurg.2004.07.024; Baird DS, 2012, J AM ACAD DERMATOL, V66, P622, DOI 10.1016/j.jaad.2009.10.009; Baker D., 2003, MED TEAMWORK PATIENT; Barling J, 1996, J APPL PSYCHOL, V81, P827, DOI 10.1037/0021-9010.81.6.827; Bass B.M., 2008, BASS HDB LEADERSHIP, V4th ed.; Bass BM, 1995, LEADERSHIP QUART, V6, P463, DOI 10.1016/1048-9843(95)90021-7; Bass BM, 2003, J APPL PSYCHOL, V88, P207, DOI 10.1037/0021-9010.88.2.207; Bass BM, 1985, MULTIFACTOR LEADERSH; Bass BM, 1993, LEADERSHIP THEORY RE, P81; Blumenthal DM, 2012, ACAD MED, V87, P513, DOI 10.1097/ACM.0b013e31824a0c47; Cohen J.E., 1988, STAT POWER ANAL BEHA; Collins-Nakai Ruth, 2006, Mcgill J Med, V9, P68; Curry LA, 2011, ANN INTERN MED, V154, P384, DOI 10.7326/0003-4819-154-6-201103150-00003; Dhaliwal G, 2014, ACAD MED, V89, P1441, DOI 10.1097/ACM.0000000000000489; Dickey C, 2014, ACAD PSYCHIATR, V38, P383, DOI 10.1007/s40596-014-0082-2; Felfe J, 2002, ZUMA INFORMATIONSSSY; Franke F, 2011, LEADERSHIP-LONDON, V7, P295, DOI 10.1177/1742715011407387; Fuller JB, 1996, PSYCHOL REP, V78, P271, DOI 10.2466/pr0.1996.78.1.271; Gabel S, 2014, ACAD MED, V89, P848, DOI 10.1097/ACM.0000000000000236; Geyer A., 1998, GERMAN J HUMAN RESOU, V12, P377, DOI [10.1177/239700229801200401, DOI 10.1177/239700229801200401]; Gordon LJ, 2015, MED EDUC, V49, P1248, DOI 10.1111/medu.12832; Hammer A, 2012, J PUBLIC HEALTH MAN, V18, P175, DOI 10.1097/PHH.0b013e31823dea94; HATER JJ, 1988, J APPL PSYCHOL, V73, P695, DOI 10.1037/0021-9010.73.4.695; Horwitz IB, 2008, J SURG RES, V148, P49, DOI 10.1016/j.jss.2008.03.007; Jardine Dinchen, 2015, J Grad Med Educ, V7, P307, DOI 10.4300/JGME-07-02-31; Johnson JM, 2014, ACAD PSYCHIATR, V38, P510, DOI 10.1007/s40596-014-0048-4; Judge TA, 2004, J APPL PSYCHOL, V89, P755, DOI 10.1037/0021-9010.89.5.755; Kiesewetter J, 2013, GMS Z MED AUSBILD, V30, DOI DOI 10.3205/ZMA000892; Kiesewetter J, 2012, DTSCH ARZTEBL, V109, P2613; Kuo AK, 2010, ACAD MED, V85, P1603, DOI 10.1097/ACM.0b013e3181eb60f6; Lee MT, 2004, MED EDUC, V38, P559, DOI 10.1111/j.1365-2929.2004.01867.x; Lowe KB, 1996, LEADERSHIP QUART, V7, P385, DOI 10.1016/S1048-9843(96)90027-2; Mullen J, 2011, WORK STRESS, V25, P41, DOI 10.1080/02678373.2011.569200; Nembhard IM, 2006, J ORGAN BEHAV, V27, P941, DOI 10.1002/job.413; Netzel J., 2015, THESIS; Prenkert F, 1997, J Nurs Manag, V5, P279, DOI 10.1046/j.1365-2834.1997.00023.x; Schmidt-Huber M, 2015, ZFPG, V1, P28; Spinelli Robert J, 2006, Hosp Top, V84, P11, DOI 10.3200/HTPS.84.2.11-19; Stockwell DC, 2007, PEDIATR CRIT CARE ME, V8, P540, DOI 10.1097/01.PCC.0000288709.15113.8A; Straus SE, 2013, ACAD MED, V88, P710, DOI 10.1097/ACM.0b013e31828af493; Sutcliffe KM, 2004, ACAD MED, V79, P186, DOI 10.1097/00001888-200402000-00019; Vandenberghe C, 2002, EUR J PSYCHOL ASSESS, V18, P16, DOI 10.1027//1015-5759.18.1.16; Wang XH, 2012, J ADV NURS, V68, P444, DOI 10.1111/j.1365-2648.2011.05762.x; Webb AMB, 2014, 1 STEP UNDERSTANDING, V89; Yukl G., 1998, LEADERSHIP ORG	50	27	28	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183019	10.1371/journal.pone.0183019	http://dx.doi.org/10.1371/journal.pone.0183019			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841662	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700015
J	Campos, R; Monica, FZ; Rodrigues, RL; Rojas-Moscoso, JA; Moreno, RA; Cogo, JC; de Oliveira, MA; Antunes, E; De Nucci, G				Campos, Rafael; Monica, Fabiola Z.; Rodrigues, Renata Lopes; Rojas-Moscoso, Julio Alejandro; Moreno, Ronilson Agnaldo; Cogo, Jose Carlos; de Oliveira, Marco Antonio; Antunes, Edson; De Nucci, Gilberto			Tetrodotoxin-insensitive electrical field stimulation-induced contractions on Crotalus durissus terrificus corpus cavernosum	PLOS ONE			English	Article							RESISTANT SODIUM-CHANNELS; PENILE ERECTION; NITRIC-OXIDE; CATECHOLAMINE UPTAKE; SMOOTH-MUSCLE; RELAXATION; RABBIT; DRUGS; DYSFUNCTION; MECHANISMS	Reptiles are the first amniotes to develop an intromitent penis, however until now the mechanisms involved in the electrical field stimulation-induced contraction on corpora cavernosa isolated from Crotalus durissus terrificus were not investigated. Crotalus and rabbit corpora cavernosa were mounted in 10 mL organ baths for isometric tension recording. Electrical field stimulation (EFS)-induced contractions were performed in presence/absence of phentolamine (10 mu M), guanethidine (30 mu M), tetrodotoxin (1 mu M and 1mM), A-803467 (10 mu M), 3-iodo-L-Tyrosine (1 mM), salsolinol (3 mu M) and a modified Krebs solution (equimolar substitution of NaCl by N-methyl-D-glucamine). Immuno-histochemistry for tyrosine hydroxylase was also performed. Electrical field stimulation (EFS; 8 Hz and 16 Hz) caused contractions in both Crotalus and rabbit corpora cavernosa. The contractions were abolished by previous incubation with either phentolamine or guanethidine. Tetrodotoxin (1 mu M) also abolished the EFS-induced contractions of rabbit CC, but did not affect EFS-induced contractions of Crotalus CC. Addition of A-803467 (10 mu M) did not change the EFS-induced contractions of Crotalus CC but abolished rabbit CC contractions. 3-iodo-L-Tyrosine and salsolinol had no effect on EFS-induced contractions of Crotalus CC and Rabbit CC. Replacement of NaCl by N-Methyl-D-glucamine (NMDG) abolished EFS-induced contractions of rabbit CC, but did not affect Crotalus CC. The presence of tyrosine hydroxylase was identified in endothelial cells only of Crotalus CC. Since the EFS-induced contractions of Crotalus CC is dependent on catecholamine release, insensitive to TTX, insensitive to A803467 and to NaCl replacement, it indicates that the source of cathecolamine is unlikely to be from adrenergic terminals. The finding that tyrosine hydroxylase is present in endothelial cells suggests that these cells can modulate Crotalus CC tone.	[Campos, Rafael; Monica, Fabiola Z.; Rodrigues, Renata Lopes; Rojas-Moscoso, Julio Alejandro; de Oliveira, Marco Antonio; Antunes, Edson; De Nucci, Gilberto] Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, Brazil; [Moreno, Ronilson Agnaldo] FACISB, Fac Hlth Sci, Dept Pharmacol, Barretos, Brazil; [Cogo, Jose Carlos; De Nucci, Gilberto] Brazil Univ, Fac Med Sci, Fernando Polis, Brazil; [De Nucci, Gilberto] Univ Sao Paulo, Inst Biomed Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade de Sao Paulo	Campos, R (corresponding author), Univ Estadual Campinas, UNICAMP, Fac Med Sci, Dept Pharmacol, Campinas, Brazil.	rafaelcampos.vet@gmail.com	Monica, Fabiola Zakia/B-4191-2013; De Nucci, Gilberto/J-5990-2012; Campos, Rafael/F-2471-2017	Monica, Fabiola Zakia/0000-0002-8449-6677; De Nucci, Gilberto/0000-0002-4346-7941; Campos, Rafael/0000-0002-9816-2061	Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP) [2011/11828-4]; Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq) [140731/2013-0]	Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de amparo a pesquisa do estado de Sao Paulo (FAPESP; 2011/11828-4) (GDN) http://www.fapesp.br/ and by Conselho Nacional de Desenvolvimento cientifico e tecnologico (CNPq; 140731/2013-0) (RMC) http://cnpq.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson KE, 2011, PHARMACOL REV, V63, P811, DOI 10.1124/pr.111.004515; BARNETT A, 1968, BRIT J PHARMACOL, V34, P484, DOI 10.1111/j.1476-5381.1968.tb08476.x; BOSSU JL, 1984, NEUROSCI LETT, V51, P241, DOI 10.1016/0304-3940(84)90558-5; BRINDLEY GS, 1983, BRIT J PSYCHIAT, V143, P332, DOI 10.1192/bjp.143.4.332; BRINDLEY GS, 1986, BRIT J PHARMACOL, V87, P495, DOI 10.1111/j.1476-5381.1986.tb10191.x; Broderick G, 1991, IN VITRO CONTRACTILE, P515; BURNETT AL, 1992, SCIENCE, V257, P401, DOI 10.1126/science.1378650; Capel RO, 2011, J SEX MED, V8, P1616, DOI 10.1111/j.1743-6109.2011.02246.x; COYLE JT, 1969, J PHARMACOL EXP THER, V170, P221; DAIL WG, 1987, J AUTON PHARMACOL, V7, P287, DOI 10.1111/j.1474-8673.1987.tb00157.x; De Oliveira JF, 2003, UROLOGY, V62, P581, DOI 10.1016/S0090-4295(03)00462-X; Dean RC, 2005, UROL CLIN N AM, V32, P379, DOI 10.1016/j.ucl.2005.08.007; Estancial CS, 2015, BJU INT, V116, P657, DOI 10.1111/bju.13105; Geffeney S, 2002, SCIENCE, V297, P1336, DOI 10.1126/science.1074310; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Gratzke C, 2010, EUR UROL, V57, P342, DOI 10.1016/j.eururo.2008.12.024; Hedlund P, 1999, BRIT J PHARMACOL, V127, P349, DOI 10.1038/sj.bjp.0702556; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; HOLMQUIST F, 1992, J PHYSIOL-LONDON, V449, P295, DOI 10.1113/jphysiol.1992.sp019087; Hurt KJ, 2012, P NATL ACAD SCI USA, V109, P16624, DOI 10.1073/pnas.1213790109; IGNARRO LJ, 1990, BIOCHEM BIOPH RES CO, V170, P843, DOI 10.1016/0006-291X(90)92168-Y; KALLEN RG, 1990, NEURON, V4, P233, DOI 10.1016/0896-6273(90)90098-Z; McGaraughty S, 2008, J PHARMACOL EXP THER, V324, P1204, DOI 10.1124/jpet.107.134148; Neurophysiology J., 1978, NEUROPHYSIOLOGY, V41; Okamura T, 1998, AM J PHYSIOL-HEART C, V274, pH1075, DOI 10.1152/ajpheart.1998.274.4.H1075; Raymond Huey WM, 2002, SCIENCE, V297, P64; ROGART RB, 1989, P NATL ACAD SCI USA, V86, P8170, DOI 10.1073/pnas.86.20.8170; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605	28	4	4	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183766	10.1371/journal.pone.0183766	http://dx.doi.org/10.1371/journal.pone.0183766			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837636	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000116
J	Deng, C; Wu, CZ; Lyu, NC; Huang, Z				Deng, Chao; Wu, Chaozhong; Lyu, Nengchao; Huang, Zhen			Driving style recognition method using braking characteristics based on hidden Markov model	PLOS ONE			English	Article							PREDICTION; SYSTEMS	Since the advantage of hidden Markov model in dealing with time series data and for the sake of identifying driving style, three driving style (aggressive, moderate and mild) are modeled reasonably through hidden Markov model based on driver braking characteristics to achieve efficient driving style. Firstly, braking impulse and the maximum braking unit area of vacuum booster within a certain time are collected from braking operation, and then general braking and emergency braking characteristics are extracted to code the braking characteristics. Secondly, the braking behavior observation sequence is used to describe the initial parameters of hidden Markov model, and the generation of the hidden Markov model for differentiating and an observation sequence which is trained and judged by the driving style is introduced. Thirdly, the maximum likelihood logarithm could be implied from the observable parameters. The recognition accuracy of algorithm is verified through experiments and two common pattern recognition algorithms. The results showed that the driving style discrimination based on hidden Markov model algorithm could realize effective discriminant of driving style.	[Deng, Chao; Wu, Chaozhong; Lyu, Nengchao] Wuhan Univ Technol, Intelligent Transportat Syst Res Ctr, Wuhan, Hubei, Peoples R China; [Deng, Chao; Wu, Chaozhong; Lyu, Nengchao] Wuhan Univ Technol, Engn Res Ctr Transportat Safety, Wuhan, Hubei, Peoples R China; [Deng, Chao; Wu, Chaozhong; Lyu, Nengchao] Wuhan Univ Technol, Natl Engn Res Ctr Water Transport Safety, Wuhan, Hubei, Peoples R China; [Huang, Zhen] Wuhan Univ Technol, Sch Automat, Wuhan, Hubei, Peoples R China	Wuhan University of Technology; Wuhan University of Technology; National Engineering Research Center for Water Transport Safety; Wuhan University of Technology; Wuhan University of Technology	Lyu, NC (corresponding author), Wuhan Univ Technol, Intelligent Transportat Syst Res Ctr, Wuhan, Hubei, Peoples R China.; Lyu, NC (corresponding author), Wuhan Univ Technol, Engn Res Ctr Transportat Safety, Wuhan, Hubei, Peoples R China.; Lyu, NC (corresponding author), Wuhan Univ Technol, Natl Engn Res Ctr Water Transport Safety, Wuhan, Hubei, Peoples R China.	lvnengchao@163.com			National Nature Science Foundation of China [51678460, U1664262]; Fundamental Research Funds for the Central Universities [2017-JL-003]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Nature Science Foundation of China (No. 51678460, No. U1664262) and the Fundamental Research Funds for the Central Universities (No. 2017-JL-003). The National Nature Science Foundation of China supported the data collection and analysis in this manuscript, and the Fundamental Research Funds for the Central Universities supported the preparation of this manuscript.	Bolovinou A., 2014, P 6 INT C AD SELF AD, P73; Chao Deng, 2016, CICTP 2016. Green and Multimodal Transportation and Logistics. Proceedings of the 16th COTA International Conference of Transportation Professionals, P308; Chen M, 2008, IEEE INT CONF ROBOT, P2019, DOI 10.1109/ROBOT.2008.4543503; Cheng H, 2015, J ECONOMETRICS, V187, P312; Demcenko A, 2008, P IEEE INT VEH S, P1181; Ding C, 2015, ACCIDENT ANAL PREV, V85, P58, DOI 10.1016/j.aap.2015.08.024; Gmbh RB, 2011, AUTOMOTIVE HDB, P89; Huang PF, 2007, INT J NEURAL SYST, V17, P467, DOI 10.1142/S0129065707001305; ITAKURA F, 1975, IEEE T ACOUST SPEECH, VAS23, P67, DOI 10.1109/TASSP.1975.1162641; Jing Zhong, 2010, Proceedings 2010 Sixth International Conference on Natural Computation (ICNC 2010), P832, DOI 10.1109/ICNC.2010.5583250; Jung EJ, 2016, STRUCT EQU MODELING, V23, P567, DOI 10.1080/10705511.2015.1138092; Limpert R, 1999, BRAKING          DEC, P61; Lu GQ, 2015, TRANSPORT RES A-POL, V73, P39, DOI 10.1016/j.tra.2015.01.001; Lu GQ, 2012, SAFETY SCI, V50, P1898, DOI 10.1016/j.ssci.2012.05.007; Ma XS, 2018, IEEE J-STARS, V11, P743, DOI 10.1109/JSTARS.2017.2768059; MacAdam C, 1998, VEHICLE SYST DYN, V29, P143, DOI 10.1080/00423119808969557; Matisic, 2016, INT MULTIDISCIPLINAR, V7, P13; Meiring GAM, 2015, SENSORS-BASEL, V15, P30653, DOI 10.3390/s151229822; Meng XN, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND BIOMIMETICS, VOLS 1-3, P274, DOI 10.1109/ROBIO.2006.340166; Murphey YL, 2009, CIVVS: 2009 IEEE WORKSHOP ON COMPUTATIONAL INTELLIGENCE IN VEHICLES AND VEHICULAR SYSTEMS, P23; Murphy K. P., 2002, PROBAB GRAPH MODELS, V13, P303; Nikolic M, 2016, 2016 24TH TELECOMMUNICATIONS FORUM (TELFOR), P691; Oliver N, 2000, PROCEEDINGS OF THE IEEE INTELLIGENT VEHICLES SYMPOSIUM 2000, P7, DOI 10.1109/IVS.2000.898310; Ou YS, 2009, J INTELL ROBOT SYST, V55, P39, DOI 10.1007/s10846-008-9292-8; Pentland A, 1999, NEURAL COMPUT, V11, P229, DOI 10.1162/089976699300016890; Qian H., 2010, J ROBOTICS, V2010, P1; Sebald DJ, 2000, IEEE T SIGNAL PROCES, V48, P3217, DOI 10.1109/78.875477; Trafalis TB, 2000, IEEE IJCNN, P348, DOI 10.1109/IJCNN.2000.859420; Wang JQ, 2013, IEEE T INTELL TRANSP, V14, P1, DOI 10.1109/TITS.2012.2205143; [王琳虹 Wang Linhong], 2014, [哈尔滨工业大学学报, Journal of Harbin Institute of Technology], V46, P102; Wu X, 2008, INT J INFORM ACQUISI, V5, P1; Xu L, 2015, IEEE T INTELL TRANSP, V16, P2522, DOI 10.1109/TITS.2015.2409870; Yang F, 2015, MATHEMATICS, V11, P53; Zhang JP, 2011, IEEE T INTELL TRANSP, V12, P1624, DOI 10.1109/TITS.2011.2158001	34	21	23	8	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182419	10.1371/journal.pone.0182419	http://dx.doi.org/10.1371/journal.pone.0182419			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837580	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000017
J	Gumz, A; Neubauer, K; Horstkotte, JK; Geyer, M; Lowe, B; Murray, AM; Kastner, D				Gumz, Antje; Neubauer, Karolin; Horstkotte, Julia Katharina; Geyer, Michael; Loewe, Bernd; Murray, Alexandra M.; Kaestner, Denise			A bottom-up approach to assess verbal therapeutic techniques. Development of the Psychodynamic Interventions List (PIL)	PLOS ONE			English	Article							STRUCTURAL-ANALYSIS; SOCIAL-BEHAVIOR; PSYCHOTHERAPY; FORMS; TIME	Objective Knowing which specific verbal techniques "good" therapists use in their daily work is important for training and evaluation purposes. In order to systematize what is being practiced in the field, our aim was to empirically identify verbal techniques applied in psychodynamic sessions and to differentiate them according to their basic semantic features using a bottom-up, qualitative approach. Method Mixed-Method-Design: In a comprehensive qualitative study, types of techniques were identified at the level of utterances based on transcribed psychodynamic therapy sessions using Qualitative Content Analysis (4211 utterances). The definitions of the identified categories were successively refined and modified until saturation was achieved. In a subsequent quantitative study, inter-rater reliability was assessed both at the level of utterances (n = 8717) and at the session level (n = 38). The convergent validity of the categories was investigated by analyzing associations with the Interpretive and Supportive Technique Scale (ISTS). Results The inductive approach resulted in a classification system with 37 categories (Psychodynamic Interventions List, PIL). According to their semantic content, the categories can be allocated to three dimensions: form (24 categories), thematic content (9) and temporal focus (4). Most categories showed good or excellent inter-rater reliability and expected associations with the ISTS were predominantly confirmed. The rare use of the residual category "Other" suggests that the identified categories might comprehensively describe the breadth of applied techniques. Conclusions The atheoretical orientation and the clear focus on overt linguistic features should enable the PIL to be used without intensive training or prior theoretical knowledge. The PIL can be used to investigate the links between verbal techniques derived from practice and micro-outcomes (at the session level) as well as the overall therapeutic outcomes. This approach might enable us to determine to what extent the outcome of therapy is due to unintended or non-theoretically relevant techniques.	[Gumz, Antje] Berlin Univ Psychol PHB, Berlin, Germany; [Gumz, Antje; Neubauer, Karolin; Loewe, Bernd; Murray, Alexandra M.; Kaestner, Denise] Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany; [Gumz, Antje; Neubauer, Karolin; Loewe, Bernd; Murray, Alexandra M.; Kaestner, Denise] Schon Klin Hamburg Eilbek, Hamburg, Germany; [Horstkotte, Julia Katharina] Univ Leipzig, Dept Med Psychol & Med Sociol, Leipzig, Germany; [Geyer, Michael] Acad Psychotherapy Erfurt, Erfurt, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University	Gumz, A (corresponding author), Berlin Univ Psychol PHB, Berlin, Germany.; Gumz, A (corresponding author), Univ Med Ctr, Dept Psychosomat Med & Psychotherapy, Hamburg, Germany.; Gumz, A (corresponding author), Schon Klin Hamburg Eilbek, Hamburg, Germany.	a.gumz@psychologische-hochschule.de	Gumz, Antje/P-9045-2014; Löwe, Bernd/AAG-4038-2020; Gumz, Antje/ABF-7163-2021	Gumz, Antje/0000-0002-2193-6540; Gumz, Antje/0000-0002-2193-6540; Lowe, Bernd/0000-0003-4220-3378; Kastner, Denise/0000-0002-1330-5626				ARLOW JA, 1987, PSYCHOANAL QUART, V56, P68, DOI 10.1080/21674086.1987.11927166; Barber JP, 2015, VISIONS PSYCHOTHERAP, P316; Benjamin LS, 2006, ANNU REV CLIN PSYCHO, V2, P83, DOI 10.1146/annurev.clinpsy.2.022305.095337; BENJAMIN LS, 1974, PSYCHOL REV, V81, P392, DOI 10.1037/h0037024; Benjamin LS, 1988, SHORT FORM INTREX US; Bergin AE, 2009, CHANGING FRONTIERS S; Brumberg J, 2012, Z PSYCHOSOM MED PSYC, V58, P219, DOI 10.13109/zptm.2012.58.3.219; Butler SF, 1995, PSYCHOTHER, V32, P629, DOI 10.1037/0033-3204.32.4.629; Castonguay LG, 2015, PSYCHOTHER RES, V25, P166, DOI 10.1080/10503307.2014.973923; Castonguay LG, 2011, PSYCHOTHER RES, V21, P125, DOI 10.1080/10503307.2011.563250; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Field A., 2013, DISCOVERING STAT USI; First M.B., 2014, STRUCTURED CLIN INTE; First M. B., 1997, STRUCTURED CLIN INTE; Fleiss J. L., 1981, STAT METHODS RATES P, V2; GROVE WM, 1982, J NERV MENT DIS, V170, P3, DOI 10.1097/00005053-198201000-00002; Gumz A, 2014, Z PSYCHOSOMATISCHE M, V60, P18; Gumz A, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01705; Gumz A, 2014, Z PSYCHOSOM MED PSYC, V60, P219, DOI 10.13109/zptm.2014.60.3.219; Gumz A, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-10; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; HILL CE, 1978, J COUNS PSYCHOL, V25, P461, DOI 10.1037/0022-0167.25.5.461; Hilsenroth MJ, 2005, PSYCHOTHERAPY, V42, P340, DOI 10.1037/0033-3204.42.3.340; Hoglend P, 2014, AM J PSYCHIAT, V171, P1056, DOI 10.1176/appi.ajp.2014.14010121; Margison FR, 2000, BRIT J PSYCHIAT, V177, P123, DOI 10.1192/bjp.177.2.123; Mayring P., 2004, COMPANION QUAL RES, P159; Mergenthaler E., 1992, TRANSKRIPTION GESPRA; Milbrath C, 1999, J Psychother Pract Res, V8, P40; Ogrodniczuk J S, 1999, J Psychother Pract Res, V8, P142; Ogrodniczuk JS, 2000, CAN J PSYCHIAT, V45, P452, DOI 10.1177/070674370004500505; Perakyla Anssi, 2005, Commun Med, V2, P163; Pincus AL, 1998, J PERS ASSESS, V70, P145, DOI 10.1207/s15327752jpa7001_10; Piper WE, 1998, J CONSULT CLIN PSYCH, V66, P558, DOI 10.1037/0022-006X.66.3.558; Schreier M., 2020, CONTENT ANAL QUALITA; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; STRUPP HH, 1993, J CONSULT CLIN PSYCH, V61, P431, DOI 10.1037/0022-006X.61.3.431; Thoma NC, 2009, PSYCHOTHERAPY, V46, P405, DOI 10.1037/a0017900; Tress W, 2002, STRUKTURALE ANAL SOZ, P35; Waldron S, 2004, PSYCHOANAL QUART, V73, P1079, DOI 10.1002/j.2167-4086.2004.tb00193.x; Wirtz M., 2002, BEURTEILERUBEREINSTI; Wittchen HU, 1997, SKID; Young JE., 2006, SCHEMA THERAPY PRACT	42	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182949	10.1371/journal.pone.0182949	http://dx.doi.org/10.1371/journal.pone.0182949			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837582	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000035
J	Hippmann, AA; Schuback, N; Moon, KM; McCrow, JP; Allen, AE; Foster, LJ; Green, BR; Maldonado, MT				Hippmann, Anna A.; Schuback, Nina; Moon, Kyung-Mee; McCrow, John P.; Allen, Andrew E.; Foster, Leonard J.; Green, Beverley R.; Maldonado, Maria T.			Contrasting effects of copper limitation on the photosynthetic apparatus in two strains of the open ocean diatom Thalassiosira oceanica	PLOS ONE			English	Article							FUCOXANTHIN-CHLOROPHYLL PROTEINS; PHAEODACTYLUM-TRICORNUTUM; ELECTRON-TRANSPORT; CARBON FIXATION; MARINE DIATOMS; SPRING BLOOM; IRON STRESS; HIGH-LIGHT; CHLAMYDOMONAS; EXPRESSION	There is an intricate interaction between iron (Fe) and copper (Cu) physiology in diatoms. However, strategies to cope with low Cu are largely unknown. This study unveils the comprehensive restructuring of the photosynthetic apparatus in the diatom Thalassiosira oceanica (CCMP1003) in response to low Cu, at the physiological and proteomic level. The restructuring results in a shift from light harvesting for photochemistry-and ultimately for carbon fixation-to photoprotection, reducing carbon fixation and oxygen evolution. The observed decreases in the physiological parameters F-v/F-m, carbon fixation, and oxygen evolution, concomitant with increases in the antennae absorption cross section (sigma(PSII)), non-photochemical quenching (NPQ) and the conversion factor (phi(e:C)/eta(PSII)) are in agreement with well documented cellular responses to low Fe. However, the underlying proteomic changes due to low Cu are very different from those elicited by low Fe. Low Cu induces a significant four-fold reduction in the Cu-containing photosynthetic electron carrier plastocyanin. The decrease in plastocyanin causes a bottleneck within the photosynthetic electron transport chain (ETC), ultimately leading to substantial stoichiometric changes. Namely, 2-fold reduction in both cytochrome b(6)f complex (cytb(6)f) and photosystem II (PSII), no change in the Fe-rich PSI and a 40- and 2-fold increase in proteins potentially involved in detoxification of reactive oxygen species (ferredoxin and ferredoxin: NADP(+) reductase, respectively). Furthermore, we identify 48 light harvesting complex (LHC) proteins in the publicly available genome of T. oceanica and provide proteomic evidence for 33 of these. The change in the LHC composition within the antennae in response to low Cu underlines the shift from photochemistry to photoprotection in T. oceanica (CCMP1003). Interestingly, we also reveal very significant intra-specific strain differences. Another strain of T. oceanica (CCMP 1005) requires significantly higher Cu concentrations to sustain both its maximal and minimal growth rate compared to CCMP 1003. Under low Cu, CCMP 1005 decreases its growth rate, cell size, Chla and total protein per cell. We argue that the reduction in protein per cell is the main strategy to decrease its cellular Cu requirement, as none of the other parameters tested are affected. Differences between the two strains, as well as differences between the well documented responses to low Fe and those presented here in response to low Cu are discussed.	[Hippmann, Anna A.; Schuback, Nina; Maldonado, Maria T.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada; [Moon, Kyung-Mee; Foster, Leonard J.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada; [McCrow, John P.; Allen, Andrew E.] J Craig Venter Inst, Dept Microbial & Environm Genom, La Jolla, CA USA; [Green, Beverley R.] Univ British Columbia, Dept Bot, Vancouver, BC, Canada	University of British Columbia; University of British Columbia; J. Craig Venter Institute; University of British Columbia	Hippmann, AA; Maldonado, MT (corresponding author), Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC, Canada.	ahippman@eoas.ubc.ca; mmaldonado@eoas.ubc.ca	Green, Beverley R./AAJ-5199-2021; Allen, Andrew E/C-4896-2012	Green, Beverley R./0000-0002-4021-9387; Allen, Andrew E/0000-0001-5911-6081; McCrow, John/0000-0002-7014-5040; Hippmann, Anna/0000-0002-9495-7414	National Sciences and Engineering Research Council of Canada (NSERC)	National Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by grants to MTM and LJF from the National Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen JF, 2003, TRENDS PLANT SCI, V8, P15, DOI 10.1016/S1360-1385(02)00006-7; Allen JF, 2002, CELL, V110, P273, DOI 10.1016/S0092-8674(02)00870-X; Amato A, 2007, PROTIST, V158, P193, DOI 10.1016/j.protis.2006.10.001; Anisimova M, 2011, SYST BIOL, V60, P685, DOI 10.1093/sysbio/syr041; Annett AL, 2008, LIMNOL OCEANOGR, V53, P2451, DOI 10.4319/lo.2008.53.6.2451; [Anonymous], 2015, RSTUDIO INT DEV ENV; Arar EJ, 1997, 4450 US EPA, P132; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bailey S, 2008, BBA-BIOENERGETICS, V1777, P269, DOI 10.1016/j.bbabio.2008.01.002; Bailleul B, 2015, NATURE, V524, P366, DOI 10.1038/nature14599; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behrenfeld MJ, 2013, ANNU REV MAR SCI, V5, P217, DOI 10.1146/annurev-marine-121211-172356; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRAND LE, 1983, LIMNOL OCEANOGR, V28, P1182, DOI 10.4319/lo.1983.28.6.1182; Bruland K. W., 1983, Trace Metals in Sea Water. Proceedings of the NATO Advanced Research Institute, P395; Castruita M, 2011, PLANT CELL, V23, P1273, DOI 10.1105/tpc.111.084400; Chen G, 2016, LIMNOL OCEANOGR; Claquin P, 2004, EUR J PHYCOL, V39, P33, DOI 10.1080/0967026032000157165; COLLIER JL, 1992, J BACTERIOL, V174, P4718, DOI 10.1128/JB.174.14.4718-4726.1992; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flicek P, 2011, NUCLEIC ACIDS RES, V39, pD800, DOI 10.1093/nar/gkq1064; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fredrickson KA, 2011, J PHYCOL, V47, P25, DOI 10.1111/j.1529-8817.2010.00942.x; Gao QM, 2014, CELL REP, V9, P1681, DOI 10.1016/j.celrep.2014.10.069; GEIDER RJ, 1993, J PHYCOL, V29, P755, DOI 10.1111/j.0022-3646.1993.00755.x; Goss R, 2005, BIOCHEMISTRY-US, V44, P4028, DOI 10.1021/bi047464k; Goss R, 2007, BBA-BIOMEMBRANES, V1768, P67, DOI 10.1016/j.bbamem.2006.06.006; Goss R, 2015, J PLANT PHYSIOL, V172, P13, DOI 10.1016/j.jplph.2014.03.004; Goss R, 2009, J PLANT PHYSIOL, V166, P1839, DOI 10.1016/j.jplph.2009.05.017; Green Beverley R., 2003, Advances in Photosynthesis and Respiration, V13, P129; Green Beverley R., 2007, P37; Green BR, 1996, ANNU REV PLANT PHYS, V47, P685, DOI 10.1146/annurev.arplant.47.1.685; Grouneva I, 2011, J PROTEOME RES, V10, P5338, DOI 10.1021/pr200600f; Gruber A, 2015, PLANT J, V81, P519, DOI 10.1111/tpj.12734; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gundermann K, 2014, ADV PHOTOSYNTH RESP, V39, P21, DOI 10.1007/978-94-017-8742-0_2; Guo J, 2015, PROTIST, V166, P58, DOI 10.1016/j.protis.2014.11.006; Guo J, 2012, J PHYCOL, V48, P312, DOI 10.1111/j.1529-8817.2012.01133.x; Guo JA, 2010, J PHYCOL, V46, P1218, DOI 10.1111/j.1529-8817.2010.00911.x; Hall T., 2013, IBIS BIOSCIENCES; Harvey EL, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01277; Helliwell KE, 2015, ISME J, V9, P1446, DOI 10.1038/ismej.2014.230; Hoffman GE, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-101; Ikeda Y, 2013, BBA-BIOENERGETICS, V1827, P529, DOI 10.1016/j.bbabio.2013.02.003; JASSBY AD, 1976, LIMNOL OCEANOGR, V21, P540, DOI 10.4319/lo.1976.21.4.0540; Jickells TD, 2005, SCIENCE, V308, P67, DOI 10.1126/science.1105959; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Katoh K, 2016, BIOINFORMATICS, V32, P1933, DOI 10.1093/bioinformatics/btw108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kern J, 2009, ADV PHOTOSYNTH RESP, V30, P203; Kim JH, 2015, J PHYCOL, V51, P159, DOI 10.1111/jpy.12263; KITAJIMA M, 1975, BIOCHIM BIOPHYS ACTA, V376, P105, DOI 10.1016/0005-2728(75)90209-1; KOLBER Z, 1993, LIMNOL OCEANOGR, V38, P1646, DOI 10.4319/lo.1993.38.8.1646; Kolber ZS, 1998, BBA-BIOENERGETICS, V1367, P88, DOI 10.1016/S0005-2728(98)00135-2; Koziol AG, 2007, PLANT PHYSIOL, V143, P1802, DOI 10.1104/pp.092536; Kremp A, 2012, ECOL EVOL, V2, P1195, DOI 10.1002/ece3.245; Kropat J, 2005, P NATL ACAD SCI USA, V102, P18730, DOI 10.1073/pnas.0507693102; Kropat J, 2015, P NATL ACAD SCI USA, V112, P2644, DOI 10.1073/pnas.1422492112; LaRoche J, 1996, NATURE, V382, P802; Lavaud J, 2002, PHOTOSYNTH RES, V74, P51, DOI 10.1023/A:1020890625141; Lebret K, 2012, ENVIRON MICROBIOL, V14, P2395, DOI 10.1111/j.1462-2920.2012.02769.x; Lefebvre SC, 2010, J PHYCOL, V46, P123, DOI 10.1111/j.1529-8817.2009.00793.x; Lelong A, 2013, LIMNOL OCEANOGR, V58, P613, DOI 10.4319/lo.2013.58.2.0613; Lennon AM, 2003, PLANTA, V218, P254, DOI 10.1007/s00425-003-1111-7; LEWIS MR, 1983, MAR ECOL PROG SER, V13, P99, DOI 10.3354/meps013099; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Lin YH, 2013, INT J MOL SCI, V14, P20913, DOI 10.3390/ijms141020913; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Lomas MW, 2000, J PHYCOL, V36, P903, DOI 10.1046/j.1529-8817.2000.99029.x; Lombardi AT, 2011, PHOTOSYNTH RES, V108, P77, DOI 10.1007/s11120-011-9655-z; Lommer M, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r66; Lommer M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-718; Mackey KRM, 2008, LIMNOL OCEANOGR, V53, P900, DOI 10.4319/lo.2008.53.3.0900; Maldonado MT, 2006, LIMNOL OCEANOGR, V51, P1729, DOI 10.4319/lo.2006.51.4.1729; Maldonado MT, 1999, DEEP-SEA RES PT II, V46, P2447, DOI 10.1016/S0967-0645(99)00071-5; Maldonado MT, 1996, MAR ECOL PROG SER, V141, P161, DOI 10.3354/meps141161; Maldonado MT, 2001, J PHYCOL, V37, P298, DOI 10.1046/j.1529-8817.2001.037002298.x; Malkin, 2015, PHYTOTOOLS PHYTOPLAN; Marchetti A, 2016, DEVEL APPL PHYCOL, V6, P233, DOI 10.1007/978-3-319-24945-2_11; Marchetti A, 2009, NATURE, V457, P467, DOI 10.1038/nature07539; McKew BA, 2013, NEW PHYTOL, V200, P74, DOI 10.1111/nph.12373; Menden-Deuer S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0031; MERCHANT S, 1986, MOL CELL BIOL, V6, P462, DOI 10.1128/MCB.6.2.462; MERCHANT S, 1991, EMBO J, V10, P1383, DOI 10.1002/j.1460-2075.1991.tb07658.x; Miloslavina Y, 2009, BBA-BIOENERGETICS, V1787, P1189, DOI 10.1016/j.bbabio.2009.05.012; Mock T, 2017, NATURE, V541, P536, DOI 10.1038/nature20803; Moniz MBJ, 2010, PROTIST, V161, P7, DOI 10.1016/j.protis.2009.07.001; Moniz MBJ, 2009, MOL ECOL RESOUR, V9, P65, DOI 10.1111/j.1755-0998.2009.02633.x; Moore JK, 2008, BIOGEOSCIENCES, V5, P631, DOI 10.5194/bg-5-631-2008; Moore JK, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002220; Nagao R, 2013, PHOTOSYNTH RES, V117, P281, DOI 10.1007/s11120-013-9903-5; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Orsini L, 2004, MAR ECOL PROG SER, V271, P87, DOI 10.3354/meps271087; Oxborough K, PHOTOSYNTHESIS RES, V54, P135; Page RD, 2002, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0602S01; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Parker MS, 2005, J PHYCOL, V41, P1142, DOI 10.1111/j.1529-8817.2005.00139.x; Peers G, 2006, NATURE, V441, P341, DOI 10.1038/nature04630; Peers G, 2005, LIMNOL OCEANOGR, V50, P1149, DOI 10.4319/lo.2005.50.4.1149; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Petrou K, 2014, MAR BIOL, V161, P925, DOI 10.1007/s00227-014-2392-z; Prasil O, 1996, PHOTOSYNTH RES, V48, P395, DOI 10.1007/BF00029472; Premvardhan L, 2010, BBA-BIOENERGETICS, V1797, P1647, DOI 10.1016/j.bbabio.2010.05.002; PRICE N M, 1988, Biological Oceanography, V6, P443; R Core Team, 2013, LANG ENV STAT COMP; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Raven JA, 2004, NEW PHYTOL, V162, P45, DOI 10.1111/j.1469-8137.2004.01022.x; Rho MN, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq747; RICHARDSON K, 1983, NEW PHYTOL, V93, P157, DOI 10.1111/j.1469-8137.1983.tb03422.x; Rodriguez RE, 2007, PLANT PHYSIOL, V143, P639, DOI 10.1104/pp.106.090449; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Rynearson TA, 2006, LIMNOL OCEANOGR, V51, P1249, DOI 10.4319/lo.2006.51.3.1249; Schmieder R, 2012, BIOINFORMATICS, V28, P433, DOI 10.1093/bioinformatics/btr669; Schuback N, 2016, BIOGEOSCIENCES, V13, P1019, DOI 10.5194/bg-13-1019-2016; Schuback N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133235; Semeniuk D. M., 2014, COPPER NUTR TRANSPOR; Semeniuk DM, 2009, DEEP-SEA RES PT I, V56, P1130, DOI 10.1016/j.dsr.2009.03.003; Sommer F, 2010, PLANT CELL, V22, P4098, DOI 10.1105/tpc.110.080069; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; SUNDA WG, 1991, NATURE, V351, P55, DOI 10.1038/351055a0; Taddei L, 2016, J EXP BOT, V67, P3939, DOI 10.1093/jxb/erw198; Terauchi AM, 2009, J BIOL CHEM, V284, P25867, DOI 10.1074/jbc.M109.023622; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Westall, 1976, MINEQL COMPUTER PROG; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wu JF, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001453; Yamori W, 2016, ANNU REV PLANT BIOL, V67, P81, DOI 10.1146/annurev-arplant-043015-112002; Zamzow H, 1998, ANAL CHIM ACTA, V377, P133, DOI 10.1016/S0003-2670(98)00618-7; Zhu SH, 2010, J PHYCOL, V46, P974, DOI 10.1111/j.1529-8817.2010.00884.x; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003; Zhu Y, 2016, J OCEANOGR, V72, P761, DOI 10.1007/s10872-016-0370-4	136	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181753	10.1371/journal.pone.0181753	http://dx.doi.org/10.1371/journal.pone.0181753			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837661	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000011
J	Jeong, G; Choi, K; Spohn, M; Park, SJ; Huwe, B; Liess, M				Jeong, Gwanyong; Choi, Kwanghun; Spohn, Marie; Park, Soo Jin; Huwe, Bernd; Liess, Mareike			Environmental drivers of spatial patterns of topsoil nitrogen and phosphorus under monsoon conditions in a complex terrain of South Korea	PLOS ONE			English	Article							SOIL TOTAL NITROGEN; FOREST; CARBON; PREDICTION; STOCKS; CLASSIFICATION; VARIABILITY; REGRESSION; SELECTION; SCALE	Nitrogen (N) and phosphorus (P) in topsoils are critical for plant nutrition. Relatively little is known about the spatial patterns of N and P in the organic layer of mountainous landscapes. Therefore, the spatial distributions of N and P in both the organic layer and the A horizon were analyzed using a light detection and ranging (LiDAR) digital elevation model and vegetation metrics. The objective of the study was to analyze the effect of vegetation and topography on the spatial patterns of N and P in a small watershed covered by forest in South Korea. Soil samples were collected using the conditioned latin hypercube method. LiDAR vegetation metrics, the normalized difference vegetation index (NDVI), and terrain parameters were derived as predictors. Spatial explicit predictions of N/P ratios were obtained using a random forest with uncertainty analysis. We tested different strategies of model validation (repeated 2-fold to 20-fold and leave-one-out cross validation). Repeated 10-fold cross validation was selected for model validation due to the comparatively high accuracy and low variance of prediction. Surface curvature was the best predictor of P contents in the organic layer and in the A horizon, while LiDAR vegetation metrics and NDVI were important predictors of N in the organic layer. N/P ratios increased with surface curvature and were higher on the convex upper slope than on the concave lower slope. This was due to P enrichment of the soil on the lower slope and a more even spatial distribution of N. Our digital soil maps showed that the topsoils on the upper slopes contained relatively little P. These findings are critical for understanding N and P dynamics in mountainous ecosystems.	[Jeong, Gwanyong; Huwe, Bernd] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Dept Geosci, Soil Phys Div, Bayreuth, Germany; [Choi, Kwanghun] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Biogeog Modelling, Bayreuth, Germany; [Spohn, Marie] Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Dept Soil Ecol, Bayreuth, Germany; [Park, Soo Jin] Seoul Natl Univ, Dept Geog, Seoul, South Korea; [Liess, Mareike] UFZ Helmholtz Ctr Environm Res, Dept Soil Phys, Halle, Germany; [Jeong, Gwanyong] Chonnam Natl Univ, Dept Geog, Gwangju, South Korea	University of Bayreuth; University of Bayreuth; University of Bayreuth; Seoul National University (SNU); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Chonnam National University	Jeong, G (corresponding author), Univ Bayreuth, Bayreuth Ctr Ecol & Environm Res BayCEER, Dept Geosci, Soil Phys Div, Bayreuth, Germany.; Jeong, G (corresponding author), Chonnam Natl Univ, Dept Geog, Gwangju, South Korea.	gyjeong@jnu.ac.kr	Ließ, Mareike/AAX-2803-2020; Spohn, Marie/R-3048-2016	Ließ, Mareike/0000-0001-9325-199X; Spohn, Marie/0000-0002-1010-7317	International Research Training Group TERRECO at the University of Bayreuth [GRK 1565/1]; German Research Foundation (DFG); University of Bayreuth	International Research Training Group TERRECO at the University of Bayreuth; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Bayreuth	This study was carried out as part of the International Research Training Group TERRECO (GRK 1565/1) at the University of Bayreuth. It was funded by the German Research Foundation (DFG). This publication was funded by the German Research Foundation (DFG) and the University of Bayreuth in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AANDAHL AR, 1948, SOIL SCI SOC AM PRO, V13, P449; Ambroise C, 2002, P NATL ACAD SCI USA, V99, P6562, DOI 10.1073/pnas.102102699; Asner G, 2015, LAND RESOURCES MONIT, P429; Ballabio C, 2009, GEODERMA, V151, P338, DOI 10.1016/j.geoderma.2009.04.022; Bedison JE, 2009, SOIL SCI SOC AM J, V73, P2105, DOI 10.2136/sssaj2008.0336; Binkley D., 2012, ECOLOGY MANAGEMENT F, V4th; Bohner J., 2002, EUR SOIL BUR, V7, P213; Braun S, 2010, ENVIRON POLLUT, V158, P2043, DOI 10.1016/j.envpol.2009.11.030; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brungard CW, 2015, GEODERMA, V239, P68, DOI 10.1016/j.geoderma.2014.09.019; Chough S.K., 2013, GEOLOGY SEDIMENTOLOG; Christian A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071172; Cichosz P., 2015, DATA MINING ALGORITH; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; DEV, 2002, GERM STAND METH EX W; Feigelson ED, 2012, MODERN STATISTICAL METHODS FOR ASTRONOMY: WITH R APPLICATIONS, P1, DOI 10.1017/CBO9781139015653; Franklin S.E., 2010, REMOTE SENSING BIODI; FREEMAN TG, 1991, COMPUT GEOSCI, V17, P413, DOI 10.1016/0098-3004(91)90048-I; Grimm R, 2008, GEODERMA, V146, P102, DOI 10.1016/j.geoderma.2008.05.008; Grunwald S., 2006, ENV SOIL LANDSCAPE M; Grunwald S, 2015, ADV AGRON, V131, P1, DOI 10.1016/bs.agron.2014.12.004; Hahm WJ, 2014, P NATL ACAD SCI USA, V111, P3338, DOI 10.1073/pnas.1315667111; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Huang WJ, 2015, SOIL BIOL BIOCHEM, V83, P12, DOI 10.1016/j.soilbio.2015.01.011; Hyyppa E J, 2015, LAND RESOURCES MONIT, P397; Hyyppa J, 2008, INT J REMOTE SENS, V29, P1339, DOI 10.1080/01431160701736489; Isenburg M., 2014, LASTOOLS EFFICIENT T; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7_1; Jang S.K., 2011, J KOREA SOC ENV ADM, V17, P183; Jensen J.R., 2015, INTRO DIGITAL IMAGE; Jeong JJ, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG001999; Johnson CE, 2000, SOIL SCI SOC AM J, V64, P1804, DOI 10.2136/sssaj2000.6451804x; Jones H.G., 2010, REMOTE SENSING VEGET; Jung BJ, 2012, J HYDROL, V440, P90, DOI 10.1016/j.jhydrol.2012.03.030; Kampichler C, 2010, ECOL INFORM, V5, P441, DOI 10.1016/j.ecoinf.2010.06.003; Kim IN, 2014, SCIENCE, V346, P1102, DOI 10.1126/science.1258396; Kim JS, 2014, IEEE T GEOSCI REMOTE, V52, P6724, DOI 10.1109/TGRS.2014.2301443; Kim TW, 2011, SCIENCE, V334, P505, DOI 10.1126/science.1206583; Korea meteorological administration, 2015, KOR WEATH SURV; Kuhn M., 2013, PACKAGEAPPLIEDPREDIC, DOI DOI 10.1007/978-1-4614-6849-3; Kunkel ML, 2011, GEODERMA, V165, P1, DOI 10.1016/j.geoderma.2011.06.011; Laliberte E, 2013, TRENDS ECOL EVOL, V28, P331, DOI 10.1016/j.tree.2013.02.008; LIESS M, 2014, APPL ENVIRON SOIL SC, V2014, pNIL1, DOI DOI 10.1155/2014/603132; Liu ZP, 2013, GEODERMA, V197, P67, DOI 10.1016/j.geoderma.2012.12.011; Malley J. D., 2011, STAT LEARNING BIOMED; Manning P, 2013, SOIL ECOLOGY AND ECOSYSTEM SERVICES, P256; McBratney AB, 2003, GEODERMA, V117, P3, DOI 10.1016/S0016-7061(03)00223-4; McKenzie NJ, 1999, GEODERMA, V89, P67, DOI 10.1016/S0016-7061(98)00137-2; Miller BA, 2015, GEODERMA, V239, P97, DOI 10.1016/j.geoderma.2014.09.018; Minasny B, 2006, COMPUT GEOSCI-UK, V32, P1378, DOI 10.1016/j.cageo.2005.12.009; Molinaro AM, 2005, BIOINFORMATICS, V21, P3301, DOI 10.1093/bioinformatics/bti499; Mulder VL, 2011, GEODERMA, V162, P1, DOI 10.1016/j.geoderma.2010.12.018; National Academy of Agricultural Science, 2013, KOR SOIL INF SYST; National Geographic Information Institute, 2015, NAT SPAT INF CLEAR; Orka HO, 2009, REMOTE SENS ENVIRON, V113, P1163, DOI 10.1016/j.rse.2009.02.002; Osman K.T., 2012, SOILS PRINCIPLES PRO; Park SJ, 2002, GEODERMA, V109, P117, DOI 10.1016/S0016-7061(02)00146-5; Park SJ, 2001, GEODERMA, V103, P249, DOI 10.1016/S0016-7061(01)00042-8; Poggio L, 2013, GEODERMA, V209, P1, DOI 10.1016/j.geoderma.2013.05.029; Remesan R., 2015, HYDROLOGICAL DATA DR, DOI 10.1007/978-3-319-09235-5; Roger A, 2014, GEODERMA, V217, P26, DOI 10.1016/j.geoderma.2013.11.001; Roudier P, 2012, DIGITAL SOIL ASSESSMENTS AND BEYOND, P227; Seibert J, 2007, GEODERMA, V141, P139, DOI 10.1016/j.geoderma.2007.05.013; SMECK NE, 1985, GEODERMA, V36, P185, DOI 10.1016/0016-7061(85)90001-1; Soethe N, 2008, J TROP ECOL, V24, P397, DOI 10.1017/S026646740800504X; Strobl C, 2009, PSYCHOL METHODS, V14, P323, DOI 10.1037/a0016973; Sumfleth K, 2008, ECOL INDIC, V8, P485, DOI 10.1016/j.ecolind.2007.05.005; Tesfa TK, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007474; Thenkabail PS, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P3; TUCKER CJ, 1986, INT J REMOTE SENS, V7, P1395, DOI 10.1080/01431168608948944; Turner BL, 2008, J ECOL, V96, P698, DOI 10.1111/j.1365-2745.2008.01384.x; Uriarte M, 2015, ECOL APPL, V25, P2022, DOI 10.1890/15-0112.1; Vesterdal L, 2008, FOREST ECOL MANAG, V255, P35, DOI 10.1016/j.foreco.2007.08.015; Vitousek PM, 2010, ECOL APPL, V20, P5, DOI 10.1890/08-0127.1; Vitousek PM, 2002, AMBIO, V31, P97, DOI 10.1639/0044-7447(2002)031[0097:NAN]2.0.CO;2; WALKER TW, 1976, GEODERMA, V15, P1, DOI 10.1016/0016-7061(76)90066-5; Wang K, 2013, APPL GEOGR, V42, P73, DOI 10.1016/j.apgeog.2013.04.002; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; Wilcke W, 2008, J PLANT NUTR SOIL SC, V171, P220, DOI 10.1002/jpln.200625210; Wohl E., 2010, MOUNTAIN RIVERS; Zellweger F, 2015, FOREST ECOL MANAG, V349, P36, DOI 10.1016/j.foreco.2015.04.008; ZEVENBERGEN LW, 1987, EARTH SURF PROCESSES, V12, P47, DOI 10.1002/esp.3290120107; Zhang ZM, 2010, ENVIRON EARTH SCI, V60, P1783, DOI 10.1007/s12665-009-0314-z; 이광률, 2004, [Journal of the Korean Geographical Society, 대한지리학회지], V39, P27	85	6	6	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183205	10.1371/journal.pone.0183205	http://dx.doi.org/10.1371/journal.pone.0183205			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837590	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000052
J	Kudumala, SR; Penserga, T; Borner, J; Slipchuk, O; Kakad, P; Lee, LH; Qureshi, A; Pielage, J; Godenschwege, TA				Kudumala, Sirisha R.; Penserga, Tyrone; Boerner, Jana; Slipchuk, Olesya; Kakad, Priyanka; Lee, LaTasha H.; Qureshi, Aater; Pielage, Jan; Godenschwege, Tanja A.			Lissencephaly-1 dependent axonal retrograde transport of L1-type CAM Neuroglian in the adult drosophila central nervous system	PLOS ONE			English	Article							ADHESION MOLECULE L1; LONG-TERM POTENTIATION; CENTRAL-SYNAPSE FORMATION; GIANT-FIBER SYSTEM; FLUORESCENT PROTEINS; ORGANELLE TRANSPORT; IN-VIVO; CHROMOPHORE MATURATION; NUCLEAR TRANSLOCATION; DYNACTIN INTERACTION	Here, we established the Drosophila Giant Fiber neurons (GF) as a novel model to study axonal trafficking of L1-type Cell Adhesion Molecules (CAM) Neuroglian (Nrg) in the adult CNS using live imaging. L1-type CAMs are well known for their importance in nervous system development and we previously demonstrated a role for Nrg in GF synapse formation. However, in the adult they have also been implicated in synaptic plasticity and regeneration. In addition, to its canonical role in organizing cytoskeletal elements at the plasma membrane, vertebrate L1CAM has also been shown to regulate transcription indirectly as well as directly via its import to the nucleus. Here, we intend to determine if the sole L1CAM homolog Nrg is retrogradley transported and thus has the potential to relay signals from the synapse to the soma. Live imaging of c-terminally tagged Nrg in the GF revealed that there are at least two populations of retrograde vesicles that differ in speed, and either move with consistent or varying velocity. To determine if endogenous Nrg is retrogradely transported, we inhibited two key regulators, Lissencephaly-1 (Lis1) and Dynactin, of the retrograde motor protein Dynein. Similar to previously described phenotypes for expression of poisonous sub-units of Dynactin, we found that developmental knock down of Lis1 disrupted GF synaptic terminal growth and that Nrg vesicles accumulated inside the stunted terminals in both mutant backgrounds. Moreover, post mitotic Lis1 knock down in mature GFs by either RNAi or Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) induced mutations, resulted in normal length terminals with fully functional GF synapses which also exhibited severe accumulation of endogenous Nrg vesicles. Thus, our data suggests that accumulation of Nrg vesicles is due to failure of retrograde transport rather than a failure of terminal development. Together with the finding that post mitotic knock down of Lis1 also disrupted retrograde transport of tagged Nrg vesicles in GF axons, it demonstrates that endogenous Nrg protein is transported from the synapse to the soma in the adult central nervous system in a Lis1-dependent manner.	[Kudumala, Sirisha R.; Penserga, Tyrone; Boerner, Jana; Slipchuk, Olesya; Kakad, Priyanka; Lee, LaTasha H.; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA; [Qureshi, Aater] Florida Atlantic Univ, Harriet L Wilkes Honors Coll, Jupiter, FL USA; [Pielage, Jan] Tech Univ Kaiserslautern, Div Zool Neurobiol, Dept Biol, Kaiserslautern, Germany	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; University of Kaiserslautern	Godenschwege, TA (corresponding author), Florida Atlantic Univ, Dept Biol Sci, Jupiter, FL 33458 USA.	godensch@fau.edu	; Godenschwege, Tanja/A-2830-2010	Pielage, Jan/0000-0002-5115-5884; Godenschwege, Tanja/0000-0003-3322-4134	National Institute for Neurological Disease and Stroke [R15NS090043]; National Institute of Child Health And Human Development [R01HD050725]; Jupiter Life Sciences Initiative; Division of Research- Florida Atlantic University; College of Science- Florida Atlantic University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD050725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R15NS090043] Funding Source: NIH RePORTER	National Institute for Neurological Disease and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health And Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Jupiter Life Sciences Initiative; Division of Research- Florida Atlantic University; College of Science- Florida Atlantic University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute for Neurological Disease and Stroke, https://www.ninds.nih.gov/, (R15NS090043) to TAG; the National Institute of Child Health And Human Development, https://www.nichd.nih.gov/Pages/index.aspx, (R01HD050725) to TAG; Jupiter Life Sciences Initiative, http://www.fau.edu/jlsi/, TAG and SRK; Division of Research- Florida Atlantic University, http://www.fau.edu/research/, TAG; College of Science- Florida Atlantic University, http://www.science.fau.edu/, TAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikawa Y, 2012, J BIOL CHEM, V287, P32312, DOI 10.1074/jbc.M112.374322; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Allen MJ, 1999, J NEUROSCI, V19, P9374; Allen MJ, 1998, J COMP NEUROL, V397, P519, DOI 10.1002/(SICI)1096-9861(19980810)397:4<519::AID-CNE5>3.0.CO;2-4; Allen MJ, 2010, COLD SPRING HARBOR P, V2010; Aridor M, 2000, TRAFFIC, V1, P836, DOI 10.1034/j.1600-0854.2000.011104.x; Baens M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000054; Bliss T, 2000, CURR BIOL, V10, P1607, DOI 10.1016/S0960-9822(00)00865-4; Boerner J, 2011, JOVE-J VIS EXP, DOI 10.3791/3080; Boerner J, 2010, J NEUROGENET, V24, P158, DOI 10.3109/01677063.2010.489624; Chen QY, 2005, SCHIZOPHR RES, V73, P269, DOI 10.1016/j.schres.2004.06.001; Chen XQ, 2012, CELL RES, V22, P677, DOI 10.1038/cr.2011.197; Cheng L, 2011, EMBO J, V30, P800, DOI 10.1038/emboj.2011.10; Chiba K, 2014, MOL BIOL CELL, V25, P3569, DOI 10.1091/mbc.E14-06-1111; Clague MJ, 2016, CURR BIOL, V26, pR332, DOI 10.1016/j.cub.2016.03.001; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Dix CI, 2013, J CELL BIOL, V202, P479, DOI 10.1083/jcb.201211052; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Drerup CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003303; Egan MJ, 2012, J CELL BIOL, V197, P971, DOI 10.1083/jcb.201112101; Enneking EM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001537; FRANSEN E, 1995, EUR J HUM GENET, V3, P273; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Garcia-Alonso L, 2000, NEURON, V28, P741, DOI 10.1016/S0896-6273(00)00150-1; Godenschwege TA, 2006, CURR BIOL, V16, P12, DOI 10.1016/j.cub.2005.11.062; Godenschwege TA, 2002, NAT NEUROSCI, V5, P1294, DOI 10.1038/nn976; Godenschwege TA, 2009, J NEUROGENET, V23, P147, DOI 10.1080/01677060802441380; Gunawardena S, 2013, HUM MOL GENET, V22, P3828, DOI 10.1093/hmg/ddt237; Hebisch E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075991; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; HOLZBAUR ELF, 1991, NATURE, V351, P579, DOI 10.1038/351579a0; Huang J, 2012, CELL, V150, P975, DOI 10.1016/j.cell.2012.07.022; Iizuka R, 2011, ANAL BIOCHEM, V414, P173, DOI 10.1016/j.ab.2011.03.036; Islam R, 2003, DEVELOPMENT, V130, P2051, DOI 10.1242/dev.00415; Itoh K, 2005, MOL CELL NEUROSCI, V29, P245, DOI 10.1016/j.mcn.2005.02.014; Jacobs K, 2000, DEVELOPMENT, V127, P5203; Janssens K, 2014, NEUROBIOL DIS, V65, P211, DOI 10.1016/j.nbd.2014.01.021; Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011; Kiefel H, 2011, TRENDS MOL MED, V17, P178, DOI 10.1016/j.molmed.2010.11.005; King SJ, 2003, MOL BIOL CELL, V14, P5089, DOI 10.1091/mbc.E03-01-0025; Kristiansen LV, 2005, MOL CELL NEUROSCI, V28, P141, DOI 10.1016/j.mcn.2004.09.003; Kudumala S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076974; Lee LH, 2015, MOL CELL NEUROSCI, V64, P24, DOI 10.1016/j.mcn.2014.11.002; Lei YD, 2000, DEV BIOL, V226, P57, DOI 10.1006/dbio.2000.9848; Lenz JH, 2006, EMBO J, V25, P2275, DOI 10.1038/sj.emboj.7601119; Liu Z, 2000, NAT CELL BIOL, V2, P776, DOI 10.1038/35041011; Liu Z, 1999, DEVELOPMENT, V126, P4477; Lloyd TE, 2012, NEURON, V74, P344, DOI 10.1016/j.neuron.2012.02.026; Lorenzo DN, 2014, J CELL BIOL, V207, P735, DOI 10.1083/jcb.201407063; LUTHI A, 1994, NATURE, V372, P777, DOI 10.1038/372777a0; Lutz D, 2013, J NEUROCHEMISTRY; Lutz D, 2012, J BIOL CHEM, V287, P17161, DOI 10.1074/jbc.M112.346759; Macdonald PJ, 2012, ANAL BIOCHEM, V421, P291, DOI 10.1016/j.ab.2011.10.040; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maness PF, 2007, NAT NEUROSCI, V10, P19, DOI 10.1038/nn1827; McKenney RJ, 2010, CELL, V141, P304, DOI 10.1016/j.cell.2010.02.035; Medioni C, 2015, NAT PROTOC, V10, P574, DOI 10.1038/nprot.2015.034; Milo R, 2010, NUCLEIC ACIDS RES, V38, pD750, DOI 10.1093/nar/gkp889; Moughamian AJ, 2013, J NEUROSCI, V33, P13190, DOI 10.1523/JNEUROSCI.0935-13.2013; Moughamian AJ, 2012, NEURON, V74, P331, DOI 10.1016/j.neuron.2012.02.025; Muresan V, 2001, MOL CELL, V7, P173, DOI 10.1016/S1097-2765(01)00165-4; Nikonenko AG, 2006, EUR J NEUROSCI, V23, P1839, DOI 10.1111/j.1460-9568.2006.04710.x; Pandey JP, 2011, J NEUROSCI, V31, P17207, DOI 10.1523/JNEUROSCI.4108-11.2011; Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105; Poltorak M, 1997, BRAIN RES, V751, P152, DOI 10.1016/S0006-8993(97)00023-1; Port F, 2015, G3-GENES GENOM GENET, V5, P1493, DOI 10.1534/g3.115.019083; Riedle S, 2009, BIOCHEM J, V420, P391, DOI 10.1042/BJ20081625; Sakurai K, 2002, MOL PSYCHIATR, V7, P412, DOI 10.1038/sj.mp.4000973; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Salinas PC, 2005, BIOCHEM SOC T, V33, P1295, DOI 10.1042/BST0331295; Sanyal S, 2004, NEURON, V41, P845, DOI 10.1016/S0896-6273(04)00152-7; Sayama K, 2010, J BIOL CHEM, V285, P30042, DOI 10.1074/jbc.M110.106484; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schmieg N, 2014, SEMIN CELL DEV BIOL, V27, P32, DOI 10.1016/j.semcdb.2013.10.004; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shao CY, 2013, TRAFFIC, V14, P785, DOI 10.1111/tra.12070; Siegenthaler D, 2015, J CELL BIOL, V208, P1003, DOI 10.1083/jcb.201407131; Siller KH, 2005, MOL BIOL CELL, V16, P5127, DOI 10.1091/mbc.E05-04-0338; Sinadinos C, 2009, NEUROBIOL DIS, V34, P389, DOI 10.1016/j.nbd.2009.02.012; Smith RB, 2012, J CELL SCI, V125, P3752, DOI 10.1242/jcs.094292; Soares L, 2014, SCI REP-UK, V4, DOI 10.1038/srep06199; Uthaman SB, THE STICKY SYNAPSE, P247; Vallee RB, 2006, GENE DEV, V20, P1384, DOI 10.1101/gad.1417206; Vallee RB, 2012, NAT CELL BIOL, V14, P224, DOI 10.1038/ncb2420; von Reyn CR, 2014, NAT NEUROSCI, V17, P962, DOI 10.1038/nn.3741; Wang SS, 2013, MOL BIOL CELL, V24, P3522, DOI 10.1091/mbc.E13-05-0283; White JA, 2015, HUM MOL GENET, V24, P7182, DOI 10.1093/hmg/ddv415; Wright AV, 2016, CELL, V164, P29, DOI 10.1016/j.cell.2015.12.035; Yamasaki M, 1997, NEUROPEDIATRICS, V28, P175, DOI 10.1055/s-2007-973696; Yi JY, 2011, J CELL BIOL, V195, P193, DOI 10.1083/jcb.201104076; Zala D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060162; Zhou B, 2012, CELL REPORTS, V2, P42, DOI 10.1016/j.celrep.2012.06.010	95	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183605	10.1371/journal.pone.0183605	http://dx.doi.org/10.1371/journal.pone.0183605			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837701	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000086
J	Pesola, AJ; Laukkanen, A; Heikkinen, R; Sipila, S; Saakslahti, A; Finni, T				Pesola, Arto J.; Laukkanen, Arto; Heikkinen, Risto; Sipila, Sarianna; Saakslahti, Arja; Finni, Taija			Accelerometer-assessed sedentary work, leisure time and cardio-metabolic biomarkers during one year: Effectiveness of a cluster randomized controlled trial in parents with a sedentary occupation and young children	PLOS ONE			English	Article							REDUCE SITTING TIME; PHYSICAL-ACTIVITY; UNITED-STATES; MUSCLE INACTIVITY; ADULTS; BREAKING; HEALTHY; INTERVENTIONS; DISEASE; RISK	Background It is unknown whether reducing sedentary time at work and during leisure time is possible and effective during one year. Methods Office workers with young children were recruited for this one-year cluster-randomized controlled trial through kindergartens and primary schools from 7 clusters in the city of Jyvaskyla, Finland. After a lecture, face-to-face tailored counseling was used to set contractually binding goals regarding reducing and breaking up sitting periods and increasing light intensity physical activity during work and leisure time. Primary outcomes of total, work and leisure sedentary time (<100 counts/min, cpm), light activity time (<2020 cpm), moderate-to-vigorous activity time (MVPA) and breaks/sedentary hour were assessed with a waist-worn Alive -accelerometer for 7 days, 5 times during the year. Anthropometrics (DXA), fasting biomarkers and self-reported diet were assessed as secondary outcomes. Data were collected between 2011-2013 and analyzed between 2013-2016 with a linear mixed-effects model fit by REML using likelihood ratio test and intention-to-treat-principle. Results Participants from intervention (N = 71) and control (N = 62) regions were assessed at baseline and 117 completed the study. Sedentary leisure time decreased [-21.2 (95% CI -37.3 to -5.1) min/8 hours, likelihood ratio P<0.001] and light activity time [13.4 (-2.2 to 29.0) min/8 hours, P = 0.008] and breaks per sedentary hour [1.0 (-0.2 to 2.2), P = 0.010] increased in the intervention group as compared to controls at 3 months. The decrease in sedentary leisure time was maintained throughout the year [-7.9 (-24.0 to 8.3) min/8 hours, P = 0.029]. Small decreases in the control group's work and leisure MVPA were observed mostly at 3 months. Small favorable intervention effects were observed for fasting plasma glucose at 3 months and for leg lean mass and apoB/apoA-1 ratio at 12 months, with no changes in other outcomes. Conclusions Behavioral counseling induced a small decline in sedentary leisure time throughout one year in parents with a sedentary occupation and young children. Small concurrent changes in different biomarkers suggest that reducing sedentary leisure time during one year may be beneficial.	[Pesola, Arto J.; Laukkanen, Arto; Heikkinen, Risto; Finni, Taija] Univ Jyvaskyla, Fac Sport & Hlth Sci, Neuromuscular Res Ctr, Jyvaskyla, Finland; [Laukkanen, Arto; Saakslahti, Arja] Univ Jyvaskyla, Fac Sport & Hlth Sci, Jyvaskyla, Finland; [Sipila, Sarianna] Univ Jyvaskyla, Fac Sport & Hlth Sci, Gerontol Res Ctr, Jyvaskyla, Finland	University of Jyvaskyla; University of Jyvaskyla; University of Jyvaskyla	Pesola, AJ (corresponding author), Univ Jyvaskyla, Fac Sport & Hlth Sci, Neuromuscular Res Ctr, Jyvaskyla, Finland.	arto.j.pesola@jyu.fi	Laukkanen, Arto/N-7433-2016; Pesola, Arto/AAF-2800-2020; Finni, Taija/AAV-9073-2020; Finni, Taija/F-6544-2014	Laukkanen, Arto/0000-0002-9722-0258; Pesola, Arto/0000-0002-2984-9847; Sipila, Sarianna/0000-0001-5934-7728; Saakslahti, Arja/0000-0003-4354-0990; Finni, Taija/0000-0002-7697-2813	Finnish Ministry of Education and Culture [DNR042/627/2010, 35/ 627/2011, 119/626/2012 /TF]; Ellen and Artturi Nyyssonen Foundation; Juho Vainio foundation; Yrjo Jahnsson foundation	Finnish Ministry of Education and Culture; Ellen and Artturi Nyyssonen Foundation; Juho Vainio foundation; Yrjo Jahnsson foundation	The study was funded by Finnish Ministry of Education and Culture (DNR042/627/2010, 35/ 627/2011, 119/626/2012 /TF), Ellen and Artturi Nyyssonen Foundation (AL), the Juho Vainio foundation (AJP, AL) and the Yrjo Jahnsson foundation (AJP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadahl M, 2014, AM J PREV MED, V47, P576, DOI 10.1016/j.amepre.2014.06.020; Abraham C, 2008, HEALTH PSYCHOL, V27, P379, DOI 10.1037/0278-6133.27.3.379; Ajzen I., 1985, ACTION CONTROL, P11, DOI DOI 10.1007/978-3-642-69746-3_2; Benatti FB, 2015, MED SCI SPORT EXER, V47, P2053, DOI 10.1249/MSS.0000000000000654; Bey L, 2003, J PHYSIOL-LONDON, V551, P673, DOI 10.1113/jphysiol.2003.045591; Bienso RS, 2012, DIABETES, V61, P1090, DOI 10.2337/db11-0884; Biswas A, 2015, ANN INTERN MED, V162, P123, DOI 10.7326/M14-1651; Borodulin K, 2016, SCAND J PUBLIC HEALT, V44, P62, DOI 10.1177/1403494815604080; Breen L, 2013, J CLIN ENDOCR METAB, V98, P2604, DOI 10.1210/jc.2013-1502; Brownson RC, 2005, ANNU REV PUBL HEALTH, V26, P421, DOI 10.1146/annurev.publhealth.26.021304.144437; Chastin SFM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139984; Chau JY, 2012, PREV MED, V54, P195, DOI 10.1016/j.ypmed.2011.12.020; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Church TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019657; Conn VS, 2011, AM J PUBLIC HEALTH, V101, P751, DOI 10.2105/AJPH.2010.194381; Dunstan DW, 2012, DIABETES CARE, V35, P976, DOI 10.2337/dc11-1931; Duvivier BMFM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055542; Ekelund U, 2016, LANCET, V388, P1302, DOI 10.1016/S0140-6736(16)30370-1; Evans RE, 2012, AM J PREV MED, V43, P293, DOI 10.1016/j.amepre.2012.05.010; Finni T, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-944; Gardner B, 2016, HEALTH PSYCHOL REV, V10, P89, DOI 10.1080/17437199.2015.1082146; Grontved A, 2011, JAMA-J AM MED ASSOC, V305, P2448, DOI 10.1001/jama.2011.812; Healy GN, 2016, MED SCI SPORT EXER, V48, P1787, DOI 10.1249/MSS.0000000000000972; Healy GN, 2013, PREV MED, V57, P43, DOI 10.1016/j.ypmed.2013.04.004; Krogh-Madsen R, 2010, J APPL PHYSIOL, V108, P1034, DOI 10.1152/japplphysiol.00977.2009; Laukkanen A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141124; Mailey EL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-657; Martin A, 2015, BRIT J SPORT MED, V49, P1056, DOI 10.1136/bjsports-2014-094524; Matthews CE, 2008, AM J EPIDEMIOL, V167, P875, DOI 10.1093/aje/kwm390; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moher D., 2010, BMJ, V340; Owen N, 2011, AM J PREV MED, V41, P189, DOI 10.1016/j.amepre.2011.05.013; Parry S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-296; Peddie MC, 2013, AM J CLIN NUTR, V98, P358, DOI 10.3945/ajcn.112.051763; Pesola AJ, 2015, MED SCI SPORT EXER, V47, P1188, DOI 10.1249/MSS.0000000000000527; Pesola AJ, 2014, MED SCI SPORT EXER, V46, P2122, DOI 10.1249/MSS.0000000000000335; Prince SA, 2014, OBES REV, V15, P905, DOI 10.1111/obr.12215; Soininen P, 2009, ANALYST, V134, P1781, DOI 10.1039/b910205a; Stephens BR, 2011, METABOLISM, V60, P941, DOI 10.1016/j.metabol.2010.08.014; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; van der Ploeg HP, 2014, PREV MED, V69, P187, DOI 10.1016/j.ypmed.2014.10.004; Walldius G, 2006, J INTERN MED, V259, P493, DOI 10.1111/j.1365-2796.2006.01643.x	42	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183299	10.1371/journal.pone.0183299	http://dx.doi.org/10.1371/journal.pone.0183299			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837598	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000058
J	Vidorreta, M; Wang, Z; Chang, YLV; Wolk, DA; Fernandez-Seara, MA; Detre, JA				Vidorreta, Marta; Wang, Ze; Chang, Yulin V.; Wolk, David A.; Fernandez-Seara, Maria A.; Detre, John A.			Whole-brain background-suppressed pCASL MRI with 1D-accelerated 3D RARE Stack-Of-Spirals readout	PLOS ONE			English	Article							PERFUSION MRI; INVERSION; SIGNAL; BLOOD; COIL; CASL; 3T	Arterial Spin Labeled (ASL) perfusion MRI enables non-invasive, quantitative measurements of tissue perfusion, and has a broad range of applications including brain functional imaging. However, ASL suffers from low signal-to-noise ratio (SNR), limiting image resolution. Acquisitions using 3D readouts are optimal for background-suppression of static signals, but can be SAR intensive and typically suffer from through-plane blurring. In this study, we investigated the use of accelerated 3D readouts to obtain whole-brain, high-SNR ASL perfusion maps and reduce SAR deposition. Parallel imaging was implemented along the partition-encoding direction in a pseudo-continuous ASL sequence with background-suppression and 3D RARE Stack-Of-Spirals readout, and its performance was evaluated in three small cohorts. First, both non-accelerated and two-fold accelerated single-shot versions of the sequence were evaluated in healthy volunteers during a motor-photic task, and the performance was compared in terms of temporal SNR, GM-WM contrast, and statistical significance of the detected activation. Secondly, single-shot 1D-accelerated imaging was compared to a two-shot accelerated version to assess benefits of SNR and spatial resolution for applications in which temporal resolution is not paramount. Third, the efficacy of this approach in clinical populations was assessed by applying the single-shot 1D-accelerated version to a larger cohort of elderly volunteers. Accelerated data demonstrated the ability to detect functional activation at the subject level, including cerebellar activity, without loss in the perfusion signal temporal stability and the statistical power of the activations. The use of acceleration also resulted in increased GM-WM contrast, likely due to reduced through-plane partial volume effects, that were further attenuated with the use of two-shot readouts. In a clinical cohort, image quality remained excellent, and expected effects of age and sex on cerebral blood flow could be detected. The sequence is freely available upon request for academic use and could benefit a broad range of cognitive and clinical neuroscience research.	[Vidorreta, Marta; Chang, Yulin V.; Wolk, David A.; Detre, John A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Vidorreta, Marta; Chang, Yulin V.] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Wang, Ze] Temple Univ, Dept Radiol, Philadelphia, PA 19122 USA; [Wang, Ze] Hangzhou Normal Univ, Ctr Cognit & Brain Disorder, Hangzhou, Zhejiang, Peoples R China; [Fernandez-Seara, Maria A.] Univ Navarra Clin, Dept Radiol, Navarra, Spain	University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Hangzhou Normal University; University of Navarra	Detre, JA (corresponding author), Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA.	detre@mail.med.upenn.edu	Fernandez-Seara, Maria A./K-1246-2014	Fernandez-Seara, Maria A./0000-0001-8536-6295	National Institutes of Health [P41EB015893, MH080729, R01 AG040271]; National Natural Science Foundation of China [81471644]; Hangzhou Innovation Seed Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015893] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040271, P30AG010124] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hangzhou Innovation Seed Fund; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work has was supported by the National Institutes of Health (http://www.nih.gov/), grants no. P41EB015893, MH080729, and R01 AG040271, by National Natural Science Foundation of China (http://www.nsfc.gov.cn/), grant no. 81471644, and Hangzhou Innovation Seed Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsop DC, 2015, MAGN RESON MED, V73, P102, DOI 10.1002/mrm.25197; Buxton RB, 2009, INTRO FUNCTIONAL MAG, P101; Chang Y V., 2016, MAGN RESON MED; Chen JJ, 2009, MAGN RESON MED, V61, P249, DOI 10.1002/mrm.21858; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; DETRE JA, 1992, MAGNET RESON MED, V23, P37, DOI 10.1002/mrm.1910230106; Duhamel G, 2004, P INT SOC MAGN RES M, P10909; Feinberg DA, 2009, P INT SOC MAGN RES M, P59223; Fernandez-Seara MA, 2005, MAGN RESON MED, V54, P1241, DOI 10.1002/mrm.20674; Frackowiak R.S.J., 2004, HUMAN BRAIN FUNCTION, V2nd ed, P793, DOI [10.1016/B978-012264841-0/50042-1, DOI 10.1016/B978-012264841-0/50042-1]; Garcia DM, 2005, MAGN RESON MED, V54, P366, DOI 10.1002/mrm.20556; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; HAACKE EM, 1991, J MAGN RESON, V92, P126, DOI 10.1016/0022-2364(91)90253-P; KAUFMAN L, 1989, RADIOLOGY, V173, P265, DOI 10.1148/radiology.173.1.2781018; Kessler RM, 2003, NEUROBIOL AGING, V24, pS21, DOI 10.1016/S0197-4580(03)00047-2; NUTTALL AH, 1981, IEEE T ACOUST SPEECH, V29, P84, DOI 10.1109/TASSP.1981.1163506; Raichle ME, 1998, P NATL ACAD SCI USA, V95, P765, DOI 10.1073/pnas.95.3.765; Robison RK, 2010, MAGN RESON MED, V63, P1683, DOI 10.1002/mrm.22327; Talagala SL, 2004, MAGNET RESON MED, V52, P131, DOI 10.1002/mrm.20124; Vidorreta M, 2015, P INT SOC MAGN RES M, P269; Vidorreta M, 2014, NMR BIOMED, V27, P1387, DOI 10.1002/nbm.3201; Vidorreta M, 2013, NEUROIMAGE, V66, P662, DOI 10.1016/j.neuroimage.2012.10.087; Wang JJ, 2005, RADIOLOGY, V235, P218, DOI 10.1148/radiol.2351031663; Wang Z, 2005, MAGN RESON MED, V54, P732, DOI 10.1002/mrm.20574; Wang Z, 2012, MAGN RESON IMAGING, V30, P1409, DOI 10.1016/j.mri.2012.05.004; WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212; Ye FQ, 2000, MAGN RESON MED, V44, P92, DOI 10.1002/1522-2594(200007)44:1<92::AID-MRM14>3.0.CO;2-M; Zhao JM, 2007, MAGN RESON MED, V58, P592, DOI 10.1002/mrm.21342; Zhao L, 2015, NEUROIMAGE, V121, P205, DOI 10.1016/j.neuroimage.2015.07.018	29	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183762	10.1371/journal.pone.0183762	http://dx.doi.org/10.1371/journal.pone.0183762			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837640	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000115
J	Ajayi, IE; Mills, PC				Ajayi, Itopa E.; Mills, Paul C.			Effects of the hippocampus on the motor expression of augmented breaths	PLOS ONE			English	Article							PERIAQUEDUCTAL GRAY; RESPIRATORY VARIABILITY; ANESTHETIZED RATS; SIGH RATE; FREQUENCY; HYPOXIA; CATS; FACILITATION; MODULATION; INCREASES	Augmented breaths, also known as sighs, constitute the normal repertoire of breathing in freely behaving humans and animals. The breaths are believed to be generated by neurones in the preBotzinger complex but under modulatory influence from higher brain centres, particularly in the limbic system due to the strong correlations between the expression of emotional behaviours such as anxiety and the occurrence of augmented breaths. The current study examines the role of the hippocampus in the motor expression of augmented breaths, and also examines the characteristics of eupneic breaths surrounding a sigh before and after stimulating the hippocampus in urethane anaesthetised Sprague-Dawley rats. Neurochemical microstimulation using the excitatory amino acid, D, L-Homocysteic acid, was used to locate areas in the hippocampus with the potential to modulated the motor expression of augmented breaths. The CA1 neurone cluster of the ventral hippocampus was found to completely suppress the expression of augmented breaths without affecting the intrinsic properties of the breaths. A similar neurone cluster, but in the dorsal field of the hippocampus, was also investigated and found to have no effects over the expression of augmented breaths. The data supports the hypothesis that there is a structural or functional relationship between neurones of the ventral hippocampus and brainstem nuclei that control augmented breaths. The implications of these findings in the context of behaviours are discussed but with due consideration of experimental conditions.	[Ajayi, Itopa E.; Mills, Paul C.] Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia	University of Queensland	Ajayi, IE (corresponding author), Univ Queensland, Sch Vet Sci, Brisbane, Qld, Australia.	mailitopa@gmail.com			International Postgraduate Research Scholarship (IPRS); Australian Postgraduate Award (APA); Asia-Pacific Centre for Neuromodulation research top-up scholarship	International Postgraduate Research Scholarship (IPRS)(Australian Government); Australian Postgraduate Award (APA)(Australian Government); Asia-Pacific Centre for Neuromodulation research top-up scholarship	Itopa Ajayi was supported by the International Postgraduate Research Scholarship (IPRS), Australian Postgraduate Award (APA), and Asia-Pacific Centre for Neuromodulation research top-up scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannerman DM, 2003, BEHAV BRAIN RES, V139, P197, DOI 10.1016/S0166-4328(02)00268-1; BARNES GE, 1985, J ABNORM PSYCHOL, V94, P64, DOI 10.1037/0021-843X.94.1.64; Bell HJ, 2010, RESP PHYSIOL NEUROBI, V171, P201, DOI 10.1016/j.resp.2010.04.002; Bell HJ, 2009, AM J PHYSIOL-REG I, V296, pR334, DOI 10.1152/ajpregu.90680.2008; CARRIVE P, 1993, BEHAV BRAIN RES, V58, P27, DOI 10.1016/0166-4328(93)90088-8; CHERNIACK NS, 1981, ACTA PHYSIOL SCAND, V111, P349, DOI 10.1111/j.1748-1716.1981.tb06747.x; Chou TC, 2003, J NEUROSCI, V23, P10691; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Cohen G, 1996, J PHYSIOL-LONDON, V490, P551, DOI 10.1113/jphysiol.1996.sp021166; Davenport P. W., 2004, 33 M SOC NEUR SAN DI, P23; DAVIS GM, 1994, PEDIATR PULM, V17, P26, DOI 10.1002/ppul.1950170106; DUFFIN J, 1972, BRAIN RES, V39, P235, DOI 10.1016/0006-8993(72)90798-6; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Floyd NS, 2000, J COMP NEUROL, V422, P556, DOI 10.1002/1096-9861(20000710)422:4<556::AID-CNE6>3.0.CO;2-U; FRIES W, 1974, EXP BRAIN RES, V21, P441; FRYSINGER RC, 1989, ELECTROEN CLIN NEURO, V72, P463, DOI 10.1016/0013-4694(89)90222-8; Gaytan SP, 1998, BRAIN RES BULL, V47, P625, DOI 10.1016/S0361-9230(98)00125-7; Golder FJ, 2005, NEUROSCI LETT, V373, P89, DOI 10.1016/j.neulet.2004.09.063; Homma I, 2008, EXP PHYSIOL, V93, P1011, DOI 10.1113/expphysiol.2008.042424; INGRAM RH, 1990, LUNG, V168, P237, DOI 10.1007/BF02719700; Janssens T, 2013, CLIN EXP ALLERGY, V43, P1000, DOI 10.1111/cea.12138; Li P, 2016, NATURE, V530, P293, DOI 10.1038/nature16964; Lieske SP, 2000, NAT NEUROSCI, V3, P600, DOI 10.1038/75776; LOVICK TA, 1993, BEHAV BRAIN RES, V58, P19, DOI 10.1016/0166-4328(93)90087-7; MARSHALL JM, 1988, J PHYSIOL-LONDON, V400, P15, DOI 10.1113/jphysiol.1988.sp017107; MATHEW OP, 1988, PEDIATR PULM, V4, P134, DOI 10.1002/ppul.1950040303; Matsumoto S, 1997, LUNG, V175, P175, DOI 10.1007/PL00007565; MEAD J, 1959, J APPL PHYSIOL, V14, P669, DOI 10.1152/jappl.1959.14.5.669; Moore J, 2012, RESP PHYSIOL NEUROBI, V180, P105, DOI 10.1016/j.resp.2011.10.016; OREM J, 1993, J APPL PHYSIOL, V74, P761, DOI 10.1152/jappl.1993.74.2.761; Pagliardini S, 2012, J NEUROSCI, V32, P11259, DOI 10.1523/JNEUROSCI.0948-12.2012; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; Poe GR, 1996, NEUROSCIENCE, V72, P39, DOI 10.1016/0306-4522(95)00525-0; Ramirez JM, 2014, PROG BRAIN RES, V209, P91, DOI 10.1016/B978-0-444-63274-6.00006-0; Reynolds CR, 2008, ADV EXP MED BIOL, V605, P274; REYNOLDS LB, 1962, J APPL PHYSIOL, V17, P683, DOI 10.1152/jappl.1962.17.4.683; Shahan CP, 2004, ANN M SOC NEUR 2004; Sody Abby Naimer, 2008, J Fam Pract, V57, pE1; Soltysik S, 2005, PHYSIOL BEHAV, V85, P598, DOI 10.1016/j.physbeh.2005.06.008; SZEREDAPRZESTASZEWSKA M, 1992, EXP PHYSIOL, V77, P109, DOI 10.1113/expphysiol.1992.sp003565; Vlemincx E, 2017, BIOL PSYCHOL, V125, P163, DOI 10.1016/j.biopsycho.2017.03.005; Vlemincx E, 2013, BIOL PSYCHOL, V93, P24, DOI 10.1016/j.biopsycho.2012.12.001; Wuyts R, 2011, INT J PSYCHOPHYSIOL, V82, P175, DOI 10.1016/j.ijpsycho.2011.07.021; ZHANG SP, 1994, J NEUROPHYSIOL, V72, P1337, DOI 10.1152/jn.1994.72.3.1337	44	4	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183619	10.1371/journal.pone.0183619	http://dx.doi.org/10.1371/journal.pone.0183619			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832663	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800073
J	Ewert, D; Hu, N; Du, XP; Li, W; West, MB; Choi, CH; Floyd, R; Kopke, RD				Ewert, Donald; Hu, Ning; Du, Xiaoping; Li, Wei; West, Matthew B.; Choi, Chul-Hee; Floyd, Robert; Kopke, Richard D.			HPN-07, a free radical spin trapping agent, protects against functional, cellular and electrophysiological changes in the cochlea induced by acute acoustic trauma	PLOS ONE			English	Article							INDUCED HEARING-LOSS; FOCAL CEREBRAL-ISCHEMIA; INNER-EAR; N-ACETYLCYSTEINE; INTENSE NOISE; ANTIOXIDANT TREATMENT; NEUROTROPHIC FACTOR; LIPID-PEROXIDATION; GAP-JUNCTIONS; LATERAL WALL	Oxidative stress is considered a major cause of the structural and functional changes associated with auditory pathologies induced by exposure to acute acoustic trauma AAT). In the present study, we examined the otoprotective effects of 2,4-disulfophenyl-N-tert-butylnitrone (HPN-07), a nitrone-based free radical trap, on the physiological and cellular changes in the auditory system of chinchilla following a six-hour exposure to 4 kHz octave band noise at 105 dB SPL. HPN-07 has been shown to suppress oxidative stress in biological models of a variety of disorders. Our results show that administration of HPN-07 beginning four hours after acoustic trauma accelerated and enhanced auditory/cochlear functional recovery, as measured by auditory brainstem responses (ABR), distortion product otoacoustic emissions (DPOAE), compound action potentials (CAP), and cochlear microphonics (CM). The normally tight correlation between the endocochlear potential (EP) and evoked potentials of CAP and CM were persistently disrupted after noise trauma in untreated animals but returned to homeostatic conditions in HPN-07 treated animals. Histological analyses revealed several therapeutic advantages associated with HPN-07 treatment following AAT, including reductions in inner and outer hair cell loss; reductions in AAT-induced loss of calretinin-positive afferent nerve fibers in the spiral lamina; and reductions in fibrocyte loss within the spiral ligament. These findings support the conclusion that early intervention with HPN07 following an AAT efficiently blocks the propagative ototoxic effects of oxidative stress, thereby preserving the homeostatic and functional integrity of the cochlea.	[Ewert, Donald; Du, Xiaoping; Li, Wei; West, Matthew B.; Kopke, Richard D.] Hough Ear Inst, Oklahoma City, OK 73112 USA; [Hu, Ning] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Choi, Chul-Hee] Catholic Univ Daegu, Coll Med Sci, Audiol & Speech Language Pathol, Gyongsan, Gyeongsangbuk D, South Korea; [Choi, Chul-Hee] Catholic Univ Daegu, Coll Med Sci, Res Inst Biomimet Sensory Control, Gyongsan, Gyeongsangbuk D, South Korea; [Floyd, Robert; Kopke, Richard D.] Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Kopke, Richard D.] Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK 73104 USA	University of Iowa; Catholic University of Daegu; Catholic University of Daegu; Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kopke, RD (corresponding author), Hough Ear Inst, Oklahoma City, OK 73112 USA.; Kopke, RD (corresponding author), Oklahoma Med Res Fdn, 825 NE 13th St, Oklahoma City, OK 73104 USA.; Kopke, RD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA.; Kopke, RD (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Otolaryngol, Oklahoma City, OK 73104 USA.	rkopke@houghear.org			Office of Naval Research [N00014-09-1-998]	Office of Naval Research(Office of Naval Research)	This work was supported by Office of Naval Research grant #N00014-09-1-998. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The excellent technical assistance by Don Nakmali and Weihua Cheng is greatly appreciated as are the comments of Dr. Thomas Van de Water in his review of the manuscript. Work supported by Office of Naval Research Grant #N00014-09-1-998.	Ahmad M, 2003, HEARING RES, V175, P82, DOI 10.1016/S0378-5955(02)00713-X; Bohne BA, 1999, HEARING RES, V134, P163, DOI 10.1016/S0378-5955(99)00082-9; Choi CH, 2014, FREE RADICAL RES, V48, P264, DOI 10.3109/10715762.2013.861599; Choi CH, 2008, FREE RADICAL BIO MED, V44, P1772, DOI 10.1016/j.freeradbiomed.2008.02.005; Choi CH, 2011, FREE RADICAL RES, V45, P1162, DOI 10.3109/10715762.2011.605360; Clausen F, 2008, J NEUROTRAUM, V25, P1449, DOI 10.1089/neu.2008.0585; Coling DE, 2003, FREE RADICAL BIO MED, V34, P873, DOI 10.1016/S0891-5849(02)01439-9; DECHESNE CJ, 1994, J COMP NEUROL, V346, P517, DOI 10.1002/cne.903460405; Du X, 2011, INT J OTOLARYNGOL; Du X, 2011, INT J OTOLARYNGOLOGY; Du XP, 2007, DEV BIOL, V305, P430, DOI 10.1016/j.ydbio.2007.02.028; Du XP, 2017, FREE RADICAL BIO MED, V108, P627, DOI 10.1016/j.freeradbiomed.2017.04.343; ELDREDGE DH, 1981, J ACOUST SOC AM, V69, P1091, DOI 10.1121/1.385688; Ewert DL, 2012, HEARING RES, V285, P29, DOI 10.1016/j.heares.2012.01.013; Floyd RA, 2008, FREE RADICAL BIO MED, V45, P1361, DOI 10.1016/j.freeradbiomed.2008.08.017; Greenwood DD, 1996, HEARING RES, V94, P157, DOI 10.1016/0378-5955(95)00229-4; Han M, 2003, CELL MOL BIOL, V49, P1249; Harding G. W, 2000, HEARING RES, V174, P158; Hayes SH, 2013, HDB CLIN NEUROPHYSIO, V10; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; Hight NG, 2003, HEARING RES, V179, P21, DOI 10.1016/S0378-5955(03)00067-4; Hirose K, 2003, JARO, V4, P339, DOI 10.1007/s10162-002-3036-4; Hsu WC, 2004, ACTA OTO-LARYNGOL, V124, P459, DOI 10.1080/00016480310000584; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; KONISHI T, 1980, EXP BRAIN RES, V40, P457; Kopke RD, 2000, HEARING RES, V149, P138, DOI 10.1016/S0378-5955(00)00176-3; Kopke RD, 2002, LARYNGOSCOPE, V112, P1515, DOI 10.1097/00005537-200209000-00001; Kopke R, 2015, HEARING RES, V323, P40, DOI 10.1016/j.heares.2015.01.002; Kuroda S, 1999, J CEREBR BLOOD F MET, V19, P778, DOI 10.1097/00004647-199907000-00008; Lees KR, 2006, NEW ENGL J MED, V354, P588, DOI 10.1056/NEJMoa052980; Lees KR, 2001, STROKE, V32, P675, DOI 10.1161/01.STR.32.3.675; Lin CY, 2010, HEARING RES, V269, P42, DOI 10.1016/j.heares.2010.07.005; Lindblad AC, 2011, NOISE HEALTH, V13, P392, DOI 10.4103/1463-1741.90293; Lorito G, 2008, MED SCI MONITOR, V14, pBR159; Lu JZ, 2014, JARO-J ASSOC RES OTO, V15, P353, DOI 10.1007/s10162-014-0441-4; Maples KR, 2004, CNS DRUGS, V18, P1071, DOI 10.2165/00023210-200418150-00003; Maples KR, 2001, FREE RADICAL RES, V34, P417, DOI 10.1080/10715760100300351; Maruyama J, 2008, NEUROBIOL DIS, V29, P14, DOI 10.1016/j.nbd.2007.07.026; MELICHAR L, 1980, HEARING RES, V2, P55, DOI 10.1016/0378-5955(80)90016-7; Miller JM, 2007, J NEUROSCI RES, V85, P1959, DOI 10.1002/jnr.21320; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Moller AR, 2006, HEARING ANATOMY PHYS, V2, P151; Mortazavi Seyedbagher, 2010, American Journal of Applied Sciences, V7, P201, DOI 10.3844/ajassp.2010.201.207; Nagase S, 2003, J NEUROCYTOL, V32, P353, DOI 10.1023/B:NEUR.0000011329.64948.82; Ohinata Y, 2000, BRAIN RES, V878, P163, DOI 10.1016/S0006-8993(00)02733-5; Ohinata Y, 2003, BRAIN RES, V966, P265, DOI 10.1016/S0006-8993(02)04205-1; Ohlemiller KK, 2007, HEARING RES, V224, P34, DOI 10.1016/j.heares.2006.11.005; Ohlemiller KK, 2008, HEARING RES, V245, P5, DOI 10.1016/j.heares.2008.08.007; Parham K, 2001, HANDBOOK OF MOUSE AUDITORY RESEARCH: FROM BEHAVIOR TO MOLECULAR BIOLOGY, P37; Peeling J, 2001, NEUROPHARMACOLOGY, V40, P433, DOI 10.1016/S0028-3908(00)00170-2; Pirvola U, 2000, J NEUROSCI, V20, P43, DOI 10.1523/JNEUROSCI.20-01-00043.2000; Ryan AF, 2016, OTOL NEUROTOL, V37, pE271, DOI 10.1097/MAO.0000000000001071; RYBAK LP, 1992, HEARING RES, V59, P189, DOI 10.1016/0378-5955(92)90115-4; Salt AN, 1997, HEARING RES, V1, P343; SPICER SS, 1991, HEARING RES, V56, P53, DOI 10.1016/0378-5955(91)90153-Z; Sydserff SG, 2002, BRIT J PHARMACOL, V135, P103, DOI 10.1038/sj.bjp.0704449; SYKA J, 1981, HEARING RES, V4, P287, DOI 10.1016/0378-5955(81)90013-7; Van Campen LE, 2002, HEARING RES, V164, P29, DOI 10.1016/S0378-5955(01)00391-4; WANG J, 1992, HEARING RES, V59, P31, DOI 10.1016/0378-5955(92)90099-9; Yamashita D, 2004, BRAIN RES, V1019, P201, DOI 10.1016/j.brainres.2004.05.104; Zhang YP, 2005, P NATL ACAD SCI USA, V102, P15201, DOI 10.1073/pnas.0501859102; Zhao HB, 2006, J MEMBRANE BIOL, V209, P177, DOI 10.1007/s00232-005-0832-x	63	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183089	10.1371/journal.pone.0183089	http://dx.doi.org/10.1371/journal.pone.0183089			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832600	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800045
J	Guerra-Carrillo, B; Katovich, K; Bunge, SA				Guerra-Carrillo, Belen; Katovich, Kiefer; Bunge, Silvia A.			Does higher education hone cognitive functioning and learning efficacy? Findings from a large and diverse sample	PLOS ONE			English	Article							LIFE-SPAN; IQ SCORES; INTELLIGENCE; ABILITIES; AGE; ACHIEVEMENT; ADOLESCENCE; PERFORMANCE; SKILLS	Attending school is a multifaceted experience. Students are not only exposed to new knowledge but are also immersed in a structured environment in which they need to respond flexibly in accordance with changing task goals, keep relevant information in mind, and constantly tackle novel problems. To quantify the cumulative effect of this experience, we examined retrospectively and prospectively, the relationships between educational attainment and both cognitive performance and learning. We analyzed data from 196,388 subscribers to an online cognitive training program. These subscribers, ages 15-60, had completed eight behavioral assessments of executive functioning and reasoning at least once. Controlling for multiple demographic and engagement variables, we found that higher levels of education predicted better performance across the full age range, and modulated performance in some cognitive domains more than others (e.g., reasoning vs. processing speed). Differences were moderate for Bachelor's degree vs. High School (d = 0.51), and large between Ph. D. vs. Some High School (d = 0.80). Further, the ages of peak cognitive performance for each educational category closely followed the typical range of ages at graduation. This result is consistent with a cumulative effect of recent educational experiences, as well as a decrement in performance as completion of schooling becomes more distant. To begin to characterize the directionality of the relationship between educational attainment and cognitive performance, we conducted a prospective longitudinal analysis. For a subset of 69,202 subscribers who had completed 100 days of cognitive training, we tested whether the degree of novel learning was associated with their level of education. Higher educational attainment predicted bigger gains, but the differences were small (d = 0.04-0.37). Altogether, these results point to the long-lasting trace of an effect of prior cognitive challenges but suggest that new learning opportunities can reduce performance gaps related to one's educational history.	[Guerra-Carrillo, Belen; Bunge, Silvia A.] Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Katovich, Kiefer] Gen Assembly Space Inc, San Francisco, CA USA; [Bunge, Silvia A.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley	Bunge, SA (corresponding author), Univ Calif Berkeley, Dept Psychol, 3210 Tolman Hall, Berkeley, CA 94720 USA.; Bunge, SA (corresponding author), Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	sbunge@berkeley.edu		Bunge, Silvia/0000-0001-8431-7627	Nationals Science Foundation Predoctoral Fellowship; James S. McDonnell Foundation 21st Century Science Initiative, Scholar Award in Understanding Human Cognition; General Assembly Space, Inc.	Nationals Science Foundation Predoctoral Fellowship; James S. McDonnell Foundation 21st Century Science Initiative, Scholar Award in Understanding Human Cognition; General Assembly Space, Inc.	B.G.C. was supported by a Nationals Science Foundation Predoctoral Fellowship. S.A.B. was supported by a James S. McDonnell Foundation 21st Century Science Initiative, Scholar Award in Understanding Human Cognition. General Assembly Space, Inc. provided support in the form of salary for K.K. The funders and employer had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2016, ED GLANC 2016 OECD I, DOI DOI 10.1787/EAG-2016-EN; Barrow L, 2015, ANNU REV ECON, V7, P519, DOI 10.1146/annurev-economics-080614-115510; Brinch CN, 2012, P NATL ACAD SCI USA, V109, P425, DOI 10.1073/pnas.1106077109; Cardak BA, 2009, ECON REC, V85, P433, DOI 10.1111/j.1475-4932.2009.00570.x; Cattell R. B., 1971, ABILITIES THEIR STRU; CECI SJ, 1991, DEV PSYCHOL, V27, P703, DOI 10.1037/0012-1649.27.5.703; Cliffordson C, 2008, INTELLIGENCE, V36, P143, DOI 10.1016/j.intell.2007.03.006; Deary IJ, 2007, INTELLIGENCE, V35, P13, DOI 10.1016/j.intell.2006.02.001; Diamond A, 2016, DEV COGN NEUROS-NETH, V18, P34, DOI 10.1016/j.dcn.2015.11.005; Falch T, 2011, ECON INQ, V49, P838, DOI 10.1111/j.1465-7295.2010.00312.x; Ferrer E, 2004, DEV PSYCHOL, V40, P935, DOI 10.1037/0012-1649.40.6.935; Ganguli M, 2010, AGING MENT HEALTH, V14, P100, DOI 10.1080/13607860903071014; Hansen KT, 2003, IZA DISCUSS PAP SER; Hardy JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134467; HARNQVIST K, 1968, SCAND J PSYCHOL, V9, P50, DOI 10.1111/j.1467-9450.1968.tb00518.x; Hartshorne JK, 2015, PSYCHOL SCI, V26, P433, DOI 10.1177/0956797614567339; Harvey L., 2000, TERT EDUC MANAG, V6, P3, DOI 10.1080/13583883.2000.9967007.; Kaufman AS, 2009, ARCH CLIN NEUROPSYCH, V24, P153, DOI 10.1093/arclin/acp015; Kuhn S., 2016, HDB PSYCHOL AGING, P105, DOI DOI 10.1016/B978-0-12-411469-2.00006-6; McArdle JJ, 2002, DEV PSYCHOL, V38, P115, DOI 10.1037//0012-1649.38.1.115; Morrow G, 2015, FRONT GENET, V6, DOI [10.3389/fgene.2015.00103, 10.3389/fpsyg.2015.01652]; Noble KG, 2013, DEVELOPMENTAL SCI, V16, P653, DOI 10.1111/desc.12077; Ritchie SJ, 2015, DEV PSYCHOL, V51, P573, DOI 10.1037/a0038981; Ritchie SJ, 2013, PSYCHOL AGING, V28, P515, DOI 10.1037/a0030820; Ryan C. L., 2016, CURRENT POPULATION R; SHIMAMURA AP, 1995, PSYCHOL SCI, V6, P271, DOI 10.1111/j.1467-9280.1995.tb00510.x; Steele CM, 1997, AM PSYCHOL, V52, P613, DOI 10.1037/0003-066X.52.6.613; WALBERG HJ, 1983, AM EDUC RES J, V20, P359, DOI 10.2307/1162605	28	51	51	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182276	10.1371/journal.pone.0182276	http://dx.doi.org/10.1371/journal.pone.0182276			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832590	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800019
J	Kim, A; Ashman, P; Ward-Peterson, M; Lozano, JM; Barengo, NC				Kim, Alice; Ashman, Peter; Ward-Peterson, Melissa; Lozano, Juan Manuel; Barengo, Noel C.			Racial disparities in cancer-related survival in patients with squamous cell carcinoma of the esophagus in the US between 1973 and 2013	PLOS ONE			English	Article							HEALTH-CARE ACCESS; MARITAL-STATUS; UNITED-STATES; MORTALITY; TRENDS; RACE	Background Esophageal cancer makes up approximately 1% of all diagnosed cancers in the US. There is a persistent disparity in incidence and cancer-related mortality rates among different races for esophageal squamous cell carcinoma (SCC). Most previous studies investigated racial disparities between black and white patients, occasionally examining disparities for Hispanic patients. Studies including Asians/Pacific Islanders (API) as a subgroup are rare. Our objective was to determine whether there is an association between race and cancerrelated survival in patients with esophageal SCC. Methods and findings This was a retrospective cohort study using the National Cancer Institute's Surveillance, Epidemiology, and End Result (SEER) database. The SEER registry is a national database that collects information on all incident cancer cases in 13 states of the United States and covers nearly 26% of the US population Patients aged 18 and over of White, Black, or Asian/Pacific Islander (API) race with diagnosed esophageal SCC from 1973 to 2013 were included (n = 13,857). To examine overall survival, Kaplan-Meier curves were estimated for each race and the log-rank test was used to compare survival distributions. Cox proportional hazards models were used to estimate unadjusted and adjusted hazard ratios with 95% confidence intervals. The final adjusted model controlled for sex, marital status, age at diagnosis, decade of diagnosis, ethnicity, stage at diagnosis, and form of treatment. Additional analyses stratified by decade of diagnosis were conducted to explore possible changes in survival disparities over time. After adjustment for potential confounders, black patients had a statistically significantly higher hazard ratio compared to white patients (HR 1.08; 95% confidence interval (CI) 1.03-1.13). However, API patients did not show a statistically significant difference in survival compared with white patients (HR 1.00; 95% CI 0.93-1.07). Patients diagnosed between 1973 and 1979 had twice the hazard of death compared to those diagnosed between 2000 and 2013 (HR 2.05, 95% CI 1.93-2.19). Patients diagnosed in 1980-1989 and 1990-1999 had had HRs of 1.59 (95% CI 1.51-1.68) and 1.33 (95% CI 1.26-1.41), respectively. After stratification according to decade of diagnosis, the HR for black patients compared with white patients was 1.14 (95% CI 1.02-1.29) in 1973-1979 and 1.12 (95% CI 1.03-1.23) in 1980-1989. These disparities were not observed after 1990; the HR for black patients compared with white patients was 1.03 (95% CI 0.93-1.13) in 1990-1999 and 1.05 (95% CI 0.96-1.15) in 2000-2013. Conclusions Black patients with esophageal SCC were found to have a higher hazard of death compared to white and API patients. Survival disparities between races appear to have decreased over time. Future research that takes insurance status and other social determinants of health into account should be conducted to further explore possible disparities by race.	[Kim, Alice; Ashman, Peter] Florida Int Univ, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Ward-Peterson, Melissa; Lozano, Juan Manuel; Barengo, Noel C.] Florida Int Univ, Dept Med & Hlth Sci Res, Herbert Wertheim Coll Med, Miami, FL 33199 USA; [Ward-Peterson, Melissa] Florida Int Univ, Dept Epidemiol, Robert Stempel Coll Publ Hlth & Social Work, Miami, FL 33199 USA	State University System of Florida; Florida International University; State University System of Florida; Florida International University; State University System of Florida; Florida International University	Barengo, NC (corresponding author), Florida Int Univ, Dept Med & Hlth Sci Res, Herbert Wertheim Coll Med, Miami, FL 33199 USA.	nbarengo@fiu.edu	Ward, Melissa K./AAJ-6016-2021	Ward, Melissa/0000-0001-9296-981X; Barengo, Noel C/0000-0003-0660-3091				BANG KM, 1988, CANCER, V61, P1255, DOI 10.1002/1097-0142(19880315)61:6<1255::AID-CNCR2820610634>3.0.CO;2-7; Baquet Claudia R, 2005, J Natl Med Assoc, V97, P1471; Bashash M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-164; Berry MF, 2014, J THORAC DIS, V6, pS289, DOI 10.3978/j.issn.2072-1439.2014.03.11; Brown LM, 2001, AM J EPIDEMIOL, V153, P114, DOI 10.1093/aje/153.2.114; Chen J, 2016, MED CARE, V54, P140, DOI 10.1097/MLR.0000000000000467; Clemans-Cope L, 2012, HEALTH AFFAIR, V31, P920, DOI 10.1377/hlthaff.2011.1086; Consuegra-Sanchez L, 2015, INT J CARDIOL, V185, P141, DOI 10.1016/j.ijcard.2015.03.113; Dominitz JA, 2002, MED CARE, V40, P14; Eslick GD, 2009, GASTROENTEROL CLIN N, V38, P1, DOI 10.1016/j.gtc.2009.01.003; Feagin J, 2014, SOC SCI MED, V103, P7, DOI 10.1016/j.socscimed.2013.09.006; Greenstein AJ, 2008, ANN SURG ONCOL, V15, P881, DOI 10.1245/s10434-007-9664-5; Jinjuvadia R, 2013, DIGEST DIS SCI, V58, P236, DOI 10.1007/s10620-012-2312-3; McLaren PJ, 2017, WORLD J SURG, V41, P1712, DOI 10.1007/s00268-017-3958-y; Miller JAG, 2004, AM J SURG, V188, P22, DOI 10.1016/j.amjsurg.2003.12.055; Polednak AP, 2004, J NATL MED ASSOC, V96, P87; Quinones PA, 2015, PREV MED, V75, P25, DOI 10.1016/j.ypmed.2015.03.013; Revels SL, 2013, ANN SURG ONCOL, V20, P1136, DOI 10.1245/s10434-012-2807-3; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Robards J, 2012, MATURITAS, V73, P295, DOI 10.1016/j.maturitas.2012.08.007; SCHOENBERG BS, 1971, JNCI-J NATL CANCER I, V46, P63; Schoenborn C., 2004, CDC ADV DATA FROM VI, V351, P2; Sealy-Jefferson S, 2015, J RACIAL ETHN HEALTH, V2, P583, DOI 10.1007/s40615-015-0113-z; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Smedley B, 2002, UNEQUAL TREATMENT CO, P125; Surveillance Epidemiology and Results Program, EP RES PROGR; Va P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026600; Younes M, 2002, SCAND J GASTROENTERO, V37, P1359, DOI 10.1080/003655202762671215	28	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183782	10.1371/journal.pone.0183782	http://dx.doi.org/10.1371/journal.pone.0183782			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832659	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800101
J	Mabuchi, F; Mabuchi, N; Sakurada, Y; Yoneyama, S; Kashiwagi, K; Iijima, H; Yamagata, Z; Takamoto, M; Aihara, M; Iwata, T; Kawase, K; Shiga, Y; Nishiguchi, KM; Nakazawa, T; Ozaki, M; Araie, M				Mabuchi, Fumihiko; Mabuchi, Nakako; Sakurada, Yoichi; Yoneyama, Seigo; Kashiwagi, Kenji; Iijima, Hiroyuki; Yamagata, Zentaro; Takamoto, Mitsuko; Aihara, Makoto; Iwata, Takeshi; Kawase, Kazuhide; Shiga, Yukihiro; Nishiguchi, Koji M.; Nakazawa, Toru; Ozaki, Mineo; Araie, Makoto		Japan Glaucoma Soc Omics Grp J	Additive effects of genetic variants associated with intraocular pressure in primary open-angle glaucoma	PLOS ONE			English	Article							TO-DISC RATIO; GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RISK-FACTORS; FAMILY-HISTORY; POPULATION; HERITABILITY; PREVALENCE; EYE; SUSCEPTIBILITY	To investigate the association between the additive effects of genetic variants associated with intraocular pressure (IOP) and IOP, vertical cup-to-disc ratio (VCDR), and high tension glaucoma (HTG) or normal tension glaucoma (NTG) as phenotypic features of primary open-angle glaucoma (POAG), and to evaluate the clinical usefulness of the additive effects of IOP-related genetic variants for predicting IOP elevation, Japanese patients with HTG (n = 255) and NTG (n = 261) and 246 control subjects were genotyped for nine IOP-related genetic variants near CAV2, GAS7, GLCCI1/ICA1, ABCA1, ARHGEF12, FAM125B, FNDC3B, ABO, and PTPRJ/AGBL2. The total number of risk alleles of these genetic variants was calculated for each participant as a genetic risk score (GRS), and the association between the GRS and the maximum IOP, mean VCDR, and phenotype (HTG or NTG) of POAG was evaluated. As the GRS increased, the maximum IOP (P = 0.012) and VCDR (P = 0.010) significantly increased. The GRS (9.1 +/- 1.9) in patients with HTG was significantly higher (P = 0.011) than that (8.7 +/- 1.8) in control subjects. The patients with GRS >= 12 as a cut-off value had a 2.54 times higher (P = 0.0085) risk on HTG (maximum IOP >= 22mmHg) compared with all patients. The IOP-related GRS approach substantiated that the IOP and VCDR were increased by the additive effects of IOP-related genetic variants in POAG. The high IOP-related GRS in patients with HTG but not NTG shows that there are differences in the genetic background between HTG and NTG and supports the notion that the phenotype (HTG or NTG) in patients with POAG depends on the additive effects of IOP-related genetic variants. The above-mentioned cut-off value of IOP-related GRS may be clinically useful for predicting the risk of IOP elevation.	[Mabuchi, Fumihiko; Mabuchi, Nakako; Sakurada, Yoichi; Yoneyama, Seigo; Kashiwagi, Kenji; Iijima, Hiroyuki] Univ Yamanashi, Dept Ophthalmol, Fac Med, Yamanashi, Japan; [Yamagata, Zentaro] Univ Yamanashi, Dept Hlth Sci, Fac Med, Yamanashi, Japan; [Takamoto, Mitsuko] Tokyo Metropolitan Police Hosp, Dept Ophthalmol, Tokyo, Japan; [Aihara, Makoto] Univ Tokyo, Grad Sch Med, Dept Ophthalmol, Tokyo, Japan; [Iwata, Takeshi] Natl Hosp Org Tokyo Med Ctr, Natl Inst Sensory Organs, Div Mol & Cellular Biol, Tokyo, Japan; [Kawase, Kazuhide] Gifu Univ Hosp, Gifu, Japan; [Shiga, Yukihiro; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi, Japan; [Nishiguchi, Koji M.; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Adv Ophthalm Med, Sendai, Miyagi, Japan; [Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Retinal Dis Control, Sendai, Miyagi, Japan; [Ozaki, Mineo] Ozaki Eye Hosp, Miyazaki, Japan; [Araie, Makoto] Kanto Cent Hosp, Mutual Aid Assoc Publ Sch Teachers, Tokyo, Japan	University of Yamanashi; University of Yamanashi; University of Tokyo; Gifu University; Tohoku University; Tohoku University; Tohoku University	Mabuchi, F (corresponding author), Univ Yamanashi, Dept Ophthalmol, Fac Med, Yamanashi, Japan.	fmabuchi@yamanashi.ac.jp		Mabuchi, Fumihiko/0000-0003-0927-3868	Japan Society for the Promotion of Science (JSPS; KAKENHI [15K10861]; Grants-in-Aid for Scientific Research [15K10861] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	FM has been supported in part by Japan Society for the Promotion of Science (JSPS, URLs http://www.jsps.go.jp) KAKENHI Grant Number 15K10861. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DR, 1989, AM J OPHTHALMOL, V108, P485, DOI 10.1016/0002-9394(89)90423-6; Balasubbu S, 2012, INVEST OPHTH VIS SCI, V53, P1861, DOI 10.1167/iovs.11-8602; Burdon KP, 2011, NAT GENET, V43, P574, DOI 10.1038/ng.824; Carbonaro F, 2008, BRIT J OPHTHALMOL, V92, P1125, DOI 10.1136/bjo.2007.133272; Chang TC, 2005, OPHTHALMOLOGY, V112, P1186, DOI 10.1016/j.ophtha.2005.03.006; Charlesworth J, 2010, INVEST OPHTH VIS SCI, V51, P3509, DOI 10.1167/iovs.09-4786; Chen YH, 2015, INVEST OPHTH VIS SCI, V56, P2595, DOI 10.1167/iovs.14-16269; Chen YH, 2014, NAT GENET, V46, P1115, DOI 10.1038/ng.3078; Donnelly P, 2013, HUM MOL GENET, V22, P4653, DOI 10.1093/hmg/ddt293; Freeman EE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055573; Gharahkhani P, 2014, NAT GENET, V46, P1120, DOI 10.1038/ng.3079; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Hysi PG, 2014, NAT GENET, V46, P1126, DOI 10.1038/ng.3087; Iwase A, 2004, OPHTHALMOLOGY, V111, P1641, DOI 10.1016/j.ophtha.2004.03.029; Jiao XD, 2009, P NATL ACAD SCI USA, V106, P17105, DOI 10.1073/pnas.0907564106; Keltner JL, 2006, OPHTHALMOLOGY, V113, P1603, DOI 10.1016/j.ophtha.2006.05.061; Kim NR, 2014, JAMA OPHTHALMOL, V132, P278, DOI 10.1001/jamaophthalmol.2013.7612; Klein BEK, 2004, INVEST OPHTH VIS SCI, V45, P59, DOI 10.1167/iovs.03-0516; Lee MK, 2012, OPHTHALMOLOGY, V119, P450, DOI 10.1016/j.ophtha.2011.09.016; LESKE MC, 1995, ARCH OPHTHALMOL-CHIC, V113, P918, DOI 10.1001/archopht.1995.01100070092031; Liu YT, 2010, P NATL ACAD SCI USA, V107, pE61, DOI 10.1073/pnas.0913838107; Mabuchi F, 2015, AM J OPHTHALMOL, V159, P437, DOI 10.1016/j.ajo.2014.11.023; Mabuchi F, 2010, P NATL ACAD SCI USA, V107, pE90, DOI 10.1073/pnas.0914903107; Micheal S, 2014, MOL VIS, V20, P1471; Miglior S, 2007, OPHTHALMOLOGY, V114, P3, DOI 10.1016/j.ophtha.2006.05.075; Nag A, 2014, HUM MOL GENET, V23, P3343, DOI 10.1093/hmg/ddu050; Ramdas WD, 2011, OPHTHALMOLOGY, V118, P2389, DOI 10.1016/j.ophtha.2011.05.040; Ramdas WD, 2011, HUM MOL GENET, V20, P2464, DOI 10.1093/hmg/ddr120; Ramdas WD, 2011, J MED GENET, V48, P190, DOI 10.1136/jmg.2010.083337; Ramdas WD, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000978; Scheetz TE, 2016, OPHTHALMOLOGY; Springelkamp H, 2015, HUM MOL GENET, V24, P2689, DOI 10.1093/hmg/ddv027; Springelkamp H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5883; Sun J, 2012, EYE, V26, P283, DOI 10.1038/eye.2011.243; Tham YC, 2015, OPHTHALMOLOGY, V122, P1149, DOI 10.1016/j.ophtha.2015.01.024; Thorleifsson G, 2010, NAT GENET, V42, P906, DOI 10.1038/ng.661; TIELSCH JM, 1994, ARCH OPHTHALMOL-CHIC, V112, P69, DOI 10.1001/archopht.1994.01090130079022; van Koolwijk LME, 2007, INVEST OPHTH VIS SCI, V48, P3669, DOI 10.1167/iovs.06-1519; van Koolwijk LME, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002611; Weih LM, 2001, OPHTHALMOLOGY, V108, P1966, DOI 10.1016/S0161-6420(01)00799-0; Wolfs RCW, 1998, ARCH OPHTHALMOL-CHIC, V116, P1640, DOI 10.1001/archopht.116.12.1640	41	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183709	10.1371/journal.pone.0183709	http://dx.doi.org/10.1371/journal.pone.0183709			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832686	Green Published, gold			2022-12-27	WOS:000408355800090
J	Zararsiz, G; Goksuluk, D; Korkmaz, S; Eldem, V; Zararsiz, GE; Duru, IP; Ozturk, A				Zararsiz, Gokmen; Goksuluk, Dincer; Korkmaz, Selcuk; Eldem, Vahap; Zararsiz, Gozde Erturk; Duru, Izzet Parug; Ozturk, Ahmet			A comprehensive simulation study on classification of RNA-Seq data	PLOS ONE			English	Article							BIOCONDUCTOR PACKAGE; MODELS	RNA sequencing (RNA-Seq) is a powerful technique for the gene-expression profiling of organisms that uses the capabilities of next-generation sequencing technologies. Developing gene-expression-based classification algorithms is an emerging powerful method for diagnosis, disease classification and monitoring at molecular level, as well as providing potential markers of diseases. Most of the statistical methods proposed for the classification of gene-expression data are either based on a continuous scale (eg. microarray data) or require a normal distribution assumption. Hence, these methods cannot be directly applied to RNASeq data since they violate both data structure and distributional assumptions. However, it is possible to apply these algorithms with appropriate modifications to RNA-Seq data. One way is to develop count-based classifiers, such as Poisson linear discriminant analysis and negative binomial linear discriminant analysis. Another way is to bring the data closer to microarrays and apply microarray-based classifiers. In this study, we compared several classifiers including PLDA with and without power transformation, NBLDA, single SVM, bagging SVM (bagSVM), classification and regression trees (CART), and random forests (RF). We also examined the effect of several parameters such as overdispersion, sample size, number of genes, number of classes, differential-expression rate, and the transformation method on model performances. A comprehensive simulation study is conducted and the results are compared with the results of two miRNA and two mRNA experimental datasets. The results revealed that increasing the sample size, differential-expression rate and decreasing the dispersion parameter and number of groups lead to an increase in classification accuracy. Similar with differential-expression studies, the classification of RNA-Seq data requires careful attention when handling data overdispersion. We conclude that, as a count-based classifier, the power transformed PLDA and, as a microarray-based classifier, vst or rlog transformed RF and SVM classifiers may be a good choice for classification. An R/BIOCONDUCTOR package, MLSeq, is freely available at https://www. bioconductor. org/packages/release/bioc/ html/MLSeq. html.	[Zararsiz, Gokmen; Goksuluk, Dincer; Korkmaz, Selcuk] Turcosa Analyt Solut Ltd Co, Erciyes Teknopk, TR-38039 Kayseri, Turkey; [Zararsiz, Gokmen; Zararsiz, Gozde Erturk; Ozturk, Ahmet] Erciyes Univ, Dept Biostat, Kayseri, Turkey; [Goksuluk, Dincer; Korkmaz, Selcuk] Hacettepe Univ, Dept Biostat, Ankara, Turkey; [Eldem, Vahap] Istanbul Univ, Dept Biol, Istanbul, Turkey; [Duru, Izzet Parug] Marmara Univ, Dept Phys, Istanbul, Turkey	Erciyes Teknopark; Erciyes University; Hacettepe University; Istanbul University; Marmara University	Zararsiz, G (corresponding author), Turcosa Analyt Solut Ltd Co, Erciyes Teknopk, TR-38039 Kayseri, Turkey.; Zararsiz, G (corresponding author), Erciyes Univ, Dept Biostat, Kayseri, Turkey.	gokmenzararsiz@erciyes.edu.tr	Zararsız, Gözde/AAH-2073-2019; Zararsız, Gökmen/E-8818-2013; Korkmaz, Selçuk/AAU-4677-2020; Eldem, Vahap/A-9160-2018; Ozturk, Ahmet/M-6564-2014; GOKSULUK, Dincer/E-9175-2013; Unver, Turgay/B-4819-2009; ZARARSIZ, GOKMEN/ABH-7959-2020; Duru, İzzet Paruğ/A-9640-2019	Zararsız, Gözde/0000-0002-5495-7540; Zararsız, Gökmen/0000-0001-5801-1835; Korkmaz, Selçuk/0000-0003-4632-6850; Eldem, Vahap/0000-0003-3767-5661; Ozturk, Ahmet/0000-0002-7130-5624; GOKSULUK, Dincer/0000-0002-2752-7668; Unver, Turgay/0000-0001-6760-443X; Duru, İzzet Paruğ/0000-0002-9227-2497	Research Fund of Erciyes University [TDK-2015-5468]	Research Fund of Erciyes University(Erciyes University)	This work was supported by the Research Fund of Erciyes University [TDK-2015-5468]. The authors declare that they have no competing interests.	Anand A, 2009, J THEOR BIOL, V259, P533, DOI 10.1016/j.jtbi.2009.04.013; Anders S., 2012, DIFFERENTIAL EXPRESS, DOI DOI 1016/j.jtbi.2009.04.013PMID:19406131; Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Auer PL, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1627; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2017, CLASSIFICATION REGRE; Bullard JH, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-94; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Di YM, 2011, STAT APPL GENET MOL, V10, DOI 10.2202/1544-6115.1637; Diaz-Uriarte R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-3; Ding C, 2003, P COMP SYST BIOINF C; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dong K, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1208-1; Dudoit S, 2003, INTERDISC STAT, P93; Dudoit S., 2001, J AM STAT ASSOC, V96, P1151; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; George G, ARXIV11091062; Goyal R, 2013, ARCH PATHOL LAB MED, V137, P467, DOI 10.5858/arpa.2012-0085-RA; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Korkmaz S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124600; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Lee ZJ, 2008, ARTIF INTELL MED, V42, P81, DOI 10.1016/j.artmed.2007.09.004; Leidinger P, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r78; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, MODERATED ESTIMATION; Morgan M, 2009, BIOINFORMATICS, V25, P2607, DOI 10.1093/bioinformatics/btp450; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441; Okun O, 2007, LECT NOTES COMPUT SC, V4478, P483; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rapaport F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-35; Robinson MD, 2007, BIOINFORMATICS, V23, P2881, DOI 10.1093/bioinformatics/btm453; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saleem M., 2013, PROC 9 INT C SEMANTI, P129, DOI DOI 10.1145/2506182.2506200; Shrestha RK, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-33; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Statnikov A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-319; Vapnik V. N., 2000, NATURE STAT LEARNING, DOI DOI 10.1007/978-1-4757-3264-1_1; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq622; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Witten D, 2013, POICLACLU CLASSIFICA; Witten D, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-58; Witten DM, 2011, ANN APPL STAT, V5, P2493, DOI 10.1214/11-AOAS493; Xing E.P., 2001, ICML CITESEER, V1, P601; Yu DN, 2013, BIOINFORMATICS, V29, P1275, DOI 10.1093/bioinformatics/btt143; Zhou YH, 2011, BIOINFORMATICS, V27, P2672, DOI 10.1093/bioinformatics/btr449; Zhu J, 2004, BIOSTATISTICS, V5, P427, DOI 10.1093/biostatistics/kxg046	52	18	18	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182507	10.1371/journal.pone.0182507	http://dx.doi.org/10.1371/journal.pone.0182507			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832679	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800026
J	Mwau, M; Bwana, P; Kithinji, L; Ogollah, F; Ochieng, S; Akinyi, C; Adhiambo, M; Ogumbo, F; Sirengo, M; Boeke, C				Mwau, Matilu; Bwana, Priska; Kithinji, Lucy; Ogollah, Francis; Ochieng, Samuel; Akinyi, Catherine; Adhiambo, Maureen; Ogumbo, Fred; Sirengo, Martin; Boeke, Caroline			Mother-to-child transmission of HIV in Kenya: A cross-sectional analysis of the national database over nine years	PLOS ONE			English	Article							EARLY INFANT DIAGNOSIS; RANDOMIZED CONTROLLED-TRIAL; HEALTH SYSTEM; PREVENTION; WOMEN; RISK; CARE; INFECTION; DELIVERY; COMMUNITY	Objective To describe factors associated with mother-to-child HIV transmission (MTCT) in Kenya and identify opportunities to increase testing/care coverage. Design Cross-sectional analysis of national early infant diagnosis (EID) database. Methods 365,841 Kenyan infants were tested for HIV from January 2007-July 2015 and results, demographics, and treatment information were entered into a national database. HIV risk factors were assessed using multivariable logistic regression. Results 11.1% of infants tested HIV positive in 2007 - 2010 and 6.9% in 2014 - 2015. Greater odds of infection were observed in females (OR: 1.08; 95% CI: 1.05 - 1.11), older children (18 - 24 months vs. 6 weeks-2 months: 4.26; 95% CI: 3.87 - 4.69), infants whose mothers received no PMTCT intervention (vs. HAART OR: 1.92; 95% CI: 1.79 - 2.06), infants receiving no prophylaxis (vs. nevirapine for 6 weeks OR: 2.76; 95% CI: 2.51 - 3.05), and infants mixed breastfed (vs. exclusive breastfeeding OR: 1.39; 95% CI: 1.30 - 1.49). In 2014 - 2015, 9.1% of infants had mothers who were not on treatment during pregnancy, 9.8% were not on prophylaxis, and 7.0% were mixed breastfed. Infants exposed to all three risky practices had a sevenfold higher odds of HIV infection compared to those exposed to recommended practices. The highest yield of HIV-positive infants were found through targeted testing of symptomatic infants in pediatric/outpatient departments (>15%); still, most infected infants were identified through PMTCT programs. Conclusion Despite impressive gains in Kenya's PMTCT program, some HIV-infected infants present late and are not benefitting from PMTCT best practices. Efforts to identify these early and enforce evidence-based practice for PMTCT should be scaled up. Infant testing should be expanded in pediatric/outpatient departments, given high yields in these portals.	[Mwau, Matilu; Akinyi, Catherine; Adhiambo, Maureen; Ogumbo, Fred] Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya; [Mwau, Matilu; Bwana, Priska; Kithinji, Lucy; Ogollah, Francis; Ochieng, Samuel] Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya; [Sirengo, Martin] Minist Hlth, Natl AIDS & STIs Control Program, Nairobi, Kenya; [Boeke, Caroline] Clinton Hlth Access Initiat, Boston, MA USA	Kenya Medical Research Institute; Kenya Medical Research Institute	Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Ctr Infect & Parasit Dis Control Res, Busia, Kenya.; Mwau, M (corresponding author), Kenya Govt Med Res Ctr, Ctr Virus Res, Nairobi, Kenya.	mmwau@kemri.org	Ogumbo, Fredrick/AAO-6964-2021	Ogumbo, Fredrick/0000-0002-5699-5591	Centers for Disease Control and Prevention (CDC); USAID/PEPFAR; UNITAID; Hewlett-Packard	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); USAID/PEPFAR(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); UNITAID; Hewlett-Packard	The authors wish to thank the Centers for Disease Control and Prevention (CDC), USAID/PEPFAR, and UNITAID for funding HIV diagnostics in Kenya. The IT infrastructure was funded by Hewlett-Packard. None of the funders had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank the Centers for Disease Control and Prevention (CDC), USAID/PEPFAR, and UNITAID for funding HIV diagnostics in Kenya, as well as the Clinton Health Access Initiative for technical support.	Ambia J, 2016, J INT AIDS SOC, V19, DOI 10.7448/IAS.19.1.20309; [Anonymous], 2000, BMJ, V320, P14681; [Anonymous], 2016, THAIL IS 1 COUNTR AS; [Anonymous], 2014, KENYA AIDS RESP PROG; Becquet R, 2008, PREV MED, V47, P27, DOI 10.1016/j.ypmed.2007.11.014; Biggar RJ, 2006, JAIDS-J ACQ IMM DEF, V41, P509, DOI 10.1097/01.qai.0000191283.85578.46; Bosire R, 2016, BREASTFEED MED, V11, P56, DOI 10.1089/bfm.2015.0071; Brahmbhatt H, 2009, J PEDIAT INF DIS-GER, V4, P275, DOI 10.3233/JPI-2009-0168; Chang J, 2014, J VIROL METHODS, V204, P25, DOI 10.1016/j.jviromet.2014.03.010; Cooper ER, 2002, J ACQ IMMUN DEF SYND, V29, P484, DOI 10.1097/00126334-200204150-00009; Dillabaugh LL, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/602120; Finocchario-Kessler S, 2014, AIDS, V28, pS313, DOI 10.1097/QAD.0000000000000332; Fowler MG, 2008, PLOS MED, V5, P359, DOI 10.1371/journal.pmed.0050063; Galli L, 2005, JAIDS-J ACQ IMM DEF, V40, P479, DOI 10.1097/01.qai.0000164247.49098.0e; Goggin K, 2016, AIDS BEHAV, V20, P2141, DOI 10.1007/s10461-016-1404-z; Goldstein M, 2013, AM ECON J-APPL ECON, V5, P58, DOI 10.1257/app.5.2.58; Hassan AS, 2012, AIDS BEHAV, V16, P5, DOI 10.1007/s10461-010-9877-7; IATT, 2016, INT TASK TEAM PREV T; Jennings L, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1131; Kageha S, 2012, J TROP PEDIATRICS, V58, P247, DOI 10.1093/tropej/fmr076; Kinuthia J, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0467-6; KNBS, 2014, KENYA DEM HLTH SURV; Lofgren SM, 2009, AIDS, V23, P2459, DOI 10.1097/QAD.0b013e328331f702; Lowther K, 2016, AIDS CARE, V28, P60, DOI 10.1080/09540121.2016.1146214; Luque-Fernandez MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056088; Ministry of Health Government of Kenya, 2012, GUIDELINES PREVENTIO, V4th ed; Mushamiri I, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1358-5; NASCOP, 2015, KENYA HIV TEST SERV; Newell ML, 2004, LANCET, V364, P1236, DOI 10.1016/S0140-6736(04)17140-7; Obermeyer CM, 2013, TROP MED INT HEALTH, V18, P1110, DOI 10.1111/tmi.12155; Odeny BM, 2016, BREASTFEED MED, V11, P252, DOI 10.1089/bfm.2016.0014; Okanda JO, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-280; Onono M, 2015, AIDS PATIENT CARE ST, V29, P204, DOI 10.1089/apc.2014.0181; Piwoz EG, 2005, AIDS, V19, P1719, DOI 10.1097/01.aids.0000184745.12338.21; Rustagi AS, 2016, J ACQUIR IMMUNE DEFI; Sharma M, 2015, NATURE, V528, pS77, DOI 10.1038/nature16044; Tao Z, 2010, J BIOL CHEM, V285, P17725, DOI 10.1074/jbc.M110.121798; Turan JM, 2015, JAIDS-J ACQ IMM DEF, V69, pe172, DOI 10.1097/QAI.0000000000000678; UNAIDS/WHO, 2013, UNAIDS REP GLOB AIDS; Wise J, 2001, BRIT MED J, V322, P511; World Health Organization, 2016, CONS GUID US ANT DRU	41	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183860	10.1371/journal.pone.0183860	http://dx.doi.org/10.1371/journal.pone.0183860			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850581	gold, Green Published, Green Submitted			2022-12-27	WOS:000408544200035
J	Lee, B; Song, T; Lee, K; Kim, J; Berggren, PO; Ryu, SH; Jo, J				Lee, Boah; Song, Taegeun; Lee, Kayoung; Kim, Jaeyoon; Berggren, Per-Olof; Ryu, Sung Ho; Jo, Junghyo			Insulin modulates the frequency of Ca2+ oscillations in mouse pancreatic islets	PLOS ONE			English	Article							BETA-CELLS; SECRETION; GLUCOSE; ENTRAINMENT; LANGERHANS; RECEPTOR; CALCIUM; SINGLE; SYNCHRONIZATION; DESENSITIZATION	Pancreatic islets can adapt to oscillatory glucose to produce synchronous insulin pulses. Can islets adapt to other oscillatory stimuli, specifically insulin? To answer this question, we stimulated islets with pulses of exogenous insulin and measured their Ca2+ oscillations. We observed that sufficiently high insulin (>500 nM) with an optimal pulse period (similar to 4 min) could make islets to produce synchronous Ca2+ oscillations. Glucose and insulin, which are key stimulatory factors of islets, modulate islet Ca2+ oscillations differently. Glucose increases the active-to-silent ratio of phases, whereas insulin increases the period of the oscillation. To examine the dual modulation, we adopted a phase oscillator model that incorporated the phase and frequency modulations. This mathematical model showed that out-of-phase oscillations of glucose and insulin were more effective at synchronizing islet Ca2+ oscillations than in-phase stimuli. This finding suggests that a phase shift in glucose and insulin oscillations can enhance inter-islet synchronization.	[Lee, Boah] Pohang Univ Sci & Technol, Dept Life Sci, Pohang, Gyeongbuk, South Korea; [Song, Taegeun; Jo, Junghyo] Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea; [Lee, Kayoung; Kim, Jaeyoon; Berggren, Per-Olof; Ryu, Sung Ho] Pohang Univ Sci & Technol, Sch Interdisciplinary Biosci & Bioengn, Pohang, Gyeongbuk, South Korea; [Berggren, Per-Olof] Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Stockholm, Sweden; [Jo, Junghyo] Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea	Pohang University of Science & Technology (POSTECH); Asia Pacific Center for Theoretical Physics; Pohang University of Science & Technology (POSTECH); Karolinska Institutet; Pohang University of Science & Technology (POSTECH)	Jo, J (corresponding author), Asia Pacific Ctr Theoret Phys, Pohang, Gyeongbuk, South Korea.; Jo, J (corresponding author), Pohang Univ Sci & Technol, Dept Phys, Pohang, Gyeongbuk, South Korea.	jojunghyo@apctp.org		Berggren, Per-Olof/0000-0001-8991-413X; Song, Taegeun/0000-0002-1511-6626	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A1B03932264]; Max Planck Society; Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; NRF - Ministry of Science, ICT & Future Planning [2016K1A1A2912722]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Max Planck Society(Max Planck Society); Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City; NRF - Ministry of Science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF, www.nrf.re.kr), funded by the Ministry of Education (2016R1D1A1B03932264), the Max Planck Society, and the Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), and by the NRF funded by the Ministry of Science, ICT & Future Planning (2016K1A1A2912722) (S.R.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education (2016R1D1A 1B03932264), the Max Planck Society, and the Korean Ministry of Education, Science and Technology, Gyeongsangbuk-Do and Pohang City (J.J.), and by the NRF funded by the Ministry of Science, ICT & Future Planning (2016K1A1A2912722) (S.R.).	Aspinwall CA, 1999, J BIOL CHEM, V274, P6360, DOI 10.1074/jbc.274.10.6360; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Barbosa RM, 1998, J PHYSIOL-LONDON, V510, P135, DOI 10.1111/j.1469-7793.1998.135bz.x; BERGGREN PO, 1994, BIOCHEM SOC T, V22, P12, DOI 10.1042/bst0220012; BERGGREN PO, 1993, ADV EXP MED BIOL, V334, P25; Bertram R, 2004, BIOPHYS J, V87, P3074, DOI 10.1529/biophysj.104.049262; Bertram R, 2007, AM J PHYSIOL-ENDOC M, V293, pE890, DOI 10.1152/ajpendo.00359.2007; Braun M, 2012, DIABETES OBES METAB, V14, P143, DOI 10.1111/j.1463-1326.2012.01642.x; Dhumpa R, 2015, INTEGR BIOL-UK, V7, P1061, DOI 10.1039/c5ib00156k; Dhumpa R, 2014, BIOPHYS J, V106, P2275, DOI 10.1016/j.bpj.2014.04.015; Gilon P, 2002, DIABETES, V51, pS144, DOI 10.2337/diabetes.51.2007.S144; Goldbeter A., 1996, BIOCH OSCILLATIONS C, Vxxiv; HOM FG, 1981, AM J PHYSIOL, V240, pE1, DOI 10.1152/ajpendo.1981.240.1.E1; Hussain MA, 1999, EUR J ENDOCRINOL, V141, P95, DOI 10.1530/eje.0.1410095; Jimenez-Feltstrom J, 2004, REGUL PEPTIDES, V122, P109, DOI 10.1016/j.regpep.2004.06.004; Johnson JD, 2002, P NATL ACAD SCI USA, V99, P14566, DOI 10.1073/pnas.222099799; KARLSSON FA, 1979, P NATL ACAD SCI USA, V76, P809, DOI 10.1073/pnas.76.2.809; Khan FA, 2001, DIABETES, V50, P2192, DOI 10.2337/diabetes.50.10.2192; Koh DS, 2012, J MOL NEUROSCI, V48, P429, DOI 10.1007/s12031-012-9752-2; LANG DA, 1979, NEW ENGL J MED, V301, P1023, DOI 10.1056/NEJM197911083011903; Lee B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172901; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; LI YX, 1992, BIOPHYS J, V61, P161, DOI 10.1016/S0006-3495(92)81824-6; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; McKenna JP, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005143; Nunemaker CS, 2006, BIOPHYS J, V91, P2082, DOI 10.1529/biophysj.106.087296; Pedersen MG, 2013, BIOPHYS J, V105, P29, DOI 10.1016/j.bpj.2013.05.036; Press WH., 2002, NUMERICAL RECIPES C, V2; Rhodes CJ, 2013, DIABETES, V62, P2157, DOI 10.2337/db13-0246; Rosenblum R, 2001, NEUROINFORMATICS NEU, P279; SHINOMOTO S, 1986, PROG THEOR PHYS, V75, P1105, DOI 10.1143/PTP.75.1105; STURIS J, 1991, J CLIN INVEST, V87, P439, DOI 10.1172/JCI115015; Ueki K, 2006, NAT GENET, V38, P583, DOI 10.1038/ng1787; Zarkovic M, 2004, AM J PHYSIOL-ENDOC M, V287, pE340, DOI 10.1152/ajpendo.00069.2004; Zhang XY, 2011, AM J PHYSIOL-ENDOC M, V301, pE742, DOI 10.1152/ajpendo.00248.2011	35	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183569	10.1371/journal.pone.0183569	http://dx.doi.org/10.1371/journal.pone.0183569			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846705	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600036
J	Fryer, CS; Seaman, EL; Clark, RS; Clark, VLP				Fryer, Craig S.; Seaman, Elizabeth L.; Clark, Rachael S.; Clark, Vicki L. Plano			Mixed methods research in tobacco control with youth and young adults: A methodological review of current strategies	PLOS ONE			English	Review							SMOKING-CESSATION; ADOLESCENTS; SERVICES; INTERVENTION; PERCEPTIONS; PREVALENCE; ADDICTION; ATTITUDES; CHILDREN; SMOKERS	Introduction Tobacco use among young people is a complex and serious global dilemma that demands innovative and diverse research approaches. The purpose of this methodological review was to examine the current use of mixed methods research in tobacco control with youth and young adult populations and to develop practical recommendations for tobacco control researchers interested in this methodology. Methods Using PubMed, we searched five peer-reviewed journals that publish tobacco control empirical literature for the use of mixed methods research to study young populations, age 12-25 years. Our team analyzed the features of each article in terms of tobacco control topic, population, youth engagement strategies, and several essential elements of mixed methods research. Results We identified 23 mixed methods studies published by authors from five different countries reported between 2004 and 2015. These 23 articles examined various topics that included tobacco use behavior, tobacco marketing and branding, and cessation among youth and young adults. The most common mixed methods approach was variations of the concurrent design in which the qualitative and quantitative strands were administered at the same time and given equal priority. This review documented several innovative applications of mixed methods research as well as challenges in the reporting of the complex research designs. Conclusions The use of mixed methods research in tobacco control has great potential for advancing the understanding of complex behavioral and sociocultural issues for all groups, especially youth and young adults.	[Fryer, Craig S.; Seaman, Elizabeth L.] Univ Maryland, Dept Behav & Community Hlth, Sch Publ Hlth, College Pk, MD 20742 USA; [Fryer, Craig S.] Univ Maryland, Maryland Ctr Hlth Equ, Sch Publ Hlth, College Pk, MD 20742 USA; [Clark, Rachael S.; Clark, Vicki L. Plano] Univ Cincinnati, Sch Educ, Educ Studies, Cincinnati, OH USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Ohio; University of Cincinnati	Fryer, CS (corresponding author), Univ Maryland, Dept Behav & Community Hlth, Sch Publ Hlth, College Pk, MD 20742 USA.; Fryer, CS (corresponding author), Univ Maryland, Maryland Ctr Hlth Equ, Sch Publ Hlth, College Pk, MD 20742 USA.	csfryer@umd.edu	Clark, Rachael S./I-8605-2019; Fryer, Craig/N-1744-2014	Clark, Rachael S./0000-0002-2725-3257; Seaman, Elizabeth L./0000-0001-5218-4540; Fryer, Craig/0000-0002-1125-3578; Plano Clark, Vicki/0000-0002-9709-7982	National Institutes of Health (NIH)/National Cancer Institute (NCI) [K01CA148789: CSF Principal Investigator]; NATIONAL CANCER INSTITUTE [K01CA148789] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the National Institutes of Health (NIH)/National Cancer Institute (NCI) by grant # K01CA148789: CSF Principal Investigator. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acosta MC, 2008, ADDICT BEHAV, V33, P106, DOI 10.1016/j.addbeh.2007.09.005; Alise MA, 2010, J MIX METHOD RES, V4, P103, DOI 10.1177/1558689809360805; Amos A, 2006, HEALTH EDUC RES, V21, P181, DOI 10.1093/her/cyh054; [Anonymous], 2013, TOB US MIDDL HIGH SC; Audrey S, 2006, SOC SCI MED, V63, P320, DOI 10.1016/j.socscimed.2005.12.010; Berg CJ, 2010, NICOTINE TOB RES, V12, P963, DOI 10.1093/ntr/ntq123; Bryman A., 2006, QUAL RES, V6, P97, DOI [10.1177/1468794106058877, DOI 10.1177/1468794106058877]; Bryman A, 2007, J MIX METHOD RES, V1, P8, DOI 10.1177/2345678906290531; Cengelli S, 2012, TOB CONTROL, V21, P355, DOI 10.1136/tc.2011.044149; Clark VLP, 2008, J FAM ISSUES, V29, P1543, DOI 10.1177/0192513X08318251; Clark VLP, 2010, QUAL INQ, V16, P428, DOI 10.1177/1077800410364609; Creswell J.W., 2003, RES DESIGN QUALQUAN, DOI DOI 10.2307/1523157; Creswell JW, 2009, J MIX METHOD RES, V3, P95, DOI 10.1177/1558689808330883; Creswell JW KA, 2011, BEST PRACTICES MIXED; Creswell W. C., 2011, DESIGNING CONDUCTING; Curry L., 2015, MIXED METHODS HLTH S; Diviak KR, 2004, ETHICS BEHAV, V14, P321, DOI 10.1207/s15327019eb1404_4; Elsey H, 2015, ADDICT BEHAV, V41, P7, DOI 10.1016/j.addbeh.2014.09.015; Eriksen M., 2014, TOBACCO ATLAS; Falkin GP, 2007, QUAL HEALTH RES, V17, P812, DOI 10.1177/1049732307303384; Fetters MD, 2015, J MIX METHOD RES, V9, P115, DOI 10.1177/1558689815581222; Freedman K, 2011, PREV CHRONIC DIS; Gendall P, 2011, NICOTINE TOB RES, V13, P911, DOI 10.1093/ntr/ntr094; Goenka S, 2010, HEALTH EDUC RES, V25, P917, DOI 10.1093/her/cyq042; Gomez A, 2014, J MIX METHOD RES, V8, P317, DOI 10.1177/1558689814527879; Greene J.C., 1989, EDUC EVAL POLICY AN, V11, P255, DOI [10.3102/01623737011003255, DOI 10.3102/01623737011003255]; Greene J. C., 2007, MIXED METHODS SOCIAL; Guest G, 2013, J MIX METHOD RES, V7, P141, DOI 10.1177/1558689812461179; Guo BL, 2009, ADDICTION, V104, P828, DOI 10.1111/j.1360-0443.2009.02519.x; Hanson WE, 2005, J COUNS PSYCHOL, V52, P224, DOI 10.1037/0022-0167.52.2.224; Hart LC, 2009, J MIX METHOD RES, V3, P26, DOI 10.1177/1558689808325771; Jha P, 2014, NEW ENGL J MED, V370, P60, DOI 10.1056/NEJMra1308383; Johnson RB, 2007, J MIX METHOD RES, V1, P112, DOI 10.1177/1558689806298224; Johnson VA, 2014, INT J DISAST RISK RE, V9, P107, DOI 10.1016/j.ijdrr.2014.04.001; Kleinjan M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-196; Kong G, 2015, NICOTINE TOB RES, V17, P847, DOI 10.1093/ntr/ntu257; Lee JP, 2010, HEALTH EDUC RES, V25, P83, DOI 10.1093/her/cyp066; Lee J, 2011, NICOTINE TOB RES, V13, P1106, DOI 10.1093/ntr/ntr169; Levin-Zamir D, 2011, HEALTH EDUC RES, V26, P323, DOI 10.1093/her/cyr007; Levy SA, 2010, NICOTINE TOB RES, V12, P191, DOI 10.1093/ntr/ntp192; Lopez-Fernandez O, 2011, QUAL QUANT, V45, P1459, DOI 10.1007/s11135-011-9543-9; MacPherson L, 2006, NICOTINE TOB RES, V8, P683, DOI 10.1080/14622200600910827; Main C, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-178; Mair M, 2006, SOC SCI MED, V62, P1009, DOI 10.1016/j.socscimed.2005.07.002; Mermelstein RJ, 2014, AM J PREV MED, V47, pS87, DOI 10.1016/j.amepre.2014.04.015; Molina-Azorin JF, 2016, J MIX METHOD RES, V10, P123, DOI 10.1177/1558689816636707; Molina-Azorin JF, 2012, ORGAN RES METHODS, V15, P33, DOI 10.1177/1094428110393023; Molina-Azorin JF, 2011, J MIX METHOD RES, V5, P7, DOI 10.1177/1558689810384490; Molyneux A, 2006, NICOTINE TOB RES, V8, P539, DOI 10.1080/14622200600789817; Moodie C, 2011, TOB CONTROL, V20, P367, DOI 10.1136/tc.2011.042911; Morgan D. L., 1988, FOCUS GROUP KIT; Morse J.M., 2009, WALNUT CREEK; Nasim A, 2014, HEALTH EDUC RES, V29, P41, DOI 10.1093/her/cyt102; Nichter M, 2004, SOC SCI MED, V59, P415, DOI 10.1016/j.socscimed.2003.10.032; O'Neill SC, 2013, TOB CONTROL, V22, P406, DOI 10.1136/tobaccocontrol-2011-050306; OCATHAIN A, 2007, BMC HEALTH SERV RES, V7; Plano Clark V. L., 2015, SAGE HDB MIXED METHO; Plano Clark V. L., 2015, MIXED METHOD RES GUI; Primack BA, 2009, HEALTH EDUC RES, V24, P608, DOI 10.1093/her/cyn062; Rubinstein ML, 2013, ADDICTION, V108, P406, DOI 10.1111/j.1360-0443.2012.04026.x; Song AV, 2015, TOB CONTROL, V24, P123, DOI 10.1136/tobaccocontrol-2014-052095; Song AV, 2014, AM J PUBLIC HEALTH, V104, pE42, DOI 10.2105/AJPH.2013.301737; Sorensen G, 2004, HEALTH EDUC RES, V19, P250, DOI 10.1093/her/cyg019; Stange KC, 2006, ANN FAM MED, V4, P292, DOI 10.1370/afm.615; Stentz JE, 2012, LEADERSHIP QUART, V23, P1173, DOI 10.1016/j.leaqua.2012.10.001; Sterling Kymberle L, 2015, Tob Regul Sci, V1, P42; Sterling KL, 2015, HEALTH EDUC RES, V30, P152, DOI 10.1093/her/cyu035; Substance Abuse and Mental Health Services Administration (SAMHSA), 2013, SUBST AB MENT HLTH S, P1; Sussman Steve, 2009, Tob Induc Dis, V5, P3, DOI 10.1186/1617-9625-5-3; Sutcliffe K, 2011, YOUNG PEOPLES ACCESS; Tashakkori A. M., 2010, SAGE HDB MIXED METHO; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Tiffany Stephen T, 2007, Nicotine Tob Res, V9 Suppl 4, pS611, DOI 10.1080/14622200701708468; Turner K, 2006, SOC SCI MED, V62, P2513, DOI 10.1016/j.socscimed.2005.11.017; USDHHS, HLTH CONSMOK 50 YE; Wilson LM, 2012, J ENVIRON PUBLIC HEA, V2012, DOI 10.1155/2012/961724; Yerger VB, 2005, NICOTINE TOB RES, V7, P163, DOI 10.1080/14622200412331328385; Yin R. K., RES SCH, V13, P41	80	8	8	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183471	10.1371/journal.pone.0183471	http://dx.doi.org/10.1371/journal.pone.0183471			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841689	Green Published, gold			2022-12-27	WOS:000408370700035
J	Gavagan, CJ; Sayers, MGL				Gavagan, Colin J.; Sayers, Mark G. L.			A biomechanical analysis of the roundhouse kicking technique of expert practitioners: A comparison between the martial arts disciplines of Muay Thai, Karate, and Taekwondo	PLOS ONE			English	Article							EXECUTION TIME; IMPACT FORCE; FULL-INSTEP; KINEMATICS; DISTANCE; VELOCITY; HIP	The purpose of this study was first, to determine whether there were differences in the roundhouse kicking leg kinematics performed by highly skilled Muay Thai, Karate and Taekwondo practitioners (n = 8 per group). Next, analysis aimed to identify the kinematic determinants of effective roundhouse kicking performance. Three-dimensional (3D) lower limb kinematics were recorded using a nine camera infra-red motion capture system (500 Hz) during three maximal roundhouse kicks. Impact forces were recorded using a strain gauge (1000 Hz) attached to a kicking pad positioned at the height of each participant's mastoid process. Results showed that linear foot velocity at impact was moderately correlated with relative impact force (r = 0.66, P = 0.001). Discipline specific analyses of the temporal data indicated that the Muay Thai group had a shorter execution time (1.02 +/- 0.15 s) than Taekwondo (1.54 +/- 0.52 s, P = 0.028). Analysis of lower limb kinematic data indicated that both Karate (-947 +/- 94 deg/s, P = 0.010) and Taekwondo (-943 +/- 106 deg/s, P = 0.011) practitioners had faster knee extension velocities than the Muay Thai group (-706 +/- 200 deg/s). Conversely, the Muay Thai practitioners (1.24 +/- 0.15 m/s) had greater vertical centre of mass movement than both Karate (0.78 +/- 0.24 m/s, P = 0.001) and Taekwondo groups (0.93 +/- 0.19 m/s, P = 0.02). Our findings show that several fundamental movement patterns were common to the roundhouse kicking techniques across the Muay Thai, Karate, and Taekwondo disciplines. Effective roundhouse kicking performance was characterized by rapid pelvic axial rotation, hip abduction, hip flexion and knee extension velocities, combined with rapid movements of the COM towards the target.	[Gavagan, Colin J.; Sayers, Mark G. L.] Univ Sunshine Coast, Sch Sport & Hlth Sci, Maroochydore, Qld, Australia	University of the Sunshine Coast	Gavagan, CJ (corresponding author), Univ Sunshine Coast, Sch Sport & Hlth Sci, Maroochydore, Qld, Australia.	cgavagan@usc.edu.au	Sayers, Mark/AAE-2849-2020	Sayers, Mark/0000-0001-6275-8982				Andries R, 1994, P 12 INT S BIOM SPOR, P260; Andrzejewski X, 2005, P 23 INT S BIOM SPOR, P843; Ball K, 2008, SPORT BIOMECH, V7, P10, DOI 10.1080/14763140701683015; Boey LW, 2002, P 20 INT S BIOM SPOR, P302; Cohen J.E., 1988, STAT POWER ANAL BEHA; Crisafulli A, 2009, APPL PHYSIOL NUTR ME, V34, P143, DOI 10.1139/H09-002; Davids K, 2010, J SCI MED SPORT, V13, P633, DOI 10.1016/j.jsams.2010.05.002; Emmermacher P, 2007, P 25 INT S BIOM SPOR, P289; Falco C, 2009, J BIOMECH, V42, P242, DOI 10.1016/j.jbiomech.2008.10.041; Ha C.-S., 2009, INT J APPL SPORTS SC, V21, P115, DOI DOI 10.24985/KJSS.2008.19.3.22; Halabchi F, 2007, J SPORT SCI MED, V6, P52; Hermann G, 2008, P 26 INT S BIOM SPOR, P416; Katis A, 2010, J SPORT SCI, V28, P1233, DOI 10.1080/02640414.2010.504781; Kim JW, 2010, SPORT BIOMECH, V9, P98, DOI 10.1080/14763141003799459; Kim YK, 2006, P 30 ANN C AM SOC BI; Kim YK, 2011, J SPORT SCI MED, V10, P31; Kong PW, 2000, P 23 INT S BIOM SPOR, P268; Lan YC, 2000, SCI P 18 INT S BIOM, P277; Landeo R, 2008, 26 INT C BIOM SPORTS, P187; Landeo R, 2007, P 25 INT C BIOM SPOR, P298; Lee KK, 2001, P 19 INT C BIOM SPOR, P162; Lees A, 2009, J SPORTS SCI, V27, P20; Levanon J, 1998, MED SCI SPORT EXER, V30, P917, DOI 10.1097/00005768-199806000-00022; Li Y., 2005, P 23 INT S BIOM SPOR, P391; Naito K, 2010, HUM MOVEMENT SCI, V29, P259, DOI 10.1016/j.humov.2009.04.008; Nunome H, 2006, J SPORT SCI, V24, P11, DOI 10.1080/02640410400021450; Nunome H, 2002, MED SCI SPORT EXER, V34, P2028, DOI 10.1097/00005768-200212000-00025; O'Sullivan D, 2009, J SPORT SCI MED, V8, P13; Pearson JN, 1997, THESIS; Phonglorpisit S, 2003, THESIS; Pozo J, 2011, J SPORT SCI, V29, P1553, DOI 10.1080/02640414.2011.605164; Sayers M, 2013, SCI FOOTBALL, P55; Sayers M, 2012, P 30 INT S BIOM SPOR, P154; Shan Gongbing, 2005, Sports Biomech, V4, P59, DOI 10.1080/14763140508522852; Sidthilaw S., 1997, THESIS; Sorensen H, 1996, J SPORT SCI, V14, P483, DOI 10.1080/02640419608727735; Sterzing T, 2008, EXERC SPORT SCI REV, V36, P91, DOI 10.1097/JES.0b013e318168ece7; Witte K, 2007, P 25 S BIOM SPORTS, P302; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Zetaruk MN, 2005, BRIT J SPORT MED, V39, P29, DOI 10.1136/bjsm.2003.010322	40	28	28	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182645	10.1371/journal.pone.0182645	http://dx.doi.org/10.1371/journal.pone.0182645			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841670	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700008
J	Lai, AY; Stewart, SM; Wan, A; Fok, H; Lai, HYW; Lam, TH; Chan, SS				Lai, Agnes Y.; Stewart, Sunita M.; Wan, Alice; Fok, Helen; Lai, Hebe Y. W.; Lam, Tai-hing; Chan, Sophia S.			Development and evaluation of a training workshop for lay health promoters to implement a community-based intervention program in a public low rent housing estate: The Learning Families Project in Hong Kong	PLOS ONE			English	Article							PEER EDUCATION; OLDER-ADULTS; LEADERS; WORKERS; MODEL; INFORMATION; NUTRITION; PEOPLE	This paper presents the development and evaluation of the train-the-trainer (TTT) workshop for lay resident leaders to be lay health promoters. The TTT workshop aimed to prepare the trainees to implement and/or assist in conducting a series of community-based family wellbeing activities for the residents in a public low rent housing estate, entitled "Learning Families Project", under the FAMILY project. The four-hour TTT workshop was conducted for 32 trainees (72% women, 43% aged >= 60, 41% <= elementary school education). The workshop aimed to promote trainees' knowledge, self-efficacy, attitude and practice of incorporating the positive psychology themes into their community activities and engaging the residents to join these activities and learn with their family members. Post-training support was provided. The effectiveness of the TTT was examined by self-administered questionnaires about trainees' reactions to training content, changes in learning and practice at three time points (baseline, and immediately and one year after training), and the difference in residents' survey results before and after participating in the community activities delivered by the trainees. The trainees' learning about the general concepts of family well-being, learning family, leadership skills and planning skills increased significantly with medium to large effect sizes (Cohen's d: 0.5-1.4) immediately after the training. The effects of perceived knowledge and attitude towards practice were sustained to one year (Cohen's d: 0.4-0.6). The application of planning skills to implement community activities was higher at one year (Cohen's d: 0.4), compared with baseline. At one year, the residents' survey results showed significant increases in the practice of positive communication behaviours and better neighbour cohesions after joining the family well-being activities of LFP. Qualitative feedback supported the quantitative results. Our TTT workshop could serve as a practical example of development and evaluation of training programs for lay personnel to be lay health promoters.	[Lai, Agnes Y.; Wan, Alice; Lam, Tai-hing] Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China; [Stewart, Sunita M.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Fok, Helen; Lai, Hebe Y. W.] Christian Family Serv Ctr, Hong Kong, Hong Kong, Peoples R China; [Chan, Sophia S.] Univ Hong Kong, Sch Nursing, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Hong Kong	Lam, TH (corresponding author), Univ Hong Kong, Sch Publ Hlth, Hong Kong, Hong Kong, Peoples R China.	hrmrlth@hku.hk	Lam, Tai Hing/C-4317-2009	Lam, Tai Hing/0000-0002-2033-9971; LAI, Agnes Yuen Kwan/0000-0002-7321-2632	Hong Kong Jockey Club Charities Trust	Hong Kong Jockey Club Charities Trust	This work is supported by The Hong Kong Jockey Club Charities Trust: http://charities. hkjc.com/charities/english/index.aspx.; This study was part of the project entitled 'FAMILY: A Jockey Club Initiative for a Harmonious Society', which was funded by The Hong Kong Jockey Club Charities Trust. Our sincere thanks must go to our community collaborators (the Christian Family Service Centre and the local organizations at Kwun Tong district in Hong Kong) and program participants. We are also grateful to our research team (Dr. Catalina Ng, Dr. David Wong, Ms. Cissy Soong, Mr. Paul Wong, Ms. Wong Xin, Ms. Jenny Leung, Mr. Terence Li, Ms. Carmen Lung, Ms. Wallis Lau) for their important contributions.	[Anonymous], 2004, J PRIM PREV, DOI [DOI 10.1023/B:JOPP.0000048111.94285.27, DOI 10.1023/B:J0PP.0000048111.94285.27]; Ayala GX, 2011, AM J PUBLIC HEALTH, V101, P2261, DOI 10.2105/AJPH.2011.300273; Ayala GX, 2010, HEALTH EDUC RES, V25, P815, DOI 10.1093/her/cyq035; Bandura A., 2004, HEALTH EDUC BEHAV, P31; Brumby S, 2009, J AGROMEDICINE, V14, P112, DOI 10.1080/10599240902772563; Census and Statistics Department, HONG KONG POV SIT RE; Centre for Suicide Research and Prevention, 2014, STUD PHEN DIV HONG K; Chan SSC, 2011, HEALTH EDUC RES, V26, P664, DOI 10.1093/her/cyr026; Cohen J, 1977, STAT POWER ANAL BEHA, V2 2 ed, DOI DOI 10.1016/B978-0-12-179060-8.50006-2; Creswell J.W., 2011, DESIGNING CONDUCTING; Crosby LE, 2013, ACAD MED, V88, P335, DOI 10.1097/ACM.0b013e318280d8de; Duncanson K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1262; Emmons RA, 2003, J PERS SOC PSYCHOL, V84, P377, DOI 10.1037/0022-3514.84.2.377; Fisher JD, 1996, HEALTH PSYCHOL, V15, P114, DOI 10.1037/0278-6133.15.2.114; Forst L, 2004, AM J IND MED, V46, P607, DOI 10.1002/ajim.20103; Francies GR, 1983, VOLUNTEER ADM, V16, P17; Goldfinger JZ, 2008, J HEALTH CARE POOR U, V19, P180, DOI 10.1353/hpu.2008.0016; JOHN OP, 1994, J PERS SOC PSYCHOL, V66, P206, DOI 10.1037/0022-3514.66.1.206; Kawachi I., 2000, SOCIAL COHESION SOCI; Kirkpatrick DL, 2006, IMPLEMENTING 4 LEVEL; Lai A, 2016, PLOS ONE; Lai AY, 2017, FRONT PUBLIC HEALTH, V5, DOI 10.3389/fpubh.2017.00141; Lamb P., 2008, NIACE; Layne JE, 2008, J AM GERIATR SOC, V56, P2323, DOI 10.1111/j.1532-5415.2008.02010.x; McClelland JW, 2002, J NUTR EDUC BEHAV, V34, pS48, DOI 10.1016/S1499-4046(06)60311-4; McLeroy KR, 2003, AM J PUBLIC HEALTH, V93, P529, DOI 10.2105/AJPH.93.4.529; Milburn K, 1995, HEALTH EDUC RES, V10, P407, DOI 10.1093/her/10.4.407; Mock J, 2006, HEALTH PROMOT PRACT, V7, p223S, DOI 10.1177/1524839906288695; Morse J. M., 1995, QUALITATIVE RES METH; Murphy E., 2005, HLTH B, V2; Murphy EM, 2005, PROMOTING HLTH BEHAV; Nation M, 2003, AM PSYCHOL, V58, P449, DOI 10.1037/0003-066X.58.6-7.449; Pearce J, 2012, J CONTIN EDUC HEALTH, V32, P215, DOI 10.1002/chp.21148; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Quandt SA, 2013, HEALTH PROMOT PRACT, V14, P425, DOI 10.1177/1524839912459652; Sampson RJ, 1997, SCIENCE, V277, P918, DOI 10.1126/science.277.5328.918; Seligman M. E. P., 2002, AUTHENTIC HAPPINESS; Shen C, 2017, PLOS ONE IN PRESS; Shiber S, 2002, PUBLIC HEALTH NURS, V19, P81, DOI 10.1046/j.1525-1446.2002.19202.x; Stange KC, 2003, AM J PREV MED, V25, P296, DOI 10.1016/S0749-3797(03)00219-8; Talbot Y, 2009, CAN FAM PHYSICIAN, V55, P613; Tobias CR, 2012, AIDS PATIENT CARE ST, V26, P53, DOI 10.1089/apc.2011.0224; Wandersman A, 2012, AM J COMMUN PSYCHOL, V50, P445, DOI 10.1007/s10464-012-9509-7; Willock RJ, 2015, HEALTH PROMOT PRACT, V16, P63, DOI 10.1177/1524839914535775	44	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183636	10.1371/journal.pone.0183636	http://dx.doi.org/10.1371/journal.pone.0183636			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841677	Green Submitted, gold, Green Published			2022-12-27	WOS:000408370700045
J	Schmuckli-Maurer, J; Reber, V; Wacker, R; Bindschedler, A; Zakher, A; Heussler, VT				Schmuckli-Maurer, Jacqueline; Reber, Vera; Wacker, Rahel; Bindschedler, Annina; Zakher, Anthony; Heussler, Volker Theo			Inverted recruitment of autophagy proteins to the Plasmodium berghei parasitophorous vacuole membrane	PLOS ONE			English	Article							TOXOPLASMA-GONDII; HOST HEPATOCYTES; LIVER STAGE; UBIQUITIN; DEGRADATION; OPTINEURIN; CELLS; LC3; RECEPTORS; BINDING	Selective autophagy and related mechanisms can act as variable defense mechanisms against pathogens and can therefore be considered as intracellular immune responses. When in hepatocytes, Plasmodium parasites reside in a parasitophorous vacuole (PV) and the PV membrane (PVM) is the main contact site between host cell and parasite. Early in infection, the PVM is directly labeled with host cell autophagy proteins LC3B and p62 (nucleoporin 62). We investigated the recruitment of different selective autophagy receptors and could show that mainly p62 and NBR1 (neighbour of BRCA1 gene 1) and to a lesser extent NDP52 (nuclear dot protein 52) associate with the PVM. To investigate the recruitment of these receptors to the PVM in Plasmodium-infected cells, we generated LC3B knock out HeLa cells. In these cell lines, autophagosome formation and autophagic flux are not different to those in WT cells. Unexpectedly, p62 and NBR1 recruitment to the PVM was strongly impaired in LC3B-negative host cells, suggesting that LC3B recruits both receptors to the PVM of Plasmodium parasites. We also noticed that LC3B recruited ubiquitin to the PVM. This indicates that, in comparison to classical selective autophagy, in P. berghei-infected cells the order of membrane labeling with autophagy proteins appears to be inverted from canonical ubiquitin-receptor-LC3B recruitment to LC3B-receptor and possibly ubiquitin.	[Schmuckli-Maurer, Jacqueline; Reber, Vera; Wacker, Rahel; Bindschedler, Annina; Zakher, Anthony; Heussler, Volker Theo] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Wacker, Rahel] Univ Bern, Grad Sch Cellular & Biomed Sci, Bern, Switzerland	University of Bern; University of Bern	Schmuckli-Maurer, J (corresponding author), Univ Bern, Inst Cell Biol, Bern, Switzerland.	jacqueline.schmuckli@izb.unibe.ch	Heussler, Volker/H-9322-2019	Heussler, Volker/0000-0001-8028-9825; Bindschedler, Annina/0000-0003-0336-0864	Schweizerischer Nationalfond [310030_159519]	Schweizerischer Nationalfond	Funded by Schweizerischer Nationalfond, grant 310030_159519 to VTH, www.snf.ch.EviMalaR EU consortium to VTH and RW, www.evimalar.org.	Agop-Nersesian C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02156-7; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Amino R, 2006, NAT MED, V12, P220, DOI 10.1038/nm1350; Andrade RM, 2006, J CLIN INVEST, V116, P2366, DOI 10.1172/JCI28796; Bano N, 2007, INT J PARASITOL, V37, P1329, DOI 10.1016/j.ijpara.2007.04.005; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Burda PC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004760; Dantuma NP, 2006, J CELL BIOL, V173, P19, DOI 10.1083/jcb.200510071; Deosaran E, 2013, J CELL SCI, V126, P939, DOI 10.1242/jcs.114819; Doudna JA, 2014, SCIENCE, V346, P1077, DOI 10.1126/science.1258096; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Hanson KK, 2014, BIOL OPEN, V3, P103, DOI 10.1242/bio.20136833; Isakson P, 2013, AUTOPHAGY, V9, P1955, DOI 10.4161/auto.26085; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Katsuragi Y, 2015, FEBS J, V282, P4672, DOI 10.1111/febs.13540; Khaminets A., 2015, TRENDS CELL BIOL; Kim PK, 2008, P NATL ACAD SCI USA, V105, P20567, DOI 10.1073/pnas.0810611105; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Korac J, 2013, J CELL SCI, V126, P580, DOI 10.1242/jcs.114926; Kraft C, 2012, EMBO J, V31, P3691, DOI 10.1038/emboj.2012.225; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Muniz-Feliciano L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003809; Nguyen TN, 2016, J CELL BIOL; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park BC, 2006, AM J PATHOL, V169, P1976, DOI 10.2353/ajpath.2006.060400; Popovic D, 2012, MOL CELL BIOL, V32, P1733, DOI 10.1128/MCB.06717-11; Prado M, 2015, AUTOPHAGY, V11, P1561, DOI 10.1080/15548627.2015.1067361; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rogov V, 2014, MOL CELL, V53, P167, DOI 10.1016/j.molcel.2013.12.014; Stolz A, 2014, NAT CELL BIOL, V16, P495, DOI 10.1038/ncb2979; Sturm A, 2007, MED MICROBIOL IMMUN, V196, P127, DOI 10.1007/s00430-007-0044-3; Thieleke-Matos C, 2016, CELL MICROBIOL, V18, P437, DOI 10.1111/cmi.12524; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Wacker R, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12754; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441	47	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183797	10.1371/journal.pone.0183797	http://dx.doi.org/10.1371/journal.pone.0183797			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841718	Green Published, gold			2022-12-27	WOS:000408370700058
J	Wessel, O; Braaen, S; Alarcon, M; Haatveit, H; Roos, N; Markussen, T; Tengs, T; Dahle, MK; Rimstad, E				Wessel, Oystein; Braaen, Stine; Alarcon, Marta; Haatveit, Hanne; Roos, Norbert; Markussen, Turhan; Tengs, Torstein; Dahle, Maria K.; Rimstad, Espen			Infection with purified Piscine orthoreovirus demonstrates a causal relationship with heart and skeletal muscle inflammation in Atlantic salmon	PLOS ONE			English	Article							PANCREAS DISEASE; REOVIRUS PRV; SALAR L.; RESPONSES; OUTBREAK; NUMBER; HSMI	Viral diseases pose a significant threat to the productivity in aquaculture. Heart-and skeletal muscle inflammation (HSMI) is an emerging disease in Atlantic salmon (Salmo salar) farming. HSMI is associated with Piscine orthoreovirus (PRV) infection, but PRV is ubiquitous in farmed Atlantic salmon and thus present also in apparently healthy individuals. This has brought speculations if additional etiological factors are required, and experiments focusing on the causal relationship between PRV and HSMI are highly warranted. A major bottleneck in PRV research has been the lack of cell lines that allow propagation of the virus. To bypass this, we propagated PRV in salmon, bled the fish at the peak of the infection, and purified virus particles from blood cells. Electron microscopy, western blot and high-throughput sequencing all verified the purity of the viral particles. Purified PRV particles were inoculated into naive Atlantic salmon. The purified virus replicated in inoculated fish, spread to naive cohabitants, and induced histopathological changes consistent with HSMI. PRV specific staining was demonstrated in the pathological lesions. A dose-dependent response was observed; a high dose of virus gave earlier peak of the viral load and development of histopathological changes compared to a lower dose, but no difference in the severity of the disease. The experiment demonstrated that PRV can be purified from blood cells, and that PRV is the etiological agent of HSMI in Atlantic salmon.	[Wessel, Oystein; Braaen, Stine; Haatveit, Hanne; Markussen, Turhan; Rimstad, Espen] Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway; [Alarcon, Marta] Norwegian Vet Inst, Harstad, Norway; [Roos, Norbert] Univ Oslo, Dept Biosci, Oslo, Norway; [Tengs, Torstein] Norwegian Univ Life Sci, Fac Chem Biotechnol & Food Sci, As, Norway; [Dahle, Maria K.] Norwegian Vet Inst, Oslo, Norway	Norwegian University of Life Sciences; Norwegian Veterinary Institute; University of Oslo; Norwegian University of Life Sciences; Norwegian Veterinary Institute	Wessel, O (corresponding author), Norwegian Univ Life Sci, Fac Vet Med, Oslo, Norway.	oystein.wessel@nmbu.no	Dahle, Maria K/AAK-5130-2021	Dahle, Maria K/0000-0003-0380-084X; Wessel, Oystein/0000-0002-0811-7305	Research Council of Norway [237315/E40, 245286]	Research Council of Norway(Research Council of Norway)	This work was supported by the Research Council of Norway Grant No. 237315/E40 and 245286 (http://www.forskningsradet.no/en/Home_page/1177315753906). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Attoui H, 2002, J GEN VIROL, V83, P1941, DOI 10.1099/0022-1317-83-8-1941; Attoui H., 2012, VIRUS TAXONOMY, P541, DOI [DOI 10.1016/B978-0-12-384684-6.00051-3, 10.1016/B978-0-12-384684-6.00051-3]; Berard A, 2009, CURRENT PROTOCOLS MI; BRUNER R, 1965, BIOCHIM BIOPHYS ACTA, V108, P18, DOI 10.1016/0005-2787(65)90104-8; Collet B, 2014, DEV COMP IMMUNOL, V43, P160, DOI 10.1016/j.dci.2013.08.017; Dahle MK, 2015, FISH SHELLFISH IMMUN, V45, P780, DOI 10.1016/j.fsi.2015.05.049; Di Cicco E, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171471; Ferguson HW, 2005, J FISH DIS, V28, P119, DOI 10.1111/j.1365-2761.2004.00602.x; Finstad OW, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-35; Finstad OW, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-27; Fredricks DN, 1996, CLIN MICROBIOL REV, V9, P18, DOI 10.1128/CMR.9.1.18; Garseth AH, 2013, J FISH DIS, V36, P483, DOI 10.1111/j.1365-2761.2012.01450.x; Garseth AH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082202; Garver KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146229; Godoy MG, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0554-y; Haatveit HM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9030049; Johansen LH, 2015, FISH SHELLFISH IMMUN, V46, P612, DOI 10.1016/j.fsi.2015.07.023; Key T, 2013, J GEN VIROL, V94, P1039, DOI 10.1099/vir.0.048637-0; Kibenge MJT, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-230; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kongtorp RT, 2006, J FISH DIS, V29, P233, DOI 10.1111/j.1365-2761.2006.00710.x; Kongtorp RT, 2004, DIS AQUAT ORGAN, V59, P217, DOI 10.3354/dao059217; Kongtorp RT, 2004, J FISH DIS, V27, P351, DOI 10.1111/j.1365-2761.2004.00549.x; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lovoll M, 2012, DIS AQUAT ORGAN, V99, P7, DOI 10.3354/dao02451; Lund M, 2016, VET RES, V47, DOI 10.1186/s13567-016-0389-y; Markussen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070075; Marty GD, 2015, J FISH DIS, V38, P713, DOI 10.1111/jfd.12285; Mendez II, 2000, J VIROL METHODS, V90, P59, DOI 10.1016/S0166-0934(00)00217-2; Nibert ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068607; Olsen AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131638; Palacios G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011487; Siah A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141475; Takano T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165424; TAMURA K, 1992, MOL BIOL EVOL, V9, P678; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Walker PJ, 2010, VET RES, V41, DOI 10.1051/vetres/2010022; Wessel O, 2015, VET RES, V46	38	70	72	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183781	10.1371/journal.pone.0183781	http://dx.doi.org/10.1371/journal.pone.0183781			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841684	Green Published, gold			2022-12-27	WOS:000408370700057
J	Garabiles, MR; Ofreneo, MAP; Hall, BJ				Garabiles, Melissa R.; Ofreneo, Mira Alexis P.; Hall, Brian J.			Towards a model of resilience for transnational families of Filipina domestic workers	PLOS ONE			English	Article							MIGRATION; FRAMEWORK; HEALTH; CARE	Many Filipinos experience poverty and poor employment opportunities. In order to alleviate poverty and provide sufficient resources for their families, numerous mothers leave the Philippines to become domestic workers. The present study aimed to build a model of family resilience for transnational families. A total of 33 participants consisting of Filipino transnational families, domestic workers, and key informants participated in a series of focus group discussions and interviews. A new model of resilience among transnational families of Filipina domestic helpers was created using a constructivist grounded theory approach. The model highlighted how temporal and spatial elements are embedded in collective migration experiences. Family narratives begin with the sacrifice of separation, where mothers leave their families for a chance to solve economic problems. To successfully adapt to their separation, the families undergo five relational processes. First, families communicate across space using technology to bridge relational distance. Second, families restructure across space through role sharing and the validation of each other's efforts in their family roles. Third, families rebuild ties through temporary family reunification that bridge physical and relational distance. Fourth, families have the collective goal of permanent family reunification by ending migration to become complete again. Fifth, they strive to commit to their families by prioritizing them instead of succumbing to difficulties. Family resilience for transnational migrants is a collectivistic process, negotiated by each family member.	[Garabiles, Melissa R.; Ofreneo, Mira Alexis P.] Ateneo Manila Univ, Dept Psychol, Quezon City, Philippines; [Hall, Brian J.] Univ Macau, Fac Social Sci, Dept Psychol, Global & Community Mental Hlth Res Grp, Taipa, Macau, Peoples R China; [Hall, Brian J.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA	Ateneo de Manila University; University of Macau; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Hall, BJ (corresponding author), Univ Macau, Fac Social Sci, Dept Psychol, Global & Community Mental Hlth Res Grp, Taipa, Macau, Peoples R China.; Hall, BJ (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Behav & Soc, Baltimore, MD 21205 USA.	brianhall@umac.mo	Hall, Brian J./B-7694-2016	Hall, Brian J./0000-0001-9358-2377; Garabiles, Melissa/0000-0002-2928-740X	Research and Development Affairs Office (R&DAO), University of Macau [MYRG2015-00124-FSS, MYRG2015-00111-FSS]; Dissertation Grant Program of the Commission on Higher Education (CHED) Philippines	Research and Development Affairs Office (R&DAO), University of Macau; Dissertation Grant Program of the Commission on Higher Education (CHED) Philippines(Commission on Higher Education (CHED), Philippines)	This work was supported by the Research and Development Affairs Office (R&DAO), University of Macau, under Grant MYRG2015-00124-FSS and MYRG2015-00111-FSS, and the Dissertation Grant Program of the Commission on Higher Education (CHED) Philippines. "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript."	Ang A., 2009, ASIA PACIFIC SOCIAL, V9, P63; [Anonymous], 2011, INT J DR STUD, DOI DOI 10.28945/1429; Asis, 2006, ASIAN POPULATION STU, V2, P45, DOI [10.1080/17441730600700556, DOI 10.1080/17441730600700556]; Asis MMB, 2004, SINGAPORE J TROP GEO, V25, P198, DOI 10.1111/j.0129-7619.2004.00182.x; Bagley C, 1997, INT SOC WORK, V40, P373, DOI 10.1177/002087289704000402; Baldassar L, 2016, GLOBAL NETW, V16, P145, DOI 10.1111/glob.12109; Bartlett D, 1997, UNDERSTANDING SOCIAL; Battistella G, 2011, PHILIPPINE I DEV STU, V2011-12, P1; Bermudez JM, 2013, HDB FAMILY RESILIENC; Birks Melanie., 2015, GROUNDED THEORY PRAC, V2nd edn.; Bonanno GA, 2015, PSYCHOL INQ, V26, P139, DOI 10.1080/1047840X.2015.992677; Bonner EP, 2014, EDUC STUD MATH, V86, P377, DOI 10.1007/s10649-014-9533-7; Bryceson D., 2002, TRANSNATIONAL FAMILY; Carandang M.L., 2007, NAWALA ANG ILAW NG T; Center for Migrant Advocacy, 2012, WORK PAP OV MIGR; Center for Migrant Advocacy and Friedrich Ebert Stiftung (FES), 2009, PHIL GLOB MOD LAB MI; Charmaz K., 2008, QUALITATIVE PSYCHOL, P675, DOI DOI 10.4135/9781526405555.N14; Coe Cati, 2011, EVERYDAY RUPTURES CH; Commission on Filipinos Overseas, 2016, CFO COMP STAT INT MI; Commission on Filipinos Overseas, 2010, HDB FIL OV; Cruz IRS, 2012, PHILIP ST HIS ETH VI, V60, P513, DOI 10.1353/phs.2012.0039; de Guzman J., 2011, THESIS; Ducanes G, 2008, 8 ILO AS REG PROGR G; Episcopal Commission for the Pastoral Care of Migrants and Itinerant People/Apostleship of the Sea-Manila Scalabrini Migration Center Overseas Workers Welfare Administration, 2004, HEARTS AP MIGR EYES; Fresnoza-Flot A, 2009, GLOBAL NETW, V9, P252, DOI 10.1111/j.1471-0374.2009.00253.x; Glaser B.G., 1968, DISCOV GROUNDED THEO; Graham E, 2013, ASIAN PAC MIGR J, V22, P297, DOI 10.1177/011719681302200301; Hall BJ, QUALITATIVE STUDY ID; Hoang LA, 2015, CHILD GEOGR, V13, P263, DOI 10.1080/14733285.2015.972653; Hochschild A., 2000, AM PROSPECT, V11, P1; Holroyd EA, 2001, WOMEN HEALTH, V33, P181, DOI 10.1300/J013v33n01_11; Human Resources Office, 2016, TABL A1 NUMB NONR WO; International Labour Organisation, 2013, DOM WORK WORLD GLOB; Justice Centre Hong Kong, 2016, COM CLEAN PREV FORC; Kofman E, 2012, SOC POLIT, V19, P142, DOI 10.1093/sp/jxr030; Liwag M.D., 1998, PHILIPPINE J PSYCHOL, V31, P1; Madianou M., 2012, MIGRATION NEW MEDIA; Madianou M, 2011, NEW MEDIA SOC, V13, P457, DOI 10.1177/1461444810393903; Masten AS, 2015, PSYCHOL INQ, V26, P187, DOI 10.1080/1047840X.2015.1012041; McKay D., 2007, MOBILITIES, V2, P175, DOI DOI 10.1080/17450100701381532; McKay D., 2006, ASIA PACIFIC J ANTHR, V7, P265, DOI DOI 10.1080/14442210600979357; McKinsey Global Institute, 2016, PEOPL MOV GLOB MIGR; Milliken PJ, 2012, INT J QUAL METH, V11, P684, DOI 10.1177/160940691201100510; Oktay J.S., 2012, GROUNDED THEORY; Parre?as R.S., 2005, ASIAN PAC MIGR J, V14, P243, DOI DOI 10.1177/011719680501400301; Parrenas R, 2005, GLOBAL NETW, V5, P317, DOI 10.1111/j.1471-0374.2005.00122.x; Patterson JM, 2002, J CLIN PSYCHOL, V58, P233, DOI 10.1002/jclp.10019; Payne S, 2007, ANAL QUALITATIVE DAT; Peng YN, 2013, GENDER SOC, V27, P491, DOI 10.1177/0891243212473197; Peng YM., 2015, J NEUROSURG ANESTH, V0, P1; Philippine Overseas Employment Administration, 2014, DEPL STAT; Philippine Statistics Authority, 2016, PHIL STAT YB; Philippine Statistics Authority, 2016, DISTR OV FIL WORK SE; Philippine Statistics Authority, 2017, EMPL RAT JAN 2017 ES; Pingol Alicia, 2001, REMAKING MASCULINITI; RS, 2000, GENDER SOC, V14, P560; RS, TRANSN MOTH SOURC GE; Simon JB, 2005, FAM J, V13, P427, DOI 10.1177/1066480705278724; Sobritchea CI, 2007, WORKING MOTHERING AS; Wall K, 2014, TRANSNATIONAL FAMILI; Walsh F, 2003, FAM PROCESS, V42, P1, DOI 10.1111/j.1545-5300.2003.00001.x; Walsh F., 2015, STRENGTHENING FAMILY; Wen Y, 2015, ASIAN SOC WORK POLIC, V9, P18, DOI 10.1111/aswp.12042; Willig C., 2008, INTRO QUALITATIVE RE, V2nd, P112; Yardley L., 2008, QUALITATIVE PSYCHOL, V2nd; Yeoh B.S, 2016, GENDER PLACE CULT, V25, P1; Zentgraf KM, 2012, J ETHN MIGR STUD, V38, P345, DOI 10.1080/1369183X.2011.646431	67	25	25	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183703	10.1371/journal.pone.0183703	http://dx.doi.org/10.1371/journal.pone.0183703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837633	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000104
J	Liao, LE; Kowal, S; Cardenas, DA; Beauchemin, CAA				Liao, Laura E.; Kowal, Szymon; Cardenas, Daniel A.; Beauchemin, Catherine A. A.			Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors	PLOS ONE			English	Article							CELL-CULTURE; RESISTANCE; HIV-1; REPLICATION; FAVIPIRAVIR; GENERATION; CLEARANCE; LACKING; HUMANS	Mathematical models (MMs) have been used to study the kinetics of influenza A virus infections under antiviral therapy, and to characterize the efficacy of antivirals such as neuraminidase inhibitors (NAIs). NAIs prevent viral neuraminidase from cleaving sialic acid receptors that bind virus progeny to the surface of infected cells, thereby inhibiting their release, suppressing infection spread. When used to study treatment with NAIs, MMs represent viral release implicitly as part of viral replication. Consequently, NAIs in such MMs do not act specifically and exclusively on virus release. We compared a MM with an explicit representation of viral release (i.e., distinct from virus production) to a simple MM without explicit release, and investigated whether parameter estimation and the estimation of NAI efficacy were affected by the use of a simple MM. Since the release rate of influenza A virus is not well-known, a broad range of release rates were considered. If the virus release rate is greater than similar to 0.1 h(-1), the simple MM provides accurate estimates of infection parameters, but underestimates NAI efficacy, which could lead to underdosing and the emergence of NAI resistance. In contrast, when release is slower than similar to 0.1 h(-1), the simple MM accurately estimates NAI efficacy, but it can significantly overestimate the infectious lifespan (i.e., the time a cell remains infectious and producing free virus), and it will significantly underestimate the total virus yield and thus the likelihood of resistance emergence. We discuss the properties of, and a possible lower bound for, the influenza A virus release rate.	[Liao, Laura E.; Kowal, Szymon; Cardenas, Daniel A.; Beauchemin, Catherine A. A.] Ryerson Univ, Dept Phys, Toronto, ON, Canada; [Beauchemin, Catherine A. A.] RIKEN, Interdisciplinary Theoret & Math Sci iTHES, iTHEMS Res Grp, Wako, Saitama, Japan	Toronto Metropolitan University; RIKEN	Beauchemin, CAA (corresponding author), Ryerson Univ, Dept Phys, Toronto, ON, Canada.; Beauchemin, CAA (corresponding author), RIKEN, Interdisciplinary Theoret & Math Sci iTHES, iTHEMS Res Grp, Wako, Saitama, Japan.	cbeau@ryerson.ca	Beauchemin, Catherine AA/G-4619-2011	Beauchemin, Catherine AA/0000-0003-0599-0069; Liao, Laura/0000-0001-6069-2633; Cardenas, Daniel/0000-0002-9785-0858	Natural Sciences and Engineering Research Council of Canada [355837-2013]; Ministry of Research and Innovation and Science of the Government of Ontario [ER13-09-040]; Interdisciplinary Theoretical and Mathematical Sciences (iTHES); Ontario Graduate Scholarship from Government of Ontario; Doctoral Canadian Graduate Scholarship (CGS-D) from Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ministry of Research and Innovation and Science of the Government of Ontario; Interdisciplinary Theoretical and Mathematical Sciences (iTHES); Ontario Graduate Scholarship from Government of Ontario; Doctoral Canadian Graduate Scholarship (CGS-D) from Natural Sciences and Engineering Research Council of Canada	This work was supported in part by Discovery Grant 355837-2013 from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca), and by Early Researcher Award ER13-09-040 from the Ministry of Research and Innovation and Science of the Government of Ontario (www.ontario.ca/page/early-researcher-awards), both awarded to CAAB, and by the Interdisciplinary Theoretical and Mathematical Sciences (iTHES, ithes.riken.jp; iTHEMS, ithems.riken.jp) research programmes at RIKEN (CAAB). Additional support in the form of an Ontario Graduate Scholarship from the Government of Ontario (www.osap.gov.on.ca) (LEL), a Michael Smith Foreign Study Supplement and a Doctoral Canadian Graduate Scholarship (CGS-D) from the Natural Sciences and Engineering Research Council of Canada (www.nserc-crsng.gc.ca) were awarded to LEL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccam P, 2006, J VIROL, V80, P7590, DOI 10.1128/JVI.01623-05; Beauchemin CAA, 2008, J THEOR BIOL, V254, P439, DOI 10.1016/j.jtbi.2008.05.031; Beauchemin CAA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S7; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; DANIELS PU, 1989, FEBS LETT, V244, P57, DOI 10.1016/0014-5793(89)81161-5; Dobrovolny HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057088; Dobrovolny HM, 2011, J THEOR BIOL, V269, P234, DOI 10.1016/j.jtbi.2010.10.017; Furuta Y, 2013, ANTIVIR RES, V100, P446, DOI 10.1016/j.antiviral.2013.09.015; Gubareva LV, 2002, J GEN VIROL, V83, P2683, DOI 10.1099/0022-1317-83-11-2683; Handel A, 2007, PLOS COMPUT BIOL, V3, P2456, DOI 10.1371/journal.pcbi.0030240; Handel A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1083; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Holder BP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014767; Holder BP, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S1-S10; Holder BP, 2011, AUTOIMMUNITY, V44, P282, DOI 10.3109/08916934.2011.523267; Hoopes JD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029778; Hughes MT, 2000, J VIROL, V74, P5206, DOI 10.1128/JVI.74.11.5206-5212.2000; Iwami S, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00319; Kiso M, 2004, LANCET, V364, P759, DOI 10.1016/S0140-6736(04)16934-1; KUNDU A, 1994, J VIROL, V68, P1812, DOI 10.1128/JVI.68.3.1812-1818.1994; Li TCM, 2015, VIRUSES-BASEL, V7, P4929, DOI 10.3390/v7092850; LIU CG, 1995, J VIROL, V69, P1099, DOI 10.1128/JVI.69.2.1099-1106.1995; Mitchell H, 2011, J VIROL, V85, P1125, DOI 10.1128/JVI.01722-10; Nunes-Correia I, 1999, BIOCHEMISTRY-US, V38, P1095, DOI 10.1021/bi9812524; Paradis EG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126115; Perelson AS, 2012, J INFECT DIS, V205, P1642, DOI 10.1093/infdis/jis265; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; Pinilla LT, 2012, J VIROL, V86, P10651, DOI 10.1128/JVI.07244-11; Ramratnam B, 1999, LANCET, V354, P1782, DOI 10.1016/S0140-6736(99)02035-8; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Simon PF, 2016, SCI REP-UK, V6, DOI 10.1038/srep24154; Tarbet EB, 2014, ARCH VIROL, V159, P1279, DOI 10.1007/s00705-013-1922-1; Weinstock DM, 2009, JAMA-J AM MED ASSOC, V301, P1066, DOI 10.1001/jama.2009.324; Weinstock DM, 2006, JAMA-J AM MED ASSOC, V295, P934, DOI 10.1001/jama.295.8.934; World Health Organization, 2016, INFL SEAS, P211	35	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183621	10.1371/journal.pone.0183621	http://dx.doi.org/10.1371/journal.pone.0183621			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837615	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000089
J	Ratnasari, N; Nurdjanah, S; Sadewa, AH; Hakimi, M; Yano, Y				Ratnasari, Neneng; Nurdjanah, Siti; Sadewa, Ahmad Hamim; Hakimi, Mohammad; Yano, Yoshihiko			Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS; EXPRESSION	Background The VEGF gene polymorphism rs699947 related to clinical pathology, mortality, and recurrence of HCC. Few studies mentioned an association between VEGF gene polymorphisms with illness progression in chronic liver disease. We aimed to explore differences of VEGF gene polymorphism rs699947 in chronic hepatitis, liver cirrhosis and hepatocellular carcinoma patients in Indonesian population. Methods A cross-sectional study with consecutive sampling and without matching was performed during a 3 years period (2011-2014) at Dr. Sardjito General Hospital Yogyakarta, Indonesia. Blood DNA was sequenced from 123 subjects with chronic liver diseases [39 chronic hepatitis (CH), 39 liver cirrhosis (LC), and 45 hepatocellular carcinoma (HCC)]. 59 healthy subjects also participated. Using isolated VEGF genes for specific primers for rs699947, blood samples were examined by targeting DNA sequences with Applied Bio systems. All data were analyzed using STATA version 11.0 with significance level at P<0.05. Results The mean of age in HCC and LC subjects were older than in CH and healthy (P value <0.05); there were more males in LC, HCC and the healthy groups but not in CH (P>0.05). HBV was the dominant etiology in HCC, LC, and CH besides HCV and non HBV-HCV (P<0.05). There were significant differences in the SNP -2578 distributions of allele C compared to allele A in all subjects (healthy vs. LC, and HCC; LC vs. CH (P<0.05), but no significant difference A>C vs. C>C, and genotypes distribution. Proportion of SNP -2578 A>C vs. C>C CH 1.8:1; HCC 1.4:1; healthy 1.7:1; but its proportion in LC was inversed (1:1.2). Genotype A was low in all subjects (5%-11%). Significant difference of allele distribution was found in healthy vs. LC, and HCC; CH vs. LC. Based on HWE analyses, distribution of allele C was dominant. There were not significant differences in deletion, insertion-deletion at -2547 until -2526, and haplotype (Ht) CCGACCCC (P>0.05). The OR analyses of allele and SNP showed that allele A can be a predictor of disease progression in LC to HCC (OR 2.26) and healthy to LC (OR 1.65); and SNP A>C also can be a predictor in healthy to HCC (OR 1.41) and CH (OR 1.14). Conclusion The occurrence of allele A and SNP A>C VEGF gene (-2578) might predict illness progression from healthy to CH, LC or HCC and LC to HCC.	[Ratnasari, Neneng; Nurdjanah, Siti] Gadjah Mada Univ, Dr Sardjito Hosp, Fac Med, Dept Internal Med, Yogyakarta, Indonesia; [Sadewa, Ahmad Hamim] Gadjah Mada Univ, Fac Med, Dept Biochem, Yogyakarta, Indonesia; [Hakimi, Mohammad] Gadjah Mada Univ, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia; [Yano, Yoshihiko] Kobe Univ, Grad Sch Med, Ctr Infect Dis, Kobe, Hyogo, Japan	Central General Hospital Dr. Sardjito; Gadjah Mada University; Gadjah Mada University; Gadjah Mada University; Kobe University	Ratnasari, N (corresponding author), Gadjah Mada Univ, Dr Sardjito Hosp, Fac Med, Dept Internal Med, Yogyakarta, Indonesia.	nenengratnasari@yahoo.com	Ahmad Hamim, Sadewa/GPC-7031-2022; Ratnasari, Neneng/GLN-5795-2022; Hakimi, Mohammad/GOV-6587-2022	Ahmad Hamim, Sadewa/0000-0002-3514-6646; Ratnasari, Neneng/0000-0003-1323-2233				Cha C, 2005, BEST PRACT RES CL GA, V19, P25, DOI 10.1016/j.bpg.2004.11.005; Chen JA, 2010, HEPATOL INT, V4, P537, DOI 10.1007/s12072-010-9192-4; Corpechot C, 2002, HEPATOLOGY, V35, P1010, DOI 10.1053/jhep.2002.32524; Coulon S, 2011, LIVER INT, V31, P146, DOI 10.1111/j.1478-3231.2010.02369.x; Elpek GO, 2015, WORLD J HEPATOL, V7, P377, DOI 10.4254/wjh.v7.i3.377; Fernandez M, 2009, J HEPATOL, V50, P604, DOI 10.1016/j.jhep.2008.12.011; Heriyanto DS, 2012, J MED VIROL, V84, P44, DOI 10.1002/jmv.22266; Hong TT, 2012, MOL BIOL REP, V39, P5283, DOI 10.1007/s11033-011-1326-9; Jin QR, 2005, CLIN CANCER RES, V11, P3647, DOI 10.1158/1078-0432.CCR-04-1803; Juniastuti, 2013, BIOMED REP, V1, P522, DOI 10.3892/br.2013.106; Kew MC, 1997, YALE J BIOL MED, V70, P119; Kong SY, 2007, HEPATOLOGY, V46, P446, DOI 10.1002/hep.21720; Korpanty G, 2010, J ONCOL, V2010, DOI 10.1155/2010/652320; Lai WK, 2005, J HEPATOL, V42, P7, DOI 10.1016/j.jhep.2004.11.008; Liu L, 2011, J CANCER RES CLIN, V137, P1027, DOI 10.1007/s00432-010-0966-9; Mendez-Sanchez N, 2008, ANN HEPATOL, V7, P46; Mohammadi Mojgan, 2003, Human Immunology, V64, pS125, DOI 10.1016/j.humimm.2003.08.234; Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452; Ratnasari N, 2016, ARAB J GASTROENTEROL, V17, P61, DOI 10.1016/j.ajg.2016.06.005; Rosmorduc O, 1999, AM J PATHOL, V155, P1065, DOI 10.1016/S0002-9440(10)65209-1; Sakakura C, 1999, BRIT J CANCER, V80, P2034, DOI 10.1038/sj.bjc.6690638; Semela D, 2004, J HEPATOL, V41, P864, DOI 10.1016/j.jhep.2004.09.006; Shahbazi M, 2002, J AM SOC NEPHROL, V13, P260, DOI 10.1681/ASN.V131260; Tamori A, 2005, CLIN CANCER RES, V11, P5821, DOI 10.1158/1078-0432.CCR-04-2055; Wu LM, 2009, ARCH MED RES, V40, P565, DOI 10.1016/j.arcmed.2009.07.011; Wu XP, 2013, INT J CANCER, V133, P1085, DOI 10.1002/ijc.28109	26	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183503	10.1371/journal.pone.0183503	http://dx.doi.org/10.1371/journal.pone.0183503			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837651	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000073
J	Tlou, B; Sartorius, B; Tanser, F				Tlou, Boikhutso; Sartorius, Benn; Tanser, Frank			Space-time variations in child mortality in a rural South African population with high HIV prevalence (2000-2014)	PLOS ONE			English	Article								Objective The aim of the study was to identify the key determinants of child mortality 'hot-spots' in space and time. Methods Comprehensive population-based mortality data collected between 2000 and 2014 by the Africa Centre Demographic Information System located in the UMkhanyakude District of KwaZulu-Natal Province, South Africa, was analysed. We assigned all mortality events and person-time of observation for children <5 years of age to an exact homestead of residence (mapped to <2m accuracy as part of the DSA platform). Using these exact locations, both the Kulldorff and Tango spatial scan statistics for regular and irregular shaped cluster detection were used to identify clusters of childhood mortality events in both space and time. Findings Of the 49 986 children aged <5 years who resided in the study area between 2000 and 2014, 2010 (4.0%) died. Childhood mortality decreased by 80% over the period from >20 per 1000 person-years in 2001-2003 to 4 per 1000 person-years in 2014. The two scanning spatial techniques identified two high-risk clusters for child mortality along the eastern border of the study site near the national highway, with a relative risk of 2.10 and 1.91 respectively. Conclusions The high-risk communities detected in this work, and the differential risk factor profile of these communities, can assist public health professionals to identify similar populations in other parts of rural South Africa. Identifying child mortality hot-spots will potentially guide policy interventions in rural, resource-limited settings.	[Tlou, Boikhutso; Sartorius, Benn; Tanser, Frank] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Tlou, Boikhutso; Sartorius, Benn; Tanser, Frank] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Tanser, Frank] Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa	University of Kwazulu Natal; University of Kwazulu Natal; University of Kwazulu Natal	Tlou, B; Tanser, F (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.; Tlou, B; Tanser, F (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa.; Tanser, F (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res South Africa CAPRISA, Durban, South Africa.	Tlou@ukzn.ac.za; ftanser@gmail.com	Tanser, Frank/ABE-8326-2021; TLOU, BOIKHUTSO/AEA-3161-2022	, bennsartorius/0000-0001-6761-2325; Tanser, Frank/0000-0001-9797-0000	Medical Education Partnership Initiative (MEPI); Wellcome Trust, UK [082384/Z/07/Z]; South African Medical Research Council Flagship grant [MRC- RFA-UFSP-01- 2013/UKZNHIVEPI]; National Institute of Child Health and Human Development [1R01HD084233-01]; UK Academy of Medical Sciences Newton Advanced Fellowship [NA150161]	Medical Education Partnership Initiative (MEPI); Wellcome Trust, UK(Wellcome Trust); South African Medical Research Council Flagship grant; National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); UK Academy of Medical Sciences Newton Advanced Fellowship	We wish to thank the Africa Centre for Health and Population Studies demographic surveillance site for allowing use of their data for the purposes of this PhD research project as well as the Medical Education Partnership Initiative (MEPI) for supporting this study.; Funding for the Africa Centre's Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (082384/Z/07/Z)]. F.T. was supported by a South African Medical Research Council Flagship grant (MRC- RFA-UFSP-01- 2013/UKZNHIVEPI), an R01 grant from the National Institute of Child Health and Human Development (1R01HD084233-01) and UK Academy of Medical Sciences Newton Advanced Fellowship (NA150161). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of this manuscript.	Arroyo MA, 2006, JAIDS-J ACQ IMM DEF, V43, P440, DOI 10.1097/01.qai.0000243053.80945.f0; Auchincloss AH, 2012, ANNU REV PUBL HEALTH, V33, P107, DOI 10.1146/annurev-publhealth-031811-124655; Bangha M., 2008, SPATIAL DISTRIBUTION; Bangha M. W., 2013, AFRICAN POPULATION S, V22; Bondi F. S., 2015, S AFRICAN J CHILD HL, V9; Clark SJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001409; Cooke GS, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-585; Danzhen Y., 2013, LEVELS TRENDS CHILD; Department of Health, 2013, NSDA LONG HLTH LIF A; Grassly NC, 2001, B WORLD HEALTH ORGAN, V79, P1121; Haidong W., 2014, GLOBAL REGIONAL NATL, V384; Hogan D., 2015, LANCET, V385, P430, DOI DOI 10.1016/S0140-6736(14)61698-6; Hosegood V, 2004, AIDS, V18, P663, DOI 10.1097/00002030-200403050-00011; Houlihan CF, 2011, INT J EPIDEMIOL, V40, P318, DOI 10.1093/ije/dyp402; Kahn K, 2007, SCAND J PUBLIC HEALT, V35, P8, DOI 10.1080/14034950701505031; Kamara M. K., 2008, CLUSTERING MORTALITY; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Madise N. J., 2003, TALE 2 CONTINENTS IN; Namosha E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069279; Nannan N., 2011, REVERSAL CHILDHOOD M, V25; Nannan N., 2011, AFRICAN POPULATION S, V25; Ndirangu J, 2010, AIDS, V24, P593, DOI 10.1097/QAD.0b013e328335cff5; Philadelphia P., 2013, GLOBAL SOURCE S 1007; Sachs JD, 2012, LANCET, V379, P2206, DOI 10.1016/S0140-6736(12)60685-0; Statistics South Africa, 2016, MORT CAUS DEATH S AF; Storeygard A, 2008, POPUL SPACE PLACE, V14, P209, DOI 10.1002/psp.484; Tango Toshiro, 2005, Int J Health Geogr, V4, P11, DOI 10.1186/1476-072X-4-11; Tanser F., 2013, HIGH COVERAGE ART AS; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2009, INT J EPIDEMIOL, V38, P1008, DOI 10.1093/ije/dyp148; UN Inter-agency Group for Child Mortality Estimation, 2015, LEV TRENDS CHILD MOR; United Nations, 2014, CONC REP WORLD POP S; Vandormael A., 2014, LANCET GLOBAL HLTH, V2; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; World Health Organization, 2015, MDG 4 RED CHILD MORT	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182478	10.1371/journal.pone.0182478	http://dx.doi.org/10.1371/journal.pone.0182478			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837576	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000019
J	Huang, YY; Shang, Q; Dai, SY; Ma, QG				Huang, Yujing; Shang, Qian; Dai, Shenyi; Ma, Qingguo			Dread of uncertain pain: An event-related potential study	PLOS ONE			English	Article							STIMULUS-PRECEDING NEGATIVITY; AFFECTIVE PICTURES; ANTICIPATION; MODULATION; BRAIN; ERP; DISORDERS; ATTENTION; RESPONSES; EMOTION	Humans experience more stress about uncertain situations than certain situations. However, the neural mechanism underlying the uncertainty of a negative stimulus has not been determined. In the present study, event-related potential was recorded to examine neural responses during the dread of unpredictable pain. We used a cueing paradigm in which predictable cues were always followed by electric shocks, unpredictable cues by electric shocks at a 50/50 ratio and safe cues by no electric shock. Visual analogue scales following electric shocks were presented to quantify subjective anxiety levels. The behavioral results showed that unpredictable cues evoked high-level anxiety compared with predictable cues in both painful and unpainful stimulation conditions. More importantly, the ERPs results revealed that unpredictable cues elicited a larger P200 at parietal sites than predictable cues. In addition, unpredictable cues evoked larger P200 compared with safe cues at frontal electrodes and compared with predictable cues at parietal electrodes. In addition, larger P3b and LPP were observed during perception of safe cues compared with predictable cues at frontal and central electrodes. The similar P3b effect was also revealed in the left sites. The present study underlined that the uncertain dread of pain was associated with threat appraisal process in pain system. These findings on early event-related potentials were significant for a neural marker and development of therapeutic interventions.	[Huang, Yujing] Zhejiang Sci Tech Univ, Sch Econ & Management, Hangzhou, Zhejiang, Peoples R China; [Shang, Qian] Hangzhou Dianzi Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Dai, Shenyi] China Jiliang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Ma, Qingguo] Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China; [Ma, Qingguo] Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China	Zhejiang Sci-Tech University; Hangzhou Dianzi University; China Jiliang University; Zhejiang University; Zhejiang University	Ma, QG (corresponding author), Zhejiang Univ, Sch Management, Hangzhou, Zhejiang, Peoples R China.; Ma, QG (corresponding author), Zhejiang Univ, Neuromanagement Lab, Hangzhou, Zhejiang, Peoples R China.	maqingguo3669@zju.edu.cn			National Natural Science Foundation of China [71371167, 71602044, 71702169]; Zhejiang Sci-Tech University [14092101-Y]; Natural Science Foundation of Zhejiang Province [LQ15G030012, LQ16G020006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Sci-Tech University(Zhejiang Sci-Tech University); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This research was supported by grant No. 71371167, grant No.71602044, and grant No. 71702169 of the National Natural Science Foundation of China. Additionally, this work has received financial support from Zhejiang Sci-Tech University (grant No.14092101-Y) and from Natural Science Foundation of Zhejiang Province (grant No.LQ15G030012 and grant No.LQ16G020006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANNETT M, 1970, BRIT J PSYCHOL, V61, P303, DOI 10.1111/j.2044-8295.1970.tb01248.x; Baas JMP, 2002, NEUROREPORT, V13, P133, DOI 10.1097/00001756-200201210-00031; Babiloni C, 2003, EUR J NEUROSCI, V18, P1692, DOI 10.1046/j.1460-9568.2003.02851.x; Bach DR, 2009, J NEUROSCI, V29, P1648, DOI 10.1523/JNEUROSCI.4578-08.2009; Berns GS, 2006, SCIENCE, V312, P754, DOI 10.1126/science.1123721; Brown CA, 2008, PAIN, V135, P240, DOI 10.1016/j.pain.2007.05.022; Carretie L, 2001, INT J PSYCHOPHYSIOL, V41, P75, DOI 10.1016/S0167-8760(00)00195-1; Chark R, 2015, J RISK UNCERTAINTY, V50, P209, DOI 10.1007/s11166-015-9220-9; Chester DS, 2014, SOC COGN AFFECT NEUR, V9, P699, DOI 10.1093/scan/nst038; Dambacher M, 2006, BRAIN RES, V1084, P89, DOI 10.1016/j.brainres.2006.02.010; Delplanque S, 2006, INT J PSYCHOPHYSIOL, V60, P315, DOI 10.1016/j.ijpsycho.2005.06.006; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; Gole M, 2012, NEUROSCI LETT, V507, P112, DOI 10.1016/j.neulet.2011.11.054; Gopalakrishnan R, 2016, CLIN NEUROPHYSIOL, V127, P1855, DOI 10.1016/j.clinph.2015.11.019; Heathcote LC, 2017, PAIN IN PRESS; Hirao T, 2016, NEUROREPORT, V27, P80, DOI 10.1097/WNR.0000000000000495; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; ITO J, 1992, INT J NEUROSCI, V65, P239, DOI 10.3109/00207459209003297; Leutgeb V, 2009, BIOL PSYCHOL, V82, P293, DOI 10.1016/j.biopsycho.2009.09.003; Lin CS, 2014, NEUROPSYCHOLOGIA, V64, P85, DOI 10.1016/j.neuropsychologia.2014.09.021; Ma QG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139954; Martin EA, 2017, BIOL PSYCHOL, V124, P119, DOI 10.1016/j.biopsycho.2017.02.001; Mehmood RM, 2016, IEEE ENG MED BIO, P279, DOI 10.1109/EMBC.2016.7590694; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Olofsson JK, 2007, BIOL PSYCHOL, V75, P101, DOI 10.1016/j.biopsycho.2006.12.006; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Petrovic P, 2005, NEURON, V46, P957, DOI 10.1016/j.neuron.2005.05.023; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Poli S, 2007, INT J PSYCHOPHYSIOL, V65, P32, DOI 10.1016/j.ijpsycho.2007.02.008; Renna ME, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00098; Rubio A, 2016, NEUROGASTROENT MOTIL, V28, P1419, DOI 10.1111/nmo.12844; Rubio A, 2015, NEUROIMAGE, V107, P10, DOI 10.1016/j.neuroimage.2014.11.043; Schapkin SA, 2000, ACTA NEUROBIOL EXP, V60, P17; Schupp HT, 2004, PSYCHOPHYSIOLOGY, V41, P441, DOI 10.1111/j.1469-8986.2004.00174.x; Seidel EM, 2015, HUM BRAIN MAPP, V36, P744, DOI 10.1002/hbm.22661; Van ZAM, 1994, CLIN NEUROPSYCHOLOGY; Visser-Keizer AC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166995; Wang XY, 2012, NEUROREPORT, V23, P862, DOI 10.1097/WNR.0b013e3283587161; Weymar M, 2013, CORTEX, V49, P819, DOI 10.1016/j.cortex.2012.02.012; Xu Q, 2011, NEUROSCI LETT, V505, P200, DOI 10.1016/j.neulet.2011.10.024; Yeung N, 2004, J NEUROSCI, V24, P6258, DOI 10.1523/JNEUROSCI.4537-03.2004; ZAJONC RB, 1980, AM PSYCHOL, V35, P151, DOI 10.1037/0003-066X.35.2.151	42	9	9	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182489	10.1371/journal.pone.0182489	http://dx.doi.org/10.1371/journal.pone.0182489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832607	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800024
J	Lee, J; Tam, H; Adler, L; Ilstad-Minnihan, A; Macaubas, C; Mellins, ED				Lee, Justin; Tam, Hanson; Adler, Lital; Ilstad-Minnihan, Alexandra; Macaubas, Claudia; Mellins, Elizabeth D.			The MHC class II antigen presentation pathway in human monocytes differs by subset and is regulated by cytokines	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; INVARIANT CHAIN; HLA-DR; CD14(++)CD16(+) MONOCYTES; DENDRITIC CELLS; MACROPHAGES; EXPRESSION; COMPLEXES; DM; DIFFERENTIATION	Monocytes play a critical role in the innate and adaptive immune systems, performing phagocytosis, presenting antigen, and producing cytokines. They are a heterogeneous population that has been divided in humans into classical, intermediate, and non-classical subsets, but the roles of these subsets are incompletely understood. In this study, we investigated the expression patterns of MHC class II (MHCII) and associated molecules and find that the intermediate monocytes express the highest levels of the MHC molecules, HLA-DR (tested in n = 30 samples), HLA-DP (n = 30), and HLA-DQ (n = 10). HLA-DM (n = 30), which catalyzes the peptide exchange on the MHC molecules, is also expressed at the highest levels in intermediate monocytes. To measure HLA-DM function, we measured levels of MHCII-bound CLIP (class II invariant chain peptide, n = 23), which is exchanged for other peptides by HLA-DM. We calculated CLIP: MHCII ratios to normalize CLIP levels to MHCII levels, and found that intermediate monocytes have the lowest CLIP: MHCII ratio. We isolated the different monocyte subsets (in a total of 7 samples) and analyzed their responses to selected cytokines as model of monocyte activation: two M1-polarizing cytokines (IFN., GM-CSF), an M2-polarizing cytokine (IL-4) and IL-10. Classical monocytes exhibit the largest increases in class II pathway expression in response to stimulatory cytokines (IFN., GM-CSF, IL-4). All three subsets decrease HLA-DR levels after IL-10 exposure. Our findings argue that intermediate monocytes are the most efficient constitutive antigen presenting subset, that classical monocytes are recruited into an antigen presentation role during inflammatory responses and that IL-10 negatively regulates this function across all subsets.	[Lee, Justin; Tam, Hanson; Adler, Lital; Ilstad-Minnihan, Alexandra; Macaubas, Claudia; Mellins, Elizabeth D.] Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA; [Lee, Justin] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Macaubas, C; Mellins, ED (corresponding author), Stanford Univ, Dept Pediat, Program Immunol, Stanford, CA 94305 USA.	macaubas@stanford.edu; mellins@stanford.edu		Mellins, Elizabeth/0000-0003-2577-139X; Tam, Hanson/0000-0001-5772-0680; Macaubas, Claudia/0000-0002-5472-8086	National Institutes of Health (NIH) [R01 AR066551]; Shriners Hospital [85100]; Cure JM Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospital; Cure JM Foundation	This work was supported by National Institutes of Health (NIH) R01 AR066551 to EDM; Shriners Hospital Grant 85100 to EDM; and Cure JM Foundation to EDM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeles D, 2012, CYTOM PART A, V81A, P823, DOI 10.1002/cyto.a.22104; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; Busch R, 2005, IMMUNOL REV, V207, P242, DOI 10.1111/j.0105-2896.2005.00306.x; Cao ZA, 2000, EUR J IMMUNOL, V30, P2604, DOI 10.1002/1521-4141(200009)30:9<2604::AID-IMMU2604>3.0.CO;2-6; DENZIN LK, 1995, CELL, V82, P155, DOI 10.1016/0092-8674(95)90061-6; Fromm SV, 2001, J INTERF CYTOK RES, V21, P199, DOI 10.1089/107999001750169790; FU XT, 1994, HUM IMMUNOL, V39, P253, DOI 10.1016/0198-8859(94)90268-2; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Gren ST, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144351; HERSHMAN MJ, 1989, CLIN EXP IMMUNOL, V77, P67; Hijdra D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00339; Hornell TMC, 2003, J IMMUNOL, V171, P2374, DOI 10.4049/jimmunol.171.5.2374; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Koppelman B, 1997, IMMUNITY, V7, P861, DOI 10.1016/S1074-7613(00)80404-5; Lachmann G, 2017, INT J MED SCI, V14, P367, DOI 10.7150/ijms.18288; LAH TT, 1995, FEBS LETT, V363, P85; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; MALEFYT RD, 1991, J EXP MED, V174, P915; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; MELLINS E, 1990, NATURE, V343, P71, DOI 10.1038/343071a0; Muczynski KA, 1998, J IMMUNOL, V160, P3207; Mukherjee R, 2015, SCI REP-UK, V5, DOI 10.1038/srep13886; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Reading JL, 2015, MOL THER, V23, P1783, DOI 10.1038/mt.2015.131; Sanchez-Torres C, 2001, INT IMMUNOL, V13, P1571, DOI 10.1093/intimm/13.12.1571; Semnani RT, 2014, INFECT IMMUN, V82, P4438, DOI 10.1128/IAI.01973-14; Spencer JV, 2002, J VIROL, V76, P1285, DOI 10.1128/JVI.76.3.1285-1292.2002; Spies C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144003; Sprangers S, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/1475435; Stang E, 1998, J IMMUNOL, V160, P4696; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Surh CD, 2000, J EXP MED, V192, pF9, DOI 10.1084/jem.192.4.F9; Thomas G.D., 2017, ARTERIOSCLER THROMB; Thomas G, 2015, ARTERIOSCL THROM VAS, V35, P1306, DOI 10.1161/ATVBAHA.114.304650; van Lith M, 2010, J BIOL CHEM, V285, P40800, DOI 10.1074/jbc.M110.148155; WATSON AJ, 1983, NATURE, V304, P358, DOI 10.1038/304358a0; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong KL, 2011, BLOOD, V118, pE15, DOI 10.1182/blood-2010-12-326355; Zawada AM, 2011, BLOOD, V118, pE50, DOI 10.1182/blood-2011-01-326827; Ziegler-Heitbrock L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00423	44	50	53	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183594	10.1371/journal.pone.0183594	http://dx.doi.org/10.1371/journal.pone.0183594			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832681	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800068
J	Wang, J; Kong, XY; Xing, ZY; Wang, XY; Zhai, J; Fang, Y; Gao, JD				Wang, Jing; Kong, Xiangyi; Xing, Zeyu; Wang, Xiangyu; Zhai, Jie; Fang, Yi; Gao, Jidong			A meta-analysis: Is there any association between MiR-608 rs4919510 polymorphism and breast cancer risks?	PLOS ONE			English	Article								Object To combine the data from previously conducted studies about the associations between miR-608 rs4919510 polymorphism (C>G) and breast cancer risks. Methods According to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we conducted a systematic review of the related literatures searched from PubMed, Embase, Cochrane Library, Web of Science, and China National Knowledge Internet (CNKI) (time: similar to December 2016). Using DerSimonian-Laird random-effects models [Pooling Model: Mantel Haenszel (MH)], odd ratios (ORs) with 95% confidence intervals (95% CIs) were estimated in the allele model, homozygote model, heterozygote model, dominant model and recessive model. Heterogeneity was analyzed using Labbr plots and I 2 statistic. Publication bias was analyzed using contour-enhanced funnel plots. Results We included 5 eligible studies with 7948 patients. The ORs and their 95% CIs in the 5 genetic models mentioned above were 1.009 (95% CI: 0.922, 1.104; p = 0.847), 1.098 (95% CI: 0.954, 1.264; p = 0.194), 1.076 (95% CI: 0.956, 1.211; p = 0.227), 1.043 (95% CI: 0.880, 1.236; p = 0.628), 1.007 (95% CI: 0.906, 1.118; p = 0.899), respectively. Conclusion In the present meta-analysis, no relationships between miR-608 rs4919510 polymorphism (C>G) and the risk of breast cancer were found. More studies are warranted to further validate the conclusion.	[Fang, Yi; Gao, Jidong] Chinese Acad Med Sci, Dept Breast Surg Oncol, China Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Fang, Y; Gao, JD (corresponding author), Chinese Acad Med Sci, Dept Breast Surg Oncol, China Natl Canc Ctr, Canc Hosp, Beijing, Peoples R China.	fangyi0501@vip.sina.com; ab168@cicams.ac.cn		He, Zheng/0000-0002-2357-1936	Beijing Municipal Natural Science Foundation [7162163]; Chinese Academy of Medical Sciences [2016-12M-1-007]; National Natural Science Foundation of China [81372829]	Beijing Municipal Natural Science Foundation(Beijing Natural Science Foundation); Chinese Academy of Medical Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by Beijing Municipal Natural Science Foundation (Y.F., no. 7162163), Medical and health science and technology innovation project of Chinese Academy of Medical Sciences (J.W., 2016-12M-1-007), and National Natural Science Foundation of China (J. W., General Program:81372829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali AM, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/8721052; Chen QH, 2014, TUMOR BIOL, V35, P529, DOI 10.1007/s13277-013-1074-7; Chetlen A, 2016, CLIN IMAG, V40, P279, DOI 10.1016/j.clinimag.2015.05.017; Copas J, 2000, Biostatistics, V1, P247, DOI 10.1093/biostatistics/1.3.247; Dai ZM, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002826; DerSimonian R, 2015, CONTEMP CLIN TRIALS, V45, P139, DOI 10.1016/j.cct.2015.09.002; Guo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030585; Hashemi M, 2016, EXP ONCOL; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hu Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep03648; Huang AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035252; Jiao LH, 2014, AM J TRANSL RES, V6, P869; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Li Wen-Jing, 2015, Asian Pac J Cancer Prev, V16, P7905; Liu H, 2016, ONCOTARGET, DOI 10.18632/oncotarget.7828; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Morales S, 2016, BMC GENET, V17, DOI 10.1186/s12863-016-0415-0; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Ryan BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036306; Shao ZM, 2012, THESIS; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sun KL, 2013, NAT REV GENET, V14, P535, DOI 10.1038/nrg3471; Truong T, 2014, ENDOCR-RELAT CANCER, V21, P629, DOI 10.1530/ERC-14-0121	23	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183012	10.1371/journal.pone.0183012	http://dx.doi.org/10.1371/journal.pone.0183012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829821	gold, Green Published, Green Submitted			2022-12-27	WOS:000408085100024
J	Belaza, AM; Hoefman, K; Ryckebusch, J; Bramson, A; van den Heuvel, M; Schoors, K				Belaza, Andres M.; Hoefman, Kevin; Ryckebusch, Jan; Bramson, Aaron; van den Heuvel, Milan; Schoors, Koen			Statistical physics of balance theory	PLOS ONE			English	Article							STRUCTURAL BALANCE; SOCIAL NETWORKS; ORGANIZATION; DYNAMICS	Triadic relationships are accepted to play a key role in the dynamics of social and political networks. Building on insights gleaned from balance theory in social network studies and from Boltzmann-Gibbs statistical physics, we propose a model to quantitatively capture the dynamics of the four types of triadic relationships in a network. Central to our model are the triads' incidence rates and the idea that those can be modeled by assigning a specific triadic energy to each type of triadic relation. We emphasize the role of the degeneracy of the different triads and how it impacts the degree of frustration in the political network. In order to account for a persistent form of disorder in the formation of the triadic relationships, we introduce the systemic variable temperature. In order to learn about the dynamics and motives, we propose a generic Hamiltonian with three terms to model the triadic energies. One term is connected with a three-body interaction that captures balance theory. The other terms take into account the impact of heterogeneity and of negative edges in the triads. The validity of our model is tested on four datasets including the time series of triadic relationships for the standings between two classes of alliances in a massively multiplayer online game (MMOG). We also analyze real-world data for the relationships between the "agents" involved in the Syrian civil war, and in the relations between countries during the Cold War era. We find emerging properties in the triadic relationships in a political network, for example reflecting itself in a persistent hierarchy between the four triadic energies, and in the consistency of the extracted parameters from comparing the model Hamiltonian to the data.	[Belaza, Andres M.; Ryckebusch, Jan; van den Heuvel, Milan] Univ Ghent, Dept Phys & Astron, Ghent, Belgium; [Belaza, Andres M.; Hoefman, Kevin; Bramson, Aaron; van den Heuvel, Milan; Schoors, Koen] Univ Ghent, Dept Gen Econ, Ghent, Belgium; [Bramson, Aaron] RIKEN Brain Sci Inst, Lab Symbol Cognit Dev, Wako, Saitama, Japan; [Bramson, Aaron] Univ North Carolina Charlotte, Dept Software & Informat Syst, Charlotte, NC USA; [Schoors, Koen] Natl Res Univ, Higher Sch Econ, Moscow, Russia	Ghent University; Ghent University; RIKEN; University of North Carolina; University of North Carolina Charlotte; HSE University (National Research University Higher School of Economics)	Belaza, AM (corresponding author), Univ Ghent, Dept Phys & Astron, Ghent, Belgium.; Belaza, AM (corresponding author), Univ Ghent, Dept Gen Econ, Ghent, Belgium.	Andres.Belaza@ugent.be	Schoors, Koen/N-7059-2019	Schoors, Koen/0000-0002-4159-8083; Belaza, Andres/0000-0003-3501-6718; van den Heuvel, Milan/0000-0003-3759-7173; Ryckebusch, Jan/0000-0001-7750-1522	Fund of Scientific Research - Flanders (FWO); Ghent University	Fund of Scientific Research - Flanders (FWO)(FWO); Ghent University(Ghent University)	This work was supported by Fund of Scientific Research - Flanders (FWO) (JR, KS, MvdH) and Research Fund of Ghent University (AMB, KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELL P, 1968, SOCIOLOGY, V2, P333, DOI 10.1177/003803856800200305; Abell P, 2009, J MATH SOCIOL, V33, P129, DOI 10.1080/00222500902718239; [Anonymous], 2015, ECONOMIST; Antal T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036121; Antal T, 2006, PHYSICA D, V224, P130, DOI 10.1016/j.physd.2006.09.028; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; CCP. EVE Online, 1997, EVE ONL, P1997; DAVIS JA, 1967, HUM RELAT, V20, P181, DOI 10.1177/001872676702000206; Doreian P, 2015, J SOCIAL STRUCTURE, V16; Estrada E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042802; Facchetti G, 2011, P NATL ACAD SCI USA, V108, P20953, DOI 10.1073/pnas.1109521108; Galam S, 1996, PHYSICA A, V230, P174, DOI 10.1016/0378-4371(96)00034-9; Gawronski P, 2005, ACTA PHYS POL B, V36, P2549; Gibler DM, 1648, INT MILITARY ALLIANC; HART J, 1974, J PEACE RES, V11, P229, DOI 10.1177/002234337401100307; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hummon NP, 2003, SOC NETWORKS, V25, P17, DOI 10.1016/S0378-8733(02)00019-9; Lerner J, 2016, SOC NETWORKS, V45, P66, DOI 10.1016/j.socnet.2015.12.002; Leskovec J, 2010, CHI 2010 MACHINE LEA; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; Palmer G, CONFLICT MANAGEMENT; Presse S, 2013, REV MOD PHYS, V85, P1115, DOI 10.1103/RevModPhys.85.1115; Saiz H, 2017, ECOGRAPHY, V40, P733, DOI 10.1111/ecog.02561; Szell M, 2010, P NATL ACAD SCI USA, V107, P13636, DOI 10.1073/pnas.1004008107; Traag VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060063; Vinogradova G, 2014, EUR PHYS J B, V87, DOI 10.1140/epjb/e2014-50264-4; Wikipedia, 2016, WIK MIL INT ISIL WIK	27	35	35	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183696	10.1371/journal.pone.0183696	http://dx.doi.org/10.1371/journal.pone.0183696			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846726	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600045
J	Buchakjian, MR; Merritt, NM; Moose, DL; Dupuy, AJ; Tanas, MR; Henry, MD				Buchakjian, Marisa R.; Merritt, Nicole M.; Moose, Devon L.; Dupuy, Adam J.; Tanas, Munir R.; Henry, Michael D.			A Trp53 (fl/fl) Pten (fl/fl) mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging	PLOS ONE			English	Article							SOFT-TISSUE SARCOMAS; TUMOR-SUPPRESSOR; P53; PROGRESSION; DEFICIENT; CANCER; GENE; MICE	Genetic mouse models of soft tissue sarcoma provide critical insights into disease pathophysiology, which are oftentimes unable to be extracted from human tumor samples or xenograft models. In this study we describe a mouse model of soft tissue sarcoma mediated by adenoviral-Cre recombinase injection into Trp53 (fl/fl) /Pten (fl/fl) lox-stop-lox luciferase mice. Injection of adenovirus expressing Cre recombinase, either subcutaneously or intramuscularly in two experimental groups, results in viral infection and gene recombination with 100% penetrance within the first 24 hours following injection. Luciferase expression measured by real-time bioluminescence imaging increases over time, with an initial robust increase following viral injection, followed by a steady rise over the next several weeks as primary tumors develop and grow. Intramuscular injections were more commonly associated with evidence of systemic viral distribution than subcutaneous injections. All mice developed soft tissue sarcomas at the primary injection site, with histological examination identifying 93% of tumors as invasive pleomorphic sarcomas based on microscopic morphology and immunohistochemical expression of sarcoma markers. A lymphocytic infiltrate was present in 64% of the sarcomas in this immunocompetent model and 71% of tumors expressed PDL1. This is the first report of a viral-Cre mediated Trp53/Pten mouse model of undifferentiated pleomorphic sarcoma. The bioluminescence imaging feature, along with high penetrance of the model and its immunological characteristics, makes it suited for pre-clinical studies of soft tissue sarcoma.	[Buchakjian, Marisa R.] Univ Iowa Hosp & Clin, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Buchakjian, Marisa R.; Moose, Devon L.; Henry, Michael D.] Univ Iowa, Dept Mol Physiol & Biophys, Carver Coll Med, Iowa City, IA USA; [Buchakjian, Marisa R.; Dupuy, Adam J.; Tanas, Munir R.; Henry, Michael D.] Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA; [Merritt, Nicole M.; Tanas, Munir R.; Henry, Michael D.] Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA; [Dupuy, Adam J.] Univ Iowa, Dept Anat & Cell Biol, Carver Coll Med, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa	Tanas, MR (corresponding author), Univ Iowa Hosp & Clin, Holden Comprehens Canc Ctr, Iowa City, IA 52242 USA.; Tanas, MR (corresponding author), Univ Iowa Hosp & Clin, Dept Pathol, Iowa City, IA 52242 USA.	munir-tanas@uiowa.edu		Buchakjian, Marisa/0000-0001-8261-1566; Moose, Devon/0000-0002-1694-3981; Dupuy, Adam/0000-0002-8561-4911; Tanas, Munir/0000-0002-6779-2642; Henry, Michael/0000-0002-7871-245X	University of Iowa Sarcoma Foundation; Veterans Health Administration Merit Review Program [1 I01 BX003644-01]; University of Iowa Sarcoma Research Program;  [P30 CA086862]; NATIONAL CANCER INSTITUTE [P30CA086862] Funding Source: NIH RePORTER; Veterans Affairs [I01BX003644] Funding Source: NIH RePORTER	University of Iowa Sarcoma Foundation; Veterans Health Administration Merit Review Program; University of Iowa Sarcoma Research Program; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Veterans Affairs(US Department of Veterans Affairs)	A portion of this work was funded by a pilot grant from the University of Iowa Sarcoma Foundation. This study was also funded by a grant from the Veterans Health Administration Merit Review Program (1 I01 BX003644-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Core facilities used in these studies were supported by P30 CA086862. This work was supported by a grant from the Veterans Health Administration Merit Review Program (1 I01 BX003644-01) to MRT and pilot grant funding from the University of Iowa Sarcoma Research Program to MDH. We would like to thank Allyn M. Lambertz and Georgina Ofori-Amanfo for assistance with tissue processing and immunohistochemical staining. We would also like to thank Rebecca D. Dodd for her careful reading and thoughtful insight into the manuscript.	Balar AV, 2017, CANCER IMMUNOL IMMUN, V1, P1; Bieging KT, 2014, NAT REV CANCER, V14, P359, DOI 10.1038/nrc3711; Borden EC, 2003, CLIN CANCER RES, V9, P1941; Collini P, 2009, SEMIN ONCOL, V36, P324, DOI 10.1053/j.seminoncol.2009.06.007; Demicco EG, 2012, ADV ANAT PATHOL, V19, P170, DOI 10.1097/PAP.0b013e318253462f; Dodd Rebecca D, 2015, Methods Mol Biol, V1267, P283, DOI 10.1007/978-1-4939-2297-0_13; Dodd RD, 2010, DIS MODEL MECH, V3, P557, DOI 10.1242/dmm.005223; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; DuPage M, 2012, NATURE, V482, P405, DOI 10.1038/nature10803; Edinger M, 2002, EUR J CANCER, V38, P2128, DOI 10.1016/S0959-8049(02)00410-0; El Hilali N, 2002, LAB INVEST, V82, P1563, DOI 10.1097/01.LAB.0000036877.36379.1F; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guijarro MV, 2013, AM J PATHOL, V182, P2015, DOI 10.1016/j.ajpath.2013.02.035; Ito M, 2011, CLIN CANCER RES, V17, P416, DOI 10.1158/1078-0432.CCR-10-2050; Kawaguchi K, 2005, HUM PATHOL, V36, P357, DOI 10.1016/j.humpath.2005.01.017; Kirsch DG, 2007, NAT MED, V13, P992, DOI 10.1038/nm1602; Marino S, 2000, GENE DEV, V14, P994; Matushansky I, 2009, EXPERT REV ANTICANC, V9, P1135, DOI [10.1586/era.09.76, 10.1586/ERA.09.76]; Mito JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008075; Puzio-Kuter AM, 2015, CELL DEATH DIFFER, V22, P1785, DOI 10.1038/cdd.2015.27; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Sachdeva M, 2016, J CLIN INVEST, V126, P1606, DOI 10.1172/JCI86573; Safran Michal, 2003, Mol Imaging, V2, P297, DOI 10.1162/153535003322750637; Sim H, 2011, CANCER RES, V71, P686, DOI 10.1158/0008-5472.CAN-10-2666; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sorrell AD, 2013, MOL DIAGN THER, V17, P31, DOI 10.1007/s40291-013-0020-0; Svensson RU, 2011, AM J PATHOL, V179, P502, DOI 10.1016/j.ajpath.2011.03.014; Taylor BS, 2011, NAT REV CANCER, V11, P541, DOI 10.1038/nrc3087	28	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183469	10.1371/journal.pone.0183469	http://dx.doi.org/10.1371/journal.pone.0183469			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841687	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700034
J	Han, WW; Zhang, ZY; He, BS; Xu, YJ; Zhang, J; Cao, WJ				Han, Weiwei; Zhang, Zhenyu; He, Bangshun; Xu, Yijun; Zhang, Jun; Cao, Weijun			Integrated analysis of long non-coding RNAs in human gastric cancer: An in silico study	PLOS ONE			English	Article							POOR-PROGNOSIS; EXPRESSION; MUTATIONS; IDENTIFICATION; GENETICS; GENOME	Accumulating evidence highlights the important role of long non-coding RNAs (lncRNAs) in a large number of biological processes. However, the knowledge of genome scale expression of lncRNAs and their potential biological function in gastric cancer is still lacking. Using RNA-seq data from 420 gastric cancer patients in The Cancer Genome Atlas (TCGA), we identified 1,294 lncRNAs differentially expressed in gastric cancer compared with adjacent normal tissues. We also found 247 lncRNAs differentially expressed between intestinal subtype and diffuse subtype. Survival analysis revealed 33 lncRNAs independently associated with patient overall survival, of which 6 lncRNAs were validated in the internal validation set. There were 181 differentially expressed lncRNAs located in the recurrent somatic copy number alterations (SCNAs) regions and their correlations between copy number and RNA expression level were also analyzed. In addition, we inferred the function of lncRNAs by construction of a co-expression network for mRNAs and lncRNAs. Together, this study presented an integrative analysis of lncRNAs in gastric cancer and provided a valuable resource for further functional research of lncRNAs in gastric cancer.	[Han, Weiwei; Zhang, Zhenyu; Xu, Yijun; Zhang, Jun; Cao, Weijun] Nanjing Med Univ, Dept Gastroenterol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China; [He, Bangshun] Nanjing Med Univ, Gen Clin Res Ctr, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Cao, WJ (corresponding author), Nanjing Med Univ, Dept Gastroenterol, Nanjing Hosp 1, Nanjing, Jiangsu, Peoples R China.	cwjonline@sina.cn			Nanjing Medical University Science and Technique Development Foundation Project [2014NMUZD033]	Nanjing Medical University Science and Technique Development Foundation Project	Funding provided by Nanjing Medical University Science and Technique Development Foundation Project (2014NMUZD033), http://www.njmu.edu.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful for all the contributions that supported this study. This study was supported by grants from Nanjing Medical University Science and Technique Development Foundation Project (2014NJMUZD033). Our gratitude also goes to The Cancer Genome Atlas project for generating, curating and providing high quality biological and clinical data about gastric cancer.	[Anonymous], 2014, R PACKAGE VERSION 1; [Anonymous], 2013, R PACKAGE VERSION 2, V1, P1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cunningham F, 2015, NUCLEIC ACIDS RES, V43, pD662, DOI 10.1093/nar/gku1010; Endo H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077070; Feigin ME, 2017, NAT GENET, V49, P825, DOI 10.1038/ng.3861; Guttman M, 2012, NATURE, V482, P339, DOI 10.1038/nature10887; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu XW, 2014, CANCER CELL, V26, P344, DOI 10.1016/j.ccr.2014.07.009; Hu Y, 2014, CANCER RES, V74, P6890, DOI 10.1158/0008-5472.CAN-14-0686; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kalamohan K, 2014, MOL ONCOL, V8, P1306, DOI 10.1016/j.molonc.2014.04.005; Kong R, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0355-8; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31, DOI 10.1111/apm.1965.64.1.31; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liao Y, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt214; Liu XH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-92; Luo Y, 2017, ONCOTARGET; McLean MIH, 2014, NAT REV GASTRO HEPAT, V11, P664, DOI 10.1038/nrgastro.2014.143; Mermel CH, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-r41; Miyanaga A, 2015, J THORAC ONCOL, V10, P844, DOI 10.1097/JTO.0000000000000493; Nohata N, 2016, ORAL ONCOL, V59, P58, DOI 10.1016/j.oraloncology.2016.05.014; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Stracquadanio G, 2016, NAT REV CANCER, V16, P251, DOI 10.1038/nrc.2016.15; Sun M, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-319; Sun TT, 2016, CANCER DISCOV, V6, P784, DOI 10.1158/2159-8290.CD-15-0921; Torre LA, 2016, CANCER EPIDEM BIOMAR, V25, P16, DOI 10.1158/1055-9965.EPI-15-0578; Tseng YY, 2014, NATURE, V512, P82, DOI 10.1038/nature13311; Van Cutsem E, 2016, LANCET, V388, P2654, DOI 10.1016/S0140-6736(16)30354-3; Wang XD, 2015, CANCER METAST REV, V34, P217, DOI 10.1007/s10555-015-9556-2; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760; Zhang B, 2016, DISCOV MED, V21, P239; Zhang L, 2017, LUNG CANCER, V109, P21, DOI 10.1016/j.lungcan.2017.04.009; Zhao J, 2015, CELL CYCLE, V14, P3112, DOI 10.1080/15384101.2015.1078034	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183517	10.1371/journal.pone.0183517	http://dx.doi.org/10.1371/journal.pone.0183517			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841672	Green Submitted, gold, Green Published			2022-12-27	WOS:000408370700038
J	Syranidou, E; Karkanorachaki, K; Amorotti, F; Repouskou, E; Kroll, K; Kolvenbach, B; Corvini, PFX; Fava, F; Kalogerakis, N				Syranidou, Evdokia; Karkanorachaki, Katerina; Amorotti, Filippo; Repouskou, Eftychia; Kroll, Kevin; Kolvenbach, Boris; Corvini, Philippe F-X; Fava, Fabio; Kalogerakis, Nicolas			Development of tailored indigenous marine consortia for the degradation of naturally weathered polyethylene films	PLOS ONE			English	Article							LOW-DENSITY POLYETHYLENE; MICROBIAL-DEGRADATION; PLASTIC DEBRIS; BIODEGRADATION; MICROPLASTICS; BACTERIA; ENVIRONMENT; COMMUNITY; ABUNDANCE; COLONIZATION	This study investigated the potential of bacterial-mediated polyethylene (PE) degradation in a two-phase microcosm experiment. During phase I, naturally weathered PE films were incubated for 6 months with the indigenous marine community alone as well as bioaugmented with strains able to grow in minimal medium with linear low-density polyethylene (LLDPE) as the sole carbon source. At the end of phase I the developed biofilm was harvested and re-inoculated with naturally weathered PE films. Bacteria from both treatments were able to establish an active population on the PE surfaces as the biofilm community developed in a time dependent way. Moreover, a convergence in the composition of these communities was observed towards an efficient PE degrading microbial network, comprising of indigenous species. In acclimated communities, genera affiliated with synthetic (PE) and natural (cellulose) polymer degraders as well as hydrocarbon degrading bacteria were enriched. The acclimated consortia (indigenous and bioaugmented) reduced more efficiently the weight of PE films in comparison to non-acclimated bacteria. The SEM images revealed a dense and compact biofilm layer and signs of bio-erosion on the surface of the films. Rheological results suggest that the polymers after microbial treatment had wider molecular mass distribution and a marginally smaller average molar mass suggesting biodegradation as opposed to abiotic degradation. Modifications on the surface chemistry were observed throughout phase II while the FTIR profiles of microbially treated films at month 6 were similar to the profiles of virgin PE. Taking into account the results, we can suggest that the tailored indigenous marine community represents an efficient consortium for degrading weathered PE plastics.	[Syranidou, Evdokia; Karkanorachaki, Katerina; Amorotti, Filippo; Kalogerakis, Nicolas] Tech Univ Crete, Sch Environm Engn, Khania, Greece; [Amorotti, Filippo; Fava, Fabio] Univ Bologna, Dept Civil Chem Environm & Mat Engn DICAM, Bologna, Italy; [Repouskou, Eftychia] Tech Univ Crete, Sch Mineral Resources Engn, Khania, Greece; [Kroll, Kevin; Kolvenbach, Boris; Corvini, Philippe F-X] FHNW, Sch Life Sci, Inst Ecopreneurship, Muttenz, Switzerland	Technical University of Crete; University of Bologna; Technical University of Crete; FHNW University of Applied Sciences & Arts Northwestern Switzerland	Kalogerakis, N (corresponding author), Tech Univ Crete, Sch Environm Engn, Khania, Greece.	nicolas.kalogerakis@enveng.tuc.gr	Syranidou, Evdokia/AAO-4883-2020; KALOGERAKIS, Nicolas/AAC-8528-2019; Kalogerakis, Nicolas/C-9254-2009	KALOGERAKIS, Nicolas/0000-0001-7033-0302; Kalogerakis, Nicolas/0000-0001-7033-0302; Syranidou, Evdokia/0000-0002-1971-3807; Karkanorachaki, Katerina/0000-0002-2560-712X; FAVA, FABIO/0000-0001-9283-0420; Amorotti, Filippo/0000-0003-3819-2565; Kolvenbach, Boris/0000-0003-3491-9026	European Union FP-7 project BIOCLEAN [312100]	European Union FP-7 project BIOCLEAN	Funding by the European Union FP-7 project BIOCLEAN (grant agreement No. 312100) is highly appreciated (www.biocleanproject.eu).; Funding by the European Union FP-7 project BIOCLEAN (grant agreement No. 312100) is highly appreciated. We thank S. Costanzo and D. Parisi (FORTH, Heraklion, Greece) for the rheological measurements and C. Chatzidoukas (Chemical Eng. Dept., AUTh, Greece) for the FTIR measurements.	Andrady AL, 2011, MAR POLLUT BULL, V62, P1596, DOI 10.1016/j.marpolbul.2011.05.030; Antoniou E, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00274; Artham T, 2009, INT BIODETER BIODEGR, V63, P884, DOI 10.1016/j.ibiod.2009.03.003; Balasubramanian V, 2010, LETT APPL MICROBIOL, V51, P205, DOI 10.1111/j.1472-765X.2010.02883.x; Bonhomme S, 2003, POLYM DEGRAD STABIL, V81, P441, DOI 10.1016/S0141-3910(03)00129-0; Bryant JA, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00024-16; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cardinale M, 2004, APPL ENVIRON MICROB, V70, P6147, DOI 10.1128/AEM.70.10.6147-6156.2004; Cole M, 2011, MAR POLLUT BULL, V62, P2588, DOI 10.1016/j.marpolbul.2011.09.025; Costanzo S, 2016, MACROMOLECULES, V49, P7054, DOI 10.1021/acs.macromol.6b01311; Cozar A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121762; Cozar A, 2014, P NATL ACAD SCI USA, V111, P10239, DOI 10.1073/pnas.1314705111; da Costa JP, 2016, SCI TOTAL ENVIRON, V566, P15, DOI 10.1016/j.scitotenv.2016.05.041; Das MP, 2015, 3 BIOTECH, V5, P81, DOI 10.1007/s13205-014-0205-1; Dealy J. M., 2018, STRUCTURE RHEOLOGY M, DOI DOI 10.3139/9781569906125; Eriksen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111913; Fazey FMC, 2016, ENVIRON POLLUT, V210, P354, DOI 10.1016/j.envpol.2016.01.026; Fontanella S, 2010, POLYM DEGRAD STABIL, V95, P1011, DOI 10.1016/j.polymdegradstab.2010.03.009; Gilan I, 2004, APPL MICROBIOL BIOT, V65, P97, DOI 10.1007/s00253-004-1584-8; Goldstein MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080020; Hadad D, 2005, J APPL MICROBIOL, V98, P1093, DOI 10.1111/j.1365-2672.2005.02553.x; Harrison JP, 2014, BMC MICROBIOL, V14, DOI 10.1186/s12866-014-0232-4; Harshvardhan K, 2013, MAR POLLUT BULL, V77, P100, DOI 10.1016/j.marpolbul.2013.10.025; Hwang SJ, 1999, J PLANKTON RES, V21, P699, DOI 10.1093/plankt/21.4.699; Jin CE, 2017, INT BIODETER BIODEGR, V118, P27, DOI 10.1016/j.ibiod.2017.01.020; Kalogerakis N, 2017, FRONT MAR SCI, P4; Koutny M, 2006, POLYM DEGRAD STABIL, V91, P1495, DOI 10.1016/j.polymdegradstab.2005.10.007; Kowalczyk A, 2016, ENVIRON SCI POLLUT R, V23, P11349, DOI 10.1007/s11356-016-6563-y; Kowalski N, 2016, MAR POLLUT BULL, V109, P310, DOI 10.1016/j.marpolbul.2016.05.064; Lee JW, 2008, J MICROBIOL, V46, P174, DOI 10.1007/s12275-008-0032-3; Lo YC, 2009, ENZYME MICROB TECH, V44, P417, DOI 10.1016/j.enzmictec.2009.03.002; Lobelle D, 2011, MAR POLLUT BULL, V62, P197, DOI 10.1016/j.marpolbul.2010.10.013; Lucas N, 2008, CHEMOSPHERE, V73, P429, DOI 10.1016/j.chemosphere.2008.06.064; Masella AP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-31; McDougald D, 2012, NAT REV MICROBIOL, V10, P39, DOI 10.1038/nrmicro2695; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Nauendorf A, 2016, MAR POLLUT BULL, V103, P168, DOI 10.1016/j.marpolbul.2015.12.024; Nie Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04968; Nkem BM, 2016, MAR POLLUT BULL, V107, P261, DOI 10.1016/j.marpolbul.2016.03.060; Pathak VM, 2017, BIORESOUR BIOPROCESS, V4, DOI 10.1186/s40643-017-0145-9; Perez-de-Mora A, 2011, MICROB ECOL, V62, P959, DOI 10.1007/s00248-011-9858-z; Plastics Europe, 2015, PLAST FACTS 2014 201; Prieto A, 2016, MICROB BIOTECHNOL, V9, P652, DOI 10.1111/1751-7915.12393; R Core Team, 2020, R LANG ENV STAT COMP; Raghul SS, 2014, INT J ENVIRON SCI TE, V11, P1827, DOI 10.1007/s13762-013-0335-8; Ramette A, 2009, APPL ENVIRON MICROB, V75, P2495, DOI 10.1128/AEM.02409-08; Reisser J, 2014, PLOS ONE, V9, P1, DOI DOI 10.1371/J0URNAL.P0NE.0100289; Restrepo-Florez JM, 2014, INT BIODETER BIODEGR, V88, P83, DOI 10.1016/j.ibiod.2013.12.014; Rochman CM, 2013, NATURE, V494, P169, DOI 10.1038/494169a; Roy PK, 2008, POLYM DEGRAD STABIL, V93, P1917, DOI 10.1016/j.polymdegradstab.2008.07.016; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; Santos RG, 2016, ENVIRON POLLUT, V214, P585, DOI 10.1016/j.envpol.2016.04.024; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Sen SK, 2015, J ENVIRON CHEM ENG, V3, P462, DOI 10.1016/j.jece.2015.01.003; Shah AA, 2008, BIOTECHNOL ADV, V26, P246, DOI 10.1016/j.biotechadv.2007.12.005; Shannon CE, 2002, MATH THEORY COMMUNIC; Sivan A, 2011, CURR OPIN BIOTECH, V22, P422, DOI 10.1016/j.copbio.2011.01.013; STANIER RY, 1966, J GEN MICROBIOL, V43, P159, DOI 10.1099/00221287-43-2-159; Sudhakar M, 2008, INT BIODETER BIODEGR, V61, P203, DOI 10.1016/j.ibiod.2007.07.011; Teuten EL, 2009, PHILOS T R SOC B, V364, P2027, DOI 10.1098/rstb.2008.0284; Thompson RC, 2009, PHILOS T R SOC B, V364, P1973, DOI 10.1098/rstb.2009.0054; Tribedi P., 2015, BIORESOUR BIOPROCESS, V2, P14, DOI [10.1186/s40643-015-0044-x, DOI 10.1186/S40643-015-0044-X]; Tribedi P, 2013, ENVIRON SCI POLLUT R, V20, P4146, DOI 10.1007/s11356-012-1378-y; Tubau X, 2015, PROG OCEANOGR, V134, P379, DOI 10.1016/j.pocean.2015.03.013; Wang JD, 2016, MAR ENVIRON RES, V113, P7, DOI 10.1016/j.marenvres.2015.10.014; Wright SL, 2013, ENVIRON POLLUT, V178, P483, DOI 10.1016/j.envpol.2013.02.031; ZERBI G, 1989, POLYMER, V30, P2324, DOI 10.1016/0032-3861(89)90269-3; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	68	53	55	3	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183984	10.1371/journal.pone.0183984	http://dx.doi.org/10.1371/journal.pone.0183984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841722	gold, Green Submitted, Green Published			2022-12-27	WOS:000408370700073
J	Leiva, JA; Nkedi-Kizza, P; Morgan, KT; Kadyampakeni, DM				Leiva, Jorge A.; Nkedi-Kizza, Peter; Morgan, Kelly T.; Kadyampakeni, Davie M.			Imidacloprid transport and sorption nonequilibrium in single and multilayered columns of Immokalee fine sand	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; NEONICOTINOID INSECTICIDE; PESTICIDE TRANSPORT; LEACHING BEHAVIOR; SOILS; CITRUS; KINETICS; THIAMETHOXAM; DEGRADATION; EQUILIBRIA	Imidacloprid (IMD) is a neonicotinoid pesticide soil-drenched to many crops to control piercing-sucking insects such as the Asian citrus psyllid (ACP). Neonicotinoids are persistent in the environment and transport analyses are helpful estimate leaching potential from soils that could result in groundwater pollution. The objective of this study was to analyze IMD breakthrough under saturated water flow in soil columns packed with three horizons (A, E, Bh) of Immokalee Fine Sand (IFS). Also, we used the dimensionless form of the convective-dispersive model (CD-Model) to compare the optimized transport parameters from each column experiment (retardation factor, R; fraction of instantaneous-to-total retardation, beta; and mass transfer coefficient, omega) with the parameters obtained from sorption batch equilibria and sorption kinetics. The tracer (Cl-) breakthrough curves (BTCs) were symmetrical and properly described by the CD-Model. IMD BTCs from A, Bh, and multilayered [A+E+Bh] soil columns showed steep fronts and tailing that were well described by the one-site nonequilibrium (OSNE) model, which was an evidence of non-ideal transport due to IMD mass transfer into the soil organic matter. In general, IMD was weakly-sorbed in the A and Bh horizons (R values of 3.72 +/- 0.04 and 3.08 +/- 0.07, respectively), and almost no retardation was observed in the E horizon (R = 1.20 +/- 0.02) due to its low organic matter content (0.3%). Using the HYDRUS-1D package, optimized parameters (R, beta, omega) from the individual columns successfully simulated IMD transport in a multilayered column mimicking an IFS soil profile. These column studies and corresponding simulations agreed with previous findings from batch sorption equilibria and kinetics experiments, where IMD showed one-site kinetic mass transfer between soil surfaces and soil solution. Ideally, sandy soils should be maintained unsaturated by crop irrigation systems and rainfall monitoring during and after soil-drench application. The unsaturated soil will increase IMD retardation factors and residence time for plant uptake, lowering leaching potential from soil layers with low sorption capacity, such as the E horizon.	[Leiva, Jorge A.; Nkedi-Kizza, Peter] Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA; [Morgan, Kelly T.] UF IFAS Southwest Florida Res & Educ Ctr, Immokalee, FL USA; [Kadyampakeni, Davie M.] UF IFAS Citrus Res & Educ Ctr, Lake Alfred, FL USA	State University System of Florida; University of Florida	Leiva, JA (corresponding author), Univ Florida, Inst Food & Agr Sci, Soil & Water Sci Dept, Gainesville, FL 32611 USA.	jorge.leiva@ufl.edu		Leiva-Sanabria, Jorge-Armando/0000-0001-7255-2726	United States Department of Agriculture; University of Florida Open Access Publishing Fund; United States Department of Agriculture; University of Florida Open Access Publishing Fund	United States Department of Agriculture(United States Department of Agriculture (USDA)); University of Florida Open Access Publishing Fund; United States Department of Agriculture(United States Department of Agriculture (USDA)); University of Florida Open Access Publishing Fund	This work was supported by the United States Department of Agriculture to PN and KTM. Publication of this article was funded in part by the University of Florida Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bi EP, 2009, J CONTAM HYDROL, V107, P58, DOI 10.1016/j.jconhyd.2009.04.001; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; BRUSSEAU ML, 1989, WATER RESOUR RES, V25, P1971, DOI 10.1029/WR025i009p01971; BRUSSEAU ML, 1991, SSSA SPEC PUBL, V27, P281; Brusseau ML, 1998, PHYSICAL NONEQUILIBR, P63; Buckingham SD, 1997, J EXP BIOL, V200, P2685; Choquette AF, 2009, WATER QUALITY EVALUA; Choquette AF, 2014, PESTICIDES NITRATE G; Fernandez-Bayo JD, 2008, J AGR FOOD CHEM, V56, P5266, DOI 10.1021/jf8004349; Fernandez-Bayo JD, 2015, J ENVIRON SCI HEAL B, V50, P190, DOI 10.1080/03601234.2015.982423; Flint AL, 2002, 2 1 BULK DENSITY LIN, P201; Flores-Cespedes F, 2002, J ENVIRON QUAL, V31, P880, DOI 10.2134/jeq2002.0880; Flury M, 1996, J ENVIRON QUAL, V25, P25, DOI 10.2134/jeq1996.00472425002500010005x; Fossen M., 2006, ENV FATE IMIDACLOPRI, P16; Gervais J.A., 2010, IMIDACLOPRID TECHNIC; Gottwald TR, 2010, ANNU REV PHYTOPATHOL, V48, P119, DOI 10.1146/annurev-phyto-073009-114418; Gupta S, 2002, B ENVIRON CONTAM TOX, V68, P502, DOI 10.1007/s001280283; Gupta S, 2008, B ENVIRON CONTAM TOX, V80, P431, DOI 10.1007/s00128-008-9420-y; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; Jeschke P, 2008, PEST MANAG SCI, V64, P1084, DOI 10.1002/ps.1631; Kadyampakeni DM, 2014, SOIL SCI SOC AM J, V78, P1351, DOI 10.2136/sssaj2014.02.0054; Kadyampakeni DM, 2014, SOIL SCI SOC AM J, V78, P645, DOI 10.2136/sssaj2013.07.0319; Karmakar R, 2006, B ENVIRON CONTAM TOX, V76, P400, DOI 10.1007/s00128-006-0935-9; Katagi T, 2013, REV ENVIRON CONTAM T, V221, P1, DOI 10.1007/978-1-4614-4448-0_1; Katayama A, 2010, REV ENVIRON CONTAM T, V203, P1, DOI 10.1007/978-1-4419-1352-4_1; Krischik V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119133; Kuntz D, 2009, J HYDROL, V369, P225, DOI 10.1016/j.jhydrol.2009.02.006; Kurwadkar S, 2014, J CONTAM HYDROL, V170, P86, DOI 10.1016/j.jconhyd.2014.09.009; Leiva JA, 2014, IMIDACLOPRID FATE TR; Leiva JA, 2015, J AGR FOOD CHEM, V63, P4915, DOI 10.1021/acs.jafc.5b00532; Ma LW, 2005, SOIL SCI SOC AM J, V69, P318, DOI 10.2136/sssaj2005.0318; Markus F, 1998, ACS SYM SER, V699, P65; Muwamba A., 2012, NITROGEN PHOSPHORUS; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nkedi Kizza P, 1984, WATER RESOUR RES, P20; Nkedi-Kizza P, 2006, J ENVIRON QUAL, V35, P268, DOI 10.2134/jeq2005.0140; Nzengung VA, 1997, ENVIRON SCI TECHNOL, V31, P1470, DOI 10.1021/es960720z; OBREZA T.A, 2008, NUTR FLORIDA CITRUS; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112331; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Radcliffe D.E., 2010, SOIL PHYS HYDRUS MOD; Selim HM, 2010, SOIL SCI, V175, P375, DOI 10.1097/SS.0b013e3181ebc9a2; Simon-Delso N, 2015, ENVIRON SCI POLLUT R, V22, P5, DOI 10.1007/s11356-014-3470-y; Simunek J., 2002, METHODS SOIL ANAL 1, P139, DOI [10.2136/sssabookser5.4.c7, DOI 10.2136/SSSABOOKSER5.4.C7]; Simunek J, 2008, VADOSE ZONE J, V7, P587, DOI 10.2136/vzj2007.0077; Simunek J, 2008, VADOSE ZONE J, V7, P782, DOI 10.2136/vzj2007.0074; SKAGGS TH, 2002, METHODS SOIL ANAL 4, P1353, DOI DOI 10.2136/SSSABOOKSER5.4.C56; Skaggs TH, 2002, SSSA BOOK SERIES, P1381; Soil Survey S, 2014, KEYS SOIL TAXONOMY; USDA-NRCS, 1998, SOIL SURV COLL COUNT; [USEPA Office of Prevention PaTS], 2008, TRANSP TRANSF TEST G; USEPA (United States Environmental Protection Agency), 1983, METH CHEM AN WAT WAS; van Genuchten MT, 2012, T ASABE, V55, P1353; van Genuchten MT, 2014, PROGR SOIL SCI, P349, DOI 10.1007/978-3-319-06013-2_15; VANGENUCHTEN MT, 1989, SOIL SCI SOC AM J, V53, P1303, DOI 10.2136/sssaj1989.03615995005300050001x; Wang DJ, 2015, VADOSE ZONE J, V14, DOI 10.2136/vzj2015.01.0007; Wauchope RD, 2002, PEST MANAG SCI, V58, P419, DOI 10.1002/ps.489; Wettstein FE, 2016, J AGR FOOD CHEM, V64, P6407, DOI 10.1021/acs.jafc.6b02619; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	60	18	18	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183767	10.1371/journal.pone.0183767	http://dx.doi.org/10.1371/journal.pone.0183767			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837702	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000117
J	Pols, DHJ; Nielen, MMJ; Bohnen, AM; Korevaar, JC; Bindels, PJE				Pols, David H. J.; Nielen, Mark M. J.; Bohnen, Arthur M.; Korevaar, Joke C.; Bindels, Patrick J. E.			Atopic children and use of prescribed medication: A comprehensive study in general practice	PLOS ONE			English	Article							DISEASES; ASTHMA; LIFE; COMORBIDITY; SYMPTOMS	Purpose A comprehensive and representative nationwide general practice database was explored to study associations between atopic disorders and prescribed medication in children. Method All children aged 0-18 years listed in the NIVEL Primary Care Database in 2014 were selected. Atopic children with atopic eczema, asthma and allergic rhinitis (AR) were matched with controls (not diagnosed with any of these disorders) within the same general practice on age and gender. Logistic regression analyses were performed to study the differences in prescribed medication between both groups by calculating odds ratios (OR); 93 different medication groups were studied. Results A total of 45,964 children with at least one atopic disorder were identified and matched with controls. Disorder-specific prescriptions seem to reflect evidence-based medicine guidelines for atopic eczema, asthma and AR. However, these disorder-specific prescriptions were also prescribed for children who were not registered as having that specific disorder. For eczema-related medication, about 3.7-8.4% of the children with non-eczematous atopic morbidity received these prescriptions, compared to 1.4-3.5% of the non-atopic children. The same pattern was observed for anti-asthmatics (having non-asthmatic atopic morbidity: 0.8-6.2% vs. controls: 0.3-2.1%) and AR-related medication (having non-AR atopic morbidity: 4.7-12.5% vs. controls: 2.8-3.1%). Also, non-atopic related medication, such as laxatives and antibiotics were more frequently prescribed for atopic children. Conclusions The present study shows that atopic children received more prescriptions, compared to non-atopic children. Non-atopic controls frequently received specific prescriptions for atopic disorders. This indicates that children with atopic disorders need better monitoring by their GP.	[Pols, David H. J.; Bohnen, Arthur M.; Bindels, Patrick J. E.] Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Nielen, Mark M. J.; Korevaar, Joke C.] Netherlands Inst Hlth Serv Res, NIVEL, Utrecht, Netherlands	Erasmus University Rotterdam; Erasmus MC; Netherlands Institute for Health Services Research	Pols, DHJ (corresponding author), Univ Med Ctr Rotterdam, Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands.	d.pols@erasmusmc.nl	Bohnen, Arthur M/F-7814-2011					Bindels PJ, 2014, HUISARTS WET, V57, P70; Chen WJ, 2016, EUR RESPIR J, V48, P1584, DOI 10.1183/13993003.01141-2016; Dirven-Meijer PCDKC., 2014, HUISARTS WET, V57, P240; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Hupkens C, 2013, ONGEVEER DRIE KWART; Lamberts H, 2002, FAM PRACT, V19, P433, DOI 10.1093/fampra/19.5.433; Mai X, 2009, ALLERGY, V64, P21; Mulder B, 2016, EUR J CLIN PHARMACOL, V72, P73, DOI 10.1007/s00228-015-1940-x; Nielen MMJ, 2012, ACCOUNTABILITY INCID; Pols DHJ, 2016, SCAND J PRIM HEALTH, V34, P143, DOI 10.3109/02813432.2016.1160629; Pols DHJ, 2017, NPJ PRIM CARE RESP M, V27, DOI 10.1038/s41533-017-0025-y; Powell N, 2007, POSTGRAD MED J, V83, P182, DOI 10.1136/pgmj.2006.049585; Sachs APE, 2006, HUISARTS WET, V49, P254; Skvorc HM, 2011, ALLERGY, V66, P553; Van Limbergen J, 2009, INFLAMM BOWEL DIS, V15, P1492, DOI 10.1002/ibd.20926	15	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182664	10.1371/journal.pone.0182664	http://dx.doi.org/10.1371/journal.pone.0182664			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837578	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000023
J	Seebacher, V; Aust, S; D'Andrea, D; Grimm, C; Reiser, E; Tiringer, D; Von Mersi, H; Polterauer, S; Reinthaller, A; Helmy-Bader, S				Seebacher, Veronika; Aust, Stefanie; D'Andrea, David; Grimm, Christoph; Reiser, Elisabeth; Tiringer, Denise; Von Mersi, Hannah; Polterauer, Stephan; Reinthaller, Alexander; Helmy-Bader, Samir			Development of a tool for prediction of ovarian cancer in patients with adnexal masses: Value of plasma fibrinogen	PLOS ONE			English	Article							PREOPERATIVE DIAGNOSIS; MENOPAUSAL STATUS; CA 125; BENIGN; RISK; MULTICENTER; ULTRASOUND; SURGERY; MODELS; DISTINGUISH	Objective To develop a tool for individualized risk estimation of presence of cancer in women with adnexal masses, and to assess the added value of plasma fibrinogen. Study design We performed a retrospective analysis of a prospectively maintained database of 906 patients with adnexal masses who underwent cystectomy or oophorectomy. Uni- and multivariate logistic regression analyses including pre-operative plasma fibrinogen levels and established predictors were performed. A nomogram was generated to predict the probability of ovarian cancer. Internal validation with split-sample analysis was performed. Decision curve analysis (DCA) was then used to evaluate the clinical net benefit of the prediction model. Results Ovarian cancer including borderline tumours was found in 241 (26.6%) patients. In multivariate analysis, elevated plasma fibrinogen, elevated CA-125, suspicion for malignancy on ultrasound, and postmenopausal status were associated with ovarian cancer and formed the basis for the nomogram. The overall predictive accuracy of the model, as measured by AUC, was 0.91 (95% CI 0.87 +/- 0.94). DCA revealed a net benefit for using this model for predicting ovarian cancer presence compared to a strategy of treat all or treat none. Conclusion We confirmed the value of plasma fibrinogen as a strong predictor for ovarian cancer in a large cohort of patients with adnexal masses. We developed a highly accurate multivariable model to help in the clinical decision-making regarding the presence of ovarian cancer. This model provided net benefit for a wide range of threshold probabilities. External validation is needed before a recommendation for its use in routine practice can be given.	[Seebacher, Veronika; Aust, Stefanie; Grimm, Christoph; Reiser, Elisabeth; Tiringer, Denise; Von Mersi, Hannah; Polterauer, Stephan; Reinthaller, Alexander; Helmy-Bader, Samir] Med Univ Vienna, Ctr Comprehens Canc, Gynecol Canc Unit, Dept Gynecol & Gynecol Oncol, Vienna, Austria; [D'Andrea, David] Med Univ Vienna, Dept Urol, Vienna, Austria; [Polterauer, Stephan; Reinthaller, Alexander] Karl Landsteiner Inst Gen Gynecol & Expt Gynecol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Grimm, C (corresponding author), Med Univ Vienna, Ctr Comprehens Canc, Gynecol Canc Unit, Dept Gynecol & Gynecol Oncol, Vienna, Austria.	christoph.grimm@meduniwien.ac.at	Polterauer, Stephan/AAG-1331-2021; Grimm, Christoph/GSJ-3020-2022	Polterauer, Stephan/0000-0002-9649-4505; Grimm, Christoph/0000-0003-2948-8129; D'Andrea, David/0000-0003-1625-1077; Aust, stefanie/0000-0002-6760-949X				Alcazar JL, 2005, HUM REPROD, V20, P3231, DOI 10.1093/humrep/dei206; Bast RC, 2012, INT J GYNECOL CANCER, V22, pS5, DOI 10.1097/IGC.0b013e318251c97d; Bristow RE, 2013, GYNECOL ONCOL, V128, P252, DOI 10.1016/j.ygyno.2012.11.022; Buys SS, 2005, AM J OBSTET GYNECOL, V193, P1630, DOI 10.1016/j.ajog.2005.05.005; CLAUSS A., 1957, ACTA HAEMATOL, V17, P237; Dearking AC, 2007, OBSTET GYNECOL, V110, P841, DOI 10.1097/01.AOG.0000267198.25223.bc; Dodge JE, 2012, GYNECOL ONCOL, V126, P157, DOI 10.1016/j.ygyno.2012.03.048; Engelen MJA, 2006, CANCER-AM CANCER SOC, V106, P589, DOI 10.1002/cncr.21616; Engelen MJA, 2000, GYNECOL ONCOL, V78, P16, DOI 10.1006/gyno.2000.5811; Feng Z, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2070-2; Gotlieb WH, 2000, AM J OBSTET GYNECOL, V183, P541, DOI 10.1067/mob.2000.105940; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HARRELL FE, 1988, J NATL CANCER I, V80, P1198, DOI 10.1093/jnci/80.15.1198; Hefler-Frischmuth K, 2015, GYNECOL ONCOL, V136, P567, DOI 10.1016/j.ygyno.2014.12.041; JACOBS I, 1990, BRIT J OBSTET GYNAEC, V97, P922, DOI 10.1111/j.1471-0528.1990.tb02448.x; Kaijser J, 2013, GYNECOL ONCOL, V130, P398, DOI 10.1016/j.ygyno.2013.04.472; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Ma CQ, 2016, ONCOTARGETS THER, V9, P4917, DOI 10.2147/OTT.S107445; Moore LE, 2012, CANCER-AM CANCER SOC, V118, P91, DOI 10.1002/cncr.26241; Moore RG, 2011, OBSTET GYNECOL, V118, P280, DOI 10.1097/AOG.0b013e318224fce2; Nolen BM, 2013, MOL DIAGN THER, V17, P139, DOI 10.1007/s40291-013-0027-6; Polterauer S, 2009, ONCOLOGIST, V14, P979, DOI 10.1634/theoncologist.2009-0079; Polterauer S, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2009.01.008; Qiu J, 2012, J OBSTET GYNAECOL RE, V38, P651, DOI 10.1111/j.1447-0756.2011.01780.x; Seebacher V, 2010, BRIT J CANCER, V102, P952, DOI 10.1038/sj.bjc.6605547; Sevinc A, 2007, LANCET ONCOL, V8, P1054, DOI 10.1016/S1470-2045(07)70357-1; Shariat FS, 2008, BJUI, V103, P492; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Timmerman D, 2005, J CLIN ONCOL, V23, P8794, DOI 10.1200/JCO.2005.01.7632; Timmerman D, 1999, ULTRASOUND OBST GYN, V13, P17, DOI 10.1046/j.1469-0705.1999.13010017.x; Timmerman D, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6839; Tingulstad S, 1996, BRIT J OBSTET GYNAEC, V103, P826, DOI 10.1111/j.1471-0528.1996.tb09882.x; Ueland FR, 2011, OBSTET GYNECOL, V117, P1289, DOI 10.1097/AOG.0b013e31821b5118; Van Calster B, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g5920; Van Gorp T, 2011, BRIT J CANCER, V104, P863, DOI 10.1038/sj.bjc.6606092; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Vickers AJ, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-53; Woo YL, 2012, GYNECOL ONCOL, V126, P286, DOI 10.1016/j.ygyno.2012.04.012	40	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182383	10.1371/journal.pone.0182383	http://dx.doi.org/10.1371/journal.pone.0182383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837575	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000016
J	Festin, K; Thomas, K; Ekberg, J; Kristenson, M				Festin, Karin; Thomas, Kristin; Ekberg, Joakim; Kristenson, Margareta			Choice of measure matters: A study of the relationship between socioeconomic status and psychosocial resources in a middle-aged normal population	PLOS ONE			English	Article							SELF-RATED HEALTH; PSYCHOLOGICAL-FACTORS; SOCIAL SUPPORT; HEART-DISEASE; RISK-FACTORS; SWEDISH MEN; FOLLOW-UP; MORTALITY; ESTEEM; COHERENCE	Psychosocial resources may serve as an important link to explain socioeconomic differences in health. Earlier studies have demonstrated that education, income and occupational status cannot be used interchangeably as indicators of a hypothetical latent social dimension. In the same manner, it is important to disentangle the effect of measuring different constructs of psychosocial resources. The aim of this study was therefore to analyse if associations between socioeconomic status (SES) and psychosocial resources differ depending on the measures used. A cross-sectional population-based study of a random sample (n = 1007) of middle-aged individuals (45-69 years old, 50% women) in Sweden was performed using questionnaire and register data. SES was measured as education, occupation, household income and self-rated economy. Psychosocial resources were measured as social integration, social support, mastery, self-esteem, sense of coherence (SOC) and trust. Logistic regression models were applied to analyse the relationships controlling for the effects of possible confounders. The measures of SES were low or moderately correlated to each other as were the measures of psychosocial resources. After controlling for age, sex, country of birth and employment status, household income and self-rated economy were associated with all six psychosocial resources; occupation was associated with three (social integration, self-esteem and trust) and education with two (social integration and self-esteem). Social integration and self-esteem showed a significant and graded relationship with all SES measures; trust was associated with all SES measures except education, whereas SOC and mastery were only associated with household income and self-rated economy. After controlling for other SES measures, no associations with psychosocial resources remained for education or occupation. In conclusion, associations between SES and psychosocial resources did differ depending on the measures used. The findings illustrate the importance of the choice of measure when investigating SES as well as psychosocial resources.	[Festin, Karin; Thomas, Kristin; Kristenson, Margareta] Linkoping Univ, Fac Med & Hlth, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden; [Ekberg, Joakim] Ctr Healthcare Dev, Unit Hlth Anal, Linkoping, Region Ostergot, Sweden	Linkoping University	Festin, K (corresponding author), Linkoping Univ, Fac Med & Hlth, Dept Med & Hlth Sci, Div Community Med, Linkoping, Sweden.	karin.festin@liu.se		Thomas, Kristin/0000-0001-6434-4855	Swedish Research Council; Swedish Heart and Lung Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The study was funded by the Swedish Research Council and the Swedish Heart and Lung Foundation. MK is the principal investigator and receiver of these grants. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen I, 2005, J EPIDEMIOL COMMUN H, V59, P1080, DOI 10.1136/jech.2005.036848; ANTONOVSKY A, 1993, SOC SCI MED, V36, P725, DOI 10.1016/0277-9536(93)90033-Z; ANTONOVSKY A, 1984, Journal of Preventive Psychiatry, V2, P1; Barefoot JC, 1998, J BEHAV MED, V21, P517, DOI 10.1023/A:1018792528008; Clark Cari Jo, 2012, Front Psychiatry, V3, P5, DOI 10.3389/fpsyt.2012.00005; Cohen S, 2007, JAMA-J AM MED ASSOC, V298, P1685, DOI 10.1001/jama.298.14.1685; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Daoud N, 2009, EUR J PUBLIC HEALTH, V19, P477, DOI 10.1093/eurpub/ckp080; Diderichsen F, 2012, SCAND J PUBLIC HEALT, V40, P10, DOI 10.1177/1403494812457732; Elgar FJ, 2010, CAN J PUBLIC HEALTH, V101, pS23; Fretz A, 2016, AM J EPIDEMIOL, V183, P452, DOI 10.1093/aje/kwv253; Gallo V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039013; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Giordano GN, 2016, J EPIDEMIOL COMMUN H, V70, P10, DOI 10.1136/jech-2015-205822; Huijts T, 2015, EUR J PUBLIC HEALTH, V25, P801, DOI 10.1093/eurpub/ckv108; Judge TA, 2002, J PERS SOC PSYCHOL, V83, P693, DOI 10.1037//0022-3514.83.3.693; Khayyam-Nekouei Z, 2013, ARYA ATHEROSCLER, V9, P102; Klein J, 2012, INT J PUBLIC HEALTH, V57, P619, DOI 10.1007/s00038-012-0356-y; Kristenson M, 2004, SOC SCI MED, V58, P1511, DOI 10.1016/S0277-9536(03)00353-8; Kristenson M, 2001, SCAND J PUBLIC HEALT, V29, P140, DOI 10.1177/14034948010290020101; Kurus M, 2005, INT UROL NEPHROL, V37, P587, DOI 10.1007/s11255-004-0011-5; Lundgren O, 2015, INT J BEHAV MED, V22, P77, DOI 10.1007/s12529-014-9387-5; Mackenbach JP, 2012, SOC SCI MED, V75, P761, DOI 10.1016/j.socscimed.2012.02.031; Matthews KA, 2011, ANNU REV PSYCHOL, V62, P501, DOI 10.1146/annurev.psych.031809.130711; Matthews KA, 2010, ANN NY ACAD SCI, V1186, P146, DOI 10.1111/j.1749-6632.2009.05332.x; Mattisson C, 2014, SCAND J PUBLIC HEALT, V42, P434, DOI 10.1177/1403494814527188; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pikhart H, 2015, RELATIONSHIP PSYCHOS; Poppius E, 2003, EUR J EPIDEMIOL, V18, P389, DOI 10.1023/A:1024213427147; Roepke SK, 2011, HEALTH PSYCHOL, V30, P615, DOI 10.1037/a0023480; ROSENBERG M, 1962, J PSYCHIAT RES, V1, P135, DOI 10.1016/0022-3956(62)90004-3; Rosengren A, 2004, EUR HEART J, V25, P56, DOI 10.1016/j.ehj.2003.10.005; Rostila M, 2014, AM J PUBLIC HEALTH, V104, P686, DOI 10.2105/AJPH.2013.301613; ROTTER JB, 1967, J PERS, V35, P651, DOI 10.1111/j.1467-6494.1967.tb01454.x; Schnittker J, 2004, SOC BIOL, V51, P1; Shavers VL, 2007, J NATL MED ASSOC, V99, P1013; Sher Y, 2010, CURR PSYCHIAT REP, V12, P255, DOI 10.1007/s11920-010-0116-8; Sjogren E, 2006, INT J BEHAV MED, V13, P193, DOI 10.1207/s15327558ijbm1303_2; Stamatakis KA, 2004, ANN EPIDEMIOL, V14, P58, DOI 10.1016/S1047-2797(03)00078-4; Statistics Sweden, 1982, SOC CLASS SEI; Statistics Sweden, POP CENS 2014; Stringhini S, 2010, JAMA-J AM MED ASSOC, V303, P1159, DOI 10.1001/jama.2010.297; Surtees PG, 2006, HEALTH PSYCHOL, V25, P102, DOI 10.1037/0278-6133.25.1.102; Twenge JM, 2002, PERS SOC PSYCHOL REV, V6, P59, DOI 10.1207/S15327957PSPR0601_3; Ullits LR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1813-3; UNDEN AL, 1989, SOC SCI MED, V29, P1387, DOI 10.1016/0277-9536(89)90240-2; Varghese T, 2016, CURR PHARM DESIGN, V22, P3853, DOI 10.2174/1381612822666160519113605; Vonneilich N, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-285	48	20	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0178929	10.1371/journal.pone.0178929	http://dx.doi.org/10.1371/journal.pone.0178929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832585	gold, Green Published			2022-12-27	WOS:000408355800001
J	Riley, SP; Pruneau, L; Martinez, JJ				Riley, Sean P.; Pruneau, Ludovic; Martinez, Juan J.			Evaluation of changes to the Rickettsia rickettsii transcriptome during mammalian infection	PLOS ONE			English	Article							OUTER SURFACE-PROTEIN; BORRELIA-BURGDORFERI; SIGNAL PEPTIDES; COXIELLA-BURNETII; LIPOPOLYSACCHARIDE; CONORII; PROWAZEKII; PREDICTION; SECRETION; CELLS	The lifecycle of Rickettsia rickettsii includes infection of both mammalian and arthropod hosts, with each environment presenting distinct challenges to survival. As such, these pathogens likely have distinctive transcriptional strategies for infection of each host. Herein, we report the utilization of next generation sequencing (RNAseq) and bioinformatic analysis techniques to examine the global transcriptional profile of R. rickettsii within an infected animal, and to compare that data to transcription in tissue culture. The results demonstrate substantial R. rickettsii transcriptional alteration in vivo, such that the bacteria are considerably altered from cell culture. Identification of significant transcriptional changes and validation of RNAseq by quantitative PCR are described with particular emphasis on known antigens and suspected virulence factors. Together, these results suggest that transcriptional regulation of a distinct cohort of genes may contribute to successful mammalian infection.	[Riley, Sean P.; Pruneau, Ludovic; Martinez, Juan J.] Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Riley, SP (corresponding author), Louisiana State Univ, Sch Vet Med, Dept Pathobiol Sci, Vector Borne Dis Labs, Baton Rouge, LA 70803 USA.	sriley@lsu.edu	Martinez, Juan/GXM-4393-2022	Riley, Sean P/0000-0002-4384-4540	National Institute of Allergy and Infectious diseases [5R01AI072606-08]; National Institute of General Medical Sciences [5P30GM110760-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072606] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110760] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institute of Allergy and Infectious diseases grant 5R01AI072606-08 to JJM and National Institute of General Medical Sciences 5P30GM110760-03 to SPR and JJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1981, AM J CLIN PATHOL, V75, P156; Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Alvarez-Hernandez G, 2017, LANCET INFECT DIS, P30173; Ammerman NC, 2008, LAB MAINTENANCE RICK; Anacker RL., 1981, RICKETTSIAE RICKETTS, P71; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; [Anonymous], 2016, SEQMANNGEN; Arguello AP, 2012, AM J TROP MED HYG, V87, P345, DOI 10.4269/ajtmh.2012.12-0153; Audia JP, 2008, APPL ENVIRON MICROB, V74, P7809, DOI 10.1128/AEM.00896-08; Bagos PG, 2010, BIOINFORMATICS, V26, P2811, DOI 10.1093/bioinformatics/btq530; Beyer AR, 2017, CELLULAR MICROBIOLOG; Bishop RE, 2014, NATURE, V511, P37, DOI 10.1038/nature13508; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; Byndloss MX, 2017, CURR OPIN MICROBIOL, V35, P1, DOI 10.1016/j.mib.2016.08.007; Cardwell MM, 2009, INFECT IMMUN, V77, P5272, DOI 10.1128/IAI.00201-09; Chan YGY, 2009, CELL MICROBIOL, V11, P629, DOI 10.1111/j.1462-5822.2008.01279.x; Chan YGY, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00139; DASCH GA, 1981, J CLIN MICROBIOL, V14, P333, DOI 10.1128/JCM.14.3.333-341.1981; DASCH GA, 1981, INFECT IMMUN, V31, P276, DOI 10.1128/IAI.31.1.276-288.1981; deSilva AM, 1996, J EXP MED, V183, P271, DOI 10.1084/jem.183.1.271; Dreher-Lesnick SM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-61; Ellison DW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005612; Feng HM, 2004, INFECT IMMUN, V72, P2222, DOI 10.1128/IAI.72.4.2222-2228.2004; Feng HM, 2000, INFECT IMMUN, V68, P6729, DOI 10.1128/IAI.68.12.6729-6736.2000; FINGERLE V, 1995, J CLIN MICROBIOL, V33, P1867, DOI 10.1128/JCM.33.7.1867-1869.1995; Fournier PE, 2003, ANN NY ACAD SCI, V990, P152, DOI 10.1111/j.1749-6632.2003.tb07356.x; Galletti MFBM, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1581-7; Galletti MFBM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077388; Gillespie JJ, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw058; Gillespie JJ, 2015, MBIO, V6, DOI 10.1128/mBio.01867-15; Gillespie JJ, 2015, FEMS MICROBIOL REV, V39, P47, DOI 10.1111/1574-6976.12084; Gillespie JJ, 2010, INFECT IMMUN, V78, P1809, DOI 10.1128/IAI.01384-09; Gong WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100253; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; JACKSON M D, 1986, Pediatric Pathology, V5, P379; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; Kaur SJ, 2012, J BACTERIOL, V194, P4920, DOI 10.1128/JB.00793-12; KENYON RH, 1977, INFECT IMMUN, V18, P840, DOI 10.1128/IAI.18.3.840-846.1977; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuley R, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2143-7; La MV, 2007, J MICROBIOL METH, V71, P292, DOI 10.1016/j.mimet.2007.09.017; LI H, 1988, INFECT IMMUN, V56, P2587, DOI 10.1128/IAI.56.10.2587-2593.1988; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maldonado RF, 2016, FEMS MICROBIOL REV, V40, P480, DOI 10.1093/femsre/fuw007; Martin M, 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, 10.10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; MOOS A, 1987, INFECT IMMUN, V55, P1144, DOI 10.1128/IAI.55.5.1144-1150.1987; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ozsolak F, 2011, METHODS MOL BIOL, V733, P51, DOI 10.1007/978-1-61779-089-8_4; Paddock CD, 2004, CLIN INFECT DIS, V38, P805, DOI 10.1086/381894; Paddock CD, 2006, AM J TROP MED HYG, V75, P732, DOI 10.4269/ajtmh.2006.75.732; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Radulovic S, 2002, INFECT IMMUN, V70, P2576, DOI 10.1128/IAI.70.5.2576-2582.2002; Renesto P, 2003, J INFECT DIS, V188, P1276, DOI 10.1086/379080; Renesto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003681; Rennoll-Bankert KE, 2016, INFECT IMMUN, V84, P3496, DOI 10.1128/IAI.00638-16; Riley SP, 2010, INFECT IMMUN, V78, P1895, DOI 10.1128/IAI.01165-09; RILEY SP, 2015, PATHOG DIS, V73, DOI DOI 10.1093/femspd/ftv101; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Sears KT, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002856; Shannon JG, 2005, P NATL ACAD SCI USA, V102, P8722, DOI 10.1073/pnas.0501863102; SILVERMAN DJ, 1978, INFECT IMMUN, V22, P233, DOI 10.1128/IAI.22.1.233-246.1978; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Verhoeve VI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163769; Walker DH, 2003, ANN NY ACAD SCI, V990, P1, DOI 10.1111/j.1749-6632.2003.tb07331.x; WALKER DH, 1985, AM J TROP MED HYG, V34, P361, DOI 10.4269/ajtmh.1985.34.361	66	5	5	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182290	10.1371/journal.pone.0182290	http://dx.doi.org/10.1371/journal.pone.0182290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832688	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800020
J	Tompkins, EM; Townsend, HM; Anderson, DJ				Tompkins, Emily M.; Townsend, Howard M.; Anderson, David J.			Decadal-scale variation in diet forecasts persistently poor breeding under ocean warming in a tropical seabird	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; BOOBIES SULA-GRANTI; NAZCA BOOBIES; CALIFORNIA CURRENT; MARINE ECOSYSTEMS; EMPEROR PENGUIN; MARKED ANIMALS; SEX-RATIO; POPULATIONS; RESPONSES	Climate change effects on population dynamics of natural populations are well documented at higher latitudes, where relatively rapid warming illuminates cause-effect relationships, but not in the tropics and especially the marine tropics, where warming has been slow. Here we forecast the indirect effect of ocean warming on a top predator, Nazca boobies in the equatorial Galapagos Islands, where rising water temperature is expected to exceed the upper thermal tolerance of a key prey item in the future, severely reducing its availability within the boobies' foraging envelope. From 1983 to 1997 boobies ate mostly sardines, a densely aggregated, highly nutritious food. From 1997 until the present, flying fish, a lower quality food, replaced sardines. Breeding success under the poor diet fell dramatically, causing the population growth rate to fall below 1, indicating a shrinking population. Population growth may not recover: rapid future warming is predicted around Galapagos, usually exceeding the upper lethal temperature and maximum spawning temperature of sardines within 100 years, displacing them permanently from the boobies' island-constrained foraging range. This provides rare evidence of the effect of ocean warming on a tropical marine vertebrate.	[Tompkins, Emily M.; Townsend, Howard M.; Anderson, David J.] Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA; [Townsend, Howard M.] NOAA, NMFS, HC, Chesapeake Bay Off,Cooperat Oxford Lab, Oxford, MD USA	Wake Forest University; National Oceanic Atmospheric Admin (NOAA) - USA	Tompkins, EM (corresponding author), Wake Forest Univ, Dept Biol, Winston Salem, NC 27109 USA.	tompem0@wfu.edu		Anderson, David/0000-0002-0826-7784	National Science Foundation [DEB 93045679, DEB 9629539, DEB 98-06606, DEB 0235818, DEB 0842199, DEB 1354473]; Division Of Environmental Biology [1354473] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This material is based upon work supported primarily by the National Science Foundation under Grant Nos. DEB 93045679, DEB 9629539, DEB 98-06606, DEB 0235818, DEB 0842199, and DEB 1354473 to DJA, www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Galapagos National Park Service for permission to work in the Park; the Charles Darwin Research Station, and TAME Airline for logistical support; the National Geographic Society and Wake Forest University for research funding; H. Osterblom, B. R. MacKenzie, and an anonymous reviewer for comments that improved the manuscript; and M. Silman, J. Grace, K. Huyvaert, M. Muller, and the members of the Anderson lab group for discussion of this topic. This material is based upon work supported primarily by the National Science Foundation under Grant Nos. DEB 93045679, DEB 9629539, DEB 98-06606, DEB 0235818, DEB 0842199, and DEB 1354473 to DJA.	ALVERSON DL, 1992, REV AQUAT SCI, V6, P203; Anchundia David, 2014, Avian Conservation and Ecology, V9, P6; ANDERSON D J, 1987, National Geographic Research, V3, P152; ANDERSON DJ, 1989, MAR ECOL PROG SER, V52, P209, DOI 10.3354/meps052209; Apanius V., 2008, ORNITHOL MONOGR, V65, P1, DOI [10.1525/om.2008.65.1.1, DOI 10.1525/OM.2008.65.1.1]; Archer E., 2016, RFPERMUTE ESTIMATE P; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Bakun A, 2014, ICES J MAR SCI, V71, P2281, DOI 10.1093/icesjms/fst242; Barbraud C, 2005, ECOLOGY, V86, P682, DOI 10.1890/04-0075; Barbraud C, 2001, NATURE, V411, P183, DOI 10.1038/35075554; Bates Douglas, 2014, LME4 LINEAR MIXED EF; Beaumont LJ, 2011, P NATL ACAD SCI USA, V108, P2306, DOI 10.1073/pnas.1007217108; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burnham KP, 2011, BEHAV ECOL SOCIOBIOL, V65, P23, DOI 10.1007/s00265-010-1029-6; Burrows MT, 2011, SCIENCE, V334, P652, DOI 10.1126/science.1210288; Cahill AE, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.1890; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Cam E, 2002, AM NAT, V159, P96, DOI 10.1086/324126; Caswell H., MATRIX POPULATION MO, V2; Checkley DM, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P1; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Clutton-Brock T, 2010, TRENDS ECOL EVOL, V25, P562, DOI 10.1016/j.tree.2010.08.002; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; Cury PM, 2011, SCIENCE, V334, P1703, DOI 10.1126/science.1212928; Dellinger T, 1999, CAN J ZOOL, V77, P1204, DOI 10.1139/cjz-77-8-1204; Ehrlen J, 2015, ECOL LETT, V18, P303, DOI 10.1111/ele.12410; FAO, 1989, 309 FAO; Forcada J, 2008, GLOBAL CHANGE BIOL, V14, P2473, DOI 10.1111/j.1365-2486.2008.01678.x; Freon P, 2009, CLIMATE CHANGE AND SMALL PELAGIC FISH, P312; Garcia-Molinos J., 2015, NAT CLIM CHANGE, V6, P83, DOI [10.1038/ nclimate2769, DOI 10.1038/NCLIMATE2769]; Grosbois V, 2008, BIOL REV, V83, P357, DOI 10.1111/j.1469-185X.2008.00047.x; Gutierrez M, 2007, FISH OCEANOGR, V16, P155, DOI 10.1111/j.1365-2419.2006.00422.x; Hammann MG, 1998, CAL COOP OCEAN FISH, V39, P169; HAREWOOD PM, 1993, J FOOD PROTECT, V56, P986, DOI 10.4315/0362-028X-56.11.986; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Houvenaghel G.T., 1978, UPWELLING ECOSYSTEMS, P181, DOI DOI 10.1007/978-3-642-66985-9; Humphries CA, 2006, OECOLOGIA, V147, P379, DOI 10.1007/s00442-005-0264-4; Hunter CM, 2010, ECOLOGY, V91, P2883, DOI 10.1890/09-1641.1; Huyvaert KP, 2004, J AVIAN BIOL, V35, P46; Jeglinski JWE, 2015, OECOLOGIA, V179, P1041, DOI 10.1007/s00442-015-3424-1; Jenouvrier S, 2005, ECOLOGY, V86, P2889, DOI 10.1890/05-0514; Jenouvrier S, 2014, NAT CLIM CHANGE, V4, P715, DOI 10.1038/NCLIMATE2280; Jenouvrier S, 2013, GLOBAL CHANGE BIOL, V19, P2036, DOI 10.1111/gcb.12195; Jenouvrier S, 2009, OIKOS, V118, P1292, DOI 10.1111/j.1600-0706.2009.17498.x; KILGOUR DM, 1986, ENVIRON BIOL FISH, V17, P281, DOI 10.1007/BF00001494; Laake J. L., 2013, R INTERFACE ANAL CAP; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lindegren M, 2013, P NATL ACAD SCI USA, V110, P13672, DOI 10.1073/pnas.1305733110; Lluch-Cota SE, 2013, P NATL ACAD SCI USA, V110, P13240, DOI 10.1073/pnas.1312347110; LLUCHBELDA D, 1991, CAL COOP OCEAN FISH, V32, P105; Luo YY, 2015, CLIM DYNAM, V45, P1945, DOI 10.1007/s00382-014-2448-2; Maness TJ, 2008, ANIM BEHAV, V76, P1267, DOI 10.1016/j.anbehav.2008.04.020; Maness TJ, 2007, WATERBIRDS, V30, P10, DOI 10.1675/1524-4695(2007)030[0010:OSRVIN]2.0.CO;2; Maness TJ, 2007, P ROY SOC B-BIOL SCI, V274, P2047, DOI 10.1098/rspb.2007.0578; Maness TJ, 2013, ORNITHOL MONOGR, P1, DOI 10.1525/om.2013.78.1.1; Martinez-Porchas M, 2009, J THERM BIOL, V34, P372, DOI 10.1016/j.jtherbio.2009.07.002; Mhlongo N, 2015, FISH OCEANOGR, V24, P1, DOI 10.1111/fog.12061; Molnar PK, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1183; Mullers RHE, 2009, ICES J MAR SCI, V66, P2244, DOI 10.1093/icesjms/fsp210; MuMIn K., 2016, MULTIMODEL INFERENCE; Ockendon N, 2014, GLOBAL CHANGE BIOL, V20, P2221, DOI 10.1111/gcb.12559; Oro D, 2010, ECOLOGY, V91, P1205, DOI 10.1890/09-0939.1; Osterblom H, 2008, JUNK FOOD MARINE ECO; Pacifici M., 2017, NAT CLIM CHANGE; Paez-Rosas D, 2010, MAR BIOL, V157, P2769, DOI 10.1007/s00227-010-1535-0; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; PITMAN RL, 1995, COLON WATERBIRD, V18, P113, DOI 10.2307/1521408; Poloczanska ES, 2016, FRONT MAR SCI, V3, DOI 10.3389/fmars.2016.00062; Poloczanska ES, 2013, NAT CLIM CHANGE, V3, P919, DOI [10.1038/nclimate1958, 10.1038/NCLIMATE1958]; Reed TE, 2008, AM NAT, V171, pE89, DOI 10.1086/524957; Rhein M, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P255; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Rosenzweig C, 2008, NATURE, V453, P353, DOI 10.1038/nature06937; Schew William A., 1998, Oxford Ornithology Series, V8, P288; Selwood KE, 2015, BIOL REV, V90, P837, DOI 10.1111/brv.12136; Stubben C, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i11; Sydeman WJ, 2015, SCIENCE, V350, P772, DOI 10.1126/science.aac9874; Sydeman WJ, 2012, MAR ECOL PROG SER, V454, P107, DOI 10.3354/meps09806; Tavecchia G, 2016, GLOBAL CHANGE BIOL, V22, P3960, DOI 10.1111/gcb.13330; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Townsend HM, 2007, EVOLUTION, V61, P1956, DOI 10.1111/j.1558-5646.2007.00169.x; van de Pol M, 2006, AM NAT, V167, P766, DOI 10.1086/503331; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weimerskirch Henri, 2002, P115; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; White GC, 2002, J APPL STAT, V29, P103, DOI 10.1080/02664760120108476; Wisz MS, 2013, BIOL REV, V88, P15, DOI 10.1111/j.1469-185X.2012.00235.x; Ying J, 2016, J CLIMATE, V29, P8051, DOI 10.1175/JCLI-D-16-0318.1; Zavalaga CB, 2012, IBIS, V154, P61, DOI 10.1111/j.1474-919X.2011.01198.x; Zwolinski JP, 2012, P NATL ACAD SCI USA, V109, P4175, DOI 10.1073/pnas.1113806109	95	9	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182545	10.1371/journal.pone.0182545	http://dx.doi.org/10.1371/journal.pone.0182545			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832597	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800028
J	Kassis, T				Kassis, Timothy			How do research faculty in the biosciences evaluate paper authorship criteria?	PLOS ONE			English	Article							SCIENTIFIC PAPERS; ETHICS; CREDIT; GHOST; ORDER	Authorship of peer-reviewed journal articles and abstracts has become the primary currency and reward unit in academia. Such a reward is crucial for students and postdocs who are often under-compensated and thus highly value authorship as an incentive. While numerous scientific and publishing organizations have written guidelines for determining author qualifications and author order, there remains much ambiguity when it comes to how these criteria are weighed by research faculty. Here, we sought to provide some initial insight on how faculty view the relative importance of 11 criteria for scientific authorship. We distributed an online survey to 564 biomedical engineering, biology, and bioengineering faculty members at 10 research institutions across the United States. The response rate was approximately 18%,resulting in a final sample of 102 respondents. Results revealed an agreement on some criteria, such as time spent conducting experiments, but there was a lack of agreement regarding the role of funding procurement. This study provides quantitative assessments of how faculty members in the biosciences evaluate authorship criteria. We discuss the implications of these findings for researchers, especially new graduate students, to help navigate the discrepancy between official policies for authorship and the contributions that faculty truly value.	[Kassis, Timothy] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kassis, T (corresponding author), MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tkassis@mit.edu						Allen L, 2014, NATURE, V508, P312, DOI 10.1038/508312a; Baerlocher MO, 2007, J INVEST MED, V55, P174, DOI 10.2310/6650.2007.06044; Bennett Dianne M, 2003, Emerg Med (Fremantle), V15, P263, DOI 10.1046/j.1442-2026.2003.00432.x; Benos DJ, 2005, ADV PHYSIOL EDUC, V29, P59, DOI 10.1152/advan.00056.2004; Bosnjak L, 2012, SCIENTOMETRICS, V93, P751, DOI 10.1007/s11192-012-0773-y; Clement TP, 2014, SCI ENG ETHICS, V20, P345, DOI 10.1007/s11948-013-9454-3; da Silva JAT, 2016, SCI ENG ETHICS, V22, P1457, DOI 10.1007/s11948-015-9716-3; Dance A, 2012, NATURE, V489, pS2, DOI 10.1038/489S2a; Flanagin A, 1998, JAMA-J AM MED ASSOC, V280, P222, DOI 10.1001/jama.280.3.222; Frandsen TF, 2010, J INFORMETR, V4, P608, DOI 10.1016/j.joi.2010.06.010; Georgia Institute of Technology, AUTH PUBL; Harvard University, 2016, AUTH GUID; Hoen WP, 1998, JAMA-J AM MED ASSOC, V280, P217, DOI 10.1001/jama.280.3.217; Hundley V., 2013, HLTH RENAISSANCE, V11, P99, DOI [DOI 10.3126/HREN.V11I2.8214, 10.3126/hren.v11i2.8214]; Ilakovac V, 2007, CAN MED ASSOC J, V176, P41; International Committee of Medical Journal Editors, 2021, RECOMMENDATIONS COND; Ivanis A, 2011, PLOS ONE, V6, P1; Marui A, 2011, PLSO ONE, V6; Masic Izet, 2012, Acta Inform Med, V20, P141, DOI 10.5455/aim.2012.20.141-148; Oberlander SE, 2006, ETHICS BEHAV, V16, P217, DOI 10.1207/s15327019eb1603_3; Osborne J. W, 2009, PRACTICAL ASSESSMENT, V14, P1, DOI DOI 10.7275/25PE-BA85; Pennock Robert T, 1996, Public Aff Q, V10, P379; Perneger TV, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013898; Sauermann H, 2013, RES POLICY, V42, P273, DOI 10.1016/j.respol.2012.05.003; SHAPIRO DW, 1994, JAMA-J AM MED ASSOC, V271, P438, DOI 10.1001/jama.271.6.438; Sheikh A, 2000, J MED ETHICS, V26, P422, DOI 10.1136/jme.26.6.422; Slone RM, 1996, AM J ROENTGENOL, V167, P571, DOI 10.2214/ajr.167.3.8751654; Smith E, 2012, SCI ENG ETHICS, V18, P199, DOI 10.1007/s11948-011-9263-5; Stanford University, AC AUTH; Tscharntke T, 2007, PLOS BIOL, V5, P13, DOI 10.1371/journal.pbio.0050018; Wager E, 2009, MATURITAS, V62, P109, DOI 10.1016/j.maturitas.2008.12.001; Wren JD, 2007, EMBO REP, V8, P988, DOI 10.1038/sj.embor.7401095; ZUCKERMAN HA, 1968, AM J SOCIOL, V74, P276, DOI 10.1086/224641	33	12	12	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183632	10.1371/journal.pone.0183632	http://dx.doi.org/10.1371/journal.pone.0183632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829822	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100061
J	Tan, TL; Cheong, SA				Tan, Teck Liang; Cheong, Siew Ann			Statistical complexity is maximized in a small-world brain	PLOS ONE			English	Article							INTEGRATE-AND-FIRE; SELF-ORGANIZED CRITICALITY; SPIKING NEURONS; SYNAPTIC INPUT; NETWORKS; MODEL; CHAOS; PLASTICITY; EDGE	In this paper, we study a network of Izhikevich neurons to explore what it means for a brain to be at the edge of chaos. To do so, we first constructed the phase diagram of a single Izhikevich excitatory neuron, and identified a small region of the parameter space where we find a large number of phase boundaries to serve as our edge of chaos. We then couple the outputs of these neurons directly to the parameters of other neurons, so that the neuron dynamics can drive transitions from one phase to another on an artificial energy landscape. Finally, we measure the statistical complexity of the parameter time series, while the network is tuned from a regular network to a random network using the Watts-Strogatz rewiring algorithm. We find that the statistical complexity of the parameter dynamics is maximized when the neuron network is most small-world-like. Our results suggest that the small-world architecture of neuron connections in brains is not accidental, but may be related to the information processing that they do.	[Tan, Teck Liang; Cheong, Siew Ann] Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore; [Tan, Teck Liang; Cheong, Siew Ann] Nanyang Technol Univ, Complex Inst, Block 2 Innovat Ctr,Level 2 Unit 245, Singapore 637723, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Tan, TL (corresponding author), Nanyang Technol Univ, Sch Phys & Math Sci, Div Phys & Appl Phys, 21 Nanyang Link, Singapore 637371, Singapore.; Tan, TL (corresponding author), Nanyang Technol Univ, Complex Inst, Block 2 Innovat Ctr,Level 2 Unit 245, Singapore 637723, Singapore.	S130004@e.ntu.edu.sg	Cheong, Siew Ann/B-6991-2011	Cheong, Siew Ann/0000-0002-8589-6699				ABBOTT LF, 1990, LECT NOTES PHYS, V368, P5; Abbott LF, 1999, BRAIN RES BULL, V50, P303, DOI 10.1016/S0361-9230(99)00161-6; Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; BAK P, 1988, PHYS REV A, V38, P364, DOI 10.1103/PhysRevA.38.364; BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Bak P., 1996, NATURE WORKS, P1, DOI [10.1007/978-1-4757-5426-1, 10.1007/978-1-4757-5426-1_1, DOI 10.1007/978-1-4757-5426-1_1]; Bassett DS, 2006, NEUROSCIENTIST, V12, P512, DOI 10.1177/1073858406293182; Beggs JM, 2008, PHILOS T R SOC A, V366, P329, DOI 10.1098/rsta.2007.2092; Bertschinger N, 2004, NEURAL COMPUT, V16, P1413, DOI 10.1162/089976604323057443; Brette R, 2007, J COMPUT NEUROSCI, V23, P349, DOI 10.1007/s10827-007-0038-6; Brunel N, 2007, BIOL CYBERN, V97, P337, DOI 10.1007/s00422-007-0190-0; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Burkitt AN, 2006, BIOL CYBERN, V95, P97, DOI 10.1007/s00422-006-0082-8; Burkitt AN, 2006, BIOL CYBERN, V95, P1, DOI 10.1007/s00422-006-0068-6; Chialvo DR, 1999, NEUROSCIENCE, V90, P1137, DOI 10.1016/S0306-4522(98)00472-2; Chialvo DR, 2008, ARXIV08040032; Crutchfield JP, 2012, NAT PHYS, V8, P17, DOI 10.1038/nphys2190; CRUTCHFIELD JP, 1989, PHYS REV LETT, V63, P105, DOI 10.1103/PhysRevLett.63.105; Crutchfield JP, 1988, COMPUTATION ONSET CH; Feldman DP, 1998, PHYS LETT A, V238, P244, DOI 10.1016/S0375-9601(97)00855-4; Glasser MF, 2016, NATURE, V536, P171, DOI 10.1038/nature18933; Guo D, 2016, SCI REP, P6; Guo DQ, 2010, IEEE T NEURAL NETWOR, V21, P895, DOI 10.1109/TNN.2010.2044419; Hansel C, 2001, NAT NEUROSCI, V4, P467, DOI 10.1038/87419; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Izhikevich E.M., 2008, SIAM REV, V50, P397; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Kitzbichler MG, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000314; Kuhlman SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002005; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Legenstein R, 2007, NEURAL NETWORKS, V20, P323, DOI 10.1016/j.neunet.2007.04.017; Lopez-Ruiz R., 2002, NLIN0205033 ARXIV; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Mozzachiodi R, 2010, TRENDS NEUROSCI, V33, P17, DOI 10.1016/j.tins.2009.10.001; Newman MEJ, 1999, PHYS REV E, V60, P7332, DOI 10.1103/PhysRevE.60.7332; Rioult-Pedotti MS, 1998, NAT NEUROSCI, V1, P230, DOI 10.1038/678; Roxin A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198101; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; Sporns O, 2000, CEREB CORTEX, V10, P127, DOI 10.1093/cercor/10.2.127; Touboul J, 2008, SIAM J APPL MATH, V68, P1045, DOI 10.1137/070687268; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Turcotte DL, 1999, REP PROG PHYS, V62, P1377, DOI 10.1088/0034-4885/62/10/201; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918	44	3	3	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183918	10.1371/journal.pone.0183918	http://dx.doi.org/10.1371/journal.pone.0183918			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850587	gold, Green Published			2022-12-27	WOS:000408544200042
J	Hyun, J; Lim, DH; Eo, DR; Hwang, S; Chung, ES; Chung, TY				Hyun, Joo; Lim, Dong Hui; Eo, Doo Ri; Hwang, Sungsoon; Chung, Eui-Sang; Chung, Tae-Young			A comparison of visual outcome and rotational stability of two types of toric implantable collamer lenses (TICL): V4 versus V4c	PLOS ONE			English	Article							PHAKIC INTRAOCULAR-LENS; HIGH MYOPIC ASTIGMATISM; CENTRAL HOLE; CLINICAL-OUTCOMES; PUPILLARY BLOCK; AXIS ALIGNMENT; GLAUCOMA; BIOMETRY; MODERATE; EYES	Purpose To compare the efficacy and rotational stability after implantation of two types of toric implantable collamer lenses (Toric ICL (TM)(TICL);V4 and V4c, STAAR Surgical Co.) Study design Retrospective case series. Methods This retrospective study evaluated total 48 eyes of 48 patients who underwent the implantation with V4 and V4c TICL with a central hole; A twenty-four eyes of 24 patients with V4 TICL and 24 eyes of 24 patients with V4c TICL with a central hole. Visual acuity, manifest refraction, and intraocular pressure were evaluated before and after surgery. Rotational stability (disparity between the intended axis and achieved axis) was assessed in both groups using digital anterior segment photographs, and vector analysis was also performed. Results Uncorrected visual acuity improved in both groups without significant difference (P = .111). There were no statistical differences between two groups in postoperative SE and cylindrical errors (P = .067 and .384, respectively). The mean value of rotation was 4.17 +/- 3.31 degrees and 3.39 +/- 2.36 degrees in the V4 and V4c TICL groups, respectively without significant difference (P = .364). Vector analysis of astigmatic correction showed no significant diffrence between two groups. Conclusion V4 and V4c TICL have similar efficacy with regard to visual acuity and refractive outcomes and rotational stability.	[Hyun, Joo; Lim, Dong Hui; Eo, Doo Ri; Hwang, Sungsoon; Chung, Tae-Young] Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea; [Hyun, Joo] Saevit Eye Hosp, Dept Ophthalmol, Goyang, South Korea; [Lim, Dong Hui] Catholic Univ Korea, Dept Prevent Med, Coll Med, Seoul, South Korea; [Chung, Eui-Sang] Rhees Eye Hosp, Daejeon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Catholic University of Korea	Chung, TY (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Ophthalmol, Sch Med, Seoul, South Korea.	tychung@skku.edu		Hyun, Joo/0000-0003-0830-807X; Chung, Tae-Young/0000-0002-7291-822X				Alfonso JF, 2014, J CATARACT REFR SURG, V40, P1155, DOI 10.1016/j.jcrs.2013.11.034; Alfonso JF, 2013, J CATARACT REFR SURG, V39, P915, DOI 10.1016/j.jcrs.2013.01.036; Alpins N, 2001, J CATARACT REFR SURG, V27, P31, DOI 10.1016/S0886-3350(00)00798-7; Bylsma SS, 2002, J CATARACT REFR SURG, V28, P2222, DOI 10.1016/S0886-3350(02)01303-2; Choi KH, 2007, J REFRACT SURG, V23, P362; Choi SH, 2011, J REFRACT SURG, V27, P91, DOI 10.3928/1081597X-20100414-01; Chung TY, 2009, J REFRACT SURG, V25, P251, DOI 10.3928/1081597X-20090301-03; Gonzalez-Lopez F, 2013, J CATARACT REFR SURG, V39, P1859, DOI 10.1016/j.jcrs.2013.06.020; Hashem AN, 2009, J REFRACT SURG, V25, pS939, DOI 10.3928/1081597X-20090915-08; HOFFER KJ, 1980, AM J OPHTHALMOL, V90, P360, DOI 10.1016/S0002-9394(14)74917-7; Huseynova T, 2014, AM J OPHTHALMOL, V157, P1136, DOI 10.1016/j.ajo.2014.01.032; Kamiya K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056453; Lee DH, 2012, OPHTHALMOLOGY, V119, P272, DOI 10.1016/j.ophtha.2011.07.047; Lee SY, 2011, EYE, V25, P1409, DOI 10.1038/eye.2011.176; Lim DH, 2014, AM J OPHTHALMOL, V158, P447, DOI 10.1016/j.ajo.2014.06.005; Lim DH, 2014, AM J OPHTHALMOL, V157, P135, DOI 10.1016/j.ajo.2013.09.004; Mori T, 2012, J CATARACT REFR SURG, V38, P568, DOI 10.1016/j.jcrs.2011.11.028; Park SC, 2009, J REFRACT SURG, V25, P403, DOI 10.3928/1081597X-20090422-01; Sanders DR, 2007, OPHTHALMOLOGY, V114, P54, DOI 10.1016/j.ophtha.2006.08.049; Sheng XL, 2012, INT J OPHTHALMOL-CHI, V5, P459, DOI 10.3980/j.issn.2222-3959.2012.04.10; Shimizu K, 2012, BRIT J OPHTHALMOL, V96, P409, DOI 10.1136/bjophthalmol-2011-300148; Smallman DS, 2004, J CATARACT REFR SURG, V30, P905, DOI 10.1016/j.jcrs.2003.09.019; Till JS, 2002, J CATARACT REFR SURG, V28, P295, DOI 10.1016/S0886-3350(01)01035-5; Vetter JM, 2006, J CATARACT REFR SURG, V32, P1065, DOI 10.1016/j.jcrs.2006.02.028	24	30	31	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183335	10.1371/journal.pone.0183335	http://dx.doi.org/10.1371/journal.pone.0183335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846701	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600024
J	Prieto, LM; McPhee, CF; Rojas, P; Mazariegos, D; Munoz, E; Mellado, MJ; Holguin, A; Navarro, ML; Gonzalez-Tome, M; Ramos, JT				Prieto, Luis M.; Fernandez McPhee, Carolina; Rojas, Patricia; Mazariegos, Diana; Munoz, Eloy; Jose Mellado, Maria; Holguin, Africa; Luisa Navarro, Maria; Isabel Gonzalez-Tome, Maria; Tomas Ramos, Jose		Madrid Cohort HIV-Infected Mother	Pregnancy outcomes in perinatally HIV-infected young women in Madrid, Spain: 2000-2015	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; FOR-GESTATIONAL-AGE; LOW RATES; ADOLESCENTS; COHORT; RISK; MORTALITY; IRELAND; BORN; UK	Background An increasing number of perinatally HIV-infected women (PHIV) are reaching adulthood and becoming pregnant. Most PHIV women have been exposed to a high number of antiretroviral regimens, and they may have difficulties to achieve viral suppression. Psychosocial problems are not uncommon and could be an important barrier for treatment adherence. The effects of chronic HIV infection and long-term exposure to antiretroviral treatment of PHIV women cause concerns on the developing fetus. The aims of this study were to describe the prevention of mother-to-child transmission strategies in PHIV women and the infant outcomes in the Madrid Cohort of HIV-infected mother-infant pairs. Methods All PHIV pregnant women registered in the Cohort that gave birth from 2000 to 2015 were included in the study. Results Twenty-eight pregnancies in twenty-two perinatally infected women were registered. Most women were Caucasian and heavily treatment-experienced. Nine cases (32.1%) were at high risk of HIV mother-to-child transmission. Maternal HIV-1 viral load was detectable close to delivery in four women (14.3%). The management of these cases was described, and the treatment strategies were discussed. None of the newborns acquired HIV infection. Eight infants (28.6%) were small for gestational age. Conclusions This study included a large series of pregnancies among PHIV women attended according to a youth-centered care model. The challenges in the management of this population by health-care providers were described. Specific strategies to minimize perinatal transmission risks should be addressed in future collaborative studies.	[Prieto, Luis M.] Hosp Univ Getafe, Paediat Dept, Madrid, Spain; [Fernandez McPhee, Carolina; Luisa Navarro, Maria] Hosp Gen Univ Gregorio Maranon, Paediat Dept, Infect Dis Unit, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] Hosp Ramon & Cajal IRYCIS, HIV Mol Epidemiol Lab 1, Microbiol & Parasitol Dept, Madrid, Spain; [Rojas, Patricia; Holguin, Africa] CIBER ESP, Madrid, Spain; [Mazariegos, Diana; Tomas Ramos, Jose] Hosp Clin Univ San Carlos, Paediat Dept, Madrid, Spain; [Munoz, Eloy] Hosp Univ 12 Octubre, Obstet & Ginecol Dept, Madrid, Spain; [Jose Mellado, Maria] Hosp Univ La Paz, Paediat Dept, Trop & Infect Dis Unit, Madrid, Spain; [Isabel Gonzalez-Tome, Maria] Hosp Univ 12 Octubre, Paediat Dept, Infect Dis Unit, Madrid, Spain	Hospital Universitario de Getafe; General University Gregorio Maranon Hospital; Hospital Universitario Ramon y Cajal; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Hospital Universitario 12 de Octubre; Hospital Universitario La Paz; Hospital Universitario 12 de Octubre	Prieto, LM (corresponding author), Hosp Univ Getafe, Paediat Dept, Madrid, Spain.	lmprieto.hugf@salud.madrid.org	Holguín, Africa/AAF-9001-2021; Prieto, Luis Enrique/HFZ-7903-2022; Roa, Miguel Angel/D-1088-2016	Holguín, Africa/0000-0002-1330-8050; Roa, Miguel Angel/0000-0003-1933-3000; Mellado Pena, Maria Jose/0000-0003-2251-9666; , Patricia/0000-0001-6935-0066				Albright JN, 2014, AIDS PATIENT CARE ST, V28, P587, DOI 10.1089/apc.2014.0162; [Anonymous], 2013, AIDS, V27, P2312, DOI 10.1097/QAD.0b013e32836378e4; [Anonymous], 2010, EST ESP CREC; Badell Martina L, 2012, AIDS Res Treat, V2012, P418630, DOI 10.1155/2012/418630; Badell Martina L, 2013, Infect Dis Obstet Gynecol, V2013, P301763, DOI 10.1155/2013/301763; Byrne L, 2015, J INT AIDS SOC, V17, P19693; Calitri C, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-277; Croucher AP, 2013, SEX TRANSM INFECT, V89, P392, DOI 10.1136/sextrans-2012-050831; Cruz MLS, 2010, AIDS, V24, P2727, DOI 10.1097/QAD.0b013e32833e50d4; Echenique M, 2017, AIDS CARE, V29, P372, DOI 10.1080/09540121.2016.1220483; Elgalib A, 2011, HIV MED, V12, P118, DOI 10.1111/j.1468-1293.2010.00878.x; EUROCAT, EUR SURV CONG AN; Fish R, 2014, HIV MED, V15, P239, DOI 10.1111/hiv.12091; Garcia-Subirats I, 2011, MATERN CHILD HLTH J, V15, P561, DOI 10.1007/s10995-010-0614-7; Giaquinto C, 2005, CLIN INFECT DIS, V40, P458, DOI 10.1086/427287; Hernandez S, 2016, J CELL MOL MED; de Jose MI, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-2; Jao J, 2015, AIDS, V29, P111, DOI 10.1097/QAD.0000000000000501; Jao J, 2012, AIDS, V26, P855, DOI 10.1097/QAD.0b013e328351f6ef; Kenny J, 2012, HIV MED, V13, P304, DOI 10.1111/j.1468-1293.2011.00967.x; Lall P, 2015, J INT AIDS SOC, V18, P41, DOI 10.7448/IAS.18.2.19393; Lopez M, 2016, J INFECT DIS, V213, P343, DOI 10.1093/infdis/jiv416; Prieto LM, 2012, PEDIATR INFECT DIS J, V31, P1053, DOI 10.1097/INF.0b013e31826fe968; McIntire DD, 1999, NEW ENGL J MED, V340, P1234, DOI 10.1056/NEJM199904223401603; Medin G, 2016, AIDS CARE, V28, P124, DOI 10.1080/09540121.2015.1071768; Millery M, 2012, J ASSOC NURSE AIDS C, V23, DOI 10.1016/j.jana.2011.05.008; Palladino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096307; Panel on Antiretroviral Guidelines for Adults and Adolescents, GUID US ANT AG HIV 1; Strauss RS, 2000, JAMA-J AM MED ASSOC, V283, P625, DOI 10.1001/jama.283.5.625; Taha TE, 2005, PEDIATRICS, V115, pE167, DOI 10.1542/peds.2004-1590; Thorne C, 2004, AIDS, V18, P344, DOI [10.1097/00002030-200401230-00033, 10.1097/01.aids.0000111440.91384.30]; Townsend CL, 2008, AIDS, V22, P973, DOI 10.1097/QAD.0b013e3282f9b67a; Townsend CL, 2014, AIDS, V28, P1049, DOI 10.1097/QAD.0000000000000212; Tubiana R, 2010, CLIN INFECT DIS, V50, P585, DOI 10.1086/650005; Warszawski J, 2008, AIDS, V22, P289, DOI 10.1097/QAD.0b013e3282f3d63c; Writing group for the Kids to Adults Working Group and Data Management and Harmonisation Group in EuroCoord, 2016, CHILDREN AND YOUNG P, V21	36	11	11	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183558	10.1371/journal.pone.0183558	http://dx.doi.org/10.1371/journal.pone.0183558			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841701	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700042
J	Taguchi, YH				Taguchi, Y-h.			Tensor decomposition- based unsupervised feature extraction applied to matrix products for multi-view data processing	PLOS ONE			English	Article							INHIBITS TUMOR-GROWTH; CELL LUNG-CANCER; BREAST-CANCER; TARGETING METADHERIN; EXPRESSION ANALYSIS; PROSTATE-CANCER; R-PACKAGE; METASTASIS; GENE; INVASION	In the current era of big data, the amount of data available is continuously increasing. Both the number and types of samples, or features, are on the rise. The mixing of distinct features often makes interpretation more difficult. However, separate analysis of individual types requires subsequent integration. A tensor is a useful framework to deal with distinct types of features in an integrated manner without mixing them. On the other hand, tensor data is not easy to obtain since it requires the measurements of huge numbers of combinations of distinct features; if there are m kinds of features, each of which has N dimensions, the number of measurements needed are as many as N m, which is often too large to measure. In this paper, I propose a new method where a tensor is generated from individual features without combinatorial measurements, and the generated tensor was decomposed back to matrices, by which unsupervised feature extraction was performed. In order to demonstrate the usefulness of the proposed strategy, it was applied to synthetic data, as well as three omics datasets. It outperformed other matrix-based methodologies.	[Taguchi, Y-h.] Chuo Univ, Dept Phys, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan	Chuo University	Taguchi, YH (corresponding author), Chuo Univ, Dept Phys, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	tag@granular.com	Taguchi, Y-h./E-1474-2011	Taguchi, Y-h./0000-0003-0867-8986	Japan Society for the Promotion of Science [17K00417]; Grants-in-Aid for Scientific Research [17K00417] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science-17K00417-Prof. Y-h. Taguchi.	Albrecht M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-016-1440-8; [Anonymous], 2016, SOX9 UPREGULATION BR; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bornachea O, 2012, SCI REP-UK, V2, DOI 10.1038/srep00434; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chen MB, 2016, ONCOTARGET; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Dong RF, 2014, ONCOTARGET, V5, P10816, DOI 10.18632/oncotarget.2522; Donzelli S, 2015, ONCOTARGET, V6, P35183, DOI 10.18632/oncotarget.5930; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Fortino V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107801; Glud M, 2010, MELANOMA RES, V20, P479, DOI 10.1097/CMR.0b013e32833e32a1; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Han X, 2015, CANCER GENE THER, V22, P122, DOI 10.1038/cgt.2014.75; He ZY, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0533-3; Hirahata M, 2016, CANCER MED-US, V5, P892, DOI 10.1002/cam4.651; Hu YJ, 2012, TUMOR BIOL, V33, P1863, DOI 10.1007/s13277-012-0446-8; Huang S, 2012, ONCOL REP, V28, P1831, DOI 10.3892/or.2012.2015; Ihnen M, 2010, DIS MARKERS, V28, P71, DOI [10.1155/2010/812509, 10.3233/DMA-2010-0685]; Ishida S, 2014, PROTEIN PEPTIDE LETT, V21, P828; King JA, 2014, CANC RES S, V66, P654; Kinoshita R, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S1-S4; Kuo YZ, 2014, ORAL DIS, V20, pe65, DOI 10.1111/odi.12133; Li Y, 2016, BRIEF BIOINFORMATICS; Li YQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122228; Liu ZL, 2013, MOL CELL BIOCHEM, V372, P35, DOI 10.1007/s11010-012-1443-3; Ma QP, 2013, INT J BIOL SCI, V9, P680, DOI 10.7150/ijbs.6623; Mudduluru G, 2011, BIOSCIENCE REP, V31, P185, DOI 10.1042/BSR20100065; Murakami Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16294; Murakami Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106314; Murakami Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048366; Nasser Mohd W, 2016, Oncoscience, V3, P52; O'Boyle G, 2012, P NATL ACAD SCI USA, V109, P4598, DOI 10.1073/pnas.1118104109; Oghumu S, 2014, IMMUNOLOGY, V143, P109, DOI 10.1111/imm.12293; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Osaki M, 2011, MOL THER, V19, P1123, DOI 10.1038/mt.2011.53; Peng XS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020341; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; R Core Team, 2013, R LANG ENV STAT COMP; Reimand J, 2016, NUCLEIC ACIDS RES, V44, pW83, DOI 10.1093/nar/gkw199; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Salavoura K, 2008, ANTICANCER RES, V28, P1263; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Strell Carina, 2008, Cell Commun Signal, V6, P10, DOI 10.1186/1478-811X-6-10; Strimmer K, 2008, BIOINFORMATICS, V24, P1461, DOI 10.1093/bioinformatics/btn209; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taguchi Y.-h., 2015, BIG DATA ANAL BIOINF, P138; Taguchi Y. H., 2017, COMPUTATIONAL METHOD, V8, P153, DOI [DOI 10.1142/9789813207981_0008, 10.1142/9789813207981_0008]; Taguchi Y.-H., 2015, COMPUTATIONAL INTELL, P1, DOI [10.1109/CIBCB.2015.7300274, DOI 10.1109/CIBCB.2015.7300274]; Taguchi YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44016; Taguchi Y, 2016, BMC MED GENOMICS, V9, DOI 10.1186/s12920-016-0196-3; Taguchi YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050696; Taguchi YH, 2016, BIODATA MIN, V9, DOI 10.1186/s13040-016-0101-9; Taguchi YH, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0574-4; Taguchi Y-h, 2014, BMC Res Notes, V7, P581, DOI 10.1186/1756-0500-7-581; Taguchi YH, 2014, LECT N BIOINFORMAT, V8590, P445, DOI 10.1007/978-3-319-09330-7_52; Taguchi YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066714; Taguchi YH, 2012, LECT NOTES COMPUT SC, V7632, P141, DOI 10.1007/978-3-642-34123-6_13; TAGUCHI YH, 2015, BMC BIOINFORMATI S18, V16; Taguchi YH., 2016, NEUROEPIGENETCIS, V8, P1, DOI [10.1016/j.nepig.2016.10.001, DOI 10.1016/J.NEPIG.2016.10.001]; Tang F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035435; Tang YY, 2015, MOL MED REP, V11, P454, DOI 10.3892/mmr.2014.2682; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Umeyama H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S9-S2; Vahey MT, 2010, J INFECT DIS, V201, P580, DOI 10.1086/650310; Versteeg HH, 2004, MOL MED, V10, P6, DOI 10.2119/2003-00047.Versteeg; Wan WN, 2014, DIAGN PATHOL, V9, DOI 10.1186/s13000-014-0178-8; Wang MZ, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0344-6; Wood LA, 1998, ACTA ONCOL, V37, P771, DOI 10.1080/028418698430197; Wu DQ, 2005, CELL RES, V15, P52, DOI 10.1038/sj.cr.7290265; Xia H, 2014, INT J MOL SCI, V15, P11973, DOI 10.3390/ijms150711973; Xin M, 2016, ONCOTARGET, V7, P44252, DOI 10.18632/oncotarget.10020; Xu C., 2013, CORR; Yan LX, 2008, RNA, V14, P2348, DOI 10.1261/rna.1034808; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yu SH, 2015, J CELL BIOCHEM, V116, P268, DOI 10.1002/jcb.24965; Zhou HC, 2016, J PATHOL, V240, P450, DOI 10.1002/path.4804; Zhu GQ, 2015, ONCOTARGET, V6, P43408, DOI 10.18632/oncotarget.6125	79	13	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183933	10.1371/journal.pone.0183933	http://dx.doi.org/10.1371/journal.pone.0183933			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841719	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700069
J	Teixeira-Coelho, F; Fonseca, CG; Barbosa, NHS; Vaz, FF; Cordeiro, LMD; Coimbra, CC; Pires, W; Soares, DD; Wanner, SP				Teixeira-Coelho, Francisco; Fonseca, Cletiana Goncalves; Santos Barbosa, Nicolas Henrique; Vaz, Filipe Ferreira; de Souza Cordeiro, Leticia Maria; Coimbra, Candido Celso; Pires, Washington; Soares, Danusa Dias; Wanner, Samuel Penna			Effects of manipulating the duration and intensity of aerobic training sessions on the physical performance of rats	PLOS ONE			English	Article							SKELETAL-MUSCLE; RUNNING ECONOMY; EXERCISE PERFORMANCE; ANAEROBIC THRESHOLD; ENDURANCE EXERCISE; OXYGEN-UPTAKE; CAPACITY; VO2MAX; INTERVAL; ADAPTATIONS	This study investigated the effects of manipulating the load components of aerobic training sessions on the physical performance of rats. To achieve this purpose, adult male Wistar rats were divided into four groups: an untrained control (CON) group and training groups with a predominant overload in intensity (INT) or duration (DUR) or alternating and similar overloads in intensity and duration (ID). Prior to, during, and after 8 weeks of the control or training protocols, the performance of the rats (evaluated by their workload) was determined during fatiguing, incremental-speed treadmill running. Two additional incremental running tests were performed prior to and at the end of the protocols to measure the peak rate of oxygen consumption (VO2peak). As expected, the rats in the trained groups exhibited increased performance, whereas the untrained rats showed stable performance throughout the 8 weeks. Notably, the performance gain exhibited by the DUR rats reached a plateau after the 4 th week. This plateau was not present in the INT or ID rats, which exhibited increased performance at the end of training protocol compared with the DUR rats. None of the training protocols changed the VO2peak values; however, these values were attained at faster speeds, which indicated increased running economy. In conclusion, our findings demonstrate that the training protocols improved the physical performance of rats, likely resulting from enhanced running economy. Furthermore, compared with overload in duration, overload in the intensity of training sessions was more effective at inducing performance improvements across the 8 weeks of the study.	[Teixeira-Coelho, Francisco; Fonseca, Cletiana Goncalves; Santos Barbosa, Nicolas Henrique; Vaz, Filipe Ferreira; de Souza Cordeiro, Leticia Maria; Pires, Washington; Soares, Danusa Dias; Wanner, Samuel Penna] Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Exercise Physiol Lab, Belo Horizonte, MG, Brazil; [Teixeira-Coelho, Francisco] Teacher Format Ctr, Amargosa, BA, Brazil; [Teixeira-Coelho, Francisco] Univ Fed Reconcavo Bahia, Amargosa, BA, Brazil; [Coimbra, Candido Celso] Univ Fed Minas Gerais, Inst Biol Sci, Lab Endocrinol & Metab, Belo Horizonte, MG, Brazil; [Pires, Washington] Univ Fed Juiz De Fora, Inst Life Sci, Dept Phys Educ, Governador Valadares, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal do Reconcavo da Bahia; Universidade Federal de Minas Gerais; Universidade Federal de Juiz de Fora	Wanner, SP (corresponding author), Univ Fed Minas Gerais, Sch Phys Educ Physiotherapy & Occupat Therapy, Exercise Physiol Lab, Belo Horizonte, MG, Brazil.	samuelwanner@ufmg.br	Soares, Danusa/H-1385-2012; Soares, Danusa/AAW-1915-2021; Wanner, Samuel P./F-9654-2012	Soares, Danusa/0000-0002-5705-8890; Wanner, Samuel P./0000-0002-4659-1032; de Souza Cordeiro, Leticia Maria/0000-0003-2115-2102	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473737/2013-2]; Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG) [APQ-01946-14]; FAPEMIG [BPD 00555-14]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); FAPEMIG	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was funded by the following agencies: Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; grant number 473737/2013-2) and Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG; grant number APQ-01946-14). LMSC was a recipient of a post-doc fellowship from FAPEMIG (grant number BPD 00555-14). CGF was recipient of a PhD fellowship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), whereas NHSB was a recipient of an undergraduate fellowship from FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baar K, 2004, P NUTR SOC, V63, P269, DOI 10.1079/PNS2004334; Carvalho JF, 2005, COMP BIOCHEM PHYS A, V140, P409, DOI 10.1016/j.cbpb.2004.12.002; Cheilleachair NJN, 2017, J SPORT SCI, V35, P1052, DOI 10.1080/02640414.2016.1209539; CONLEY DL, 1980, MED SCI SPORT EXER, V12, P357, DOI 10.1249/00005768-198012050-00010; COSTILL DL, 1991, MED SCI SPORT EXER, V23, P371; Damasceno WC, 2015, NEUROSCI LETT, V590, P193, DOI 10.1016/j.neulet.2015.01.082; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; de Araujo GG, 2015, PHYSIOL RES, V64, P209, DOI 10.33549/physiolres.932693; Drummond LR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155919; Fiskerstrand A, 2004, SCAND J MED SCI SPOR, V14, P303, DOI 10.1046/j.1600-0838.2003.370.x; Franch J, 1998, MED SCI SPORT EXER, V30, P1250, DOI 10.1097/00005768-199808000-00011; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Ingham SA, 2008, MED SCI SPORT EXER, V40, P579, DOI [10.1249/mss.0b013e31815ecc6a, 10.1249/MSS.0b013e31815ecc6a]; Joyner MJ, 2008, J PHYSIOL-LONDON, V586, P35, DOI 10.1113/jphysiol.2007.143834; Kemi OJ, 2005, CARDIOVASC RES, V67, P161, DOI 10.1016/j.cardiores.2005.03.010; Kunstetter AC, 2014, BRAZ J MED BIOL RES, V47, P679, DOI 10.1590/1414-431X20143561; LAMBERT MI, 1989, J APPL PHYSIOL, V66, P1620, DOI 10.1152/jappl.1989.66.4.1620; Laursen PB, 2010, SCAND J MED SCI SPOR, V20, P1, DOI 10.1111/j.1600-0838.2010.01184.x; Londeree BR, 1997, MED SCI SPORT EXER, V29, P837, DOI 10.1097/00005768-199706000-00016; Marton O, 2015, PFLUG ARCH EUR J PHY, V467, P779, DOI 10.1007/s00424-014-1554-7; Mclaughlin JE, 2010, MED SCI SPORT EXER, V42, P991, DOI 10.1249/MSS.0b013e3181c0669d; Meeusen R, 2013, MED SCI SPORT EXER, V45, P186, DOI 10.1249/MSS.0b013e318279a10a; Moreira JBN, 2013, J APPL PHYSIOL, V114, P1029, DOI 10.1152/japplphysiol.00760.2012; PATE RR, 1984, SPORTS MED, V1, P87, DOI 10.2165/00007256-198401020-00001; PICA AJ, 1982, MED SCI SPORT EXER, V14, P249; PILIS W, 1993, COMP BIOCHEM PHYS A, V106, P285, DOI 10.1016/0300-9629(93)90513-4; Primola-Gomes TN, 2009, J APPL PHYSIOL, V107, P593, DOI 10.1152/japplphysiol.91218.2008; Rabelo PCR, 2015, BRAIN RES BULL, V112, P7, DOI 10.1016/j.brainresbull.2015.01.006; SALTIN B, 1969, SCAND J CLIN LAB INV, V24, P323, DOI 10.3109/00365516909080169; Santiago HP, 2016, CLIN EXP PHARMACOL P, V43, P116, DOI 10.1111/1440-1681.12507; Saunders PU, 2004, SPORTS MED, V34, P465, DOI 10.2165/00007256-200434070-00005; Skinner JS, 1985, J APPL PHYSIOL, V2001, P1770; Soya H, 2007, NEUROSCI RES, V58, P341, DOI 10.1016/j.neures.2007.04.004; TAYLOR CR, 1981, RESP PHYSIOL, V44, P25, DOI 10.1016/0034-5687(81)90075-X; Wanner SP, 2007, BRAIN RES BULL, V73, P28, DOI 10.1016/j.brainresbull.2007.03.004; WENGER HA, 1986, SPORTS MED, V3, P346, DOI 10.2165/00007256-198603050-00004; Weston KS, 2014, BRIT J SPORT MED, V48, P1227, DOI 10.1136/bjsports-2013-092576; Wisloff U, 2001, AM J PHYSIOL-HEART C, V280, pH1301, DOI 10.1152/ajpheart.2001.280.3.H1301; Zoladz JA, 2016, PFLUG ARCH EUR J PHY, V468, P1709, DOI 10.1007/s00424-016-1867-9	43	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183763	10.1371/journal.pone.0183763	http://dx.doi.org/10.1371/journal.pone.0183763			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841706	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700056
J	Scott, K; George, AS; Harvey, SA; Mondal, S; Patel, G; Ved, R; Garimella, S; Sheikh, K				Scott, Kerry; George, Asha S.; Harvey, Steven A.; Mondal, Shinjini; Patel, Gupteswar; Ved, Rajani; Garimella, Surekha; Sheikh, Kabir			Beyond form and functioning: Understanding how contextual factors influence village health committees in northern India	PLOS ONE			English	Article							PRIMARY-CARE; GOVERNANCE; SECTOR; POLICY	Health committees are a common strategy to foster community participation in health. Efforts to strengthen committees often focus on technical inputs to improve committee form (e.g. representative membership) and functioning (e.g. meeting procedures). However, porous and interconnected contextual spheres also mediate committee effectiveness. Using a framework for contextual analysis, we explored the contextual features that facilitated or hindered Village Health, Sanitation and Nutrition Committee (VHSNC) functionality in rural north India. We conducted interviews (n = 74), focus groups (n = 18) and observation over 1.5 years. Thematic content analysis enabled the identification and grouping of themes, and detailed exploration of sub-themes. While the intervention succeeded in strengthening committee form and functioning, participant accounts illuminated the different ways in which contextual influences impinged on VHSNC efficacy. Women and marginalized groups navigated social hierarchies that curtailed their ability to assert themselves in the presence of men and powerful local families. These dynamics were not static and unchanging, illustrated by pre-existing cross-caste problem solving, and the committee's creation of opportunities for the careful violation of social norms. Resource and capacity deficits in government services limited opportunities to build relationships between health system actors and committee members and engendered mistrust of government institutions. Fragmented administrative accountability left committee members bearing responsibility for improving local health without access to stakeholders who could support or respond to their efforts. The committee's narrow authority was at odds with widespread community needs, and committee members struggled to involve diverse government services across the health, sanitation, and nutrition sectors. Multiple parallel systems (political decentralization, media and other village groups) presented opportunities to create more enabling VHSNC contexts, although the potential to harness these opportunities was largely unmet. This study highlights the urgent need for supportive contexts in which people can not only participate in health committees, but also access the power and resources needed to bring about actual improvements to their health and wellbeing.	[Scott, Kerry; Harvey, Steven A.] Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Scott, Kerry; Mondal, Shinjini; Patel, Gupteswar; Garimella, Surekha; Sheikh, Kabir] Publ Hlth Fdn India, New Delhi, Delhi National, India; [George, Asha S.] Univ Western Cape, Cape Town, Western Cape, South Africa; [Patel, Gupteswar] Univ Newcastle, Callaghan, NSW, Australia; [Ved, Rajani] Natl Hlth Syst Resource Ctr, New Delhi, Delhi National, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Public Health Foundation of India; University of the Western Cape; University of Newcastle	Scott, K (corresponding author), Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.; Scott, K (corresponding author), Publ Hlth Fdn India, New Delhi, Delhi National, India.	kscott26@jhu.edu	Harvey, Steven/AAP-5520-2020	Patel, Gupteswar/0000-0002-6989-5848; Sheikh, Kabir/0000-0003-4755-2075; Garimella, Surekha/0000-0003-2706-0268; George, Asha/0000-0002-5968-1424; Harvey, Steven/0000-0001-6936-0213	World Health Organization's Alliance for Health Policy and Systems Research, Switzerland [201104232]; Government of Canada's International Development Research Centre, Canada [107313-001]	World Health Organization's Alliance for Health Policy and Systems Research, Switzerland; Government of Canada's International Development Research Centre, Canada	The authors are grateful for financial support from (1) the World Health Organization's Alliance for Health Policy and Systems Research, Switzerland (grant 201104232 received by Kabir Sheikh) and (2) the Government of Canada's International Development Research Centre, Canada (grant 107313-001 received by Kabir Sheikh). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhay Shukla, 2011, Economic and Political Weekly, V46, P78; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Belaid L, 2014, HLTH POLICY PLAN, P1; Bishai D, 2002, HEALTH POLICY PLANN, V17, P202, DOI 10.1093/heapol/17.2.202; Commission Planning, 2012, 12 5 YEAR PLAN 2012, VIII, P1; Du Mortier S, 2005, INT J QUAL HEALTH C, V17, P293, DOI 10.1093/intqhc/mzi042; Foley E. E., 2001, Urban Anthropology, V30, P1; George A, 2015, SOC SCI MED, V133, P159, DOI 10.1016/j.socscimed.2015.03.049; Ghosh J, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1632; Goodman C, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-229; Israr SM, 2006, INT J HEALTH PLAN M, V21, P313, DOI 10.1002/hpm.852; Iwami M, 2002, J PUBLIC HEALTH MED, V24, P246, DOI 10.1093/pubmed/24.4.246; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Loewenson R, 2000, PUBLIC PARTICIPATION, V31, P15; London, 2010, CRIT HLTH PERSPECT, V2, P1; Malviya A, 2013, ONLINE J HLTH ALLIED, V12, P1; McCoy DC, 2012, HEALTH POLICY PLANN, V27, P449, DOI 10.1093/heapol/czr077; Menghaney L, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1734; MoHFW India, 2005, NAT RUR HLTH MISS 20; MoHFW India, 2013, GUID COMM PROC; Molyneux S, 2012, HEALTH POLICY PLANN, V27, P541, DOI 10.1093/heapol/czr083; Mosquera M, 2001, HEALTH POLICY PLANN, V16, P52, DOI 10.1093/heapol/16.suppl_2.52; Nandan D, 2008, RAPID APPRAISAL FUNC; OECD, 2011, OEC EC SURV IND OV, V50; Patton MQ., 2002, QUALITATIVE RES EVAL, V3rd; Pawson R., 1997, REALISTIC EVALUATION; Peters DH., 2013, IMPLEMENTATION RES H; Planning Commission HLEG, 2011, HIGH LEV EXP GROUP R; Scott K, INT J EQUITY HLTH; Semwal V, 2013, INDAN J COMMUNITY HE, V25, P472; Sheikh K, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001073; Singh R, 2012, INT J MED PUBLIC HEA, V2; Ssengooba Freddie, 2007, Hum Resour Health, V5, P3, DOI 10.1186/1478-4491-5-3; TAWIL O, 1995, AIDS, V9, P1299, DOI 10.1097/00002030-199512000-00001; WALT G, 1994, HEALTH POLICY PLANN, V9, P353, DOI 10.1093/heapol/9.4.353; Yin R.K., 2009, CASE STUDY RES DESIG, V5; ZAKUS JDL, 1998, HLTH POLICY PLAN, V13	37	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182982	10.1371/journal.pone.0182982	http://dx.doi.org/10.1371/journal.pone.0182982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837574	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000038
J	Surachat, K; Sangket, U; Deachamag, P; Chotigeat, W				Surachat, Komwit; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan			In silico analysis of protein toxin and bacteriocins from Lactobacillus paracasei SD1 genome and available online databases	PLOS ONE			English	Article							SWISS-MODEL REPOSITORY; LACTIC-ACID BACTERIA; WEB-BASED RESOURCE; RHAMNOSUS GG; TRNASCAN-SE; MUTANS STREPTOCOCCI; MICROBIAL GENOMES; SAFETY ASSESSMENT; RAPID ANNOTATION; GASSERICIN-A	Lactobacillus paracasei SD1 is a potential probiotic strain due to its ability to survive several conditions in human dental cavities. To ascertain its safety for human use, we therefore performed a comprehensive bioinformatics analysis and characterization of the bacterial protein toxins produced by this strain. We report the complete genome of Lactobacillus paracasei SD1 and its comparison to other Lactobacillus genomes. Additionally, we identify and analyze its protein toxins and antimicrobial proteins using reliable online database resources and establish its phylogenetic relationship with other bacterial genomes. Our investigation suggests that this strain is safe for human use and contains several bacteriocins that confer health benefits to the host. An in silico analysis of protein-protein interactions between the target bacteriocins and the microbial proteins gtfB and luxS of Streptococcus mutans was performed and is discussed here.	[Surachat, Komwit; Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Dept Mol Biotechnol & Bioinformat, Fac Sci, Hat Yai 90112, Songkhla, Thailand; [Sangket, Unitsa; Deachamag, Panchalika; Chotigeat, Wilaiwan] Prince Songkla Univ, Ctr Genom & Bioinformat Res, Fac Sci, Hat Yai 90112, Songkhla, Thailand; [Surachat, Komwit] Prince Songkla Univ, Fac Sci, Informat & Commun Technol Programme, Hat Yai 90112, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University; Prince of Songkla University	Chotigeat, W (corresponding author), Prince Songkla Univ, Dept Mol Biotechnol & Bioinformat, Fac Sci, Hat Yai 90112, Songkhla, Thailand.; Chotigeat, W (corresponding author), Prince Songkla Univ, Ctr Genom & Bioinformat Res, Fac Sci, Hat Yai 90112, Songkhla, Thailand.	wilaiwan58@hotmail.com	Surachat, Komwit/AAX-3087-2020	Surachat, Komwit/0000-0001-7793-7561	Department of Molecular Biotechnology and Bioinformatics, Information Communication Technology Program; Center for Genomics and Bioinformatics Research of Faculty of Science, Prince of Songkla University	Department of Molecular Biotechnology and Bioinformatics, Information Communication Technology Program; Center for Genomics and Bioinformatics Research of Faculty of Science, Prince of Songkla University	The study was supported by Department of Molecular Biotechnology and Bioinformatics, Information Communication Technology Program, and Center for Genomics and Bioinformatics Research of Faculty of Science, Prince of Songkla University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2014, PAK J PHARM SCI, V27, P1523; Aktas B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145784; [Anonymous], 2006, PROB FOOD HLTH NUTR; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Besemer J, 1999, NUCLEIC ACIDS RES, V27, P3911, DOI 10.1093/nar/27.19.3911; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; Bi DX, 2012, NUCLEIC ACIDS RES, V40, pD621, DOI 10.1093/nar/gkr846; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Borrero J, 2011, J BIOTECHNOL, V156, P76, DOI 10.1016/j.jbiotec.2011.07.038; Cai H, 2009, GENOME BIOL EVOL, V1, P239, DOI 10.1093/gbe/evp019; Chakraborty A, 2012, NUCLEIC ACIDS RES, V40, pD615, DOI 10.1093/nar/gkr942; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen LH, 2016, NUCLEIC ACIDS RES, V44, pD694, DOI 10.1093/nar/gkv1239; Chen LH, 2012, NUCLEIC ACIDS RES, V40, pD641, DOI 10.1093/nar/gkr989; Ciandrini E, 2016, APPL MICROBIOL BIOT, V100, P6767, DOI 10.1007/s00253-016-7531-7; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Comeau SR, 2004, NUCLEIC ACIDS RES, V32, pW96, DOI 10.1093/nar/gkh354; Comeau SR, 2007, PROTEINS, V69, P781, DOI 10.1002/prot.21795; Cotter PD, 2005, NAT REV MICROBIOL, V3, P777, DOI 10.1038/nrmicro1273; da Cunha LR, 2012, GUT MICROBES, V3, P15, DOI 10.4161/gmic.19489; Davis CD, 2009, J NUTR BIOCHEM, V20, P743, DOI 10.1016/j.jnutbio.2009.06.001; de Jong A, 2006, NUCLEIC ACIDS RES, V34, pW273, DOI 10.1093/nar/gkl237; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Devine Deirdre A, 2009, J Oral Microbiol, V1, DOI 10.3402/jom.v1i0.1949; Dhillon BK, 2015, NUCLEIC ACIDS RES, V43, pW104, DOI 10.1093/nar/gkv401; Diep DB, 2007, P NATL ACAD SCI USA, V104, P2384, DOI 10.1073/pnas.0608775104; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Gabrielsen C, 2014, APPL ENVIRON MICROB, V80, P6854, DOI 10.1128/AEM.02284-14; Gibson MK, 2015, ISME J, V9, P207, DOI 10.1038/ismej.2014.106; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Hammami R, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-89; Hammami R, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-22; Hu CB, 2010, APPL ENVIRON MICROB, V76, P4542, DOI 10.1128/AEM.02264-09; Hunt M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0849-0; Husain S, 2008, CURR MICROBIOL, V57, P331, DOI 10.1007/s00284-008-9198-5; Hynonen U, 2013, APPL MICROBIOL BIOT, V97, P5225, DOI 10.1007/s00253-013-4962-2; Ito Y, 2009, APPL ENVIRON MICROB, V75, P6340, DOI 10.1128/AEM.00195-09; Jiang QR, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0759-7; Kallberg M, 2014, METHODS MOL BIOL, V1137, P17, DOI 10.1007/978-1-4939-0366-5_2; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kaushik JK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008099; Kawai Y, 1998, BIOSCI BIOTECH BIOCH, V62, P887, DOI 10.1271/bbb.62.887; Kawai Y, 2004, CURR PROTEIN PEPT SC, V5, P393, DOI 10.2174/1389203043379549; Kawai Y, 2004, APPL ENVIRON MICROB, V70, P2906, DOI 10.1128/AEM.70.5.2906-2911.2004; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008; Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056; Kozakov D, 2006, PROTEINS, V65, P392, DOI 10.1002/prot.21117; Krumsiek J, 2007, BIOINFORMATICS, V23, P1026, DOI 10.1093/bioinformatics/btm039; Kuo YC, 2013, APPL MICROBIOL BIOT, V97, P237, DOI 10.1007/s00253-012-4149-2; Kwak Shin-Hye, 2014, J Cancer Prev, V19, P253, DOI 10.15430/JCP.2014.19.4.253; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lowe TM, 2016, NUCLEIC ACIDS RES, V44, pW54, DOI 10.1093/nar/gkw413; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Nakamura K, 2013, ANIM SCI J, V84, P144, DOI 10.1111/j.1740-0929.2012.01048.x; Niers LEM, 2007, CLIN EXP IMMUNOL, V149, P344, DOI 10.1111/j.1365-2249.2007.03421.x; Olson Nathan D, 2015, Biomol Detect Quantif, V3, P17, DOI 10.1016/j.bdq.2015.01.004; Ouwehand AC, 2004, CLIN INFECT DIS, V39, P1858, DOI 10.1086/425741; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Pan T, 2014, BENEF MICROBES, V5, P315, DOI 10.3920/BM2013.0041; Pandey N, 2013, WORLD J MICROB BIOT, V29, P1977, DOI 10.1007/s11274-013-1368-3; Preidis GA, 2009, GASTROENTEROLOGY, V136, P2015, DOI 10.1053/j.gastro.2009.01.072; Ritthagol W, 2014, CLEFT PALATE-CRAN J, V51, P257, DOI 10.1597/12-243; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schrodinger LLC., 2015, PYMOL MOL GRAPHICS S; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Senan S, 2015, PROBIOTICS ANTIMICRO, V7, P249, DOI 10.1007/s12602-015-9199-1; Songisepp E, 2012, J DAIRY SCI, V95, P5495, DOI 10.3168/jds.2011-4756; Tapiovaara L, 2014, INT J PEDIATR OTORHI, V78, P1637, DOI 10.1016/j.ijporl.2014.07.011; Teanpaisan R, 2014, CLIN ORAL INVEST, V18, P857, DOI 10.1007/s00784-013-1057-5; Terai T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128657; Tsai YT, 2012, APPL MICROBIOL BIOT, V96, P853, DOI 10.1007/s00253-012-4407-3; Vesterlund S, 2007, INT J FOOD MICROBIOL, V116, P325, DOI 10.1016/j.ijfoodmicro.2007.02.002; Vetrovsky T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057923; Wang S, 2016, NUCLEIC ACIDS RES, V44, pW430, DOI 10.1093/nar/gkw306; Wannun P, 2014, ANAEROBE, V27, P17, DOI 10.1016/j.anaerobe.2014.03.001; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Yang J, 2008, NUCLEIC ACIDS RES, V36, pD539, DOI 10.1093/nar/gkm951; Yang Jianyi, 2015, Curr Protoc Bioinformatics, V52, DOI 10.1002/0471250953.bi0508s52; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yli-Knuuttila H, 2006, ORAL MICROBIOL IMMUN, V21, P129, DOI 10.1111/j.1399-302X.2006.00258.x; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2009, PROTEINS, V77, P100, DOI 10.1002/prot.22588; Zhang ZY, 2012, INT J FOOD MICROBIOL, V153, P166, DOI 10.1016/j.ijfoodmicro.2011.11.003; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	92	20	20	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183548	10.1371/journal.pone.0183548	http://dx.doi.org/10.1371/journal.pone.0183548			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837656	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000078
J	Szpiech, ZA; Strauli, NB; White, KA; Ruiz, DG; Jacobson, MP; Barber, DL; Hernandez, RD				Szpiech, Zachary A.; Strauli, Nicolas B.; White, Katharine A.; Ruiz, Diego Garrido; Jacobson, Matthew P.; Barber, Diane L.; Hernandez, Ryan D.			Prominent features of the amino acid mutation landscape in cancer	PLOS ONE			English	Article							CLONAL EVOLUTION; DYSREGULATED PH; DYNAMICS; EPIDEMIOLOGY; METABOLISM; MECHANISMS; SIGNATURES; EXCHANGER; RESIDUES	Cancer can be viewed as a set of different diseases with distinctions based on tissue origin, driver mutations, and genetic signatures. Accordingly, each of these distinctions have been used to classify cancer subtypes and to reveal common features. Here, we present a different analysis of cancer based on amino acid mutation signatures. Non-negative Matrix Factorization and principal component analysis of 29 cancers revealed six amino acid mutation signatures, including four signatures that were dominated by either arginine to histidine (Arg>His) or glutamate to lysine (Glu>Lys) mutations. Sample-level analyses reveal that while some cancers are heterogeneous, others are largely dominated by one type of mutation. Using a non-overlapping set of samples from the COSMIC somatic mutation database, we validate five of six mutation signatures, including signatures with prominent arginine to histidine (Arg>His) or glutamate to lysine (Glu>Lys) mutations. This suggests that our classification of cancers based on amino acid mutation patterns may provide avenues of inquiry pertaining to specific protein mutations that may generate novel insights into cancer biology.	[Szpiech, Zachary A.; Strauli, Nicolas B.; Jacobson, Matthew P.; Hernandez, Ryan D.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Strauli, Nicolas B.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [White, Katharine A.; Barber, Diane L.] Univ Calif San Francisco, Dept Cell & Tissue Biol, San Francisco, CA 94143 USA; [Ruiz, Diego Garrido; Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Hernandez, Ryan D.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Szpiech, ZA; Hernandez, RD (corresponding author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA.; Hernandez, RD (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA.; Hernandez, RD (corresponding author), Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA.	zachary.szpiech@ucsf.edu; ryan.hernandez@ucsf.edu	Jacobson, Matthew/Y-5161-2018; White, Katharine A./X-9101-2019	Jacobson, Matthew/0000-0001-6262-655X; White, Katharine A./0000-0002-5831-1886; Strauli, Nicolas/0000-0001-8575-006X	National Institutes of Health [CM 78706, CM 97855, HG007644, CM 77085, CA178706, CA197855, CA177085]; NATIONAL CANCER INSTITUTE [R01CA197855, F32CA177085, R21CA178706] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG007644] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by National Institutes of Health (https://www.nih.gov/) grant CM 78706 to DLB and RDH; National Institutes of Health grant CM 97855 to DLB; National Institutes of Health grant HG007644 to RDH; and National Institutes of Health F32 grant CM 77085 to KAW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National Institutes of Health grants CA178706 to Diane L. Barber and Ryan D. Hernandez; CA197855 to Diane L. Barber, and HG007644 to Ryan D. Hernandez; and National Institutes of Health F32 grant CA177085 to Katharine A. White.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alfarouk KO, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0221-1; Alfarouk Khalid O, 2014, Oncoscience, V1, P777; Anoosha P, 2016, BBA-MOL BASIS DIS, V1862, P155, DOI 10.1016/j.bbadis.2015.11.006; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Chimenti MS, 2012, STRUCTURE, V20, P1071, DOI 10.1016/j.str.2012.03.023; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Choi CH, 2013, J CELL BIOL, V202, P849, DOI 10.1083/jcb.201302131; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Frantz C, 2008, J CELL BIOL, V183, P865, DOI 10.1083/jcb.200804161; Gaujoux R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-367; Gillies RJ, 2015, CANCER J, V21, P88, DOI 10.1097/PPO.0000000000000102; Gillies RJ, 2012, NAT REV CANCER, V12, P487, DOI 10.1038/nrc3298; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grillo-Hill BK, 2015, ELIFE, V4, DOI 10.7554/eLife.03270; Huang CH, 2008, CELL CYCLE, V7, P1151, DOI 10.4161/cc.7.9.5817; Meyer DS, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.38; Nishi A, 2016, EXPERT REV MOL DIAGN, V16, P11, DOI 10.1586/14737159.2016.1115346; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Ogino S, 2011, GUT, V60, P397, DOI 10.1136/gut.2010.217182; Parks SK, 2013, NAT REV CANCER, V13, P611, DOI 10.1038/nrc3579; Stahelin RV, 2009, J LIPID RES, V50, pS299, DOI 10.1194/jlr.R800078-JLR200; Tan H, 2015, SCI REP-UK, V5, DOI 10.1038/srep12566; Tsuber V, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030049; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Webb BA, 2016, J BIOL CHEM, V291, P24096, DOI 10.1074/jbc.M116.736215; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110; White KA, 2017, J CELL SCI, V130, P663, DOI 10.1242/jcs.195297; Zhang Z, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/3/035001; Zheng YQ, 2017, PROTEINS, V85, P268, DOI 10.1002/prot.25213	35	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183273	10.1371/journal.pone.0183273	http://dx.doi.org/10.1371/journal.pone.0183273			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837668	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000056
J	Chen, JC; Peng, C; Lei, L; Zhang, JL; Zeng, WQ; Chen, X				Chen, Junchen; Peng, Cong; Lei, Li; Zhang, Jianglin; Zeng, Weiqi; Chen, Xiang			Nuclear envelope-distributed CD147 interacts with and inhibits the transcriptional function of RING1 and promotes melanoma cell motility	PLOS ONE			English	Article							MATRIX GLA PROTEIN; EXPRESSION; CANCER; EMMPRIN; PROGRESSION; RESISTANCE; ABCG2; CDNA	Melanoma accounts for nearly 80% of all deaths associated with skin cancer. CD147 plays a very important role in melanoma progression and the expression level may correlate with tumor malignancy. RING1 can bind DNA and act as a transcriptional repressor, play an important role in the aggressive phenotype in melanoma. The interactions between CD147 and RING1 were identified with a yeast two-hybrid and RING1 interacted with CD147 through the transmembrane domain. RING1 inhibits CD147's capability promoting melanoma cell migration. In conclusion, the study identified novel interactions between CD147 and RING1, recovered CD147 nuclear envelope distribution in melanoma cells, and suggested a new mechanism underlying how cytoplasmic CD147 promotes melanoma development.	[Chen, Junchen; Peng, Cong; Lei, Li; Zhang, Jianglin; Zeng, Weiqi; Chen, Xiang] Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China; [Chen, Junchen; Peng, Cong; Lei, Li; Zhang, Jianglin; Zeng, Weiqi; Chen, Xiang] Cent South Univ, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zeng, WQ; Chen, X (corresponding author), Cent South Univ, Xiangya Hosp, Dept Dermatol, Changsha, Hunan, Peoples R China.; Zeng, WQ; Chen, X (corresponding author), Cent South Univ, Hunan Key Lab Skin Canc & Psoriasis, Changsha, Hunan, Peoples R China.	Weiqizeng@gmail.com; chenxiangck@126.com		Jianglin, Zhang/0000-0003-0434-1729	National Natural Science Key Foundation of China [81430075]; International Cooperation and Exchanges National Natural Science Foundation of China [81620108024]; National Natural Science Foundation of China [81572677]	National Natural Science Key Foundation of China(National Natural Science Foundation of China (NSFC)); International Cooperation and Exchanges National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grant 81430075 from the National Natural Science Key Foundation of China (Xiang Chen), grant 81620108024 from International Cooperation and Exchanges National Natural Science Foundation of China (Xiang Chen), and grant 81572677 from the National Natural Science Foundation of China (Weiqi Zeng). http://www.nsfc.gov.cn.	Agrawal SM, 2011, BBA-MOL BASIS DIS, V1812, P213, DOI 10.1016/j.bbadis.2010.07.018; [Anonymous], 2007, J INVEST DERMATOL, V127, P1516; BARTELS H, 1975, CHEMOTHERAPY, V21, P1, DOI 10.1159/000221838; Basigin Takashi M., 2015, J BIOCH, V159, P481; Bi XC, 2011, CLIN INVEST MED, V34, pE358; BISWAS C, 1995, CANCER RES, V55, P434; Burke B, 2013, NAT REV MOL CELL BIO, V14, P13, DOI 10.1038/nrm3488; CANCELA L, 1990, J BIOL CHEM, V265, P15040; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; CHEN L, 1990, ONCOGENE, V5, P1391; Chen Y, 2003, CANCER RES, V63, P1927; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Ferlay J, 2015, EUR J CANCER, V51, P1201, DOI 10.1016/j.ejca.2015.05.004; Gabison EE, 2009, PROG RETIN EYE RES, V28, P19, DOI 10.1016/j.preteyeres.2008.11.001; Grass GD, 2014, ADV CANCER RES, V123, P351, DOI 10.1016/B978-0-12-800092-2.00013-7; Hough CD, 2001, CANCER RES, V61, P3869; Huang XQ, 2014, INT J CLIN EXP PATHO, V7, P1651; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Ke X, 2014, HEPATOL INT, V8, P405, DOI 10.1007/s12072-014-9536-6; Knutti N, 2015, FEBS J, V282, P4187, DOI 10.1111/febs.13414; Korn EL, 2008, J CLIN ONCOL, V26, P527, DOI 10.1200/JCO.2007.12.7837; Lescaille G, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-115; LEVEDAKOU EN, 1992, INT J CANCER, V52, P534, DOI 10.1002/ijc.2910520406; Liao CG, 2011, MOL CELL BIOL, V31, P2591, DOI 10.1128/MCB.05160-11; Long TT, 2013, CANCER LETT, V339, P93, DOI 10.1016/j.canlet.2013.07.019; Luo Z, 2014, CURR MOL MED, V14, P1252, DOI 10.2174/1566524014666141202144601; McHugh JB, 2007, J CUTAN PATHOL, V34, P597, DOI 10.1111/j.1600-0560.2006.00678.x; Nabeshima K, 2006, PATHOL INT, V56, P359, DOI 10.1111/j.1440-1827.2006.01972.x; Piao SL, 2012, J CANCER RES CLIN, V138, P627, DOI 10.1007/s00432-011-1142-6; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Su J, 2015, ONCOTARGET; Sweeny L, 2012, EXP CELL RES, V318, P1788, DOI 10.1016/j.yexcr.2012.04.022; Walters DK, 2013, CELL CYCLE, V12, P3175, DOI 10.4161/cc.26193; Weidle Ulrich H., 2010, Cancer Genomics & Proteomics, V7, P157; Wu J, 2015, MOL CANCER THER, V14, P553, DOI 10.1158/1535-7163.MCT-14-0618; Zeng W, 2014, CURR MOL MED, V14, P163, DOI 10.2174/15665240113136660077; Zhao S, 2013, J DERMATOL SCI, V70, P182, DOI 10.1016/j.jdermsci.2013.02.005; Zhou SY, 2013, CANCER LETT, V337, P285, DOI 10.1016/j.canlet.2013.04.025; Zhou WH, 2013, CELL RES, V23, P599, DOI 10.1038/cr.2013.44	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183689	10.1371/journal.pone.0183689	http://dx.doi.org/10.1371/journal.pone.0183689			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832687	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800082
J	Grewal, DS; Merlau, DJ; Giri, P; Munk, MR; Fawzi, AA; Jampol, LM; Tanna, AP				Grewal, Dilraj S.; Merlau, Daniel J.; Giri, Pushpanjali; Munk, Marion R.; Fawzi, Amani A.; Jampol, Lee M.; Tanna, Angelo P.			Peripapillary retinal splitting visualized on OCT in glaucoma and glaucoma suspect patients	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; VITREOMACULAR TRACTION SYNDROME; POSTERIOR VITREOUS DETACHMENT; MORNING GLORY SYNDROME; MACULAR SCHISIS; DISC PIT; INTRAOCULAR-PRESSURE; VITRECTOMY; MACULOPATHY	Purpose To identify the risk factors for development of peripapillary retinal splitting (schisis) in patients with glaucoma or suspicion of glaucoma Setting Glaucoma Clinic, Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL Methods In this institutional cross-sectional study, 495 patients (990 eyes) who had undergone spectral-domain optical coherence tomography (OCT Spectralis HRA-OCT, Heidelberg Engineering) optic nerve head (ONH) imaging and did not have identifiable optic nerve pits, pseudopits or coloboma were included. OCT scans were reviewed by two observers. Main outcome measures Presence of peripapillary retinal splitting identified on OCT raster scans. Results Eleven of 990 glaucoma and glaucoma suspect eyes (1.1%) of 7 patients (2 females, 5 males, mean age 64.5 +/- 9.2 years) had peripapillary retinal splitting. Two of these 11 eyes had extension of the splitting into the macula but none to the fovea. Of these 11 patients, 2 (28.6%) were glaucoma suspects, 3 (42.9%) had primary open-angle glaucoma, 1 (14.3%) had chronic angle-closure glaucoma and 1 (14.3%) had pigmentary glaucoma. 7/11 (63.6%) eyes had vitreous traction to the disc visualized on OCT and 6/11 eyes (54.5%) had beta-zone peripapillary atrophy. Conclusions We observed peripapillary retinal splitting in 1.1% of a series of 990 glaucoma and glaucoma-suspect eyes. Evidence of adherent vitreous with traction and peripapillary atrophy was found in a majority of the involved eyes. A comparison to an age and axial length matched cohort is required to determine if this is a condition that is associated with glaucoma.	[Grewal, Dilraj S.; Merlau, Daniel J.; Giri, Pushpanjali; Munk, Marion R.; Fawzi, Amani A.; Jampol, Lee M.; Tanna, Angelo P.] Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA; [Grewal, Dilraj S.] Duke Univ, Med Ctr, Dept Ophthalmol, Duke Eye Ctr, Durham, NC 27710 USA; [Merlau, Daniel J.] Columbia Univ, New York, NY USA	Northwestern University; Feinberg School of Medicine; Duke University; Columbia University	Tanna, AP (corresponding author), Northwestern Univ, Dept Ophthalmol, Feinberg Sch Med, Chicago, IL 60611 USA.	atanna@northwestern.edu	fawzi, amani/AAA-9199-2021	fawzi, amani/0000-0002-9568-3558; Tanna, Angelo/0000-0003-3089-6664; Grewal, Dilraj/0000-0002-2229-5343	Research to Prevent Blindness, NY; Ronald G. Michels Fellowship Foundation (Riderwood, MD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER	Research to Prevent Blindness, NY(Research to Prevent Blindness (RPB)); Ronald G. Michels Fellowship Foundation (Riderwood, MD); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Supported by an unrestricted grant from Research to Prevent Blindness, NY to the Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Heed Ophthalmic Foundation (San Francisco, CA) and Ronald G. Michels Fellowship Foundation (Riderwood, MD) (DSG). None of the authors have any financial or proprietary interest in this manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akimoto M, 2012, CASE REP OPHTHALM, V3, P169, DOI 10.1159/000339292; Batta P, 2010, ARCH OPHTHALMOL-CHIC, V128, P692, DOI 10.1001/archophthalmol.2010.99; Besada Eulogio, 2003, Clin Exp Optom, V86, P390; Chang S, 2012, EYE, V26, P494, DOI 10.1038/eye.2011.354; COLL GE, 1995, GRAEF ARCH CLIN EXP, V233, P441, DOI 10.1007/BF00180949; Farjad H, 2010, OPTOMETRY VISION SCI; Fellman RL, 2012, ARCH OPHTHALMOL-CHIC, V130, P1220, DOI 10.1001/archophthalmol.2012.441; Freund KB, 2011, ARCH OPHTHALMOL-CHIC, V129, P1096, DOI 10.1001/archophthalmol.2011.208; FRIBERG TR, 1992, AM J OPHTHALMOL, V114, P767, DOI 10.1016/S0002-9394(14)74060-7; Gandorfer A, 2005, AM J OPHTHALMOL, V139, P638, DOI 10.1016/j.ajo.2004.11.035; Georgalas I, 2011, GRAEF ARCH CLIN EXP, V249, P1113, DOI 10.1007/s00417-011-1698-5; Haruta M, 2012, CLIN OPHTHALMOL, V6, P1361, DOI 10.2147/OPTH.S34962; Hasegawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130175; HIKICHI T, 1995, AM J OPHTHALMOL, V119, P55, DOI 10.1016/S0002-9394(14)73813-9; Hirakata A, 2005, JPN J OPHTHALMOL, V49, P264, DOI 10.1007/s10384-004-0185-5; Hirakata A, 2012, OPHTHALMOLOGY, V119, P810, DOI 10.1016/j.ophtha.2011.09.026; Hollander DA, 2005, ARCH OPHTHALMOL-CHIC, V123, P270, DOI 10.1001/archopht.123.2.270; Hubschman Jean-Pierre, 2010, Ophthalmic Surg Lasers Imaging, P1, DOI 10.3928/15428877-20100215-60; Hwang YH, 2013, SEMINARS OPHTHALMOLO; Hwang YH, 2014, BRIT J OPHTHALMOLOGY; Johnson Mark W, 2005, Trans Am Ophthalmol Soc, V103, P537; Johnson TM, 2004, ARCH OPHTHALMOL-CHIC, V122, P1793, DOI 10.1001/archopht.122.12.1793; Kahook MY, 2007, AM J OPHTHALMOL, V143, P697, DOI 10.1016/j.ajo.2006.10.054; Kusaka S, 2001, OPHTHALMOLOGICA, V215, P139, DOI 10.1159/000050847; LAMPERT PW, 1968, INVEST OPHTH VISUAL, V7, P199; Lee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094070; Mavrikakis E, 2011, ACTA OPHTHALMOL, V89, P95, DOI 10.1111/j.1755-3768.2009.01553.x; Ornek N, 2013, BMJ CASE REPORTS, V2013; Ouyang YL, 2013, INVEST OPHTH VIS SCI, V54, P1144, DOI 10.1167/iovs.12-9903; Park SC, 2012, OPHTHALMOLOGY, V119, P3, DOI 10.1016/j.ophtha.2011.07.012; Pilon A, 2006, OPTOMETRY VISION SCI, V83, P415, DOI 10.1097/01.opx.0000218430.40132.68; Postel E A, 1998, Trans Am Ophthalmol Soc, V96, P73; Rutledge BK, 1996, OPHTHALMOLOGY, V103, P1047, DOI 10.1016/S0161-6420(96)30568-X; Shimada N, 2007, OPHTHALMOLOGY, V114, P2070, DOI 10.1016/j.ophtha.2007.01.016; Shimada Noriaki, 2009, International Ophthalmology, V29, P99, DOI 10.1007/s10792-007-9174-2; Silverman AL, 2015, OPHTHALMOLOGY; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P238, DOI 10.1097/00006982-200304000-00017; Takashina S, 2013, CLIN OPHTHALMOL, V7, P883, DOI 10.2147/OPTH.S42085; Xin DY, 2011, INVEST OPHTH VIS SCI, V52, P7180, DOI 10.1167/iovs.11-7716; Zhao M, 2011, GRAEF ARCH CLIN EXP, V249, P1255, DOI 10.1007/s00417-011-1668-y; Zumbro DS, 2007, AM J OPHTHALMOL, V144, P70, DOI 10.1016/j.ajo.2007.03.027	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182816	10.1371/journal.pone.0182816	http://dx.doi.org/10.1371/journal.pone.0182816			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832670	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800034
J	Herklots, T; van Acht, L; Meguid, T; Franx, A; Jacod, B				Herklots, Tanneke; van Acht, Lieke; Meguid, Tarek; Franx, Arie; Jacod, Benoit			Severe maternal morbidity in Zanzibar's referral hospital: Measuring the impact of in-hospital care	PLOS ONE			English	Article							QUALITY-OF-CARE; TERTIARY HOSPITALS; PUBLIC HOSPITALS; NEAR-MISSES; HEALTH	Objective to analyse the impact of in-hospital care on severe maternal morbidity using WHO's near-miss approach in the low-resource, high mortality setting of Zanzibar's referral hospital. Setting Mnazi Mmoja Hospital, a tertiary care facility, in Zanzibar, Tanzania. Methods We identified all cases of morbidity and mortality in women admitted within 42 days after the end of pregnancy at Mnazi Mmoja Hospital in the period from April to October 2016. The severity of complications was classified using WHO's near-miss approach definitions: potentially life-threatening condition (PLTC), maternal near-miss (MNM) or maternal death (MD). Quality of in-hospital care was assessed using the mortality index (MI) defined as ratio between mortality and severe maternal outcome (SMO) where SMO = MD + MNM, cause-specific case facility rates and comparison with predicted mortality based on the Maternal Severity Index model. Main outcomes 5551 women were included. 569 (10.3%) had a potentially life-threatening condition and 65 (1.2%) a severe maternal outcome (SMO): 37 maternal near-miss cases and 28 maternal deaths. The mortality index was high at 0.43 and similar for women who developed a SMO within 12 hours of admission and women who developed a SMO after 12 hours. A standardized mortality ratio of 6.03 was found; six times higher than that expected in moderate maternal mortality settings given the same severity of cases. Obstetric haemorrhage was found to be the main cause of SMO. Ruptured uterus and admission to ICU had the highest case-fatality rates. Maternal death cases seemed to have received essential interventions less often. Conclusions WHO's near-miss approach can be used in this setting. The high mortality index observed shows that in-hospital care is not preventing progression of disease adequately once a severe complication occurs. Almost one in two women experiencing life-threatening complications will die. This is six times higher than in moderate mortality settings.	[Herklots, Tanneke; van Acht, Lieke; Franx, Arie] Univ Med Ctr Utrecht, Div Woman & Baby, Utrecht, Netherlands; [Meguid, Tarek] Mnazi Mmoja Hosp, Dept Obstet & Gynaecol, Stone Town, Zanzibar, Tanzania; [Meguid, Tarek] State Univ Zanzibar SUZA, Sch Hlth & Med Sci, Zanzibar, Tanzania; [Jacod, Benoit] Radboud Univ Nijmegen, Med Ctr, Dept Obstet & Gynaecol, Nijmegen, Netherlands	Utrecht University; Utrecht University Medical Center; Radboud University Nijmegen	Herklots, T (corresponding author), Univ Med Ctr Utrecht, Div Woman & Baby, Utrecht, Netherlands.	tannekeherklots@gmail.com	Franx, Arie/AAA-1739-2021					Alkema L, 2016, LANCET, V387, P462, DOI 10.1016/S0140-6736(15)00838-7; [Anonymous], 2014, MIDWIFERY, V30; [Anonymous], 2004, NUMB REV MAT DEATH C; Bashour H, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0733-7; Cecatti JG, 2016, BJOG-INT J OBSTET GY, V123, P946, DOI 10.1111/1471-0528.13614; Filippi V, 2006, LANCET, V368, P1535, DOI 10.1016/S0140-6736(06)69384-7; Jabir M, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-11; Kalisa R, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1119-1; Karolinski A, 2013, BJOG-INT J OBSTET GY, V120, P1685, DOI 10.1111/1471-0528.12395; Nakimuli A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0811-5; Nelissen EJT, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-141; Norhayati MN, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2895-2; Oladapo OT, 2016, BJOG-INT J OBSTET GY, V123, P928, DOI 10.1111/1471-0528.13450; Owolabi OO, 2016, INCIDENCE ABORTION R; Rulisa S, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0619-8; Say L, 2009, BEST PRACT RES CL OB, V23, P287, DOI 10.1016/j.bpobgyn.2009.01.007; Shapovalova ND, 2015, LANCET GLOB HEALTH, V3, pE249, DOI 10.1016/S2214-109X(15)70104-X; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Souza JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044129; Tanimia H, 2016, AUST NZ J OBSTET GYN, V56, P148, DOI 10.1111/ajo.12430; Tuncalp O, 2012, BJOG-INT J OBSTET GY, V119, P653, DOI 10.1111/j.1471-0528.2012.03294.x; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P58, DOI 10.1016/j.ijgo.2013.06.003; van den Akker T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054805; World Health Organization (WHO), 2011, EV QUAL CAR SEV PREG	24	21	21	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181470	10.1371/journal.pone.0181470	http://dx.doi.org/10.1371/journal.pone.0181470			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832665	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800004
J	Huber, C; Marx, A				Huber, Claudia; Marx, Andreas			Variants of sequence family B Thermococcus kodakaraensis DNA polymerase with increased mismatch extension selectivity	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE ACTIVITY; ACTIVE-SITE TIGHTNESS; AMINO-ACID; SUBSTITUTIONS INCREASE; CRYSTAL-STRUCTURE; FIDELITY; PRIMER; MECHANISM; BINDING; 5-METHYLCYTOSINE	Fidelity and selectivity of DNA polymerases are critical determinants for the biology of life, as well as important tools for biotechnological applications. DNA polymerases catalyze the formation of DNA strands by adding deoxynucleotides to a primer, which is complementarily bound to a template. To ensure the integrity of the genome, DNA polymerases select the correct nucleotide and further extend the nascent DNA strand. Thus, DNA polymerase fidelity is pivotal for ensuring that cells can replicate their genome with minimal error. DNA polymerases are, however, further optimized for more specific biotechnological or diagnostic applications. Here we report on the semi-rational design of mutant libraries derived by saturation mutagenesis at single sites of a 3'-5'-exonuclease deficient variant of Thermococcus kodakaraensis DNA polymerase (KOD pol) and the discovery for variants with enhanced mismatch extension selectivity by screening. Sites of potential interest for saturation mutagenesis were selected by their proximity to primer or template strands. The resulting libraries were screened via quantitative real-time PCR. We identified three variants with single amino acid exchanges-R501C, R606Q, and R606W-which exhibited increased mismatch extension selectivity. These variants were further characterized towards their potential in mismatch discrimination. Additionally, the identified enzymes were also able to differentiate between cytosine and 5-methylcytosine. Our results demonstrate the potential in characterizing and developing DNA polymerases for specific PCR based applications in DNA biotechnology and diagnostics.	[Huber, Claudia; Marx, Andreas] Univ Konstanz, Dept Chem, Constance, Germany	University of Konstanz	Marx, A (corresponding author), Univ Konstanz, Dept Chem, Constance, Germany.	andreas.marx@uni-konstanz.de			European Research Council (ERC) [339834]	European Research Council (ERC)(European Research Council (ERC))	We gratefully acknowledge the European Research Council (ERC Advanced Grant 339834) for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschenbrenner J, 2016, NUCLEIC ACIDS RES, V44, P3495, DOI 10.1093/nar/gkw200; Aschenbrenner J, 2014, ANGEW CHEM INT EDIT, V53, P8154, DOI 10.1002/anie.201403745; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Beechem JM, 1998, BIOCHEMISTRY-US, V37, P10144, DOI 10.1021/bi980074b; Bergen K, 2013, CHEMBIOCHEM, V14, P1058, DOI 10.1002/cbic.201300175; Biles BD, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh174; BIRD AP, 1980, NUCLEIC ACIDS RES, V8, P1499, DOI 10.1093/nar/8.7.1499; BLOOM LB, 1994, BIOCHEMISTRY-US, V33, P7576, DOI 10.1021/bi00190a010; BOOSALIS MS, 1987, J BIOL CHEM, V262, P14689; CREIGHTON S, 1992, J BIOL CHEM, V267, P2633; de Vega M, 2000, J MOL BIOL, V304, P1, DOI 10.1006/jmbi.2000.4178; Drum M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096640; ECHOLS H, 1991, ANNU REV BIOCHEM, V60, P477, DOI 10.1146/annurev.biochem.60.1.477; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Fa M, 2004, J AM CHEM SOC, V126, P1748, DOI 10.1021/ja038525p; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Ghadessy FJ, 2004, NAT BIOTECHNOL, V22, P755, DOI 10.1038/nbt974; Gloeckner C, 2007, ANGEW CHEM INT EDIT, V46, P3115, DOI 10.1002/anie.200603987; GOODMAN MF, 1993, CRIT REV BIOCHEM MOL, V28, P83, DOI 10.3109/10409239309086792; Goodman MF, 1997, P NATL ACAD SCI USA, V94, P10493, DOI 10.1073/pnas.94.20.10493; Hashimoto H, 2001, J MOL BIOL, V306, P469, DOI 10.1006/jmbi.2000.4403; Huber C, 2016, NUCLEIC ACIDS RES, V44, P9881, DOI 10.1093/nar/gkw812; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Iyer RR, 2006, CHEM REV, V106, P302, DOI 10.1021/cr0404794; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; JOYCE CM, 1994, ANNU REV BIOCHEM, V63, P777, DOI 10.1146/annurev.bi.63.070194.004021; Kim TW, 2005, P NATL ACAD SCI USA, V102, P15803, DOI 10.1073/pnas.0505113102; Kirby TW, 2006, J BIOL CHEM, V281, P38466, DOI 10.1074/jbc.M606917200; Kool ET, 2002, ANNU REV BIOCHEM, V71, P191, DOI 10.1146/annurev.biochem.71.110601.135453; Kunkel TA, 2009, COLD SH Q B, V74, P91, DOI 10.1101/sqb.2009.74.027; Kunkel TA, 2000, ANNU REV BIOCHEM, V69, P497, DOI 10.1146/annurev.biochem.69.1.497; Kunkel TA, 2005, ANNU REV BIOCHEM, V74, P681, DOI 10.1146/annurev.biochem.74.082803.133243; Kunkel TA, 2004, J BIOL CHEM, V279, P16895, DOI 10.1074/jbc.R400006200; Kuroita T, 2005, J MOL BIOL, V351, P291, DOI 10.1016/j.jmb.2005.06.015; Loh E, 2007, J BIOL CHEM, V282, P12201, DOI 10.1074/jbc.M611294200; Marchiori A, 2007, HAEMATOLOGICA, V92, P1107, DOI 10.3324/haematol.10234; Matray TJ, 1999, NATURE, V399, P704, DOI 10.1038/21453; Mildvan A S, 1974, Annu Rev Biochem, V43, P357, DOI 10.1146/annurev.bi.43.070174.002041; Minnick DT, 1999, J BIOL CHEM, V274, P3067, DOI 10.1074/jbc.274.5.3067; Ong JL, 2006, J MOL BIOL, V361, P537, DOI 10.1016/j.jmb.2006.06.050; Patel PH, 2001, NAT STRUCT BIOL, V8, P656, DOI 10.1038/90344; Patel PH, 2001, J BIOL CHEM, V276, P5044, DOI 10.1074/jbc.M008701200; Patel PH, 2000, J BIOL CHEM, V275, P40266, DOI 10.1074/jbc.M005757200; PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580; PETRUSKA J, 1988, P NATL ACAD SCI USA, V85, P6252, DOI 10.1073/pnas.85.17.6252; PETRUSKA J, 1995, J BIOL CHEM, V270, P746, DOI 10.1074/jbc.270.2.746; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; REHAKRANTZ LJ, 1994, J BIOL CHEM, V269, P5635; Rothwell PJ, 2005, ADV PROTEIN CHEM, V71, P401, DOI 10.1016/S0065-3233(04)71011-6; Rudinger NZ, 2007, CHEM BIOL, V14, P185, DOI 10.1016/j.chembiol.2006.11.016; Sauter KBM, 2006, ANGEW CHEM INT EDIT, V45, P7633, DOI 10.1002/anie.200602772; SHEN JC, 1992, NUCLEIC ACIDS RES, V20, P5119, DOI 10.1093/nar/20.19.5119; Strerath M, 2007, CHEMBIOCHEM, V8, P395, DOI 10.1002/cbic.200600337; Summerer D, 2005, ANGEW CHEM INT EDIT, V44, P4712, DOI 10.1002/anie.200500047; Suzuki M, 2000, J BIOL CHEM, V275, P32728, DOI 10.1074/jbc.M000097200; Trzemecka A, 2010, J MOL BIOL, V404, P778, DOI 10.1016/j.jmb.2010.09.058; Tsai YC, 2006, BIOCHEMISTRY-US, V45, P9675, DOI 10.1021/bi060993z; Wang J, 1997, CELL, V89, P1087, DOI 10.1016/S0092-8674(00)80296-2; WATSON JD, 1953, COLD SPRING HARB SYM, V18, P123, DOI 10.1101/SQB.1953.018.01.020; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhong XJ, 2008, NUCLEIC ACIDS RES, V36, P3892, DOI 10.1093/nar/gkn312	62	3	3	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183623	10.1371/journal.pone.0183623	http://dx.doi.org/10.1371/journal.pone.0183623			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832623	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800074
J	Rehnus, M; Palme, R				Rehnus, Maik; Palme, Rupert			How genetic data improve the interpretation of results of faecal glucocorticoid metabolite measurements in a free-living population	PLOS ONE			English	Article							HARES LEPUS-TIMIDUS; CORTISOL METABOLITES; DOMINANCE STATUS; PERSONALITY; STRESS; CHAMOIS; SEASON; SEX; IDENTIFICATION; CONSERVATION	Measurement of glucocorticoid metabolites (GCM) in faeces has become a widely used and effective tool for evaluating the amount of stress experienced by animals. However, the potential sampling bias resulting from an oversampling of individuals when collecting "anonymous" (unknown sex or individual) faeces has rarely been investigated. We used non-invasive genetic sampling (NIGS) to investigate potential interpretation errors of GCM measurements in a free-living population of mountain hares during the mating and post-reproductive periods. Genetic data improved the interpretation of results of faecal GCM measurements. In general GCM concentrations were influenced by season. However, genetic information revealed that it was sex-dependent. Within the mating period, females had higher GCM levels than males, but individual differences were more expressed in males. In the post-reproductive period, GCM concentrations were neither influenced by sex nor individual. We also identified potential pitfalls in the interpretation of anonymous faecal samples by individual differences in GCM concentrations and resampling rates. Our study showed that sex- and individual-dependent GCM levels led to a misinterpretation of GCM values when collecting "anonymous" faeces. To accurately evaluate the amount of stress experienced by free-living animals using faecal GCM measurements, we recommend documenting individuals and their sex of the sampled population. In stress-sensitive and elusive species, such documentation can be achieved by using NIGS and for diurnal animals with sexual and individual variation in appearance or marked individuals, it can be provided by a detailed field protocol.	[Rehnus, Maik] Snow & Landscape Res WSL, Swiss Fed Res Inst Forest, Zurcherstr 111, Birmensdorf, Switzerland; [Rehnus, Maik] WILDTIER SCHWEIZ, Winterthurerstr 92, Zurich, Switzerland; [Palme, Rupert] Univ Vet Med, Dept Biomed Sci, Vet Pl 1, Vienna, Austria	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Veterinary Medicine Vienna	Rehnus, M (corresponding author), Snow & Landscape Res WSL, Swiss Fed Res Inst Forest, Zurcherstr 111, Birmensdorf, Switzerland.; Rehnus, M (corresponding author), WILDTIER SCHWEIZ, Winterthurerstr 92, Zurich, Switzerland.	maik.rehnus@wsl.ch	Palme, Rupert/A-3499-2008; Rehnus, Maik/F-7270-2011	Palme, Rupert/0000-0001-9466-3662; Rehnus, Maik/0000-0002-1973-4878	Margarethe and Rudolf Gsell Foundation; Migros; Bristol Foundation	Margarethe and Rudolf Gsell Foundation; Migros; Bristol Foundation	We thank the Margarethe and Rudolf Gsell Foundation, Migros and the Bristol Foundation for financially supporting the genetic analyses.	Alonso JC, 2010, BEHAV ECOL SOCIOBIOL, V64, P1589, DOI 10.1007/s00265-010-0972-6; Arlettaz R, 2015, ECOL APPL, V25, P1197, DOI 10.1890/14-1141.1; Bisi F, 2011, EUR J WILDLIFE RES, V57, P305, DOI 10.1007/s10344-010-0429-2; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Cavigelli SA, 2003, HORM BEHAV, V43, P166, DOI 10.1016/S0018-506X(02)00031-4; Cavigelli SA, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0103; Clutton-Brock TH, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0074; Corlatti L, 2014, NATURWISSENSCHAFTEN, V101, P577, DOI 10.1007/s00114-014-1195-x; Corlatti L, 2012, ANIM BEHAV, V84, P1061, DOI 10.1016/j.anbehav.2012.08.005; Dantzer B, 2016, J MAMMAL, V97, P1385, DOI 10.1093/jmammal/gyw095; Forsman A, 2016, ECOGRAPHY, V39, P630, DOI 10.1111/ecog.01357; Ganswindt A, 2010, HORM BEHAV, V57, P506, DOI 10.1016/j.yhbeh.2010.02.009; Goossens Benoit, 2009, V17, P167; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; GRAF RP, 1985, CAN J ZOOL, V63, P468, DOI 10.1139/z85-066; Gross MR, 1996, TRENDS ECOL EVOL, V11, P92, DOI 10.1016/0169-5347(96)81050-0; Hadinger U, 2015, METHODS ECOL EVOL, V6, P1349, DOI 10.1111/2041-210X.12422; Haller H., 2013, ATLAS SCHWEIZERISCHE; HEWSON R, 1990, J ZOOL, V220, P287, DOI 10.1111/j.1469-7998.1990.tb04309.x; HOLLEY AJF, 1986, MAMMAL REV, V16, P181, DOI 10.1111/j.1365-2907.1986.tb00040.x; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; IUCN, 2016, PROT AR CAT GLAND IU; Jacob G, 2010, CONSERV GENET, V11, P33, DOI 10.1007/s10592-008-9794-8; Joly K, 2015, PLOS ONE, P10; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Lotz A., 2006, ALPINE HABITAT DIVER; Mesa-Cruz JB, 2016, J TROP ECOL, V32, P226, DOI 10.1017/S0266467416000213; Mooring MS, 2006, HORM BEHAV, V49, P369, DOI 10.1016/j.yhbeh.2005.08.008; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Noer CL, 2016, APPL ANIM BEHAV SCI, V181, P191, DOI 10.1016/j.applanim.2016.05.003; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Palme R, 2013, WIEN TIERARZTL MONAT, V100, P238; R Development Core Team, 2016, R LANG ENV STAT COMP; Rehnus M., 2013, SCHNEEHASE ALPEN UBE; Rehnus M, 2016, EUR J WILDLIFE RES, V62, P737, DOI 10.1007/s10344-016-1053-6; Rehnus M, 2014, J APPL ECOL, V51, P6, DOI 10.1111/1365-2664.12174; Rehnus M, 2010, MAMMALIA, V74, P347, DOI 10.1515/MAMM.2010.032; Rehnus M, 2009, EUR J WILDLIFE RES, V55, P615, DOI 10.1007/s10344-009-0297-9; Saltzman W, 1998, HORM BEHAV, V33, P58, DOI 10.1006/hbeh.1998.1436; Sands J, 2004, ANIM BEHAV, V67, P387, DOI 10.1016/j.anbehav.2003.03.019; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; Schopper H, 2012, GEN COMP ENDOCR, V176, P18, DOI 10.1016/j.ygcen.2011.12.010; Schwartz MK, 2007, TRENDS ECOL EVOL, V22, P25, DOI 10.1016/j.tree.2006.08.009; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sloane MA, 2000, MOL ECOL, V9, P1233, DOI 10.1046/j.1365-294x.2000.00993.x; Smith BR, 2008, BEHAV ECOL, V19, P448, DOI 10.1093/beheco/arm144; Sun K, 1998, PLACENTA, V19, P353, DOI 10.1016/S0143-4004(98)90074-1; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Thulin C.-G., 2003, HDB SAUGETIERE EUROP, P155; Thulin CG, 2003, MAMMAL REV, V33, P29, DOI 10.1046/j.1365-2907.2003.00008.x; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Wallner B, 2001, MAMM BIOL, V66, P190; Wasser SK, 2011, FRONT ECOL ENVIRON, V9, P546, DOI 10.1890/100071; Wasser SK, 2004, CAN J ZOOL, V82, P475, DOI 10.1139/Z04-020; Wasserman MD, 2012, HORM BEHAV, V62, P553, DOI 10.1016/j.yhbeh.2012.09.005	57	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183718	10.1371/journal.pone.0183718	http://dx.doi.org/10.1371/journal.pone.0183718			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832649	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800093
J	Song, J; Kang, HJ; Lee, JW; Wenas, MA; Jeong, SH; Lee, T; Oh, K; Min, KH				Song, Jiho; Kang, Hae Ju; Lee, Jung Wuk; Wenas, Michelle A.; Jeong, Seung Hwarn; Lee, Taeho; Oh, Kyungsoo; Min, Kyung Hoon			Transetherification of 2,4-dimethoxynitrobenzene by aromatic nucleophilic substitution	PLOS ONE			English	Article							ORTHO-SELECTIVITY; SNAR REACTION; CATALYST	In view of the few reports concerning aromatic nucleophilic substitution reactions featuring an alkoxy group as a leaving group, the aromatic nucleophilic substitution of 2,4-dimethoxynitrobenzene was investigated with a bulky t-butoxide nucleophile under microwave irradiation. The transetherification of 2,4-dimethoxynitrobenezene with sodium t-butoxide under specific conditions, namely for 20 min at 110 degrees C in 10% dimethoxyethane in toluene, afforded the desired product in 87% yield with exclusive ortho-selectivity. A variety of reaction conditions were screened to obtain the maximum yield. The aromatic nucleophilic substitution of 2,4-dimethoxynitrobenzene with t-butoxide should be carried out under controlled conditions in order to avoid the formation of byproducts, unlike that of dihalogenated activated benzenes. Among the formed byproducts, a major compound was elucidated as 2,4-dimethoxy-N-(5-methoxy-2-nitrophenyl) aniline by X-ray crystallography.	[Song, Jiho; Kang, Hae Ju; Lee, Jung Wuk; Wenas, Michelle A.; Jeong, Seung Hwarn; Oh, Kyungsoo; Min, Kyung Hoon] Chung Ang Univ, Coll Pharm, Seoul, South Korea; [Lee, Taeho] Kyungpook Natl Univ, Coll Pharm, Daegu, South Korea	Chung Ang University; Kyungpook National University	Min, KH (corresponding author), Chung Ang Univ, Coll Pharm, Seoul, South Korea.	khmin@cau.ac.kr		Song, Jiho/0000-0002-0528-8096	National Research Foundation of Korea (NRF) grant - Korean government (MSIP) [NRF-2015R1A5A1008958]	National Research Foundation of Korea (NRF) grant - Korean government (MSIP)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIP) (NRF-2015R1A5A1008958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], CCDC 1544020 CONT SU, V3; Baumann M, 2013, BEILSTEIN J ORG CHEM, V9, P2265, DOI 10.3762/bjoc.9.265; Bergman Y, 2012, PCT INT APPL; Bhadra S, 2012, J AM CHEM SOC, V134, P9938, DOI 10.1021/ja304539j; Bhosale SM, 2014, TETRAHEDRON LETT, V55, P155, DOI 10.1016/j.tetlet.2013.10.140; Buckingham F, 2015, J FLUORINE CHEM, V180, P33, DOI 10.1016/j.jfluchem.2015.07.030; BUNNETT JF, 1951, CHEM REV, V49, P273, DOI 10.1021/cr60153a002; BUNNETT JF, 1955, J AM CHEM SOC, V77, P5051, DOI 10.1021/ja01624a033; GALBRAITH HW, 1951, J AM CHEM SOC, V73, P1323, DOI 10.1021/ja01147a138; Gund SH, 2014, RSC ADV, V4, P42947, DOI 10.1039/c4ra06027j; Isley NA, 2015, ORG LETT, V17, P4734, DOI 10.1021/acs.orglett.5b02240; Kumar MS, 2013, SYNTH REACT INORG M, V43, P977, DOI 10.1080/15533174.2012.752395; Liu G, 2006, U.S. Pat. Appl, Patent No. 20060089398; O'Brien AG, 2012, ANGEW CHEM INT EDIT, V51, P7028, DOI 10.1002/anie.201202795; Scales S, 2013, ORG LETT, V15, P2156, DOI 10.1021/ol4006695; Sythana SK, 2014, ORG PROCESS RES DEV, V18, P912, DOI 10.1021/op500120z; Taniguchi T, 2013, PCT INT APPL; Tapia RA, 2007, SYNTHESIS-STUTTGART, P3773, DOI 10.1055/s-2007-990895; Terrier F, 2013, MODERN NUCLEOPHILIC AROMATIC SUBSTITUTION, P1, DOI 10.1002/9783527656141; Wang YD, 2000, BIOORG MED CHEM LETT, V10, P2477, DOI 10.1016/S0960-894X(00)00493-5; Wendt MD, 2010, TETRAHEDRON LETT, V51, P3041, DOI 10.1016/j.tetlet.2010.03.124; Yang L, 2013, CATAL COMMUN, V30, P36, DOI 10.1016/j.catcom.2012.10.017; Yap JL, 2011, TETRAHEDRON LETT, V52, P4172, DOI 10.1016/j.tetlet.2011.06.007; Zhu L, 2004, J ORG CHEM, V69, P7371, DOI 10.1021/jo049056s	24	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183575	10.1371/journal.pone.0183575	http://dx.doi.org/10.1371/journal.pone.0183575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832632	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800065
J	Findik, BT; Randall, LL				Findik, Bahar T.; Randall, Linda L.			Determination of the intracellular concentration of the export chaperone SecB in Escherichia coli	PLOS ONE			English	Article							MALTOSE-BINDING-PROTEIN; TRANSLOCATION MACHINERY; DNA INTERACTIONS; MEMBRANE; SPECIFICITY; EXPRESSION; COMPONENTS; COMPLEXES; CHEMOTAXIS; SUFFICIENT	SecB, a small tetrameric chaperone in Escherichia coli, plays a crucial role during protein export via the general secretory pathway by binding precursor polypeptides in a nonnative conformation and passing them to SecA, the ATPase of the translocon. The dissociation constants for the interactions are known; however to relate studies in vitro to export in a living cell requires knowledge of the concentrations of the proteins in the cell. Presently in the literature there is no report of a rigorous determination of the intracellular concentration of SecB. The values available vary over 60 fold and the details of the techniques used are not given. Here we use quantitative immunoblotting to determine the level of SecB expressed from the chromosome in E. coli grown in two commonly used media. In rich medium SecB was present at 1.6 +/- 0.2 mu M and in minimal medium at 2.5 +/- 0.6 mu M. These values allow studies of SecB carried out in vitro to be applied to the situation in the cell as SecB interacts with its binding partners to move precursor polypeptides through the export pathway.	[Findik, Bahar T.; Randall, Linda L.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Randall, LL (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	craneje@missouri.edu	Findik, Bahar Tuba/ABB-3198-2021	Findik, Bahar Tuba/0000-0002-0030-4106	National Institutes of Health [GM29798]; Hugo Wurdack Trust at the University of Missouri	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hugo Wurdack Trust at the University of Missouri	This work was funded by National Institutes of Health Grant GM29798, L.L.R., https://www.nih.gov/, and Hugo Wurdack Trust at the University of Missouri, L.L.R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baars L, 2006, J BIOL CHEM, V281, P10024, DOI 10.1074/jbc.M509929200; CABELLI RJ, 1991, J BIOL CHEM, V266, P24420; Cayley DS, 2000, BIOPHYS J, V78, P1748, DOI 10.1016/S0006-3495(00)76726-9; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3; denBlaauwen T, 1997, FEBS LETT, V416, P35, DOI 10.1016/S0014-5793(97)01142-3; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; FEKKES P, 1995, BIOCHEMISTRY-US, V34, P10078, DOI 10.1021/bi00031a032; Fekkes P, 1997, EMBO J, V16, P6105, DOI 10.1093/emboj/16.20.6105; GANNON PM, 1989, J BACTERIOL, V171, P813, DOI 10.1128/jb.171.2.813-818.1989; Gouridis G, 2009, NATURE, V462, P363, DOI 10.1038/nature08559; HARDY SJS, 1991, SCIENCE, V251, P439, DOI 10.1126/science.1989077; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Knoblauch NTM, 1999, J BIOL CHEM, V274, P34219, DOI 10.1074/jbc.274.48.34219; KUMAMOTO CA, 1988, J BIOL CHEM, V263, P11554; KUMAMOTO CA, 1985, J BACTERIOL, V163, P267, DOI 10.1128/JB.163.1.267-274.1985; KUSTERS R, 1989, J BIOL CHEM, V264, P20827; KUSUKAWA N, 1989, EMBO J, V8, P3517, DOI 10.1002/j.1460-2075.1989.tb08517.x; LARSEN PI, 1987, ARCH MICROBIOL, V147, P1, DOI 10.1007/BF00492896; Li MS, 2004, J BACTERIOL, V186, P3687, DOI 10.1128/JB.186.12.3687-3694.2004; LIU GP, 1989, P NATL ACAD SCI USA, V86, P9213, DOI 10.1073/pnas.86.23.9213; MATSUYAMA S, 1992, BIOCHIM BIOPHYS ACTA, V1122, P77, DOI 10.1016/0167-4838(92)90130-6; MATSUYAMA S, 1995, ADV CELL MOL BIOL M, V4, P61; Miller JH, 1974, EXPERIMENTS IN MOLEC; Patel CN, 2006, PROTEIN SCI, V15, P1379, DOI 10.1110/ps.062141006; POGLIANO KJ, 1994, J BACTERIOL, V176, P804, DOI 10.1128/jb.176.3.804-814.1994; POWERS EL, 1995, J BACTERIOL, V177, P1906, DOI 10.1128/jb.177.7.1906-1907.1995; Randall LL, 1998, PROTEIN SCI, V7, P2384, DOI 10.1002/pro.5560071115; Randall LL, 2005, J MOL BIOL, V348, P479, DOI 10.1016/j.jmb.2005.02.036; Randall LL, 1998, PROTEIN SCI, V7, P1195, DOI 10.1002/pro.5560070514; Randall LL, 2004, PROTEIN SCI, V13, P1124, DOI 10.1110/ps.03410104; RANDALL LL, 1995, TRENDS BIOCHEM SCI, V20, P65, DOI 10.1016/S0968-0004(00)88959-8; RANDALL LL, 1986, CELL, V46, P921, DOI 10.1016/0092-8674(86)90074-7; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; SCHATZ PJ, 1991, EMBO J, V10, P1749, DOI 10.1002/j.1460-2075.1991.tb07699.x; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Seoh HK, 1999, J BACTERIOL, V181, P1892, DOI 10.1128/JB.181.6.1892-1899.1999; Seoh HK, 1997, J BACTERIOL, V179, P1077, DOI 10.1128/jb.179.4.1077-1081.1997; Shimizu H, 1997, MOL MICROBIOL, V26, P1013, DOI 10.1046/j.1365-2958.1997.6392003.x; Ullers RS, 2007, P NATL ACAD SCI USA, V104, P3101, DOI 10.1073/pnas.0608232104; WATANABE M, 1989, P NATL ACAD SCI USA, V86, P2728, DOI 10.1073/pnas.86.8.2728; Woodbury RL, 2000, J BIOL CHEM, V275, P24191, DOI 10.1074/jbc.M002885200	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183231	10.1371/journal.pone.0183231	http://dx.doi.org/10.1371/journal.pone.0183231			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850586	Green Submitted, Green Published, gold			2022-12-27	WOS:000408544200011
J	Chouaid, C; Debieuvre, D; Durand-Zaleski, I; Fernandes, J; Scherpereel, A; Westeel, V; Blein, C; Gaudin, AF; Ozan, N; Leblanc, S; Vainchtock, A; Chauvin, P; Cotte, FE; Souquet, PJ				Chouaid, Christos; Debieuvre, Didier; Durand-Zaleski, Isabelle; Fernandes, Jerome; Scherpereel, Arnaud; Westeel, Virginie; Blein, Cecile; Gaudin, Anne-Francoise; Ozan, Nicolas; Leblanc, Soline; Vainchtock, Alexandre; Chauvin, Pierre; Cotte, Francois-Emery; Souquet, Pierre-Jean			Survival inequalities in patients with lung cancer in France: A nationwide cohort study (the TERRITOIRE Study)	PLOS ONE			English	Article							COLORECTAL-CANCER; HEALTH-CARE; MORTALITY; DISPARITIES; STAGE; ACCESS; DEPRIVATION; MANAGEMENT; DIAGNOSIS; PATTERNS	The French healthcare system is a universal healthcare system with no financial barrier to access to health services and cancer drugs. The objective of the study is to investigate associations between, on the one hand, incidence and survival of patients diagnosed with lung cancer in France and, on the other, the socioeconomic deprivation and population density of their municipality of residence. A national, longitudinal analysis using data from the French National Hospital database crossed with the population density of the municipality and a social deprivation index based on census data aggregated at the municipality level. For lung cancer diagnosed at the metastatic stage, one-year and two-year survival was not associated with the population density of the municipality of residence. In contrast, mortality was higher for people living in very deprived, deprived and privileged areas compared to very privileged areas (hazard ratios at two years: 1.19 [1.13 - 1.25], 1.14 [1.08 - 1.20] and 1.10 [1.04 - 1.16] respectively). Similar associations are also observed in patients diagnosed with non-metastatic disease (hazard ratios at two years: 1.21 [1.13 - 1.30], 1.15 [1.08 - 1.23] and 1.10 [1.03 - 1.18] for people living in very deprived, deprived and privileged areas compared to very privileged areas). Despite a universal healthcare coverage, survival inequalities in patients with lung cancer can be observed in France with respect to certain socioeconomic indicators.	[Chouaid, Christos] Creteil Univ Hosp, Dept Chest Med, Creteil, France; [Debieuvre, Didier] Mulhouse Univ Hosp, Dept Chest Med, Mulhouse, France; [Durand-Zaleski, Isabelle] Hop Hotel Dieu, URCEco lle France, Paris, France; [Durand-Zaleski, Isabelle] Henri Mondor Hosp, Dept Publ Hlth, Creteil, France; [Fernandes, Jerome] Oc Sante, Montpellier, France; [Scherpereel, Arnaud] Lille Univ Hosp, Pulm & Thorac Oncol Dept, Lille, France; [Westeel, Virginie] Jean Minjoz Univ Hosp, Dept Chest Med, Besancon, France; [Blein, Cecile; Leblanc, Soline; Vainchtock, Alexandre] HEVA, Lyon, France; [Gaudin, Anne-Francoise; Ozan, Nicolas; Cotte, Francois-Emery] Lab Bristol Myers Squibb, Hlth Econ & Outcomes Res, Rueil Malmaison, France; [Chauvin, Pierre] Sorbonne Univ, UPMC Univ Paris 06, INSERM, IPLESP UMRS 1136,Dept Social Epidemiol, Paris, France; [Souquet, Pierre-Jean] Hosp Civils Lyon, Ctr Hosp Lyon Sud, Dept Chest Med, Pierre Benite, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; CHI Creteil; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Hotel-Dieu - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Universite de Lille - ISITE; CHU Lille; Universite de Franche-Comte; CHU Besancon; Bristol-Myers Squibb; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Lyon	Cotte, FE (corresponding author), Lab Bristol Myers Squibb, Hlth Econ & Outcomes Res, Rueil Malmaison, France.	Francois-Emery.Cotte@bms.com	Chauvin, Pierre/S-2981-2019; Chauvin, Pierre/G-1095-2015; christos, chouaid/R-4477-2018	Chauvin, Pierre/0000-0002-9183-6406; Chauvin, Pierre/0000-0002-9183-6406; christos, chouaid/0000-0002-4290-5524	Bristol-Myers Squibb (BMS); BMS	Bristol-Myers Squibb (BMS)(Bristol-Myers Squibb); BMS(Bristol-Myers Squibb)	This study was funded by Bristol-Myers Squibb (BMS), a company which markets pharmaceuticals used in the treatment of lung cancer. AF Gaudin, N Ozan and FE Cotte are salaried employees of BMS. BMS contracted the data analysis for this study to HEVA, a contract research organisation. C Blein, S Leblanc and A Vainchtock are employees or shareholders of HEVA. BMS have funded editorial support in the form of preparation of slide sets or posters for presentations of data from the TERRITOIRE study on behalf of CC, IDZ and PJS, as well as editorial support for the preparation of this manuscript. The funders initiated, designed and supervised the study.	Atkins GT, 2017, ANN AM THORAC SOC, V14, P403, DOI 10.1513/AnnalsATS.201606-469OC; Bain NSC, 2000, FAM PRACT, V17, P475, DOI 10.1093/fampra/17.6.475; Berglund A, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001048; Berglund A, 2010, THORAX, V65, P327, DOI 10.1136/thx.2009.125914; Booth CM, 2010, CANCER-AM CANCER SOC, V116, P4160, DOI 10.1002/cncr.25427; Coleman MP, 2001, CANCER, V91, P208, DOI 10.1002/1097-0142(20010101)91:1+<208::AID-CNCR6>3.0.CO;2-E; Dalton SO, 2015, ACTA ONCOL, V54, P797, DOI 10.3109/0284186X.2014.1001037; Debieuvre D, 2016, LUNG CANCER, V91, P1, DOI 10.1016/j.lungcan.2015.11.001; Dejardin O, 2014, HEALTH PLACE, V30, P36, DOI 10.1016/j.healthplace.2014.08.002; Doat S, 2016, REV EPIDEMIOL SANTE, V64, P145, DOI 10.1016/j.respe.2015.12.020; Erhunmwunsee L, 2012, CANCER-AM CANCER SOC, V118, P5117, DOI 10.1002/cncr.26185; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Forrest LF, 2015, THORAX, V70, P138, DOI 10.1136/thoraxjnl-2014-205517; Gisquet E., 2012, B EPID MIOLOGIQUE HE, V48, P547; Guignard R., 2015, Bulletin Epidemiologique Hebdomadaire, P281; International Agency for Research on Cancer World Health Organization, 2014, EUR CANC OBS EUCAN N; Johnson AM, 2014, LUNG CANCER, V83, P401, DOI 10.1016/j.lungcan.2014.01.008; Locher C, 2013, LUNG CANCER, V81, P32, DOI 10.1016/j.lungcan.2013.03.001; McMahon M, 2011, THORAX, V66, P453, DOI 10.1136/thoraxjnl-2011-200039; McPhail S, 2015, BRIT J CANCER, V112, pS108, DOI 10.1038/bjc.2015.49; Melvan JN, 2015, J AM COLL SURGEONS, V221, P550, DOI 10.1016/j.jamcollsurg.2015.03.056; Morere JF, 2015, EUR J CANCER PREV, V24, pS82, DOI 10.1097/CEJ.0000000000000143; Murage P, 2016, HEALTH PLACE, V42, P11, DOI 10.1016/j.healthplace.2016.08.014; O'Dowd EL, 2015, THORAX, V70, P161, DOI 10.1136/thoraxjnl-2014-205692; Pearce J, 2005, SOC SCI MED, V60, P2833, DOI 10.1016/j.socscimed.2004.11.014; Pozet A, 2008, LUNG CANCER, V59, P291, DOI 10.1016/j.lungcan.2007.08.039; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Riaz SP, 2011, J THORAC ONCOL, V6, P2005, DOI 10.1097/JTO.0b013e31822b02db; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sogaard Mette, 2013, Clin Epidemiol, V5, P3, DOI 10.2147/CLEP.S47150; Wagenaar KP, 2012, CANCER EPIDEMIOL, V36, P329, DOI 10.1016/j.canep.2012.03.003; World Health Organization, 2010, INT CLASSIFICATION D; Yang R, 2010, CANCER-AM CANCER SOC, V116, P2437, DOI 10.1002/cncr.24986	33	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182798	10.1371/journal.pone.0182798	http://dx.doi.org/10.1371/journal.pone.0182798			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841679	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700010
J	Hong, SN; Son, HJ; Choi, SK; Chang, DK; Kim, YH; Jung, SH; Rhee, PL				Hong, Sung Noh; Son, Hee Jung; Choi, Sun Kyu; Chang, Dong Kyung; Kim, Young-Ho; Jung, Sin-Ho; Rhee, Poong-Lyul			A prediction model for advanced colorectal neoplasia in an asymptomatic screening population	PLOS ONE			English	Article							MISSING DATA; RISK; CANCER; COLONOSCOPY; VALIDATION; GUIDELINES; SCORE; INDEX; TOOL; MEN	Background An electronic medical record (EMR) database of a large unselected population who received screening colonoscopies may minimize sampling error and represent real-world estimates of risk for screening target lesions of advanced colorectal neoplasia (CRN). Our aim was to develop and validate a prediction model for assessing the probability of advanced CRN using a clinical data warehouse. Methods A total of 49,450 screenees underwent their first colonoscopy as part of a health check-up from 2002 to 2012 at Samsung Medical Center, and the dataset was constructed by means of natural language processing from the computerized EMR system. The screenees were randomized into training and validation sets. The prediction model was developed using logistic regression. The model performance was validated and compared with existing models using area under receiver operating curve (AUC) analysis. Results In the training set, age, gender, smoking duration, drinking frequency, and aspirin use were identified as independent predictors for advanced CRN (adjusted P <.01). The developed model had good discrimination (AUC = 0.726) and was internally validated (AUC = 0.713). The high-risk group had a 3.7-fold increased risk of advanced CRN compared to the low-risk group (1.1% vs. 4.0%, P <.001). The discrimination performance of the present model for high-risk patients with advanced CRN was better than that of the Asia-Pacific Colorectal Screening score (AUC = 0.678, P <.001) and Schroy's CAN index (AUC = 0.672, P <.001). Conclusion The present 5-item risk model can be calculated readily using a simple questionnaire and can identify the low- and high-risk groups of advanced CRN at the first screening colonoscopy. This model may increase colorectal cancer risk awareness and assist healthcare providers in encouraging the high-risk group to undergo a colonoscopy.	[Hong, Sung Noh; Son, Hee Jung; Chang, Dong Kyung; Kim, Young-Ho; Rhee, Poong-Lyul] Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea; [Son, Hee Jung] Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea; [Choi, Sun Kyu; Jung, Sin-Ho] Samsung Med Ctr, Samsung Canc Res Inst, Biostat & Bioinformat Ctr, Seoul, South Korea; [Jung, Sin-Ho] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Duke University	Rhee, PL (corresponding author), Sungkyunkwan Univ, Dept Med, Samsung Med Ctr, Sch Med, Seoul, South Korea.	plrhee@skku.edu		choe, seongyu/0000-0001-8827-7060; Rhee, Poong-Lyul/0000-0003-0495-5296				Al-Haddad MA, 2010, HPB, V12, P688, DOI 10.1111/j.1477-2574.2010.00235.x; [Anonymous], 2002, GASTROINTESTINAL E S, V58, pS3; Cai QC, 2012, AM J EPIDEMIOL, V175, P584, DOI 10.1093/aje/kwr337; Colditz GA, 2000, CANCER CAUSE CONTROL, V11, P477, DOI 10.1023/A:1008984432272; Driver JA, 2007, AM J MED, V120, P257, DOI 10.1016/j.amjmed.2006.05.055; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fox-Wasylyshyn SM, 2005, RES NURS HEALTH, V28, P488, DOI 10.1002/nur.20100; Freedman AN, 2009, J CLIN ONCOL, V27, P686, DOI 10.1200/JCO.2008.17.4797; Friedlin Jeff, 2010, AMIA Annu Symp Proc, V2010, P237; Graham JW, 2009, ANNU REV PSYCHOL, V60, P549, DOI 10.1146/annurev.psych.58.110405.085530; Han DS, 2015, CLIN ENDOSC, V48, P216, DOI 10.5946/ce.2015.48.3.216; Hazlehurst B, 2005, AM J PREV MED, V29, P434, DOI 10.1016/j.amepre.2005.08.007; Hong SN, 2010, GASTROINTEST ENDOSC, V72, P480, DOI 10.1016/j.gie.2010.06.022; Imperiale TF, 2003, ANN INTERN MED, V139, P959, DOI 10.7326/0003-4819-139-12-200312160-00005; Kaminski MF, 2014, GUT, V63, P1112, DOI 10.1136/gutjnl-2013-304965; Khalid-de Bakker C, 2011, ENDOSCOPY, V43, P1059, DOI 10.1055/s-0031-1291430; Lee Bo In, 2012, Korean J Gastroenterol, V59, P65; Lieberman DA, 2012, GASTROENTEROLOGY, V143, P844, DOI 10.1053/j.gastro.2012.06.001; Moiel David, 2011, Perm J, V15, P30; Park Y, 2009, J CLIN ONCOL, V27, P694, DOI 10.1200/JCO.2008.17.4813; Rampal S, 2014, GASTROENTEROLOGY, V147, P78, DOI 10.1053/j.gastro.2014.03.006; Rex DK, 2009, AM J GASTROENTEROL, V104, P739, DOI 10.1038/ajg.2009.104; Savova GK, 2008, J AM MED INFORM ASSN, V15, P25, DOI 10.1197/jamia.M2437; Schroy PC, 2015, AM J GASTROENTEROL, V110, P1062, DOI 10.1038/ajg.2015.146; Shin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088079; Strauss JA, 2013, J AM MED INFORM ASSN, V20, P349, DOI 10.1136/amiajnl-2012-000928; Wei EK, 2009, AM J EPIDEMIOL, V170, P863, DOI 10.1093/aje/kwp210; Yeoh KG, 2011, GUT, V60, P1236, DOI 10.1136/gut.2010.221168	28	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0181040	10.1371/journal.pone.0181040	http://dx.doi.org/10.1371/journal.pone.0181040			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841657	gold, Green Submitted, Green Published			2022-12-27	WOS:000408370700002
J	Kucklich, M; Moller, M; Marcillo, A; Einspanier, A; Weiss, BM; Birkemeyer, C; Widdig, A				Kuecklich, Marlen; Moeller, Manfred; Marcillo, Andrea; Einspanier, Almuth; Weiss, Brigitte M.; Birkemeyer, Claudia; Widdig, Anja			Different methods for volatile sampling in mammals	PLOS ONE			English	Article							GAS CHROMATOGRAPHY/MASS SPECTROMETRY; CHEMICAL-COMPOSITION; THERMAL-DESORPTION; ORGANIC-COMPOUNDS; BODY ODOR; SCENT; IDENTIFICATION; SECRETIONS; COMMUNICATION; ECOLOGY	Previous studies showed that olfactory cues are important for mammalian communication. However, many specific compounds that convey information between conspecifics are still unknown. To understand mechanisms and functions of olfactory cues, olfactory signals such as volatile compounds emitted from individuals need to be assessed. Sampling of animals with and without scent glands was typically conducted using cotton swabs rubbed over the skin or fur and analysed by gas chromatography-mass spectrometry (GC-MS). However, this method has various drawbacks, including a high level of contaminations. Thus, we adapted two methods of volatile sampling from other research fields and compared them to sampling with cotton swabs. To do so we assessed the body odor of common marmosets (Callithrix jacchus) using cotton swabs, thermal desorption (TD) tubes and, alternatively, a mobile GC-MS device containing a thermal desorption trap. Overall, TD tubes comprised most compounds (N = 113), with half of those compounds being volatile (N = 52). The mobile GC-MS captured the fewest compounds (N = 35), of which all were volatile. Cotton swabs contained an intermediate number of compounds (N = 55), but very few volatiles (N = 10). Almost all compounds found with the mobile GC-MS were also captured with TD tubes (94%). Hence, we recommend TD tubes for state of the art sampling of body odor of mammals or other vertebrates, particularly for field studies, as they can be easily transported, stored and analysed with high performance instruments in the lab. Nevertheless, cotton swabs capture compounds which still may contribute to the body odor, e.g. after bacterial fermentation, while profiles from mobile GC-MS include only the most abundant volatiles of the body odor.	[Kuecklich, Marlen; Weiss, Brigitte M.; Widdig, Anja] Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Dept Primatol, Leipzig, Germany; [Kuecklich, Marlen; Weiss, Brigitte M.; Widdig, Anja] Univ Leipzig, Behav Ecol Res Grp, Inst Biol, Leipzig, Germany; [Moeller, Manfred; Birkemeyer, Claudia] Rhein Westfal TH Aachen, Inst & Out Patient Clin Occupat Med, Aachen, Germany; [Marcillo, Andrea] Univ Leipzig, Res Grp Mass Spectrometry, Inst Analyt Chem, Leipzig, Germany; [Einspanier, Almuth] Univ Leipzig, Inst Physiol Chem, Fac Vet Med, Leipzig, Germany; [Widdig, Anja] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany	Max Planck Society; Leipzig University; RWTH Aachen University; Leipzig University; Leipzig University	Kucklich, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Jr Res Grp Primate Kin Select, Dept Primatol, Leipzig, Germany.; Kucklich, M (corresponding author), Univ Leipzig, Behav Ecol Res Grp, Inst Biol, Leipzig, Germany.	marlen_kuecklich@eva.mpg.de	; Birkemeyer, Claudia/L-8687-2015	Weiss, Brigitte/0000-0001-6316-5636; Kucklich, Marlen/0000-0001-7694-6474; Birkemeyer, Claudia/0000-0002-8538-8838	University of Leipzig; European Fund for Regional Structure Development, EFRE [100195810]; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT-Ecuador [861-2012]	University of Leipzig; European Fund for Regional Structure Development, EFRE; Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT-Ecuador	This work was supported by the University of Leipzig including a graduate funding of the University of Leipzig to MK; the European Fund for Regional Structure Development, EFRE ("Europe funds Saxony", http://ec.europa.eu/ regional_policy/de/funding/erdf/, grant no. 100195810 to AW); and Secretaria Nacional de Educacion Superior, Ciencia, Tecnologia e Innovacion, SENESCYT-Ecuador (http://www. senescyt.gob.ec/web/guest, grant no. 861-2012 to AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baayen H., 2008, ANAL LINGUISTIC DATA; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Birkemeyer CS, 2016, CHEM SENSES, V41, P525, DOI 10.1093/chemse/bjw056; Burger BV, 2005, TOP CURR CHEM, V240, P231, DOI 10.1007/b98318; Burger BV, 1999, J CHEM ECOL, V25, P2099, DOI 10.1023/A:1021040923988; Charpentier MJE, 2012, FUNCT ECOL, V26, P769, DOI 10.1111/j.1365-2435.2012.01998.x; CONVERSE LJ, 1995, ANIM BEHAV, V49, P615; Costello BD, 2014, J BREATH RES, V8, DOI 10.1088/1752-7155/8/1/014001; Curran AM, 2010, J FORENSIC SCI, V55, P50, DOI 10.1111/j.1556-4029.2009.01236.x; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; De Preter V, 2009, J CHROMATOGR A, V1216, P1476, DOI 10.1016/j.chroma.2008.12.095; Dettmer K, 2002, ANAL BIOANAL CHEM, V373, P490, DOI 10.1007/s00216-002-1352-5; Dobson AJ., 2008, INTRO GEN LINEAR MOD, DOI 10.1201/9780367807849; Dormont L, 2013, J EXP BIOL, V216, P2783, DOI 10.1242/jeb.085936; Dormont L, 2013, J CHEM ECOL, V39, P569, DOI 10.1007/s10886-013-0286-z; Doving KB, 1998, J EXP BIOL, V201, P2913; Drea CM, 2013, AM J PRIMATOL, V75, P621, DOI 10.1002/ajp.22143; Dulac C, 2003, NAT REV NEUROSCI, V4, P551, DOI 10.1038/nrn1140; Ezenwa VO, 2014, BIOESSAYS, V36, P847, DOI 10.1002/bies.201400016; FERKIN MH, 1995, ANIM BEHAV, V49, P37, DOI 10.1016/0003-3472(95)80151-0; Forstmeier W, 2011, BEHAV ECOL SOCIOBIOL, V65, P47, DOI 10.1007/s00265-010-1038-5; Gallego E, 2010, TALANTA, V81, P916, DOI 10.1016/j.talanta.2010.01.037; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Giron-Calva PS, 2014, J CHEM ECOL, V40, P1203, DOI 10.1007/s10886-014-0514-1; Heymann EW, 2006, AM J PRIMATOL, V68, P519, DOI 10.1002/ajp.20249; Hoover KC, 2010, AM J PHYS ANTHROPOL, P63, DOI 10.1002/ajpa.21441; Juan-Peiro L, 2012, J ANAL METHODS CHEM, V2012, DOI 10.1155/2012/728143; Leclaire S, 2014, BEHAV ECOL, V25, P996, DOI 10.1093/beheco/aru074; Leclaire S, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1054; Lenochova P, 2009, CHEM SENSES, V34, P127, DOI 10.1093/chemse/bjn067; Marcillo A, J CHROMATOG IN PRESS; Marneweck C, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2016.2376; McCormick AC, 2014, PLANT CELL ENVIRON, V37, P1836, DOI 10.1111/pce.12357; Mietsch M, 2015, LAB ANIM-UK, V49, P241, DOI 10.1177/0023677214565843; Nagashima H, 2015, J CHROMATOGR A, V1406, P279, DOI 10.1016/j.chroma.2015.06.011; Peron F, 2014, ANIM COGN, V17, P1007, DOI 10.1007/s10071-013-0717-9; R Core Team, 2013, R LANG ENV STAT COMP; Rabaud NE, 2002, J AGR FOOD CHEM, V50, P5139, DOI 10.1021/jf020204u; Royal Society of Chemistry, 2017, CHEMSPIDER SEARCH SH; Salthammer T., 2009, ORGANIC INDOOR AIR P; Schielzeth H, 2009, BEHAV ECOL, V20, P416, DOI 10.1093/beheco/arn145; Schirmer A, 2010, SCIENCE, V329, P559, DOI 10.1126/science.1187936; Scordato ES, 2007, CHEM SENSES, V32, P493, DOI 10.1093/chemse/bjm018; Setchell JM, 2010, CHEM SENSES, V35, P205, DOI 10.1093/chemse/bjp105; Sigma-Aldrich Co, 1997, AMB XAD 2 POLYM ADS; Smith TE, 2001, CHEM SENSES, V26, P449, DOI 10.1093/chemse/26.5.449; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Stulp G, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0028991, 10.1371/journal.pone.0020497]; Theis KR, 2013, P NATL ACAD SCI USA, V110, P19832, DOI 10.1073/pnas.1306477110; Theis KR, 2012, SCI REP-UK, V2, DOI 10.1038/srep00615; Tholl D, 2006, PLANT J, V45, P540, DOI 10.1111/j.1365-313X.2005.02612.x; van Dam NM, 2010, J CHEM ECOL, V36, P1006, DOI 10.1007/s10886-010-9844-9; Woolfenden E, 1997, J AIR WASTE MANAGE, V47, P20, DOI 10.1080/10473289.1997.10464411; Wypych G., 2001, HDB SOLVENTS; Zhang SC, 2010, SENSOR ACTUAT B-CHEM, V146, P427, DOI 10.1016/j.snb.2009.11.028	56	20	21	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183440	10.1371/journal.pone.0183440	http://dx.doi.org/10.1371/journal.pone.0183440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841690	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700032
J	Lei, Y; Wang, SL; Ren, BS; Wang, J; Chen, J; Lu, J; Zhan, SH; Fu, YF; Huang, LH; Tan, JM				Lei, Yan; Wang, Shuiliang; Ren, Bingshuang; Wang, Jin; Chen, Jin; Lu, Jun; Zhan, Shihuai; Fu, Yunfeng; Huang, Lianghu; Tan, Jianming			CHOP favors endoplasmic reticulum stress-induced apoptosis in hepatocellular carcinoma cells via inhibition of autophagy	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; C/EBP-HOMOLOGOUS PROTEIN; DOUBLE-EDGED-SWORD; GENE-EXPRESSION; CANCER-CELLS; A549 CELLS; DEATH; MECHANISMS; PATHWAY; DISEASE	C/EBP-homologous protein (CHOP) is an important component of the endoplasmic reticulum (ER) stress response. We demonstrated the induction of ER stress in response to tunicamycin stimulation, as evidenced by increased expression of chaperone proteins Grp78, Grp94, and enhanced eukaryotic initiation factor 2 subunit 1 (eIF2 alpha) phosphorylation in hepatocellular carcinoma cells. Tunicamycin-induced ER stress resulted in apoptosis and autophagy simultaneously. While inhibition of autophagy mediated by 3-methyladenine pretreatment or direct knockdown of LC3B promoted cell apoptosis, activation of autophagy with rapamycin decreased tunicamycin-induced apoptosis in HCC cells. Furthermore, CHOP was shown to be significantly upregulated upon treatment with tunicamycin in HCC cells. Specific knockdown of CHOP not only enhanced tunicamycin-induced autophagy, but also significantly attenuated ER stress-induced apoptosis in HCC cells. Accordingly, simultaneous inhibition of autophagy in HCC cells with CHOP-knockdown could partially resensitize ER stress-induced apoptosis. Taken together, our data indicate that CHOP may favor ER stress-induced apoptosis in HCC cells via inhibition of autophagy in vitro.	[Lei, Yan; Wang, Shuiliang; Ren, Bingshuang; Wang, Jin; Chen, Jin; Lu, Jun; Zhan, Shihuai; Fu, Yunfeng; Huang, Lianghu; Tan, Jianming] Xiamen Univ, Fuzhou Gen Hosp, Dept Fujian Prov Key Lab Transplant Biol, Fuzhou, Fujian, Peoples R China	Xiamen University	Huang, LH; Tan, JM (corresponding author), Xiamen Univ, Fuzhou Gen Hosp, Dept Fujian Prov Key Lab Transplant Biol, Fuzhou, Fujian, Peoples R China.	huanglianghu@xmu.edu.cn; tanjm156@xmu.edu.cn	Lu, Jun/ADP-4733-2022; Wang, Shuiliang/R-4080-2019; Tan, Ming-Jen/A-3862-2011	Wang, Shuiliang/0000-0002-5054-9064; Tan, Ming-Jen/0000-0002-3583-1723; Chen, Jin/0000-0003-0794-3995	National Natural Science Foundation of China [81270431]; Natural Science Foundation of Fujian Province of China [2016J01577]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Fujian Province of China(Natural Science Foundation of Fujian Province)	This work was supported in part by the National Natural Science Foundation of China (No. 81270431) (LH). This work was also supported in part by the Natural Science Foundation of Fujian Province of China (No.2016J01577) (SW).	B'chir W, 2014, CELL SIGNAL, V26, P1385, DOI 10.1016/j.cellsig.2014.03.009; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Chandrika BB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140025; Chikka MR, 2013, J BIOL CHEM, V288, P4405, DOI 10.1074/jbc.M112.432344; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Hsu HC, 2016, EUR J NUTR, V55, P2245, DOI 10.1007/s00394-015-1034-7; Inagi R, 2014, NAT REV NEPHROL, V10, P369, DOI 10.1038/nrneph.2014.67; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Li SY, 2015, CELL PHYSIOL BIOCHEM, V36, P2403, DOI 10.1159/000430202; Li XQ, 2010, AUTOPHAGY, V6, P1066, DOI 10.4161/auto.6.8.13366; Li XQ, 2010, CANCER RES, V70, P5942, DOI 10.1158/0008-5472.CAN-10-0157; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Rodriguez D, 2011, BBA-MOL CELL RES, V1813, P564, DOI 10.1016/j.bbamcr.2010.11.012; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubiolo JA, 2013, CELL SIGNAL; Rzymski T, 2009, CELL CYCLE, V8, P3838, DOI 10.4161/cc.8.23.10086; Saha A, 2010, BIOL PHARM BULL, V33, P1291, DOI 10.1248/bpb.33.1291; Seong YA, 2014, CELL BIOCHEM BIOPHYS, V68, P369, DOI 10.1007/s12013-013-9717-2; Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang H, 2015, INT J NANOMED, V10, P5505, DOI 10.2147/IJN.S83838; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; White E, 2009, CLIN CANCER RES, V15, P5308, DOI 10.1158/1078-0432.CCR-07-5023; Zhang JL, 2015, J SURG RES, V195, P588, DOI 10.1016/j.jss.2015.01.039; Zhang N, 2015, BIOCHEM BIOPH RES CO, V464, P1107, DOI 10.1016/j.bbrc.2015.07.086	29	52	56	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183680	10.1371/journal.pone.0183680	http://dx.doi.org/10.1371/journal.pone.0183680			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841673	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700049
J	Yeh, KT; Lee, RP; Chen, IH; Yu, TC; Liu, KL; Peng, CH; Wang, JH; Chang, PY; Wu, WT				Yeh, Kuang-Ting; Lee, Ru-Ping; Chen, Ing-Ho; Yu, Tzai-Chiu; Liu, Kuan-Lin; Peng, Cheng-Huan; Wang, Jen-Hung; Chang, Pau-Yuan; Wu, Wen-Tien			Fresh frozen cortical strut allograft in two-level anterior cervical corpectomy and fusion	PLOS ONE			English	Article							FIBULAR ALLOGRAFT; PLATE FIXATION; RIGID PLATES; RECONSTRUCTION; COMPLICATIONS; MYELOPATHY; SPONDYLOSIS; AUTOGRAFT; KYPHOSIS; FAILURE	Anterior cervical corpectomy and fusion (ACCF) is one of the main surgical strategies for the management of multilevel cervical spondylotic myelopathy (MCSM). High complication rates of graft bone fracture, resorption, displacement, and fusion collapse or pseudarthrosis have been previously reported. The strategies to prevent the aforementioned complications include using fresh frozen cortical strut allograft (FFCSA) to keep most of the original bone quality and using additional anterior plate fixation to improve the fusion stability and union rate. In this study, we evaluated 4-year follow-ups for surgical outcomes and analyzed the risk factors of MCSM patients who received 2-level ACCF with FFCSA and titanium dynamic plate fixation. We retrospectively collected preoperative and postoperative radiographic and clinical data of patients from 2005 to 2009; the inclusion criteria were having been diagnosed as MCSM and having received 2-level ACCF with an FFCSA fibular shaft and an anterior dynamic plate. The cervical curvature lordosis improved and the neurogenic function recovered well postoperatively. Visual analog scale for neck pain and neck disability index scores both decreased after 12 and 48 months following surgery. The Japanese Orthopaedic Association score recovery rate at postoperative 4 years was 87.5%. Fusion rates achieved 100% at 12 months. The preoperative Nurick score seemed to be the only significant risk factor correlated with the functional recovery rate at 4 years after the surgery. In conclusion, based on a minimum 4-year follow-up of 2-level ACCF with FFCSA and dynamic titanium plates for patients with MCSM, the surgical results were satisfying and the complication rates were low.	[Yeh, Kuang-Ting; Chen, Ing-Ho; Yu, Tzai-Chiu; Liu, Kuan-Lin; Peng, Cheng-Huan; Wu, Wen-Tien] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Orthoped, Hualien, Taiwan; [Yeh, Kuang-Ting; Chen, Ing-Ho; Yu, Tzai-Chiu; Wu, Wen-Tien] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Lee, Ru-Ping; Wu, Wen-Tien] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Wang, Jen-Hung] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Med Res, Hualien, Taiwan; [Chang, Pau-Yuan] Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Radiol, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital	Wu, WT (corresponding author), Buddhist Tzu Chi Med Fdn, Hualien Tzu Chi Hosp, Dept Orthoped, Hualien, Taiwan.; Wu, WT (corresponding author), Tzu Chi Univ, Sch Med, Hualien, Taiwan.; Wu, WT (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	wentien2003@yahoo.com.tw	Yeh, Kuang-Ting/ABD-4398-2020					Aponte-Tinao LA, 2014, ORTHOP CLIN N AM, V45, P257, DOI 10.1016/j.ocl.2013.12.008; Chen Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102008; Daubs MD, 2005, SPINE, V30, P1402, DOI 10.1097/01.brs.0000166526.78058.3c; DiPaola CP, 2008, SPINE J, V8, P717, DOI 10.1016/j.spinee.2007.06.016; Douglas AF, 2007, NEUROSURGERY, V60, P137, DOI 10.1227/01.NEU.0000249224.59494.A0; FERNYHOUGH JC, 1991, SPINE, V16, pS561, DOI 10.1097/00007632-199110001-00022; Ghogawala Z, 2007, SPINE, V32, P429, DOI 10.1097/01.brs.0000255068.94058.8a; GROSSMAN W, 1992, SPINE, V17, P565, DOI 10.1097/00007632-199205000-00015; Hee HT, 2003, J SPINAL DISORD TECH, V16, P1, DOI 10.1097/00024720-200302000-00001; HERMAN JM, 1994, J NEUROSURG, V80, P963, DOI 10.3171/jns.1994.80.6.0963; Hirai T, 2011, SPINE, V36, P1940, DOI 10.1097/BRS.0b013e3181feeeb2; Kaminsky S B, 2004, Iowa Orthop J, V24, P95; MacDonald RL, 1997, J NEUROSURG, V86, P990, DOI 10.3171/jns.1997.86.6.0990; Nakase H, 2006, J SPINAL DISORD TECH, V19, P353, DOI 10.1097/01.bsd.0000210113.09521.aa; Nunley PD, 2009, SPINE J, V9, P121, DOI 10.1016/j.spinee.2007.11.009; Okawa A, 2011, SPINE, V36, pE582, DOI 10.1097/BRS.0b013e3181e0f06a; Pitzen TR, 2009, SPINE, V34, P641, DOI 10.1097/BRS.0b013e318198ce10; Resnick DK, 2007, NEUROSURGERY, V60, P112, DOI 10.1227/01.NEU.0000215350.95209.CA; Rhee JM, 2007, J AM ACAD ORTHOP SUR, V15, P640, DOI 10.5435/00124635-200711000-00002; Riew KD, 1999, SPINE, V24, P2404, DOI 10.1097/00007632-199911150-00019; Saunders RL, 1976, 4 LEVEL CERVICAL COR, P23; Schnee CL, 1997, SPINE, V22, P2222, DOI 10.1097/00007632-199710010-00005; Stulik J, 2007, EUR SPINE J, V16, P1689, DOI 10.1007/s00586-007-0451-6; Vaccaro AR, 1998, J SPINAL DISORD, V11, P410; Vitzthum HE, 2007, EUR SPINE J, V16, P2096, DOI 10.1007/s00586-007-0512-x; Witwer BP, 2007, NEUROSURGERY, V60, P130, DOI 10.1227/01.NEU.0000215351.32372.CE; Yan N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112423; ZDEBLICK TA, 1989, J BONE JOINT SURG AM, V71A, P170, DOI 10.2106/00004623-198971020-00002	28	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183112	10.1371/journal.pone.0183112	http://dx.doi.org/10.1371/journal.pone.0183112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841652	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700018
J	Carlsson, J; Svennerstam, H; Moritz, T; Egertsdotter, U; Ganeteg, U				Carlsson, Johanna; Svennerstam, Henrik; Moritz, Thomas; Egertsdotter, Ulrika; Ganeteg, Ulrika			Nitrogen uptake and assimilation in proliferating embryogenic cultures of Norway spruce-Investigating the specific role of glutamine	PLOS ONE			English	Article							SCOTS PINE-SEEDLINGS; AMINO-ACID-UPTAKE; BOREAL FOREST PLANTS; SOMATIC EMBRYOGENESIS; INORGANIC NITROGEN; PICEA-ABIES; ORGANIC NITROGEN; ALANINE AMINOTRANSFERASE; ARABIDOPSIS-THALIANA; NITRATE UPTAKE	Somatic embryogenesis is an in vitro system employed for plant propagation and the study of embryo development. Nitrogen is essential for plant growth and development and, hence, the production of healthy embryos during somatic embryogenesis. Glutamine has been shown to increase plant biomass in many in vitro applications, including somatic embryogenesis. However, several aspects of nitrogen nutrition during somatic embryogenesis remain unclear. Therefore, we investigated the uptake and assimilation of nitrogen in Norway spruce pro-embryogenic masses to elucidate some of these aspects. In our study, addition of glutamine had a more positive effect on growth than inorganic nitrogen. The nitrogen uptake appeared to be regulated, with a strong preference for glutamine; 67% of the assimilated nitrogen in the free amino acid pool originated from glutamine-nitrogen. Glutamine addition also relieved the apparently limited metabolism (as evidenced by the low concentration of free amino acids) of pro-embryogenic masses grown on inorganic nitrogen only. The unusually high alanine concentration in the presence of glutamine, suggests that alanine biosynthesis was involved in alleviating these constraints. These findings inspire further studies of nitrogen nutrition during the somatic embryogenesis process; identifying the mechanism(s) that govern glutamine enhancement of pro-embryogenic masses growth is especially important in this regard.	[Carlsson, Johanna; Svennerstam, Henrik; Moritz, Thomas; Egertsdotter, Ulrika; Ganeteg, Ulrika] Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Carlsson, Johanna] Svenska Skogsplantor AB, Seed Prod, Lagan, Sweden; [Svennerstam, Henrik] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden; [Egertsdotter, Ulrika] Georgia Inst Technol, GW Woodruff Sch Mech Engn, Atlanta, GA 30332 USA	Swedish University of Agricultural Sciences; Umea University; Umea University; University System of Georgia; Georgia Institute of Technology	Ganeteg, U (corresponding author), Swedish Univ Agr Sci, Dept Forest Genet & Plant Physiol, Umea Plant Sci Ctr, Umea, Sweden.	ulrika.ganeteg@slu.se		Egertsdotter, Ulrika/0000-0002-0696-4279; Moritz, Thomas/0000-0002-4258-3190	Svenska Skogsplantor AB; Swedish Governmental Agency for Innovation Systems (VINNOVA; UPSC Berzelii Center for Forest Biotechnology) [2012-01560]; Knut & Alice Wallenberg foundation [2011.02.12]; Nils and Dorthi Troedsson Foundation [859/15]	Svenska Skogsplantor AB; Swedish Governmental Agency for Innovation Systems (VINNOVA; UPSC Berzelii Center for Forest Biotechnology); Knut & Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation); Nils and Dorthi Troedsson Foundation	This study was conducted within the 2nd Research School of Forest Genetics, Biotechnology and Breeding (http://resschool.slu.se/), Umea Plant Science Centre (UPSC) and Swedish University of Agricultural Sciences (SLU) Sweden, in collaboration with Svenska Skogsplantor AB (http://www.skogsplantor.se/). The work was financed by Svenska Skogsplantor AB, the Swedish Governmental Agency for Innovation Systems (VINNOVA; UPSC Berzelii Center for Forest Biotechnology 2012-01560; www2.vinnova.se; including support to U.E, T.M. and U.G.), grants awarded to T.M. (Knut & Alice Wallenberg foundation; 2011.02.12; kaw.wallenberg.org) and H.S. (Nils and Dorthi Troedsson Foundation; 859/15; www.troedssonfonden.se). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JD, 1997, PLANT CELL REP, V16, P411, DOI 10.1007/BF01146784; Bernard SM, 2009, NEW PHYTOL, V182, P608, DOI 10.1111/j.1469-8137.2009.02823.x; Bloom AJ, 1997, NITROGEN LIMITING FA; Bonga JM, 2010, PLANT CELL TISS ORG, V100, P241, DOI 10.1007/s11240-009-9647-2; BOZHKOV PV, 1993, J PLANT PHYSIOL, V142, P735, DOI 10.1016/S0176-1617(11)80911-9; BUCHMANN N, 1995, OECOLOGIA, V102, P361, DOI 10.1007/BF00329803; Canovas FM, 2007, J EXP BOT, V58, P2307, DOI 10.1093/jxb/erm051; Chalupa W, 1985, COMMUN I FOR CZECH R, V14, P57; de la Torre F, 2014, J EXP BOT, V65, P5527, DOI 10.1093/jxb/eru240; Dodeman VL, 1997, J EXP BOT, V48, P1493, DOI 10.1093/jexbot/48.313.1493; Filonova LH, 2000, J EXP BOT, V51, P249, DOI 10.1093/jexbot/51.343.249; Forde BG, 2007, J EXP BOT, V58, P2339, DOI 10.1093/jxb/erm121; Ganeteg U, 2017, PLANT CELL ENVIRON, V40, P413, DOI 10.1111/pce.12881; George E, 2008, PLANT PROPAGATION TI, V1; Gessler A, 1998, NEW PHYTOL, V138, P275, DOI 10.1046/j.1469-8137.1998.00107.x; GEZELIUS K, 1993, TREE PHYSIOL, V13, P71, DOI 10.1093/treephys/13.1.71; GOOD AG, 1989, PLANT PHYSIOL, V90, P1305, DOI 10.1104/pp.90.4.1305; Grossnickle S. C., 1996, Tree Planters' Notes, V47, P48; Gruffman L, 2014, TREE PHYSIOL, V34, P205, DOI 10.1093/treephys/tpt121; Gruffman L, 2013, TREE PHYSIOL, V33, P590, DOI 10.1093/treephys/tpt041; Gullberg J, 2004, ANAL BIOCHEM, V331, P283, DOI 10.1016/j.ab.2004.04.037; HAKMAN I, 1985, PLANT SCI, V38, P53, DOI 10.1016/0168-9452(85)90079-2; Hamasaki Regina M., 2005, Braz. J. Plant Physiol., V17, P383, DOI 10.1590/S1677-04202005000400006; Hirner A, 2006, PLANT CELL, V18, P1931, DOI 10.1105/tpc.106.041012; HRISTOFOROGLU K, 1995, PLANT CELL TISS ORG, V40, P277, DOI 10.1007/BF00048134; HUPPE HC, 1994, ANNU REV PLANT PHYS, V45, P577, DOI 10.1146/annurev.pp.45.060194.003045; Joy RW, 1997, J PLANT PHYSIOL, V151, P306, DOI 10.1016/S0176-1617(97)80257-X; KHLIFI S, 1995, PLANT CELL TISS ORG, V41, P23, DOI 10.1007/BF00124083; KIRBY EG, 1982, PHYSIOL PLANTARUM, V56, P114, DOI 10.1111/j.1399-3054.1982.tb04908.x; Krapp A, 2015, CURR OPIN PLANT BIOL, V25, P115, DOI 10.1016/j.pbi.2015.05.010; KROGSTRUP P, 1986, CAN J FOREST RES, V16, P664, DOI 10.1139/x86-116; Kronzucker HJ, 1996, PLANT PHYSIOL, V110, P773, DOI 10.1104/pp.110.3.773; Kronzucker HJ, 1997, NATURE, V385, P59, DOI 10.1038/385059a0; Lam HM, 1996, ANNU REV PLANT PHYS, V47, P569, DOI 10.1146/annurev.arplant.47.1.569; Lea PJ, 1999, BOOK SOIL P, P1; Lee YH, 2007, PLANT J, V50, P305, DOI 10.1111/j.1365-313X.2007.03045.x; Lelu-Walter MA, 2013, TREE GENET GENOMES, V9, P883, DOI 10.1007/s11295-013-0620-1; Li HX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01318; Limami AM, 2008, J EXP BOT, V59, P2325, DOI 10.1093/jxb/ern102; Limami AM, 2014, PLANTA, V239, P531, DOI 10.1007/s00425-013-2015-9; Malagoli M, 2000, PLANT SOIL, V221, P1, DOI 10.1023/A:1004720002898; MARSCHNER H, 1991, TREES-STRUCT FUNCT, V5, P14, DOI 10.1007/BF00225330; Metcalfe RJ, 2011, CAN J FOREST RES, V41, P1626, DOI [10.1139/X11-090, 10.1139/x11-090]; Michaeli S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00419; Miller BD, 2007, TREE PHYSIOL, V27, P901, DOI 10.1093/treephys/27.6.901; Miyashita Y, 2007, PLANT J, V49, P1108, DOI 10.1111/j.1365-313X.2006.03023.x; Narsai R, 2011, NEW PHYTOL, V190, P472, DOI 10.1111/j.1469-8137.2010.03589.x; Nasholm T, 2009, NEW PHYTOL, V182, P31, DOI 10.1111/j.1469-8137.2008.02751.x; Nehra NS, 2005, IN VITRO CELL DEV-PL, V41, P701, DOI 10.1079/IVP2005691; Nunes-Nesi A, 2010, MOL PLANT, V3, P973, DOI 10.1093/mp/ssq049; Ogita S, 2001, IN VITRO CELL DEV-PL, V37, P268, DOI 10.1007/s11627-001-0048-4; Ohlund J, 2004, TREE PHYSIOL, V24, P1397; Ohlund J, 2001, TREE PHYSIOL, V21, P1319, DOI 10.1093/treephys/21.18.1319; Park YS, 2002, ANN FOR SCI, V59, P651, DOI 10.1051/forest:2002051; Paungfoo-Lonhienne C, 2012, PLANT SOIL, V359, P1, DOI 10.1007/s11104-012-1357-6; Perchlik M, 2014, J EXP BOT, V65, P5193, DOI 10.1093/jxb/eru278; Persson J, 2003, OECOLOGIA, V137, P252, DOI 10.1007/s00442-003-1334-0; Persson J, 2001, ECOL LETT, V4, P434, DOI 10.1046/j.1461-0248.2001.00260.x; Persson J, 2006, J EXP BOT, V57, P2651, DOI 10.1093/jxb/erl028; PINTO ACQ, 1993, IN VITRO CELL DEV-PL, V29P, P55, DOI 10.1007/BF02632252; Pullman GS, 2016, NEW FOREST, V47, P453, DOI 10.1007/s11056-016-9525-9; Pullman GS, 2014, NEW FOREST, V45, P353, DOI 10.1007/s11056-014-9407-y; Schmidt S, 1999, AUST J PLANT PHYSIOL, V26, P253, DOI 10.1071/PP98116; Shelp BJ, 1999, TRENDS PLANT SCI, V4, P446, DOI 10.1016/S1360-1385(99)01486-7; SIMOLA LK, 1990, PHYSIOL PLANTARUM, V80, P27; Svennerstam H, 2008, NEW PHYTOL, V180, P620, DOI 10.1111/j.1469-8137.2008.02589.x; Svennerstam H, 2011, NEW PHYTOL, V191, P459, DOI 10.1111/j.1469-8137.2011.03699.x; Vasudevan A, 2004, BIOL PLANTARUM, V48, P125, DOI 10.1023/B:BIOP.0000024288.82679.50; von Arnold S, 2002, PLANT CELL TISS ORG, V69, P233, DOI 10.1023/A:1015673200621; VONARNOLD S, 1981, CAN J BOT, V59, P870, DOI 10.1139/b81-121; WIJK CK, 1993, PLANT SOIL, V151, P91	71	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181785	10.1371/journal.pone.0181785	http://dx.doi.org/10.1371/journal.pone.0181785			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837647	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000012
J	Hsu, WT; Lai, CC; Wang, YH; Tseng, PH; Wang, K; Wang, CY; Chen, LK				Hsu, Wan-Tseng; Lai, Chih-Cheng; Wang, Ya-Hui; Tseng, Ping-Huei; Wang, Kun; Wang, Cheng-Yi; Chen, Likwang			Risk of pneumonia in patients with gastroesophageal reflux disease: A population-based cohort study	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; PROTON PUMP INHIBITORS; METAANALYSIS; OMEPRAZOLE; DRUGS	Purpose The prevalence of gastroesophagel reflux disease (GERD) has steadily increased. However, the association between GERD itself and the risk of pneumonia remains unclear. This study aimed to investigate the association between GERD and long-term risk of pneumonia and to identify the major risk factors for pneumonia in GERD patients. Methods Using the Taiwan National Health Insurance Research Database, we identified patients who were newly diagnosed with GERD and treated with proton pump inhibitors (PPIs) from January 1, 2004 through December 31, 2010. Two groups comprising 15,715 GERD cases and 15,715 non-GERD matched controls were generated using propensity score matching, thereby making the differences in basic demographics, concomitant medication use, and comorbidities between the two groups inconsiderable. Results Cumulative incidence of pneumonia was significantly higher in the patients with GERD than that in the non-GERD matched controls, with an adjusted HR of 1.48 (95% confidence interval [CI] = 1.31-1.67; P < 0.001) within 6-year follow-ups. Multivariate stratified analyses revealed similar results in many subgroups, with a highest risk in individuals younger than 40 years of age (HR = 2.17, 95% CI = 1.48-3.19). Crucially, patients with GERD using PPIs longer than 4 months were at a significantly increased risk of pneumonia than those who did not use PPIs or took PPIs less than 4 months. Conclusions GERD was significantly associated with long-term risk of pneumonia, especially in GERD with PPI use longer than 4 months or in the young population. Further prospective longitudinal studies should be conducted for validation and implementing clinical practice guidelines.	[Hsu, Wan-Tseng] Natl Taiwan Univ, Sch Pharm, Taipei, Taiwan; [Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan; [Wang, Ya-Hui] Fu Jen Catholic Univ, Med Res Ctr, Cardinal Tien Hosp, Coll Med, New Taipei, Taiwan; [Wang, Ya-Hui; Wang, Kun; Wang, Cheng-Yi] Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan; [Tseng, Ping-Huei] Natl Taiwan Univ Hosp, Dept Internal Med, Coll Med, Taipei, Taiwan; [Wang, Kun; Wang, Cheng-Yi] Fu Jen Catholic Univ, Dept Internal Med, Cardinal Tien Hosp, New Taipei, Taiwan; [Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan, Miaoli County, Taiwan	National Taiwan University; Chi Mei Hospital; Fu Jen Catholic University; Fu Jen Catholic University; National Taiwan University; National Taiwan University Hospital; Fu Jen Catholic University; National Health Research Institutes - Taiwan	Wang, K (corresponding author), Fu Jen Catholic Univ, Sch Med, Coll Med, New Taipei, Taiwan.; Wang, K (corresponding author), Fu Jen Catholic Univ, Dept Internal Med, Cardinal Tien Hosp, New Taipei, Taiwan.	kunwang@mospital.com	Tseng, Ping-Huei/GZA-8772-2022	TSENG, PING-HUEI/0000-0002-7483-7538; Hsu, Wan-Tseng/0000-0001-6358-999X	National Health Research Institutes;  [CTH 106A-2603]	National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan); 	This study was supported by grants CTH 106A-2603 (Dr. Kun Wang, Cardinal Tien Hospital, Taiwan) and National Health Research Institutes (Dr. Likwang Chen, intramural funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin PC, 2017, STAT METHODS MED RES, V26, P201, DOI 10.1177/0962280214543508; AYBAY C, 1995, GEN PHARMACOL-VASC S, V26, P1413, DOI 10.1016/0306-3623(94)00301-3; Chao CT, 2014, J CANCER RES CLIN, V140, P613, DOI 10.1007/s00432-014-1600-z; El-Serag HB, 2014, GUT, V63, P871, DOI 10.1136/gutjnl-2012-304269; Eom CS, 2011, CAN MED ASSOC J, V183, P310, DOI 10.1503/cmaj.092129; Filion KB, 2014, GUT, V63, P552, DOI 10.1136/gutjnl-2013-304738; Giuliano C, 2012, EXPERT REV CLIN PHAR, V5, P337, DOI [10.1586/ECP.12.20, 10.1586/ecp.12.20]; Gulmez SE, 2007, ARCH INTERN MED, V167, P950, DOI 10.1001/archinte.167.9.950; Ho SW, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001227; Ho SW, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-006710; Johnstone J, 2010, ALIMENT PHARM THER, V31, P1165, DOI 10.1111/j.1365-2036.2010.04284.x; Laheij RJF, 2004, JAMA-J AM MED ASSOC, V292, P1955, DOI 10.1001/jama.292.16.1955; Lee Shou-Wu, 2015, J Clin Med Res, V7, P880, DOI 10.14740/jocmr2322w; Lee SW, 2015, J RES MED SCI, V20, P263; Morehead RS, 2009, EUR RESPIR REV, V18, P233, DOI 10.1183/09059180.00002509; Perng DW, 2007, CHEST, V132, P1548, DOI 10.1378/chest.07-1373; Sarkar M, 2008, ANN INTERN MED, V149, P391, DOI 10.7326/0003-4819-149-6-200809160-00005; Scaringi L, 1996, SCAND J IMMUNOL, V44, P204, DOI 10.1046/j.1365-3083.1996.d01-300.x; Shih CJ, 2014, INT J CARDIOL, V177, P292, DOI 10.1016/j.ijcard.2014.09.036; Vakil N, 2009, AM J GASTROENTEROL, V104, pS17, DOI 10.1038/ajg.2009.47; Yoshida N, 2000, ALIMENT PHARM THERAP, V14, P74, DOI 10.1046/j.1365-2036.2000.014s1074.x	21	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183808	10.1371/journal.pone.0183808	http://dx.doi.org/10.1371/journal.pone.0183808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837700	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000126
J	Kim, J; Kim, KH; Lee, BJ				Kim, Jihye; Kim, Keun Ho; Lee, Bum Ju			Association of peptic ulcer disease with obesity, nutritional components, and blood parameters in the Korean population	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; NATIONAL-HEALTH; DUODENAL-ULCER; GASTRIC-ULCER; UNITED-STATES; RISK-FACTORS; MEN; LIFE; AGE; ERADICATION	Objectives Peptic ulcer disease (PUD) is a common disorder, but whether an association exists between PUD and anthropometric indicators remains controversial. Furthermore, no studies on the association of PUD with anthropometric indices, blood parameters, and nutritional components have been reported. The aim of this study was to assess associations of anthropometrics, blood parameters, nutritional components, and lifestyle factors with PUD in the Korean population. Methods Data were collected from a nationally representative sample of the South Korean population using the Korea National Health and Nutrition Examination Survey. Logistic regression was used to examine associations of anthropometrics, blood parameters and nutritional components among patients with PUD. Results Age was the factor most strongly associated with PUD in women (p = < 0.0001, odds ratio (OR) = 0.770 [0.683-0.869]) and men (p = < 0.0001, OR = 0.715 [0.616-0.831]). In both crude and adjusted analyses, PUD was highly associated with weight (adjusted p = 0.0008, adjusted OR = 1.251 [95% CI: 1.098-1.426]), hip circumference (adjusted p = 0.005, adjusted OR = 1.198 [1.056-1.360]), and body mass index (adjusted p = 0.0001, adjusted OR = 1.303 [1.139-1.490]) in women and hip circumference (adjusted p = 0.0199, adjusted OR = 1.217 [1.031-1.435]) in men. PUD was significantly associated with intake of fiber (adjusted p = 0.0386, adjusted OR = 1.157 [1.008-1.328], vitamin B2 (adjusted p = 0.0477, adjusted OR = 1.155 [1.001-1.333]), sodium (adjusted p = 0.0154, adjusted OR = 1.191 [1.034-1.372]), calcium (adjusted p = 0.0079, adjusted OR = 1.243 [1.059-1.459]), and ash (adjusted p = 0.0468, adjusted OR = 1.152 [1.002-1.325] in women but not in men. None of the assessed blood parameters were associated with PUD in women, and only triglyceride level was associated with PUD in men (adjusted p = 0.0169, adjusted OR = 1.227 [1.037-1.451]). Discussion We found that obesity was associated with PUD in the Korean population; additionally, the association between nutritional components and PUD was greater in women than in men.	[Kim, Jihye; Kim, Keun Ho; Lee, Bum Ju] Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM)	Lee, BJ (corresponding author), Korea Inst Oriental Med, KM Fundamental Res Div, Daejeon, South Korea.	bjlee@kiom.re.kr		Kim, Jihye/0000-0003-3534-9627; Lee, Bum Ju/0000-0003-2682-5716	technology innovation program - Ministry of Trade, Industry & Energy, Republic of Korea [MOTIE 100060251, D16330]	technology innovation program - Ministry of Trade, Industry & Energy, Republic of Korea	This work was supported by a technology innovation program funded by the Ministry of Trade, Industry & Energy, Republic of Korea (MOTIE 100060251, D16330).	Aditi A, 2012, DIGEST DIS SCI, V57, P2504, DOI 10.1007/s10620-012-2203-7; Aldoori WH, 1997, AM J EPIDEMIOL, V145, P42, DOI 10.1093/oxfordjournals.aje.a009030; Anderson JW, 2009, NUTR REV, V67, P188, DOI 10.1111/j.1753-4887.2009.00189.x; Aro P, 2006, AM J EPIDEMIOL, V163, P1025, DOI 10.1093/aje/kwj129; Bae SJ, 2010, HLTH INSURANCE REV A; BLANCO CD, 1993, GASTROINTEST ENDOSC, V39, P50, DOI 10.1016/S0016-5107(93)70010-3; BLASER MJ, 1995, CANCER RES, V55, P562; Boylan MR, 2014, CLIN GASTROENTEROL H, V12, P1688, DOI 10.1016/j.cgh.2014.03.021; Brambilla P, 2006, INT J OBESITY, V30, P23, DOI 10.1038/sj.ijo.0803163; Cheng Y, 2000, WESTERN J MED, V173, P101, DOI 10.1136/ewjm.173.2.101; Deding U, 2016, BMC GASTROENTEROL, V16, DOI 10.1186/s12876-016-0554-9; El-Serag HB, 2005, GUT, V54, P11, DOI 10.1136/gut.2004.040337; Everhart JE, 1998, AM J EPIDEMIOL, V147, P529; Jones MP, 2006, J PSYCHOSOM RES, V60, P407, DOI 10.1016/j.jpsychores.2005.08.009; Kalichman L, 2006, AM J HUM BIOL, V18, P350, DOI 10.1002/ajhb.20506; Ko GTC, 1999, INT J OBESITY, V23, P1136, DOI 10.1038/sj.ijo.0801043; Ko SH, 2016, SCI REP-UK, V6, DOI 10.1038/srep36925; Korea Centers for Disease Control and Prevention, 2 4 KOR NAT HLTH NUT, P2001; Korea Centers for Disease Control and Prevention, 2010, 5 6 4 KOR NAT HLTH N; Kurata JH, 1997, J CLIN GASTROENTEROL, V24, P2, DOI 10.1097/00004836-199701000-00002; Kuri-Morales P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-9; Kweon S, 2014, INT J EPIDEMIOL, V43, P69, DOI 10.1093/ije/dyt228; Lee BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165622; Lee BJ, 2015, IEEE J BIOMED HEALTH, V19, P1747, DOI 10.1109/JBHI.2014.2350014; Lee BJ, 2015, COMPUT BIOL MED, V57, P201, DOI 10.1016/j.compbiomed.2014.12.005; Lee BJ, 2014, IEEE J BIOMED HEALTH, V18, P555, DOI 10.1109/JBHI.2013.2264509; Lee BJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084897; Levenstein S, 1998, BRIT MED J, V316, P538, DOI 10.1136/bmj.316.7130.538; Malfertheiner P, 2000, BEST PRACT RES CL GA, V14, P119, DOI 10.1053/bega.1999.0063; Malfertheiner P, 2009, LANCET, V374, P1449, DOI 10.1016/S0140-6736(09)60938-7; Ministry of Health and Social Welfare National Health and Nutrition Survey, REP 1998 1 NAT HLTH; Miyake K, 2013, J NUTR SCI VITAMINOL, V59, P503, DOI 10.3177/jnsv.59.503; NOMURA A, 1994, ANN INTERN MED, V120, P977, DOI 10.7326/0003-4819-120-12-199406150-00001; Park HS, 2007, DIABETES OBES METAB, V9, P50, DOI 10.1111/j.1463-1326.2005.00569.x; RAUWS EAJ, 1990, LANCET, V335, P1233, DOI 10.1016/0140-6736(90)91301-P; Raybould HE, 2012, J PHYSIOL-LONDON, V590, P441, DOI 10.1113/jphysiol.2011.222133; Rosmond R, 1996, OBES RES, V4, P245, DOI 10.1002/j.1550-8528.1996.tb00542.x; Ryan-Harshman M, 2004, CAN FAM PHYSICIAN, V50, P727; SCHOON IM, 1991, AGE AGEING, V20, P371, DOI 10.1093/ageing/20.5.371; SEGAWA K, 1995, AM J GASTROENTEROL, V90, P399; Sonnenberg A, 1996, AM J PUBLIC HEALTH, V86, P200, DOI 10.2105/AJPH.86.2.200; SONNENBERG A, 1988, GASTROENTEROLOGY, V95, P42, DOI 10.1016/0016-5085(88)90288-0; TAYLOR DN, 1991, EPIDEMIOL REV, V13, P42, DOI 10.1093/oxfordjournals.epirev.a036078; Torpy J. M., 2012, PEPTIC ULCER DIS J A, V307, P1329, DOI DOI 10.1001/JAMA.2012.184; Tsai WL, 2004, AM J EPIDEMIOL, V160, P557, DOI 10.1093/aje/kwh251; WEATHERALL R, 1988, EUR J CLIN NUTR, V42, P221; Wu AH, 2007, CANCER CAUSE CONTROL, V18, P713, DOI 10.1007/s10552-007-9014-8; Yun S, 2017, NUTR RES PRACT, V11, P147, DOI 10.4162/nrp.2017.11.2.147	48	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183777	10.1371/journal.pone.0183777	http://dx.doi.org/10.1371/journal.pone.0183777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837684	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000120
J	Ros-Santaella, JL; Pintus, E				Ros-Santaella, Jose Luis; Pintus, Eliana			Rooibos (Aspalathus linearis) extract enhances boar sperm velocity up to 96 hours of semen storage	PLOS ONE			English	Article							TEA CAMELLIA-SINENSIS; AFRICAN HERBAL TEAS; OXIDATIVE STRESS; SPERMATOZOA; QUERCETIN; MOTILITY; GREEN; SUPPLEMENTS; FERTILITY; CAPACITY	Rooibos (Aspalathus linearis) is a native shrub from South African fynbos and has become very popular in the last decades for its antioxidant and medicinal attributes. Several studies have shown its beneficial properties in numerous cell lines, but to date, the in vitro effects of rooibos extract on sperm cells are still unknown. In this study, boar semen was supplemented with four concentrations both of fermented and unfermented rooibos extracts during 96 h of liquid storage at 17 degrees C. The effects of rooibos extracts on sperm velocity, membrane integrity, and acrosomal status were evaluated at 2 h, 48 h, and 96 h of semen storage. Overall our results indicate that rooibos extract enhances sperm velocity, protects the acrosome structure, and tends to preserve the membrane integrity during semen storage. Although the unfermented rooibos showed higher total polyphenol content and total antioxidant capacity than the fermented one, the latter had better effects on sperm velocity leading to, for instance, an increase of 30% in the rectilinear velocity (VSL) at 48 h compared to the control group. Taking into account the different storage times, we established a suitable range of extracts concentrations to be used in boar semen. The rooibos extract ought to be considered as a powerful and natural source of antioxidants for the preservation of boar semen.	[Ros-Santaella, Jose Luis; Pintus, Eliana] Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic	Czech University of Life Sciences Prague	Ros-Santaella, JL; Pintus, E (corresponding author), Czech Univ Life Sci Prague, Fac Agrobiol Food & Nat Resources, Dept Vet Sci, Prague, Czech Republic.	rossantaella@gmail.com; eliana.pintus27@gmail.com	Ros-Santaella, José Luis/F-9890-2019; Pintus, Eliana/AAF-8383-2021	Ros-Santaella, José Luis/0000-0002-4186-7730; Pintus, Eliana/0000-0002-8496-0820				Aitken RJ, 2012, J ANDROL, V33, P1096, DOI 10.2164/jandrol.112.016535; Awda BJ, 2009, BIOL REPROD, V81, P553, DOI 10.1095/biolreprod.109.076471; Awoniyi DO, 2011, AFR J BIOTECHNOL, V10, P17317, DOI 10.5897/AJB11.2210; Awoniyi DO, 2012, PHYTOTHER RES, V26, P1231, DOI 10.1002/ptr.3717; Birck A, 2010, THERIOGENOLOGY, V73, P1180, DOI 10.1016/j.theriogenology.2009.10.010; Bramati L, 2003, J AGR FOOD CHEM, V51, P7472, DOI 10.1021/jf0347721; Brouwers JF, 2005, THERIOGENOLOGY, V63, P458, DOI 10.1016/j.theriogenology.2004.09.046; Chan PJ, 1996, ARCH ANDROLOGY, V36, P25, DOI 10.3109/01485019608987881; CHENEY RALPH H., 1963, ECON BOT, V17, P186, DOI 10.1007/BF02859435; Comizzoli P, 2001, THERIOGENOLOGY, V56, P261, DOI 10.1016/S0093-691X(01)00561-1; DELAMIRANDE E, 1995, HUM REPROD, V10, P15, DOI 10.1093/humrep/10.suppl_1.15; Dludla PV, 2014, PHYTOMEDICINE, V21, P595, DOI 10.1016/j.phymed.2013.10.029; Erel O, 2004, CLIN BIOCHEM, V37, P277, DOI 10.1016/j.clinbiochem.2003.11.015; Hernandez-Caravaca I, 2015, THERIOGENOLOGY, V83, P655, DOI 10.1016/j.theriogenology.2014.10.032; Hernandez-Caravaca I, 2012, ANIM REPROD SCI, V136, P14, DOI 10.1016/j.anireprosci.2012.10.007; Holt C, 1997, J ANDROL, V18, P312; Johinke D, 2014, ANIM REPROD SCI, V151, P208, DOI 10.1016/j.anireprosci.2014.10.017; Johnson LA, 2000, ANIM REPROD SCI, V62, P143, DOI 10.1016/S0378-4320(00)00157-3; Joubert E, 2008, J ETHNOPHARMACOL, V119, P376, DOI 10.1016/j.jep.2008.06.014; Joubert E, 2004, FOOD RES INT, V37, P133, DOI 10.1016/j.foodres.2003.09.011; Joubert E, 2011, S AFR J BOT, V77, P869, DOI 10.1016/j.sajb.2011.07.004; Koziorowska-Gilun M, 2011, REPROD DOMEST ANIM, V46, P527, DOI 10.1111/j.1439-0531.2010.01701.x; Magcwebeba TU, 2016, J PHARM PHARMACOL, V68, P1440, DOI 10.1111/jphp.12629; Malo C, 2010, CRYOBIOLOGY, V61, P142, DOI 10.1016/j.cryobiol.2010.06.009; Marnewick J, 2005, CANCER LETT, V224, P193, DOI 10.1016/j.canlet.2004.11.014; Matthijs A, 2000, J REPROD FERTIL, V120, P265, DOI 10.1530/reprod/120.2.265; McKay DL, 2007, PHYTOTHER RES, V21, P1, DOI 10.1002/ptr.1992; Monsees TK, 2017, S AFR J BOT, V110, P208, DOI 10.1016/j.sajb.2016.11.013; Moretti E, 2012, REPROD TOXICOL, V34, P651, DOI 10.1016/j.reprotox.2012.10.002; Nash LA, 2016, FOOD FUNCT, V7, P1166, DOI [10.1039/C5FO01222H, 10.1039/c5fo01222h]; Opuwari CS, 2015, ANDROLOGIA, V47, P52, DOI 10.1111/and.12221; Opuwari CS, 2014, ANDROLOGIA, V46, P867, DOI 10.1111/and.12158; Parrilla I, 2015, SCI REP, V5; PURSEL VG, 1972, J ANIM SCI, V34, P278; Schmidt H, 2004, REPRODUCTION, V128, P171, DOI 10.1530/rep.1.00153; Schroer SC, 2000, ZYGOTE, V8, P107, DOI 10.1017/S0967199400000885; Sikka SC, 2004, J ANDROL, V25, P5; Singleton VL., 1965, AM J ENOL VITICULT, V16, P144, DOI DOI 10.12691/IJEBB-2-1-5; Tvrda E, 2016, REPROD DOMEST ANIM, V51, P524, DOI 10.1111/rda.12714; Yeste M, 2017, ANIM REPROD, V14, P69, DOI 10.21451/1984-3143-AR895; Yeste M, 2016, THERIOGENOLOGY, V85, P47, DOI 10.1016/j.theriogenology.2015.09.047	41	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183682	10.1371/journal.pone.0183682	http://dx.doi.org/10.1371/journal.pone.0183682			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837611	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000101
J	Barcelo-Coblijn, L; Salazar, DS; Isaza, G; Ossa, LFC; Bedia, MG				Barcelo-Coblijn, Lluis; Serna Salazar, Diego; Isaza, Gustavo; Castillo Ossa, Luis F.; Bedia, Manuel G.			Netlang: A software for the linguistic analysis of corpora by means of complex networks	PLOS ONE			English	Article							DEVELOPMENTAL LANGUAGE DISORDERS; SYNTACTIC DEVELOPMENT; HEARING IMPAIRMENT; CHILDREN	To date there is no software that directly connects the linguistic analysis of a conversation to a network program. Networks programs are able to extract statistical information from data basis with information about systems of interacting elements. Language has also been conceived and studied as a complex system. However, most proposals do not analyze language according to linguistic theory, but use instead computational systems that should save time at the price of leaving aside many crucial aspects for linguistic theory. Some approaches to network studies on language do apply precise linguistic analyses, made by a linguist. The problem until now has been the lack of interface between the analysis of a sentence and its integration into the network that could be managed by a linguist and that could save the analysis of any language. Previous works have used old software that was not created for these purposes and that often produced problems with some idiosyncrasies of the target language. The desired interface should be able to deal with the syntactic peculiarities of a particular language, the options of linguistic theory preferred by the user and the preservation of morpho-syntactic information (lexical categories and syntactic relations between items). Netlang is the first program able to do that. Recently, a new kind of linguistic analysis has been developed, which is able to extract a complexity pattern from the speaker's linguistic production which is depicted as a network where words are inside nodes, and these nodes connect each other by means of edges or links (the information inside the edge can be syntactic, semantic, etc.). The Netlang software has become the bridge between rough linguistic data and the network program. Netlang has integrated and improved the functions of programs used in the past, namely the DGA annotator and two scripts (ToXML. pl and Xml2Pairs. py) used for transforming and pruning data. Netlang allows the researcher to make accurate linguistic analysis by means of syntactic dependency relations between words, while tracking record of the nature of such syntactic relationships (subject, object, etc). The Netlang software is presented as a new tool that solve many problems detected in the past. The most important improvement is that Netlang integrates three past applications into one program, and is able to produce a series of file formats that can be read by a network program. Through the Netlang software, the linguistic network analysis based on syntactic analyses, characterized for its low cost and the completely non-invasive procedure aims to evolve into a sufficiently fine grained tool for clinical diagnosis in potential cases of language disorders.	[Barcelo-Coblijn, Lluis] Univ Balearic Isl, Dept Catalan Philol & Gen Linguist, Palma De Mallorca, Balearic Island, Spain; [Serna Salazar, Diego; Isaza, Gustavo; Castillo Ossa, Luis F.] Univ Caldas, Dept Sistemas & Informat, Manizales, Caldas, Colombia; [Castillo Ossa, Luis F.] Univ Nacl Colombia, Dept Ingn Ind, Sede Manizales, Caldas, Colombia; [Bedia, Manuel G.] Univ Zaragoza, Dept Comp Sci & Syst, Zaragoza, Aragon, Spain; [Barcelo-Coblijn, Lluis] Cra Valldemossa Km 7,5, Palma De Mallorca, Mallorca, Spain; [Isaza, Gustavo; Castillo Ossa, Luis F.] Cl 65 26-10, Manizales, Caldas, Colombia; [Castillo Ossa, Luis F.] Carrera 27 64-60, Manizales, Caldas, Colombia; [Bedia, Manuel G.] Calle Pedro Cerbuna 12, Zaragoza, Spain	Universitat de les Illes Balears; Universidad de Caldas; Universidad Nacional de Colombia; University of Zaragoza	Barcelo-Coblijn, L (corresponding author), Univ Balearic Isl, Dept Catalan Philol & Gen Linguist, Palma De Mallorca, Balearic Island, Spain.; Barcelo-Coblijn, L (corresponding author), Cra Valldemossa Km 7,5, Palma De Mallorca, Mallorca, Spain.	lluis.barcelo@uib.cat	Barceló-Coblijn, Lluís/L-1054-2019	Barceló-Coblijn, Lluís/0000-0002-8765-6314; Isaza, Gustavo/0000-0002-1089-4605; Castillo Ossa, Luis Fernando/0000-0002-2878-8229	Spanish National Programme for Fostering Excellence in Scientific and Technical Research [PSI2014-62092-EXP]; Spanish Ministry of Economy and Competitiveness [TIN2011-24660, TIN2016-80347-R]	Spanish National Programme for Fostering Excellence in Scientific and Technical Research; Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work has been supperted by the grants PSI2014-62092-EXP from the Spanish National Programme for Fostering Excellence in Scientific and Technical Researchand and TIN2011-24660 from the Spanish Ministry of Economy and Competitiveness. There was no additional external funding received for this study.; This work has been supported by the Spanish National Programme for Fostering Excellence in Scientific and Technical Research project PSI2014-62092-EXP and by the project TIN2016-80347-R funded by the Spanish Ministry of Economy and Competitiveness.	Abbeduto L, 2007, MENT RETARD DEV D R, V13, P247, DOI 10.1002/mrdd.20158; Abney Steven., 1987, ENGLISH NOUN PHRASE; Arbesman S, 2010, INT J BIFURCAT CHAOS, V20, P679, DOI 10.1142/S021812741002596X; Baker MC, 2005, INNATE MIND STRUCTUR, P156, DOI DOI 10.1093/ACPROF:OSO/9780195179675.003.0010; Barcelo-Coblijn L, APPL COMPLE IN PRESS; Barcelo-Coblijn L, 2015, BIOLINGUISTICS, V9, P43; Barcelo-Coblijn L, 2012, ADAPT BEHAV, V20, P427, DOI 10.1177/1059712312455439; Bastian M, 2009, P INT AAAI C WEB SOC, V2009, P361, DOI 10.13140/2.1.1341.1520; Beckage N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019348; Bedi G, 2015, NPJ SCHIZOPHR, V1, DOI 10.1038/npjschz.2015.30; Benitez-Burraco A, 2016, J COMMUN DISORD, V60, P51, DOI 10.1016/j.jcomdis.2016.03.001; Bernstein JB, 2008, HDB CONT SYNTACTIC T, P536; BOL G, 1990, CLIN LINGUIST PHONET, V4, P77, DOI 10.3109/02699209008985472; Bol GW, 2009, CLIN LINGUIST PHONET, V23, P631, DOI 10.1080/02699200902995677; Brown R., 1973, 1 LANGUAGE EARLY STA; Cancho RFI, 2001, P ROY SOC B-BIOL SCI, V268, P2261, DOI 10.1098/rspb.2001.1800; Chomsky N., 1975, REFLECTIONS LANGUAGE; Corominas-Murtra B, 2007, NETWORK STAT EARLY E; Corominas-Murtra B, 2009, ADV COMPLEX SYST, V12, P371, DOI 10.1142/S0219525909002192; Deuchar Margaret, 2000, BILINGUAL ACQUISITIO; FELDMAN H, 1989, TOP EARLY CHILD SPEC, V9, P32, DOI 10.1177/027112148900900104; Goodglass H., 1976, HDB PERCEPTIONVOL 7, P389; Hudson R., 1990, ENGLISH WORD GRAMMAR; Kolb B., 2003, FUNDAMENTALS HUMAN N; Kyle K, 2015, TESOL QUART, V49, P757, DOI 10.1002/tesq.194; Lenneberg, 1967, BIOL FDN LANGUAGE, DOI 10.1080/21548331.1967.11707799; Leonard LB, 2003, J SPEECH LANG HEAR R, V46, P878, DOI 10.1044/1092-4388(2003/068); LONGOBARDI G, 1994, LINGUIST INQ, V25, P609; Longobardi G, 2001, HDB CONT SYNTACTIC T, P562, DOI DOI 10.1002/9780470756416.CH18; MacWhinney B., 2000, CHILDES PROJECT, V2; Mehler J, 1974, CONNAITRE DESSAPRENT, P25; Ninio A, 2014, PHYS LIFE REV, V11, P632, DOI 10.1016/j.plrev.2014.05.004; PIATTELLIPALMARINI M, 1989, COGNITION, V31, P1, DOI 10.1016/0010-0277(89)90016-4; Poeppel D, 2004, COGNITION, V92, P1, DOI 10.1016/j.cognition.2003.11.001; Popescu M., 2003, BUILDING AWARENESS L, P17; Rice ML, 2010, J SPEECH LANG HEAR R, V53, P333, DOI 10.1044/1092-4388(2009/08-0183); Roberts JE, 2007, MENT RETARD DEV D R, V13, P26, DOI 10.1002/mrdd.20136; Rollins P., 1996, FIRST LANG, V16, P243, DOI [DOI 10.1177/014272379601604705, 10.1177/014272379601604705]; Sagae K, 2010, J CHILD LANG, V37, P705, DOI 10.1017/S0305000909990407; SCARBOROUGH HS, 1990, APPL PSYCHOLINGUIST, V11, P1, DOI 10.1017/S0142716400008262; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; STOWELL T, 1989, ALTERNATIVE CONCEPTIONS OF PHRASE STRUCTURE, P232; Tomasello M., 2005, CONSTRUCTING LANGUAG; Vitevitch MS, 2008, J SPEECH LANG HEAR R, V51, P408, DOI 10.1044/1092-4388(2008/030); Vitevitch MS, 2015, INT J SPEECH-LANG PA, V17, P13, DOI 10.3109/17549507.2014.987819; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zamparelli R, 2014, LAYERS DETERMINER PH; Zweig KA, 2016, THEORETICAL FRAMEWOR, P153	48	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181341	10.1371/journal.pone.0181341	http://dx.doi.org/10.1371/journal.pone.0181341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832598	Green Published, gold			2022-12-27	WOS:000408355800003
J	Maij, DLR; van Harreveld, F; Gervais, W; Schrag, Y; Mohr, C; van Elk, M				Maij, David. L. R.; van Harreveld, Frenk; Gervais, Will; Schrag, Yann; Mohr, Christine; van Elk, Michiel			Mentalizing skills do not differentiate believers from non-believers, but credibility enhancing displays do	PLOS ONE			English	Article							EXPLAIN RELIGIOUS BELIEF; HIGH-FUNCTIONING AUTISM; NORMAL SEX-DIFFERENCES; SPECTRUM QUOTIENT AQ; PARANORMAL BELIEF; EMPATHY QUOTIENT; SYSTEMATIZING QUOTIENT; ASPERGER-SYNDROME; MIND PERCEPTION; BRAIN	The ability to mentalize has been marked as an important cognitive mechanism enabling belief in supernatural agents. In five studies we cross-culturally investigated the relationship between mentalizing and belief in supernatural agents with large sample sizes (over 67,000 participants in total) and different operationalizations of mentalizing. The relative importance of mentalizing for endorsing supernatural beliefs was directly compared with credibility enhancing displays-the extent to which people observed credible religious acts during their upbringing. We also compared autistic with neurotypical adolescents. The empathy quotient and the autism-spectrum quotient were not predictive of belief in supernatural agents in all countries (i.e., The Netherlands, Switzerland and the United States), although we did observe a curvilinear effect in the United States. We further observed a strong influence of credibility enhancing displays on belief in supernatural agents. These findings highlight the importance of cultural learning for acquiring supernatural beliefs and ask for reconsiderations of the importance of mentalizing.	[Maij, David. L. R.; van Harreveld, Frenk; van Elk, Michiel] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Gervais, Will] Univ Kentucky, Dept Psychol, Lexington, KY 40506 USA; [Schrag, Yann; Mohr, Christine] Univ Lausanne, Inst Psychol, Lausanne, Switzerland	University of Amsterdam; University of Kentucky; University of Lausanne	Maij, DLR (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.	d.l.r.maij@uva.nl		Mohr, Christine/0000-0002-3720-7115	Netherlands Organization for Scientific Research (NWO) [016.135.135]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was funded by a grant from the Netherlands Organization for Scientific Research (NWO: VENI Grant No. 016.135.135).; In loving memory of Joop van der Pligt, who was co-initiator of the study. We sincerely thank Quest, Tom Cuijpers of the Heer Bokel College, Henk May of the Wolfert van Borselen and all participants for making this study possible. This study was funded by a grant from the Netherlands Organization for Scientific Research (NWO: VENI Grant No. 016.135.135).	Atran S, 2004, BEHAV BRAIN SCI, V27, P713, DOI 10.1017/S0140525X04000172; Atran S., 2002, NEUROTHEOLOGY BRAIN, P163; Badcock C, 2004, EVOLUTIONARY PSYCHOLOGY, PUBLIC POLICY AND PERSONAL DECISIONS, P99; Badcock C., 2009, IMPRINTED BRAIN GENE; Baron-Cohen S, 2003, PHILOS T ROY SOC B, V358, P361, DOI 10.1098/rstb.2002.1206; Baron-Cohen S, 2001, J AUTISM DEV DISORD, V31, P5, DOI 10.1023/A:1005653411471; Baron-Cohen S, 2004, J AUTISM DEV DISORD, V34, P163, DOI 10.1023/B:JADD.0000022607.19833.00; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 1997, MINDBLINDNESS ESSAY; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Bering J., 2002, J COGN CULT, V2, P263, DOI DOI 10.1163/15685370260441008; Bering JM, 2006, BEHAV BRAIN SCI, V29, P453, DOI 10.1017/S0140525X06009101; Bering JM, 2002, REV GEN PSYCHOL, V6, P3, DOI 10.1037//1089-2680.6.1.3; Bloom P, 2007, DEVELOPMENTAL SCI, V10, P147, DOI 10.1111/j.1467-7687.2007.00577.x; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Boyer P, 2003, TRENDS COGN SCI, V7, P119, DOI 10.1016/S1364-6613(03)00031-7; Braun C., 2012, EXPLAINING GLOBAL SE, P1; Brezis RS, 2012, ENCULTURED BRAIN: AN INTRODUCTION TO NEUROANTHROPOLOGY, P291; Broekhof E, 2015, J AUTISM DEV DISORD, V45, P2035, DOI 10.1007/s10803-015-2363-3; Bulbulia J, 2004, BIOL PHILOS, V19, P655, DOI 10.1007/s10539-005-5568-6; Caldwell-Harris C, 2011, RELIG BELIEF SYSTEMS; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Coleman T. J., 2016, SOCIAL BRAIN HUMAN R; Crespi B, 2008, BEHAV BRAIN SCI, V31, P241, DOI 10.1017/S0140525X08004214; De Corte K, 2006, AUTHORIZED DUT UNPUB; Deeley Q., 2009, J RELIG DISABILITY H, V13, P77, DOI [10.1080/15228960802581479, DOI 10.1080/15228960802581479]; Deeley Q, 2004, ANTHROPOL MED, V11, P245; Epley N, 2009, P NATL ACAD SCI USA, V106, P21533, DOI 10.1073/pnas.0908374106; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Ge JQ, 2009, HUM BRAIN MAPP, V30, P4012, DOI 10.1002/hbm.20825; Geertz AW, 2010, METH THEORY STUD REL, V22, P304, DOI 10.1163/157006810X531094; Geertz AW, 2010, RELIGION, V40, P152, DOI 10.1016/j.religion.2009.11.003; Gervais WM, 2015, PSYCHOL RELIG SPIRIT, V7, P327, DOI 10.1037/rel0000044; Gervais WM, 2013, PERSPECT PSYCHOL SCI, V8, P380, DOI 10.1177/1745691613489836; Gervais WM, 2011, RELIGION, V41, P389, DOI 10.1080/0048721X.2011.604510; Gray K, 2011, P NATL ACAD SCI USA, V108, P477, DOI 10.1073/pnas.1015493108; Harris P. L., 2014, TRUST SKEPTICISM CHI, P28; Heider F, 1944, AM J PSYCHOL, V57, P243, DOI 10.2307/1416950; Henrich J, 2009, EVOL HUM BEHAV, V30, P244, DOI 10.1016/j.evolhumbehav.2009.03.005; Hoekstra RA, 2008, J AUTISM DEV DISORD, V38, P1555, DOI 10.1007/s10803-008-0538-x; Jack AI, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149989; Jong J, 2013, SOPHIA, V52, P521, DOI 10.1007/s11841-012-0338-9; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Lanman JA, 2015, RELIG BRAIN BEHAV, P1; Lanman JA, 2012, J CONTEMP RELIG, V27, P49, DOI 10.1080/13537903.2012.642726; LEVIN JS, 1994, J GERONTOL, V49, pS137, DOI 10.1093/geronj/49.3.S137; Lindeman M, 2015, J INDIVIDUAL DIFFERE; Lindeman M, 2015, COGNITION, V134, P63, DOI 10.1016/j.cognition.2014.09.008; Lindeman M, 2012, REV GEN PSYCHOL, V16, P241, DOI 10.1037/a0027158; Lisdorf A, 2007, J COGN CULT, V7, P341, DOI 10.1163/156853707X208549; Mahy CEV, 2014, DEV COGN NEUROS-NETH, V9, P68, DOI 10.1016/j.dcn.2014.01.002; McCauley Robert N., 2011, WHY RELIG IS NATURAL; McDonald J.H., 2009, HDB BIOL STAT; Meisenberg G., 2012, TEMAS PSICOLOGIA, V20, P101; Miles JH, 2011, GENET MED, V13, P278, DOI 10.1097/GIM.0b013e3181ff67ba; Muncer SJ, 2006, PERS INDIV DIFFER, V40, P1111, DOI 10.1016/j.paid.2005.09.020; Neubauer RL, 2014, RELIG BRAIN BEHAV, V4, P92, DOI 10.1080/2153599X.2013.768288; Norenzayan A, 2013, TRENDS COGN SCI, V17, P20, DOI 10.1016/j.tics.2012.11.006; Norenzayan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036880; Pennycook G, 2012, COGNITION, V123, P335, DOI 10.1016/j.cognition.2012.03.003; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Reddish P, 2016, INT J PSYCHOL RELIG, V26, P95, DOI 10.1080/10508619.2014.1003518; Riekki T, 2014, SOC NEUROSCI-UK, V9, P400, DOI 10.1080/17470919.2014.906366; Schaap-Jonker H, 2013, INT J PSYCHOL RELIG, V23, P145, DOI 10.1080/10508619.2012.688005; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schmeets H., 2014, RELIG KAART NEDERLAN; Schurz M, 2014, NEUROSCI BIOBEHAV R, V42, P9, DOI 10.1016/j.neubiorev.2014.01.009; Schweizerische Steuerkonferenz, SCHWEIZ STEUERK; Sierro G, 2016, EUROPEAN J PSYCHOL A; Sierro G, 2016, COMPR PSYCHIAT, V68, P147, DOI 10.1016/j.comppsych.2016.03.011; Swanson S., 2010, J RELIG DISABILITY H, V14, P238, DOI [10.1080/15228961003622393, DOI 10.1080/15228961003622393]; Tinbergen N., 1963, Zeitschrift fuer Tierpsychologie, V20, P410; van Elk M, 2013, CONSCIOUS COGN, V22, P1041, DOI 10.1016/j.concog.2013.07.004; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; Wakabayashi A, 2006, PERS INDIV DIFFER, V41, P929, DOI 10.1016/j.paid.2006.03.017; Walsh Mary Beth, 2008, AUTISM FAITH JOURNEY; Willard AK, 2013, COGNITION, V129, P379, DOI 10.1016/j.cognition.2013.07.016; Wilschut-pennings AE, 2012, PSYCHE GELOOF, V23, P211; Xygalatas Dimitris, 2014, ENCY PSYCHOL RELIG, V2nd, P343, DOI 10.1007/978-3-642-27771-9_9261-4; Zuckerman M, 2013, PERS SOC PSYCHOL REV, V17, P325, DOI 10.1177/1088868313497266; Zuckerman P, 2007, CAMBR COMPANION PHIL, P47, DOI 10.1017/CCOL0521842700.004	84	39	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182764	10.1371/journal.pone.0182764	http://dx.doi.org/10.1371/journal.pone.0182764			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832606	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800033
J	Wegwarth, O; Wagner, GG; Gigerenzer, G				Wegwarth, Odette; Wagner, Gert G.; Gigerenzer, Gerd			Can facts trump unconditional trust? Evidence-based information halves the influence of physicians' non-evidence-based cancer screening recommendations	PLOS ONE			English	Article							HEALTH INFORMATION; SURVIVAL RATES; PROSTATE; MORTALITY; BENEFITS; KNOWLEDGE; DOCTORS; BREAST; TELL; LUNG	Informed decision making in medicine, defined as basing one's decision on the best current medical evidence, requires both informed physicians and informed patients. In cancer screening, however, studies document that these prerequisites are not yet met. Many physicians do not know or understand the medical evidence behind screening tests, do not adequately counsel (asymptomatic) people on screening, and make recommendations that conflict with existing guidelines on informed choice. Consistent with this situation, nationwide studies showed that the general public misperceives the contribution of cancer screening but that understanding considerably improves when evidence-based information is provided. However, can evidence-based patient information about cancer screening make people also less likely to simply follow a physician's non-evidence-based advice? A national sample of 897 German citizens, surveyed in face-to-face computer-assisted personal interviews, received either evidence-based (e.g., absolute risks on benefits and harms; n = 451) or non-evidence-based (e.g., relative risks on benefits only; n = 446) patient information about a cancer screening test and were then asked to make their initial cancer screening choice. Thereafter, participants received a hypothetical physician's recommendation, which was non-evidence-based in terms of existing guidelines on informed decision making (i.e., reporting either benefits or harms but not both; no provision of numbers). When provided with non-evidence-based patient information (n = 446), a mean of 33.1% of 235 participants whose initial screening choice contradicted the hypothetical physician's non-evidencebased recommendation adjusted their choice in deference to that recommendation (95% CI: 27.4 to 39.4%), whereas with evidence-based patient information (n = 451), only half as many, a mean of 16.0% of 225 (95% CI: 11.8 to 21.4%), modified their choice. Thus, evidence-based patient information makes people less likely to simply follow non-evidencebased recommendations of physicians and supports people in making evidence-based decisions even when not adequately counseled on cancer screening.	[Wegwarth, Odette; Gigerenzer, Gerd] Harding Ctr Risk Literacy, Max Planck Inst Human Dev, Berlin, Germany; [Wagner, Gert G.] German Inst Econ Res, Berlin, Germany; [Wagner, Gert G.] Max Planck Inst Human Dev, Berlin, Germany	Max Planck Society; DIW Berlin - Deutsches Institut fur Wirtschaftsforschung; Max Planck Society	Wegwarth, O (corresponding author), Harding Ctr Risk Literacy, Max Planck Inst Human Dev, Berlin, Germany.	wegwarth@mpib-berlin.mpg.de	Gigerenzer, Gerd/A-6250-2012; Wagner, Gert G./AIC-8679-2022; Gigerenzer, Gerd/M-5595-2013	Gigerenzer, Gerd/0000-0002-6163-5419; 	German Federal Ministry for Education and Research (BMBF) [01UW0706]; Harding Center for Risk Literacy at the Max Planck Institute for Human Development (Germany)	German Federal Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Harding Center for Risk Literacy at the Max Planck Institute for Human Development (Germany)	The study was funded by the German Federal Ministry for Education and Research (BMBF Grant No. 01UW0706) (www.bmbf.de) and by the Harding Center for Risk Literacy at the Max Planck Institute for Human Development (Germany)-a nonprofit research organization (www.mpib-berlin.mpg.de/en/research/harding-center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert US, 2012, GESUNDHEITSWESEN, V74, P61, DOI 10.1055/s-0030-1268441; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bodemer N, 2012, VACCINE, V30, P3747, DOI 10.1016/j.vaccine.2012.03.005; Bramwell R, 2006, BMJ-BRIT MED J, V333, P284, DOI 10.1136/bmj.38884.663102.AE; Buys SS, 2011, JAMA-J AM MED ASSOC, V305, P2295, DOI 10.1001/jama.2011.766; Campbell EG, 2007, NEW ENGL J MED, V356, P1742, DOI 10.1056/NEJMsa064508; CASSCELLS W, 1978, NEW ENGL J MED, V299, P999, DOI 10.1056/NEJM197811022991808; Covey J, 2007, MED DECIS MAKING, V27, P638, DOI 10.1177/0272989x07306783; Eddy DM, 1982, JUDGMENT UNCERTAINTY, P249; Gaissmaier W, UNPUB; Gigerenzer G., 2007, PSYCHOL SCI PUBL INT, V8, P53, DOI [10.1111/j.1539-6053.2008.00033.x, DOI 10.1111/J.1539-6053.2008.00033.X]; Gigerenzer G, 2009, JNCI-J NATL CANCER I, V101, P1216, DOI 10.1093/jnci/djp237; Gordis L, 2008, EPIDEMIOLOGY; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Gotzsche PC, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub4; Hoffrage U, 1998, ACAD MED, V73, P538, DOI 10.1097/00001888-199805000-00024; Jain BP, 1998, ANN INTERN MED, V128, P72, DOI 10.7326/0003-4819-128-1-199801010-00019; Kurzenhauser S., 2005, NATURAL FREQUENCIES; Kurzenhauser Stephanie, 2003, Z Arztl Fortbild Qualitatssich, V97, P53; MALENKA DJ, 1993, J GEN INTERN MED, V8, P543, DOI 10.1007/BF02599636; McGettigan P, 1999, J GEN INTERN MED, V14, P633, DOI 10.1046/j.1525-1497.1999.09038.x; Miron-Shatz T, 2011, STRUNGMANN FORUM REP, P191; Moxey A, 2003, J GEN INTERN MED, V18, P948, DOI 10.1046/j.1525-1497.2003.20928.x; NAYLOR CD, 1992, ANN INTERN MED, V117, P916, DOI 10.7326/0003-4819-117-11-916; Neumeyer-Gromen A, 2011, BUNDESGESUNDHEITSBLA, V54, P1197, DOI 10.1007/s00103-011-1347-5; Neuner-Jehle S, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-15; Perneger TV, 2011, J GEN INTERN MED, V26, P1411, DOI 10.1007/s11606-011-1810-x; Prinz R, 2015, CURR HIV RES, V13, P369, DOI 10.2174/1570162X13666150511125200; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Schroder FH, 2012, NEW ENGL J MED, V366, P981, DOI 10.1056/NEJMoa1113135; Schwartz Lisa M., 1999, Journal of the National Cancer Institute Monographs, P124; Schwartz LM, 2007, MED DECIS MAKING, V27, P655, DOI 10.1177/0272989x07306786; Schwartz LM, 2005, KNOW YOUR CHANCES UN; Slaytor EK, 1998, BRIT MED J, V317, P263, DOI 10.1136/bmj.317.7153.263; Steckelberg A, 2001, Z Arztl Fortbild Qualitatssich, V95, P535; Steckelberg Anke, 2005, Z Arztl Fortbild Qualitatssich, V99, P343; Steckelberg A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3193; Steurer J, 2009, J EVAL CLIN PRACT, V15, P390, DOI 10.1111/j.1365-2753.2008.01024.x; Studdert DM, 2006, NEW ENGL J MED, V354, P2024, DOI 10.1056/NEJMsa054479; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; Thaler R.H., 2021, NUDGE FINAL EDITION; Wegwarth O, 2014, VACCINE, V32, P1388, DOI 10.1016/j.vaccine.2013.12.038; Wegwarth O., 2013, SIMPLE HEURISTICS SO, P67, DOI DOI 10.1093/ACPROF:OSO/9780195388435.003.0003; Wegwarth O, 2015, LANCET, V386, P429, DOI 10.1016/S0140-6736(15)61442-8; Wegwarth O, 2013, JAMA INTERN MED, V173, P2086, DOI 10.1001/jamainternmed.2013.10363; Wegwarth O, 2012, ANN INTERN MED, V156, P340, DOI 10.7326/0003-4819-156-5-201203060-00005; Wegwarth O, 2011, PATIENT EDUC COUNS, V84, P251, DOI 10.1016/j.pec.2010.07.025; Wegwarth O, 2011, MED DECIS MAKING, V31, P386, DOI 10.1177/0272989X10391469; Welch HG, 2007, ARCH INTERN MED, V167, P2289, DOI 10.1001/archinte.167.21.2289; Welch HG, 2000, JAMA-J AM MED ASSOC, V283, P2975, DOI 10.1001/jama.283.22.2975; Woloshin S, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5132; Woloshin S, 2009, JNCI-J NATL CANCER I, V101, P1596, DOI 10.1093/jnci/djp409	52	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183024	10.1371/journal.pone.0183024	http://dx.doi.org/10.1371/journal.pone.0183024			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832633	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800043
J	Szalus-Jordanow, O; Czopowicz, M; Witkowski, L; Mickiewicz, M; Frymus, T; Markowska-Daniel, I; Bagnicka, E; Kaba, J				Szalus-Jordanow, Olga; Czopowicz, Michal; Witkowski, Lucjan; Mickiewicz, Marcin; Frymus, Tadeusz; Markowska-Daniel, Iwona; Bagnicka, Emilia; Kaba, Jaroslaw			Reference intervals of echocardiographic measurements in healthy adult dairy goats	PLOS ONE			English	Article							REFERENCE VALUES; SAANEN-GOATS; HEART; RANGE	Objectives To determine references intervals for echocardiographic measurements in adult dairy goats. Animals 125 clinically healthy, adult dairy goats aged 2-9 years, belonging to two breeds-Polish Fawn Improved (PFI, n = 64, weight range from 46 to 73, median of 58.5kg) and Polish White Improved (PWI, n = 61, weight range from 48 to 80 kg, median of 67.9kg), closely related to French Alpine and Saanen, respectively. Methods Non-invasive transthoracic echocardiography examination was performed in unsedated goats in a standing position. Two-dimensional, M-mode and pulsed wave Doppler measurements were obtained. A non-parametric method was applied for determination of reference intervals. Measurements for the two breeds were compared using an analysis of covariance to control for their body weight. Repeatability was assessed using a between-day coefficient of variation and a coefficient of repeatability. Results Following reference intervals were determined: aortic diameter in diastole 2.2-3.3, left atrial diameter in systole 2.5-4.3cm cm, the ratio of the left atrial diameter to the aortic diameter 0.96-1.5, right ventricular internal diameter in diastole 0.4-1.7cm, left ventricular internal diameter in systole and diastole 1.8-3.2 and 3.2-5.6 cm, respectively, inter-ventricular septum thickness in systole and diastole 0.7-1.5 and 0.5-1.1cm, respectively, left ventricular posterior-wall in systole and diastole 0.8-1.6 and 0.5-1.2cm, respectively, E-point to septal separation 0.3-0.8cm, left ventricular fractional shortening 28-54%, left ventricular ejection fraction 55-86%, maximum Left and Right Ventricular Outflow Tract velocity 80-140 cm/s and 70-130 cm/s, respectively Left and Right Ventricular Outflow Tract pressure gradient 2.5-8.9mmHg and 1.9-6.5mmHg, respectively. Most of the differences between the two breeds could be attributed to different body weight. Conclusions The study provides echocardiographic reference intervals determined on the highest sample of apparently healthy goats so far enrolled.	[Szalus-Jordanow, Olga; Frymus, Tadeusz] Warsaw Univ Life Sci SGGW, Div Infect Dis, Dept Small Anim Dis Clin, Warsaw, Poland; [Czopowicz, Michal; Witkowski, Lucjan; Mickiewicz, Marcin; Markowska-Daniel, Iwona; Kaba, Jaroslaw] Warsaw Univ Life Sci SGGW, Lab Vet Epidemiol & Econ, Warsaw, Poland; [Bagnicka, Emilia] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland	Warsaw University of Life Sciences; Warsaw University of Life Sciences; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences	Szalus-Jordanow, O (corresponding author), Warsaw Univ Life Sci SGGW, Div Infect Dis, Dept Small Anim Dis Clin, Warsaw, Poland.	olga_szalus@sggw.pl	Mickiewicz, Marcin M.M./P-9486-2017; Czopowicz, Michał/U-5452-2018; Kaba, Jarosław/AAH-7685-2020; Mickiewicz, Marcin/GQA-5521-2022; Bagnicka, Emilia/J-2008-2019; Witkowski, Lucjan Adam/AAE-9239-2019; Mickiewicz, Marcin/ABD-1619-2020	Czopowicz, Michał/0000-0002-4238-8360; Mickiewicz, Marcin/0000-0001-9747-6803; Bagnicka, Emilia/0000-0001-7193-2006; Witkowski, Lucjan Adam/0000-0003-1069-3384; Mickiewicz, Marcin/0000-0001-9747-6803; Markowska-Daniel, Iwona/0000-0003-2889-6745; Kaba, Jaroslaw/0000-0002-7977-9875; Szalus-Jordanow, Olga/0000-0002-2532-3338; Frymus, Tadeusz/0000-0002-9160-1455	Ministry of Science and Higher Education [05-1/KNOW2/2015]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	Publication was funded by KNOW (Leading National Research Centre) Scientific Consortium "Healthy Animal - Safe Food", decision of Ministry of Science and Higher Education No. 05-1/KNOW2/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2015, ARTIF ORGANS, V39, P670, DOI 10.1111/aor.12543; Acorda J. A., 2005, Philippine Journal of Veterinary Medicine, V42, P66; Bagnicka E, 2015, ANIM SCI PAP REP, V33, P59; Bartlett JW, 2008, ULTRASOUND OBST GYN, V31, P466, DOI 10.1002/uog.5256; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boon J. A., 2011, VET ECHOCARDIOGRAPHY, P97; Dukes-McEwan Joanna, 2003, J Vet Cardiol, V5, P7, DOI 10.1016/S1760-2734(06)70047-9; Friedrichs K, 2011, SCOPE 2011; Fulton L. K., 1994, ILAR News, V36, P21; GARDNER SY, 1992, J AM VET MED ASSOC, V200, P521; Geffre A, 2011, VET CLIN PATH, V40, P107, DOI 10.1111/j.1939-165X.2011.00287.x; Hallowell GD, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-181; Horn PS, 1998, CLIN CHEM, V44, P622; Horowitz GL, 2008, CLIN LAB STANDARDS I; Jones R, 1997, CASTLE RISING CASTLE, P123; KABA J., 2009, DAIRY GOAT J, V87, P46; Kleijn SA, 2015, EUR HEART J-CARD IMG, V16, P410, DOI 10.1093/ehjci/jeu213; Leroux AA, 2012, VET REC, V170, P154, DOI 10.1136/vr.100192; Leroux AA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-190; Matthews J., 2009, DIS OF THE GOAT; Olsson K, 2001, EXP PHYSIOL, V86, P93, DOI 10.1113/eph8602078; PFISTERER ME, 1985, EUR HEART J, V6, P647, DOI 10.1093/oxfordjournals.eurheartj.a061916; REED AH, 1971, CLIN CHEM, V17, P275; Steininger K, 2011, SCHWEIZ ARCH TIERH, V153, P553, DOI 10.1024/0036-7281/a000273; Umeki A, 2013, J ARTIF ORGANS, V16, P119, DOI 10.1007/s10047-012-0682-0; Zar JH, 2010, BIOSTAT ANAL, P126	26	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183293	10.1371/journal.pone.0183293	http://dx.doi.org/10.1371/journal.pone.0183293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829836	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100037
J	Tartari, F; Conti, A; Cerqueti, R				Tartari, Francesca; Conti, Alessandro; Cerqueti, Roy			Assessing the relationship between toxicity and economic cost of oncological target agents: A systematic review of clinical trials	PLOS ONE			English	Review							METASTATIC PROSTATE-CANCER; RENAL-CELL CARCINOMA; DOUBLE-BLIND; PHASE-III; 1ST-LINE TREATMENT; INCREASED SURVIVAL; INTERFERON-ALPHA; LUNG-CANCER; MULTICENTER; PLACEBO	Target agents are peculiar oncological drugs which differ from the traditional therapies in their ability of recognizing specific molecules expressed by tumor cells and microenvironment. Thus, their toxicity is generally lower than that associated to chemotherapy, and they represent nowadays a new standard of care in a number of tumors. This paper deals with the relationship between economic costs and toxicity of target agents. At this aim, a cluster analysis-based exploration of the main features of a large collection of them is carried out, with a specific focus on the variables leading to the identification of their toxicity and related costs. The analysis of the toxicity is based on the Severe Adverse Events (SAE) and Discontinuation (D) rates of each target agent considering data published on PubMed from 1965 to 2016 in the phase II and III studies that have led to the approval of these drugs for cancer patients by US Food and Drug Administration. The construction of the dataset represents a key step of the research, and is grounded on the critical analysis of a wide set of clinical studies. In order to capture different evaluation strategies of the toxicity, clustering is performed according to three different criteria (including Voronoi tessellation). Our procedure allows us to identify 5 different groups of target agents pooled by similar SAE and D rates and, at the same time, 3 groups based on target agents' costs for 1 month and for the median whole duration of therapy. Results highlight several specific regularities for toxicity and costs. This study present several limitations, being realized starting from clinical trials and not from individual patients' data. However, a macroscopic perspective suggests that costs are rather heterogeneous, and they do not clearly follow the clustering based on SAE and D rates.	[Tartari, Francesca; Cerqueti, Roy] Univ Macerata, Dept Econ & Law, Via Crescimbeni, Macerata, Italy; [Conti, Alessandro] Bressanone Brissen Hosp, Azienda Osped dellAlto Adige, Via Dante, Bressanone Brissen, Italy	University of Macerata	Cerqueti, R (corresponding author), Univ Macerata, Dept Econ & Law, Via Crescimbeni, Macerata, Italy.	roy.cerqueti@unimc.it		CERQUETI, ROY/0000-0002-1871-7371				Ademi Z, 2013, BRIT J CLIN PHARMACO, V75, P944, DOI 10.1111/j.1365-2125.2012.04421.x; Arondekar Bhakti, 2015, J Manag Care Spec Pharm, V21, P158; Bailly S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157318; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Bilir SP, 2016, AM HEALTH DRUG BENEF, V9, P203; Blanco MR, 2015, NAT METHODS, V12, P1077, DOI [10.1038/NMETH.3602, 10.1038/nmeth.3602]; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Bradley CJ, 2016, MED CARE, V54, P490, DOI 10.1097/MLR.0000000000000510; Brzezianska E, 2006, MUTAT RES-FUND MOL M, V599, P26, DOI 10.1016/j.mrfmmm.2005.12.013; Cappuzzo F, 2010, LANCET ONCOL, V11, P521, DOI 10.1016/S1470-2045(10)70112-1; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Demetri GD, 2006, LANCET, V368, P1329, DOI 10.1016/S0140-6736(06)69446-4; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Ekwueme DU, 2014, MMWR-MORBID MORTAL W, V63, P505; Elisei R, 2013, J CLIN ONCOL, V31, P3639, DOI 10.1200/JCO.2012.48.4659; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Escudier B, 2007, CLIN CANCER RES, V13, P1801, DOI 10.1158/1078-0432.CCR-06-1432; Finn RS, 2015, LANCET ONCOL, V16, P25, DOI 10.1016/S1470-2045(14)71159-3; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gerber S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500163; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Guy GP, 2015, AM J PREV MED, V49, pS489, DOI 10.1016/j.amepre.2015.09.002; Guy GP, 2014, HEALTH AFFAIR, V33, P1024, DOI 10.1377/hlthaff.2013.1425; Guy GP, 2013, J CLIN ONCOL, V31, P3749, DOI 10.1200/JCO.2013.49.1241; Hana ezankova, 2014, STATISTIKA, V94; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Larkin J, 2014, NEW ENGL J MED, V371, P1867, DOI 10.1056/NEJMoa1408868; Liao ML, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0238-2; Liu XT, 2009, J ECOLOGY RURAL ENV, V2; Long GV, 2014, NEW ENGL J MED, V371, P1877, DOI 10.1056/NEJMoa1406037; Migden MR, 2015, LANCET ONCOL, V16, P716, DOI 10.1016/S1470-2045(15)70100-2; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; Motzer RJ, 2015, NEW ENGL J MED, V373, P1803, DOI 10.1056/NEJMoa1510665; Motzer RJ, 2009, J CLIN ONCOL, V27, P3584, DOI 10.1200/JCO.2008.20.1293; Perrier L, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0537-x; Requia WJ, 2016, ENVIRON RES, V150, P452, DOI 10.1016/j.envres.2016.06.027; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Roncato R, 2017, CLIN PHARM THER; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Russi A, 2017, INT J TECHNOL ASSESS, V13, P1; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; Schlumberger M, 2015, NEW ENGL J MED, V372, P621, DOI 10.1056/NEJMoa1406470; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shih YCT, 2015, J CLIN ONCOL, V33, P2190, DOI 10.1200/JCO.2014.58.2320; Tabernero J, 2015, LANCET ONCOL, V16, P499, DOI 10.1016/S1470-2045(15)70127-0; TOWNSEND RJ, 1987, DRUG INTEL CLIN PHAR, V21, P134, DOI 10.1177/10600280870211P216; Turner NC, 2015, NEW ENGL J MED, V373, P209, DOI 10.1056/NEJMoa1505270; Van Cutsem E, 2012, J CLIN ONCOL, V30, P3499, DOI 10.1200/JCO.2012.42.8201; Vaz E, 2014, ENTREP REGION DEV, V26, P23, DOI 10.1080/08985626.2013.860193; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Vermorken JB, 2008, NEW ENGL J MED, V359, P1116, DOI 10.1056/NEJMoa0802656; Voronoi G.F., 1908, J REINE ANGEW MATH, V134, P198, DOI 10.1515/crll.1908.134.198; WEINSTEIN MC, 1977, NEW ENGL J MED, V296, P716, DOI 10.1056/NEJM197703312961304; Wong NS, 2016, LANCET, V388, P90	63	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183639	10.1371/journal.pone.0183639	http://dx.doi.org/10.1371/journal.pone.0183639			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829823	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000408085100062
J	Liu, NN; Wang, K; Jin, X; Gao, BY; Dellandrea, E; Chen, LM				Liu, Ningning; Wang, Kai; Jin, Xin; Gao, Boyang; Dellandrea, Emmanuel; Chen, Liming			Visual affective classification by combining visual and text features	PLOS ONE			English	Article							RECOGNITION; EXPRESSION; SENTIMENT; AUDIO	Affective analysis of images in social networks has drawn much attention, and the texts surrounding images are proven to provide valuable semantic meanings about image content, which can hardly be represented by low-level visual features. In this paper, we propose a novel approach for visual affective classification (VAC) task. This approach combines visual representations along with novel text features through a fusion scheme based on Dempster-Shafer (D-S) Evidence Theory. Specifically, we not only investigate different types of visual features and fusion methods for VAC, but also propose textual features to effectively capture emotional semantics from the short text associated to images based on word similarity. Experiments are conducted on three public available databases: the International Affective Picture System (IAPS), the Artistic Photos and the MirFlickr Affect set. The results demonstrate that the proposed approach combining visual and textual features provides promising results for VAC task.	[Liu, Ningning] Univ Int Business & Econ, Sch Informat Technol & Management, Beijing, Peoples R China; [Wang, Kai] Sichuan Univ, Sch Mfg Sci & Engn, Chengdu, Sichuan, Peoples R China; [Jin, Xin] Beijing Elect Sci & Technol Inst, Dept Comp Sci & Technol, Beijing, Peoples R China; [Gao, Boyang] Ist Italiano Tecnol, Dept Adv Robot, Via Morego, Genoa, Italy; [Dellandrea, Emmanuel; Chen, Liming] Univ Lyon, CNRS, Ecole Cent Lyon, LIRIS,UMR5205, Lyon, France	University of International Business & Economics; Sichuan University; Beijing Electronic Science & Technology Institute; Istituto Italiano di Tecnologia - IIT; Centre National de la Recherche Scientifique (CNRS); Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon	Wang, K (corresponding author), Sichuan Univ, Sch Mfg Sci & Engn, Chengdu, Sichuan, Peoples R China.	kai.wang@scu.edu.cn			National Natural Science Foundation of China [51435011, 51505309]; Fundamental Research Funds for the Central University in UIBE [14QD21]; Sichuan Province Science and Technology Support Program [2015JY0172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central University in UIBE; Sichuan Province Science and Technology Support Program	This work was supported by the National Natural Science Foundation of China under Grant (51435011, 51505309), the Fundamental Research Funds for the Central University in UIBE (14QD21) and the Sichuan Province Science and Technology Support Program Project under Grant 2015JY0172. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This work was supported by the National Natural Science Foundation of China under Grant (51435011, 51505309), the Fundamental Research Funds for the Central University in UIBE (14QD21) and the Sichuan Province Science and Technology Support Program Project under Grant 2015JY0172.	Al-Ani M, 2002, J ARTIF INTELL RES, V17, P333, DOI 10.1613/jair.1026; Alameda-Pineda X, 2016, IEEE INT C COMP VIS; [Anonymous], 2009, NATURAL LANGUAGE PRO; [Anonymous], 2008, ACM ICMIR, DOI DOI 10.1145/1460096.1460104; Awad FJMMJDKWSAFOR G, 2016, P TRECVID; Banziger T, 2009, EMOTION, V9, P691, DOI 10.1037/a0017088; Ballester P, PERFORMANCE GOOGLENE; Binder A, 2011, JOINT SUBMISSION TU; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Bradley M., 1999, TECHNICAL REPORT, DOI DOI 10.1109/MIC.2008.114; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Colombo C, 1999, IEEE MULTIMEDIA, V6, P38, DOI 10.1109/93.790610; Datta R, 2006, LECT NOTES COMPUT SC, V3953, P288, DOI 10.1007/11744078_23; Datta Ritendra, 2005, P MIR, P253; Dellandrea E., 2010, INT WORKSH CONT BAS, P99, DOI DOI 10.1109/CBMI.2010.5529906; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dumais ST., 2005, LATENT SEMANTIC ANAL; Dunker P., 2008, P 1 ACM INT C MULTIM, P97; Esuli A., 2006, P 5 INT C LANG RES E, V5, P417, DOI DOI 10.1155/2015/715730; Feist A, 2007, ENTWICKLUNG VERFAHRE; GUILLAUMIN M, 2010, PROC CVPR IEEE, P902, DOI DOI 10.1109/CVPR.2010.5540120; Guo Y, 2006, PROCEEDINGS OF THE FIFTH IEEE INTERNATIONAL CONFERENCE ON COGNITIVE INFORMATICS, VOLS 1 AND 2, P73; HARALICK RM, 1979, P IEEE, V67, P786, DOI 10.1109/PROC.1979.11328; Hevner K, 1936, AM J PSYCHOL, V48, P246, DOI 10.2307/1415746; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Itten J., 1973, ART COLOR SUBJECTIVE; Jia D, 2013, PROC CVPR IEEE, P580, DOI 10.1109/CVPR.2013.81; Jia Y., 2014, ARXIV14085093, P675; Jurgens David, 2012, P 1 JOINT C LEX COMP; Karpathy A, 2014, PROC CVPR IEEE, P1725, DOI 10.1109/CVPR.2014.223; Ke Yan, 2006, 2006 IEEE COMPUTER S, V1, P419, DOI DOI 10.1109/CVPR.2006.303; Kim Y, 2013, INT CONF ACOUST SPEE, P3687, DOI 10.1109/ICASSP.2013.6638346; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Lang PJ, 1999, A4 U FLOR CTR RES PS, DOI DOI 10.1016/J.BIOPSYCH.2010.04.020; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Li Bing, 2012, P 20 ACM INT C MULT, P721; Lin D, 1998, P INT C MACH LEARN; Liu N, 2012, CLEF WORKSH NOT PAP; Liu N, 2011, LIRIS IMAGINE IMAGEC; Liu N., 2011, INT C COMP VIS THEOR; Liu NN, 2013, COMPUT VIS IMAGE UND, V117, P493, DOI 10.1016/j.cviu.2012.10.009; Liu NN, 2011, LECT NOTES COMPUT SC, V6974, P195, DOI 10.1007/978-3-642-24600-5_23; Liu SY, 2010, OPT ENG, V49, DOI 10.1117/1.3518051; Liu W, 2016, LECT NOTES COMPUT SC, V9905, P21, DOI 10.1007/978-3-319-46448-0_2; Maas A. L., 2011, P 49 ANN M ASS COMP, P142; MACHAJDIK J, 2010, P 18 ACM INT C MULTI, P83, DOI DOI 10.1145/1873951.1873965; Malinowski M, 2015, COMPUTER SCI; Malinowski M, 2014, ADV NEUR IN, V27; Malinowski M, 2015, IEEE I CONF COMP VIS, P1, DOI 10.1109/ICCV.2015.9; McNair DM., 1992, EDITS MANUAL PROFILE; Mensink T, 2010, LEAR XRCES PARTICIPA; Mikels JA, 2005, BEHAV RES METHODS, V37, P626, DOI 10.3758/BF03192732; Mikolov T., 2013, P 1 INT C LEARN REPR, P2013; Ngiam J., 2011, IEEE INT C MACH LEAR, P689, DOI DOI 10.5555/3104482.3104569; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Osgood CE, 1957, MEASUREMENT MEANING, P189; Peng KC, 2015, IEEE C COMP VIS PATT; Picard R.W., 2000, AFFECTIVE COMPUTING; Poria S, 2016, NEUROCOMPUTING, V174, P50, DOI 10.1016/j.neucom.2015.01.095; Pujol A, 2007, PROCEEDINGS OF THE SEVENTH IASTED INTERNATIONAL CONFERENCE ON VISUALIZATION, IMAGING, AND IMAGE PROCESSING, P201; Resnik P, 1995, CORR; Scherer K.R., 2001, SERIES AFFECTIVE SCI; Sivic J, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P1470, DOI 10.1109/iccv.2003.1238663; Sohn K., 2014, ADV NEURAL INFORM PR, P2141; Solli Martin, 2010, P ACM INT C IM VID R, P398; Sussna M., 1993, CIKM 93. Proceedings of the Second International Conference on Information and Knowledge Management, P67, DOI 10.1145/170088.170106; Tamura H, 1978, IEEE T SYST MAN CYB, P6; Thelwall M, 2010, J AM SOC INF SCI TEC, V61, P2544, DOI 10.1002/asi.21416; VALDEZ P, 1994, J EXP PSYCHOL GEN, V123, P394, DOI 10.1037/0096-3445.123.4.394; Viola PA, 2001, P CCV, V57, P137, DOI DOI 10.1023/B:VISL00000; Wang G, 2009, PROC CVPR IEEE, P1367, DOI 10.1109/CVPRW.2009.5206816; Wang G, 2008, CHINA POLICY SER, V1, P1; Wang WN, 2008, IEEE IMAGE PROC, P117, DOI 10.1109/ICIP.2008.4711705; Wang Y, NINGNING LIU TITLE B; Wang YB, 2004, INT C PATT RECOG, P926, DOI 10.1109/ICPR.2004.1334680; Wu Z, 1994, CORR; Yanulevskaya V, 2008, IEEE IMAGE PROC, P101, DOI 10.1109/ICIP.2008.4711701; Yao BP, 2012, PROC CVPR IEEE, P3466, DOI 10.1109/CVPR.2012.6248088; You QZ, 2015, IEEE T MULTIMEDIA, V17, P2271, DOI 10.1109/TMM.2015.2487863; Zeng ZH, 2009, IEEE T PATTERN ANAL, V31, P39, DOI 10.1109/TPAMI.2008.52; Zhila A., 2013, COMBINING HETEROGENE, P1000	83	7	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183018	10.1371/journal.pone.0183018	http://dx.doi.org/10.1371/journal.pone.0183018			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850566	Green Published, Green Submitted, gold			2022-12-27	WOS:000408544200008
J	Kim, J; Heise, RL; Reynolds, AM; Pidaparti, RM				Kim, JongWon; Heise, Rebecca L.; Reynolds, Angela M.; Pidaparti, Ramana M.			Aging effects on airflow dynamics and lung function in human bronchioles	PLOS ONE			English	Article							PRESSURE-VOLUME CHARACTERISTICS; PARTICLE DEPOSITION; MECHANICAL VENTILATION; EMPHYSEMATOUS LUNGS; SENILE LUNG; AGE; MODELS; HEALTHY; MICE; RESISTANCE	Background and objective The mortality rate for patients requiring mechanical ventilation is about 35% and this rate increases to about 53% for the elderly. In general, with increasing age, the dynamic lung function and respiratory mechanics are compromised, and several experiments are being conducted to estimate these changes and understand the underlying mechanisms to better treat elderly patients. Materials and methods Human tracheobronchial (G1 similar to G9), bronchioles (G10 similar to G22) and alveolar sacs (G23) geometric models were developed based on reported anatomical dimensions for a 50 and an 80-year-old subject. The aged model was developed by altering the geometry and material properties of the model developed for the 50-year-old. Computational simulations using coupled fluid-solid analysis were performed for geometric models of bronchioles and alveolar sacs under mechanical ventilation to estimate the airflow and lung function characteristics. Findings The airway mechanical characteristics decreased with aging, specifically a 38% pressure drop was observed for the 80-year-old as compared to the 50-year-old. The shear stress on airway walls increased with aging and the highest shear stress was observed in the 80-year-old during inhalation. A 50% increase in peak strain was observed for the 80-year-old as compared to the 50-year-old during exhalation. The simulation results indicate that there is a 41% increase in lung compliance and a 35%-50% change in airway mechanical characteristics for the 80-year-old in comparison to the 50-year-old. Overall, the airway mechanical characteristics as well as lung function are compromised due to aging. Conclusion Our study demonstrates and quantifies the effects of aging on the airflow dynamics and lung capacity. These changes in the aging lung are important considerations for mechanical ventilation parameters in elderly patients. Realistic geometry and material properties need to be included in the computational models in future studies.	[Kim, JongWon; Pidaparti, Ramana M.] Univ Georgia, Coll Engn, Athens, GA 30602 USA; [Heise, Rebecca L.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Heise, Rebecca L.; Reynolds, Angela M.] Virginia Commonwealth Univ, Med Ctr, VCU Johnson Ctr, Richmond, VA USA; [Reynolds, Angela M.] Virginia Commonwealth Univ, Dept Math & Appl Math, Richmond, VA USA	University System of Georgia; University of Georgia; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University	Pidaparti, RM (corresponding author), Univ Georgia, Coll Engn, Athens, GA 30602 USA.	rmparti@uga.edu			NIH - National Institute on Aging of the National Institutes of Health [R01AG041823]; NATIONAL INSTITUTE ON AGING [R01AG041823] Funding Source: NIH RePORTER	NIH - National Institute on Aging of the National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH - National Institute on Aging of the National Institutes of Health under Award Number R01AG041823.	Albaiceta GM, 2011, CRIT CARE, V15, DOI 10.1186/cc10052; ANDREOTTI L, 1983, GERONTOLOGY, V29, P377, DOI 10.1159/000213148; [Anonymous], 1963, MORPHOMETRY HUMAN LU, DOI DOI 10.1007/978-3-642-87553-3_10; [Anonymous], MORPHOMETRY HUMAN LU; [Anonymous], 2015, MECH PROPERTIES AGIN, DOI DOI 10.1007/978-3-319-03970-1_5; BEREND N, 1980, J APPL PHYSIOL, V49, P558, DOI 10.1152/jappl.1980.49.4.558; Bozanich EM, 2005, J APPL PHYSIOL, V99, P108, DOI 10.1152/japplphysiol.01111.2004; Cakmak S, 2011, ENVIRON RES, V111, P1309, DOI 10.1016/j.envres.2011.09.016; Chan ED, 1998, CHEST, V114, P1704, DOI 10.1378/chest.114.6.1704; COHN JE, 1963, J CLIN INVEST, V42, P1406, DOI 10.1172/JCI104825; Elliott JE, 2016, AM J PHYSL LUNG CELL; Felippa CA, 2001, COMPUT METHOD APPL M, V190, P3247, DOI 10.1016/S0045-7825(00)00391-1; FRANK NR, 1957, J CLIN INVEST, V36, P1680, DOI 10.1172/JCI103569; Gattinoni L, 2012, CURR OPIN CRIT CARE, V18, P42, DOI 10.1097/MCC.0b013e32834f17d9; Gattinoni L, 2011, CHEST, V140, P11, DOI 10.1378/chest.11-0827; Gattinoni L, 2010, CRIT CARE MED, V38, pS539, DOI 10.1097/CCM.0b013e3181f1fcf7; Gefen A, 1999, J BIOMECH, V32, P891, DOI 10.1016/S0021-9290(99)00092-5; GIBSON GJ, 1976, J APPL PHYSIOL, V41, P20, DOI 10.1152/jappl.1976.41.1.20; Gonzalez-Lopez A, 2012, INTENS CARE MED, V38, P240, DOI 10.1007/s00134-011-2403-1; Grinnan DC, 2005, CRIT CARE, V9, P472, DOI 10.1186/cc3516; HAMMERSLEY JR, 1992, J APPL PHYSIOL, V72, P2402, DOI 10.1152/jappl.1992.72.6.2402; HEISTRACHER T, 1995, J AEROSOL SCI, V26, P497, DOI 10.1016/0021-8502(94)00113-D; Herbert JA, 2016, EXP GERONTOL, V81, P101, DOI 10.1016/j.exger.2016.05.005; HORSFIEL.K, 1971, J APPL PHYSIOL, V31, P207, DOI 10.1152/jappl.1971.31.2.207; Huang KW, 2007, J APPL PHYSIOL, V102, P200, DOI 10.1152/japplphysiol.00400.2006; Janssens JP, 1999, EUR RESPIR J, V13, P197, DOI 10.1034/j.1399-3003.1999.13a36.x; KNUDSON RJ, 1977, J APPL PHYSIOL, V43, P1054, DOI 10.1152/jappl.1977.43.6.1054; Koch B, 2013, RESPIROLOGY, V18, P170, DOI 10.1111/j.1440-1843.2012.02268.x; Koombua K, 2008, MODELLING SIMULATION, V2008, P4; Lai-Fook SJ, 2000, J APPL PHYSIOL, V89, P163, DOI 10.1152/jappl.2000.89.1.163; MEAD J, 1960, J APPL PHYSIOL, V15, P736, DOI 10.1152/jappl.1960.15.4.736; MITTMAN C, 1965, J APPL PHYSIOL, V20, P1211, DOI 10.1152/jappl.1965.20.6.1211; Montaudon M, 2007, J ANAT, V211, P579, DOI 10.1111/j.1469-7580.2007.00811.x; NIEWOEHNER DE, 1974, J APPL PHYSIOL, V36, P412, DOI 10.1152/jappl.1974.36.4.412; Oakes JM, 2016, J BIOMECH, V49, P2213, DOI 10.1016/j.jbiomech.2015.11.026; Oakes JM, 2015, J BIOMECH, V48, P1147, DOI 10.1016/j.jbiomech.2015.01.004; Oakes JM, 2014, J APPL PHYSIOL, V116, P1561, DOI 10.1152/japplphysiol.01165.2013; Oakes JM, 2014, ANN BIOMED ENG, V42, P899, DOI 10.1007/s10439-013-0954-8; Oakes JM, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000870; Owen MR, 2001, SIAM J APPL MATH, V61, P1731; PEDLEY TJ, 1970, RESP PHYSIOL, V9, P387, DOI 10.1016/0034-5687(70)90094-0; PERMUTT S, 1960, J APPL PHYSIOL, V15, P819, DOI 10.1152/jappl.1960.15.5.819; Pidaparti Ramana M., 2011, Molecular & Cellular Biomechanics, V8, P149; PIERCE JA, 1960, J CLIN INVEST, V39, P8, DOI 10.1172/JCI104030; Protti A, 2011, AM J RESP CRIT CARE, V183, P1354, DOI 10.1164/rccm.201010-1757OC; Russo J, 2008, MED ENG PHYS, V30, P581, DOI 10.1016/j.medengphy.2007.06.010; Singer BD, 2009, SOUTH MED J, V102, P1238, DOI 10.1097/SMJ.0b013e3181bfac4f; Sly PD, 2003, J APPL PHYSIOL, V94, P1460, DOI 10.1152/japplphysiol.00596.2002; Takubo Y, 1999, EXP GERONTOL, V34, P353, DOI 10.1016/S0531-5565(99)00017-0; Taylor D., 1996, HUMAN RESP TRACT MOD; Tehrani JN, 2015, PHYS MED BIOL, V60, P8833, DOI 10.1088/0031-9155/60/22/8833; TSUNODA S, 1974, RESP PHYSIOL, V22, P285, DOI 10.1016/0034-5687(74)90078-4; TURNER JM, 1968, J APPL PHYSIOL, V25, P664, DOI 10.1152/jappl.1968.25.6.664; VERBEKEN EK, 1992, CHEST, V101, P793, DOI 10.1378/chest.101.3.793; VERBEKEN EK, 1992, CHEST, V101, P800, DOI 10.1378/chest.101.3.800; Tramont CVVE, 2009, CLINICS, V64, P1065, DOI 10.1590/S1807-59322009001100006; WAHBA WM, 1983, ANESTH ANALG, V62, P764; Wunsch H, 2010, CRIT CARE MED, V38, P1947, DOI 10.1097/CCM.0b013e3181ef4460; Xia GH, 2010, ANN BIOMED ENG, V38, P1836, DOI 10.1007/s10439-010-9956-y; YEH HC, 1980, B MATH BIOL, V42, P461, DOI 10.1007/BF02460796; Zeleznik J, 2003, CLIN GERIATR MED, V19, P1, DOI 10.1016/S0749-0690(02)00063-0	61	31	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183654	10.1371/journal.pone.0183654	http://dx.doi.org/10.1371/journal.pone.0183654			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846719	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600044
J	Masuda, H; Hirano, S; Takahashi, N; Hatsugano, E; Uzawa, A; Uchida, T; Ohtani, R; Kuwabara, S; Mori, M				Masuda, Hiroki; Hirano, Shigeki; Takahashi, Nobuyoshi; Hatsugano, Etsuko; Uzawa, Akiyuki; Uchida, Tomohiko; Ohtani, Ryohei; Kuwabara, Satoshi; Mori, Masahiro			Comparison of cognitive and brain grey matter volume profiles between multiple sclerosis and neuromyelitis optica spectrum disorder	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY	Objective Brain regions responsible for cognitive dysfunction in MS and neuromyelitis optica spectrum disorder (NMOSD) are not known. Our aim of this study was to investigate whether cognitive function and brain volume differed between MS and NMOSD in Japanese patients. Methods Brain MRI and neuropsychological tests including the Wechsler Adult Intelligence Scale-III (WAIS-III), Wechsler Memory Scale-Revised (WMS-R), Trail Making Test (TMT) and Clinical Assessment for Attention (CAT) were performed. Parametric grey matter (GM) and white matter (WM) volumes determined from lesion-filled T1-weighted images using wholebrain voxel-based morphometry (VBM) were compared by two-tailed t test. Results Twenty relapsing-remitting MS and sixteen NMOSD patients were included. MS patients were younger than NMOSD patients. Processing speed intelligence quotient (IQ), general memory, verbal memory and delayed recall were significantly worse in MS patients than in NMOSD patients. Furthermore, left superior temporal gyrus (STG) GM volume was smaller in MS patients than in NMOSD patients (P < 0.05, family-wise error [FWE] corrected, Zmax = 4.97, 62 voxel). The left STG GM volume tended to be positively correlated with delayed recall in MS patients. Conclusions Despite being younger, MS patients demonstrated worse performance in certain cognitive variables than NMOSD patients, which might be associated with left STG GM volume loss.	[Masuda, Hiroki; Hirano, Shigeki; Uzawa, Akiyuki; Uchida, Tomohiko; Ohtani, Ryohei; Kuwabara, Satoshi; Mori, Masahiro] Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan; [Takahashi, Nobuyoshi] Chiba Prefectural Univ Hlth Sci, Dept Rehabil Sci, Chiba, Japan; [Hatsugano, Etsuko] Chiba Univ, Sch Med, Chiba, Japan	Chiba University; Chiba University	Mori, M (corresponding author), Chiba Univ, Grad Sch Med, Dept Neurol, Chiba, Japan.	morim@faculty.chiba-u.jp		Kuwabara, Satoshi/0000-0002-4716-8578				Achiron A, 2013, BRAIN STRUCT FUNCT, V218, P943, DOI 10.1007/s00429-012-0440-3; Alexander Rae-Grant M., 2013, MULTIPLE SCLEROSIS R; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Blanc F, 2008, ARCH NEUROL-CHICAGO, V65, P84, DOI 10.1001/archneurol.2007.16; Chanson JB, 2013, EUR J NEUROL, V20, P361, DOI 10.1111/j.1468-1331.2012.03867.x; COLLINS DL, 1994, J COMPUT ASSIST TOMO, V18, P192, DOI 10.1097/00004728-199403000-00005; Duan YY, 2012, EUR J RADIOL, V81, pE110, DOI 10.1016/j.ejrad.2011.01.065; Hayakawa S, 2008, J NEUROIMMUNOL, V196, P181, DOI 10.1016/j.jneuroim.2008.03.009; Kim SH, 2016, MULT SCLER J, V22, P1850, DOI 10.1177/1352458516636246; Moore P, 2016, J NEUROL SCI, V360, P4, DOI 10.1016/j.jns.2015.11.031; Polman CH, 2011, ANN NEUROL, V69, P292, DOI 10.1002/ana.22366; Prinster A, 2006, NEUROIMAGE, V29, P859, DOI 10.1016/j.neuroimage.2005.08.034; Saji E, 2013, ANN NEUROL, V73, P65, DOI 10.1002/ana.23721; Schmidt P, 2012, NEUROIMAGE, V59, P3774, DOI 10.1016/j.neuroimage.2011.11.032; Wingerchuk DM, 2015, NEUROLOGY, V85, P177, DOI 10.1212/WNL.0000000000001729	15	11	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184012	10.1371/journal.pone.0184012	http://dx.doi.org/10.1371/journal.pone.0184012			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846745	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600066
J	Juhel, AS; Barbu, CM; Franck, P; Roger-Estrade, J; Butier, A; Bazot, M; Valantin-Morison, M				Juhel, Amandine Suzanne; Barbu, Corentin Mario; Franck, Pierre; Roger-Estrade, Jean; Butier, Arnaud; Bazot, Mathieu; Valantin-Morison, Muriel			Characterization of the pollen beetle, Brassicogethes aeneus, dispersal from woodlands to winter oilseed rape fields	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; BRASSICA-NAPUS L.; MELIGETHES-AENEUS; INSECT PESTS; CROPS; DAMAGE; PERSPECTIVES; PARASITOIDS; STRATEGIES	Many crop pests rely on resources out of crop fields; understanding how they colonize the fields is an important factor to develop integrated pest management. In particular, the time of crop colonization and damage severity might be determined by pest movements between fields and non-crop areas. Notably, the pollen beetle, Brassicogethes aeneus, previously named Meligethes aeneus, one of the most important pests of winter oilseed rape, overwinters in woodlands. As a result, its abundance increases in oilseed rape fields near wooded areas. Here, we assessed the spatio-temporal patterns of the dispersal from woodlands to oilseed rape fields in diversified landscapes of a same region. We observed on four dates the abundance of pollen beetles in 24 fields spread in the Eure department, France. We modeled the abundance as a result of the dispersal from the neighboring woodlands. We compared the modalities of dispersal corresponding to different hypotheses on the dispersal origin, kernel shape and sources of variability. Within oilseed rape the distance to the edges of woodlands is not the main determinant of pollen beetle abundance. On the contrary, the variability of the abundance between fields is largely explained by the dispersal from neighboring woodlands but there is considerable variability between dates, sites and, to a lesser extent, between fields. The two dispersal kernels received similar support from the data and lead to similar conclusions. The mean dispersal distance is 1.2 km but seems to increase from a few hundred meters the first week to more than two kilometers the fourth, allowing the pollen beetles to reach more distant OSR fields. These results suggest that early varieties away from woodlands and late varieties close to the woodlands may limit attacks at the time when oilseed rape is the most sensitive.	[Juhel, Amandine Suzanne; Barbu, Corentin Mario; Roger-Estrade, Jean; Butier, Arnaud; Bazot, Mathieu; Valantin-Morison, Muriel] Univ Paris Saclay, AgroParisTech, INRA, UMR Agron, Thiverval Grignon, France; [Franck, Pierre] INRA, Plantes & Syst Culture Hort UR1115, Avignon, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; INRAE	Juhel, AS (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, UMR Agron, Thiverval Grignon, France.	juhelamandine1@gmail.com		Roger-Estrade, Jean/0000-0003-1443-0303; Franck, Pierre/0000-0002-1904-8325	Predictive Ecological Engineering for landscape ecosystem services and sustainability [ANR-12-AGRO-0006]; Sustainable Management of Crop Health	Predictive Ecological Engineering for landscape ecosystem services and sustainability; Sustainable Management of Crop Health	Funding provided by Predictive Ecological Engineering for landscape ecosystem services and sustainability (ANR-12-AGRO-0006), PF MVM; and Sustainable Management of Crop Health (http://www.smach.inra.fr/).	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Audisio P., 1993, COLEOPTERA NITIDULID; Barbu CM, 2017, YET ANOTHER METROPOL; Barbu C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000777; Bivand R, 2013, INTERFACE GEOMETRY E; Blitzer EJ, 2012, AGR ECOSYST ENVIRON, V146, P34, DOI 10.1016/j.agee.2011.09.005; Buchi R, 2002, AGR ECOSYST ENVIRON, V90, P255, DOI 10.1016/S0167-8809(01)00213-4; Cook SM, 2007, ARTHROPOD-PLANT INTE, V1, P57, DOI 10.1007/s11829-007-9004-5; Cook SM, 2007, ANNU REV ENTOMOL, V52, P375, DOI 10.1146/annurev.ento.52.110405.091407; Cook Samantha M., 2004, IOBC-WPRS Bulletin, V27, P199; Ferguson AW, 2003, AGR ECOSYST ENVIRON, V95, P509, DOI 10.1016/S0167-8809(02)00200-1; Ferguson AW, 2014, PEST MANAG SCI; Frearson DJT, 2005, ENTOMOL EXP APPL, V116, P21, DOI 10.1111/j.1570-7458.2005.00299.x; FREE JB, 1978, J AGR SCI, V90, P417, DOI 10.1017/S0021859600055520; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Geweke J, 1991, BAYESIAN STAT, V4; Hansen LM, 2004, CROP PROT, V23, P43, DOI 10.1016/S0261-2194(03)00167-4; Hansen LM, 2003, PEST MANAG SCI, V59, P1057, DOI 10.1002/ps.737; Heimbach U, 2013, PEST MANAG SCI, V69, P209, DOI 10.1002/ps.3351; Herve MR, 2014, ARTHROPOD-PLANT INTE, V8, P383, DOI 10.1007/s11829-014-9321-4; Hokkanen Heikki M.T., 2004, IOBC-WPRS Bulletin, V27, P293; Husberg GB, 2001, BIOCONTROL, V46, P261, DOI 10.1023/A:1011479616787; Junk J, 2016, METEOROL Z, V25, P357, DOI 10.1127/metz/2015/0665; Mauchline AL, 2017, PEST MANAG SCI, V73, P1076, DOI 10.1002/ps.4550; McCollin D, 2000, J ENVIRON MANAGE, V60, P77, DOI 10.1006/jema.2000.0363; Nathan R, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P187; Nilsson Christer, 2004, IOBC-WPRS Bulletin, V27, P215; Raftery AE., 1992, BAYESIAN STAT, V4, P763; Richardson D. M., 2008, Bulletin OEPP, V38, P68, DOI 10.1111/j.1365-2338.2008.01183.x; Rusch A, 2012, LANDSCAPE URBAN PLAN, V105, P62, DOI 10.1016/j.landurbplan.2011.11.021; Rusch A, 2013, AGR ECOSYST ENVIRON, V166, P118, DOI 10.1016/j.agee.2011.05.004; Rusch A, 2012, AGR FOREST ENTOMOL, V14, P37, DOI 10.1111/j.1461-9563.2011.00547.x; Schneider G, 2015, J APPL ECOL, V52, P1283, DOI 10.1111/1365-2664.12471; Skellern MP, 2017, AGR ECOSYST ENVIRON, V241, P150, DOI 10.1016/j.agee.2017.03.008; STECHMANN DH, 1976, ANZ SCHADLINGSKD PFL, V49, P183, DOI 10.1007/BF01984584; TAIMR LUBOMIR, 1967, ACTA ENTOMOL BOHEMOSLOV, V64, P325; Tscharntke T, 2005, ECOL LETT, V8, P857, DOI 10.1111/j.1461-0248.2005.00782.x; Valantin-Morison M, 2007, CROP PROT, V26, P1108, DOI 10.1016/j.cropro.2006.10.005; Veromann E., 2006, Agronomy Research, V4, P447; Williams IH, 2010, BIOCONTROL-BASED INTEGRATED MANAGEMENT OF OILSEED RAPE PESTS, P1, DOI 10.1007/978-90-481-3983-5; Williams IH, 2007, AGR FOREST ENTOMOL, V9, P279, DOI 10.1111/j.1461-9563.2007.00343.x; Zaller JG, 2008, BASIC APPL ECOL, V9, P682, DOI 10.1016/j.baae.2007.10.004; Zaller JG, 2008, AGR ECOSYST ENVIRON, V123, P233, DOI 10.1016/j.agee.2007.07.002	43	10	10	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183878	10.1371/journal.pone.0183878	http://dx.doi.org/10.1371/journal.pone.0183878			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841712	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700067
J	Calazans, A; Boggiano, C; Lindsay, R				Calazans, Alexandre; Boggiano, Cesar; Lindsay, Ross			A DNA inducing VLP vaccine designed for HIV and tested in mice	PLOS ONE			English	Article							NEUTRALIZING ANTIBODY; T-CELLS; VIRUS; GLYCOPROTEINS; RESPONSES; EPITOPES; ENVELOPE; DISEASE	We developed a DNA vaccine that induces the formation of a VLP in vivo. This VLP was designed to elicit neutralizing antibodies, to induce better T-cell responses and to activate the innate immune system. Overall, 5 groups of 10 mice were electroporated with the following constructs: pVLP-LTR-GagPro [full], pVLP-GagPro [VLP wihout RNA], pVLP-LTR-Gag [VLP immature], pVLP-Gag and pVLP-EnvBG505 [regular DNA vaccine] and a mock group. We performed ICS on the mouse spleens and performed ELISA for ENV antibodies and a Luminex assay for inflammatory cytokines. The VLP showed good binding to the neutralizing antibodies. The percentage of CD4 cells producing cytokines was 0.1% [IFNg], 0.15% [IL-2] and 0.2% [TNFa] for the construct pVLP-LTR-GagPro. The percentage of CD8 cells producing cytokines was 0.3%[IFNg], 0.2%[IL-2] and 0.25%[TNFa]. All pVLP constructs induced more antibodies for EnvBG505 than the regular DNA vaccine Env. The pVLP-LTR-GagPro induced more IL-1B than the other constructs 24 hours post-vaccination.	[Calazans, Alexandre; Boggiano, Cesar; Lindsay, Ross] Int AIDS Vaccine Initiat, Design & Dev Lab, Brooklyn, NY USA; [Calazans, Alexandre] Fundacao Oswaldo Cruz, Ctr Technol Dev Hlth, Rio De Janeiro, Brazil	International AIDS Vaccine Initiative; Center for Technological Development in Health (CDTS); Fundacao Oswaldo Cruz	Calazans, A (corresponding author), Int AIDS Vaccine Initiat, Design & Dev Lab, Brooklyn, NY USA.; Calazans, A (corresponding author), Fundacao Oswaldo Cruz, Ctr Technol Dev Hlth, Rio De Janeiro, Brazil.	acalazans@cdts.fiocruz.br		Calazans, Alexandre/0000-0002-4628-2862	Gilead Foundation	Gilead Foundation(Gilead Sciences)	This work was supported by a Gilead Foundation Fellowship Grant to Alexandre Calazans.	Barouch DH, 2008, NATURE, V455, P613, DOI 10.1038/nature07352; BARRESINOUSSI F, 1983, SCIENCE, V220, P868, DOI 10.1126/science.6189183; Cale EM, 2017, IMMUNITY, V46, P777, DOI 10.1016/j.immuni.2017.04.011; Chapman R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173352; Deml L, 1997, VIROLOGY, V235, P26, DOI 10.1006/viro.1997.8668; Excler JL, 2015, VACCINE, V33, pD4, DOI 10.1016/j.vaccine.2015.03.059; FULLER DH, 1994, AIDS RES HUM RETROV, V10, P1433, DOI 10.1089/aid.1994.10.1433; Gunn BM, 2016, TRENDS MOL MED, V22, P969, DOI 10.1016/j.molmed.2016.09.002; Heil F, 2012, SCIENCE, P1526; Hoffenberg S, 2013, J VIROL, V87, P5372, DOI 10.1128/JVI.02827-12; Julien JP, 2013, P NATL ACAD SCI USA, V110, P4351, DOI 10.1073/pnas.1217537110; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Kuscetti FW, 1984, SCIENCE, V224, P500; Levitz SM, 2012, CELL, V148, P1284, DOI 10.1016/j.cell.2012.02.012; Liao HX, 2013, NATURE, V496, P469, DOI 10.1038/nature12053; Liu MA, 2010, IMMUNITY, V33, P504, DOI 10.1016/j.immuni.2010.10.004; Lu K, 2011, SCIENCE, V334, P242, DOI 10.1126/science.1210460; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; Moussa M, 2015, VACCINE, V33, P2273, DOI 10.1016/j.vaccine.2015.03.021; Pulendran B, 2011, NAT IMMUNOL, V12, P509, DOI 10.1038/ni.2039; Rolland M, 2012, NATURE, V490, P417, DOI 10.1038/nature11519; Sacha JB, 2008, J VIROL, V82, P9293, DOI 10.1128/JVI.00749-08; Vaccari M, 2016, NAT MED, V22; Visciano ML, 2011, VACCINE, V29, P4903, DOI 10.1016/j.vaccine.2011.05.005; Williamson AL, 2015, EXPERT REV VACCINES, V15, P1	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183803	10.1371/journal.pone.0183803	http://dx.doi.org/10.1371/journal.pone.0183803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837706	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000125
J	Christie, D; Rashid, H; El-Bashir, H; Sweeney, F; Shore, T; Booy, R; Viner, RM				Christie, Deborah; Rashid, Harunor; El-Bashir, Haitham; Sweeney, Faye; Shore, Tim; Booy, Robert; Viner, Russell M.			Impact of meningitis on intelligence and development: A systematic review and meta-analysis	PLOS ONE			English	Review							BACTERIAL-MENINGITIS; SEQUELAE; OUTCOMES; CHILDREN; DISEASE; YOUTH	Background We undertook a systematic review and meta-analysis to address the question "what is the impact of meningitis on IQ and development." Methods Search: conducted using standardized search terms across Medline, PsychInfo and EMBASE to 06/2014. Eligibility: human studies of any infectious aetiology of meningitis reporting IQ or infant developmental age or stage outcomes. Quality: Centre for Evidence Based Medicine, Oxford, quality tools. Analysis: random effects meta-analysis by organism. Results 39 studies were included in the review, 34 providing data on IQ (2015 subjects) and 12 on developmental delay (382 subjects). Across all bacterial organisms, meningitis survivors had a mean IQ 5.50 (95% CI: -7.19, -3.80; I-2 = 47%, p = 0.02) points lower than controls. IQ was significantly lower than controls for Neisseria meningitides (NM: 5 points) and Haemophilus influenzae b (Hib: 6 points) but not in viral meningitis, with only single studies included for Streptococcus pneumoniae (SP) and group B streptococcus (GBS). The pooled relative risk (RR) for low IQ (IQ<70) in survivors of bacterial meningitis compared with controls was 4.99 (95% CI: 3.17, 7.86) with no significant heterogeneity (I2 = 49%, p = 0.07). Developmental delay of approximately 0.5SD was reported in studies of bacterial meningitis but no delay in the only study of viral meningitis. Conclusions We found moderate evidence that surviving bacterial meningitis has a deleterious impact on IQ and development but no evidence that viral meningitis had meaningful cognitive impacts. Survivors of bacterial meningitis should be routinely offered screening for cognitive deficits and developmental delay in addition to hearing loss.	[Christie, Deborah] UCL Inst Epidemiol & Hlth Care, London, England; [Rashid, Harunor; Booy, Robert] Childrens Hosp Westmead, Natl Ctr Immunisat Res & Surveillance Vaccine Pre, Westmead, NSW, Australia; [Rashid, Harunor; Booy, Robert] Univ Sydney, Sydney Med Sch, Discipline Paediat & Child Hlth, Sydney, NSW, Australia; [El-Bashir, Haitham] Al Jalila Children Specialty Hosp, Rehabil Dept, Dubai, U Arab Emirates; [Sweeney, Faye; Shore, Tim; Viner, Russell M.] UCL Inst Child Hlth, London, England	University of London; University College London; University of Sydney; University of Sydney; University of London; University College London	Viner, RM (corresponding author), UCL Inst Child Hlth, London, England.	r.viner@ucl.ac.uk	Viner, Russell/A-1441-2009	Viner, Russell/0000-0003-3047-2247	UK Meningitis Trust; UK Meningitis Trust	UK Meningitis Trust; UK Meningitis Trust	This work was funded by a grant by the UK Meningitis Trust to the first and last authors. The Meningitis Trust is now named Meningitis Now.	BARAFF LJ, 1993, PEDIATR INFECT DIS J, V12, P389, DOI 10.1097/00006454-199305000-00008; Calvin CM, 2011, INT J EPIDEMIOL, V40, P626, DOI 10.1093/ije/dyq190; Damsgaard J, 2015, INFECT DIS-NOR, V47, P357, DOI 10.3109/23744235.2015.1018838; Edmond K, 2010, LANCET INFECT DIS, V10, P317, DOI 10.1016/S1473-3099(10)70048-7; FASS PS, 1980, AM J EDUC, V88, P431, DOI 10.1086/443541; McIntyre PB, 2012, LANCET, V380, P1703, DOI 10.1016/S0140-6736(12)61187-8; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Ramakrishnan M, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-47; Sadarangani M, 2015, ARCH DIS CHILD, V100, P292, DOI 10.1136/archdischild-2014-306813; van de Beek D, 2012, LANCET, V380, P1693, DOI 10.1016/S0140-6736(12)61186-6; Viner RM, 2012, LANCET NEUROL, V11, P774, DOI 10.1016/S1474-4422(12)70180-1; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wraw C, 2015, INTELLIGENCE, V53, P23, DOI 10.1016/j.intell.2015.08.001	14	18	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0175024	10.1371/journal.pone.0175024	http://dx.doi.org/10.1371/journal.pone.0175024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837564	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000001
J	Curtis, CE; Al Bahar, F; Marriott, JF				Curtis, Christopher E.; Al Bahar, Fares; Marriott, John F.			The effectiveness of computerised decision support on antibiotic use in hospitals: A systematic review	PLOS ONE			English	Review							ANTIMICROBIAL STEWARDSHIP PROGRAM; BROAD-SPECTRUM ANTIBIOTICS; LENGTH-OF-STAY; STAPHYLOCOCCUS-AUREUS; PATIENT OUTCOMES; CONTROLLED-TRIAL; APPROVAL SYSTEM; ORDER SET; IMPACT; IMPLEMENTATION	Background Inappropriate antimicrobial use has been shown to be an important determinant of the emergence of antimicrobial resistance (AMR). Health information technology (HIT) in the form of Computerised Decision Support (CDS) represents an option for improving antimicrobial prescribing and containing AMR. Objectives To evaluate the evidence for CDS in improving quantitative and qualitative measures of antibiotic prescribing in inpatient hospital settings. Methods A systematic literature search was conducted of articles published from inception to 20th December 2014 using eight electronic databases: MEDLINE, EMBASE, PUBMED, Web of Science, CINAHL, Cochrane Library, HMIC and PsychINFo. An updated systematic literature search was conducted from January 1st 2015 to October 1st 2016 using PUBMED. The search strategy used combinations of the following terms: (electronic prescribing) OR (clinical decision support) AND (antibiotic or antibacterial or antimicrobial) AND (hospital or secondary care or inpatient). Studies were evaluated for quality using a 10-point rating scale. Results Eighty-one studies were identified matching the inclusion criteria. Seven outcome measures were evaluated: adequacy of antibiotic coverage, mortality, volume of antibiotic usage, length of stay, antibiotic cost, compliance with guidelines, antimicrobial resistance, and CDS implementation and uptake. Meta-analysis of pooled outcomes showed CDS significantly improved the adequacy of antibiotic coverage (n = 13; odds ratio [OR], 2.11 [95% CI, 1.67 to 2.66, p <= 0.00001]). Also, CDS was associated with marginally lowered mortality (n = 20; OR, 0.85 [CI, 0.75 to 0.96, p = 0.01]). CDS was associated with lower antibiotic utilisation, increased compliance with antibiotic guidelines and reductions in antimicrobial resistance. Conflicting effects of CDS on length of stay, antibiotic costs and system uptake were also noted. Conclusions CDS has the potential to improve the adequacy of antibiotic coverage and marginally decrease mortality in hospital-related settings.	[Curtis, Christopher E.; Al Bahar, Fares; Marriott, John F.] Univ Birmingham, Sch Pharm, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Al Bahar, Fares] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Curtis, CE (corresponding author), Univ Birmingham, Sch Pharm, Coll Med & Dent Sci, Birmingham, W Midlands, England.	c.e.curtis@bham.ac.uk		Al Bahar, Fares/0000-0002-4302-6636; Curtis, Christopher/0000-0002-2244-867X	University of Birmingham, UK; Zarqa University, Zarqa, Jordan	University of Birmingham, UK; Zarqa University, Zarqa, Jordan	Fares AI Bahar has had his Ph.D student course fees to attend the University of Birmingham, UK, paid for by Zarqa University, Zarqa, Jordan.	Agwu AL, 2008, CLIN INFECT DIS, V47, P747, DOI 10.1086/591133; Arboe B, 2014, INT J INFECT DIS, V29, P156, DOI 10.1016/j.ijid.2014.08.019; Bates DW, 2003, J AM MED INFORM ASSN, V10, P523, DOI 10.1197/jamia.M1370; Baysari MT, 2016, INT J MED INFORM, V92, P15, DOI 10.1016/j.ijmedinf.2016.04.008; Black AD, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000387; Bourdeaux CP, 2014, BMJ QUAL SAF, V23, P382, DOI 10.1136/bmjqs-2013-002395; Brady PW, 2014, BMJ QUAL SAF, V23, P499, DOI 10.1136/bmjqs-2013-002179; Bright TJ, 2012, ANN INTERN MED, V157, P29, DOI 10.7326/0003-4819-157-1-201207030-00450; Buising KL, 2008, J ANTIMICROB CHEMOTH, V62, P608, DOI 10.1093/jac/dkn218; Buising KL, 2008, BMC MED INFORM DECIS, V8, DOI 10.1186/1472-6947-8-35; Burke JP, 1999, J CHEMOTHERAPY, V11, P530, DOI 10.1179/joc.1999.11.6.530; BURTON ME, 1991, CLIN PHARMACOL THER, V49, P685, DOI 10.1038/clpt.1991.86; Calloway Stacy, 2013, Hosp Pharm, V48, P744, DOI 10.1310/hpj4809-744; Caplinger C, 2016, ANTIBIOTICS-BASEL, V5, DOI 10.3390/antibiotics5010007; Chan ALF, 2006, AM J HEALTH-SYST PH, V63, P1344, DOI 10.2146/ajhp050474; Chan YY, 2011, INT J ANTIMICROB AG, V38, P486, DOI 10.1016/j.ijantimicag.2011.08.011; Chow AL, 2016, INT J ANTIMICROB AG, V47, P132, DOI 10.1016/j.ijantimicag.2015.12.006; Chow ALP, 2016, J AM MED INFORM ASSN, V23, pE58, DOI 10.1093/jamia/ocv120; Cook PP, 2011, J ANTIMICROB CHEMOTH, V66, P205, DOI 10.1093/jac/dkq404; Dean NC, 2015, ANN EMERG MED, V66, P511, DOI 10.1016/j.annemergmed.2015.02.003; Dellit TH, 2007, CLIN INFECT DIS, V44, P159, DOI 10.1086/510393; Demonchy E, 2014, J ANTIMICROB CHEMOTH, V69, P2857, DOI 10.1093/jac/dku191; DerSimonian R, 2007, CONTEMP CLIN TRIALS, V28, P105, DOI 10.1016/j.cct.2006.04.004; Diasinos N, 2015, INTERN MED J, V45, P55, DOI 10.1111/imj.12627; Evans R S, 1995, Proc Annu Symp Comput Appl Med Care, P651; Evans RS, 1999, ANN PHARMACOTHER, V33, P1026, DOI 10.1345/aph.18391; Evans RS, 1998, NEW ENGL J MED, V338, P232, DOI 10.1056/NEJM199801223380406; EVANS RS, 1994, ARCH INTERN MED, V154, P878, DOI 10.1001/archinte.154.8.878; Filice GA, 2013, INFECT CONT HOSP EP, V34, P558, DOI 10.1086/670627; Fischer MA, 2003, ARCH INTERN MED, V163, P2585, DOI 10.1001/archinte.163.21.2585; Garg AX, 2005, JAMA-J AM MED ASSOC, V293, P1223, DOI 10.1001/jama.293.10.1223; Giuliano KK, 2011, AM J CRIT CARE, V20, P313, DOI 10.4037/ajcc2011421; Grayson ML, 2004, MED J AUSTRALIA, V180, P455, DOI 10.5694/j.1326-5377.2004.tb06022.x; Holstiege J, 2015, J AM MED INFORM ASSN, V22, P236, DOI 10.1136/amiajnl-2014-002886; Hum RS, 2014, APPL CLIN INFORM, V5, P368, DOI 10.4338/ACI-2013-09-RA-0069; Hunt DL, 1998, JAMA-J AM MED ASSOC, V280, P1339, DOI 10.1001/jama.280.15.1339; Karsies Todd J, 2014, Ann Am Thorac Soc, V11, P1569, DOI 10.1513/AnnalsATS.201408-389OC; Kawamoto K, 2005, BMJ-BRIT MED J, V330, P765, DOI 10.1136/bmj.38398.500764.8F; Kim J, 2013, EUR J CLIN MICROBIOL, V32, P937, DOI 10.1007/s10096-013-1829-5; King WJ, 2007, BMC PEDIAT, V7; Kofoed K, 2009, J ANTIMICROB CHEMOTH, V63, P400, DOI 10.1093/jac/dkn504; Leibovici L, 1997, J INTERN MED, V242, P395, DOI 10.1046/j.1365-2796.1997.00232.x; Leibovici L, 2013, J ANTIMICROB CHEMOTH, V68, P2664, DOI 10.1093/jac/dkt222; Linares LA, 2011, INFECT CONT HOSP EP, V32, P644, DOI 10.1086/660764; McGregor JC, 2006, J AM MED INFORM ASSN, V13, P378, DOI 10.1197/jamia.M2049; Micek ST, 2014, CRIT CARE MED, V42, P1832, DOI 10.1097/CCM.0000000000000337; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mullett CJ, 2004, INT J MED INFORM, V73, P455, DOI 10.1016/j.ijmedinf.2004.04.002; Mullett CJ, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.4.e75; Nachtigall I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005370; Pearson Sallie-Anne, 2009, BMC Health Serv Res, V9, P154, DOI 10.1186/1472-6963-9-154; Pestotnik SL, 1996, ANN INTERN MED, V124, P884, DOI 10.7326/0003-4819-124-10-199605150-00004; Pogue JM, 2014, INFECT CONT HOSP EP, V35, P132, DOI 10.1086/674849; Potasman I, 2012, ISR MED ASSOC J, V14, P415; Revolinski S, 2015, ANTIBIOTICS-BASEL, V4, P667, DOI 10.3390/antibiotics4040667; Rodriguez-Maresca M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/395434; Rohrig R, 2008, STUD HEALTH TECHNOL, V136, P63; Schulz L, 2013, INFECT CONT HOSP EP, V34, P1259, DOI 10.1086/673977; Shebl NA, 2007, PHARM WORLD SCI, V29, P342, DOI 10.1007/s11096-007-9113-3; Shojania KG, 1998, J AM MED INFORM ASSN, V5, P554, DOI 10.1136/jamia.1998.0050554; Sintchenko V, 2005, J AM MED INFORM ASSN, V12, P398, DOI 10.1197/jamia.M1798; Sintchenko V, 2004, J AM MED INFORM ASSN, V11, P71, DOI 10.1197/jamia.M1166; Staicu ML, 2016, AM J HEALTH-SYST PH, V73, P298, DOI 10.2146/ajhp150288; Stevenson KB, 2005, AM J MED QUAL, V20, P313, DOI 10.1177/1062860605281175; Tafelski S, 2010, J INT MED RES, V38, P1605, DOI 10.1177/147323001003800505; Thiel SW, 2009, CRIT CARE MED, V37, P819, DOI 10.1097/CCM.0b013e318196206b; Thursky KA, 2006, INT J QUAL HEALTH C, V18, P224, DOI 10.1093/intqhc/mzi095; Van Sise MA, 2012, OBSTET GYNECOL, V120, P1382, DOI [http://10.1097/AOG.0b013e318273754d, 10.1097/AOG.0b013e318273754d]; Westphal JF, 2011, PHARMACOEPIDEM DR S, V20, P162, DOI 10.1002/pds.2078; Yong MK, 2010, J ANTIMICROB CHEMOTH, V65, P1062, DOI 10.1093/jac/dkq058	70	48	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183062	10.1371/journal.pone.0183062	http://dx.doi.org/10.1371/journal.pone.0183062			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837665	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000044
J	Shin, J; Song, SY; Ahn, HS; An, BC; Choi, YD; Yang, EG; Na, KJ; Lee, ST; Park, JI; Kim, SY; Lee, C; Lee, SW				Shin, Jihye; Song, Sang-Yun; Ahn, Hee-Sung; An, Byung Chull; Choi, Yoo-Duk; Yang, Eun Gyeong; Na, Kook-Joo; Lee, Seung-Taek; Park, Jae-Il; Kim, Seon-Young; Lee, Cheolju; Lee, Seung-won			Integrative analysis for the discovery of lung cancer serological markers and validation by MRM-MS	PLOS ONE			English	Article							GLUTATHIONE-PEROXIDASE GPX3; CHOLINESTERASE ACTIVITY; BIOMARKER CANDIDATES; MASS-SPECTROMETRY; PROTEOMICS; PREDICTION; ADENOCARCINOMA; QUANTIFICATION; QUANTITATION; VERIFICATION	Non-small-cell lung cancer (NSCLC) constitutes approximately 80% of all diagnosed lung cancers, and diagnostic markers detectable in the plasma/serum of NSCLC patients are greatly needed. In this study, we established a pipeline for the discovery of markers using 9 transcriptome datasets from publicly available databases and profiling of six lung cancer cell secretomes. Thirty-one out of 312 proteins that overlapped between two-fold differentially expressed genes and identified cell secretome proteins were detected in the pooled plasma of lung cancer patients. To quantify the candidates in the serum of NSCLC patients, multiple- reaction-monitoring mass spectrometry (MRM-MS) was performed for five candidate biomarkers. Finally, two potential biomarkers (BCHE and GPx3; AUC = 0.713 and 0.673, respectively) and one two-marker panel generated by logistic regression (BCHE/GPx3; AUC = 0.773) were identified. A validation test was performed by ELISA to evaluate the reproducibility of GPx3 and BCHE expression in an independent set of samples (BCHE and GPx3; AUC = 0.630 and 0.759, respectively, BCHE/GPx3 panel; AUC = 0.788). Collectively, these results demonstrate the feasibility of using our pipeline for marker discovery and our MRM-MS platform for verifying potential biomarkers of human diseases.	[Shin, Jihye; Ahn, Hee-Sung; Yang, Eun Gyeong; Lee, Cheolju] Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea; [Shin, Jihye; Lee, Seung-Taek] Yonsei Univ, Dept Biochem, Coll Life Sci & Biotechnol, Seoul, South Korea; [Song, Sang-Yun; Na, Kook-Joo] Chonnam Natl Univ, Dept Thorac & Cardiovasc Surg, Hwasun Hosp, Hwasun Gun, Jeollanam Do, South Korea; [Ahn, Hee-Sung; Lee, Cheolju] Korea Univ Sci & Technol, KIST Sch, Daejeon, South Korea; [An, Byung Chull; Lee, Seung-won] Chonnam Natl Univ, Dept Anat, Med Sch, Hwasun Gun, Jeollanam Do, South Korea; [Choi, Yoo-Duk] Chonnam Natl Univ Hosp, Dept Pathol, Gwangju, South Korea; [Park, Jae-Il] Korea Basic Sci Inst, Anim Facil Aging Sci, Gwangju, South Korea; [Kim, Seon-Young] Korea Res Inst Biosci & Biotechnol, Personalized Genom Res Ctr, Daejeon, South Korea; [Kim, Seon-Young] Univ Sci & Technol, Dept Funct Genom, Daejeon, South Korea	Korea Institute of Science & Technology (KIST); Yonsei University; Chonnam National University; Korea Institute of Science & Technology (KIST); University of Science & Technology (UST); Chonnam National University; Chonnam National University; Chonnam National University Hospital; Korea Basic Science Institute (KBSI); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Lee, C (corresponding author), Korea Inst Sci & Technol, Ctr Theragnosis, Seoul, South Korea.; Lee, C (corresponding author), Korea Univ Sci & Technol, KIST Sch, Daejeon, South Korea.; Lee, SW (corresponding author), Chonnam Natl Univ, Dept Anat, Med Sch, Hwasun Gun, Jeollanam Do, South Korea.	clee270@kist.re.kr; seunglee@chonnam.ac.kr		Ahn, Hee-Sung/0000-0003-2241-6536	National Research Foundation of Korea [NRF-2017M3A9F9030559, NRF-2017M3A9F9030565]; Korea Health Industry Development Institute [HI14C3484]; Chonnam National University Hospital Biomedical Research Institute [CRI 15023-21]	National Research Foundation of Korea(National Research Foundation of Korea); Korea Health Industry Development Institute(Korea Health Industry Development Institute (KHIDI)); Chonnam National University Hospital Biomedical Research Institute	The study was supported by grants from the National Research Foundation of Korea (NRF-2017M3A9F9030559, NRF-2017M3A9F9030565) and Korea Health Industry Development Institute (HI14C3484) to CL. This study was also supported by a grant (CRI 15023-21) from the Chonnam National University Hospital Biomedical Research Institute to SWL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnani D, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-18; Ahn JM, 2014, MOL CELL PROTEOMICS, V13, P30, DOI 10.1074/mcp.M113.028621; AVISSAR N, 1994, AM J PHYSIOL, V266, pC367, DOI 10.1152/ajpcell.1994.266.2.C367; Barrett CW, 2013, CANCER RES, V73, P1245, DOI 10.1158/0008-5472.CAN-12-3150; Bendtsen JD, 2004, PROTEIN ENG DES SEL, V17, P349, DOI 10.1093/protein/gzh037; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boja ES, 2014, J PROTEOME RES, V13, P5325, DOI 10.1021/pr500753r; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brigelius-Flohe R, 2009, BBA-GEN SUBJECTS, V1790, P1555, DOI 10.1016/j.bbagen.2009.03.006; Broet P, 2009, CANCER RES, V69, P1055, DOI 10.1158/0008-5472.CAN-08-1116; Brown KJ, 2012, EXPERT REV PROTEOMIC, V9, P337, DOI [10.1586/epr.12.21, 10.1586/EPR.12.21]; Chen BS, 2011, CANCER LETT, V309, P37, DOI 10.1016/j.canlet.2011.05.013; Chen CD, 2014, J PROTEOME RES, V13, P2818, DOI 10.1021/pr4012377; Crispi S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007016; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Domanski D, 2012, PROTEOMICS, V12, P1222, DOI 10.1002/pmic.201100568; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gould MK, 2013, CHEST, V143, pE93, DOI 10.1378/chest.12-2351; Gregorc V, 2014, LANCET ONCOL, V15, P713, DOI 10.1016/S1470-2045(14)70162-7; Han SH, 2014, MOL CELL PROTEOMICS, V13, P407, DOI 10.1074/mcp.M113.028639; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huttenhain R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003989; KANIARIS P, 1979, ANESTH ANALG, V58, P82; Kim JS, 2014, ANAL CHIM ACTA, V840, P1, DOI 10.1016/j.aca.2014.06.024; Kim JS, 2013, J PROTEOME RES, V12, P2582, DOI 10.1021/pr3011414; Kim YJ, 2015, J PROTEOME RES, V14, P1412, DOI 10.1021/pr5010828; Kobayashi M, 2015, LUNG CANCER, V90, P342, DOI 10.1016/j.lungcan.2015.08.015; Kuner R, 2009, LUNG CANCER, V63, P32, DOI 10.1016/j.lungcan.2008.03.033; Kuzyk MA, 2009, MOL CELL PROTEOMICS, V8, P1860, DOI 10.1074/mcp.M800540-MCP200; Li LL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4536; Li XJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007013; Lim E, 2010, THORAX, V65, P1, DOI 10.1136/thx.2010.145938; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martinez-Moreno P, 2006, CARCINOGENESIS, V27, P429, DOI 10.1093/carcin/bgi250; Moller S, 2001, BIOINFORMATICS, V17, P646, DOI 10.1093/bioinformatics/17.7.646; Murawaki Y, 2008, CANCER LETT, V259, P218, DOI 10.1016/j.canlet.2007.10.019; Naidich DP, 2013, RADIOLOGY, V266, P304, DOI 10.1148/radiol.12120628; Oh IJ, 2014, THORAC CANCER, V5, P425, DOI 10.1111/1759-7714.12113; Olson GE, 2010, AM J PHYSIOL-RENAL, V298, pF1244, DOI 10.1152/ajprenal.00662.2009; Percy AJ, 2013, PROTEOMICS, V13, P2202, DOI 10.1002/pmic.201200316; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Rai AJ, 2005, PROTEOMICS, V5, P3262, DOI 10.1002/pmic.200401245; Sanchez-Palencia A, 2011, INT J CANCER, V129, P355, DOI 10.1002/ijc.25704; Shi TJ, 2012, P NATL ACAD SCI USA, V109, P15395, DOI 10.1073/pnas.1204366109; Shin J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121692; Thomas A, 2013, ANN ONCOL, V24, P577, DOI 10.1093/annonc/mds478; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Ummanni R, 2014, BBA-PROTEINS PROTEOM, V1844, P950, DOI 10.1016/j.bbapap.2013.11.017; Van Schil PE, 2012, EUR RESPIR J, V39, P478, DOI 10.1183/09031936.00027511; Wei TYW, 2012, CANCER SCI, V103, P1640, DOI 10.1111/j.1349-7006.2012.02367.x; Wrage M, 2009, CLIN CANCER RES, V15, P1566, DOI 10.1158/1078-0432.CCR-08-2188; Wu HY, 2015, J PROTEOME RES, V14, P3039, DOI 10.1021/pr501195t; Yamauchi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043923; Yu YP, 2007, CANCER RES, V67, P8043, DOI 10.1158/0008-5472.CAN-07-0648; Zanini D, 2013, MOL CELL BIOCHEM, V374, P137, DOI 10.1007/s11010-012-1513-6; Zhang X, 2010, INT J ONCOL, V36, P405, DOI 10.3892/ijo_00000513	57	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183896	10.1371/journal.pone.0183896	http://dx.doi.org/10.1371/journal.pone.0183896			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837649	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000134
J	Tapia, F; Jordan, I; Genzel, Y; Reichl, U				Tapia, Felipe; Jordan, Ingo; Genzel, Yvonne; Reichl, Udo			Efficient and stable production of Modified Vaccinia Ankara virus in two-stage semi-continuous and in continuous stirred tank cultivation systems	PLOS ONE			English	Article							SERUM-FREE MEDIA; INFLUENZA-VIRUS; MALARIA VACCINES; CULTURES; MVA; IMMUNOGENICITY; BIOREACTORS; BACULOVIRUS; PROTECTION; VECTORS	One important aim in cell culture-based viral vaccine and vector production is the implementation of continuous processes. Such a development has the potential to reduce costs of vaccine manufacturing as volumetric productivity is increased and the manufacturing footprint is reduced. In this work, continuous production of Modified Vaccinia Ankara (MVA) virus was investigated. First, a semi-continuous two-stage cultivation system consisting of two shaker flasks in series was established as a small-scale approach. Cultures of the avian AGE1.CR.pIX cell line were expanded in the first shaker, and MVA virus was propagated and harvested in the second shaker over a period of 8-15 days. A total of nine small-scale cultivations were performed to investigate the impact of process parameters on virus yields. Harvest volumes of 0.7-1 L with maximum TCID50 titers of up to 1.0x10(9) virions/mL were obtained. Genetic analysis of control experiments using a recombinant MVA virus containing green-fluorescent-protein suggested that the virus was stable over at least 16 d of cultivation. In addition, a decrease or fluctuation of infectious units that may indicate an excessive accumulation of defective interfering particles was not observed. The process was automated in a two-stage continuous system comprising two connected 1 L stirred tank bioreactors. Stable MVA virus titers, and a total production volume of 7.1 L with an average TCID50 titer of 9x10(7) virions/mL was achieved. Because titers were at the lower range of the shake flask cultivations potential for further process optimization at large scale will be discussed. Overall, MVA virus was efficiently produced in continuous and semi-continuous cultivations making two-stage stirred tank bioreactor systems a promising platform for industrial production of MVA-derived recombinant vaccines and viral vectors.	[Tapia, Felipe] Int Max Planck Res Sch Adv Methods Proc & Syst En, Magdeburg, Germany; [Tapia, Felipe; Genzel, Yvonne; Reichl, Udo] Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany; [Jordan, Ingo] ProBioGen AG, Berlin, Germany; [Reichl, Udo] Otto von Guericke Univ, Bioproc Engn, Magdeburg, Germany; [Jordan, Ingo] CureVac AG, Tubingen, Germany	Max Planck Society; Otto von Guericke University; CureVac N.V.	Tapia, F (corresponding author), Int Max Planck Res Sch Adv Methods Proc & Syst En, Magdeburg, Germany.; Tapia, F (corresponding author), Max Planck Inst Dynam Complex Tech Syst, Magdeburg, Germany.	tapia@mpi-magdeburg.mpg.de		Jordan, Ingo/0000-0003-2711-7252; Tapia Delgado, Felipe/0000-0002-8470-2047	Max Planck Society	Max Planck Society(Max Planck Society)	This work was supported by the Max Planck Society to FT. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BATT BC, 1990, BIOTECHNOL PROGR, V6, P458, DOI 10.1021/bp00006a600; deGooijer CD, 1996, ENZYME MICROB TECH, V18, P202, DOI 10.1016/0141-0229(95)00090-9; Dunachie S, 2015, VACCINE, V33, P5321, DOI 10.1016/j.vaccine.2015.07.087; Ewer K, 2016, NEW ENGL J MED, V374, P1635, DOI 10.1056/NEJMoa1411627; Frensing T, 2015, BIOTECHNOL J, V10, P681, DOI 10.1002/biot.201400429; Frensing T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072288; Genzel Y, 2006, VACCINE, V24, P6074, DOI 10.1016/j.vaccine.2006.05.023; GORI GB, 1965, APPL MICROBIOL, V13, P909, DOI 10.1128/AEM.13.6.909-917.1965; Green CA, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5745; Henry O, 2008, BIOTECHNOL PROGR, V24, P921, DOI [10.1002/btpr.17, 10.1021/bp.17]; Ortiz JMJ, 2014, VACCINE, V32, P4625, DOI 10.1016/j.vaccine.2014.06.075; Jordan I, 2009, VACCINE, V27, P748, DOI 10.1016/j.vaccine.2008.11.066; Jordan I, 2013, VIRUSES-BASEL, V5, P321, DOI 10.3390/v5010321; Jordan I, 2011, BIOLOGICALS, V39, P50, DOI 10.1016/j.biologicals.2010.11.005; Konstantinov KB, 2015, J PHARM SCI-US, V104, P813, DOI 10.1002/jps.24268; Kreijtz JHCM, 2015, J INFECT DIS, V211, P791, DOI 10.1093/infdis/jiu528; Kremer Melanie, 2012, Methods Mol Biol, V890, P59, DOI 10.1007/978-1-61779-876-4_4; Leung-Theung-Long S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143552; Lohr V, 2009, VACCINE, V27, P4975, DOI 10.1016/j.vaccine.2009.05.083; Lohr V., 2014, THESIS; Marin-Lopez A, 2016, METHODS MOL BIOL, V1349, P137, DOI 10.1007/978-1-4939-3008-1_9; Milligan ID, 2016, JAMA-J AM MED ASSOC, V315, P1610, DOI 10.1001/jama.2016.4218; MOSS B, 1981, P NATL ACAD SCI-BIOL, V78, P1614, DOI 10.1073/pnas.78.3.1614; MOYER RW, 1980, VIROLOGY, V102, P119, DOI 10.1016/0042-6822(80)90075-6; Sebastian S, 2016, EXPERT REV VACCINES, V15, P91, DOI 10.1586/14760584.2016.1106319; Tapia F, 2016, APPL MICROBIOL BIOT, V100, P2121, DOI 10.1007/s00253-015-7267-9; vanLier FLJ, 1996, ENZYME MICROB TECH, V18, P460, DOI 10.1016/0141-0229(95)00129-8; VANLIER FLJ, 1990, APPL MICROBIOL BIOT, V33, P43, DOI 10.1007/BF00170567; Verheust C, 2012, VACCINE, V30, P2623, DOI 10.1016/j.vaccine.2012.02.016; Vijayan A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133595; Volz A, 2016, VACCINE, V34, P1915, DOI 10.1016/j.vaccine.2016.02.042; Walther J, 2015, J BIOTECHNOL, V213, P3, DOI 10.1016/j.jbiotec.2015.05.010; Weber C, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003684; WESTGATE PJ, 1990, BIOTECHNOL BIOENG, V35, P437, DOI 10.1002/bit.260350502; Zitzmann-Roth EM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122653	35	11	11	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182553	10.1371/journal.pone.0182553	http://dx.doi.org/10.1371/journal.pone.0182553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837572	gold, Green Published			2022-12-27	WOS:000408365000020
J	Tung, CH; Lu, MC; Lai, NS; Wu, SF				Tung, Chien-Hsueh; Lu, Ming-Chi; Lai, Ning-Sheng; Wu, Shu-Fen			Tumor necrosis factor-alpha blockade treatment decreased CD154 (CD40-ligand) expression in rheumatoid arthritis	PLOS ONE			English	Article							CARTILAGE PANNUS JUNCTION; TNF-ALPHA; CD40 LIGAND; T-CELLS; PEPTIDE ANTIBODY; DISEASE-ACTIVITY; SERUM-LEVELS; THERAPY; METHOTREXATE; INFLIXIMAB	Contexts CD154 (commonly referred to as CD40-ligand) is a critical T cell factor that participates in the pathogenesis of autoimmune and is over-expressed in rheumatoid arthritis (RA). TNF-alpha blockade treatment had dramatic efficacy in RA. Objective To investigate whether TNF-alpha blockade treatment can inhibit CD154 expression in RA. Methods Blood samples were collected from 33 patients with rheumatoid arthritis before and 3 months after TNF-alpha blockade treatment. Clinical serological data determined by standard assays and T cell CD154 expression levels determined by flow cytometry were statistically analyzed for these two time points. Results The percentage of CD154 expression on gated CD4+ T cells of PBMCs from RA patients after 3 months TNF-alpha blockade treatment was significantly lower than before treatment (2.94 +/- 3.21% vs. 7.21 +/- 5.64%; p = 0.0001). The disease activity and anti-CCP antibody levels were also significantly reduced after TNF-alpha blockade treatment. The CD154 expression levels were positively correlated with disease activity index DAS28, and CRP. The post-stimulated CD154 expression percentage of purified CD4+ T cells between baseline and after TNF-alpha blockade treatment was not significantly different (p = 0.221). Baseline CD154 levels were positively correlated with treatment-induced changes in DAS28 (p = 0.014; r2 = 0.187). Conclusions TNF-alpha blockade treatment significantly decreased the CD154 expression on CD4+ T cells, disease activity and anti-CCP antibody simultaneously in RA patients. However TNF-alpha blockade did not impair T cell capacity to express CD154 after stimulation. These results suggest that decreased CD154 expression after TNF-alpha blockade may be due to decreased RA disease activity but not direct inhibition of CD154 responsiveness of T cells.	[Tung, Chien-Hsueh; Lu, Ming-Chi; Lai, Ning-Sheng] Buddhist Tzu Chi Med Fdn, Dalin Tzu Chi Hosp, Div Allergy Immunol & Rheumatol, Chiayi, Taiwan; [Tung, Chien-Hsueh; Lu, Ming-Chi; Lai, Ning-Sheng] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Tung, Chien-Hsueh; Wu, Shu-Fen] Natl Chung Cheng Univ, Inst Mol Biol, Dept Life Sci, Min Hsiung, Chia Yi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Tzu Chi University; National Chung Cheng University	Wu, SF (corresponding author), Natl Chung Cheng Univ, Inst Mol Biol, Dept Life Sci, Min Hsiung, Chia Yi, Taiwan.	biosfw@ccu.edu.tw						Alessandri C, 2004, ANN RHEUM DIS, V63, P1218, DOI 10.1136/ard.2003.014647; Aspalter RM, 2003, J LEUKOCYTE BIOL, V74, P572, DOI 10.1189/jlb.0303112; Berner B, 2000, ANN RHEUM DIS, V59, P190, DOI 10.1136/ard.59.3.190; Brunner M, 2008, GENES IMMUN, V9, P640, DOI 10.1038/gene.2008.67; CASAMAYORPALLEJA M, 1995, J EXP MED, V181, P1293, DOI 10.1084/jem.181.4.1293; Charles P, 1999, J IMMUNOL, V163, P1521; Chatzidakis I, 2010, CURR DIR AUTOIMMUN, V11, P105, DOI 10.1159/000289200; CHU CQ, 1991, ARTHRITIS RHEUM, V34, P1125, DOI 10.1002/art.1780340908; Clavel C, 2008, ARTHRITIS RHEUM-US, V58, P678, DOI 10.1002/art.23284; Cuchacovich M, 2008, CLIN EXP RHEUMATOL, V26, P1067; Danese S, 2006, J IMMUNOL, V176, P2617, DOI 10.4049/jimmunol.176.4.2617; Gonzalez-Alvaro I, 2003, CLIN EXP RHEUMATOL, V21, P639; Goules A, 2006, J AUTOIMMUN, V26, P165, DOI 10.1016/j.jaut.2006.02.002; Ichikawa T, 2010, RHEUMATOL INT, V30, P725, DOI 10.1007/s00296-009-1356-y; Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217; Klareskog L, 2004, LANCET, V363, P675, DOI 10.1016/S0140-6736(04)15640-7; Koshy M, 1996, J CLIN INVEST, V98, P826, DOI 10.1172/JCI118855; Kroot EJJA, 2000, ARTHRITIS RHEUM, V43, P1831, DOI 10.1002/1529-0131(200008)43:8<1831::AID-ANR19>3.0.CO;2-6; Lin Q, 2010, RHEUMATOL INT, V30, P317, DOI 10.1007/s00296-009-0958-8; Lin ZM, 2014, INFLAMMATION, V37, P2056, DOI 10.1007/s10753-014-9938-6; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Liu MF, 2001, AUTOIMMUNITY, V34, P107, DOI 10.3109/08916930109001958; Liu S, 2014, IMMUNOL CELL BIOL, V92, P752, DOI 10.1038/icb.2014.45; Lourenco EV, 2011, AUTOIMMUNITY, V44, P33, DOI 10.3109/08916931003782155; Lowe RM, 2014, GENES IMMUN, V15, P137, DOI 10.1038/gene.2014.3; Lu MC, 2010, ARTHRITIS RHEUM-US, V62, P1213, DOI 10.1002/art.27386; Lun SWM, 2007, INT IMMUNOPHARMACOL, V7, P1668, DOI 10.1016/j.intimp.2007.08.021; MacDonald KPA, 1997, J CLIN INVEST, V100, P2404, DOI 10.1172/JCI119781; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Petrovic-Rackov L, 2006, CLIN RHEUMATOL, V25, P448, DOI 10.1007/s10067-005-0106-0; Reparon-Schuijt CC, 2001, ARTHRITIS RHEUM, V44, P41, DOI 10.1002/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0; Schonbeck U, 2001, CELL MOL LIFE SCI, V58, P4, DOI 10.1007/PL00000776; SCHUBERT LA, 1995, J BIOL CHEM, V270, P29624; SHIOZAWA S, 1983, ARTHRITIS RHEUM-US, V26, P472, DOI 10.1002/art.1780260404; Szalay B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104298; Toubi E, 2004, AUTOIMMUNITY, V37, P457, DOI 10.1080/08916930400002386; Valencia X, 2006, BLOOD, V108, P253, DOI 10.1182/blood-2005-11-4567; van Kooten C, 2000, J LEUKOCYTE BIOL, V67, P2, DOI 10.1002/jlb.67.1.2; Vastesaeger N, 2016, RHEUMATOLOGY, V55, P1466, DOI 10.1093/rheumatology/kew179; Wagner C, 2013, J RHEUMATOL, V40, P590, DOI 10.3899/jrheum.120889	40	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183726	10.1371/journal.pone.0183726	http://dx.doi.org/10.1371/journal.pone.0183726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837666	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000105
J	Hochberg, NS; Sarkar, S; Horsburgh, CR; Knudsen, S; Pleskunas, J; Sahu, S; Kubiak, RW; Govindarajan, S; Salgame, P; Lakshminarayanan, S; Sivaprakasam, A; White, LF; Joseph, NM; Ellner, JJ; Roy, G				Hochberg, Natasha S.; Sarkar, Sonali; Horsburgh, C. Robert, Jr.; Knudsen, Selby; Pleskunas, Jane; Sahu, Swaroop; Kubiak, Rachel W.; Govindarajan, S.; Salgame, Padmini; Lakshminarayanan, Subitha; Sivaprakasam, Amsaveni; White, Laura F.; Joseph, Noyal Maria; Ellner, Jerrold J.; Roy, Gautam			Comorbidities in pulmonary tuberculosis cases in Puducherry and Tamil Nadu, India: Opportunities for intervention	PLOS ONE			English	Article							RISK-FACTORS; PROGRAM; DEATH	Background We aimed to define characteristics of TB patients in Puducherry and two districts of Tamil Nadu, India and calculate the population attributable fractions (PAF) of TB from malnutrition and alcohol. Methods New smear-positive TB cases were enrolled into the Regional Prospective Observational Research for Tuberculosis (RePORT India) cohort. Census and National Family Health Survey data were used for comparisons. Results Data were analyzed for 409 participants enrolled between May 2014-June 2016; 307 (75.1%) were male, 60.2% were malnourished (body mass index [BMI] <18.5 kg/m(2)), and 29.1% severely malnourished (BMI <16). "Hazardous" alcohol use (based on AUDIT-C score) was reported by 155/305 (50.8%) of males. Tuberculosis cases were more likely than the Puducherry population to be malnourished (62.6% v 10.2% males and 71.7% v 11.3% of females; both p<0.001), and male cases were more likely to use alcohol than male non-cases (84.4% v 41%; p < .001). The PAF of malnutrition was 57.4% in males and 61.5% in females; the PAF for alcohol use was 73.8% in males and 1.7% in females. Conclusions Alcohol use in men and malnutrition are helping drive the TB epidemic in Southern India. Reducing the TB burden in this population will require efforts to mitigate these risk factors.	[Hochberg, Natasha S.; Horsburgh, C. Robert, Jr.; Ellner, Jerrold J.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02215 USA; [Hochberg, Natasha S.; Horsburgh, C. Robert, Jr.; Knudsen, Selby; White, Laura F.] Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA; [Hochberg, Natasha S.; Pleskunas, Jane; Kubiak, Rachel W.; Ellner, Jerrold J.] Boston Med Ctr, Boston, MA 02215 USA; [Sarkar, Sonali; Sahu, Swaroop; Lakshminarayanan, Subitha; Sivaprakasam, Amsaveni; Joseph, Noyal Maria; Roy, Gautam] Jawaharlal Inst Postgraduate Med Educ & Res, Dept Prevent & Social Med, Gorimedu, Puducherry, India; [Govindarajan, S.] Govt Chest Clin, Pondicherry, India; [Salgame, Padmini] Rutgers State Univ, Newark, NJ USA	Boston University; Boston University; Boston Medical Center; Jawaharlal Institute of Postgraduate Medical Education & Research; Rutgers State University Newark; Rutgers State University New Brunswick	Hochberg, NS (corresponding author), Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02215 USA.; Hochberg, NS (corresponding author), Boston Univ, Sch Publ Hlth, Boston, MA 02215 USA.; Hochberg, NS (corresponding author), Boston Med Ctr, Boston, MA 02215 USA.	nhoch@bu.edu	Sarkar, Sonali/AAU-8993-2020; Lakshminarayanan, Subitha/AAV-3661-2020; Joseph, Noyal Mariya/AAW-2061-2020	Lakshminarayanan, Subitha/0000-0002-1205-5741; Joseph, Noyal Mariya/0000-0001-6586-2742; Sarkar, Sonali/0000-0003-0528-6805; White, Laura F/0000-0002-0588-8235; Horsburgh, C./0000-0001-6838-7895; Hochberg, Natasha/0000-0002-5449-9973; Kubiak, Rachel/0000-0002-2315-4112	U.S. Civilian Research & Development Foundation (CRDF Global) [USB1-31150-XX-13]; National Science Foundation [OISE-9531011]; Federal funds from the Government of India's Department of Biotechnology (DBT) [G01]; Indian Council of Medical Research (ICMR); United States National Institutes of Health (NIH); National Institute of Allergy and Infectious Diseases (NIAID); Office of AIDS Research (OAR)	U.S. Civilian Research & Development Foundation (CRDF Global); National Science Foundation(National Science Foundation (NSF)); Federal funds from the Government of India's Department of Biotechnology (DBT); Indian Council of Medical Research (ICMR)(Indian Council of Medical Research (ICMR)); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research (OAR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Award No. USB1-31150-XX-13 of the U.S. Civilian Research & Development Foundation (CRDF Global) and by the National Science Foundation under Cooperative Agreement No. OISE-9531011. This project has been funded in whole or in part with Federal funds from the Government of India's (G01) Department of Biotechnology (DBT), the Indian Council of Medical Research (ICMR), the United States National Institutes of Health (NIH), National Institute of Allergy and Infectious Diseases (NIAID), Office of AIDS Research (OAR), and distributed in part by CRDF Global. The contents of this publication are solely the responsibility of the authors and do not represent the official views of the DBT, the ICMR, the NIH, or CRDF Global. Any mention of trade names, commercial projects, or organizations does not imply endorsement by any of the sponsoring organizations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhargava A, 2014, NATL MED J INDIA, V27, P128; Cegielski JP, 2012, AM J EPIDEMIOL, V176, P409, DOI 10.1093/aje/kws007; Chiang CY, 2007, INT J TUBERC LUNG D, V11, P258; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Frank D, 2008, J GEN INTERN MED, V23, P781, DOI 10.1007/s11606-008-0594-0; Geadas C, 2017, TUBERCULOSIS, V102, P55, DOI 10.1016/j.tube.2016.11.006; Gupta Soham, 2011, J Infect Public Health, V4, P140, DOI 10.1016/j.jiph.2011.03.005; Hamilton CD, 2015, CLIN INFECT DIS, V61, pS155, DOI 10.1093/cid/civ611; Higgins-Biddle J., 2010, ALCOHOL USE DISORDER; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Jeon CY, 2008, PLOS MED, V5, P1091, DOI 10.1371/journal.pmed.0050152; Kolappan C, 2007, INT J TUBERC LUNG D, V11, P999; Lienhardt C, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001965; Lonnroth K, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-289; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Lonnroth K, 2010, INT J EPIDEMIOL, V39, P149, DOI 10.1093/ije/dyp308; Long R, 1998, CHEST, V113, P933, DOI 10.1378/chest.113.4.933; Mathew TA, 2009, EUR J PUBLIC HEALTH, V19, P16, DOI 10.1093/eurpub/ckn093; Nanditha A, 2016, DIABETES CARE, V39, P472, DOI 10.2337/dc15-1536; Ottmani SE, 2010, INT J TUBERC LUNG D, V14, P1513; Padmapriyadarsini C, 2016, INDIAN J MED RES, V143, P11, DOI 10.4103/0971-5916.193278; Rothman K., 1998, MODERN EPIDEMIOLOGY; Santha T, 2002, INT J TUBERC LUNG D, V6, P780; Singla Neeta, 2009, Indian J Tuberc, V56, P206; Suhadev M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019485; Sujiv Akkilagunta, 2015, Ind Psychiatry J, V24, P135, DOI 10.4103/0972-6748.181711; Thapa P, 2014, J Nepal Health Res Counc, V12, P177; Thomas B, 2011, PLO; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Zachariah R, 2002, T ROY SOC TROP MED H, V96, P291, DOI 10.1016/S0035-9203(02)90103-3	30	24	26	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183195	10.1371/journal.pone.0183195	http://dx.doi.org/10.1371/journal.pone.0183195			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832615	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800051
J	Setien-Suero, E; Neergaard, K; Ramirez-Bonilla, M; Correa-Ghisays, P; Fananas, L; Crespo-Facorro, B; Ayesa-Arriola, R				Setien-Suero, Esther; Neergaard, Karl; Ramirez-Bonilla, Mariluz; Correa-Ghisays, Patricia; Fananas, Lourdes; Crespo-Facorro, Benedicto; Ayesa-Arriola, Rosa			Cannabis use in male and female first episode of non-affective psychosis patients: Long-term clinical, neuropsychological and functional differences	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; GENDER-DIFFERENCES; 1ST-EPISODE PSYCHOSIS; SCHIZOPHRENIC-PATIENTS; FOLLOW-UP; ONSET; OUTCOMES; IMPACT; ABUSE; PSYCHOPATHOLOGY	Background Numerous studies show the existence of a high prevalence of cannabis use among patients with psychosis. However, the differences between men and women who debut with a first episode of psychosis (FEP) regarding cannabis use have not been largely explored. The aim of this study was to identify the specific sex factors and differences in clinical evolution associated with cannabis use. Method Sociodemographic characteristics at baseline were considered in our sample of FEP patients to find differences depending on sex and the use of cannabis. Clinical, functional and neurocognitive variables at baseline, 1-year, and 3-years follow-up were also explored. Results A total of 549 patients, of whom 43% (N = 236) were cannabis users, 79% (N = 186) male and 21% (N = 50) female, were included in the study. There was a clear relationship between being male and being a user of cannabis (OR = 5.6). Cannabis users were younger at illness onset. Longitudinal analysis showed that women significantly improved in all three dimensions of psychotic symptoms, both in the subgroup of cannabis users and in the non-users subgroup. Conversely, subgroups of men did not show improvement in the negative dimension. In cognitive function, only men presented a significant time by group interaction in processing speed, showing a greater improvement in the subgroup of cannabis users. Conclusion Despite knowing that there is a relationship between cannabis use and psychosis, due to the high prevalence of cannabis use among male FEP patients, the results showed that there were very few differences in clinical and neurocognitive outcomes between men and women who used cannabis at the start of treatment compared to those who did not.	[Setien-Suero, Esther; Ramirez-Bonilla, Mariluz; Crespo-Facorro, Benedicto; Ayesa-Arriola, Rosa] Univ Cantabria, Univ Hosp Marques Valdecilla, Dept Psychiat, Sch Med, Santander, Spain; [Setien-Suero, Esther; Correa-Ghisays, Patricia; Fananas, Lourdes; Crespo-Facorro, Benedicto; Ayesa-Arriola, Rosa] CIBERSAM, Biomed Res Network Mental Hlth Area, Madrid, Spain; [Setien-Suero, Esther; Crespo-Facorro, Benedicto; Ayesa-Arriola, Rosa] Valdecilla Biomed Res Inst, IDIVAL, Santander, Spain; [Neergaard, Karl] Aix Marseille Univ, Lab Parole & Langage, Aix En Provence, France; [Correa-Ghisays, Patricia] Univ Valencia, Fac Psychol, Valencia, Spain; [Fananas, Lourdes] Univ Barcelona, Dept Biol Anim, Fac Biol, IBUB, Barcelona, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; Hospital Universitario Marques de Valdecilla (HUMV); UDICE-French Research Universities; Aix-Marseille Universite; University of Valencia; University of Barcelona	Setien-Suero, E (corresponding author), Univ Cantabria, Univ Hosp Marques Valdecilla, Dept Psychiat, Sch Med, Santander, Spain.; Setien-Suero, E (corresponding author), CIBERSAM, Biomed Res Network Mental Hlth Area, Madrid, Spain.; Setien-Suero, E (corresponding author), Valdecilla Biomed Res Inst, IDIVAL, Santander, Spain.	setiensuero@hotmail.com	Correa-Ghisays, Patricia/M-9017-2019; Crespo-Facorro, BENEDICTO/GXZ-9830-2022; Ayesa-Arriola, Rosa/AFS-1408-2022; Crespo-Facorro, BENEDICTO/AAY-2238-2021; Saura, Lourdes Fañanás/C-7586-2017; Correa-Ghisays, Patricia/J-7390-2018; Neergaard, Karl David/AAL-6258-2020	Correa-Ghisays, Patricia/0000-0002-1752-7349; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Ayesa-Arriola, Rosa/0000-0003-0570-5352; Crespo-Facorro, BENEDICTO/0000-0003-0033-7132; Saura, Lourdes Fañanás/0000-0001-6266-7706; Correa-Ghisays, Patricia/0000-0002-1752-7349; Neergaard, Karl David/0000-0002-1055-9495; Setien-Suero, Esther/0000-0002-8027-6546				Abel KM, 2010, INT REV PSYCHIATR, V22, P417, DOI 10.3109/09540261.2010.515205; ADDINGTON D, 1992, SCHIZOPHR RES, V6, P201, DOI 10.1016/0920-9964(92)90003-N; Addington J, 2007, ACTA PSYCHIAT SCAND, V115, P304, DOI 10.1111/j.1600-0447.2006.00900.x; Addington J, 1998, BRIT J PSYCHIAT, V172, P134, DOI 10.1192/S0007125000297791; AMADOR XF, 1994, ARCH GEN PSYCHIAT, V51, P826; American Psychiatric Association A, 2002, MAN DIAGN EST TRAST; Andreasen N. C., 1984, SCALE ASSESSMENT POS; Andreasen N. C, 1983, SCALE FOR THE ASSESS; Arranz B, 2015, J DUAL DIAGN, V11, P153, DOI 10.1080/15504263.2015.1113761; Bahorik AL, 2014, SCHIZOPHRENIA BULL, V40, P856, DOI 10.1093/schbul/sbt099; Barnes TRE, 2006, BRIT J PSYCHIAT, V188, P237, DOI 10.1192/bjp.bp.104.007237; Barnett JH, 2007, BRIT J PSYCHIAT, V190, P515, DOI 10.1192/bjp.bp.106.024448; Barrowclough C, 2015, SCHIZOPHRENIA BULL, V41, P382, DOI 10.1093/schbul/sbu095; Blanchard JJ, 2000, CLIN PSYCHOL REV, V20, P207, DOI 10.1016/S0272-7358(99)00033-1; Canuso CM, 2007, PSYCHOPHARMACOL BULL, V40, P178; Carra G, 2009, SOC PSYCH PSYCH EPID, V44, P429, DOI 10.1007/s00127-008-0458-2; Caton CLM, 2014, J DUAL DIAGN, V10, P177, DOI 10.1080/15504263.2014.961882; Compton MT, 2009, AM J PSYCHIAT, V166, P1251, DOI 10.1176/appi.ajp.2009.09030311; Coulston CM, 2007, SCHIZOPHR RES, V96, P169, DOI 10.1016/j.schres.2007.08.006; Crespo-Facorro B, 2007, J PSYCHIATR RES, V41, P659, DOI 10.1016/j.jpsychires.2006.05.002; Degenhardt L, 2003, DRUG ALCOHOL DEPEN, V71, P37, DOI 10.1016/S0376-8716(03)00064-4; Dervaux A, 2003, ENCEPHALE, V29, P11; Donoghue K, 2014, PSYCHIAT RES, V215, P528, DOI 10.1016/j.psychres.2013.12.038; Dubertret C, 2006, SCHIZOPHR RES, V86, P284, DOI 10.1016/j.schres.2006.05.006; First M.B., 2014, STRUCTURED CLIN INTE; Grube BS, 1998, SCHIZOPHR RES, V31, P113, DOI 10.1016/S0920-9964(98)00011-5; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Hambrecht M, 1996, BIOL PSYCHIAT, V40, P1155, DOI 10.1016/S0006-3223(95)00609-5; HARRISON ER, 1993, AM J DRUG ALCOHOL AB, V19, P423, DOI 10.3109/00952999309001632; Henquet C, 2005, SCHIZOPHRENIA BULL, V31, P608, DOI 10.1093/schbul/sbi027; Henquet C, 2005, BMJ-BRIT MED J, V330, P11, DOI 10.1136/bmj.38267.664086.63; Horwood LJ, 2010, DRUG ALCOHOL DEPEN, V110, P247, DOI 10.1016/j.drugalcdep.2010.03.008; IBM, 2010, IBM SPSS STAT WIND V; Jockers-Scherubl MC, 2007, PROG NEURO-PSYCHOPH, V31, P1054, DOI 10.1016/j.pnpbp.2007.03.006; Koskinen J, 2010, SCHIZOPHRENIA BULL, V36, P1115, DOI 10.1093/schbul/sbp031; Koster A, 2008, SOC PSYCH PSYCH EPID, V43, P940, DOI 10.1007/s00127-008-0384-3; Krohn MD, 1997, J HEALTH SOC BEHAV, V38, P87, DOI 10.2307/2955363; Lange EH, 2014, COMPR PSYCHIAT, V55, P274, DOI 10.1016/j.comppsych.2013.08.018; Large M, 2014, AUST NZ J PSYCHIAT, V48, P418, DOI 10.1177/0004867414525838; Large M, 2011, ARCH GEN PSYCHIAT, V68, P555, DOI 10.1001/archgenpsychiatry.2011.5; Leeson VC, 2012, SCHIZOPHRENIA BULL, V38, P873, DOI 10.1093/schbul/sbq153; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Machielsen M, 2010, AUST NZ J PSYCHIAT, V44, P721, DOI 10.3109/00048671003689710; Malla A, 2005, SCHIZOPHRENIA BULL, V31, P650, DOI 10.1093/schbul/sbi031; Mana S., 1998, REV PSIQUIATRIA FACU, V25, P6; Modestin J, 2001, J ADDICT DIS, V20, P41; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; Mullin K, 2012, AUST NZ J PSYCHIAT, V46, P826, DOI 10.1177/0004867412440192; Ochoa S, 2012, SCHIZOPHR RES TREAT, V2012, DOI 10.1155/2012/916198; Osterrieth PA., 1944, ARCH PSYCHOL-GENEVE, V30, P286; Pang S, 2016, EARLY INTERV PSYCHIA, V10, P528, DOI 10.1111/eip.12208; Pelayo-Teran JM, 2008, EARLY INTERV PSYCHIA, V2, P178, DOI 10.1111/j.1751-7893.2008.00074.x; PNSD. Plan Nacional Sobre Drogas, 2013, PNSD PLAN NAC DROG I; Pope HG, 2001, ARCH GEN PSYCHIAT, V58, P909, DOI 10.1001/archpsyc.58.10.909; Preston NJ, 2002, SCHIZOPHR RES, V55, P285, DOI 10.1016/S0920-9964(01)00215-8; Rabin RA, 2013, PSYCHIAT RES, V206, P158, DOI 10.1016/j.psychres.2012.11.019; Rabinowitz J, 1998, PSYCHOL MED, V28, P1411, DOI 10.1017/S0033291798007399; Reichenberg A, 2009, SCHIZOPHRENIA BULL, V35, P1022, DOI 10.1093/schbul/sbn044; Reitan RM, 1985, THE HALSTEAD REITAN; Rey A, 1964, LEXAMEN CLINIQUE PSY; Schaefer J, 2013, SCHIZOPHR RES, V150, P42, DOI 10.1016/j.schres.2013.07.009; Thorup A, 2014, EUR PSYCHIAT, V29, P44, DOI 10.1016/j.eurpsy.2012.11.005; Usall J, 2002, ACTA PSYCHIAT SCAND, V106, P337, DOI 10.1034/j.1600-0447.2002.01351.x; van Dijk D, 2012, SCHIZOPHR RES, V137, P50, DOI 10.1016/j.schres.2012.01.016; Vigil Cegalis J., 1991, VIGIL SOFTWARE ASSES; Wechler, 1997, WECHSLER ADULT INTEL; White RK, 2008, SCHIZOPHR RES, V104, P237, DOI 10.1016/j.schres.2008.05.019; Wobrock T, 2013, SCHIZOPHR RES, V147, P132, DOI 10.1016/j.schres.2013.03.001; Yucel M, 2012, SCHIZOPHRENIA BULL, V38, P316, DOI 10.1093/schbul/sbq079	69	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183613	10.1371/journal.pone.0183613	http://dx.doi.org/10.1371/journal.pone.0183613			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832666	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800071
J	Sutton, GJ; Hoskins, AJ; Berlincourt, M; Arnould, JPY				Sutton, Grace J.; Hoskins, Andrew J.; Berlincourt, Maud; Arnould, John P. Y.			Departure time influences foraging associations in little penguins	PLOS ONE			English	Article							EUDYPTULA-MINOR; DIVING BEHAVIOR; PHILLIP-ISLAND; BASS STRAIT; GROUP-SIZE; INFORMATION; FOOD; AVAILABILITY; ENVIRONMENTS; DIMORPHISM	Recent studies have documented that little penguins (Eudyptula minor) associate at sea, displaying synchronised diving behaviour throughout a foraging trip. However, previous observations were limited to a single foraging trip where only a small number of individuals were simultaneously tracked. Consequently, it is not known whether coordinated behaviour is consistent over time, or what factors influence it. In the present study, breeding adults were concurrently instrumented with GPS and dive behaviour data loggers for at least 2 consecutive foraging trips during guard and post-guard stage at two breeding colonies (London Bridge and Gabo Island, south-eastern Australia) of contrasting population size (approximately 100 and 30,000-40,000, respectively). At both colonies, individuals were sampled in areas of comparable nesting density and spatial area. At London Bridge, where individuals use a short (23 m) common pathway from their nests to the shoreline, > 90% (n = 42) of birds displayed foraging associations and 53-60% (n = 20) maintained temporally consistent associations with the same conspecifics. Neither intrinsic (sex, size or body condition) nor extrinsic (nest proximity) factors were found to influence foraging associations. However, individuals that departed from the colony at a similar time were more likely to associate during a foraging trip. At Gabo Island, where individuals use a longer (116 m) pathway with numerous tributaries to reach the shoreline, few individuals (< 31%; n = 13) from neighbouring nests associated at sea and only 1% (n = 1) maintained associations over subsequent trips. However, data from animal-borne video cameras indicated individuals at this colony displayed foraging associations of similar group size to those at London Bridge. This study reveals that group foraging behaviour occurs at multiple colonies and the pathways these individuals traverse with conspecifics may facilitate opportunistic group formation and resulting in foraging associations irrespective of nesting proximity and other factors.	[Sutton, Grace J.; Berlincourt, Maud; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic 3217, Australia; [Hoskins, Andrew J.] CSIRO Land & Water, Canberra, ACT, Australia	Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sutton, GJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic 3217, Australia.	gsutton@deakin.edu.au	Hoskins, Andrew/T-2694-2019	Hoskins, Andrew/0000-0001-8907-6682	Deakin University	Deakin University	The study was funded by Deakin University internal research funds.	Agnew P, 2013, MAR BIOL, V160, P2375, DOI 10.1007/s00227-013-2231-7; Aivaz AN, 2011, BEHAV ECOLOGY; Arnould JPY, 2004, EMU, V104, P261, DOI 10.1071/MU04035; Beauchamp Guy, 2013, SOCIAL PREDATION GRO; BELOVSKY GE, 1989, THEOR POPUL BIOL, V36, P144, DOI 10.1016/0040-5809(89)90026-9; Berlincourt M, 2015, MAR BIOL, V162, P1485, DOI 10.1007/s00227-015-2685-x; Berlincourt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105065; Bethge P, 1997, J ZOOL, V242, P483; Cellerier A, VIDEOLAN VLC MEDIA P; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; CLARK CW, 1984, AM NAT, V123, P626, DOI 10.1086/284228; Clua E, 2001, AQUAT LIVING RESOUR, V14, P11, DOI 10.1016/S0990-7440(00)01097-4; Crawford RJM, 2006, BIOL CONSERV, V132, P119, DOI 10.1016/j.biocon.2006.03.019; Croxall J, 1987, FOOD FEEDING ECOLOGY; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; DANN P, 1992, EMU, V91, P263, DOI 10.1071/MU9910263; DANN P, 1992, EMU, V91, P278, DOI 10.1071/MU9910278; Donazar JA, 1999, BEHAV ECOL SOCIOBIOL, V45, P55, DOI 10.1007/s002650050539; Duffy-Echevarria EE, 2008, MAR MAMMAL SCI, V24, P202, DOI 10.1111/j.1748-7692.2007.00151.x; ESRI, 2014, ARCMAP 10 2; Forero MG, 2005, STABLE ISOTOPES REVE; Fullagar PJ, 1995, GABO ISLAND PENGUIN; GIBBS CF, 1986, AUST J MAR FRESH RES, V37, P451; GODIN JGJ, 1986, CAN J ZOOL, V64, P1675, DOI 10.1139/z86-251; Grand TC, 1999, ANIM BEHAV, V58, P443, DOI 10.1006/anbe.1999.1174; HEDRICK AV, 1989, TRENDS ECOL EVOL, V4, P136, DOI 10.1016/0169-5347(89)90212-7; Hoskins AJ, 2008, MAR ECOL PROG SER, V366, P293, DOI 10.3354/meps07507; KLOMP NI, 1991, EMU, V91, P32, DOI 10.1071/MU9910032; Luque SP., 2007, R NEWS, V7, P8, DOI DOI 10.1155/2007/92385; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; Miyazaki M, 2003, J AVIAN BIOL, V34, P229, DOI 10.1034/j.1600-048X.2003.03099.x; MURPHY MT, 1986, AUK, V103, P465, DOI 10.1093/auk/103.3.465; NOWAK MA, 1992, NATURE, V355, P250, DOI 10.1038/355250a0; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; PINSHOW B, 1977, SCIENCE, V195, P592, DOI 10.1126/science.835018; POYSA H, 1992, ORNIS SCAND, V23, P159, DOI 10.2307/3676444; Putz K, 2005, MAR BIOL, V147, P281, DOI 10.1007/s00227-005-1577-x; PYKE GH, 1984, ANNU REV ECOL SYST, V15, P523, DOI 10.1146/annurev.es.15.110184.002515; R CORE TEAM, 2016, R LANG ENV STAT COMP; Radford AN, 2003, J ANIM ECOL, V72, P258, DOI 10.1046/j.1365-2656.2003.00697.x; REILLY PN, 1981, EMU, V81, P1, DOI 10.1071/MU9810001; Report-Coudert Y, 2003, WATERBIRDS INT J WAT, V26, P403; Robinson S, 2005, IBIS, V147, P483, DOI 10.1111/j.1474-919x.2005.00431.x; Saraux C, 2011, ECOLOGY, V92, P1909, DOI 10.1890/11-0407.1; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shaw T. R, 2008, THESIS; Sherratt TN, 2002, J THEOR BIOL, V215, P47, DOI 10.1006/jtbi.2001.2495; Sinervo B, 1997, OPTIMAL FORAGING THE, P105; STACEY PB, 1986, BEHAV ECOL SOCIOBIOL, V18, P175, DOI 10.1007/BF00290821; Stahel C., 1987, LITTLE PENGUIN FAIRY; Sumner M., 2012, TRIP SPATIAL ANAL AN; Sutton GJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144297; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Thiebot J- B, 2016, MAR BIOL, V163, P1, DOI DOI 10.1007/S00227-016-2890-2); Thomas Giraldeau L-AaC, 2000, SOCIAL FORAGING THEO; Tremblay Y, 1999, CONDOR, V101, P179, DOI 10.2307/1370462; VANHEEZIK Y, 1990, NEW ZEAL J ZOOL, V17, P201, DOI 10.1080/03014223.1990.10422597; WALTZ EC, 1987, ANIM BEHAV, V35, P48, DOI 10.1016/S0003-3472(87)80209-9; WARD P, 1973, IBIS, V115, P517, DOI 10.1111/j.1474-919X.1973.tb01990.x; WETTERER JK, 1989, THEOR POPUL BIOL, V36, P267, DOI 10.1016/0040-5809(89)90034-8; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Williams T.D., 1995, PENGUINS	64	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182734	10.1371/journal.pone.0182734	http://dx.doi.org/10.1371/journal.pone.0182734			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832641	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800030
J	Toprak, S; Ersoy, G				Toprak, Sadik; Ersoy, Gokhan			Femicide in Turkey between 2000 and 2010	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; NATIONAL CLINICAL SURVEY; GENDER-BASED VIOLENCE; GLOBAL PREVALENCE; MENTAL-DISORDER; HOMICIDE; WOMEN	Although intimate partner violence (IPV) is an important problem that threatens women's health, very few studies focus on the victim-perpetrator relationship or examine this relationship across Turkey. The aim of this study is to contribute to a better understanding of femicide cases in Turkey and to describe the socio-demographic, clinical, forensic, and criminological characteristics of femicide victims and offenders. This study analysed 162 femicide cases that occurred in 12 cities in Turkey from 1 January 2000 to 31 December 2010. Eighty women were killed by their partners (classified as intimate partner femicide, IPF), and 81 women were killed by one of their relatives, friends, or strangers (classified as non-intimate partner femicide, non-IPF). According to our results, the typical IPF victim is of child-bearing age, does not have a paid job, is married or divorced, is killed in a domestic setting due to injuries to the thorax or abdomen produced by an edged/pointed weapon or firearm, and is possibly a victim of overkill. The typical IPF perpetrator is close to his victim's age, has a paid job, has no mental disability, owns a gun, and has threatened his partner or ex-partner previously because of jealousy/infidelity/honour or separation. The typical non-IPF victim is very similar to the IPF victim; however, her marital status can be single, married or divorced, and she is commonly killed by a relative. The surveillance and screening of femicide and IPV is an important step when analysing and attempting to prevent femicide. Second, the training and sensitization of health professionals are important. Moreover, health staff should be encouraged to participate in advocacy interventions. Third, gun ownership must be brought under control.	[Toprak, Sadik] Bulent Ecevit Univ, Dept Forens Med, Zonguldak, Turkey; [Ersoy, Gokhan] Istanbul Univ, Inst Forens Med, Istanbul, Turkey	Bulent Ecevit University; Istanbul University; Ministry of Justice - Turkey	Toprak, S (corresponding author), Bulent Ecevit Univ, Dept Forens Med, Zonguldak, Turkey.	sadik_toprak@yahoo.com	Toprak, Sadik/AAC-6480-2020; Ersoy, Gokhan/D-9279-2019	Toprak, Sadik/0000-0002-8065-1334; Ersoy, Gokhan/0000-0002-4594-7172	Scientific and Technology Research Council of Turkey (TUBITAK) [115S024]	Scientific and Technology Research Council of Turkey (TUBITAK)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by the grant of The Scientific and Technology Research Council of Turkey (TUBITAK) Project Numbers: 115S024. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams N, 2010, SAMJ S AFR MED J, V100, P586, DOI 10.7196/SAMJ.3904; [Anonymous], 2017, MARR DIV STAT; [Anonymous], 2017, NOMENCLATURE TERRITO; [Anonymous], 2017, EMPL STAT; [Anonymous], 2015, ANN REPORT; Basbakanlik Aile Arastirma Kurumu, 1995, AIL IC SIDD SEB VE S; Bhanbhro S, 2016, INT J HUM RIGHTS HEA, V9, P198, DOI 10.1108/IJHRH-10-2015-0032; Block C.R., 2000, CHICAGO WOMENS HLTH; Breitman Noelia, 2004, Violence Vict, V19, P321, DOI 10.1891/vivi.19.3.321.65764; Campbell J. C., 2005, INTIMATE PARTNER VIO; Campbell JC, 2003, AM J PUBLIC HEALTH, V93, P1089, DOI 10.2105/AJPH.93.7.1089; Capaldi DM, 2012, PARTN ABUSE, V3, P231, DOI 10.1891/1946-6560.3.2.231; Cilingiroglu N, 2016, INJURY PREV, V22, pA143, DOI 10.1136/injuryprev-2016-042156.390; COOK PJ, 1981, ANN AM ACAD POLIT SS, V455, P63, DOI 10.1177/000271628145500107; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Dogan KH, 2010, J FORENSIC SCI, V55, P110, DOI 10.1111/j.1556-4029.2009.01239.x; Eronen M, 1996, ARCH GEN PSYCHIAT, V53, P497; European Union Agency for Fundamental Rights, 2014, VIOL WOM EU WID SURV; Fong WL, 2016, FORENSIC SCI INT, V266, P80, DOI 10.1016/j.forsciint.2016.05.008; Goussinsky R, 2012, AGGRESS VIOLENT BEH, V17, P553, DOI 10.1016/j.avb.2012.07.009; ISCH COST Action IS1206, IS1206 ISCH COST, P201; Karbeyaz K, 2013, J FORENSIC LEG MED, V20, P736, DOI 10.1016/j.jflm.2013.04.007; Kulczycki A, 2011, VIOLENCE AGAINST WOM, V17, P1442, DOI 10.1177/1077801211434127; MAHONEY P, 1999, VIOLENCE AGAINST WOM, V0005; Ministry of Justice, 2012, CRIM REC OFF; Mohanty Manoj Kumar, 2004, Leg Med (Tokyo), V6, P151, DOI 10.1016/j.legalmed.2004.05.001; Moreschi C, 2016, J FORENSIC LEG MED, V39, P65, DOI 10.1016/j.jflm.2016.01.017; Palermo T, 2014, AM J EPIDEMIOL, V179, P602, DOI 10.1093/aje/kwt295; Pereira AR, 2013, J FORENSIC LEG MED, V20, P1099, DOI 10.1016/j.jflm.2013.09.015; Richard-Devantoy S, 2016, J FORENSIC LEG MED, V39, P117, DOI 10.1016/j.jflm.2016.01.014; Rivas C, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005043.pub3; Sebire J, 2017, J INTERPERS VIOLENCE, V32, P1476, DOI 10.1177/0886260515589565; Shaw J, 2006, BRIT J PSYCHIAT, V188, P143, DOI 10.1192/bjp.188.2.143; Shaw J, 1999, BRIT MED J, V318, P1240; SILVERMAN RA, 1987, J CRIM LAW CRIM, V78, P272, DOI 10.2307/1143450; Sorenson SB, 2006, EVALUATION REV, V30, P229, DOI 10.1177/0193841X06287220; Stockl H, 2013, LANCET, V382, P859, DOI 10.1016/S0140-6736(13)61030-2; Trojan C, 2012, J INTERPERS VIOLENCE, V27, P2869, DOI 10.1177/0886260512438285; Turkish Statistical Institute, 2017, POP STAT; Tutunculer A, 2015, OMEGA-J DEATH DYING, V71, P198, DOI 10.1177/0030222815570600; Unal EO, 2016, J FORENSIC LEG MED, V40, P42, DOI 10.1016/j.jflm.2015.11.025; United Nations Office on Drugs and Crime, PERC MAL FEM INT HOM; United Nations Office on Drugs and Crime, INT HOM COUNT RAT PE; Vives-Cases C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154060; WHO, 2014, GLOB ALC REP COUNTR; WILSON M, 1995, CAN J CRIMINOL, V37, P331; Wilson M, 1993, Violence Vict, V8, P3; World Health Organization, 2012, UNDERSTANDING ADDRES; Yilmaz E, 2015, J FORENSIC LEG MED, V34, P17, DOI 10.1016/j.jflm.2015.04.018	49	16	18	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182409	10.1371/journal.pone.0182409	http://dx.doi.org/10.1371/journal.pone.0182409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832596	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800022
J	Chen, YJ; Wan, WH; Wu, WY; Hsu, CC; Wei, LR; Wang, SF; Hsu, YW; Liaw, CC; Tsai, WC				Chen, Yi-Jin; Wan, Wen-Hung; Wu, Wan-Yu; Hsu, Chia-Chi; Wei, Ling-Rung; Wang, Sheng-Fan; Hsu, Ya-Wen; Liaw, Chih-Chuang; Tsai, Wan-Chi			Novel histone deacetylase inhibitor AR-42 exhibits antitumor activity in pancreatic cancer cells by affecting multiple biochemical pathways	PLOS ONE			English	Article							ACETYL-L-CYSTEINE; HUMAN LEUKEMIA-CELLS; DNA-DAMAGE; KAPPA-B; APOPTOSIS; DEATH; THIOREDOXIN; AUTOPHAGY; GROWTH; AIF	Objective Pancreatic cancer is one of the most lethal types of cancer with a 5-year survival rate of similar to 5%. Histone deacetylases (HDACs) participate in many cellular processes, including carcinogenesis, and pharmacological inhibition of HDACs has emerged as a potential therapeutic strategy. In this study, we explored antitumor activity of the novel HDAC inhibitor AR-42 in pancreatic cancer. Methods Human pancreatic cancer cell lines BxPC-3 and PANC-1 were used in this study. Real-time PCR, RT-PCR, and western blotting were employed to investigate expression of specific genes and proteins, respectively. Translocation of apoptosis-inducing factor was investigated by immunofluorescence and subcellular fractionation. The number of apoptotic cells, cell cycle stages, and reactive oxygen species (ROS) generation levels were determined by flow cytometry. Cell invasiveness was examined by the Matrigel invasion assay. Efficacy of AR-42 in vivo was evaluated by utilizing BxPC-3 xenograft mouse model. Results AR-42 inhibited pancreatic cancer cell proliferation by causing G2/M cell cycle arrest via regulating expression levels of genes and proteins involved in cell cycle. AR-42 also induced ROS generation and DNA damage, triggering apoptosis of pancreatic cancer cells via both caspase-3-dependent and caspase-3-independent pathways. In addition, AR-42 increased expression levels of negative regulators of p53 (miR-125b, miR-30d, and miR33), which could contribute to lower expression level of mutant p53 in pancreatic cancer cells. Cell invasion assay showed that AR-42 reduced cancer cell aggressiveness and significantly diminished BxPC-3 xenograft tumor growth in vivo. Conclusion AR-42, a novel HDAC inhibitor, inhibited pancreatic cancer cells by regulating p53 expression, inducing cell cycle arrest, particularly at the G2/M stage, and activating multiple apoptosis pathways. Additionally, AR-42 inhibited cell invasiveness and potently suppressed pancreatic cancer tumors in vivo. We conclude that by virtue of its multiple mechanisms of action, AR-42 possesses a considerable potential as an antitumor agent in pancreatic cancer.	[Chen, Yi-Jin; Wu, Wan-Yu; Hsu, Chia-Chi; Wei, Ling-Rung; Wang, Sheng-Fan; Tsai, Wan-Chi] Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Wan, Wen-Hung] Cathay Gen Hosp, Dept Otolaryngol, Taipei, Taiwan; [Wan, Wen-Hung] Sijhih Cathay Gen Hosp, Dept Otolaryngol, New Taipei, Taiwan; [Wan, Wen-Hung] FuJen Catholic Univ, Sch Med, New Taipei, Taiwan; [Wang, Sheng-Fan; Tsai, Wan-Chi] Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan; [Hsu, Ya-Wen] Chia Nan Univ Pharm Sci, Dept Hosp & Hlth Care Adm, Tainan, Taiwan; [Liaw, Chih-Chuang] Natl Sun Yat Sen Univ, Doctoral Degree Program Marine Biotechnol, Kaohsiung, Taiwan; [Liaw, Chih-Chuang] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Tsai, Wan-Chi] Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan	Kaohsiung Medical University; Cathay General Hospital; Cathay General Hospital; Kaohsiung Medical University; Chia Nan University of Pharmacy & Science; National Sun Yat Sen University; National Sun Yat Sen University; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Tsai, WC (corresponding author), Kaohsiung Med Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan.; Tsai, WC (corresponding author), Kaohsiung Med Univ, Ctr Infect Dis & Canc Res, Kaohsiung, Taiwan.; Tsai, WC (corresponding author), Kaohsiung Med Univ Hosp, Dept Lab Med, Kaohsiung, Taiwan.	wanchi@kmu.edu.tw	Wang, Sheng-Fan/ABA-7842-2020	Wang, Sheng-Fan/0000-0002-8142-4707; Tsai, Wan-Chi/0000-0002-4490-3581	National Sun Yat-Sen UniversityKaoshiung Medical University Joint Research Project [NSYSU-KMU 105-I008, 106-I007]; Kaohsiung Medical University Research Foundation [KMU-M105019]	National Sun Yat-Sen UniversityKaoshiung Medical University Joint Research Project; Kaohsiung Medical University Research Foundation	This work was supported by National Sun Yat-Sen UniversityKaoshiung Medical University Joint Research Project, grant NSYSU-KMU 105-I008, 106-I007; Kaohsiung Medical University Research Foundation, grant KMU-M105019.	Akimoto M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126605; Almenara J, 2002, LEUKEMIA, V16, P1331, DOI 10.1038/sj.leu.2402535; Bellucci L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054102; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Blattmann C, 2010, INT J RADIAT ONCOL, V78, P237, DOI 10.1016/j.ijrobp.2010.03.010; Burns SS, 2013, CANCER RES, V73, P792, DOI 10.1158/0008-5472.CAN-12-1888; Bush ML, 2011, NEURO-ONCOLOGY, V13, P983, DOI 10.1093/neuonc/nor072; Butler LM, 2002, P NATL ACAD SCI USA, V99, P11700, DOI 10.1073/pnas.182372299; Cadet J, 2013, COLD SPRING HARBOR P, V5; Catalano MG, 2005, J CLIN ENDOCR METAB, V90, P1383, DOI 10.1210/jc.2004-1355; Chang MC, 2014, WORLD J GASTROENTERO, V20, P2358, DOI 10.3748/wjg.v20.i9.2358; Chun SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119379; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Curtin JF, 2002, J IMMUNOL METHODS, V265, P49, DOI 10.1016/S0022-1759(02)00070-4; Deer EL, 2010, PANCREAS, V39, P425, DOI 10.1097/MPA.0b013e3181c15963; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Gordon J, 2003, INT J CANCER, V103, P316, DOI 10.1002/ijc.10828; Grasso D, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/760498; Groselj B, 2013, BRIT J CANCER, V108, P748, DOI 10.1038/bjc.2013.21; Guzman ML, 2014, MOL CANCER THER, V13, P1979, DOI 10.1158/1535-7163.MCT-13-0963; Hajji N, 2008, ONCOGENE, V27, P3134, DOI 10.1038/sj.onc.1210976; Halasi M, 2013, BIOCHEM J, V454, P201, DOI 10.1042/BJ20130282; Helland O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158208; Henderson SE, 2016, NEOPLASIA, V18, P765, DOI 10.1016/j.neo.2016.10.003; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Hua KF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067603; Kroemer G, 2007, PHYSIOL REV, V87, P99, DOI 10.1152/physrev.00013.2006; Kulp SK, 2006, CLIN CANCER RES, V12, P5199, DOI 10.1158/1078-0432.CCR-06-0429; Li DR, 2015, J UROLOGY, V194, P547, DOI 10.1016/j.juro.2015.02.2918; Liu JH, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/294303; Lu Q, 2005, J MED CHEM, V48, P5530, DOI 10.1021/jm0503749; Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762; Marullo R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081162; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Nebbioso A, 2012, MOL ONCOL, V6, P657, DOI 10.1016/j.molonc.2012.09.004; New M, 2012, MOL ONCOL, V6, P637, DOI 10.1016/j.molonc.2012.09.003; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Qanungo S, 2004, J BIOL CHEM, V279, P50455, DOI 10.1074/jbc.M406749200; Qiu TZ, 2013, FUTURE ONCOL, V9, P255, DOI [10.2217/fon.12.173, 10.2217/FON.12.173]; Ribas J, 2015, CURR DRUG TARGETS, V16, P31, DOI 10.2174/1389450115666141114153536; Rishi A, 2015, SEMIN ONCOL, V42, P28, DOI 10.1053/j.seminoncol.2014.12.004; Robert C, 2012, ADV CANCER RES, V116, P87, DOI 10.1016/B978-0-12-394387-3.00003-3; Rosato RR, 2016, J BIOL CHEM, V291, P17535, DOI 10.1074/jbc.A109.095208; Ruefli AA, 2001, P NATL ACAD SCI USA, V98, P10833, DOI 10.1073/pnas.191208598; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Spagnuolo G, 2006, BIOMATERIALS, V27, P1803, DOI 10.1016/j.biomaterials.2005.10.022; Stojanovic N, 2017, ONCOGENE, V36, P1804, DOI 10.1038/onc.2016.344; Ungerstedt JS, 2005, P NATL ACAD SCI USA, V102, P673, DOI 10.1073/pnas.0408732102; Wang F, 2011, J GASTROINTEST ONCOL, V2, P157, DOI 10.3978/j.issn.2078-6891.2011.032; Wang LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036418; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yang XJ, 2013, BIOCHEM BIOPH RES CO, V431, P617, DOI 10.1016/j.bbrc.2012.12.083; Yang YT, 2009, NEOPLASIA, V11, P552, DOI 10.1593/neo.09204; Zhang P., 2015, J SENSORS, V2015, P10, DOI DOI 10.1371/J0URNAL.P0NE.0133137; Zhang SH, 2011, INT J CANCER, V129, P204, DOI 10.1002/ijc.25660; Zhang T, 2014, NEOPLASIA, V16, P665, DOI 10.1016/j.neo.2014.07.009	57	15	15	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183368	10.1371/journal.pone.0183368	http://dx.doi.org/10.1371/journal.pone.0183368			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829799	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100041
J	Haj, S; Chodick, G; Refaeli, R; Goren, S; Shalev, V; Muhsen, K				Haj, Saeda; Chodick, Gabriel; Refaeli, Rotem; Goren, Sophy; Shalev, Varda; Muhsen, Khitam			Associations of Helicobacter pylori infection and peptic disease with diabetic mellitus: Results from a large population-based study	PLOS ONE			English	Article							HUMAN GASTRIC-MUCOSA; SOCIOECONOMIC POSITION; CELLULAR-LOCALIZATION; RISK-FACTORS; METAANALYSIS; PEPSINOGENS; GHRELIN; STOMACH; LEPTIN; IMMUNOFLUORESCENCE	Background Evidence is conflicting regarding the association between Helicobacter pylori infection and diabetes mellitus. The study objective was to examine associations of H. pylori infection, gastric ulcers and duodenal ulcers, with diabetes mellitus. Methods This cross-sectional study was undertaken using coded data from the computerized database of Maccabi Health Services in Israel, on 147,936 individuals aged 25-95 years who underwent the urea breath test during 2002-2012. Multiple logistic regression models were conducted, while adjusting for known risk factors for diabetes mellitus. Results A H. pylori positive test was recorded for 76,992 (52.0%) individuals and diabetes for 12,207 (8.3%). The prevalence of diabetes was similar in individuals with and without H. pylori infection, but this association was modified (P for heterogeneity 0.049) by body mass index (BMI): adjusted odds ratio (aOR) 1.16 (95% confidence intervals (CI) 1.04-1.29) in persons with BMI<25 kg/m(2) versus aOR 1.03 (95% CI 0.98-1.08) in persons with BMI >= 25 kg/m(2). Diabetes mellitus prevalence was higher in persons with gastric (aOR 1.20 (95% CI 1.06-1.34)) and duodenal ulcers (aOR 1.20 (95% CI 1.12-1.28)) compared to persons without these diagnoses. Conclusions In this large population-based study, we demonstrated significant positive associations, albeit of small magnitude, of H. pylori infection and peptic disease with diabetes. The long-term gastric inflammation and associated-damage to the gastric mucosa might play a role in such associations.	[Haj, Saeda; Chodick, Gabriel; Refaeli, Rotem; Goren, Sophy; Shalev, Varda; Muhsen, Khitam] Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel; [Chodick, Gabriel; Shalev, Varda] Maccabi Hlth Serv, Med Div, Tel Aviv, Israel	Tel Aviv University; Sackler Faculty of Medicine	Muhsen, K (corresponding author), Tel Aviv Univ, Dept Epidemiol & Prevent Med, Sch Publ Hlth, Sackler Fac Med, Tel Aviv, Israel.	kmuhsen@post.tau.ac.il		Muhsen, Khitam/0000-0003-1086-7559; /0000-0002-5189-8995				Abramson Joseph H, 2011, Epidemiol Perspect Innov, V8, P1, DOI 10.1186/1742-5573-8-1; Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Atherton JC, 2006, ANNU REV PATHOL-MECH, V1, P63, DOI 10.1146/annurev.pathol.1.110304.100125; Atherton JC, 2009, J CLIN INVEST, V119, P2475, DOI 10.1172/JCI38605; Bado A, 1998, NATURE, V394, P790, DOI 10.1038/29547; Bahadoran Z, 2015, ENDOCRINOL METAB, V30, P280; Bajaj Sarita, 2014, Indian J Endocrinol Metab, V18, P694, DOI 10.4103/2230-8210.139235; Baudron CR, 2013, HELICOBACTER, V18, P44, DOI 10.1111/hel.12077; Bener A, 2007, TURK J GASTROENTEROL, V18, P225; Chen Y, 2012, J INFECT DIS, V205, P1195, DOI 10.1093/infdis/jis106; Chuang CH, 2009, HELICOBACTER, V14, P54, DOI 10.1111/j.1523-5378.2009.00653.x; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Demir M, 2008, DIGEST DIS SCI, V53, P2646, DOI 10.1007/s10620-007-0185-7; Devrajani BR, 2010, INT J DIABETES DEV C, V30, P22, DOI 10.4103/0973-3930.60008; Dore MP, 2000, NUTRITION, V16, P407, DOI 10.1016/S0899-9007(00)00267-7; Espelt A, 2011, CURR DIABETES REV, V7, P148, DOI 10.2174/157339911795843131; Francois F, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-37; Gillum RF, 2004, J NATL MED ASSOC, V96, P1470; Goll R, 2007, HELICOBACTER, V12, P185, DOI 10.1111/j.1523-5378.2007.00495.x; Graham DY, 2006, CLIN GASTROENTEROL H, V4, P306, DOI 10.1016/j.cgh.2005.11.003; Han X, 2016, DIABETES-METAB RES, V32, P95, DOI 10.1002/dmrr.2677; HARRIS MI, 1995, CLIN INVEST MED, V18, P231; Heymann AD, 2006, DIABETES RES CLIN PR, V71, P290, DOI 10.1016/j.diabres.2005.07.002; Hsieh MC, 2013, EUR J CLIN INVEST, V43, P949, DOI 10.1111/eci.12124; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Israel Centeral Bureau of Statistics, 2013, CHAR CLASS GEAGR UN; Israel Minsitry of Health, 2014, NAT PROGR QUAL IND C; Israel Minsitry of Health, 2012, ISR NAT HLTH INT SUR; Jeon CY, 2012, DIABETES CARE, V35, P520, DOI 10.2337/dc11-1043; Ko GTC, 2001, ENDOCR RES, V27, P171, DOI 10.1081/ERC-100107178; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Lutsey PL, 2009, DIABETIC MED, V26, P149, DOI 10.1111/j.1464-5491.2008.02632.x; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MEDALIE JH, 1975, ARCH INTERN MED, V135, P811, DOI 10.1001/archinte.135.6.811; Miki K, 2007, J DIGEST DIS, V8, P8, DOI 10.1111/j.1443-9573.2007.00278.x; Muhsen K, 2012, EPIDEMIOL INFECT, V140, P1207, DOI 10.1017/S0950268811002081; Muhsen K, 2012, J TROP PEDIATRICS, V58, P208, DOI 10.1093/tropej/fmr068; Powers AC, 2013, HARRISONS PRINCIPLES; Robinson K, 2008, GUT, V57, P1375, DOI 10.1136/gut.2007.137539; Roper J, 2008, J CLIN ENDOCR METAB, V93, P2350, DOI 10.1210/jc.2007-2057; SAMLOFF IM, 1973, GASTROENTEROLOGY, V65, P36; SAMLOFF IM, 1971, GASTROENTEROLOGY, V61, P185; Steyn NP, 2004, PUBLIC HEALTH NUTR, V7, P147, DOI 10.1079/PHN2003586; Tamura T, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1371-2; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wang F, 2013, SCAND J INFECT DIS, V45, P930, DOI 10.3109/00365548.2013.844351; Weitzman D, 2014, HYPERTENSION, V64, P501, DOI 10.1161/HYPERTENSIONAHA.114.03718; Xia HHX, 2001, AM J GASTROENTEROL, V96, P1039, DOI 10.1111/j.1572-0241.2001.03604.x; Zhou XY, 2013, DIABETES RES CLIN PR, V99, P200, DOI 10.1016/j.diabres.2012.11.012	49	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183687	10.1371/journal.pone.0183687	http://dx.doi.org/10.1371/journal.pone.0183687			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850590	Green Published, gold, Green Submitted			2022-12-27	WOS:000408544200024
J	Boemer, F; Detilleux, J; Cello, C; Amory, H; Marcillaud-Pitel, C; Richard, E; van Galen, G; van Loon, G; Lefere, L; Votion, DM				Boemer, Francois; Detilleux, Johann; Cello, Christophe; Amory, Helene; Marcillaud-Pitel, Christel; Richard, Eric; van Galen, Gaby; van Loon, Gunther; Lefere, Laurence; Votion, Dominique-Marie			Acylcarnitines profile best predicts survival in horses with atypical myopathy	PLOS ONE			English	Article							JAMAICAN VOMITING SICKNESS; ACYL-COA DEHYDROGENASE; EUROPEAN OUTBREAKS; HYPOGLYCIN; ACID; METABOLITE; IDENTIFICATION; INACTIVATION; MECHANISM; HISTORY	Equine atypical myopathy (AM) is caused by hypoglycin A intoxication and is characterized by a high fatality rate. Predictive estimation of survival in AM horses is necessary to prevent unnecessary suffering of animals that are unlikely to survive and to focus supportive therapy on horses with a possible favourable prognosis of survival. We hypothesized that outcome may be predicted early in the course of disease based on the assumption that the acylcarnitine profile reflects the derangement of muscle energetics. We developed a statistical model to prognosticate the risk of death of diseased animals and found that estimation of outcome may be drawn from three acylcarnitines (C2, C10:2 and C18 -carnitines) with a high sensitivity and specificity. The calculation of the prognosis of survival makes it possible to distinguish the horses that will survive from those that will die despite severe signs of acute rhabdomyolysis in both groups.	[Boemer, Francois; Cello, Christophe] Univ Liege, CHU Sart Tilman, Biochem Genet Lab, Liege, Belgium; [Detilleux, Johann] Univ Liege, Fac Vet Med, Dept Anim Prod Biostat Econ & Anim Select, FARAH, Liege, Belgium; [Amory, Helene; van Galen, Gaby; Votion, Dominique-Marie] Univ Liege, Fac Vet Med, Equine Pole, FARAH, Liege, Belgium; [Marcillaud-Pitel, Christel] RESPE, Caen, France; [Richard, Eric] UNICAEN, Normandie Univ, Labeo Frank Duncombe, Caen, France; [van Loon, Gunther; Lefere, Laurence] Univ Ghent, Large Anim Internal Med, Ghent, Belgium; [van Galen, Gaby] Univ Copenhagen, Dept Large Anim Sci, Copenhagen, Denmark	University of Liege; University of Liege; University of Liege; Universite de Caen Normandie; Ghent University; University of Copenhagen	Votion, DM (corresponding author), Univ Liege, Fac Vet Med, Equine Pole, FARAH, Liege, Belgium.	dominique.votion@ulg.ac.be	Richard, Eric A./T-9257-2017; van Loon, Gunther/B-8526-2009; van Galen, Gaby/J-4405-2013	Richard, Eric A./0000-0002-5890-8658; van Loon, Gunther/0000-0001-5191-5241; van Galen, Gaby/0000-0002-0689-7141; Votion, Dominique-Marie/0000-0003-2899-8207; BOEMER, Francois/0000-0003-4470-9524	"Institut francais du cheval et de I'equitation (ifce)" of France; "Les Fonds Speciaux pour la Recherche (FSR)" of Liege University (Belgium)	"Institut francais du cheval et de I'equitation (ifce)" of France; "Les Fonds Speciaux pour la Recherche (FSR)" of Liege University (Belgium)	The study was supported by the "Institut francais du cheval et de I'equitation (ifce)" of France and by "Les Fonds Speciaux pour la Recherche (FSR)" of Liege University (Belgium). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baise E., 2015, EQUINE VET J; Barceloux DG, 2009, DM-DIS MON, V55, P318, DOI [10.1016/j.disamonth.2009.03.006, 10.1016/j.disamonth.2009.03.005, 10.1016/j.disamonth.2009.03.010, 10.1016/j.disamonth.2009.03.007, 10.1016/j.disamonth.2009.03.011, 10.1016/j.disamonth.2009.03.002, 10.1016/j.disamonth.2009.03.004, 10.1016/j.disamonth.2009.03.003, 10.1016/j.disamonth.2009.03.008]; Bochnia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136785; Boemer F, 2015, J CHROMATOGR B, V997, P75, DOI 10.1016/j.jchromb.2015.06.004; Carlier J, 2015, J CHROMATOGR B, V978, P70, DOI 10.1016/j.jchromb.2014.11.029; Chace DH, 2003, PEDIATR RES, V53, P823, DOI 10.1203/01.PDR.0000059220.39578.3D; Delguste C, 2002, ANN MED VET, V146, P235; Detilleux J, 1999, PREV VET MED, V41, P75, DOI 10.1016/S0167-5877(99)00054-9; ENTMAN M, 1967, MOL PHARMACOL, V3, P333; Filee R, 2014, JIMD REP, V13, P119, DOI 10.1007/8904_2013_265; Gonzalez-Medina S, 2017, EQUINE VET J; Grunes DE, 2012, CASE REPORTS TRANSPL; Hoffer SE, 2016, J EQUINE VET SCI, V47, P77, DOI 10.1016/j.jevs.2016.08.010; IKEDA Y, 1990, BIOCHIM BIOPHYS ACTA, V1038, P216, DOI 10.1016/0167-4838(90)90208-W; LAI MT, 1993, J AM CHEM SOC, V115, P1619, DOI 10.1021/ja00058a001; McKenzie RK, 2016, NEW ZEAL VET J, V64, P182, DOI 10.1080/00480169.2015.1123123; OSMUNDSEN H, 1975, FEBS LETT, V55, P38, DOI 10.1016/0014-5793(75)80951-3; Sander J, 2016, J VET DIAGN INVEST, V28, P98, DOI 10.1177/1040638715624736; SHIH VE, 1978, CLIN CHIM ACTA, V88, P539, DOI 10.1016/0009-8981(78)90289-9; TANAKA K, 1971, P NATL ACAD SCI USA, V68, P20, DOI 10.1073/pnas.68.1.20; TANAKA K, 1976, NEW ENGL J MED, V295, P461, DOI 10.1056/NEJM197608262950901; TANAKA K, 1972, J BIOL CHEM, V247, P7465; van Galen G, 2013, EQUINE VET EDUC, V25, P264, DOI 10.1111/j.2042-3292.2012.00439.x; van Galen G, 2013, J VET INTERN MED, V27, P186, DOI 10.1111/jvim.12003; van Galen G, 2012, EQUINE VET J, V44, P621, DOI 10.1111/j.2042-3306.2012.00555.x; van Galen G, 2012, EQUINE VET J, V44, P614, DOI 10.1111/j.2042-3306.2012.00556.x; Verheyen T, 2012, J VET INTERN MED, V26, P1019, DOI 10.1111/j.1939-1676.2012.00945.x; VONHOLT C, 1966, BIOCHIM BIOPHYS ACTA, V125, P1, DOI 10.1016/0005-2760(66)90138-X; Votion DM, 2014, EQUINE VET J, V46, P146, DOI 10.1111/evj.12117; Votion DM, 2007, J VET INTERN MED, V21, P1380, DOI 10.1892/07-053.1; Votion DM, 2009, VET J, V180, P77, DOI 10.1016/j.tvjl.2008.01.016; Westermann CM, 2008, NEUROMUSCULAR DISORD, V18, P355, DOI 10.1016/j.nmd.2008.02.007; Westermann CM, 2016, J VET INTERN MED, V30, P880, DOI 10.1111/jvim.13927	33	14	14	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182761	10.1371/journal.pone.0182761	http://dx.doi.org/10.1371/journal.pone.0182761			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846683	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600013
J	Irizarry, KJL; Downs, E; Bryden, R; Clark, J; Griggs, L; Kopulos, R; Boettger, CM; Carr, TJ; Keeler, CL; Collisson, E; Drechsler, Y				Irizarry, Kristopher J. L.; Downs, Eileen; Bryden, Randall; Clark, Jory; Griggs, Lisa; Kopulos, Renee; Boettger, Cynthia M.; Carr, Thomas J., Jr.; Keeler, Calvin L.; Collisson, Ellen; Drechsler, Yvonne			RNA sequencing demonstrates large-scale temporal dysregulation of gene expression in stimulated macrophages derived from MHC-defined chicken haplotypes	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOLL-LIKE RECEPTOR; PRO-INFLAMMATORY CYTOKINE; AVIAN INFLUENZA-VIRUS; CD8(+) T-LYMPHOCYTES; INTERFERON-GAMMA; SALMONELLA-ENTERITIDIS; MYCOBACTERIUM-BOVIS; DISEASE RESISTANCE; HOST-RESISTANCE	Discovering genetic biomarkers associated with disease resistance and enhanced immunity is critical to developing advanced strategies for controlling viral and bacterial infections in different species. Macrophages, important cells of innate immunity, are directly involved in cellular interactions with pathogens, the release of cytokines activating other immune cells and antigen presentation to cells of the adaptive immune response. IFN gamma. is a potent activator of macrophages and increased production has been associated with disease resistance in several species. This study characterizes the molecular basis for dramatically different nitric oxide production and immune function between the B2 and the B19 haplotype chicken macrophages. A large-scale RNA sequencing approach was employed to sequence the RNA of purified macrophages from each haplotype group (B2 vs. B19) during differentiation and after stimulation. Our results demonstrate that a large number of genes exhibit divergent expression between B2 and B19 haplotype cells both prior and after stimulation. These differences in gene expression appear to be regulated by complex epigenetic mechanisms that need further investigation.	[Irizarry, Kristopher J. L.; Bryden, Randall; Clark, Jory; Griggs, Lisa; Collisson, Ellen; Drechsler, Yvonne] Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA; [Irizarry, Kristopher J. L.] Western Univ Hlth Sci, Grad Coll Biomed Sci, Appl Genom Ctr, Pomona, CA 91766 USA; [Downs, Eileen] Michigan State Univ, Coll Vet Med, E Lansing, MI 48824 USA; [Boettger, Cynthia M.; Carr, Thomas J., Jr.; Keeler, Calvin L.] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Kopulos, Renee] Northern Illinois Univ, Dept Biol Sci, De Kalb, IL USA	Western University of Health Sciences; Western University of Health Sciences; Michigan State University; University of Delaware; Northern Illinois University	Irizarry, KJL; Drechsler, Y (corresponding author), Western Univ Hlth Sci, Coll Vet Med, Pomona, CA 91766 USA.; Irizarry, KJL (corresponding author), Western Univ Hlth Sci, Grad Coll Biomed Sci, Appl Genom Ctr, Pomona, CA 91766 USA.	kirizarry@westernu.edu; ydrechsler@westernu.edu			United States Department of Agriculture [2008-35204-04806]	United States Department of Agriculture(United States Department of Agriculture (USDA))	Funded by United States Department of Agriculture 2008-35204-04806 http://www.reeis.usda.gov/web/crisprojectpages/0214956-impact-of-immune-resporses-of-chickensas-with-defined-b-haplotypes-on-resistance-to-respiratory-coronavirus-infection.html and Merial Veterinary-Scholars Program http://www.merialscholars.com/ Pages/home.aspx.	Banat GR, 2013, DEV COMP IMMUNOL, V39, P430, DOI 10.1016/j.dci.2012.10.006; Bellamy R, 2003, GENES IMMUN, V4, P4, DOI 10.1038/sj.gene.6363915; Bharti D, 2014, IMMUNOGENETICS, V66, P675, DOI 10.1007/s00251-014-0806-1; Biswas SK, 2012, IMMUNOL RES, V53, P11, DOI 10.1007/s12026-012-8291-9; Castillo-Velazquez U, 2013, VET IMMUNOL IMMUNOP, V154, P8, DOI 10.1016/j.vetimm.2013.04.010; Chan G, 2008, J IMMUNOL, V181, P698, DOI 10.4049/jimmunol.181.1.698; Collisson E, 2017, DEV COMP IMMUNOL, V67, P249, DOI 10.1016/j.dci.2016.09.013; Crippen TL, 2003, DEV COMP IMMUNOL, V27, P603, DOI 10.1016/S0145-305X(03)00035-1; Nguyen CT, 2014, J INFECT DIS, V210, P1745, DOI 10.1093/infdis/jiu352; Dalpke AH, 2003, EUR J IMMUNOL, V33, P1776, DOI 10.1002/eji.200323621; DARMANI H, 1994, INT J EXP PATHOL, V75, P363; Dawes ME, 2014, POULTRY SCI, V93, P830, DOI 10.3382/ps.2013-03511; Drechsler Y, 2013, J ZOO WILDLIFE MED, V44, P251, DOI 10.1638/2011-0229R1.1; Drechsler Y, 2009, VIROLOGY, V386, P380, DOI 10.1016/j.virol.2009.01.027; Ferro PJ, 2004, EPIDEMIOL INFECT, V132, P1029, DOI 10.1017/S0950268804002687; Gautier EL, 2014, J EXP MED, V211, P1525, DOI 10.1084/jem.20140570; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Hasko G, 2009, TRENDS IMMUNOL, V30, P263, DOI 10.1016/j.it.2009.04.001; Hasko G, 2007, PHARMACOL THERAPEUT, V113, P264, DOI 10.1016/j.pharmthera.2006.08.003; He HQ, 2006, MOL IMMUNOL, V43, P783, DOI 10.1016/j.molimm.2005.07.002; HEINZELMANN EW, 1981, POULTRY SCI, V60, P2171, DOI 10.3382/ps.0602171; HONG CC, 1971, APPL MICROBIOL, V22, P818, DOI 10.1128/AEM.22.5.818-820.1971; Hu XY, 2008, IMMUNOL REV, V226, P41, DOI 10.1111/j.1600-065X.2008.00707.x; Hu XY, 2007, J LEUKOCYTE BIOL, V82, P237, DOI 10.1189/jlb.1206763; Hunt HD, 2010, AVIAN DIS, V54, P572, DOI 10.1637/8888-042409-ResNote.1; KASPERS B, 1994, VET IMMUNOL IMMUNOP, V44, P71, DOI 10.1016/0165-2427(94)90170-8; Kaufman J, 1996, CURR TOP MICROBIOL, V212, P129; Kim DK, 2008, POULTRY SCI, V87, P433, DOI 10.3382/ps.2007-00383; LAMONT SJ, 1989, J DAIRY SCI, V72, P1328, DOI 10.3168/jds.S0022-0302(89)79240-7; Lowenthal JW, 1997, J INTERF CYTOK RES, V17, P551, DOI 10.1089/jir.1997.17.551; Malek M, 2003, GENET SEL EVOL, V35, pS99, DOI 10.1051/gse:2003019; Medzhitov R, 1997, CURR OPIN IMMUNOL, V9, P4, DOI 10.1016/S0952-7915(97)80152-5; Medzhitov R, 2000, IMMUNOL REV, V173, P89, DOI 10.1034/j.1600-065X.2000.917309.x; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Mita Y, 2001, IMMUNOL LETT, V78, P97, DOI 10.1016/S0165-2478(01)00241-3; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Qureshi T, 1996, VET IMMUNOL IMMUNOP, V50, P55, DOI 10.1016/0165-2427(95)05492-8; Raza S, 2014, J LEUKOCYTE BIOL, V96, P167, DOI 10.1189/jlb.6HI0313-169R; SCHAT KA, 1994, POULTRY SCI, V73, P502, DOI 10.3382/ps.0730502; Schroder K, 2007, J IMMUNOL, V179, P3495, DOI 10.4049/jimmunol.179.6.3495; Schroder K, 2007, J LEUKOCYTE BIOL, V81, P1577, DOI 10.1189/jlb.0107036; Shi KQ, 2012, J VIRAL HEPATITIS, V19, pE66, DOI 10.1111/j.1365-2893.2011.01540.x; Si ZH, 2006, P NATL ACAD SCI USA, V103, P7454, DOI 10.1073/pnas.0600771103; Singh S, 2010, VIROLOGY, V405, P62, DOI 10.1016/j.virol.2010.05.002; Swaggerty CL, 2008, VET IMMUNOL IMMUNOP, V126, P35, DOI 10.1016/j.vetimm.2008.06.005; Sweet MJ, 2003, ARCH IMMUNOL THER EX, V51, P169; van Erp K, 2006, PHYSIOL GENOMICS, V25, P75, DOI 10.1152/physiolgenomics.00188.2005; van Hateren A, 2013, J BIOL CHEM, V288, P32797, DOI 10.1074/jbc.M113.474031; YOO BH, 1992, BRIT POULTRY SCI, V33, P613, DOI 10.1080/00071669208417500	49	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0179391	10.1371/journal.pone.0179391	http://dx.doi.org/10.1371/journal.pone.0179391			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846708	gold, Green Submitted, Green Published			2022-12-27	WOS:000408438600001
J	Kormann, MSD; Dewerth, A; Eichner, F; Baskaran, P; Hector, A; Regamey, N; Hartl, D; Handgretinger, R; Antony, JS				Kormann, Michael S. D.; Dewerth, Alexander; Eichner, Felizitas; Baskaran, Praveen; Hector, Andreas; Regamey, Nicolas; Hartl, Dominik; Handgretinger, Rupert; Antony, Justin S.			Transcriptomic profile of cystic fibrosis patients identifies type I interferon response and ribosomal stalk proteins as potential modifiers of disease severity	PLOS ONE			English	Article							GENE-EXPRESSION; PSEUDOMONAS-AERUGINOSA; RNA-SEQ; DISORDERS; CHILDREN; CFTR	Cystic Fibrosis (CF) is the most common monogenic disease among people of Western European descent and caused by mutations in the CFTR gene. However, the disease severity is immensely variable even among patients with similar CFTR mutations due to the possible effect of 'modifier genes'. To identify genetic modifiers, we applied RNA-seq based transcriptomic analyses in CF patients with a mild and severe lung phenotype. Global gene expression and enrichment analyses revealed that genes of the type I interferon response and ribosomal stalk proteins are potential modifiers of CF related lung dysfunction. The results provide a new set of CF modifier genes with possible implications as new therapeutic targets for the treatment of CF.	[Kormann, Michael S. D.; Dewerth, Alexander; Eichner, Felizitas; Antony, Justin S.] Univ Tubingen, Dept Pediat Pediat Infectiol & Immunol Translat G, Tubingen, Germany; [Baskaran, Praveen] Univ Tubingen, Ctr Quantitat Biol, Tubingen, Germany; [Hector, Andreas; Hartl, Dominik] Univ Tubingen, Univ Childrens Clin, Dept Paediat Paediat Infectiol & Immunol 1, Tubingen, Germany; [Regamey, Nicolas] Univ Bern, Div Paediat Resp Med, Bern, Switzerland; [Regamey, Nicolas] Univ Bern, Dept Clin Res, Bern, Switzerland; [Regamey, Nicolas] Childrens Hopsital Lucerne, Paediat Pulmonol, Luzern, Switzerland; [Handgretinger, Rupert] Univ Tubingen, Univ Childrens Clin, Dept Paediat Hematol & Oncol 1, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Bern; University of Bern; Eberhard Karls University of Tubingen	Antony, JS (corresponding author), Univ Tubingen, Dept Pediat Pediat Infectiol & Immunol Translat G, Tubingen, Germany.	justin.s.antony@gmail.com	ANTONY, JUSTIN S/F-3994-2010	Hector, Andreas/0000-0002-5745-4746; Regamey, Nicolas/0000-0001-6849-6469	Europe Research Council Starting Grant [637752]; HMZ Private Foundation; Open Access Publishing Fund from University of Ribingen	Europe Research Council Starting Grant; HMZ Private Foundation; Open Access Publishing Fund from University of Ribingen	JSA was supported by Europe Research Council Starting Grant (to M.S.D.K., No. 637752). AD was supported by HMZ Private Foundation (to M.S.D.K.). The authors acknowledge the support of the Open Access Publishing Fund from University of Ribingen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Balloy V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140979; Blanchard AC, 2017, J CYST FIBROS, V16, P395, DOI 10.1016/j.jcf.2017.01.007; Cai ZW, 2011, ACTA PHARMACOL SIN, V32, P693, DOI 10.1038/aps.2011.71; Chen FY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135720; Clarke LA, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-38; Corvol H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9382; Cutting GR, 2015, NAT REV GENET, V16, P45, DOI 10.1038/nrg3849; Cutting GR, 2010, ANN NY ACAD SCI, V1214, P57, DOI 10.1111/j.1749-6632.2010.05879.x; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorfman R, 2008, J CLIN INVEST, V118, P1040, DOI [10.1172/JCI337S4, 10.1172/JCI33754]; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Frickmann H, 2012, EUR J MICROBIOL IMMU, V2, P161, DOI 10.1556/EuJMI.2.2012.3.1; Furlan LL, 2016, HUM GENET, V135, P881, DOI 10.1007/s00439-016-1684-4; Gallati S, 2014, APPL CLIN GENET, V7, P133, DOI 10.2147/TACG.S18675; Genin E, 2008, HUM GENET, V124, P357, DOI 10.1007/s00439-008-0560-2; Gu YY, 2009, NATURE, V458, P1039, DOI 10.1038/nature07811; Hamilton BA, 2012, PLOS GENET, V8, P326, DOI 10.1371/journal.pgen.1002644; HAMOSH A, 1993, NEW ENGL J MED, V329, P1308; Hector A, 2013, AM J RESP CELL MOL, V48, P71, DOI 10.1165/rcmb.2012-0061OC; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Mekus F, 2000, Twin Res, V3, P277, DOI 10.1375/twin.3.4.277; Nair RP, 2006, AM J HUM GENET, V78, P827, DOI 10.1086/503821; O'Sullivan BP, 2009, LANCET, V373, P1891, DOI 10.1016/S0140-6736(09)60327-5; Ogilvie V, 2011, GENOMICS, V98, P327, DOI 10.1016/j.ygeno.2011.06.008; Parker D, 2012, AM J RESP CELL MOL, V46, P6, DOI 10.1165/rcmb.2011-0080OC; Parker D, 2011, MBIO, V2, DOI 10.1128/mBio.00016-11; Parker D, 2011, TRENDS IMMUNOL, V32, P582, DOI 10.1016/j.it.2011.09.003; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Shah VS, 2016, SCIENCE, V351, P503, DOI 10.1126/science.aad5589; Smeekens SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2343; Trouve P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173822; Valdivieso AG, 2016, CELL PHYSIOL BIOCHEM, V38, P49, DOI 10.1159/000438608; Vanscoy LL, 2007, AM J RESP CRIT CARE, V175, P1036, DOI 10.1164/rccm.200608-1164OC; Veit G, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002462; Verhaeghe C, 2007, BIOCHEM PHARMACOL, V73, P1982, DOI 10.1016/j.bcp.2007.03.019; Virella-Lowell I, 2004, MOL THER, V10, P562, DOI 10.1016/j.ymthe.2004.06.215; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wright FA, 2011, NAT GENET, V43, P539, DOI 10.1038/ng.838; Wright JM, 2006, AM J RESP CELL MOL, V35, P327, DOI 10.1165/rcmb.2005-0359OC; Zabner J, 2005, AM J PHYSIOL-LUNG C, V289, pL545, DOI 10.1152/ajplung.00065.2005; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644	44	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183526	10.1371/journal.pone.0183526	http://dx.doi.org/10.1371/journal.pone.0183526			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846703	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600032
J	Markaki, I; Klironomos, S; Kostulas, K; Sjostrand, C				Markaki, Ioanna; Klironomos, Stefanos; Kostulas, Konstantinos; Sjostrand, Christina			Elevated plasma homocysteine upon ischemic stroke is associated with increased long-term mortality in women	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; DISEASE; DEATH; RISK	Background Ischemic stroke is a leading cause of death worldwide, despite preventive and therapeutic advances during the last twenty years. Blood-borne biomarkers have been studied in association to short-and long-term outcome, in order to investigate possible modifiable predictors of disability and death. Increased homocysteine has been associated with increased vascular risk and unfavorable outcome, but homocysteine lowering treatment has not consistently been successful in risk reduction. The aim of this study was to investigate homocysteine levels upon acute ischemic stroke in association to long-term mortality. Methods Of 622 patients included in our hospital-based registry, 331 survived the first month after admission, and had a diagnosis of ischemic stroke and available homocysteine values. All-cause and vascular mortality were investigated based on the national patient-and cause of death-registries. Survival analysis and Cox proportional hazard models were used to investigate time to death and predictors of outcome. Results Of 331 patients, 148 (45%) had low homocysteine (<13 micromol/L) and 183 (55%) had high homocysteine (>= 13 micromol/L). During 10 years of follow-up (median 5.5 years), 47 patients (32%) with low homocysteine and 94 (51%) with high homocysteine died (p<0.0001). Estimated median survival was not reached for the low homocysteine group, and was 80 months in the high homocysteine group (p with log-rank test 0.002). High homocysteine was not independently associated with increased risk for death after adjustment for age, sex, comorbidities, and eGFR (HR 1.29, 95% CI 0.86-1.93; p = 0.2). Subgroup analysis by sex showed that high homocysteine was an independent predictor of mortality in women after adjustment for age and vascular comorbidities (HR 1.85; 95% CI 1.03-3.31; p = 0.04), but not in men (HR 0.87; 95% CI 0.52-1.43; p = 0.6). Conclusion Increased plasma homocysteine (>= 13 micromol/L) upon acute ischemic stroke was not independently associated with mortality in our study. In the subgroup of women, high homocysteine was associated with increased five-year risk of death. Our study's retrospective design and the exploratory nature of subgroup analysis, prevent robust conclusions based on that observation. Future studies on homocysteine levels before as well as upon stroke will shed further light on a possible causal association.	[Markaki, Ioanna; Klironomos, Stefanos; Kostulas, Konstantinos; Sjostrand, Christina] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden	Karolinska Institutet	Markaki, I (corresponding author), Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.	ioanna.markaki@ki.se		Klironomos, Stefanos/0000-0002-3279-7902; Markaki, Ioanna/0000-0003-3328-5746	Stockholm County Council (ALF project) [20150335, 20160454]	Stockholm County Council (ALF project)(Stockholm County Council)	This study was supported by grants (20150335, 20160454) provided by the Stockholm County Council (ALF project). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnadottir M, 1996, SCAND J CLIN LAB INV, V56, P41, DOI 10.3109/00365519609088586; Barron E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127550; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Forti P, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.460; Ham AC, 2014, DRUG AGING, V31, P611, DOI 10.1007/s40266-014-0192-2; Hankey GJ, 2012, LANCET NEUROL, V11, P512, DOI 10.1016/S1474-4422(12)70091-1; Ji Y, 2013, NEUROLOGY, V81, P1298, DOI 10.1212/WNL.0b013e3182a823cc; Koton S, 2010, NEUROEPIDEMIOLOGY, V34, P90, DOI 10.1159/000264826; Lewerin C, 2007, J INTERN MED, V261, P65, DOI 10.1111/j.1365-2796.2006.01732.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mueller C, 2008, SWISS MED WKLY, V138, P225, DOI 2008/15/smw-12180; Sahebkar A, 2016, CURR MED CHEM, V23, P4490, DOI 10.2174/0929867323666161007155310; Shi ZH, 2015, STROKE, V46, P2419, DOI 10.1161/STROKEAHA.115.009136; Swart KMA, 2012, EUR J CLIN NUTR, V66, P188, DOI 10.1038/ejcn.2011.186; Toole JF, 2004, JAMA-J AM MED ASSOC, V291, P565, DOI 10.1001/jama.291.5.565; Zhong C, 2016, MOL NEUROBIOL	17	6	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183571	10.1371/journal.pone.0183571	http://dx.doi.org/10.1371/journal.pone.0183571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846725	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600037
J	Han, SY; Liu, H; Yan, M; Qi, FY; Wang, YQ; Sun, ZQ; Huang, BY; Dong, WZ; Tang, FS; Zhang, XY; He, GH				Han, Suoyi; Liu, Hua; Yan, Mei; Qi, Feiyan; Wang, Yaqi; Sun, Ziqi; Huang, Bingyan; Dong, Wenzhao; Tang, Fengshou; Zhang, Xinyou; He, Guohao			Differential gene expression in leaf tissues between mutant and wild-type genotypes response to late leaf spot in peanut (Arachis hypogaea L.)	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; RNA-SEQ; PHOTOSYNTHETIC CONSEQUENCES; CERCOSPORIDIUM-PERSONATUM; CORE COLLECTION; RESISTANCE; SENESCENCE; ARABIDOPSIS; RUST; PROTEINS	Late leaf spot (LLS) is a major foliar disease in peanut (A. hypogaea L.) worldwide, causing significant losses of potential yield in the absence of fungicide applications. Mutants are important materials to study the function of disease-related genes. In this study, the mutant line M14 was derived from cultivar Yuanza 9102 treated with EMS. Yuanza 9102 was selected from an interspecific cross of cultivar Baisha 1016 with A. diogoi, and is resistant to several fungal diseases. By contrast, the M14 was highly susceptible to late leaf spot. RNA-Seq analysis in the leaf tissues of the M14 and its wild type Yuanza 9102 under pathogen challenge showed 2219 differentially expressed genes including1317 up-regulated genes and 902 down-regulated genes. Of these genes, 1541, 1988, 1344, 643 and 533 unigenes were obtained and annotated by public protein databases of SwissPort, TrEMBL, gene ontology (GO), KEGG and clusters of orthologous groups (COG), respectively. Differentially expressed genes (DEGs) showed that expression of inducible pathogenesis-related (PR) proteins was significantly up-regulated; in the meantime DEGs related to photosynthesis were down-regulated in the susceptible M14 in comparison to the resistant WT. Moreover, the up-regulated WRKY transcription factors and down-regulated plant hormones related to plant growth were detected in the M14. The results suggest that down-regulated chloroplast genes, up-regulated WRKY transcription factors, and depressed plant hormones related to plant growth in the M14 might coordinately render the susceptibility though there was a significant high level of PRs. Those negative effectors might be triggered in the susceptible plant by fungal infection and resulted in reduction of photosynthesis and phytohormones and led to symptom formation.	[Han, Suoyi; Liu, Hua; Yan, Mei; Qi, Feiyan] Henan Acad Agr Sci, Ind Crops Res Inst, Zhengzhou, Henan, Peoples R China; [Han, Suoyi; He, Guohao] Tuskegee Univ, Coll Agr Environm & Nutr Sci, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA; [Wang, Yaqi; Sun, Ziqi; Huang, Bingyan] Henan Prov Key Lab Oil Crops Improvement, Zhengzhou, Henan, Peoples R China; [Dong, Wenzhao; Tang, Fengshou; Zhang, Xinyou] Minist Agr, Key Lab Oil Crops Huanghuaihai Plains, Zhengzhou, Henan, Peoples R China	Henan Academy of Agricultural Sciences; Tuskegee University; Ministry of Agriculture & Rural Affairs	He, GH (corresponding author), Tuskegee Univ, Coll Agr Environm & Nutr Sci, Dept Agr & Environm Sci, Tuskegee, AL 36088 USA.; Zhang, XY (corresponding author), Minist Agr, Key Lab Oil Crops Huanghuaihai Plains, Zhengzhou, Henan, Peoples R China.	haasz@126.com; hguohao@mytu.tuskegee.edu			National High-Tech R&D Program of China (863 program) [2013AA102602-6]; China Agriculture Research System [CARS-13]; Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences [2013YQ08]	National High-Tech R&D Program of China (863 program); China Agriculture Research System; Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences	This work was funded by grants to XYZ, National High-Tech R&D Program of China (863 program), 2013AA102602-6, http://program.most.gov.cn/; XYZ, China Agriculture Research System, CARS-13, http://119.253.58.231/; SYH, Science Technology Foundation for Outstanding Young Scientists of Henan Academy of Agricultural Sciences, 2013YQ08, http://www.hriagri.org.cn/kygl/index.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERS S, 2010, NATURE P; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bassanezi RB, 2002, J PHYTOPATHOL, V150, P37, DOI 10.1046/j.1439-0434.2002.00714.x; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Cho WK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136736; El-Kereamy A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017973; Erickson JE, 2004, NEW PHYTOL, V161, P577, DOI 10.1046/j.1469-8137.2003.00968.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gremillion SK, 2011, PLANT DIS, V95, P263, DOI 10.1094/PDIS-06-10-0454; Guo YF, 2005, CURR TOP DEV BIOL, V71, P83, DOI 10.1016/S0070-2153(05)71003-6; HENSEL LL, 1993, PLANT CELL, V5, P553, DOI 10.1105/tpc.5.5.553; HOLBROOK CC, 1995, CROP SCI, V35, P1700, DOI 10.2135/cropsci1995.0011183X003500060032x; JOGLOY S, 1987, Peanut Science, V14, P86, DOI 10.3146/i0095-3679-14-2-9; Khedikar YP, 2010, THEOR APPL GENET, V121, P971, DOI 10.1007/s00122-010-1366-x; Kim MJ, 2005, PLANT MOL BIOL, V59, P981, DOI 10.1007/s11103-005-2619-y; KNAUFT D A, 1986, Peanut Science, V13, P82, DOI 10.3146/i0095-3679-13-2-11; KNAUFT D A, 1988, Peanut Science, V15, P9, DOI 10.3146/i0095-3679-15-1-3; Kong LF, 2014, MOL PLANT, V7, P691, DOI 10.1093/mp/sst158; KORNEGAY J L, 1980, Peanut Science, V7, P4, DOI 10.3146/i0095-3679-7-1-2; Kumar D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117559; de Sa MEL, 2012, GENET MOL BIOL, V35, P272, DOI 10.1590/S1415-47572012000200008; Luo M, 2005, PHYTOPATHOLOGY, V95, P381, DOI 10.1094/PHYTO-95-0381; Mahdavi F, 2012, APPL BIOCHEM BIOTECH, V166, P1008, DOI 10.1007/s12010-011-9489-3; Mallikarjuna N, 2012, EUR J PLANT PATHOL, V132, P17, DOI 10.1007/s10658-011-9859-2; Martin LBB, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00066; MAUCH F, 1991, PLANT MOL BIOL, V16, P1089, DOI 10.1007/BF00016083; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; MILLER I L, 1990, Peanut Science, V17, P52, DOI 10.3146/i0095-3679-17-2-2; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NEVILL DJ, 1982, OLEAGINEUX, V37, P355; PENSUK V, 2003, SONGKLANAKARIN J SCI, V25, P289; Petre B, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-33; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Radhajeyalakshmi R., 2003, Acta Phytopathologica et Entomologica Hungarica, V38, P251, DOI 10.1556/APhyt.38.2003.3-4.5; Reddy DS Bhatnagar-Mathur, 2013, PLOS ONE, V8; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robatzek S, 2001, PLANT J, V28, P123, DOI 10.1046/j.1365-313X.2001.01131.x; Selitrennikoff CP, 2001, APPL ENVIRON MICROB, V67, P2883, DOI 10.1128/AEM.67.7.2883-2894.2001; Shoba D, 2012, EUPHYTICA, V188, P265, DOI 10.1007/s10681-012-0718-9; Singh BK, 2013, PLOS ONE, V8; Singh MP, 2011, CROP SCI, V51, P2741, DOI 10.2135/cropsci2011.03.0144; Singh MP, 2011, AGRON J, V105, P1307; SUBRAHMANYAM P, 1989, ECON BOT, V43, P444, DOI 10.1007/BF02935917; Sudini H, 2015, AUSTRALAS PLANT PATH, V44, P557, DOI 10.1007/s13313-015-0368-1; Ulker B, 2007, PLANTA, V226, P125, DOI 10.1007/s00425-006-0474-y; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Verma V, 2016, BMC PLANT BIOL, V16, DOI 10.1186/s12870-016-0771-y; Zheng ZY, 2006, PLANT J, V48, P592, DOI 10.1111/j.1365-313X.2006.02901.x	49	8	10	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183428	10.1371/journal.pone.0183428	http://dx.doi.org/10.1371/journal.pone.0183428			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841668	Green Submitted, gold, Green Published			2022-12-27	WOS:000408370700030
J	Solomon, RB; Conover, K; Shizgal, P				Solomon, Rebecca Brana; Conover, Kent; Shizgal, Peter			Valuation of opportunity costs by rats working for rewarding electrical brain stimulation	PLOS ONE			English	Article							LATERAL HYPOTHALAMIC-STIMULATION; SUBJECTIVE MAGNITUDE; OPERANT PERFORMANCE; TIME-LEFT; STRENGTH; COMPETITION; FREQUENCY; SUMMATION; DURATION; SUCROSE	Pursuit of one goal typically precludes simultaneous pursuit of another. Thus, each exclusive activity entails an "opportunity cost:" the forgone benefits from the next-best activity eschewed. The present experiment estimates, in laboratory rats, the function that maps objective opportunity costs into subjective ones. In an operant chamber, rewarding electrical brain stimulation was delivered when the cumulative time a lever had been depressed reached a criterion duration. The value of the activities forgone during this duration is the opportunity cost of the electrical reward. We determined which of four functions best describes how objective opportunity costs, expressed as the required duration of lever depression, are translated into their subjective equivalents. The simplest account is the identity function, which equates subjective and objective opportunity costs. A variant of this function called the "sigmoidal-slope function," converges on the identity function at longer durations but deviates from it at shorter durations. The sigmoidal-slope function has the form of a hockey stick. The flat "blade" denotes a range over which opportunity costs are subjectively equivalent; these durations are too short to allow substitution of more beneficial activities. The blade extends into an upward-curving portion over which costs become discriminable and finally into the straight "handle," over which objective and subjective costs match. The two remaining functions are based on hyperbolic and exponential temporal discounting, respectively. The results are best described by the sigmoidal-slope function. That this is so suggests that different principles of intertemporal choice are involved in the evaluation of time spent working for a reward or waiting for its delivery. The subjective opportunitycost function plays a key role in the evaluation and selection of goals. An accurate description of its form and parameters is essential to successful modeling and prediction of instrumental performance and reward-related decision making.	[Solomon, Rebecca Brana; Conover, Kent; Shizgal, Peter] Concordia Univ, Ctr Studies Behav Neurobiol, Grp Rech Neurobiol Comportementale, Dept Psychol, Montreal, PQ, Canada	Concordia University - Canada	Shizgal, P (corresponding author), Concordia Univ, Ctr Studies Behav Neurobiol, Grp Rech Neurobiol Comportementale, Dept Psychol, Montreal, PQ, Canada.	peter.shizgal@concordia.ca	Shizgal, Peter/H-9823-2013; Shizgal, Peter/V-5602-2019	Shizgal, Peter/0000-0003-4265-0792	Bourse de Doctorat de Recherche scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies to Rebecca Solomon; Bourse de Doctorat de Recherche scholarship from the Natural Sciences and Engineering Research Council of Canada [RGPIN-308-06 RGPIN-308-11]; Concordia University Research Chairs program; Fonds de recherche du Que-bec-Sante; Concordia University	Bourse de Doctorat de Recherche scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies to Rebecca Solomon; Bourse de Doctorat de Recherche scholarship from the Natural Sciences and Engineering Research Council of Canada; Concordia University Research Chairs program; Fonds de recherche du Que-bec-Sante(Fonds de la Recherche en Sante du Quebec); Concordia University	This study was supported by a Bourse de Doctorat de Recherche scholarship from the Fonds Quebecois de Recherche sur la Nature et les Technologies to Rebecca Solomon, grants from the Natural Sciences and Engineering Research Council of Canada (Peter Shizgal, p.i., RGPIN-308-06 & RGPIN-308-11), and support to Peter Shizgal from the Concordia University Research Chairs program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Steve Cabilio developed and maintained the experimental-control and data acquisition software used in this study. The experimental-control and data acquisition hardware was designed, built, and maintained by David Munro. The experiments were carried out in the facilities of the "Groupe de Recherche en Neurobiologie Comportementale" / Center for Studies in Behavioural Neurobiology, which was supported by grants from the "Fonds de recherche du Que-bec-Sante" and Concordia University. The authors thank Peter Dayan and Sarah Nolan-Poupart for much appreciated, helpful comments on the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Arvanitogiannis A, 2008, BEHAV NEUROSCI, V122, P1126, DOI 10.1037/a0012679; Breton YA, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00284; Breton YA, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00125; Breton YA, 2009, BEHAV BRAIN RES, V202, P77, DOI 10.1016/j.bbr.2009.03.019; Cerutti DT, 2004, J EXP PSYCHOL-ANIM B, V30, P45, DOI 10.1037/0097-7403.30.1.45; Conover KL, 2005, GAME ECON BEHAV, V52, P283, DOI 10.1016/j.geb.2004.08.003; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P549; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P559; CONOVER KL, 1994, BEHAV NEUROSCI, V108, P537, DOI 10.1037/0735-7044.108.3.537; Efron B., 1993, INTRO BOOTSTRAP, V57; Fouriezos G, 1997, BEHAV BRAIN RES, V87, P111, DOI 10.1016/S0166-4328(97)02280-8; Frank Robert H., 2010, MICROECONOMICS BEHAV; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; GALLISTEL CR, 1991, BEHAV NEUROSCI, V105, P913, DOI 10.1037/0735-7044.105.6.913; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GIBBON J, 1977, PSYCHOL REV, V84, P279, DOI 10.1037/0033-295X.84.3.279; GIBBON J, 1981, J EXP PSYCHOL ANIM B, V7, P87, DOI 10.1037/0097-7403.7.2.87; HAMILTON AL, 1985, PHYSIOL BEHAV, V35, P897, DOI 10.1016/0031-9384(85)90257-4; Hartmann MN, 2013, BEHAV PROCESS, V100, P192, DOI 10.1016/j.beproc.2013.09.014; Hernandez G, 2012, J NEUROSCI, V32, P11032, DOI 10.1523/JNEUROSCI.1051-12.2012; Hernandez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015081; HERRNSTE.RJ, 1974, J EXP ANAL BEHAV, V21, P159, DOI 10.1901/jeab.1974.21-159; Herrnstein RJ, 1970, J EXP ANAL BEHAV, V13, P243, DOI 10.1901/jeab.1970.13-243; HERRNSTEIN RJ, 1961, J EXP ANAL BEHAV, V4, P267, DOI 10.1901/jeab.1961.4-267; Kagel John H., 1995, EC CHOICE THEORY EXP; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kalenscher T, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00082; Klein-Flugge MC, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004116; Krugman P. R., 2009, ECONOMICS; LEON M, 1992, BEHAV BRAIN RES, V52, P183, DOI 10.1016/S0166-4328(05)80229-3; MARK TA, 1993, BEHAV NEUROSCI, V107, P389, DOI 10.1037/0735-7044.107.2.389; Marsh B, 2002, P NATL ACAD SCI USA, V99, P3352, DOI 10.1073/pnas.042491999; MAZUR JE, 1987, BEHAV PROCESS, V15, P143, DOI 10.1016/0376-6357(87)90003-9; MAZUR JE, 1986, J EXP ANAL BEHAV, V46, P67, DOI 10.1901/jeab.1986.46-67; McDowell JJ, 2005, J EXP ANAL BEHAV, V84, P111, DOI 10.1901/jeab.2005.59-04; MCFARLAND DJ, 1975, PHILOS T ROY SOC B, V270, P265, DOI 10.1098/rstb.1975.0009; Namboodiri V.M.K., 2014, TIMING TIME PERCEPT, V1, P1; Namboodiri VMK, 2014, FRONT BEHAV NEUROSCI, P8; Niv Y, 2007, PSYCHOPHARMACOLOGY, V191, P507, DOI 10.1007/s00213-006-0502-4; Niyogi RK, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003894; Niyogi RK, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0969; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; ROBBINS L, 1935, ESSAY NATURE SIGNIFI; Samuelson PA, 1938, ECONOMICA-NEW SER, V5, P61, DOI 10.2307/2548836; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Shizgal P, 1997, CURR OPIN NEUROBIOL, V7, P198, DOI 10.1016/S0959-4388(97)80008-6; Shizgal P, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00020; SIMMONS JM, 1994, BEHAV NEUROSCI, V108, P151, DOI 10.1037/0735-7044.108.1.151; Solomon RB, 2015, BEHAV BRAIN RES, V292, P327, DOI 10.1016/j.bbr.2015.06.008; Solomon RB, 2006, SUBJECTIVE ESTIMATES; Solomon RB, 2007, SOC NEUR ABSTR, V37, P742; Solomon RB, 2014, THESIS; Sonnenschein B, 2003, BEHAV NEUROSCI, V117, P978, DOI 10.1037/0735-7044.117.5.978; Staddon JER, 1999, J EXP ANAL BEHAV, V71, P215, DOI 10.1901/jeab.1999.71-215; Stephens D., 2007, FORAGING BEHAV ECOLO; Stephens D.W., 1986, pi; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; Trujillo-Pisanty I, 2014, PSYCHOPHARMACOLOGY, V231, P1351, DOI 10.1007/s00213-013-3328-x; Trujillo-Pisanty I, 2011, J NEUROSCI, V31, P5426, DOI 10.1523/JNEUROSCI.0079-11.2011; TVERSKY A, 1992, J RISK UNCERTAINTY, V5, P297, DOI 10.1007/BF00122574; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wikenheiser AM, 2013, P NATL ACAD SCI USA, V110, P8308, DOI 10.1073/pnas.1220738110	63	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182120	10.1371/journal.pone.0182120	http://dx.doi.org/10.1371/journal.pone.0182120			40	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841663	Green Submitted, Green Accepted, gold, Green Published			2022-12-27	WOS:000408370700005
J	Whatcott, CJ; Ng, S; Barrett, MT; Hostetter, G; Von Hoff, DD; Han, HY				Whatcott, Clifford J.; Ng, Serina; Barrett, Michael T.; Hostetter, Galen; Von Hoff, Daniel D.; Han, Haiyong			Inhibition of ROCK1 kinase modulates both tumor cells and stromal fibroblasts in pancreatic cancer	PLOS ONE			English	Article							DUCTAL ADENOCARCINOMA; TGF-BETA; GEMCITABINE; DESMOPLASIA; ACTIVATION; EXPRESSION; MIGRATION; MOLECULE; FIBROSIS; COLLAGEN	ROCK, or Rho-associated coiled coil-containing protein kinase, is a member of the AGC kinase family and has been shown to play a role in cell migration, ECM synthesis, stressfiber assembly, and cell contraction. Increased ROCK expression has been reported in multiple pathological conditions, including cancer. Here, we report increased expression of ROCK 1 in pancreatic tumor epithelial cells as well as in cancer associated fibroblasts (CAF). In our analysis, 62% of tumor samples exhibited >= 2+ in staining intensity by IHC analysis, versus 40% of adjacent normal tissue samples (P<0.0001). Thus, we hypothesized that ROCKs may play a significant role in pancreatic cancer progression, and may serve as a suitable target for treatment. We report a low frequency (4/34) amplification of the ROCK1 gene locus at chromosome 18q11.1 in pancreatic ductal adenocarcinoma (PDAC) patient tissue samples by aCGH analysis. Inhibition of ROCK kinase activity by a small molecule inhibitor (fasudil) resulted in moderate (IC(50)s of 6-71 mu M) inhibition of PDAC cell proliferation, migration, and activation of co-cultured stellate cells. In the KPC mouse model for pancreatic cancer, fasudil decreased tumor collagen deposition. This translated to an enhanced overall survival of the mice and an increase in gemcitabine uptake. Though fasudil may target both the tumor epithelial cells and the CAFs, our findings are consistent with the hypothesis that inhibition of tumor stroma enhances drug penetration and efficacy in PDAC. Overall, our data suggests that ROCK1 may serve as a potential therapeutic target to enhance current treatment regimens for pancreatic cancer.	[Whatcott, Clifford J.; Ng, Serina; Von Hoff, Daniel D.; Han, Haiyong] Translat Genom Res Inst, Div Mol Med, Phoenix, AZ 85004 USA; [Barrett, Michael T.] Mayo Clin, Ctr Canc, Scottsdale, AZ USA; [Hostetter, Galen] Van Andel Res Inst, Lab Analyt Pathol, Grand Rapids, MI USA	Translational Genomics Research Institute; Mayo Clinic; Mayo Clinic Phoenix; Van Andel Institute	Han, HY (corresponding author), Translat Genom Res Inst, Div Mol Med, Phoenix, AZ 85004 USA.	hhan@tgen.org			NIH/NCI [R01 (CM 69281), U01 (CA128454)]; National Foundation for Cancer Research; Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant [SU2C-AACR-DT-20-16]; NATIONAL CANCER INSTITUTE [R01CA169281] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Foundation for Cancer Research; Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by a R01 (CM 69281) grant and a U01 (CA128454) grant from the NIH/NCI, a grant from the National Foundation for Cancer Research, and a Stand Up To Cancer-Cancer Research UK-Lustgarten Foundation Pancreatic Cancer Dream Team Research Grant (Grant Number: SU2C-AACR-DT-20-16). Stand Up To Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian K, 2009, CANCER RES, V69, P9169, DOI 10.1158/0008-5472.CAN-09-1705; Agbunag C, 2004, CANCER RES, V64, P5659, DOI 10.1158/0008-5472.CAN-04-0807; Bailey JM, 2008, CLIN CANCER RES, V14, P5995, DOI 10.1158/1078-0432.CCR-08-0291; Bapiro TE, 2011, CANCER CHEMOTH PHARM, V68, P1243, DOI 10.1007/s00280-011-1613-0; Bouzin C, 2007, DRUG RESIST UPDATE, V10, P109, DOI 10.1016/j.drup.2007.03.001; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Chauhan VP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3516; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Diep CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032783; Diep CH, 2011, CLIN CANCER RES, V17, P2744, DOI 10.1158/1078-0432.CCR-10-2214; Gabet AS, 2011, CELL DEATH DIFFER, V18, P678, DOI 10.1038/cdd.2010.140; Garton AJ, 2008, METHOD ENZYMOL, V439, P491, DOI 10.1016/S0076-6879(07)00433-8; Grzesiak JJ, 2007, PANCREAS, V35, P293, DOI 10.1097/mpa.0b013e31811f4526; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haudek SB, 2009, CARDIOVASC RES, V83, P511, DOI 10.1093/cvr/cvp135; Herpin A, 2007, FEBS J, V274, P2977, DOI 10.1111/j.1742-4658.2007.05840.x; Herrlich P, 2000, ANN NY ACAD SCI, V910, P106; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Hirooka Yoshitaka, 2005, Am J Cardiovasc Drugs, V5, P31, DOI 10.2165/00129784-200505010-00005; Hong SP, 2009, INT J CANCER, V125, P2323, DOI 10.1002/ijc.24573; Jacobetz MA, 2013, GUT, V62, P112, DOI 10.1136/gutjnl-2012-302529; Kaneko K, 2002, PANCREAS, V24, P251, DOI 10.1097/00006676-200204000-00007; Kolar C, 1997, PANCREAS, V15, P265, DOI 10.1097/00006676-199710000-00008; Lane J, 2008, INT J ONCOL, V33, P585, DOI 10.3892/ijo_00000044; Lipson D, 2006, J COMPUT BIOL, V13, P215, DOI 10.1089/cmb.2006.13.215; Liu XZ, 2011, J ORTHOP RES, V29, P1259, DOI 10.1002/jor.21403; Lochhead PA, 2010, ONCOGENE, V29, P2591, DOI 10.1038/onc.2010.3; Magzoub M, 2008, FASEB J, V22, P276, DOI 10.1096/fj.07-9150com; Masamune A, 2003, BRIT J PHARMACOL, V140, P1292, DOI 10.1038/sj.bjp.0705551; Masamune A, 2009, CLIN GASTROENTEROL H, V7, pS48, DOI 10.1016/j.cgh.2009.07.038; Naber HPH, 2008, CURR CANCER DRUG TAR, V8, P466, DOI 10.2174/156800908785699342; Noma K, 2006, AM J PHYSIOL-CELL PH, V290, pC661, DOI 10.1152/ajpcell.00459.2005; Ozdemir BC, 2014, CANCER CELL, V25, P719, DOI 10.1016/j.ccr.2014.04.005; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Papadimitriou E, 2011, CELL PHYSIOL BIOCHEM, V28, P229, DOI 10.1159/000331734; Pham NA, 2007, DIAGN PATHOL, V2, DOI 10.1186/1746-1596-2-8; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2012, CANCER CELL, V21, P418, DOI 10.1016/j.ccr.2012.01.007; Rath N, 2017, EMBO MOL MED, V9, P198, DOI 10.15252/emmm.201606743; Rhim AD, 2014, CANCER CELL, V25, P735, DOI 10.1016/j.ccr.2014.04.021; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ruiz C, 2011, P NATL ACAD SCI USA, V108, P12054, DOI 10.1073/pnas.1104009108; Sasaki Y, 2002, PHARMACOL THERAPEUT, V93, P225, DOI 10.1016/S0163-7258(02)00191-2; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; SKEHAN P, 1990, J NATL CANCER I, V82, P1107, DOI 10.1093/jnci/82.13.1107; Smith PC, 2006, J PERIODONTAL RES, V41, P418, DOI 10.1111/j.1600-0765.2006.00886.x; Stylianopoulos T, 2012, P NATL ACAD SCI USA, V109, P15101, DOI 10.1073/pnas.1213353109; Vardouli L, 2005, J BIOL CHEM, V280, P11448, DOI 10.1074/jbc.M402651200; Von Hoff DD, 2013, NEW ENGL J MED, V369, P1691, DOI 10.1056/NEJMoa1304369; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Yen TNF, 2002, SURGERY, V131, P129, DOI 10.1067/msy.2002.119192	51	50	51	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183871	10.1371/journal.pone.0183871	http://dx.doi.org/10.1371/journal.pone.0183871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841710	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700066
J	Apostolidis, L; Schwarz, D; Xia, A; Weiler, M; Heckel, A; Godel, T; Heiland, S; Schlemmer, HP; Jager, D; Bendszus, M; Baumer, P				Apostolidis, Leonidas; Schwarz, Daniel; Xia, Annie; Weiler, Markus; Heckel, Andreas; Godel, Tim; Heiland, Sabine; Schlemmer, Heinz-Peter; Jaeger, Dirk; Bendszus, Martin; Baeumer, Philipp			Dorsal root ganglia hypertrophy as in vivo correlate of oxaliplatin-induced polyneuropathy	PLOS ONE			English	Article							INDUCED PERIPHERAL NEUROPATHY; ADVANCED COLORECTAL-CANCER; INDUCED NEUROTOXICITY; NERVOUS-SYSTEM; CISPLATIN; CHEMOTHERAPY; FLUOROURACIL; LEUCOVORIN; TRIAL; RAT	Purpose To investigate in vivo morphological and functional correlates of oxaliplatin-induced peripheral neuropathy (OXA-PNP) by magnetic resonance neurography (MRN). Methods Twenty patients (7 female, 13 male, 58.9 +/- 10.0 years) with mild to moderate OXA-PNP and 20 matched controls (8 female, 12 male, 55.7 +/- 15.6 years) were prospectively enrolled. All patients underwent a detailed neurophysiological examination prior to neuroimaging. A standardized imaging protocol at 3.0 Tesla included the lumbosacral plexus and both sciatic nerves and their branches using T2-weighted fat-saturated sequences and diffusion tensor imaging. Quantitative assessment included volumetry of the dorsal root ganglia (DRG), sciatic nerve normalized T2 (nT2) signal and caliber, and fractional anisotropy (FA), mean diffusivity (MD), axial (AD) and radial diffusivity (RD). Additional qualitative evaluation of sciatic, peroneal, and tibial nerves evaluated the presence, degree, and distribution of nerve lesions. Results DRG hypertrophy in OXA-PNP patients (207.3 +/- 47.7mm(3) vs. 153.0 +/- 47.1mm(3) in controls, p = 0.001) was found as significant morphological correlate of the sensory neuronopathy. In contrast, peripheral nerves only exhibited minor morphological alterations qualitatively. Quantitatively, sciatic nerve caliber (27.3 +/- 6.7mm(2) vs. 27.4 +/- 7.4mm(2), p = 0.80) and nT2 signal were not significantly changed in patients (1.32 +/- 0.22 vs. 1.22 +/- 0.26, p = 0.16). AD, RD, and MD showed a non-significant decrease in patients, while FA was unchanged. Conclusion OXA-PNP manifests with morphological and functional correlates that can be detected in vivo by MRN. We report hypertrophy of the DRG that stands in contrast to experimental and postmortem studies. DRG volume should be further investigated as a biomarker in other sensory peripheral neuropathies and ganglionopathies.	[Apostolidis, Leonidas; Jaeger, Dirk] Natl Ctr Tumor Dis, Dept Med Oncol, Heidelberg, Germany; [Schwarz, Daniel; Xia, Annie; Heckel, Andreas; Godel, Tim; Heiland, Sabine; Bendszus, Martin; Baeumer, Philipp] Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany; [Weiler, Markus] Heidelberg Univ Hosp, Dept Neurol, Heidelberg, Germany; [Schlemmer, Heinz-Peter; Baeumer, Philipp] German Canc Res Ctr, Dept Radiol, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ)	Baumer, P (corresponding author), Heidelberg Univ Hosp, Dept Neuroradiol, Heidelberg, Germany.; Baumer, P (corresponding author), German Canc Res Ctr, Dept Radiol, Heidelberg, Germany.	p.baeumer@dkfz-heidelberg.de	Apostolidis, Leonidas/AAV-9989-2021	Apostolidis, Leonidas/0000-0002-6358-8206; Schwarz, Daniel/0000-0002-9017-8245				Al-Batran SE, 2008, J CLIN ONCOL, V26, P1435, DOI 10.1200/JCO.2007.13.9378; Alberti P, 2014, ANN ONCOL, V25, P257, DOI 10.1093/annonc/mdt409; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Argyriou AA, 2008, CANCER TREAT REV, V34, P368, DOI 10.1016/j.ctrv.2008.01.003; Argyriou AA, 2012, CRIT REV ONCOL HEMAT, V82, P51, DOI 10.1016/j.critrevonc.2011.04.012; Avan A, 2015, ONCOLOGIST, V20, P411, DOI 10.1634/theoncologist.2014-0044; Baumer P, 2016, NEUROLOGY, V87, P1884, DOI 10.1212/WNL.0000000000003287; Baumer P, 2011, RADIOLOGY, V260, P199, DOI 10.1148/radiol.11102357; Baumer P, 2014, RADIOLOGY; Birnbaum J, 2014, MEDICINE, V93, P121, DOI 10.1097/MD.0000000000000024; Burakgazi AZ, 2011, NEUROLOGY, V77, P980, DOI 10.1212/WNL.0b013e31822cfc59; CAVALETTI G, 1991, INT J TISSUE REACT, V13, P151; CAVALETTI G, 1992, ACTA NEUROPATHOL, V84, P364; Cavaletti G, 2001, EUR J CANCER, V37, P2457, DOI 10.1016/S0959-8049(01)00300-8; Conroy T, 2011, NEW ENGL J MED, V364, P1817, DOI 10.1056/NEJMoa1011923; Coriat R, 2014, J CLIN INVEST, V124, P262, DOI 10.1172/JCI68730; de Gramont A, 2000, J CLIN ONCOL, V18, P2938, DOI 10.1200/JCO.2000.18.16.2938; Dyck PJ, 2010, MUSCLE NERVE, V42, P157, DOI 10.1002/mus.21661; Godel T, 2016, NEUROIMAGE, V141, P81, DOI 10.1016/j.neuroimage.2016.07.030; Golfinopoulos V, 2007, LANCET ONCOL, V8, P898, DOI 10.1016/S1470-2045(07)70281-4; GREGG RW, 1992, J CLIN ONCOL, V10, P795, DOI 10.1200/JCO.1992.10.5.795; Grothey Axel, 2005, Clin Colorectal Cancer, V5 Suppl 1, pS38, DOI 10.3816/CCC.2005.s.006; Heckel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130833; Holmes J, 1998, TOXICOL SCI, V46, P342, DOI 10.1093/toxsci/46.2.342; JACOBS JM, 1978, ENVIRON HEALTH PERSP, V26, P107, DOI 10.2307/3428830; Jamieson SMF, 2005, CANCER CHEMOTH PHARM, V56, P391, DOI 10.1007/s00280-004-0953-4; Jimenez-Andrade JM, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-10; Krarup-Hansen A, 1999, NEUROPATH APPL NEURO, V25, P29; LEVI FA, 1994, JNCI-J NATL CANCER I, V86, P1608, DOI 10.1093/jnci/86.21.1608; Park SB, 2011, ONCOLOGIST, V16, P708, DOI 10.1634/theoncologist.2010-0248; Park SB, 2009, BRAIN, V132, P2712, DOI 10.1093/brain/awp219; Pham M, 2015, ANN NEUROL, V78, P939, DOI 10.1002/ana.24524; Pietrangeli A, 2006, EUR NEUROL, V56, P13, DOI 10.1159/000094376; Postma TJ, 2005, EUR J CANCER, V41, P1135, DOI 10.1016/j.ejca.2005.02.012; Postma TJ, 1998, ANN ONCOL, V9, P739, DOI 10.1023/A:1008344507482; Shen J, 2006, AM J NEURORADIOL, V27, P2098; Silverstein MP, 2015, INT J SPINE SURG, V9, DOI 10.14444/2003; Velasco R, 2014, J NEUROL NEUROSUR PS, V85, P392, DOI 10.1136/jnnp-2013-305334	38	19	19	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183845	10.1371/journal.pone.0183845	http://dx.doi.org/10.1371/journal.pone.0183845			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837658	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000130
J	Dobler, L; de Carvalho, BR; Alves, WD; Neves, BC; Freire, DMG; Almeida, RV				Dobler, Leticia; de Carvalho, Bruna Rocha; Alves, Wilber de Sousa; Neves, Bianca Cruz; Guimaraes Freire, Denise Maria; Almeida, Rodrigo Volcan			Enhanced rhamnolipid production by Pseudomonas aeruginosa overexpressing estA in a simple medium	PLOS ONE			English	Article							ESCHERICHIA-COLI; BIOSURFACTANT; MEMBRANE; DISPLAY; CARBON	A modified Pseudomonas aeruginosa strain capable of overexpressing the estA gene, an encoding gene for a membrane-bound esterase, was constructed and its rhamnolipid RML) production was studied. Fermentations using wild-type WT) and modified P. aeruginosa strains were conducted until exhaustion of glycerol in Medium Salt Production, using two different C/N ratios. At a C/N of 83.2, the modified strain produced up to 3.9 times more RMLs than the WT, yielding a maximum concentration of 14.62 g/L RML when measured by HPLC and 22 g/L by the orcinol assay. Cell-free supernatant from the modified strain reduced surface tension to 29.4 mN/m and had a CMC of 240 mg/L and CMD of 56.05. This is the first report on the construction of an estA-based recombinant strain for RML production.	[Dobler, Leticia; de Carvalho, Bruna Rocha; Alves, Wilber de Sousa; Neves, Bianca Cruz; Almeida, Rodrigo Volcan] Univ Fed Rio de Janeiro, Chem Inst, LaMMP Lab Microbiol Mol & Prot, Rio De Janeiro, Brazil; [Guimaraes Freire, Denise Maria] Univ Fed Rio de Janeiro, Chem Inst, LaBiM Lab Biotecnol Microbiana, Rio De Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Dobler, L; Almeida, RV (corresponding author), Univ Fed Rio de Janeiro, Chem Inst, LaMMP Lab Microbiol Mol & Prot, Rio De Janeiro, Brazil.; Freire, DMG (corresponding author), Univ Fed Rio de Janeiro, Chem Inst, LaBiM Lab Biotecnol Microbiana, Rio De Janeiro, Brazil.	ledobler@ufrj.br; freire@iq.ifrj.br; volcan@iq.ufrj.br	Almeida, Rodrigo V/I-4362-2013; Almeida, Rodrigo/GZH-0682-2022; Almeida, Rodrigo/AAE-3019-2019; Dobler, Leticia/F-2086-2016; Neves, Bianca C/D-8929-2015; Freire, Denise Maria Guimaraes/D-8699-2014	Almeida, Rodrigo V/0000-0002-0164-6044; Almeida, Rodrigo/0000-0002-0164-6044; Dobler, Leticia/0000-0002-1582-4198; Neves, Bianca C/0000-0002-6985-8828; Freire, Denise Maria Guimaraes/0000-0002-8298-5936	Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)	Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis; Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work is supported by Agencia Nacional do Petroleo, Gas Natural e Biocombustiveis (www:anp.gov.br) - LD, Coordenagao de Aperfeigoamento de Pessoal de Nivel Superior (www.capes.gov.br) - LD, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (www.cnpg.br) - BRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Professor Herbert Schweizer from Colorado State University for providing the pUCP26 vector, ANP (Agencia Nacional de Petroleo) and CAPES (Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior) for their financial support, the engineer Antonio Carlos de Oliveira Machado for his help with the CMC calculus, and Fabio Diniz Vale for his help with the TS/CMC measurements. All authors are disclose to any conflict of interest.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Becker S, 2005, FEBS LETT, V579, P1177, DOI 10.1016/j.febslet.2004.12.087; Becker S, 2008, ANGEW CHEM INT EDIT, V47, P5085, DOI 10.1002/anie.200705236; Benincasa M, 2002, J FOOD ENG, V54, P283, DOI 10.1016/S0260-8774(01)00214-X; Binder U, 2010, J MOL BIOL, V400, P783, DOI 10.1016/j.jmb.2010.05.049; Cha M, 2008, BIORESOURCE TECHNOL, V99, P2192, DOI 10.1016/j.biortech.2007.05.035; Chandrasekaran E V., 1980, METHODS CARBOHYDRATE, P372; Choi KH, 2006, J MICROBIOL METH, V64, P391, DOI 10.1016/j.mimet.2005.06.001; Colak A. K., 2013, Environmental and Experimental Biology, V11, P125; Dobler L, 2016, NEW BIOTECHNOL, V33, P123, DOI 10.1016/j.nbt.2015.09.005; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Giani C, 1997, US, Patent No. [US5641659 A, US5641659]; Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Kahraman H, 2012, APPL BIOCHEM MICRO+, V48, P188, DOI 10.1134/S000368381202007X; KOCH AK, 1991, J BACTERIOL, V173, P4212, DOI 10.1128/jb.173.13.4212-4219.1991; Lourith N., 2009, International Journal of Cosmetic Science, V31, P255, DOI 10.1111/j.1468-2494.2009.00493.x; Matsufuji M, 1997, BIOTECHNOL LETT, V19, P1213, DOI 10.1023/A:1018489905076; Mendes AN., 2015, J BIOMATERIALS NANOB, V6, P64, DOI DOI 10.4236/JBNB.2015.61007; Muller MM, 2011, APPL MICROBIOL BIOT, V89, P585, DOI 10.1007/s00253-010-2901-z; Muller MM, 2010, APPL MICROBIOL BIOT, V87, P167, DOI 10.1007/s00253-010-2513-7; OCHSNER UA, 1994, J BIOL CHEM, V269, P19787; Prim N, 2003, J MOL CATAL B-ENZYM, V22, P339, DOI 10.1016/S1381-1177(03)00048-1; Rhamnolipid IM., 2015, J SERB CHEM, V80, P279; Santos AS, 2002, APPL BIOCHEM BIOTECH, V98, P1025, DOI 10.1385/ABAB:98-100:1-9:1025; Sekhon Randhawa Kamaljeet K, 2014, Front Microbiol, V5, P454, DOI 10.3389/fmicb.2014.00454; Tavares LFD, 2013, APPL MICROBIOL BIOT, V97, P1909, DOI 10.1007/s00253-012-4454-9; Tielen P, 2010, MICROBIOL-SGM, V156, P2239, DOI 10.1099/mic.0.037036-0; van den Berg B, 2010, J MOL BIOL, V396, P627, DOI 10.1016/j.jmb.2009.12.061; WEST SEH, 1994, GENE, V148, P81, DOI 10.1016/0378-1119(94)90237-2; Wilhelm S, 1999, J BACTERIOL, V181, P6977, DOI 10.1128/JB.181.22.6977-6986.1999; Wilhelm S, 2007, J BACTERIOL, V189, P6695, DOI 10.1128/JB.00023-07; Wittgens A, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-80	33	19	20	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183857	10.1371/journal.pone.0183857	http://dx.doi.org/10.1371/journal.pone.0183857			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837648	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000132
J	McPheeters, MT; Wang, YT; Werdich, AA; Jenkins, MW; Laurita, KR				McPheeters, Matthew T.; Wang, Yves T.; Werdich, Andreas A.; Jenkins, Michael W.; Laurita, Kenneth R.			An infrared optical pacing system for screening cardiac electrophysiology in human cardiomyocytes	PLOS ONE			English	Article							CELL-DERIVED CARDIOMYOCYTES; QT INTERVAL PROLONGATION; VENTRICULAR-FIBRILLATION; NEONATAL CARDIOMYOCYTES; MULTIELECTRODE ARRAY; ATRIAL-FIBRILLATION; PREMATURE STIMULUS; INDUCED ARRHYTHMIA; ACTION-POTENTIALS; IN-VITRO	Human cardiac myocytes derived from pluripotent stem cells (hCM) have invigorated interest in genetic disease mechanisms and cardiac safety testing; however, the technology to fully assess electrophysiological function in an assay that is amenable to high throughput screening has lagged. We describe a fully contactless system using optical pacing with an infrared (IR) laser and multi-site high fidelity fluorescence imaging to assess multiple electrophysiological parameters from hCM monolayers in a standard 96-well plate. Simultaneous multi-site action potentials (FluoVolt) or Ca2+ transients (Fluo4-AM) were measured, from which high resolution maps of conduction velocity and action potential duration (APD) were obtained in a single well. Energy thresholds for optical pacing were determined for cell plating density, laser spot size, pulse width, and wavelength and found to be within ranges reported previously for reliable pacing. Action potentials measured using FluoVolt and a microelectrode exhibited the same morphology and rate of depolarization. Importantly, we show that this can be achieved accurately with minimal damage to hCM due to optical pacing or fluorescence excitation. Finally, using this assay we demonstrate that hCM exhibit reproducible changes in repolarization and impulse conduction velocity for Flecainide and Quinidine, two well described reference compounds. In conclusion, we demonstrate a high fidelity electrophysiological screening assay that incorporates optical pacing with IR light to control beating rate of hCM monolayers.	[McPheeters, Matthew T.; Wang, Yves T.; Jenkins, Michael W.] Case Western Reserve Univ, Pediat, Cleveland, OH 44106 USA; [McPheeters, Matthew T.; Wang, Yves T.; Jenkins, Michael W.; Laurita, Kenneth R.] Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA; [Werdich, Andreas A.] Harvard Med Sch, Brigham & Womens Hosp, Cardiovasc Div, Boston, MA USA; [Laurita, Kenneth R.] Case Western Reserve Univ, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA; Case Western Reserve Univ, Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Case Western Reserve University; MetroHealth System; Case Western Reserve University	Laurita, KR (corresponding author), Case Western Reserve Univ, Biomed Engn, Cleveland, OH 44106 USA.; Laurita, KR (corresponding author), Case Western Reserve Univ, Heart & Vasc Res Ctr, MetroHlth Campus, Cleveland, OH 44106 USA.	Kenneth.Laurita@case.edu		Jenkins, Michael/0000-0002-8908-5383; Wang, Yves/0000-0003-2095-3506; Werdich, Andreas/0000-0002-1222-1180	National Institutes of Health [HL123012, HL118807, HL126747, T32EB007509]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL123012, R43HL118807, R01HL126747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB007509] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This material is based upon work supported by National Institutes of Health (https://www.nih.gov/) grants HL123012, HL118807 (KRL), HL126747 (MWJ), and T32EB007509. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert ES, 2012, J NEUROPHYSIOL, V107, P3227, DOI 10.1152/jn.00424.2011; Aliot E, 2011, EUROPACE, V13, P161, DOI 10.1093/europace/euq382; Asakura K, 2015, J PHARMACOL TOX MET, V75, P17, DOI 10.1016/j.vascn.2015.04.002; Askar SFA, 2011, CARDIOVASC RES, V90, P295, DOI 10.1093/cvr/cvr011; Bedut S, 2016, AM J PHYSIOL-HEART C, V311, pH44, DOI 10.1152/ajpheart.00793.2015; BOYETT MR, 1978, J PHYSIOL-LONDON, V285, P359, DOI 10.1113/jphysiol.1978.sp012576; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Cayce JM, 2014, CELL CALCIUM, V55, P183, DOI 10.1016/j.ceca.2014.01.004; Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038; Chuck ET, 2001, J CARD FAIL, V7, P1; Coumel P, 2003, J CARDIOVASC PHARM, V41, P771, DOI 10.1097/00005344-200305000-00015; Dempsey GT, 2016, J PHARMACOL TOX MET, V81, P240, DOI 10.1016/j.vascn.2016.05.003; Dittami GM, 2011, J PHYSIOL-LONDON, V589, P1295, DOI 10.1113/jphysiol.2010.198804; Duke AR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02600; FAST VG, 1995, CARDIOVASC RES, V29, P697, DOI 10.1016/S0008-6363(96)88643-3; Ford SM, 2017, CONGENIT HEART DIS, V12, P322, DOI 10.1111/chd.12443; Gibson JK, 2014, J PHARMACOL TOX MET, V70, P255, DOI 10.1016/j.vascn.2014.09.005; Gotoh M, 1997, CIRCULATION, V95, P2141, DOI 10.1161/01.CIR.95.8.2141; Harris K, 2013, TOXICOL SCI, V134, P412, DOI 10.1093/toxsci/kft113; Hoffmann Peter, 2006, Journal of Pharmacological and Toxicological Methods, V53, P87, DOI 10.1016/j.vascn.2005.07.003; HOLMES B, 1985, DRUGS, V29, P1, DOI 10.2165/00003495-198529010-00001; Hou LQ, 2010, CIRC RES, V107, P1503, DOI 10.1161/CIRCRESAHA.110.232470; Jahnke HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068971; Jenkins MW, 2010, NAT PHOTONICS, V4, P623, DOI 10.1038/NPHOTON.2010.166; Jenkins MW, 2013, BIOMED OPT EXPRESS, V4, P1626, DOI 10.1364/BOE.4.001626; JURKIEWICZ NK, 1993, CIRC RES, V72, P75, DOI 10.1161/01.RES.72.1.75; Katritsis D, 1995, EUR HEART J, V16, P1930, DOI 10.1093/oxfordjournals.eurheartj.a060850; Kattman SJ, 2011, J CARDIOVASC TRANSL, V4, P66, DOI 10.1007/s12265-010-9235-1; KIDWELL GA, 1993, J CARDIOVASC PHARM, V21, P621, DOI 10.1097/00005344-199304000-00017; Kitaguchi T, 2016, J PHARMACOL TOX MET, V78, P93, DOI 10.1016/j.vascn.2015.12.002; Klimas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11542; KNISLEY SB, 1994, BIOPHYS J, V66, P719, DOI 10.1016/S0006-3495(94)80846-X; KRISHNAN SC, 1993, CIRCULATION, V87, P562, DOI 10.1161/01.CIR.87.2.562; Laurita KR, 1996, CIRC RES, V79, P493, DOI 10.1161/01.RES.79.3.493; Lee P, 2012, CIRC RES, V110, P1556, DOI 10.1161/CIRCRESAHA.111.262535; Liang P, 2013, CIRCULATION, V127, P1677, DOI 10.1161/CIRCULATIONAHA.113.001883; Liu Q, 2014, BIOPHYS J, V106, P1570, DOI 10.1016/j.bpj.2014.03.008; Lothet EH, 2014, NEUROPHOTONICS, V1, DOI 10.1117/1.NPh.1.1.011010; Lumbreras V, 2014, J NEUROPHYSIOL, V112, P1246, DOI 10.1152/jn.00253.2014; Martin CA, 2011, PFLUG ARCH EUR J PHY, V462, P495, DOI 10.1007/s00424-011-0989-3; Matiukas A, 2007, HEART RHYTHM, V4, P1441, DOI 10.1016/j.hrthm.2007.07.012; Miller EW, 2012, P NATL ACAD SCI USA, V109, P2114, DOI 10.1073/pnas.1120694109; Navarrete EG, 2013, CIRCULATION, V128, pS3, DOI 10.1161/CIRCULATIONAHA.112.000570; NEUNLIST M, 1995, BIOPHYS J, V68, P2310, DOI 10.1016/S0006-3495(95)80413-3; Nikolski VP, 2002, AM J PHYSIOL-HEART C, V282, pH565, DOI 10.1152/ajpheart.00544.2001; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Peters MF, 2012, ASSAY DRUG DEV TECHN, V10, P525, DOI 10.1089/adt.2011.442; Pollard CE, 2010, BRIT J PHARMACOL, V159, P12, DOI 10.1111/j.1476-5381.2009.00207.x; RODEN DM, 1986, NEW ENGL J MED, V315, P36, DOI 10.1056/NEJM198607033150106; RUDY Y, 1987, CIRC RES, V61, P815, DOI 10.1161/01.RES.61.6.815; SANCHEZCHAPULA J, 1983, CIRC RES, V52, P557, DOI 10.1161/01.RES.52.5.557; Sattayaprasert P, 2016, J MOL CELL CARDIOL, V98, P138, DOI 10.1016/j.yjmcc.2016.05.014; SAUMAREZ RC, 1992, CIRCULATION, V86, P467, DOI 10.1161/01.CIR.86.2.467; Shapiro MG, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1742; Shintani SA, 2015, BIOCHEM BIOPH RES CO, V457, P165, DOI 10.1016/j.bbrc.2014.12.077; Teudt IU, 2011, IEEE T BIO-MED ENG, V58, P1648, DOI 10.1109/TBME.2011.2108297; Thompson Alexander C, 2014, Curr Mol Imaging, V3, P162; Valentin JP, 2010, BRIT J PHARMACOL, V159, P25, DOI 10.1111/j.1476-5381.2009.00530.x; WALTON MK, 1983, BIOPHYS J, V44, P9, DOI 10.1016/S0006-3495(83)84273-8; Wang YT, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.060505; Wang YT, 2014, BIOMED OPT EXPRESS, V5, P1000, DOI 10.1364/BOE.5.001000; Wells J, 2005, OPT LETT, V30, P504, DOI 10.1364/OL.30.000504; Wells JD, 2007, LASER SURG MED, V39, P513, DOI 10.1002/lsm.20522; Werdich AA, 2012, PROG BIOPHYS MOL BIO, V110, P154, DOI 10.1016/j.pbiomolbio.2012.07.006	65	21	22	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183761	10.1371/journal.pone.0183761	http://dx.doi.org/10.1371/journal.pone.0183761			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837652	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000114
J	Saar, M; Gilad, T; Kilon-Kallner, T; Rosenfeld, A; Subach, A; Scharf, I				Saar, Maya; Gilad, Tomer; Kilon-Kallner, Tal; Rosenfeld, Adar; Subach, Aziz; Scharf, Inon			The interplay between maze complexity, colony size, learning and memory in ants while solving a maze: A test at the colony level	PLOS ONE			English	Article							GIGANTIOPS-DESTRUCTOR; FORAGING STRATEGIES; LASIUS-NIGER; BEHAVIOR; ENVIRONMENT; CUES; ORIENTATION; EVOLUTION; INSECTS; COSTS	Central-place foragers need to explore their immediate habitat in order to reach food. We let colonies of the individually foraging desert ant Cataglyphis niger search for a food reward in a maze. We did so for three tests per day over two successive days and an additional test after a time interval of 4-20 days (seven tests in total). We examined whether the colonies reached the food reward faster, consumed more food and changed the number of workers searching over time, within and between days. Colonies' food-discovery time shortened within and between days, indicating that some workers learnt and became more efficient in moving through the maze. Such workers, however, also forgot and deteriorated in their food-discovery time, leveling off back to initial performance after about two weeks. We used mazes of increasing complexity levels, differing in the potential number of wrong turns. The number of workers searching increased with colony size. Food-discovery time also increased with colony size in complex mazes but not in simple ones, perhaps due to the more frequent interactions among workers in large colonies having to move through narrow routes. Finally, the motivation to solve the maze was probably not only the food reward, because food consumption did not change over time.	[Saar, Maya; Gilad, Tomer; Kilon-Kallner, Tal; Rosenfeld, Adar; Subach, Aziz; Scharf, Inon] Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel	Tel Aviv University	Scharf, I (corresponding author), Tel Aviv Univ, Sch Zool, Fac Life Sci, Tel Aviv, Israel.	scharfi@post.tau.ac.il	Scharf, Inon/AAF-2343-2020; Saar, Maya/AAJ-6973-2021	Scharf, Inon/0000-0002-8506-7161; Saar, Maya/0000-0002-2734-1871	US-Israel Binational Science Foundation [2013086]; Israel Science Foundation [442/16]	US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation)	This work was supported by US-Israel Binational Science Foundation (grant no. 2013086) and Israel Science Foundation (grant no. 442/16).	ALLOWAY TM, 1972, ANNU REV ENTOMOL, V17, P43, DOI 10.1146/annurev.en.17.010172.000355; BECKERS R, 1989, Psyche (Cambridge), V96, P239, DOI 10.1155/1989/94279; Bernays Elizabeth A., 1993, P1; Beugnon G, 2016, J COMP PHYSIOL A, V202, P287, DOI 10.1007/s00359-016-1075-2; Brown S, 2009, LEARN MEMORY, V16, P210, DOI 10.1101/lm.1241909; Burns JG, 2011, P ROY SOC B-BIOL SCI, V278, P923, DOI 10.1098/rspb.2010.2488; Cunningham JP, 2004, J EXP BIOL, V207, P87, DOI 10.1242/jeb.00733; Czaczkes TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2723; Czaczkes TJ, 2013, J EXP BIOL, V216, P188, DOI 10.1242/jeb.076570; Dornhaus A, 2008, BEHAV ECOL SOCIOBIOL, V63, P43, DOI 10.1007/s00265-008-0634-0; Dukas R, 2000, P NATL ACAD SCI USA, V97, P2637, DOI 10.1073/pnas.050461497; Dukas Reuven, 1998, P89; Dukas Reuven, 1998, P129; Dunlap AS, 2012, BEHAV PROCESS, V89, P86, DOI 10.1016/j.beproc.2011.10.005; Freas CA, 2017, J COMP PHYSIOL A, V203, P353, DOI 10.1007/s00359-017-1174-8; GIRALDEAU LA, 1982, ANIM BEHAV, V30, P1036, DOI 10.1016/S0003-3472(82)80193-0; Gonzalo A, 2009, ANIM COGN, V12, P745, DOI 10.1007/s10071-009-0232-1; Gordon DM, 1996, ECOLOGY, V77, P2393, DOI 10.2307/2265741; Gruter C, 2015, ANIM BEHAV, V104, P189, DOI 10.1016/j.anbehav.2015.03.017; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; Hollis KL, 2011, COMP COGN BEHAV REV, V6, P24, DOI 10.3819/ccbr.2011.6004; Hollis KL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017958; Hunt ER, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0945; JAFFE K, 1990, INSECT SOC, V37, P101, DOI 10.1007/BF02224024; Karson MA, 2003, J COMP PSYCHOL, V117, P149, DOI 10.1037/0735-7036.117.2.149; Kelber A, 1996, J EXP BIOL, V199, P1127; Korb J, 2004, NATURWISSENSCHAFTEN, V91, P291, DOI 10.1007/s00114-004-0529-5; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Krakauer DC, 1995, J THEOR BIOL, V177, P417, DOI 10.1006/jtbi.1995.0258; Kramer BH, 2014, BEHAV ECOL SOCIOBIOL, V68, P41, DOI 10.1007/s00265-013-1620-8; Kuszewska K, 2016, ANIM COGN, V19, P1037, DOI 10.1007/s10071-016-1000-7; Langridge EA, 2004, BEHAV ECOL SOCIOBIOL, V56, P523, DOI 10.1007/s00265-004-0824-3; Macquart D, 2008, ANIM BEHAV, V75, P1693, DOI 10.1016/j.anbehav.2007.10.023; MCGUIRE TR, 1984, BEHAV GENET, V14, P479, DOI 10.1007/BF01065445; Pamminger T, 2011, BEHAV ECOL, V22, P255, DOI 10.1093/beheco/arq191; Papaj D.R., 1993, INSECT LEARNING ECOL; Reid CR, 2011, J EXP BIOL, V214, P50, DOI 10.1242/jeb.048173; Sakiyama T, 2013, INSECT SOC, V60, P155, DOI 10.1007/s00040-012-0279-x; Scharf I, 2016, ANIM BEHAV, V119, P37, DOI 10.1016/j.anbehav.2016.06.019; Scharf I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033314; Schatz B, 1999, NATURE, V399, P769, DOI 10.1038/21625; SCHMIDHEMPEL P, 1984, INSECT SOC, V31, P345, DOI 10.1007/BF02223652; Shettleworth S. J., 2009, COGNITION EVOLUTION; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; STRATTON LO, 1973, J COMP PHYSIOL PSYCH, V83, P7, DOI 10.1037/h0034261; Tapia DH, 2015, ANIM BEHAV, V106, P1, DOI 10.1016/j.anbehav.2015.04.027; Thomas ML, 2003, NATURWISSENSCHAFTEN, V90, P88, DOI 10.1007/s00114-002-0396-x; TRANIELLO JFA, 1989, ANNU REV ENTOMOL, V34, P191, DOI 10.1146/annurev.en.34.010189.001203; van Baaren J, 1998, BEHAV ECOL SOCIOBIOL, V42, P9, DOI 10.1007/s002650050406; WEIER JA, 1995, BEHAV ECOL SOCIOBIOL, V36, P291, DOI 10.1007/BF00167790; Wray MK, 2011, ANIM BEHAV, V81, P559, DOI 10.1016/j.anbehav.2010.11.027; Zhang SW, 1996, NEUROBIOL LEARN MEM, V66, P267, DOI 10.1006/nlme.1996.0069	52	14	14	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183753	10.1371/journal.pone.0183753	http://dx.doi.org/10.1371/journal.pone.0183753			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837675	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000111
J	Azpiazu, D; Gonzalez-Parra, E; Ortiz, A; Egido, J; Villa-Bellosta, R				Azpiazu, Daniel; Gonzalez-Parra, Emilio; Ortiz, Alberto; Egido, Jesus; Villa-Bellosta, Ricardo			Impact of post-dialysis calcium level on ex vivo rat aortic wall calcification	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; VASCULAR CALCIFICATION; TISSUE CALCIFICATION; PARATHYROID-HORMONE; MORTALITY RISK; HEMODIALYSIS; ACETAZOLAMIDE; ASSOCIATION; PHOSPHORUS; DEPOSITION	Objectives Vascular calcification is a frequent complication in chronic haemodialysis patients and is associated with adverse outcomes. Serum calcium and phosphate levels and imbalances in calcification regulators are thought to contribute to the process. In this regard, the dialysate calcium concentration is a modifiable tool for modulating the risk of vascular calcification. We explored pre-and post-dialysis phosphate and calcium concentrations in stable chronic haemodialysis patients treated by dialysis with the KDIGO-suggested 1.5 mmol/L calcium dialysate to investigate the effects on ex vivo calcification of rat aortic rings. Approach and results At the end of haemodialysis, mean serum calcium levels were increased in 88% of paired pre-/post-dialysis samples, while mean serum phosphate and parathyroid hormone levels were decreased. Rat aortic ring cultures grown at the same calcium and phosphate concentrations revealed that pre-and post-dialysis resulted in a similar degree of calcification. By contrast, haemodialysis with unchanged serum calcium resulted in a 5-fold reduction in calcium deposition. Conclusion Dialysis with the widely prescribed 1.5 mmol/L calcium dose results in persistent high serum calcification potential in a sizable proportion of patients, driven by increased post-dialysis calcium concentration. This could potentially be mitigated by individualising dialysate calcium dosage based on pre-dialysis serum calcium levels.	[Azpiazu, Daniel; Gonzalez-Parra, Emilio; Ortiz, Alberto; Egido, Jesus; Villa-Bellosta, Ricardo] FJD, FIIS, Madrid, Spain		Villa-Bellosta, R (corresponding author), FJD, FIIS, Madrid, Spain.	ricardo.villa@fjd.es	ortiz, alberto/Y-7582-2018	ortiz, alberto/0000-0002-9805-9523; Villa-Bellosta, Ricardo/0000-0002-1680-552X	Spanish Ministerio de Economia y Competitividad (MINECO) [SAF-2014-60699-JIN]; Foundation SENEFRO (Spanish Nephrology Society)	Spanish Ministerio de Economia y Competitividad (MINECO); Foundation SENEFRO (Spanish Nephrology Society)	This study was supported by grant SAF-2014-60699-JIN from the Spanish Ministerio de Economia y Competitividad (MINECO) to RVB and grant from Foundation SENEFRO (Spanish Nephrology Society). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basile C, 2015, CLIN KIDNEY J, V8, P393, DOI 10.1093/ckj/sfv038; Basile C, 2012, AM J KIDNEY DIS, V59, P92, DOI 10.1053/j.ajkd.2011.08.033; Block GA, 1998, AM J KIDNEY DIS, V31, P607, DOI 10.1053/ajkd.1998.v31.pm9531176; de Solis AJ, 2009, J NEPHROL, V22, P647; Finer G, 2014, AM J MED GENET A, V164, P1545, DOI 10.1002/ajmg.a.36476; Ganesh SK, 2001, J AM SOC NEPHROL, V12, P2131, DOI 10.1681/ASN.V12102131; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gonzalez-Parra E, 2014, BLOOD PURIFICAT, V38, P224, DOI 10.1159/000366126; Gotch FA, 2010, KIDNEY INT, V78, P343, DOI 10.1038/ki.2010.157; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Leibrock CB, 2016, J MOL MED, V94, P95, DOI 10.1007/s00109-015-1331-x; Locatelli F, 2015, CLIN KIDNEY J, V8, P580, DOI 10.1093/ckj/sfv057; Mendoza FJ, 2008, KIDNEY INT, V73, P407, DOI 10.1038/sj.ki.5002646; O'Neill WC, 2007, KIDNEY INT, V72, P792, DOI 10.1038/sj.ki.5002412; Ok E, 2016, J AM SOC NEPHROL, V27, P2475, DOI 10.1681/ASN.2015030268; Shanahan CM, 2011, CIRC RES, V109, P697, DOI 10.1161/CIRCRESAHA.110.234914; Villa-Bellosta R, 2015, CURR CARDIOL REV, V11, P341, DOI 10.2174/1573403X11666150805120505; Villa-Bellosta R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159858; Villa-Bellosta R, 2015, METHODS MOL BIOL, V1339, P119, DOI 10.1007/978-1-4939-2929-0_8; Villa-Bellosta R, 2013, CIRC J, V77, P2145, DOI 10.1253/circj.CJ-13-0016; Villa-Bellosta R, 2011, AM J PHYSIOL-CELL PH, V300, pC210, DOI 10.1152/ajpcell.00229.2010	21	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183730	10.1371/journal.pone.0183730	http://dx.doi.org/10.1371/journal.pone.0183730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832652	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800097
J	Cerretti, P; Stireman, JO; Pape, T; O'Hara, JE; Marinho, MAT; Rognes, K; Grimaldi, DA				Cerretti, Pierfilippo; Stireman, John O., III; Pape, Thomas; O'Hara, James E.; Marinho, Marco A. T.; Rognes, Knut; Grimaldi, David A.			First fossil of an oestroid fly (Diptera: Calyptratae: Oestroidea) and the dating of oestroid divergences	PLOS ONE			English	Article							MOLECULAR PHYLOGENETICS; CALLIPHORIDAE; MITOCHONDRIAL; TACHINIDAE; NUCLEAR; GENUS; TREE; DIVERSIFICATION; RHINOPHORIDAE; PERFORMANCE	Calyptrate flies include about 22,000 extant species currently classified into Hippoboscoidea (tsetse, louse, and bat flies), the muscoid grade (house flies and relatives) and the Oestroidea (blow flies, bot flies, flesh flies, and relatives). Calyptrates are abundant in nearly all terrestrial ecosystems, often playing key roles as decomposers, parasites, parasitoids, vectors of pathogens, and pollinators. For oestroids, the most diverse group within calyptrates, definitive fossils have been lacking. The first unambiguous fossil of Oestroidea is described based on a specimen discovered in amber from the Dominican Republic. The specimen was identified through digital dissection by CT scans, which provided morphological data for a cladistic analysis of its phylogenetic position among extant oestroids. The few known calyptrate fossils were used as calibration points for a molecular phylogeny (16S, 28S, CAD) to estimate the timing of major diversification events among the Oestroidea. Results indicate that: (a) the fossil belongs to the family Mesembrinellidae, and it is identified and described as Mesembrinella caenozoica sp. nov.; (b) the mesembrinellids form a sister clade to the Australian endemic Ulurumyia macalpinei (Ulurumyiidae) (McAlpine's fly), which in turn is sister to all remaining oestroids; (c) the most recent common ancestor of extant Calyptratae lived just before the K-Pg boundary (ca. 70 mya); and (d) the radiation of oestroids began in the Eocene (ca. 50 mya), with the origin of the family Mesembrinellidae dated at ca. 40 mya. These results provide new insight into the timing and rate of oestroid diversification and highlight the rapid radiation of some of the most diverse and ecologically important families of flies. ZooBank accession number-urn: lsid: zoobank. org: pub: 0DC5170B-1D16-407A-889E-56EED3FE3627.	[Cerretti, Pierfilippo] Sapienza Univ Roma, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy; [Stireman, John O., III] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA; [Pape, Thomas] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [O'Hara, James E.] Canadian Natl Collect Insects Agr & Agri Food Can, Ottawa, ON, Canada; [Marinho, Marco A. T.] Univ Sao Paulo, Lab Morfol & Evolucao Diptera, Dept Biol, Fac Filosofia Ciencias & Letras, Sao Paulo, SP, Brazil; [Marinho, Marco A. T.] Univ Fed Pelotas, Inst Biol, Dept Ecol Zool & Genet, Pelotas, RS, Brazil; [Rognes, Knut] Univ Stavanger, Dept Early Childhood Educ, Fac Arts & Educ, Stavanger, Norway; [Grimaldi, David A.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA	Sapienza University Rome; University System of Ohio; Wright State University Dayton; University of Copenhagen; Universidade de Sao Paulo; Universidade Federal de Pelotas; Universitetet i Stavanger; American Museum of Natural History (AMNH)	Cerretti, P (corresponding author), Sapienza Univ Roma, Dipartimento Biol & Biotecnol Charles Darwin, Rome, Italy.	pierfilippo.cerretti@uniroma1.it	Pape, Thomas/E-7520-2011; Cerretti, Pierfilippo/L-6504-2016; Marinho, Marco Antonio T/H-5458-2012	Pape, Thomas/0000-0001-6609-0609; Cerretti, Pierfilippo/0000-0002-9204-3352; Marinho, Marco Antonio T/0000-0003-4220-7598; Stireman, John/0000-0001-8792-3980	U.S. National Science Foundation OPUS grant [DEB 1556502]; U.S. National Science Foundation [DEB 1146269, DEB 1442134]; FAPESP [2012/23200-2]; CNPq [150441/2016-2]	U.S. National Science Foundation OPUS grant; U.S. National Science Foundation(National Science Foundation (NSF)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors acknowledge funding by U.S. National Science Foundation OPUS grant DEB 1556502 (DAG) (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1556502& U.S. National Science Foundation grant DEB 1146269 (JOS, JEOH, PC) (https://www.nsf.gov/awardsearch/showAward?AWD_ID=1146269); U.S. National Science Foundation grant DEB 1442134 (JOS); and FAPESP (2012/23200-2) and CNPq (150441/2016-2) (MATTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MANUAL CENTRAL AM DI; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bowsher JH, 2013, EVOLUTION, V67, P1069, DOI 10.1111/evo.12006; Caravas J, 2013, SYST ENTOMOL, V38, P93, DOI 10.1111/j.1365-3113.2012.00657.x; Cerretti P, 2014, SYST ENTOMOL, V39, P335, DOI 10.1111/syen.12062; Claramunt S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1501005; Colless Donald H., 1998, Records of the Australian Museum, V50, P85; Crosskey RW, 1965, ENTOMOLOGY, V16, P33; De Baets K, 2016, PHILOS T R SOC B, V371; Ding SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134170; Donoghue MJ, 2003, INTEGR COMP BIOL, V43, P261, DOI 10.1093/icb/43.2.261; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Evenhuis Neal L., 1994, P1; FERRAR P, 1976, SYST ENTOMOL, V1, P107; Goloboff PA, 2016, CLADISTICS IN PRESS; Goloboff P, 2008, CLADISTICS, V24, P91; Grimaldi D, 1999, B AM MUS NAT HIST, P1; Grimaldi DA, 1995, ACS SYM SER, V617, P203; Grimaldi DA., 1996, AMBER WINDOW; Grimaldi David, 2005, pi; Grimaldi D, 2013, AM MUS NOVIT, P1; Grimaldi David A., 1994, Curator, V37, P251; Hall JPW, 2004, P ROY SOC B-BIOL SCI, V271, P797, DOI 10.1098/rspb.2004.2691; IturraldeVinent MA, 1996, SCIENCE, V273, P1850, DOI 10.1126/science.273.5283.1850; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kutty SN, 2008, MOL PHYLOGENET EVOL, V49, P639, DOI 10.1016/j.ympev.2008.08.012; Kutty SN, 2014, MOL PHYLOGENET EVOL, V78, P349, DOI 10.1016/j.ympev.2014.05.027; Kutty SN, 2010, SYST ENTOMOL, V35, P614, DOI 10.1111/j.1365-3113.2010.00536.x; Lambkin CL, 2013, SYST ENTOMOL, V38, P164, DOI 10.1111/j.1365-3113.2012.00652.x; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Lepage T, 2007, MOL BIOL EVOL, V24, P2669, DOI 10.1093/molbev/msm193; Maddison, 2018, MESQUITE MODULAR SYS; Marinho MAT, 2012, MOL PHYLOGENET EVOL, V65, P840, DOI 10.1016/j.ympev.2012.08.007; Marshall Stephen A., 2012, P1; MCALPINE JF, 1970, CAN ENTOMOL, V102, P342, DOI 10.4039/Ent102342-3; Meier R, 1999, BIOL REV, V74, P199, DOI 10.1017/S0006323199005320; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Michelsen V, 1996, BIOL J LINN SOC, V58, P441; Michelsen V, 2017, SYSTEMATIC ENTOMOLOG; Michelsen V., 2007, STUD DIPTEROL, V13, P361; Michelsen Verner, 2000, Studia Dipterologica, V7, P11; Miller M.A., 2010, P GAT COMP ENV WORKS; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Moll P., 2014, THESIS; Moulton JK, 2004, MOL PHYLOGENET EVOL, V31, P363, DOI 10.1016/S1055-7903(03)00284-7; Nelson LA, 2012, GENE, V511, P131, DOI 10.1016/j.gene.2012.09.103; Nixon K.C., 2002, WINCLADA VERSION 1 0; O'Hara JE, 2013, ZOOKEYS, P27, DOI 10.3897/zookeys.361.6448; O'Hara JE, 2011, ZOOTAXA, P1; Oosterbroek Pjotr, 2005, Entomologische Berichten (Amsterdam), V65, P142; Pape T, 2006, OESTRID FLIES: BIOLOGY, HOST-PARASITE RELATIONSHIPS, IMPACT AND MANAGEMENT, P20, DOI 10.1079/9780851996844.0020; PAPE T, 1992, Tijdschrift voor Entomologie, V135, P43; PAPE T, 1986, Tijdschrift voor Entomologie, V129, P15; Pape T, 2001, ZOOL SCR, V30, P257, DOI 10.1046/j.1463-6409.2001.00064.x; Pape T, 2001, SYST ENTOMOL, V26, P133, DOI 10.1046/j.1365-3113.2001.00143.x; Pape T, 2006, ZOOTAXA, P21; Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Poinar G, 2012, SYST PARASITOL, V81, P79, DOI 10.1007/s11230-011-9339-2; Poinar G, 2013, HIST BIOL, V25, P101, DOI 10.1080/08912963.2012.710443; Poinar GO., 1992, LIFE AMBER; Poinar Jr G, 2010, ANN SOC ENTOMOLOGIQU, V46, p[1, 23]; Pont Adrian C., 1997, Studia Dipterologica, V4, P173; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Richards PW, 1999, TROPICAL RAIN FOREST; ROGNES K, 1986, ENTOMOL SCAND, V17, P75, DOI 10.1163/187631286X00125; Rognes K, 1997, CLADISTICS, V13, P27, DOI 10.1111/j.1096-0031.1997.tb00240.x; Singh B, 2013, J MED ENTOMOL, V50, P15, DOI 10.1603/ME11288; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Toma Ronaldo, 1995, Revista Brasileira de Zoologia, V12, P127, DOI 10.1590/S0101-81751995000100014; Marinho MAT, 2017, CLADISTICS, V33, P134, DOI 10.1111/cla.12157; Vargas John, 2010, P1297; Wiegmann BM, 2011, P NATL ACAD SCI USA, V108, P5690, DOI 10.1073/pnas.1012675108; Winkler IS, 2015, MOL PHYLOGENET EVOL, V88, P38, DOI 10.1016/j.ympev.2015.03.021; Winkler Isaac S., 2014, Tachinid Times, V27, P11; Wolff M, 2013, REV COLOMB ENTOMOL, V39, P120; Zhal PA, 1977, NATL GEOGR, V152, P422; Zhang D, 2016, INT J BIOL SCI, V12, P489, DOI 10.7150/ijbs.12148; Zhao Z, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052044, 10.1371/journal.pone.0061814, 10.1371/journal.pone.0080574]; Zwickl D. J, 2006, GENETIC ALGORITHM AP	82	36	40	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182101	10.1371/journal.pone.0182101	http://dx.doi.org/10.1371/journal.pone.0182101			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832610	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800011
J	Ge, LX; Yap, CW; Ong, RB; Heng, BH				Ge, Lixia; Yap, Chun Wei; Ong, Reuben; Heng, Bee Hoon			Social isolation, loneliness and their relationships with depressive symptoms: A population-based study	PLOS ONE			English	Article							OLDER MEN; HEALTH; ADULTS; SCALE; WOMEN; TIES	Objectives To assess the relationship between various social isolation indicators and loneliness, and to examine the differential associations that social isolation indicators, loneliness have with depressive symptoms. Methods Baseline data for 1,919 adults (aged 21 years and above) from a representative health survey in the Central region of Singapore was used for this study. The association between social isolation indicators (marital status, living arrangement, social connectedness with relatives and friends) and loneliness (the three-item UCLA Loneliness) were assessed, and their differential associations with depressive symptoms (the Patient Health Questionnaire-9) were examined using multiple linear regression, controling for relevant covariates. Results There was significant overlap between loneliness and social isolation. Social connectedness with relatives and friends were mildly correlated with loneliness score (|r| = 0.14 similar to 0.16). Social isolation in terms of weak connectedness with relatives and with friends and loneliness were associated with depressive symptoms even after controling for age, gender, employment status and other covariates. The association of loneliness with depressive symptoms (beta = 0.33) was independent of and stronger than that of any social isolation indicators (|beta| = 0.00 similar to 0.07). Conclusions The results of the study establishes a significant and unique association of different social isolation indicators and loneliness with depressive symptoms in community-dwelling adults aged 21 and above.	[Ge, Lixia; Yap, Chun Wei; Ong, Reuben; Heng, Bee Hoon] Natl Healthcare Grp Pte Ltd, Hlth Serv & Outcomes Res, Singapore, Singapore		Ge, LX (corresponding author), Natl Healthcare Grp Pte Ltd, Hlth Serv & Outcomes Res, Singapore, Singapore.	lixia_ge@nhg.com.sg; Chun_Wei_YAP@nhg.com.sg	Yap, Chun Wei/B-2587-2010; GE, LIXIA/ABA-5474-2020	Yap, Chun Wei/0000-0002-2004-3492; GE, LIXIA/0000-0001-8080-7020				Adams KB, 2004, AGING MENT HEALTH, V8, P475, DOI 10.1080/13607860410001725054; Rico-Uribe LA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145264; Alpass FM, 2003, AGING MENT HEALTH, V7, P212, DOI 10.1080/1360786031000101193; Barg FK, 2006, J GERONTOL B-PSYCHOL, V61, pS329, DOI 10.1093/geronb/61.6.S329; Cacioppo JT, 2014, SOC PERSONAL PSYCHOL, V8, P58, DOI 10.1111/spc3.12087; Cacioppo JT, 2010, PSYCHOL AGING, V25, P453, DOI 10.1037/a0017216; Cacioppo JT, 2006, PSYCHOL AGING, V21, P140, DOI 10.1037/0882-7974.21.1.140; Chan A, 2015, DEMOGR RES, V32, P1361, DOI 10.4054/DemRes.2015.32.49; Chan A, 2011, INT J GERIATR PSYCH, V26, P630, DOI 10.1002/gps.2574; Chen RL, 2005, ARCH INTERN MED, V165, P2019, DOI 10.1001/archinte.165.17.2019; Chou KL, 2011, J CLIN PSYCHIAT, V72, P1468, DOI 10.4088/JCP.10m06019gry; Cornwell EY, 2009, J HEALTH SOC BEHAV, V50, P31, DOI 10.1177/002214650905000103; Drageset J, 2004, SCAND J CARING SCI, V18, P65, DOI 10.1111/j.0283-9318.2003.00251.x; Gierveld JD, 2004, CAN J AGING, V23, P109, DOI 10.1353/cja.2004.0021; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Heikkinen RL, 2004, ARCH GERONTOL GERIAT, V38, P239, DOI 10.1016/j.archger.2003.10.004; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Santini ZI, 2015, J AFFECT DISORDERS, V175, P53, DOI 10.1016/j.jad.2014.12.049; Kawachi I, 2001, J URBAN HEALTH, V78, P458, DOI 10.1093/jurban/78.3.458; Kim B., 2017, J BUS ETHICS, V154, P1; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lim LL, 2011, CURR GERONTOL GERIAT, V2011; Lubben J, 2006, GERONTOLOGIST, V46, P503, DOI 10.1093/geront/46.4.503; Lubben JE, 1988, FAM COMMUNITY HEALTH, V11, P42, DOI [10.1097/00003727-198811000-00008, DOI 10.1097/00003727-198811000-00008]; MCWHIRTER BT, 1990, J COUNS DEV, V68, P417, DOI 10.1002/j.1556-6676.1990.tb02521.x; Miller G, 2011, SCIENCE, V331, P138, DOI 10.1126/science.331.6014.138; Nolen-Hoeksema S, 2002, PSYCHOL AGING, V17, P116, DOI 10.1037//0882-7974.17.1.116; Ryan AK, 2007, J AGING HEALTH, V19, P907, DOI 10.1177/0898264307308340; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Taylor HO, 2016, J AGING HLTH; Teo AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062396; Uchino BN, 2006, J BEHAV MED, V29, P377, DOI 10.1007/s10865-006-9056-5; Valtorta NK, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010799; Victor CR, 2012, J PSYCHOL, V146, P85, DOI 10.1080/00223980.2011.613875	34	133	139	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182145	10.1371/journal.pone.0182145	http://dx.doi.org/10.1371/journal.pone.0182145			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832594	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800014
J	Seki, Y; Miyasaka, Y; Suzuki, S; Wada, K; Yasuda, SP; Matsuoka, K; Ohshiba, Y; Endo, K; Ishii, R; Shitara, H; Kitajiri, S; Nakagata, N; Takebayashi, H; Kikkawa, Y				Seki, Yuta; Miyasaka, Yuki; Suzuki, Sari; Wada, Kenta; Yasuda, Shumpei P.; Matsuoka, Kunie; Ohshiba, Yasuhiro; Endo, Kentaro; Ishii, Rie; Shitara, Hiroshi; Kitajiri, Shin-ichiro; Nakagata, Naomi; Takebayashi, Hirohide; Kikkawa, Yoshiaki			A novel splice site mutation of myosin VI in mice leads to stereociliary fusion caused by disruption of actin networks in the apical region of inner ear hair cells	PLOS ONE			English	Article							NONSYNDROMIC HEARING-LOSS; VESTIBULAR DYSFUNCTION; UNCONVENTIONAL MYOSIN; COCHLEAR STEREOCILIA; MUTANT MOUSE; DEAFNESS; BUNDLES; PROTEIN; EXPRESSION; MEMBRANE	An unconventional myosin encoded by the myosin VI gene (MYO6) contributes to hearing loss in humans. Homozygous mutations of MYO6 result in nonsyndromic profound congenital hearing loss, DFNB37. Kumamoto shaker/waltzer (ksv) mice harbor spontaneous mutations, and homozygous mutants exhibit congenital defects in balance and hearing caused by fusion of the stereocilia. We identified a Myo6(c.1381G>A) mutation that was found to be a p.E461K mutation leading to alternative splicing errors in Myo6 mRNA in ksv mutants. An analysis of the mRNA and protein expression in animals harboring this mutation suggested that most of the abnormal alternatively spliced isoforms of MYO6 are degraded in ksv mice. In the hair cells of ksv/ksv homozygotes, the MYO6 protein levels were significantly decreased in the cytoplasm, including in the cuticular plates. MYO6 and stereociliary taper-specific proteins were mislocalized along the entire length of the stereocilia of ksv/ksv mice, thus suggesting that MYO6 attached to taper-specific proteins at the stereociliary base. Histological analysis of the cochlear hair cells showed that the stereociliary fusion in the ksv/ksv mutants, developed through fusion between stereociliary bundles, raised cuticular plate membranes in the cochlear hair cells and resulted in incorporation of the bundles into the sheaths of the cuticular plates. Interestingly, the expression of the stereociliary rootlet-specific TRIO and F-actin binding protein (TRIOBP) was altered in ksv/ksv mice. The abnormal expression of TRIOBP suggested that the rootlets in the hair cells of ksv/ksv mice had excessive growth. Hence, these data indicated that decreased MYO6 levels in ksv/ksv mutants disrupt actin networks in the apical region of hair cells, thereby maintaining the normal structure of the cuticular plates and rootlets, and additionally provided a cellular basis for stereociliary fusion in Myo6 mutants.	[Seki, Yuta; Miyasaka, Yuki; Suzuki, Sari; Wada, Kenta; Yasuda, Shumpei P.; Matsuoka, Kunie; Ohshiba, Yasuhiro; Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Mammalian Genet Project, Tokyo, Japan; [Miyasaka, Yuki] Nagoya Univ, Ctr Promot Med Res & Educ, Grad Sch Med, Div Expt Animals, Nagoya, Aichi, Japan; [Wada, Kenta] Tokyo Univ Agr, Fac Bioind, Dept Bioprod, Lab Anim Biotechnol, Abashiri, Hokkaido, Japan; [Endo, Kentaro] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Adv Tech Support Dept, Histol Lab, Tokyo, Japan; [Ishii, Rie; Shitara, Hiroshi] Tokyo Metropolitan Inst Med Sci, Ctr Basic Technol Res, Anim Res Div, Lab Transgen Technol, Tokyo, Japan; [Kitajiri, Shin-ichiro] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Nakagata, Naomi] Kumamoto Univ, CARD, Div Reprod Engn, Kumamoto, Japan; [Takebayashi, Hirohide] Niigata Univ, Grad Sch Med & Dent Sci, Div Neurobiol & Anat, Niigata, Japan	Tokyo Metropolitan Institute of Medical Science; Nagoya University; Tokyo University of Agriculture; Tokyo Metropolitan Institute of Medical Science; Tokyo Metropolitan Institute of Medical Science; Kyoto University; Kumamoto University; Niigata University	Kikkawa, Y (corresponding author), Tokyo Metropolitan Inst Med Sci, Dept Genome Med, Mammalian Genet Project, Tokyo, Japan.	kikkawa-ys@igakuken.or.jp	Kikkawa, Yoshiaki/AAI-7229-2020; Takebayashi, Hirohide/AAO-1693-2020	Kikkawa, Yoshiaki/0000-0001-8859-4998; Nakagata, Naomi/0000-0002-5737-9993	Japan Society for the Promotion of Science [JP23300160, JP16H06383, JP15K15625, JP23890253, JP15K18393]; Grants-in-Aid for Scientific Research [26293369] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (Grants-in-Aid for Scientific Research B) [Grant Num ber JP23300160 to YK] and (Grants-in-Aid for Scientific Research S) [Grant Number JP16H06383 to YK]; (Challenging Exploratory Research) [Grant Number JP15K15625 to YK]; (Grant-in-Aid for Research Activity start-up) [Grant Number JP23890253 to YS]; and (Grant-in-Aid for Young Scientists B) [Grant Number JP15K18393 to YS]. <https://www.jsps.gojp/index.html>; [Accessed: 2016-12-19]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2003, AM J HUM GENET, V72, P1315, DOI 10.1086/375122; ANNIKO M, 1983, ANAT EMBRYOL, V166, P355, DOI 10.1007/BF00305923; ARIMA T, 1987, HEARING RES, V25, P61, DOI 10.1016/0378-5955(87)90079-7; AVRAHAM KB, 1995, NAT GENET, V11, P369, DOI 10.1038/ng1295-369; Baker KE, 2004, CURR OPIN CELL BIOL, V16, P293, DOI 10.1016/j.ceb.2004.03.003; Barr-Gillespie PG, 2015, MOL BIOL CELL, V26, P2727, DOI 10.1091/mbc.E14-04-0940; Cao HR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056516; Chacon-Heszele MF, 2009, BRAIN RES, V1277, P130, DOI 10.1016/j.brainres.2009.02.004; COTANCHE DA, 1991, HEARING RES, V52, P379, DOI 10.1016/0378-5955(91)90027-7; Coureux PD, 2003, NATURE, V425, P419, DOI 10.1038/nature01927; Diaz-Horta O, 2014, P NATL ACAD SCI USA, V111, P9864, DOI 10.1073/pnas.1401950111; Ezan J, 2013, NAT CELL BIOL, V15, P1107, DOI 10.1038/ncb2819; Furness DN, 2008, J NEUROSCI, V28, P6342, DOI 10.1523/JNEUROSCI.1154-08.2008; Gagnon LH, 2006, J NEUROSCI, V26, P10188, DOI 10.1523/JNEUROSCI.2166-06.2006; Goodyear RJ, 2003, J NEUROSCI, V23, P9208; Goodyear RJ, 2003, J NEUROSCI, V23, P4878; HASSON T, 1994, J CELL BIOL, V127, P425, DOI 10.1083/jcb.127.2.425; Hasson T, 1997, J CELL BIOL, V137, P1287, DOI 10.1083/jcb.137.6.1287; Hertzano R, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000207; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; Houdusse A, 1999, CELL, V97, P459, DOI 10.1016/S0092-8674(00)80756-4; Jung EJ, 2006, MOL CELL BIOL, V26, P2175, DOI 10.1128/MCB.26.6.2175-2186.2006; KALTENBACH JA, 1994, J COMP NEUROL, V350, P187, DOI 10.1002/cne.903500204; Karolyi IJ, 2003, HUM MOL GENET, V12, P2797, DOI 10.1093/hmg/ddg308; Khan SY, 2007, HUM MUTAT, V28, P417, DOI 10.1002/humu.20469; Kitajiri S, 2004, J CELL BIOL, V166, P559, DOI 10.1083/jcb.200402007; Kitajiri S, 2010, CELL, V141, P786, DOI 10.1016/j.cell.2010.03.049; Kozlov AS, 2007, NAT NEUROSCI, V10, P87, DOI 10.1038/nn1818; Li Y, 2010, AM J HUM GENET, V86, P479, DOI 10.1016/j.ajhg.2010.02.003; May-Simera H, 2012, CURR TOP DEV BIOL, V101, P111, DOI 10.1016/B978-0-12-394592-1.00006-5; Mburu P, 2006, P NATL ACAD SCI USA, V103, P10973, DOI 10.1073/pnas.0600923103; Melchionda S, 2001, AM J HUM GENET, V69, P635, DOI 10.1086/323156; Menetrey J, 2005, NATURE, V435, P779, DOI 10.1038/nature03592; Menetrey J, 2008, EMBO J, V27, P244, DOI 10.1038/sj.emboj.7601937; Miyasaka Y, 2013, EXP ANIM TOKYO, V62, P333, DOI 10.1538/expanim.62.333; Mochizuki E, 2010, EXP ANIM TOKYO, V59, P57, DOI 10.1538/expanim.59.57; Nayak GD, 2007, INT J DEV BIOL, V51, P597, DOI 10.1387/ijdb.072392gn; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pollock LM, 2015, BIRTH DEFECTS RES C, V105, P126, DOI 10.1002/bdrc.21098; Rehman AU, 2010, AM J HUM GENET, V86, P378, DOI 10.1016/j.ajhg.2010.01.030; Sakaguchi H, 2008, CELL MOTIL CYTOSKEL, V65, P528, DOI 10.1002/cm.20275; Salles FT, 2014, CYTOSKELETON, V71, P61, DOI 10.1002/cm.21159; Schraders M, 2010, AM J HUM GENET, V86, P604, DOI 10.1016/j.ajhg.2010.02.015; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Seco CZ, 2015, EUR J HUM GENET, V23, P189, DOI 10.1038/ejhg.2014.83; Self T, 1999, DEV BIOL, V214, P331, DOI 10.1006/dbio.1999.9424; Szarama KB, 2012, DEVELOPMENT, V139, P2187, DOI 10.1242/dev.073734; TAKASAKA T, 1983, ANN OTO RHINOL LARYN, V92, P1, DOI 10.1177/00034894830920S101; Vranceanu F, 2012, P NATL ACAD SCI USA, V109, P4473, DOI 10.1073/pnas.1101003109; Vreugde S, 2006, MOL CELL, V23, P749, DOI 10.1016/j.molcel.2006.07.005; Wells AL, 1999, NATURE, V401, P505, DOI 10.1038/46835; Williams LH, 2013, HEARING RES, V299, P53, DOI 10.1016/j.heares.2013.02.006; Wong EYM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154984; Zhao B, 2016, ELIFE, V5, DOI 10.7554/eLife.14222	54	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183477	10.1371/journal.pone.0183477	http://dx.doi.org/10.1371/journal.pone.0183477			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832620	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800060
J	Goto, K; Sumi, D; Kojima, C; Ishibashi, A				Goto, Kazushige; Sumi, Daichi; Kojima, Chihiro; Ishibashi, Aya			Post-exercise serum hepcidin levels were unaffected by hypoxic exposure during prolonged exercise sessions	PLOS ONE			English	Article							IRON STATUS; REGULATES HEPCIDIN; INFLAMMATION; METABOLISM; ERYTHROPOIESIS; PERFORMANCE; EXPRESSION; INTENSITY; RESPONSES; HEMOLYSIS	The purpose of the present study was to determine the influence of hypoxic exposure during prolonged endurance exercise sessions (79 min in total) on post-exercise hepcidin levels in trained male endurance athletes. Ten endurance athletes (mean +/- standard deviation; height: 169.8 +/- 7.1 cm, weight: 57.1 +/- 5.0 kg) conducted two endurance exercise sessions under either a normobaric hypoxic condition [inspired O-2 fraction (FiO(2)) = 14.5%] or a normoxic condition (FiO(2) = 20.9%). Exercise consisted of 10 x 3 min running on a treadmill at 95% of maximal oxygen uptake ((V) over dot O-2max) with 60s of active rest at 60% of (V) over dot O-2max. After 10 min of rest, they subsequently performed 30 min of continuous running at 85% of (V) over dot O-2max. Running velocities were significantly lower in the HYPO than in the NOR (P < 0.0001). Exercise- induced blood lactate elevation was significantly greater in the HYPO (P < 0.01). There were significant increases in plasma interleukin-6, serum iron, and blood glucose levels after exercise, with no significant difference between the trials [interaction (trial x time) or main effect for trial, P > 0.05]. Serum hepcidin levels increased significantly 120 min after exercise (HYPO: from 10.7 +/- 9.4 ng/mL to 15.8 +/- 11.2 ng/mL; NOR: from 7.9 +/- 4.7 ng/mL to 13.2 +/- 7.9 ng/mL, P < 0.05), and no difference was observed between the trials. In conclusion, endurance exercise at lower running velocity in hypoxic conditions resulted in similar post-exercise hepcidin elevations as higher running velocity in normoxic conditions.	[Goto, Kazushige; Sumi, Daichi; Kojima, Chihiro; Ishibashi, Aya] Ritsumeikan Univ, Grad Sch Sports & Hlth Sci, Kusatsu, Shiga, Japan; [Goto, Kazushige] Ritsumeikan Univ, Fac Sports & Hlth Sci, Kusatsu, Shiga, Japan; [Ishibashi, Aya] Japan Inst Sports Sci, Kita Ku, Tokyo, Japan	Ritsumeikan University; Ritsumeikan University	Goto, K (corresponding author), Ritsumeikan Univ, Grad Sch Sports & Hlth Sci, Kusatsu, Shiga, Japan.; Goto, K (corresponding author), Ritsumeikan Univ, Fac Sports & Hlth Sci, Kusatsu, Shiga, Japan.	kagoto@fc.ritsumei.ac.jp	Sumi, Daichi/AAV-7107-2021		Japan Society for the Promotion of Science [26282180]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science, 26282180 (https://www.jsps.go.jp/enalish/index.html). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auersperger I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058090; Babic Z, 2001, J SPORT MED PHYS FIT, V41, P399; Badenhorst CE, 2015, EUR J APPL PHYSL, V115, P1; Badenhorst CE, 2015, EUR J APPL PHYSIOL, V115, P2521, DOI 10.1007/s00421-015-3252-3; Badenhorst CE, 2014, EUR J APPL PHYSIOL, V114, P951, DOI 10.1007/s00421-014-2829-6; Beard J, 2000, AM J CLIN NUTR, V72, p594S, DOI 10.1093/ajcn/72.2.594S; Buchman AL, 1998, J AM COLL NUTR, V17, P124, DOI 10.1080/07315724.1998.10718737; DeRuisseau KC, 2002, INT J SPORT NUTR EXE, V12, P428, DOI 10.1123/ijsnem.12.4.428; Di Santolo M, 2008, EUR J APPL PHYSIOL, V102, P703, DOI 10.1007/s00421-007-0647-9; Diaz V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12475; Dufour SP, 2006, J APPL PHYSIOL, V100, P1238, DOI 10.1152/japplphysiol.00742.2005; Faiss R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056522; Gassmann M, 2015, J APPL PHYSIOL, V119, P1432, DOI 10.1152/japplphysiol.00248.2015; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Goetze O, 2013, HEPATOLOGY, V58, P2153, DOI 10.1002/hep.26581; Govus AD, 2016, SCANDINAVIAN J MED S; Govus AD, 2014, EUR J APPL PHYSIOL, V114, P2183, DOI 10.1007/s00421-014-2938-2; Hinton PS, 2014, APPL PHYSIOL NUTR ME, V39, P1012, DOI 10.1139/apnm-2014-0147; Ishibashi A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030277; Karl JP, 2010, AM J CLIN NUTR, V92, P93, DOI 10.3945/ajcn.2010.29185; Katayama K, 2009, SUBSTRATE UTILIZATIO, V59, P1; Liu QD, 2012, J CLIN INVEST, V122, P4635, DOI 10.1172/JCI63924; Ma XY, 2013, INT J SPORT NUTR EXE, V23, P513, DOI 10.1123/ijsnem.23.5.513; Malczewska J, 2000, INT J SPORT NUTR, V10, P260, DOI 10.1123/ijsnem.10.3.260; Mastrogiannaki M, 2012, HAEMATOL-HEMATOL J, V97, P827, DOI 10.3324/haematol.2011.056119; McClung JP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-141; McInnis MD, 1998, EUR J APPL PHYSIOL O, V79, P99; McLean BD, 2014, SPORTS MED, V44, P1275, DOI 10.1007/s40279-014-0204-8; Milic R, 2011, EUR J APPL PHYSIOL, V111, P449, DOI 10.1007/s00421-010-1656-7; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Nemeth E, 2004, J CLIN INVEST, V113, P1271, DOI 10.1172/JCI200420945; Nicolas G, 2002, BLOOD CELL MOL DIS, V29, P327, DOI 10.1006/bcmd.2002.0573; Pasiakos SM, 2016, PHYSIOL REP, V4, DOI 10.14814/phy2.12820; Peeling P, 2010, EUR J APPL PHYSIOL, V110, P877, DOI 10.1007/s00421-010-1594-4; Peeling P, 2009, INT J SPORT NUTR EXE, V19, P583, DOI 10.1123/ijsnem.19.6.583; Peeling P, 2009, MED SCI SPORT EXER, V41, P1138, DOI 10.1249/MSS.0b013e318192ce58; Sim M, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/1550-2783-11-14; Skarpanska-Stejnborn A, 2014, J INT SOC SPORT NUTR, V11, DOI 10.1186/s12970-014-0048-5; Steinbicker AU, 2013, NUTRIENTS, V5, P3034, DOI 10.3390/nu5083034; Telford RD, 2003, J APPL PHYSIOL, V94, P38, DOI 10.1152/japplphysiol.00631.2001; Troutt JS, 2012, CLIN CHEM, V58, P1225, DOI 10.1373/clinchem.2012.186866; Wahl P, 2013, INT J SPORTS MED, V34, P95, DOI 10.1055/s-0032-1314815; WILSON RC, 1991, CLIN SCI, V80, P309, DOI 10.1042/cs0800309; Zoller H, 2004, NUTRITION, V20, P615, DOI 10.1016/j.nut.2004.04.006	44	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183629	10.1371/journal.pone.0183629	http://dx.doi.org/10.1371/journal.pone.0183629			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829838	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100060
J	Tseng, CC; Jia, BL; Berndt, R; Gu, Y; Chen, CY; Tseng, IC; Su, SF; Wang, JK; Johnson, MD; Lin, CY				Tseng, Chun-Che; Jia, Bailing; Berndt, Robert; Gu, Yayun; Chen, Chien-Yu; Tseng, I-Chu; Su, Sheng-Fang; Wang, Jehng-Kang; Johnson, Michael D.; Lin, Chen-Yong			Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; AUTOSOMAL RECESSIVE ICHTHYOSIS; SERINE-PROTEASE; EPITHELIAL-CELLS; BARRIER FUNCTION; IN-VITRO; EXPRESSION; CHYMOTRYPSINOGEN; CONTRIBUTES; DELINEATION	The type 2 transmembrane serine protease matriptase is involved in many pathophysiological processes probably via its enzymatic activity, which depends on the dynamic relationship between zymogen activation and protease inhibition. Matriptase shedding can prolong the life of enzymatically active matriptase and increase accessibility to substrates. We show here that matriptase shedding occurs via a de novo proteolytic cleavage at sites located between the SEA domain and the CUB domain. Point or combined mutations at the four positively charged amino acid residues in the region following the SEA domain allowed Arg-186 to be identified as the primary cleavage site responsible for matriptase shedding. Kinetic studies further demonstrate that matriptase shedding is temporally coupled with matriptase zymogen activation. The onset of matriptase shedding lags one minute behind matriptase zymogen activation. Studies with active site triad Ser-805 point mutated matriptase, which no longer undergoes zymogen activation or shedding, further suggests that matriptase shedding depends on matriptase zymogen activation, and that matriptase proteolytic activity may be involved in its own shedding. Our studies uncover an autonomous mechanism coupling matriptase zymogen activation, proteolytic activity, and shedding such that a proportion of newly generated active matriptase escapes HAI-1-mediated rapid inhibition by shedding into the extracellular milieu.	[Tseng, Chun-Che; Jia, Bailing; Berndt, Robert; Gu, Yayun; Tseng, I-Chu; Su, Sheng-Fang; Johnson, Michael D.; Lin, Chen-Yong] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Jia, Bailing] Henan Prov Peoples Hosp, Dept Gastroenterol, Zhengzhou, Henan, Peoples R China; [Chen, Chien-Yu; Wang, Jehng-Kang] Natl Def Med Ctr, Dept Biochem, Taipei, Taiwan; [Chen, Chien-Yu] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Tseng, I-Chu] Aging & Stem Cell Res Ctr, Sanford Burnham Prebys Med Discovery Inst, E Webb Neurosci, 10901 North Torrey Pines Rd, La Jolla, CA USA; [Su, Sheng-Fang] Natl Taiwan Univ, Ctr Biotechnol, 1 Sec4,Roosevelt Rd, Taipei 10617, Taiwan	Georgetown University; Zhengzhou University; National Defense Medical Center; National Defense Medical Center; Sanford Burnham Prebys Medical Discovery Institute; National Taiwan University	Johnson, MD; Lin, CY (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA.	johnsom@georgetown.edu; lincy@georgetown.edu	Su, Sheng-Fang/AAT-3642-2021; Lin, Chen/GRR-2799-2022	Su, Sheng-Fang/0000-0002-1624-5745; Tseng, Chun-che/0000-0001-9637-4127; Lin, Chen-Yong/0000-0002-6391-2571	National Cancer Institute (NCI) [R01 CA 123223]; Department of Defense, Taiwan [MAB-105-047]; Chi-Mei Medical Center [CMNDMC10506]; NIH/NCI [P30-CA051008]; NATIONAL CANCER INSTITUTE [P30CA051008] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense, Taiwan(United States Department of Defense); Chi-Mei Medical Center; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute (NCI) Grant R01 CA 123223 (to M. D. Johnson and C.-Y. Lin), Grant (MAB-105-047) from the Department of Defense, Taiwan (to J.-K. Wang), and Grant CMNDMC10506 from Chi-Mei Medical Center (to J.-K. Wang). We are very grateful to the Ruthellen L. Holtz Memorial Fund for Breast Cancer Research for its ongoing support of our work. We also acknowledge the assistance provided by the Lombardi Comprehensive Cancer Center the Proteomics & Metabolomics Shared Resources that are supported in part by NIH/NCI grant P30-CA051008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avrahami L, 2008, CLIN GENET, V74, P47, DOI 10.1111/j.1399-0004.2008.01006.x; Basel-Vanagaite L, 2007, AM J HUM GENET, V80, P467, DOI 10.1086/512487; Benaud C, 2002, J BIOL CHEM, V277, P10539, DOI 10.1074/jbc.M109064200; Benaud C, 2001, EUR J BIOCHEM, V268, P1439, DOI 10.1046/j.1432-1327.2001.02016.x; Camerer E, 2010, DEV CELL, V18, P25, DOI 10.1016/j.devcel.2009.11.014; Chen YW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062826; Chen YW, 2010, J BIOL CHEM, V285, P31755, DOI 10.1074/jbc.M110.150367; Cho EG, 2001, J BIOL CHEM, V276, P44581, DOI 10.1074/jbc.M107059200; Chou FP, 2013, AM J PATHOL, V183, P1306, DOI 10.1016/j.ajpath.2013.06.024; Chu LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092244; Darragh MR, 2010, CANCER RES, V70, P1505, DOI 10.1158/0008-5472.CAN-09-1640; Deng DW, 2013, BIOSENS BIOELECTRON, V49, P216, DOI 10.1016/j.bios.2013.05.018; Friis S, 2011, J BIOL CHEM, V286, P5793, DOI 10.1074/jbc.M110.186874; Godiksen S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077146; Hayashida K, 2010, ANAT REC, V293, P925, DOI 10.1002/ar.20757; HESS GP, 1970, PHILOS T ROY SOC B, V257, P89, DOI 10.1098/rstb.1970.0011; Inouye K, 2010, J BIOCHEM, V147, P485, DOI 10.1093/jb/mvp190; KERR MA, 1976, BIOCHEMISTRY-US, V15, P5566, DOI 10.1021/bi00670a022; Kim MG, 1999, IMMUNOGENETICS, V49, P420, DOI 10.1007/s002510050515; Kiyomiya KI, 2006, AM J PHYSIOL-CELL PH, V291, pC40, DOI 10.1152/ajpcell.00351.2005; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lai CH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152904; LeBeau AM, 2013, P NATL ACAD SCI USA, V110, P93, DOI 10.1073/pnas.1218694110; Lee HS, 2014, BIOCHEM BIOPH RES CO, V452, P1084, DOI 10.1016/j.bbrc.2014.09.055; Lee MS, 2007, AM J PHYSIOL-CELL PH, V293, pC95, DOI 10.1152/ajpcell.00611.2006; Lee MS, 2005, AM J PHYSIOL-CELL PH, V288, pC932, DOI 10.1152/ajpcell.00497.2004; Lee SL, 2000, J BIOL CHEM, V275, P36720, DOI 10.1074/jbc.M007802200; Lin CY, 1999, J BIOL CHEM, V274, P18237, DOI 10.1074/jbc.274.26.18237; Lin CY, 1999, J BIOL CHEM, V274, P18231, DOI 10.1074/jbc.274.26.18231; List K, 2006, AM J PATHOL, V168, P1513, DOI 10.2353/ajpath.2006.051071; List K, 2002, ONCOGENE, V21, P3765, DOI 10.1038/sj.onc.1205502; List K, 2005, GENE DEV, V19, P1934, DOI 10.1101/gad.1300705; List K, 2009, AM J PATHOL, V175, P1453, DOI 10.2353/ajpath.2009.090240; LONSDALEECCLES JD, 1978, BIOCHEMISTRY-US, V17, P2805, DOI 10.1021/bi00607a016; Macao B, 2006, NAT STRUCT MOL BIOL, V13, P71, DOI 10.1038/nsmb1035; Milner JM, 2010, ARTHRITIS RHEUM-US, V62, P1955, DOI 10.1002/art.27476; Miyake Y, 2009, J BIOCHEM, V146, P273, DOI 10.1093/jb/mvp066; MORGAN PH, 1972, P NATL ACAD SCI USA, V69, P3312, DOI 10.1073/pnas.69.11.3312; Najy AJ, 2016, AM J PHYSIOL-CELL PH, V310, pC293, DOI 10.1152/ajpcell.00043.2015; Nimishakavi S, 2012, AM J PHYSIOL-LUNG C, V303, pL97, DOI 10.1152/ajplung.00303.2011; Oberst MD, 2005, AM J PHYSIOL-CELL PH, V289, pC462, DOI 10.1152/ajpcell.00076.2005; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Oberst MD, 2003, J HISTOCHEM CYTOCHEM, V51, P1017, DOI 10.1177/002215540305100805; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Satomi S, 2001, BIOCHEM BIOPH RES CO, V287, P995, DOI 10.1006/bbrc.2001.5686; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Seals DF, 2003, GENE DEV, V17, P7, DOI 10.1101/gad.1039703; Seitz I, 2007, ARTERIOSCL THROM VAS, V27, P769, DOI 10.1161/01.ATV.0000258862.61067.14; STAMPFER MR, 1985, P NATL ACAD SCI USA, V82, P2394, DOI 10.1073/pnas.82.8.2394; Takeuchi T, 2000, J BIOL CHEM, V275, P26333, DOI 10.1074/jbc.M002941200; Takeuchi T, 1999, P NATL ACAD SCI USA, V96, P11054, DOI 10.1073/pnas.96.20.11054; Tseng IC, 2010, J BIOL CHEM, V285, P3261, DOI 10.1074/jbc.M109.055640; Tsuzuki S, 2010, BIOSCI BIOTECH BIOCH, V74, P1295, DOI 10.1271/bbb.100074; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Ustach CV, 2010, CANCER RES, V70, P9631, DOI 10.1158/0008-5472.CAN-10-0511; Wang JK, 2009, AM J PHYSIOL-CELL PH, V297, pC459, DOI 10.1152/ajpcell.00201.2009; Wang X.D., 2014, J APPL MATH, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0093899; Weber S, 2012, DEVELOPMENT, V139, P3693, DOI 10.1242/dev.076398; Zoratti GL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7776	60	22	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183507	10.1371/journal.pone.0183507	http://dx.doi.org/10.1371/journal.pone.0183507			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829816	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100051
J	Moreno-Torres, KI; Pomeroy, LW; Moritz, M; Saville, W; Wolfe, B; Garabed, R				Moreno-Torres, Karla I.; Pomeroy, Laura W.; Moritz, Mark; Saville, William; Wolfe, Barbara; Garabed, Rebecca			Host species heterogeneity in the epidemiology of Nesopora caninum	PLOS ONE			English	Article							NEOSPORA-CANINUM; BEEF-CATTLE; ECONOMIC-IMPACT; RISK-FACTORS; DAIRY; TRANSMISSION; SEROPREVALENCE; INFECTION; VALIDATION; ABORTION	Pathogen transmission across species drives disease emergence; however, mechanisms by which multi-host pathogens cross species boundaries are not well identified. This knowledge gap prevents integrated and targeted control in an epidemiologically continuous ecosystem. Our goal is to describe the impact of host species heterogeneity on the epidemiology of Neospora caninum circulating between livestock and wildlife in southeastern Ohio. We collected biological samples from Pere David's deer (Elaphurus davidianus) located at an outdoor wildlife conservation center; from cattle raised at farms adjacent to the center; and from wild white-tailed deer that roamed across farm and center boundaries. We designed nested infectious disease models of competing hypotheses about transmission and used collected data to fit the models, thereby estimating important immunological and transmission quantities which describe the species-specific contribution to the persistence of this pathogen in the community. We applied these data and models to suggest appropriate species-specific disease control methods. Results show that immunity in cattle and Pere David's deer wanes over time, while in white-tailed deer immunity appears to be lifelong. Transmission quantities for cattle were estimated at values below the threshold for an outbreak (R-t < 1), meaning that chains of transmission are not maintained within this population and infections must occur due to reintroduction from an outside source. Pere David's deer and white-tailed deer both could maintain continuous chains of transmission within their group (R-t > 1). Therefore, we propose that control of contact with outside sources will be useful for disease control in cattle; boosting immunity with vaccines might be an avenue to prevent infection in cattle and Pere David's deer. White-tailed deer are a potential maintenance host for infection and require further study to determine optimal control methods. Community-level investigations like this allow us to better evaluate heterogeneities in transmission processes that ultimately guide targeted control.	[Moreno-Torres, Karla I.; Pomeroy, Laura W.; Saville, William; Garabed, Rebecca] Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA; [Moritz, Mark] Ohio State Univ, Dept Anthropol, Columbus, OH 43210 USA; [Wolfe, Barbara] Morris Anim Fdn, Denver, CO USA; [Garabed, Rebecca] Ohio State Univ, Publ Hlth Preparedness Infect Dis Program, Columbus, OH 43210 USA; [Moreno-Torres, Karla I.] USDA, Ctr Epidemiol & Anim Hlth, Monitoring & Modeling, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80526 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; United States Department of Agriculture (USDA)	Moreno-Torres, KI (corresponding author), Ohio State Univ, Dept Vet Prevent Med, Columbus, OH 43210 USA.; Moreno-Torres, KI (corresponding author), USDA, Ctr Epidemiol & Anim Hlth, Monitoring & Modeling, Anim & Plant Hlth Inspect Serv, Ft Collins, CO 80526 USA.	irazema.moreno@gmail.com	Moritz, Mark/X-4052-2019	Moritz, Mark/0000-0003-0644-0069; Moreno Torres, Karla/0000-0001-9755-0938	National Science Foundation Ecology and Evolution of Infectious Diseases program [DEB-1015908]; OSU CARES [2012 Seed]; Columbus Zoo Aquarium [GRT00030170]	National Science Foundation Ecology and Evolution of Infectious Diseases program; OSU CARES; Columbus Zoo Aquarium	LWP was funded by the National Science Foundation Ecology and Evolution of Infectious Diseases program under DEB-1015908. This research was supported by OSU CARES (Grant/Award Number: '2012 Seed') and Columbus Zoo & Aquarium (Grant/Award Number: GRT00030170). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1987, PSYCHOMETRIKA, V52, P317, DOI 10.1007/BF02294359; Almeria S, 2009, VET PARASITOL, V163, P323, DOI 10.1016/j.vetpar.2009.04.026; Almeria Sonia, 2013, ISRN Parasitol, V2013, P947347, DOI 10.5402/2013/947347; ANDERSON R M, 1991; Armengol R, 2007, J PARASITOL, V93, P1029, DOI 10.1645/GE-1242R.1; Bapodra P, 2015, VET REC OPEN, V2; Bartels CJM, 2006, VET PARASITOL, V137, P17, DOI 10.1016/j.vetpar.2005.12.016; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; Baszler TV, 1999, J CLIN MICROBIOL, V37, P4059, DOI 10.1128/JCM.37.12.4059-4064.1999; Baszler TV, 1996, J CLIN MICROBIOL, V34, P1423, DOI 10.1128/JCM.34.6.1423-1428.1996; Baszler TV, 2001, J CLIN MICROBIOL, V39, P3851, DOI 10.1128/JCM.39.11.3851-3857.2001; Cain AT, 2001, A GUIDE TO AGE DETER; Davison HC, 1999, INT J PARASITOL, V29, P1683, DOI 10.1016/S0020-7519(99)00129-0; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Dubey JP, 2011, VET PARASITOL, V180, P90, DOI 10.1016/j.vetpar.2011.05.031; Eiras C, 2011, PREV VET MED, V98, P128, DOI 10.1016/j.prevetmed.2010.10.014; England RB, 1984, A GUIDE TO AGE DETER; French NP, 1999, INT J PARASITOL, V29, P1691, DOI 10.1016/S0020-7519(99)00131-9; Ghanem ME, 2009, CAN VET J, V50, P389; Giraudoux P, 2008, PARASITE, V15, P469, DOI 10.1051/parasite/2008153469; Gondim LFP, 2006, TRENDS PARASITOL, V22, P247, DOI 10.1016/j.pt.2006.03.008; Greiner M, 2000, PREV VET MED, V45, P3, DOI 10.1016/S0167-5877(00)00114-8; Haddad JPA, 2005, CAN VET J, V46, P230; Hamilton R, 1985, P ANN C SE ASS FISH; Haydon DT, 2002, EMERG INFECT DIS, V8, P1468; Hinrichs KC, 2003, SEROPREVALENCE OF AN; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Lembo T, 2007, P ROY SOC B-BIOL SCI, V274, P2123, DOI 10.1098/rspb.2007.0664; Lewis FI, 2012, EMERG THEMES EPIDEMI, V9, DOI 10.1186/1742-7622-9-9; Monney T, 2011, ANIMALS-BASEL, V1, P306, DOI 10.3390/ani1030306; Monney T, 2014, EXP PARASITOL, V140, P52, DOI 10.1016/j.exppara.2014.02.015; Moore DP, 2014, VET PARASITOL, V203, P259, DOI 10.1016/j.vetpar.2014.04.011; Moreno Torres K., 2016, THE WILDLIFE LIVESTO; Moreno-Torres K, 2016, ECOL EVOL, V6, P2216, DOI 10.1002/ece3.2050; Muench H, 1959, CATALYTIC MODELS IN; Munir M, 2014, TRANSBOUND EMERG DIS, V61, P411, DOI 10.1111/tbed.12052; Nash JC, 2016, OPTIMR A REPLACEMENT; Pomeroy LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136642; R. Core Team, 2015, R A LANGUAGE AND ENV; Reichel MP, 2013, INT J PARASITOL, V43, P133, DOI 10.1016/j.ijpara.2012.10.022; RICHARDSON C, 1990, VET REC, V126, P279; Rinaldi L, 2005, VET PARASITOL, V128, P219, DOI 10.1016/j.vetpar.2004.12.011; Sanderson MW, 2000, VET PARASITOL, V90, P15, DOI 10.1016/S0304-4017(00)00234-X; Santolaria P, 2011, VET PARASITOL, V178, P70, DOI 10.1016/j.vetpar.2010.12.018; Streicker DG, 2013, ECOL LETT, V16, P975, DOI 10.1111/ele.12122; Trees AJ, 1999, INT J PARASITOL, V29, P1195, DOI 10.1016/S0020-7519(99)00093-4; Weston JF, 2012, PREV VET MED, V103, P136, DOI 10.1016/j.prevetmed.2011.08.010; Woolhouse MEJ, 2001, SCIENCE, V292, P1109, DOI 10.1126/science.1059026	49	4	4	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183900	10.1371/journal.pone.0183900	http://dx.doi.org/10.1371/journal.pone.0183900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850580	Green Published, gold, Green Submitted			2022-12-27	WOS:000408544200039
J	Park, C; Kang, MY; Kim, D; Park, J; Eom, H; Kim, EA				Park, Chulyong; Kang, Mo-Yeol; Kim, Dohyung; Park, Jaechan; Eom, Huisu; Kim, Eun-A			Prevalence of abortion and adverse pregnancy outcomes among working women in Korea: A cross-sectional study	PLOS ONE			English	Article							ETHYLENE-GLYCOL ETHERS; FEMALE FLIGHT ATTENDANTS; PLASTICS INDUSTRY; HAIRDRESSERS; INFERTILITY; NURSES; RISK	Objectives To investigate incidence and distribution of major adverse reproductive health problems related to various kinds of industries in Korea and to compare risks for major reproductive outcomes to assess maternal health in working and non-working women. Methods We requested claim data from the Korean National Health Insurance. We defined reference groups as (1) non-working women and (2) workers in the education field. Women working in each industry were compared with reference groups regarding rates of miscarriage, threatened abortion, preterm labor, and intrauterine growth restriction. Logistic regression was used for multivariate analysis, and age and income adjustment was performed. Results The percentages of all adverse obstetric outcomes were higher in working women than in non-working women. Working women had higher and statistically significant adjusted odds ratios (ORs) for miscarriage in 18 of the 21 industries. The age and income-adjusted OR for miscarriage for all working women was 1.26 (95% confidence interval, 1.23-1.28). Business facilities management and business support services, manufacturing, human health and social work activities, wholesale and retail trade, and professional, scientific, and technical activities were major industries with higher adjusted ORs for adverse obstetric outcomes. Conclusions We confirmed that compared to non-working women, working women have a higher risk for adverse pregnancy outcomes. Thus, adverse pregnancy outcomes such as threatened abortion, preterm labor, and intrauterine growth restriction may be associated with working status. This exploratory study identified several industries where in-depth studies are required in future to improve occupational safety in women of reproductive age.	[Park, Chulyong; Kim, Dohyung; Park, Jaechan; Eom, Huisu; Kim, Eun-A] Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea; [Park, Chulyong] Sungkyunkwan Univ, Dept Occupat & Environm Med, Sch Med, Seoul, South Korea; [Kang, Mo-Yeol] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Seoul National University (SNU)	Kim, EA (corresponding author), Korea Occupat Safety & Hlth Agcy, Occupat Safety & Hlth Res Inst, Ulsan, South Korea.	toxneuro@gmail.com	Eun-A, KIM/AAK-4245-2020; Park, Chulyong/AAN-1464-2020	Eun-A, KIM/0000-0002-8582-234X; Park, Chulyong/0000-0001-8584-5376				AHLBORG G, 1987, AM J IND MED, V12, P507, DOI 10.1002/ajim.4700120505; Aspholm R, 1999, J OCCUP ENVIRON MED, V41, P486, DOI 10.1097/00043764-199906000-00015; Axmon A, 2006, SCAND J WORK ENV HEA, V32, P51, DOI 10.5271/sjweh.976; Bonde JP, 2013, SCAND J WORK ENV HEA, V39, P325, DOI 10.5271/sjweh.3337; Burdorf A, 2006, OCCUP MED-OXFORD, V56, P516, DOI 10.1093/occmed/kql113; Chen PC, 2002, EPIDEMIOLOGY, V13, P191, DOI 10.1097/00001648-200203000-00014; Cone JE, 1998, J OCCUP ENVIRON MED, V40, P210, DOI 10.1097/00043764-199803000-00002; Correa A, 1996, AM J EPIDEMIOL, V143, P707; Elliott RC, 1999, AM J IND MED, V36, P557, DOI 10.1002/(SICI)1097-0274(199911)36:5<557::AID-AJIM8>3.0.CO;2-Q; Figa-Talamanca I, 2000, EPIDEMIOL REV, V22, P249, DOI 10.1093/oxfordjournals.epirev.a018037; Gan HF, 2003, J OCCUP HEALTH, V45, P400, DOI 10.1539/joh.45.400; Halliday-Bell JA, 2010, OCCUP MED-OXFORD, V60, P310, DOI 10.1093/occmed/kqq018; Halliday-Bell JA, 2009, OCCUP MED-OXFORD, V59, P180, DOI 10.1093/occmed/kqp017; Hougaard KS, 2006, HUM REPROD, V21, P3122, DOI 10.1093/humrep/del160; Hougaard KS, 2009, REPROD TOXICOL, V27, P186, DOI 10.1016/j.reprotox.2009.01.003; Hsieh GY, 2005, OCCUP ENVIRON MED, V62, P510, DOI 10.1136/oem.2004.016014; Jin LZ, 2004, J OCCUP ENVIRON MED, V46, P1144, DOI 10.1097/01.jom.0000145168.21614.21; Jones RK, 2011, OBSTET GYNECOL, V117, P1358, DOI 10.1097/AOG.0b013e31821c405e; Jorgensen KT, 2013, SCAND J WORK ENV HEA, V39, P302, DOI 10.5271/sjweh.3330; Kim D, 2016, INT ARCH OCC ENV HEA, V89, P739, DOI 10.1007/s00420-016-1112-z; Kim I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123679; Kumar S, 2011, REPROD SCI, V18, P915, DOI 10.1177/1933719111413298; Lauria L, 2006, AVIAT SPACE ENVIR MD, V77, P533; Lawson CC, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.030; LEMASTERS GK, 1989, J OCCUP ENVIRON MED, V31, P115; LEMASTERS GK, 1989, J CLIN EPIDEMIOL, V42, P975, DOI 10.1016/0895-4356(89)90162-5; LINDBOHM M-L, 1985, Public Health Reviews, V13, P55; PASTIDES H, 1988, J OCCUP ENVIRON MED, V30, P543; Ratner PA, 2010, BMC NURS, V9, DOI 10.1186/1472-6955-9-15; Ronda E, 2010, INT ARCH OCC ENV HEA, V83, P945, DOI 10.1007/s00420-010-0517-3; Rylander L, 2002, OCCUP ENVIRON MED, V59, P517, DOI 10.1136/oem.59.8.517; SAURELCUBIZOLLES MJ, 1994, INT ARCH OCC ENV HEA, V66, P235, DOI 10.1007/BF00454361; Silva ID, 2009, J OCCUP ENVIRON MED, V51, P1298, DOI 10.1097/JOM.0b013e3181b9ae2f; Tang Ning, 2003, Int J Occup Med Environ Health, V16, P359; Wennborg H, 2002, SCAND J WORK ENV HEA, V28, P5, DOI 10.5271/sjweh.640; Whelan EA, 2007, EPIDEMIOLOGY, V18, P350, DOI 10.1097/01.ede.0000259988.77314.a4; Yang HJ, 2014, BIRTH-ISS PERINAT C, V41, P262, DOI 10.1111/birt.12118	37	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182341	10.1371/journal.pone.0182341	http://dx.doi.org/10.1371/journal.pone.0182341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850585	gold, Green Published, Green Submitted			2022-12-27	WOS:000408544200002
J	Gal, B; Vesely, M; Collakova, J; Nekulova, M; Juzova, V; Chmelik, R; Vesely, P				Gal, Bretislav; Vesely, Miroslav; Collakova, Jana; Nekulova, Marta; Juzova, Veronika; Chmelik, Radim; Vesely, Pavel			Distinctive behaviour of live biopsy-derived carcinoma cells unveiled using coherence-controlled holographic microscopy	PLOS ONE			English	Article							CANCER; P63; LINES; HEAD	Head and neck squamous cell carcinoma is one of the most aggressive tumours and is typically diagnosed too late. Late diagnosis requires an urgent decision on an effective therapy. An individualized test of chemosensitivity should quickly indicate the suitability of chemotherapy and radiotherapy. No ex vivo chemosensitivity assessment developed thus far has become a part of general clinical practice. Therefore, we attempted to explore the new technique of coherence-controlled holographic microscopy to investigate the motility and growth of live cells from a head and neck squamous cell carcinoma biopsy. We expected to reveal behavioural patterns characteristic for malignant cells that can be used to imrove future predictive evaluation of chemotherapy. We managed to cultivate primary SACR2 carcinoma cells from head and neck squamous cell carcinoma biopsy verified through histopathology. The cells grew as a cohesive sheet of suspected carcinoma origin, and western blots showed positivity for the tumour marker p63 confirming cancerous origin. Unlike the roundish colonies of the established FaDu carcinoma cell line, the SACR2 cells formed irregularly shaped colonies, eliciting the impression of the collective invasion of carcinoma cells. Time-lapse recordings of the cohesive sheet activity revealed the rapid migration and high plasticity of these epithelial-like cells. Individual cells frequently abandoned the swiftly migrating crowd by moving aside and crawling faster. The increasing mass of fast migrating epithelial-like cells before and after mitosis confirmed the continuation of the cell cycle. In immunofluorescence, analogously shaped cells expressed the p63 tumour marker, considered proof of their origin from a carcinoma. These behavioural traits indicate the feasible identification of carcinoma cells in culture according to the proposed concept of the carcinoma cell dynamic phenotype. If further developed, this approach could later serve in a new functional online analysis of reactions of carcinoma cells to therapy. Such efforts conform to current trends in precision medicine.	[Gal, Bretislav; Vesely, Miroslav] St Annes Univ Hosp FNUSA, Dept Otorhinolaryngol & Head & Neck Surg, Brno, Czech Republic; [Collakova, Jana; Juzova, Veronika; Chmelik, Radim; Vesely, Pavel] Brno Univ Technol, CEITEC Cent European Inst Technol, Brno, Czech Republic; [Collakova, Jana; Chmelik, Radim] Brno Univ Technol, Fac Mech Engn, Inst Phys Engn IPE, Brno, Czech Republic; [Nekulova, Marta] Masaryk Mem Canc Inst, Reg Ctr Appl Mol Oncol RECAMO, Brno, Czech Republic	St Anne's University Hospital Brno (FNUSA-ICRC); Brno University of Technology; Brno University of Technology; Masaryk Memorial Cancer Institute	Gal, B (corresponding author), St Annes Univ Hosp FNUSA, Dept Otorhinolaryngol & Head & Neck Surg, Brno, Czech Republic.	b.gal@fnusa.cz	Vesely, Pavel/D-9921-2012; Nekulova, Marta/D-2334-2013; Gal, Bretislav/AAK-5738-2021; Chmelik, Radim/D-7616-2012	Vesely, Pavel/0000-0003-3420-395X; Gal, Bretislav/0000-0003-3351-4449; Chmelik, Radim/0000-0001-5410-4794	Ministry of Education, Youth and Sports of the Czech Republic projects CEITEC, 2020 [LQ1601]; Nanofabrication and Nanocharacterization Core Facility, CEITEC [LM2011020]; CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging [LM2015062]; Project MEYS - NPS I [LO1413]; League against Cancer Prague; Brno University of Technology, Application of Advanced Optical Methods [FSI-S-14-2494]; Czech Science Foundation [15-14612S]; St. Anne's University Hospital (FNUSA); Brno University of Technology [FSI-S-14-2494]; Nanofabrication and Nanocharacterization Core Facility, CEITEC under the activity "Projects of major infrastructures for research, development and innovations" [LM2011020];  [MEYS-NPS I-LO1413]	Ministry of Education, Youth and Sports of the Czech Republic projects CEITEC, 2020; Nanofabrication and Nanocharacterization Core Facility, CEITEC; CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging; Project MEYS - NPS I; League against Cancer Prague; Brno University of Technology, Application of Advanced Optical Methods; Czech Science Foundation(Grant Agency of the Czech Republic); St. Anne's University Hospital (FNUSA); Brno University of Technology; Nanofabrication and Nanocharacterization Core Facility, CEITEC under the activity "Projects of major infrastructures for research, development and innovations"; 	Funded by The Ministry of Education, Youth and Sports of the Czech Republic projects CEITEC, 2020, ID number LQ1601; http://www.msmt.cz/, RC; Nanofabrication and Nanocharacterization Core Facility, CEITEC, ID number LM2011020;https://www.ceitec.eu/, RC; CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging, ID number LM2015062;http://www.czech-bioimaging.cz/ RC, MV; Project MEYS - NPS I, ID number LO1413; http://www.msmt.cz/, MN; The League against Cancer Prague grant, https://www.lpr.cz/index.php/english, PV; Brno University of Technology, Application of Advanced Optical Methods, ID number FSI-S-14-2494; https://www.vutbr.cz/en/ RC; Czech Science Foundation grant, ID number 15-14612S; https://www.vutbr.cz/en/, RC; St. Annes University Hospital (FNUSA) institutional grant;, http://www.fnusa.cz/, BG.r This research was financially supported by the Ministry of Education, Youth and Sports of the Czech Republic under the projects CEITEC 2020 (LQ1601), Nanofabrication and Nanocharacterization Core Facility, CEITEC open access project, ID number LM2011020, under the activity "Projects of major infrastructures for research, development and innovations," and CZECH-BIOIMAGING: National Infrastructure for Biological and Medical Imaging (LM2015062) and Brno University of Technology in grant FSI-S-14-2494 (Application of Advanced Optical Methods), Czech Science Foundation (15-14612S). M. Nekulova was supported by the project MEYS-NPS I-LO1413. The League against Cancer Prague, and the St. Anne's University Hospital (FNUSA) also supported this work.	Balvan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145016; Balvan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121674; BARER R, 1957, J OPT SOC AM, V47, P545, DOI 10.1364/JOSA.47.000545; Brozova M, 2007, BREAST CANCER RES TR, V103, P247, DOI 10.1007/s10549-006-9358-x; Burstein HJ, 2011, J CLIN ONCOL, V29, P3328, DOI 10.1200/JCO.2011.36.0354; Chmelik R, 2011, patent, Patent No. 302491; Chmelik R, 2014, PROG OPTICS, V59, P267, DOI 10.1016/B978-0-444-63379-8.00005-2; Collakova J, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.11.111213; Dang TT, 2016, ONCOTARGET, DOI 10.18632/oncotarget.8696; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dotsch V, 2010, COLD SPRING HARBOR P, V2; DUNN GA, 1993, SYM SOC EXP BIOL, V47, P91; Friedman AA, 2015, NAT REV CANCER, V15, P747, DOI 10.1038/nrc4015; Gandalovicova A, 2017, TRENDS CANCER, V3, P391, DOI 10.1016/j.trecan.2017.04.008; Jinushi M, 2011, P NATL ACAD SCI USA, V108, P12425, DOI 10.1073/pnas.1106645108; Kalia M, 2013, METABOLISM, V62, pS11, DOI 10.1016/j.metabol.2012.08.016; Kalluri R, 2010, J CLIN INVEST, V120, P1786, DOI 10.1172/JCI39104C1; Kepp O, 2011, NAT REV DRUG DISCOV, V10, P221, DOI 10.1038/nrd3373; Khan NR, 2012, ASIAN PAC J CANCER P, V13, P975, DOI 10.7314/APJCP.2012.13.3.975; Krizova A, 2015, J BIOMED OPT, V20, DOI 10.1117/1.JBO.20.11.111214; Li H, 2014, MOL CANCER RES, V12, P571, DOI 10.1158/1541-7786.MCR-13-0396; Liebertz DJ, 2010, HEAD NECK ONCOL, V2, DOI 10.1186/1758-3284-2-5; Lippert TH, 2011, INT J MED SCI, V8, P245, DOI 10.7150/ijms.8.245; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; Palm D, 2005, SEMIN CANCER BIOL, V15, P396, DOI 10.1016/j.semcancer.2005.06.008; PARTIN AW, 1989, P NATL ACAD SCI USA, V86, P1254, DOI 10.1073/pnas.86.4.1254; Popescu G, 2008, AJP CELL PHYSL, V295; RANGAN SRS, 1972, CANCER, V29, P117, DOI 10.1002/1097-0142(197201)29:1<117::AID-CNCR2820290119>3.0.CO;2-R; Re M, 2014, EUR ARCH OTO-RHINO-L, V271, P1641, DOI 10.1007/s00405-013-2833-1; Sinha Anju, 2015, J Oral Biol Craniofac Res, V5, P165, DOI 10.1016/j.jobcr.2015.07.001; Slaby T, 2013, OPT EXPRESS, V21, P14747, DOI 10.1364/OE.21.014747; Su YR, 2016, CANCER MED-US, V5, P558, DOI 10.1002/cam4.616; Svitkina TM, 1997, J CELL BIOL, V139, P397, DOI 10.1083/jcb.139.2.397; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; VESELY P, 1985, SCANNING, V7, P141, DOI 10.1002/sca.4950070307; Watanabe E, 2013, OPT LETT, V38, P1319, DOI 10.1364/OL.38.001319; Zhao M, 2011, CLIN CANC RES; Zhao TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1209-x	38	8	8	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183399	10.1371/journal.pone.0183399	http://dx.doi.org/10.1371/journal.pone.0183399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846747	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600028
J	Llontop, C; Garcia-Quero, C; Castro, A; Dalmau, R; Casitas, R; Galera, R; Iglesias, A; Martinez-Ceron, E; Soriano, JB; Garcia-Rio, F				Llontop, Claudia; Garcia-Quero, Cristina; Castro, Almudena; Dalmau, Regina; Casitas, Raquel; Galera, Raul; Iglesias, Alberto; Martinez-Ceron, Elisabet; Soriano, Joan B.; Garcia-Rio, Francisco			Small airway dysfunction in smokers with stable ischemic heart disease	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; LUNG-FUNCTION; IMPULSE OSCILLOMETRY; FORCED OSCILLATION; FLOW LIMITATION; COPD; PREVALENCE; SPIROMETRY; EMPHYSEMA; STANDARDIZATION	Background A higher prevalence of airflow limitation (AL) has been described in patients with ischemic heart disease (IHD). Although small airway dysfunction (SAD) is an early feature of AL, there is little information about its occurrence in IHD patients. Our objective was to describe the prevalence of SAD in IHD patients, while comparing patient-related outcomes and future health risk among IHD patients with AL, SAD and normal lung function. Methods In 118 consecutive smoking patients with stable IHD, comorbidities, utilization of healthcare resources, current treatment, blood biochemistry and health status were recorded. SAD was evaluated by impulse oscillometry, and pre- and post-bronchodilator spirometry was performed. Results The prevalence of AL and SAD were 20.3 (95% CI, 13.1-27.6%) and 26.3% (95% CI, 18.3-34.2%), respectively. Compared to the normal lung function group, patients with SAD and without AL had lower spirometric values, poorer quality of life and higher levels of C-reactive protein (CRP), as well as increased cardiovascular risk and more vascular age. In patients with normal spirometry, the presence of SAD was independently associated with pack-years, HDL-cholesterol and CRP levels. Conclusion In patients with IHD, the presence of SAD is common and that it is associated with reduced health status and increased future cardiac risk.	[Llontop, Claudia] Hop La Pitie Salpetriere, Serv Pneumol & Reanimat Med, Paris, France; [Garcia-Quero, Cristina; Casitas, Raquel; Galera, Raul; Iglesias, Alberto; Martinez-Ceron, Elisabet; Garcia-Rio, Francisco] Hosp Univ La Paz, IdiPAZ, Serv Neumol, Madrid, Spain; [Castro, Almudena; Dalmau, Regina] Hosp Univ La Paz, IdiPAZ, Serv Cardiol, Madrid, Spain; [Casitas, Raquel; Galera, Raul; Martinez-Ceron, Elisabet; Garcia-Rio, Francisco] CIBER Enfermedades Resp CIBERES, Madrid, Spain; [Soriano, Joan B.] Hosp Univ Princesa IISP, Inst Invest, Madrid, Spain; [Soriano, Joan B.; Garcia-Rio, Francisco] Univ Autonoma Madrid, Fac Med, Madrid, Spain	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Hospital Universitario La Paz; Hospital Universitario La Paz; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Hospital de La Princesa; Autonomous University of Madrid	Garcia-Rio, F (corresponding author), Hosp Univ La Paz, IdiPAZ, Serv Neumol, Madrid, Spain.; Garcia-Rio, F (corresponding author), CIBER Enfermedades Resp CIBERES, Madrid, Spain.; Garcia-Rio, F (corresponding author), Univ Autonoma Madrid, Fac Med, Madrid, Spain.	fgr01m@gmail.com	Garcia-Rio, Francisco/AAC-9981-2020; Soriano, Joan B/O-1215-2017	Dalmau, Regina/0000-0003-0112-4382; Garcia-Rio, Francisco/0000-0002-7227-2238; Soriano, Joan B/0000-0001-9740-2994	Consejeria de Educacion, Comunidad de Madrid, Spain [S2010/BMD-2542]	Consejeria de Educacion, Comunidad de Madrid, Spain	This work was supported by the Consejeria de Educacion, Comunidad de Madrid, Spain [grant number S2010/BMD-2542].	Berend N, 2016, RESPIROLOGY, V21, P237, DOI 10.1111/resp.12644; Bhatt SP, 2016, AM J RESP CRIT CARE, V194, P178, DOI 10.1164/rccm.201511-2219OC; Burkart KM, 2014, EUR RESPIR J, V43, P1003, DOI 10.1183/09031936.00147612; Crim C, 2011, RESP MED, V105, P1069, DOI 10.1016/j.rmed.2011.01.010; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Franssen FME, 2016, AM J RESP CRIT CARE, V194, P568, DOI 10.1164/rccm.201512-2480OC; Friedman SM, 2011, AM J RESP CRIT CARE, V184, P582, DOI 10.1164/rccm.201011-1909OC; Garcia-Rio F, 2013, ARCH BRONCONEUMOL, V49, P388, DOI 10.1016/j.arbres.2013.04.001; Gimeno D, 2011, EUR J EPIDEMIOL, V26, P135, DOI 10.1007/s10654-010-9526-5; Goldman MD, 2005, RESP PHYSIOL NEUROBI, V148, P179, DOI 10.1016/j.resp.2005.05.026; HALES CA, 1974, NEW ENGL J MED, V290, P761, DOI 10.1056/NEJM197404042901402; Hogg JC, 2013, CHEST, V143, P1436, DOI 10.1378/chest.12-1766; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Martinez FJ, 2008, COPD, V5, P85, DOI 10.1080/15412550801940721; McDonough JE, 2011, NEW ENGL J MED, V365, P1567, DOI 10.1056/NEJMoa1106955; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Mitzner W, 2011, NEW ENGL J MED, V365, P1637, DOI 10.1056/NEJMe1110635; Montalescot G, 2013, EUR HEART J, V34, P2949, DOI 10.1093/eurheartj/eht296; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Onishi K, 2014, INT J CHRONIC OBSTR, V9, P563, DOI 10.2147/COPD.S59962; Oostveen E, 2003, EUR RESPIR J, V22, P1026, DOI 10.1183/09031936.03.00089403; Oostveen E, 2013, EUR RESPIR J, V42, P1513, DOI 10.1183/09031936.00126212; PATAKAS D, 1983, THORAX, V38, P108, DOI 10.1136/thx.38.2.108; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Puhan MA, 2009, LANCET, V374, P704, DOI 10.1016/S0140-6736(09)61301-5; Quanjer PH, 2012, EUR RESPIR J, V40, P1324, DOI 10.1183/09031936.00080312; Rodriguez-Roisin R, 2017, AM J RESP CRIT CARE, V195, P17, DOI 10.1164/rccm.201607-1376PP; Schermer T, 2010, RESPIROLOGY, V15, P975, DOI 10.1111/j.1440-1843.2010.01809.x; Sin Don D, 2005, Proc Am Thorac Soc, V2, P8, DOI 10.1513/pats.200404-032MS; Soriano JB, 2010, CHEST, V137, P333, DOI 10.1378/chest.09-1264; Sorkness RL, 2013, AM J RESP CELL MOL, V49, P808, DOI 10.1165/rcmb.2013-0096OC; Spyratos DG, 2011, HEART LUNG, V40, P97, DOI 10.1016/j.hrtlng.2010.05.055; Timmins SC, 2012, CHEST, V142, P312, DOI 10.1378/chest.11-2169; VANNOORD JA, 1989, EUR RESPIR J, V2, P846; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wada H, 2010, RESPIROLOGY, V15, P1252, DOI 10.1111/j.1440-1843.2010.01854.x; Walter RE, 2008, CHEST, V133, P19, DOI 10.1378/chest.07-0058; Woodruff PG, 2016, NEW ENGL J MED, V374, P1811, DOI 10.1056/NEJMoa1505971; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Young RP, 2016, AM J RESP CELL MOL, V54, P161, DOI 10.1165/rcmb.2015-0250PS	41	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182858	10.1371/journal.pone.0182858	http://dx.doi.org/10.1371/journal.pone.0182858			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846677	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600017
J	Wang, HK; Qu, YY; Dai, B; Zhu, Y; Shi, GH; Zhu, YP; Shen, YJ; Zhang, HL; Ye, DW				Wang, HongKai; Qu, YuanYuan; Dai, Bo; Zhu, Yao; Shi, GuoHai; Zhu, YiPing; Shen, YiJun; Zhang, HaiLiang; Ye, DingWei			PBRM1 regulates proliferation and the cell cycle in renal cell carcinoma through a chemokine/chemokine receptor interaction pathway	PLOS ONE			English	Article							BAF180; EXPRESSION; CHEMOKINES; INDUCTION	PBRM1 is a novel tumor suppressor gene that can inhibit cancer cell proliferation and predict the outcome of renal cell carcinoma (RCC), but its biological role needs further elucidation. We examined expression of the PBRM1 gene in RCC cell lines and the effect of PBRM1 on cell proliferation and cell cycle in RCC ACHN cells. Microarray processing and analysis was used to explore novel pathways involved in tumorigenesis related to PBRM1 knockdown. PBRM1 was expressed at high levels in RCC ACHN cells and lentivirus-mediated PBRM1 knockdown in these cells caused an increase in the proportion of cells in S phase of the cell cycle and promoted in vitro proliferation and migration. In vivo experiments showed that downregulation of PBRM1 promoted tumorigenesis in nude mice. In pathway gene chip analysis, the chemokine/chemokine receptor interaction pathway showed the greatest difference in gene expression upon PBRM1 knockdown. Protein levels of IL6ST and CCL2 were increased, whereas levels of interleukin (IL)-8, IL-6, and CXCL2 were decreased, in knockdown cells. Re-expression of IL-8 in PBRM1 knockdown ACHN cells could significantly decrease cell proliferation/migration and induced cell arrest in the G2/M phase. These findings indicate that PBRM1 alters cell cycle progression and inhibits proliferation and migration of ACHN cells through the chemokine/chemokine receptor pathway.	[Wang, HongKai; Qu, YuanYuan; Dai, Bo; Zhu, Yao; Shi, GuoHai; Zhu, YiPing; Shen, YiJun; Zhang, HaiLiang; Ye, DingWei] Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China; [Wang, HongKai; Qu, YuanYuan; Dai, Bo; Zhu, Yao; Shi, GuoHai; Zhu, YiPing; Shen, YiJun; Zhang, HaiLiang; Ye, DingWei] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China	Fudan University; Fudan University	Zhang, HL; Ye, DW (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Urol, Shanghai, Peoples R China.; Zhang, HL; Ye, DW (corresponding author), Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai, Peoples R China.	zhanghl918@163.com; dwyeli@163.com	Zhang, Hailiang/AAF-4937-2020; Shen, Yi/GRS-3602-2022		National Natural Science Foundation of China [81202004, 81472377]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81202004 and no. 81472377). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brownlee PM, 2014, CELL REP, V6, P973, DOI 10.1016/j.celrep.2014.02.012; Burrows AE, 2010, P NATL ACAD SCI USA, V107, P14280, DOI 10.1073/pnas.1009559107; Capitanio U, 2016, LANCET, V387, P894, DOI 10.1016/S0140-6736(15)00046-X; Cheville JC, 2003, AM J SURG PATHOL, V27, P612, DOI 10.1097/00000478-200305000-00005; Chowdhury B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153718; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Creighton CJ, 2013, NATURE, V499, P43, DOI 10.1038/nature12222; da Costa WH, 2014, BJU INT, V113, pE157, DOI 10.1111/bju.12426; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Jeong SM, 2010, J BIOL CHEM, V285, P2340, DOI 10.1074/jbc.M109.026997; Johrer K, 2005, CLIN CANCER RES, V11, P2459, DOI 10.1158/1078-0432.CCR-04-0405; Kakarougkas A, 2014, MOL CELL, V55, P723, DOI 10.1016/j.molcel.2014.06.028; KASAMA T, 1994, J IMMUNOL, V152, P3559; Khanjani S, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/504952; Klatte T, 2008, J UROLOGY, V179, P61, DOI 10.1016/j.juro.2007.08.148; Li ZH, 2015, EURASIP J ADV SIG PR, DOI 10.1186/s13634-015-0222-1; Masliah-Planchon J, 2015, ANNU REV PATHOL-MECH, V10, P145, DOI 10.1146/annurev-pathol-012414-040445; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Mestas J, 2005, J IMMUNOL, V175, P5351, DOI 10.4049/jimmunol.175.8.5351; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Pan JD, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-56; Parihar Jaspreet S, 2014, Rev Urol, V16, P118; Pawlowski R, 2013, INT J CANCER, V132, pE11, DOI 10.1002/ijc.27822; Payne AS, 2002, J INVEST DERMATOL, V118, P915, DOI 10.1046/j.1523-1747.2002.01725.x; Shuch B, 2015, EUR UROL, V67, P85, DOI 10.1016/j.eururo.2014.04.029; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang Z, 2004, GENE DEV, V18, P3106, DOI 10.1101/gad.1238104; Wente MN, 2006, CANCER LETT, V241, P221, DOI 10.1016/j.canlet.2005.10.041; Wurster AL, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-9; Xia W, 2008, CANCER RES, V68, P1667, DOI 10.1158/0008-5472.CAN-07-5276	34	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180862	10.1371/journal.pone.0180862	http://dx.doi.org/10.1371/journal.pone.0180862			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846693	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600004
J	Rehman, A; Hu, SH; Tnimov, Z; Whitten, AE; King, GJ; Jarrott, RJ; Norwood, SJ; Alexandrov, K; Collins, BM; Christie, MP; Martin, JL				Rehman, Asma; Hu, Shu-Hong; Tnimov, Zakir; Whitten, Andrew E.; King, Gordon J.; Jarrott, Russell J.; Norwood, Suzanne J.; Alexandrov, Kirill; Collins, Brett M.; Christie, Michelle P.; Martin, Jennifer L.			The nature of the Syntaxin4 C-terminus affects Munc18c-supported SNARE assembly	PLOS ONE			English	Article							N-PEPTIDE; MEMBRANE-FUSION; CLOSED-CONFORMATION; MUNC18-1 BINDING; COMPLEX; MODES; TRAFFICKING; ACTIVATION; EXOCYTOSIS; LACKING	Vesicular transport of cellular cargo requires targeted membrane fusion and formation of a SNARE protein complex that draws the two apposing fusing membranes together. Insulin-regulated delivery and fusion of glucose transporter-4 storage vesicles at the cell surface is dependent on two key proteins: the SNARE integral membrane protein Syntaxin4 (Sx4) and the soluble regulatory protein Munc18c. Many reported in vitro studies of Munc18c:Sx4 interactions and of SNARE complex formation have used soluble Sx4 constructs lacking the native transmembrane domain. As a consequence, the importance of the Sx4 C-terminal anchor remains poorly understood. Here we show that soluble C-terminally truncated Sx4 dissociates more rapidly from Munc18c than Sx4 where the C-terminal transmembrane domain is replaced with a T4-lysozyme fusion. We also show that Munc18c appears to inhibit SNARE complex formation when soluble C-terminally truncated Sx4 is used but does not inhibit SNARE complex formation when Sx4 is C-terminally anchored (by a C-terminal His-tag bound to resin, by a C-terminal T4L fusion or by the native C-terminal transmembrane domain in detergent micelles). We conclude that the C- terminus of Sx4 is critical for its interaction with Munc18c, and that the reported inhibitory role of Munc18c may be an artifact of experimental design. These results support the notion that a primary role of Munc18c is to support SNARE complex formation and membrane fusion.	[Rehman, Asma; Hu, Shu-Hong; Whitten, Andrew E.; King, Gordon J.; Jarrott, Russell J.; Christie, Michelle P.; Martin, Jennifer L.] Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia; [Tnimov, Zakir; Norwood, Suzanne J.; Alexandrov, Kirill; Collins, Brett M.] Univ Queensland, Inst Mol Biosci, Div Cell Biol & Mol Med, Brisbane, Qld, Australia; [Rehman, Asma] Inst Biophys, Dulbecco Telethon Inst, Genoa, Italy; [Hu, Shu-Hong; Jarrott, Russell J.; Martin, Jennifer L.] Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia; [Tnimov, Zakir] MRC Lab Mol Biol, Cambridge, England; [Whitten, Andrew E.] Australian Nucl Sci & Technol Org, Lucas Heights, NSW, Australia; [Christie, Michelle P.] St Vincents Inst Med Res, Fitzroy, Vic, Australia	University of Queensland; University of Queensland; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Fondazione Telethon; Dulbecco Telethon Institute (DTI); Griffith University; MRC Laboratory Molecular Biology; Australian Nuclear Science & Technology Organisation; St. Vincent's Institute of Medical Research	Christie, MP; Martin, JL (corresponding author), Univ Queensland, Inst Mol Biosci, Div Chem & Struct Biol, Brisbane, Qld, Australia.; Martin, JL (corresponding author), Griffith Univ, Griffith Inst Drug Discovery, Nathan, Qld, Australia.; Christie, MP (corresponding author), St Vincents Inst Med Res, Fitzroy, Vic, Australia.	mchristie@svi.edu.au; jlm@griffith.edu.au	Tnimov, Zakir/L-3052-2019; Alexandrov, Kirill/A-5830-2013; Rehman, Asma/X-4632-2018; Collins, Brett/J-1563-2014; Martin, Jennifer L./A-6039-2010	Tnimov, Zakir/0000-0003-2466-2220; Alexandrov, Kirill/0000-0002-0957-6511; Rehman, Asma/0000-0002-0653-9053; Collins, Brett/0000-0002-6070-3774; Christie, Michelle/0000-0002-7001-3400; Martin, Jennifer L./0000-0002-9225-8863; Whitten, Andrew/0000-0001-8856-3120; Jarrott, Russell/0000-0003-4326-1203	Australian National Health and Medical Research Council (NHMRC) [535921, 1066069]; NHMRC Peter Doherty Fellowship [569864]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Peter Doherty Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the Australian National Health and Medical Research Council (NHMRC) program grant 535921 and project grant 1066069. At the time of this work, AEW was supported by an NHMRC Peter Doherty Fellowship (569864); KA was an ARC Future Fellow (FT0991611); BMC was an ARC Future Fellow (FT100100027) and is now an NHMRC Career Development Fellow (APP1061574); and JLM was an ARC Australian Laureate Fellow (FL0992138) and honorary NHMRC Fellow (APP455829). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aran V, 2009, BIOCHEM J, V419, P655, DOI 10.1042/BJ20082293; Archbold JK, 2014, CURR OPIN STRUC BIOL, V29, P44, DOI 10.1016/j.sbi.2014.09.003; Brandie FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004074; Burkhardt P, 2008, EMBO J, V27, P923, DOI 10.1038/emboj.2008.37; Burkhardt P, 2011, P NATL ACAD SCI USA, V108, P15264, DOI 10.1073/pnas.1106189108; Chen XC, 2008, J BIOMOL NMR, V41, P43, DOI 10.1007/s10858-008-9239-1; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Christie MP, 2012, P NATL ACAD SCI USA, V109, P9816, DOI 10.1073/pnas.1116975109; Colbert KN, 2013, P NATL ACAD SCI USA, V110, P12637, DOI 10.1073/pnas.1303753110; Deak F, 2009, J CELL BIOL, V184, P751, DOI 10.1083/jcb.200812026; Diao JJ, 2010, ACS CHEM NEUROSCI, V1, P168, DOI 10.1021/cn900034p; Dulubova I, 2007, P NATL ACAD SCI USA, V104, P2697, DOI 10.1073/pnas.0611318104; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gerber SH, 2008, SCIENCE, V321, P1507, DOI 10.1126/science.1163174; Han L, 2009, MOL BIOL CELL, V20, P4962, DOI 10.1091/mbc.E09-08-0712; HATA Y, 1993, NATURE, V366, P347, DOI 10.1038/366347a0; Hu SH, 2011, P NATL ACAD SCI USA, V108, P1040, DOI 10.1073/pnas.0914906108; Latham CF, 2006, TRAFFIC, V7, P1408, DOI 10.1111/j.1600-0854.2006.00474.x; Liang BY, 2013, P NATL ACAD SCI USA, V110, P19384, DOI 10.1073/pnas.1314699110; Ma C, 2011, NAT STRUCT MOL BIOL, V18, P542, DOI 10.1038/nsmb.2047; Malintan NT, 2009, J BIOL CHEM, V284, P21637, DOI 10.1074/jbc.M109.013508; Martin LB, 1998, J BIOL CHEM, V273, P1444, DOI 10.1074/jbc.273.3.1444; Meijer M, 2012, EMBO J, V31, P2156, DOI 10.1038/emboj.2012.72; Misura KMS, 2000, NATURE, V404, P355, DOI 10.1038/35006120; Peng RW, 2010, BIOCHEM J, V431, P353, DOI 10.1042/BJ20100145; Rathore SS, 2010, P NATL ACAD SCI USA, V107, P22399, DOI 10.1073/pnas.1012997108; Rea S, 1998, J BIOL CHEM, V273, P18784, DOI 10.1074/jbc.273.30.18784; Rehman A, 2014, IUCRJ, V1, P505, DOI 10.1107/S2052252514020727; Rehman A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083499; Rickman C, 2007, J BIOL CHEM, V282, P12097, DOI 10.1074/jbc.M700227200; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Rodkey TL, 2008, MOL BIOL CELL, V19, P5422, DOI 10.1091/mbc.E08-05-0538; Schollmeier Y, 2011, J BIOL CHEM, V286, P30582, DOI 10.1074/jbc.M111.269886; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; Shen JS, 2010, J CELL BIOL, V190, P55, DOI 10.1083/jcb.201003148; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Sudhof TC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005637; Tareste D, 2008, P NATL ACAD SCI USA, V105, P2380, DOI 10.1073/pnas.0712125105; TELLAM JT, 1995, J BIOL CHEM, V270, P5857, DOI 10.1074/jbc.270.11.5857; Toonen RFG, 2003, TRENDS CELL BIOL, V13, P177, DOI 10.1016/S0962-8924(03)00031-X; Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Yu HJ, 2013, P NATL ACAD SCI USA, V110, pE3271, DOI 10.1073/pnas.1311232110; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	46	4	4	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183366	10.1371/journal.pone.0183366	http://dx.doi.org/10.1371/journal.pone.0183366			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841669	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700027
J	Cornwell, B; Schneider, JA				Cornwell, Benjamin; Schneider, John A.			Social venue range and referral chain impact: Implications for the sampling of hidden communities	PLOS ONE			English	Article							HIV RISK; BEHAVIORAL SURVEILLANCE; AFFILIATION NETWORKS; RESPONDENT; SEX; MEN; POPULATIONS; METHODOLOGY	Background It has been argued that the success of respondent-driven sampling (RDS) in generating unbiased estimates for epidemiologic outcomes depends on participants' abilities to generate long referral chains. While this is thought to depend on the number of people participants know in the target population, this idea is rarely tested. Furthermore, little attention has been paid to the role of other aspects of social connectedness in recruitment, such as participants' involvement in local clubs and venues. Methods We examine whether the recruitment potential of young Black men who have sex with men (YBMSM) depends on (1) their social network size and (2) their affiliations with a variety of sex venues across geographic areas. We analyze data from a 2014 RDS study of 598 YBMSM on the south side of Chicago. Results Both a participant's personal network size and the number of different types of sex venues with which he was affiliated were significantly positively associated with (1) the total number of recruits in the participant's prospective referral chains and (2) the lengths of those chains. However, only venue affiliation remain significantly associated with recruitment potential in the multivariate model. Conclusions The success of RDS in generating valid samples may depend more on recruiting participants who are involved in multiple venues within the community (i.e., their affiliation networks) than on recruiting those who have large personal social networks.	[Cornwell, Benjamin] Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA; [Schneider, John A.] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Schneider, John A.] Univ Chicago, Dept Publ Hlth Sci, Chicago, IL 60637 USA	Cornell University; University of Chicago; University of Chicago	Cornwell, B (corresponding author), Cornell Univ, Dept Sociol, Uris Hall, Ithaca, NY 14853 USA.	btc49@cornell.edu			NIH [R01 DA039934, R01 MH100021, R01DA033875]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH100021] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JS received funding from NIH - R01 DA039934; R01 MH100021; R01DA033875.	Binson D, 2001, AM J PUBLIC HEALTH, V91, P1482, DOI 10.2105/AJPH.91.9.1482; Borgatti SP, 1997, SOC NETWORKS, V19, P243, DOI 10.1016/S0378-8733(96)00301-2; Burt R. S, 1992, STRUCTURAL HOLES; Chicago Department of Public Health, 2014, HIV STI SURV REP 201; Cornwell B, 2015, INT ENCY SOCIAL BEHA; Frost SDW, 2007, SEX TRANSM INFECT, V83, pI37, DOI 10.1136/sti.2006.023580; Fujimoto K, 2013, SEX TRANSM DIS, V40, P453, DOI 10.1097/OLQ.0b013e31829186e5; Gile KJ, 2011, J AM STAT ASSOC, V106, P135, DOI 10.1198/jasa.2011.ap09475; Gile KJ, 2010, SOCIOL METHODOL, V40, P285, DOI 10.1111/j.1467-9531.2010.01223.x; Goel S, 2010, P NATL ACAD SCI USA, V107, P6743, DOI 10.1073/pnas.1000261107; Grov C, 2012, AIDS BEHAV, V16, P807, DOI 10.1007/s10461-011-9999-6; Heckathorn DD, 2002, SOC PROBL, V49, P11, DOI 10.1525/sp.2002.49.1.11; Heckathorn DD, 1997, SOC PROBL, V44, P174, DOI 10.1525/sp.1997.44.2.03x0221m; Horvath KJ, 2006, HEALTH PSYCHOL, V25, P237, DOI 10.1037/0278-6133.25.2.237; Johnston LG, 2008, AIDS BEHAV, V12, pS131, DOI 10.1007/s10461-008-9413-1; Kuhns LM, 2015, J URBAN HEALTH, V92, P151, DOI 10.1007/s11524-014-9897-0; Laboy M, 2013, SEXUALITIES, V16, P501; Laboy M, ARCH SEX BEHAV; Latapy M, 2008, SOC NETWORKS, V30, P31, DOI 10.1016/j.socnet.2007.04.006; Laumann E. O., 1994, SOCIAL ORG SEXUALITY; Laumann EO, 2005, SEXUAL ORG CITY; Lu X, 2012, J R STAT SOC A STAT, V175, P191, DOI 10.1111/j.1467-985X.2011.00711.x; Magnani R, 2005, AIDS, V19, pS67, DOI 10.1097/01.aids.0000172879.20628.e1; Malekinejad M, 2008, AIDS BEHAV, V12, pS105, DOI 10.1007/s10461-008-9421-1; Mauk D, 2013, ARCH SEX BEHAV, V42, P793, DOI 10.1007/s10508-013-0079-z; McCreesh N, 2012, EPIDEMIOLOGY, V23, P138, DOI 10.1097/EDE.0b013e31823ac17c; McCullagh P, 1989, GEN LINEAR MODELS; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Morineau G, 2012, HARM REDUCT J, V9, DOI 10.1186/1477-7517-9-37; Niekamp AM, 2013, SOC NETWORKS, V35, P223, DOI 10.1016/j.socnet.2013.02.006; Oster AM, 2013, SEX TRANSM DIS, V40, P206, DOI 10.1097/OLQ.0b013e3182840373; Parsons JT, 2002, AIDS CARE, V14, P815, DOI 10.1080/0954012021000031886; Penrod Janice, 2003, J Transcult Nurs, V14, P100, DOI 10.1177/1043659602250614; Reisner SL, 2010, J URBAN HEALTH, V87, P467, DOI 10.1007/s11524-010-9439-3; Rudolph AE, 2014, AIDS BEHAV, V18, P2325, DOI 10.1007/s10461-014-0838-4; Salganik MJ, 2004, SOCIOL METHODOL, V34, P193, DOI 10.1111/j.0081-1750.2004.00152.x; Thiede H, 2009, AM J PUBLIC HEALTH, V99, pS157, DOI 10.2105/AJPH.2006.098582; Volz E, 2008, J OFF STAT, V24, P79; Wang JC, 2005, DRUG ALCOHOL DEPEN, V78, P147, DOI 10.1016/j.drugalcdep.2004.10.011; Youm Y, 2010, SEX TRANSM INFECT, V86, P24, DOI 10.1136/sti.2010.044008	41	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181494	10.1371/journal.pone.0181494	http://dx.doi.org/10.1371/journal.pone.0181494			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832587	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800005
J	Hesen, NA; Riksen, NP; Aalders, B; Ritskes-Hoitinga, M; El Messaoudi, S; Wever, KE				Hesen, Nienke A.; Riksen, Niels P.; Aalders, Bart; Ritskes-Hoitinga, Merel; El Messaoudi, Saloua; Wever, Kimberley E.			A systematic review and meta-analysis of the protective effects of metformin in experimental myocardial infarction	PLOS ONE			English	Review							IMPROVES CARDIAC-FUNCTION; LEFT-VENTRICULAR FUNCTION; ACTIVATED PROTEIN-KINASE; OXIDE SYNTHASE INHIBITOR; REPERFUSION INJURY; SEARCH FILTER; CARDIOPROTECTION; HEART; ISCHEMIA; OUTCOMES	Metformin improves cardiovascular prognosis in patients with diabetes mellitus, compared to alternative glucose-lowering drugs, despite similar glycemic control. Direct cardiovascular protective properties have therefore been proposed, and studied in preclinical models of myocardial infarction. We now aim to critically assess the quality and outcome of these studies. We present a systematic review, quality assessment and meta-analysis of the effect of metformin in animal studies of experimental myocardial infarction. Through a comprehensive search in Pubmed and EMBASE, we identified 27 studies, 11 reporting on ex vivo experiments and 18 reporting on in vivo experiments. The primary endpoint infarct size as percentage of area at risk was significantly reduced by metformin in vivo (MD -18.11 [-24.09,-12.14]) and ex vivo (MD - 18.70[-25.39, -12.02]). Metformin improved the secondary endpoints left ventricular ejection fraction (LVEF) and left ventricular end systolic diameter. A borderline significant effect on mortality was observed, and there was no overall effect on cardiac hypertrophy. Subgroup analyses could be performed for comorbidity and timing of treatment (infarct size and mortality) and species and duration of ischemia (LVEF), but none of these variables accounted for significant amounts of heterogeneity. Reporting of possible sources of bias was extremely poor, including randomization (reported in 63%), blinding (33%), and sample size calculation (0%). As a result, risk of bias (assessed using SYRCLE's risk of bias tool) was unclear in the vast majority of studies. We conclude that metformin limits infarct-size and improves cardiac function in animal models of myocardial infarction, but our confidence in the evidence is lowered by the unclear risk of bias and residual unexplained heterogeneity. We recommend an adequately powered, high quality confirmatory animal study to precede a randomized controlled trial of acute administration of metformin in patients undergoing reperfusion for acute myocardial infarction.	[Hesen, Nienke A.; Aalders, Bart; Ritskes-Hoitinga, Merel; Wever, Kimberley E.] Radboud Univ Nijmegen, SYstemat Review Ctr Lab Anim Experimentat SYRCLE, Dept Hlth Evidence, Nijmegen Inst Hlth Sci,Med Ctr, Nijmegen, Netherlands; [Riksen, Niels P.] Radboud Univ Nijmegen, Dept Internal Med, Med Ctr, Nijmegen, Netherlands; [El Messaoudi, Saloua] Radboud Univ Nijmegen, Dept Cardiol, Med Ctr, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Wever, KE (corresponding author), Radboud Univ Nijmegen, SYstemat Review Ctr Lab Anim Experimentat SYRCLE, Dept Hlth Evidence, Nijmegen Inst Hlth Sci,Med Ctr, Nijmegen, Netherlands.	kim.wever@radboudumc.nl	Riksen, Niels P/G-8260-2015; Ritskes-Hoitinga, J./H-8083-2014; Ritskes-Hoitinga, Merel/GLT-8517-2022; Wever, Kimberley E./D-9705-2016	Riksen, Niels P/0000-0001-9197-8124; Ritskes-Hoitinga, Merel/0000-0001-5315-284X; Wever, Kimberley E./0000-0003-3635-3660; Brouwer, Michelle/0000-0003-4265-0098				Apaijai N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102374; Barreto-Torres G, 2012, INT J MOL SCI, V13, P7694, DOI 10.3390/ijms13067694; Bhamra GS, 2008, BASIC RES CARDIOL, V103, P274, DOI [10.1007/s00395-007-0691-y, 10.1007/s00395-008-0736-x]; Calvert JW, 2008, DIABETES, V57, P696, DOI 10.2337/db07-1098; Cantin B, 2002, J HEART LUNG TRANSPL, V21, P637, DOI 10.1016/S1053-2498(01)00768-9; Chin Jocelyn T., 2011, Yale Journal of Biology and Medicine, V84, P423; de Vries RBM., 2015, EVID BASED PRECLIN M, V2, DOI [10.1002/ebm2.7, DOI 10.1002/EBM2.7]; de Vries RBM, 2014, LAB ANIM-UK, V48, P88, DOI 10.1177/0023677213494374; El Messaoudi S, 2015, LANCET DIABETES ENDO, V3, P615, DOI 10.1016/S2213-8587(15)00121-7; El Messaoudi S, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-013-0314-z; Elmadhun NY, 2014, J SURG RES, V192, P50, DOI 10.1016/j.jss.2014.05.005; Elmadhun NY, 2013, J THORAC CARDIOV SUR, V145, P258, DOI 10.1016/j.jtcvs.2012.09.028; Gundewar S, 2009, CIRC RES, V104, P403, DOI 10.1161/CIRCRESAHA.108.190918; HOLM S, 1979, SCAND J STAT, V6, P65; Hooijmans CR, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-43; Hooijmans CR, 2010, LAB ANIM-UK, V44, P170, DOI 10.1258/la.2010.009117; Inthachai T, 2015, EXP PHYSIOL, V100, P667, DOI 10.1113/EP085108; Jonker SJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150863; Kawabata H, 2003, DIABETES-METAB RES, V19, P299, DOI 10.1002/dmrr.379; Kawabata H, 2003, HYPERTENS RES, V26, P107; King P, 1999, BRIT J CLIN PHARMACO, V48, P643, DOI 10.1046/j.1365-2125.1999.00092.x; Kravchuk E, 2011, EXP DIABETES RES, DOI 10.1155/2011/907496; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lassaletta AD, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0243-y; Legtenberg RJ, 2002, HORM METAB RES, V34, P182, DOI 10.1055/s-2002-26705; Lexis CPH, 2014, JAMA-J AM MED ASSOC, V311, P1526, DOI 10.1001/jama.2014.3315; Lexis CPH, 2012, CARDIOVASC DRUG THER, V26, P417, DOI 10.1007/s10557-012-6413-1; Li J, 2014, CARDIOLOGY, V127, P133, DOI 10.1159/000355574; Macleod MR, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002273; Noyan-Ashraf MH, 2009, DIABETES, V58, P975, DOI 10.2337/db08-1193; Paiva M, 2009, J CARDIOVASC PHARM, V53, P373, DOI 10.1097/FJC.0b013e31819fd4e7; Paiva MA, 2010, CARDIOVASC DRUG THER, V24, P25, DOI 10.1007/s10557-010-6222-3; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Riksen NP, 2014, CURR OPIN LIPIDOL, V25, P446, DOI 10.1097/MOL.0000000000000128; Rongen GA, 2015, EUR J PHARMACOL, V759, P200, DOI 10.1016/j.ejphar.2015.03.035; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Solskov L, 2008, BASIC CLIN PHARMACOL, V103, P82, DOI 10.1111/j.1742-7843.2008.00234.x; Wang XF, 2011, CLIN EXP PHARMACOL P, V38, P94, DOI 10.1111/j.1440-1681.2010.05470.x; Wever KE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142021; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Whittington HJ, 2013, CARDIOVASC DRUG THER, V27, P5, DOI 10.1007/s10557-012-6425-x; Yin MM, 2011, AM J PHYSIOL-HEART C, V301, pH459, DOI 10.1152/ajpheart.00054.2011	43	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183664	10.1371/journal.pone.0183664	http://dx.doi.org/10.1371/journal.pone.0183664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832637	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800078
J	Wang, HS; Williams, D; Griffin, J; Saito, T; Saido, TC; Fraser, PE; Rogaeva, E; Schmitt-Ulms, G				Wang, Hansen; Williams, Declan; Griffin, Jennifer; Saito, Takashi; Saido, Takaomi C.; Fraser, Paul E.; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold			Time-course global proteome analyses reveal an inverse correlation between A beta burden and immunoglobulin M levels in the APP(NL-F) mouse model of Alzheimer disease	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; TRANSGENIC MICE; QUANTITATIVE PROTEOMICS; PEPTIDE IDENTIFICATION; NATURAL ANTIBODIES; PLASMA; PHOSPHORYLCHOLINE; IMPAIRMENT; CLEARANCE; DEFICITS	Alzheimer disease (AD) stands out amongst highly prevalent diseases because there is no effective treatment nor can the disease be reliably diagnosed at an early stage. A hallmark of AD is the accumulation of aggregation-prone amyloid beta peptides (A beta), the main constituent of amyloid plaques. To identify A beta-dependent changes to the global proteome we used the recently introduced APP(NL-F) mouse model of AD, which faithfully recapitulates the A beta pathology of the disease, and a workflow that interrogated the brain proteome of these mice by quantitative mass spectrometry at three different ages. The elevated A beta burden in these mice was observed to cause almost no changes to steady-state protein levels of the most abundant >2,500 brain proteins, including 12 proteins encoded by well-confirmed AD risk loci. The notable exception was a striking reduction in immunoglobulin heavy mu chain (IGHM) protein levels in homozygote APP(NL-F/NL-F) mice, relative to APP(NL-F/wt) littermates. Follow-up experiments revealed that IGHM levels generally increase with age in this model. Although discovered with brain samples, the relative IGHM depletion in APP(NL-F/NL-F) mice was validated to manifest systemically in the blood, and did not extend to other blood proteins, including immunoglobulin G. Results presented are consistent with a cause-effect relationship between the excessive accumulation of A beta and the selective depletion of IGHM levels, which may be of relevance for understanding the etiology of the disease and ongoing efforts to devise blood-based AD diagnostics.	[Wang, Hansen; Williams, Declan; Griffin, Jennifer; Fraser, Paul E.; Rogaeva, Ekaterina; Schmitt-Ulms, Gerold] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Saito, Takashi; Saido, Takaomi C.] RIKEN, Lab Proteolyt Neurosci, Brain Sci Inst, Wako, Saitama, Japan; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Rogaeva, Ekaterina] Univ Toronto, Dept Med Neurol, Toronto, ON, Canada; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	University of Toronto; RIKEN; University of Toronto; University of Toronto; University of Toronto	Schmitt-Ulms, G (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.; Schmitt-Ulms, G (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	g.schmittulms@utoronto.ca	Saido, Takaomi C/N-5472-2015; Sado, Takaomi/AAN-2759-2021; Saito, Takashi/G-2563-2015; Wang, Hansen/H-7703-2014	Saido, Takaomi C/0000-0003-1970-6903; Sado, Takaomi/0000-0003-1970-6903; Saito, Takashi/0000-0002-9659-9251; Wang, Hansen/0000-0003-4414-3372	Canadian Institute for Health Research (CIHR); Canadian Foundation for Innovation; National Institutes of Health	Canadian Institute for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work on this project was supported by an operating grant from the Canadian Institute for Health Research (CIHR) to GS, an infrastructure grant from the Canadian Foundation for Innovation to GS, PF and ER, as well as support from the National Institutes of Health to ER. The authors are most grateful to the Irwin family for their continued support and acknowledge a generous gift by the Rosiak family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bohm C, 2015, MOL CELL NEUROSCI, V66, P3, DOI 10.1016/j.mcn.2015.02.016; Calhoun ME, 1998, NATURE, V395, P755, DOI 10.1038/27351; Chin J, 2011, METHODS MOL BIOL, V670, P169, DOI 10.1007/978-1-60761-744-0_13; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dayon Loic, 2012, Methods Mol Biol, V893, P115, DOI 10.1007/978-1-61779-885-6_9; deCathelineau AM, 2003, ESSAYS BIOCHEM, V39, P105, DOI 10.1042/bse0390105; Eriksson UK, 2010, J ALZHEIMERS DIS, V21, P577, DOI 10.3233/JAD-2010-091705; GAMES D, 1995, NATURE, V373, P523, DOI 10.1038/373523a0; GASKIN F, 1993, J EXP MED, V177, P1181, DOI 10.1084/jem.177.4.1181; Ghani M, 2017, NEURODEGENERATIVE DI; Giedraitis V, 2007, NEUROSCI LETT, V427, P127, DOI 10.1016/j.neulet.2007.09.023; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gunawardana CG, 2015, MOL CELL PROTEOMICS, V14, P3000, DOI 10.1074/mcp.M115.050724; Gustaw-Rothenberg KA, 2010, EXP GERONTOL, V45, P47, DOI 10.1016/j.exger.2009.10.003; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; INOUE T, 1986, J CLIN IMMUNOL, V6, P130, DOI 10.1007/BF00918745; Janus C, 2000, NATURE, V408, P979, DOI 10.1038/35050110; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kawarabayashi T, 2008, CURR OPIN PSYCHIATR, V21, P260, DOI 10.1097/YCO.0b013e3282fc989f; Li QY, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-22; Lindhagen-Persson M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013928; Lundgren DH, 2010, EXPERT REV PROTEOMIC, V7, P39, DOI 10.1586/EPR.09.69; Marcello A, 2011, NEUROBIOL AGING, V32, P1379, DOI 10.1016/j.neurobiolaging.2009.08.011; Marcello A, 2009, J NEURAL TRANSM, V116, P913, DOI 10.1007/s00702-009-0224-y; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Moir RD, 2005, J BIOL CHEM, V280, P17458, DOI 10.1074/jbc.M414176200; Pihlgren M, 2013, BLOOD, V121, P85, DOI 10.1182/blood-2012-02-413831; Prince M, 2015, GLOBAL IMPACT DEMENT; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaw PX, 2000, J CLIN INVEST, V105, P1731, DOI 10.1172/JCI8472; Silajdzic E, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0260-1; Song F, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-5; SturchlerPierrat C, 1997, P NATL ACAD SCI USA, V94, P13287, DOI 10.1073/pnas.94.24.13287; Tahara K, 2006, BRAIN, V129, P3006, DOI 10.1093/brain/awl249; Udan MLD, 2008, J NEUROCHEM, V104, P524, DOI 10.1111/j.1471-4159.2007.05001.x; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Yung S, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/139365; Zhang W, 2012, J NEUROL SCI, V315, P67, DOI 10.1016/j.jns.2011.11.032	43	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182844	10.1371/journal.pone.0182844	http://dx.doi.org/10.1371/journal.pone.0182844			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832675	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800036
J	Nielson, DM; Sederberg, PB				Nielson, Dylan M.; Sederberg, Per B.			MELD: Mixed effects for large datasets	PLOS ONE			English	Article							FREE CLUSTER-ENHANCEMENT; RECOGNITION MEMORY; EEG; INFERENCE; ARTIFACT	Mixed effects models provide significant advantages in sensitivity and flexibility over typical statistical approaches to neural data analysis, but mass univariate application of mixed effects models to large neural datasets is computationally intensive. Threshold free cluster enhancement also provides a significant increase in sensitivity, but requires computationally-intensive permutation-based significance testing. Not surprisingly, the combination of mixed effects models with threshold free cluster enhancement and nonparametric permutation-based significance testing is currently completely impractical. With mixed effects for large datasets (MELD) we circumvent this impasse by means of a singular value decomposition to reduce the dimensionality of neural data while maximizing signal. Singular value decompositions become unstable when there are large numbers of noise features, so we precede it with a bootstrap-based feature selection step employing threshold free cluster enhancement to identify stable features across subjects. By projecting the dependent data into the reduced space of the singular value decomposition we gain the power of a multivariate approach and we can greatly reduce the number of mixed effects models that need to be run, making it feasible to use permutation testing to determine feature level significance. Due to these innovations, MELD is much faster than an element-wise mixed effects analysis, and on simulated data MELD was more sensitive than standard techniques, such as element-wise t-tests combined with threshold-free cluster enhancement. When evaluated on an EEG dataset, MELD identified more significant features than the t-tests with threshold free cluster enhancement in a comparable amount of time.	[Nielson, Dylan M.] NIMH, Data Sci & Sharing Team, Bethesda, MD 20892 USA; [Sederberg, Per B.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Ohio; Ohio State University	Sederberg, PB (corresponding author), Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA.	sederberg.1@osu.edu		Nielson, Dylan/0000-0003-4613-6643	Choose Ohio First for Bioinformatics Scholarship; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002960] Funding Source: NIH RePORTER	Choose Ohio First for Bioinformatics Scholarship; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	D.M.N. was supported by the Choose Ohio First for Bioinformatics Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by an allocation of computing time from the Ohio Supercomputer Center. D.M.N. was supported by the Choose Ohio First for Bioinformatics Scholarship.	Amsel BD, 2011, NEUROPSYCHOLOGIA, V49, P970, DOI 10.1016/j.neuropsychologia.2011.01.003; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bagiella E, 2000, PSYCHOPHYSIOLOGY, V37, P13, DOI 10.1017/S0048577200980648; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Beckmann CF, 2003, NEUROIMAGE, V20, P1052, DOI 10.1016/S1053-8119(03)00435-X; Brysbaert M, 2009, BEHAV RES METHODS, V41, P977, DOI 10.3758/BRM.41.4.977; Castellanos NP, 2006, J NEUROSCI METH, V158, P300, DOI 10.1016/j.jneumeth.2006.05.033; Cnaan A, 1997, STAT MED, V16, P2349, DOI 10.1002/(SICI)1097-0258(19971030)16:20<2349::AID-SIM667>3.0.CO;2-E; Curran T, 2004, NEUROPSYCHOLOGIA, V42, P1088, DOI 10.1016/j.neuropsychologia.2003.12.011; Duzel E, 1997, P NATL ACAD SCI USA, V94, P5973, DOI 10.1073/pnas.94.11.5973; Efron B., 1994, INTRO BOOTSTRAP; Geller AS, 2007, BEHAV RES METHODS, V39, P950, DOI 10.3758/BF03192990; Gershman SJ, 2014, NEUROIMAGE, V98, P91, DOI 10.1016/j.neuroimage.2014.04.055; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mensen A, 2013, NEUROIMAGE, V67, P111, DOI 10.1016/j.neuroimage.2012.10.027; Pernet CR, 2014, J NEUROSCIENCE METHO; Ratcliff R, 2016, NEUROPSYCHOLOGIA, V93, P128, DOI 10.1016/j.neuropsychologia.2016.09.026; Rossion B, 2011, VISION RES, V51, P1297, DOI 10.1016/j.visres.2011.04.003; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; SATTERTHWAITE FE, 1946, BIOMETRICS BULL, V2, P110, DOI 10.2307/3002019; SMITH ME, 1993, J COGNITIVE NEUROSCI, V5, P1, DOI 10.1162/jocn.1993.5.1.1; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Strozak P, 2016, PSYCHOPHYSIOLOGY, V53, P1669, DOI 10.1111/psyp.12730; Waskom M, 2014, SEABORN V0 5 0; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510	30	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0182797	10.1371/journal.pone.0182797	http://dx.doi.org/10.1371/journal.pone.0182797			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829807	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100016
J	Qi, Y; Wang, N; He, YL; Zhang, J; Zou, H; Zhang, WJ; Gu, WY; Huang, YL; Lian, XJ; Hu, JM; Zhao, J; Cui, XB; Pang, L; Li, F				Qi, Yan; Wang, Ning; He, Yonglai; Zhang, Jun; Zou, Hong; Zhang, Wenjie; Gu, Wenyi; Huang, Yalan; Lian, Xiaojuan; Hu, Jianming; Zhao, Jin; Cui, Xiaobin; Pang, Lijuan; Li, Feng			Transforming growth factor-beta 1 signaling promotes epithelial-mesenchymal transition-like phenomena, cell motility, and cell invasion in synovial sarcoma cells	PLOS ONE			English	Article							TGF-BETA; PATHWAY; MORPHOLOGY; FUSION; SNAIL; EMT	The epithelial-to-mesenchymal transition (EMT) and the reverse process (the mesenchymal-to-epithelial transition [MET]) have been shown to be associated with tumor cell invasion and metastasis in different carcinomas. The EMT and MET have recently been shown to play a key role in the pathogenic processes of sarcomas, which are completely different from those of carcinomas. However, the definitive roles of the EMT in the tumorigenesis of synovial sarcomas remain unknown. Here, we explored whether transforming growth factor (TGF)-beta signaling, an important oncogenic event in synovial sarcoma, modulates tumor cell characteristics related to the EMT, such as cell adhesion, migration, invasion, and proliferation. Interestingly, we found that TGF-beta 1 induced tumor cell activation, resulting in a tendency to aggregate and biphasic-like features. TGF-beta 1 also caused downregulation of Ecadherin and subsequent upregulation of N-cadherin, Snail, and Slug, which are responsible for EMT-like phenomena and increased cell motility and invasion. To further investigate the roles of TGF-beta 1 in the EMT, we established a SW982 cell line with stable TGF-beta 1 inhibition viaSB431542. These cells exhibited significantly decreased motility, migration, and proliferation (P = 0.001). Taken together, our data demonstrated that alterations in the TGF-beta 1/Smad signaling pathway could regulate the expression of EMT-related factors and the EMT process, resulting in changes in tumor cell invasion, migration, and proliferation in synovial sarcoma cells. These results may provide a important insights into therapeutic interventions and contribute to the present understanding of tumor progression in patients.	[Qi, Yan; Wang, Ning; Zou, Hong; Zhang, Wenjie; Huang, Yalan; Hu, Jianming; Zhao, Jin; Cui, Xiaobin; Pang, Lijuan; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Qi, Yan; Wang, Ning; Zou, Hong; Zhang, Wenjie; Huang, Yalan; Hu, Jianming; Zhao, Jin; Cui, Xiaobin; Pang, Lijuan; Li, Feng] Shihezi Univ, Sch Med, Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [He, Yonglai] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept ICU Intens Care, Shihezi, Xinjiang, Peoples R China; [Zhang, Jun] Shihezi Univ, Sch Med, Dept Med Genet, Shihezi, Xinjiang, Peoples R China; [Gu, Wenyi] Univ Queensland, AIBN, Brisbane, Qld, Australia; [Lian, Xiaojuan] Jiangjin Cent Hosp Chongqing, Dept Tumor Blood, Chongqing, Peoples R China; [Li, Feng] Capital Med Univ, Dept Pathol, Beijing Chaoyang Hosp, Beijing, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University; University of Queensland; Capital Medical University	Pang, L; Li, F (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China.; Pang, L; Li, F (corresponding author), Shihezi Univ, Sch Med, Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China.; Li, F (corresponding author), Capital Med Univ, Dept Pathol, Beijing Chaoyang Hosp, Beijing, Peoples R China.	ocean123456@163.com; lifeng7855@126.com			National Natural Science Foundation of China [81560053, 81202120]; Outstanding Youth Science and Technology Talent Cultivation Plan of Shihezi University [2015ZRKXJQ07, 2013ZRKXJQ05]; Corps Doctor Foundation [2014BB018]; Research Project of High Level Talents of Shihezi University [RCZX201549]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Outstanding Youth Science and Technology Talent Cultivation Plan of Shihezi University; Corps Doctor Foundation; Research Project of High Level Talents of Shihezi University	This work was supported by grants from the National Natural Science Foundation of China (nos. 81560053 and 81202120), the Outstanding Youth Science and Technology Talent Cultivation Plan of Shihezi University (nos. 2015ZRKXJQ07 and 2013ZRKXJQ05), the Corps Doctor Foundation (no. 2014BB018), and the Research Project of High Level Talents of Shihezi University (no. RCZX201549).	Barham W, 2013, CANCER DISCOV, V3, P1286, DOI 10.1158/2159-8290.CD-13-0138; Barrott JJ, 2015, ONCOTARGET, V6, P22758, DOI 10.18632/oncotarget.4283; Cheng G, 2015, ONCOL REP, V34, P987, DOI 10.3892/or.2015.4053; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Dwivedi SKD, 2015, ONCOTARGET, V6, P14646, DOI 10.18632/oncotarget.3711; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Han KS, 2015, MOL CANCER THER, V14, P1024, DOI 10.1158/1535-7163.MCT-14-0771; Kawai A, 1998, NEW ENGL J MED, V338, P153, DOI 10.1056/NEJM199801153380303; Khan P, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2078-7; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lee KW, 2014, CANCER LETT, V343, P62, DOI 10.1016/j.canlet.2013.09.013; Machado I, 2012, VIRCHOWS ARCH, V461, P333, DOI 10.1007/s00428-012-1288-x; Pickup M, 2013, NAT REV CANCER, V13, P788, DOI 10.1038/nrc3603; Qi Y, 2013, INT J CLIN EXP PATHO, V6, P2787; Saito T, 2006, CANCER RES, V66, P6919, DOI 10.1158/0008-5472.CAN-05-3697; Saito T, 2013, INT J CLIN EXP PATHO, V6, P2272; Wang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121448; Wang YF, 2013, CURR CANCER DRUG TAR, V13, P963, DOI 10.2174/15680096113136660102; Wiles Elizabeth T, 2013, Genes Cancer, V4, P486, DOI 10.1177/1947601913506115; Yamada S, 2014, ANN SURG ONCOL, V21, P3882, DOI 10.1245/s10434-014-3779-2; Yang JL, 2014, EUR J CANCER, V50, P593, DOI 10.1016/j.ejca.2013.11.006; Yang JL, 2010, MOL CELL PROTEOMICS, V9, P2405, DOI 10.1074/mcp.M110.000240	22	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0182680	10.1371/journal.pone.0182680	http://dx.doi.org/10.1371/journal.pone.0182680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829837	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100011
J	Thanapprapasr, K; Nartthanarung, A; Thanapprapasr, D; Jinawath, A				Thanapprapasr, Kamolrat; Nartthanarung, Adisak; Thanapprapasr, Duangmani; Jinawath, Artit			pFAK-Y397 overexpression as both a prognostic and a predictive biomarker for patients with metastatic osteosarcoma	PLOS ONE			English	Article							FOCAL ADHESION KINASE; HIGH-GRADE OSTEOSARCOMA; STUDY-GROUP PROTOCOLS; NEOADJUVANT CHEMOTHERAPY; POOR-PROGNOSIS; HEPATOCELLULAR-CARCINOMA; EXTREMITY OSTEOSARCOMA; SINGLE INSTITUTION; LUNG METASTASIS; CANCER	Focal adhesion kinase (FAK) is important for tumor cell survival and metastasis in various cancers. However, its expression and prognostic value in patients with metastatic osteosarcoma remain unknown. We investigated the expression of FAK and its phosphorylated form (pFAK-Y397) in osteosarcoma tissues from 53 patients by immunohistochemistry and evaluated their correlations with clinicopathologic characteristics and outcomes. The prognostic values were assessed using Kaplan-Meier survival and Cox regression analyses. Total FAK and pFAK-Y397 were overexpressed in 48 (90.6%) and 33 (62.3%) cases, respectively. pFAK-Y397 overexpression was correlated with poor histologic response after neoadjuvant chemotherapy in patients with osteosarcoma regardless of the presence of metastasis or not. Kaplan-Meier curve showed that patients with metastatic osteosarcoma with pFAKY397 overexpression had significantly worse overall survival (OS) than those with non-overexpression (P = 0.044). Multivariate Cox regression analysis confirmed pFAK-Y397 overexpression as an independent prognostic predictor for OS and post metastases OS (PMOS) (P = 0.017, P = 0.006, respectively). Age at diagnosis was also an independent indicator for PMOS (P = 0.003). However, total FAK expression was not correlated with any clinicopathologic characteristics or OS in patients with metastatic osteosarcoma. In conclusion, our findings identified FAK as a common aberrant protein overexpression in various subtypes of osteosarcoma. pFAK-Y397 overexpression can be used as a prognostic biomarker predicting poor OS for patients with metastatic osteosarcoma, and the expression of pFAK-Y397 differentiated good and poor responders to neoadjuvant chemotherapy.	[Thanapprapasr, Kamolrat] Natl Sci & Technol Dev Agcy, Natl Met & Mat Technol Ctr, Biomed Engn Res Unit, Pathum Thani, Thailand; [Nartthanarung, Adisak] Mahidol Univ, Ramathibodi Hosp, Fac Med, Musculoskeletal Oncol Unit,Dept Orthopaed, Bangkok, Thailand; [Thanapprapasr, Duangmani] Bangkok Hosp, Wattanosoth Canc Hosp, Med Ctr, Surg Oncol Unit, Bangkok, Thailand; [Jinawath, Artit] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok, Thailand	National Science & Technology Development Agency - Thailand; National Metal & Materials Technology Center (MTEC); Mahidol University; Mahidol University	Thanapprapasr, K (corresponding author), Natl Sci & Technol Dev Agcy, Natl Met & Mat Technol Ctr, Biomed Engn Res Unit, Pathum Thani, Thailand.; Jinawath, A (corresponding author), Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Pathol, Bangkok, Thailand.	kamolrat.thanapprapasr@nstda.or.th; artitjp@yahoo.com		jinawath, artit/0000-0003-3506-6694	National Metal and Materials Technology Center (MTEC); National Science and Technology Development Agency (NSTDA), Thailand [P1450113]	National Metal and Materials Technology Center (MTEC); National Science and Technology Development Agency (NSTDA), Thailand	This research work was supported by the National Metal and Materials Technology Center (MTEC), National Science and Technology Development Agency (NSTDA), Thailand (Grant No. P1450113). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albasri A, 2014, ANTICANCER RES, V34, P3969; Aust S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-67; Bacci G, 2003, CANCER, V97, P3068, DOI 10.1002/cncr.11456; Bacci G, 2006, CANCER-AM CANCER SOC, V106, P1154, DOI 10.1002/cncr.21724; Bacci G, 2003, ANN ONCOL, V14, P1126, DOI 10.1093/annonc/mdg286; Bielack SS, 2002, J CLIN ONCOL, V20, P776, DOI 10.1200/JCO.20.3.776; Chang HP, 2015, BIOCHEM BIOPH RES CO, V464, P45, DOI 10.1016/j.bbrc.2015.05.092; Ding LS, 2010, TRANSL RES, V156, P45, DOI 10.1016/j.trsl.2010.05.001; Durnali AG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152621; Fujii T, 2004, J HEPATOL, V41, P104, DOI 10.1016/j.jhep.2004.03.029; Gabriel B, 2006, CLIN CANCER RES, V12, P2476, DOI 10.1158/1078-0432.CCR-05-1867; Golubovskaya VM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-769; Gvozdenovic A, 2013, J BONE MINER RES, V28, P838, DOI 10.1002/jbmr.1817; Haddox CL, 2014, SARCOMA, V2014, DOI DOI 10.1155/2014/402509; Han XJ, 2013, EXP MOL PATHOL, V95, P270, DOI 10.1016/j.yexmp.2013.07.008; Harting MT, 2010, J CANCER RES CLIN, V136, P561, DOI 10.1007/s00432-009-0690-5; Iwata S, 2014, ANN SURG ONCOL, V21, P263, DOI 10.1245/s10434-013-3210-4; Janeway KA, 2012, CANCER-AM CANCER SOC, V118, P4597, DOI 10.1002/cncr.27414; Ji HF, 2013, J CANCER RES CLIN, V139, P429, DOI 10.1007/s00432-012-1342-8; Kager L, 2003, J CLIN ONCOL, V21, P2011, DOI 10.1200/JCO.2003.08.132; Kim MS, 2009, ANN ONCOL, V20, P955, DOI 10.1093/annonc/mdn723; Kim MS, 2008, ANN SURG ONCOL, V15, P906, DOI 10.1245/s10434-007-9779-8; Lai IR, 2010, AM J PATHOL, V177, P1629, DOI 10.2353/ajpath.2010.100172; Le Guellec S, 2013, HUM PATHOL, V44, P2149, DOI 10.1016/j.humpath.2013.03.020; Liang SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127236; Mialou V, 2005, CANCER-AM CANCER SOC, V104, P1100, DOI 10.1002/cncr.21263; Miwa S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071362; Murata T, 2008, INT J ONCOL, V32, P791; OWENS LV, 1995, CANCER RES, V55, P2752; Picci P, 2010, ANN ONCOL, V21, P1366, DOI 10.1093/annonc/mdp502; Ren K, 2015, ONCOTARGET, V6, P31085, DOI 10.18632/oncotarget.5044; Ren ZW, 2016, TUMOR BIOL, V37, P5089, DOI 10.1007/s13277-015-4352-8; Salah S, 2015, MOL CLIN ONCOL, V3, P157, DOI 10.3892/mco.2014.426; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Stone RL, 2014, CANCER BIOL THER, V15, P919, DOI 10.4161/cbt.28882; Sulzmaier FJ, 2014, NAT REV CANCER, V14, P598, DOI 10.1038/nrc3792; Thanapprapasr D, 2015, MOL CANCER THER, V14, P1466, DOI 10.1158/1535-7163.MCT-14-1077; Thanapprapasr D, 2012, CURR PHARM DESIGN, V18, P2713, DOI 10.2174/138161212800626201; Wang JL, 2014, TUMOR BIOL, V35, P1551, DOI 10.1007/s13277-013-1214-0; Whelan JS, 2012, ANN ONCOL, V23, P1607, DOI 10.1093/annonc/mdr491; Yoon H, 2015, J HISTOCHEM CYTOCHEM, V63, P114, DOI 10.1369/0022155414561498; Yuan Z, 2010, J CANCER RES CLIN, V136, P1489, DOI 10.1007/s00432-010-0806-y; Zhang M, 2015, INT J CLIN EXP PATHO, V8, P14965; Zhou J, 2013, GYNECOL ONCOL, V128, P344, DOI 10.1016/j.ygyno.2012.07.128	44	19	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e182989	10.1371/journal.pone.0182989	http://dx.doi.org/10.1371/journal.pone.0182989			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846700	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600020
J	Werbowy, O; Werbowy, S; Kaczorowski, T				Werbowy, Olesia; Werbowy, Slawomir; Kaczorowski, Tadeusz			Plasmid stability analysis based on a new theoretical model employing stochastic simulations	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEMS; RECOMBINANT ESCHERICHIA-COLI; COPY NUMBER PLASMIDS; BACTERIAL PLASMIDS; MULTICOPY PLASMIDS; GENETIC ELEMENTS; METABOLIC BURDEN; CARRIES GENES; RNA DECAY; MAINTENANCE	Here, we present a simple theoretical model to study plasmid stability, based on one input parameter which is the copy number of plasmids present in a host cell. The Monte Carlo approach was used to analyze random fluctuations affecting plasmid replication and segregation leading to gradual reduction in the plasmid population within the host cell. This model was employed to investigate maintenance of pEC156 derivatives, a high-copy number ColE1-type Escherichia coli plasmid that carries an EcoVIII restriction-modification system. Plasmid stability was examined in selected Escherichia coli strains (MG1655, wild-type; MG1655 pcnB, and hyper-recombinogenic JC8679 sbcA). We have compared the experimental data concerning plasmid maintenance with the simulations and found that the theoretical stability patterns exhibited an excellent agreement with those empirically tested. In our simulations, we have investigated the influence of replication fails (a parameter) and uneven partition as a consequence of multimer resolution fails (delta parameter), and the post-segregation killing factor (beta parameter). All of these factors act at the same time and affect plasmid inheritance at different levels. In case of pEC156-derivatives we concluded that multimerization is a major determinant of plasmid stability. Our data indicate that even small changes in the fidelity of segregation can have serious effects on plasmid stability. Use of the proposed mathematical model can provide a valuable description of plasmid maintenance, as well as enable prediction of the probability of the plasmid loss.	[Werbowy, Olesia; Kaczorowski, Tadeusz] Univ Gdansk, Dept Microbiol, Fac Biol, Lab Extremophiles Biol, Wita Stwosza 59, Gdansk, Poland; [Werbowy, Slawomir] Univ Gdansk, Fac Math Phys & Informat, Inst Expt Phys, Ul Wita Stwosza 57, Gdansk, Poland	Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; University of Gdansk	Kaczorowski, T (corresponding author), Univ Gdansk, Dept Microbiol, Fac Biol, Lab Extremophiles Biol, Wita Stwosza 59, Gdansk, Poland.	tadeusz.kaczorowski@biol.ug.edu.pl	Kaczorowski, Tadeusz/AAX-2027-2020	Werbowy, Slawomir/0000-0002-5255-9880; Werbowy, Olesia/0000-0002-0194-0673	National Science Center, Poland [N302 654240]	National Science Center, Poland(National Science Centre, Poland)	This work was supported by grant N302 654240 from the National Science Center, Poland.; We want to thank Dr. George Szatmari for critical reading of the manuscript and for providing us with helpful comments and suggestions. This work was supported by grant N302 654240 from the National Science Center, Poland.	Actis Luis A., 1999, Frontiers in Bioscience, V4, pD43, DOI 10.2741/Actis; AUSTIN SJ, 1984, J BACTERIOL, V158, P742, DOI 10.1128/JB.158.2.742-745.1984; BEDBROOK JR, 1976, CELL, V9, P707, DOI 10.1016/0092-8674(76)90134-3; BENTLEY WE, 1993, BIOTECHNOL BIOENG, V42, P222, DOI 10.1002/bit.260420210; BENTLEY WE, 1990, BIOTECHNOL BIOENG, V35, P668, DOI 10.1002/bit.260350704; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOUMA JE, 1988, NATURE, V335, P351, DOI 10.1038/335351a0; Broach JR, 1991, GENOME DYNAMICS PROT, P297; Camps Manel, 2010, Recent Pat DNA Gene Seq, V4, P58; COOPER NS, 1987, J GEN MICROBIOL, V133, P1871; Dahlberg C, 2003, GENETICS, V165, P1641; De Gelder L, 2004, GENETICS, V168, P1131, DOI 10.1534/genetics.104.033431; De Gelder L, 2007, MICROBIOL-SGM, V153, P452, DOI 10.1099/mic.0.2006/001784-0; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; GERDES K, 1986, P NATL ACAD SCI USA, V83, P3116, DOI 10.1073/pnas.83.10.3116; GILLEN JR, 1981, J BACTERIOL, V145, P521, DOI 10.1128/JB.145.1.521-532.1981; Harrison Ellie, 2016, Mob Genet Elements, V6, pe1179074, DOI 10.1080/2159256X.2016.1179074; HE L, 1993, MOL MICROBIOL, V9, P1131, DOI 10.1111/j.1365-2958.1993.tb01243.x; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Hulter N, 2017, CURR OPIN MICROBIOL, V38, P74, DOI 10.1016/j.mib.2017.05.001; JENSEN KF, 1993, J BACTERIOL, V175, P3401, DOI 10.1128/jb.175.11.3401-3407.1993; Joanny G, 2007, NUCLEIC ACIDS RES, V35, P2494, DOI 10.1093/nar/gkm120; KULAKAUSKAS S, 1995, J BACTERIOL, V177, P3451, DOI 10.1128/jb.177.12.3451-3454.1995; KUSANO K, 1995, P NATL ACAD SCI USA, V92, P11095, DOI 10.1073/pnas.92.24.11095; LAMOTTE D, 1994, BIOTECHNOL LETT, V16, P1113, DOI 10.1007/BF01020835; Lau BTC, 2013, PLASMID, V70, P353, DOI 10.1016/j.plasmid.2013.07.007; Leclercq Sebastien, 2012, Mob Genet Elements, V2, P115; LEDERBERG J, 1952, PHYSIOL REV, V32, P403, DOI 10.1152/physrev.1952.32.4.403; LEONARD AC, 1988, J BACTERIOL, V170, P1380, DOI 10.1128/jb.170.3.1380-1383.1988; LEVIN BR, 1993, CURR OPIN GENET DEV, V3, P849, DOI 10.1016/0959-437X(93)90004-9; LIU JD, 1989, J BACTERIOL, V171, P1254, DOI 10.1128/jb.171.3.1254-1261.1989; Lobato-Marquez D, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00066; MASUKATA H, 1990, CELL, V62, P331, DOI 10.1016/0092-8674(90)90370-T; Miller R, 2014, NAT COMMUN, V5, P5208; Million-Weaver S, 2014, PLASMID, V75, P27, DOI 10.1016/j.plasmid.2014.07.002; Mruk I, 2003, APPL ENVIRON MICROB, V69, P2638, DOI 10.1128/AEM.69.5.2638-2650.2003; Mruk I, 2001, PLASMID, V46, P128, DOI 10.1006/plas.2001.1534; Mruk I, 2007, APPL ENVIRON MICROB, V73, P4286, DOI 10.1128/AEM.00119-07; Mruk I, 2014, NUCLEIC ACIDS RES, V42, P70, DOI 10.1093/nar/gkt711; NAITO T, 1995, SCIENCE, V267, P897, DOI 10.1126/science.7846533; Nordstrom K, 2003, PLASMID, V50, P95, DOI 10.1016/S0147-619X(03)00056-8; NORDSTROM K, 1984, MOL GEN GENET, V197, P1, DOI 10.1007/BF00327915; NORDSTROM K, 1989, ANNU REV GENET, V23, P37, DOI 10.1146/annurev.genet.23.1.37; OHARA EB, 1995, P NATL ACAD SCI USA, V92, P1807, DOI 10.1073/pnas.92.6.1807; ORSKOV I, 1973, ACTA PATH MICRO IM B, VB 81, P59; Patnaik PR, 2000, BIOCHEM ENG J, V5, P101, DOI 10.1016/S1369-703X(99)00058-3; Paulsson J, 1998, J MOL BIOL, V279, P73, DOI 10.1006/jmbi.1998.1751; Plotka M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169846; Pogliano J, 2001, P NATL ACAD SCI USA, V98, P4486, DOI 10.1073/pnas.081075798; Ponciano JM, 2007, GENETICS, V176, P957, DOI 10.1534/genetics.106.061937; Regnier P, 2009, PROG MOL BIOL TRANSL, V85, P137, DOI 10.1016/S0079-6603(08)00804-0; Reyes-Lamothe R, 2014, NUCLEIC ACIDS RES, V42, P1042, DOI 10.1093/nar/gkt918; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schmidt T, 1999, ANAL BIOCHEM, V274, P235, DOI 10.1006/abio.1999.4291; Sengupta M, 2011, INFECT IMMUN, V79, P2502, DOI 10.1128/IAI.00127-11; Silva F, 2012, BIOTECHNOL ADV, V30, P691, DOI 10.1016/j.biotechadv.2011.12.005; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; SUMMERS DK, 1991, TRENDS BIOTECHNOL, V9, P273, DOI 10.1016/0167-7799(91)90089-Z; SUMMERS DK, 1984, CELL, V36, P1097, DOI 10.1016/0092-8674(84)90060-6; SUMMERS DK, 1993, MOL MICROBIOL, V8, P1031, DOI 10.1111/j.1365-2958.1993.tb01648.x; Toussaint A, 2002, PLASMID, V47, P26, DOI 10.1006/plas.2001.1552; Vazquez M, 2005, J MOL BIOL, V346, P493, DOI 10.1016/j.jmb.2004.11.055; Venkatesan MM, 2001, INFECT IMMUN, V69, P3271, DOI 10.1128/IAI.69.5.3271-3285.2001; Wang Y, 2017, PLASMID, V91, P2, DOI 10.1016/j.plasmid.2017.02.005; Wang Y, 2016, BIOPHYS J, V111, P467, DOI 10.1016/j.bpj.2016.06.033; Werbowy O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148355; Werbowy O, 2015, PLASMID, V77, P39, DOI 10.1016/j.plasmid.2014.12.002; WILLIAMS DR, 1992, J GEN MICROBIOL, V138, P1; Wrobel B, 1998, GENE, V212, P57, DOI 10.1016/S0378-1119(98)00127-9; XU FF, 1993, P NATL ACAD SCI USA, V90, P6756, DOI 10.1073/pnas.90.14.6756; Yao SY, 2007, J BACTERIOL, V189, P1946, DOI 10.1128/JB.01451-06; Zielenkiewicz U, 2001, ACTA BIOCHIM POL, V48, P1003; Zillig W, 1996, FEMS MICROBIOL REV, V18, P225, DOI 10.1111/j.1574-6976.1996.tb00239.x	73	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183512	10.1371/journal.pone.0183512	http://dx.doi.org/10.1371/journal.pone.0183512			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846713	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600030
J	van den Besselaar, P; Sandstrom, U				van den Besselaar, Peter; Sandstrom, Ulf			Vicious circles of gender bias, lower positions, and lower performance: Gender differences in scholarly productivity and impact	PLOS ONE			English	Article							SCIENTIFIC PRODUCTIVITY; CHARACTERISTIC SCORES; INSTITUTIONS; FACULTY; CAREERS; SCIENCE; PUZZLE; SCALES; WOMEN	It is often argued that female researchers publish on average less than male researchers do, but male and female authored papers have an equal impact. In this paper we try to better understand this phenomenon by (i) comparing the share of male and female researchers within different productivity classes, and (ii) by comparing productivity whereas controlling for a series of relevant covariates. The study is based on a disambiguated Swedish author dataset, consisting of 47,000 researchers and their WoS-publications during the period of 2008-2011 with citations until 2015. As the analysis shows, in order to have impact quantity does make a difference for male and female researchers alike D but women are vastly underrepresented in the group of most productive researchers. We discuss and test several possible explanations of this finding, using a data on personal characteristics from several Swedish universities. Gender differences in age, authorship position, and academic rank do explain quite a part of the productivity differences.	[van den Besselaar, Peter] Vrije Univ Amsterdam, Network Inst, Amsterdam, Netherlands; [van den Besselaar, Peter] Inst Societal Resilience, Amsterdam, Netherlands; [Sandstrom, Ulf] KTH Royal Inst Technol, INDEK, Stockholm, Sweden	Vrije Universiteit Amsterdam; Royal Institute of Technology	van den Besselaar, P (corresponding author), Vrije Univ Amsterdam, Network Inst, Amsterdam, Netherlands.; van den Besselaar, P (corresponding author), Inst Societal Resilience, Amsterdam, Netherlands.	p.a.a.vanden.besselaar@vu.nl	Sandström, Ulf/G-2833-2011; van den Besselaar, Peter A A/E-5938-2013	Sandström, Ulf/0000-0003-1292-8239; van den Besselaar, Peter A A/0000-0002-8304-8565	European Research Council [610706]; Riksbankens Jubileumsfond [P12-1302:1]; ERC through the GendERC [610706]	European Research Council(European Research Council (ERC)European Commission); Riksbankens Jubileumsfond; ERC through the GendERC	This study was supported by the European Research Council, grant 610706; and Riksbankens Jubileumsfond, grant P12-1302:1.; The authors acknowledge support from the ERC through the GendERC grant (610706), and from the Riksbankens Jubileumsfond (P12-1302:1).	ALLISON PD, 1990, AM SOCIOL REV, V55, P469, DOI 10.2307/2095801; [Anonymous], 2015, 23SM1601 UF; [Anonymous], 2008, 23SM0901 UF; Beaudry C, 2016, RES POLICY, V45, P1790, DOI 10.1016/j.respol.2016.05.009; Bland CJ, 2006, J HIGH EDUC, V77, P89, DOI 10.1353/jhe.2006.0002; Cameron EZ, 2016, BIOSCIENCE, V66, P245, DOI 10.1093/biosci/biv173; Carayol N, 2006, INF ECON POLICY, V18, P55, DOI 10.1016/j.infoecopol.2005.09.002; De Solla Price D. J., 1963, LITTLE SCI BIG SCI; Glanzel W, 2011, J INF SCI, V37, P40, DOI 10.1177/0165551510392316; GLANZEL W, 1988, J INFORM SCI, V14, P123, DOI 10.1177/102831538801400208; Gurney T, 2012, SCIENTOMETRICS, V91, P435, DOI 10.1007/s11192-011-0589-1; Klavans R, 2015, P ENID C; Knorr KD, 1980, SCIENTOMETRICS, V47, P515; Lariviere V, 2016, PLOS ONE, V11; Lariviere V, 2015, PRO INT CONF SCI INF, P590; Moed HF., 2005, CITATION ANAL RES EV; Nakhaie MR, 2002, CAN REV SOC ANTHROP, V39, P151; Sandstrom U, 2015, THINKING AHEAD RES F; Sandstrom U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166149; Sandstrom U, 2009, RES EVALUAT, V18, P243, DOI 10.3152/095820209X466892; Sandstrom U, 2009, RES EVALUAT, V18, P135, DOI 10.3152/095820209X441790; Sandstrom Ulf, 2014, CONTEXT COUNTS PATHW, P523; Sheltzer JM, 2014, P NATL ACAD SCI USA, V111, P10107, DOI 10.1073/pnas.1403334111; Soler JM, 2007, SCIENTOMETRICS, V72, P281, DOI 10.1007/s11192-007-1730-z; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Symonds MRE, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000127; van Arensbergen P, 2012, SCIENTOMETRICS, V93, P857, DOI 10.1007/s11192-012-0712-y; van den Besselaar P, 2015, PRO INT CONF SCI INF, P577; van den Besselaar P, 2016, SCIENTOMETRICS, V106, P143, DOI 10.1007/s11192-015-1775-3; van den Besselaar P, 2015, J INFORMETR, V9, P826, DOI 10.1016/j.joi.2015.07.011; Van der Weijden I, 2009, ORG MANAGEMENT ONDER; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Xie Y, 1998, AM SOCIOL REV, V63, P847, DOI 10.2307/2657505; Zhang L, 2010, J INFORMETR, V4, P185, DOI 10.1016/j.joi.2009.11.005	34	59	59	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183301	10.1371/journal.pone.0183301	http://dx.doi.org/10.1371/journal.pone.0183301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841666	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700023
J	Zhang, AL; Wang, DY; Li, JY; Gao, F; Fan, XC				Zhang, Ailian; Wang, Danyang; Li, Jinyao; Gao, Feng; Fan, Xucheng			The effect of aqueous extract of Xinjiang Artemisia rupestris L. (an influenza virus vaccine adjuvant) on enhancing immune responses and reducing antigen dose required for immunity	PLOS ONE			English	Article							CHINESE HERBAL MEDICINE; IN-VIVO; CTL RESPONSE; POLYSACCHARIDES; INFECTION; IMMUNIZATION; ADULTS; CELLS; MACROPHAGES; MATURATION	Potent adjuvant can improve the effectiveness of vaccines and reduce the antigen doses required for initiating the protective immunity. In this study, we identified that aqueous extract of Artemisia rupestris L. (AEAR) could be employed as an efficient adjuvant for influenza virus vaccine (V) to enhance immune responses and reduce the antigen doses required for initiating immunity, without compromising the immune response. ICR mice were subcutaneously co-administrated with V combined with different concentrations of AEAR demonstrated that 300 mu g AEAR could significantly improve hemagglutination inhibition (HI) and increase IgG antibody titers in serum (P < 0.05) and the population of CD4(+)CD44(+) and CD8(+)CD44(+) (P < 0.05). Next, 300 mu g AEAR combined with different doses of V in vivo markedly increased HI and specific IgG antibody level(P < 0.05). It also significantly increased the amount of CD4(+) and CD8(+) T cells, CD4(+)CD44(+) and CD8(+)CD44(+) T cells (P < 0.05), improved lymphocyte proliferation, the secretion of CD4(+) IL-4, CD4(+) IFN-gamma and CD8(+)IFN-gamma (P < 0.05), and the killing efficacy of cytotoxic T lymphocyte (CTL) (P < 0.05). Furthermore, the combination increased the expression of major histocompatibility complex-II (MHC-II) and co-stimulatory molecules including CD40, CD80, and CD86 on dendritic cells (DCs), and downregulated the expression of CD25(+) Foxp3(+)Treg cells (P < 0.05). No significant difference was observed between high-dose V and low-dose AEAR-V (10-fold lower) vaccination group (P > 0.05), indicating a 10-fold reduction of antigen required for V vaccine administration. In conclusion, this study demonstrated that AEAR, as an adjuvant for influenza vaccine, could stimulate potent humoral and cellular immune responses and reduce the antigen dose required for effective vaccination, which were mediated by promoting DCs activation and repressing Treg expression.	[Zhang, Ailian; Wang, Danyang; Li, Jinyao] Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China; [Gao, Feng; Fan, Xucheng] Urumqi Ctr Dis Control & Prevent, Urumqi, Peoples R China	Xinjiang University	Zhang, AL (corresponding author), Xinjiang Univ, Coll Life Sci & Technol, Xinjiang Key Lab Biol Resources & Genet Engn, Urumqi, Peoples R China.	xjzal@163.com			National Natural Science Foundation of China [31360224, 31660259]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31360224,31660259). The funders had no role in study design, data collection and analysis, decision to publish, preparation or of the manuscript.	Akira S, 2011, PHILOS T R SOC B, V366, P2748, DOI 10.1098/rstb.2011.0106; Aucouturier J, 2001, VACCINE, V19, P2666, DOI 10.1016/S0264-410X(00)00498-9; Belska NV, 2010, INT IMMUNOPHARMACOL, V10, P933, DOI 10.1016/j.intimp.2010.05.005; Bijker MS, 2007, J IMMUNOL, V179, P5033, DOI 10.4049/jimmunol.179.8.5033; Chen H, 2016, J MED FOOD, V19, P253, DOI 10.1089/jmf.2015.3513; Ciabattini A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019346; Didierlaurent AM, 2009, J IMMUNOL, V183, P6186, DOI 10.4049/jimmunol.0901474; Feng HB, 2015, INT J BIOL MACROMOL, V78, P405, DOI 10.1016/j.ijbiomac.2015.04.044; Feng HB, 2015, IMMUNOL INVEST, V44, P288, DOI 10.3109/08820139.2015.1009546; Gritzapis AD, 2006, CANCER RES, V66, P5452, DOI 10.1158/0008-5472.CAN-05-4018; Hasegawa H, 2015, CURR TOP MICROBIOL, V386, P371, DOI 10.1007/82_2014_402; Honda-Okubo Y, 2012, VACCINE, V30, P5373, DOI 10.1016/j.vaccine.2012.06.021; Huber VC, 2006, CLIN VACCINE IMMUNOL, V13, P981, DOI 10.1128/CVI.00156-06; Hung YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159333; Jager E, 2000, P NATL ACAD SCI USA, V97, P12198, DOI 10.1073/pnas.220413497; Jiang MH, 2010, EXPERT OPIN THER TAR, V14, P1367, DOI 10.1517/14728222.2010.531010; Jin ML, 2014, INT J BIOL MACROMOL, V64, P257, DOI 10.1016/j.ijbiomac.2013.12.002; Khurana S, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002336; Lai CY, 2010, VACCINE, V28, P4945, DOI 10.1016/j.vaccine.2010.05.037; Li JY, 2015, J ETHNOPHARMACOL, V171, P184, DOI 10.1016/j.jep.2015.05.050; Liu G, 2011, PLOS ONE, V6, P9408; Loubet P, 2016, EXPERT REV VACCINES, V15, P1507, DOI 10.1080/14760584.2016.1188696; Muranski P, 2009, CURR OPIN IMMUNOL, V21, P200, DOI 10.1016/j.coi.2009.02.004; Oleszycka E, 2014, CURR OPIN IMMUNOL, V28, P1, DOI 10.1016/j.coi.2013.12.007; Principi N, 2012, HUM VACC IMMUNOTHER, V8, P59, DOI 10.4161/hv.8.1.18011; Raghavan S, 2010, INFECT IMMUN, V78, P4251, DOI 10.1128/IAI.00536-10; Rechtsteiner G, 2005, J IMMUNOL, V174, P2476, DOI 10.4049/jimmunol.174.5.2476; Rupp R, 2015, VACCINE, V33, P6351, DOI 10.1016/j.vaccine.2015.09.008; Shim BS, 2013, J MICROBIOL, V51, P130, DOI 10.1007/s12275-013-2399-z; Tan S, 2011, J INFECTION, V62, P388, DOI 10.1016/j.jinf.2011.03.002; Tsai TF, 2011, YAKUGAKU ZASSHI, V131, P1733, DOI 10.1248/yakushi.131.1733; Ulrich JT, 2000, J IMMUNOL, V164, P5492, DOI 10.4049/jimmunol.164.10.5492; Walker WT, 2010, EXPERT REV VACCINES, V9, P1385, DOI [10.1586/erv.10.141, 10.1586/ERV.10.141]; Wang M, 2016, INT J BIOL MACROMOL, V6, p809 ; Xu ZT, 2011, AM J CHINESE MED, V39, P15, DOI 10.1142/S0192415X11008610; Yoo DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033678; Yoshida A, 2009, ANTICANCER RES, V29, P4867; Yu HJ, 2013, LANCET, V382, P138, DOI 10.1016/S0140-6736(13)61207-6; Zaragoza B, 2016, NAT MED, V22, P16, DOI 10.1038/nm.4019; Zhang AL, 2017, VACCINE, V35, P1037, DOI 10.1016/j.vaccine.2017.01.002; Zhu FJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00066	41	11	16	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183720	10.1371/journal.pone.0183720	http://dx.doi.org/10.1371/journal.pone.0183720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841693	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700052
J	Challacombe, JF; Pillai, S; Kuske, CR				Challacombe, Jean F.; Pillai, Segaran; Kuske, Cheryl R.			Shared features of cryptic plasmids from environmental and pathogenic Francisella species	PLOS ONE			English	Article							SP NOV.; BACTERIAL CONJUGATION; HELICOBACTER-PYLORI; COMB. NOV; REPLICATION; GENOME; DNA; SYSTEMS; TULARENSIS; SEQUENCES	The Francisella genus includes several recognized species, additional potential species, and other representatives that inhabit a range of incredibly diverse ecological niches, but are not closely related to the named species. Francisella species have been obtained from a wide variety of clinical and environmental sources; documented species include highly virulent human and animal pathogens, fish pathogens, opportunistic human pathogens, tick endosymbionts, and free-living isolates inhabiting brackish water. While more than 120 Francisella genomes have been sequenced to date, only a few contain plasmids, and most of these appear to be cryptic, with unknown benefit to the host cell. We have identified several putative cryptic plasmids in the sequenced genomes of three Francisella novicida and F. novicida-like strains (TX07-6608, AZ06-7470, DPG_3A-IS) and two new Francisella species (F. frigiditurris CA97-1460 and F. opportunistica MA06-7296). These plasmids were compared to each other and to previously identified plasmids from other Francisella species. Some of the plasmids encoded functions potentially involved in replication, conjugal transfer and partitioning, environmental survival (transcriptional regulation, signaling, metabolism), and hypothetical proteins with no assignable functions. Genomic and phylogenetic comparisons of these new plasmids to the other known Francisella plasmids revealed some similarities that add to our understanding of the evolutionary relationships among the diverse Francisella species.	[Challacombe, Jean F.; Kuske, Cheryl R.] Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA; [Pillai, Segaran] US FDA, Off Lab Sci & Safety, Silver Spring, MD USA	United States Department of Energy (DOE); Los Alamos National Laboratory; US Food & Drug Administration (FDA)	Challacombe, JF (corresponding author), Los Alamos Natl Lab, Biosci Div, Los Alamos, NM 87545 USA.	jchalla@lanl.gov						Actis L. A., 1999, FRONT BIOSCI-LANDMRK, V4, P43; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Barkay T, 2005, ASM NEWS, V71, P412; Barns SM, 2005, APPL ENVIRON MICROB, V71, P5494, DOI 10.1128/AEM.71.9.5494-5500.2005; Barns SM, 2005, LAUR062332 DHS; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Bignell C, 2001, J BIOTECHNOL, V91, P1, DOI 10.1016/S0168-1656(01)00293-0; Birdsell Dawn N, 2009, BMC Res Notes, V2, P223, DOI 10.1186/1756-0500-2-223; Brett ME, 2014, CLIN INFECT DIS, V59, P826, DOI 10.1093/cid/ciu430; Brevik OJ, 2011, J APPL MICROBIOL, V111, P1044, DOI 10.1111/j.1365-2672.2011.05133.x; Brown CJ, 2013, APPL ENVIRON MICROB, V79, P7684, DOI 10.1128/AEM.02252-13; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Byrd DR, 1997, MOL MICROBIOL, V25, P1011, DOI 10.1046/j.1365-2958.1997.5241885.x; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; Challacombe J--F, 2016, APPL ENVIRON MICROB, V83; Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/NMETH.2474, 10.1038/nmeth.2474]; Colquhoun DJ, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-47; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Gao F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-79; Gordon D, 2013, BIOINFORMATICS, V29, P2936, DOI 10.1093/bioinformatics/btt515; Grant JR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-202; Han CS, 2006, 2006 INT C BIOINF CO; Heuer H, 2012, FEMS MICROBIOL REV, V36, P1083, DOI 10.1111/j.1574-6976.2012.00337.x; Hofler C, 2004, INT J MED MICROBIOL, V294, P141, DOI 10.1016/j.ijmm.2004.06.021; HOLLIS DG, 1989, J CLIN MICROBIOL, V27, P1601, DOI 10.1128/JCM.27.7.1601-1608.1989; hrman C, 2015, GENOME ANNOUNC, V3; Huber B, 2010, INT J SYST EVOL MICR, V60, P1887, DOI 10.1099/ijs.0.015941-0; Johansson A, 2004, APMIS, V112, P898, DOI 10.1111/j.1600-0463.2004.apm11211-1212.x; Johnson SL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01046-15; Johnson SL, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.00147-15; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Khan SA, 2005, PLASMID, V53, P126, DOI 10.1016/j.plasmid.2004.12.008; KUES U, 1989, MICROBIOL REV, V53, P491; Kugeler KJ, 2008, J CLIN MICROBIOL, V46, P2428, DOI 10.1128/JCM.00698-08; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Kurenbach B, 2006, MICROBIOL-SGM, V152, P637, DOI 10.1099/mic.0.28468-0; Kuske CR, 2006, J FORENSIC SCI, V51, P548, DOI 10.1111/j.1556-4029.2006.00131.x; LANKA E, 1995, ANNU REV BIOCHEM, V64, P141, DOI 10.1146/annurev.bi.64.070195.001041; Larson MA, 2016, INT J SYST EVOL MICR, V66, P1200, DOI 10.1099/ijsem.0.000855; Le Pihive E, 2009, PLASMID, V62, P147, DOI 10.1016/j.plasmid.2009.07.001; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mackiewicz P, 2004, NUCLEIC ACIDS RES, V32, P3781, DOI 10.1093/nar/gkh699; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; ORTEGA S, 1986, NUCLEIC ACIDS RES, V14, P4865, DOI 10.1093/nar/14.12.4865; Ottem KF, 2008, J FISH DIS, V31, P525, DOI 10.1111/j.1365-2761.2008.00930.x; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; Pavlov VM, 1996, FEMS IMMUNOL MED MIC, V13, P253, DOI 10.1111/j.1574-695X.1996.tb00247.x; Petersen JM, 2009, LETT APPL MICROBIOL, V48, P663, DOI 10.1111/j.1472-765X.2009.02589.x; Pomerantsev AP, 2001, PLASMID, V46, P210, DOI 10.1006/plas.2001.1548; Qu PH, 2016, INT J SYST EVOL MICR, V66, P4832, DOI 10.1099/ijsem.0.001437; Qu PH, 2013, INT J SYST EVOL MICR, V63, P3628, DOI 10.1099/ijs.0.049916-0; Rajewska M, 2012, FEMS MICROBIOL REV, V36, P408, DOI 10.1111/j.1574-6976.2011.00300.x; Respicio-Kingry LB, 2013, J CLIN MICROBIOL, V51, P3456, DOI 10.1128/JCM.01105-13; Rydzewski K, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-169; Schroder G, 2002, J BACTERIOL, V184, P2767, DOI 10.1128/JB.184.10.2767-2779.2002; SCOTT JR, 1984, MICROBIOL REV, V48, P1; Siddaramappa S, 2014, GENOME, V57, P137, DOI 10.1139/gen-2013-0231; Siddaramappa S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-422; Siddaramappa S, 2011, APPL ENVIRON MICROB, V77, P5110, DOI 10.1128/AEM.00337-11; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Stothard P, 2005, BIOINFORMATICS, V21, P537, DOI 10.1093/bioinformatics/bti054; Warburton PE, 2004, GENOME RES, V14, P1861, DOI 10.1101/gr.2542904; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	74	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183554	10.1371/journal.pone.0183554	http://dx.doi.org/10.1371/journal.pone.0183554			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837612	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000080
J	Chaston, JJ; Stewart, AG; Christie, M				Chaston, Jessica J.; Stewart, Alastair Gordon; Christie, Mary			Structural characterisation of TNRC6A nuclear localisation signal in complex with importinalpha	PLOS ONE			English	Article							CRYSTALLOGRAPHIC ANALYSIS; TERMINAL DOMAIN; GW182; ARGONAUTE; PROTEINS; IMPORT; RECOGNITION; BINDING; DEADENYLASE; SEQUENCES	The GW182/TNRC6 family of proteins are central scaffolds that link microRNA-associated Argonaute proteins to the cytoplasmic decay machinery for targeted mRNA degradation processes. Although nuclear roles for the GW182/TNRC6 proteins are unknown, recent reports have demonstrated nucleocytoplasmic shuttling activity that utilises the importin-alpha and importin-beta transport receptors for nuclear translocation. Here we describe the structure of mouse importin-alpha in complex with the TNRC6A nuclear localisation signal peptide. We further show that the interactions observed between TNRC6A and importin-alpha are conserved between mouse and human complexes. Our results highlight the ability of monopartite cNLS sequences to maximise contacts at the importin-alpha major binding site, as well as regions outside the main binding cavities.	[Chaston, Jessica J.; Stewart, Alastair Gordon; Christie, Mary] Victor Chang Cardiac Res Inst, Mol Struct & Computat Biol Div, Sydney, NSW, Australia; [Chaston, Jessica J.; Stewart, Alastair Gordon; Christie, Mary] Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; University of New South Wales Sydney	Christie, M (corresponding author), Victor Chang Cardiac Res Inst, Mol Struct & Computat Biol Div, Sydney, NSW, Australia.; Christie, M (corresponding author), Univ New South Wales, St Vincents Clin Sch, Fac Med, Sydney, NSW, Australia.	m.christie@victorchang.edu.au	Stewart, Alastair G/A-7182-2012	Stewart, Alastair/0000-0002-2070-6030; Christie, Mary/0000-0002-0955-665X	Australian Research Council [DE160100608]; National Health and Medical Research Council [APP1090408]	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	MC is the recipient of an Australian Research Council Discovery Early Career Research Award (DE160100608). AGS is the recipient of a National Health and Medical Research Council Peter Doherty Fellowship (APP1090408). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ameres SL, 2013, NAT REV MOL CELL BIO, V14, P475, DOI 10.1038/nrm3611; Ameyar-Zazoua M, 2012, NAT STRUCT MOL BIOL, V19, P998, DOI 10.1038/nsmb.2373; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411; Bernardes NE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128687; Braun JE, 2013, ADV EXP MED BIOL, V768, P147, DOI 10.1007/978-1-4614-5107-5_9; Braun JE, 2011, MOL CELL, V44, P120, DOI 10.1016/j.molcel.2011.09.007; Chang CW, 2013, TRAFFIC, V14, P1144, DOI 10.1111/tra.12098; Chang CW, 2012, PLANT CELL, V24, P5074, DOI 10.1105/tpc.112.104422; Chekulaeva M, 2011, NAT STRUCT MOL BIOL, V18, P1218, DOI 10.1038/nsmb.2166; Chen CYA, 2009, NAT STRUCT MOL BIOL, V16, P1160, DOI 10.1038/nsmb.1709; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen Y, 2014, MOL CELL, V54, P737, DOI 10.1016/j.molcel.2014.03.034; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Christie M, 2013, MOL CELL, V51, P360, DOI 10.1016/j.molcel.2013.07.011; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; de Barros AC, 2016, J MOL BIOL, V428, P2120, DOI 10.1016/j.jmb.2016.01.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eulalio A, 2009, RNA, V15, P1067, DOI 10.1261/rna.1605509; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fabian MR, 2011, NAT STRUCT MOL BIOL, V18, P1211, DOI 10.1038/nsmb.2149; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fontes MRM, 2003, BIOCHEM J, V375, P339, DOI 10.1042/BJ20030510; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Jinek M, 2010, NAT STRUCT MOL BIOL, V17, P238, DOI 10.1038/nsmb.1768; Kalantari R, 2016, NUCLEIC ACIDS RES, V44, P524, DOI 10.1093/nar/gkv1305; Kim MS, 2010, J PATHOL, V221, P139, DOI 10.1002/path.2683; Kobe B, 1999, NAT STRUCT BIOL, V6, P388, DOI 10.1038/7625; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Kozlov G, 2010, J BIOL CHEM, V285, P13599, DOI 10.1074/jbc.M109.089540; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lazzaretti D, 2009, RNA, V15, P1059, DOI 10.1261/rna.1606309; Lian SL, 2009, RNA, V15, P804, DOI 10.1261/rna.1229409; Lott K, 2011, BBA-MOL CELL RES, V1813, P1578, DOI 10.1016/j.bbamcr.2010.10.012; Marfori M, 2012, TRAFFIC, V13, P532, DOI 10.1111/j.1600-0854.2012.01329.x; Mathys H, 2014, MOL CELL, V54, P751, DOI 10.1016/j.molcel.2014.03.036; Matsui M, 2015, SCI REP-UK, V5, DOI 10.1038/srep12855; Matsuura Y, 2005, EMBO J, V24, P3681, DOI 10.1038/sj.emboj.7600843; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nishi K, 2015, NUCLEIC ACIDS RES, V43, P9856, DOI 10.1093/nar/gkv1026; Nishi K, 2013, RNA, V19, P17, DOI 10.1261/rna.034769.112; Ohrt T, 2008, NUCLEIC ACIDS RES, V36, P6439, DOI 10.1093/nar/gkn693; Robb GB, 2005, NAT STRUCT MOL BIOL, V12, P133, DOI 10.1038/nsmb886; Rona G, 2013, ACTA CRYSTALLOGR D, V69, P2495, DOI 10.1107/S0907444913023354; Rudel S, 2008, RNA, V14, P1244, DOI 10.1261/rna.973808; Sankhala RS, 2016, J BIOL CHEM, V291, P11420, DOI 10.1074/jbc.M116.724393; Schraivogel D, 2015, NUCLEIC ACIDS RES, V43, P7447, DOI 10.1093/nar/gkv705; Schraivogel D, 2014, TRENDS BIOCHEM SCI, V39, P420, DOI 10.1016/j.tibs.2014.07.004; Suzawa M, 2017, J MOL BIOL; Takeda AAS, 2011, J MOL BIOL, V412, P226, DOI 10.1016/j.jmb.2011.07.038; Takimoto K, 2009, RNA, V15, P1078, DOI 10.1261/rna.1363109; Teh T, 1999, ACTA CRYSTALLOGR D, V55, P561, DOI 10.1107/S0907444998012943; Till S, 2007, NAT STRUCT MOL BIOL, V14, P897, DOI 10.1038/nsmb1302; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; Weis K, 1996, EMBO J, V15, P1818, DOI 10.1002/j.1460-2075.1996.tb00531.x; Wilson RC, 2013, ANNU REV BIOPHYS, V42, P217, DOI 10.1146/annurev-biophys-083012-130404; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang SNY, 2010, J BIOL CHEM, V285, P19935, DOI 10.1074/jbc.M109.079574; Zipprich JT, 2009, RNA, V15, P781, DOI 10.1261/rna.1448009	71	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183587	10.1371/journal.pone.0183587	http://dx.doi.org/10.1371/journal.pone.0183587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837617	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000083
J	Kiouptsi, K; Grill, A; Mann, A; Dohrmann, M; Lillich, M; Jackel, S; Malinarich, F; Formes, H; Manukyan, D; Subramaniam, S; Khandagale, A; Karwot, C; Thal, SC; Bosmann, M; Scharrer, I; Jurk, K; Reinhardt, C				Kiouptsi, Klytaimnistra; Grill, Alexandra; Mann, Amrit; Doehrmann, Mareike; Lillich, Maren; Jaeckel, Sven; Malinarich, Frano; Formes, Henning; Manukyan, Davit; Subramaniam, Saravanan; Khandagale, Avinash; Karwot, Cornelia; Thal, Serge C.; Bosmann, Markus; Scharrer, Inge; Jurk, Kerstin; Reinhardt, Christoph			Mice deficient in the anti-haemophilic coagulation factor VIII show increased von Willebrand factor plasma levels	PLOS ONE			English	Article							VONWILLEBRAND-FACTOR VWF; RECOMBINANT FACTOR-VIII; ENDOTHELIAL-CELLS; DOMINANT MODIFIER; MOUSE MODEL; A MICE; ADAMTS13; CLEAVAGE; HEMOSTASIS; ACTIVATION	Von Willebrand factor (VWF) is the carrier protein of the anti-haemophilic Factor VIII (FVIII) in plasma. It has been reported that the infusion of FVIII concentrate in haemophilia A patients results in lowered VWF plasma levels. However, the impact of F8-deficiency on VWF plasma levels in F8(-/y) mice is unresolved. In order to avoid confounding variables, we back-crossed F8-deficient mice onto a pure C57BL/6J background and analysed VWF plasma concentrations relative to C57BL/6J WT (F8(+/y)) littermate controls. F8(-/y) mice showed strongly elevated VWF plasma concentrations and signs of hepatic inflammation, as indicated by increased TNF-alpha, CD45, and TLR4 transcripts and by elevated macrophage counts in the liver. Furthermore, immunohistochemistry showed that expression of VWF antigen was significantly enhanced in the hepatic endothelium of F8-/y mice, most likely resulting from increased macrophage recruitment. There were no signs of liver damage, as judged by glutamate-pyruvate-transaminase (GPT) and glutamate-oxalacetate-transaminase (GOT) in the plasma and no signs of systemic inflammation, as white blood cell subsets were unchanged. As expected, impaired haemostasis was reflected by joint bleeding, prolonged in vitro clotting time and decreased platelet-dependent thrombin generation. Our results point towards a novel role of FVIII, synthesized by the liver endothelium, in the control of hepatic low-grade inflammation and VWF plasma levels.	[Kiouptsi, Klytaimnistra; Grill, Alexandra; Mann, Amrit; Doehrmann, Mareike; Lillich, Maren; Jaeckel, Sven; Malinarich, Frano; Formes, Henning; Subramaniam, Saravanan; Khandagale, Avinash; Karwot, Cornelia; Bosmann, Markus; Scharrer, Inge; Jurk, Kerstin; Reinhardt, Christoph] Univ Med Ctr Mainz, CTH, Mainz, Germany; [Jaeckel, Sven; Reinhardt, Christoph] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Mainz, Germany; [Manukyan, Davit] Univ Med Ctr Mainz, Inst Clin Chem & Lab Med, Mainz, Germany; [Thal, Serge C.] Univ Med Ctr Mainz, Dept Anesthesiol, Mainz, Germany	Johannes Gutenberg University of Mainz; German Centre for Cardiovascular Research; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz	Reinhardt, C (corresponding author), Univ Med Ctr Mainz, CTH, Mainz, Germany.; Reinhardt, C (corresponding author), German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Mainz, Germany.	Christoph.Reinhardt@unimedizin-mainz.de	Jurk, Kerstin/AAT-7768-2020; Thal, Serge/D-6593-2011	Thal, Serge/0000-0002-1222-8729; Bosmann, Markus/0000-0003-2773-1033; Subramaniam, Saravanan/0000-0002-0194-5044	CTH Junior Group Translational Research in Thrombosis and Hemostasis (Bundesministerium fur Bildung and Forschung) [01EO1003, 01EO1503]; Boehringer Ingelheim Foundation	CTH Junior Group Translational Research in Thrombosis and Hemostasis (Bundesministerium fur Bildung and Forschung); Boehringer Ingelheim Foundation(Boehringer Ingelheim)	The project was funded by the CTH Junior Group Translational Research in Thrombosis and Hemostasis (Bundesministerium fur Bildung and Forschung 01EO1003 and 01EO1503), and a project grant from the Boehringer Ingelheim Foundation to CR. SJ, AG, and CR are members of Young Deutsches Zentrum fur Herz-Kreislauf-Forschung (DZHK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAHOU WF, 1989, J CLIN INVEST, V84, P56, DOI 10.1172/JCI114169; BI L, 1995, NAT GENET, V10, P119, DOI 10.1038/ng0595-119; Cao WJ, 2008, P NATL ACAD SCI USA, V105, P7416, DOI 10.1073/pnas.0801735105; Cao WJ, 2012, J BIOL CHEM, V287, P32459, DOI 10.1074/jbc.M112.390690; Dargaud Y, 2005, THROMB HAEMOSTASIS, V93, P475, DOI 10.1160/TH04-10-0706; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FURIE B, 1992, NEW ENGL J MED, V326, P800; Groth MP, 2014, LAB ANIM-UK, V48, P225, DOI 10.1177/0023677214524381; Kawecki C, 2017, J THROMB HAEMOST, V15, P1285, DOI 10.1111/jth.13696; LAKICH D, 1993, NAT GENET, V5, P236, DOI 10.1038/ng1193-236; Landskroner KA, 2005, HAEMOPHILIA, V11, P346, DOI 10.1111/j.1365-2516.2005.01104.x; Lau AG, 2014, HAEMOPHILIA, V20, P716, DOI 10.1111/hae.12399; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Macauley MS, 2014, J BIOL CHEM, V289, P35149, DOI 10.1074/jbc.M114.606517; Mohlke KL, 1999, CELL, V96, P111, DOI 10.1016/S0092-8674(00)80964-2; MORFINI M, 1993, THROMB HAEMOSTASIS, V70, P270; Oldenburg J, 2001, THROMB HAEMOSTASIS, V85, P577; Ovlisen K, 2008, J THROMB HAEMOST, V6, P969, DOI 10.1111/j.1538-7836.2008.02954.x; Pendu R, 2006, BLOOD, V108, P3746, DOI 10.1182/blood-2006-03-010322; Roosendaal G, 1999, HISTOPATHOLOGY, V34, P144; Shi QZ, 2010, BLOOD, V116, P3049, DOI 10.1182/blood-2010-03-272419; Skipwith CG, 2010, J BIOL CHEM, V285, P28596, DOI 10.1074/jbc.M110.131227; STEL HV, 1983, NATURE, V303, P530, DOI 10.1038/303530a0; Teyssandier M, 2012, HAEMATOL-HEMATOL J, V97, P1115, DOI 10.3324/haematol.2012.065235; van Bladel ER, 2014, HAEMOPHILIA, V20, P92, DOI 10.1111/hae.12266; Vischer UM, 1998, THROMB HAEMOSTASIS, V80, P1002	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183590	10.1371/journal.pone.0183590	http://dx.doi.org/10.1371/journal.pone.0183590			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837614	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000084
J	Liu, YD; Li, Q; Zhou, ZH; Yeah, YW; Chang, CC; Lee, CY; Tsui, PH				Liu, Yi-Da; Li, Qiang; Zhou, Zhuhuang; Yeah, Yao-Wen; Chang, Chien-Cheng; Lee, Chia-Yen; Tsui, Po-Hsiang			Adaptive ultrasound temperature imaging for monitoring radiofrequency ablation	PLOS ONE			English	Article							THERMAL ABLATION; ECHO-SHIFTS; ATTENUATION; DEPENDENCE; TISSUE	Radiofrequency ablation (RFA) has been widely used as an alternative treatment modality for liver tumors. Monitoring the temperature distribution in the tissue during RFA is required to assess the thermal dosage. Ultrasound temperature imaging based on the detection of echo time shifts has received the most attention in the past decade. The coefficient k, connecting the temperature change and the echo time shift, is a medium-dependent parameter used to describe the confounding effects of changes in the speed of sound and thermal expansion as temperature increases. The current algorithm of temperature estimate based on echo time shift detection typically uses a constant k, resulting in estimation errors when ablation temperatures are higher than 50 degrees C. This study proposes an adaptive-k algorithm that enables the automatic adjustment of the coefficient k during ultrasound temperature monitoring of RFA. To verify the proposed algorithm, RFA experiments on in vitro porcine liver samples (total n = 15) were performed using ablation powers of 10, 15, and 20 W. During RFA, a clinical ultrasound system equipped with a 7.5-MHz linear transducer was used to collect backscattered signals for ultrasound temperature imaging using the constant-and adaptive-k algorithms. Concurrently, an infrared imaging system and thermocouples were used to measure surface temperature distribution of the sample and internal ablation temperatures for comparisons with ultrasound estimates. Experimental results demonstrated that the proposed adaptive-k method improved the performance in visualizing the temperature distribution. In particular, the estimation errors were also reduced even when the temperature of the tissue is higher than 50 degrees C. The proposed adaptive-k ultrasound temperature imaging strategy has potential to serve as a thermal dosage evaluation tool for monitoring high-temperature RFA.	[Liu, Yi-Da; Li, Qiang] Tianjin Univ, Sch Elect Informat Engn, Tianjin, Peoples R China; [Zhou, Zhuhuang] Beijing Univ Technol, Coll Life Sci & Bioengn, Beijing, Peoples R China; [Zhou, Zhuhuang] Beijing Univ Technol, Fac Informat Technol, Beijing, Peoples R China; [Yeah, Yao-Wen; Chang, Chien-Cheng] Natl Taiwan Univ, Inst Appl Mech, Taipei, Taiwan; [Lee, Chia-Yen] Natl United Univ, Dept Elect Engn, Miaoli, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan; [Tsui, Po-Hsiang] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan	Tianjin University; Beijing University of Technology; Beijing University of Technology; National Taiwan University; National United University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Chang, CC (corresponding author), Natl Taiwan Univ, Inst Appl Mech, Taipei, Taiwan.; Tsui, PH (corresponding author), Chang Gung Univ, Coll Med, Dept Med Imaging & Radiol Sci, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Univ, Inst Radiol Res, Med Imaging Res Ctr, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Mem Hosp Linkou, Taoyuan, Taiwan.; Tsui, PH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan.	mechang@iam.ntu.edu.tw; tsuiph@mail.cgu.edu.tw	Tsui, Po-Hsiang/AHE-7426-2022; Zhou, Zhuhuang/M-3301-2019; Li, Qiang/ABF-4555-2021	Zhou, Zhuhuang/0000-0003-0570-8473; Tsui, Po-Hsiang/0000-0002-5604-1800	Ministry of Science and Technology (Taiwan) [MOST 103-2221-E-182-001-MY3]; Chang Gung Memorial Hospital (Linkou, Taiwan) [CIRPD1E0023, CMRPD1G0401, CMRPD1F0311]; National Natural Science Foundation of China [61471263]; Natural Science Foundation of Tianjin, China [16JCZDJC31100]	Ministry of Science and Technology (Taiwan)(Ministry of Science and Technology, TaiwanMinistry of Science, ICT & Future Planning, Republic of Korea); Chang Gung Memorial Hospital (Linkou, Taiwan)(Chang Gung Memorial Hospital); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This work was supported by the Ministry of Science and Technology (Taiwan) under Grant No. MOST 103-2221-E-182-001-MY3 and the Chang Gung Memorial Hospital (Linkou, Taiwan) under Grant Nos. CIRPD1E0023, CMRPD1G0401, and CMRPD1F0311. This work was also supported by the National Natural Science Foundation of China (No. 61471263) and the Natural Science Foundation of Tianjin, China under Grant 16JCZDJC31100. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand A, 2008, ULTRASOUND MED BIOL, V34, P1449, DOI 10.1016/j.ultrasmedbio.2008.02.004; Arthur RM, 2005, INT J HYPERTHER, V21, P589, DOI 10.1080/02656730500159103; Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chiou SY, 2007, J ULTRAS MED, V26, P487, DOI 10.7863/jum.2007.26.4.487; Curley SA, 1999, ANN SURG, V230, P1, DOI 10.1097/00000658-199907000-00001; Damianou CA, 1997, J ACOUST SOC AM, V102, P628, DOI 10.1121/1.419737; Daniels MJ, 2007, PHYS MED BIOL, V52, P4827, DOI 10.1088/0031-9155/52/16/008; Daniels MJ, 2010, PHYS MED BIOL, V55, P4735, DOI 10.1088/0031-9155/55/16/008; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Foiret J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134938; Fuhrmann TA, 2016, J THER ULTRASOUND, V4, P1, DOI 10.1186/s40349-016-0071-x; Geng X, 2014, JPN J APPL PHYS, V53, P205; Goldberg S N, 2001, Eur J Ultrasound, V13, P129, DOI 10.1016/S0929-8266(01)00126-4; Iseki Y, 2016, THERM MED, V32, p17 ; Jiao LR, 1999, AM J SURG, V177, P303, DOI 10.1016/S0002-9610(99)00043-4; Lencioni R, 2007, TECH VASC INTERV RAD, V10, P38, DOI 10.1053/j.tvir.2007.08.006; Lewis MA, 2015, INT J HYPERTHER, V31, P163, DOI 10.3109/02656736.2015.1009180; Liu DL, 2010, IEEE T BIO-MED ENG, V57, P12, DOI 10.1109/TBME.2009.2035103; MaassMoreno R, 1996, J ACOUST SOC AM, V100, P2514, DOI 10.1121/1.417359; MaassMoreno R, 1996, J ACOUST SOC AM, V100, P2522, DOI 10.1121/1.417360; Machi J, 2002, SURG LAPARO ENDO PER, V12, P160, DOI 10.1097/00129689-200206000-00004; Miller NR, 2002, ULTRASOUND MED BIOL, V28, P1319, DOI 10.1016/S0301-5629(02)00608-7; Pernot M, 2004, IEEE T ULTRASON FERR, V51, P606, DOI 10.1109/TUFFC.2004.1320832; Seip R, 1996, IEEE T ULTRASON FERR, V43, P1063, DOI 10.1109/58.542050; Seo CH, 2011, INTERFACE FOCUS, V1, P649, DOI 10.1098/rsfs.2011.0010; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Simon C, 1998, IEEE T ULTRASON FERR, V45, P1088, DOI 10.1109/58.710592; Sokka SD, 2003, PHYS MED BIOL, V48, P223, DOI 10.1088/0031-9155/48/2/306; STRAUBE WL, 1994, ULTRASOUND MED BIOL, V20, P915, DOI 10.1016/0301-5629(94)90051-5; Subramanian S, 2014, ULTRASOUND MED BIOL, V40, P102, DOI 10.1016/j.ultrasmedbio.2013.09.007; Trobaugh JW, 2008, ULTRASOUND MED BIOL, V34, P289, DOI 10.1016/j.ultrasmedbio.2007.07.015; Tsui PH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162488; Tsui PH, 2012, ULTRASONICS, V52, P925, DOI 10.1016/j.ultras.2012.03.001; Tyreus PD, 2004, PHYS MED BIOL, V49, P533, DOI 10.1088/0031-9155/49/4/005; Varghese T, 2002, ULTRASOUND MED BIOL, V28, P321, DOI 10.1016/S0301-5629(01)00519-1; Varghese T, 2002, ULTRASOUND MED BIOL, V28, P1467, DOI 10.1016/S0301-5629(02)00656-7; Wang CY, 2013, MED PHYS, V40, DOI 10.1118/1.4808115	37	14	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182457	10.1371/journal.pone.0182457	http://dx.doi.org/10.1371/journal.pone.0182457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837584	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000018
J	Lopez-de-Andres, A; Hernandez-Barrera, V; Martinez-Huedo, MA; Villanueva-Martinez, M; Jimenez-Trujillo, I; Jimenez-Garcia, R				Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Martinez-Huedo, Maria A.; Villanueva-Martinez, Manuel; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo			Type 2 diabetes and in-hospital complications after revision of total hip and knee arthroplasty	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; UNITED-STATES; ASEPTIC REVISION; GLYCEMIC CONTROL; MORBID-OBESITY; RISK-FACTORS; REPLACEMENT; OUTCOMES; INFECTION; MELLITUS	Purpose To assess the effect of type 2 diabetes (T2DM) on hospital outcomes such as in hospital postoperative complications (IHPC), length of hospital stay (LOHS) and in-hospital mortality (IHM) after the revision of total hip arthroplasty (RHA) and total knee arthroplasty (RKA) and to identify factors associated with IHPC among T2DM patients undergoing these procedures. Methods We performed a retrospective study using the Spanish National Hospital Discharge Database, 2005-2014. We included patients who were >= 40 years old that had undergone RHA and RKA. For each T2DM patient, we selected a year-, gender-, age- and Charlson Comorbidity Index-matched non-diabetic patient. Results We identified 44,055 and 39,938 patients who underwent RHA (12.72% with T2DM) and RKA (15.01% with T2DM). We matched 4,700 and 5,394 couples with RHA and RKA, respectively. Any IHPC was more frequent among patients with T2DM than among non-2DM patients (19% vs. 15.64% in the RHA cohort and 12.94% vs. 11.09% in the RKA cohort, respectively). For patients who underwent RHA, postoperative infection (4.51% vs. 2.94%, p<0.001), acute post-hemorrhagic anemia (9.53% vs. 7.70%, p<0.001), mean LOHS and IHM were significantly higher in patients with T2DM. Among RKA patients, the incidence of acute posthemorrhagic anemia (7.21% vs. 5.62%; p = 0.001) and urinary tract infection (1.13% vs. 0.72%; p = 0.029) was significantly higher in patients with diabetes. Older age, obesity, infection due to internal joint prosthesis, myocardial infarction, congestive heart failure, mild liver disease and renal disease and emergency room admission were significantly associated with a higher risk of IHPC in T2DM patients. IHPC decreased over time only in T2DM patients who underwent RHA (OR 0.94, 95% CI 0.89-0.98). Conclusions Patients with T2DM who underwent RHA and RKA procedures had more IHPC after controlling for the effects of possible confounders. LOHS and IHM were also higher among RHA patients with diabetes. Older age, comorbidity, obesity and emergency room admission were strong predictors of IHPC in diabetic patients.	[Lopez-de-Andres, Ana; Hernandez-Barrera, Valentin; Jimenez-Trujillo, Isabel; Jimenez-Garcia, Rodrigo] Univ Rey Juan Carlos, Med & Surg Psychol Prevent Med & Publ Hlth Med Mi, Comunidad Madrid, Mostoles, Spain; [Martinez-Huedo, Maria A.] Hosp Univ La Paz, Prevent Med Dept, Madrid, Spain; [Villanueva-Martinez, Manuel] Hosp Beata Maria, Unit Revis Hip & Knee Arthroplasty, Unidad Recambios Protes, Madrid, Spain	Universidad Rey Juan Carlos; Hospital Universitario La Paz	Jimenez-Garcia, R (corresponding author), Univ Rey Juan Carlos, Med & Surg Psychol Prevent Med & Publ Hlth Med Mi, Comunidad Madrid, Mostoles, Spain.	rodrigo.jimenez@urjc.es	Lopez-de-Andres, Ana/D-4498-2019; Jimenez-Trujillo, Isabel/AAP-7746-2021; Jimenez-Garcia, Rodrigo/D-4953-2019; Lopez-de-Andres, Ana/AAD-8703-2019	Lopez-de-Andres, Ana/0000-0001-5551-5181; Jimenez-Trujillo, Isabel/0000-0002-9394-6799; Jimenez-Garcia, Rodrigo/0000-0001-5906-9393; Lopez-de-Andres, Ana/0000-0001-5551-5181; Hernandez-Barrera, Valentin/0000-0001-5790-1959	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) - European Union through Fondo Europeo de Desarrollo Regional (FEDER) [PI13/00118, PI16/00564]; Grupo de Excelencia Investigadora URJC-Banco Santander [30VCPIGI03]	FIS (Fondo de Investigaciones Sanitarias-Health Research Fund) - European Union through Fondo Europeo de Desarrollo Regional (FEDER); Grupo de Excelencia Investigadora URJC-Banco Santander	This study is part of research funded by the FIS (Fondo de Investigaciones Sanitarias-Health Research Fund, grant no. PI13/00118 & grant no. PI16/00564, Institute de Salud Carlos III) co-financed by the European Union through the Fondo Europeo de Desarrollo Regional (FEDER, "Una manera de hacer Europa") and by the Grupo de Excelencia Investigadora URJC-Banco Santander No30VCPIGI03: Investigacion traslacional en el proceso de salud - enfermedad (ITPSE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antwi-Bafour Samuel, 2016, J Med Case Rep, V10, P110, DOI 10.1186/s13256-016-0889-4; Basilico FC, 2008, ARTHRITIS RHEUM, V58, P1915, DOI 10.1002/art.23607; Bolognesi MP, 2008, J ARTHROPLASTY, V23, P92, DOI 10.1016/j.arth.2008.05.012; Chun Young-Soo, 2014, Hip Pelvis, V26, P136, DOI 10.5371/hp.2014.26.3.136; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Dieterich JD, 2014, J ARTHROPLASTY, V29, P2163, DOI 10.1016/j.arth.2014.07.004; Dronge AS, 2006, ARCH SURG-CHICAGO, V141, P375, DOI 10.1001/archsurg.141.4.375; Ekinci EI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0168471; Fu AZ, 2014, J DIABETES COMPLICAT, V28, P805, DOI 10.1016/j.jdiacomp.2014.06.009; George J, 2017, CLIN ORTHOP RELAT RE; Hamilton DF, 2015, BONE JOINT J, V97B, P723, DOI 10.1302/0301-620X.97B6.35185; Houdek MT, 2015, J BONE JOINT SURG AM, V97A, P326, DOI 10.2106/JBJS.N.00515; Jain Ravi Kant, 2015, Eur J Orthop Surg Traumatol, V25, P251, DOI 10.1007/s00590-014-1475-3; Jamsen E, 2013, ANN RHEUM DIS, V72, P1975, DOI 10.1136/annrheumdis-2012-202064; Jiang Jason, 2016, CMAJ Open, V4, pE646, DOI 10.9778/cmajo.20160128; Kamath AF, 2015, J ARTHROPLASTY, V30, P1492, DOI 10.1016/j.arth.2015.03.035; Khokhar B, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009952; King KB, 2013, CLIN ORTHOP RELAT R, V471, P3049, DOI 10.1007/s11999-013-3026-3; Koenig K, 2012, J ARTHROPLASTY, V27, P1402, DOI 10.1016/j.arth.2011.11.013; Kowalik TD, 2016, J AM ACAD ORTHOP SUR, V24, P393, DOI 10.5435/JAAOS-D-15-00596; Kunutsor SK, 2016, PLOS ONE, V11, DOI [10.1371/journal.pone.0150866, 10.1371/journal.pone.0151537]; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Lakomkin N, 2016, J ARTHROPLASTY; Liodakis E, 2015, J ARTHROPLASTY, V30, P1868, DOI 10.1016/j.arth.2015.05.029; Lohmander LS, 2006, ACTA ORTHOP, V77, P733, DOI 10.1080/17453670610012917; Lubbeke A, 2008, ARTHRIT RHEUM-ARTHR, V59, P738, DOI 10.1002/art.23562; Marchant MH, 2009, J BONE JOINT SURG AM, V91A, P1621, DOI 10.2106/JBJS.H.00116; Martinez- Huedo MA, 2008, EUR J ORTHOP SURG TR, V23, P53, DOI DOI 10.1007/S00590-011-0915-6; Ministerio de Sanidad, SERV SOC IG REG ALT; Namba RS, 2013, J ARTHROPLASTY, V28, P122, DOI 10.1016/j.arth.2013.04.050; Parvizi J, 2013, BONE JOINT J, V95B, P1450, DOI 10.1302/0301-620X.95B11.33135; Pedersen AB, 2010, J BONE JOINT SURG BR, V92B, P929, DOI 10.1302/0301-620X.92B7.24461; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Ribera A, 2008, REV ESP CARDIOL, V61, P843, DOI 10.1016/S1885-5857(08)60232-7; Sams JD, 2012, J ARTHROPLASTY, V27, P758, DOI 10.1016/j.arth.2011.09.007; Sams JD, 2010, J ARTHROPLASTY, V25, P826, DOI 10.1016/j.arth.2010.01.097; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmolders J, 2015, INT ORTHOP, V39, P1771, DOI 10.1007/s00264-015-2810-y; Soriguer F, 2012, DIABETOLOGIA, V55, P88, DOI 10.1007/s00125-011-2336-9; Villanueva-Martinez M, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-37; Viola J, 2015, J ARTHROPLASTY, V30, P846, DOI 10.1016/j.arth.2014.12.026; Watts CD, 2015, CLIN ORTHOP RELAT R, V473, P2621, DOI 10.1007/s11999-015-4283-0; Wild Sarah, 2016, J Diabetes Sci Technol, V10, P1073, DOI 10.1177/1932296816645120; Yang Z, 2014, BONE JOINT J, V96B, P1637, DOI 10.1302/0301-620X.96B12.34378; Zmistowski B, 2013, J ARTHROPLASTY, V28, P1486, DOI 10.1016/j.arth.2013.02.021	46	19	19	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183796	10.1371/journal.pone.0183796	http://dx.doi.org/10.1371/journal.pone.0183796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837689	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000123
J	Jee, K; Rodrigues, M; Kashiwabuchi, F; Applewhite, BP; Han, I; Lutty, G; Goldberg, MF; Semenza, GL; Montaner, S; Sodhi, A				Jee, Kathleen; Rodrigues, Murilo; Kashiwabuchi, Fabiana; Applewhite, Brooks P.; Han, Ian; Lutty, Gerard; Goldberg, Morton F.; Semenza, Gregg L.; Montaner, Silvia; Sodhi, Akrit			Expression of the angiogenic mediator, angiopoietin-like 4, in the eyes of patients with proliferative sickle retinopathy	PLOS ONE			English	Article							RANDOMIZED CLINICAL-TRIAL; INTRAVITREAL BEVACIZUMAB AVASTIN; DIABETIC-RETINOPATHY; CELL RETINOPATHY; PANRETINAL PHOTOCOAGULATION; UP-REGULATION; RANIBIZUMAB; PROMOTE; VEGF	The recent success of therapies directly targeting the angiogenic mediator, vascular endothelial growth factor (VEGF), for the treatment of proliferative diabetic retinopathy has encouraged clinicians to extend the use of anti-VEGF therapies for the treatment of another ischemic retinal vascular disease, proliferative sickle cell retinopathy (PSR), the most common cause of irreversible blindness in patients with sickle cell disease. However, results from case reports evaluating anti-VEGF therapies for PSR have been mixed. This highlights the need to identify alternative therapeutic targets for the treatment of retinal neovascularization in sickle cell patients. In this regard, angiopoietin-like 4 (ANGPTL4) is a novel angiogenic factor regulated by the transcription factor, hypoxia-inducible factor 1, the master regulator of angiogenic mediators (including VEGF) in ischemic retinal disease. In an effort to identify alternative targets for the treatment of sickle cell retinopathy, we have explored the expression of ANGPTL4 in the eyes of patients with PSR. To this end, we examined expression and localization of ANGPTL4 by immunohistochemistry in autopsy eyes from patients with known PSR (n = 5 patients). Complementary studies were performed using enzyme-linked immunosorbent assays in aqueous (n = 8; 7 patients, 2 samples from one eye of same patient) and vitreous (n = 3 patients) samples from a second group of patients with active PSR. We detected expression of ANGPTL4 in neovascular tissue and in the ischemic inner retina in PSR, but not control, eyes. We further observed elevated expression of ANGPTL4 in the aqueous and vitreous of PSR patients compared to controls. These results suggest that ANGPTL4 could contribute to the development of retinal neovascularization in sickle cell patients and could therefore be a therapeutic target for the treatment of PSR.	[Jee, Kathleen; Rodrigues, Murilo; Kashiwabuchi, Fabiana; Applewhite, Brooks P.; Han, Ian; Lutty, Gerard; Goldberg, Morton F.; Sodhi, Akrit] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Radiat Oncol, Baltimore, MD USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Semenza, Gregg L.] Johns Hopkins Univ, Sch Med, Dept Med Genet, Baltimore, MD 21205 USA; [Montaner, Silvia] Sch Dent, Dept Oncol & Diagnost Sci, Baltimore, MD USA; [Montaner, Silvia] Sch Med, Dept Pathol, Baltimore, MD USA; [Montaner, Silvia] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Sodhi, A (corresponding author), Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA.	asodhi1@jhmi.edu	Rodrigues, Murilo W/GRR-8095-2022; Rodrigues, Murilo/P-3222-2019; Junior, Murilo Wendeborn Rodrigues/M-4125-2019	Rodrigues, Murilo W/0000-0001-9734-8617; Rodrigues, Murilo/0000-0001-9734-8617; Applewhite, Brooks/0000-0001-6514-2542; Han, Ian/0000-0002-2371-727X	National Eye Institute, National Institutes of Health [K08-EY021189]; Research to Prevent Blindness; Research to Prevent Blindness, Inc.; NATIONAL EYE INSTITUTE [K08EY021189] Funding Source: NIH RePORTER	National Eye Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute hips//nei.nih.gov/, National Institutes of Health Grant, K08-EY021189 (AS) and an Unrestricted Grant from Research to Prevent Blindness (AS) https//www.rpbusa.org/rpb/?. The funding organization had no role in the design or conduct of this research.; The authors would like to thank Drs. Howard Ying, Sharon Solomon, James Handa, and Adrienne Scott for providing aqueous and vitreous samples for this study. This work was supported by the National Eye Institute, National Institutes of Health Grant, K08-EY021189 (AS), and an Unrestricted Grant from Research to Prevent Blindness (AS). Dr. Sodhi gratefully acknowledges the support he receives as a Special Scholar Award recipient from Research to Prevent Blindness, Inc.	AIELLO LP, 1994, NEW ENGL J MED, V331, P1480, DOI 10.1056/NEJM199412013312203; Babalola OE, 2010, BMJ CASE REP, V2010; Babapoor-Farrokhran S, 2015, P NATL ACAD SCI USA, V112, pE3030, DOI 10.1073/pnas.1423765112; Bender M.A., 1993, GENEREVIEWS; Bressler NM, 2011, NEW ENGL J MED, V365, P1520, DOI 10.1056/NEJMct0908432; Bressler SB, 2013, JAMA OPHTHALMOL, V131, P1033, DOI 10.1001/jamaophthalmol.2013.4154; COHEN SB, 1986, OPHTHALMIC SURG LAS, V17, P369; FARBER MD, 1991, ARCH OPHTHALMOL-CHIC, V109, P363, DOI 10.1001/archopht.1991.01080030065040; Goldberg M F, 1976, Birth Defects Orig Artic Ser, V12, P475; GOLDBERG MF, 1971, AM J OPHTHALMOL, V71, P649, DOI 10.1016/0002-9394(71)90429-6; Goldberg MF, 1977, T SECT OPHTHALMOL AM, V83; Gross JG, 2015, JAMA-J AM MED ASSOC, V314, P2137, DOI 10.1001/jama.2015.15217; Hahn P, 2012, CURR OPIN OPHTHALMOL, V23, P175, DOI 10.1097/ICU.0b013e3283524148; Hellstrom A, 2013, LANCET, V382, P1445, DOI 10.1016/S0140-6736(13)60178-6; Hu K, 2016, ONCOTARGET, V7, P7816, DOI 10.18632/oncotarget.6868; Ip MS, 2015, OPHTHALMOLOGY, V122, P367, DOI 10.1016/j.ophtha.2014.08.048; JAMPOL L M, 1991, Eye (London), V5, P260; MCLEOD DS, 1993, ARCH OPHTHALMOL-CHIC, V111, P1234, DOI 10.1001/archopht.1993.01090090086026; Montaner S, 2003, CANCER CELL, V3, P23, DOI 10.1016/S1535-6108(02)00237-4; Moshiri Ala, 2013, Retin Cases Brief Rep, V7, P204, DOI 10.1097/ICB.0b013e3182845d31; Myint KT, 2015, COCHRANE DB SYST REV, V10; Rodrigues M, 2016, INVEST OPHTH VIS SCI, V57, P6739, DOI 10.1167/iovs.16-19513; Shaikh S, 2008, INDIAN J OPHTHALMOL, V56, P259, DOI 10.4103/0301-4738.40380; Siqueira RC, 2006, ACTA OPHTHALMOL SCAN, V84, P834, DOI 10.1111/j.1600-0420.2006.00779.x; Sodhi A, 2015, JAMA OPHTHALMOL, V133, P1375, DOI 10.1001/jamaophthalmol.2015.3723; Xin XB, 2013, P NATL ACAD SCI USA, V110, pE3425, DOI 10.1073/pnas.1217091110	26	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183320	10.1371/journal.pone.0183320	http://dx.doi.org/10.1371/journal.pone.0183320			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832635	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800056
J	Lance, RM; Stalcup, L; Wojtylak, B; Bass, CR				Lance, Rachel M.; Stalcup, Lucas; Wojtylak, Brad; Bass, Cameron R.			Air blast injuries killed the crew of the submarine H. L. Hunley	PLOS ONE			English	Article							FLUID-STRUCTURE INTERACTION; FREESTANDING PLATES; CHEMICAL EXPLOSIVES; DETONATION; WAVES; RISK	The submarine H. L. Hunley was the first submarine to sink an enemy ship during combat; however, the cause of its sinking has been a mystery for over 150 years. The Hunley set off a 61.2 kg (135 lb) black powder torpedo at a distance less than 5 m (16 ft) off its bow. Scaled experiments were performed that measured black powder and shock tube explosions underwater and propagation of blasts through a model ship hull. This propagation data was used in combination with archival experimental data to evaluate the risk to the crew from their own torpedo. The blast produced likely caused flexion of the ship hull to transmit the blast wave; the secondary wave transmitted inside the crew compartment was of sufficient magnitude that the calculated chances of survival were less than 16% for each crew member. The submarine drifted to its resting place after the crew died of air blast trauma within the hull.	[Lance, Rachel M.] Naval Surface Warfare Ctr, Panama City Div, Code Underwater Syst Dev & Acquisit E15, Panama City, FL 32407 USA; [Lance, Rachel M.; Bass, Cameron R.] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA; [Stalcup, Lucas] Duke Univ, Sch Med, Durham, NC USA; [Wojtylak, Brad] Bur Alcohol Tobacco Firearms & Explos, Wilmington, NC USA	Duke University; Duke University	Lance, RM (corresponding author), Naval Surface Warfare Ctr, Panama City Div, Code Underwater Syst Dev & Acquisit E15, Panama City, FL 32407 USA.; Lance, RM (corresponding author), Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA.	Rachel.lance@duke.edu		Lance, Rachel/0000-0003-3103-533X	Josiah Charles Trent Memorial Foundation Endowment Fund at Duke University; DoD SMART Scholarship Program; US Army MURI program [U Penn prime-W911NF-10-1-0526]; Hagley Library's Center for the History of Business, Technology and Society	Josiah Charles Trent Memorial Foundation Endowment Fund at Duke University; DoD SMART Scholarship Program; US Army MURI program; Hagley Library's Center for the History of Business, Technology and Society	We would like to gratefully acknowledge funding and support from the Josiah Charles Trent Memorial Foundation Endowment Fund at Duke University for directly funding this research. We would also like to acknowledge funding from the DoD SMART Scholarship Program for the research and education of Rachel M. Lance. We also gratefully acknowledge funding provided by the US Army MURI program (U Penn prime-W911NF-10-1-0526) partially supporting Cameron Bass. In addition, we would like to thank the Hagley Library's Center for the History of Business, Technology and Society for funding via an Exploratory Research Grant that enabled the historical black powder research.	Alexander WA, 1902, DAILY PICAYUNE  0629; Anderson J.D., 2004, MODERN COMPRESSIBLE; ZUCKERMAN S., 1941, Proceedings of the Royal Society of Medicine, V31, P171; [Anonymous], 2001, HUNL ONL HAD CREW 8; [Anonymous], 2001, 8 HUNL CREWM FOUND; [Anonymous], BLAST OVERPRESSURE S; [Anonymous], 2002, HUNL CREW REM STUD S; ARONS AB, 1954, J ACOUST SOC AM, V26, P343, DOI 10.1121/1.1907339; Bass CR, 2008, J TRAUMA, V65, P604, DOI 10.1097/TA.0b013e3181454ab4; Bass Cameron R Dale, 2005, Int J Occup Saf Ergon, V11, P347; BJORNO L, 1976, ULTRASONICS, V14, P263, DOI 10.1016/0041-624X(76)90033-0; BJORNO L, 1970, J ENG IND, V92, P29, DOI 10.1115/1.3427715; Bowen IG, 1966, BIOPHYSICAL MECH SCA; Bowen IG., 1968, ESTIMATE MANS TOLERA, P35; Brown JA, 1967, EXPLOSION PHENOMENA; Cole R.H., 1948, UNDERWATER EXPLOSION; Cooper P. W., 1994, COMMENTS TNT EQUIVAL; Cooper PW., 1996, EXPLOSIVES ENG; Crocker M.J., 1998, HDB ACOUSTICS; Dobashi R, 2011, P COMBUST INST, V33, P2295, DOI 10.1016/j.proci.2010.07.059; duPont, 1969, DUPONT BLASTERS HDB; duPont L, L DUPONT PAPERS; Ermolaev BS, 2010, RUSS J PHYS CHEM B+, V4, P428, DOI 10.1134/S1990793110030103; Fatt MSH, 1997, J PRESS VESS-T ASME, V119, P467; FOTH, 2012, THE BLUE LIGHT, P5; FOTH, 2008, THE BLUE LIGHT, P6; FOTH, 2006, THE BLUE LIGHT, P6; Grujicic M, 2013, P I MECH ENG L-J MAT, V227, P124, DOI 10.1177/1464420712470356; Hirshberg B, 1999, CHEST, V116, P1683, DOI 10.1378/chest.116.6.1683; Jacobsen M., 2005, HL HUNLEY PROJECT 20; Jacobsen M, 2012, MAR TECHNOL SOC J, V46, P38, DOI 10.4031/MTSJ.46.6.2; Jones CH, 2001, ARTILLERY FUSES CIVI; Kambouchev N, 2006, J APPL PHYS, V100, DOI 10.1063/1.2349483; Kambouchev N, 2007, COMPUT STRUCT, V85, P923, DOI 10.1016/j.compstruc.2006.11.005; Kambouchev N, 2007, J APPL MECH-T ASME, V74, P1042, DOI 10.1115/1.2712230; Kedrinskii V, 1972, FIZ GOREN VZRYVA, V8, P115; Kloeppel JE, 1987, DANGER WAVES HIST CO; Kosanke KL, 1995, J PYROTECHNICS, V9, P51; Kosanke KL, 2003, PYROTECHNIC BURN RAT, P664; Lance RM, 2017, FORENSIC SCI INT, V270, P103, DOI 10.1016/j.forsciint.2016.11.038; Lance RM, 2016, FORENSIC SCI INT, V260, P59, DOI 10.1016/j.forsciint.2016.01.008; Martin A, 2011, SECRET WEAPON CONFED, P90; MCGRATH JR, 1966, J APPL PHYS, V37, P4439, DOI 10.1063/1.1708057; Murphy LE, 1998, 62 SUBM CULT RES UN; Napadensky HS, 1972, TNT EQUIVALENCY BLAC, V1; [NCRE Establishment NCR], 1948, SCAL LAWS DAM UND EX; Neuberger A, 2007, INT J IMPACT ENG, V34, P859, DOI 10.1016/j.ijimpeng.2006.04.001; Oceaneering International I. H. L, 2000, HUNL GEN REC PROC; Panzer M, 2012, J TRAUMA, V72, P565; Peng W, 2011, J APPL MECH, P78; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reid WD., 1996, RESPONSE SURFACE SHI; Richmond D R, 1989, Ann Otol Rhinol Laryngol Suppl, V140, P35; Richmond D.R., 1968, RELATIONSHIP SELECTE; Sharrer EA, 2001, GEOL SOC AM ANN M NO; Taylor G., 1963, SCI PAPERS GI TAYLOR, V3, P287; USN, NARA MICR PUBL; USN, NARA MICR PUBL; von Maltitz I., 2003, BLACK POWDER MANUFAC; Wilson C, 1995, J PYROTECHNICS, P49; Workman L, 2011, PVC PIPING SYSTEMS; Wright HC, 1947, SUBJECTIVE EFFECTS D	62	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182244	10.1371/journal.pone.0182244	http://dx.doi.org/10.1371/journal.pone.0182244			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832592	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800017
J	Leung, HW; Foo, G; Banumurthy, G; Chai, XR; Ghosh, S; Mitra-Ganguli, T; VanDongen, AMJ				Leung, How-Wing; Foo, Gabriel; Banumurthy, Gokulakrishna; Chai, Xiaoran; Ghosh, Sujoy; Mitra-Ganguli, Tora; VanDongen, Antonius M. J.			The effect of Bacopa monnieri on gene expression levels in SH-SY5Y human neuroblastoma cells	PLOS ONE			English	Article							TRANSCRIPTION FACTORS NRF2; INDUCED OXIDATIVE STRESS; SYNAPTIC PLASTICITY; STANDARDIZED EXTRACT; DENDRITIC ARBORIZATION; THERAPEUTIC TARGET; MEMORY DEFICITS; IN-VITRO; ATF4; BRAIN	Bacopa monnieri is a plant used as a nootropic in Ayurveda, a 5000-year-old system of traditional Indian medicine. Although both animal and clinical studies supported its role as a memory enhancer, the molecular and cellular mechanism underlying Bacopa's nootropic action are not understood. In this study, we used deep sequencing (RNA-Seq) to identify the transcriptome changes upon Bacopa treatment on SH-SY5Y human neuroblastoma cells. We identified several genes whose expression levels were regulated by Bacopa. Biostatistical analysis of the RNA-Seq data identified biological pathways and molecular functions that were regulated by Bacopa, including regulation of mRNA translation and transmembrane transport, responses to oxidative stress and protein misfolding. Pathway analysis using the Ingenuity platform suggested that Bacopa may protect against brain damage and improve brain development. These newly identified molecular and cellular determinants may contribute to the nootropic action of Bacopa and open up a new direction of investigation into its mechanism of action.	[Leung, How-Wing; Foo, Gabriel; Banumurthy, Gokulakrishna; Chai, Xiaoran; Ghosh, Sujoy; VanDongen, Antonius M. J.] Duke NUS Med Sch, Program Neurosci & Behav Disorders, Singapore, Singapore; [Mitra-Ganguli, Tora] GlaxoSmithKline Consumer Healthcare, Gurgaon, Haryana, India; [Mitra-Ganguli, Tora] Indian Inst Technol Tirupati, Tirupati, Andhra Pradesh, India	National University of Singapore; GlaxoSmithKline; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Tirupati	Mitra-Ganguli, T (corresponding author), GlaxoSmithKline Consumer Healthcare, Gurgaon, Haryana, India.; Mitra-Ganguli, T (corresponding author), Indian Inst Technol Tirupati, Tirupati, Andhra Pradesh, India.	tora.mitra@gmail.com			GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	The work was supported by a grant from GlaxoSmithKline to AV, which were involved in the study design. The funders had no role in data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the form of salaries for authors HL, GF and GB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aarti I, 2010, APOPTOSIS, V15, P679, DOI 10.1007/s10495-010-0474-z; Aguiar S, 2013, REJUV RES, V16, P313, DOI 10.1089/rej.2013.1431; Allan JJ, 2007, FOOD CHEM TOXICOL, V45, P1928, DOI 10.1016/j.fct.2007.04.010; An Z., 2015, ARCH PHARM RES; Association IDM, 2002, IND HERB PHARM IND D; Balaji B, 2015, TOXICOL IND HEALTH, V31, P18, DOI 10.1177/0748233712468018; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; Boal F, 2015, SCI REP-UK, V5, DOI 10.1038/srep16104; Charles PD, 2011, J ETHNOPHARMACOL, V134, P55, DOI 10.1016/j.jep.2010.11.045; Chen A, 2003, NEURON, V39, P655, DOI 10.1016/S0896-6273(03)00501-4; Chung YM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2008; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Das A, 2002, PHARMACOL BIOCHEM BE, V73, P893, DOI 10.1016/S0091-3057(02)00940-1; Davila D, 2008, MOL BIOL CELL, V19, P2014, DOI 10.1091/mbc.E07-08-0811; Desrivieres S, 2015, MOL PSYCHIATR, V20, P263, DOI 10.1038/mp.2013.197; Dhanasekaran M, 2007, PHYTOTHER RES, V21, P965, DOI 10.1002/ptr.2195; Dwane Susan, 2013, BMC Res Notes, V6, P366, DOI 10.1186/1756-0500-6-366; Dwivedi S, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/294501; Ehren JL, 2013, BIOCHEM PHARMACOL, V85, P1816, DOI 10.1016/j.bcp.2013.04.010; Farr SA, 2014, FREE RADICAL BIO MED, V67, P387, DOI 10.1016/j.freeradbiomed.2013.11.014; Green TA, 2008, J NEUROSCI, V28, P2025, DOI 10.1523/JNEUROSCI.5273-07.2008; He CH, 2001, J BIOL CHEM, V276, P20858, DOI 10.1074/jbc.M101198200; Hosamani R, 2009, NEUROTOXICOLOGY, V30, P977, DOI 10.1016/j.neuro.2009.08.012; Hu DY, 2006, J NEUROSCI, V26, P3933, DOI 10.1523/JNEUROSCI.5566-05.2006; Huang TT, 2015, ARCH BIOCHEM BIOPHYS, V576, P2, DOI 10.1016/j.abb.2015.03.014; Jiang S, 2016, MOL NEUROBIOL; Jyoti A, 2006, NEUROTOXICOLOGY, V27, P451, DOI 10.1016/j.neuro.2005.12.007; Kanninen K, 2009, P NATL ACAD SCI USA, V106, P16505, DOI 10.1073/pnas.0908397106; Kean JD, 2015, NUTRIENTS, V7, P9931, DOI 10.3390/nu7125507; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kongkeaw C, 2014, J ETHNOPHARMACOL, V151, P528, DOI 10.1016/j.jep.2013.11.008; Lee DS, 2014, MOLECULES, V19, P10818, DOI 10.3390/molecules190810818; Lewerenz J, 2012, CELL DEATH DIFFER, V19, P847, DOI 10.1038/cdd.2011.165; Lewerenz J, 2009, J BIOL CHEM, V284, P1106, DOI 10.1074/jbc.M807325200; Li XH, 2012, NEUROSCI LETT, V514, P46, DOI 10.1016/j.neulet.2012.02.054; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Limpeanchob N, 2008, J ETHNOPHARMACOL, V120, P112, DOI 10.1016/j.jep.2008.07.039; Lin K, 1997, SCIENCE, V278, P1319, DOI 10.1126/science.278.5341.1319; Lojewski M, 2015, PLANTA MED; Mitsuda T, 2007, BIOCHEM BIOPH RES CO, V352, P722, DOI 10.1016/j.bbrc.2006.11.075; Mukherjee G D, 1966, J Exp Med Sci, V10, P5; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Owczarek S, 2011, J NEUROCHEM, V117, P984, DOI 10.1111/j.1471-4159.2011.07269.x; Pase MP, 2012, J ALTERN COMPLEM MED, V18, P647, DOI 10.1089/acm.2011.0367; Pasini S, 2015, CELL REP, V11, P183, DOI 10.1016/j.celrep.2015.03.025; Peth-Nui T., 2012, EVID-BASED COMPL ALT, DOI DOI 10.1155/2012/606424; Pravina K, 2007, PHYTOMEDICINE, V14, P301, DOI 10.1016/j.phymed.2007.03.010; Preethi J, 2014, CELL MOL NEUROBIOL, V34, P577, DOI 10.1007/s10571-014-0042-0; Preethi J, 2012, NEUROCHEM RES, V37, P2167, DOI 10.1007/s11064-012-0840-z; Rajan KE, 2011, NEUROCHEM RES, V36, P2136, DOI 10.1007/s11064-011-0538-7; Rastogi M, 2012, BIOGERONTOLOGY, V13, P183, DOI 10.1007/s10522-011-9367-y; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Rossler OG, 2017, J CELL BIOCHEM, V118, P127, DOI 10.1002/jcb.25619; Roodenrys S, 2002, NEUROPSYCHOPHARMACOL, V27, P279, DOI 10.1016/S0893-133X(01)00419-5; ROSS RA, 1983, J NATL CANCER I, V71, P741; Rozpedek W, 2015, CURR MED CHEM, V22, P3169, DOI 10.2174/0929867322666150818104254; Saini N, 2012, NEUROCHEM RES, V37, P1928, DOI 10.1007/s11064-012-0811-4; Sandri M, 2012, NAT CELL BIOL, V14, P786, DOI 10.1038/ncb2550; Sarlak Z, 2015, IRAN J BASIC MED SCI, V18, P398; Scholey A, 2014, patentWO, Patent No. [2014085851 A1, 2014085851]; Segev Y, 2015, J NEUROSCI, V35, P12986, DOI 10.1523/JNEUROSCI.5241-14.2015; Shinomol GK, 2012, NEUROTOX RES, V22, P102, DOI 10.1007/s12640-011-9303-6; Sidrauski C, 2013, ELIFE, V2, DOI 10.7554/eLife.00498; SINGH HK, 1982, J ETHNOPHARMACOL, V5, P205, DOI 10.1016/0378-8741(82)90044-7; Singh R, 2014, PHYTOTHER RES, V28, P1419, DOI 10.1002/ptr.5116; Smalla KH, 2000, P NATL ACAD SCI USA, V97, P4327, DOI 10.1073/pnas.080389297; Stough C, 2001, PSYCHOPHARMACOLOGY, V156, P481, DOI 10.1007/s002130100815; Stough C, 2015, EVID-BASED COMPL ALT, V2015; Stough C, 2008, PHYTOTHER RES, V22, P1629, DOI 10.1002/ptr.2537; Stough CK, 2012, NUTR J, V11, DOI 10.1186/1475-2891-11-11; Subramanian A, 2007, BIOINFORMATICS, V23, P3251, DOI 10.1093/bioinformatics/btm369; Trinh MA, 2012, CELL REP, V1, P676, DOI 10.1016/j.celrep.2012.04.010; Uabundit N, 2010, J ETHNOPHARMACOL, V127, P26, DOI 10.1016/j.jep.2009.09.056; Vollala VR, 2011, BRATISL MED J, V112, P663; Vollala VR, 2011, ANAT SCI INT, V86, P179, DOI 10.1007/s12565-011-0104-z; Vollala VR, 2011, CLINICS, V66, P663, DOI 10.1590/S1807-59322011000400023; Wei N, 2015, MOL NEUROBIOL, V52, P1765, DOI 10.1007/s12035-014-8970-8; Wu J. Y., 2013, Journal of Agricultural Science and Applications, V2, P8, DOI 10.14511/jasa.2013.020102; Xie Y, 2014, PHARMACOL BIOCHEM BE, V126, P181, DOI 10.1016/j.pbb.2014.08.005; Xing Y, 2006, NUCLEIC ACIDS RES, V34, P3150, DOI 10.1093/nar/gkl396; Yadav Kapil Deo, 2014, Ayu, V35, P325, DOI 10.4103/0974-8520.153755; Ye JB, 2009, CURR MOL MED, V9, P411, DOI 10.2174/156652409788167096; Ye P, 2014, MOL CELL BIOL, V34, P3421, DOI 10.1128/MCB.00221-14; Zhang MJ, 2013, PROG NEUROBIOL, V100, P30, DOI 10.1016/j.pneurobio.2012.09.003; Zhu WG, 2012, ACTA PHARMACOL SIN, V33, P577, DOI 10.1038/aps.2012.48	86	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182984	10.1371/journal.pone.0182984	http://dx.doi.org/10.1371/journal.pone.0182984			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832626	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800040
J	Serrano-Gomez, SJ; Sanabria-Salas, MAC; Garay, J; Baddoo, MC; Hernandez-Suarez, G; Mejia, JC; Garcia, O; Miele, L; Fejerman, L; Zabaleta, J				Serrano-Gomez, Silvia J.; Carolina Sanabria-Salas, Maria A.; Garay, Jone; Baddoo, Melody C.; Hernandez-Suarez, Gustavo; Carlos Mejia, Juan; Garcia, Oscar; Miele, Lucio; Fejerman, Laura; Zabaleta, Jovanny			Ancestry as a potential modifier of gene expression in breast tumors from Colombian women	PLOS ONE			English	Article							CANCER INTRINSIC SUBTYPES; GRB7; HER2; IMMUNOHISTOCHEMISTRY; CHEMOTHERAPY; CLASSIFICATION; IDENTIFICATION; POLYMORPHISMS; ASSOCIATION; MANAGEMENT	Background Hispanic/Latino populations are a genetically admixed and heterogeneous group, with variable fractions of European, Indigenous American and African ancestries. The molecular profile of breast cancer has been widely described in non-Hispanic Whites but equivalent knowledge is lacking in Hispanic/Latinas. We have previously reported that the most prevalent breast cancer intrinsic subtype in Colombian women was Luminal B as defined by St. Gallen 2013 criteria. In this study we explored ancestry-associated differences in molecular profiles of Luminal B tumors among these highly admixed women. Methods We performed whole-transcriptome RNA-seq analysis in 42 Luminal tumors (21 Luminal A and 21 Luminal B) from Colombian women. Genetic ancestry was estimated from a panel of 80 ancestry-informative markers (AIM). We categorized patients according to Luminal subtype and to the proportion of European and Indigenous American ancestry and performed differential expression analysis comparing Luminal B against Luminal A tumors according to the assigned ancestry groups. Results We found 5 genes potentially modulated by genetic ancestry: ERBB2 (log2FC = 2.367, padj<0.01), GRB7 (log2FC = 2.327, padj<0.01), GSDMB (log2FC = 1.723, padj<0.01, MIEN1 (log2FC = 2.195, padj<0.01 and ONECUT2 (log2FC = 2.204, padj<0.01). In the replication set we found a statistical significant association between ERBB2 expression with Indigenous American ancestry (p = 0.02, B = 3.11). This association was not biased by the distribution of HER2+ tumors among the groups analyzed. Conclusions Our results suggest that genetic ancestry in Hispanic/Latina women might modify ERBB2 gene expression in Luminal tumors. Further analyses are needed to confirm these findings and explore their prognostic value.	[Serrano-Gomez, Silvia J.; Carolina Sanabria-Salas, Maria A.; Hernandez-Suarez, Gustavo] Inst Nacl Cancerol, Grp Invest Biol Canc, Bogota, Colombia; [Serrano-Gomez, Silvia J.] Pontificia Univ Javeriana, Programa Doctorado Ciencias Biol, Bogota, Colombia; [Garay, Jone; Zabaleta, Jovanny] LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA; [Baddoo, Melody C.] Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Carlos Mejia, Juan] Inst Nacl Cancerol, Grp Patol, Bogota, Colombia; [Garcia, Oscar] Inst Nacl Cancerol, Grp Seno & Tejidos Blandos, Bogota, Colombia; [Miele, Lucio] LSUHSC, Dept Genet, New Orleans, LA USA; [Fejerman, Laura] Univ Calif San Francisco, Dept Med, Inst Human Genet, San Francisco, CA USA; [Zabaleta, Jovanny] LSUHSC, Dept Pediat, New Orleans, LA 70112 USA	Pontificia Universidad Javeriana; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Tulane University; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; University of California System; University of California San Francisco; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Zabaleta, J (corresponding author), LSUHSC, Stanley S Scott Canc Ctr, New Orleans, LA 70112 USA.; Zabaleta, J (corresponding author), LSUHSC, Dept Pediat, New Orleans, LA 70112 USA.	jzabal@lsuhsc.edu		Fejerman, Laura/0000-0003-3179-1151; SANABRIA SALAS, MARIA CAROLINA/0000-0002-7946-2026; Miele, Lucio/0000-0002-5853-7287	National Institute of General Medical Sciences (NIGMS) [P20GM103501, P30GM114732, U54GM104940-01]; National Institute on Minority Health and Health Disparities (NIMHD) [P20MD004817, U54MD008176-01]; NATIONAL CANCER INSTITUTE [P20CA202922] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM114732] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Colombian National Cancer Institute (C41030610-110 to MCSS). National Cancer Institute (CA 160607 to L.F.). J.Z. has been partially supported by grants from the National Institute of General Medical Sciences (NIGMS, P20GM103501 subproject # 2, P30GM114732, U54GM104940-01) and the National Institute on Minority Health and Health Disparities (NIMHD, P20MD004817, U54MD008176-01).	Ades F, 2014, J CLIN ONCOL, V32, P2794, DOI 10.1200/JCO.2013.54.1870; Aronesty E., 2011, EA UTILS COMMAND LIN; Artigalas O, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0373-9; Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Bertucci F, 2004, ONCOGENE, V23, P2564, DOI 10.1038/sj.onc.1207361; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Carey LA, 2006, J AM MED ASS, V295; Chavez-MacGregor M, 2014, CANCER EPIDEM BIOMAR, V23, P316, DOI 10.1158/1055-9965.EPI-13-0929; Cheang MCU, 2009, JNCI-J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Creighton CJ, 2012, BIOL-TARGETS THER, V6, P289, DOI 10.2147/BTT.S29923; Creighton CJ, 2009, BREAST CANCER RES TR, V114, P287, DOI 10.1007/s10549-008-0017-2; D'Arcy M, 2015, BREAST CANCER RES TR, V152, P437, DOI 10.1007/s10549-015-3474-4; de Ronde JJ, 2010, BREAST CANCER RES TR, V119, P119, DOI 10.1007/s10549-009-0499-6; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eroles P, 2012, CANCER TREAT REV, V38, P698, DOI 10.1016/j.ctrv.2011.11.005; Evans EE, 2006, MOL CANCER THER, V5, P2919, DOI 10.1158/1535-7163.MCT-06-0389; Fejerman L, 2008, CANCER RES, V68, P9723, DOI 10.1158/0008-5472.CAN-08-2039; Fejerman L, 2013, CANCER RES, V73, P7243, DOI 10.1158/0008-5472.CAN-13-2014; Field LA, 2012, CANCER-AM CANCER SOC, V118, P1334, DOI 10.1002/cncr.26405; Gianni L, 2005, J CLIN ONCOL, V23, P7265, DOI 10.1200/JCO.2005.02.0818; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Grunda Jessica M, 2012, BMC Res Notes, V5, P248, DOI 10.1186/1756-0500-5-248; Han DC, 1999, J BIOL CHEM, V274, P24425, DOI 10.1074/jbc.274.34.24425; Han DC, 2001, ONCOGENE, V20, P6315, DOI 10.1038/sj.onc.1204775; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Huang X, 2015, CANC MED; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Katz E, 2010, BRIT J CANCER, V103, P401, DOI 10.1038/sj.bjc.6605763; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kpetemey M, 2016, ONCOTARGET, V7, P54913, DOI 10.18632/oncotarget.10798; Kpetemey M, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0428-8; Kristensen VN, 2005, J STEROID BIOCHEM, V95, P105, DOI 10.1016/j.jsbmb.2005.04.028; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li ZH, 2016, ONCOTARGET, V7, P65024, DOI 10.18632/oncotarget.11344; Lips EH, 2013, BREAST CANCER RES TR, V140, P63, DOI 10.1007/s10549-013-2620-0; Long JR, 2006, CANCER EPIDEM BIOMAR, V15, P2115, DOI 10.1158/1055-9965.EPI-06-0464; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lusa L, 2007, JNCI-J NATL CANCER I, V99, P1715, DOI 10.1093/jnci/djm216; Martin DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004531; Nadler Y, 2010, ANN ONCOL, V21, P466, DOI 10.1093/annonc/mdp346; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Prat A, 2015, BREAST, V24, pS26, DOI 10.1016/j.breast.2015.07.008; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Pritchard JK, 2000, GENETICS, V155, P945; Reis JS, 2011, LANCET, V378, P1812, DOI 10.1016/S0140-6736(11)61539-0; Rojas W, 2010, AM J PHYS ANTHROPOL, V143, P13, DOI 10.1002/ajpa.21270; Romero A, 2011, AM J PATHOL, V178, P1453, DOI 10.1016/j.ajpath.2010.12.042; Rugo HS, 2008, ANN ONCOL, V19, P16, DOI 10.1093/annonc/mdm282; Serrano-Gomez SJ, 2016, CARCINOGENESIS; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2003, P NATL ACAD SCI USA, V100, P10393, DOI 10.1073/pnas.1732912100; Sparano JA, 2009, CLIN CANCER RES, V15, P7693, DOI 10.1158/1078-0432.CCR-09-1450; Staaf J, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju386; STEIN D, 1994, EMBO J, V13, P1331, DOI 10.1002/j.1460-2075.1994.tb06386.x; Stern Mariana C, 2016, Curr Epidemiol Rep, V3, P181, DOI 10.1007/s40471-016-0083-7; Stewart PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082460; Tao YM, 2014, P NATL ACAD SCI USA, V111, pE4429, DOI 10.1073/pnas.1407139111; Tishchenko I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158259; Vinatzer U, 2005, CLIN CANCER RES, V11, P8348, DOI 10.1158/1078-0432.CCR-05-0841; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wu Y, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1844; Yersal O, 2014, WORLD J CLIN ONCOL, V5, P412, DOI 10.5306/wjco.v5.i3.412; Yu DH, 2000, ONCOGENE, V19, P6115, DOI 10.1038/sj.onc.1203972	66	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183179	10.1371/journal.pone.0183179	http://dx.doi.org/10.1371/journal.pone.0183179			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832682	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800050
J	Song, JY; Jeong, JU; Yoon, MS; Ahn, SJ; Chung, WK; Nam, TK				Song, Ju-Young; Jeong, Jae-Uk; Yoon, Mee Sun; Ahn, Sung-Ja; Chung, Woong-Ki; Nam, Taek-Keun			Dosimetric evaluation of MobiusFX in the RapidArc delivery quality assurance comparing with 3DVH	PLOS ONE			English	Article							HETEROGENEOUS ANTHROPOMORPHIC PHANTOM; DOSE RECONSTRUCTION; IMRT QA; RADIATION-THERAPY; DIODE-ARRAY; VMAT QA; VALIDATION; SYSTEM; VERIFICATION; GEOMETRIES	The dosimetric characteristics of MobiusFX, which uses the treatment machine log file to calculate the dose inside the patient body, were analyzed for use in the RapidArc delivery quality assurance (DQA) process. The accuracy and usefulness of MobiusFX in clinical cases was evaluated by comparing the dose calculated by MobiusFX with that calculated by the conventional measurement dose based program, 3DVH. The results of gamma evaluation with three different criteria (3%-3 mm, 4%-3 mm, 5%-3 mm) were analyzed, and the dose changes were calculated while simulating variable position errors (6 mm, 3 mm) and dosimetric output increases (6%, 3%). Although the doses calculated by each tool were not identical due to differences in the calculation algorithms, the doses calculated by MobiusFX were generally similar to those calculated by 3DVH. Based on these results, MobiusFX exhibited the required accuracy for clinical application. However, it could not determine the dosimetric output variation. It should therefore be considered a supplementary DQA tool that can verify the error in the daily treatment process, but not an ideal DQA tool that can replace conventional measurement based DQA methods.	[Song, Ju-Young; Jeong, Jae-Uk; Yoon, Mee Sun; Ahn, Sung-Ja; Chung, Woong-Ki; Nam, Taek-Keun] Chonnam Natl Univ, Sch Med, Dept Radiat Oncol, Gwangju, South Korea	Chonnam National University	Nam, TK (corresponding author), Chonnam Natl Univ, Sch Med, Dept Radiat Oncol, Gwangju, South Korea.	tknam67@gmail.com						Agnew CE, 2014, J APPL CLIN MED PHYS, V15, P204, DOI 10.1120/jacmp.v15i6.4994; Au IWL, 2017, AUSTRALAS PHYS ENG S, V40, P181, DOI 10.1007/s13246-016-0503-5; Calvo-Ortega JF, 2014, J APPL CLIN MED PHYS, V15, P100, DOI 10.1120/jacmp.v15i2.4665; Carrasco P, 2012, MED PHYS, V39, P5040, DOI 10.1118/1.4736949; Chaswal V, 2014, J APPL CLIN MED PHYS, V15, P212, DOI 10.1120/jacmp.v15i4.4832; Childress N, 2015, J APPL CLIN MED PHYS, V16, P4, DOI 10.1120/jacmp.v16i1.5385; Defoor DL, 2015, J APPL CLIN MED PHYS, V16, P206, DOI 10.1120/jacmp.v16i3.5283; Ezzell GA, 2003, MED PHYS, V30, P2089, DOI 10.1118/1.1591194; Ezzell GA, 2009, MED PHYS, V36, P5359, DOI 10.1118/1.3238104; Feygelman V, 2011, J APPL CLIN MED PHYS, V12, P146, DOI 10.1120/jacmp.v12i2.3346; Fontenot JD, 2014, J APPL CLIN MED PHYS, V15, P207, DOI 10.1120/jacmp.v15i5.4990; Gordon JD, 2011, MED PHYS, V38, P1641, DOI 10.1118/1.3555298; Hauri P, 2014, J APPL CLIN MED PHYS, V15, P181, DOI 10.1120/jacmp.v15i2.4647; Infusino E, 2014, MED DOSIM, V39, P276, DOI 10.1016/j.meddos.2014.04.004; Jolly D, 2017, J APPL CLIN MED PHYS, V18, P59, DOI 10.1002/acm2.12009; Kadoya N, 2015, J APPL CLIN MED PHYS, V16, P179, DOI 10.1120/jacmp.v16i3.5251; Li GJ, 2013, J APPL CLIN MED PHYS, V14, P13, DOI 10.1120/jacmp.v14i5.3828; Li JS, 2010, MED PHYS, V37, P2491, DOI 10.1118/1.3413997; Nakaguchi Y, 2015, J APPL CLIN MED PHYS, V16, P264, DOI 10.1120/jacmp.v16i1.5199; Olch AJ, 2012, MED PHYS, V39, P81, DOI 10.1118/1.3666771; Opp D, 2013, J APPL CLIN MED PHYS, V14, P70, DOI 10.1120/jacmp.v14i4.4154; Palta JR, 2008, INT J RADIAT ONCOL, V71, pS108, DOI 10.1016/j.ijrobp.2007.05.092; Sun BZ, 2012, J APPL CLIN MED PHYS, V13, P140, DOI 10.1120/jacmp.v13i5.3837; Tyagi N, 2014, J APPL CLIN MED PHYS, V15, P54, DOI 10.1120/jacmp.v15i4.4645; Vikraman S, 2015, J APPL CLIN MED PHYS, V16, P192, DOI 10.1120/jacmp.v16i1.5128	25	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183165	10.1371/journal.pone.0183165	http://dx.doi.org/10.1371/journal.pone.0183165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832605	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800049
J	Tsuboko-Ishii, S; Burton, RS				Tsuboko-Ishii, Satomi; Burton, Ronald S.			Sex-specific rejection in mate-guarding pair formation in the intertidal copepod, Tigriopus californicus	PLOS ONE			English	Article							MATING SYSTEM; RATIOS; SWITCH; MODEL; FIELD; TIME	Securing a potential mate is one of the most important processes in sexual reproduction of animals. Intertidal copepods of the genus Tigriopus show mate-guarding behavior where a male captures a female and continues to clasp her for up to two weeks prior to copulation. Although these copepods form a mate-guarding pair between a male and a female with high accuracy, interactions between the sexes in pair formation have not been well described and the mechanism allowing successful male-female pair formation is not yet understood. In this study, we performed experiments with Tigriopus californicus to analyze the behavior of both a capturer (male) and a captured individual (female or male) in formation of a guarding pair. While capturer males were attracted by both females and males, capture of virgin males was terminated in a significantly shorter time than that of virgin females. However, when presented freshly killed females or males, regardless of the sex of the body, capturer males continued to clasp the body for a comparable time as in an attempt on a living female. Our results suggest that a sex-specific rejection signal actively sent by captured males prevents male-male pair formation. Experiments also suggest that mated females reject an attempt of pair formation. To our knowledge, this is the first study to suggest involvement of active rejection by a captured individual in facilitation of reproductively successful malefemale guarding pair formation in the genus Tigriopus.	[Tsuboko-Ishii, Satomi; Burton, Ronald S.] Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Tsuboko-Ishii, S (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Marine Biol Res Div, La Jolla, CA 92093 USA.	tsuboko.medaka@gmail.com	Burton, R/F-7694-2010; Tsuboko-Ishii, Satomi/J-2713-2019	Burton, R/0000-0002-6995-5329; Tsuboko-Ishii, Satomi/0000-0003-4374-6200	Sumitomo Foundation, Japan [150932]	Sumitomo Foundation, Japan	This work is supported by Grant for Basic Science Research Projects from the Sumitomo Foundation, Japan (to STI and RB, 150932, http:// www.sumitomo.or.jp/e/index.htm). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work is supported by Grant for Basic Science Research Projects from the Sumitomo Foundation, Japan. We thank Ms. Kiana Michelle Woodward for assistance with maintenance of the animals.	Alexander HJ, 2015, J EVOLUTION BIOL, V28, P2196, DOI 10.1111/jeb.12743; Alexander HJ, 2014, J EVOLUTION BIOL, V27, P1921, DOI 10.1111/jeb.12449; Andrew DR, 2012, J COMP NEUROL, V520, P3446, DOI 10.1002/cne.23099; Ar-Rushdi AH, 1958, 10 INT C GEN MCGILL; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BURTON RS, 1985, MAR BIOL, V86, P247, DOI 10.1007/BF00397511; Buss David M, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P23; Coxworth JE, 2015, P NATL ACAD SCI USA, V112, P11806, DOI 10.1073/pnas.1599993112; Edward DA, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a017707; Egami N., 1951, Annotationes Zoologicae Japonenses, V24, P131; Egloff DA, 1966, TIGRIOPUS CALIFORNIC; Fraser J. H., 1936, Journal of the Marine Biological Association Plymouth, V20, P523; GETZ LL, 1981, BEHAV ECOL SOCIOBIOL, V8, P189, DOI 10.1007/BF00299829; GRAFEN A, 1983, J THEOR BIOL, V102, P549, DOI 10.1016/0022-5193(83)90390-9; HAGIWARA A, 1995, FISHERIES SCI, V61, P618, DOI 10.2331/fishsci.61.618; Hockham LR, 1997, J INSECT BEHAV, V10, P247, DOI 10.1007/BF02765557; Ito T., 1988, ANN REPORT SETO MARI, V2, P28; Jormalainen V, 1998, Q REV BIOL, V73, P275, DOI 10.1086/420306; Kelly LS, 1998, PHILOS T R SOC B, V353, P737, DOI 10.1098/rstb.1998.0239; LAZZARETTO I, 1990, CRUSTACEANA, V59, P171, DOI 10.1163/156854090X00642; LAZZARETTO I, 1994, HYDROBIOLOGIA, V293, P229; Obara Y, 2011, NATURWISSENSCHAFTEN, V98, P989, DOI 10.1007/s00114-011-0847-3; PARKER GA, 1974, BEHAVIOUR, V48, P157, DOI 10.1163/156853974X00327; Peterson DL, 2013, J BIOGEOGR, V40, P1664, DOI 10.1111/jbi.12107; Raisuddin S, 2007, AQUAT TOXICOL, V83, P161, DOI 10.1016/j.aquatox.2007.04.005; Rondeau A, 2001, BIOL BULL-US, V201, P204, DOI 10.2307/1543335; Setchell JM, 2005, ANIM BEHAV, V70, P1105, DOI 10.1016/j.anbehav.2005.02.021; VACQUIER VD, 1965, SCIENCE, V150, P1619, DOI 10.1126/science.150.3703.1619; Vittor BA, 1971, TIGRIOPUS CALIFORNIC; Voordouw MJ, 2002, BIOL J LINN SOC, V76, P511, DOI 10.1046/j.1095-8312.2002.00087.x; Yang CH, 2009, NEURON, V61, P519, DOI 10.1016/j.neuron.2008.12.021; Yapici N, 2008, NATURE, V451, P33, DOI 10.1038/nature06483; Yokoi S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005009	33	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183758	10.1371/journal.pone.0183758	http://dx.doi.org/10.1371/journal.pone.0183758			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832683	Green Published, gold			2022-12-27	WOS:000408355800098
J	Lobner, M; Stein, J; Luppa, M; Konnopka, A; Meisel, HJ; Gunther, L; Meixensberger, J; Stengler, K; Angermeyer, MC; Konig, HH; Riedel-Heller, SG				Loebner, Margrit; Stein, Janine; Luppa, Melanie; Konnopka, Alexander; Meisel, Hans Joerg; Guenther, Lutz; Meixensberger, Juergen; Stengler, Katarina; Angermeyer, Matthias C.; Koenig, Hans-Helmut; Riedel-Heller, Steffi G.			Choosing the right rehabilitation setting after herniated disc surgery: Motives, motivations and expectations from the patients' perspective	PLOS ONE			English	Article							LOW-BACK-PAIN; CHRONIC MUSCULOSKELETAL PAIN; QUALITY-OF-LIFE; MEDICAL REHABILITATION; GENDER-DIFFERENCES; MULTIDISCIPLINARY REHABILITATION; FOLLOW-UP; SATISFACTION; OUTCOMES; ABILITY	Objectives This study aims to investigate (1) motives, motivations and expectations regarding the choice for a specific rehabilitation setting after herniated disc surgery and (2) how rehabilitation-related motivations and expectations are associated with rehabilitation outcome (ability to work, health-related quality of life and satisfaction with rehabilitation) three months after disc surgery. Methods The longitudinal cohort study refers to 452 disc surgery patients participating in a subsequent rehabilitation. Baseline interviews took part during acute hospital stay (pre-rehabilitation), follow-up interviews three months later (post-rehabilitation). Binary logistic regression and multiple linear regression analyses were applied. Results (1) Motives, motivations and expectations: Inpatient rehabilitation (IPR) patients stated "less effort/stress" (40.9%), more "relaxation and recreation" (39.1%) and greater "intensity of care and treatment" (37.0%) regarding their setting preference, whereas outpatient rehabilitation (OPR) patients indicated "family reasons" (45.3%), the wish for "staying in familiar environment" (35.9%) as well as "job-related reasons" (11.7%) as most relevant. IPR patients showed significantly higher motivation/expectation scores regarding regeneration (p < .001), health (p < .05), coping (p < .001), retirement/job (p < .01), psychological burden (p < .05) and physical burden (p < .001) compared to OPR patients. (2) Associations with rehabilitation outcome: Besides other factors (e.g. age, gender and educational level) rehabilitation-related motivations/expectations were significantly associated with rehabilitation outcome measures. For example, patients with less motivations/expectations to achieve improvements regarding "physical burden" showed a better health-related quality of life (p < .01) three months after disc surgery. Less motivations/expectations to achieve improvements regarding "psychological burden" was linked to a better mental health status (p < .001) and a greater satisfaction with rehabilitation (OR = .806; p < .05). Conclusion Rehabilitation-related motivations and expectations differed substantially between IPR and OPR patients before rehabilitation and were significantly associated with rehabilitation outcome. Taking motivational and expectation-related aspects into account may help to improve allocation procedures for different rehabilitation settings and may improve rehabilitation success.	[Loebner, Margrit; Stein, Janine; Luppa, Melanie; Riedel-Heller, Steffi G.] Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany; [Konnopka, Alexander; Koenig, Hans-Helmut] Univ Med Ctr Hamburg Eppendorf, Dept Hlth Econ & Hlth Serv Res, Hamburg, Germany; [Meisel, Hans Joerg] Berufsgenossenschaftl Kliniken Bergmannstrost, Dept Neurosurg, Halle, Saale, Germany; [Guenther, Lutz] Klinikum St Georg gGmbH, Dept Neurosurg, Leipzig, Germany; [Meixensberger, Juergen] Univ Leipzig, Dept Neurosurg, Leipzig, Germany; [Stengler, Katarina] HELIOS Pk Hosp Leipzig, Dept Psychiat Psychosomat Med & Psychotherapy, Leipzig, Germany; [Angermeyer, Matthias C.] Ctr Publ Mental Hlth, Gosing Am Wagram, Austria; [Angermeyer, Matthias C.] Univ Cagliari, Dept Publ Hlth, Cagliari, Italy	Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Leipzig University; University of Cagliari	Lobner, M (corresponding author), Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlth, Leipzig, Germany.	Margrit.Loebner@medizin.uni-leipzig.de	Löbner, Margrit/AAD-7309-2022; König, Hans-Helmut/P-1211-2018; Riedel-Heller, Steffi/ABG-1537-2021; Luppa, Melanie/AAQ-7338-2021	Löbner, Margrit/0000-0001-5984-8127; König, Hans-Helmut/0000-0001-5711-6862; 	Deutsche Rentenversicherung Bund [8011-106-31/31.81]; German Research Foundation (DFG); Universitat Leipzig within the program of Open Access Publishing	Deutsche Rentenversicherung Bund; German Research Foundation (DFG)(German Research Foundation (DFG)); Universitat Leipzig within the program of Open Access Publishing	This publication was supported by the Deutsche Rentenversicherung Bund (Project: Psychiatric comorbidity and early retirement in patients with somatic diseases. Reference Number: 8011-106-31/31.81). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors acknowledge support from the German Research Foundation (DFG) and Universitat Leipzig within the program of Open Access Publishing.	Bergmann S, 2004, PAIN, V108, P115, DOI 10.1016/j.pain.2003.12.013; Bjelland I, 2008, SOC SCI MED, V66, P1334, DOI 10.1016/j.socscimed.2007.12.019; Bullinger M, 1998, SF 36 FRAGEBOGEN ZUM; Bullinger M., 2000, BUNDESGESUNDHEITSBLA, V43, P190, DOI DOI 10.1007/S001030050034; Cherepanov D, 2010, QUAL LIFE RES, V19, P1115, DOI 10.1007/s11136-010-9673-x; Davidson M, 2002, PHYS THER, V82, P8, DOI 10.1093/ptj/82.1.8; Deck R, 1998, Rehabilitation (Stuttg), V37, P140; Deutsche Rentenversicherung Bund, 2010, REH BER 2010 MED BER; Dionne CE, 2005, CAN MED ASSOC J, V172, P1559, DOI 10.1503/cmaj.1041159; Dionne CE, 2001, J EPIDEMIOL COMMUN H, V55, P455, DOI 10.1136/jech.55.7.455; Du Bois M, 2009, SPINE J, V9, P350, DOI 10.1016/j.spinee.2008.07.003; Elliott MN, 2012, HEALTH SERV RES, V47, P1482, DOI 10.1111/j.1475-6773.2012.01389.x; Emery CF, 2004, PSYCHOSOM MED, V66, P190, DOI 10.1097/01.psy.0000116775.98593.f4; Eriksen L R, 1995, J Nurs Meas, V3, P59; Goldberg R T, 1994, Disabil Rehabil, V16, P21; Grahn B, 2000, DISABIL REHABIL, V22, P639, DOI 10.1080/096382800445443; HALL JA, 1988, SOC SCI MED, V27, P637, DOI 10.1016/0277-9536(88)90012-3; Hush JM, 2011, PHYS THER, V91, P25, DOI 10.2522/ptj.20100061; IBM Corporation, 2011, IBM SPSS STAT 20 0; Iles RA, 2009, J OCCUP REHABIL, V19, P25, DOI 10.1007/s10926-008-9161-0; Johansson AC, 2010, DISABIL REHABIL, V32, P521, DOI 10.3109/09638280903177243; Junge A, 2004, ORTHOPADE, V33, P545, DOI 10.1007/s00132-003-0613-0; Keith RA, 1998, ARCH PHYS MED REHAB, V79, P1122, DOI 10.1016/S0003-9993(98)90182-4; Lillefjell M, 2006, J OCCUP REHABIL, V16, P543, DOI 10.1007/s10926-005-9011-2; Lillefjell M, 2006, J OCCUP REHABIL, V16, P659, DOI 10.1007/s10926-006-9056-x; Lindell O, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-53; Lobner M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089200; Mancuso M, 2003, ARCH PHYS MED REHAB, V84, P1343, DOI 10.1016/S0003-9993(03)00144-8; Mayring P., 2000, QUALITATIVE INHALTSA; Mayring P., 2010, QUALITITATIVE INHALT; Meng K, 2006, INT J REHABIL RES, V29, P65, DOI 10.1097/01.mrr.0000185955.33046.fd; Mittag O, 2003, Rehabilitation (Stuttg), V42, P169; Mittag O, 2003, SOZ PRAVENTIV MED, V48, P361, DOI 10.1007/s00038-003-2037-3; Moock J, 2006, J PUBLIC HEALTH-HEID, V14, P333, DOI 10.1007/s10389-006-0065-1; Nubling R, 2005, PATIENTENFRAGEBOGEN; Pascoe G C, 1983, Eval Program Plann, V6, P185, DOI 10.1016/0149-7189(83)90002-2; Pohontsch N, 2011, REHABILITATION, V50, P244, DOI 10.1055/s-0031-1275689; Skatteboe S, 2014, EUR J PHYS REHAB MED, V50, P649; StataCorp, 2011, STAT STAT SOFTW REL, P173; Thies S, 2008, REHABILITATION, V47, P308, DOI 10.1055/s-2008-1076709; WILSON KG, 1995, ARCH PHYS MED REHAB, V76, P899, DOI 10.1016/S0003-9993(95)80063-8; WINTER PL, 1988, REHABIL PSYCHOL, V33, P131, DOI 10.1037//0090-5550.33.3.131; Wittchen HU, 1997, INSTRUKTIONSMANUAL D; Zimmermann T, 2015, PSYCHIAT PRAX, V42, pS44, DOI 10.1055/s-0034-1387686; Zwingmann C, 2005, Rehabilitation (Stuttg), V44, P307	45	1	2	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183698	10.1371/journal.pone.0183698	http://dx.doi.org/10.1371/journal.pone.0183698			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829828	gold, Green Submitted, Green Published			2022-12-27	WOS:000408085100067
J	Odetoyin, BW; Labar, AS; Lamikanra, A; Aboderin, AO; Okeke, IN				Odetoyin, Babatunde W.; Labar, Amy S.; Lamikanra, Adebayo; Aboderin, Aaron O.; Okeke, Iruka N.			Classes 1 and 2 integrons in faecal Escherichia coli strains isolated from mother-child pairs in Nigeria	PLOS ONE			English	Article							GENE CASSETTES; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; SALMONELLA-ENTERICA; DIVERSITY; SEQUENCE; SPREAD; ENTEROBACTERIACEAE; PREVALENCE; ANIMALS	Background Antimicrobial resistance among enteric bacteria in Africa is increasingly mediated by integrons on horizontally acquired genetic elements. There have been recent reports of such elements in invasive pathogens across Africa, but very little is known about the faecal reservoir of integron-borne genes. Methods and findings We screened 1098 faecal Escherichia coli isolates from 134 mother-child pairs for integron cassettes by PCR using primers that anneal to the 5' and 3' conserved ends of the cassette regions and for plasmid replicons. Genetic relatedness of isolates was determined by flagellin and multi-locus sequence typing. Integron cassettes were amplified in 410 (37.5%) isolates and were significantly associated with resistance to trimethoprim and multiple resistance. Ten cassette combinations were found in class 1 and two in class 2 integrons. The most common class 1 cassette configurations were single aadA1 (23.4%), dfrA7 (18.3%) and dfrA5 (14.4%). Class 2 cassette configurations were all either dfrA1-satI-aadA1 (n = 31, 7.6%) or dfrA1-satI (n = 13, 3.2%). A dfr cassette was detected in 294 (31.1%) of trimethoprim resistant strains and an aadA cassette in 242 (23%) of streptomycin resistant strains. Strains bearing integrons carried a wide range of plasmid replicons of which FIB/Y (n = 169; 41.2%) was the most frequently detected. Nine isolates from five different individuals carried the dfrA17-aadA5-bearing ST69 clonal group A (CGA). The same integron cassette combination was identified from multiple distinct isolates within the same host and between four mother-child pairs. Conclusions Integrons are important determinants of resistance in faecal E. coli. Plasmids in integroncontaining strains may contribute to dispersing resistance genes. There is a need for improved surveillance for resistance and its mechanisms of dissemination and persistence and mobility of resistance genes in the community and clinical settings.	[Odetoyin, Babatunde W.; Aboderin, Aaron O.] Obafemi Awolowo Univ, Dept Med Microbiol & Parasitol, Ife, Osun State, Nigeria; [Labar, Amy S.; Okeke, Iruka N.] Haverford Coll, Dept Biol, Haverford, PA 19041 USA; [Lamikanra, Adebayo] Obafemi Awolowo Univ, Fac Pharm, Dept Pharmaceut, Ife, Oyo State, Nigeria; [Okeke, Iruka N.] Univ Ibadan, Fac Pharm, Ibadan, Oyo State, Nigeria	Obafemi Awolowo University; Haverford College; Obafemi Awolowo University; University of Ibadan	Odetoyin, BW (corresponding author), Obafemi Awolowo Univ, Dept Med Microbiol & Parasitol, Ife, Osun State, Nigeria.	odetoyin@yahoo.com	Aboderin, Aaron/V-8025-2019; Odetoyin, Babatunde/F-3969-2018; Okeke, Iruka N/N-1595-2019	Aboderin, Aaron/0000-0002-4280-2218; Odetoyin, Babatunde/0000-0002-3412-1551; Okeke, Iruka N/0000-0002-1694-7587	Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO; American Society for Microbiology; Branco Weiss Fellowship from the Society in Science; International fellowship for Africa from American Society for Microbiology	Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO; American Society for Microbiology; Branco Weiss Fellowship from the Society in Science; International fellowship for Africa from American Society for Microbiology	This work was supported by a Branco Weiss Fellowship from the Society-in-Science, ETHZ, Switzerland INO. BWO was supported by an International fellowship for Africa from American Society for Microbiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a Branco Weiss Fellowship from the Society in Science to Iruka Okeke and an International fellowship for Africa from American Society for Microbiology to Babatunde Odetoyin. We thank all the workers at Osun State hospital, Oke-Ogbo and the participants (mothers and their children) that provided the stool samples used in this study for their cooperation and Erin Remaly for technical assistance.	Adesoji AT, 2017, CHEMOTHERAPY, V62, P34, DOI 10.1159/000446150; Ajiboye RM, 2009, CLIN INFECT DIS, V49, P365, DOI 10.1086/600301; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2016, PERF STAND ANT SUSC; Bennett PM, 2008, BRIT J PHARMACOL, V153, pS347, DOI 10.1038/sj.bjp.0707607; Blahna MT, 2006, J ANTIMICROB CHEMOTH, V57, P666, DOI 10.1093/jac/dkl020; Boucher Y, 2007, TRENDS MICROBIOL, V15, P301, DOI 10.1016/j.tim.2007.05.004; Brinkley C, 2006, INFECT IMMUN, V74, P5408, DOI 10.1128/IAI.01840-05; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2009, ANTIMICROB AGENTS CH, V53, P2227, DOI 10.1128/AAC.01707-08; Chah KF, 2010, J BASIC MICROB, V50, pS18, DOI 10.1002/jobm.200900325; Cocchi S, 2007, FEMS IMMUNOL MED MIC, V50, P126, DOI 10.1111/j.1574-695X.2007.00242.x; Deng Y, 2015, ANN CLIN MICROB ANTI, V14, DOI 10.1186/s12941-015-0100-6; Domingues S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002837; Fields PI, 1997, J CLIN MICROBIOL, V35; Frank T, 2007, J ANTIMICROB CHEMOTH, V59, P742, DOI 10.1093/jac/dkl538; Hassan MM, 2010, THAMMASAT INT J SCI, V15, P48; Igbinosa E. O., 2014, Journal of Applied Sciences and Environmental Management, V18, P165; Johnson JR, 2007, EMERG INFECT DIS, V13, P520; Johnson TJ, 2007, APPL ENVIRON MICROB, V73, P1976, DOI 10.1128/AEM.02171-06; Jun L, 2002, PLASMID, V48, P24, DOI 10.1016/S0147-619X(02)00007-0; Kang HY, 2005, J ANTIMICROB CHEMOTH, V55, P639, DOI 10.1093/jac/dki076; Kingsley RA, 2009, GENOME RES, V19, P2279, DOI 10.1101/gr.091017.109; Labar AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038142; Lee JC, 2001, J ANTIMICROB CHEMOTH, V47, P599, DOI 10.1093/jac/47.5.599; LEVESQUE C, 1995, ANTIMICROB AGENTS CH, V39, P185, DOI 10.1128/AAC.39.1.185; Mathai E, 2004, APMIS, V112, P159, DOI 10.1111/j.1600-0463.2004.apm1120301.x; Mathers AJ, 2015, ANTIMICROB AGENTS CH, V59, P1661, DOI 10.1128/AAC.04292-14; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Mordi RM, 2009, AFR J BIOTECHNOL, V8, P725; Odetoyin BW, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1365-x; Odumosu BT, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-29; Okeke IN, 2000, EMERG INFECT DIS, V6, P393; Okeke IN, 2002, J CLIN MICROBIOL, V40, P301, DOI 10.1128/JCM.40.1.301-305.2002; Okoro CK, 2012, NAT GENET, V44, P1215, DOI 10.1038/ng.2423; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Partridge SR, 2009, FEMS MICROBIOL REV, V33, P757, DOI 10.1111/j.1574-6976.2009.00175.x; Rodriguez I, 2006, J ANTIMICROB CHEMOTH, V58, P1124, DOI 10.1093/jac/dkl400; SCHOENHALS G, 1993, J BACTERIOL, V175, P5395, DOI 10.1128/JB.175.17.5395-5402.1993; Sepp E, 2009, ANN CLIN MICROB ANTI, V8, DOI 10.1186/1476-0711-8-34; Singha P, 2016, INDIAN J MED MICROBI, V34, P303, DOI 10.4103/0255-0857.188319; Solberg OD, 2006, J CLIN MICROBIOL, V44, P1347, DOI 10.1128/JCM.44.4.1347-1351.2006; Sunde M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128797; SUNDSTROM L, 1993, J BACTERIOL, V175, P1796; Tobe T, 1999, INFECT IMMUN, V67, P5455, DOI 10.1128/IAI.67.10.5455-5462.1999; Venturini C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078862; Vinue L, 2008, J ANTIMICROB CHEMOTH, V62, P934, DOI 10.1093/jac/dkn331; White PA, 2001, ANTIMICROB AGENTS CH, V45, P2658, DOI 10.1128/AAC.45.9.2658-2661.2001; Wirth T, 2006, MOL MICROBIOL, V60, P1136, DOI 10.1111/j.1365-2958.2006.05172.x; World Health Organization (WHO), 2014, WHO 1 GLOB REP ANT R; Yang CM, 2009, JPN J INFECT DIS, V62, P177; Yang QE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00964	52	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183383	10.1371/journal.pone.0183383	http://dx.doi.org/10.1371/journal.pone.0183383			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829804	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100042
J	Makela, A; Witte, U; Archambault, P				Makela, Anni; Witte, Ursula; Archambault, Philippe			Benthic macroinfaunal community structure, resource utilisation and trophic relationships in two Canadian Arctic Archipelago polynyas	PLOS ONE			English	Article							FOOD-WEB STRUCTURE; NORTHEAST WATER POLYNYA; MARGINAL ICE-ZONE; STABLE-ISOTOPE RATIOS; BEAUFORT SEA SHELF; BERING-SEA; BARENTS SEA; DEEP-SEA; DELTA-N-15 ANALYSIS; ORGANIC-MATTER	Climate change driven alterations to patterns of Arctic marine primary production, with increasing phytoplankton-and decreasing ice algal production, have the potential to change the resource utilisation and trophic structure of the benthic communities relying on the algae for food. To predict the benthic responses to dietary changes, we studied the macroinfaunal community compositions, and used the faunal delta(13) C and delta(15) N signatures to investigate their main food sources and trophic positions in North Water (NOW) and Lancaster Sound (LS) polynyas in the Canadian Arctic Archipelago. Macroinfaunal density (10 952 ind. m(-2)) and biomass (3190 mg C m(-2)) recorded in NOW were higher than previously found in the Arctic at depths >500m, and significantly higher than in LS (8355 ind. m-2 and 2110 mg C m(-2)). This was attributed to higher particulate organic matter fluxes to seafloor in NOW. Polychaetes were significant taxa at both sites in terms of density and biomass, and in addition crustacean density in NOW and bivalve density in LS were high. Facultative filter and surface deposit feeders were highly prevalent at both sites, suggesting feeding plasticity is a successful strategy for accessing different food sources. The macrofaunal delta(13) C signatures reflected the signatures of pelagic particulate organic matter at the sites, and an isotope mixing model confirmed phytoplankton as the main food source for most taxa and feeding guilds. The food web length in LS was longer than in NOW (3.2 vs. 2.8 trophic levels). This was attributed to a larger reliance on reworked organic matter by the benthic community in LS, whereas the high export fluxes at the highly productive NOW resulted in higher rates of selective consumption of fresh algal matter. Despite studies suggesting that loss of ice algae from consumer diets in the Arctic might have a negative impact on the benthos, this study suggests that Arctic macrobenthic communities thrive using phytoplankton as their main food source and should thus be able to cope or even benefit from predicted changes to patterns of primary production.	[Makela, Anni; Witte, Ursula] Univ Aberdeen, Sch Biol Sci, Oceanlab, Newburgh, Aberdeen, Scotland; [Archambault, Philippe] Univ Quebec, Inst Sci Mer Rimouski, Rimouski, PQ, Canada; [Archambault, Philippe] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Archambault, Philippe] Univ Laval, Dept Biol, Quebec City, PQ, Canada	University of Aberdeen; University of Quebec; Stanford University; Laval University	Makela, A (corresponding author), Univ Aberdeen, Sch Biol Sci, Oceanlab, Newburgh, Aberdeen, Scotland.	anni.makela10@gmail.com		Makela, Anni/0000-0001-6115-7747	Natural Environment Research Council [NE/J023094]; University of Aberdeen "The North" theme; Natural Environment Research Council [NE/J023094/1] Funding Source: researchfish; NERC [NE/J023094/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); University of Aberdeen "The North" theme; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by Natural Environment Research Council grant NE/J023094, http://www.nerc.ac.uk (UW); University of Aberdeen The North theme (AM); ArcticNet, http://www.arcticnet.ulaval.ca/ (PA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE WG, 1995, J GEOPHYS RES-OCEANS, V100, P4411, DOI 10.1029/94JC01982; Ardyna M, 2011, MAR ECOL PROG SER, V442, P37, DOI 10.3354/meps09378; Arrigo KR, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL035028; Barber DG, 2015, PROG OCEANOGR, V139, P122, DOI 10.1016/j.pocean.2015.09.003; Belanger S, 2013, BIOGEOSCIENCES, V9, P13987; Bell LE, 2016, MAR ECOL PROG SER, V550, P1, DOI 10.3354/meps11725; Bergmann M, 2009, DEEP-SEA RES PT I, V56, P408, DOI 10.1016/j.dsr.2008.10.004; Bicknell AWJ, 2011, RAPID COMMUN MASS SP, V25, P1794, DOI 10.1002/rcm.5049; Bluhm BA, 2005, POLAR BIOL, V28, P218, DOI 10.1007/s00300-004-0675-4; Bodil Bluhm A., 2011, Marine Biodiversity, V41, P87, DOI 10.1007/s12526-010-0078-4; Boetius A, 2013, SCIENCE, V339, P1430, DOI 10.1126/science.1231346; BORSTAD GA, 1984, ARCTIC, V37, P224; Bosley KL, 1999, CAN J FISH AQUAT SCI, V56, P2181, DOI 10.1139/cjfas-56-11-2181; Brandt A, 1999, POLAR BIOL, V22, P75, DOI 10.1007/s003000050392; BRANDT A, 1995, MAR ECOL PROG SER, V121, P39, DOI 10.3354/meps121039; CADEE GC, 1984, LETHAIA, V17, P289, DOI 10.1111/j.1502-3931.1984.tb00674.x; CAREY AG, 1987, MAR ECOL PROG SER, V40, P247, DOI 10.3354/meps040247; Carroll ML, 2012, POLAR BIOL, V35, P1259, DOI 10.1007/s00300-012-1171-x; Challenges H., 2012, POLAR BIOL, V35, P447; Clough LM, 2005, CAN J FISH AQUAT SCI, V62, P1756, DOI 10.1139/F05-102; Clough LM, 1997, DEEP-SEA RES PT II, V44, P1683, DOI 10.1016/S0967-0645(97)00052-0; Cochrane SKJ, 2009, J SEA RES, V61, P222, DOI 10.1016/j.seares.2009.01.003; Conlan K, 2008, J MARINE SYST, V74, P864, DOI 10.1016/j.jmarsys.2007.10.002; Cooper LW, 2013, DEEP-SEA RES PT II, V94, P31, DOI 10.1016/j.dsr2.2013.03.009; Coyle KO, 2007, DEEP-SEA RES PT II, V54, P2885, DOI 10.1016/j.dsr2.2007.08.025; Degen R, 2015, POLAR RES, V34, DOI 10.3402/polar.v34.24008; Deming JW, 2002, DEEP-SEA RES PT II, V49, P4887, DOI 10.1016/S0967-0645(02)00168-6; Demopoulos AWJ, 2007, OECOLOGIA, V153, P675, DOI 10.1007/s00442-007-0751-x; DENIRO MJ, 1981, GEOCHIM COSMOCHIM AC, V45, P341, DOI 10.1016/0016-7037(81)90244-1; Deubel H., 2003, P MARINE SCI, P237; DEUBEL H, 2000, BER POLARFORSCH, V370, P1; Divine LM, 2015, MAR ECOL PROG SER, V531, P15, DOI 10.3354/meps11340; Drazen JC, 2008, MAR ECOL PROG SER, V372, P157, DOI 10.3354/meps07707; Duerksen SW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114070; Dunton KH, 2012, ESTUAR COAST, V35, P416, DOI 10.1007/s12237-012-9475-1; DUNTON KH, 1987, MAR BIOL, V93, P615, DOI 10.1007/BF00392799; Edwards MS, 2002, COPEIA, P1106; Falk-Petersen S, 1998, POLAR BIOL, V20, P41, DOI 10.1007/s003000050274; Fanelli E, 2010, J EXP MAR BIOL ECOL, V395, P93, DOI 10.1016/j.jembe.2010.08.020; Fauchald K., 1979, Oceanography and Marine Biology an Annual Review, V17, P193; Feder HM, 2011, POLAR BIOL, V34, P521, DOI 10.1007/s00300-010-0906-9; Gaillard B, 2015, MAR ECOL PROG SER, V536, P175, DOI 10.3354/meps11424; Galeron J, 2000, MAR ECOL PROG SER, V197, P121, DOI 10.3354/meps197121; Gontikaki E, 2011, DEEP-SEA RES PT I, V58, P160, DOI 10.1016/j.dsr.2010.11.011; Gonzalez-Bergonzoni I, 2015, METHODS ECOL EVOL, V6, P307, DOI 10.1111/2041-210X.12313; Gradinger R, 2009, DEEP-SEA RES PT II, V56, P1201, DOI 10.1016/j.dsr2.2008.10.016; Grant J, 2002, DEEP-SEA RES PT II, V49, P5259, DOI 10.1016/S0967-0645(02)00189-3; Grebmeier J.M., 1991, Journal of Marine Systems, V2, P495, DOI 10.1016/0924-7963(91)90049-Z; Grebmeier JM, 2007, ELSEV OCEANOGR SERIE, V74, P363, DOI 10.1016/S0422-9894(06)74011-9; GREBMEIER JM, 1989, MAR ECOL PROG SER, V51, P253, DOI 10.3354/meps051253; GREBMEIER JM, 1988, MAR ECOL PROG SER, V48, P57, DOI 10.3354/meps048057; Harada N, 2016, GLOBAL PLANET CHANGE, V136, P1, DOI 10.1016/j.gloplacha.2015.11.005; Heide-Jorgensen MP, 2013, AMBIO, V42, P596, DOI 10.1007/s13280-012-0357-3; HOBSON KA, 1992, MAR ECOL PROG SER, V84, P9, DOI 10.3354/meps084009; Hobson KA, 2002, DEEP-SEA RES PT II, V49, P5131, DOI 10.1016/S0967-0645(02)00182-0; Hobson KA, 1995, MAR ECOL PROG SER, V128, P1, DOI 10.3354/meps128001; Hudson IR, 2004, MAR ECOL PROG SER, V281, P109, DOI 10.3354/meps281109; Iken K, 2005, POLAR BIOL, V28, P238, DOI 10.1007/s00300-004-0669-2; Iken K, 2001, PROG OCEANOGR, V50, P383, DOI 10.1016/S0079-6611(01)00062-3; Iken K, 2010, DEEP-SEA RES PT II, V57, P71, DOI 10.1016/j.dsr2.2009.08.007; Kaehler S, 2001, MAR ECOL PROG SER, V219, P299, DOI 10.3354/meps219299; Kaufman MR, 2008, OECOLOGIA, V158, P11, DOI 10.1007/s00442-008-1122-y; Kazanidis G, 2016, MAR BIOL RES, V12, P932, DOI 10.1080/17451000.2016.1216569; Kedra M, 2012, ESTUAR COAST SHELF S, V114, P183, DOI 10.1016/j.ecss.2012.08.015; Kenchington E, 2011, IDENTIFICATION MEGA; Klein B, 2002, DEEP-SEA RES PT II, V49, P4983, DOI 10.1016/S0967-0645(02)00174-1; Kroncke I, 1998, POLAR BIOL, V19, P383, DOI 10.1007/s003000050263; KRONCKE I, 1994, POLAR BIOL, V14, P519, DOI 10.1007/BF00238221; Kroncke I, 2000, MAR ECOL PROG SER, V199, P31, DOI 10.3354/meps199031; Lalande C., 2003, COMPOSITION STRUCTUR; Lalande C, 2009, CONT SHELF RES, V29, P2157, DOI 10.1016/j.csr.2009.08.009; Lau DCP, 2012, LIMNOL OCEANOGR-METH, V10, P75, DOI 10.4319/lom.2012.10.75; Layman CA, 2013, MAR BIOL RES, V9, P831; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Leu E, 2015, PROG OCEANOGR, V139, P151, DOI 10.1016/j.pocean.2015.07.012; Leu E, 2011, PROG OCEANOGR, V90, P18, DOI 10.1016/j.pocean.2011.02.004; Leu E, 2006, CAN J FISH AQUAT SCI, V63, P2760, DOI 10.1139/F06-159; Link H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074077; Link H, 2011, POLAR BIOL, V34, P2025, DOI 10.1007/s00300-011-1046-6; Lovvorn JR, 2016, MAR ECOL PROG SER, V548, P11, DOI 10.3354/meps11651; Lovvorn JR, 2005, MAR ECOL PROG SER, V291, P135, DOI 10.3354/meps291135; MacDonald IR, 2010, DEEP-SEA RES PT II, V57, P136, DOI 10.1016/j.dsr2.2009.08.012; Macdonald TA, 2012, MAR ECOL PROG SER, V445, P129, DOI 10.3354/meps09478; Mateo MA, 2008, OECOLOGIA, V157, P105, DOI 10.1007/s00442-008-1052-8; MCCONNAUGHEY T, 1979, MAR BIOL, V53, P257, DOI 10.1007/BF00952434; McMahon KW, 2006, MAR ECOL PROG SER, V310, P1, DOI 10.3354/meps310001; Michel C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2000JC000408; Michel C, 2006, PROG OCEANOGR, V71, P379, DOI 10.1016/j.pocean.2006.09.006; Michener RH, 2007, ECOL METHOD CONCEPT, P238, DOI 10.1002/9780470691854.ch9; Mincks SL, 2008, DEEP-SEA RES PT II, V55, P2502, DOI 10.1016/j.dsr2.2008.06.009; NAIDU AS, 1993, CONT SHELF RES, V13, P669, DOI 10.1016/0278-4343(93)90099-J; North CA, 2014, ECOL APPL, V24, P1525, DOI 10.1890/13-0486.1; Overland JE, 2013, GEOPHYS RES LETT, V40, P2097, DOI 10.1002/grl.50316; Pabi S, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004578; Parnell A. C., 2013, SIAR STABLE ISOTOPE; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; PAUL AZ, 1974, MAR BIOL, V27, P251, DOI 10.1007/BF00391950; Piepenburg D, 2005, POLAR BIOL, V28, P733, DOI 10.1007/s00300-005-0013-5; Piepenburg D, 1997, J MARINE SYST, V10, P467, DOI 10.1016/S0924-7963(96)00050-4; PIEPENBURG D, 1995, MAR ECOL PROG SER, V118, P199, DOI 10.3354/meps118199; Piepenburg Dieter, 2011, Marine Biodiversity, V41, P51, DOI 10.1007/s12526-010-0059-7; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Renaud PE, 2007, J EXP MAR BIOL ECOL, V349, P248, DOI 10.1016/j.jembe.2007.05.021; Renaud PE, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00031; Renaud PE, 2011, MAR BIOL RES, V7, P13, DOI 10.1080/17451001003671597; Riaux-Gobin C, 1993, HDB METHODS AQUATIC, P369, DOI DOI 10.1201/9780203752746-43; Roy V, 2015, DEEP-SEA RES PT I, V102, P55, DOI 10.1016/j.dsr.2015.04.009; Roy V, 2015, ARCTIC, V68, P180, DOI 10.14430/arctic4486; Roy V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100900; Sakshaug E, 2004, ORGANIC CARBON CYCLE IN THE ARCTIC OCEAN, P57; Sarakinos HC, 2002, CAN J ZOOL, V80, P381, DOI 10.1139/z02-007; Schonberg SV, 2014, DEEP-SEA RES PT II, V102, P144, DOI 10.1016/j.dsr2.2013.11.004; Slagstad D, 2015, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00085; Smith CR, 2008, TRENDS ECOL EVOL, V23, P518, DOI 10.1016/j.tree.2008.05.002; Soltwedel T, 1998, POLAR BIOL, V19, P52; Soreide JE, 2010, GLOBAL CHANGE BIOL, V16, P3154, DOI 10.1111/j.1365-2486.2010.02175.x; STEWART PL, 1985, ARCTIC, V38, P281; STIRLING I, 1980, ARCTIC, V33, P303; Stoker S. W, 1978, BENTHIC INVERTEBRATE; Sun MY, 2009, J EXP MAR BIOL ECOL, V376, P110, DOI 10.1016/j.jembe.2009.06.018; Sweetman AK, 2008, DEEP-SEA RES PT I, V55, P1503, DOI 10.1016/j.dsr.2008.06.004; Tamelander T, 2006, MAR ECOL PROG SER, V310, P33, DOI 10.3354/meps310033; Tamelander T, 2008, DEEP-SEA RES PT II, V55, P2330, DOI 10.1016/j.dsr2.2008.05.019; THOMSON DH, 1982, ARCTIC, V35, P61; Tremblay JE, 2002, DEEP-SEA RES PT II, V49, P4927, DOI 10.1016/S0967-0645(02)00171-6; Tremblay JE, 2006, PROG OCEANOGR, V71, P402, DOI 10.1016/j.pocean.2006.10.006; Tu KL, 2015, MAR ECOL PROG SER, V528, P19, DOI 10.3354/meps11216; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; WASSMANN P, 1991, POLAR RES, V10, P209, DOI 10.1111/j.1751-8369.1991.tb00647.x; Wassmann P, 2006, PROG OCEANOGR, V71, P232, DOI 10.1016/j.pocean.2006.10.003; WELCH HE, 1992, ARCTIC, V45, P343; Wlodarska Maria, 1996, Oceanologia, V38, P251; Wlodarska-Kowalczuk M, 2004, DEEP-SEA RES PT I, V51, P1903, DOI 10.1016/j.dsr.2004.07.013; WoRMS Editorial Board, 2016, WORLD REGISTER MARIN; Wurzberg L, 2011, DEEP-SEA RES PT II, V58, P153, DOI 10.1016/j.dsr2.2010.10.014; Xu J, 2011, AQUAT ECOL, V45, P483, DOI 10.1007/s10452-011-9369-5; Yokoyama H, 2005, MAR ECOL PROG SER, V296, P115, DOI 10.3354/meps296115	137	7	11	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183034	10.1371/journal.pone.0183034	http://dx.doi.org/10.1371/journal.pone.0183034			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850574	Green Submitted, Green Published, gold			2022-12-27	WOS:000408544200009
J	Belykh, E; Kalinin, AA; Patel, AA; Miller, EJ; Bohl, MA; Stepanov, IA; Bardonova, LA; Kerimbaev, T; Asantsev, AO; Giers, MB; Preul, MC; Byvaltsev, VA				Belykh, Evgenii; Kalinin, Andrey A.; Patel, Arpan A.; Miller, Eric J.; Bohl, Michael A.; Stepanov, Ivan A.; Bardonova, Liudmila A.; Kerimbaev, Talgat; Asantsev, Anton O.; Giers, Morgan B.; Preul, Mark C.; Byvaltsev, Vadim A.			Apparent diffusion coefficient maps in the assessment of surgical patients with lumbar spine degeneration	PLOS ONE			English	Article							INTERVERTEBRAL DISC DEGENERATION; NERVE ROOT ENTRAPMENT; MODIC CHANGES; WEIGHTED MRI; HERNIATION; DISEASE; SYMPTOMS; SYSTEM	Purpose To assess the utility of apparent diffusion coefficient (ADC) maps for the assessment of patients with advanced degenerative lumbar spine disease and describe characteristic features of ADC maps in various degenerative lumbar spinal conditions. Methods T1-weighted, T2-weighted and diffusion weighted (DWI) MR images of 100 consecutive patients admitted to the spinal surgery service were assessed. ADC maps were generated from DWI images using Osyrix software. The ADC values and characteristic ADC maps were assessed in the regions of interest over the different pathological entities of the lumbar spine. Results The study included 452 lumbar vertebral segments available for analysis of ADCs. Characteristic ADC map features were identified for protrusion, extrusion and sequester types of lumbar disk herniations, spondylolisthesis, reactive Modic endplate changes, Pfirrmann grades of IVD degeneration, and compromised spinal nerves. Compromised nerve roots had significantly higher mean ADC values than adjacent (p < 0.001), contralateral (p < 0.001) or adjacent contralateral (p < 0.001) nerve roots. Compared to the normal bone marrow, Modic I changes showed higher ADC values (p = 0.01) and Modic 2 changes showed lower ADC values (p = 0.02) respectively. ADC values correlated with the Pfirrmann grading, however differed from herniated and non-herniated disks of the matched Pfirrmann 3 and 4 grades. Conclusion Quantitative and qualitative evaluation of ADC mapping may provide additional useful information regarding the fluid dynamics of the degenerated spine and may complement standard MRI imaging protocol for the comprehensive assessment of surgical patients with lumbar spine pathology. ADC maps were advantageous in differentiating reactive bone marrow changes, and more precise assessment of the disk degeneration state. ADC mapping of compressed nerve roots showed promise but requires further investigation on a larger cohort of patients.	[Belykh, Evgenii; Kalinin, Andrey A.; Stepanov, Ivan A.; Bardonova, Liudmila A.; Asantsev, Anton O.; Byvaltsev, Vadim A.] Irkutsk Sci Ctr Surg & Traumatol, Lab Neurosurg, Irkutsk, Russia; [Belykh, Evgenii; Kalinin, Andrey A.; Stepanov, Ivan A.; Bardonova, Liudmila A.; Asantsev, Anton O.; Byvaltsev, Vadim A.] Irkutsk State Med Univ, Dept Neurosurg, Irkutsk, Russia; [Belykh, Evgenii; Patel, Arpan A.; Miller, Eric J.; Bohl, Michael A.; Giers, Morgan B.; Preul, Mark C.] St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA; [Kerimbaev, Talgat] JSC Natl Sci Ctr Neurosurg, Dept Spinal Surg & Pathol Peripheral Nervous Syst, Astana, Kazakhstan	Irkutsk Science Centre of the Russian Academy of Sciences; Irkutsk Scientific Center of Surgery & Traumatology; Irkutsk State Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Belykh, E (corresponding author), Irkutsk Sci Ctr Surg & Traumatol, Lab Neurosurg, Irkutsk, Russia.; Belykh, E (corresponding author), Irkutsk State Med Univ, Dept Neurosurg, Irkutsk, Russia.; Belykh, E (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Dept Neurosurg, Phoenix, AZ 85013 USA.	belykhevgenii@gmail.com	Kerimbayev, Talgat/Y-2409-2018; Belykh, Evgenii/O-8279-2017; Kerimbayev, Talgat/N-7615-2019; Giers, Morgan/AAT-1536-2021; Byvaltsev, Vadim A./GPX-8832-2022; Byvaltsev, Vadim/D-1962-2018; Kalinin, Andrei A./R-7408-2016	Belykh, Evgenii/0000-0003-2060-5739; Byvaltsev, Vadim/0000-0003-4349-7101; Kalinin, Andrei A./0000-0002-6059-4344; Stepanov, Ivan/0000-0001-9039-9147; Giers, Morgan B/0000-0002-2247-1167	Russian Science Foundation [15-15-30037]; Newsome Chair in Neurosurgery Research	Russian Science Foundation(Russian Science Foundation (RSF)); Newsome Chair in Neurosurgery Research	This work was supported by Russian Science Foundation, Project 15-15-30037, WWW rsct.ru/en. Dr. Preul acknowledges support from a Newsome Chair in Neurosurgery Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are thankful to the staff of the radiology department at the Irkutsk Railway Clinical Hospital. Dr. Preul acknowledges support from a Newsome Chair in Neurosurgery Research.	Beattie PF, 2000, SPINE, V25, P819, DOI 10.1097/00007632-200004010-00010; Belykh E, 2015, WORLD NEUROSURG, V84, P871, DOI 10.1016/j.wneu.2015.08.011; Chuanting L, 2014, ACTA RADIOL, V55, P969; Dudli S, 2016, EUR SPINE J, V25, P3723, DOI 10.1007/s00586-016-4459-7; Eguchi Y, 2016, BONE JOINT J, V98B, P387, DOI 10.1302/0301-620X.98B3.36036; Eguchi Y, 2011, SPINE, V36, pE198, DOI 10.1097/BRS.0b013e3181d5ff05; Eguchi Y, 2010, EUR SPINE J, V19, P1874, DOI 10.1007/s00586-010-1520-9; Fardon DF, 2014, SPINE, V39, pE1448, DOI 10.1097/BRS.0b013e3182a8866d; Feng ZY, 2016, SPINE, V41, pE987, DOI 10.1097/BRS.0000000000001526; Griffith JF, 2007, SPINE, V32, pE708, DOI 10.1097/BRS.0b013e31815a59a0; Hoy D, 2014, ANN RHEUM DIS, V73, P968, DOI 10.1136/annrheumdis-2013-204428; Huang YC, 2014, NAT REV RHEUMATOL, V10, P561, DOI 10.1038/nrrheum.2014.91; Kottlors M, 2010, J NEUROSURG-SPINE, V12, P314, DOI 10.3171/2009.9.SPINE09114; Koyama H, 2013, CLIN IMAG, V37, P925, DOI 10.1016/j.clinimag.2013.05.001; Messiou C, 2012, BRIT J RADIOL, V85, pE1198, DOI 10.1259/bjr/52759767; MODIC MT, 1988, RADIOLOGY, V168, P177, DOI 10.1148/radiology.168.1.3289089; Niinimaki J, 2009, MAGN RESON IMAGING, V27, P641, DOI 10.1016/j.mri.2008.10.005; Patel KB, 2014, AM J NEURORADIOL, V35, P1647, DOI 10.3174/ajnr.A3948; Pfirrmann CWA, 2001, SPINE, V26, P1873, DOI 10.1097/00007632-200109010-00011; Reinhold M, 2015, EUR SPINE J, V24, P319, DOI 10.1007/s00586-014-3602-6; Rim Dae Cheol, 2016, Korean J Spine, V13, P1, DOI 10.14245/kjs.2016.13.1.1; Sakai T, 2014, J MED INVESTIG, V61, P197, DOI 10.2152/jmi.61.197; Sartoretti-Schefer S, 2013, CLIN IMAG, V37, P176, DOI 10.1016/j.clinimag.2012.02.022; Sucu HK, 2006, EUR SPINE J, V15, P570, DOI 10.1007/s00586-005-0971-x; Takashima H, 2013, SPINE, V38, pE998, DOI 10.1097/BRS.0b013e31829862d3; Yu HJ, 2015, EUR SPINE J, V24, P2442, DOI 10.1007/s00586-014-3721-0; Zhang W, 2014, EUR SPINE J, V23, P1830, DOI 10.1007/s00586-014-3285-z; Zhang ZP, 2012, MAGN RESON IMAGING, V30, P181, DOI 10.1016/j.mri.2011.09.021; Zhang ZW, 2009, SPINE, V34, pE245, DOI 10.1097/BRS.0b013e318197162e	29	6	11	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183697	10.1371/journal.pone.0183697	http://dx.doi.org/10.1371/journal.pone.0183697			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846710	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600046
J	Plein, M; Morris, WK; Moir, ML; Vesk, PA				Plein, Michaela; Morris, William K.; Moir, Melinda L.; Vesk, Peter A.			Identifying species at coextinction risk when detection is imperfect: Model evaluation and case study	PLOS ONE			English	Article							PLANT; SPECIALIZATION; BIODIVERSITY; EXTINCTION; NETWORKS; CONSERVATION; POLLINATORS; COMMUNITIES; TURNOVER; ECOLOGY	Losing a species from a community can cause further extinctions, a process also known as coextinction. The risk of being extirpated with an interaction partner is commonly inferred from a species' host-breadth, derived from observing interactions between species. But observational data suffers from imperfect detection, making coextinction estimates highly unreliable. To address this issue and to account for data uncertainty, we fit a hierarchical N-mixture model to individual-level interaction data from a mutualistic network. We predict (1) with how many interaction partners each species interacts (to indicate their coextinction risk) and (2) how completely the community was sampled. We fit the model to simulated interactions to investigate how variation in sampling effort, interaction probability, and animal abundances influence model accuracy and apply it to an empirical dataset of flowering plants and their insect visitors. The model performed well in predicting the number of interaction partners for scenarios with high abundances, but indicated high parameter uncertainty for networks with many rare species. Yet, model predictions were generally closer to the true value than the observations. Our mutualistic plant-insect community most closely resembled the scenario of high interaction rates with low abundances. Median estimates of interaction partners were frequently much higher than the empirical data indicate, but uncertainty was high. Our analysis suggested that we only detected 14-59% of the flower-visiting insect species, indicating that our study design, which is common for pollinator studies, was inadequate to detect many species. Imperfect detection strongly affects the inferences from observed interaction networks and hence, host specificity, specialisation estimates and network metrics from observational data may be highly misleading for assessing a species' coextinction risks. Our study shows how models can help to estimate coextinction risk, but also indicates the need for better data (i.e., intensified sampling and individual-level observations) to reduce uncertainty.	[Plein, Michaela] Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld 4072, Australia; [Plein, Michaela; Morris, William K.; Vesk, Peter A.] Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia; [Moir, Melinda L.] Univ Western Australia, Sch Biol Sci, Crawley, WA 6009, Australia	University of Queensland; University of Melbourne; University of Western Australia	Plein, M (corresponding author), Univ Queensland, Sch Earth & Environm Sci, St Lucia, Qld 4072, Australia.; Plein, M (corresponding author), Univ Melbourne, Sch BioSci, Parkville, Vic 3010, Australia.	m.plein@uq.edu.au	Vesk, Peter/AAG-9970-2020	Vesk, Peter/0000-0003-2008-7062; Moir, Melinda/0000-0002-6765-5162; Plein, Michaela/0000-0002-7912-2486	Centre of Excellence for Environmental Decisions, Australian Research Council Australian Postgraduate Award	Centre of Excellence for Environmental Decisions, Australian Research Council Australian Postgraduate Award(Australian Research Council)	This work was supported by Centre of Excellence for Environmental Decisions, Australian Research Council Australian Postgraduate Award.	Aizen MA, 2012, SCIENCE, V335, P1486, DOI 10.1126/science.1215320; Almeida-Neto M, 2011, ENVIRON MODELL SOFTW, V26, P173, DOI 10.1016/j.envsoft.2010.08.003; Barrett S, 2015, AUSTRAL ECOL, V40, P423, DOI 10.1111/aec.12199; Bartomeus I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069200; Bascompte J, 2007, ANNU REV ECOL EVOL S, V38, P567, DOI 10.1146/annurev.ecolsys.38.091206.095818; Beckett SJ, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.140536; Bluthgen N, 2007, CURR BIOL, V17, P341, DOI 10.1016/j.cub.2006.12.039; Bluthgen N, 2010, BASIC APPL ECOL, V11, P185, DOI 10.1016/j.baae.2010.01.001; Bluthgen N, 2008, ECOLOGY, V89, P3387, DOI 10.1890/07-2121.1; CaraDonna PJ, 2017, ECOL LETT, V20, P385, DOI 10.1111/ele.12740; Chacoff NP, 2012, J ANIM ECOL, V81, P190, DOI 10.1111/j.1365-2656.2011.01883.x; Cressie N, 2009, ECOL APPL, V19, P553, DOI 10.1890/07-0744.1; Dorado J, 2011, ECOLOGY, V92, P19, DOI 10.1890/10-0794.1; Dorazio RM, 2006, ECOLOGY, V87, P842, DOI 10.1890/0012-9658(2006)87[842:ESRAAB]2.0.CO;2; Dormann C.F., 2009, OPN ECOL J, V2, P7, DOI 10.2174/1874213000902010007; Evans R, 2003, GIANT ANDERSONIA AND; Fonseca CR, 2009, CONSERV BIOL, V23, P1507, DOI 10.1111/j.1523-1739.2009.01327.x; Fontaine C, 2009, P R SOC B, V276, P3027, DOI 10.1098/rspb.2009.0635; Frund J, 2016, OIKOS, V125, P502, DOI 10.1111/oik.02256; Gelman Andrew, 2006, DATA ANALYSIS USING; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hall DB, 2000, BIOMETRICS, V56, P1030, DOI 10.1111/j.0006-341X.2000.01030.x; Hastings A, 1999, AM NAT, V153, P295, DOI 10.1086/303172; Hegland SJ, 2010, BIOL CONSERV, V143, P2092, DOI 10.1016/j.biocon.2010.05.018; Hopper SD, 2004, ANNU REV ECOL EVOL S, V35, P623, DOI 10.1146/annurev.ecolsys.35.112202.130201; Kaiser-Bunbury CN, 2015, AOB PLANTS, V7, DOI 10.1093/aobpla/plv076; Kaiser-Bunbury CN, 2010, ECOL LETT, V13, P442, DOI 10.1111/j.1461-0248.2009.01437.x; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Krishna A, 2008, OIKOS, V117, P1609, DOI 10.1111/j.1600-0706.2008.16540.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; McGill BJ, 2007, ECOL LETT, V10, P995, DOI 10.1111/j.1461-0248.2007.01094.x; Moir ML, 2013, NATIONAL CLIMATE CHA; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nipperess DA, 2012, BIODIVERS CONSERV, V21, P323, DOI 10.1007/s10531-011-0185-y; Olesen JM, 2007, P NATL ACAD SCI USA, V104, P19891, DOI 10.1073/pnas.0706375104; Olesen JM, 2011, P ROY SOC B-BIOL SCI, V278, P725, DOI 10.1098/rspb.2010.1371; Phillimore R, 2001, THE INTERIM RECOVERY; Plein M, 2013, ECOLOGY, V94, P1296, DOI 10.1890/12-1213.1; Plummer M., 2015, RJAGS BAYESIAN GRAPH; Poulin R, 2011, TRENDS PARASITOL, V27, P355, DOI 10.1016/j.pt.2011.05.003; R Development Core Team, 2008, A LANGUAGE AND ENVIR; Regan HM, 2002, ECOL APPL, V12, P618, DOI 10.2307/3060967; Rohr RP, 2014, SCIENCE, V345, P416, DOI 10.1126/science.1253497; Schleuning M, 2015, ECOGRAPHY, V38, P380, DOI 10.1111/ecog.00983; Staniczenko PPA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2422; Strona G, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2723; Thacker JI, 2006, ORYX, V40, P233, DOI 10.1017/S0030605306000123; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Tylianakis JM, 2010, BIOL CONSERV, V143, P2270, DOI 10.1016/j.biocon.2009.12.004; V. Optimal Foraging and Predator-Prey Dynamics, 1996, THEORETICAL POPULATI, V49, P265; Vamosi JC, 2014, ECOL EVOL, V4, P2303, DOI 10.1002/ece3.1051; Vazquez DP, 2015, ECOL LETT, V18, P385, DOI 10.1111/ele.12411; Vazquez DP, 2009, ECOLOGY, V90, P2039, DOI 10.1890/08-1837.1; Vazquez DP, 2005, OIKOS, V108, P421, DOI 10.1111/j.0030-1299.2005.13619.x; Vazquez DP, 2004, ECOLOGY, V85, P1251, DOI 10.1890/03-3112; Vesk PA, 2010, METHODS ECOL EVOL, V1, P292, DOI 10.1111/j.2041-210X.2010.00026.x; Vieira MC, 2015, ECOL LETT, V18, P144, DOI 10.1111/ele.12394; Walker JG, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0095; Wells K, 2013, METHODS ECOL EVOL, V4, P1, DOI 10.1111/j.2041-210x.2012.00249.x	59	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183351	10.1371/journal.pone.0183351	http://dx.doi.org/10.1371/journal.pone.0183351			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846734	Green Published, gold			2022-12-27	WOS:000408438600027
J	Serrano-Urrea, R; Gomez-Rubio, V; Palacios-Cena, D; Fernandez-de-las-Penas, C; Garcia-Meseguer, MJ				Serrano-Urrea, Ramon; Gomez-Rubio, Virgilio; Palacios-Cena, Domingo; Fernandez-de-las-Penas, Cesar; Jose Garcia-Meseguer, Maria			Individual and institutional factors associated with functional disability in nursing home residents: An observational study with multilevel analysis	PLOS ONE			English	Article							SPANISH POPULATION; OLDER-ADULTS; HEALTH; CARE; OUTCOMES; FRAILTY; LIMITATIONS; PREVALENCE; UNDERSTOOD; DEPENDENCE	Background High prevalence of functional limitations has been previously observed in nursing homes. Disability may depend not only on the characteristics of the residents but also on the facility characteristics. The aims of this study were: 1, to describe the prevalence of functional disability in older people living in Spanish nursing homes; and 2, to analyze the relationships between individual and nursing home characteristics and residents' functional disability. Methods A cross-sectional study with data collected from 895 residents in 34 nursing homes in the province of Albacete (Spain) was conducted. Functional status was assessed by the Barthel Index. Taking into account both levels of data (individual and institutional characteristics) we resorted to a multilevel analysis in order to take different sources of variability in the data. Results The prevalence of functional disability of the total sample was 79.8%. The best fitting multilevel model showed that female gender, older age, negative self-perception of health, and living in private nursing homes were factors significantly associated with functional disability. After separating individual and institutional effects, the institutions showed significant differences. Conclusions In line with previous findings, our study found high levels of functional dependence among institutionalized elders. Gender, age, self-perception of health, and institution ownership were associated with functional status. Disentangling individual and institutional effects by means of multilevel models can help evaluate the quality of the residences.	[Serrano-Urrea, Ramon] Univ Castilla La Mancha, Fac Comp Sci Engn, Dept Math, Albacete, Spain; [Gomez-Rubio, Virgilio] Univ Castilla La Mancha, Fac Ind Engn, Dept Math, Albacete, Spain; [Palacios-Cena, Domingo; Fernandez-de-las-Penas, Cesar] Rey Juan Carlos Univ, Dept Phys Therapy Occupat Therapy Rehabil & Phys, Madrid, Spain; [Jose Garcia-Meseguer, Maria] Univ Castilla La Mancha, Fac Nursing, Dept Nursing & Physiotherapy, Albacete, Spain	Universidad de Castilla-La Mancha; Universidad de Castilla-La Mancha; Universidad Rey Juan Carlos; Universidad de Castilla-La Mancha	Serrano-Urrea, R (corresponding author), Univ Castilla La Mancha, Fac Comp Sci Engn, Dept Math, Albacete, Spain.	ramon.serrano@uclm.es	Rubio, Virgilio Gómez/K-5496-2012; PALACIOS-CEÑA, DOMINGO/B-6944-2015	Rubio, Virgilio Gómez/0000-0002-4791-3072; PALACIOS-CEÑA, DOMINGO/0000-0003-0669-6339; Fernandez-de-las-Penas, Cesar/0000-0003-3772-9690	University of Castilla-La Mancha; Department of Health and Social Welfare of Castilla -La Mancha; University of Castilla-La Mancha, Spain [AT687]	University of Castilla-La Mancha; Department of Health and Social Welfare of Castilla -La Mancha; University of Castilla-La Mancha, Spain	This research was supported in part by a grant from the University of Castilla-La Mancha, Spain (AT687). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors are very grateful to (1) Rosa Maria Iglesias Llopart and Llanos Arenas Tebar for their contribution in the data collection, (2) managers of the nursing homes who accepted to take part in this survey, (3) nursing home staffs for their cooperation, and, (4) residents who accepted to take part in the survey. The authors also acknowledge the support of the University of Castilla-La Mancha and the Department of Health and Social Welfare of Castilla -La Mancha.	Abellan Garcia A, 2017, PROFILE ELDERLY SPAI; Abizanda P, 2014, J Nutr Health Aging, V18, P622, DOI 10.1007/s12603-014-0033-3; Almazan-Isla J, 2017, INT J EQUITY HEALTH, V16, DOI 10.1186/s12939-016-0498-2; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beltran B, 2001, J Nutr Health Aging, V5, P259; Boonen A, 2007, CLIN RHEUMATOL, V26, P1803, DOI 10.1007/s10067-007-0623-0; Brownie S, 2013, CLIN INTERV AGING, V8, P1, DOI 10.2147/CIA.S38589; Casado-Marin David, 2006, Gac Sanit, V20 Suppl 1, P135, DOI 10.1157/13086037; Chang YP, 2013, J AM MED DIR ASSOC, V14, P293, DOI 10.1016/j.jamda.2013.01.013; Cho HY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13080826; Cohen-Mansfield J, 2008, INT J GERIATR PSYCH, V23, P376, DOI 10.1002/gps.1888; Consejo Superior de Investigaciones Cientificas (CSIC), 2015, STAT RES DISTR CTR P; d'Orsi E, 2014, J AM GERIATR SOC, V62, P1630, DOI 10.1111/jgs.12990; Dahlin-Ivanoff S, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0345-8; de la Rica-Escuin M, 2014, MATURITAS, V78, P329, DOI 10.1016/j.maturitas.2014.05.022; den Ouden MEM, 2011, MATURITAS, V69, P208, DOI 10.1016/j.maturitas.2011.04.008; Doumit JH, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-629; Farzianpour Fereshteh, 2015, Glob J Health Sci, V8, P127, DOI 10.5539/gjhs.v8n4p127; Flores Ruano Teresa, 2014, Rev Esp Geriatr Gerontol, V49, P235, DOI 10.1016/j.regg.2014.05.002; Fuller-Thomson E., 2005, J GERONTOL A-BIOL, V64, P1333, DOI DOI 10.1093/GER0NA/GLP130; Hacihasanoglu R, 2012, ARCH GERONTOL GERIAT, V54, P61, DOI 10.1016/j.archger.2011.03.011; Harris LJ, 2013, VERSITA DISCIPLIN, P1, DOI 10.2478/9788376560052; Harris-Kojetin L., 2016, VITAL HLTH STAT, V3, DOI DOI 10.1111/J.1532-5415.2010.02875.X; Hayward RD, 2013, J BEHAV MED, V36, P354, DOI 10.1007/s10865-012-9430-4; Hybels CF, 2012, GERONTOLOGIST, V52, P676, DOI 10.1093/geront/gnr156; Idler EL, 1997, J GERONTOL B-PSYCHOL, V52, pS306, DOI 10.1093/geronb/52B.6.S306; Levy CR, 2016, GERONTOLOGIST, V56, P52, DOI 10.1093/geront/gnv099; Li JX, 2014, INT J NURS STUD, V51, P1395, DOI 10.1016/j.ijnurstu.2014.04.003; MAHONEY F I, 1965, Md State Med J, V14, P61; Molina Schmid A., 2010, SPANISH ACCREDITATIO; Moser C, 2011, J GERONTOL B-PSYCHOL, V66, P675, DOI 10.1093/geronb/gbr052; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; Nakazawa A, 2012, J EPIDEMIOL, V22, P501, DOI 10.2188/jea.JE20110153; Onder G, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-5; Onem Y, 2010, ARCH GERONTOL GERIAT, V50, P56, DOI 10.1016/j.archger.2009.01.010; Organisation for Economic Co-operation and Development (OECD), 2015, HLTH AT A GLANC; Palacios-Cena D, 2014, GERIATR GERONTOL INT, V14, P212, DOI 10.1111/ggi.12066; Palacios-Cena D, 2013, J NURS MANAGE, V21, P1044, DOI 10.1111/j.1365-2834.2012.01445.x; Palacios-Cena D, 2012, J AM MED DIR ASSOC, V13, P136, DOI 10.1016/j.jamda.2010.05.007; Palese A, 2016, J AM MED DIR ASSOC, V17, P694, DOI 10.1016/j.jamda.2016.04.002; Peafiel-Olivar AE, 2010, STANDARD CARE NURSIN; Perez-del-Molino-Martin J, 2008, SINDROMES CUIDADOS P, P167; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Rijnaard MD, 2016, J AGING RES, V2016; Roberts HC, 2014, AGE AGEING, V43, P241, DOI 10.1093/ageing/aft118; Rosen M, 2005, SCAND J PUBLIC HEALT, V33, P151, DOI 10.1080/14034940510032121; Sarasa S, 2011, SPANISH WELFARE STATE IN EUROPEAN CONTEXT, P237; Sato S, 2001, Environ Health Prev Med, V6, P92, DOI 10.1007/BF02897952; Serrano-Urrea R, 2013, GERONTOLOGY, V59, P490, DOI 10.1159/000351763; Serrano-Urrea R, 2014, MATURITAS, V78, P323, DOI 10.1016/j.maturitas.2014.05.021; SHAH S, 1989, J CLIN EPIDEMIOL, V42, P703, DOI 10.1016/0895-4356(89)90065-6; Spanish Government Bulletin, 1999, PERS DAT PROT ACT; Spanish Government Bulletin, 2007, BIOM RES ACT; Strandberg TE, 2007, LANCET, V369, P1328, DOI 10.1016/S0140-6736(12)62167-9; Strathmann S, 2013, J NUTR HEALTH AGING, V17, P271, DOI 10.1007/s12603-012-0410-8; Suhonen R, 2011, J NURS MANAGE, V19, P883, DOI 10.1111/j.1365-2834.2011.01243.x; Talley KMC, 2014, NURS RES, V63, P94, DOI 10.1097/NNR.0000000000000017; Taylor Janice, 2016, Nurs Stand, V30, P51, DOI 10.7748/ns.30.29.51.s47; United Nations, 2015, TRENDS INT MIGR STOC; Vaida F, 2005, BIOMETRIKA, V92, P351, DOI 10.1093/biomet/92.2.351; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Wang J, 2010, J AM GERIATR SOC, V58, P2275, DOI 10.1111/j.1532-5415.2010.03173.x; Wang J, 2009, J GERONTOL A-BIOL, V64, P473, DOI 10.1093/gerona/gln040; Wang P, 2016, HEALTH QUAL LIFE OUT, V14, DOI 10.1186/s12955-016-0503-x; World Health Organization, 2012, World Health Organ Tech Rep Ser, P1; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Xiao HM, 2016, WESTERN J NURS RES, V38, P738, DOI 10.1177/0193945915621260; Yeh SCJ, 2004, J NURS CARE QUAL, V19, P58, DOI 10.1097/00001786-200401000-00011; Yoon JY, 2016, INT J NURS STUD, V53, P238, DOI 10.1016/j.ijnurstu.2015.07.010; Zunzunegui MV, 2006, AGING CLIN EXP RES, V18, P352, DOI 10.1007/BF03324830	70	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183945	10.1371/journal.pone.0183945	http://dx.doi.org/10.1371/journal.pone.0183945			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846744	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600060
J	Sevilhano, T; de Carvalho, RF; Oliveira, NAD; Oliveira, JE; Maltarollo, VG; Trossini, G; Garcez, R; Bartolini, P				Sevilhano, Thais; de Carvalho, Roberto Feitosa; de Jesus Oliveira, Nelio Alessandro; Oliveira, Joao Ezequiel; Maltarollo, Vinicius Goncalves; Trossini, Gustavo; Garcez, Riviane; Bartolini, Paolo			Molecular cloning and characterization of pirarucu (Arapaima gigas) follicle-stimulating hormone and luteinizing hormone beta-subunit cDNAs	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; ACTIVE RECOMBINANT FSH; GLYCOPROTEIN HORMONE; ALPHA-SUBUNIT; LH-BETA; GONADOTROPIN SUBUNITS; RECEPTOR-BINDING; SEAT-BELT; SEQUENCE; FOLLITROPIN	The common gonadotrophic hormone alpha-subunit (GTH alpha) has been previously isolated by our research group from A. gigas pituitaries; in the present work the cDNA sequences encoding FSH beta and LH beta subunits have also been isolated from the same species of fish. The FSH beta-subunit consists of 126 amino acids with a putative 18 amino acid signal peptide and a 108 amino acid mature peptide, while the LH beta-subunit consists of 141 amino acids with a putative 24 amino acid amino acid signal peptide and a 117 amino acid mature peptide. The highest identity, based on the amino acid sequences, was found with the order of Anguilliformes (61%) for FSH beta and of Cypriniformes (76%) for LH beta, followed by Siluriformes, 53% for FSH beta and 75% for LH beta. Interestingly, the identity with the corresponding human amino acid sequences was still remarkable: 45.1% for FSH beta and 51.4% for LH beta. Three dimensional models of ag-FSH and ag-LH, generated by using the crystal structures of h-FSH and h-LH as the respective templates and carried out via comparative modeling and molecular dynamics simulations, suggested the presence of the so-called "seat-belt", favored by a disulfide bond formed between the 3rd and 12th cysteine in both beta-subunits. The sequences found will be used for the biotechnological synthesis of A. gigas gonadotrophic hormones (ag-FSH and ag-LH). In a first approach, to ascertain that the cloned transcripts allow the expression of the heterodimeric hormones, ag-FSH has been synthesized in human embryonic kidney 293 (HEK293) cells, preliminarily purified and characterized.	[Sevilhano, Thais; de Carvalho, Roberto Feitosa; de Jesus Oliveira, Nelio Alessandro; Oliveira, Joao Ezequiel; Bartolini, Paolo] IPEN CNEN SP, Dept Biotechnol, Cidade Univ, Sao Paulo, SP, Brazil; [Maltarollo, Vinicius Goncalves; Trossini, Gustavo] Univ Sao Paulo, Fac Pharmaceut Sci, Dept Pharm, Sao Paulo, Brazil; [Garcez, Riviane] Univ Sao Paulo, Genet Ichthyol Lab, Biosci Inst, Sao Paulo, Brazil	Comissao Nacional de Energia Nuclear (CNEN); Instituto de Pesquisas Energeticas e Nucleares (IPEN); Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Bartolini, P (corresponding author), IPEN CNEN SP, Dept Biotechnol, Cidade Univ, Sao Paulo, SP, Brazil.	pbartoli@ipen.br	Maltarollo, Vinicius Gonçalves/AAV-6849-2021; Trossini, Gustavo/A-5789-2013; Trossini, Gustavo/AAQ-2537-2020	Maltarollo, Vinicius Gonçalves/0000-0001-9675-5907; Trossini, Gustavo/0000-0003-3634-2531; Trossini, Gustavo/0000-0003-3634-2531; Oliveira, Joao Ezequiel/0000-0002-6937-1120	Sao Paulo State Research Financing Agency (FAPESP) [2012/10779-2]; National Research Council (CNPq - Brasilia) [2015-5/142319]	Sao Paulo State Research Financing Agency (FAPESP); National Research Council (CNPq - Brasilia)	This work was supported by the Sao Paulo State Research Financing Agency (FAPESP), Project N 2012/10779-2 and National Research Council (CNPq - Brasilia), Project N 2015-5/142319. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Sao Paulo State Research Financing Agency (FAPESP), Project N 2012/10779-2 and National Research Council (CNPq Brasilia), Project N 2015-5/142319.	Aizen J, 2007, BIOL REPROD, V76, P692, DOI 10.1095/biolreprod.106.055822; Aizen J, 2014, GEN COMP ENDOCR, V207, P28, DOI 10.1016/j.ygcen.2014.05.028; Aizen J, 2012, MOL CELL ENDOCRINOL, V364, P89, DOI 10.1016/j.mce.2012.08.013; Almeida BE, 2014, ANAL METHODS-UK, V6, P6688, DOI 10.1039/c4ay01104j; Baldwin RL, 2008, ANNU REV BIOPHYS, V37, P1, DOI 10.1146/annurev.biophys.37.032807.125948; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Boime I, 1999, RECENT PROG HORM RES, V54, P271; Borella M, 2009, FISH PHYSIOL BIOCHEM, V35, P3, DOI 10.1007/s10695-008-9254-x; Bousfield GR, 2007, MOL CELL ENDOCRINOL, V260, P40, DOI 10.1016/j.mce.2006.02.017; Butnev VY, 1998, BIOL REPROD, V58, P458, DOI 10.1095/biolreprod58.2.458; CAMPBELL RK, 1991, P NATL ACAD SCI USA, V88, P760, DOI 10.1073/pnas.88.3.760; Cao H, 2009, MOL CELL ENDOCRINOL, V303, P34, DOI 10.1016/j.mce.2009.01.015; Carvalho CM, 2009, J CHROMATOGR A, V1216, P1431, DOI 10.1016/j.chroma.2008.12.096; Castello L, 2011, REV FISH BIOL FISHER, V21, P623, DOI 10.1007/s11160-010-9197-z; Cerda J, 2008, GEN COMP ENDOCR, V156, P470, DOI 10.1016/j.ygcen.2008.02.006; Chatterjee A, 2005, GEN COMP ENDOCR, V143, P278, DOI 10.1016/j.ygcen.2005.04.004; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Choi E, 2005, FISHERIES SCI, V71, P1193, DOI 10.1111/j.1444-2906.2005.01083.x; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Chu-Koo F, 2009, FISH PHYSIOL BIOCHEM, V35, P125, DOI 10.1007/s10695-008-9211-8; COMBARNOUS Y, 1992, ENDOCR REV, V13, P670, DOI 10.1210/edrv-13-4-670; Degani G, 2003, COMP BIOCHEM PHYS B, V136, P283, DOI 10.1016/S1096-4959(03)00207-0; DIAS JA, 1994, J BIOL CHEM, V269, P25289; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan H, 2004, PROTEIN SCI, V13, P211, DOI 10.1110/ps.03381404; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Faria MT, 2013, FISH PHYSIOL BIOCHEM, V39, P683, DOI 10.1007/s10695-012-9730-1; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; GAVEL Y, 1990, PROTEIN ENG, V3, P433, DOI 10.1093/protein/3.5.433; Grossmann M, 1997, J BIOL CHEM, V272, P15532, DOI 10.1074/jbc.272.24.15532; Guzman JM, 2013, GEN COMP ENDOCR, V193, P37, DOI 10.1016/j.ygcen.2013.07.007; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Han YS, 2002, FISH PHYSIOL BIOCHEM, V26, P111, DOI 10.1023/A:1025478031158; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Huang H, 2009, GEN COMP ENDOCR, V162, P192, DOI 10.1016/j.ygcen.2009.02.012; Hurvitz A, 2005, GEN COMP ENDOCR, V140, P61, DOI 10.1016/j.ygcen.2004.09.019; Jiang XL, 2012, P NATL ACAD SCI USA, V109, P12491, DOI 10.1073/pnas.1206643109; Kamei H, 2003, GEN COMP ENDOCR, V134, P244, DOI 10.1016/S0016-6480(03)00259-4; Kasuto H, 2005, GEN COMP ENDOCR, V140, P222, DOI 10.1016/j.ygcen.2004.10.016; Kawauchi H, 2006, GEN COMP ENDOCR, V148, P3, DOI 10.1016/j.ygcen.2005.10.011; Kazeto Y, 2008, BIOL REPROD, V79, P938, DOI 10.1095/biolreprod.108.070052; Kim DJ, 2005, GEN COMP ENDOCR, V141, P282, DOI 10.1016/j.ygcen.2005.01.001; Kobayashi M, 2003, FISH PHYSIOL BIOCHEM, V28, P469, DOI 10.1023/B:FISH.0000030631.25673.a7; Kobayashi M, 1997, GEN COMP ENDOCR, V105, P372, DOI 10.1006/gcen.1996.6840; Lapthorn AJ, 1994, NATURE; LEHLE L, 1978, EUR J BIOCHEM, V83, P563, DOI 10.1111/j.1432-1033.1978.tb12124.x; Levavi-Sivan B, 2010, GEN COMP ENDOCR, V165, P412, DOI 10.1016/j.ygcen.2009.07.019; Li MD, 1998, J ENDOCRINOL, V156, P529, DOI 10.1677/joe.0.1560529; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Loureiro RF, 2006, J CHROMATOGR A, V1136, P10, DOI 10.1016/j.chroma.2006.09.037; Lovell S.C., 2003, PROTEINS STRUCT FUNC, V50, P437, DOI [10.1002/prot.10286, DOI 10.1002/PROT.10286]; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Martins W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/654170; Mittelholzer C, 2009, COMP BIOCHEM PHYS B, V153, P288, DOI 10.1016/j.cbpb.2009.03.011; Morgan AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053785; Mylonas CC, 2010, GEN COMP ENDOCR, V165, P516, DOI 10.1016/j.ygcen.2009.03.007; Ohta K, 2008, J EXP ZOOL PART A, V309A, P534, DOI 10.1002/jez.485; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; PIERCE JG, 1981, ANNU REV BIOCHEM, V50, P465, DOI 10.1146/annurev.bi.50.070181.002341; Querat B, 2000, BIOL REPROD, V63, P222, DOI 10.1095/biolreprod63.1.222; Querat B, 2001, GEN COMP ENDOCR, V124, P308, DOI 10.1006/gcen.2001.7715; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sant'Ana CD, 2008, BIOCHIMIE, V90, P500, DOI 10.1016/j.biochi.2007.10.005; Schulz RW, 2010, GEN COMP ENDOCR, V65, P490; Senthilkumaran B, 2011, FRONT BIOSCI-LANDMRK, V16, P1898, DOI 10.2741/3829; SHEETS MD, 1990, NUCLEIC ACIDS RES, V18, P5799, DOI 10.1093/nar/18.19.5799; So WK, 2005, BIOL REPROD, V72, P1382, DOI 10.1095/biolreprod.104.038216; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; STEELMAN SL, 1953, ENDOCRINOLOGY, V53, P604, DOI 10.1210/endo-53-6-604; Storring PL, 2001, J ENDOCRINOL, V171, P119, DOI 10.1677/joe.0.1710119; SUZUKI K, 1988, GEN COMP ENDOCR, V71, P292, DOI 10.1016/0016-6480(88)90257-2; Swanson P, 2003, FISH PHYSIOL BIOCHEM, V28, P53, DOI 10.1023/B:FISH.0000030476.73360.07; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ulloa-Aguirre A, 2007, ENDOCRINE, V32, P251, DOI 10.1007/s12020-008-9041-6; van Gunsteren W, 1996, BIOMOLECULAR SIMULAT; WAKO H, 1995, BBA-PROTEIN STRUCT M, V1247, P104, DOI 10.1016/0167-4838(94)00216-4; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; Weltzien FA, 2003, GEN COMP ENDOCR, V131, P87, DOI 10.1016/S0016-6480(02)00606-8; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; WU H, 1994, STRUCTURE, V2, P545, DOI 10.1016/S0969-2126(00)00054-X; Xing YN, 2004, J BIOL CHEM, V279, P35449, DOI 10.1074/jbc.M403054200; Yoshiura Y, 1997, GEN COMP ENDOCR, V105, P379, DOI 10.1006/gcen.1996.6839; Yu XB, 2010, FISH PHYSIOL BIOCHEM, V36, P273, DOI 10.1007/s10695-008-9244-z; Zaqueo KD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/595186; Zmora N, 2007, J ENDOCRINOL, V194, P407, DOI 10.1677/JOE-07-0171	87	6	9	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183545	10.1371/journal.pone.0183545	http://dx.doi.org/10.1371/journal.pone.0183545			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846736	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600034
J	Pati, S; Schellevis, FG				Pati, Sandipana; Schellevis, F. G.			Prevalence and pattern of co morbidity among type2 diabetics attending urban primary healthcare centers at Bhubaneswar (India)	PLOS ONE			English	Article							MULTIPLE CHRONIC CONDITIONS; MELLITUS; MULTIMORBIDITY; COMORBIDITY; IMPACT; EPIDEMIOLOGY; HYPERTENSION; POPULATION; DEPRESSION; DISEASE	Objective India has the second largest diabetic population in the world. The chronic nature of the disease and high prevalence of co-existing chronic medical conditions or "co morbidities" makes diabetes management complex for the patient and for health care providers. Hence a strong need was felt to explore the problem of co morbidity among diabetics and its dimensions in primary health care practices. Method This cross sectional survey was carried out on 912 type 2 diabetes patients attending different urban primary health care facilities at Bhubaneswar. Data regarding existence of co morbidity and demographical details were elicited by a predesigned, pretested questionnaire "Diabetes Co morbidity Evaluation Tool in Primary Care (DCET-PC)". Statistical analyses were done using STATA. Results Overall 84% had one ormore than one comorbid condition. The most frequent co morbid conditions were hypertension [62%], acid peptic disease [28%], chronic back ache [22%] and osteoarthritis [21%]. The median number of co morbid conditions among both males and females is 2[IQR = 2]. The range of the number of co morbid conditions was wider among males [0 - 14] than females [0 - 6]. The number of co morbidities was highest in the age group > = 60 across both sexes. Most of the male patients below 40 years of age had either single [53%] or three co morbidities [11%] whereas among female patients of the same age group single [40%] or two co morbidities [22%] were more predominantly present. Age was found to be a strong independent predictor for diabetes co morbidity. The odds of having co morbidity among people above poverty line and schedule caste were found to be [OR = 3.50; 95% CI 1.85 - 6.62] and [OR = 2.46; CI 95% 1.16 - 5.25] respectively. Odds were increased for retired status [OR = 1.21; 95% CI 1.01 - 3.91] and obesity [OR = 3.96; 95% CI 1.01 - 15.76]. Conclusion The results show a high prevalence of co morbidities in patients with type 2 diabetes attending urban primary health care facilities. Hypertension, acid peptic disease, chronic back ache and arthritis being the most common, strategies need to be designed taking into account the multiple demands of co morbidities.	[Pati, Sandipana] Govt Odisha, Dept Hlth & Family Welf, Bhubaneswar, Orissa, India; [Schellevis, F. G.] NIVEL Netherlands Inst Hlth Serv Res, Utrecht, Netherlands; [Schellevis, F. G.] Vrije Univ Amsterdam, Dept Gen Practice & Elderly Care Med, Amsterdam Publ Hlth Res Inst, Med Ctr, Amsterdam, Netherlands	Netherlands Institute for Health Services Research; Vrije Universiteit Amsterdam	Pati, S (corresponding author), Govt Odisha, Dept Hlth & Family Welf, Bhubaneswar, Orissa, India.	sandipana.pati@gmail.com						Agrawal S, 2012, PUBLIC HEALTH NUTR, V15, P1065, DOI 10.1017/S1368980011002813; Alaba O, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-63; Amaducci L, 1997, INT J EPIDEMIOL, V26, P995; Ashton CM, 2003, AM J MANAG CARE, V9, P145; Bai P V, 1999, J Assoc Physicians India, V47, P1060; Banjare P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097832; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Bhojani U, 2013, CONSTRAINTS FACED UR, P6; Bhojani U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106522; Bratzke LC, 2015, INT J NURS STUD, V52, P744, DOI 10.1016/j.ijnurstu.2014.10.010; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Cheraghi-Sohi S, 2013, SAGE OPEN MED, V1, DOI 10.1177/2050312113503955; Druss Benjamin G., 2001, COMP NATL EC BURDEN, V20, P233; Du Y, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-166; Ganguly S, 2013, J ADOLESCENT HEALTH, V52, P546, DOI 10.1016/j.jadohealth.2012.09.012; Gross R, 1996, Public Health Rev, V24, P167; Guruprasad K G, 2012, Indian J Psychol Med, V34, P30, DOI 10.4103/0253-7176.96153; Huber CA, 2014, DIABET METAB SYND OB, V7, P455, DOI 10.2147/DMSO.S69520; Jacob B, 2015, ACAD MED J INDIA, V3, P8; Jacob R, 2014, AM J HEALTH BEHAV, V38, P297, DOI 10.5993/AJHB.38.2.15; Joshi SR, 2012, DIABETES TECHNOL THE, V14, P8, DOI 10.1089/dia.2011.0243; Joshi Shashank R, 2008, J Assoc Physicians India, V56, P443; Kerr EA, 2007, J GEN INTERN MED, V22, P1635, DOI 10.1007/s11606-007-0313-2; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Krein SL, 2005, DIABETES CARE, V28, P65, DOI 10.2337/diacare.28.1.65; Lin PJ, 2015, AM J MANAG CARE, V21, pE23; Liu ZL, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-62; Lkhagva D, 2012, J DIABETES COMPLICAT, V26, P129, DOI 10.1016/j.jdiacomp.2011.12.004; Luijks H, 2012, MULTIMORBIDITY, V10, P19; Patel M, 2011, ELECT PHYS, P3; Pati S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6582487; Pati S, 2015, ANN FAM MED, V13, P446, DOI 10.1370/afm.1843; Piette JD, 2006, DIABETES CARE, V29, P725, DOI 10.2337/diacare.29.03.06.dc05-2078; Poongothai S, 2010, DIABETES TECHNOL THE, V12, P989, DOI 10.1089/dia.2010.0081; Promberger R, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-132; Ramachandran A, 1999, J Assoc Physicians India, V47, P1152; Rema M, 2000, BRIT J OPHTHALMOL, V84, P1058, DOI 10.1136/bjo.84.9.1058; Salisbury C, 2011, BRIT J GEN PRACT, V61, DOI 10.3399/bjgp11X548929; Schoenberg NE, 2009, J HEALTH CARE POOR U, V20, P134, DOI 10.1353/hpu.0.0115; Siddiqui S, 2014, POSTGRADUATE MED J; Singh RB, 1998, INT J CARDIOL, V66, P65, DOI 10.1016/S0167-5273(98)00141-7; Struijs JN, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-84; Tinetti ME, 2004, NEW ENGL J MED, V351, P2870, DOI 10.1056/NEJMsb042458; Unwin N, 2012, IDF DIAB ATL 2012 UP; Vijayakumar G, 2009, J Assoc Physicians India, V57, P563; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yadav Dhananjay, 2014, Osong Public Health Res Perspect, V5, P169, DOI 10.1016/j.phrp.2014.04.009; Yadav N, ASS SOZIODEMOGRAPHIC	48	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0181661	10.1371/journal.pone.0181661	http://dx.doi.org/10.1371/journal.pone.0181661			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841665	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700003
J	Lev-Ari, S				Lev-Ari, Shiri			Talking to fewer people leads to having more malleable linguistic representations	PLOS ONE			English	Article							SOCIAL NETWORK; LANGUAGE; PERCEPTION	We learn language from our social environment. In general, the more sources we have, the less informative each of them is, and the less weight we should assign it. If this is the case, people who interact with fewer others should be more susceptible to the influence of each of their interlocutors. This paper tests whether indeed people who interact with fewer other people have more malleable phonological representations. Using a perceptual learning paradigm, this paper shows that individuals who regularly interact with fewer others are more likely to change their boundary between /d/ and /t/ following exposure to an atypical speaker. It further shows that the effect of number of interlocutors is not due to differences in ability to learn the speaker's speech patterns, but specific to likelihood of generalizing the learned pattern. These results have implications for both language learning and language change, as they suggest that individuals with smaller social networks might play an important role in propagating linguistic changes.	[Lev-Ari, Shiri] Max Planck Inst Psycholinguist, Nijmegen, Netherlands	Max Planck Society	Lev-Ari, S (corresponding author), Max Planck Inst Psycholinguist, Nijmegen, Netherlands.	shirilevari@gmail.com						[Anonymous], 2003, EFFECTS 2 LANGUAGE 1; Bakshy E., 2012, P 21 INT C WORLD WID, P519, DOI [10.1145/2187836.2187907, DOI 10.1145/2187836.2187907]; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Brysbaert M, 2011, EXP PSYCHOL, V58, P412, DOI 10.1027/1618-3169/a000123; Corriveau KH, 2009, PSYCHOL SCI, V20, P372, DOI 10.1111/j.1467-9280.2009.02291.x; Fagyal Z, 2010, LINGUA, V120, P2061, DOI 10.1016/j.lingua.2010.02.001; FLEGE JE, 1987, J PHONETICS, V15, P47, DOI 10.1016/S0095-4470(19)30537-6; Goldinger SD, 1998, PSYCHOL REV, V105, P251, DOI 10.1037/0033-295X.105.2.251; Goodman JC, 2008, J CHILD LANG, V35, P515, DOI 10.1017/S0305000907008641; Granovetter M., 1983, SOCIOLOGICAL THEORY, V1, P201, DOI [10.2307/202051, DOI 10.2307/202051]; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Harrington J, 2000, NATURE, V408, P927, DOI 10.1038/35050160; Haun DBM, 2012, CURR BIOL, V22, P727, DOI 10.1016/j.cub.2012.03.006; Herrmann PA, 2013, COGNITION, V129, P536, DOI 10.1016/j.cognition.2013.08.010; HOAGLIN DC, 1978, AM STAT, V32, P17, DOI 10.2307/2683469; Johnson Keith, 1997, TALKER VARIABILITY S, P145, DOI DOI 10.1017/S1366728914000790; Kleinschmidt DF, 2015, PSYCHOL REV, V122, P148, DOI 10.1037/a0038695; Kraljic T, 2007, J MEM LANG, V56, P1, DOI 10.1016/j.jml.2006.07.010; Lev-Ari S., 2017, P 30 CUNY C HUM SENT; Lev-Ari S, 2017, MEM COGNITION, V45, P528, DOI 10.3758/s13421-016-0675-y; Lev-Ari S, 2016, COGNITIVE SCI, V40, P2050, DOI 10.1111/cogs.12317; Lev-Ari S, 2014, MEM COGNITION, V42, P247, DOI 10.3758/s13421-013-0352-3; Lev-Ari S, 2013, J PHONETICS, V41, P320, DOI 10.1016/j.wocn.2013.06.002; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; Maye J, 2002, COGNITION, V82, pB101, DOI 10.1016/S0010-0277(01)00157-3; MILROY J, 1985, J LINGUIST, V21, P339, DOI 10.1017/S0022226700010306; Muhlenbernd R., 2012, P EVOLANG, P242; Nettle D, 1999, LINGUA, V108, P95, DOI 10.1016/S0024-3841(98)00046-1; Nettle D., 1999, LINGUA, V118, P2; Norris D, 2003, COGNITIVE PSYCHOL, V47, P204, DOI 10.1016/S0010-0285(03)00006-9; Pavlenko A, 2002, APPL LINGUIST, V23, P190, DOI 10.1093/applin/23.2.190; Pickering MJ, 2007, TRENDS COGN SCI, V11, P105, DOI 10.1016/j.tics.2006.12.002; R Core Team, 2021, R LANGUAGE ENV STAT; Rott S., 1999, STUD SECOND LANG ACQ, V21, P589, DOI DOI 10.1017/S0272263199004039; Saffran JR, 1996, SCIENCE, V274, P1926, DOI 10.1126/science.274.5294.1926; Sankoff Gillian., 2013, OXFORD HDB SOCIOLING, P261, DOI DOI 10.1093/OXFORDHB/9780199744084.001.0001; Schillaci RS, 2014, J COGN DEV, V15, P569, DOI 10.1080/15248372.2013.784973; WEIMANN G, 1982, AM SOCIOL REV, V47, P764, DOI 10.2307/2095212	38	16	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183593	10.1371/journal.pone.0183593	http://dx.doi.org/10.1371/journal.pone.0183593			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837699	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000085
J	Pepin, KM; Davis, AJ; Cunningham, FL; VerCauteren, KC; Eckery, DC				Pepin, Kim M.; Davis, Amy J.; Cunningham, Fred L.; VerCauteren, Kurt C.; Eckery, Doug C.			Potential effects of incorporating fertility control into typical culling regimes in wild pig populations	PLOS ONE			English	Article							PREDATOR-PREY THEORY; BOAR SUS-SCROFA; FERAL PIGS; SOUTHERN TEXAS; NATIONAL-PARK; BRUSHTAIL POSSUMS; DYNAMICS; REPRODUCTION; ERADICATION; HELICOPTER	Effective management of widespread invasive species such as wild pigs (Sus scrofa) is limited by resources available to devote to the effort. Better insight of the effectiveness of different management strategies on population dynamics is important for guiding decisions of resource allocation over space and time. Using a dynamic population model, we quantified effects of culling intensities and time between culling events on population dynamics of wild pigs in the USA using empirical culling patterns and data-based demographic parameters. In simulated populations closed to immigration, substantial population declines (50-100%) occurred within 4 years when 20-60% of the population was culled annually, but when immigration from surrounding areas occurred, there was a maximum of 50% reduction, even with the maximum culling intensity of 60%. Incorporating hypothetical levels of fertility control with realistic culling intensities was most effective in reducing populations when they were closed to immigration and when intrinsic population growth rate was too high (> = 1.78) to be controlled by culling alone. However, substantial benefits from fertility control used in conjunction with culling may only occur over a narrow range of net population growth rates (i.e., where net is the result of intrinsic growth rates and culling) that varies depending on intrinsic population growth rate. The management implications are that the decision to use fertility control in conjunction with culling should rely on concurrent consideration of achievable culling intensity, underlying demographic parameters, and costs of culling and fertility control. The addition of fertility control reduced abundance substantially more than culling alone, however the effects of fertility control were weaker than in populations without immigration. Because these populations were not being reduced substantially by culling alone, fertility control could be an especially helpful enhancement to culling for reducing abundance to target levels in areas where immigration can't be prevented.	[Pepin, Kim M.; Davis, Amy J.; VerCauteren, Kurt C.; Eckery, Doug C.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80524 USA; [Cunningham, Fred L.] USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Mississippi State, MS 80720 USA	United States Department of Agriculture (USDA); Mississippi State University; United States Department of Agriculture (USDA)	Pepin, KM (corresponding author), USDA, APHIS, Wildlife Serv, Natl Wildlife Res Ctr, Ft Collins, CO 80524 USA.	kim.m.pepin@aphis.usda.gov	Davis, Amy/ABE-2065-2021					[Anonymous], HCSU004 U HAW HIL; [Anonymous], 1996, MANAGING VERTEBRATE; Artois M, 1997, REPROD FERT DEVELOP, V9, P17, DOI 10.1071/R96090; BABER DW, 1986, J MAMMAL, V67, P512, DOI 10.2307/1381283; Baber DW, 1977, SOCIAL ORG BEHAV FER; Barlow ND, 2000, J APPL ECOL, V37, P897, DOI 10.1046/j.1365-2664.2000.00591.x; Barlow ND, 1997, WILDLIFE RES, P24; Barlow ND, 1994, J APPL ECOL, V31; BARRETT RH, 1978, HILGARDIA, V46, P283, DOI 10.3733/hilg.v46n09p283; Barrett RH, 1971, ECOLOGY FERAL HOG TE; Barrios-Garcia MN, 2012, BIOL INVASIONS, V14, P2283, DOI 10.1007/s10530-012-0229-6; Belden Robert C., 1990, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V44, P231; Bieber C, 2005, J APPL ECOL, V42, P1203, DOI 10.1111/j.1365-2664.2005.01094.x; Burton JL, 2013, US ARMY CORPS ENG ER, P1; Campbell TA, 2009, FOREST ECOL MANAG, V257, P2319, DOI 10.1016/j.foreco.2009.03.036; CAUGHLEY G, 1992, WILDLIFE RES, V19, P623, DOI 10.1071/WR9920623; CHOQUENOT D, 1993, WILDLIFE RES, V20, P15, DOI 10.1071/WR9930015; Choquenot D, 1999, WILDLIFE RES, V26, P251, DOI 10.1071/WR98006; Courchamp F, 2000, J APPL ECOL, V37, P903, DOI 10.1046/j.1365-2664.2000.00545.x; Cowled BD, 2006, J WILDLIFE MANAGE, V70, P1690, DOI 10.2193/0022-541X(2006)70[1690:MTDAGE]2.0.CO;2; Crouch LC, 1983, MOVEMENTS HABITAT UT; Cruz F, 2005, BIOL CONSERV, V121, P473, DOI 10.1016/j.biocon.2004.05.018; Delgado-Acevedo J, 2013, INT J PEST MANAGE, V59, P122, DOI 10.1080/09670874.2013.776723; Dexter N, 1996, WILDLIFE RES, V23, P435, DOI 10.1071/WR9960435; Dexter N, 2015, ECOL EVOL, V5, P2036, DOI 10.1002/ece3.1489; Diong CH, 1982, KIPAHULA VALLEY; Ditchkoff SS, 2012, J WILDLIFE MANAGE, V76, P1235, DOI 10.1002/jwmg.356; Duncan RW, 1974, REPROD BIOL EUROPEAN; Gabor TM, 1999, J ZOOL, V247, P311, DOI 10.1111/j.1469-7998.1999.tb00994.x; Garcelon DK, 2005, P 6 CAL ISL S 2003 D; Gee RW, 2002, AUST VET J, V80, P96, DOI 10.1111/j.1751-0813.2002.tb12850.x; Gentle M, 2013, WILDLIFE RES, V40, P459, DOI 10.1071/WR13100; Gese EM, 2015, BIOL CONSERV, V192, P11, DOI 10.1016/j.biocon.2015.09.003; Gonyou HW, 2001, SOCIAL BEHAV FARM AN; Gunduz A, 2007, WILD ENVIRON MED, V18, P117, DOI 10.1580/06-WEME-CR-033R1.1; Hanson LB, 2009, WILDLIFE RES, V36, P185, DOI 10.1071/WR08077; Hanson LB, 2006, DEMOGRAPHY FERAL PIG; HENRY VG, 1968, J WILDLIFE MANAGE, V32, P406, DOI 10.2307/3798986; Henry VG, 1978, P ANN C SE ASS FISH, V32, P406; HONE J, 1990, AUST WILDLIFE RES, V17, P123, DOI 10.1071/WR9900123; HONE J, 1992, J APPL ECOL, V29, P695, DOI 10.2307/2404478; Hone J, 2002, BIOL CONSERV, V105, P231, DOI 10.1016/S0006-3207(01)00185-9; Hughes TW, 1985, HOME RANGE HABITAT U; ILSE LM, 1995, J MAMMAL, V76, P993, DOI 10.2307/1382593; Ji WH, 2000, J APPL ECOL, V37, P926, DOI 10.1046/j.1365-2664.2000.00546.x; Johnson K.G., 1982, Proceedings of the Annual Conference Southeastern Association of Fish and Wildlife Agencies, V36, P552; Kaminski G, 2005, CAN J ZOOL, V83, P474, DOI 10.1139/Z05-019; KATAHIRA LK, 1993, WILDLIFE SOC B, V21, P269; Kay SL, 2017, MOV ECOL, V5, DOI 10.1186/s40462-017-0105-1; Keuling O, 2010, EUR J WILDLIFE RES, V56, P159, DOI 10.1007/s10344-009-0296-x; Klinger R., 2011, Occasional Papers of the IUCN Species Survival Commission, V42, P78; Lombardo CA, 2000, P 5 CAL ISL S APR WA; Massei G, 2015, PEST MANAG SCI, V71, P492, DOI 10.1002/ps.3965; Mayer JJ, 2009, ENERGY DO; Mccann BE, 2008, J WILDLIFE MANAGE, V72, P1287, DOI 10.2193/2007-164; McLeod SR, 2014, ECOL MODEL, V273, P1, DOI 10.1016/j.ecolmodel.2013.10.016; McMahon CR, 2010, METHODS ECOL EVOL, V1, P53, DOI 10.1111/j.2041-210X.2009.00002.x; Mellish JM, 2014, SOUTHEAST NAT, V13, P367, DOI 10.1656/058.013.0217; Merrill JA, 2006, J WILDLIFE MANAGE, V70, P268, DOI 10.2193/0022-541X(2006)70[268:MAODPB]2.0.CO;2; Miller LA, 2013, J ZOO WILDLIFE MED, V44, pS84, DOI 10.1638/1042-7260-44.4S.S84; Morrison SA, 2007, FRONT ECOL ENVIRON, V5, P271, DOI 10.1890/1540-9295(2007)5[271:FTDAEE]2.0.CO;2; Otto SP, 2007, BIOL GUIDE MATH MODE; Parkes JP, 2010, BIOL CONSERV, V143, P634, DOI 10.1016/j.biocon.2009.11.028; Peine JD, 1990, WILD HOG MANAGEMENT; Ramsey D, 2005, J APPL ECOL, V42, P348, DOI 10.1111/j.1365-2664.2005.01006.x; Rushton SP, 2006, J WILDLIFE MANAGE, V70, P1102, DOI 10.2193/0022-541X(2006)70[1102:EOCFPA]2.0.CO;2; Salinas RA, 2015, NAT RESOUR MODEL, V28, P18, DOI 10.1111/nrm.12055; SAUNDERS G, 1988, AUST WILDLIFE RES, V15, P73, DOI 10.1071/WR9880073; Sims R, W70001135 PWD RP; Smith TN, 2014, WILDLIFE SOC B, V38, P175, DOI 10.1002/wsb.376; Snow NP, 2017, J APPL ECOL IN PRESS; Sparklin BD, 2009, J WILDLIFE MANAGE, V73, P497, DOI 10.2193/2007-585; Steen D., 2006, P 22 VET PEST C, P361; Taylor RB, 1998, J MAMMAL, V79, P1325, DOI 10.2307/1383024; Timmons J., 2012, FERAL HOG POPULATION; West Ben C., 2009, P1; Williams BL, 2011, J WILDLIFE MANAGE, V75, P432, DOI 10.1002/jwmg.64; Wood GW, 1977, RES MANAGEMENT WILD, P23; Yoak AJ, 2016, ECOL MODEL, V341, P53, DOI 10.1016/j.ecolmodel.2016.09.018	79	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183441	10.1371/journal.pone.0183441	http://dx.doi.org/10.1371/journal.pone.0183441			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837610	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000067
J	Toyomaki, A; Hashimoto, N; Kako, Y; Murohashi, H; Kusumi, I				Toyomaki, Atsuhito; Hashimoto, Naoki; Kako, Yuki; Murohashi, Harumitsu; Kusumi, Ichiro			Neural responses to feedback information produced by self-generated or other-generated decision-making and their impairment in schizophrenia	PLOS ONE			English	Article							COROLLARY DISCHARGE DYSFUNCTION; AUDITORY HALLUCINATIONS; NEGATIVITY; OSCILLATIONS; POTENTIALS; P300; TASK	Several studies of self-monitoring dysfunction in schizophrenia have focused on the sense of agency to motor action using behavioral and psychophysiological techniques. So far, no study has ever tried to investigate whether the sense of agency or causal attribution for external events produced by self-generated decision-making is abnormal in schizophrenia. The purpose of this study was to investigate neural responses to feedback information produced by self-generated or other-generated decision-making in a multiplayer gambling task using even-related potentials and electroencephalogram synchronization. We found that the late positive component and theta/alpha synchronization were increased in response to feedback information in the self-decision condition in normal controls, but that these responses were significantly decreased in patients with schizophrenia. These neural activities thus reflect the self-reference effect that affects the cognitive appraisal of external events following decision-making and their impairment in schizophrenia.	[Toyomaki, Atsuhito; Hashimoto, Naoki; Kako, Yuki; Kusumi, Ichiro] Hokkaido Univ, Dept Psychiat, Grad Sch Med, Sapporo, Hokkaido, Japan; [Murohashi, Harumitsu] Hokkaido Univ, Grad Sch Educ, Sapporo, Hokkaido, Japan; [Murohashi, Harumitsu] Sapporo Gakuin Univ, Dept Clin Psychol, Ebetsu, Hokkaido, Japan	Hokkaido University; Hokkaido University	Toyomaki, A (corresponding author), Hokkaido Univ, Dept Psychiat, Grad Sch Med, Sapporo, Hokkaido, Japan.	toyomaki@med.hokudai.ac.jp						Bellebaum C, 2008, EUR J NEUROSCI, V27, P1823, DOI 10.1111/j.1460-9568.2008.06138.x; Blakemore SJ, 2000, PSYCHOL MED, V30, P1131, DOI 10.1017/S0033291799002676; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Dube C, 2013, PSYCHOL SCI, V24, P2398, DOI 10.1177/0956797613492426; Foffani G, 2005, J PHYSIOL-LONDON, V568, P699, DOI 10.1113/jphysiol.2005.089722; Ford JM, 2005, INT J PSYCHOPHYSIOL, V58, P179, DOI 10.1016/j.ijpsycho.2005.01.014; Ford JM, 2001, AM J PSYCHIAT, V158, P1914, DOI 10.1176/appi.ajp.158.11.1914; Ford JM, 2004, J PSYCHIATR RES, V38, P37, DOI 10.1016/S0022-3956(03)00095-5; Ford JM, 2001, AM J PSYCHIAT, V158, P2069, DOI 10.1176/appi.ajp.158.12.2069; Ford JM, 2008, BIOL PSYCHIAT, V63, P736, DOI 10.1016/j.biopsych.2007.09.013; Ford JM, 2007, PSYCHOPHYSIOLOGY, V44, P522, DOI 10.1111/j.1469-8986.2007.00533.x; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Gandal MJ, 2011, NEUROPHARMACOLOGY; Gehring WJ, 2002, SCIENCE, V295, P2279, DOI 10.1126/science.1066893; Gonul AS, 2003, PROG NEURO-PSYCHOPH, V27, P173, DOI 10.1016/S0278-5846(02)00349-4; Hermann CS, 2004, EVENT RELATED POTENT; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Kamarajan C, 2009, BEHAV BRAIN RES, V197, P62, DOI 10.1016/j.bbr.2008.08.011; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Miltner WHR, 1997, J COGNITIVE NEUROSCI, V9, P788, DOI 10.1162/jocn.1997.9.6.788; Pallanti S, 1999, PSYCHIAT RES, V86, P239, DOI 10.1016/S0165-1781(99)00033-5; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Synofzik M, 2010, BRAIN, V133, P262, DOI 10.1093/brain/awp291; Toyomaki A, 2005, NEUROREPORT, V16, P1865, DOI 10.1097/01.wnr.0000185962.96217.36; Uhlhaas PJ, 2010, NAT REV NEUROSCI, V11, P100, DOI 10.1038/nrn2774; Vinogradov S, 1997, AM J PSYCHIAT, V154, P1530, DOI 10.1176/ajp.154.11.1530	28	3	3	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183792	10.1371/journal.pone.0183792	http://dx.doi.org/10.1371/journal.pone.0183792			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837639	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000122
J	Gauvin, HS; Mertens, J; Marien, P; Santens, P; Pickut, BA; Hartsuiker, RJ				Gauvin, Hanna S.; Mertens, Jolien; Marien, Peter; Santens, Patrick; Pickut, Barbara A.; Hartsuiker, Robert J.			Verbal monitoring in Parkinson's disease: A comparison between internal and external monitoring	PLOS ONE			English	Article							SENTENCE COMPREHENSION; LANGUAGE PRODUCTION; SPEECH PRODUCTION; SYNTAX COMPREHENSION; NONDEMENTED PATIENTS; COGNITIVE FUNCTION; WORKING-MEMORY; NORMATIVE DATA; BASAL GANGLIA; DEFICITS	Patients with Parkinson's disease (PD) display a variety of impairments in motor and non-motor language processes; speech is decreased on motor aspects such as amplitude, prosody and speed and on linguistic aspects including grammar and fluency. Here we investigated whether verbal monitoring is impaired and what the relative contributions of the internal and external monitoring route are on verbal monitoring in patients with PD relative to controls. Furthermore, the data were used to investigate whether internal monitoring performance could be predicted by internal speech perception tasks, as perception based monitoring theories assume. Performance of 18 patients with Parkinson's disease was measured on two cognitive performance tasks and a battery of 11 linguistic tasks, including tasks that measured performance on internal and external monitoring. Results were compared with those of 16 age-matched healthy controls. PD patients and controls generally performed similarly on the linguistic and monitoring measures. However, we observed qualitative differences in the effects of noise masking on monitoring and disfluencies and in the extent to which the linguistic tasks predicted monitoring behavior. We suggest that the patients differ from healthy subjects in their recruitment of monitoring channels.	[Gauvin, Hanna S.; Mertens, Jolien; Hartsuiker, Robert J.] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Gauvin, Hanna S.] Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia; [Marien, Peter] Vrije Univ Brussel, Clin & Expt Neurolinguist, Brussels, Belgium; [Marien, Peter] ZNA Middelheim Hosp, Dept Neurol, Antwerp, Belgium; [Santens, Patrick] Univ Ghent, Dept Neurol, Ghent Univ Hosp, Ghent, Belgium; [Pickut, Barbara A.] Univ Antwerp, Antwerp, Belgium; [Pickut, Barbara A.] Antwerp Univ Hosp, Dept Neurol, Edegem, Belgium; [Pickut, Barbara A.] Mercy Hlth St Marys Hauenstein Neurosci, Grand Rapids, MI USA; [Pickut, Barbara A.] Michigan State Univ, Coll Human Med, Dept Translat Sci & Mol Med, Grand Rapids, MI USA	Ghent University; Queensland University of Technology (QUT); Vrije Universiteit Brussel; ZNA Middelheim Hospital; Ghent University; Ghent University Hospital; University of Antwerp; University of Antwerp; Michigan State University; Michigan State University College of Human Medicine	Gauvin, HS (corresponding author), Univ Ghent, Dept Expt Psychol, Ghent, Belgium.; Gauvin, HS (corresponding author), Queensland Univ Technol, Sch Psychol & Counselling, Brisbane, Qld, Australia.	Hanna.Gauvin@qut.edu.au	Gauvin, Hanna/AAN-8261-2020; Gauvin, Hanna/A-6618-2019; santens, patrick/O-2505-2013; Hartsuiker, Robert J./N-1668-2019	Gauvin, Hanna/0000-0002-2204-9222; Gauvin, Hanna/0000-0002-2204-9222; 	Fund for Scientific Research Flanders (FWD), project "Internal self-monitoring: speech perception or forward models?" [G.0335.11N]	Fund for Scientific Research Flanders (FWD), project "Internal self-monitoring: speech perception or forward models?"	This work was supported by Fund for Scientific Research Flanders (FWD), project "Internal self-monitoring: speech perception or forward models?" no. G.0335.11N, awarded to RH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Fund for Scientific Research Flanders (FWO), project "Internal self-monitoring: speech perception or forward models?" no. G.0335.11N.	Angwin AJ, 2005, COGNITIVE BRAIN RES, V25, P78, DOI 10.1016/j.cogbrainres.2005.04.008; Angwin AJ, 2009, CORTEX, V45, P950, DOI 10.1016/j.cortex.2009.02.012; [Anonymous], 1998, PROGR COLOURED MATRI; [Anonymous], 1979, SENTENCE PROCESSING; Auriacombe S., 1993, NEUROPSYCHOLOGY, V7, P182, DOI DOI 10.1037/0894-4105.7.2.182; Bastiaanse R, 2007, COGNITION, V105, P457; Benton AL, 1976, MULTILINGUAL APHASIA; Berg E, 2003, CLIN LINGUIST PHONET, V17, P63, DOI 10.1080/0269920021000055540; Bertella L, 2002, BRAIN COGNITION, V48, P277, DOI 10.1006/brcg.2001.1361; BOWLES NL, 1987, CORTEX, V23, P519, DOI 10.1016/S0010-9452(87)80012-6; Braak H, 2005, NEUROLOGY, V64, P1404, DOI 10.1212/01.WNL.0000158422.41380.82; Castner JE, 2007, BRAIN, V130, P1395, DOI 10.1093/brain/awm059; Colman KSF, 2009, CORTEX, V45, P930, DOI 10.1016/j.cortex.2008.12.010; Connor LT, 2004, J GERONTOL B-PSYCHOL, V59, pP203, DOI 10.1093/geronb/59.5.P203; Copland D, 2003, J INT NEUROPSYCH SOC, V9, P1041, DOI 10.1017/S1355617703970081; Cotelli M, 2007, EUR J NEUROL, V14, P632, DOI 10.1111/j.1468-1331.2007.01797.x; Crescentini C, 2008, NEUROPSYCHOLOGIA, V46, P434, DOI 10.1016/j.neuropsychologia.2007.08.021; CRITCHLEY EMR, 1981, J NEUROL NEUROSUR PS, V44, P751, DOI 10.1136/jnnp.44.9.751; Daley TC, 2003, PSYCHOL SCI, V14, P215, DOI 10.1111/1467-9280.02434; FLINT AJ, 1992, J PSYCHOLINGUIST RES, V21, P383, DOI 10.1007/BF01067922; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Frank EM, 1996, J COMMUN DISORD, V29, P183, DOI 10.1016/0021-9924(95)00021-6; GOLDENBERG G, 1986, J NEUROL NEUROSUR PS, V49, P1266, DOI 10.1136/jnnp.49.11.1266; Golfinopoulos E, 2010, NEUROIMAGE, V52, P862, DOI 10.1016/j.neuroimage.2009.10.023; Goodglass H., 1983, BOSTON NAMING TEST; Goodglass H., 2001, ASSESSMENT APHASIA R; GOTHAM AM, 1988, BRAIN, V111, P299, DOI 10.1093/brain/111.2.299; Grossman M, 2002, NEUROPSYCHOLOGY, V16, P174, DOI 10.1037//0894-4105.16.2.174; GROSSMAN M, 1992, BRAIN LANG, V42, P347, DOI 10.1016/0093-934X(92)90074-O; GROSSMAN M, 1991, NEUROLOGY, V41, P1620; GROSSMAN M, 1993, J COGNITIVE NEUROSCI, V5, P480, DOI 10.1162/jocn.1993.5.4.480; Guenther FH, 1998, PSYCHOL REV, V105, P611, DOI 10.1037/0033-295X.105.4.611-633; Hammen VL, 1990, THESIS; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Hickok G, 2012, NAT REV NEUROSCI, V13, P135, DOI 10.1038/nrn3158; Hochstadt J, 2006, BRAIN LANG, V97, P243, DOI 10.1016/j.bandl.2005.10.011; ILLES J, 1989, BRAIN LANG, V37, P628, DOI 10.1016/0093-934X(89)90116-8; ILLES J, 1988, BRAIN LANG, V33, P146, DOI 10.1016/0093-934X(88)90059-4; Indefrey P, 2004, COGNITION, V92, P101, DOI 10.1016/j.cognition.2002.06.001; Indefrey P, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00255; KOLK H, 1995, BRAIN LANG, V50, P282, DOI 10.1006/brln.1995.1049; Levelt W., 1989, SPEAKING INTENTION A; LEVELT WJM, 1983, COGNITION, V14, P41, DOI 10.1016/0010-0277(83)90026-4; LIEBERMAN P, 1992, BRAIN LANG, V43, P169, DOI 10.1016/0093-934X(92)90127-Z; LIEBERMAN P, 1990, J NERV MENT DIS, V178, P360, DOI 10.1097/00005053-199006000-00003; Lindeboom J, 1999, Tijdschr Gerontol Geriatr, V30, P249; Liss JM, 1998, BRAIN LANG, V62, P342, DOI 10.1006/brln.1997.1907; Longworth CE, 2005, BRAIN, V128, P584, DOI 10.1093/brain/awh387; LUDLOW CL, 1987, BRAIN LANG, V32, P195, DOI 10.1016/0093-934X(87)90124-6; Mani A, 2013, SCIENCE, V341, P976, DOI 10.1126/science.1238041; Marien P, 1998, BRAIN LANG, V65, P447, DOI 10.1006/brln.1998.2000; MARSHALL RC, 1985, BRAIN LANG, V24, P297, DOI 10.1016/0093-934X(85)90137-3; MARSHALL RC, 1994, APHASIOLOGY, V8, P535, DOI 10.1080/02687039408248680; MATISON R, 1982, NEUROLOGY, V32, P567, DOI 10.1212/WNL.32.5.567; MCNAMARA P, 1992, BRAIN LANG, V42, P38, DOI 10.1016/0093-934X(92)90055-J; McNamara P, 2003, BRAIN LANG, V84, P414, DOI 10.1016/S0093-934X(02)00558-8; METTER EJ, 1986, J COMMUN DISORD, V19, P347, DOI 10.1016/0021-9924(86)90026-2; Miatton M, 2004, PSYCHOL BELG, V44, P189; MICELI G, 1980, BRAIN LANG, V11, P159, DOI 10.1016/0093-934X(80)90117-0; Monetta L, 2007, BRAIN LANG, V101, P80, DOI 10.1016/j.bandl.2006.06.007; Monetta L, 2009, CORTEX, V45, P972, DOI 10.1016/j.cortex.2009.02.021; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; NATSOPOULOS D, 1993, NEUROPSYCHOLOGIA, V31, P951, DOI 10.1016/0028-3932(93)90150-X; NATSOPOULOS D, 1991, CORTEX, V27, P255, DOI 10.1016/S0010-9452(13)80130-X; NICKELS L, 1995, CORTEX, V31, P209, DOI 10.1016/S0010-9452(13)80360-7; Nozari N, 2011, COGNITIVE PSYCHOL, V63, P1, DOI 10.1016/j.cogpsych.2011.05.001; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; OLEARY UM, 1991, J CLIN PSYCHOL, V47, P277, DOI 10.1002/1097-4679(199103)47:2<277::AID-JCLP2270470215>3.0.CO;2-I; Oomen C. E., 2005, PHONOLOGICAL ENCODIN, P209; Oomen CCE, 2001, CORTEX, V37, P627, DOI 10.1016/S0010-9452(08)70610-5; Peran P, 2003, MOVEMENT DISORD, V18, P150, DOI 10.1002/mds.10306; Piatt AL, 1999, J CLIN EXP NEUROPSYC, V21, P435, DOI 10.1076/jcen.21.4.435.885; Piatt AL, 1999, NEUROPSYCHOLOGIA, V37, P1499, DOI 10.1016/S0028-3932(99)00066-4; Pickering MJ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00132; Pickering MJ, 2013, BEHAV BRAIN SCI, V36, P329, DOI 10.1017/S0140525X12001495; Postma A, 1996, LANG SPEECH, V39, P375, DOI 10.1177/002383099603900403; POSTMA A, 1993, J SPEECH HEAR RES, V36, P472, DOI 10.1044/jshr.3603.472; Roelofs A., 2005, PHONOLOGICAL ENCODIN, P209; Ruberg M., 1988, HDB PSYCHOPHARMACOLO, P157; SCHLENCK KJ, 1987, BRAIN LANG, V30, P226, DOI 10.1016/0093-934X(87)90100-3; Stuss DT, 1998, J INT NEUROPSYCH SOC, V4, P265, DOI 10.1017/S1355617798002653; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Troyer AK, 1998, J INT NEUROPSYCH SOC, V4, P137, DOI 10.1017/S1355617798001374; Ullman MT, 1997, J COGNITIVE NEUROSCI, V9, P266, DOI 10.1162/jocn.1997.9.2.266; [No title captured]	85	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182159	10.1371/journal.pone.0182159	http://dx.doi.org/10.1371/journal.pone.0182159			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832595	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800015
J	Huang, MR; Chen, RA; Ren, GC				Huang, Miaorong; Chen, Ruiai; Ren, Guangcai			Secretory expression and purification of Bacillus licheniformis keratinase in insect cells	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA KERATINASE; KERATINOLYTIC SERINE PROTEINASE; FUNCTIONAL EXPRESSION; SUBTILIS; CLONING; OPTIMIZATION; GENES	The keratinase (kerA) gene from Bacillus licheniformis PWD-1 was expressed and purified in insect cells. First, the sequence encoding Ker-His-Flag was designed based on the amino acid sequence of the protein and peptide and codon optimization in order to ensure the high expression in insect cells. In the next step, the synthetic DNA was inserted into the pUC57 vector and then sub-cloned in the pFastBac (TM)-1 donor vector by BamHI/ HindIII restriction sites. The constructed vector was transformed to E. coli wDH10Bac (TM) cell to generate recombinant bacmid carrying Ker-His-Flag. Recombinant viruses were produced by infecting insect Spodoptera frugiperda (Sf9) cells with bacmid DNA and used for proteins production. Target proteins were purified from the cell supernatants by Ni2+-NTA affinity chromatography and evaluated by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDSPAGE) and western blot. The purified product contained two peptides with molecular weights of 38 kDa and 30 kDa and had an optimal pH and temperature at 8.0 and 45 degrees C for keratinolytic activity, respectively. The final product had a specific activity of about 635 U/mg. In summary, we have demonstrated that the open reading frame containing recombinant Ker-His-Flag was expressed and secreted by leader peptide of mellittin from Apis mellitera in insect cells and affinity purification through 8His-Flag tag. It presents an alternative technology for producing keratinases. To our knowledge, it was the first report on the expression of functional keratinase from Bacillus licheniformis in insect cells system.	[Huang, Miaorong; Chen, Ruiai; Ren, Guangcai] Minist Agr, Key Lab Biotechnol & Drug Mfg Anim Epidem Prevent, Zhaoqing, Peoples R China; [Chen, Ruiai] South China Agr Univ, Coll Vet Med, Guangzhou, Guangdong, Peoples R China	Ministry of Agriculture & Rural Affairs; South China Agricultural University	Huang, MR (corresponding author), Minist Agr, Key Lab Biotechnol & Drug Mfg Anim Epidem Prevent, Zhaoqing, Peoples R China.	747526035@qq.com			Guangdong Wens Dahuanong biotechnology Co., Ltd [03-3A201309-1]	Guangdong Wens Dahuanong biotechnology Co., Ltd	Our work was financially supported by Guangdong Wens Dahuanong biotechnology Co., Ltd (No. 03-3A201309-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 1995, FOCUS, V17, P53; BOCKLE B, 1995, APPL ENVIRON MICROB, V61, P3705; Bressollier P, 1999, APPL ENVIRON MICROB, V65, P2570; Cai CG, 2008, J ZHEJIANG UNIV-SC B, V9, P713, DOI 10.1631/jzus.B0820128; Cao ZJ, 2012, ENVIRON SCI POLLUT R, V19, P2690, DOI 10.1007/s11356-012-0763-x; Fang Z, 2016, SCI REP-UK, V6, DOI 10.1038/srep27953; Fang Z, 2016, MICROB BIOTECHNOL, V9, P35, DOI 10.1111/1751-7915.12300; Fang Z, 2014, PROCESS BIOCHEM, V49, P647, DOI 10.1016/j.procbio.2014.01.009; Gopinath SC, 2015, BIOMED RES INT; Guler-Gane G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155340; Hassan MA, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/175012; Hemmerich J, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0604-6; Hola-Jamriska L, 2000, PROTEIN EXPRES PURIF, V19, P384, DOI 10.1006/prep.2000.1261; Hu H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058393; Huang MR, 2013, TRANSGENIC RES, V22, P779, DOI 10.1007/s11248-012-9681-4; Jaouadi NZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076722; Kim Jeong-Dong, 2005, Mycobiology, V33, P121, DOI 10.4489/MYCO.2005.33.2.121; Kim Jeong-Dong, 2007, Mycobiology, V35, P219, DOI 10.4489/MYCO.2007.35.4.219; Kornillowicz-Kowalska T, 2011, WASTE MANAGE, V31, P1689, DOI 10.1016/j.wasman.2011.03.024; Krammer F, 2010, MOL BIOTECHNOL, V45, P226, DOI 10.1007/s12033-010-9268-3; Lateef A, 2015, BIOTECHNOL BIOTEC EQ, V29, P54, DOI 10.1080/13102818.2014.986360; Lin HH, 2009, J AGR FOOD CHEM, V57, P7779, DOI 10.1021/jf901903p; Lin HH, 2009, J AGR FOOD CHEM, V57, P5321, DOI 10.1021/jf900417t; Lin HH, 2009, J AGR FOOD CHEM, V57, P3506, DOI 10.1021/jf803752j; LIN XA, 1992, APPL ENVIRON MICROB, V58, P3271, DOI 10.1128/AEM.58.10.3271-3275.1992; Lo WH, 2012, J BIOSCI BIOENG, V114, P640, DOI 10.1016/j.jbiosc.2012.07.014; LUCKOW VA, 1993, J VIROL, V67, P4566, DOI 10.1128/JVI.67.8.4566-4579.1993; Majorek KA, 2014, PROTEIN SCI, V23, P1359, DOI 10.1002/pro.2520; Prateek AB, 2010, TALANTA, V81, P1477; Qiu GF, 2009, J BIOMED BIOTECHNOL, DOI 10.1155/2009/746289; Radha S, 2007, J APPL MICROBIOL, V103, P1301, DOI 10.1111/j.1365-2672.2007.03372.x; Sharma R, 2010, BIOTECHNOL LETT, V32, P1863, DOI 10.1007/s10529-010-0361-2; Sletta H, 2007, APPL ENVIRON MICROB, V73, P906, DOI 10.1128/AEM.01804-06; Stepanyuk GA, 2008, PROTEIN EXPRES PURIF, V61, P142, DOI 10.1016/j.pep.2008.05.013; Zhao DX, 2016, BIOINORG CHEM APPL, V2016, DOI 10.1155/2016/8206854	35	5	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183764	10.1371/journal.pone.0183764	http://dx.doi.org/10.1371/journal.pone.0183764			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832667	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800099
J	Lexomboon, D; Karlsson, P; Adolfsson, J; Ekbom, A; Naimi-Akbar, A; Bahmanyar, S; Montgomery, S; Sandborgh-Englund, G				Lexomboon, Duangjai; Karlsson, Par; Adolfsson, Jan; Ekbom, Anders; Naimi-Akbar, Aron; Bahmanyar, Shahram; Montgomery, Scott; Sandborgh-Englund, Gunilla			Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort study	PLOS ONE			English	Article							EPIDEMIOLOGY; RADIATION; RISK	Patients with head and neck (H&N) cancer are commonly treated with surgery and/or radiotherapy, which can increase the risk of oral infection, dental caries, and periodontal disease. The present study investigated dental care consumption and costs in patient with H&N cancer before and after the cancer diagnosis. Data from Swedish regional and national registers were used to follow up dental care utilization and dental procedure costs. The analysis included 2,754 patients who had been diagnosed with H&N cancer (exposed cohort) in Stockholm County, Sweden, during 2000-2012 and 13,036 matched persons without cancer (unexposed cohort). The exposed cohort was sub-grouped into irradiated and non-irradiated patients for analysis. The exposed cohort underwent a moderately higher number of dental procedures per year than the unexposed cohort in both the year of the cancer diagnosis and the year after cancer diagnosis; in addition, these numbers were higher in the irradiated than in the non-irradiated subgroup of the exposed cohort. Dental care consumption and costs in the exposed cohort declined over time but remained at a slightly higher level than in the unexposed cohort over the long term (more than two years). Examinations and preventive procedures accounted for most of the higher consumption in the short term (2 years) and at the longer term follow-up. Swedish national insurance subsidized costs for dental treatment, which were highest in the irradiated subgroup and lowest in the unexposed cohort. Direct costs to the patient, however, were similar among the groups. Swedish national health insurance protects patients with H&N cancer from high dental expenditures. Further studies on the cost-effectiveness of preventive dental care for patients are needed.	[Lexomboon, Duangjai; Sandborgh-Englund, Gunilla] Acad Ctr Geriatr Dent, Stockholm, Sweden; [Lexomboon, Duangjai] Karlstad Univ, Dept Hlth Sci, Karlstad, Sweden; [Karlsson, Par; Bahmanyar, Shahram] Karolinska Inst, Dept Med, Ctr Pharmacoepidemiol, Stockholm, Sweden; [Adolfsson, Jan] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Ekbom, Anders; Montgomery, Scott] Karolinska Inst, Dept Med, Clin Epidemiol Unit, Stockholm, Sweden; [Naimi-Akbar, Aron; Sandborgh-Englund, Gunilla] Karolinska Inst, Dept Dent Med, Stockholm, Sweden; [Montgomery, Scott] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Montgomery, Scott] UCL, Dept Epidemiol & Publ Hlth, London, England	Karlstad University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Orebro University; University of London; University College London	Lexomboon, D (corresponding author), Acad Ctr Geriatr Dent, Stockholm, Sweden.; Lexomboon, D (corresponding author), Karlstad Univ, Dept Hlth Sci, Karlstad, Sweden.	duangjai.lexomboon@kau.se	Montgomery, Scott/AAN-2546-2020	Montgomery, Scott/0000-0001-6328-5494; Bahmanyar, Shahram/0000-0002-9205-6540; Sandborgh Englund, Gunilla/0000-0002-7260-4706; Karlsson, Par/0000-0002-7177-1713; Adolfsson, Jan/0000-0003-2992-1869	Stockholm County council (SOF) [0F18101423]; Stockholm County Council (SOF)	Stockholm County council (SOF)(Stockholm County Council); Stockholm County Council (SOF)(Stockholm County Council)	This work was supported by Grant no 0F18101423 from the Stockholm County council (SOF) to GSE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by grants from Stockholm County Council (SOF).	Anell Anders, 2012, Health Syst Transit, V14, P1; Carson Susan J, 2016, Evid Based Dent, V17, P73, DOI 10.1038/sj.ebd.6401182; Cognetti DM, 2008, CANCER-AM CANCER SOC, V113, P1911, DOI 10.1002/cncr.23654; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Frydrych AM, 2016, AUST DENT J; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Heegaard K, 2011, J PUBLIC HEALTH DENT, V71, P318, DOI 10.1111/j.1752-7325.2011.00276.x; Hjern A, 2001, COMMUNITY DENT ORAL, V29, P167, DOI 10.1034/j.1600-0528.2001.290302.x; Jawad H, 2015, BRIT DENT J, V218, P65, DOI 10.1038/sj.bdj.2015.28; Jawad H, 2015, BRIT DENT J, V218, P69, DOI 10.1038/sj.bdj.2015.29; Jensen SB, 2010, SUPPORT CARE CANCER, V18, P1039, DOI 10.1007/s00520-010-0827-8; Joshi VK, 2010, ORAL ONCOL, V46, P475, DOI 10.1016/j.oraloncology.2010.03.010; Khan Z, 2014, J CANCER EPIDEMIOL, V2014, DOI 10.1155/2014/394696; Ludvigsson JF, 2009, EUR J EPIDEMIOL, V24, P659, DOI 10.1007/s10654-009-9350-y; Maasland DHE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-187; Meurman JH, 2010, ORAL ONCOL, V46, P464, DOI 10.1016/j.oraloncology.2010.02.025; Molarius A, 2014, BMC ORAL HEALTH, V14, DOI 10.1186/1472-6831-14-134; Montero PH, 2015, SURG ONCOL CLIN N AM, V24, P491, DOI 10.1016/j.soc.2015.03.006; Pezzuto F, 2015, ONCOLOGY-BASEL, V89, P125, DOI 10.1159/000381717; Rettig EM, 2015, SURG ONCOL CLIN N AM, V24, P379, DOI 10.1016/j.soc.2015.03.001; Roosaar A, 2008, INT J CANCER, V123, P168, DOI 10.1002/ijc.23469; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Swedish Association of Local Authorities and Regions (SALAR), 2015, STAT HLS OCH REG UTV; Swedish National Board of Health and Welfare, 2015, CAUS DEATH REG; Swedish Social Insurance Agency, DEMT CAR; The Dental and Pharmaceutical Benefits Agency (TLV), HDB TILL TLVFS 2010, V2010, P2; The Swedish National Board of Health and Welfare, DENT HLTH REG; The Swedish Social Insurance Administration (Fo E rsa E kringskassan), NAT DENT CAR SUBS; Vissink A, 2015, ORAL DIS, V21, pE1, DOI 10.1111/odi.12222; Zhou JC, 2013, INT J CANCER, V132, P1911, DOI 10.1002/ijc.27839	30	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182877	10.1371/journal.pone.0182877	http://dx.doi.org/10.1371/journal.pone.0182877			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832673	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800038
J	Zhang, XW; Jiang, QT; Wei, YM; Liu, CJ				Zhang, Xiao-Wei; Jiang, Qian-Tao; Wei, Yu-Ming; Liu, Chunji			Inheritance analysis and mapping of quantitative trait loci (QTL) controlling individual anthocyanin compounds in purple barley (Hordeum vulgare L.) grains	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; WHEAT; BLUE; MAP; STABILITY; CAPACITY; BLACK; CULTIVARS; EXTRACTS; PIGMENTS	Anthocyanin-rich barley can have great potential in promoting human health and in developing nutraceuticals and functional foods. As different anthocyanin compounds have different antioxidant activities, breeding cultivars with pre-designed anthocyanin compositions could be highly desirable. Working toward this possibility, we assessed and reported for the first time the genetic control of individual anthocyanin compounds in barley. Of the ten anthocyanins assessed, two, peonidin-3-glucoside (P3G) and cyanidin-3-glucoside (C3G), were major components in the purple pericarp barley genotype RUSSIA68. Quantitative trait locus (QTL) mapping showed that both anthocyanin compounds were the interactive products of two loci, one located on chromosome arm 2HL and the other on 7HS. However, the two different anthocyanin components seem to be controlled by different interactions between the two loci. The effects of the 7HS locus on P3G and C3G were difficult to detect without removing the effect of the 2HL locus. At least one copy of the 2HL alleles from the purple pericarp parent was required for the synthesis of P3G. This does not seem to be the case for the production of C3G which was produced in each of all the different allele combinations between the two loci. Typical maternal effect was also observed in the inheritance of purple pericarp grains in barley. The varied values of different compounds, coupled with their different genetic controls, highlight the need for targeting individual anthocyanins in crop breeding and food processing.	[Zhang, Xiao-Wei; Liu, Chunji] CSIRO Agr & Food, St Lucia, Qld, Australia; [Zhang, Xiao-Wei; Jiang, Qian-Tao; Wei, Yu-Ming] Sichuan Agr Univ, Triticeae Res Inst, Chengdu, Sichuan, Peoples R China	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Sichuan Agricultural University	Liu, CJ (corresponding author), CSIRO Agr & Food, St Lucia, Qld, Australia.	chunji.liu@csiro.au	Jiang, Qiantao/C-6229-2017; Liu, Chunji/B-5243-2009	Jiang, Qiantao/0000-0003-3192-3732; 	Commonwealth Scientific and Industrial Research Organisation in Australia (CSIRO) [R-7730-01]; China Scholarship Council (CSC) [201406910070]	Commonwealth Scientific and Industrial Research Organisation in Australia (CSIRO); China Scholarship Council (CSC)(China Scholarship Council)	This work was supported by funding from the Commonwealth Scientific and Industrial Research Organisation in Australia (CSIRO; https://www.csiro.au/; No: R-7730-01) and China Scholarship Council (CSC; http://www.csc.edu.cn/; No: 201406910070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Aal ESM, 2006, J AGR FOOD CHEM, V54, P4696, DOI 10.1021/jf0606609; Abdel-Aal ESM, 1999, CEREAL CHEM, V76, P350, DOI 10.1094/CCHEM.1999.76.3.350; Abdel-Aal ESM, 2003, J AGR FOOD CHEM, V51, P2174, DOI 10.1021/jf021043x; Anderson JA, 1992, THEOR APPL GENET, V83, P1035, DOI 10.1007/BF00232969; [Anonymous], 2006, SOFTWARE CALCULATION, P33; Bellido GG, 2009, J AGR FOOD CHEM, V57, P1022, DOI 10.1021/jf802846x; Chen GD, 2012, THEOR APPL GENET, V125, P1385, DOI 10.1007/s00122-012-1918-3; Deguchi T, 2000, J AGR FOOD CHEM, V48, P3198, DOI 10.1021/jf990944b; Delgado-Vargas F, 2000, CRIT REV FOOD SCI, V40, P173, DOI 10.1080/10408690091189257; Diczhazi I, 2014, CEREAL CHEM, V91, P195, DOI 10.1094/CCHEM-05-13-0091-R; FINCH RA, 1978, Z PFLANZENZUCHT, V81, P40; FRANCIS FJ, 1989, CRIT REV FOOD SCI, V28, P273, DOI 10.1080/10408398909527503; Grace MH, 2009, PHYTOMEDICINE, V16, P406, DOI 10.1016/j.phymed.2009.02.018; Grando S., 2005, P INT WORKSH FOOD BA; He YH, 2006, SCAND J RHEUMATOL, V35, P356, DOI 10.1080/03009740600704155; Hearnden PR, 2007, THEOR APPL GENET, V115, P383, DOI 10.1007/s00122-007-0572-7; Hecker KD, 1998, J SCI FOOD AGR, V77, P179, DOI 10.1002/(SICI)1097-0010(199806)77:2&lt;179::AID-JSFA23&gt;3.0.CO;2-0; Hecker KD, 2008, FOOD RES INT, V41, P850; Himi E, 2005, EUPHYTICA, V143, P239, DOI 10.1007/s10681-005-7854-4; Himi E, 2015, MOL GENET GENOMICS, V290, P1287, DOI 10.1007/s00438-015-0991-0; Jia QJ, 2016, EUPHYTICA, V208, P215, DOI 10.1007/s10681-015-1593-y; Jurgonski A, 2008, PLANT FOOD HUM NUTR, V63, P176, DOI 10.1007/s11130-008-0087-7; Kang SY, 2003, CANCER LETT, V194, P13, DOI 10.1016/S0304-3940(02)00583-9; Karaaslan M, 2011, LWT-FOOD SCI TECHNOL, V44, P1065, DOI 10.1016/j.lwt.2010.12.009; Kim MJ, 2007, J AGR FOOD CHEM, V55, P4802, DOI 10.1021/jf0701943; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Lee C, 2013, INT J FOOD SCI TECH, V48, P984, DOI 10.1111/ijfs.12050; Lin JY, 2008, FOOD CHEM, V109, P771, DOI 10.1016/j.foodchem.2008.01.039; Lundqvist U, 1997, BARLEY GENET NEWSL, V26, P105; MYLER JAMES L., 1942, JOUR AMER SOC AGRON, V34, P427; Nam SH, 2006, FOOD CHEM, V94, P613, DOI 10.1016/j.foodchem.2004.12.010; Patras A, 2010, TRENDS FOOD SCI TECH, V21, P3, DOI 10.1016/j.tifs.2009.07.004; Philpott M, 2004, J AGR FOOD CHEM, V52, P1511, DOI 10.1021/jf034593j; Prior RL, 2006, FREE RADICAL RES, V40, P1014, DOI 10.1080/10715760600758522; Ryu SN, 1998, J FOOD DRUG ANAL, V6, P729; Shoeva OY, 2015, PLANT BREEDING, V134, P400, DOI 10.1111/pbr.12277; Sui XN, 2014, FOOD CHEM, V163, P163, DOI 10.1016/j.foodchem.2014.04.075; Tall JM, 2004, BEHAV BRAIN RES, V153, P181, DOI 10.1016/j.bbr.2003.11.011; Tsuda T, 2002, J NUTR SCI VITAMINOL, V48, P305, DOI 10.3177/jnsv.48.305; Van Ooijen J., 2004, SOFTWARE MAPPING QUA; Varshney RK, 2007, THEOR APPL GENET, V114, P1091, DOI 10.1007/s00122-007-0503-7; Wang H, 1997, J AGR FOOD CHEM, V45, P304, DOI 10.1021/jf960421t; Wildman R. E. C., 2001, HDB NUTRACEUTICALS F; WOODWARD RW, 1953, AGRON J, V45, P182, DOI 10.2134/agronj1953.00021962004500050002x; ZEVEN AC, 1991, EUPHYTICA, V56, P243, DOI 10.1007/BF00042371	45	10	15	4	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183704	10.1371/journal.pone.0183704	http://dx.doi.org/10.1371/journal.pone.0183704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832657	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800088
J	Gao, B; Shen, XD; Shiroishi, MS; Pang, MF; Li, ZQ; Yu, BX; Shen, GQ				Gao, Bo; Shen, Xudong; Shiroishi, Mark S.; Pang, Mingfan; Li, Zhiqian; Yu, Benxia; Shen, Guiquan			A pilot study of pre-operative motor dysfunction from gliomas in the region of corticospinal tract: Evaluation with diffusion tensor imaging	PLOS ONE			English	Article							WHITE-MATTER TRACTS; FIBER TRACKING; DENSITY; TUMOR; DTI; TRACTOGRAPHY; INVASION; METABOLISM; RESECTION; PATTERNS	Background and purpose Brain tumors in the corticospinal tract (CST) region are more likely to cause motor dysfunction. The aim of this study is to evaluate the effect of gliomas located in the CST region on motor function with diffusion tensor imaging (DTI) preoperatively. Materials and methods Forty-five patients with histopathologically confirmed gliomas were included in this pilot study, in all cases (low-grade n = 13, high-grade n = 32) CST but not the motor cortex were involved by the tumor. DTI image were acquired and the posterior limb of the internal capsule fractional anisotropy (FA) and relative FA (rFA = affected FA/contralateral FA) were measured. Injury of the CST from tumor was divided into three grades (grade 1: displacement, grade 2: displacement and infiltration, grade 3: displacement and disruption). The fiber density index (FDi) and relative FDi (rFDi = affected FDi/contralateral FDi) of the injured and contralateral CST were measured. The correlations between muscle strength and the CST injury grade and the rFA, affected FDi, rFDi values were calculated using Spearman rank correlation analysis. rFA and rFDi values of muscle strength groups (MMT2-5) were compared with one-way analysis of variance (ANOVA). The difference of muscle strength between low-and high-grade glioma groups were analysed with the Mann-Whitney U-test. Results Muscle strength was negatively correlated with the injury grade of the CST (r = -0.840, P<0.001). Muscle strength was positively correlated with rFA, FDi and rFDi (correlation coefficients (r) were 0.615, 0.643 and 0.567 for rFA, FDi and rFDi, respectively). The rFA values between grades (2&3, 2&4, 2&5, 3&5, 4&5) of muscle strength were significantly different (P<0.05), the rFDi values between grades (2&4, 2&5, 3&4, 3&5) of muscle strength were significantly different (P<0.05), while the rFA and rFDi values in the remaining groups of muscle strength grades showed no significant differences(P>0.05). Conclusions Preoperative DTI and diffusion tensor tractography may quantify the injury degrees of CST and the extent of motor dysfunction in patients with brain glioma.	[Gao, Bo; Yu, Benxia] Yantai Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China; [Shen, Xudong] Enshi Cent Hosp, Dept Radiol, Enshi, Hubei, Peoples R China; [Shiroishi, Mark S.] Univ Southern Calif, Keck Sch Med, Dept Radiol, Los Angeles, CA USA; [Pang, Mingfan] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Li, Zhiqian; Shen, Guiquan] Guizhou Med Univ, Dept Radiol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China	University of Southern California; Chinese Center for Disease Control & Prevention; Guizhou Medical University	Yu, BX (corresponding author), Yantai Yuhuangding Hosp, Dept Radiol, Yantai, Shandong, Peoples R China.; Shen, GQ (corresponding author), Guizhou Med Univ, Dept Radiol, Affiliated Hosp, Guiyang, Guizhou, Peoples R China.	ytradiology@sina.com; gzshenguiquan@163.corn			Natural Science Foundation of Shandong Province [ZR2014HL084]; Shandong Provincial Key Research & Development Project [2015GSF118185]; SC CTSI (NIH/NCRR/NCATS) Grant [KL2TR000131]; NIH Loan Repayment Program [1 L30 CA209248-01]	Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Shandong Provincial Key Research & Development Project; SC CTSI (NIH/NCRR/NCATS) Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH Loan Repayment Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	B.G. is supported by Natural Science Foundation of Shandong Province (ZR2014HL084) and Shandong Provincial Key Research & Development Project (2015GSF118185). M.S.S. is partially supported by SC CTSI (NIH/NCRR/NCATS) Grant KL2TR000131 and NIH Loan Repayment Program 1 L30 CA209248-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Barajas RF, 2013, AM J NEURORADIOL, V34, P1319, DOI 10.3174/ajnr.A3400; Bello L, 2008, NEUROIMAGE, V39, P369, DOI 10.1016/j.neuroimage.2007.08.031; Beppu T, 2005, SURG NEUROL, V63, P56, DOI 10.1016/j.surneu.2004.02.034; Bogovic JA, 2008, I S BIOMED IMAGING, P895, DOI 10.1109/ISBI.2008.4541141; Brodbelt A, 2011, BRIT J RADIOL, V84, pS205, DOI 10.1259/bjr/19282704; Cavers D, 2012, CAN MED ASSOC J, V184, pE373, DOI 10.1503/cmaj.111622; Chen YY, 2010, J CLIN NEUROSCI, V17, P824, DOI 10.1016/j.jocn.2009.11.022; Deng XF, 2015, J NEUROSURG, V122, P996, DOI 10.3171/2014.12.JNS14629; Field AS, 2004, J MAGN RESON IMAGING, V20, P555, DOI 10.1002/jmri.20169; Goebell E, 2006, RADIOLOGY, V239, P217, DOI 10.1148/radiol.2383050059; Grant Ryan, 2014, CNS Oncol, V3, P123, DOI 10.2217/cns.14.7; Heckel A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130833; Hervey-Jumper SL, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0284-7; Jeong JW, 2015, MAGN RESON IMAGING, V33, P895, DOI 10.1016/j.mri.2015.05.003; Jia XX, 2013, CAN J NEUROL SCI, V40, P558, DOI 10.1017/S0317167100014669; Jones LW, 2010, CANCER-AM CANCER SOC, V116, P695, DOI 10.1002/cncr.24808; Josefsen R, 2011, EUR J RADIOL, V80, P462; Kallenberg K, 2013, J NEURO-ONCOL, V112, P217, DOI 10.1007/s11060-013-1049-y; Kinno R, 2014, BRAIN, V137, P1193, DOI 10.1093/brain/awu013; Lin CC, 2013, EUR J RADIOL, V82, pE610, DOI 10.1016/j.ejrad.2013.06.016; Majos A, 2017, CLIN NEURORADIOL, V27, P71, DOI 10.1007/s00062-015-0398-7; Mosayebi P, 2012, MED IMAGE ANAL, V16, P361, DOI 10.1016/j.media.2011.10.001; Ng WH, 2008, NEUROSURGERY, V63, P452, DOI 10.1227/01.NEU.0000325259.95571.20; Painter KJ, 2013, J THEOR BIOL, V323, P25, DOI 10.1016/j.jtbi.2013.01.014; Peck KK, 2009, MED SCI MONITOR, V15, pMT55; Prabhu SP, 2011, CHILD NERV SYST, V27, P11, DOI 10.1007/s00381-010-1323-7; Price SJ, 2003, CLIN RADIOL, V58, P455, DOI 10.1016/S0009-9260(03)00115-6; Price SJ, 2007, EUR RADIOL, V17, P1675, DOI 10.1007/s00330-006-0561-2; Stadlbauer A, 2007, AM J NEURORADIOL, V28, P462; Stadlbauer A, 2012, NEUROSURGERY, V71, P454, DOI 10.1227/NEU.0b013e318258e332; Stadlbauer A, 2010, RADIOLOGY, V257, P846, DOI 10.1148/radiol.10100343; Stadlbauer A, 2009, ACTA NEUROCHIR, V151, P1061, DOI 10.1007/s00701-009-0378-2; Witwer BP, 2002, J NEUROSURG, V97, P568, DOI 10.3171/jns.2002.97.3.0568; Zhang DG, 2013, BRAIN STRUCT FUNCT, V218, P1429, DOI 10.1007/s00429-012-0468-4; Zhu W, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-31; Zolal A, 2013, J NEURORADIOLOGY, V40, P71, DOI 10.1016/j.neurad.2012.05.006	36	6	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0182795	10.1371/journal.pone.0182795	http://dx.doi.org/10.1371/journal.pone.0182795			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829841	Green Submitted, gold, Green Published			2022-12-27	WOS:000408085100015
J	Lauren, P; Somersalo, P; Pitkanen, I; Lou, YR; Urtti, A; Partanen, J; Seppala, J; Madetoja, M; Laaksonen, T; Makitie, A; Yliperttula, M				Lauren, Patrick; Somersalo, Petter; Pitkanen, Irina; Lou, Yan-Ru; Urtti, Arto; Partanen, Jouni; Seppala, Jukka; Madetoja, Mari; Laaksonen, Timo; Makitie, Antti; Yliperttula, Marjo			Nanofibrillar cellulose-alginate hydrogel coated surgical sutures as cell-carrier systems	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; BIOMEDICAL APPLICATIONS; NANOCELLULOSE; TRANSPLANTATION; ENCAPSULATION; MODEL; COCULTURE; ADHESION; THERAPY; FISTULA	Hydrogel nanomaterials, especially those that are of non-human and non-animal origins, have great potential in biomedical and pharmaceutical sciences due to their versatility and inherent soft-tissue like properties. With the ability to simulate native tissue function, hydrogels are potentially well suited for cellular therapy applications. In this study, we have fabricated nano-fibrillar cellulose-alginate (NFCA) suture coatings as biomedical devices to help overcome some of the limitations related to cellular therapy, such as low cell survivability and distribution out of target tissue. The addition of sodium alginate 8% (w/v) increased the NFCA hydrogel viscosity, storage and loss moduli by slightly under one order of magnitude, thus contributing significantly to coating strength. Confocal microscopy showed nearly 100% cell viability throughout the 2-week incubation period within and on the surface of the coating. Additionally, typical morphologies in the dual cell culture of spheroid forming HepG2 and monolayer type SK-HEP-1 were observed. Twelve out of 14 NFCA coated surgical sutures remained intact during the suturing operation with various mice and rat tissue; however, partial peeling off was observed in 2 of the coated sutures. We conclude that NFCA suture coatings could perform as cell-carrier systems for cellular based therapy and post-surgical treatment.	[Lauren, Patrick; Somersalo, Petter; Lou, Yan-Ru; Urtti, Arto; Laaksonen, Timo; Yliperttula, Marjo] Univ Helsinki, Fac Pharm, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland; [Pitkanen, Irina; Partanen, Jouni; Seppala, Jukka] Aalto Univ, Sch Engn, Dept Engn Design & Prod, Espoo, Finland; [Urtti, Arto] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Madetoja, Mari] Made Consulting, Turku, Finland; [Laaksonen, Timo] Tampere Univ Technol, Dept Chem & Bioengn, Tampere, Finland; [Makitie, Antti] Univ Helsinki, Dept Otorhinolaryngol Head & Neck Surg, Helsinki, Finland; [Makitie, Antti] Helsinki Univ Hosp, Helsinki, Finland	University of Helsinki; Aalto University; University of Eastern Finland; Tampere University; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Lauren, P (corresponding author), Univ Helsinki, Fac Pharm, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland.	patrick.lauren@helsinki.fi	Laaksonen, Timo J/C-7141-2009; Seppälä, Jukka V/G-7698-2012; Lou, Yan-Ru/AAX-4008-2020; Partanen, Jouni P/K-4291-2013; Lou, Yan-Ru/K-4348-2012	Lou, Yan-Ru/0000-0001-7717-6010; Lou, Yan-Ru/0000-0001-7717-6010; Lauren, Patrick/0000-0002-7115-3093; Laaksonen, Timo/0000-0002-6699-3004	Orion Foundation; University of Helsinki; Finnish Funding Agency for Technology and Innovation (TEKES), Functional materials program; UPM-Kymmene Corporation, Finland (UPM-TEKES driven GrowDex II project); TEKES	Orion Foundation; University of Helsinki; Finnish Funding Agency for Technology and Innovation (TEKES), Functional materials program(Finnish Funding Agency for Technology & Innovation (TEKES)); UPM-Kymmene Corporation, Finland (UPM-TEKES driven GrowDex II project); TEKES(Finnish Funding Agency for Technology & Innovation (TEKES))	This work has been supported by the Orion Foundation, University of Helsinki and the Finnish Funding Agency for Technology and Innovation (TEKES), Functional materials program (https://www.tekes.fi/en/programmes-and-services/recently-ended-programmes/toiminnalliset-materiaalit/material/) and UPM-Kymmene Corporation, Finland (UPM-TEKES driven GrowDex II project) (http//www.upm.com/Pages/default.aspx). In regards of Orion Foundation, TEKES and University of Helsinki, the funders provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Small-animal studies were performed by Made Consulting, Finland; with expert consulting and handling of the small-animal study process. The specific roles of these authors are articulated in the 'author contributions' section.	Alamoudi NM, 2014, J CLIN PEDIATR DENT, V38, P215, DOI 10.17796/jcpd.38.3.193115427jg6vl60; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Becker TA, 2002, J BIOMED MATER RES, V61, P533, DOI 10.1002/jbm.10202; Bhattacharya M, 2012, J CONTROL RELEASE, V164, P291, DOI 10.1016/j.jconrel.2012.06.039; Binyamin G, 2006, SEMIN PEDIATR SURG, V1, P276; Bodin A, 2007, BIOMACROMOLECULES, V8, P3697, DOI 10.1021/bm070343q; Carvalho KAT, 2006, TRANSPL P, V38, P1596, DOI 10.1016/j.transproceed.2006.03.023; Charreau H, 2013, RECENT PAT NANOTECH, V7, P56, DOI 10.2174/187221013804484854; Chiu LL, 2005, LASER SURG MED, V37, P231, DOI 10.1002/lsm.20213; Del Papa N, 2014, CELL TRANSPLANT; Eichhorn SJ, 2010, J MATER SCI, V45, P1, DOI 10.1007/s10853-009-3874-0; Gaharwar AK, 2014, BIOTECHNOL BIOENG, V111, P441, DOI 10.1002/bit.25160; Gao JM, 2008, BIORESOURCE TECHNOL, V99, P7623, DOI 10.1016/j.biortech.2008.02.005; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Garcia-Olmo D, 2008, EXPERT OPIN BIOL TH, V8, P1417, DOI 10.1517/14712598.8.9.1417 ; Garcia-Olmo D, 2009, INT J COLORECTAL DIS, V24, P27, DOI 10.1007/s00384-008-0559-0; Gentileschi Paolo, 2003, JSLS, V7, P377; Georgiev-Hristov T, 2012, EUR J CARDIO-THORAC, V42, pE40, DOI 10.1093/ejcts/ezs357; GRANT GT, 1973, FEBS LETT, V32, P195, DOI 10.1016/0014-5793(73)80770-7; Guyette JP, 2013, J BIOMED MATER RES A, V101, P809, DOI 10.1002/jbm.a.34386; Herberts CA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-29; Hewitt KJ, 2014, ADV WOUND CARE, V3, P742, DOI 10.1089/wound.2013.0480; Hunt NC, 2010, BIOTECHNOL LETT, V32, P733, DOI 10.1007/s10529-010-0221-0; Khattak SF, 2007, BIOTECHNOL BIOENG, V96, P156, DOI 10.1002/bit.21151; Klemm D, 2011, ANGEW CHEM INT EDIT, V50, P5438, DOI 10.1002/anie.201001273; Kuzmenko V, 2013, MAT SCI ENG C-MATER, V33, P4599, DOI 10.1016/j.msec.2013.07.031; Lauren P, 2014, EUR J PHARM SCI, V65, P79, DOI 10.1016/j.ejps.2014.09.013; Lee JE, 2013, ACTA BIOMATER, V9, P8318, DOI 10.1016/j.actbio.2013.06.003; Lee KY, 2012, PROG POLYM SCI, V37, P106, DOI 10.1016/j.progpolymsci.2011.06.003; LIM F, 1980, SCIENCE, V210, P908, DOI 10.1126/science.6776628; Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025; Lou YR, 2015, SCI REP-UK, V5, DOI 10.1038/srep13635; Lou YR, 2014, STEM CELLS DEV, V23, P380, DOI 10.1089/scd.2013.0314; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Malinen MM, 2014, BIOMATERIALS, V35, P5110, DOI 10.1016/j.biomaterials.2014.03.020; Malinen MM, 2012, TISSUE ENG PT A, V18, P2418, DOI [10.1089/ten.tea.2012.0046, 10.1089/ten.TEA.2012.0046]; Markstedt K, 2015, BIOMACROMOLECULES, V16, P1489, DOI 10.1021/acs.biomac.5b00188; Martson M, 1999, BIOMATERIALS, V20, P1989, DOI 10.1016/S0142-9612(99)00094-0; Mertaniemi H, 2016, BIOMATERIALS, V82, P208, DOI 10.1016/j.biomaterials.2015.12.020; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Miron-Mendoza M, 2010, BIOMATERIALS, V31, P6425, DOI 10.1016/j.biomaterials.2010.04.064; Missoum K, 2013, MATERIALS, V6, P1745, DOI 10.3390/ma6051745; Orive G, 2003, NAT MED, V9, P104, DOI 10.1038/nm0103-104; Paakko M, 2007, BIOMACROMOLECULES, V8, P1934, DOI 10.1021/bm061215p; Reckhenrich AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091169; Rowley JA, 1999, BIOMATERIALS, V20, P45, DOI 10.1016/S0142-9612(98)00107-0; Tan WH, 2007, ADV MATER, V19, P2696, DOI 10.1002/adma.200700433; Vartiainen J, 2011, CELLULOSE, V18, P775, DOI 10.1007/s10570-011-9501-7; Wikstrom J, 2008, BIOMATERIALS, V29, P869, DOI 10.1016/j.biomaterials.2007.10.056	49	15	15	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183487	10.1371/journal.pone.0183487	http://dx.doi.org/10.1371/journal.pone.0183487			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829830	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100048
J	Cottineau, C				Cottineau, Cleamentine			MetaZipf. A dynamic meta-analysis of city size distributions	PLOS ONE			English	Article							ZIPFS LAW; CITIES; PERSPECTIVE	The results from urban scaling in recent years have held the promise of increased efficiency to the societies who could actively control the distribution of their cities' size. However, little evidence exists as to the factors which influence the level of urban unevenness, as expressed by the slope of the rank-size distribution, partly because the diversity of results found in the literature follows the heterogeneity of analysis specifications. In this study, I set up a meta-analysis of Zipf's law which accounts for technical as well as topical factors of variations of Zipf's coefficient. I found 86 studies publishing at least one empirical estimation of this coefficient and recorded their metadata into an open database. I regressed the 1962 corresponding estimates with variables describing the study and the estimation process as well as socio-demographic variables describing the territory under enquiry. A dynamic meta-analysis was also performed to look for factors of evolution of city size unevenness. The results of the most interesting models are presented in the article, whereas all analyses can be reproduced on a dedicated online platform. The results show that on average, 40% of the variation of Zipf's coefficients is due to the technical choices. The main other variables associated with distinct evolutions are linked to the urbanisation process rather than the process of economic development and population growth. Finally, no evidence was found to support the effectiveness of past planning actions in modifying this urban feature.	[Cottineau, Cleamentine] UCL, Ctr Adv Spatial Anal, Urban Dynam Lab, London W1T 4TJ, England	University of London; University College London	Cottineau, C (corresponding author), UCL, Ctr Adv Spatial Anal, Urban Dynam Lab, London W1T 4TJ, England.	c.cottineau@ucl.ac.uk		Cottineau, Clementine/0000-0002-2452-3901	Engineering and Physical Sciences Research Council [EP/MO23583/1]; EPSRC [EP/MO23583/1]	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by Engineering and Physical Sciences Research Council project number EP/MO23583/1. The funders had no role in study design, data collection and analysis, decision topublish, or preparation of the manuscript.; The author acknowledges the funding of the EPSRC project number EP/MO23583/1. She thanks Denise Pumain, Elsa Arcaute, Michael Batty and two anonymous reviewers for useful comments and suggestions.	Auerbach F, 1913, PETERMANNS MITT, V59, P74; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Cristelli M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00812; Gabaix X, 2011, J BUS ECON STAT, V29, P24, DOI 10.1198/jbes.2009.06157; Gomez-Lievano A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040393; Gonzalez-Val R, 2010, J REGIONAL SCI, V50, P952, DOI 10.1111/j.1467-9787.2010.00685.x; Harris CD, 1970, CITIES SOVIET UNION, V5; Jiang B, 2011, INT J GEOGR INF SCI, V25, P1269, DOI 10.1080/13658816.2010.510801; JOHNSON GA, 1980, ECON GEOGR, V56, P234, DOI 10.2307/142715; Krugman P, 1996, J JPN INT ECON, V10, P399, DOI 10.1006/jjie.1996.0023; Kuninaka H, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.114801; Kuznets S, 1955, AM ECON REV, V45, P1; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Martinez-Fernandez C, 2012, INT J URBAN REGIONAL, V36, P213, DOI 10.1111/j.1468-2427.2011.01092.x; Moriconi-Ebrard F, 1993, URBANISATION MONDE D; Morrill RL, 1970, SPATIAL ORG SOC; Nitsch V, 2005, J URBAN ECON, V57, P86, DOI 10.1016/j.jue.2004.09.002; PARR JB, 1985, J URBAN ECON, V18, P199, DOI 10.1016/0094-1190(85)90017-8; Pumain D., 2004, SCALING LAWS URBAN S, P4; Pumain D., 2012, REGION DEV, V36, P31; ROSEN KT, 1980, J URBAN ECON, V8, P165, DOI 10.1016/0094-1190(80)90043-1; Savage SH, 1997, J ARCHAEOL SCI, V24, P233, DOI 10.1006/jasc.1996.0106; Soo KT, 2005, REG SCI URBAN ECON, V35, P239, DOI 10.1016/j.regsciurbeco.2004.04.004; UN, 2015, 2015 REV WORLD POP P; United Nations, 2014, 2014 REV WORLD URBAN; World Bank, 2016, WORLD BANK GDP PER C; Xu ZL, 2009, URBAN STUD, V46, P2159, DOI 10.1177/0042098009339432; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	28	21	22	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183919	10.1371/journal.pone.0183919	http://dx.doi.org/10.1371/journal.pone.0183919			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850594	Green Submitted, Green Published, gold			2022-12-27	WOS:000408544200043
J	Alidori, S; Thorek, DLJ; Beattie, BJ; Ulmert, D; Almeida, BA; Monette, S; Scheinberg, DA; McDevitt, MR				Alidori, Simone; Thorek, Daniel L. J.; Beattie, Bradley J.; Ulmert, David; Almeida, Bryan Aristega; Monette, Sebastien; Scheinberg, David A.; McDevitt, Michael R.			Carbon nanotubes exhibit fibrillar pharmacology in primates	PLOS ONE			English	Article							PHARMACOKINETICS; EXCRETION; TOXICITY; SIRNA; PET; DNA	Nanomedicine rests at the nexus of medicine, bioengineering, and biology with great potential for improving health through innovation and development of new drugs and devices. Carbon nanotubes are an example of a fibrillar nanomaterial poised to translate into medical practice. The leading candidate material in this class is ammonium-functionalized carbon nanotubes (fCNT) that exhibits unexpected pharmacological behavior in vivo with important biotechnology applications. Here, we provide a multi-organ evaluation of the distribution, uptake and processing of fCNT in nonhuman primates using quantitative whole body positron emission tomography (PET), compartmental modeling of pharmacokinetic data, serum biomarkers and ex vivo pathology investigation. Kidney and liver are the two major organ systems that accumulate and excrete [Y-86] fCNT in nonhuman primates and accumulation is cell specific as described by compartmental modeling analyses of the quantitative PET data. A serial two-compartment model explains renal processing of tracer-labeled fCNT; hepatic data fits a parallel two-compartment model. These modeling data also reveal significant elimination of the injected activity (>99.8%) from the primate within 3 days (t(1/2) = 11.9 hours). These favorable results in nonhuman primates provide important insight to the fate of fCNT in vivo and pave the way to further engineering design considerations for sophisticated nanomedicines to aid late stage development and clinical use in man.	[Alidori, Simone; Ulmert, David; Almeida, Bryan Aristega; McDevitt, Michael R.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Thorek, Daniel L. J.] Johns Hopkins Sch Med, Dept Radiol, Baltimore, MD USA; [Thorek, Daniel L. J.] Johns Hopkins Sch Med, Dept Radiol Sci, Baltimore, MD USA; [Beattie, Bradley J.] Mem Sloan Kettering Canc Ctr, Dept Med Phys, New York, NY 10021 USA; [Monette, Sebastien] Rockefeller Univ, Mem Sloan Kettering Canc Ctr, Weill Cornell Med, Triinst Lab Comparat Pathol, 1230 York Ave, New York, NY 10021 USA; [Scheinberg, David A.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol Program, 1275 York Ave, New York, NY 10021 USA; [Scheinberg, David A.] Weill Cornell Med, Dept Pharmacol, New York, NY USA; [Scheinberg, David A.] Weill Cornell Med, Dept Med, New York, NY USA; [McDevitt, Michael R.] Weill Cornell Med, Dept Radiol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Rockefeller University; Memorial Sloan Kettering Cancer Center; Cornell University; Cornell University; Cornell University	McDevitt, MR (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.; McDevitt, MR (corresponding author), Weill Cornell Med, Dept Radiol, New York, NY 10065 USA.	m-mcdevitt@ski.mskcc.org		Aristega Almeida, Bryan/0000-0001-9347-3998	Office of Science (BER), U.S. Department of Energy [DE-SC0002456]; NIH MSTP Grant [GM07739, R21 CM 28406, R01 CM 66078, R01 CA55349, R25T CA046945, R24 CA83084, P30 CA008748, P01 CA33049, F31 CA167863]; Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CM INT); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE [F31CA167863, P01CA033049, R01CA055349, P30CA008748, R21CA128406, R24CA083084, R01CA166078] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER	Office of Science (BER), U.S. Department of Energy(United States Department of Energy (DOE)); NIH MSTP Grant; Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CM INT); Commonwealth Foundation for Cancer Research; Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Office of Science (BER), U.S. Department of Energy (Award DE-SC0002456), NIH MSTP Grant GM07739, R21 CM 28406, R01 CM 66078, R01 CA55349, R25T CA046945, R24 CA83084, P30 CA008748, P01 CA33049, F31 CA167863, the Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CM INT), Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, and The Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center.; The authors acknowledge the expert assistance of Mr. Muc Du and Mr. Simon Marim of the Cornel Bioimaging Core Facility, Dr. Heather Martin of the MSKCC veterinary staff, Ms. Desiree Powell of the MSKCC LCP, Ms. Amy Carol McDevitt for graphic illustration, Mr. Yevgeniy Romin of the MSK Molecular Cytology Core Facility, and Dr. Tong Wang of the CUNY Advanced Science Research Center. This work was supported by the Office of Science (BER), U. S. Department of Energy (Award DE-SC0002456), NIH MSTP Grant GM07739, R21 CA128406, R01 CA166078, R01 CA55349, R25T CA046945, R24 CA83084, P30 CA008748, P01 CA33049, F31 CA167863, the Memorial Sloan Kettering Center for Molecular Imaging and Nanotechnology (CMINT), Mr. William H. and Mrs. Alice Goodwin and the Commonwealth Foundation for Cancer Research, and The Center for Experimental Therapeutics of Memorial Sloan Kettering Cancer Center.	Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Alidori S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12343; Alidori S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aac9647; Alidori S, 2013, J PHYS CHEM C, V117, P5982, DOI 10.1021/jp312416d; Bartholomeusz G, 2009, NANO RES, V2, P279, DOI 10.1007/s12274-009-9026-7; Beattie BJ, 2003, MED PHYS, V30, P2410, DOI 10.1118/1.1595599; Chamanza R, 2010, TOXICOL PATHOL, V38, P642, DOI 10.1177/0192623310368981; Elgrabli D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124490; Fitzgerald K, 2017, NEW ENGL J MED, V376, P41, DOI 10.1056/NEJMoa1609243; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Kostarelos K, 2008, NAT BIOTECHNOL, V26, P774, DOI 10.1038/nbt0708-774; Kostarelos K, 2010, NAT MATER, V9, P793, DOI 10.1038/nmat2871; Lacerda L, 2008, SMALL, V4, P1130, DOI 10.1002/smll.200800323; Lacerda L, 2008, NANOMEDICINE-UK, V3, P149, DOI 10.2217/17435889.3.2.149; Lacerda L, 2008, ADV MATER, V20, P225, DOI 10.1002/adma.200702334; McDevitt MR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000907; McDevitt Michael R., 2014, Critical Reviews in Oncogenesis, V19, P261; Mulvey JJ, 2014, INT J NANOMED, V9, P4245, DOI 10.2147/IJN.S66050; Mulvey JJ, 2013, NAT NANOTECHNOL, V8, P763, DOI 10.1038/nnano.2013.190; Park HK, 2016, LAB ANIM RES, V32, P79; Phillips KA, 2014, AM J PRIMATOL, V76, P801, DOI 10.1002/ajp.22281; Ruggiero A, 2010, P NATL ACAD SCI USA, V107, P12369, DOI 10.1073/pnas.0913667107; Sato J, 2012, J TOXICOL PATHOL, V25, P63, DOI 10.1293/tox.25.63; Scheinberg DA, 2010, NAT REV CLIN ONCOL, V7, P266, DOI 10.1038/nrclinonc.2010.38; Schluep T, 2009, P NATL ACAD SCI USA, V106, P11394, DOI 10.1073/pnas.0905487106; Singh R, 2006, P NATL ACAD SCI USA, V103, P3357, DOI 10.1073/pnas.0509009103; Xie L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064892	27	13	13	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183902	10.1371/journal.pone.0183902	http://dx.doi.org/10.1371/journal.pone.0183902			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846728	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600056
J	Cardea, E; Nordhjem, B; Marcusson-Clavertz, D; Holmqvist, K				Cardea, Etzel; Nordhjem, Barbara; Marcusson-Clavertz, David; Holmqvist, Kenneth			The "hypnotic state" and eye movements: Less there than meets the eye?	PLOS ONE			English	Article							HYPNOSIS; SUSCEPTIBILITY; HYPOTHESIS	Responsiveness to hypnotic procedures has been related to unusual eye behaviors for centuries. Kallio and collaborators claimed recently that they had found a reliable index for "the hypnotic state" through eye-tracking methods. Whether or not hypnotic responding involves a special state of consciousness has been part of a contentious debate in the field, so the potential validity of their claim would constitute a landmark. However, their conclusion was based on 1 highly hypnotizable individual compared with 14 controls who were not measured on hypnotizability. We sought to replicate their results with a sample screened for High (n = 16) or Low (n = 13) hypnotizability. We used a factorial 2 (high vs. low hypnotizability) x 2 (hypnosis vs. resting conditions) counterbalanced order design with these eye-tracking tasks: Fixation, Saccade, Optokinetic nystagmus (OKN), Smooth pursuit, and Antisaccade (the first three tasks has been used in Kallio et al.'s experiment). Highs reported being more deeply in hypnosis than Lows but only in the hypnotic condition, as expected. There were no significant main or interaction effects for the Fixation, OKN, or Smooth pursuit tasks. For the Saccade task both Highs and Lows had smaller saccades during hypnosis, and in the Antisaccade task both groups had slower Antisaccades during hypnosis. Although a couple of results suggest that a hypnotic condition may produce reduced eye motility, the lack of significant interactions (e.g., showing only Highs expressing a particular eye behavior during hypnosis) does not support the claim that eye behaviors (at least as measured with the techniques used) are an indicator of a "hypnotic state." Our results do not preclude the possibility that in a more spontaneous or different setting the experience of being hypnotized might relate to specific eye behaviors.	[Cardea, Etzel; Marcusson-Clavertz, David] Lund Univ, Dept Psychol, Ctr Res Consciousness & Anomalous Psychol CERCAP, Lund, Sweden; [Nordhjem, Barbara] Univ Groningen, Univ Med Ctr Groningen, Sch Behav & Cognit Neurosci, Lab Expt Ophthalmol, Groningen, Netherlands; [Marcusson-Clavertz, David] Penn State Univ, Dept Biobehav Hlth, University Pk, PA 16802 USA; [Holmqvist, Kenneth] Lund Univ, Humanities Lab, Eye Tracking Grp, Lund, Sweden; [Holmqvist, Kenneth] UPSET, NWU Vaal, Vanderbijlpark, South Africa	Lund University; University of Groningen; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Lund University	Cardea, E (corresponding author), Lund Univ, Dept Psychol, Ctr Res Consciousness & Anomalous Psychol CERCAP, Lund, Sweden.	etzel.cardena@psy.lu.se		Cardena, Etzel/0000-0001-6775-8017; Nordhjem, Barbara/0000-0001-7725-4437	Bial [227-10]; European Union's Horizon 2020 Research and Innovation Programme [641805]	Bial(Bial Group); European Union's Horizon 2020 Research and Innovation Programme	The first author's contribution was partly supported by Bial grant # 227-10. The authors also gratefully acknowledge the Lund University Humanities Lab. The second author (BN) received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement no. 641805. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The first author's contribution was partly supported by Bial grant # 227-10. The authors also gratefully acknowledge the Lund University Humanities Lab. The second author (BN) received funding from the European Union's Horizon 2020 Research and Innovation Programme under the Marie Sklodowska-Curie grant agreement No 641805. We thank Sakari Kallio, Ph. D., for sending us his three eye tracking programs, on which we modeled our corresponding ones. The ms. also includes our responses to his review (as per PLOS ONE policy). We are also grateful to two anonymous reviewers who provided very useful suggestions to improve the paper.	Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Braffman W, 1999, J PERS SOC PSYCHOL, V77, P578, DOI 10.1037/0022-3514.77.3.578; Cardena E., 2016, PSYCHOL CONSCIOUS, V3, P61, DOI [10.1037/cns0000080, DOI 10.1037/CNS0000080]; Cardena E, 2013, CORTEX, V49, P375, DOI 10.1016/j.cortex.2012.04.001; Carlson EB, ASSESSMENT; Charcot JM, 1972, DEMONIAQUES ART; Cornelissen FW, 2002, BEHAV RES METH INS C, V34, P613, DOI 10.3758/BF03195489; Council Jr, 1999, DISSOCIAT TRAUM MEM, P119; Crawford HJ, 2000, NEUROIMAGE, P11; Deuter CE, 2013, PSYCHOPHYSIOLOGY, V50, P1056, DOI 10.1111/psyp.12083; Di Gruttola F, 2014, EXP BRAIN RES, V232, P3763, DOI 10.1007/s00221-014-4073-z; DUNWOODY RC, 1974, AM J CLIN HYPN, V16, P270; Eckstein MK, 2016, DEV COGN NEUROSCI; Ellenberger H., 1970, DISCOV UNCONSCIOUS; EVANS FJ, 1966, INT J CLIN EXP HYP, V14, P333, DOI 10.1080/00207146608412976; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; Irwin HJ, 1999, PERCEPT MOTOR SKILL, V89, P1230; Kallio S, 2016, INT J CLIN EXP HYP, V64, P261, DOI 10.1080/00207144.2016.1171088; Kallio S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026374; Kihlstrom J.F., 2008, OXFORD HDB HYPNOSIS, P21, DOI [https://doi.org/10.1093/oxfordhb/9780198570097.013.0002, DOI 10.1093/OXFORDHB/9780198570097.013.0002]; KIRSCH I, 1995, AM PSYCHOL, V50, P846, DOI 10.1037/0003-066X.50.10.846; KIRSCH I, 1990, INT J CLIN EXP HYP, V38, P112, DOI 10.1080/00207149008414506; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; LAURENCE JR, 1986, INT J CLIN EXP HYP, V34, P215, DOI 10.1080/00207148608406987; Levy Deborah L, 2004, World Psychiatry, V3, P32; Lichtenberg P, 2008, INT J CLIN EXP HYP, V56, P243, DOI 10.1080/00207140802039474; LINDSAY S, 1993, INT J CLIN EXP HYP, V41, P92, DOI 10.1080/00207149308414540; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; McGeown WJ, 2009, CONSCIOUS COGN, V18, P848, DOI 10.1016/j.concog.2009.09.001; O'Driscoll GA, 2008, BRAIN COGNITION, V68, P359, DOI 10.1016/j.bandc.2008.08.023; REGISTER PA, 1986, INT J CLIN EXP HYP, V34, P84, DOI 10.1080/00207148608406974; Sargant W, 1973, MIND POSSESSED PHYSL; Sargant W., 1957, BATTLE FOR THE MIND; SHEEHAN DV, 1979, INT J CLIN EXP HYP, V27, P103, DOI 10.1080/00207147908407550; Shor R. E., 1962, HARVARD GROUP SCALE; Smilek D, 2010, PSYCHOL SCI, V21, P786, DOI 10.1177/0956797610368063; Spiegel H., 1978, TRANCE TREATMENT CLI; TEBECIS AK, 1975, BIOL PSYCHOL, V3, P31, DOI 10.1016/0301-0511(75)90004-6; Weitzenhoffer A., 1969, AM J CLIN HYPN, p11 221; WEITZENHOFFER A M, 1971, American Journal of Clinical Hypnosis, V14, P102; WEITZENHOFFER AM, 1969, PERCEPT MOTOR SKILL, V28, P671, DOI 10.2466/pms.1969.28.2.671; Weitzenhoffer AM, 1962, STANFORD HYPNOTIC SU, V27; Woody Erik Z., 1994, P52; Yeates LB, 2013, THESIS	44	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182546	10.1371/journal.pone.0182546	http://dx.doi.org/10.1371/journal.pone.0182546			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846696	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600012
J	Ferrero, M; West, G; Vadillo, MA				Ferrero, Marta; West, Gillian; Vadillo, Miguel A.			Is crossed laterality associated with academic achievement and intelligence? A systematic review and meta-analysis	PLOS ONE			English	Review							EYE-HAND PREFERENCE; READING RETARDATION; FAMILIAL HANDEDNESS; CEREBRAL-DOMINANCE; COGNITIVE-ABILITY; PHYSICAL SKILLS; CHILDREN; PATTERNS; PERFORMANCE; DISABILITY	Over the last century, sporadic research has suggested that people whose hand, eye, foot, or ear dominances are not consistently right- or left-sided are at special risk of suffering academic difficulties. This phenomenon is known as crossed laterality. Although the bulk of this research dates from 1960's and 1970's, crossed laterality is becoming increasingly popular in the area of school education, driving the creation of several interventions aimed at restoring or consolidating lateral dominance. However, the available evidence is fragmentary. To determine the impact of crossed laterality on academic achievement and intelligence, we conducted a systematic review and meta-analysis of articles published since 1900. The inclusion criteria for the review required that studies used one or more lateral preference tasks for at least two specific parts of the body; they included a valid measure of crossed laterality; they measured the impact of crossed laterality on academic achievement or intelligence; and they included participants between 3 and 17 years old. The final sample included 26 articles that covered a total population of 3578 children aged 5 to 12. Taken collectively, the results of these studies do not support the claim that there is a reliable association between crossed laterality and either academic achievement or intelligence. Along with this, we detected important shortcomings in the literature, such as considerable heterogeneity among the variables used to measure laterality and among the tasks utilized to measure the outcomes. The educational implications of these results are discussed.	[Ferrero, Marta] UCL, Dept Expt Psychol, London, England; [Ferrero, Marta] Univ Deusto, Fac Ingn, Bilbao, Spain; [West, Gillian] UCL, Dept Language & Cognit, London, England; [Vadillo, Miguel A.] Kings Coll London, Primary Care & Publ Hlth Sci, London, England; [Vadillo, Miguel A.] Univ Autonoma Madrid, Dept Psicol Basica, Madrid, Spain	University of London; University College London; University of Deusto; University of London; University College London; University of London; King's College London; Autonomous University of Madrid	Ferrero, M (corresponding author), UCL, Dept Expt Psychol, London, England.; Ferrero, M (corresponding author), Univ Deusto, Fac Ingn, Bilbao, Spain.	marta.ferrero@deusto.es	Vadillo, Miguel A./A-8702-2011; Ferrero, Marta/ABD-4325-2020	Vadillo, Miguel A./0000-0001-8421-816X; Ferrero, Marta/0000-0002-4156-6137; West, Gillian/0000-0002-4413-3601	bizkaia:talent, Diputacion Foral de Bizkaia [AYD-000-235]; Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor, Gobierno Vasco; madri+d Science Foundation [2016-T1/SOC-1395]	bizkaia:talent, Diputacion Foral de Bizkaia; Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor, Gobierno Vasco; madri+d Science Foundation	MF was supported by Grant AYD-000-235 from bizkaia:talent, Diputacion Foral de Bizkaia, and by Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor, Gobierno Vasco. MAV was supported by Grant 2016-T1/SOC-1395 from madri+d Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; MF was supported by Grant AYD-000-235 from bizkaia:talent, Diputacion Foral de Bizkaia, and by Programa Posdoctoral de Perfeccionamiento de Personal Investigador Doctor, Gobierno Vasco. MAV was supported by Grant 2016-T1/SOC-1395 from madri+d Science Foundation.	ANNETT M, 1974, BRIT J EDUC PSYCHOL, V44, P37, DOI 10.1111/j.2044-8279.1974.tb00764.x; ANNETT M, 1990, J CHILD PSYCHOL PSYC, V31, P511, DOI 10.1111/j.1469-7610.1990.tb00795.x; ANNETT M, 1990, NEUROPSYCHOLOGIA, V28, P61, DOI 10.1016/0028-3932(90)90086-4; ANNETT M, 1982, CORTEX, V18, P547, DOI 10.1016/S0010-9452(82)80053-1; ANNETT M, 1984, J CHILD PSYCHOL PSYC, V25, P357, DOI 10.1111/j.1469-7610.1984.tb00158.x; Annett M, 2011, PERCEPT MOTOR SKILL, V112, P417, DOI 10.2466/10.19.24.PMS.112.2.417-425; [Anonymous], 2016, LEARNING SUCCESS BLO; BALOW IH, 1964, AM EDUC RES J, V1, P139, DOI 10.2307/1162214; Batchelor ES, 1997, INT J NEUROSCI, V89, P241, DOI 10.3109/00207459708988477; BELMONT L, 1965, CHILD DEV, V36, P57, DOI 10.2307/1126780; BELMONT L, 1963, CHILD DEV, V34, P257, DOI 10.2307/1126726; BISHOP DVM, 1979, CORTEX, V15, P659, DOI 10.1016/S0010-9452(79)80053-2; BOAKE C, 1983, J ABNORM CHILD PSYCH, V11, P77, DOI 10.1007/BF00912179; Borenstein M., 2009, INTRO METAANALYSIS; BROD N, 1971, AMER J OPT ARCH AM A, V48, P123; BRYDEN MP, 1970, NEUROPSYCHOLOGIA, V8, P443, DOI 10.1016/0028-3932(70)90040-0; Busso DS, 2014, LEARN MEDIA TECHNOL; CLYMER PE, 1985, J HUM MOVEMENT STUD, V11, P59; COLEMAN RI, 1964, PERCEPT MOTOR SKILL, V19, P43, DOI 10.2466/pms.1964.19.1.13; CONNOLLY BH, 1983, PHYS THER, V63, P183, DOI 10.1093/ptj/63.2.183; Cruickshank WM, 1968, EXCEPT CHILDREN, V35, P93; DEAN RS, 1981, J CONSULT CLIN PSYCH, V49, P227, DOI 10.1037/0022-006X.49.2.227; Di Nuovo S, 2003, PERCEPT MOTOR SKILL, V96, P400; DOMAN RJ, 1960, JAMA-J AM MED ASSOC, V174, P257, DOI 10.1001/jama.1960.03030030037007; DUNLOP D B, 1973, Cortex, V9, P227; Fagard J, 2008, DEV PSYCHOBIOL, V50, P789, DOI 10.1002/dev.20328; FENNELL EB, 1983, J EXP CHILD PSYCHOL, V35, P248, DOI 10.1016/0022-0965(83)90082-6; Gates AI, 1936, J EDUC PSYCHOL, V27, P450, DOI 10.1037/h0057820; GORDON HW, 1980, NEUROPSYCHOLOGIA, V18, P645, DOI 10.1016/0028-3932(80)90104-9; GUYER BL, 1975, CHILD DEV, V46, P658, DOI 10.2307/1128563; HARDYCK C, 1977, PSYCHOL BULL, V84, P385, DOI 10.1037/0033-2909.84.3.385; HARRIS AJ, 1957, J PSYCHOL, V44, P283, DOI 10.1080/00223980.1957.9713084; HILLERICH RL, 1964, AM EDUC RES J, V1, P121; HUNTER EJ, 1971, J LEARN DISABIL, V4, P572, DOI 10.1177/002221947100401006; Hyatt KJ, 2007, REM SPEC EDUC, V28, P117, DOI 10.1177/07419325070280020201; KERSHNER JR, 1978, DEV PSYCHOBIOL, V11, P309, DOI 10.1002/dev.420110404; Kirk SA, 1934, PEDAGOG SEMIN J GEN, V44, P192; KOOS EM, 1964, J GENET PSYCHOL, V104, P155, DOI 10.1080/00221325.1964.10532549; KRAFT RH, 1985, PERCEPT MOTOR SKILL, V61, P1147, DOI 10.2466/pms.1985.61.3f.1147; KRAFT RH, 1983, NEUROPSYCHOLOGIA, V21, P79; KRAFT RH, 1987, NEUROPSYCHOLOGIA, V25, P817, DOI 10.1016/0028-3932(87)90119-9; Leconte P, 2006, DEV PSYCHOBIOL, V48, P492, DOI 10.1002/dev.20167; Lewandowski L, 1985, DEV NEUROPSYCHOL, V1, P277, DOI 10.1080/87565648509540314; LEWANDOWSKI LJ, 1986, INT J CLIN NEUROPSYC, V8, P173; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lilienfeld SO, 2007, PERSPECT PSYCHOL SCI, V2, P53, DOI 10.1111/j.1745-6916.2007.00029.x; LONGONI AM, 1989, INT J NEUROSCI, V44, P41, DOI 10.3109/00207458908986181; Mahone EM, 2006, PERCEPT MOTOR SKILL, V102, P691, DOI 10.2466/PMS.102.3.691-702; Mapp AP, 2003, PERCEPT PSYCHOPHYS, V65, P310, DOI 10.3758/BF03194802; MUEHL S, 1963, J EDUC PSYCHOL, V54, P316, DOI 10.1037/h0046729; Muehl S, 1966, CEC CONV TOR, P8; Novella S., 1996, CONNECTICUT SKEPT, V1, P6; OBRZUT JE, 1986, J LEARN DISABIL, V19, P308, DOI 10.1177/002221948601900511; Orton ST., 1937, READING WRITING SPEE; Papadatou-Pastou M, 2015, NEUROSCI BIOBEHAV R, V56, P151, DOI 10.1016/j.neubiorev.2015.06.017; Pasquinelli E, 2012, MIND BRAIN EDUC, V6, P89, DOI 10.1111/j.1751-228X.2012.01141.x; RICHARDSON JTE, 1979, CORTEX, V15, P581, DOI 10.1016/S0010-9452(79)80047-7; Rosa F, 2013, REV CEFAC, V15, P864; ROSZKOWSKI MJ, 1987, DEV NEUROPSYCHOL, V3, P53, DOI 10.1080/87565648709540363; SABATINO DA, 1971, CHILD DEV, V42, P2055; Sappington J, 2005, LATERALITY, V10, P369, DOI 10.1080/13576500442000157; SAWYER CE, 1977, EDUC REV, V29, P81, DOI 10.1080/0013191770290201; SCHWARTZ NH, 1978, PERCEPT MOTOR SKILL, V47, P869, DOI 10.2466/pms.1978.47.3.869; Shakouri N, 2016, BRAIN-BROAD RES ARTI, V7, P69; SHAYWITZ SE, 1984, J PEDIATR-US, V104, P819, DOI 10.1016/S0022-3476(84)80474-6; SHEARER E, 1968, EDUC RES, V10, P197, DOI 10.1080/0013188680100304; SILVER AA, 1966, READ TEACH, V19, P253; SILVER AA, 1960, COMPR PSYCHIAT, V1, P126, DOI 10.1016/S0010-440X(60)80017-X; Smith LC, 1950, J EXP EDUC, V18, P321, DOI 10.1080/00220973.1950.11010415; Somers M, 2015, BRAIN LANG, V144, P10, DOI 10.1016/j.bandl.2015.03.006; STEIN GM, 1980, CORTEX, V16, P223, DOI 10.1016/S0010-9452(80)80058-X; STEPHENS WE, 1967, EXCEPT CHILDREN, V33, P481, DOI 10.1177/001440296703300706; SULZBACHER S, 1994, DEV NEUROPSYCHOL, V10, P473, DOI 10.1080/87565649409540596; THOMSON M, 1975, BRIT J EDUC PSYCHOL, V45, P317, DOI 10.1111/j.2044-8279.1975.tb02971.x; TOUWEN BCL, 1972, DEV MED CHILD NEUROL, V14, P747; Tran US, 2014, NEUROPSYCHOLOGIA, V62, P220, DOI 10.1016/j.neuropsychologia.2014.07.027; TRUSSELL EM, 1969, RES QUART, V40, P383, DOI 10.1080/10671188.1969.10614840; ULLMAN DG, 1977, J SCHOOL PSYCHOL, V15, P36, DOI 10.1016/0022-4405(77)90059-0; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; WHEELER TJ, 1977, BRIT J EDUC PSYCHOL, V47, P126, DOI 10.1111/j.2044-8279.1977.tb02337.x; Witty PA, 1936, J EDUC PSYCHOL, V27, P119, DOI 10.1037/h0063645; Wolfe LS, 1941, PEDAGOG SEMIN J GEN, V58, P45; WUSSLER M, 1970, PERCEPT MOTOR SKILL, V31, P419, DOI 10.2466/pms.1970.31.2.419; Ziring PR, 1999, PEDIATRICS, V104, P1149; ZURIF EB, 1970, NEUROPSYCHOLOGIA, V8, P351, DOI 10.1016/0028-3932(70)90079-5	85	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183618	10.1371/journal.pone.0183618	http://dx.doi.org/10.1371/journal.pone.0183618			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846704	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600042
J	Oliveira, AF; Fernandes, FF; Mariano, VS; Almeida, F; Ruas, LP; Oliveira, LL; Oliver, C; Jamur, MC; Roque-Barreira, MC				Oliveira, Aline Ferreira; Fernandes, Fabricio Freitas; Mariano, Vania Sammartino; Almeida, Fausto; Ruas, Luciana Pereira; Oliveira, Leandro Licursi; Oliver, Constance; Jamur, Maria Celia; Roque-Barreira, Maria Cristina			Paracoccin distribution supports its role in Paracoccidioides brasiliensis growth and dimorphic transformation	PLOS ONE			English	Article							CANDIDA-ALBICANS; CELL-WALL; YEAST FORM; SACCHAROMYCES-CEREVISIAE; CHITIN SYNTHESIS; BINDING LECTIN; SPITZENKORPER; EXPRESSION; GENE; IDENTIFICATION	Paracoccidioides brasiliensis yeast was reported to express paracoccin, a GlcNAc-binding protein that displays N-acetyl-beta-D-glucosaminidase (NAGase) activity. Highly specific antiparacoccin antibodies have been previously used to examine the localization of paracoccin in yeast and inhibit its growth in vitro. In the present study, anti-paracoccin antibodies were used to characterize, by scanning confocal microscopy, the distribution of paracoccin in P. brasiliensis hyphae, transition forms from hyphae to yeast, and mature yeast. In the mycelial phase, paracoccin was detected mainly in the hyphae tips, where it demonstrated a punctate distribution, and was associated with the cell wall. During the first 48 hours after a temperature shift from 26 degrees C to 37 degrees C, paracoccin expression in the differentiating hyphae was mainly detected in the budding regions, i.e. lateral protrusions, and inside the new daughter cells. There was an increased number of chlamydoconidia that expressed a high concentration of paracoccin on their surfaces and/or in their interiors 72-96 hours after the temperature shift. After 120 hours, yeast cells were the predominant form and their cytoplasm stained extensively for paracoccin, whereas Wheat Germ Agglutinin (WGA) staining was predominant on their exterior walls. After 10 days at 37 degrees C, the interior of both mother and daughter yeast cells, as well as the budding regions, stained intensely for paracoccin. The comparison of mRNA-expression in the different fungal forms showed that PCN transcripts, although detected in all evaluated morphological forms, were higher in hypha and yeast-tohypha transition forms. In conclusion, the pattern of paracoccin distribution in all P. brasiliensis morphotypes supports prevalent beliefs that it plays important roles in fungal growth and dimorphic transformation.	[Oliveira, Aline Ferreira; Fernandes, Fabricio Freitas; Mariano, Vania Sammartino; Almeida, Fausto; Ruas, Luciana Pereira; Oliver, Constance; Jamur, Maria Celia; Roque-Barreira, Maria Cristina] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, SP, Brazil; [Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Biol Geral, Vicosa, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Vicosa	Roque-Barreira, MC (corresponding author), Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Biol Celular & Mol & Bioagentes Patogen, Ribeirao Preto, SP, Brazil.	mcrbarre@fmrp.usp.br	Mariano, Vânia Sammartino/AAV-1851-2020; de Oliveira Pereira, Aline Ferreira/AAT-5134-2020; de Oliveira, Leandro Licursi/D-3616-2009; Ruas, Luciana/A-4259-2013; Almeida, Fausto/N-6540-2013; Roque Barreira, Maria Cristina/A-4552-2008	Mariano, Vânia Sammartino/0000-0002-5399-5676; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Ruas, Luciana/0000-0002-1028-7872; Almeida, Fausto/0000-0002-3782-3698; Roque Barreira, Maria Cristina/0000-0001-7425-0908	FAPESP [2007/58879-7, 2009/51197-3, 2013/10741-8, 2006/60642-2]; CNPq; FAEPA	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAEPA	This work was supported by FAPESP, grant numbers 2007/58879-7, 2009/51197-3, 2013/10741-8 and 2006/60642-2. Additional financial help was provided by CNPq and FAEPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by FAPESP, grant numbers 2007/58879-7, 2009/51197-3, 2013/10741-8 and 2006/60642-2. Additional financial help was provided by CNPq and FAEPA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Sandra Thomaz and Patricia Vendruscolo for technical support.	Almeida F, 2016, CURR GENOMICS, V17, P112, DOI 10.2174/1389202917666151116212705; BRUMMER E, 1993, CLIN MICROBIOL REV, V6, P89, DOI 10.1128/CMR.6.2.89-117.1993; BULAWA CE, 1993, ANNU REV MICROBIOL, V47, P505, DOI 10.1146/annurev.micro.47.1.505; CABIB E, 1982, ANNU REV BIOCHEM, V51, P763, DOI 10.1146/annurev.bi.51.070182.003555; CARBONELL LM, 1970, J BACTERIOL, V101, P636, DOI 10.1128/JB.101.2.636-642.1970; CARBONELL LM, 1967, J BACTERIOL, V94, P213, DOI 10.1002/path.1700940130; CARBONELL LM, 1965, J BACTERIOL, V90, P504, DOI 10.1128/JB.90.2.504-510.1965; CARBONELL LM, 1969, J BACTERIOL, V100, P1076, DOI 10.1128/JB.100.2.1076-1082.1969; Chen DL, 2007, MOL MICROBIOL, V65, P761, DOI 10.1111/j.1365-2958.2007.05824.x; Coltri KC, 2006, MICROBES INFECT, V8, P704, DOI 10.1016/j.micinf.2005.09.008; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; da Silva SP, 1999, MOL MICROBIOL, V31, P1039, DOI 10.1046/j.1365-2958.1999.01236.x; Dasilva AMM, 1994, MYCOSES, V37; Almeida FBD, 2014, YEAST, V31, P1, DOI 10.1002/yea.2983; Almeida FBD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029216; Almeida FBD, 2010, YEAST, V27, P67, DOI 10.1002/yea.1731; Dunkler A, 2005, FUNGAL GENET BIOL, V42, P935, DOI 10.1016/j.fgb.2005.08.001; Fernandes FF, 2017, MBIO, V8, DOI [10.1128/mBio.00537-17, 10.1128/mbio.00537-17]; Franco M, 1987, Rev Soc Bras Med Trop, V20, P129, DOI 10.1590/S0037-86821987000200012; FRANCO M, 1989, REV I MED TROP, V31, P151, DOI 10.1590/S0036-46651989000300004; Ganiko L, 2007, MICROBES INFECT, V9, P695, DOI 10.1016/j.micinf.2007.02.012; Goldman GH, 2003, EUKARYOT CELL, V2, P34, DOI 10.1128/EC.2.1.34-48.2003; GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970; Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005; Hernandez O, 2011, YEAST, V28, P771, DOI 10.1002/yea.1902; KANETSUNA F, 1972, J BACTERIOL, V110, P208, DOI 10.1128/JB.110.1.208-218.1972; KANETSUNA F, 1969, J BACTERIOL, V97, P1036, DOI 10.1128/JB.97.3.1036-1041.1969; MCEWEN JG, 1987, AM J TROP MED HYG, V36, P603, DOI 10.4269/ajtmh.1987.36.603; Miyaji Makoto, 2003, Nihon Ishinkin Gakkai Zasshi, V44, P133, DOI 10.3314/jjmm.44.133; Munro CA, 1998, MICROBIOL-SGM, V144, P391, DOI 10.1099/00221287-144-2-391; Nunes LR, 2005, EUKARYOT CELL, V4, P2115, DOI 10.1128/EC.4.12.2115-2128.2005; Alegre ACP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002788; PATINO MM, 1984, SABOURAUDIA, V22, P509; Puccia R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00257; Rezende TCV, 2011, J PROTEOMICS, V75, P572, DOI 10.1016/j.jprot.2011.08.020; SALAZAR ME, 1988, INFECT IMMUN, V56, P711, DOI 10.1128/IAI.56.3.711-713.1988; San-Blas G, 2008, MYCOPATHOLOGIA, V165, P183, DOI 10.1007/s11046-007-9040-9; SANTANNA OA, 1982, J IMMUNOGENET, V9, P191; Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06; Sudbery PE, 2011, NAT REV MICROBIOL, V9, P737, DOI 10.1038/nrmicro2636; Tanaka R, 2001, MYCOSES, V44, P9, DOI 10.1046/j.1439-0507.2001.00612.x; Tavares AH, 2015, FUNGAL GENET BIOL, V81, P98, DOI 10.1016/j.fgb.2014.01.008; VALDIVIESO MH, 1991, J CELL BIOL, V114, P101, DOI 10.1083/jcb.114.1.101	43	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184010	10.1371/journal.pone.0184010	http://dx.doi.org/10.1371/journal.pone.0184010			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846733	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600064
J	Popo, E; Kenyon, S; Dann, SA; MacArthur, C; Blissett, J				Popo, Emma; Kenyon, Sara; Dann, Sophie-Anna; MacArthur, Christine; Blissett, Jacqueline			Effects of lay support for pregnant women with social risk factors on infant development and maternal psychological health at 12 months postpartum	PLOS ONE			English	Article							POSTNATAL DEPRESSION; MIND-MINDEDNESS; COGNITIVE-DEVELOPMENT; ATTACHMENT SECURITY; MOTOR DEVELOPMENT; SEVERE DISORDERS; BONDING SCALE; CHILD HEALTH; MOTHERS; LINKS	Background The ELSIPS (Evaluation of Lay Support in Pregnant Women with Social Risk) RCT showed that lay support for women with social risk had a positive effect on maternal mental health and mother-infant bonding. This exploratory study examined whether these observed benefits would impact infant development at 1 year. Methods A sub-sample of women whose infants were under one year who had participated in the ELSIPS RCT which randomised women to receive either standard care or the services of a Pregnancy Outreach Worker (POW), and who were contactable, were eligible to participate in the follow up. At home visits, the Bayley Scales of Infant Development (3rd Edition) and standardised measures of depression, self efficacy, mind-mindedness and bonding were completed. Results 486 women were eligible for follow up, of whom 154 agreed to participate. 61/273 were successfully followed up in the standard maternity care arm and 51/213 in the POW arm. Women who completed follow up were less depressed and had higher selfefficacy scores at 8-12 weeks postpartum than those who did not complete follow up. There were no significant differences in maternal outcomes, infant cognitive development, receptive communication, expressive communication, fine motor development or social/emotional functioning between groups at 12 month follow up. Infants of mothers who received the POW intervention had significantly better gross motor development than infants whose mothers received standard care (p<0.03). Conclusions The provision of lay support to women with social risk may facilitate infant gross motor skill development at one year but there were no other demonstrable benefits. The effects of the intervention may be underestimated given that those women who completed follow up had better mental health than the original study sample.	[Popo, Emma; Kenyon, Sara; Dann, Sophie-Anna; MacArthur, Christine] Univ Birmingham, Coll Med & Dent Sci, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Blissett, Jacqueline] Coventry Univ, Ctr Technol Enabled Hlth Res, Coventry, W Midlands, England; [Blissett, Jacqueline] Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England	University of Birmingham; Coventry University; University of Birmingham	Blissett, J (corresponding author), Coventry Univ, Ctr Technol Enabled Hlth Res, Coventry, W Midlands, England.; Blissett, J (corresponding author), Univ Birmingham, Sch Psychol, Birmingham, W Midlands, England.	jacqueline.blissett@coventry.ac.uk	MacArthur, Christine/ABA-8601-2021	MacArthur, Christine/0000-0003-0434-2158; Kenyon, Sara/0000-0002-0756-9617; Blissett, Jacqueline/0000-0002-0275-6413	National Institute of Health Research (NIHR); Birmingham and Black Country Collaboration for Leadership and Applied Health Research and Care; ISRCTN35027323	National Institute of Health Research (NIHR)(National Institute for Health Research (NIHR)); Birmingham and Black Country Collaboration for Leadership and Applied Health Research and Care; ISRCTN35027323	Funded by National Institute of Health Research (NIHR), Birmingham and Black Country Collaboration for Leadership and Applied Health Research and Care. http://www2.warwick.ac.uk/fac/med/about/centres/clahr/. Controlled-Trials. com number, ISRCTN35027323.The funders had no role in the follow up study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aber JL, 1997, ANNU REV PUBL HEALTH, V18, P463, DOI 10.1146/annurev.publhealth.18.1.463; [Anonymous], 2001, ARCH WOMENS MENTAL H, DOI DOI 10.1007/S007370170010; Arnott B, 2007, B MENNINGER CLIN, V71, P132, DOI 10.1521/bumc.2007.71.2.132; Bayley N., 2019, BAYLEY SCALES INFANT; Bayley N., 2006, J PSYCHOEDUC ASSESS, V25, P180, DOI [10.1177/0734282906297199, DOI 10.1177/0734282906297199]; Brockington IF, 2006, ARCH WOMEN MENT HLTH, V9, P233, DOI 10.1007/s00737-006-0132-1; COLLINS NL, 1993, J PERS SOC PSYCHOL, V65, P1243, DOI 10.1037/0022-3514.65.6.1243; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CRNIC KA, 1990, CHILD DEV, V61, P1628, DOI 10.2307/1130770; Dennis CL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001134.pub3; Desai S, 1998, DEMOGRAPHY, V35, P71, DOI 10.2307/3004028; Diamond A, 2000, CHILD DEV, V71, P44, DOI 10.1111/1467-8624.00117; Field T, 2010, INFANT BEHAV DEV, V33, P1, DOI 10.1016/j.infbeh.2009.10.005; FRANKS F, 1990, RES NURS HEALTH, V13, P283, DOI 10.1002/nur.4770130504; Grace S L, 2003, Arch Womens Ment Health, V6, P263, DOI 10.1007/s00737-003-0024-6; Haslam DM, 2006, INFANT MENT HEALTH J, V27, P276, DOI 10.1002/imhj.20092; Herrera E, 2004, J AFFECT DISORDERS, V81, P29, DOI 10.1016/j.jad.2003.07.001; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Hipwell AE, 2016, ARCH WOMEN MENT HLTH, V19, P871, DOI 10.1007/s00737-016-0627-3; Huizink AC, 2003, J CHILD PSYCHOL PSYC, V44, P810, DOI 10.1111/1469-7610.00166; Karlsen S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-606; Kenyon S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009203; Kenyon S, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-11; Kingston D, 2012, CHILD PSYCHIAT HUM D, V43, P683, DOI 10.1007/s10578-012-0291-4; Knight M, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b542; Kramer MS, 2000, PAEDIATR PERINAT EP, V14, P194, DOI 10.1046/j.1365-3016.2000.00266.x; Kumar RC, 1997, BRIT J PSYCHIAT, V171, P175, DOI 10.1192/bjp.171.2.175; Kurstjens S, 2001, J CHILD PSYCHOL PSYC, V42, P623, DOI 10.1017/S0021963001007296; Lorant V, 2003, AM J EPIDEMIOL, V157, P98, DOI 10.1093/aje/kwf182; Lovejoy MC, 2000, CLIN PSYCHOL REV, V20, P561, DOI 10.1016/S0272-7358(98)00100-7; Mackenbach JP, 2008, NEW ENGL J MED, V359, pE14; Martins C, 2000, J CHILD PSYCHOL PSYC, V41, P737, DOI 10.1111/1469-7610.00661; Meins E, 1999, Attach Hum Dev, V1, P325, DOI 10.1080/14616739900134181; Meins E, 2002, CHILD DEV, V73, P1715, DOI 10.1111/1467-8624.00501; Meins E, 2001, J CHILD PSYCHOL PSYC, V42, P637, DOI 10.1111/1469-7610.00759; Meins E., 1997, SECURITY OF ATTACHME; Moehler E, 2006, ARCH WOMEN MENT HLTH, V9, P273, DOI 10.1007/s00737-006-0149-5; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Petterson SM, 2001, WOMEN HEALTH, V32, P79, DOI 10.1300/J013v32n01_04; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Piek JP, 2008, HUM MOVEMENT SCI, V27, P668, DOI 10.1016/j.humov.2007.11.002; Raymond NC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-336; Sanders MR, 2005, CHILD CARE HLTH DEV, V31, P65, DOI 10.1111/j.1365-2214.2005.00487.x; Schiborr J, 2013, MEASUREMENT, V46, P2492, DOI 10.1016/j.measurement.2013.05.007; Sharp D, 1995, J CHILD PSYCHOL PSYC, V36, P1315, DOI 10.1111/j.1469-7610.1995.tb01666.x; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Taylor A, 2005, ARCH WOMEN MENT HLTH, V8, P45, DOI 10.1007/s00737-005-0074-z; TETI DM, 1991, CHILD DEV, V62, P918, DOI 10.2307/1131143; van Bussel JCH, 2010, ARCH WOMEN MENT HLTH, V13, P267, DOI 10.1007/s00737-009-0127-9; Walker TM, 2012, CLIN CHILD PSYCHOL P, V17, P318, DOI 10.1177/1359104511409142; Yoshida K, 2012, ARCH WOMEN MENT HLTH, V15, P343, DOI 10.1007/s00737-012-0291-1	52	2	3	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182544	10.1371/journal.pone.0182544	http://dx.doi.org/10.1371/journal.pone.0182544			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846688	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000408438600011
J	Haldar, K; Bafadhel, M; Lau, K; Berg, A; Kwambana, B; Kebadze, T; Ramsheh, MY; Barker, B; Haldar, P; Johnston, S; Ketley, JM; Brightling, CE; Barer, MR				Haldar, Koirobi; Bafadhel, Mona; Lau, Kelvin; Berg, Adam; Kwambana, Brenda; Kebadze, Tatiana; Ramsheh, Mohammadali Yavari; Barker, Bethan; Haldar, Pranabashis; Johnston, Sebastian; Ketley, Julian M.; Brightling, Christopher E.; Barer, Michael R.			Microbiome balance in sputum determined by PCR stratifies COPD exacerbations and shows potential for selective use of antibiotics	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIRWAY MICROBIOME; BRONCHIECTASIS; DYNAMICS	Background While a subgroup of patients with exacerbations of chronic obstructive pulmonary disease (COPD) clearly benefit from antibiotics, their identification remains challenging. We hypothesised that selective assessment of the balance between the two dominant bacterial groups (Gammaproteobacteria (G) and Firmicutes (F)) in COPD sputum samples might reveal a subgroup with a bacterial community structure change at exacerbation that was restored to baseline on recovery and potentially reflects effective antibiotic treatment. Methods Phylogenetically specific 16S rRNA genes were determined by quantitative real time PCR to derive a G: F ratio in serial sputum samples from 66 extensively-phenotyped COPD exacerbation episodes. Results Cluster analysis based on Euclidean distance measures, generated across the 4 visit times (stable and exacerbation day: 0,14 and 42) for the 66 exacerbation episodes, revealed three subgroups designated HG, HF, and GF reflecting predominance or equivalence of the two target bacterial groups. While the other subgroups showed no change at exacerbation, the HG cluster (n = 20) was characterized by G:F ratios that increased significantly at exacerbation and returned to baseline on recovery (p<0.00001); ratios in the HG group also correlated positively with inflammatory markers and negatively with FEV1. At exacerbation G:F showed a significant receiver-operator-characteristic curve to identify the HG subgroup (AUC 0.90, p<0.0001). Conclusions The G:F ratio at exacerbation can be determined on a timescale compatible with decisions regarding clinical management. We propose that the G:F ratio has potential for use as a biomarker enabling selective use of antibiotics in COPD exacerbations and hence warrants further clinical evaluation.	[Haldar, Koirobi; Bafadhel, Mona; Lau, Kelvin; Berg, Adam; Kwambana, Brenda; Ramsheh, Mohammadali Yavari; Barker, Bethan; Haldar, Pranabashis; Brightling, Christopher E.; Barer, Michael R.] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Bafadhel, Mona; Barker, Bethan; Haldar, Pranabashis; Brightling, Christopher E.; Barer, Michael R.] Univ Leicester, Glenfield Hosp, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England; [Lau, Kelvin; Berg, Adam; Ketley, Julian M.] Univ Leicester, Dept Genet, Leicester, Leics, England; [Kebadze, Tatiana; Johnston, Sebastian] Imperial Coll, Natl Heart & Lung Inst, Airway Dis Infect Sect, London, England; [Brightling, Christopher E.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Barer, Michael R.] Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England; [Bafadhel, Mona] Univ Oxford, Nuffield Dept Clin Med, Resp Med Unit, Oxford, England; [Lau, Kelvin] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Kwambana, Brenda] MRC Unit, Vaccinol Theme, Fajara, Gambia	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of Leicester; Imperial College London; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; University of Oxford; University of Auckland; University of London; London School of Hygiene & Tropical Medicine	Barer, MR (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England.; Barer, MR (corresponding author), Univ Leicester, Glenfield Hosp, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.; Barer, MR (corresponding author), Univ Hosp Leicester NHS Trust, Dept Clin Microbiol, Leicester, Leics, England.	mrb19@le.ac.uk	Lau, Kelvin/ABA-6687-2021; Kwambana, Brenda/U-5786-2017; Bafadhel, Mona/ABB-1170-2021; Johnston, Sebastian Lennox/I-2423-2012; haldar, kairabi/HDO-4827-2022	Lau, Kelvin/0000-0003-0977-1357; Kwambana, Brenda/0000-0002-1202-8540; Johnston, Sebastian Lennox/0000-0003-3009-9200; Bafadhel, Mona/0000-0002-9993-2478; brightling, chris/0000-0002-9345-4903; Barer, Michael/0000-0002-0377-3100; Haldar, Pranabashis/0000-0002-1572-5421	Medical Research Council (UK); Wellcome Trust Senior Fellowship (CEB); National Institute for Health Research (NIHR Senior Investigator Award CEB); National Institute for Health Research (NIHR Post-Doctoral Fellowship award MB); Leicester Respiratory Biomedical Research Unit; National Institute for Health Research (NIHR); Biotechnology and Biological Sciences Research Council [BB/J016667/1] Funding Source: researchfish; Medical Research Council [G0601369, G0801980] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10018, PDF-2013-06-052] Funding Source: researchfish; Asthma UK [CH11SJ] Funding Source: researchfish; BBSRC [BB/J016667/1] Funding Source: UKRI; MRC [G0801980, G0601369] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Senior Fellowship (CEB); National Institute for Health Research (NIHR Senior Investigator Award CEB); National Institute for Health Research (NIHR Post-Doctoral Fellowship award MB); Leicester Respiratory Biomedical Research Unit; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Asthma UK; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was part funded by Medical Research Council (UK), a Wellcome Trust Senior Fellowship (CEB) and a National Institute for Health Research (NIHR Senior Investigator Award CEB; NIHR Post-Doctoral Fellowship award MB) and the Leicester Respiratory Biomedical Research Unit. This paper presents independent research funded by the National Institute for Health Research (NIHR). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	ANTHONISEN NR, 1987, ANN INTERN MED, V106, P196, DOI 10.7326/0003-4819-106-2-196; Bafadhel M, 2012, AM J RESP CRIT CARE, V186, P48, DOI 10.1164/rccm.201108-1553OC; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Barker BL, 2014, CHEST; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Dickson RP, 2014, LANCET, V384, P691, DOI 10.1016/S0140-6736(14)61136-3; Dickson RP, 2013, EXPERT REV RESP MED, V7, P245, DOI [10.1586/ers.13.24, 10.1586/ERS.13.24]; Dorak M.T., 2006, REAL TIME PCR, P89; Haldar K, 2011, THORAX, V66, pA10, DOI 10.1136/thoraxjnl-2011-201054b.16; Health Protection Agency, 2009, INV BRONCH LAV SPUT, P3; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Huang YJ, 2014, J CLIN MICROBIOL, V52, P2813, DOI 10.1128/JCM.00035-14; Huang YJ, 2010, OMICS, V14, P9, DOI 10.1089/omi.2009.0100; Molton JS, 2013, CLIN INFECT DIS, V56, P1310, DOI 10.1093/cid/cit020; Muhling M, 2008, ISME J, V2, P379, DOI 10.1038/ismej.2007.97; NICE, 2010, CHRON OBSTR PULM DIS; Rogers Geraint B, 2014, Ann Am Thorac Soc, V11, P496, DOI 10.1513/AnnalsATS.201310-335OC; Sethi Sanjay, 2009, Proc Am Thorac Soc, V6, P532, DOI 10.1513/pats.200905-025DS; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Wang Z, 2016, EUR RESPIR J, V47, P1082, DOI 10.1183/13993003.01406-2015; Wilson CB, 1997, AM J RESP CRIT CARE, V156, P536, DOI 10.1164/ajrccm.156.2.9607083; Zhao JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033127	23	20	21	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182833	10.1371/journal.pone.0182833	http://dx.doi.org/10.1371/journal.pone.0182833			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841671	Green Published, gold			2022-12-27	WOS:000408370700011
J	Kojima, T; Kanzaki, S; Oishi, N; Ogawa, K				Kojima, Takashi; Kanzaki, Sho; Oishi, Naoki; Ogawa, Kaoru			Clinical characteristics of patients with tinnitus evaluated with the Tinnitus Sample Case History Questionnaire in Japan: A case series	PLOS ONE			English	Article							PURE-TONE THRESHOLDS; PREVALENCE; ANXIETY; CARE	Background The Tinnitus Sample Case History Questionnaire was determined as a standardized questionnaire for obtaining patient case histories and for characterizing patients into subgroups at the Tinnitus Research Initiative in 2006. In this study, we developed a Japanese version of this questionnaire for evaluating the clinical characteristics of patients with tinnitus. The Japanese version of the questionnaire will be available for evaluating treatments for tinnitus and for comparing data on tinnitus in research centers. Aims/Objectives To evaluate the clinical characteristics of patients with tinnitus in Japan using a newly developed Japanese version of Tinnitus Sample Case History Questionnaire. Study design This was a prospective study based on patient records. Setting University hospitals, general hospitals, and clinics. Subjects and methods We collected patient data using a Japanese translated version of the Tinnitus Sample Case History Questionnaire. In total, 584 patients who visited our institutions in Japan between August 2012 and March 2014 were included (280 males and 304 females; age 13 - 92 years; mean age, 60.8). We examined patients after dividing them into two groups according to the presence or absence of hyperacusis. The collected results were compared with those from the Tinnitus Research Initiative database. Results Compared with the TRI database, there were significantly more elderly female patients and fewer patients with trauma-associated tinnitus. There was a statistically lower ratio of patients with hyperacusis. We found that patients with tinnitus in addition to hyperacusis had greater tinnitus severity and exhibited higher rates of various complications. Conclusion The Japanese version of the Tinnitus Sample Case History Questionnaire developed in this study can be a useful tool for evaluating patients with tinnitus in Japan. The results of this multicenter study reflect the characteristics of patients with tinnitus who require medical care in Japan. Our data provides a preliminary basis for an international comparison of tinnitus epidemiology.	[Kojima, Takashi; Kanzaki, Sho; Oishi, Naoki; Ogawa, Kaoru] Keio Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, Tokyo, Japan; [Kojima, Takashi] Machida Municipal Hosp, Dept Otorhinolaryngol, Machida, Tokyo, Japan	Keio University	Kanzaki, S (corresponding author), Keio Univ, Dept Otolaryngol Head & Neck Surg, Sch Med, Shinjuku Ku, Tokyo, Japan.	skan@keio.jp	Oishi, Naoki/ABG-7065-2020; Kanzaki, Sho/AAU-6136-2020	Oishi, Naoki/0000-0001-8204-9518; Kojima, Takashi/0000-0002-7492-165X	Japan Agency for Medical Research and Development grant [16dk0310065s0801]	Japan Agency for Medical Research and Development grant(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Japan Agency for Medical Research and Development grant (16dk0310065s0801) (http://www.amed.go.jp/en/program/).	Baguley DM, 2003, J ROY SOC MED, V96, P582, DOI 10.1258/jrsm.96.12.582; Bruggemann P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00341; Cima RFF, 2012, LANCET, V379, P1951, DOI 10.1016/S0140-6736(12)60469-3; Dreisbach LE, 2007, INT J AUDIOL, V46, P419, DOI 10.1080/14992020701355074; Fujii K, 2011, J EPIDEMIOL, V21, P299, DOI 10.2188/jea.JE20100124; Gallus S, 2015, NEUROEPIDEMIOLOGY, V45, P12, DOI 10.1159/000431376; Guichard E, 2016, HEADACHE, V56, P987, DOI 10.1111/head.12845; HAZELL JWP, 1990, J OTOLARYNGOL, V19, P1; JASTREBOFF PJ, 1993, BRIT J AUDIOL, V27, P7, DOI 10.3109/03005369309077884; Katzenell U, 2001, OTOL NEUROTOL, V22, P321, DOI 10.1097/00129492-200105000-00009; Kim HJ, 2014, LARYNGOSCOPE, V124, P2155, DOI 10.1002/lary.24722; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127578; Kreuzer PM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045599; Krog NH, 2010, J PSYCHOSOM RES, V69, P289, DOI 10.1016/j.jpsychores.2010.03.008; Landgrebe M, 2010, BMC MED INFORM DECIS, V10, DOI 10.1186/1472-6947-10-42; Langguth B, 2007, PROG BRAIN RES, V166, P525, DOI 10.1016/S0079-6123(07)66050-6; Langguth B, 2013, LANCET NEUROL, V12, P920, DOI 10.1016/S1474-4422(13)70160-1; Lee SY, 2014, J AFFECT DISORDERS, V155, P130, DOI 10.1016/j.jad.2013.10.037; Levine RA, 2007, PROG BRAIN RES, V166, P195, DOI 10.1016/S0079-6123(07)66017-8; Newman CW, 1996, ARCH OTOLARYNGOL, V122, P143; Oishi N, 2011, INT J AUDIOL, V50, P491, DOI 10.3109/14992027.2011.560904; Oiticica J, 2015, BRAZ J OTORHINOLAR, V81, P167, DOI 10.1016/j.bjorl.2014.12.004; Rosenthal Robert, 1994, HDB RES SYNTHESIS, V621, P231; Savage J, 2014, BMJ CLIN EVIDENCE, V2014; Schecklmann M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086944; Shargorodsky J, 2010, AM J MED, V123, P711, DOI 10.1016/j.amjmed.2010.02.015; She WD, 2009, MED SCI MONITOR, V15, pPI35; Tunkel DE, 2014, OTOLARYNG HEAD NECK, V151, pS1, DOI 10.1177/0194599814545325; Vielsmeier V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038887; Zeman F, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-7; Zeman F, 2012, HEALTH QUAL LIFE OUT, V10, DOI 10.1186/1477-7525-10-128; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	33	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0180609	10.1371/journal.pone.0180609	http://dx.doi.org/10.1371/journal.pone.0180609			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841656	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700001
J	Ranhem, C; Larsson, GL; Hedman, H; Lindquist, D; Karlsson, MG; Hellstrom, AC; Ostensson, E; Sorbe, B; Hellman, K; Andersson, S				Ranhem, Cecilia; larsson, Gabriella Lillsunde; Hedman, Hakan; Lindquist, David; Karlsson, Mats G.; Hellstrom, Ann-Cathrin; Ostensson, Ellinor; Sorbe, Bengt; Hellman, Kristina; Andersson, Sonia			Expression of LRIG proteins as possible prognostic factors in primary vaginal carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS STATUS; PATIENT SURVIVAL; CERVICAL-CANCER; TUMOR-MARKERS; BIOMARKER; IMPACT	Background Primary vaginal carcinoma (PVC) is a rare malignancy. Established prognostic factors include tumour stage and age at diagnosis. The leucine-rich repeats and immunoglobuline-like domains (LRIG)-1 protein functions as a tumour suppressor, but less is known about the functions of LRIG2 and LRIG3. The present study aimed to evaluate the expression of LRIG proteins and analyse their possible associations with clinical characteristics and survival in a cohort of PVC patients. Methods We used immunohistochemistry to investigate LRIG1, LRIG2, and LRIG3 expression in tumour samples from a consecutive cohort of 70 PVC patients. The association between LRIG protein expression and clinical characteristics and cancer-specific survival was investigated using univariate and multivariate analyses. Results The majority of PVC patients (72%) had > 50% LRIG1-and LRIG2-positive cells, and no or low LRIG3-positive cells. HPV status was significantly correlated with LRIG1 expression (p = 0.0047). Having high LRIG1 expression was significantly correlated with superior cancer-specific survival in univariate and multivariate analyses. LRIG2 and LRIG3 expression did not significantly correlate with clinical characteristics or survival. Conclusion LRIG1 expression might be of interest as a prognostic marker in PVC patients, whereas the role of LRIG2 and LRIG3 expression remains to be clarified.	[Ranhem, Cecilia; Hellstrom, Ann-Cathrin; Ostensson, Ellinor; Andersson, Sonia] Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden; [Ranhem, Cecilia] Reg Vastmanland Uppsala Univ, Clin Res Ctr, Hosp Vastmanland Vasteras, Vasteras, Sweden; [larsson, Gabriella Lillsunde] Orebro Univ, Sch Hlth & Med Sci, Orebro, Sweden; [larsson, Gabriella Lillsunde] Orebro Univ Hosp, Dept Lab Med, Orebro, Sweden; [Hedman, Hakan; Lindquist, David] Umea Univ, Dept Radiat Sci, Umea, Sweden; [Karlsson, Mats G.] Orebro Univ, Fac Med & Hlth, Dept Lab Med, Orebro, Sweden; [Ostensson, Ellinor] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Sorbe, Bengt] Orebro Univ Hosp, Dept Oncol, Orebro, Sweden; [Hellman, Kristina] Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden	Karolinska Institutet; Vasteras Central Hospital; Orebro University; Orebro University; Umea University; Orebro University; Karolinska Institutet; Orebro University; Karolinska Institutet	Andersson, S (corresponding author), Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden.	sonia.andersson@ki.se	Lindquist, David/AAM-3662-2020; Hedman, Håkan/F-9495-2012; Karlsson, Mats G/AAV-7542-2021; Hellman, Kristina/Q-2154-2015	Lindquist, David/0000-0002-7507-937X; Karlsson, Mats G/0000-0001-6881-237X; Andersson, Sonia/0000-0003-2120-7222	Swedish Cancer Foundation [070623, CAN 2007/1044, 11 0544, CAN 2011/471]; Karolinska Institutet Cancer Strategic Grants [5888/05-722]; Swedish Research Council [521-2008-2899]; Stockholm County Council [20130097]; Region Orebro County [OLL-526041]; Lion's Cancer Research Foundation; University of Umea; Gustaf V Jubilee Fund [154022]; Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras	Swedish Cancer Foundation; Karolinska Institutet Cancer Strategic Grants; Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Region Orebro County; Lion's Cancer Research Foundation; University of Umea; Gustaf V Jubilee Fund; Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras	The Swedish Cancer Foundation (070623, CAN 2007/1044, 11 0544, CAN 2011/471) URL: www.cancerfonden.se, SA; Karolinska Institutet Cancer Strategic Grants (5888/05-722) URL: www.ki.se, SA; The Swedish Research Council (521-2008-2899), URL: www.vr.se, SA; Stockholm County Council (20130097) URL: www.skl.se, SA; Region Orebro County (OLL-526041) URL: http://www.fou.nu/is/oll/ansokan/526041, GLL, MK; Lion's Cancer Research Foundation, University of Umea, URL: http://www.cancerforskningsfond-umea.lions.se, DL; The Gustaf V Jubilee Fund (154022) URL: www.rahfo.se, SA; Region Vastmanland - Uppsala University Centre for Clinical Research Hospital of Vastmanland Vasteras, URL: https://www.researchweb.org/is/ltv/ansokan/564291, CR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso I, 2012, GYNECOL ONCOL, V125, P194, DOI 10.1016/j.ygyno.2011.12.449; An YZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002081; Beller U, 2006, INT J GYNECOL OBSTET, V95, pS29, DOI 10.1016/S0020-7292(06)60029-5; Brunner AH, 2011, INT J GYNECOL CANCER, V21, P923, DOI 10.1097/IGC.0b013e31821bc615; Chang JH, 2016, J GYNECOL ONCOL, V27, DOI 10.3802/jgo.2016.27.e17; Fuste V, 2010, HISTOPATHOLOGY, V57, P907, DOI 10.1111/j.1365-2559.2010.03727.x; Giuliano AR, 2008, VACCINE, V26, pK17, DOI 10.1016/j.vaccine.2008.06.021; Gunderson CC, 2013, J LOW GENIT TRACT DI, V17, P409, DOI 10.1097/LGT.0b013e3182800ee2; Guo DS, 2006, ACTA NEUROPATHOL, V111, P238, DOI 10.1007/s00401-006-0032-5; Habermann JK, 2004, CANCER GENET CYTOGEN, V148, P7, DOI 10.1016/S0165-4608(03)00245-0; Hacker NF, 2015, INT J GYNECOL OBSTET, V131, pS84, DOI 10.1016/j.ijgo.2015.06.003; Hedman H, 2010, ACTA ONCOL, V49, P812, DOI 10.3109/0284186X.2010.492789; Hellman K, 2004, INT J GYNECOL CANCER, V14, P491, DOI 10.1111/j.1048-891x.2004.014310.x; Hellman K, 2014, BRIT J CANCER, V110, P1561, DOI 10.1038/bjc.2014.32; Hellman K, 2013, INT J GYNECOL CANCER, V23, P41, DOI 10.1097/IGC.0b013e31827670c4; Holmlund C, 2004, GENE, V332, P35, DOI 10.1016/j.gene.2004.02.002; Krig SR, 2011, MOL CANCER RES, V9, P1406, DOI 10.1158/1541-7786.MCR-11-0227; Kvarnbrink S, 2015, ACTA ONCOL, V54, P1113, DOI 10.3109/0284186X.2015.1021427; Lando M, 2015, EPIGENETICS-US, V10, P970, DOI 10.1080/15592294.2015.1085140; Larsson GL, 2013, GYNECOL ONCOL, V129, P406, DOI 10.1016/j.ygyno.2013.02.004; Lindquist D, 2014, BRIT J CANCER, V110, P1793, DOI 10.1038/bjc.2014.87; Lindquist D, 2014, ACTA ONCOL, V53, P1135, DOI 10.3109/0284186X.2014.953258; Lindstrom AK, 2008, INT J GYNECOL CANCER, V18, P312, DOI 10.1111/j.1525-1438.2007.01021.x; Lindstrom AK, 2011, GYNECOL ONCOL, V122, P372, DOI 10.1016/j.ygyno.2011.04.049; Lindstrom AK, 2014, EUR J HISTOCHEM, V58, P83, DOI 10.4081/ejh.2014.2227; Muller S, 2013, INT J ONCOL, V42, P247, DOI 10.3892/ijo.2012.1702; Nilsson J, 2003, CELL TISSUE RES, V312, P65, DOI 10.1007/s00441-003-0697-1; Orton A, 2016, GYNECOL ONCOL, V141, P501, DOI 10.1016/j.ygyno.2016.03.011; Rafidi H, 2013, J BIOL CHEM, V288, P21593, DOI 10.1074/jbc.M113.486050; Rajagopalan MS, 2014, GYNECOL ONCOL, V135, P495, DOI 10.1016/j.ygyno.2014.09.018; Simion C, 2014, ENDOCR-RELAT CANCER, V21, pR431, DOI 10.1530/ERC-14-0179; Smith JS, 2009, OBSTET GYNECOL, V113, P917, DOI 10.1097/AOG.0b013e31819bd6e0; Tanemura A, 2005, DERMATOL SURG, V31, P423, DOI 10.1097/00042728-200504000-00008; Wu XP, 2012, ACTA ONCOL, V51, P69, DOI 10.3109/0284186X.2011.562239; Yi W, 2011, EXP CELL RES, V317, P504, DOI 10.1016/j.yexcr.2010.11.005	35	7	8	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183816	10.1371/journal.pone.0183816	http://dx.doi.org/10.1371/journal.pone.0183816			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841699	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700059
J	Shen, XQ; Wang, TT; Cao, XS; Cai, L				Shen, Xiaoqin; Wang, Tiantian; Cao, Xiaoshan; Cai, Li			The geometric model of the human mitral valve	PLOS ONE			English	Article								The mitral valve, which lies between the left atrium and the left ventricle, plays an important role in controlling the uniflux of blood from the left atrium to the left ventricle as one of the four human heart valves. A precise description of the shape of human mitral valve has vital significance in studying its physiological structure and periodic movement. Unsatisfyingly, there is almost no unified mathematical description of the same shape of human mitral valve in literature. In this paper, we present a geometric model for human mitral valve, as an elastic shell with a special shape. Parametric equations for the shape of human mitral valve are provided, including the anterior and the posterior parts, which can be thought as portions of two interfacing semi-elliptic cylindrical shells. The minor axis of one ellipse is equal to the major axis of the other. All the parameters are determined from the statistical data. Comparison of fitting results with existing examples validates the accuracy of our geometric model. Based on the fitting shape, one can further simulate the physiological function of the mitral valve using a suitable dynamic physical equation.	[Shen, Xiaoqin; Wang, Tiantian; Cao, Xiaoshan] Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China; [Cao, Xiaoshan] Chinese Acad Sci, State Key Lab Transducer Technol, Shanghai 200050, Peoples R China; [Cai, Li] Northwestern Polytech Univ, NPU UoG Int Cooperat Lab Computat & Applicat Card, Xian 710072, Shaanxi, Peoples R China	Xi'an University of Technology; Chinese Academy of Sciences; Northwestern Polytechnical University	Shen, XQ (corresponding author), Xian Univ Technol, Sch Sci, Xian 710054, Shaanxi, Peoples R China.	xqshen@xaut.edu.cn	Li, Cai/Y-7599-2018	, Xiaoshan/0000-0003-2711-3921	National Natural Science Foundation of China [11571275, 11572244, 11471261]; Program of Industry in Shaanxi Province [2015GY021, 2015JQ1001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Industry in Shaanxi Province	This paper is supported by National Natural Science Foundation of China (11571275, 11572244, 11471261) and Program of Industry in Shaanxi Province (2015GY021, 2015JQ1001).	Ajit P, 2010, THESIS; CHIECHI MA, 1956, J THORAC SURG, V32, P378; Dagum P, 2001, J THORAC CARDIOV SUR, V122, P665, DOI 10.1067/mtc.2001.116313; Dominik J, 2010, HEART VALVE SURG ILU; Gao H, 2016, INT J NUMERICAL METH; Howe R, 2011, THESIS; Kunzelman K S, 1994, J Heart Valve Dis, V3, P491; Kunzelman K S, 1993, J Heart Valve Dis, V2, P326; Liu MX, 2016, IEEE T MED IMAGING, V35, P1463, DOI 10.1109/TMI.2016.2515021; Liu MX, 2015, HUM BRAIN MAPP, V36, P1847, DOI 10.1002/hbm.22741; Ma XS, 2013, COMPUT FLUIDS, V71, P417, DOI 10.1016/j.compfluid.2012.10.025; RANGANATHAN N, 1970, CIRCULATION, V41, P459, DOI 10.1161/01.CIR.41.3.459; RUSTED IE, 1952, CIRCULATION, V6, P825, DOI 10.1161/01.CIR.6.6.825; Sacks MS, 2007, PHILOS T R SOC B, V362, P1369, DOI 10.1098/rstb.2007.2122; Schneider RJ, 2011, LECT NOTES COMPUT SC, V6893, P520, DOI 10.1007/978-3-642-23626-6_64; Schneider RJ, 2011, LECT NOTES COMPUT SC, V6666, P215, DOI 10.1007/978-3-642-21028-0_27; Stevanella M, 2009, BIOMECHANICAL ENG T, V131, P1011; Timek TA, 2003, ANN THORAC SURG, V76, P1944, DOI 10.1016/S0003-4975(03)01078-6; Weinberg EJ, 2007, J BIOMECH, V40, P705, DOI 10.1016/j.jbiomech.2006.01.003; [钟琪 Zhong Qi], 2014, [医用生物力学, Journal of Medical Biomechanics], V29, P53	20	13	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183362	10.1371/journal.pone.0183362	http://dx.doi.org/10.1371/journal.pone.0183362			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841703	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700026
J	Gesing, J; Scheuermann, K; Wagner, IV; Loffler, D; Friebe, D; Kiess, W; Schuster, V; Korner, A				Gesing, Julia; Scheuermann, Kathrin; Wagner, Isabel Viola; Loeffler, Dennis; Friebe, Daniela; Kiess, Wieland; Schuster, Volker; Koerner, Antje			NAMPT serum levels are selectively elevated in acute infectious disease and in acute relapse of chronic inflammatory diseases in children	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; VISFATIN; ADIPOCYTOKINE; ARTHRITIS; PROTEIN	Nicotinamide phosphoribosyl transferase (NAMPT) is an inflammatory adipocytokine shown to interact in immune modulation in chronic inflammatory diseases, acute respiratory distress syndrome, sepsis, cancer and obesity in adulthood. It is, however, not clear whether this association reflects a chronic elevation or acute inflammatory response. We analyzed NAMPT concentrations in distinct states of inflammation in 102 children and found consistently significantly increased NAMPT levels in subjects with acute infections. NAMPT concentrations in children with stable chronic inflammatory diseases were not significantly different, whereas in patients with acute relapse of chronic disease NAMPT was significantly higher than in children in remission or healthy controls. In states of low-grade inflammation (children with atopic disease or obesity) we did not detect alterations in NAMPT serum levels. NAMPT correlated positively with inflammatory markers such as CRP. The most predictive factor for NAMPT serum concentrations was leucocyte count and therein the neutrophil count. Furthermore, systemic circulating NAMPT levels were closely associated with NAMPT release from corresponding cultured PBMCs. In conclusion, NAMPT is selectively increased in states of acute but not chronic inflammation in children. The close relationship between systemic circulating NAMPT with leucocyte counts and release indicate that leucocytes most probably are the source of inflammation related NAMPT levels.	[Gesing, Julia; Scheuermann, Kathrin; Friebe, Daniela; Kiess, Wieland; Schuster, Volker; Koerner, Antje] Univ Leipzig, Hosp Children & Adolescents, Leipzig, Saxony, Germany; [Scheuermann, Kathrin; Kiess, Wieland; Koerner, Antje] Leipzig Univ Med Ctr IFB Adipos Dis, Leipzig, Saxony, Germany; [Wagner, Isabel Viola] Univ Hosp Cologne, Hosp Children & Adolescents, Cologne, North Rhine Wes, Germany; [Loeffler, Dennis] Fraunhofer Inst Cell Therapy & Immunol Leipzig, Leipzig, Saxony, Germany	Leipzig University; University of Cologne	Korner, A (corresponding author), Univ Leipzig, Hosp Children & Adolescents, Leipzig, Saxony, Germany.; Korner, A (corresponding author), Leipzig Univ Med Ctr IFB Adipos Dis, Leipzig, Saxony, Germany.	antje.koerner@medizin.uni-leipzig.de	Körner, Antje/B-3988-2015; Frielitz, Fabian/ABH-2518-2020	Körner, Antje/0000-0001-6001-0356; 	German Research Foundation [CRC1052/1 C05]; LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig) - European Union; uropean Regional Development Fund (ERFD); Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ [01EO1001]; German Research Foundation (DFG) [CRC1052/1 C05]	German Research Foundation(German Research Foundation (DFG)); LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig) - European Union; uropean Regional Development Fund (ERFD); Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ; German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by the German Research Foundation for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and by the LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative, and by the Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ: 01EO1001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the pediatric endocrinology and immunology teams and colleagues for their assistance in the collection of blood samples. This work was supported by the German Research Foundation (DFG) for the Clinical Research Center "Obesity Mechanisms" CRC1052/1 C05 and by the LIFE (Leipzig Research Center for Civilization Diseases, Universitat Leipzig), funded by the European Union, by the European Regional Development Fund (ERFD) by means of the Free State of Saxony within the framework of the excellence initiative, and by the Federal Ministry of Education and Research (BMBF), Germany, Integrated Research and Treatment Centre (IFB) Adiposity Diseases FKZ: 01EO1001.	Brentano F, 2007, ARTHRITIS RHEUM, V56, P2829, DOI 10.1002/art.22833; Bruzzone S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007897; Busso N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002267; Camp SM, 2015, SCI REP-UK, V5, DOI 10.1038/srep13135; Cekmez F, 2011, EUR CYTOKINE NETW, V22, P113, DOI 10.1684/ecn.2011.0283; Damanaki A, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/912821; Dogan S, 2016, J CLIN LAB ANAL, V30, P552, DOI 10.1002/jcla.21901; Friebe D, 2011, DIABETOLOGIA, V54, P1200, DOI 10.1007/s00125-010-2042-z; Fukuhara A, 2005, SCIENCE, V307, P426, DOI 10.1126/science.1097243; Funk RS, 2016, CTS-CLIN TRANSL SCI, V9, P149, DOI 10.1111/cts.12399; Gao ZY, 2015, GENET MOL RES, V14, P5287, DOI 10.4238/2015.May.18.21; Garten A, 2011, HANDB EXP PHARMACOL, V203, P147, DOI 10.1007/978-3-642-17214-4_7; Garten A, 2009, TRENDS ENDOCRIN MET, V20, P130, DOI 10.1016/j.tem.2008.10.004; Haider DG, 2006, J PEDIATR GASTR NUTR, V43, P548, DOI 10.1097/01.mpg.0000235749.50820.b3; Hollensted M, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0253-3; Hu W, 2013, PEPTIDES, V43, P8, DOI 10.1016/j.peptides.2013.02.017; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Korner A, 2007, J CLIN ENDOCR METAB, V92, P4783, DOI 10.1210/jc.2007-1304; Kralisch S, 2005, J ENDOCRINOL, V185, pR1, DOI 10.1677/joe.1.06211; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Lee KA, 2011, CHEST, V140, P382, DOI 10.1378/chest.10-3100; Martos-Moreno GA, 2014, INT J PEDIATR ENDOCR, DOI 10.1186/1687-9856-2014-9; Meier FMP, 2012, J BIOL CHEM, V287, P28378, DOI 10.1074/jbc.M111.312884; Montecucco F, 2013, CURR TOP MED CHEM, V13, P2930, DOI 10.2174/15680266113136660208; Moschen AR, 2007, J IMMUNOL, V178, P1748, DOI 10.4049/jimmunol.178.3.1748; NOKHBEHSAIM M, 2013, MEDIAT INFLAMM, V2013, DOI DOI 10.1155/2013/437123; Oh H, 2015, OSTEOARTHR CARTILAGE, V23, P2288, DOI 10.1016/j.joca.2015.07.009; Rongvaux A, 2002, EUR J IMMUNOL, V32, P3225, DOI 10.1002/1521-4141(200211)32:11<3225::AID-IMMU3225>3.0.CO;2-L; SAMAL B, 1994, MOL CELL BIOL, V14, P1431, DOI 10.1128/MCB.14.2.1431; Sawicka-Gutaj N, 2016, ENDOCRINE, V53, P497, DOI 10.1007/s12020-015-0855-8; Schuster S, 2015, BIOCHEM BIOPH RES CO, V458, P334, DOI 10.1016/j.bbrc.2015.01.111; Tabassum R, 2012, DIABETES, V61, P626, DOI 10.2337/db11-1501; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Valentini L, 2009, NUTRITION, V25, P172, DOI 10.1016/j.nut.2008.07.020; Zhang LQ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.132	35	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183027	10.1371/journal.pone.0183027	http://dx.doi.org/10.1371/journal.pone.0183027			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837586	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000042
J	Michaelis, S; Kriston, L; Harter, M; Watzke, B; Schulz, H; Melchior, H				Michaelis, Svea; Kriston, Levente; Haerter, Martin; Watzke, Birgit; Schulz, Holger; Melchior, Hanne			Predicting the preferences for involvement in medical decision making among patients with mental disorders	PLOS ONE			English	Article							HEALTH-CARE DECISIONS; ADULT CANCER-PATIENTS; SELF-EFFICACY SCALE; BREAST-CANCER; PARTICIPATION PREFERENCES; INFORMATION NEEDS; PATIENTS WANT; ROUTINE CARE; AUTONOMY; PEOPLE	Background The involvement of patients in medical decision making has been investigated widely in somatic diseases. However, little is known about the preferences for involvement and variables that could predict these preferences in patients with mental disorders. Objective This study aims to determine what roles mentally ill patients actually want to assume when making medical decisions and to identify the variables that could predict this role, including patients' self-efficacy. Method Demographic and clinical data of 798 patients with mental disorders from three psychotherapeutic units in Germany were elicited using self-report questionnaires. Control preference was measured using the Control Preferences Scale, and patients' perceived self-efficacy was assessed using the Self-Efficacy Scale. Bivariate and multivariate regression analyses were conducted to investigate the associations between patient variables and control preference. Results Most patients preferred a collaborative role (57.5%), followed by a semi passive (21.2%), a partly autonomous (16.2%), an autonomous (2.8%) and a fully passive (2.3%) role when making medical decisions. Age, sex, diagnosis, employment status, medical pretreatment and perceived self-efficacy were associated with the preference for involvement in the multivariate logistic model. Conclusion Our results confirm the preferences for involvement in medical decisions of mentally ill patients. We reconfirmed previous findings that older patients prefer a shared role over an autonomous role and that subjects with a high qualification prefer a more autonomous role over a shared role. The knowledge about predictors may help strengthen treatment effectiveness because matching the preferred and actual role preferences has been shown to improve clinical outcome.	[Michaelis, Svea; Kriston, Levente; Haerter, Martin; Schulz, Holger; Melchior, Hanne] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany; [Watzke, Birgit] Univ Zurich, Dept Psychol Clin Psychol & Psychotherapy Res, Zurich, Switzerland	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Zurich	Michaelis, S (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	sveamichaelis@hotmail.com	Kriston, Levente/D-1713-2013	Kriston, Levente/0000-0003-0748-264X; Harter, Martin/0000-0001-7443-9890	Wilhelm Foundation for Rehabilitation Research [T115 - 15.149]	Wilhelm Foundation for Rehabilitation Research	This research was supported by the Wilhelm Foundation for Rehabilitation Research (project number T115 - 15.149).	Adams JR, 2006, COMMUNITY MENT HLT J, V42, P87, DOI 10.1007/s10597-005-9005-8; Adams RJ, 2001, THORAX, V56, P126, DOI 10.1136/thorax.56.2.126; American Psychiatric Association, 2010, PRACTICE GUIDELINE T, V3rd; Arora NK, 2000, MED CARE, V38, P335, DOI 10.1097/00005650-200003000-00010; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Barlow JH, 1996, ARTHRIT CARE RES, V9, P189, DOI 10.1002/1529-0131(199606)9:3<189::AID-ANR1790090307>3.0.CO;2-#; Beaver K, 1996, CANCER NURS, V19, P8, DOI 10.1097/00002820-199602000-00002; BLANCHARD CG, 1988, SOC SCI MED, V27, P1139, DOI 10.1016/0277-9536(88)90343-7; Burton D, 2010, PATIENT EDUC COUNS, V80, P173, DOI 10.1016/j.pec.2009.10.013; Clayman M. L., 2015, MED DECIS MAK; Davis MA, 1999, ACAD EMERG MED, V6, P781, DOI 10.1111/j.1553-2712.1999.tb01206.x; De las Cuevas C, 2014, PATIENT EDUC COUNS, V96, P222, DOI 10.1016/j.pec.2014.05.009; Deber RB, 1996, ARCH INTERN MED, V156, P1414, DOI 10.1001/archinte.156.13.1414; Degner L F, 1997, Can J Nurs Res, V29, P21; Degner LF, 1997, JAMA-J AM MED ASSOC, V277, P1485, DOI 10.1001/jama.277.18.1485; DEGNER LF, 1992, J CLIN EPIDEMIOL, V45, P941, DOI 10.1016/0895-4356(92)90110-9; Deucher ABar, 2016, EUR PSYCHIAT, V35, p[39, 1778]; Drake Robert E, 2009, Dialogues Clin Neurosci, V11, P455; Elwyn G, 2016, PATIENT EDUC COUNS, V99, P571, DOI 10.1016/j.pec.2015.10.011; Elwyn G, 2010, MED DECIS MAKING, V30, P701, DOI 10.1177/0272989X10386231; EMANUEL EJ, 1992, JAMA-J AM MED ASSOC, V267, P2221, DOI 10.1001/jama.267.16.2221; ENDE J, 1989, J GEN INTERN MED, V4, P23, DOI 10.1007/BF02596485; Ernst J, 2011, PSYCHO-ONCOLOGY, V20, P186, DOI 10.1002/pon.1723; Florin J, 2008, J CLIN NURS, V17, P2935, DOI 10.1111/j.1365-2702.2008.02328.x; Garfield S, 2007, PATIENT EDUC COUNS, V66, P361, DOI 10.1016/j.pec.2007.01.012; Gattellari M, 2005, J EVAL CLIN PRACT, V11, P237, DOI 10.1111/j.1365-2753.2005.00530.x; GIBSON PG, 1995, CHEST, V107, P1003, DOI 10.1378/chest.107.4.1003; Giordano A, 2008, J NEUROL SCI, V275, P86, DOI 10.1016/j.jns.2008.07.026; Hamann J, 2003, ACTA PSYCHIAT SCAND, V107, P403, DOI 10.1034/j.1600-0447.2003.00130.x; Hamann J, 2007, HEALTH EXPECT, V10, P358, DOI 10.1111/j.1369-7625.2007.00458.x; Hamann J, 2010, J NERV MENT DIS, V198, P309, DOI 10.1097/NMD.0b013e3181d6128c; Hinz A, 2006, DIAGNOSTICA, V52, P26, DOI 10.1026/0012-1924.52.1.26; Joosten EAG, 2008, PSYCHOTHER PSYCHOSOM, V77, P219, DOI 10.1159/000126073; Keating NL, 2002, J CLIN ONCOL, V20, P1473, DOI 10.1200/JCO.20.6.1473; Kiesler DJ, 2006, PATIENT EDUC COUNS, V61, P319, DOI 10.1016/j.pec.2005.08.002; Kremer H, 2008, MED DECIS MAKING, V28, P899, DOI 10.1177/0272989X08317014; Kryworuchko J, 2008, PATIENT EDUC COUNS, V73, P497, DOI 10.1016/j.pec.2008.07.011; Kumar R, 2010, J GEN INTERN MED, V25, P517, DOI 10.1007/s11606-010-1275-3; Lantz PM, 2005, HEALTH SERV RES, V40, P745, DOI 10.1111/j.1475-6773.2005.00383.x; Levinson W, 2005, J GEN INTERN MED, V20, P531, DOI 10.1111/j.1525-1497.2005.04101.x; Llewellyn-Thomas HA, 2006, HEALTH EXPECT, V9, P305, DOI 10.1111/j.1369-7625.2006.00418.x; Loh A, 2007, EFFEKTE PARTIZIPATIV; Melchior H, 2016, PSYCHIAT RES, V238, P228, DOI 10.1016/j.psychres.2016.02.046; National Institute for Health and Cinical Excellence, 2009, DEPR AD TREATM MAN D, V90; National Institute for Health and Clinical Excellence, 2011, AD MAN PRIM SEC COMM, V113; NEASE RF, 1995, J GEN INTERN MED, V10, P593, DOI 10.1007/BF02602742; O'Dell KJ, 1999, J FAM PRACTICE, V48, P682; O'Neal EL, 2008, AM J GERIAT PSYCHIAT, V16, P826, DOI 10.1097/JGP.0b013e318181f992; Patel SR, 2010, COMMUNITY MENT HLT J, V46, P466, DOI 10.1007/s10597-010-9323-3; Perestelo-Perez L, 2011, CURR CLIN PHARMACOL, V6, P83, DOI 10.2174/157488411796151192; Pinquart M, 2004, J PSYCHOSOC ONCOL, V22, P1, DOI 10.1300/J077v22n03_01; Puschner B, 2016, EPIDEMIOL PSYCH SCI, V25, P69, DOI 10.1017/S204579601400078X; Puschner B, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-90; Pyke-Grimm K A, 1999, J Pediatr Oncol Nurs, V16, P13, DOI 10.1016/S1043-4542(99)90003-6; Rabung S, 2009, Z PSYCHOSOM MED PSYC, V55, P162, DOI 10.13109/zptm.2009.55.2.162; Rodriguez KL, 2008, HEART LUNG, V37, P440, DOI 10.1016/j.hrtlng.2008.02.003; Rosen P, 2001, HEALTH POLICY, V55, P121, DOI 10.1016/S0168-8510(00)00122-6; Say R, 2006, PATIENT EDUC COUNS, V60, P102, DOI 10.1016/j.pec.2005.02.003; Schulz H, 2008, PSYCHOTHERAPEUTISCHE; Seale C, 2006, SOC SCI MED, V62, P2861, DOI 10.1016/j.socscimed.2005.11.002; Sepucha KR, 2014, CIRC-CARDIOVASC QUAL, V7, P620, DOI 10.1161/CIRCOUTCOMES.113.000350; Singh JA, 2010, AM J MANAG CARE, V16, P688; Stiggelbout AM, 1997, CAN MED ASSOC J, V157, P383; Sulmasy DP, 2007, J AM GERIATR SOC, V55, P1981, DOI 10.1111/j.1532-5415.2007.01473.x; Wallberg B, 2000, ACTA ONCOL, V39, P467; World Health Organization, 1992, ICD 10 CLASS MENT BE, Vxii; World Health Organization, 1992, ICD 10 CLASSIFICATIO	67	10	10	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182203	10.1371/journal.pone.0182203	http://dx.doi.org/10.1371/journal.pone.0182203			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837621	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000015
J	Olusanya, BO; Slusher, TM; Imosemi, DO; Emokpae, AA				Olusanya, Bolajoko O.; Slusher, Tina M.; Imosemi, Donald O.; Emokpae, Abieyuwa A.			Maternal detection of neonatal jaundice during birth hospitalization using a novel twocolor icterometer	PLOS ONE			English	Article							NEWBORN; HYPERBILIRUBINEMIA; COUNTRIES; DISCHARGE; KERNICTERUS; READMISSION; BILIRUBIN; VIETNAM; INFANTS; MOTHERS	Background Mothers are frequently the first to observe the onset of jaundice in their newborn infants before the decision to seek treatment. However, simple-to-use tools that could facilitate early detection of jaundice and assist mothers to seek professional care, especially after hospital discharge, are rare. This study therefore, set out to evaluate the performance of a -two-color icterometer (Bilistrip T) as a possible screening tool for detecting significant jaundice by mothers or care-givers in the first week of life. Methods Prior to discharge, mothers in a maternity hospital were trained to use the Bilistrip T on the blanched skin of their baby's nose to ascertain absence (Light Yellow) or presence (Dark Yellow) of significant jaundice. Their babies had transcutaneous bilirubin (TcB) measurements independently, along with total serum bilirubin (TSB) if indicated. The reliability of Bilistrip T as a screening test for significant jaundice was determined at different TcB and TSB thresholds. The predictive performance of Bilistrip T was also evaluated with multivariable logistic regression. Results Some 2492 mother-infant pairs were enrolled over 15 months, of which 347 (13.9%) chose Dark Yellow. The mean TcB for Dark Yellow (10mg/ dL) was significantly higher (p < 0.001) than for Light Yellow (6.1mg/ dL). Bilistrip T showed increasing sensitivity (47.0% -92.6%) and negative predictive value (NPV) (91.4% -99.9%) for selected TcB thresholds (>= 10mg/ dL, >= 12mg/ dL, >= 15mg/ dL, and >= 17mg/ dL). Among neonates with TSB measurements (n = 124), Bilistrip T was associated also with increasing sensitivity (86.8% -100%) and NPV (62.5% -100%). The sensitivity and NPV for detecting neonates requiring phototherapy were 95.8% respectively. Only one of the 24 neonates who required phototherapy was missed by the Bilistrip (TM) Conclusions Bilistrip T is a potential decision-making tool for empowering mothers to detect neonates with clinically significant jaundice that may require close monitoring or treatment, and neonates not requiring treatment for jaundice in the first week of life.	[Olusanya, Bolajoko O.] Ctr Hlth Start Initiat, Lagos, Nigeria; [Slusher, Tina M.] Univ Minnesota, Dept Pediat, Div Global Hlth, Minneapolis, MN 55455 USA; [Slusher, Tina M.] Hennepin Cty Med Ctr, Minneapolis, MN 55415 USA; [Imosemi, Donald O.] Lagos Isl Matern Hosp, Lagos, Nigeria; [Emokpae, Abieyuwa A.] Massey St Childrens Hosp, Lagos, Nigeria	University of Minnesota System; University of Minnesota Twin Cities; Hennepin County Medical Center	Olusanya, BO (corresponding author), Ctr Hlth Start Initiat, Lagos, Nigeria.	bolajoko.olusanya@uclmail.net	Olusanya, Bolajoko O./F-4504-2012	Olusanya, Bolajoko O./0000-0002-3826-0583	Advanced Instruments Norwood, MA	Advanced Instruments Norwood, MA	Draeger Medical Telford, PA loaned the JM103 (R) transcutaneous bilirubinometer; Advanced Instruments Norwood, MA provided BR2 kits at a subsidized cost for our Advanced Bilirubin Stat-Analyzer. Bilimetrix and sponsors had no role in conceptualizing, analyzing, interpreting, writing, or the decision to submit this paper for publication. The authors have indicated they have no other financial relationships relevant to this article to disclose.	American Academy of Pediatrics Subcommittee on Hyperbilirrubinemia, 2004, PEDIATRICS, V114, P297, DOI DOI 10.1542/PEDS.114.1.297; Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Boo N Y, 2011, Med J Malaysia, V66, P239; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Burke BL, 2009, PEDIATRICS, V123, P524, DOI 10.1542/peds.2007-2915; Carlin JB, 2008, LANCET, V371, P135, DOI 10.1016/S0140-6736(08)60106-3; CHAIBVA NTR, 1974, S AFR MED J, V48, P1533; Ezeaka CV, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-192; GOSSET IH, 1960, LANCET, V1, P87; Goulet L, 2007, BIRTH-ISS PERINAT C, V34, P131, DOI 10.1111/j.1523-536X.2007.00159.x; GUPTA P C, 1991, Indian Pediatrics, V28, P473; HAMEL BCJ, 1982, TROP DOCT, V12, P213, DOI 10.1177/004947558201200429; Hannon PR, 2001, ARCH PEDIAT ADOL MED, V155, P1357, DOI 10.1001/archpedi.155.12.1357; Hansen TWR, 2011, DEV MED CHILD NEUROL, V53, P24, DOI 10.1111/j.1469-8749.2011.04059.x; Herbert HK, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001183; Lain SJ, 2015, PEDIATRICS, V135, P314, DOI 10.1542/peds.2014-2388; Le LT, 2014, BMC PEDIATR, V14, DOI 10.1186/1471-2431-14-264; Luu MN, 2014, J PAEDIATR CHILD H, V50, P674, DOI 10.1111/jpc.12611; Madlon-Kay DJ, 2002, J FAM PRACTICE, V51, P445; MadlonKay DJ, 1997, PEDIATRICS, V100, DOI 10.1542/peds.100.3.e3; Maisels MJ, 2016, ACTA PAEDIATR, V105, pE567, DOI 10.1111/apa.13599; Moawad EMI, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004804; NICE. UK National Institute for Health and Clinical Excellence, 2010, CLIN GUID NEON JAUND; Obuchowski N A, 1998, Stat Methods Med Res, V7, P371, DOI 10.1191/096228098678080061; Olusanya BO, 2016, NIGER J CLIN PRACT, V19, P1, DOI 10.4103/1119-3077.173703; Olusanya BO, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0907; Olusanya BO, 2015, WORLD J PEDIATR, V11, P293, DOI 10.1007/s12519-015-0037-z; Olusanya BO, 2014, ARCH DIS CHILD, V99, P1117, DOI 10.1136/archdischild-2013-305506; SCHUMACHER RE, 1985, PEDIATRICS, V76, P10; Slusher TM, 2015, NEW ENGL J MED, V373, P1115, DOI 10.1056/NEJMoa1501074; Xue GC, 2016, ACTA PAEDIATR, V105, pE561, DOI 10.1111/apa.13542; Zhang L, 2015, MED SCI MONITOR, V21, P1668	33	13	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183882	10.1371/journal.pone.0183882	http://dx.doi.org/10.1371/journal.pone.0183882			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837635	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000133
J	Van Goor, A; Stromberg, ZR; Mellata, M				Van Goor, Angelica; Stromberg, Zachary R.; Mellata, Melha			A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli	PLOS ONE			English	Article							IMMUNE-RESPONSES; COMPARATIVE GENOMICS; TRAT PROTEIN; DNA-SEQUENCE; VIRULENCE; RESISTANCE; SERUM; CHICKEN; CELLS; IL-18	Chickens are a major source of protein worldwide, yet infectious diseases continue to threaten the poultry industry. Avian pathogenic Escherichia coli (APEC), a subgroup of extraintestinal pathogenic E. coli (ExPEC), causes colibacillosis in chickens resulting in economic loss because of treatment, condemnation of products, and death. In this study, we evaluated a recombinant antigens (rAg) vaccine combining common ExPEC surface proteins EtsC, OmpA, OmpT, and TraT for broad protective potential against APEC infections in chickens. The specific objectives were to evaluate antibody (serum) and cytokines (lymphoid organs) responses to vaccination; in vitro bactericidal ability of serum and splenocytes against multiple APEC serotypes; and in vivo protection against APEC challenge in chickens. Groups of four-day old chickens (N = 10) were vaccinated twice (two-week interval) subcutaneously with rAgs alone or in combination and CpG adjuvant or PBS (control). IgY antibody in the serum and mRNA expression of IL-1 beta, IL-6, IL-18, IFN-gamma, IL-4, IFN-beta, and IL-8 in bursa, spleen, and thymus were measured using ELISA and RT-qPCR, respectively. Serum and splenocytes were tested for their bactericidal ability in vitro against multiple APEC isolates. Vaccinated and non-vaccinated chickens were challenged with 10(8) CFU of APEC-O2 via air sac at 31 days post first vaccination. Vaccine protection was determined by the decrease of bacterial loads in blood and organs (lung, heart, spleen, and liver), as well as gross colibacillosis lesion scores in air sac, heart, and liver. Vaccination significantly (P < 0.05) elicited IgY against specific antigens, induced immune related mRNA expression in the spleen and bursa, reduced in vitro growth of multiple APEC serotypes, and decreased bacterial loads in the heart and spleen, and gross lesion scores of the air sac, heart and liver in chickens. The vaccine reported may be used to provide broad protection against APEC strains, increasing animal welfare and food production.	[Van Goor, Angelica; Stromberg, Zachary R.; Mellata, Melha] Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA	Iowa State University	Mellata, M (corresponding author), Iowa State Univ, Dept Food Sci & Human Nutr, Ames, IA 50011 USA.	mmellata@iastate.edu	Mellata, Melha/AAP-5491-2020; Stromberg, Zachary/ABF-4365-2021; Stromberg, Zachary R/H-8711-2018	Stromberg, Zachary/0000-0002-1137-1128; Stromberg, Zachary R/0000-0002-1137-1128; Mellata, Melha/0000-0002-4967-7173; Van Goor, Angelica/0000-0002-0385-7187	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI [2011-67005-25080]; Iowa State University	U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI; Iowa State University	This research was supported by a grant from the U.S. Department of Agriculture National Research Initiative USDA-NIFA-AFRI grant 2011-67005-25080 (https://nifa.usda.gov/) to MM and Iowa State University (http://www.iastate.edu/) start-up funding to MM. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1977, P NATL ACAD SCI USA, V74, P5104, DOI 10.1073/pnas.74.11.5104; Antao EM, 2008, MICROB PATHOGENESIS, V45, P361, DOI 10.1016/j.micpath.2008.08.005; Ariaans MP, 2008, VET IMMUNOL IMMUNOP, V123, P240, DOI 10.1016/j.vetimm.2008.02.003; Barbieri NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072322; BINNS MM, 1979, NATURE, V279, P778, DOI 10.1038/279778a0; Brown PK, 1996, P NATL ACAD SCI USA, V93, P11149, DOI 10.1073/pnas.93.20.11149; CROFT S, 1991, J IMMUNOL, V146, P793; Degen WGJ, 2005, VACCINE, V23, P4212, DOI 10.1016/j.vaccine.2005.04.003; FAO, 2009, FEED WORLD 2050 HIGH; Gobel TW, 2003, J IMMUNOL, V171, P1809, DOI 10.4049/jimmunol.171.4.1809; Guabiraba R, 2015, FEMS MICROBIOL LETT, V362, DOI 10.1093/femsle/fnv118; Guan QF, 2015, APPL MICROBIOL BIOT, V99, P5451, DOI 10.1007/s00253-014-6339-6; HARRISON JL, 1990, RES MICROBIOL, V141, P1009, DOI 10.1016/0923-2508(90)90142-D; Hejair HMA, 2017, RES VET SCI, V115, P109, DOI 10.1016/j.rvsc.2017.01.026; Johnson TJ, 2008, J CLIN MICROBIOL, V46, P3987, DOI 10.1128/JCM.00816-08; Johnson TJ, 2005, ANTIMICROB AGENTS CH, V49, P4681, DOI 10.1128/AAC.49.11.4681-4688.2005; Johnson TJ, 2006, J BACTERIOL, V188, P745, DOI 10.1128/JB.188.2.745-758.2006; Jorgensen SL, 2017, STAND GENOMIC SCI, V12, DOI 10.1186/s40793-017-0245-3; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Markland SM, 2015, ZOONOSES PUBLIC HLTH, V62, P491, DOI 10.1111/zph.12194; Maturana Victor Goncalves, 2011, Open Microbiol J, V5, P55, DOI 10.2174/1874285801105010055; Mellata M, 2003, INFECT IMMUN, V71, P536, DOI 10.1128/IAI.71.1.536-540.2003; Mellata M, 2016, VACCINE, V34, P656, DOI 10.1016/j.vaccine.2015.12.014; Mellata M, 2013, FOODBORNE PATHOG DIS, V10, P916, DOI 10.1089/fpd.2013.1533; Mitchell NM, 2015, APPL ENVIRON MICROB, V81, P1177, DOI 10.1128/AEM.03524-14; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Nakano H, 2003, INT IMMUNOL, V15, P611, DOI 10.1093/intimm/dxg062; Nie QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041645; Okamura M, 2004, COMP IMMUNOL MICROB, V27, P255, DOI 10.1016/j.cimid.2003.12.001; Olsen RH, 2012, VET MICROBIOL, V158, P384, DOI 10.1016/j.vetmic.2012.03.008; Pfaff-McDonough SJ, 2000, AVIAN DIS, V44, P23, DOI 10.2307/1592504; Pollock KGJ, 2003, IMMUNOLOGY, V108, P137, DOI 10.1046/j.1365-2567.2003.01581.x; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; PRAMOONJAGO P, 1992, J IMMUNOL, V148, P827; RUSSELLJONES GJ, 1993, VACCINE, V11, P1310, DOI 10.1016/0264-410X(93)90100-C; Sadeyen JR, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-19; Sandford Erin E, 2012, Results Immunol, V2, P44, DOI 10.1016/j.rinim.2012.02.003; Sandford EE, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-469; Schouler C, 2012, J CLIN MICROBIOL, V50, P1673, DOI 10.1128/JCM.05057-11; Smith SGJ, 2007, FEMS MICROBIOL LETT, V273, P1, DOI 10.1111/j.1574-6968.2007.00778.x; Stacy AK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086565; Stromberg ZR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180599; Sun H, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1209-2; Teng CH, 2006, INFECT IMMUN, V74, P5609, DOI 10.1128/IAI.00321-06; Wan L, 2014, PAK J PHARM SCI, V27, P617; Wang Y, 2010, AVIAN PATHOL, V39, P297, DOI 10.1080/03079457.2010.495742; WEISER JN, 1991, INFECT IMMUN, V59, P2252, DOI 10.1128/IAI.59.7.2252-2258.1991; Wieser A, 2012, INT J MED MICROBIOL, V302, P10, DOI 10.1016/j.ijmm.2011.09.012; Wieser A, 2010, INFECT IMMUN, V78, P3432, DOI 10.1128/IAI.00174-10; Wijetunge DS, 2015, GENOME ANNOUNC, V3; Xie Y, 2008, BIOCHEM BIOPH RES CO, V365, P201, DOI 10.1016/j.bbrc.2007.10.174	52	12	14	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183929	10.1371/journal.pone.0183929	http://dx.doi.org/10.1371/journal.pone.0183929			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837660	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000136
J	Lujic, S; Simpson, JM; Zwar, N; Hosseinzadeh, H; Jorm, L				Lujic, Sanja; Simpson, Judy M.; Zwar, Nicholas; Hosseinzadeh, Hassan; Jorm, Louisa			Multimorbidity in Australia: Comparing estimates derived using administrative data sources and survey data	PLOS ONE			English	Article							CO-MORBIDITY; RXRISK-V; HEALTH; PREVALENCE; CHARLSON; VALIDITY; INDEX; CLASSIFICATION; INFORMATION; MEDICATIONS	Background Estimating multimorbidity (presence of two or more chronic conditions) using administrative data is becoming increasingly common. We investigated (1) the concordance of identification of chronic conditions and multimorbidity using self- report survey and administrative datasets; (2) characteristics of people with multimorbidity ascertained using different data sources; and (3) whether the same individuals are classified as multimorbid using different data sources. Methods Baseline survey data for 90,352 participants of the 45 and Up Study D a cohort study of residents of New South Wales, Australia, aged 45 years and over D were linked to prior twoyear pharmaceutical claims and hospital admission records. Concordance of eight selfreport chronic conditions (reference) with claims and hospital data were examined using sensitivity (Sn), positive predictive value (PPV), and kappa (k). The characteristics of people classified as multimorbid were compared using logistic regression modelling. Results Agreement was found to be highest for diabetes in both hospital and claims data (k=0.79, 0.78; Sn = 79%, 72%; PPV = 86%, 90%). The prevalence of multimorbidity was highest using self-report data (37.4%), followed by claims data (36.1%) and hospital data (19.3%). Combining all three datasets identified a total of 46 683 (52%) people with multimorbidity, with half of these identified using a single dataset only, and up to 20% identified on all three datasets. Characteristics of persons with and without multimorbidity were generally similar. However, the age gradient was more pronounced and people speaking a language other than English at home were more likely to be identified as multimorbid by administrative data. Conclusions Different individuals, with different combinations of conditions, are identified as multimorbid when different data sources are used. As such, caution should be applied when ascertaining morbidity from a single data source as the agreement between self-report and administrative data is generally poor. Future multimorbidity research exploring specific disease combinations and clusters of diseases that commonly co-occur, rather than a simple disease count, is likely to provide more useful insights into the complex care needs of individuals with multiple chronic conditions.	[Lujic, Sanja; Jorm, Louisa] Univ New South Wales, Ctr Big Data Res Hlth, Sydney, NSW, Australia; [Simpson, Judy M.] Univ Sydney, Sch Publ Hlth, Sydney, NSW, Australia; [Zwar, Nicholas; Hosseinzadeh, Hassan] Univ New South Wales, Sch Publ Hlth & Community Med, Sydney, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney	Lujic, S (corresponding author), Univ New South Wales, Ctr Big Data Res Hlth, Sydney, NSW, Australia.	s.lujic@unsw.edu.au	Jorm, Louisa/AAN-6874-2020; Hosseinzadeh, Hassan/AAZ-9650-2021	Jorm, Louisa/0000-0003-0390-661X; Hosseinzadeh, Hassan/0000-0002-8638-5372; Zwar, Nicholas/0000-0001-6462-9121; Lujic, Sanja/0000-0002-9555-0261	National Health and Medical Research Council Partnership Project Grant [1036858]; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation and the NSW Bureau of Health Information	National Health and Medical Research Council Partnership Project Grant; Australian Commission on Safety and Quality in Health Care; Agency for Clinical Innovation and the NSW Bureau of Health Information	This work was supported by a National Health and Medical Research Council Partnership Project Grant (#1036858) and by partner agencies the Australian Commission on Safety and Quality in Health Care, the Agency for Clinical Innovation and the NSW Bureau of Health Information. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assareh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147087; Australian Bureau of Statistics, 2012, AUSTR HLTH SURV 1 RE; Australian Bureau of Statistics, 2007, NAT HLTH SURV SUMM R; Australian Institute of Health and Welfare, NAT HLTH PRIOR AR 20; Australian Institute of Health and Welfare, 2014, AUSTR HLTH SER, V14; Banks E, 2008, INT J EPIDEMIOL, V37, P941, DOI 10.1093/ije/dym184; Bayliss Elizabeth A, 2005, Health Qual Life Outcomes, V3, P51; Brett T, 2013, ANN FAM MED, V11, P535, DOI 10.1370/afm.1570; Britt HC, 2008, MED J AUSTRALIA, V189, P72, DOI 10.5694/j.1326-5377.2008.tb01919.x; Byles JE, 2005, J CLIN EPIDEMIOL, V58, P997, DOI 10.1016/j.jclinepi.2005.02.025; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chini F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-688; Chong WF, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-105; Comino EJ, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-481; Crimmins EM, 2004, ANNU REV PUBL HEALTH, V25, P79, DOI 10.1146/annurev.publhealth.25.102802.124401; Tran DT, 2012, AUST NZ J PUBL HEAL, V36, P310, DOI 10.1111/j.1753-6405.2012.00893.x; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fleiss J. L., 1981, STAT METHODS RATES P, V2, P22; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Fortin M, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-111; Halfon P, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-453; Harrison C, 2016, AUST NZ J PUBL HEAL, V40, P239, DOI 10.1111/1753-6405.12509; Harrison C, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004694; Held FP, 2015, J GERONTOL A; Henderson T, 2006, MED CARE, V44, P1011, DOI 10.1097/01.mlr.0000228018.48783.34; Holden L, 2011, POPUL HEALTH METR, V9, DOI 10.1186/1478-7954-9-15; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; Inacio MCS, 2015, BMC MUSCULOSKEL DIS, V16, DOI 10.1186/s12891-015-0835-4; Islam MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083783; Jowsey T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059379; Kelman CW, 2002, AUST NZ J PUBL HEAL, V26, P251, DOI 10.1111/j.1467-842X.2002.tb00682.x; Lamers LM, 2004, HEALTH POLICY, V68, P113, DOI 10.1016/j.healthpol.2003.09.001; Leal JR, 2010, CLIN MICROBIOL INFEC, V16, P715, DOI 10.1111/j.1469-0691.2009.02867.x; Lix L, 2006, DEFINING VALIDATING; Lix LM, 2008, CHRONIC DIS CAN, V29, P31; Lu CY, 2011, J CLIN EPIDEMIOL, V64, P223, DOI 10.1016/j.jclinepi.2010.02.015; Lujic S, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005768; Marengoni A, 2016, EUR J INTERN MED, V31, P29, DOI 10.1016/j.ejim.2016.02.014; Mcrae I, 2013, AUST J PRIM HEALTH, V19, P144, DOI 10.1071/PY12035; Mellish Leigh, 2015, BMC Res Notes, V8, P634, DOI 10.1186/s13104-015-1616-8; Muggah E, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-16; National Centre for Classification in Health, 2006, INT STAT CLASS DIS H; Ng SP, 2011, AUST NZ J PUBL HEAL, V35, P557, DOI 10.1111/j.1753-6405.2011.00742.x; O'Shea M, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-23; Olesen JB, 2011, BMJ, V342; Orueta JF, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-365; Pache B, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1515-x; Preen DB, 2006, J CLIN EPIDEMIOL, V59, P940, DOI 10.1016/j.jclinepi.2005.12.013; Preen DB, 2004, J CLIN EPIDEMIOL, V57, P1295, DOI 10.1016/j.jclinepi.2004.03.016; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Quinones AR, 2011, J GERONTOL B-PSYCHOL, V66, P739, DOI 10.1093/geronb/gbr106; Rector TS, 2004, HEALTH SERV RES, V39, P1839, DOI 10.1111/j.1475-6773.2004.00321.x; SAS Institute, 2010, SAS VERS 9 3 SOFTW; Schneider F, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13533; Sloan KL, 2003, MED CARE, V41, P761, DOI 10.1097/00005650-200306000-00009; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; van den Akker M, 1996, EUR J GEN PRACT, V2, P65, DOI [DOI 10.3109/13814789609162146, 10.3109/13814789609162146]; van den Bussche H, 2013, J CLIN EPIDEMIOL, V66, P209, DOI 10.1016/j.jclinepi.2012.07.019; Violan C, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-251; Vitry A, 2009, AUST NZ J PUBL HEAL, V33, P126, DOI 10.1111/j.1753-6405.2009.00357.x; Vivas D, 2011, HEALTH POLICY, V103, P9, DOI 10.1016/j.healthpol.2011.08.014; Vogeli C, 2007, J GEN INTERN MED, V22, P391, DOI 10.1007/s11606-007-0322-1; World Health Organization, 2014, GLOB HLTH EST DEATHS, DOI 10.1371/journal.pgen.1004412.20	64	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183817	10.1371/journal.pone.0183817	http://dx.doi.org/10.1371/journal.pone.0183817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850593	Green Published, Green Submitted, gold			2022-12-27	WOS:000408544200029
J	Barradas-Bautista, D; Fernandez-Recio, J				Barradas-Bautista, Didier; Fernandez-Recio, Juan			Docking-based modeling of protein-protein interfaces for extensive structural and functional characterization of missense mutations	PLOS ONE			English	Article							SCALE MAP; NETWORKS; DATABASE; REFINEMENT; PRINCIPLES; SITES	Next-generation sequencing (NGS) technologies are providing genomic information for an increasing number of healthy individuals and patient populations. In the context of the large amount of generated genomic data that is being generated, understanding the effect of disease-related mutations at molecular level can contribute to close the gap between genotype and phenotype and thus improve prevention, diagnosis or treatment of a pathological condition. In order to fully characterize the effect of a pathological mutation and have useful information for prediction purposes, it is important first to identify whether the mutation is located at a protein-binding interface, and second to understand the effect on the binding affinity of the affected interaction/s. Computational methods, such as protein docking are currently used to complement experimental efforts and could help to build the human structural inter-actome. Here we have extended the original pyDockNIP method to predict the location of disease-associated nsSNPs at protein-protein interfaces, when there is no available structure for the protein-protein complex. We have applied this approach to the pathological interaction networks of six diseases with low structural data on PPIs. This approach can almost double the number of nsSNPs that can be characterized and identify edgetic effects in many nsSNPs that were previously unknown. This can help to annotate and interpret genomic data from large-scale population studies, and to achieve a better understanding of disease at molecular level.	[Barradas-Bautista, Didier; Fernandez-Recio, Juan] BSC, Life Sci Dept, Barcelona, Spain; [Fernandez-Recio, Juan] CSIC, Inst Biol Mol Barcelona, Struct Biol Unit, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB)	Fernandez-Recio, J (corresponding author), BSC, Life Sci Dept, Barcelona, Spain.; Fernandez-Recio, J (corresponding author), CSIC, Inst Biol Mol Barcelona, Struct Biol Unit, Barcelona, Spain.	juanf@bsc.es	Barradas-Bautista, Didier/D-3269-2018	Barradas-Bautista, Didier/0000-0002-6464-6607; Fernandez-Recio, Juan/0000-0002-3986-7686	Spanish Ministry of Economy and Competitiveness [BI02013-48213-R, BI02016-79930-R]; Interreg POCTEFA [EFA086/15]; CONACyT from the Mexican Government	Spanish Ministry of Economy and Competitiveness(Spanish Government); Interreg POCTEFA; CONACyT from the Mexican Government	This work was funded by grants number BI02013-48213-R and BI02016-79930-R from the Spanish Ministry of Economy and Competitiveness, and grant number EFA086/15 from Interreg POCTEFA. D. Barradas-Bautista was supported by a CONACyT predoctoral fellowship from the Mexican Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Aranda B, 2010, NUCLEIC ACIDS RES, V38, pD525, DOI 10.1093/nar/gkp878; Baase WA, 2010, PROTEIN SCI, V19, P631, DOI 10.1002/pro.344; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Cheng TMK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002738; Cheng TMK, 2007, PROTEINS, V68, P503, DOI 10.1002/prot.21419; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; David A, 2015, J MOL BIOL, V427, P2886, DOI 10.1016/j.jmb.2015.07.004; David A, 2012, HUM MUTAT, V33, P359, DOI 10.1002/humu.21656; Fraser JS, 2013, MOL CELL, V49, P222, DOI 10.1016/j.molcel.2013.01.003; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Grosdidier S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-447; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guney E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10331; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jackson RM, 1998, J MOL BIOL, V276, P265, DOI 10.1006/jmbi.1997.1519; Kanehisa M., NOVARTIS FOUNDATION, P91; Keskin O, 2007, STRUCTURE, V15, P341, DOI 10.1016/j.str.2007.01.007; Kiel C, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.20145092; Kiel C, 2012, STRUCTURE, V20, P1806, DOI 10.1016/j.str.2012.10.002; Kuhner S, 2009, SCIENCE, V326, P1235, DOI 10.1126/science.1176343; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Mashiach E, 2010, PROTEINS, V78, P1503, DOI 10.1002/prot.22668; Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078; Mosca R, 2015, NAT METHODS, V12, P167, DOI 10.1038/nmeth.3289; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Mosca R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000490; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sahni N, 2015, CELL, V161, P647, DOI 10.1016/j.cell.2015.04.013; Scott AF, BIOIN FORMATICS DATA, P77; Sim NL, 2012, NUCLEIC ACIDS RES, V40, pW452, DOI 10.1093/nar/gks539; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Teng SL, 2009, BIOPHYS J, V96, P2178, DOI 10.1016/j.bpj.2008.12.3904; Wang XJ, 2012, NAT BIOTECHNOL, V30, P159, DOI 10.1038/nbt.2106; Wu XG, 2014, J THEOR BIOL, V362, P44, DOI 10.1016/j.jtbi.2014.05.031; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zanzoni A, 2009, FEBS LETT, V583, P1759, DOI 10.1016/j.febslet.2009.03.001; Zhang CS, 2011, J COMPUT CHEM, V32, P2598, DOI 10.1002/jcc.21839; Zhong Q, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.80	44	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183643	10.1371/journal.pone.0183643	http://dx.doi.org/10.1371/journal.pone.0183643			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841721	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700046
J	Shokry, E; Pereira, J; Marques, JG; da Cunha, PHJ; Noronha, ADF; da Silva, JA; Fioravanti, MCS; de Oliveira, AE; Antoniosi, NR				Shokry, Engy; Pereira, Juliao; Marques Junior, Jair Gonzalez; Jorge da Cunha, Paulo Henrique; Feitosa Noronha Filho, Antonio Dionisio; da Silva, Jessica Alves; Soares Fioravanti, Maria Clorinda; de Oliveira, Anselmo Elcana; Antoniosi Filho, Nelson Roberto			Earwax metabolomics: An innovative pilot metabolic profiling study for assessing metabolic changes in ewes during periparturition period	PLOS ONE			English	Article							LATE PREGNANCY; BLOOD; PARAMETERS; LACTATION; HORMONES; UREA; BIOMARKERS; COLOSTRUM; EXPOSURE; CERUMEN	Important metabolic changes occur during transition period of late pregnancy and early lactation to meet increasing energy demands of the growing fetus and for milk production. The aim of this investigation is to present an innovative and non-invasive tool using ewe earwax sample analysis to assess the metabolic profile in ewes during late pregnancy and early lactation. In this work, earwax samples were collected from 28 healthy Brazilian Santa Ines ewes divided into 3 sub-groups: 9 non-pregnant ewes, 6 pregnant ewes in the last 30 days of gestation, and 13 lactating ewes <= 30 days postpartum. Then, a range of metabolites including volatile organic compounds (VOC), amino acids (AA), and minerals were profiled and quantified in the samples by applying headspace gas chromatography/mass spectrometry, high performance liquid chromatography/tandem mass spectrometry, and inductively coupled plasma-optical emission spectrometry, respectively. As evident in our results, significant changes were observed in the metabolite profile of earwax between the studied groups where a remarkable elevation was detected in the levels of non-esterified fatty acids, alcohols, ketones, and hydroxy urea in the VOC profile of samples obtained from pregnant and lactating ewes. Meanwhile, a significant decrease was detected in the levels of 9 minerals and 14 AA including essential AA (leucine, phenyl alanine, lysine, isoleucine, threonine, valine), conditionally essential AA (arginine, glycine, tyrosine, proline, serine), and a nonessential AA (alanine). Multivariate analysis using robust principal component analysis and hierarchical cluster analysis was successfully applied to discriminate the three study groups using the variations of metabolites in the two stress states (pregnancy and lactation) from the healthy non-stress condition. The innovative developed method was successful in evaluating pre- and post-parturient metabolic changes using earwax and can in the future be applied to recognize markers for diagnosis, prevention, and intervention of pregnancy complications in ewes.	[Shokry, Engy; Pereira, Juliao; Marques Junior, Jair Gonzalez; Antoniosi Filho, Nelson Roberto] Univ Fed Goias, Lab Metodos Extracao & Separacao LAMES, IQ, Campus Samambaia, Goiania, Go, Brazil; [Jorge da Cunha, Paulo Henrique; Feitosa Noronha Filho, Antonio Dionisio; da Silva, Jessica Alves; Soares Fioravanti, Maria Clorinda] Univ Fed Goias, Escola Vet & Zootecnia, Campus Samambaia, Goiania, Go, Brazil; [de Oliveira, Anselmo Elcana] Univ Fed Goias, IQ, Campus Samambaia, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Universidade Federal de Goias	Shokry, E (corresponding author), Univ Fed Goias, Lab Metodos Extracao & Separacao LAMES, IQ, Campus Samambaia, Goiania, Go, Brazil.	angeliqa26582@yahoo.com	Filho, Nelson Roberto Antoniosi/R-8297-2019; Jorge da Cunha, Paulo Henrique/E-7107-2019; Shokry, Engy/P-8269-2014; de Oliveira, A. E./I-2736-2015	Filho, Nelson Roberto Antoniosi/0000-0002-3067-0385; Jorge da Cunha, Paulo Henrique/0000-0002-1478-3670; Shokry, Engy/0000-0002-5932-9332; de Oliveira, A. E./0000-0001-7468-8221; Soares Fioravanti, Maria Clorinda/0000-0002-4993-5523	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [1516965]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [312280]	Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	We wish to acknowledge Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the research fund (grant number 1516965) provided within the postdoc program (PNPD) for the first author, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the research productivity grant (grant number 312280) to Nelson Antoniosi and FUNAPE for management of financial resources.; We wish to acknowledge Coordenadoria de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the research fund (grant number 1516965) provided within the postdoc program (PNPD) for the first author, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) for the research productivity grant (grant number 312280) to Nelson Antoniosi and FUNAPE for management of financial resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvord L S, 1997, J Am Acad Audiol, V8, P383; [Anonymous], GUID BIOAN METH VAL; Antunovic Z, 2011, BULG J AGRIC SCI, V17, P687; Antunovic Z, 2011, ARCH TIERZUCHT, V54, P535, DOI 10.5194/aab-54-535-2011; Araz O.B., 2013, J ANIM SCI, V2, P11; Assfalg M, 2008, P NATL ACAD SCI USA, V105, P1420, DOI 10.1073/pnas.0705685105; Azab ME, 1999, SMALL RUMINANT RES, V34, P77, DOI 10.1016/S0921-4488(99)00049-8; Balaraman S, 2014, ALCOHOL CLIN EXP RES, V38, P1390, DOI 10.1111/acer.12378; Banchero GE, 2006, REPROD NUTR DEV, V46, P447, DOI 10.1051/rnd:2006024; Bell C., 1975, OBSTET GYNECOL SURV, V30, P359; BORTZ JT, 1990, J AM ACAD DERMATOL, V23, P845, DOI 10.1016/0190-9622(90)70301-W; BRANDAURABAN A, 1972, J INVEST DERMATOL, V58, P14, DOI 10.1111/1523-1747.ep13077196; Burkhart CN, 2000, AM J OTOL, V21, P157, DOI 10.1016/S0196-0709(00)80002-2; Castagnino DD, 2015, REV BRAS ZOOTECN, V44, P92, DOI 10.1590/S1806-92902015000300003; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Dakka A. A., 1992, Assiut Veterinary Medical Journal, V28, P242; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Durak MH, 2006, TURK J VET ANIM SCI, V30, P497; El-Sherif MMA, 2001, SMALL RUMINANT RES, V40, P269, DOI 10.1016/S0921-4488(01)00174-2; Enjalbert F, 2001, J DAIRY SCI, V84, P583, DOI 10.3168/jds.S0022-0302(01)74511-0; Eski F, 2015, TURK J VET ANIM SCI, V39, P401, DOI 10.3906/vet-1412-25; FAICHNEY G J, 1981, Proceedings of the Nutrition Society of Australia Annual Conference, V6, P48; Filzmoser P., 2009, MULTIVARIATE STAT AN, V66, P112; Firat A., 1996, Turk Veterinerlik ve Hayvancilik Dergisi, V20, P387; Gurgoze SY, 2009, KAFKAS UNIV VET FAK, V15, P957; Harmeyer J, 2006, RES VET SCI, V81, P254, DOI 10.1016/j.rvsc.2005.10.010; Kamel FM, 1988, THESIS; Kataoka H, 2013, BIOANALYSIS, V5, P1443, DOI [10.4155/BIO.13.85, 10.4155/bio.13.85]; Khatun A, 2011, ASIAN J ANIM VET ADV, V6, P175, DOI 10.3923/ajava.2011.175.181; Loor J. J., 2010, Energy and protein metabolism and nutrition. 3rd EAAP International Symposium on Energy and Protein Metabolism and Nutrition, Parma, Italy, 6-10 September, 2010, P59; Maeda Y., 2012, Journal of Veterinary Medicine and Animal Health, V4, P124; Oliveira Roseane Pinto Martins de, 2014, Ciênc. anim. bras., V15, P81, DOI 10.5216/cab.v15i1.15720; Mesquita FS, 2012, ANIM REPROD, V9, P713; Murtagh R, 2013, WIEN TIERARZTL MONAT, V100, P247; ODoherty JV, 1997, ANIM SCI, V64, P87, DOI 10.1017/S1357729800015587; Otten JJ, 2006, 309100917 NAT AC SCI; Ozpinar A, 2003, ANN NUTR METAB, V47, P139, DOI 10.1159/000070036; Piccione G, 2009, ANIM SCI PAP REP, V27, P321; Regnault TRH, 2005, PLACENTA, V26, pS52, DOI 10.1016/j.placenta.2005.01.003; Rios C, 2006, ARCH MED VET, V38, P19, DOI 10.4067/S0301-732X2006000100003; Robinson JJ, 1999, ANIM SCI, V68, P315, DOI 10.1017/S1357729800050323; Rodriguez MN, 1996, CAN J ANIM SCI, V76, P469, DOI 10.4141/cjas96-070; SANSOM BF, 1982, BRIT VET J, V138, P393, DOI 10.1016/S0007-1935(17)30984-3; Scalbert A, 2009, METABOLOMICS, V5, P435, DOI 10.1007/s11306-009-0168-0; Schlumbohm C, 2004, J DAIRY SCI, V87, P350, DOI 10.3168/jds.S0022-0302(04)73174-4; Shagun Agrawal, 2007, Indian Journal of Small Ruminants, V13, P192; Shetaewi M. M., 1994, Assiut Veterinary Medical Journal, V30, P64; Shokry E, 2017, TOXICON, V137, P54, DOI 10.1016/j.toxicon.2017.07.014; Shokry E, 2017, FORENSIC TOXICOL, V35, P389, DOI 10.1007/s11419-017-0370-0; Shokry E, 2017, FORENSIC TOXICOL, V35, P348, DOI 10.1007/s11419-017-0363-z; Shokry E, 2017, J PROTEOMICS, V159, P92, DOI 10.1016/j.jprot.2017.03.005; Soliman E. B., 2014, Egyptian Journal of Sheep and Goat Sciences, V9, P33; Tanritanir P, 2009, J ANIM VET ADV, V8, P530; Trumble SJ, 2013, P NATL ACAD SCI USA, V110, P16922, DOI 10.1073/pnas.1311418110; Waziri MA, 2010, VET ARHIV, V80, P215; Yassin A, 1966, J Laryngol Otol, V80, P933, DOI 10.1017/S0022215100066196	56	9	9	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183538	10.1371/journal.pone.0183538	http://dx.doi.org/10.1371/journal.pone.0183538			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841695	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700040
J	Hollings, T; Robinson, A; van Andel, M; Jewell, C; Burgman, M				Hollings, Tracey; Robinson, Andrew; van Andel, Mary; Jewell, Chris; Burgman, Mark			Species distribution models: A comparison of statistical approaches for livestock and disease epidemics	PLOS ONE			English	Article							MOUTH-DISEASE; GLOBAL DISTRIBUTION; FOOT; OUTBREAK; CLASSIFICATION; POULTRY; AFRICA; ASSIST; IMPACT; DUCKS	In livestock industries, reliable up-to-date spatial distribution and abundance records for animals and farms are critical for governments to manage and respond to risks. Yet few, if any, countries can afford to maintain comprehensive, up-to-date agricultural census data. Statistical modelling can be used as a proxy for such data but comparative modelling studies have rarely been undertaken for livestock populations. Widespread species, including livestock, can be difficult to model effectively due to complex spatial distributions that do not respond predictably to environmental gradients. We assessed three machine learning species distribution models (SDM) for their capacity to estimate national-level farm animal population numbers within property boundaries: boosted regression trees (BRT), random forests (RF) and K-nearest neighbour (K-NN). The models were built from a commercial livestock database and environmental and socio-economic predictor data for New Zealand. We used two spatial data stratifications to test (i) support for decision making in an emergency response situation, and (ii) the ability for the models to predict to new geographic regions. The performance of the three model types varied substantially, but the best performing models showed very high accuracy. BRTs had the best performance overall, but RF performed equally well or better in many simulations; RFs were superior at predicting livestock numbers for all but very large commercial farms. K-NN performed poorly relative to both RF and BRT in all simulations. The predictions of both multi species and single species models for farms and within hypothetical quarantine zones were very close to observed data. These models are generally applicable for livestock estimation with broad applications in disease risk modelling, biosecurity, policy and planning.	[Hollings, Tracey; Robinson, Andrew; Burgman, Mark] Univ Melbourne, Ctr Excellence Biosecur Risk Anal, Melbourne, Vic, Australia; [van Andel, Mary] Minist Primary Ind, Wellington, New Zealand; [Jewell, Chris] Univ Lancaster, Dept Hlth & Med, Lancaster, England; [Burgman, Mark] Imperial Coll, Ctr Environm Policy, London, England	University of Melbourne; Lancaster University; Imperial College London	Hollings, T (corresponding author), Univ Melbourne, Ctr Excellence Biosecur Risk Anal, Melbourne, Vic, Australia.	tracey.hollings@unimelb.edu.au		Jewell, Chris/0000-0002-7902-2178; Burgman, Mark/0000-0003-0435-4829	Centre of Excellence for Biosecurity Risk Analysis (CEBRA) at the University of Melbourne of the New Zealand Ministry for Primary Industries (MPI); Australian Federal Department of Agriculture and Water Resources	Centre of Excellence for Biosecurity Risk Analysis (CEBRA) at the University of Melbourne of the New Zealand Ministry for Primary Industries (MPI); Australian Federal Department of Agriculture and Water Resources	The work was funded by the Centre of Excellence for Biosecurity Risk Analysis (CEBRA) at the University of Melbourne, on behalf of the New Zealand Ministry for Primary Industries (MPI) and Australian Federal Department of Agriculture and Water Resources. MPI provided the data, gave input to the study design and have given permission the publish.	Anderson I., 2002, FOOT MOUTH DIS 2001; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bogh C, 2007, AM J TROP MED HYG, V76, P875; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bruhn Mark C, 2012, Methods Rep RTI Press, VMR-0023-1201, P1; Cartin-Rojas A, 2012, TRANSBOUNDARY ANIMAL; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; Davies G, 2002, COMP IMMUNOL MICROB, V25, P331, DOI 10.1016/S0147-9571(02)00030-9; Diggle PJ, 1998, J R STAT SOC C-APPL, V47, P299, DOI 10.1111/1467-9876.00113; Elith J, 2008, J ANIM ECOL, V77, P802, DOI 10.1111/j.1365-2656.2008.01390.x; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2008, REASONS DIFFERING PE; Emelyanova IV, 2009, ENVIRON MODEL ASSESS, V14, P449, DOI 10.1007/s10666-008-9140-z; Eurostat, 2013, GLOSS LIV UN LSU; Everett KR, 2011, AUSTRALAS PLANT DIS, V6, P67, DOI 10.1007/s13314-011-0023-9; Ferguson NM, 2001, NATURE, V413, P542, DOI 10.1038/35097116; Forbes B.R., 2014, FOOT AND MOUTH DIS E; Franceschini G, 2009, VET ITAL, V45, P491; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Guisan A, 2000, ECOL MODEL, V135, P147, DOI 10.1016/S0304-3800(00)00354-9; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Haydon DT, 2004, NAT REV MICROBIOL, V2, P675, DOI 10.1038/nrmicro960; Hijmans RJ, 2014, R PACKAGE VERSION; Kao RR, 2002, TRENDS MICROBIOL, V10, P279, DOI 10.1016/S0966-842X(02)02371-5; Keeling MJ, 2001, SCIENCE, V294, P813, DOI 10.1126/science.1065973; Leathwick J., 2002, LAND ENV NZ TECHNICA; Levine JM, 2003, CONSERV BIOL, V17, P322, DOI 10.1046/j.1523-1739.2003.02038.x; Meinshausen N, 2006, J MACH LEARN RES, V7, P983; Meyerson LA, 2002, BIOSCIENCE, V52, P593, DOI 10.1641/0006-3568(2002)052[0593:BMTACA]2.0.CO;2; Ministry for Primary Industries, 2012, EX TAUR 2012 FIN REP; Ministry for Primary Industries, 2013, INF POLL SEC LOC GOV; Morris ST, 2009, SMALL RUMINANT RES, V86, P59, DOI 10.1016/j.smallrumres.2009.09.019; Neumann K, 2009, LANDSCAPE ECOL, V24, P1207, DOI 10.1007/s10980-009-9357-5; Nicolas G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150424; Pebesma E.J., 2005, R NEWS, V5; Prosser DJ, 2011, AGR ECOSYST ENVIRON, V141, P381, DOI 10.1016/j.agee.2011.04.002; R Core Team, 2021, R LANGUAGE ENV STAT; Ridgeway G., 2013, R PACKAGE VERSION; Robinson Timothy P, 2014, PLoS One, V9, pe96084, DOI 10.1371/journal.pone.0096084; Robinson Timothy P, 2007, Vet Ital, V43, P745; Segurado P, 2004, J BIOGEOGR, V31, P1555, DOI 10.1111/j.1365-2699.2004.01076.x; Stevens FR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0107042; Stevens KB, 2013, SPAT SPATIO-TEMPORAL, V4, P1, DOI 10.1016/j.sste.2012.11.002; Sumption K, 2008, TRANSBOUND EMERG DIS, V55, P5, DOI 10.1111/j.1865-1682.2007.01017.x; The Scottish Government, 2014, INF LIV UN; Thompson D, 2002, REV SCI TECH OIE, V21, P675, DOI 10.20506/rst.21.3.1353; Thompson S., 2003, NZ LAND COVER DATABA; Tsoar A, 2007, DIVERS DISTRIB, V13, P397, DOI 10.1111/j.1472-4642.2007.00346.x; Van Boeckel TP, 2012, AGR ECOSYST ENVIRON, V149, P144, DOI 10.1016/j.agee.2011.12.019; Van Boeckel TP, 2011, AGR ECOSYST ENVIRON, V141, P373, DOI 10.1016/j.agee.2011.04.013; Venables WN., 2002, MODERN APPL STAT S, V4; Volkova VV, 2011, VET REC, V169, P124, DOI 10.1136/vr.d2715; Waage JK, 2008, PHILOS T R SOC B, V363, P863, DOI 10.1098/rstb.2007.2188; White DH, 2001, ENVIRON INT, V27, P181, DOI 10.1016/S0160-4120(01)00080-0	56	19	19	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183626	10.1371/journal.pone.0183626	http://dx.doi.org/10.1371/journal.pone.0183626			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837685	Green Published, gold			2022-12-27	WOS:000408365000091
J	Husser, D; Ueberham, L; Hindricks, G; Buttner, P; Ingram, C; Weeke, P; Shoemaker, MB; Adams, V; Arya, A; Sommer, P; Darbar, D; Roden, DM; Bollmann, A				Husser, Daniela; Ueberham, Laura; Hindricks, Gerhard; Buettner, Petra; Ingram, Christie; Weeke, Peter; Shoemaker, M. Benjamin; Adams, Volker; Arya, Arash; Sommer, Philipp; Darbar, Dawood; Roden, Dan M.; Bollmann, Andreas			Rare variants in genes encoding the cardiac sodium channel and associated compounds and their impact on outcome of catheter ablation of atrial fibrillation	PLOS ONE			English	Article							LONG-QT SYNDROME; PULMONARY VEIN ISOLATION; BRUGADA-SYNDROME; MUTATIONS; RECURRENCE; SCN5A; SUSCEPTIBILITY; POLYMORPHISM; PREVALENCE; DISEASE	Aim Rare variants of genes encoding the cardiac sodium channel and associated compounds have been linked with atrial fibrillation (AF). Nevertheless, current expert consensus does not support genetic testing in AF, which is in part based on the fact that "there is no therapeutic impact derived from AF genetic test results". However, there are no studies available supporting this recommendation. Consequently, this study analyzed the impact of rare variants affecting the cardiac sodium channel on rhythm outcome of AF catheter ablation. Methods and results In 137 consecutive patients with lone AF enrolled in the Leipzig Heart Center AF ablation registry, screening for mutations in SCN5A, SCN1B - 4B, CAV3, GPD1L, SNTA1 and MOG1 was performed. We identified 3 rare non-synonymous variants in SCN5A, 5 in SCN1B, 1 in SCN4B, 1 in CAV3, 6 in GPD1L, 3 in SNTA1 and 3 in MOG1 (16%). Variant carriers were otherwise comparable with non-variant carriers. Analysis of AF recurrence rates after radiofrequency AF catheter ablation by serial 7-day Holter ECG monitoring between 3 and 12 months revealed no difference between groups, i.e. 45% in variant carriers vs. 49% in non-variant carriers. Conclusions Rare variants in genes encoding the cardiac sodium channel and associated compounds are frequently found in lone AF but were not found to impact the outcome of AF catheter ablation. This finding supports current recommendations not to screen for rare variants for the ablation outcome in AF. Nevertheless, it may at least be helpful for understanding AF mechanisms and larger studies are needed to further explore the possible association between genotype and response to AF therapies.	[Husser, Daniela; Ueberham, Laura; Hindricks, Gerhard; Buettner, Petra; Adams, Volker; Arya, Arash; Sommer, Philipp; Bollmann, Andreas] Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany; [Ingram, Christie; Weeke, Peter; Shoemaker, M. Benjamin; Roden, Dan M.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Weeke, Peter] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Hellerup, Denmark; [Darbar, Dawood] Univ Illinois, Div Cardiol, Chicago, IL USA	Heart Center Leipzig GMBH; Leipzig University; University of Hamburg; University Medical Center Hamburg-Eppendorf; Vanderbilt University; University of Copenhagen; Herlev & Gentofte Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Husser, D (corresponding author), Univ Leipzig, Ctr Heart, Dept Electrophysiol, Leipzig, Germany.	Dani11@gmx.net	Büttner, Petra/ADR-1721-2022; Roden, Dan/ABD-5412-2021; Sommer, Philipp/AAV-3133-2020	Buttner, Petra/0000-0003-0799-4725	Volkswagen Foundation Germany [84901]; German Cardiac Society; National Institutes of Health (NIH) [1K23HL127704]; American Heart Association (AHA) [11CRP7420009]; NIH [U19HL65962, UL1RR024975, R01HL092217]; AHA [EIA094116N]; Office Of The Director [1157751] Funding Source: National Science Foundation	Volkswagen Foundation Germany(Volkswagen); German Cardiac Society; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association (AHA)(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); Office Of The Director(National Science Foundation (NSF)NSF - Office of the Director (OD))	DH was supported by the Volkswagen Foundation Germany (84901), LU was supported by the German Cardiac Society (Otto Hess Stipend). MBS was supported by grants from the National Institutes of Health (NIH) (1K23HL127704) and American Heart Association (AHA) (11CRP7420009). DR was supported by grants from the NIH (U19HL65962 and UL1RR024975). DD was supported by grants from the NIH (R01HL092217) and AHA (EIA094116N).	Ackerman MJ, 2004, HEART RHYTHM, V1, P600, DOI 10.1016/j.hrthm.2004.07.013; Bezzina C, 1999, CIRC RES, V85, P1206; Chakrabarti S, 2013, CIRC-ARRHYTHMIA ELEC, V6, P392, DOI 10.1161/CIRCEP.111.000206; Cheng JD, 2013, J MOL CELL CARDIOL, V61, P102, DOI 10.1016/j.yjmcc.2013.03.013; Cheng JD, 2009, CIRC-ARRHYTHMIA ELEC, V2, P667, DOI 10.1161/CIRCEP.109.891440; Conte G, 2014, EUROPACE, V16, P528, DOI 10.1093/europace/eut309; Darbar D, 2008, CIRCULATION, V117, P1927, DOI 10.1161/CIRCULATIONAHA.107.757955; Effinor PT, 2008, HEART RHYTHM, V5, P99, DOI [10.1016/j.hrthm.2007.09.015, 10.1016/j.hrthm.2008.01.014]; Eitel C, 2010, HEART RHYTHM, V7, P157, DOI 10.1016/j.hrthm.2009.10.003; Hu RM, 2013, AM J PHYSIOL-HEART C, V304, pH994, DOI 10.1152/ajpheart.00705.2012; Hu YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057593, 10.1371/journal.pone.0056362, 10.1371/journal.pone.0073264, 10.1371/journal.pone.0056440]; Husser D, 2010, J AM COLL CARDIOL, V55, P747, DOI 10.1016/j.jacc.2009.11.041; Johnson JN, 2008, HEART RHYTHM, V5, P704, DOI 10.1016/j.hrthm.2008.02.007; Kattygnarath D, 2011, CIRC-CARDIOVASC GENE, V4, P261, DOI 10.1161/CIRCGENETICS.110.959130; Kusano KF, 2008, J AM COLL CARDIOL, V51, P1169, DOI 10.1016/j.jacc.2007.10.060; Leong IUS, 2015, BMC MED GENET, V16, DOI 10.1186/s12881-015-0176-z; London B, 2007, CIRCULATION, V116, P2260, DOI 10.1161/CIRCULATIONAHA.107.703330; Olesen MS, 2012, HEART RHYTHM, V9, P770, DOI 10.1016/j.hrthm.2011.12.005; Olesen MS, 2011, CAN J CARDIOL, V27, DOI 10.1016/j.cjca.2011.01.003; Priori SG, 2013, EUROPACE, V15, P1389, DOI 10.1093/europace/eut272; Sairaku A, 2013, INT J CARDIOL, V168, P5273, DOI 10.1016/j.ijcard.2013.08.016; Shirai N, 2002, CARDIOVASC RES, V53, P348, DOI 10.1016/S0008-6363(01)00494-1; Shoemaker MB, 2015, CIRC-ARRHYTHMIA ELEC, V8, P296, DOI 10.1161/CIRCEP.114.001909; Shoemaker MB, 2013, HEART RHYTHM, V10, P394, DOI 10.1016/j.hrthm.2012.11.012; Ueberham L, 2013, CIRC-ARRHYTHMIA ELEC, V6, P732, DOI 10.1161/CIRCEP.113.000253; Vaidyanathan R, 2013, J BIOL CHEM, V288, P17472, DOI 10.1074/jbc.M112.435370; Van Norstrand DW, 2007, CIRCULATION, V116, P2253, DOI 10.1161/CIRCULATIONAHA.107.704627; Vatta M, 2006, CIRCULATION, V114, P2104, DOI 10.1161/CIRCULATIONAHA.106.635268; Wang QS, 2015, J RENIN-ANGIO-ALDO S, V16, P888, DOI 10.1177/1470320315594315; Watanabe H, 2009, CIRC-ARRHYTHMIA ELEC, V2, P268, DOI 10.1161/CIRCEP.108.779181; Wilde AAM, 2011, CIRC RES, V108, P884, DOI 10.1161/CIRCRESAHA.110.238469; Wu G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099623; Wu GR, 2008, CIRC-ARRHYTHMIA ELEC, V1, P193, DOI 10.1161/CIRCEP.108.769224; Wutzler A, 2013, INT J CARDIOL, V168, P3647, DOI 10.1016/j.ijcard.2013.05.010	34	5	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183690	10.1371/journal.pone.0183690	http://dx.doi.org/10.1371/journal.pone.0183690			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837624	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000103
J	Spivey, TJ; Lindberg, MS; Meixell, BW; Smith, KR; Puryear, WB; Davis, KR; Runstadler, JA; Stallknecht, DE; Ramey, AM				Spivey, Timothy J.; Lindberg, Mark S.; Meixell, Brandt W.; Smith, Kyle R.; Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.; Stallknecht, David E.; Ramey, Andrew M.			Maintenance of influenza A viruses and antibody response in mallards (Anas platyrhynchos) sampled during the non-reeding season in Alaska	PLOS ONE			English	Article							AVIAN INFLUENZA; NORTHERN EUROPE; ANNUAL CYCLE; WILD BIRDS; DUCKS; WATERFOWL; SURVEILLANCE; INFECTION; PARAMYXOVIRUSES; TRANSMISSION	Prevalence of influenza A virus (IAV) infections in northern-breeding waterfowl has previously been reported to reach an annual peak during late summer or autumn; however, little is known about IAV infection dynamics in waterfowl populations persisting at high-latitude regions such as Alaska, during winter. We captured mallards (Anas platyrhynchos) throughout the non-breeding season (August-April) of 2012-2015 in Fairbanks and Anchorage, the two largest cities in Alaska, to assess patterns of IAV infection and antibody production using molecular methods and a standard serologic assay. In addition, we used virus isolation, genetic sequencing, and a virus microneutralization assay to characterize viral subtypes and to evaluate the immune response of mallards captured on multiple occasions through time. We captured 923 mallards during three successive sampling years: Fairbanks in 2012/13 and 2013/14, and Anchorage in 2014/15. Prevalence varied by age, season, and year/site with high and relatively stable estimates throughout the non-breeding season. Infected birds were detected in all locations/seasons except early-winter in Fairbanks during 2013/14. IAVs with 17 combinations of hemagglutinin (H1-5, H7-9, H11, H12) and neuraminidase (N1-6, N8, N9) subtypes were isolated. Antibodies to IAVs were detected throughout autumn and winter for all sampling locations and years, however, seroprevalence was higher among adults and varied among years. Mallards exhibited individual heterogeneity with regard to immune response, providing instances of both seroconversion and seroreversion to detected viral subtypes. The probability that an individual transitioned from one serostatus to another varied by age, with juvenile mallards having higher rates of seroconversion and seroreversion than adults. Our study provides evidence that a diversity	[Spivey, Timothy J.; Lindberg, Mark S.] Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA; [Spivey, Timothy J.; Meixell, Brandt W.; Ramey, Andrew M.] US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA; [Lindberg, Mark S.] Univ Alaska, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Smith, Kyle R.] Alaska Dept Fish & Game, 333 Raspberry Rd, Anchorage, AK 99518 USA; [Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.] MIT, Dept Biol Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.] MIT, Div Comparat Med, Cambridge, MA 02139 USA; [Stallknecht, David E.] Univ Georgia, Coll Vet Med, Dept Populat Hlth, Athens, GA USA; [Puryear, Wendy B.; Davis, Kimberly R.; Runstadler, Jonathan A.] Tufts Univ, Sch Vet Med, Dept Infect Dis & Global Hlth, 200 Westboro Rd, North Grafton, MA 01536 USA	University of Alaska System; University of Alaska Fairbanks; United States Department of the Interior; United States Geological Survey; University of Alaska System; University of Alaska Fairbanks; Alaska Department of Fish & Game; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; Tufts University	Spivey, TJ (corresponding author), Univ Alaska Fairbanks, Dept Biol & Wildlife, Fairbanks, AK 99775 USA.; Spivey, TJ (corresponding author), US Geol Survey, Alaska Sci Ctr, Anchorage, AK 99508 USA.	tspivey@alaska.edu			U.S. Geological Survey Wildlife Program of the Ecosystems Mission area; National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services [HHSN272201400006C, HHSN272201400008C]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007020] Funding Source: NIH RePORTER	U.S. Geological Survey Wildlife Program of the Ecosystems Mission area; National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was received by BWM and AMR from the U.S. Geological Survey Wildlife Program of the Ecosystems Mission area. Additional funding was provided in part by the National Institute of Allergy and Infectious Diseases, National Institute of Health, Department of Health and Human Services, under contracts HHSN272201400006C received by DES and HHSN272201400008C received by JAR. The funding agencies were not involved in the design, implementation, or publishing of this study, and the research presented herein represents the opinions of the authors but not necessarily the opinions of the funding agencies. There was no additional external funding received for this study.	[Anonymous], 2021, LANG ENV STAT COMP; Arnold TW, 2010, J WILDLIFE MANAGE, V74, P1175, DOI 10.2193/2009-367; Brown JD, 2009, CLIN VACCINE IMMUNOL, V16, P824, DOI 10.1128/CVI.00084-09; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; BROWNIE C, 1993, BIOMETRICS, V49, P1173, DOI 10.2307/2532259; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carney S.M., 1992, SPECIES AGE SEX IDEN; Ely CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057614; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Hanson BA, 2003, AVIAN DIS, V47, P867, DOI 10.1637/0005-2086-47.s3.867; Henaux V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031471; Henaux V, 2011, J WILDLIFE DIS, V47, P566, DOI 10.7589/0090-3558-47.3.566; Hill NJ, 2016, ECOL LETT, V19, P915, DOI 10.1111/ele.12629; Hill SC, 2016, P R SOC B, V283, P1; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; HINSHAW VS, 1985, B WORLD HEALTH ORGAN, V63, P711; HOCHBAUM H. A., 1942, Transactions 7th N. Amer. Wildlife Conf., P299; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; ITO T, 1995, ARCH VIROL, V140, P1163, DOI 10.1007/BF01322743; Jourdain E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008935; Lang AS, 2008, J GEN VIROL, V89, P509, DOI 10.1099/vir.0.83369-0; Latorre-Margalef N, BIO REV UNPUB; Latorre-Margalef N, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003443; Meixell BW, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1666-3; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; National Audubon Society, 2015, CHRISTM BIRD COUNT H; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Ramey AM, 2015, J WILDLIFE DIS, V51, P938, DOI 10.7589/2015-03-057; Reeves AB, 2011, INFECT GENET EVOL, V11, P2004, DOI 10.1016/j.meegid.2011.09.011; Runstadler JA, 2007, ARCH VIROL, V152, P1901, DOI 10.1007/s00705-007-0994-1; Samuel MD, 2015, ECOL APPL, V25, P1851, DOI 10.1890/14-1820.1; Shriner SA, 2016, J VIROL METHODS, V228, P130, DOI 10.1016/j.jviromet.2015.11.021; SLEMONS RD, 1974, AVIAN DIS, V18, P119, DOI 10.2307/1589250; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Spackman E, 2009, AVIAN DIS, V53, P276, DOI 10.1637/8520-111708-Reg.1; STALLKNECHT DE, 1988, VET RES COMMUN, V12, P125, DOI 10.1007/BF00362792; STALLKNECHT DE, 1990, AVIAN DIS, V34, P398, DOI 10.2307/1591427; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Verhagen JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038256; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; WEBSTER RG, 1976, J GEN VIROL, V32, P217, DOI 10.1099/0022-1317-32-2-217; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wilson HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058308; Winker K, 2007, EMERG INFECT DIS, V13, P547, DOI 10.3201/eid1304.061072	47	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183505	10.1371/journal.pone.0183505	http://dx.doi.org/10.1371/journal.pone.0183505			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837606	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000074
J	Tschiderer, L; Willeit, J; Schett, G; Kiechl, S; Willeit, P				Tschiderer, Lena; Willeit, Johann; Schett, Georg; Kiechl, Stefan; Willeit, Peter			Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based metaanalysis involving 26,442 participants	PLOS ONE			English	Article							KAPPA-B LIGAND; PLASMA OSTEOPROTEGERIN; SERUM OSTEOPROTEGERIN; RECEPTOR ACTIVATOR; PROGRESSIVE ATHEROSCLEROSIS; HEART-FAILURE; DISEASE; ASSOCIATION; MORTALITY; BONE	Background Recent experimental and epidemiological studies have suggested that osteoprotegerin, a key regulator in bone metabolism, may be involved in vascular calcification and atherosclerosis. Our aim was to reliably quantify the associations of osteoprotegerin concentration and incidence of first-ever cardiovascular disease outcomes in the general population. Methods Using the electronic databases MEDLINE, EMBASE and Web of Science (January 1975 and April 2017, no language restrictions), nine relevant studies were identified involving a total of 26,442 participants recruited from the general population. Over a mean follow-up of 8.5 years, 2,160 cardiovascular disease, 2,123 coronary heart disease, and 1,102 stroke outcomes were recorded. Study-specific risk ratios were combined with random-effects meta-analysis. Results When comparing individuals in the top with those in the bottom third of osteoprotegerin concentration, the combined risk ratio was 1.83 (95% confidence interval: 1.46, 2.30; P < 0.001; I 2 = 76.8%) for cardiovascular disease, 1.72 for coronary heart disease (1.26, 2.37; P = 0.001; I 2 = 83.5%), and 1.58 for stroke (1.18, 2.12; P = 0.002; I 2 = 65.2%). Associations appeared stronger at younger age (P = 0.018 for cardiovascular disease), in studies that did not employ statistical adjustment (P = 0.023 for cardiovascular disease and 0.018 for coronary heart disease), and potentially in studies that measured osteoprotegerin in plasma rather than in serum (P = 0.005 for cardiovascular disease and 0.018 for coronary heart disease). Magnitudes of associations did not differ according to the proportion of males, geographical region, or osteoprotegerin assay manufacturer. There was no evidence for publication bias for any of the outcomes assessed (all P > 0.05). Conclusions Elevated osteoprotegerin concentration is associated with an increased risk of incident cardiovascular disease in the general population. The mechanisms underlying this observation deserve further investigation.	[Tschiderer, Lena; Willeit, Johann; Kiechl, Stefan; Willeit, Peter] Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria; [Schett, Georg] Univ Erlangen Nurnberg, Dept Internal Med 3, Erlangen, Germany; [Willeit, Peter] Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England	Medical University of Innsbruck; University of Erlangen Nuremberg; University of Cambridge	Willeit, P (corresponding author), Innsbruck Med Univ, Dept Neurol, Innsbruck, Austria.; Willeit, P (corresponding author), Univ Cambridge, Dept Publ Hlth & Primary Care, Cambridge, England.	peter.willeit@i-med.ac.at	Willeit, Peter/HCI-7091-2022	Willeit, Peter/0000-0002-1866-7159; Tschiderer, Lena/0000-0001-7988-853X	excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: Research Center of Excellence in Vascular Ageing Tyrol, VASCage - Bundesministerium fur Verkehr, Innovation und Technologie (BMVIT); Bundesministerium fur Wissenschaft, Forschung und Wirtschaft (BMWFW); Wirtschaftsagentur Wien; Standortagentur Tirol	excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: Research Center of Excellence in Vascular Ageing Tyrol, VASCage - Bundesministerium fur Verkehr, Innovation und Technologie (BMVIT); Bundesministerium fur Wissenschaft, Forschung und Wirtschaft (BMWFW); Wirtschaftsagentur Wien; Standortagentur Tirol	All authors were supported by the excellence initiative (Competence Centers for Excellent Technologies - COMET) of the Austrian Research Promotion Agency FFG: Research Center of Excellence in Vascular Ageing Tyrol, VASCage (K-Project No. 843536; https //www.tfg.at/) funded by the Bundesministerium fur Verkehr, Innovation und Technologie (BMVIT), Bundesministerium fur Wissenschaft, Forschung und Wirtschaft (BMWFW), Wirtschaftsagentur Wien and Standortagentur Tirol. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aramburu-Bodas O, 2015, J CARDIOVASC MED, V16, P438, DOI 10.2459/JCM.0000000000000229; Bernardi S, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/1752854; Browner WS, 2001, J CLIN ENDOCR METAB, V86, P631, DOI 10.1210/jc.86.2.631; Bucay N, 1998, GENE DEV, V12, P1260, DOI 10.1101/gad.12.9.1260; Bumdelger B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147088; Callegari A, 2014, J VASC RES, V51, P118, DOI 10.1159/000358920; Cao RY, 2016, BIOMARK MED, V10, P525, DOI 10.2217/bmm-2015-0029; Chan BYY, 2003, CLIN CHEM, V49, P2083, DOI 10.1373/clinchem.2003.023747; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; De Voogd FAE, 2016, J GASTROEN HEPATOL, V31, P1386, DOI 10.1111/jgh.13324; Di Angelantonio E, 2009, CIRCULATION, V120, P2177, DOI 10.1161/CIRCULATIONAHA.109.884866; Di Giuseppe R, 2017, EUR J EPIDEMIOL, V32, P113, DOI 10.1007/s10654-016-0172-4; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Golledge J, 2004, STROKE, V35, P1636, DOI 10.1161/01.STR.0000129790.00318.a3; Haycock PC, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4227; Heymann M-F, 2015, CYTOKINE; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hofbauer LC, 2004, JAMA-J AM MED ASSOC, V292, P490, DOI 10.1001/jama.292.4.490; Hosbond SE, 2012, SCAND CARDIOVASC J, V46, P203, DOI 10.3109/14017431.2012.685491; Kiechl S, 2004, ATHEROSCLEROSIS SUPP, V5, P10; Kiechl S, 2004, CIRCULATION, V109, P2175, DOI 10.1161/01.CIR.0000127957.43874.BB; Kiechl Stefan, 2006, Expert Rev Cardiovasc Ther, V4, P801, DOI 10.1586/14779072.4.6.801; Koyama S, 2014, HORM METAB RES, V46, P581, DOI 10.1055/s-0034-1375611; Kwan JSH, 2014, HUM MOL GENET, V23, P6684, DOI 10.1093/hmg/ddu386; Lewis JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134266; Lieb W, 2010, ARTERIOSCL THROM VAS, V30, P1849, DOI 10.1161/ATVBAHA.109.199661; Mogelvang R, 2013, HEART, V99, P106, DOI 10.1136/heartjnl-2012-302240; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Mosheimer BA, 2005, J CLIN ENDOCR METAB, V90, P2964, DOI 10.1210/jc.2004-1895; Nybo M, 2008, CLIN CHEM, V54, P1969, DOI 10.1373/clinchem.2008.110593; Nybo M, 2008, ATHEROSCLEROSIS, V201, P33, DOI 10.1016/j.atherosclerosis.2008.03.026; Omland T, 2007, HYPERTENSION, V49, P1392, DOI 10.1161/HYPERTENSIONAHA.107.087742; Park JS, 2011, EUR J ENDOCRINOL, V164, P69, DOI 10.1530/EJE-10-0875; de Ciriza CP, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/564934; de Ciriza CP, 2014, CLIN BIOCHEM, V47, P1279, DOI 10.1016/j.clinbiochem.2014.05.006; Sandberg WJ, 2006, ARTERIOSCL THROM VAS, V26, P857, DOI 10.1161/01.ATV.0000204334.48195.6a; Semb AG, 2009, ARTERIOSCL THROM VAS, V29, P975, DOI 10.1161/ATVBAHA.109.184101; Shen C, 2012, AM J CARDIOL, V110, P1138, DOI 10.1016/j.amjcard.2012.05.053; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Song DH, 2016, MED SCI MONITOR, V22, P1223, DOI 10.12659/MSM.895434; Toffoli B, 2011, ATHEROSCLEROSIS, V218, P61, DOI 10.1016/j.atherosclerosis.2011.05.019; Uzui H, 2014, J CARDIOVASC PHARM T, V19, P304, DOI 10.1177/1074248413511692; Venuraju SM, 2010, J AM COLL CARDIOL, V55, P2049, DOI 10.1016/j.jacc.2010.03.013; Vik A, 2011, J THROMB HAEMOST, V9, P638, DOI 10.1111/j.1538-7836.2011.04222.x; Vik A, 2007, THROMB HAEMOSTASIS, V98, P148, DOI 10.1160/TH06-11-0671; Wells G.A., NEWCASTLE OTTAWA SCA; Willeit P, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.001833; Zauli G, 2007, BLOOD, V110, P536, DOI 10.1182/blood-2007-01-068395	49	25	28	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183910	10.1371/journal.pone.0183910	http://dx.doi.org/10.1371/journal.pone.0183910			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837646	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000135
J	Dai, YH; Zhou, WX				Dai, Yue-Hua; Zhou, Wei-Xing			Temporal and spatial correlation patterns of air pollutants in Chinese cities	PLOS ONE			English	Article							FRACTIONAL GAUSSIAN NOISES; BID-ASK SPREADS; COMPUTER EXPERIMENTS; MOVING AVERAGE; MULTIFRACTAL CHARACTERISTICS; INTRADAY PATTERNS; TIME-SERIES; POLLUTION; MORTALITY; QUALITY	As a huge threat to the public health, China's air pollution has attracted extensive attention and continues to grow in tandem with the economy. Although the real-time air quality report can be utilized to update our knowledge on air quality, questions about how pollutants evolve across time and how pollutants are spatially correlated still remain a puzzle. In view of this point, we adopt the PMFG network method to analyze the six pollutants' hourly data in 350 Chinese cities in an attempt to find out how these pollutants are correlated temporally and spatially. In terms of time dimension, the results indicate that, except for O-3, the pollutants have a common feature of the strong intraday patterns of which the daily variations are composed of two contraction periods and two expansion periods. Besides, all the time series of the six pollutants possess strong long- term correlations, and this temporal memory effect helps to explain why smoggy days are always followed by one after another. In terms of space dimension, the correlation structure shows that O-3 is characterized by the highest spatial connections. The PMFGs reveal the relationship between this spatial correlation and provincial administrative divisions by filtering the hierarchical structure in the correlation matrix and refining the cliques as the tinny spatial clusters. Finally, we check the stability of the correlation structure and conclude that, except for PM10 and O-3, the other pollutants have an overall stable correlation, and all pollutants have a slight trend to become more divergent in space. These results not only enhance our understanding of the air pollutants' evolutionary process, but also shed lights on the application of complex network methods into geographic issues.	[Dai, Yue-Hua; Zhou, Wei-Xing] East China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China; [Dai, Yue-Hua] Washington State Univ, Dept Finance & Management Sci, Carson Coll Business, Pullman, WA 99163 USA; [Zhou, Wei-Xing] East China Univ Sci & Technol, Dept Math, Shanghai 200237, Peoples R China; [Zhou, Wei-Xing] East China Univ Sci & Technol, Res Ctr Econophys, Shanghai 200237, Peoples R China	East China University of Science & Technology; Washington State University; East China University of Science & Technology; East China University of Science & Technology	Zhou, WX (corresponding author), East China Univ Sci & Technol, Sch Business, Shanghai 200237, Peoples R China.; Zhou, WX (corresponding author), East China Univ Sci & Technol, Dept Math, Shanghai 200237, Peoples R China.; Zhou, WX (corresponding author), East China Univ Sci & Technol, Res Ctr Econophys, Shanghai 200237, Peoples R China.	wxzhou@ecust.edu.cn	Zhou, Wei-Xing/B-1250-2008	Zhou, Wei-Xing/0000-0002-8952-8228	China Scholarship Council [20150674]; Fundamental Research Funds for the Central Universities [222201718006]	China Scholarship Council(China Scholarship Council); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by the China Scholarship Council (http://www.csc .edu.cn/) grant number 20150674 and the Fundamental Research Funds for the Central Universities (http:// www.moe.gov.cn) grant number 222201718006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We appreciate Shanghai Qingyue Open Environmental Protection Data Center (QOEPDC) for providing the hourly data and Miss Faping Yang (Social and Public Administration School in East China University of Science and Technology) collected all the Chinese cities' information. This work is partially supported by the China Scholarship Council (20150674) and the Fundamental Research Funds for the Central Universities (222201718006).	Admati AR, 1988, REV FINANC STUD, V1, P3, DOI 10.1093/rfs/1.1.3; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Alessio E, 2002, EUR PHYS J B, V27, P197, DOI 10.1140/epjb/e20020150; Arianos S, 2007, PHYSICA A, V382, P9, DOI 10.1016/j.physa.2007.02.074; Azmi SZ, 2010, AIR QUAL ATMOS HLTH, V3, P53, DOI 10.1007/s11869-009-0051-1; Bao JZ, 2015, INT J ENV RES PUB HE, V12, P15875, DOI 10.3390/ijerph121215029; Bhardwaj R, 2016, PROCEEDINGS ON 2016 2ND INTERNATIONAL CONFERENCE ON NEXT GENERATION COMPUTING TECHNOLOGIES (NGCT), P553, DOI 10.1109/NGCT.2016.7877476; Buytaert W, 2006, J HYDROL, V329, P413, DOI 10.1016/j.jhydrol.2006.02.031; Cao JJ, 2004, ATMOS ENVIRON, V38, P4447, DOI 10.1016/j.atmosenv.2004.05.016; Carbone A, 2004, PHYSICA A, V344, P267, DOI 10.1016/j.physa.2004.06.130; Carbone A, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.026105; Carbone A, 2003, PROC SPIE, V5114, P406, DOI 10.1117/12.497039; Chan CK, 2008, ATMOS ENVIRON, V42, P1, DOI 10.1016/j.atmosenv.2007.09.003; Chen Z, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041107; Dan M, 2004, ATMOS ENVIRON, V38, P3443, DOI 10.1016/j.atmosenv.2004.02.052; Expert P, 2011, P NATL ACAD SCI USA, V108, P7663, DOI 10.1073/pnas.1018962108; Gastner MT, 2006, EUR PHYS J B, V49, P247, DOI 10.1140/epjb/e2006-00046-8; Gillespie J, 2017, ATMOS ENVIRON, V150, P295, DOI 10.1016/j.atmosenv.2016.11.035; Gu GF, 2007, EUR PHYS J B, V57, P81, DOI 10.1140/epjb/e2007-00158-7; Gu GF, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.011136; He H, 2015, PARTICUOLOGY, V20, P32, DOI 10.1016/j.partic.2014.06.004; Huang W, 2015, ATMOS POLLUT RES, V6, P842, DOI 10.5094/APR.2015.093; Jiang S, 2012, DATA MIN KNOWL DISC, V25, P478, DOI 10.1007/s10618-012-0264-z; Jiang ZQ, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016106; KASSEM KO, 2014, WORLD ENV, V4, P143; Keggenhoff I, 2015, WEATHER CLIM EXTREME, V8, P34, DOI 10.1016/j.wace.2014.11.002; Kleinow T, 2002, TESTING CONTINUOUS T; Lee CK, 2002, WATER AIR SOIL POLL, V135, P389, DOI 10.1023/A:1014768632318; Li L, 2014, ENVIRON POLLUT, V190, P75, DOI 10.1016/j.envpol.2014.03.020; Liu MM, 2017, ENVIRON INT, V98, P75, DOI 10.1016/j.envint.2016.10.003; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Luo YP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104013; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P228, DOI 10.1029/WR005i001p00228; MANDELBR.BB, 1969, WATER RESOUR RES, V5, P967, DOI 10.1029/WR005i005p00967; MANDELBROT BB, 1968, WATER RESOUR RES, V4, P909, DOI 10.1029/WR004i005p00909; MANDELBROT BB, 1969, WATER RESOUR RES, V5, P260, DOI 10.1029/WR005i001p00260; MANDELBROT BB, 1969, WATER RESOUR RES, V5, P242, DOI 10.1029/WR005i001p00242; Mayer H, 1999, ATMOS ENVIRON, V33, P4029, DOI 10.1016/S1352-2310(99)00144-2; MCINISH TH, 1992, J FINANC, V47, P753, DOI 10.2307/2329122; Mitra S.K., 2012, ASIAN SOCIAL SCI, V8, P111, DOI [10.5539/ass.v8n8p111, DOI 10.5539/ASS.V8N8P111]; Ni XH, 2009, J KOREAN PHYS SOC, V54, P786, DOI 10.3938/jkps.54.786; Ott W.R., 1994, ENV STAT DATA ANAL; Panday AK, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD009777; Pardo A, 2002, ENERG ECON, V24, P55, DOI 10.1016/S0140-9883(01)00082-2; Shao YH, 2015, FRACTALS, V23, DOI 10.1142/S0218348X15500346; Shao YH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00835; Shen CH, 2016, PHYSICA A, V451, P171, DOI 10.1016/j.physa.2016.01.061; Song WM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004574; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Tang GQ, 2017, ATMOS ENVIRON, V150, P238, DOI 10.1016/j.atmosenv.2016.11.045; Tao MH, 2016, ATMOS ENVIRON, V144, P100, DOI 10.1016/j.atmosenv.2016.08.049; Tumminello M, 2007, EUR PHYS J B, V55, P209, DOI 10.1140/epjb/e2006-00414-4; Tumminello M, 2005, P NATL ACAD SCI USA, V102, P10421, DOI 10.1073/pnas.0500298102; Tumminello M, 2007, INT J BIFURCAT CHAOS, V17, P2319, DOI 10.1142/S0218127407018415; Tumminello M, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/1/013041; Tumminello M, 2010, J ECON BEHAV ORGAN, V75, P40, DOI 10.1016/j.jebo.2010.01.004; Vandewalle N, 1998, EUR PHYS J B, V4, P257, DOI 10.1007/s100510050376; Wang JF, 2016, ECOL INDIC, V67, P250, DOI 10.1016/j.ecolind.2016.02.052; Wang JF, 2013, ENVIRON PLANN A, V45, P2515, DOI 10.1068/a44710; Wang JF, 2012, POPUL ENVIRON, V33, P186, DOI 10.1007/s11111-011-0142-4; Wang WQ, 2015, RESP MED, V109, P372, DOI 10.1016/j.rmed.2015.01.006; Wang YG, 2014, ENVIRON INT, V73, P413, DOI 10.1016/j.envint.2014.08.016; Xia XL, 2017, ISPRS INT GEO-INF, V6, DOI 10.3390/ijgi6010002; Xie WJ, 2014, ECON MODEL, V36, P8, DOI 10.1016/j.econmod.2013.09.011; Xie XY, 2017, J CLEAN PROD, V142, P936, DOI 10.1016/j.jclepro.2016.09.117; Zhang YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep12558	66	25	26	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182724	10.1371/journal.pone.0182724	http://dx.doi.org/10.1371/journal.pone.0182724			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832599	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800029
J	Nangendo, J; Obuku, EA; Kawooya, I; Mukisa, J; Nalutaaya, A; Musewa, A; Semitala, FC; Karamagi, CA; Kalyango, JN				Nangendo, Joanita; Obuku, Ekwaro A.; Kawooya, Ismael; Mukisa, John; Nalutaaya, Annet; Musewa, Angella; Semitala, Fred C.; Karamagi, Charles A.; Kalyango, Joan N.			Diagnostic accuracy and acceptability of rapid HIV oral testing among adults attending an urban public health facility in Kampala, Uganda	PLOS ONE			English	Article							PERFORMANCE	Background The prevalence of HIV in Uganda is 7.3%, and yet nearly 40% of people living with HIV are unaware of their status. The current HIV testing policy which is strictly blood-based poses several challenges including: a need for high level laboratory skills, stringent waste disposal needs, and painful sample collection. It is envisaged that introduction of a rapid, painless HIV oral fluid test as a potential alternative is likely to increase the number of people testing. The aim of this study was to determine the diagnostic accuracy and acceptability of rapid HIV oral testing among adults attending Kisenyi Health Centre IV in Kampala. Methods and findings We conducted a cross-sectional study among 440 adults recruited consecutively at Kisenyi Health Centre IV from January to March 2016. The diagnostic accuracy of the HIV oral test was assessed by comparing to the national HIV serial testing algorithm. We also assessed for acceptability among patients and health care workers (HCWs) by triangulating responses from a structured questionnaire, three focus group discussions and seven key informant interviews. Acceptability was defined as willingness to take the test at the time of the study and intention for future use of the test if it was availed. The prevalence of HIV infection among study participants was 14.8%. The HIV oral fluid test was highly accurate with sensitivity of 100% (95% CI; 94.5-100.0), specificity of 100% (95% CI; 99.0-100.0), positive predictive value (PPV) of 100% (95% CI; 94.5-100.0) and negative predictive value (NPV) of 100% (95% CI; 99.0-100.0). Acceptability of HIV oral testing was also high at 87.0% (95% CI; 83.6-89.9). Participants preferred HIV oral testing because it was: pain free (91%, n = 399) and did not require blood draw (82%, n = 360). Conclusion The HIV oral fluid test has high diagnostic accuracy and acceptability. HIV oral testing is a suitable addition to the national HIV testing strategies with the potential of increasing access to HIV testing services in Uganda.	[Nangendo, Joanita; Obuku, Ekwaro A.; Kawooya, Ismael; Mukisa, John; Nalutaaya, Annet; Musewa, Angella; Karamagi, Charles A.; Kalyango, Joan N.] Makerere Univ, Coll Hlth Sci, Sch Med, Clin Epidemiol Unit, Kampala, Uganda; [Obuku, Ekwaro A.] Makerere Univ, Coll Hlth Sci, Africa Ctr Systemat Reviews & Knowledge Translat, Kampala, Uganda; [Obuku, Ekwaro A.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, London, England; [Semitala, Fred C.] Makerere Univ, Coll Hlth Sci, Dept Internal Med, Kampala, Uganda; [Semitala, Fred C.] Makerere Univ, Joint AIDS Program MJAP, Kampala, Uganda; [Karamagi, Charles A.] Makerere Univ, Coll Hlth Sci, Dept Pediat & Child Hlth, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Coll Hlth Sci, Dept Pharm, Kampala, Uganda	Makerere University; Makerere University; University of London; London School of Hygiene & Tropical Medicine; Makerere University; Makerere University; Makerere University; Makerere University	Nangendo, J (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Med, Clin Epidemiol Unit, Kampala, Uganda.	joannangendo@gmail.com; nakayaga2001@yahoo.com	Obuku, Ekwaro A./H-4988-2011; Kawooya, Ismael/AAN-6274-2020; Kawooya, Ismael/O-4541-2016	Kawooya, Ismael/0000-0002-7159-7153; Kawooya, Ismael/0000-0002-7159-7153; Nangendo, Joanita/0000-0002-0458-2111; mukisa, john/0000-0002-9208-0313	Fogarty International Center of the National Institutes of Health [D43 TW010037]; FOGARTY INTERNATIONAL CENTER [D43TW010037] Funding Source: NIH RePORTER	Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Research reported in this publication was supported by the Fogarty International Center of the National Institutes of Health under Award Number D43 TW010037. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. JN received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baltazar CS, 2014, J CLIN MICROBIOL, V52, P3544, DOI 10.1128/JCM.01098-14; Baveewo Steven, 2012, BMC Res Notes, V5, P154, DOI 10.1186/1756-0500-5-154; Choko AT, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001102; Delaney KP, 2006, AIDS, V20, P1655, DOI 10.1097/01.aids.0000238412.75324.82; Delaney KP, 2011, CLIN INFECT DIS, V52, P257, DOI 10.1093/cid/ciq068; FDA, 2004, FOOD DRUG ADM APPR 1; Galiwango RM, 2013, J VIROL METHODS, V192, P25, DOI 10.1016/j.jviromet.2013.04.003; Gari S, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-198; Gupta GR, 2008, LANCET, V372, P764, DOI 10.1016/S0140-6736(08)60887-9; Hulley SB, 2007, DESIGNING CLIN RES; Joint United Nations Programme on HIV/ AIDS, 2014, GAP REP; Kenyon CR, 2015, JAIDS-J ACQ IMM DEF, V69, P92, DOI 10.1097/QAI.0000000000000546; Kish L, 1965, SURVEY SAMPLING; Knapp H, 2013, INT J STD AIDS, V24, P5, DOI 10.1258/ijsa.2012.012140; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; MoH, 2010, NAT IMPL GUID HCT UG; MoPHa S, 2010, NAT GUID HIV TEST CO; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Pant PN, 2007, ORAL FLUID BASED RAP; Pant PN, 2008, PLOS MED, V5, pe367; Pascoe SJS, 2009, AIDS PATIENT CARE ST, V23, P571, DOI 10.1089/apc.2008.0225; Pavie J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011581; Reynolds SJ, 2004, ORAQUICK ADV RAPID H; South African H, 2012, JOINT STAT HIV TEST; UAC, 2014, UG AIDS COMM HIV AID; UAIS, 2011, UG AIDS IND SURV 201; UNAIDS, 2015, GAP REP 2014 BEG END; Xun HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080594; Young SD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103790; Zachary D, 2012, PLOS ONE, V12, P183; Zachary D, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-183	33	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182050	10.1371/journal.pone.0182050	http://dx.doi.org/10.1371/journal.pone.0182050			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832588	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800010
J	Mitsides, N; Cornelis, T; Broers, NJH; Diederen, NMP; Brenchley, P; van der Sande, FM; Schalkwijk, CG; Kooman, JP; Mitra, S				Mitsides, Nicos; Cornelis, Tom; Broers, Natascha J. H.; Diederen, Nanda M. P.; Brenchley, Paul; van der Sande, Frank M.; Schalkwijk, Casper G.; Kooman, Jeroen P.; Mitra, Sandip			Extracellular overhydration linked with endothelial dysfunction in the context of inflammation in haemodialysis dependent chronic kidney disease	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; PERITONEAL-DIALYSIS PATIENTS; CARDIOVASCULAR RISK; MATRIX METALLOPROTEINASES; ARTERIAL STIFFNESS; BLOOD-PRESSURE; SURFACE-LAYER; VOLUME STATUS; P-CRESOL; ASSOCIATION	Background Haemodialysis (HD) patients are predisposed to dysregulated fluid balance leading to extracellular water (ECW) expansion. Fluid overload has been closely linked with outcome in these patients. This has mainly been attributed to cardiac volume overload, but the relation between abnormalities in fluid status with micro-and macrovascular dysfunction has not been studied in detail. We studied the interaction of macro-and microvascular factors in states of normal and over-hydration in HD-dependent CKD. Methods Fluid compartments [total body water (TBW) and ECW] and overhydration index (OH) were measured with Multifrequency bio-impedance (BCM). Overhydration was defined as OH/ECW>7%. Overhydration was also assessed using the ECW/TBW ratio. Macrocirculation was assessed by pulse-wave velocity (PWV) and mean arterial pressure (MAP) measurements while microcirculation through sublingual capillaroscopy assessment of the Perfused Boundary Region of the endothelial glycocalyx (PBR 5-25mcg). A panel of pro-inflammatory and vascular serum biomarkers and growth factors was analysed. Results Of 72 HD participants, 30 were in normohydration (N) range and 42 overhydrated according to the OH/ECW ratio. Average ECW/TBW was 0.48 +/- 0.03. Overhydrated patients had higher MAP (122.9 +/- 22.5 v 111.7 +/- 22.2mmHg, p = 0.04) and comorbidities (median Davies score 1.5 v 1.0, p = 0.03). PWV (p = 0.25) and PBR 5-25mcg (p = 0.97) did not differ between the 2 groups. However, Vascular Adhesion Molecule (VCAM)-1, Interleukin-6 and Thrombomodulin, and reduced Leptin were observed in the overhydrated group. Elevation in VCAM-1 levels (OR 1.03; 95% CI 1.01-1.06; p = 0.02) showed a strong independent association with OH/ECW>7% in an adjusted logistic regression analysis and exhibited a strong linear relationship with ECW/TBW (Bata = 0.210, p = 0.03) in an also adjusted model. Conclusion Extracellular fluid overload is significantly linked to microinflammation and markers of endothelial dysfunction. The study provides novel insight in the cardiovascular risk profile associated with overhydration in uraemia.	[Mitsides, Nicos; Brenchley, Paul; Mitra, Sandip] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Cardiovasc Sci,Sch Med Sci, Manchester, Lancs, England; [Mitsides, Nicos; Brenchley, Paul; Mitra, Sandip] Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Nephrol Dept, Manchester, Lancs, England; [Mitsides, Nicos; Mitra, Sandip] Royal Hallamshire Hosp, NIHR Devices Dign Healthcare Technol Cooperat, Sheffield, S Yorkshire, England; [Cornelis, Tom] Jessa Hosp, Hasselt, Belgium; [Broers, Natascha J. H.; Diederen, Nanda M. P.; van der Sande, Frank M.; Schalkwijk, Casper G.; Kooman, Jeroen P.] Maastricht Univ, Med Ctr, Div Nephrol, Dept Internal Med, Maastricht, Netherlands; [Broers, Natascha J. H.; Kooman, Jeroen P.] Maastricht Univ, NUTRIM Sch Nutr & Translat Res Metab, Maastricht, Netherlands; [Schalkwijk, Casper G.] Maastricht Univ, CARIM Sch Cardiovasc Dis, Maastricht, Netherlands	University of Manchester; University of Manchester; University of Sheffield; Maastricht University; Maastricht University; Maastricht University Medical Centre (MUMC); Maastricht University	Mitsides, N (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Div Cardiovasc Sci,Sch Med Sci, Manchester, Lancs, England.; Mitsides, N (corresponding author), Cent Manchester Univ Hosp NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Nephrol Dept, Manchester, Lancs, England.; Mitsides, N (corresponding author), Royal Hallamshire Hosp, NIHR Devices Dign Healthcare Technol Cooperat, Sheffield, S Yorkshire, England.	nicos.mitsides@cmft.nhs.uk	Mitsides, Nicos/ABB-9868-2021	Mitsides, Nicos/0000-0003-4588-4738; Schalkwijk, Casper G/0000-0003-0190-2690	Dutch Kidney Foundation [SB 166]; Baxter International [110ECHHDEU1004]; Clinical Evidence Council of High Dose Hemodialysis; National Institute for Health Research (NIHR) Devices for Dignity Healthcare Technology Co-operative; NIHR Clinical Research Network (CRN) (NIHR UK CRN) [17528]; Manchester Renal Research; Transplant Laboratory	Dutch Kidney Foundation; Baxter International; Clinical Evidence Council of High Dose Hemodialysis; National Institute for Health Research (NIHR) Devices for Dignity Healthcare Technology Co-operative(National Institute for Health Research (NIHR)); NIHR Clinical Research Network (CRN) (NIHR UK CRN); Manchester Renal Research; Transplant Laboratory	Funding for the INTHEMO study was secured through grants from the Dutch Kidney Foundation grant (SB 166; Grant recipient: Dr T Cornelis) and the Clinical Evidence Council of High Dose Hemodialysis, Baxter International (110ECHHDEU1004; Grant recipient: Dr T Cornelis). The research reported in this publication was supported by the National Institute for Health Research (NIHR) Devices for Dignity Healthcare Technology Co-operative and was supported by the NIHR Clinical Research Network (CRN) (NIHR UK CRN ID: 17528). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The above funding and supporting institutions had no role in the study design data collection and analysis, decision to publish or preparation of the manuscript.; We would also like to thank the clinical and technical staff at the participating units and the Manchester Renal Research and Transplant Laboratory for their help and support. The research reported in this publication was supported by the National Institute for Health Research (NIHR) Devices for Dignity Healthcare Technology Co-operative and was supported by the NIHR Clinical Research Network (CRN) (NIHR UK CRN ID: 17528). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.	Ahbap E, 2015, CLIN NEPHROL, V83, P154, DOI 10.5414/CN108450; Akdam H, 2014, RENAL FAILURE, V36, P28, DOI 10.3109/0886022X.2013.830224; Bao YS, 2014, BIOMARKERS, V19, P275, DOI 10.3109/1354750X.2014.904000; Beberashvili I, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-68; Beckman JA, 2002, JAMA-J AM MED ASSOC, V287, P2570, DOI 10.1001/jama.287.19.2570; Bemelmans RHH, 2009, NEPHROL DIAL TRANSPL, V24, P3487, DOI 10.1093/ndt/gfp267; Bernardo AP, 2015, THER APHER DIAL, V19, P144, DOI 10.1111/1744-9987.12239; Bia D, 2015, INT J NEPHROL, V2015, DOI 10.1155/2015/628654; Bijuklic K, 2007, AM J PHYSL CELL PHYS, V293; Caballo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043374; Calton MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094549; Chamney PW, 2007, AM J CLIN NUTR, V85, P80, DOI 10.1093/ajcn/85.1.80; Chen YC, 2009, NEPHRON CLIN PRACT, V113, pC112, DOI 10.1159/000228543; Cornelis T, 2014, BLOOD PURIFICAT, V38, P203, DOI 10.1159/000369055; D'Apolito M, 2015, ATHEROSCLEROSIS, V239, P393, DOI 10.1016/j.atherosclerosis.2015.01.034; Dane MJC, 2014, CLIN J AM SOC NEPHRO, V9, P698, DOI 10.2215/CJN.08160813; Davies SJ, 2014, KIDNEY INT, V86, P489, DOI 10.1038/ki.2014.207; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; Death AK, 2003, ATHEROSCLEROSIS, V168, P263, DOI 10.1016/S0021-9150(03)00140-0; Dekker MJE, 2017, KIDNEY INT, V91, P1214, DOI 10.1016/j.kint.2016.12.008; Di Iorio B, 2010, NEPHROL DIAL TRANSPL, V25, P1579, DOI 10.1093/ndt/gfp662; Distasi MR, OPENING FLOOD GATES; Donati A, 2013, MICROVASC RES, V90, P86, DOI 10.1016/j.mvr.2013.08.007; Friese RS, 2009, CLIN EXP HYPERTENS, V31, P521, DOI 10.3109/10641960802668730; Gu YM, 2015, HYPERTENSION, V65, P993, DOI 10.1161/HYPERTENSIONAHA.114.05119; Hung SC, 2014, KIDNEY INT, V85, P703, DOI 10.1038/ki.2013.336; Ioannou K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138461; Jiang B, 2008, ULTRASOUND MED BIOL, V34, P509, DOI 10.1016/j.ultrasmedbio.2007.09.008; Edul VSK, 2012, CRIT CARE MED, V40, P1443, DOI 10.1097/CCM.0b013e31823dae59; Katzarski KS, 1999, NEPHROL DIAL TRANSPL, V14, P369, DOI 10.1093/ndt/14.2.369; Kim ED, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0131-4; Kougias P, 2005, J SURG RES, V126, P121, DOI 10.1016/j.jss.2004.12.023; Koutroumbas G, 2015, NEPHROL DIAL TRANSPL, V30, P2046, DOI 10.1093/ndt/gfv090; Lee BT, 2015, BMC NEPHROL, V16, DOI 10.1186/s12882-015-0068-7; Levick JR, 2010, CARDIOVASC RES, V87, P198, DOI 10.1093/cvr/cvq062; Lin YP, 2002, KIDNEY INT, V62, P1828, DOI 10.1046/j.1523-1755.2002.00610.x; Lindley EJ, 2015, KIDNEY INT, V87, P240, DOI 10.1038/ki.2014.310; Machnik A, 2010, HYPERTENSION, V55, P755, DOI 10.1161/HYPERTENSIONAHA.109.143339; Meijers BKI, 2008, KIDNEY INT, V73, P1174, DOI 10.1038/ki.2008.31; Meijers BKI, 2010, CLIN J AM SOC NEPHRO, V5, P1182, DOI 10.2215/CJN.07971109; Mitra S, 2014, KIDNEY INT, V85, P510, DOI 10.1038/ki.2013.481; Mitsides Nicos, 2015, Journal of Medical Engineering & Technology, V39, P424, DOI 10.3109/03091902.2015.1088089; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nongnuch A, 2014, KIDNEY INT, V87, P1; Nugent WH, 2016, REPROD SCI, V23, P542, DOI 10.1177/1933719115607998; Oberleithner H, 2014, NEPHROL DIAL TRANSPL, V29, P240, DOI 10.1093/ndt/gft461; Patel TV, 2008, NEPHRON CLIN PRACT, V110, pC244, DOI 10.1159/000167872; Rodrigues SF, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688370.2014.978720; Spoto B, 2015, CLIN J AM SOC NEPHRO, V10, P232, DOI 10.2215/CJN.07000714; Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839; Tsai YC, 2015, CLIN J AM SOC NEPHRO, V10, P39, DOI 10.2215/CJN.03610414; de Voorde J, 2013, METABOLISM, V62, P1513, DOI 10.1016/j.metabol.2013.06.004; van Sloten TT, 2015, AM J HYPERTENS, V28, P868, DOI 10.1093/ajh/hpu246; van Wetering S, 2003, AM J PHYSIOL-CELL PH, V285, pC343, DOI 10.1152/ajpcell.00048.2003; VanTeeffelen JW, 2007, TRENDS CARDIOVAS MED, V17, P101, DOI 10.1016/j.tcm.2007.02.002; VanTeeffelen JWGE, 2008, CRIT CARE, V12, DOI 10.1186/cc6939; Vlahu CA, 2012, J AM SOC NEPHROL, V23, P1900, DOI 10.1681/ASN.2011121181; WAAGE A, 1990, EUR J IMMUNOL, V20, P2439, DOI 10.1002/eji.1830201112; Wizemann V, 2009, NEPHROL DIAL TRANSPL, V24, P1574, DOI 10.1093/ndt/gfn707; Zahran Manal, 2015, Electron Physician, V7, P1270, DOI 10.14661/1270	60	43	45	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183281	10.1371/journal.pone.0183281	http://dx.doi.org/10.1371/journal.pone.0183281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829810	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100035
J	InanlooRahatloo, K; Liang, G; Vo, D; Ebert, A; Nguyen, I; Nguyen, PK				InanlooRahatloo, Kolsoum; Liang, Grace; Vo, Davis; Ebert, Antje; Nguyen, Ivy; Nguyen, Patricia K.			Sex-based differences in myocardial gene expression in recently deceased organ donors with no prior cardiovascular disease	PLOS ONE			English	Article							GENDER-RELATED DIFFERENCES; KAPPA-B; HEART; HYPERTROPHY; 17-BETA-ESTRADIOL; ATHEROSCLEROSIS; MECHANISMS; VCAM-1; MICE	Sex differences in the development of the normal heart and the prevalence of cardiomyopathies have been reported. The molecular basis of these differences remains unclear. Sex differences in the human heart might be related to patterns of gene expression. Recent studies have shown that sex specific differences in gene expression in tissues including the brain, kidney, skeletal muscle, and liver. Similar data is limited for the heart. Herein we address this issue by analyzing donor and post-mortem adult human heart samples originating from 46 control individuals to study whole-genome gene expression in the human left ventricle. Using data from the genotype tissue expression (GTEx) project, we compared the transcriptome expression profiles of male and female hearts. We found that genes located on sex chromosomes were the most abundant ones among the sexually dimorphic genes. The majority of differentially expressed autosomal genes were those involved in the regulation of inflammation, which has been found to be an important contributor to left ventricular remodeling. Specifically, genes on autosomal chromosomes encoding chemokines with inflammatory functions (e.g. CCL4, CX3CL1, TNFAIP3) and a gene that regulates adhesion of immune cells to the endothelium (e.g., VCAM1) were identified with sex-specific expression levels. This study underlines the relevance of sex as an important modifier of cardiac gene expression. These results have important implications in the understanding of the differences in the physiology of the male and female heart transcriptome and how they may lead to different sex specific difference in human cardiac health and its control.	[InanlooRahatloo, Kolsoum; Liang, Grace; Vo, Davis; Ebert, Antje; Nguyen, Ivy; Nguyen, Patricia K.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA; [InanlooRahatloo, Kolsoum; Nguyen, Patricia K.] Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [InanlooRahatloo, Kolsoum] Univ Social Welf & Rehabil Sci, Dept Genet, Genet Res Ctr, Tehran, Iran; [Nguyen, Patricia K.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Nguyen, Patricia K.] Stanford Univ, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA; [Nguyen, Patricia K.] Vet Affairs Palo Alto, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Nguyen, PK (corresponding author), Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Stanford, CA 94305 USA.; Nguyen, PK (corresponding author), Stanford Univ, Dept Med, Div Cardiol, Sch Med, Stanford, CA 94305 USA.; Nguyen, PK (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Nguyen, PK (corresponding author), Stanford Univ, Dept Med, Div Cardiovasc Med, Palo Alto, CA 94304 USA.; Nguyen, PK (corresponding author), Vet Affairs Palo Alto, Palo Alto, CA 94304 USA.	pknguyen@stanford.edu	Inanloorahatloo, kolsoum/D-7701-2017	Inanloorahatloo, kolsoum/0000-0002-5316-8259; Nguyen, Ivy/0000-0001-5612-8159	American Heart Association [10SDG4280129]; Stanford University School of Medicine; U.S. Department of Veterans Affairs [HSRD 10-032]	American Heart Association(American Heart Association); Stanford University School of Medicine; U.S. Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the American Heart Association (10SDG4280129) to Dr. Patricia Nguyen; Stanford University School of Medicine to Ivy Nguyen; and U.S. Department of Veterans Affairs (HSRD 10-032) to Dr. Patricia Nguyen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apostolakis S, 2013, ACTA PHARMACOL SIN, V34, P1251, DOI 10.1038/aps.2013.92; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Boheler KR, 2003, P NATL ACAD SCI USA, V100, P2754, DOI 10.1073/pnas.0436564100; Bowden RA, 2002, CIRC RES, V90, P562, DOI 10.1161/01.RES.0000013835.53611.97; Chang TT, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0439-9; Chen C.Y, 2016, BIORXIV, DOI [10.1101/082289, DOI 10.1101/082289]; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Czubryt MP, 2006, CAN J PHYSIOL PHARM, V84, P93, DOI 10.1139/Y05-151; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dubey RK, 1998, HYPERTENSION, V31, P522, DOI 10.1161/01.HYP.31.1.522; Fernandez-Ruiz I, 2016, NAT REV CARDIOL, V13, P503, DOI [10.1038/nrcardio.2016.127, 10.1038/nrcardio.2016.58]; Hamik A, 2007, J BIOL CHEM, V282, P13769, DOI 10.1074/jbc.M700078200; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hewagama A, 2009, GENES IMMUN, V10, P509, DOI 10.1038/gene.2009.12; Isensee J, 2008, J MOL MED, V86, P61, DOI 10.1007/s00109-007-0240-z; Kwon AT, 2012, G3-GENES GENOM GENET, V2, P987, DOI 10.1534/g3.112.003202; Ley K, 2001, J CLIN INVEST, V107, P1209, DOI 10.1172/JCI13005; Liao XD, 2015, J CLIN INVEST, V125, P3461, DOI 10.1172/JCI79964; Liao XD, 2011, J CLIN INVEST, V121, P2736, DOI 10.1172/JCI45444; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Maas AHEM, 2010, NETH HEART J, V18, P598, DOI 10.1007/s12471-010-0841-y; Mahmoodzadeh S, 2012, CARDIOVASC RES, V96, P411, DOI 10.1093/cvr/cvs281; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Mathur P, 2015, CARDIOVASC DRUG THER, V29, P319, DOI 10.1007/s10557-015-6596-3; Merz CNB, 1996, AM HEART J, V131, P704; Meyer S, 2014, EUR J HEART FAIL, V16, P238, DOI 10.1002/ejhf.15; Miklos DB, 2005, BLOOD, V105, P2973, DOI 10.1182/blood-2004-09-3660; Miller Virginia M, 2011, Sex Reprod Menopause, V9, P21; Nemska S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161273; Ostadal B, 2007, RESP PHYSIOL NEUROBI, V158, P224, DOI 10.1016/j.resp.2007.03.005; Petrov G, 2010, CIRCULATION, V122, pS23, DOI 10.1161/CIRCULATIONAHA.109.927764; Regitz-Zagrosek V, 2010, CIRC J, V74, P1265, DOI 10.1253/circj.CJ-10-0196; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sharma N, 2012, ARTERIOSCL THROM VAS, V32, P2836, DOI 10.1161/ATVBAHA.112.300471; Skelton RJP, 2014, STEM CELL RES, V13, P172, DOI 10.1016/j.scr.2014.04.016; Song HY, 1996, P NATL ACAD SCI USA, V93, P6721, DOI 10.1073/pnas.93.13.6721; Van der Heiden K, 2010, CLIN SCI, V118, P593, DOI 10.1042/CS20090557; Vassalle C, 2012, GYNECOL ENDOCRINOL, V28, P746, DOI 10.3109/09513590.2011.652720; Yoshida T, 2014, J BIOL CHEM, V289, P26107, DOI 10.1074/jbc.M114.582809; Zhou L, 2007, EUR J PHARMACOL, V567, P186, DOI 10.1016/j.ejphar.2007.03.047	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183874	10.1371/journal.pone.0183874	http://dx.doi.org/10.1371/journal.pone.0183874			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850583	Green Published, gold, Green Submitted			2022-12-27	WOS:000408544200036
J	Zhang, JQ; Yu, JD; Bao, Y; Xie, Q; Xu, Y; Zhang, JM; Wang, P				Zhang, Jiaqi; Yu, Jiadan; Bao, Yong; Xie, Qing; Xu, Yang; Zhang, Junmei; Wang, Pu			Constraint-induced aphasia therapy in post-stroke aphasia rehabilitation: A systematic review and meta-analysis of randomized controlled trials	PLOS ONE			English	Review							INDUCED MOVEMENT THERAPY; INDUCED LANGUAGE THERAPY; QUALITY-OF-LIFE; CLINICAL-TRIAL; MIRROR THERAPY; STROKE; RECOVERY; PILOT; REORGANIZATION; INDIVIDUALS	Background Constraint-induced aphasia therapy (CIAT) has been widely used in post-stroke aphasia rehabilitation. An increasing number of clinical controlled trials have investigated the efficacy of the CIAT for the post-stroke aphasia. Purpose To systematically review the randomized controlled trials (RCTs) concerning the effect of the CIAT in post-stroke patients with aphasia, and to identify the useful components of CIAT in post-stroke aphasia rehabilitation. Methods A computerized database search was performed through five databases (Pubmed, EMbase, Medline, ScienceDirect and Cochrane library). Cochrane handbook domains were used to evaluate the methodological quality of the included RCTs. Results Eight RCTs qualified in the inclusion criteria. Inconsistent results were found in comparing the CIAT with conventional therapies without any component from the CIAT based on the results of three RCTs. Five RCTs showed that the CIAT performed equally well as other intensive aphasia therapies, in terms of improving language performance. One RCT showed that therapies embedded with social interaction were likely to enhance the efficacy of the CIAT. Conclusion CIAT may be useful for improving chronic post-stroke aphasia, however, limited evidence to support its superiority to other aphasia therapies. Massed practice is likely to be a useful component of CIAT, while the role of constraint is needed to be further explored. CIAT embedded with social interaction may gain more benefits.	[Zhang, Jiaqi] Chinese Univ Hong Kong, Fac Med, Master Sci Neurol Sci, Hong Kong, Hong Kong, Peoples R China; [Yu, Jiadan; Xu, Yang] Sichuan Univ, West China Sch Med, Sch Rehabil Sci, Chengdu, Sichuan, Peoples R China; [Bao, Yong] Shanghai Jiao Tong Univ, Ruijin Rehabil Hosp, Shanghai, Peoples R China; [Xie, Qing; Wang, Pu] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Rehabil Med, Shanghai, Peoples R China; [Zhang, Junmei] Wuhan Univ Technol, Dept Phys Educ, Wuhan, Peoples R China	Chinese University of Hong Kong; Sichuan University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wuhan University of Technology	Wang, P (corresponding author), Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Rehabil Med, Shanghai, Peoples R China.	wangpu_03@126.com		/0000-0001-5783-3693; ZHANG, Jack Jiaqi/0000-0002-4656-1909; Yu, Jiadan/0000-0002-9660-8736				Balardin Joana Bisol, 2009, Dement. neuropsychol., V3, P275, DOI 10.1590/S1980-57642009DN30400003; Bang DH, 2015, NEUROREHABILITATION, V37, P131, DOI 10.3233/NRE-151245; Berthier ML, 2011, NEUROPSYCHOL REV, V21, P302, DOI 10.1007/s11065-011-9177-7; Boehme AK, 2016, NEUROLOGY, V87, P2348, DOI 10.1212/WNL.0000000000003297; Brady MC, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000425.pub4, 10.1002/14651858.CD000425.pub3]; Breier JI, 2009, ARCH PHYS MED REHAB, V90, P2026, DOI 10.1016/j.apmr.2009.08.144; Chen WL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01665; Cherney LR, 2008, J SPEECH LANG HEAR R, V51, P1282, DOI 10.1044/1092-4388(2008/07-0206); Ciccone N, 2016, APHASIOLOGY, V30, P566, DOI 10.1080/02687038.2015.1071480; Difrancesco S, 2012, APHASIOLOGY, V26, P1317, DOI 10.1080/02687038.2012.705815; Dignam J, 2015, STROKE, V46, P2206, DOI 10.1161/STROKEAHA.115.009522; Dignam JK, 2016, PM&R, V8, P254, DOI 10.1016/j.pmrj.2015.06.010; Fama ME, 2016, TOP STROKE REHABIL, V23, P276, DOI 10.1080/10749357.2016.1155277; Fang YN, 2003, CLIN REHABIL, V17, P608, DOI 10.1191/0269215503cr655oa; Hamilton RH, 2011, BRAIN LANG, V118, P40, DOI 10.1016/j.bandl.2011.02.005; Hung GKN, 2015, HONG KONG J OCCUP TH, V26, P51, DOI 10.1016/j.hkjot.2015.12.003; Johnson ML, 2014, AM J SPEECH-LANG PAT, V23, P60, DOI 10.1044/1058-0360(2013/12-0168); Kavian S, 2014, INT J PREVENTIVE MED, V5, P782; Koleck M, 2017, QUAL LIFE RES, V26, P45, DOI 10.1007/s11136-016-1361-z; Kristensen LF, 2015, APHASIOLOGY, V29, P1152, DOI 10.1080/02687038.2015.1028328; Kurland J, 2016, AM J SPEECH-LANG PAT, V25, pS798, DOI 10.1044/2016_AJSLP-15-0135; Kurland J, 2012, AM J SPEECH-LANG PAT, V21, pS65, DOI 10.1044/1058-0360(2012/11-0113); Lee H, 2015, YONSEI MED J, V56, P1694, DOI 10.3349/ymj.2015.56.6.1694; Leung DPK, 2009, HUM MOVEMENT SCI, V28, P798, DOI 10.1016/j.humov.2009.04.006; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Maher LM, 2006, J INT NEUROPSYCH SOC, V12, P843, DOI 10.1017/S1355617706061029; Meinzer M, 2005, STROKE, V36, P1462, DOI 10.1161/01.STR.0000169941.29831.2a; Meinzer M, 2007, J INT NEUROPSYCH SOC, V13, P846, DOI 10.1017/S1355617707071111; Meinzer M, 2007, NEUROREHABILITATION, V22, P311; Meinzer M, 2012, ARCH PHYS MED REHAB, V93, pS35, DOI 10.1016/j.apmr.2011.06.040; Mohr B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00919; Mohr B, 2016, NEUROPSYCHOLOGIA, V93, P413, DOI 10.1016/j.neuropsychologia.2016.04.006; Morris DM, 1997, NEUROREHABILITATION, V9, P29, DOI 10.3233/NRE-1997-9104; Mozeiko J, 2016, APHASIOLOGY, V30, P339, DOI 10.1080/02687038.2015.1070949; Nickels L, 2016, NEUROREHABILITATION, V39, P97, DOI 10.3233/NRE-161341; Norise C, 2017, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00675; Pulvermuller F, 2005, NEUROIMAGE, V28, P481, DOI 10.1016/j.neuroimage.2005.06.038; Pulvermuller F, 2001, STROKE, V32, P1621, DOI 10.1161/01.STR.32.7.1621; Rosbergen ICM, 2017, CLIN REHABIL, V31, P1516, DOI 10.1177/0269215517705181; Rose ML, 2013, AM J SPEECH-LANG PAT, V22, pS227, DOI 10.1044/1058-0360(2012/12-0091); Sickert A, 2014, J NEUROL NEUROSUR PS, V85, P51, DOI 10.1136/jnnp-2012-304297; Stahl B, 2016, CORTEX, V85, P90, DOI 10.1016/j.cortex.2016.09.021; Szaflarski JP, 2008, MED SCI MONITOR, V14, pCR243; Szaflarski JP, 2015, MED SCI MONITOR, V21, P2861, DOI 10.12659/MSM.894291; Thrane G, 2014, J REHABIL MED, V46, P833, DOI 10.2340/16501977-1859; Toh SFM, 2012, HONG KONG J OCCUP TH, V22, P84, DOI 10.1016/j.hkjot.2012.12.009; van de Sandt-Koenderman ME, 2012, ARCH PHYS MED REHAB, V93, pS1, DOI 10.1016/j.apmr.2011.08.037; Wilssens I, 2015, AM J SPEECH-LANG PAT, V24, P281, DOI 10.1044/2015_AJSLP-14-0018; Woldag H, 2017, NEUROREHAB NEURAL RE, V31, P72, DOI 10.1177/1545968316662707; Yu KW, 2014, J NEUROL SCI, V347, P275, DOI 10.1016/j.jns.2014.10.022	50	24	25	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183349	10.1371/journal.pone.0183349	http://dx.doi.org/10.1371/journal.pone.0183349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846724	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600026
J	Gong, X; Hung, KH; Ting, YW; Hsu, TW; Malikova, L; Tran, HT; Huang, CL; Liu, SH; Chiang, TY				Gong, Xun; Hung, Kuo-Hsiang; Ting, Yu-Wei; Hsu, Tsai-Wen; Malikova, Lenka; Huyen Trang Tran; Huang, Chao-Li; Liu, Shih-Hui; Chiang, Tzen-Yuh			Frequent gene flow blurred taxonomic boundaries of sections in Lilium L. (Liliaceae)	PLOS ONE			English	Article							TRANSCRIBED SPACER REGION; MOLECULAR PHYLOGENY; EUROPEAN LILIES; DNA; CHLOROPLAST; EVOLUTION; GENOME; DIVERGENCE; SEQUENCES; INTROGRESSION	Gene flow between species may last a long time in plants. Reticulation inevitably causes difficulties in phylogenetic reconstruction. In this study, we looked into the genetic divergence and phylogeny of 20 Lilium species based on multilocus analyses of 8 genes of chloroplast DNA (cpDNA), the internally transcribed nuclear ribosomal DNA (nrITS) spacer and 20 loci extracted from the expressed sequence tag (EST) libraries of L. longiflorum Thunb. and L. formosanum Wallace. The phylogeny based on the combined data of the maternally inherited cpDNA and nrITS was largely consistent with the taxonomy of Lilium sections. This phylogeny was deemed the hypothetical species tree and uncovered three groups, i.e., Cluster A consisting of 4 taxa from the sections Pseudolirium and Liriotypus, Cluster B consisting of the 4 taxa from the sections Leucolirion, Archelirion and Daurolirion, and Cluster C comprising 10 taxa mostly from the sections Martagon and Sinomartagon. In contrast, systematic inconsistency occurred across the EST loci, with up to 19 genes (95%) displaying tree topologies deviating from the hypothetical species tree. The phylogenetic incongruence was likely attributable to the frequent genetic exchanges between species/sections, as indicated by the high levels of genetic recombination and the IMa analyses with the EST loci. Nevertheless, multilocus analysis could provide complementary information among the loci on the species split and the extent of gene flow between the species. In conclusion, this study not only detected frequent gene flow among Lilium sections that resulted in phylogenetic incongruence but also reconstructed a hypothetical species tree that gave insights into the nature of the complex relationships among Lilium species.	[Gong, Xun] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming, Yunnan, Peoples R China; [Hung, Kuo-Hsiang] Natl Pingtung Univ Sci & Technol, Grad Inst Bioresources, Pingtung, Taiwan; [Ting, Yu-Wei; Malikova, Lenka; Huyen Trang Tran; Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan; [Hsu, Tsai-Wen] Endem Species Res Inst, Nantou, Taiwan; [Malikova, Lenka] Inst Bot CAS, Trebon, Czech Republic; [Huyen Trang Tran] Vinh Univ, Inst Nat Sci Educ, Vinh, Nghe An, Vietnam; [Huang, Chao-Li] Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan, Taiwan; [Liu, Shih-Hui] St Louis Univ, Dept Biol, St Louis, MO 63107 USA; [Liu, Shih-Hui] Missouri Bot Garden, St Louis, MO 63110 USA; [Chiang, Tzen-Yuh] Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; National Pingtung University Science & Technology; National Cheng Kung University; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Vinh University; National Cheng Kung University; Saint Louis University; Missouri Botanical Gardens; National Cheng Kung University	Chiang, TY (corresponding author), Natl Cheng Kung Univ, Dept Life Sci, Tainan, Taiwan.; Huang, CL (corresponding author), Natl Cheng Kung Univ, Inst Trop Plant Sci, Tainan, Taiwan.; Liu, SH (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63107 USA.; Liu, SH (corresponding author), Missouri Bot Garden, St Louis, MO 63110 USA.; Chiang, TY (corresponding author), Natl Cheng Kung Univ, Univ Ctr Biosci & Biotechnol, Tainan, Taiwan.	clhuang65535@gmail.com; liushihhui@gmail.com; tychiang@mail.ncku.edu.tw	Liu, Shih-Hui/HHC-0223-2022	Liu, Shih-Hui/0000-0002-5429-6869; Huang, Chao-Li/0000-0002-1059-432X	Ministry of Science and Technology [104-2621-B-006-002]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by Ministry of Science and Technology: 104-2621-B-006-002, https://www.most.gov.tw/en/.public. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriola PE, 1996, AM J BOT, V83, P1153, DOI 10.2307/2446198; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BALDWIN BG, 1995, ANN MO BOT GARD, V82, P247, DOI 10.2307/2399880; Bao L. Y., 2004, FOR PROD SPECIALITY, V69, P54; BARANOVA M V, 1988, Botanicheskii Zhurnal (St. Petersburg), V73, P1319; BYRNE M, 1994, HEREDITY, V73, P18, DOI 10.1038/hdy.1994.94; Comas I, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S7; Comber HF, 1949, R HORT SOC LILY YB, V13, P86; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Endlicher S., 1840, GENERA PLANTARUM SEC; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Gao YD, 2013, MOL PHYLOGENET EVOL, V68, P443, DOI 10.1016/j.ympev.2013.04.026; Gao YD, 2012, PLANT SYST EVOL, V298, P69, DOI 10.1007/s00606-011-0524-1; Gauthier O, 2007, SYST BOT, V32, P8, DOI 10.1600/036364407780360238; Gojobori T, 2016, ECOLOGICAL GENETICS, V1, P8; Hayashi K, 2005, ACTA HORTIC, P43, DOI 10.17660/ActaHortic.2005.673.3; Hayashi Kazuhiko, 2000, Plant Species Biology, V15, P73, DOI 10.1046/j.1442-1984.2000.00025.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; HUDSON RR, 1985, GENETICS, V111, P147; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Ikinci Nursel, 2006, Willdenowia, V36, P647, DOI 10.3372/wi.36.36201; Jefferson-Brown MJ, 1995, GARDENERS GUIDE GROW; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Ji YH, 2006, ANN BOT-LONDON, V98, P245, DOI 10.1093/aob/mcl095; Kane NC, 2009, EVOLUTION, V63, P2061, DOI 10.1111/j.1558-5646.2009.00703.x; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lee CS, 2011, J PLANT BIOL, V54, P159, DOI 10.1007/s12374-011-9152-0; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lu-Irving P, 2013, BOT J LINN SOC, V171, P103, DOI 10.1111/j.1095-8339.2012.01305.x; MacRae EA., 1998, LILIES GUIDE GROWERS; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Minder AM, 2008, MOL ECOL, V17, P1552, DOI 10.1111/j.1365-294X.2008.03709.x; MOENS PB, 1970, J CELL SCI, V7, P55; Muller Kai, 2005, Appl Bioinformatics, V4, P65; Muratovic E, 2010, ADV SCI LETT, V3, P180, DOI 10.1166/asl.2010.1116; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Naciri Y, 2015, TAXON, V64, P3, DOI 10.12705/641.24; Nishikawa T, 1999, J MOL EVOL, V49, P238, DOI 10.1007/PL00006546; Nishikawa T, 2001, BREEDING SCI, V51, P39, DOI 10.1270/jsbbs.51.39; Nishikawa T., 2008, MOL PHYLOGENY GENUS; Patterson TB, 2002, EVOLUTION, V56, P233, DOI 10.1111/j.0014-3820.2002.tb01334.x; Peruzzi L, 2009, ANN BOT-LONDON, V103, P459, DOI 10.1093/aob/mcn230; Peterson A, 2004, PLANT SYST EVOL, V245, P145, DOI 10.1007/s00606-003-0114-y; Philippe H, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000602; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Rokas A, 2003, EVOL DEV, V5, P346, DOI 10.1046/j.1525-142X.2003.03042.x; Rong LP, 2011, GENET RESOUR CROP EV, V58, P115, DOI 10.1007/s10722-010-9584-2; Rozen S, 2000, Methods Mol Biol, V132, P365; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Sang T, 1997, AM J BOT, V84, P1120, DOI 10.2307/2446155; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Soltis ED, 2000, PLANT MOL BIOL, V42, P45, DOI 10.1023/A:1006371803911; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Syvanen M, 2012, ANNU REV GENET, V46, P341, DOI 10.1146/annurev-genet-110711-155529; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Tuyl JM, 2011, ACTA HORTIC, V900, P223; Wang WK, 2011, PLANT MOL BIOL REP, V29, P88, DOI 10.1007/s11105-010-0214-0; Wang WK, 2010, NEW PHYTOL, V188, P488, DOI 10.1111/j.1469-8137.2010.03383.x; Wendel JF, 1998, MOL SYSTEMATICS PLAN, P26; Wilson E.H.., 1925, LILIES E ASIA; Woerner AE, 2007, BIOINFORMATICS, V23, P1851, DOI 10.1093/bioinformatics/btm253; Woodcock H, 1950, LILIES WORLD THEIR C; Wu X. W., 2006, PLANT GENET RES, V7, P327; Xu B, 2012, MOL PHYLOGENET EVOL, V62, P346, DOI 10.1016/j.ympev.2011.10.007; ZIMMER EA, 1980, P NATL ACAD SCI-BIOL, V77, P2158, DOI 10.1073/pnas.77.4.2158	72	8	8	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183209	10.1371/journal.pone.0183209	http://dx.doi.org/10.1371/journal.pone.0183209			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841664	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700020
J	Ali, M; Sen Gupta, S; Arora, N; Khasnobis, P; Venkatesh, S; Sur, D; Nair, GB; Sack, DA; Ganguly, NK				Ali, Mohammad; Sen Gupta, Sanjukta; Arora, Nisha; Khasnobis, Pradeep; Venkatesh, Srinivas; Sur, Dipika; Nair, Gopinath B.; Sack, David A.; Ganguly, Nirmal K.			Identification of burden hotspots and risk factors for cholera in India: An observational study	PLOS ONE			English	Article							DRINKING-WATER; VACCINE; EPIDEMIOLOGY; COUNTRIES; OUTBREAK; KOLKATA; NIGERIA	Background Even though cholera has existed for centuries and many parts of the country have sporadic, endemic and epidemic cholera, it is still an under-recognized health problem in India. A Cholera Expert Group in the country was established to gather evidence and to prepare a road map for control of cholera in India. This paper identifies cholera burden hotspots and factors associated with an increased risk of the disease. Methodology/Principle findings We acquired district level data on cholera case reports of 2010-2015 from the Integrated Disease Surveillance Program. Socioeconomic characteristics and coverage of water and sanitation was obtained from the 2011 census. Spatial analysis was performed to identify cholera hotspots, and a zero-inflated Poisson regression was employed to identify the factors associated with cholera and predicted case count in the district. 27,615 cholera cases were reported during the 6-year period. Twenty-four of 36 states of India reported cholera during these years, and 13 states were classified as endemic. Of 641 districts, 78 districts in 15 states were identified as "hotspots" based on the reported cases. On the other hand, 111 districts in nine states were identified as "hotspots" from model-based predicted number of cases. The risk for cholera in a district was negatively associated with the coverage of literate persons, households using treated water source and owning mobile telephone, and positively associated with the coverage of poor sanitation and drainage conditions and urbanization level in the district. Conclusions/Significance The study reaffirms that cholera continues to occur throughout a large part of India and identifies the burden hotspots and risk factors. Policymakers may use the findings of the article to develop a roadmap for prevention and control of cholera in India.	[Ali, Mohammad; Sack, David A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Sen Gupta, Sanjukta; Arora, Nisha; Ganguly, Nirmal K.] Translat Hlth Sci & Technol Inst, Policy Ctr Biomed Res, New Delhi, India; [Khasnobis, Pradeep; Venkatesh, Srinivas] Natl Ctr Dis Control, New Delhi, India; [Sur, Dipika] Indian Publ Hlth Assoc, New Delhi, India; [Nair, Gopinath B.] WHO, New Delhi, India	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Department of Biotechnology (DBT) India; Translational Health Science & Technology Institute (THSTI); National Centre for Disease Control (NCDC); World Health Organization	Ganguly, NK (corresponding author), Translat Hlth Sci & Technol Inst, Policy Ctr Biomed Res, New Delhi, India.	nkganguly@thsti.res.in			BMGF [OPP1126283]; Delivering Oral Vaccine Effectively (DOVE) project; Bill and Melinda Gates Foundation (BMGF) [OPP1148763]	BMGF; Delivering Oral Vaccine Effectively (DOVE) project; Bill and Melinda Gates Foundation (BMGF)(Bill & Melinda Gates Foundation)	The project on "Creation of a roadmap for cholera prevention and control" is being funded by BMGF grant OPP1126283 administered through The Translational Health Science and Technology Institute. Financial support for the data analysis and preparation of the manuscript was provided by the Delivering Oral Vaccine Effectively (DOVE) project. DOVE is funded by the Bill and Melinda Gates Foundation (BMGF) grant OPP1148763 and administered through the Johns Hopkins Bloomberg School of Public Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], ANN REPORT; [Anonymous], 2004, ASS OUTBR RESP IMPR; Azman AS, 2016, LANCET, V387, P28, DOI 10.1016/S0140-6736(15)01294-5; Bhattacharya S, 2013, LANCET INFECT DIS, V13, P1050, DOI 10.1016/S1473-3099(13)70273-1; Charles RC, 2011, CURR OPIN INFECT DIS, V24, P472, DOI 10.1097/QCO.0b013e32834a88af; Chen T, 2016, STAT MED, V35, P2770, DOI 10.1002/sim.6892; Cholera, 2014, WKLY EPIDEMIOL REC, V90, P517; Das D., 2012, INT J ADV RES TECHNO; Dey S, 2014, INDIAN J MED RES, V140, P420; Graham AJ, 2004, ACTA TROP, V91, P219, DOI 10.1016/j.actatropica.2004.05.001; Guevart E, 2006, Med Trop (Mars), V66, P283; Jensen PK, 2002, TROP MED INT HEALTH, V7, P604, DOI 10.1046/j.1365-3156.2002.00901.x; Kanungo S, 2010, B WORLD HEALTH ORGAN, V88, P185, DOI 10.2471/BLT.09.073460; Kar SK, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002629; Kulldorff M, 1998, AM J PUBLIC HEALTH, V88, P1377, DOI 10.2105/AJPH.88.9.1377; Lawoyin TO, 1999, EUR J EPIDEMIOL, V15, P367, DOI 10.1023/A:1007547117763; Leckebusch GC, 2015, HEALTH PLACE, V34, P107, DOI 10.1016/j.healthplace.2015.04.006; Lessler J, 2017, AM J TROP MED HYG, V96, P1270, DOI 10.4269/ajtmh.16-0427; LOADER CR, 1991, ADV APPL PROBAB, V23, P751, DOI 10.2307/1427674; LOPEZ AL, 2015, PLOS NEGLECT TROP D, V9, P66880; Luquero FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019005; Osei FB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-44; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Sack RB, 2003, J INFECT DIS, V187, P96, DOI 10.1086/345865; Sarkar BL, 2012, INDIAN J MED RES, V135, P246; Sobsey MD, 2008, ENVIRON SCI TECHNOL, V42, P4261, DOI 10.1021/es702746n; Sundaram N, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2710-0; Sur D, 2005, ARCH DIS CHILD, V90, P1175, DOI 10.1136/adc.2004.071316; Sur D, 2009, LANCET, V374, P1694, DOI 10.1016/S0140-6736(09)61297-6; Talavera A, 2009, J INFECT DEV COUNTR, V3, P408, DOI 10.3855/jidc.410; Taylor DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135676; Verma R, 2012, HUM VACC IMMUNOTHER, V8, P682, DOI 10.4161/hv.19083; WHO, 2009, WKLY EPIDEMIOL REC, V84, P517; You YA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071173	34	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183100	10.1371/journal.pone.0183100	http://dx.doi.org/10.1371/journal.pone.0183100			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837645	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000047
J	Pong, AC; Juge, L; Bilston, LE; Cheng, S				Pong, Alice C.; Juge, Lauriane; Bilston, Lynne E.; Cheng, Shaokoon			Development of acute hydrocephalus does not change brain tissue mechanical properties in adult rats, but in juvenile rats	PLOS ONE			English	Article							MAGNETIC-RESONANCE ELASTOGRAPHY; NORMAL-PRESSURE HYDROCEPHALUS; MR ELASTOGRAPHY; VISCOELASTIC PROPERTIES; DIFFUSION TENSOR; IN-VIVO; STIFFNESS; ELASTICITY; WAVES	Introduction Regional changes in brain stiffness were previously demonstrated in an experimental obstructive hydrocephalus juvenile rat model. The open cranial sutures in the juvenile rats have influenced brain compression and mechanical properties during hydrocephalus development and the extent by which closed cranial sutures in adult hydrocephalic rat models affect brain stiffness in-vivo remains unclear. The aims of this study were to determine changes in brain tissue mechanical properties and brain structure size during hydrocephalus development in adult rat with fixed cranial volume and how these changes were related to brain tissue deformation. Methods Hydrocephalus was induced in 9 female ten weeks old Sprague-Dawley rats by injecting 60 mu L of a kaolin suspension (25%) into the cisterna magna under anaesthesia. 6 sham-injected age-matched female SD rats were used as controls. MR imaging (9.4T, Bruker) was performed 1 day before and then at 3 days post injection. T2-weighted anatomical MR images were collected to quantify ventricle and brain tissue cross-sectional areas. MR elastography (800 Hz) was used to measure the brain stiffness (G*, shear modulus). Results Brain tissue in the adult hydrocephalic rats was more compressed than the juvenile hydrocephalic rats because the skulls of the adult hydrocephalic rats were unable to expand like the juvenile rats. In the adult hydrocephalic rats, the cortical gray matter thickness and the caudate-putamen cross-sectional area decreased (Spearman, P < 0.001 for both) but there were no significant changes in cranial cross-sectional area (Spearman, P = 0.35), cortical gray matter stiffness (Spearman, P = 0.24) and caudate-putamen (Spearman, P = 0.11) stiffness. No significant changes in the size of brain structures were observed in the controls. Conclusions This study showed that although brain tissue in the adult hydrocephalic rats was severely compressed, their brain tissue stiffness did not change significantly. These results are in contrast with our previous findings in juvenile hydrocephalic rats which had significantly less brain compression (as the brain circumference was able to stretch with the cranium due to the open skull sutures) and had a significant increase in caudate putamen stiffness. These results suggest that change in brain mechanical properties in hydrocephalus is complex and is not solely dependent on brain tissue deformation. Further studies on the interactions between brain tissue stiffness, deformation, tissue oedema and neural damage are necessary before MRE can be used as a tool to track changes in brain biomechanics in hydrocephalus.	[Pong, Alice C.; Juge, Lauriane; Bilston, Lynne E.] Neurosci Res Australia, Margarete Ainsworth Bldg,Barker St, Sydney, NSW, Australia; [Juge, Lauriane] Univ New South Wales, Sch Med Sci, Wallace Wurth Bldg, Sydney, NSW, Australia; [Bilston, Lynne E.] Univ New South Wales, Prince Wales Clin Sch, Edmund Blacket Bldg, Sydney, NSW, Australia; [Cheng, Shaokoon] Macquarie Univ, Fac Sci & Engn, Dept Engn, Sydney, NSW, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University	Cheng, S (corresponding author), Macquarie Univ, Fac Sci & Engn, Dept Engn, Sydney, NSW, Australia.	shaokoon.cheng@mq.edu.au	Jugé, Lauriane/F-7085-2014; Bilston, Lynne/C-9665-2011	Jugé, Lauriane/0000-0002-4136-8069; Cheng, Shaokoon/0000-0002-2057-4605; Bilston, Lynne/0000-0001-8250-9019	National Health and Medical Research Council of Australia [APP 1027684, APP 1077934]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work is supported by a project grant from the National Health and Medical Research Council of Australia (APP 1027684). Lynne Bilston is supported by a senior research fellowship from the National Health and Medical Research Council of Australia (APP 1077934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheng S, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4001025; Clarke EC, 2011, J BIOMECH, V44, P2461, DOI 10.1016/j.jbiomech.2011.06.023; Deren KE, 2010, EXP NEUROL, V226, P110, DOI 10.1016/j.expneurol.2010.08.010; Fattahi N, 2016, AM J NEURORADIOL, V37, P462, DOI 10.3174/ajnr.A4560; Freimann FB, 2012, NEURORADIOLOGY, V54, P189, DOI 10.1007/s00234-011-0871-1; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hakim S, 1976, Surg Neurol, V5, P187; Hatt A, 2015, AM J NEURORADIOL, V36, P1971, DOI 10.3174/ajnr.A4361; Juge L, 2016, PLOS ONE, P11; Juge L, 2015, NMR BIOMED, V28, P1763, DOI 10.1002/nbm.3438; Li J, 2008, EXP NEUROL, V211, P351, DOI 10.1016/j.expneurol.2007.12.030; MUTHUPILLAI R, 1995, SCIENCE, V269, P1854, DOI 10.1126/science.7569924; PENN RD, 1984, NEUROSURGERY, V14, P670, DOI 10.1227/00006123-198406000-00004; Qin EC, 2013, J MAGN RESON IMAGING, V37, P217, DOI 10.1002/jmri.23797; Schregel K, 2012, P NATL ACAD SCI USA, V109, P6650, DOI 10.1073/pnas.1200151109; SKLAR FH, 1977, J NEUROSURG, V47, P670, DOI 10.3171/jns.1977.47.5.0670; SKLAR FH, 1980, J NEUROSURG, V53, P173, DOI 10.3171/jns.1980.53.2.0173; Streitberger KJ, 2011, NMR BIOMED, V24, P385, DOI 10.1002/nbm.1602; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Tu TW, 2014, J NEUROPATH EXP NEUR, V73, P1152, DOI 10.1097/NEN.0000000000000140	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182808	10.1371/journal.pone.0182808	http://dx.doi.org/10.1371/journal.pone.0182808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837671	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000029
J	Hurnakova, J; Hulejova, H; Zavada, J; Hanova, P; Komarc, M; Mann, H; Klein, M; Sleglova, O; Olejarova, M; Forejtova, S; Ruzickova, O; Vencovsky, J; Pavelka, K; Senolt, L				Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Komarc, Martin; Mann, Herman; Klein, Martin; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav			Relationship between serum calprotectin (S100A8/9) and clinical, laboratory and ultrasound parameters of disease activity in rheumatoid arthritis: A large cohort study	PLOS ONE			English	Article							CALCIUM-BINDING PROTEINS; ACUTE-PHASE REACTANTS; LEUKOCYTE PROTEIN; ACTIVITY INDEX; SYNOVITIS; ULTRASONOGRAPHY; ASSOCIATION; PREDICTOR; PLASMA; JOINTS	Background Calprotectin may be a sensitive biomarker of rheumatoid arthritis (RA) disease activity. Objectives In the current study, we investigated whether calprotectin is a better biomarker than CRP for predicting clinical activity and ultrasound parameters in patients with RA. Methods A total of 160 patients with RA underwent clinical (swollen joint count-SJC, tender joint count-TJC, Disease Activity Score-DAS28, Clinical Disease Activity Index-CDAI, and simplified Disease Activity Index-SDAI) and ultrasound (German US7) examination. Clinical and laboratory measures were correlated with ultrasound findings using Spearman's correlation coefficient. Differences in serum calprotectin levels in patients with variable disease activity according to the DAS28-ESR and CDAI scores were assessed using ANOVA. Multivariate regression analysis was used to determine the predictive values of calprotectin, CRP and SJC for CDAI and PD US synovitis scores. Results Serum calprotectin was significantly associated with DAS28-ESR (r = 0.321, p<0.001), DAS28-CRP (r = 0.346, p<0.001), SDAI (r = 0.305, p<0.001), CDAI (r = 0.279, p<0.001) scores and CRP levels (r = 0.556, p<0.001). Moreover, calprotectin was significantly correlated with GS (r = 0.379, p<0.001) and PD synovitis scores (r = 0.419, p<0.001). The multi-variate regression analysis showed that calprotectin is a better predictor of the CDAI score and PD US synovitis than CRP. Conclusions The results of this study support an additional role of calprotectin in assessing inflammatory activity in patients with RA.	[Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Mann, Herman; Klein, Martin; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Inst Rheumatol, Prague, Czech Republic; [Hurnakova, Jana; Hulejova, Hana; Zavada, Jakub; Hanova, Petra; Mann, Herman; Klein, Martin; Sleglova, Olga; Olejarova, Marta; Forejtova, Sarka; Ruzickova, Olga; Vencovsky, Jiri; Pavelka, Karel; Senolt, Ladislav] Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic; [Klein, Martin] Charles Univ Prague, Fac Phys Educ & Sport, Dept Methodol, Prague, Czech Republic	Institute of Rheumatology; Charles University Prague; Charles University Prague	Senolt, L (corresponding author), Inst Rheumatol, Prague, Czech Republic.; Senolt, L (corresponding author), Charles Univ Prague, Fac Med 1, Dept Rheumatol, Prague, Czech Republic.	senolt@revma.cz	Komarc, Martin/A-7308-2017; Hulejová, Hana/H-1909-2019; Pavelka, Karel/E-6578-2017; Vencovsky, Jiri/G-6094-2017; Závada, Jakub/N-3159-2017; Komarc, Martin/O-2575-2019; Mann, Herman Felix/G-5871-2014; Hanova, Petra/O-6675-2017; Forejtova, Sarka/N-7448-2017; Senolt, Ladislav/O-6097-2017; Klein, Martin/N-6958-2017; Ruzickova, Olga/O-4214-2017; Olejarova, Marta/O-8800-2017; Sleglova, Olga/N-3022-2017; Hurnakova, Jana/P-1932-2017	Komarc, Martin/0000-0003-4106-5217; Hulejová, Hana/0000-0002-2335-6996; Pavelka, Karel/0000-0003-1952-8422; Vencovsky, Jiri/0000-0002-0851-0713; Závada, Jakub/0000-0002-9802-6545; Komarc, Martin/0000-0003-4106-5217; Mann, Herman Felix/0000-0002-4243-235X; Hanova, Petra/0000-0003-4473-9766; Forejtova, Sarka/0000-0002-7510-7895; Senolt, Ladislav/0000-0001-5500-7312; Klein, Martin/0000-0002-1027-0923; Ruzickova, Olga/0000-0003-4284-1003; Olejarova, Marta/0000-0002-0586-361X; Sleglova, Olga/0000-0003-1764-5852; Hurnakova, Jana/0000-0002-1139-539X	project of the Ministry of Health of the Czech Republic for conceptual research development by organization [023728]; Specific Academy Research Projects (SW) [260 373]	project of the Ministry of Health of the Czech Republic for conceptual research development by organization; Specific Academy Research Projects (SW)	This work was supported by a project of the Ministry of Health of the Czech Republic for conceptual research development by organization [023728] and Specific Academy Research Projects (SW) [260 373]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Andersson AK, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2370; Backhaus M, 2009, ARTHRIT RHEUM-ARTHR, V61, P1194, DOI 10.1002/art.24646; BERNTZEN HB, 1991, SCAND J RHEUMATOL, V20, P74, DOI 10.3109/03009749109165280; BRUN JG, 1994, J RHEUMATOL, V21, P733; BRUN JG, 1992, J RHEUMATOL, V19, P859; Cerezo LA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3426; Choi IY, 2015, ANN RHEUM DIS, V74, P499, DOI 10.1136/annrheumdis-2013-203923; Colebatch AN, 2013, ANN RHEUM DIS, V72, P804, DOI 10.1136/annrheumdis-2012-203158; DALE I, 1983, J IMMUNOL METHODS, V65, P245, DOI 10.1016/0022-1759(83)90321-6; DALE I, 1983, EUR J BIOCHEM, V134, P1, DOI 10.1111/j.1432-1033.1983.tb07522.x; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Garcia-Arias M, 2013, MOL DIAGN THER, V17, P49, DOI 10.1007/s40291-013-0016-9; Hammer HB, 2007, ANN RHEUM DIS, V66, P1093, DOI 10.1136/ard.2006.064741; Hammer HB, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3503; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; Hurnakova J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165498; Hurnakova J, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0764-5; Inciarte-Mundo J, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1032-z; Inciarte-Mundo J, 2016, ARTHRIT CARE RES, V68, P899, DOI 10.1002/acr.22795; Inciarte-Mundo J, 2015, RHEUMATOLOGY, V54, P2239, DOI 10.1093/rheumatology/kev251; Johne B, 1997, J CLIN PATHOL-MOL PA, V50, P113; Nair SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152362; Naredo E, 2005, ANN RHEUM DIS, V64, P375, DOI 10.1136/ard.2004.023929; Nordal HH, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-016-1201-0; ODINK K, 1987, NATURE, V330, P80, DOI 10.1038/330080a0; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rammes A, 1997, J BIOL CHEM, V272, P9496; Roth J, 2003, TRENDS IMMUNOL, V24, P155, DOI 10.1016/S1471-4906(03)00062-0; Silman AJ, 2002, ARTHRITIS RES THER, V4, pS265, DOI 10.1186/ar578; Smolen JS, 2003, RHEUMATOLOGY, V42, P244, DOI 10.1093/rheumatology/keg072; Szkudlarek M, 2003, ARTHRITIS RHEUM, V48, P955, DOI 10.1002/art.10877; WILKINSON MM, 1988, J CELL SCI, V91, P221	35	19	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183420	10.1371/journal.pone.0183420	http://dx.doi.org/10.1371/journal.pone.0183420			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832684	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800058
J	Komatsu, H; Cook, C; Wang, CH; Medrano, L; Lin, H; Kandeel, F; Tai, YC; Mullen, Y				Komatsu, Hirotake; Cook, Colin; Wang, Chia-Hao; Medrano, Leonard; Lin, Henry; Kandeel, Fouad; Tai, Yu-Chong; Mullen, Yoko			Oxygen environment and islet size are the primary limiting factors of isolated pancreatic islet survival	PLOS ONE			English	Article							INSULIN-SECRETION; BETA-CELLS; TRANSPLANTATION; RAT; GLUCOSE; MASS; AUTOTRANSPLANTATION; CONSUMPTION; METABOLISM; STRATEGIES	Background Type 1 diabetes is an autoimmune disease that destroys insulin-producing beta cells in the pancreas. Pancreatic islet transplantation could be an effective treatment option for type 1 diabetes once several issues are resolved, including donor shortage, prevention of islet necrosis and loss in pre-and post-transplantation, and optimization of immunosuppression. This study seeks to determine the cause of necrotic loss of isolated islets to improve transplant efficiency. Methodology The oxygen tension inside isolated human islets of different sizes was simulated under varying oxygen environments using a computational in silico model. In vitro human islet viability was also assessed after culturing in different oxygen conditions. Correlation between simulation data and experimentally measured islet viability was examined. Using these in vitro viability data of human islets, the effect of islet diameter and oxygen tension of the culture environment on islet viability was also analyzed using a logistic regression model. Principal findings Computational simulation clearly revealed the oxygen gradient inside the islet structure. We found that oxygen tension in the islet core was greatly lower (hypoxic) than that on the islet surface due to the oxygen consumption by the cells. The hypoxic core was expanded in the larger islets or in lower oxygen cultures. These findings were consistent with results from in vitro islet viability assays that measured central necrosis in the islet core, indicating that hypoxia is one of the major causes of central necrosis. The logistic regression analysis revealed a negative effect of large islet and low oxygen culture on islet survival. Conclusions/Significance Hypoxic core conditions, induced by the oxygen gradient inside islets, contribute to the development of central necrosis of human isolated islets. Supplying sufficient oxygen during culture could be an effective and reasonable method to maintain isolated islets viable.	[Komatsu, Hirotake; Wang, Chia-Hao; Medrano, Leonard; Lin, Henry; Kandeel, Fouad; Mullen, Yoko] City Hope Natl Med Ctr, Dept Diabet & Metab Res, Div Dev & Translat Diabet & Endocrinol Res, Beckman Res Inst, Duarte, CA 91010 USA; [Cook, Colin; Tai, Yu-Chong] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA	City of Hope; Beckman Research Institute of City of Hope; California Institute of Technology	Komatsu, H (corresponding author), City Hope Natl Med Ctr, Dept Diabet & Metab Res, Div Dev & Translat Diabet & Endocrinol Res, Beckman Res Inst, Duarte, CA 91010 USA.	hkomatsu@coh.org	KOMATSU, HIROTAKE/R-7234-2019	KOMATSU, HIROTAKE/0000-0003-0876-4809	Nora Eccles Treadwell Foundation [30.6990.973667]	Nora Eccles Treadwell Foundation	This work was supported by a grant from the Nora Eccles Treadwell Foundation (30.6990.973667). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIELI R, 1988, COMP BIOCHEM PHYS A, V91, P221, DOI 10.1016/0300-9629(88)90408-2; Avgoustiniatos ES, 1997, ANN NY ACAD SCI, V831, P145; Barkai Uriel, 2016, World J Transplant, V6, P69, DOI 10.5500/wjt.v6.i1.69; Barshes NR, 2005, J LEUKOCYTE BIOL, V77, P587, DOI 10.1189/jlb.1104649; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Buchwald P, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-5; Carlsson PO, 1998, DIABETES, V47, P1027, DOI 10.2337/diabetes.47.7.1027; Carlsson PO, 2001, DIABETES, V50, P489, DOI 10.2337/diabetes.50.3.489; Chavko M, 2008, EUR J APPL PHYSIOL, V102, P525, DOI 10.1007/s00421-007-0611-8; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; Citro A, 2013, CURR DIABETES REP, V13, P733, DOI 10.1007/s11892-013-0401-0; CLARK JM, 1988, EXP LUNG RES, V14, P897, DOI 10.3109/01902148809064182; Farhat B, 2013, ISLETS, V5, P87, DOI 10.4161/isl.24780; Farney AC, 2016, PANCREAS, V45, P8, DOI 10.1097/MPA.0000000000000391; FINEGOOD DT, 1995, DIABETES, V44, P249, DOI 10.2337/diabetes.44.3.249; Fullerton B, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012161; JANSSON L, 1983, DIABETOLOGIA, V25, P45; Johnson MB, 2016, LANCET DIABETES ENDO, V4, P862, DOI 10.1016/S2213-8587(16)30095-X; Komatsu H, 2016, CELL TRANSPLANT, V25, P1777, DOI 10.3727/096368915X689721; Komatsu H, 2016, BIOCHEM BIOPH RES CO, V470, P534, DOI 10.1016/j.bbrc.2016.01.110; Lehmann R, 2007, DIABETES, V56, P594, DOI 10.2337/db06-0779; LI W, 2014, J DIABETES RES, V2014, DOI DOI 10.1155/2014/192093; Lilly MA, 2016, AM J STEM CELLS, V5, P87; LONGO EA, 1991, J BIOL CHEM, V266, P9314; Ma ZH, 2014, BIOCHEM BIOPH RES CO, V443, P223, DOI 10.1016/j.bbrc.2013.11.088; Miao G, 2006, AM J TRANSPLANT, V6, P2636, DOI 10.1111/j.1600-6143.2006.01541.x; Migliorini A, 2014, MOL METAB, V3, P268, DOI 10.1016/j.molmet.2014.01.010; Montazeri L, 2016, BIOMATERIALS, V89, P157, DOI 10.1016/j.biomaterials.2016.02.043; Mueller-Klieser W, 2000, CRIT REV ONCOL HEMAT, V36, P123, DOI 10.1016/S1040-8428(00)00082-2; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Omori K, 2015, MINERVA ENDOCRINOL, V40, P85; Pedraza E, 2012, P NATL ACAD SCI USA, V109, P4245, DOI 10.1073/pnas.1113560109; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1991, PANCREAS, V6, P242, DOI 10.1097/00006676-199103000-00018; Rodriguez-Brotons A, 2016, TISSUE ENG PT A, V22, P1327, DOI 10.1089/ten.tea.2016.0064; Ryan EA, 2002, DIABETES, V51, P2148, DOI 10.2337/diabetes.51.7.2148; Sakai T, 2011, PANCREAS, V40, P403, DOI 10.1097/MPA.0b013e318204e815; Sakata N, 2014, DIABETES-METAB RES, V30, P1, DOI 10.1002/dmrr.2463; Shapiro A M James, 2012, Rev Diabet Stud, V9, P385, DOI 10.1900/RDS.2012.9.385; Shapiro AMJ, 2006, NEW ENGL J MED, V355, P1318, DOI 10.1056/NEJMoa061267; Sterkers A, 2013, AM J TRANSPLANT, V13, P891, DOI 10.1111/ajt.12136; Striegel DA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004423; Suszynski T., 2016, J DIABETES RES, V2016; Suszynski Thomas M, 2014, J Diabetes Sci Technol, V8, P575, DOI 10.1177/1932296814525827; Suszynski TM, 2014, TRANSPLANTATION, V97, P1286, DOI 10.1097/01.TP.0000441873.35383.1e; Sweet IR, 2008, AM J TRANSPLANT, V8, P183, DOI 10.1111/j.1600-6143.2007.02041.x; Umpierrez G, 2016, NAT REV ENDOCRINOL, V12, P222, DOI 10.1038/nrendo.2016.15; Visperas A, 2016, J IMMUNOL, V197, P3762, DOI 10.4049/jimmunol.1601118	48	69	69	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183780	10.1371/journal.pone.0183780	http://dx.doi.org/10.1371/journal.pone.0183780			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832685	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000408355800100
J	Tracy, LM; Gibson, SJ; Georgiou-Karistianis, N; Giummarra, MJ				Tracy, Lincoln M.; Gibson, Stephen J.; Georgiou-Karistianis, Nellie; Giummarra, Melita J.			Effects of explicit cueing and ambiguity on the anticipation and experience of a painful thermal stimulus	PLOS ONE			English	Article							HEART-RATE CHANGES; SKIN-CONDUCTANCE; ANXIETY; FEAR; ACTIVATION; REPRESENTATION; CONSEQUENCES; STIMULATION; VARIANCE; DILATION	Many factors can influence the way in which we perceive painful events and noxious stimuli, but less is known about how pain perception is altered by explicit knowledge about the impending sensation. This study aimed to investigate the impact of explicit cueing on anxiety, arousal, and pain experience during the anticipation and delivery of noxious thermal heat stimulations. Fifty-two healthy volunteers were randomised to receive explicit instructions about visual cue-stimulus temperature pairings, or no explicit instructions about the cue-stimulus pairs. A pain anxiety task was used to investigate the effects of explicit cueing on anticipatory anxiety, pain experience and electrophysiological responses. Participants who received explicit instructions about the cue-stimulus pairs (i.e., the relationship between the colour of the cue and the temperature of the associated stimuli) reported significantly higher subjective anxiety prior to the delivery of the thermal heat stimuli (p = .025, partial eta squared = .10). There were no effects of explicit cueing on subsequent pain intensity, unpleasantness, or the electrophysiological response to stimulus delivery. The perceived intensity and unpleasantness of the stimuli decreased across the blocks of the paradigm. In both groups anticipating the ambiguous cue elicited the largest change in electrophysiological arousal, indicating that not knowing the impending stimulus temperature led to increased arousal, compared to being certain of receiving a high temperature thermal stimulus (both p < .001). Perceived stimulus intensity varied between ambiguous and non-ambiguous cues, depending on the temperature of the stimulus. Together these findings highlight the impact and importance of explicit cueing and uncertainty in experimental pain studies, and how these factors influence the way healthy individuals perceive and react to noxious and innocuous thermal stimuli.	[Tracy, Lincoln M.; Georgiou-Karistianis, Nellie] Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia; [Tracy, Lincoln M.; Georgiou-Karistianis, Nellie] Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia; [Tracy, Lincoln M.; Gibson, Stephen J.; Giummarra, Melita J.] Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia; [Giummarra, Melita J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Giummarra, Melita J.] Monash Univ, Inst Safety Compensat & Recovery Res, Melbourne, Vic, Australia	Monash University; Monash University; Monash University; Monash University	Tracy, LM (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic, Australia.; Tracy, LM (corresponding author), Monash Univ, Monash Inst Cognit & Clin Neurosci, Clayton, Vic, Australia.; Tracy, LM (corresponding author), Caulfield Hosp, Caulfield Pain Management & Res Ctr, Caulfield, Vic, Australia.	lincoln.tracy@monash.edu	Georgiou-Karistianis, Nellie/ABC-5623-2020; Giummarra, Melita/H-8387-2012; Tracy, Lincoln M./I-4400-2019	Georgiou-Karistianis, Nellie/0000-0003-0718-6760; Giummarra, Melita/0000-0001-7839-6058; Tracy, Lincoln M./0000-0002-9783-6415	Australian Research Council [LP120200033]; National Health and Medical Research Council Early Career Researcher Fellowship [APP1036124]; Australian Government Research Training Program Scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council Early Career Researcher Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This study was funded by an Australian Research Council Linkage Project Grant (LP120200033) between the Victorian Transport Accident Commission and the School of Psychological Sciences, Monash University. Melita Giummarra was supported by a National Health and Medical Research Council Early Career Researcher Fellowship (APP1036124). Lincoln Tracy was supported by an Australian Government Research Training Program Scholarship.	Bair MJ, 2003, ARCH INTERN MED, V163, P2433, DOI 10.1001/archinte.163.20.2433; Barlow DH, 1996, NEBRASKA S MOTIVATIO; Barrett LF, 2015, NAT REV NEUROSCI, V16, P419, DOI 10.1038/nrn3950; Beck A.T., 1990, BECK SCALE SUICIDE I; Beck AT, 1996, PSYCHOL ASSESS; Berna C, 2010, BIOL PSYCHIAT, V67, P1083, DOI 10.1016/j.biopsych.2010.01.014; Bradley MM, 2008, PAIN, V137, P156, DOI 10.1016/j.pain.2007.08.027; Bradley MM, 2005, PSYCHOL SCI, V16, P468; Colloca L, 2006, EUR J PAIN, V10, P659, DOI 10.1016/j.ejpain.2005.10.009; Crombez G, 1998, BEHAV RES THER, V36, P195, DOI 10.1016/S0005-7967(97)10008-0; Crombez G, 1998, PAIN, V75, P187, DOI 10.1016/S0304-3959(97)00219-4; Dalton KM, 2005, J COGNITIVE NEUROSCI, V17, P969, DOI 10.1162/0898929054021094; DAVIS M, 1993, BEHAV BRAIN RES, V58, P175, DOI 10.1016/0166-4328(93)90102-V; Dawson ME, 2007, PRINCIPLES PSYCHOPHY, P159; Destrebecqz A, 2005, PROG BRAIN RES, V150, P69, DOI 10.1016/S0079-6123(05)50006-2; Dube AA, 2009, NEUROIMAGE, V45, P169, DOI 10.1016/j.neuroimage.2008.10.024; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Dutt-Gupta J, 2007, BRIT J ANAESTH, V99, P871, DOI 10.1093/bja/aem308; Dworkin RH, 2008, J PAIN, V9, P105, DOI 10.1016/j.jpain.2007.09.005; Eriksson M, 2008, ACTA PAEDIATR, V97, P27, DOI 10.1111/j.1651-2227.2007.00586.x; Field A., 2013, DISCOVERING STAT USI; Girden ER., 1992, ANOVA REPEATED MEASU, P84; GLASS GV, 1972, REV EDUC RES, V42, P237, DOI 10.2307/1169991; GRACELY RH, 1988, PAIN, V32, P55, DOI 10.1016/0304-3959(88)90023-1; HAMPF G, 1990, PHYSIOL BEHAV, V47, P217, DOI 10.1016/0031-9384(90)90064-B; Harrison D, 2006, EARLY HUM DEV, V82, P603, DOI 10.1016/j.earlhumdev.2005.12.008; HARWELL MR, 1992, J EDUC STAT, V17, P315, DOI 10.2307/1165127; Hawkins J, 2004, ON INTELLEGENCE; HELLER PH, 1984, PAIN, V18, P33, DOI 10.1016/0304-3959(84)90124-6; Keltner JR, 2006, J NEUROSCI, V26, P4437, DOI 10.1523/JNEUROSCI.4463-05.2006; KREGEL KC, 1992, J PHYSIOL-LONDON, V454, P359, DOI 10.1113/jphysiol.1992.sp019268; Lang EV, 2005, PAIN, V114, P303, DOI 10.1016/j.pain.2004.12.028; Lavigne GJ, 2001, CLIN NEUROPHYSIOL, V112, P532, DOI 10.1016/S1388-2457(00)00558-7; Lin CS, 2013, BRAIN RES, V1493, P40, DOI 10.1016/j.brainres.2012.11.035; Lix LM, 1996, REV EDUC RES, V66, P579, DOI 10.3102/00346543066004579; Loggia ML, 2011, PAIN, V152, P592, DOI 10.1016/j.pain.2010.11.032; MOLTNER A, 1990, PAIN, V43, P81, DOI 10.1016/0304-3959(90)90052-F; Moseley GL, 2007, PAIN, V133, P64, DOI 10.1016/j.pain.2007.03.002; Oka S, 2007, CLIN NEUROPHYSIOL, V118, P2016, DOI 10.1016/j.clinph.2007.04.023; Ott J, 2012, CLIN J PAIN, V28, P324, DOI 10.1097/AJP.0b013e3182321cc3; Petrovic P, 2002, PAIN, V95, P1, DOI 10.1016/S0304-3959(01)00467-5; Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110; Ploghaus A, 2001, J NEUROSCI, V21, P9896, DOI 10.1523/JNEUROSCI.21-24-09896.2001; Ploghaus A, 1999, SCIENCE, V284, P1979, DOI 10.1126/science.284.5422.1979; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Price DD, 1999, PAIN, V83, P147, DOI 10.1016/S0304-3959(99)00081-0; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Rhudy JL, 2000, PAIN, V84, P65, DOI 10.1016/S0304-3959(99)00183-9; Schestatsky P, 2007, CLIN AUTON RES, V17, P349, DOI 10.1007/s10286-007-0446-8; Seifert F, 2013, HUM BRAIN MAPP, V34, P1768, DOI 10.1002/hbm.22035; Seth AK, 2013, TRENDS COGN SCI, V17, P565, DOI 10.1016/j.tics.2013.09.007; Sethi AK, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2011.00395; Strigo IA, 2013, INT J EAT DISORDER, V46, P23, DOI 10.1002/eat.22045; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Thibodeau MA, 2013, PAIN, V154, P419, DOI 10.1016/j.pain.2012.12.001; Tousignant-Laflamme Y, 2005, J PAIN, V6, P341, DOI 10.1016/j.jpain.2005.01.351; Tousignant-Laflamme Y, 2006, EUR J PAIN, V10, P603, DOI 10.1016/j.ejpain.2005.09.003; Tracy LM, 2016, EUR J PAIN, V20, P1721, DOI 10.1002/ejp.895; Tsay A, 2015, NEUROSCI BIOBEHAV R, V52, P221, DOI 10.1016/j.neubiorev.2015.03.004; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2005, PAIN, V115, P225, DOI 10.1016/j.pain.2005.03.018; Wiech K, 2009, NEUROIMAGE, V47, P987, DOI 10.1016/j.neuroimage.2009.05.059; Williams ACD, 2016, PAIN, V157, P2420, DOI 10.1097/j.pain.0000000000000613; Yang LL, 2003, ANESTHESIOLOGY, V99, P1281, DOI 10.1097/00000542-200312000-00008	64	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183650	10.1371/journal.pone.0183650	http://dx.doi.org/10.1371/journal.pone.0183650			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832636	Green Published, gold			2022-12-27	WOS:000408355800076
J	Di Bono, MG; Begliomini, C; Budisavljevic, S; Sartori, L; Miotto, D; Motta, R; Castiello, U				Di Bono, Maria Grazia; Begliomini, Chiara; Budisavljevic, Sanja; Sartori, Luisa; Miotto, Diego; Motta, Raffaella; Castiello, Umberto			Decoding social intentions in human prehensile actions: Insights from a combined kinematics-fMRI study	PLOS ONE			English	Article							CORTICAL CONTROL; NEURAL BASIS; MIRROR; BRAIN; MOTOR; SELF; COGNITION; SYSTEMS; REPRESENTATIONS; NEUROSCIENCE	Consistent evidence suggests that the way we reach and grasp an object is modulated not only by object properties (e.g., size, shape, texture, fragility and weight), but also by the types of intention driving the action, among which the intention to interact with another agent (i.e., social intention). Action observation studies ascribe the neural substrate of this 'intentional' component to the putative mirror neuron (pMNS) and the mentalizing (MS) systems. How social intentions are translated into executed actions, however, has yet to be addressed. We conducted a kinematic and a functional Magnetic Resonance Imaging (fMRI) study considering a reach-to-grasp movement performed towards the same object positioned at the same location but with different intentions: passing it to another person (social condition) or putting it on a concave base (individual condition). Kinematics showed that individual and social intentions are characterized by different profiles, with a slower movement at the level of both the reaching (i.e., arm movement) and the grasping (i.e., hand aperture) components. fMRI results showed that: (i)distinct voxel pattern activity for the social and the individual condition are present within the pMNS and the MS during action execution; (ii) decoding accuracies of regions belonging to the pMNS and the MS are correlated, suggesting that these two systems could interact for the generation of appropriate motor commands. Results are discussed in terms of motor simulation and inferential processes as part of a hierarchical generative model for action intention understanding and generation of appropriate motor commands.	[Di Bono, Maria Grazia; Begliomini, Chiara; Budisavljevic, Sanja; Sartori, Luisa; Castiello, Umberto] Univ Padua, Dept Gen Psychol, Neurosci Movement NeMo Lab, Padua, Italy; [Miotto, Diego; Motta, Raffaella] Univ Padua, Dept Med, Padua, Italy; [Castiello, Umberto] Accademia Lincei, Ctr Interdisciplinare Beniamino Segre, Rome, Italy	University of Padua; University of Padua	Di Bono, MG (corresponding author), Univ Padua, Dept Gen Psychol, Neurosci Movement NeMo Lab, Padua, Italy.	mgdibono@gmail.com	Budisavljevic, Sanja/AAC-9119-2020; BEGLIOMINI, CHIARA/D-1516-2014	Castiello, Umberto/0000-0003-0629-1286; BEGLIOMINI, CHIARA/0000-0001-7433-0414; Budisavljevic, Sanja/0000-0002-5019-9121; MOTTA, RAFFAELLA/0000-0002-1886-9826	MIUR [287713]; FP7: REWIRE project; Progetto Strategico, Universitaa di Padova [2010XPMFVV4]; SIR grant (Scientific Independence of Young Researchers) [RBSI141QKX]	MIUR(Ministry of Education, Universities and Research (MIUR)); FP7: REWIRE project; Progetto Strategico, Universitaa di Padova; SIR grant (Scientific Independence of Young Researchers)	This work was supported by a grant from the MIUR (N. 287713), the FP7: REWIRE project, by Progetto Strategico, Universitaa di Padova (N. 2010XPMFVV4) to UC and by SIR grant (Scientific Independence of Young Researchers - N. RBSI141QKX) to LS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by a grant from the MIUR (N. 287713), the FP7: REWIRE project, by Progetto Strategico, Universitaa di Padova (N. 2010XPMFW4) to UC and by SIR grant (Scientific Independence of Young Researchers N. RBSI141QKX) to LS.	Amodio DM, 2006, NAT REV NEUROSCI, V7, P268, DOI 10.1038/nrn1884; Ansuini C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00815; Avikainen S, 2002, NEUROIMAGE, V15, P640, DOI 10.1006/nimg.2001.1029; Becchio C, 2008, CONSCIOUS COGN, V17, P557, DOI 10.1016/j.concog.2007.03.003; Becchio C, 2008, COGNITION, V106, P894, DOI 10.1016/j.cognition.2007.05.004; Becchio C, 2012, NEUROIMAGE, V61, P240, DOI 10.1016/j.neuroimage.2012.03.013; Becchio C, 2010, CURR DIR PSYCHOL SCI, V19, P183, DOI 10.1177/0963721410370131; Brewer JA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00647; Buccino G, 2007, NEUROIMAGE, V36, pT119, DOI 10.1016/j.neuroimage.2007.03.036; Budisavljevic S, 2017, CEREB CORTEX, V27, P1532, DOI 10.1093/cercor/bhv348; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Calvo-Merino B, 2006, CURR BIOL, V16, P1905, DOI 10.1016/j.cub.2006.07.065; Canessa N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042347; Castiello U, 2005, NAT REV NEUROSCI, V6, P726, DOI 10.1038/nrn1744; Castiello U, 2008, NEUROSCIENTIST, V14, P157, DOI 10.1177/1073858407312080; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Chang SW, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00064; Ciaramidaro A, 2014, SOC COGN AFFECT NEUR, V9, P909, DOI 10.1093/scan/nst062; Culham JC, 2006, CURR OPIN NEUROBIOL, V16, P205, DOI 10.1016/j.conb.2006.03.005; De Lange FP, 2008, CURR BIOL, V18, P454, DOI 10.1016/j.cub.2008.02.057; Di Bono MG, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.412; Fabbri S, 2014, NEUROIMAGE, V94, P138, DOI 10.1016/j.neuroimage.2014.03.017; Filimon F, 2010, NEUROSCIENTIST, V16, P388, DOI 10.1177/1073858410375468; Frith CD, 2006, NEURON, V50, P531, DOI 10.1016/j.neuron.2006.05.001; Gallagher S, 2001, J CONSCIOUSNESS STUD, V8, P83; Gallagher S, 2008, CONSCIOUS COGN, V17, P535, DOI 10.1016/j.concog.2008.03.003; Gallivan JP, 2011, J NEUROSCI, V31, P9599, DOI 10.1523/JNEUROSCI.0080-11.2011; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gazzola V, 2006, CURR BIOL, V16, P1824, DOI 10.1016/j.cub.2006.07.072; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Georgiou I, 2007, COGNITION, V102, P415, DOI 10.1016/j.cognition.2006.01.008; Hagberg GE, 2001, NEUROIMAGE, V14, P1193, DOI 10.1006/nimg.2001.0880; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jacob P, 2005, TRENDS COGN SCI, V9, P21, DOI 10.1016/j.tics.2004.11.003; Jimura K, 2012, NEUROPSYCHOLOGIA, V50, P544, DOI 10.1016/j.neuropsychologia.2011.11.007; Johnson MK, 2006, SOC COGN AFFECT NEUR, V1, P56, DOI 10.1093/scan/nsl004; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Kilner James M, 2007, Cogn Process, V8, P159, DOI 10.1007/s10339-007-0170-2; Knoblich G., 2002, ADV CONSCIOU RES, V42, P115, DOI [10.1075/aicr.42.10kno, DOI 10.1075/AICR.42.10KNO, DOI 10.1075/AICR.42.10KN0]; Kriegeskorte N, 2009, NAT NEUROSCI, V12, P535, DOI 10.1038/nn.2303; Lombardo MV, 2010, J COGNITIVE NEUROSCI, V22, P1623, DOI 10.1162/jocn.2009.21287; Newman-Norlund RD, 2007, SOC NEUROSCI-UK, V2, P48, DOI 10.1080/17470910701224623; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Poldrack RA, 2009, SOC COGN AFFECT NEUR, V4, P208, DOI 10.1093/scan/nsp011; Rizzolatti G, 2001, NAT REV NEUROSCI, V2, P661, DOI 10.1038/35090060; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Sartori L, 2009, J EXP PSYCHOL HUMAN, V35, P1490, DOI 10.1037/a0015777; Saxe R, 2006, PSYCHOL SCI, V17, P692, DOI 10.1111/j.1467-9280.2006.01768.x; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Tanne-Gariepy J, 2002, EXP BRAIN RES, V145, P91, DOI 10.1007/s00221-002-1078-9; Thioux M, 2008, CURR BIOL, V18, pR431, DOI 10.1016/j.cub.2008.03.018; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Van Overwalle F, 2009, NEUROIMAGE, V48, P564, DOI 10.1016/j.neuroimage.2009.06.009; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; Vesia M, 2012, EXP BRAIN RES, V221, P1, DOI 10.1007/s00221-012-3158-9; Wolpert DM, 2003, PHILOS T R SOC B, V358, P593, DOI 10.1098/rstb.2002.1238; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Zaki J, 2009, P NATL ACAD SCI USA, V106, P11382, DOI 10.1073/pnas.0902666106; Zorzi M, 2011, NEUROIMAGE, V56, P674, DOI 10.1016/j.neuroimage.2010.06.035	61	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184008	10.1371/journal.pone.0184008	http://dx.doi.org/10.1371/journal.pone.0184008			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846741	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600063
J	Stafylis, C; Klausner, JD				Stafylis, Chrysovalantis; Klausner, Jeffrey D.			Evaluation of two 4th generation point-of-care assays for the detection of Human Immunodeficiency Virus infection	PLOS ONE			English	Article							ACUTE HIV-INFECTION; P24 ANTIGEN; ANTIBODY; IMMUNOASSAY	Background Fourth generation assays detect simultaneously antibodies for HIV and the p24 antigen, identifying HIV infection earlier than previous generation tests. Previous studies have shown that the Alere Determine HIV-1/2 Combo has lower than anticipated performance in detecting antibodies for HIV and the p24 antigen. Furthermore, there are currently very few studies evaluating the performance of Standard Diagnostics BIOLINE HIV Ag/Ab Combo. Objective To evaluate the performance of the Alere Determine HIV-1/2 Combo and the Standard Diagnostics BIOLINE HIV Ag/Ab Combo in a panel of frozen serum samples. Study design The testing panel included 133 previously frozen serum specimens from the UCLA Clinical Microbiology & Immunoserology laboratory. Reference testing included testing for HIV antibodies by a 3rd generation enzyme immunoassay followed by HIV RNA detection. Antibody negative and RNA positive sera were also tested by a laboratory 4th generation HIV Ab/Ag enzyme immunoassay. Results Reference testing yielded 97 positives for HIV infection and 36 negative samples. Sensitivity of the Alere test was 95% (88-98%), while the SD Bioline sensitivity was 91% (83-96%). Both assays showed 100% (90-100%) specificity. No indeterminate or invalid results were recorded. Among 13 samples with acute infection (HIV RNA positive, HIV antibody negative), 12 were found positive by the first assay and 8 by the second. The antigen component of the Alere assay detected 10 acute samples, while the SD Bioline assay detected only one. Conclusions Both rapid assays showed very good overall performance in detecting HIV infection in frozen serum samples, but further improvements are required to improve the performance in acute infection.	[Stafylis, Chrysovalantis; Klausner, Jeffrey D.] UCLA, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Stafylis, C (corresponding author), UCLA, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	cstafylis@mednet.ucla.edu	Stafylis, Chrysovalantis/S-3569-2019	Stafylis, Chrysovalantis/0000-0002-1486-1130				[Anonymous], 2013, SD BIOLINE HIV AG AB; [Anonymous], DETERMINE HIV 1 2 AG, V1, P1; Brauer M, 2013, J VIROL METHODS, V189, P180, DOI 10.1016/j.jviromet.2013.01.017; Chetty V, 2012, J CLIN VIROL, V54, P180, DOI 10.1016/j.jcv.2012.02.021; Cragin L, 2012, HIV CLIN TRIALS, V13, P11, DOI [10.1310/hct1301-11, 10.1310/hct1301-011]; Faraoni S, 2013, J CLIN VIROL, V57, P84, DOI 10.1016/j.jcv.2013.01.007; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Fitzgerald N, 2017, SEX TRANSM INFECT, V93, P100, DOI 10.1136/sextrans-2015-052491; Fransen K, 2016, J CLIN VIROLOGY; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Pandori MW, 2009, J CLIN MICROBIOL, V47, P2639, DOI 10.1128/JCM.00119-09; Qiu XX, 2017, J CLIN VIROL, V92, P62, DOI 10.1016/j.jcv.2017.05.005; Rosenberg NE, 2012, J INFECT DIS, V205, P528, DOI 10.1093/infdis/jir789; Smallwood M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149592; World Health Organization (WHO), 2013, WHO PREQ DIAGN PROGR	15	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183944	10.1371/journal.pone.0183944	http://dx.doi.org/10.1371/journal.pone.0183944			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846743	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600059
J	Genschow, O; Demanet, J; Hersche, L; Brass, M				Genschow, Oliver; Demanet, Jelle; Hersche, Lea; Brass, Marcel			An empirical comparison of different implicit measures to predict consumer choice	PLOS ONE			English	Article							AFFECTIVE SIMON TASK; ASSOCIATION TEST; AUTOMATIC ACTIVATION; COGNITIVE FOCUS; SELF-CONCEPT; ATTITUDES; AVOIDANCE; EXPLICIT; PREDISPOSITIONS; PREJUDICE	While past research has found that implicit measures are good predictors of affectively driven, but not cognitively driven, behavior it has not yet been tested which implicit measures best predict behavior. By implementing a consumer context, in the present experiment, we assessed two explicit measures (i.e. self-reported habit and tastiness) and three implicit measures (i.e. manikin task, affective priming, ID-EAST) in order to test the predictive validity of affectively versus cognitively driven choices. The results indicate that irrespective of whether participants chose affectively or cognitively, both explicit measures, but not the implicit measures, predicted consumer choice very strongly. Likewise, when comparing the predictive validity among all measures, the explicit measures were the best predictors of consumer choice. Theoretical implications and limitations of the study are discussed.	[Genschow, Oliver] Univ Cologne, Social Cognit Ctr Cologne, Cologne, Germany; [Demanet, Jelle; Brass, Marcel] Univ Ghent, Dept Expt Psychol, Ghent, Belgium; [Hersche, Lea] Univ Basel, Dept Psychol, Basel, Switzerland	University of Cologne; Ghent University; University of Basel	Genschow, O (corresponding author), Univ Cologne, Social Cognit Ctr Cologne, Cologne, Germany.	oliver.genschow@uni-koeln.de	Brass, Marcel/J-7082-2012; Demanet, Jelle/A-5667-2008; Demanet, Jelle/AAW-2886-2020	Brass, Marcel/0000-0002-3364-4019; 	Swiss National Science Foundation [PZ00P1_168007]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by a grant from the Swiss National Science Foundation (grant number PZ00P1_168007). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L.S., 1996, MULTIPLE REGRESSION; Asendorpf JB, 2002, J PERS SOC PSYCHOL, V83, P380, DOI 10.1037//0022-3514.83.2.380; Bamford S, 2008, EMOTION, V8, P174, DOI 10.1037/1528-3542.8.2.174; Bar-Anan Y, 2014, BEHAV RES METHODS, V46, P668, DOI 10.3758/s13428-013-0410-6; Bar-Anan Y, 2009, EXP PSYCHOL, V56, P329, DOI 10.1027/1618-3169.56.5.329; Brendl CM, 2005, J EXP SOC PSYCHOL, V41, P346, DOI 10.1016/j.jesp.2004.07.006; Brunel FF, 2004, J CONSUM PSYCHOL, V14, P385, DOI 10.1207/s15327663jcp1404_8; Chen M, 1999, PERS SOC PSYCHOL B, V25, P215, DOI 10.1177/0146167299025002007; Crocker L, 1986, INTRO CLASSICAL MODE; Cronbach Lee J., 1990, ESSENTIALS PSYCHOL T, V5th; De Houwer J, 2003, EXP PSYCHOL, V50, P77, DOI 10.1026//1618-3169.50.2.77; De Houwer J, 2001, COGNITION EMOTION, V15, P189, DOI 10.1080/0269993004200051; De Houwer J., 2006, HDB IMPLICIT COGNITI, P11, DOI [10.4135/9781412976237.n2, DOI 10.4135/9781412976237.N2]; De Houwer J, 2007, J BEHAV THER EXP PSY, V38, P133, DOI 10.1016/j.jbtep.2006.10.004; De Houwer J, 2007, BRIT J SOC PSYCHOL, V46, P401, DOI 10.1348/014466606X130346; De Houwer J, 2009, PSYCHOL BULL, V135, P347, DOI 10.1037/a0014211; Degner J, 2010, J PERS SOC PSYCHOL, V98, P356, DOI 10.1037/a0017993; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; Eder AB, 2008, J EXP PSYCHOL GEN, V137, P262, DOI 10.1037/0096-3445.137.2.262; Elliot AJ, 2008, HANDBOOK OF APPROACH AND AVOIDANCE MOTIVATION, P1; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; Florack A, 2010, J CONSUM PSYCHOL, V20, P193, DOI 10.1016/j.jcps.2010.02.001; Friese M., 2009, SOCIAL PSYCHOL CONSU, P335; Friese M, 2008, BRIT J SOC PSYCHOL, V47, P397, DOI 10.1348/014466607X241540; Friese M, 2006, PSYCHOL MARKET, V23, P727, DOI 10.1002/mar.20126; Genschow O, 2014, SOCIAL PSYCHOL, P904; Genschow O, 2013, BASIC APPL SOC PSYCH, V35, P298, DOI 10.1080/01973533.2013.785399; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2009, J PERS SOC PSYCHOL, V97, P17, DOI 10.1037/a0015575; Hayes AF, 2009, BEHAV RES METHODS, V41, P924, DOI 10.3758/BRM.41.3.924; Hofmann Wilhelm, 2005, EUROPEAN REV SOCIAL, V16, P335, DOI [DOI 10.1080/10463280500443228, 10.1080/10463280500443228]; Huijding J, 2005, PSYCHOL BELG, V45, P241, DOI 10.5334/pb-45-4-241; Karpinski A, 2006, J PERS SOC PSYCHOL, V91, P16, DOI 10.1037/0022-3514.91.1.16; Krieglmeyer R, 2010, COGNITION EMOTION, V24, P810, DOI 10.1080/02699930903047298; Krieglmeyer R, 2010, PSYCHOL SCI, V21, P607, DOI 10.1177/0956797610365131; Lang PJ, 2008, INT AFFECTIVE PICTUR; Maison D, 2004, J CONSUM PSYCHOL, V14, P405, DOI 10.1207/s15327663jcp1404_9; MILLAR MG, 1992, CONSTRUCTION OF SOCIAL JUDGMENTS, P277; MILLAR MG, 1986, J PERS SOC PSYCHOL, V51, P270, DOI 10.1037/0022-3514.51.2.270; Morange F, 1996, EARLY DEV PARENTING, V5, P81, DOI 10.1002/(SICI)1099-0917(199606)5:2<81::AID-EDP119>3.0.CO;2-M; Nosek BA, 2001, SOC COGNITION, V19, P625, DOI 10.1521/soco.19.6.625.20886; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Scarabis M, 2006, PSYCHOL MARKET, V23, P1015, DOI 10.1002/mar.20144; Schmukle SC, 2006, EXP PSYCHOL, V53, P149, DOI 10.1027/1618-3169.53.2.149; Schulz R, 1985, HDB PSYCHOL AGING, P931; Seibt B, 2008, J EXP SOC PSYCHOL, V44, P713, DOI 10.1016/j.jesp.2007.04.013; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; Smith CT, 2011, SOC PSYCHOL-GERMANY, V42, P300, DOI 10.1027/1864-9335/a000072; Sriram N, 2009, EXP PSYCHOL, V56, P283, DOI 10.1027/1618-3169.56.4.283; Stevens M, 2006, BEHAV RES METHODS, V38, P280, DOI 10.3758/BF03192779; Teige S, 2004, EUR J PERSONALITY, V18, P495, DOI 10.1002/per.531; Topolinski S, 2009, COGNITION EMOTION, V23, P1465, DOI 10.1080/02699930802420745; van Dantzig S, 2008, Q J EXP PSYCHOL, V61, P1298, DOI 10.1080/17470210802027987; VONHOFSTEN C, 1988, J EXP PSYCHOL HUMAN, V14, P610, DOI 10.1037/0096-1523.14.4.610; Wilson TD, 2000, PSYCHOL REV, V107, P101, DOI 10.1037/0033-295X.107.1.101; Zanna M.P., 2008, SOCIAL PSYCHOL KNOWL, P315	58	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183937	10.1371/journal.pone.0183937	http://dx.doi.org/10.1371/journal.pone.0183937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841700	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700070
J	Rickard, JP; Ryan, G; Hall, E; de Graaf, SP; Hermes, R				Rickard, Jessica Paige; Ryan, Gabrielle; Hall, Evelyn; de Graaf, Simon Paul; Hermes, Robert			Using transrectal ultrasound to examine the effect of exogenous progesterone on early embryonic loss in sheep	PLOS ONE			English	Article							EARLY-PREGNANCY DIAGNOSIS; ESTROUS-CYCLE; SURVIVAL; EWES; MORTALITY; CONCEPTUS; ULTRASONOGRAPHY; SUPPLEMENTATION; FERTILIZATION; IMPLANTATION	The financial impact of early embryonic loss in Australia may be as high as $137 million AUD/year. Embryos may be lost due to environmental conditions, or maternal factors such as nutrition or progesterone (P4) profiles. However, studies on the supplementation of P4 during early pregnancy have returned contradictory results, partly as a reliable method of detecting embryos in the early stages of gestation (<day 20) has yet be established. As such, Merino ewes (n = 62) were either not supplemented (control) or were given exogenous P4 at the time of insemination (day 0) or 3 days later (day 3). Transrectal ultrasound (TRUS) was performed on day 10, 12, 14, 17, 19 and 29 following laparoscopic artificial insemination. Transcutaneous ultrasound (TCUS) was performed on day 54 to confirm pregnancy and peripheral blood was collected for hormone analysis on day 19 to compare the accuracy of all three pregnancy diagnosis methods. Data were then analysed in developmental periods. The percentage of ewes detected as pregnant by TRUS during pre-, peri- and post implantation was 66% (41/62; day 12 and 14), 61% (38/62; day 17 and 19) and 58% (36/62; day 29), respectively. TCUS during established gestation recorded a pregnancy rate of 60% (37/62). The sensitivity of TRUS to correctly diagnose ewes as pregnant during pre-, peri- and post implantation was 68% (25/37), 89% (33/37) and 100% (36/36), respectively, while the sensitivity to correctly identify multiples was 49% (16/33), 60% (21/35) and 97% (34/35), respectively (P<0.05). The majority of embryonic loss occurred between pre- and peri-implantation (0.9 +/- 0.15 per ewe; P<0.001). No further loss was recorded after this point. Ewes that were given P4 at day 0 had significantly higher embryonic loss (77%) compared to the control (52%) and day 3-ewes (56%; P<0.05). These results show TRUS is a viable tool for investigating early embryonic loss and that the variability noted in previous P4 supplementation studies may be due to variation in time and length of treatment.	[Rickard, Jessica Paige; Ryan, Gabrielle; Hall, Evelyn; de Graaf, Simon Paul; Hermes, Robert] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Hermes, Robert] Leibniz Inst Zoo & Wildlife Res, Dept Reprod Management, Berlin, Germany	University of Sydney; Leibniz Institut fur Zoo und Wildtierforschung	Rickard, JP (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	jessica.rickard@sydney.edu.au	de Graaf, Simon P/B-8295-2013; Ryan, Greg/B-7618-2016	de Graaf, Simon P/0000-0002-0870-4219; Rickard, Jessica/0000-0002-4137-2818	University of Sydney; New South Wales, Department of Primary Industries (NSW DPI) [R5089 20601 1122904]; New South Wales Department of Primary Industries (NSW DPI)	University of Sydney(University of Sydney); New South Wales, Department of Primary Industries (NSW DPI); New South Wales Department of Primary Industries (NSW DPI)	Dr Rickard received research compact funding from the University of Sydney and the New South Wales, Department of Primary Industries (NSW DPI), account code: R5089 20601 1122904. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by research compact funding from The University of Sydney and the New South Wales Department of Primary Industries (NSW DPI). Zoetis Australia (Rhodes, Australia) are thanked for the donation of EaziBreed CIDRs and Vetoquinol Australia (Brisbane, Australia) for the donation of Ovagest sponges and eCG (Pregancol). The authors would also like to thank Mr Brian Sharrock (Hamilton Genetics) for donating his time during inseminations and Dr Gordon Refshauge, Mr Cameron Sharpe, Miss Taylor Pini, Miss Naomi Bernecic, Miss Jessie Maddison, Dr Angela Crean, Miss Nicola Culey, Miss Bethan Arthur, Miss Kiri Farmer and Mr Max Lloyd for their on-farm assistance.	ABARES, 2016, AGR COMM STAT; Abecia JA, 2015, ZYGOTE, V23, P116, DOI 10.1017/S096719941300035X; Abecia JA, 1999, THERIOGENOLOGY, V52, P1203, DOI 10.1016/S0093-691X(99)00212-5; Ashworth C.J., 1984, P 10 INT C ANIMAL RE, P74; ASHWORTH CJ, 1989, J REPROD FERTIL, V87, P23, DOI 10.1530/jrf.0.0870023; ASHWORTH CJ, 1989, BIOL REPROD, V40, P425, DOI 10.1095/biolreprod40.2.425; Bari F, 2003, THERIOGENOLOGY, V59, P1265, DOI 10.1016/S0093-691X(02)01162-7; BEDFORD CA, 1972, J ENDOCRINOL, V55, P105, DOI 10.1677/joe.0.0550105; BINDON BM, 1971, AUST J BIOL SCI, V24, P149, DOI 10.1071/BI9710149; BINDON BM, 1971, AUST J BIOL SCI, V24, P131, DOI 10.1071/BI9710131; Bolet G., 1986, Embryonic mortality in farm animals., P12; BOSHIER DP, 1969, J REPROD FERTIL, V19, P51, DOI 10.1530/jrf.0.0190051; BRYDEN MM, 1972, J MORPHOL, V138, P169, DOI 10.1002/jmor.1051380204; Carr A. L., 2001, Sheep and Goat Research Journal, V17, P27; CHANG MC, 1965, ANAT REC, V152, P303, DOI 10.1002/ar.1091520310; DAY BN, 1968, J REPROD FERTIL, V17, P227, DOI 10.1530/jrf.0.0170227; Diskin MG, 2008, REPROD DOMEST ANIM, V43, P260, DOI 10.1111/j.1439-0531.2008.01171.x; DISKIN MG, 1989, J ANIM SCI, V67, P1559; Dixon AB, 2007, J ANIM SCI, V85, P1274, DOI 10.2527/jas.2006-129; DUTT RH, 1963, J ANIM SCI, V22, P713, DOI 10.2527/jas1963.223713x; EDEY TN, 1967, J REPROD FERTIL, V13, P437, DOI 10.1530/jrf.0.0130437; EDEY TN, 1966, J AGR SCI-CAMBRIDGE, V67, P287, DOI 10.1017/S0021859600017299; Evans G., 1987, SALAMONS ARTIFICIAL; GARCIA A, 1993, THERIOGENOLOGY, V39, P847, DOI 10.1016/0093-691X(93)90423-3; GARRETT JE, 1988, J REPROD FERTIL, V84, P437, DOI 10.1530/jrf.0.0840437; Grazul-Bilska AT, 2011, REPRODUCTION, V141, P529, DOI 10.1530/REP-10-0505; Green WW, 1945, TECH B MINN AGR EXP, P169; GUILLOMOT M, 1981, PLACENTA, V2, P169, DOI 10.1016/S0143-4004(81)80021-5; Holler TL, 2014, J ANIM SCI, V92, P3108, DOI 10.2527/jas.2013-7489; HOLST PJ, 1986, AUST J AGR RES, V37, P647, DOI 10.1071/AR9860647; KLEEMANN DO, 1991, REPROD FERT DEVELOP, V3, P71, DOI 10.1071/RD9910071; KLEEMANN DO, 1994, J REPROD FERTIL, V102, P411, DOI 10.1530/jrf.0.1020411; LAWSON RAS, 1983, J REPROD FERTIL, V67, P473, DOI 10.1530/jrf.0.0670473; Lonergan P, 2007, REPROD FERT DEVELOP, V19, P861, DOI 10.1071/RD07089; MILLER BG, 1977, AUST J BIOL SCI, V30, P279, DOI 10.1071/BI9770279; MLA, 2017, HOOKS IND SHEEP LAMB; Moufort JD, 1990, COMPENDIUM CONTINUIN, V12, P1182; O'Connell AR, 2016, THERIOGENOLOGY, V86, P1285, DOI 10.1016/j.theriogenology.2016.04.069; O'Connell AR, 2013, THERIOGENOLOGY, V80, P269, DOI 10.1016/j.theriogenology.2013.04.006; OTTOBRE JS, 1980, BIOL REPROD, V23, P1046, DOI 10.1095/biolreprod23.5.1046; PARR RA, 1992, REPROD FERT DEVELOP, V4, P297, DOI 10.1071/RD9920297; PARR RA, 1982, J AGR SCI, V98, P39, DOI 10.1017/S0021859600041083; QUINLIVAN TD, 1966, J REPROD FERTIL, V11, P379, DOI 10.1530/jrf.0.0110379; RESTALL BJ, 1976, AUST J EXP AGR, V16, P329, DOI 10.1071/EA9760329; RHIND SM, 1989, ANIM PROD, V48, P149, DOI 10.1017/S0003356100003883; ROBERTSON HA, 1971, J ENDOCRINOL, V49, P407, DOI 10.1677/joe.0.0490407; Romano JE, 2008, SMALL RUMINANT RES, V77, P51, DOI 10.1016/j.smallrumres.2008.02.004; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Scenna FN, 2005, PROSTAG OTH LIPID M, V78, P38, DOI 10.1016/j.prostaglandins.2005.02.003; SCHRICK FN, 1993, THERIOGENOLOGY, V40, P295, DOI 10.1016/0093-691X(93)90267-9; Shorten PR, 2013, J ANIM SCI, V91, P4641, DOI 10.2527/jas.2013-6415; Sirard MA, 2006, THERIOGENOLOGY, V65, P126, DOI 10.1016/j.theriogenology.2005.09.020; Soede NM, 2012, REPROD DOMEST ANIM, V47, P835, DOI 10.1111/j.1439-0531.2011.01977.x; Spencer TE, 2004, REPRODUCTION, V128, P657, DOI 10.1530/rep.1.00398; VINCENT DL, 1986, ENDOCRINOLOGY, V119, P527, DOI 10.1210/endo-119-2-527; VINCENT DL, 1986, PROSTAG OTH LIPID M, V31, P715, DOI 10.1016/0090-6980(86)90176-0; Vinoles C, 2012, REPROD FERT DEVELOP, V24, P1040, DOI 10.1071/RD11281; WILMUT I, 1985, THERIOGENOLOGY, V23, P107, DOI 10.1016/0093-691X(85)90076-7; WILMUT I, 1986, J REPROD FERTIL, V76, P851, DOI 10.1530/jrf.0.0760851; Wilsher S, 2012, EQUINE VET J, V44, P432, DOI 10.1111/j.2042-3306.2011.00473.x; WOODY CO, 1967, J ANIM SCI, V26, P139, DOI 10.2527/jas1967.261139x	61	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183659	10.1371/journal.pone.0183659	http://dx.doi.org/10.1371/journal.pone.0183659			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841708	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700048
J	Adeniyi, OV; Ajayi, AI; Selanto-Chairman, N; Ter Goon, D; Boon, G; Fuentes, YO; Hofmeyr, GJ; Avramovic, G; Carty, C; Lambert, J				Adeniyi, Oladele Vincent; Ajayi, Anthony Idowu; Selanto-Chairman, Nonkosi; Ter Goon, Daniel; Boon, Gerry; Fuentes, Yusimi Ordaz; Hofmeyr, George Justus; Avramovic, Gordana; Carty, Craig; Lambert, John		East London Prospective Cohort	Demographic, clinical and behavioural determinants of HIV serostatus nondisclosure to sex partners among HIV-infected pregnant women in the Eastern Cape, South Africa	PLOS ONE			English	Article							TRANSMISSION RISK; DISCLOSURE; PEOPLE; HIV/AIDS; PREDICTORS; ABSENT	Objectives Drawing from a baseline sample of a cohort study, the study examines the extent and correlates of serostatus non-disclosure to sex partners and family members, and reasons for non-disclosure among HIV-infected pregnant women in the Eastern Cape Province, South Africa. Methods This longitudinal cohort study recruited 1709 pregnant women living with HIV who attended three of the largest maternity centres in the Eastern Cape, South Africa, for delivery between September 2015 and May 2016. Relevant items on demographics, serostatus awareness, disclosure to sex partners and family members, and lifestyle behaviours were obtained using structured interviews. Age-stratified binary logistic regression models were used to determine the significant correlates of non-disclosure among the participants. Results A higher rate of HIV serostatus non-disclosure to sex partners (25.6%) in comparison to family members (20%) was reported by the participants. Younger age, not living with partners and alcohol use were significantly associated with non-disclosure of HIV serostatus to sex partners. Non-disclosure of HIV serostatus to sex partners was significantly (p<0.05) associated with poor adherence to the highly active anti-retroviral therapy (HAART), failure to keep clinic appointments and high viral load at the delivery of the baby. Perceived fear of intimate partner violence, fear of rejection, guilt of not disclosing at the onset of the relationship, sex partner's non-disclosure of HIV serostatus, and guilt of unfaithfulness were some of the reasons for non-disclosure of HIV serostatus to sex partners. Conclusions Non-disclosure of HIV serostatus is a public health concern with serious implications for both mother-to-child transmission, as well as horizontal transmission, in our setting. Strategic efforts toward ending the epidemic of HIV and AIDS in South Africa should address the sociocultural and behavioural determinants of non-disclosure.	[Adeniyi, Oladele Vincent] Walter Sisulu Univ, Cecilia Makiwane Hosp, Dept Family Med & Rural Hlth, East London Hosp Complex, East London, South Africa; [Ajayi, Anthony Idowu] Univ Ft Hare, Dept Sociol, East London, South Africa; [Selanto-Chairman, Nonkosi] Buffalo City Metro Dept Hlth, East London, South Africa; [Ter Goon, Daniel] Univ Ft Hare, Fac Hlth Sci, East London, South Africa; [Boon, Gerry] Walter Sisulu Univ, Frere Hosp, Dept Paediat, East London Hosp Complex, East London, South Africa; [Fuentes, Yusimi Ordaz] Cecilia Makiwane Hosp, Dept Family Med, East London Hosp Complex, East London, South Africa; [Hofmeyr, George Justus] Walter Sisulu Univ, Frere Hosp, Effect Care Res Unit, East London Hosp Complex, East London, South Africa; [Avramovic, Gordana] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Catherine McAuley Educ & Res Ctr, Dublin, Ireland; [Carty, Craig] Relevance Network, Johannesburg, South Africa; [Lambert, John] Univ Coll Dublin, Mater Misericordiae Univ Hosp, Catherine McAuley Educ & Res Ctr, Dublin, Ireland	Walter Sisulu University; University of Fort Hare; University of Fort Hare; Walter Sisulu University; Walter Sisulu University; Mater Misericordiae University Hospital; University College Dublin; Mater Misericordiae University Hospital; University College Dublin	Adeniyi, OV (corresponding author), Walter Sisulu Univ, Cecilia Makiwane Hosp, Dept Family Med & Rural Hlth, East London Hosp Complex, East London, South Africa.	vincoladele@gmail.com	Goon, Daniel Ter/C-2912-2019; Ajayi, Anthony Idowu/N-4272-2016	Goon, Daniel Ter/0000-0001-9070-7875; Ajayi, Anthony Idowu/0000-0002-6004-3972; Avramovic, Gordana/0000-0001-9610-6472; ADENIYI, OLADELE VINCENT/0000-0003-0216-6701; lambert, john/0000-0001-5404-2415	Positive Action Grant from ViiV Healthcare Limited; Discovery Foundation; Association of African Universities	Positive Action Grant from ViiV Healthcare Limited; Discovery Foundation; Association of African Universities	Development and implementation of electronic database was supported by the Positive Action Grant from ViiV Healthcare Limited to CC, JL & OVA. OVA received research grants from Discovery Foundation and Association of African Universities. Funders have no involvement in the process of the study or content thereof.	Adeniyi VO, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0414-8; Ahn JV, 2016, AIDS BEHAV, V20, P174, DOI 10.1007/s10461-015-1089-8; Amoran OE, 2012, NIGER J CLIN PRACT, V15, P385, DOI 10.4103/1119-3077.104507; Anglewicz P, 2011, AIDS CARE, V23, P998, DOI 10.1080/09540121.2010.542130; Antelman G, 2001, AIDS, V15, P1865, DOI 10.1097/00002030-200109280-00017; Arnold EM, 2008, AIDS CARE, V20, P80, DOI 10.1080/09540120701449138; Bachanas P, 2013, AIDS PATIENT CARE ST, V27, P425, DOI 10.1089/apc.2012.0388; Bedelu M, 2007, J INFECT DIS, V196, pS464, DOI 10.1086/521114; Biadgilign S, 2009, SAHARA J J SOCIAL AS, V6; Brou H, 2007, PLOS MED, V4, P1912, DOI 10.1371/journal.pmed.0040342; Conserve DF, 2014, AIDS BEHAV, V18, P1037, DOI 10.1007/s10461-013-0685-8; Denis P, 2006, BABA MEN FATHERHOOD, P237; Gadisa T, 2016, AIDS BEHAV, P1; Holt R, 1998, AIDS CARE, V10, P49, DOI 10.1080/09540129850124578; Jasseron C, 2013, AIDS BEHAV, V17, P488, DOI 10.1007/s10461-011-0084-y; King R, 2008, AIDS BEHAV, V12, P232, DOI 10.1007/s10461-007-9307-7; Kiula ES, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-433; Madhavan S, 2008, J S AFR STUD, V34, P647, DOI 10.1080/03057070802259902; Makin JD, 2008, AIDS PATIENT CARE ST, V22, P907, DOI 10.1089/apc.2007.0194; NDoHS, 2015, NAT CONS GUID PREV M; Norman A, 2007, AM J PUBLIC HEALTH, V97, P1775, DOI 10.2105/AJPH.2005.082511; O'Connell AA, 2015, AIDS BEHAV, V19, P283, DOI 10.1007/s10461-014-0848-2; Onovo AA, 2015, BMC PUBLIC HEALTH, V15, P1; Padi T, 2014, S AFR REV SOCIOL, V45, P44, DOI 10.1080/21528586.2014.917879; Pinkerton SD, 2007, AIDS BEHAV, V11, P698, DOI 10.1007/s10461-006-9187-2; Przybyla SM, 2013, AIDS CARE, V25, P566, DOI 10.1080/09540121.2012.722601; Qiao S, 2016, AIDS CARE, P1; Rujumba J, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17429; Seid M, 2012, AFRICAN J REPROD HLT, V16; Sendo EG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-765; Stirratt MJ, 2006, AIDS BEHAV, V10, P483, DOI 10.1007/s10461-006-9106-6; Stutterheim SE, 2011, AIDS CARE, V23, P195, DOI 10.1080/09540121.2010.498873; Titilope Adeyemo A, 2011, Niger Med J, V52, P55; Trinh TT, 2014, PARTNER DISCLOSURE E; Tsai AC, 2013, ANN BEHAV MED, V46, P285, DOI 10.1007/s12160-013-9514-6; UNAIDS, 2016, PREP S AFR GEN; Vu L, 2012, AIDS BEHAV, V16, P132, DOI 10.1007/s10461-010-9873-y; Yonah G, 2014, AIDS RES THER, V11, DOI 10.1186/1742-6405-11-5; Zuma K, 2016, AJAR-AFR J AIDS RES, V15, P67, DOI 10.2989/16085906.2016.1153491	39	23	25	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181730	10.1371/journal.pone.0181730	http://dx.doi.org/10.1371/journal.pone.0181730			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837563	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000010
J	Flechsenhar, AF; Gamer, M				Flechsenhar, Aleya Felicia; Gamer, Matthias			Top-down influence on gaze patterns in the presence of social features	PLOS ONE			English	Article							HIGH-LEVEL POP; VISUAL-ATTENTION; FACES; EYES; SELECTION; CONTINGENT; PERCEPTION; RESPONSES; FIXATION; OBJECTS	Visual saliency maps reflecting locations that stand out from the background in terms of their low-level physical features have proven to be very useful for empirical research on attentional exploration and reliably predict gaze behavior. In the present study we tested these predictions for socially relevant stimuli occurring in naturalistic scenes using eye tracking. We hypothesized that social features (i.e. human faces or bodies) would be processed preferentially over non-social features (i.e. objects, animals) regardless of their low-level saliency. To challenge this notion, we included three tasks that deliberately addressed non-ocial attributes. In agreement with our hypothesis, social information, especially heads, was preferentially attended compared to highly salient image regions across all tasks. Social information was never required to solve a task but was regarded nevertheless. More so, after completing the task requirements, viewing behavior reverted back to that of free-viewing with heavy prioritization of social features. Additionally, initial eye movements reflecting potentially automatic shifts of attention, were predominantly directed towards heads irrespective of top-down task demands. On these grounds, we suggest that social stimuli may provide exclusive access to the priority map, enabling social attention to override reflexive and controlled attentional processes. Furthermore, our results challenge the generalizability of saliency-based attention models.	[Flechsenhar, Aleya Felicia; Gamer, Matthias] Julius Maximilian Univ Wuerzburg, Dept Psychol, Wurzburg, Germany	University of Wurzburg	Flechsenhar, AF (corresponding author), Julius Maximilian Univ Wuerzburg, Dept Psychol, Wurzburg, Germany.	aleya.flechsenhar@uni-wuerzburg.de	Gamer, Matthias/E-7967-2010	Gamer, Matthias/0000-0002-9676-9038; Flechsenhar, Aleya/0000-0003-1287-4832	European Research Council (ERC-StG) [336305]	European Research Council (ERC-StG)(European Research Council (ERC))	The present research was supported by a grant of the European Research Council (ERC-2013-StG #336305) awarded to M.G. The funding agency was not involved in decisions concerning the study design, the data collection, the analysis and interpretation of data, the writing of the report, and the submission of the article for publication.	Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; Bindemann M, 2007, J VISION, V7, DOI 10.1167/7.10.15; Birmingham E, 2008, Q J EXP PSYCHOL, V61, P986, DOI 10.1080/17470210701410375; Birmingham E, 2008, VIS COGN, V16, P341, DOI 10.1080/13506280701434532; Birmingham E, 2009, VISION RES, V49, P2992, DOI 10.1016/j.visres.2009.09.014; Borji A, 2013, IEEE T PATTERN ANAL, V35, P185, DOI 10.1109/TPAMI.2012.89; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; Cerf M, 2008, PROCEEDINGS OF THE EYE TRACKING RESEARCH AND APPLICATIONS SYMPOSIUM (ETRA 2008), P143, DOI 10.1145/1344471.1344508; Cohen J.E., 1988, STAT POWER ANAL BEHA; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crouzet SM, 2010, J VISION, V10, DOI 10.1167/10.4.16; DeAngelus M, 2009, VIS COGN, V17, P790, DOI 10.1080/13506280902793843; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Einhauser W, 2008, J VISION, V8, DOI 10.1167/8.2.2; Elazary L, 2008, J VISION, V8, DOI 10.1167/8.3.3; End A, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00418; Fitzgerald DA, 2006, NEUROIMAGE, V30, P1441, DOI 10.1016/j.neuroimage.2005.11.003; Fletcher-Watson S, 2008, PERCEPTION, V37, P571, DOI 10.1068/p5705; Folk CL, 1998, J EXP PSYCHOL HUMAN, V24, P847, DOI 10.1037/0096-1523.24.3.847; Foulsham T, 2011, ATTEN PERCEPT PSYCHO, V73, P266, DOI 10.3758/s13414-010-0014-5; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Gamer M, 2013, CURR BIOL, V23, pR917, DOI 10.1016/j.cub.2013.09.008; Gamer M, 2009, J NEUROSCI, V29, P9123, DOI 10.1523/JNEUROSCI.1883-09.2009; Henderson John M., 2007, P537, DOI 10.1016/B978-008044980-7/50027-6; Hershler O, 2005, VISION RES, V45, P1707, DOI 10.1016/j.visres.2004.12.021; Itti L, 1998, IEEE T PATTERN ANAL, V20, P1254, DOI 10.1109/34.730558; Jednorog K, BEHAV RES METHODS; Johnson MH, 2005, NAT REV NEUROSCI, V6, P766, DOI 10.1038/nrn1766; Judd T., 2012, MITCSAILTR2012001; Kennedy DP, 2011, NEUROPSYCHOLOGIA, V49, P589, DOI 10.1016/j.neuropsychologia.2011.02.026; Knudsen EI, 2007, ANNU REV NEUROSCI, V30, P57, DOI 10.1146/annurev.neuro.30.051606.094256; Koval MJ, 2005, EXP BRAIN RES, V167, P475, DOI 10.1007/s00221-005-0206-8; Kuhn G, 2016, COGNITION, V146, P136, DOI 10.1016/j.cognition.2015.08.005; Lawrence M., 2016, EASY ANAL VISUALIZAT; Liu J, 2002, NAT NEUROSCI, V5, P910, DOI 10.1038/nn909; Loschky LC, 2002, J EXP PSYCHOL-APPL, V8, P99, DOI 10.1037/1076-898X.8.2.99; Morris JS, 2001, BRAIN, V124, P1241, DOI 10.1093/brain/124.6.1241; Nuthmann A, 2015, ANN NY ACAD SCI, V1339, P82, DOI 10.1111/nyas.12705; Pegna AJ, 2004, HUM BRAIN MAPP, V22, P300, DOI 10.1002/hbm.20039; Perona, 2007, ADV NEURAL INFORM PR, P545, DOI DOI 10.7551/MITPRESS/7503.003.0073; Ricciardelli P, 2002, NEUROREPORT, V13, P2259, DOI 10.1097/00001756-200212030-00018; Ro T, 2001, PSYCHOL SCI, V12, P94, DOI 10.1111/1467-9280.00317; Scheller E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041792; Sharma P, 2015, J IMAGING SCI TECHN, V59, DOI 10.2352/AmagingSci.Technol.2015.59.5.050501; Tatler BW, 2011, J VISION, V11, DOI 10.1167/11.5.5; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; van Diepen PMJ, 2003, VIS COGN, V10, P79, DOI 10.1080/13506280143000023; VanRullen R, 2006, VISION RES, V46, P3017, DOI 10.1016/j.visres.2005.07.009; Vuilleumier P, 2001, NEUROPSYCHOLOGIA, V39, P1144, DOI 10.1016/S0028-3932(01)00048-3; Vuilleumier P, 2000, NEUROPSYCHOLOGIA, V38, P693, DOI 10.1016/S0028-3932(99)00107-4; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	52	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183799	10.1371/journal.pone.0183799	http://dx.doi.org/10.1371/journal.pone.0183799			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837673	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000124
J	Liang, JY; Kulasiri, D; Samarasinghe, S				Liang, Jingyi; Kulasiri, Don; Samarasinghe, Sandhya			Computational investigation of Amyloid-beta-induced location- and subunit-specific disturbances of NMDAR at hippocampal dendritic spine in Alzheimer's disease	PLOS ONE			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-II; GLUTAMATE UPTAKE; SYNAPTIC PLASTICITY; CALCIUM HYPOTHESIS; RECEPTOR TRAFFICKING; SENSITIVITY-ANALYSIS; CULTURED ASTROCYTES; SOLUBLE OLIGOMERS; MEMORY FORMATION	In Alzheimer's disease (AD), dysregulation of intracellular Ca2+ signalling has been observed as an early event prior to the presence of clinical symptoms and is believed to be a crucial factor contributing to AD pathogenesis. Amyloid-beta oligomers (A beta Os) disturb the N-methyl-D-aspartate receptor (NMDAR)-mediated postsynaptic Ca2+ signalling in response to presynaptic stimulation by increasing the availability of extracellular glutamate as well as directly disturbing the NMDARs. The abnormal Ca2+ response can further lead to impairments in long-term potentiation (LTP), an important process in memory formation. In this study, we develop a mathematical model of a CA1 pyramidal dendritic spine and conduct computational experiments. We use this model to mimic alterations by A beta Os under AD conditions to investigate how they are involved in the Ca2+ dysregulation in the dendritic spine. The alterations in glutamate availability, as well as NMDAR availability and activity, are studied both individually and globally. The simulation results suggest that alterations in glutamate availability mostly affect the synaptic response and have limited effects on the extra-synaptic receptors. Moreover, overactivation of extrasynaptic NMDARs in AD is unlikely to be induced by presynaptic stimulation, but by upregulation of the resting level of glutamate, possibly resulting from these alterations. Furthermore, internalisation of synaptic NR2A-NMDAR shows greater damage to the postsynaptic Ca2+ response in comparison with the internalisation of NR2B-NMDARs; thus, the suggested neuroprotective role of the latter is very limited during synaptic transmission in AD. We integrate a CaMKII state transition model with the Ca2+ model to further study the effects of alterations of NMDARs in the CaMKII state transition, an important downstream event in the early phase of LTP. The model reveals that cooperation between NR2A- and NR2B-NMDAR is required for LTP induction. Under AD conditions, internalisation of membrane NMDARs is suggested to be the cause of the loss of synapse numbers by disrupting CaMKII-NMDAR formation.	[Liang, Jingyi; Kulasiri, Don; Samarasinghe, Sandhya] Lincoln Univ, Ctr Adv Computat Solut C FACS, Christchurch, New Zealand	Lincoln University - New Zealand	Kulasiri, D (corresponding author), Lincoln Univ, Ctr Adv Computat Solut C FACS, Christchurch, New Zealand.	Don.Kulasiri@lincoln.ac.nz	Kulasiri, Don/C-8789-2018; samarasinghe, sandhya/O-9809-2018	Kulasiri, Don/0000-0001-8744-1578; samarasinghe, sandhya/0000-0003-2943-4331				Abramov E, 2009, NAT NEUROSCI, V12, P1567, DOI 10.1038/nn.2433; Alberdi E, 2010, CELL CALCIUM, V47, P264, DOI 10.1016/j.ceca.2009.12.010; ARIAS C, 1995, J NEUROSCI RES, V41, P561, DOI 10.1002/jnr.490410416; Arispe N, 2007, BBA-BIOMEMBRANES, V1768, P1952, DOI 10.1016/j.bbamem.2007.03.014; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Berridge MJ, 2010, PFLUG ARCH EUR J PHY, V459, P441, DOI 10.1007/s00424-009-0736-1; Bloodgood BL, 2007, CURR OPIN NEUROBIOL, V17, P345, DOI 10.1016/j.conb.2007.04.003; Bobich JA, 2004, J ALZHEIMERS DIS, V6, P243; Bordji K, 2010, J NEUROSCI, V30, P15927, DOI 10.1523/JNEUROSCI.3021-10.2010; Butterfield DA, 2003, CNS DRUGS, V17, P641, DOI 10.2165/00023210-200317090-00004; Chen QS, 2002, NEUROBIOL LEARN MEM, V77, P354, DOI 10.1006/nlme.2001.4034; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Chin JH, 2007, J NEUROSCI, V27, P9262, DOI 10.1523/JNEUROSCI.1843-07.2007; Chua JJE, 2010, J CELL SCI, V123, P819, DOI 10.1242/jcs.052696; CHUANG DM, 1992, MOL PHARMACOL, V42, P210; Chung S. -H., 2007, BIOL MEMBRANE ION CH, p507?543; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; Demuro A, 2010, J BIOL CHEM, V285, P12463, DOI 10.1074/jbc.R109.080895; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028; Fernandez-Tome P, 2004, NEUROBIOL DIS, V15, P580, DOI 10.1016/j.nbd.2003.12.006; Foster KA, 2010, J NEUROSCI, V30, P2676, DOI 10.1523/JNEUROSCI.4022-09.2010; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Goto Y, 2006, BIOCHEM BIOPH RES CO, V351, P259, DOI 10.1016/j.bbrc.2006.10.030; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gu ZL, 2009, J BIOL CHEM, V284, P10639, DOI 10.1074/jbc.M806508200; Haario H, 2001, BERNOULLI, V7, P223, DOI 10.2307/3318737; Haario H, 2006, STAT COMPUT, V16, P339, DOI 10.1007/s11222-006-9438-0; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Harris AZ, 2007, J PHYSIOL-LONDON, V584, P509, DOI 10.1113/jphysiol.2007.137679; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS ME, 1995, NEUROREPORT, V6, P1875, DOI 10.1097/00001756-199510020-00013; Harris ME, 1996, J NEUROCHEM, V67, P277; He Y, 2015, J THEOR BIOL, V365, P403, DOI 10.1016/j.jtbi.2014.11.001; JONAS P, 1993, J PHYSIOL-LONDON, V472, P615, DOI 10.1113/jphysiol.1993.sp019965; Kabogo D, 2010, NEUROBIOL AGING, V31, P1164, DOI 10.1016/j.neurobiolaging.2008.08.009; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; KHACHATURIAN ZS, 1994, ANN NY ACAD SCI, V747, P1; Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Kovalchuk Y, 2000, J NEUROSCI, V20, P1791; Kuchibhotla KV, 2009, SCIENCE, V323, P1211, DOI 10.1126/science.1169096; Kulasiri D, 2017, J THEOR BIOL, V419, P116, DOI 10.1016/j.jtbi.2017.02.003; Kumar A, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00007; Kurup P, 2010, J NEUROSCI, V30, P5948, DOI 10.1523/JNEUROSCI.0157-10.2010; Lacor PN, 2007, J NEUROSCI, V27, P796, DOI 10.1523/JNEUROSCI.3501-06.2007; LaFerla FM, 2002, NAT REV NEUROSCI, V3, P862, DOI 10.1038/nrn960; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Liang JY, 2015, BIOSYSTEMS, V134, P1, DOI 10.1016/j.biosystems.2015.05.003; Marino S, 2008, J THEOR BIOL, V254, P178, DOI 10.1016/j.jtbi.2008.04.011; Masugi-Tokita M, 2007, J NEUROSCI, V27, P2135, DOI 10.1523/JNEUROSCI.2861-06.2007; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MAYER ML, 1989, NATURE, V338, P425, DOI 10.1038/338425a0; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Moussawi K, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00094; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Noda M, 1999, NEUROSCIENCE, V92, P1465, DOI 10.1016/S0306-4522(99)00036-6; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2006, AM J PATHOL, V168, P184, DOI 10.2353/ajpath.2006.050593; Ondrejcak T, 2010, NEUROMOL MED, V12, P13, DOI 10.1007/s12017-009-8091-0; Orellana JA, 2011, J NEUROSCI, V31, P4962, DOI 10.1523/JNEUROSCI.6417-10.2011; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Papouin T, 2012, CELL, V150, P633, DOI 10.1016/j.cell.2012.06.029; ParpuraGill A, 1997, BRAIN RES, V754, P65, DOI 10.1016/S0006-8993(97)00043-7; Petralia RS, 2012, SCI WORLD J, DOI 10.1100/2012/267120; Prince M., 2016, WORLD ALZHEIMER REPO; Regehr WG, 1990, NATURE, P345; Rusakov DA, 2001, BIOPHYS J, V81, P1947, DOI 10.1016/S0006-3495(01)75846-8; Rusakov DA, 1998, J NEUROSCI, V18, P3158; Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1; Santucci DM, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000208; Selkoe DJ, 2008, BEHAV BRAIN RES, V192, P106, DOI 10.1016/j.bbr.2008.02.016; Singh P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002106; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005; Sorra KE, 2000, HIPPOCAMPUS, V10, P501, DOI 10.1002/1098-1063(2000)10:5<501::AID-HIPO1>3.0.CO;2-T; Stys PK, 2012, J PHYSIOL-LONDON, V590, P1357, DOI 10.1113/jphysiol.2011.225276; Takumi Y, 1999, NAT NEUROSCI, V2, P618, DOI 10.1038/10172; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; VanDongen AMJ, 2009, FRONT NEUROSCI; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999; Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046	91	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182743	10.1371/journal.pone.0182743	http://dx.doi.org/10.1371/journal.pone.0182743			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837653	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000024
J	Liland, NS; Biancarosa, I; Araujo, P; Biemans, D; Bruckner, CG; Waagbo, R; Torstensen, BE; Lock, EJ				Liland, Nina S.; Biancarosa, Irene; Araujo, Pedro; Biemans, Daan; Bruckner, Christian G.; Waagbo, Rune; Torstensen, Bente E.; Lock, Erik-Jan			Modulation of nutrient composition of black soldier fly (Hermetia illucens) larvae by feeding seaweed-enriched media	PLOS ONE			English	Article							AMINO-ACID-COMPOSITION; PROTEIN; CONVERSION; NITROGEN; FOODS; MEAL	Black soldier fly (Hermetia illucens) larvae are a promising source of protein and lipid for animal feeds. The nutritional composition of the BSF larvae depend partly on the composition of the feeding medium. The BSF lipid profile in part mimics the feeding media lipid profile, and micronutrients, like minerals and vitamins, can readily accumulate in black soldier fly larvae. However, investigative studies on bioconversion and accumulation of nutrients from media to black soldier fly larvae are scarce. Here we show that inclusion of the brown algae Ascophyllum nodosum in the substrate for black soldier fly larvae can introduce valuable nutrients, commonly associated with the marine environment, into the larvae. The omega-3 fatty acid eicosapentaenoic acid (20:5n-3), iodine and vitamin E concentrations increased in the larvae when more seaweed was included in the diet. When the feeding media consisted of more than 50% seaweed, the larvae experienced poorer growth, lower nutrient retention and lower lipid levels, compared to a pure plant based feeding medium. Our results confirm the plasticity of the nutritional make-up of black soldier fly larvae, allowing it to accumulate both lipid-and water-soluble compounds. A broader understanding of the effect of the composition of the feeding media on the larvae composition can help to tailor black soldier fly larvae into a nutrient profile more suited for specific feed or food purposes.	[Liland, Nina S.; Biancarosa, Irene; Araujo, Pedro; Waagbo, Rune; Torstensen, Bente E.; Lock, Erik-Jan] Natl Inst Nutr & Seafood Res, Bergen, Norway; [Biemans, Daan] Protix Biosyst BV, Ind Str 3, Dongen, Netherlands; [Bruckner, Christian G.] Norwegian Inst Bioecon Res NIBIO, Torggarden, Norway; [Torstensen, Bente E.] NOFIMA, Kjerreidviken 16, Fyllingsdalen, Norway	Norwegian Institute of Bioeconomy Research; Nofima	Lock, EJ (corresponding author), Natl Inst Nutr & Seafood Res, Bergen, Norway.	erik-jan.lock@nifes.no	Waagbø, Rune/M-4567-2019; Liland, Nina Sylvia/AAC-8701-2020; Lock, Erik-Jan/AAM-9766-2020	Waagbo, Rune/0000-0001-6075-3221; Araujo, Pedro/0000-0002-1962-6084; Lock, Erik-Jan/0000-0002-8157-5249; Liland, Nina Sylvia/0000-0002-1310-0620	Norwegian Research Council (NRC) [238997]; RAFFPINN [220634]	Norwegian Research Council (NRC)(Research Council of Norway); RAFFPINN	This study was funded by the Norwegian Research Council (NRC) project Aquafly, grant number 238997 and RAFFPINN, grant number 220634. The funder provided support in the form of salaries for authors (NLI, IBI, PAR, CBR, RWA, BTO, ELO) and the costs of analyses, but did not have any additional role in the study design, data collection and type of analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Protix Biosystems BV has facilitated the experiment, however did not contribute financially or intellectually to this trial.	Ackman R.G., 1980, ADV FISH SCI TECHNOL, P87; Araujo P, 2005, ACCREDIT QUAL ASSUR, V10, P185, DOI 10.1007/s00769-005-0907-5; Araujo P, 2008, ISR J AQUACULT-BAMID, V60, P134; Biancarosa I, 2017, J APPL PHYCOL, V29, P1001, DOI 10.1007/s10811-016-0984-3; Cherian G, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0029-9; Cickova H, 2015, WASTE MANAGE, V35, P68, DOI 10.1016/j.wasman.2014.09.026; COLLETT JI, 1976, J INSECT PHYSIOL, V22, P1395, DOI 10.1016/0022-1910(76)90163-3; Dayrit FM, 2015, J AM OIL CHEM SOC, V92, P1, DOI 10.1007/s11746-014-2562-7; Diener S, 2009, WASTE MANAGE RES, V27, P603, DOI 10.1177/0734242X09103838; Dominguez H, 2013, WOODHEAD PUBL FOOD S, V256, P1, DOI 10.1533/9780857098689; Espe M, 2014, BRIT J NUTR, V112, P1274, DOI 10.1017/S0007114514002062; FAO, 2014, STATE WORLD FISHERIE; Finke MD, 2013, ZOO BIOL, V32, P27, DOI 10.1002/zoo.21012; Guiry MD, 2016, ALGAEBASE WORLD WIDE; Hamre K, 2010, FOOD CHEM, V119, P270, DOI 10.1016/j.foodchem.2009.06.024; HARKINS RW, 1968, J AMER MED ASSOC, V203, P272, DOI 10.1001/jama.203.4.272; Henry M, 2015, ANIM FEED SCI TECH, V203, P1, DOI 10.1016/j.anifeedsci.2015.03.001; Jiao GL, 2011, MAR DRUGS, V9, P196, DOI 10.3390/md9020196; Julshamn K, 2001, J AOAC INT, V84, P1976; Konings EJM, 1996, J AOAC INT, V79, P902; Kraan S, 2013, WOODHEAD PUBL FOOD S, V256, P205, DOI 10.1533/9780857098689.1.205; Kroeckel S, 2012, AQUACULTURE, V364, P345, DOI 10.1016/j.aquaculture.2012.08.041; LIE O, 1991, J CHROMATOGR-BIOMED, V565, P119, DOI 10.1016/0378-4347(91)80376-N; Liu Y., 2015, J ANIM SCI BIOTECHNO, V6; Lourenco SO, 2004, EUR J PHYCOL, V39, P17, DOI 10.1080/0967026032000157156; Maehre HK, 2014, J SCI FOOD AGR, V94, P3281, DOI 10.1002/jsfa.6681; Makkar HPS, 2016, ANIM FEED SCI TECH, V212, P1, DOI 10.1016/j.anifeedsci.2015.09.018; Marono S, 2015, ITAL J ANIM SCI, V14, DOI 10.4081/ijas.2015.3889; NEWTON GL, 1977, J ANIM SCI, V44, P395, DOI 10.2527/jas1977.443395x; Njaa L.R., 1982, Fiskeridirektoratets Skrifter Serie Ernaering, V2, P25; NRC, 2011, COMM NUTR REQ FISH S, P363; Oonincx DGAB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144601; R Development Core Team, 2011, R FDN STAT COMP; RONNESTAD I, 1993, MAR BIOL, V116, P349, DOI 10.1007/BF00350051; Ronnestad Ivar, 1993, Reviews in Fisheries Science, V1, P239; Ruperez P, 2002, FOOD CHEM, V79, P23, DOI 10.1016/S0308-8146(02)00171-1; Salmo salar L, 2004, AQUACULT NUTR, V10, P175; SaloVaananen PP, 1996, FOOD CHEM, V57, P27, DOI 10.1016/0308-8146(96)00157-4; Sissener N, 2016, EFFEKTER ENDRET FETT, P99; Skjermo J, 2012, VALUE CREATED PRODUC, P83; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P309, DOI 10.1111/j.1749-7345.2007.00101.x; St-Hilaire S, 2007, J WORLD AQUACULT SOC, V38, P59, DOI 10.1111/j.1749-7345.2006.00073.x; Tschirner M, 2015, J INSECTS FOOD FEED, V1, P249, DOI 10.3920/JIFF2014.0008; Urich K., 1994, COMPARATIVE ANIMAL B, P403; Veldkamp T, 2012, REPORT 639, P62; Vlahakis C, 2000, J AM OIL CHEM SOC, V77, P49, DOI 10.1007/s11746-000-0008-6; Wang XS, 2008, FOOD CHEM, V107, P11, DOI 10.1016/j.foodchem.2007.06.064	47	195	200	29	132	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183188	10.1371/journal.pone.0183188	http://dx.doi.org/10.1371/journal.pone.0183188			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837591	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000051
J	Robinson-Garcia, N; Costas, R; Isett, K; Melkers, J; Hicks, D				Robinson-Garcia, Nicolas; Costas, Rodrigo; Isett, Kimberley; Melkers, Julia; Hicks, Diana			The unbearable emptiness of tweeting-About journal articles	PLOS ONE			English	Article							SOCIAL MEDIA; HEALTH-CARE; TWITTER; CHALLENGES; MEDICINE; TOOL	Enthusiasm for using Twitter as a source of data in the social sciences extends to measuring the impact of research with Twitter data being a key component in the new altmetrics approach. In this paper, we examine tweets containing links to research articles in the field of dentistry to assess the extent to which tweeting about scientific papers signifies engagement with, attention to, or consumption of scientific literature. The main goal is to better comprehend the role Twitter plays in scholarly communication and the potential value of tweet counts as traces of broader engagement with scientific literature. In particular, the pattern of tweeting to the top ten most tweeted scientific dental articles and of tweeting by accounts is examined. The ideal that tweeting about scholarly articles represents curating and informing about state-of-the-art appears not to be realized in practice. We see much presumably human tweeting almost entirely mechanical and devoid of original thought, no evidence of conversation, tweets generated by monomania, duplicate tweeting from many accounts under centralized professional management and tweets generated by bots. Some accounts exemplify the ideal, but they represent less than 10% of tweets. Therefore, any conclusions drawn from twitter data is swamped by the mechanical nature of the bulk of tweeting behavior. In light of these results, we discuss the compatibility of Twitter with the research enterprise as well as some of the financial incentives behind these patterns.	[Robinson-Garcia, Nicolas] Univ Politecn Valencia, CSIC, INGENIO, Valencia, Spain; [Costas, Rodrigo] Leiden Univ, Ctr Sci & Technol Studies CWTS, Leiden, Netherlands; [Isett, Kimberley; Melkers, Julia; Hicks, Diana] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Leiden University; Leiden University - Excl LUMC; University System of Georgia; Georgia Institute of Technology	Robinson-Garcia, N (corresponding author), Univ Politecn Valencia, CSIC, INGENIO, Valencia, Spain.	elrobin@ingenio.upv.es	Robinson-Garcia, Nicolas/B-3590-2012; Isett, Kimberley/AAH-7676-2021; Melkers, Julia/C-4310-2019	Robinson-Garcia, Nicolas/0000-0002-0585-7359; Isett, Kimberley/0000-0002-7584-0181; Costas, Rodrigo/0000-0002-7465-6462	Juan de la Cierva-Formacion postdoctoral fellowship from Spanish Ministry of Economy and Competitiveness; Fulbright Commission; Georgia Institute of Technology; NIH [U19-DE-22516]; NSF [1445121]; Direct For Social, Behav & Economic Scie [1445121] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [U19DE022516] Funding Source: NIH RePORTER	Juan de la Cierva-Formacion postdoctoral fellowship from Spanish Ministry of Economy and Competitiveness; Fulbright Commission; Georgia Institute of Technology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Nicolas Robinson-Garcia has received support from a Juan de la Cierva-Formacion postdoctoral fellowship from the Spanish Ministry of Economy and Competitiveness. He also received funding from the Fulbright Commission and Jose Castillejo for a short stay at Georgia Institute of Technology hosted by Diana Hicks. This work was partially supported by NIH grant U19-DE-22516 and NSF award number 1445121. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adie E, 2014, PROF INFORM, V23, P349, DOI 10.3145/epi.2014.jul.01; Alpert JM, 2016, HEALTH COMMUN, V31, P824, DOI 10.1080/10410236.2015.1007551; Altmetric. com, 2016, DOES ALTM TRACK TWIT; [Anonymous], [No title captured]; [Anonymous], 2015, PLOS ONE, V10; Bornmann L, 2015, SCIENTOMETRICS, V103, P1123, DOI 10.1007/s11192-015-1565-y; Cardona-Grau D, 2016, J PEDIATR UROL, V12, P334, DOI 10.1016/j.jpurol.2016.11.003; Choo EK, 2015, MED TEACH, V37, P411, DOI 10.3109/0142159X.2014.993371; Chu Z, 2012, IEEE T DEPEND SECURE, V9, P811, DOI 10.1109/TDSC.2012.75; Costas R, 2015, J ASSOC INF SCI TECH, V66, P2003, DOI 10.1002/asi.23309; Cresci S, 2015, DECIS SUPPORT SYST, V80, P56, DOI 10.1016/j.dss.2015.09.003; Eysenbach G, 2011, J MED INTERNET RES, V13, DOI 10.2196/jmir.2012; Eysenbach G, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1030; Forgie SE, 2013, MED TEACH, V35, P8, DOI 10.3109/0142159X.2012.746448; Freitas C, 2015, PROCEEDINGS OF THE 2015 IEEE/ACM INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2015), P25, DOI 10.1145/2808797.2809292; Friedrich N, 2015, PRO INT CONF SCI INF, P107; Fuller MY, 2016, ARCH PATHOL LAB MED, V140, P956, DOI 10.5858/arpa.2016-0172-SA; Grande D, 2014, HEALTH AFFAIR, V33, P1278, DOI 10.1377/hlthaff.2014.0300; Haustein S., 2016, SCIENTOMETRICS, P1; Haustein S, 2016, J ASS INF SCI TECHNO; Haustein S, 2014, SCIENTOMETRICS, V101, P1145, DOI 10.1007/s11192-013-1221-3; Haustein S, 2014, J ASSOC INF SCI TECH, V65, P656, DOI 10.1002/asi.23101; Haustein V., 2016, ARXIV160808112; Hawn C, 2009, HEALTH AFFAIR, V28, P361, DOI 10.1377/hlthaff.28.2.361; Jimenez-Contreras E., 2013, ALTMETRICS NEW INDIC, V21; Ke Q, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175368; Kolahi J, 2016, BRIT DENT J, V220, P569, DOI 10.1038/sj.bdj.2016.411; Konkiel S., 2016, ALTMETRICS LIB 100 T, DOI 10.6084/m9.figshare.3749838; Letierce J., 2010, UNDERSTANDING TWITTE; Maclean F, 2013, BRIT J OCCUP THER, V76, P295, DOI 10.4276/030802213X13706169933021; McGinnigle E, 2016, EUR HEART J, V37, P1264; Nason GJ, 2015, BJU INT, V115, P486, DOI 10.1111/bju.12840; Philp D., 2017, 500 HOUSE DEROIT REB; Piwowar H, 2016, INVESTIGATING METRIC; Priem J., 2010, ALTMETRICS MANIFESTO; Priem J., 2010, P AM SOC INFORM SCI, V47, P1, DOI [10.1002/meet.14504701201, DOI 10.1002/MEET.14504701201]; Robinson-Garcia N, 2017, UNDERLYING DATA STUD; Robinson-Garcia N, 2014, PROF INFORM, V23, P359, DOI 10.3145/epi.2014.jul.03; Roupret M, 2015, PROG UROL, V25, P11, DOI 10.1016/j.purol.2014.10.009; Schnitzler K, 2016, INT J NURS STUD, V59, P15, DOI 10.1016/j.ijnurstu.2016.02.004; Sugimoto CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062403; Thelwall M., 2013, CYBERMETRICS INT J S, V17, P1; Thompson MA, 2015, CURR HEMATOL MALIG R, V10, P405, DOI 10.1007/s11899-015-0286-x; Tufekci Z., 2014, ICWSM, V14, P505; Twitter in retweet, 2016, ECONOMIST; Vainio J., 2017, SCIENTOMETRICS, P1; van Dijck J., 2013, UNDERSTANDING SOCIAL; Wang X, 2016, SPRINGER THESES-RECO, P1, DOI 10.1007/978-3-319-03236-8; Wilsdon J, 2015, 1013140RG214929; Wouters P, USERS NARCISSISM CON; Zahedi Z, 2014, SCIENTOMETRICS, V101, P1491, DOI 10.1007/s11192-014-1264-0; Zimmer M, 2014, ASLIB J INFORM MANAG, V66, P250, DOI 10.1108/AJIM-09-2013-0083	52	75	76	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183551	10.1371/journal.pone.0183551	http://dx.doi.org/10.1371/journal.pone.0183551			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837664	Green Published, gold			2022-12-27	WOS:000408365000079
J	Ross, SL; Sherman, M; McElroy, PL; Lofgren, JA; Moody, G; Baeuerle, PA; Coxon, A; Arvedson, T				Ross, Sandra L.; Sherman, Marika; McElroy, Patricia L.; Lofgren, Julie A.; Moody, Gordon; Baeuerle, Patrick A.; Coxon, Angela; Arvedson, Tara			Bispecific T cell engager (BiTE (R)) antibody constructs can mediate bystander tumor cell killing	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; INTERFERON-GAMMA; UP-REGULATION; CANCER; ACTIVATION; LINES; FAS; INDUCTION; LEUKEMIA; PATHWAY	For targets that are homogenously expressed, such as CD19 on cells of the B lymphocyte lineage, immunotherapies can be highly effective. Targeting CD19 with blinatumomab, a CD19/CD3 bispecific antibody construct (BiTE (R)), or with chimeric antigen receptor T cells (CAR-T) has shown great promise for treating certain CD19-positive hematological malignancies. In contrast, solid tumors with heterogeneous expression of the tumor-associated antigen (TAA) may present a challenge for targeted therapies. To prevent escape of TAA-negative cancer cells, immunotherapies with a local bystander effect would be beneficial. As a model to investigate BiTE (R)-mediated bystander killing in the solid tumor setting, we used epidermal growth factor receptor (EGFR) as a target. We measured lysis of EGFR-negative populations in vitro and in vivo when co-cultured with EGFR-positive cells, human T cells and an EGFR/CD3 BiTE (R) antibody construct. Bystander EGFR-negative cells were efficiently lysed by BiTE (R)-activated T cells only when proximal to EGFR-positive cells. Our mechanistic analysis suggests that cytokines released by BiTE (R)-activated T-cells induced upregulation of ICAM-1 and FAS on EGFR-negative bystander cells, contributing to T cell-induced bystander cell lysis.	[Ross, Sandra L.; Sherman, Marika; McElroy, Patricia L.; Lofgren, Julie A.; Moody, Gordon; Coxon, Angela; Arvedson, Tara] Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA; [Baeuerle, Patrick A.] Amgen Inc, Dept Amgen Res Munich, Munich, Germany; [Sherman, Marika] Kite Pharma Inc, Dept Translat Sci, Santa Monica, CA USA; [Moody, Gordon] Medimmune, Dept Oncol, Gaithersburg, MD USA; [Baeuerle, Patrick A.] MPM Capital, Cambridge, MA USA	Amgen; Amgen; Amgen Research Munich GmbH; AstraZeneca; Medimmune	Arvedson, T (corresponding author), Amgen Inc, Dept Oncol Res, Thousand Oaks, CA 91320 USA.	taraa@amgen.com			Amgen Inc.	Amgen Inc.(Amgen)	The authors received no specific funding for this work. Amgen Inc. provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AKIYAMA S, 1988, JPN J SURG, V18, P438, DOI 10.1007/BF02471470; Azuma A, 1992, CANC RES; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Bander NH, 2013, METHODS MOL BIOL, V1045, P29, DOI 10.1007/978-1-62703-541-5_2; Zhang B, 2008, J CLIN INVEST, V118, P1398, DOI 10.1172/JCI33522; Bornstein GG, 2015, AAPS J, V17, P525, DOI 10.1208/s12248-015-9738-4; Brandl C, 2007, CANCER IMMUNOL IMMUN, V56, P1551, DOI 10.1007/s00262-007-0298-z; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; CHONG ASF, 1994, CANCER IMMUNOL IMMUN, V39, P127, DOI 10.1007/s002620050103; Cullen SP, 2008, CELL DEATH DIFFER, V15, P251, DOI 10.1038/sj.cdd.4402244; de Vries JF, 2007, HAEMATOLOGICA, V92, P1671, DOI 10.3324/haematol.11308; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Dustin ML, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002873; Dustin ML, 2010, IMMUNOL REV, V235, P24, DOI 10.1111/j.0105-2896.2010.00904.x; DUSTIN ML, 1986, J IMMUNOL, V137, P245; Frankel SR, 2013, CURR OPIN CHEM BIOL, V17, P385, DOI 10.1016/j.cbpa.2013.03.029; Friedrich M, 2014, MOL CANCER THER, V13, P1549, DOI 10.1158/1535-7163.MCT-13-0956; Friedrich M, 2012, MOL CANCER THER, V11, P2664, DOI 10.1158/1535-7163.MCT-12-0042; Gaglia JL, 2000, J IMMUNOL, V165, P6091, DOI 10.4049/jimmunol.165.11.6091; Goebeler ME, 2016, J CLIN ONCOL, V34, P1104, DOI 10.1200/JCO.2014.59.1586; Haas C, 2009, IMMUNOBIOLOGY, V214, P441, DOI 10.1016/j.imbio.2008.11.014; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hassin D, 2011, IMMUNOLOGY, V133, P190, DOI 10.1111/j.1365-2567.2011.03426.x; HENKART PA, 1994, IMMUNITY, V1, P343, DOI 10.1016/1074-7613(94)90063-9; Hipp S, 2017, LEUKEMIA; Hoffmann P, 2005, INT J CANCER, V115, P98, DOI 10.1002/ijc.20908; Huehls AM, 2015, IMMUNOL CELL BIOL, V93, P290, DOI 10.1038/icb.2014.93; Jenkinson SR, 2005, J IMMUNOL, V174, P3401, DOI 10.4049/jimmunol.174.6.3401; Klinger M, 2016, IMMUNOL REV, V270, P193, DOI 10.1111/imr.12393; Klinger M, 2012, BLOOD, V119, P6226, DOI 10.1182/blood-2012-01-400515; Kojima H, 1997, J IMMUNOL, V159, P2728; LEIBOVITZ A, 1976, CANCER RES, V36, P4562; Li D, 2009, J BIOL CHEM, V284, P21001, DOI 10.1074/jbc.M109.002865; Li Y, 2000, BIOCHEM BIOPH RES CO, V268, P398, DOI 10.1006/bbrc.2000.2129; LOLLO BA, 1993, J BIOL CHEM, V268, P21693; Lutterbuese R, 2010, P NATL ACAD SCI USA, V107, P12605, DOI 10.1073/pnas.1000976107; Mack M, 1997, J IMMUNOL, V158, P3965; Matsuo Y, 1997, LEUKEMIA, V11, P1469, DOI 10.1038/sj.leu.2400768; Melis M, 1996, EUR RESPIR J, V9, P1831, DOI 10.1183/09031936.96.09091831; Mori S, 1997, CANCER IMMUNOL IMMUN, V44, P282, DOI 10.1007/s002620050384; Offner S, 2006, MOL IMMUNOL, V43, P763, DOI 10.1016/j.molimm.2005.03.007; Osada T, 2010, BRIT J CANCER, V102, P124, DOI 10.1038/sj.bjc.6605364; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Peter ME, 2015, CELL DEATH DIFFER, V22, P549, DOI 10.1038/cdd.2015.3; Ramsey P, 1993, CANC RES; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; Shin EC, 2001, INT J CANCER, V93, P262, DOI 10.1002/ijc.1310; SINGH S, 1992, J EXP MED, V175, P139, DOI 10.1084/jem.175.1.139; Smyth MJ, 1998, J VIROL, V72, P5948, DOI 10.1128/JVI.72.7.5948-5954.1998; van der Zouwen B, 2014, BIOL BLOOD MARROW TR, V20, P760, DOI 10.1016/j.bbmt.2014.03.002; Wang Y, 2009, J BIOL CHEM, V284, P12645, DOI 10.1074/jbc.M807207200; Waring P, 1999, IMMUNOL CELL BIOL, V77, P312, DOI 10.1046/j.1440-1711.1999.00837.x; Xu XL, 1998, CANCER RES, V58, P2832	54	42	52	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183390	10.1371/journal.pone.0183390	http://dx.doi.org/10.1371/journal.pone.0183390			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837681	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000062
J	Sauer-Budge, AF; Brookfield, SJ; Janzen, R; McGray, S; Boardman, A; Wirz, H; Pollock, NR				Sauer-Budge, Alexis F.; Brookfield, Samuel J.; Janzen, Ronald; McGray, Sarah; Boardman, Anna; Wirz, Holger; Pollock, Nira R.			A novel device for collecting and dispensing fingerstick blood for point of care testing	PLOS ONE			English	Article							SOUTH-AFRICA	The increased world-wide availability of point-of-care ( POC) tests utilizing fingerstick blood has led to testing scenarios in which multiple separate fingersticks are performed during a single patient encounter, generating cumulative discomfort and reducing testing efficiency. We have developed a device capable of a) collection of up to 100 mu L of fingerstick blood from a single fingerstick by capillary action, and b) dispensing this blood in variable increments set by the user. We tested the prototype device both in a controlled laboratory setting and in a fingerstick study involving naive device users, and found it to have accuracy and precision similar to a conventional pipettor. The users also found the device to be easy to use, and recommended minor ergonomic improvements. Our device would allow performance of multiple POC tests from a single fingerstick blood sample, thus providing a novel functionality that may be of use in many testing settings worldwide.	[Sauer-Budge, Alexis F.; Brookfield, Samuel J.; Janzen, Ronald; Boardman, Anna; Wirz, Holger] Fraunhofer USA, Ctr Mfg Innovat, Brookline, MA USA; [Sauer-Budge, Alexis F.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [McGray, Sarah] PATH, Seattle, WA USA; [Pollock, Nira R.] Boston Childrens Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Boston University; Harvard University; Beth Israel Deaconess Medical Center; Boston Children's Hospital	Pollock, NR (corresponding author), Boston Childrens Hosp, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	nira.pollock@childrens.harvard.edu	Sauer-Budge, Alexis/L-2286-2019	Sauer-Budge, Alexis/0000-0001-5961-5286	Center for Integration of Medicine and Innovative Technology (CIMIT) [5 U54 EB015408-03]; Innovestment Grant from Boston Children's Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [U54EB015408] Funding Source: NIH RePORTER	Center for Integration of Medicine and Innovative Technology (CIMIT); Innovestment Grant from Boston Children's Hospital; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by a grant from the Center for Integration of Medicine and Innovative Technology (CIMIT; 5 U54 EB015408-03) and an Innovestment Grant from Boston Children's Hospital.	Abel G, 2015, EXPERT REV MOL DIAGN, V15, P853, DOI 10.1586/14737159.2015.1060126; Daneau G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161891; Donnell-Fink LA, 2012, JAIDS-J ACQ IMM DEF, V61, P588, DOI [10.1097/QAI.0b013e31826a6d67., 10.1097/QAI.0b013e31826a6d67]; Ferguson I, 2013, ACAD EMERG MED, V20, P954, DOI 10.1111/acem.12207; Glencross DK, 2012, J INT AIDS SOC, V15, DOI 10.1186/1758-2652-15-3; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Lee SR, 2011, J VIROL METHODS, V172, P27, DOI 10.1016/j.jviromet.2010.12.009; Maiers TJ, 2015, SAMJ S AFR MED J, V105, P228, DOI 10.7196/SAMJ.7799; Miller E, 2015, NANOBIOMEDICINE, P2; Palombi LC, 2014, J AM PHARM ASSOC, V54, P56, DOI 10.1331/JAPhA.2014.13122; Pollock NR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075616; Scott L, 2013, SAMJ S AFR MED J, V103, P883, DOI 10.7196/SAMJ.7167; St John Andrew, 2014, Clin Biochem Rev, V35, P155; Tucker JD, 2010, LANCET INFECT DIS, V10, P381, DOI 10.1016/S1473-3099(10)70092-X; White DAE, 2009, JAIDS-J ACQ IMM DEF, V52, P75, DOI 10.1097/QAI.0b013e3181afd33d; World Health Organization, WHO LIST PREQ IN VIT	16	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183625	10.1371/journal.pone.0183625	http://dx.doi.org/10.1371/journal.pone.0183625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837616	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000090
J	Kuot, A; Hewitt, AW; Snibson, GR; Souzeau, E; Mills, R; Craig, JE; Burdon, KP; Sharma, S				Kuot, Abraham; Hewitt, Alex W.; Snibson, Grant R.; Souzeau, Emmanuelle; Mills, Richard; Craig, Jamie E.; Burdon, Kathryn P.; Sharma, Shiwani			TGC repeat expansion in the TCF4 gene increases the risk of Fuchs' endothelial corneal dystrophy in Australian cases	PLOS ONE			English	Article							CTG18.1 TRINUCLEOTIDE REPEAT; MYOTONIC-DYSTROPHY; MISSENSE MUTATIONS; SPINOCEREBELLAR ATAXIA; NUCLEAR FOCI; RNA TOXICITY; ASSOCIATION; DISEASE; PROTEINS; POLYMORPHISMS	Fuchs' endothelial corneal dystrophy (FECD) is a progressive, vision impairing disease. Common single nucleotide polymorphisms (SNPs) and a trinucleotide repeat polymorphism, thymine-guanine-cytosine (TGC), in the TCF4 gene have been associated with the risk of FECD in some populations. We previously reported association of SNPs in TCF4 with FECD risk in the Australian population. The aim of this study was to determine whether TGC repeat polymorphism in TCF4 is associated with FECD in the Australian population. In 189 unrelated Australian cases with advanced late-onset FECD and 183 matched controls, the TGC repeat polymorphism located in intron 3 of TCF4 was genotyped using a short tandem repeat (STR) assay. The repeat length was verified by direct sequencing in selected homozygous carriers. We found significant association between the expanded TGC repeat (>= 40 repeats) in TCF4 and advanced FECD (P = 2.58 x 10(-22); OR = 15.66 (95% CI: 7.79-31.49)). Genotypic analysis showed that 51% of cases (97) compared to 5% of controls (9) were heterozygous or homozygous for the expanded repeat allele. Furthermore, the repeat expansion showed stronger association than the most significantly associated SNP, rs613872, in TCF4, with the disease in the Australian cohort. This and haplotype analysis of both the polymorphisms suggest that considering both the polymorphisms together rather than either of the two alone would better predict susceptibility to FECD in the Australian population. This is the first study to report association of the TGC trinucleotide repeat expansion in TCF4 with advanced FECD in the Australian population.	[Kuot, Abraham; Souzeau, Emmanuelle; Mills, Richard; Craig, Jamie E.; Burdon, Kathryn P.; Sharma, Shiwani] Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Ophthalmol, Adelaide, SA, Australia; [Hewitt, Alex W.; Snibson, Grant R.] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, Melbourne, Vic, Australia; [Hewitt, Alex W.; Burdon, Kathryn P.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia	Flinders University South Australia; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Tasmania; Menzies Institute for Medical Research	Sharma, S (corresponding author), Flinders Univ S Australia, Coll Med & Publ Hlth, Dept Ophthalmol, Adelaide, SA, Australia.	shiwani.sharma@flinders.edu.au	Kuot, Abraham/W-7246-2019; Burdon, Kathryn/A-5026-2009; Souzeau, Emmanuelle/AAB-5608-2022; Burdon, Kathryn/AAD-2334-2022	Burdon, Kathryn/0000-0001-8217-1249; Souzeau, Emmanuelle/0000-0002-2015-6577; Burdon, Kathryn/0000-0001-8217-1249; Sharma, Shiwani/0000-0002-0828-025X; Craig, Jamie/0000-0001-9955-9696; Hewitt, Alex/0000-0002-5123-5999; Mills, Richard/0000-0002-7386-2571	National Health and Medical Research Council (NHMRC), Australia [1023911]; Ophthalmic Research Institute of Australia; Flinders Medical Centre Foundation, South Australia, Australia; NHMRC	National Health and Medical Research Council (NHMRC), Australia(National Health and Medical Research Council (NHMRC) of Australia); Ophthalmic Research Institute of Australia; Flinders Medical Centre Foundation, South Australia, Australia; NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by grants from the National Health and Medical Research Council (NHMRC), Australia, grant #1023911, Ophthalmic Research Institute of Australia, and the Flinders Medical Centre Foundation, South Australia, Australia. JEC and KPB are recipients of NHMRC practitioner and research fellowships, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMIS AP, 1993, SURV OPHTHALMOL, V38, P149, DOI 10.1016/0039-6257(93)90099-S; Afshari NA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14898; Awadalla MS, 2014, JAMA OPHTHALMOL, V132, P970, DOI 10.1001/jamaophthalmol.2014.946; Baratz KH, 2010, NEW ENGL J MED, V363, P1016, DOI 10.1056/NEJMoa1007064; Batra R, 2014, MOL CELL, V56, P311, DOI 10.1016/j.molcel.2014.08.027; Biswas S, 2001, HUM MOL GENET, V10, P2415, DOI 10.1093/hmg/10.21.2415; Breschel TS, 1997, HUM MOL GENET, V6, P1855, DOI 10.1093/hmg/6.11.1855; Brusco A, 2004, ARCH NEUROL-CHICAGO, V61, P727, DOI 10.1001/archneur.61.5.727; Burdon KP, 2011, INVEST OPHTH VIS SCI, V52, P8514, DOI 10.1167/iovs.11-8261; Coffey N, AUSTR CORNEAL GRAFT; Dimasi DP, 2012, AM J OPHTHALMOL, V154, P833, DOI 10.1016/j.ajo.2012.04.023; Du JT, 2015, J BIOL CHEM, V290, P5979, DOI 10.1074/jbc.M114.621607; Echeverria GV, 2012, BRAIN RES, V1462, P100, DOI 10.1016/j.brainres.2012.02.030; Fardaei M, 2002, HUM MOL GENET, V11, P805, DOI 10.1093/hmg/11.7.805; Goodwin M, 2015, CELL REP, V12, P1159, DOI 10.1016/j.celrep.2015.07.029; Hamill CE, 2013, SEMIN OPHTHALMOL, V28, P281, DOI 10.3109/08820538.2013.825283; Kabosova A, 2007, INVEST OPHTH VIS SCI, V48, P4989, DOI 10.1167/iovs.07-0654; Kannabiran C, 2009, J GENET, V88, P487, DOI 10.1007/s12041-009-0067-1; KENNEY MC, 1984, EXP EYE RES, V39, P267, DOI 10.1016/0014-4835(84)90015-0; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Konieczny P, 2014, NUCLEIC ACIDS RES, V42, P10873, DOI 10.1093/nar/gku767; Kozlowski P, 2010, NUCLEIC ACIDS RES, V38, P4027, DOI 10.1093/nar/gkq127; KRACHMER JH, 1978, ARCH OPHTHALMOL-CHIC, V96, P2036, DOI 10.1001/archopht.1978.03910060424004; Kuot A, 2012, EUR J HUM GENET, V20, P632, DOI 10.1038/ejhg.2011.248; Li YJ, 2015, MOL THER, V23, P1055, DOI 10.1038/mt.2015.41; Li YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018044; Mankodi A, 2001, HUM MOL GENET, V10, P2165, DOI 10.1093/hmg/10.19.2165; Mehta JS, 2008, INVEST OPHTH VIS SCI, V49, P184, DOI 10.1167/iovs.07-0847; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Mok JW, 2009, EYE, V23, P895, DOI 10.1038/eye.2008.116; Mootha VV, 2015, INVEST OPHTH VIS SCI, V56, P2003, DOI 10.1167/iovs.14-16222; Mootha VV, 2014, INVEST OPHTH VIS SCI, V55, P33, DOI 10.1167/iovs.13-12611; Nakano M, 2015, INVEST OPHTH VIS SCI, V56, P4865, DOI 10.1167/iovs.15-17082; Nanda GG, 2014, INVEST OPHTH VIS SCI, V55, P7674, DOI 10.1167/iovs.14-15297; Nelson DL, 2013, NEURON, V77, P825, DOI 10.1016/j.neuron.2013.02.022; O'Rourke JR, 2009, J BIOL CHEM, V284, P7419, DOI 10.1074/jbc.R800025200; Oodak M, 2015, BIOMED RES INT, V2015; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Price MO, 2010, OPHTHALMOLOGY, V117, P438, DOI 10.1016/j.ophtha.2009.07.036; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Riazuddin SA, 2013, AM J HUM GENET, V93, P758, DOI 10.1016/j.ajhg.2013.08.010; Riazuddin SA, 2012, AM J HUM GENET, V90, P533, DOI 10.1016/j.ajhg.2012.01.013; Riazuddin SA, 2011, INVEST OPHTH VIS SCI, V52, P2825, DOI 10.1167/iovs.10-6497; Riazuddin SA, 2010, HUM MUTAT, V31, P1261, DOI 10.1002/humu.21356; Riazuddin SA, 2010, AM J HUM GENET, V86, P45, DOI 10.1016/j.ajhg.2009.12.001; SANTO RM, 1995, OPHTHALMOLOGY, V102, P557, DOI 10.1016/S0161-6420(95)30982-7; Santos R, 2010, ANTIOXID REDOX SIGN, V13, P651, DOI 10.1089/ars.2009.3015; Thalamuthu A, 2011, INVEST OPHTH VIS SCI, V52, P5573, DOI 10.1167/iovs.11-7568; Vasanth S, 2015, INVEST OPHTH VIS SCI, V56, P4531, DOI 10.1167/iovs.14-16122; Vithana EN, 2008, HUM MOL GENET, V17, P656, DOI 10.1093/hmg/ddm337; Wieben ED, 2017, INVEST OPHTH VIS SCI, V58, P343, DOI 10.1167/iovs.16-20900; Wieben ED, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049083; Xing C, 2014, INVEST OPHTH VIS SCI, V55, P7073, DOI 10.1167/iovs.14-15390; Zoghbi HY, 2009, J BIOL CHEM, V284, P7425, DOI 10.1074/jbc.R800041200	54	13	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183719	10.1371/journal.pone.0183719	http://dx.doi.org/10.1371/journal.pone.0183719			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832669	Green Accepted, Green Published, gold			2022-12-27	WOS:000408355800094
J	Levi, A; Sabuco, J; Sanjuan, MAF				Levi, Asaf; Sabuco, Juan; Sanjuan, Miguel A. F.			When the firm prevents the crash: Avoiding market collapse with partial control	PLOS ONE			English	Article							TRANSIENT CHAOS; DYNAMICS; CRISIS	Market collapse is one of the most dramatic events in economics. Such a catastrophic event can emerge from the nonlinear interactions between the economic agents at the micro level of the economy. Transient chaos might be a good description of how a collapsing market behaves. In this work, we apply a new control method, the partial control method, with the goal of avoiding this disastrous event. Contrary to common control methods that try to influence the system from the outside, here the market is controlled from the bottom up by one of the most basic components of the market-the firm. This is the first time that the partial control method is applied on a strictly economical system in which we also introduce external disturbances. We show how the firm is capable of controlling the system avoiding the collapse by only adjusting the selling price of the product or the quantity of production in accordance to the market circumstances. Additionally, we demonstrate how a firm with a large market share is capable of influencing the demand achieving price stability across the retail and wholesale markets. Furthermore, we prove that the control applied in both cases is much smaller than the external disturbances.	[Levi, Asaf; Sabuco, Juan; Sanjuan, Miguel A. F.] Univ Rey Juan Carlos, Dept Fis, Nonlinear Dynam Chaos & Complex Syst Grp, Tulipan S-N, Madrid 28933, Spain; [Sanjuan, Miguel A. F.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	Universidad Rey Juan Carlos; University System of Maryland; University of Maryland College Park	Sanjuan, MAF (corresponding author), Univ Rey Juan Carlos, Dept Fis, Nonlinear Dynam Chaos & Complex Syst Grp, Tulipan S-N, Madrid 28933, Spain.; Sanjuan, MAF (corresponding author), Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA.	miguel.sanjuan@urjc.es	Sanjuán, Miguel AF/B-7709-2011	Sanjuán, Miguel AF/0000-0003-3515-0837	Spanish Ministry of Economy and Competitiveness [FIS2013-40653-P]; Spanish State Research Agency (AEI); European Regional Development Fund (FEDER) [FIS2016-76883-P]; Fulbright Program; Spanish Ministry of Education [FMECD-ST-2016]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Spanish State Research Agency (AEI)(Spanish Government); European Regional Development Fund (FEDER)(European Commission); Fulbright Program; Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Economy and Competitiveness under Project No. FIS2013-40653-P and by the Spanish State Research Agency (AEI) and the European Regional Development Fund (FEDER) under Project No. FIS2016-76883-P. MAFS acknowledges the jointly sponsored financial support by the Fulbright Program and the Spanish Ministry of Education (Program No. FMECD-ST-2016).	Agarwal V, 2017, INT J NONLIN MECH; Batten D.F., 2000, DISCOVERING ARTIFICI; Capeans R, 2017, PHILOS T R SOC A, V375, DOI 10.1098/rsta.2016.0211; Chian ACL, 2006, CHAOS SOLITON FRACT, V29, P1194, DOI 10.1016/j.chaos.2005.08.218; Chiarella C, 2002, J ECON BEHAV ORGAN, V49, P173, DOI 10.1016/S0167-2681(02)00066-5; Coccolo M, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500089; DANGOISSE D, 1986, PHYS REV LETT, V57, P2657, DOI 10.1103/PhysRevLett.57.2657; Das S, 2016, J DIFFER EQU APPL, V22, P217, DOI 10.1080/10236198.2015.1079181; DAY RH, 1990, J ECON BEHAV ORGAN, V14, P299, DOI 10.1016/0167-2681(90)90061-H; Dhamala M, 1999, PHYS REV E, V59, P1646, DOI 10.1103/PhysRevE.59.1646; Duarte J., 2009, CHAOS, V58, P863; Ezekiel M, 1938, Q J ECON, V52, P255, DOI 10.2307/1881734; Harmon D, 2011, ARXIV11022620V1; Holyst JA, 1996, J EVOL ECON, V6, P31, DOI 10.1007/BF01202371; HOMMES CH, 1994, J ECON BEHAV ORGAN, V24, P315, DOI 10.1016/0167-2681(94)90039-6; In V, 1997, CHAOS, V7, P605, DOI 10.1063/1.166260; Kristoufek L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02857; Ladislav K, 2012, ARXIV12034979V1; Levi A, 2017, ARXIV170107333; Petruzzi NC, 1999, OPER RES, V47, P183, DOI 10.1287/opre.47.2.183; Sabuco J, 2012, CHAOS, V22, DOI 10.1063/1.4754874; Sabuco J, 2012, COMMUN NONLINEAR SCI, V17, P4274, DOI 10.1016/j.cnsns.2012.02.033; Sabuco J, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/11/113038; Sornette D, 2003, WHY STOCK MARKETS CRASH: CRITICAL EVENTS IN COMPLEX FINANCIAL SYSTEMS, P1; Sornette D., 2001, Quantitative Finance, V1, P452, DOI 10.1088/1469-7688/1/4/305; Sornette D., 2009, INT J TERRASPACE SCI, V2, P1, DOI 10.2139/ssrn.1596032; Tramontana F, 2009, DISCRETE DYN NAT SOC, V2009, DOI 10.1155/2009/310471; Wu WJ, 2010, NONLINEAR ANAL-REAL, V11, P4363, DOI 10.1016/j.nonrwa.2010.05.022; Zambrano S, 2014, COMMUN NONLINEAR SCI, V19, P726, DOI 10.1016/j.cnsns.2013.06.016; Zambrano S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.026217; Zambrano S, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.055201	31	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181925	10.1371/journal.pone.0181925	http://dx.doi.org/10.1371/journal.pone.0181925			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832608	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800008
J	Suptawiwat, O; Ruangrung, K; Boonarkart, C; Puthavathana, P; Maneechotesuwan, K; Charngkaew, K; Chomanee, N; Auewarakul, P				Suptawiwat, Ornpreya; Ruangrung, Kanyarat; Boonarkart, Chompunuch; Puthavathana, Pilaipan; Maneechotesuwan, Kittipong; Charngkaew, Komgrid; Chomanee, Nusara; Auewarakul, Prasert			Microparticle and anti-influenza activity in human respiratory secretion	PLOS ONE			English	Article							INFLUENZA-A VIRUSES; EXTRACELLULAR VESICLES; ANTIVIRAL ACTIVITY; IN-VIVO; LUNG; NEURAMINIDASE; DEFENSE; FLUID	Respiratory secretions, such as saliva and bronchoalveolar fluid, contain anti-influenza activity. Multiple soluble factors have been described that exert anti-influenza activity and are believed to be responsible for the anti-influenza activity in respiratory secretions. It was previously shown that a bronchial epithelial cell culture could produce exosome-like particles with anti-influenza activity. Whether such extracellular vesicles in respiratory secretions have anti-influenza activity is unknown. Therefore, we characterized bronchoalveolar lavage fluid and found microparticles, which mostly stained positive for epithelial cell markers and both alpha 2,3- and alpha 2,6-linked sialic acid. Microparticles were purified from bronchoalveolar lavage fluid and shown to exhibit anti-influenza activity by a hemagglutination inhibition (HI) assay and a neutralization (NT) assay. In addition, physical binding between influenza virions and microparticles was demonstrated by electron microscopy. These findings indicate that respiratory microparticles containing viral receptors can exert anti-viral activity by probably trapping viral particles. This innate mechanism may play an important role in the defense against respiratory viruses.	[Suptawiwat, Ornpreya; Ruangrung, Kanyarat; Boonarkart, Chompunuch; Auewarakul, Prasert] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Microbiol, Bangkok, Thailand; [Puthavathana, Pilaipan] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand; [Maneechotesuwan, Kittipong] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Med, Bangkok, Thailand; [Charngkaew, Komgrid; Chomanee, Nusara] Mahidol Univ, Fac Med, Siriraj Hosp, Dept Pathol, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University; Mahidol University	Auewarakul, P (corresponding author), Mahidol Univ, Fac Med, Siriraj Hosp, Dept Microbiol, Bangkok, Thailand.	prasert.aue@mahidol.ac.th		Auewarakul, Prasert/0000-0002-4745-4291	National Research Council of Thailand [61047]; Faculty of Medicine Siriraj hospital, Mahidol University; Thailand Research Fund [RTA5780009]	National Research Council of Thailand(National Research Council of Thailand (NRCT)); Faculty of Medicine Siriraj hospital, Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by a research grant (61047) from the National Research Council of Thailand. O.S. and C.B. were supported by the research assistant program, Faculty of Medicine Siriraj hospital, Mahidol University, and P.A. was supported by a grant (RTA5780009) from Thailand Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNE CA, 1995, J INFECT DIS, V171, P335, DOI 10.1093/infdis/171.2.335; Cocucci E, 2015, TRENDS CELL BIOL, V25, P364, DOI 10.1016/j.tcb.2015.01.004; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Gyorgy B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049726; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Harms A, 2015, TRANSPLANTATION, V99, P2394, DOI 10.1097/TP.0000000000000881; Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003; HARTSHORN KL, 1994, J CLIN INVEST, V94, P311, DOI 10.1172/JCI117323; Job ER, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059623; Kadota T, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111801; Kesimer M, 2009, FASEB J, V23, P1858, DOI 10.1096/fj.08-119131; LeVine AM, 2001, J IMMUNOL, V167, P5868, DOI 10.4049/jimmunol.167.10.5868; Nieri D, 2016, EUR RESPIR REV, V25, P266, DOI 10.1183/16000617.0009-2016; Novelli F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095013; Organization WH, 2009, ORG WH; Pan Q, 2012, J INNATE IMMUN, V4, P312, DOI 10.1159/000335670; Reading PC, 2008, J IMMUNOL, V180, P3391, DOI 10.4049/jimmunol.180.5.3391; Robbins PD, 2016, J CLIN INVEST, V126, P1173, DOI 10.1172/JCI81131; Robinson SM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004045; Ruangrung K, 2016, J VIROL, V90, P4637, DOI 10.1128/JVI.00013-16; Shefler I, 2010, J IMMUNOL, V185, P4206, DOI 10.4049/jimmunol.1000409; Verma A, 2012, J IMMUNOL, V189, P2478, DOI 10.4049/jimmunol.1103786; Vinuela-Berni V, 2015, CLIN EXP IMMUNOL, V180, P442, DOI 10.1111/cei.12598	23	10	10	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183717	10.1371/journal.pone.0183717	http://dx.doi.org/10.1371/journal.pone.0183717			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832645	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800092
J	Zhao, PY; Zhang, F; Liu, DL; Imani, J; Langen, G; Kogel, KH				Zhao, Puyan; Zhang, Fei; Liu, Dilin; Imani, Jafargholi; Langen, Gregor; Kogel, Karl-Heinz			Matrix metalloproteinases operate redundantly in Arabidopsis immunity against necrotrophic and biotrophic fungal pathogens	PLOS ONE			English	Article							SOYBEAN LEAF METALLOPROTEINASE; INNATE IMMUNITY; CELL-DEATH; LOCALIZATION; THALIANA; FAMILY; SENESCENCE; GENE; METALLOENDOPROTEINASE; INFLAMMATION	Matrix metalloproteinases (MMPs) are evolutionarily conserved and multifunctional effector molecules playing pivotal roles in development and homeostasis. In this study we explored the involvement of the five Arabidopsis thaliana At-MMPs in plant defence against microbial pathogens. Expression of At2-MMP was most responsive to inoculation with fungi and a bacterial pathogen followed by At3-MMP and At5-MMP, while At1-MMP and At4-MMP were non-responsive to these biotic stresses. Loss-of-function mutants for all tested At-MMPs displayed increased susceptibility to the necrotrophic fungus Botrytis cinerea and double mutant at2,3-mmp and triple mutant at2,3,5-mmp plants developed even stronger symptoms. Consistent with this, transgenic Arabidopsis plants that expressed At2-MMP constitutively under the Cauliflower mosaic virus 35S promoter showed enhanced resistance to the necrotrophic pathogen. Similarly, resistance to the biotrophic Arabidopsis powdery mildew fungus Golovinomyces orontii was also compromised particularly in the at2,3-mmp / at2,3,5-mmp multiplex mutants, and increased in At2-MMP overexpressor plants. The degree of disease resistance of at-mmp mutants and At2-MMP overexpressor plants also correlated positively with the degree of MAMP-triggered callose deposition in response to the bacterial flagellin peptide flg22, suggesting that matrix metalloproteinases contribute to pattern-triggered immunity (PTI) in interactions of Arabidopsis with necrotrophic and biotrophic pathogens.	[Zhao, Puyan; Zhang, Fei; Liu, Dilin; Imani, Jafargholi; Langen, Gregor; Kogel, Karl-Heinz] Justus Liebig Univ Giessen, Inst Phytopathol, Giessen, Germany; [Zhao, Puyan] South China Agr Univ, Coll Hort, Guangzhou, Guangdong, Peoples R China; [Zhang, Fei] Guangdong Acad Agr Sci, Rice Res Inst, Guangzhou, Guangdong, Peoples R China; [Langen, Gregor] Univ Cologne, Bot Inst, Zulpicher Str 47b, Cologne, Germany	Justus Liebig University Giessen; South China Agricultural University; Guangdong Academy of Agricultural Sciences; University of Cologne	Langen, G; Kogel, KH (corresponding author), Justus Liebig Univ Giessen, Inst Phytopathol, Giessen, Germany.; Langen, G (corresponding author), Univ Cologne, Bot Inst, Zulpicher Str 47b, Cologne, Germany.	glangen1@uni-koeln.de; karl-heinz.kogel@agrar.uni-giessen.de	Langen, Gregor/B-1407-2014; Kogel, KH/K-1626-2019	Langen, Gregor/0000-0002-8321-1756; Kogel, KH/0000-0003-1226-003X	German Research Foundation [DFG FOR666]; CSC (China Scholarship Council); Cluster of Excellence on Plant Sciences (CEPLAS) [EXC 1028]	German Research Foundation(German Research Foundation (DFG)); CSC (China Scholarship Council)(China Scholarship Council); Cluster of Excellence on Plant Sciences (CEPLAS)	This work was supported in part by the German Research Foundation grant DFG FOR666 to KHK, the CSC (China Scholarship Council) scholarship granted to PZ and FZ and by the Cluster of Excellence on Plant Sciences (CEPLAS, EXC 1028) to GL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank M. Claar, E. Stein (Justus Liebig University Giessen) and L. Leson (University of Cologne) for their excellent technical assistance. This work was supported in part by the German Research Foundation grant DFG FOR666 to KHK, the CSC (China Scholarship Council) scholarship granted to PZ and FZ and by the Cluster of Excellence on Plant Sciences (CEPLAS, EXC 1028) to GL.	Altincicek B, 2008, DEV COMP IMMUNOL, V32, P400, DOI 10.1016/j.dci.2007.08.001; Altincicek B, 2009, BIOL CHEM, V390, P1303, DOI 10.1515/BC.2009.128; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; Chen H, 2006, BIOINFORMATICS, V22, P376, DOI 10.1093/bioinformatics/bti822; Cho CW, 2009, BIOL PLANTARUM, V53, P461, DOI 10.1007/s10535-009-0086-z; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Combier JP, 2007, PLANT PHYSIOL, V144, P703, DOI 10.1104/pp.106.092585; Delorme VGR, 2000, PLANT PHYSIOL, V123, P917, DOI 10.1104/pp.123.3.917; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Flinn BS, 2008, FUNCT PLANT BIOL, V35, P1183, DOI 10.1071/FP08182; Golldack D, 2002, J BIOL CHEM, V277, P5541, DOI 10.1074/jbc.M106197200; Gomez-Gomez L, 1999, PLANT J, V18, P277, DOI 10.1046/j.1365-313X.1999.00451.x; GRAHAM JS, 1991, PLANT PHYSIOL, V97, P786, DOI 10.1104/pp.97.2.786; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Kang S, 2010, PLANT PATHOLOGY J, V26, P402, DOI 10.5423/PPJ.2010.26.4.402; Khokha R, 2013, NAT REV IMMUNOL, V13, P649, DOI 10.1038/nri3499; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Li DY, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0536-z; Liu YQ, 2001, PLANT PHYSIOL, V127, P1788, DOI 10.1104/pp.010593; Lohaus G, 2001, PHYSIOL PLANTARUM, V111, P457, DOI 10.1034/j.1399-3054.2001.1110405.x; LOW MG, 1987, BIOCHEM J, V244, P1; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Maidment JM, 1999, J BIOL CHEM, V274, P34706, DOI 10.1074/jbc.274.49.34706; Mandal MK, 2010, PLANTA, V232, P899, DOI 10.1007/s00425-010-1221-y; Marino G, 2014, BIOCHEM J, V457, P335, DOI 10.1042/BJ20130196; Marino G, 2012, PHYSIOL PLANTARUM, V145, P196, DOI 10.1111/j.1399-3054.2011.01544.x; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; MCGEEHAN G, 1992, PLANT PHYSIOL, V99, P1179, DOI 10.1104/pp.99.3.1179; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Pak JH, 1997, FEBS LETT, V404, P283, DOI 10.1016/S0014-5793(97)00141-5; Parks WC, 2004, NAT REV IMMUNOL, V4, P617, DOI 10.1038/nri1418; Pham GH, 2004, PLANT SURFACE MICROBIOLOGY, P593; Schiermeyer A, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-83; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stein E, 2008, PLANT CELL PHYSIOL, V49, P1747, DOI 10.1093/pcp/pcn147; Svetek J, 1999, J BIOL CHEM, V274, P14724, DOI 10.1074/jbc.274.21.14724; VANWART HE, 1990, P NATL ACAD SCI USA, V87, P5578, DOI 10.1073/pnas.87.14.5578; Wilson CL, 1999, SCIENCE, V286, P113, DOI 10.1126/science.286.5437.113; Zimmermann D, 2016, PLANT PHYSIOL, V171, P1456, DOI 10.1104/pp.16.00513; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	42	11	12	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183577	10.1371/journal.pone.0183577	http://dx.doi.org/10.1371/journal.pone.0183577			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832648	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800067
J	Byun, MK; Chang, J; Kim, HJ; Jeong, SH				Byun, Min Kwang; Chang, Joon; Kim, Hyung Jung; Jeong, Seok Hoon			Differences of lung microbiome in patients with clinically stable and exacerbated bronchiectasis	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; NON-CF BRONCHIECTASIS; CYSTIC-FIBROSIS; PSEUDOMONAS-AERUGINOSA; DIVERSITY	Background Molecular-based diagnostic techniques can compensate for the inherent limitations of culture-based microbiology and provide a more comprehensive description of an entire community of bacteria at a particular anatomical site. Using culture-independent DNA-based molecular techniques, the aim of the present study was to characterize, differentiate, and compare the composition of lower airway bacterial microbiome between clinically stable and acutely infected patients with bronchiectasis experiencing exacerbation. Methods Patients with clinically stable bronchiectasis and those experiencing acutely exacerbated bronchiectasis were recruited. All patients underwent bronchoscopy. Paired sputum and bronchoalveolar lavage (BAL) samples were collected for microbiological tests. Molecular analysis was performed for BAL samples using 16S ribosomal RNA (rRNA) gene sequencing. Results The mean age of the 14 recruited patients was 60 years (range 42 to 78 years), and nine (64%) were female. Using quantitative culture and 16S rRNA sequencing, the common organisms identified from 14 BAL samples were Haemophilus influenzae, Pseudomonas aeruginosa and Moraxella catarrhalis, and Prevotella. Molecular techniques revealed Prevotella and Veillonella as potentially pathogenic anaerobic species. 16S rRNA gene sequencing yielded similar relative abundances and distributions of taxa in the stable and exacerbated bronchiectasis groups. Alpha diversity with richness, Simpson's and Shannon indices, and beta diversity using principal coordinate analysis revealed no significant differences in lung microbiome between patients with clinically stable and exacerbated bronchiectasis. Conclusion Culture-based microbiological and molecular-based techniques did not reveal significant differences in the lung microbiome of patients who were clinically stable and those experiencing exacerbated bronchiectasis. Patient-specific microbial communities were dominated by one or several genera, regardless of clinical status. DNA sequencing could identify potentially pathogenic organisms unable to be identified using microbiological methods.	[Byun, Min Kwang; Kim, Hyung Jung] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Internal Med,Div Pulmonol, Seoul, South Korea; [Chang, Joon] Yonsei Univ, Severance Hosp, Coll Med, Dept Internal Med,Div Pulmonol, Seoul, South Korea; [Jeong, Seok Hoon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea; [Jeong, Seok Hoon] Yonsei Univ, Gangnam Severance Hosp, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Jeong, SH (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Dept Lab Med, Seoul, South Korea.; Jeong, SH (corresponding author), Yonsei Univ, Gangnam Severance Hosp, Coll Med, Res Inst Bacterial Resistance, Seoul, South Korea.	kscpjsh@yuhs.ac		Byun, Min Kwang/0000-0003-1525-1745; Seok Hoon, Jeong/0000-0001-9290-897X; Chang, Joon/0000-0003-4542-6841	faculty research grant of Yonsei University College of Medicine [6-2014-0146]	faculty research grant of Yonsei University College of Medicine	This study was supported by a faculty research grant of Yonsei University College of Medicine for 2014 (6-2014-0146). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angrill J, 2002, THORAX, V57, P15, DOI 10.1136/thorax.57.1.15; Barker AF, 2002, NEW ENGL J MED, V346, P1383, DOI 10.1056/NEJMra012519; Bilton D, 2006, CHEST, V130, P1503, DOI 10.1378/chest.130.5.1503; Chalmers JD, 2011, THORAX, V66, P1094, DOI 10.1136/thx.2010.156554; Cohen M, 1999, CHEST, V116, P1063, DOI 10.1378/chest.116.4.1063; Drago L, 2016, EUR J GASTROEN HEPAT, V28, P532, DOI 10.1097/MEG.0000000000000581; Drago Lorenzo, 2016, Clin Mol Allergy, V14, P2, DOI 10.1186/s12948-016-0038-z; Evans DJ, 2003, RESP MED, V97, P851, DOI 10.1016/S0954-6111(03)00063-5; Evans SA, 1996, EUR RESPIR J, V9, P1601, DOI 10.1183/09031936.96.09081601; Fodor AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045001; Franasiak JM, 2016, J ASSIST REPROD GEN, V33, P129, DOI 10.1007/s10815-015-0614-z; FUCHS HJ, 1994, NEW ENGL J MED, V331, P637, DOI 10.1056/NEJM199409083311003; Goodrich JK, 2014, CELL, V158, P250, DOI 10.1016/j.cell.2014.06.037; Han MK, 2012, THORAX, V67, P456, DOI 10.1136/thoraxjnl-2011-201183; Martinez-Garcia MA, 2007, CHEST, V132, P1565, DOI 10.1378/chest.07-0490; Murphy TF, 2008, AM J RESP CRIT CARE, V177, P853, DOI 10.1164/rccm.200709-1413OC; Navas-Molina JA, 2013, METHOD ENZYMOL, V531, P371, DOI 10.1016/B978-0-12-407863-5.00019-8; Pasteur MC, 2010, THORAX, V65, pI1, DOI 10.1136/thx.2010.136119; Pasteur MC, 2000, AM J RESP CRIT CARE, V162, P1277, DOI 10.1164/ajrccm.162.4.9906120; Roberts ME, 2012, INTERN MED J, V42, pE129, DOI 10.1111/j.1445-5994.2011.02444.x; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rogers GB, 2013, THORAX, V68, P731, DOI 10.1136/thoraxjnl-2012-203105; Salipante SJ, 2014, APPL ENVIRON MICROB, V80, P7583, DOI 10.1128/AEM.02206-14; Seitz AE, 2010, CHEST, V138, P944, DOI 10.1378/chest.10-0099; Sethi S, 2007, AM J RESP CRIT CARE, V176, P356, DOI 10.1164/rccm.200703-417OC; Stressmann FA, 2012, THORAX, V67, P867, DOI 10.1136/thoraxjnl-2011-200932; Sze MA, 2012, AM J RESP CRIT CARE, V185, P1073, DOI 10.1164/rccm.201111-2075OC; Toscano M, 2017, DIGEST LIVER DIS, V49, P261, DOI 10.1016/j.dld.2016.11.011; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Tunney MM, 2013, AM J RESP CRIT CARE, V187, P1118, DOI 10.1164/rccm.201210-1937OC; van der Gast CJ, 2011, ISME J, V5, P780, DOI 10.1038/ismej.2010.175; Worlitzsch D, 2009, CLIN MICROBIOL INFEC, V15, P454, DOI 10.1111/j.1469-0691.2008.02659.x	32	25	25	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183553	10.1371/journal.pone.0183553	http://dx.doi.org/10.1371/journal.pone.0183553			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829833	gold, Green Submitted, Green Published			2022-12-27	WOS:000408085100056
J	Jaya, Z; Drain, PK; Mashamba-Thompson, TP				Jaya, Ziningi; Drain, Paul K.; Mashamba-Thompson, Tivani P.			Evaluating quality management systems for HIV rapid testing services in primary healthcare clinics in rural KwaZulu-Natal, South Africa	PLOS ONE			English	Article							MISSED OPPORTUNITIES; DIAGNOSTICS; SETTINGS; PREVENTION; PROGRAM; UGANDA; WOMEN; LABOR	Introduction Rapid HIV tests have improved access to HIV diagnosis and treatment by providing quick and convenient testing in rural clinics and resource-limited settings. In this study, we evaluated the quality management system for voluntary and provider-initiated point-of-care HIV testing in primary healthcare (PHC) clinics in rural KwaZulu-Natal (KZN), South Africa. Material and methods We conducted a quality assessment audit in eleven PHC clinics that offer voluntary HIV testing and counselling in rural KZN, South Africa from August 2015 to October 2016. All the participating clinics were purposively selected from the province-wide survey of diagnostic services. We completed an on-site monitoring checklist, adopted from the WHO guidelines for assuring accuracy and reliability of HIV rapid tests, to assess the quality management system for HIV rapid testing at each clinic. To determine clinic's compliance to WHO quality standards for HIV rapid testing the following quality measure was used, a 3-point scale (high, moderate and poor). A high score was defined as a percentage rating of 90 to 100%, moderate was defined as a percentage rating of 70 to 90%, and poor was defined as a percentage rating of less than 70%. Clinic audit scores were summarized and compared. We employed Pearson pair wise correlation coefficient to determine correlations between clinics audit scores and clinic and clinics characteristics. Linear regression model was computed to estimate statistical significance of the correlates. Correlations were reported as significant at p <= 0.05. Results Nine out of 11 audited rural PHC clinics are located outside 20Km of the nearest town and hospital. Majority (18.2%) of the audited rural PHC clinics reported that HIV rapid test was performed by HIV lay counsellors. Overall, ten clinics were rated moderate, in terms of their compliance to the stipulated WHO guidelines. Audit results showed that rural PHC clinics' average rating score for compliance to the WHO guidelines ranged between 64.4% (CI: 44%-84%) and 89.2% (CI: 74%-100%). Ten out of eleven of the clinics were rated as moderate (70-89%). All clinic have scored highest for the following audit component: equipment; process control and specimen management; and facility ad safety, with 100%. Clinics obtained the lowest scores for the assessment audit component followed by process improvement and organisation, with 40.9% (CI: 15.7-66.1%), 45.5% (CI: 10.4-80.5%) and 56.8% (CI: 31.8 81.8%), respectively. A statistically significant correlation was observed between the following: category of staff performing the HIV rapid tests in the audited clinics and service and satisfactory audit component; weekly average number of patients using the audited PHC clinics and service and satisfactory audit component; number of HIV lay counsellors in the audited clinics and quality control audit component with p<0.05. Discussion In the small audit of primary healthcare clinics located within the rural part of KwaZulu-Natal, results revealed an overall moderate rating of the quality management system for rapid HIV testing. Improvements in the organisation, quality control, process improvement and assessment components could enable a higher quality assurance rating for rural HIV testing in KwaZulu-Natal.	[Jaya, Ziningi; Mashamba-Thompson, Tivani P.] Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa; [Drain, Paul K.] Univ Washington, Int Clin Res Ctr, Dept Global Hlth, Seattle, WA 98195 USA; [Drain, Paul K.] Univ Washington, Dept Med, Div Infect Dis, Seattle, WA USA; [Drain, Paul K.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Drain, Paul K.] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA	University of Kwazulu Natal; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Harvard University; Massachusetts General Hospital	Mashamba-Thompson, TP (corresponding author), Univ KwaZulu Natal, Sch Nursing & Publ Hlth, Discipline Publ Hlth Med, Durban, South Africa.	Mashamba-Thompson@ukzn.ac.za	Mashamba-Thompson, Tivani/GRO-3709-2022	Mashamba-Thompson, Tivani/0000-0002-4193-2416	College of Health Sciences, University of KwaZulu-Natal; South African Centre; African Population Health Research Centre; National Institute of Allergy and Infectious Disease of the National Institutes of Health [K23 AI108293]; Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI108293] Funding Source: NIH RePORTER	College of Health Sciences, University of KwaZulu-Natal; South African Centre; African Population Health Research Centre; National Institute of Allergy and Infectious Disease of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation; University of KwaZulu-Natal; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We would also like to thank the following institutions: College of Health Sciences, University of KwaZulu-Natal; South African Centre for Epidemiological Modelling and Analysis as well as the African Population Health Research Centre; and National Institute of Allergy and Infectious Disease of the National Institutes of Health (K23 AI108293) for their support and enabling access to resources used in conducting this study. We also like to thank the KZN Language institute for editorial assistance.; The author would also like to thank Mr Mnqobi Dlamini and all the PHC members of staff who assisted with the audit. The authors would also like to thank KwaZulu-Natal Health District managers for granting us permission to conduct this study in the rural PHC clinics. We would also like to thank the following institutions: College of Health Sciences, University of KwaZulu-Natal; South African Centre for Epidemiological Modelling and Analysis as well as the African Population Health Research Centre; and National Institute of Allergy and Infectious Disease of the National Institutes of Health (K23 AI108293) for their financial support and enabling access to resources used in conducting this study. We also like to thank the KZN Language institute for editorial assistance. We would also like to acknowledge Dr Sign, Dr Heather and Dr David for 2017/2018 Harvard Medical School GCSRT June 2017 workshop. Open access publication of this article has been made possible through support from the Victor Daitz Information Gateway, an initiative of the Victor Daitz Foundation and the University of KwaZulu-Natal.	Aleku GA, 2014, J INFECT DEV COUNTR, V8, P1231, DOI 10.3855/jidc.4664; Bhattacharya R, 2008, AIDS CARE, V20, P560, DOI 10.1080/09540120701867206; Dennis RL, 2007, J PERINAT NEONAT NUR, V21, P298, DOI 10.1097/01.JPN.0000299787.24291.8d; Drain PK, 2014, LANCET INFECT DIS, V14, P239, DOI 10.1016/S1473-3099(13)70250-0; Dyhdalo KS, 2014, ARCH PATHOL LAB MED, V138, P1444, DOI 10.5858/arpa.2013-0552-CP; Gaede B.M., 2011, S AFRICAN HLTH REV, P99; Gaedeim B., 2011, STATE RIGHT HLTH RUR; Gous N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085265; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Heller T, 2011, INT J STD AIDS, V22, P742, DOI 10.1258/ijsa.2011.011262; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Jewkes R, 2010, J INT AIDS SOC, V13, DOI 10.1186/1758-2652-13-6; Kharsany Ayesha B M, 2016, Open AIDS J, V10, P34, DOI 10.2174/1874613601610010034; Kissin DM, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2007.09.005; Kizito D, 2008, TROP MED INT HEALTH, V13, P680, DOI 10.1111/j.1365-3156.2008.02052.x; Kosack CS, 2017, J INT AIDS SOC, V20; LaBarre P, 2011, PROC SPIE, V8029, DOI 10.1117/12.882868; Lewandrowski K, 2011, ARCH PATHOL LAB MED, V135, P1405, DOI 10.5858/arpa.2011-0157-RA; Liddicoat RV, 2004, J GEN INTERN MED, V19, P349, DOI 10.1111/j.1525-1497.2004.21251.x; Mashamba-Thompson TP, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011155; Mashamba-Thompson TP, 2017, POINT CARE, V16, P67, DOI 10.1097/POC.0000000000000135; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Nogueira SA, 2001, J HUMAN VIROL, V4, P278; Pai N, 2015, BARRIERS IMPLEMENTAT, V14, P7; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Patel P, 2012, J CLIN VIROL, V54, P42, DOI 10.1016/j.jcv.2012.01.022; Petti C. A, 2005, CLIN INFECT DIS, V42, P6; Petti CA, 2006, CLIN INFECT DIS, V42, P377, DOI 10.1086/499363; Republic of South Africa, 2009, GUID ASS ACC REL HIV; Shanks L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059906; Sharma S, 2015, BIOSENSORS-BASEL, V5, P577, DOI 10.3390/bios5030577; Shisana O, 2014, S AFRICAN NATL HIV P; Shott JP, 2012, J TROPICAL MED, V2012; Smit PW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-530; Smith Adriana, 2015, Int J Gynaecol Obstet, V130 Suppl 1, pS70, DOI 10.1016/j.ijgo.2015.04.009; U. S. Department of Health and Human Services: Centers for Disease Control and Prevention, 2005, GUID ASS ACC REL HIV; UNAIDS, 90 90 90 AMB TREATM; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2	38	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183044	10.1371/journal.pone.0183044	http://dx.doi.org/10.1371/journal.pone.0183044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829801	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100025
J	Mishra, P; Kumar, A; Nagireddy, A; Shukla, AK; Sundaresan, V				Mishra, Priyanka; Kumar, Amit; Nagireddy, Akshitha; Shukla, Ashutosh K.; Sundaresan, Velusamy			Evaluation of single and multilocus DNA barcodes towards species delineation in complex tree genus Terminalia	PLOS ONE			English	Article							IDENTIFICATION; REGIONS; PLANTS; TOOL	DNA barcoding is used as a universal tool for delimiting species boundaries in taxonomically challenging groups, with different plastid and nuclear regions (rbcL, matK, ITS and psbA-trnH) being recommended as primary DNA barcodes for plants. We evaluated the feasibility of using these regions in the species-rich genus Terminalia, which exhibits various overlapping morphotypes with pantropical distribution, owing to its complex taxonomy. Terminalia bellerica and T. chebula are ingredients of the famous Ayurvedic Rasayana formulation Triphala, used for detoxification and rejuvenation. High demand for extracted phytochemicals as well as the high trade value of several species renders mandatory the need for the correct identification of traded plant material. Three different analytical methods with single and multilocus barcoding regions were tested to develop a DNA barcode reference library from 222 individuals representing 41 Terminalia species. All the single barcodes tested had a lower discriminatory power than the multilocus regions, and the combination of matK+ITS had the highest resolution rate (94.44%). The average intra-specific variations (0.0188 +/- 0.0019) were less than the distance to the nearest neighbour (0.106 +/- 0.009) with matK and ITS. Distance-based Neighbour Joining analysis outperformed the character-based Maximum Parsimony method in the identification of traded species such as T. arjuna, T. chebula and T. tomentosa, which are prone to adulteration. rbcL was shown to be a highly conservative region with only 3.45% variability between all of the sequences. The recommended barcode combination, rbcL+matK, failed to perform in the genus Terminalia. Considering the complexity of resolution observed with single regions, the present study proposes the combination of matK+ITS as the most successful barcode in Terminalia.	[Mishra, Priyanka; Kumar, Amit; Nagireddy, Akshitha; Sundaresan, Velusamy] CSIR, Cent Inst Med & Aromat Plants, Plant Biol & Systemat, Res Ctr, Bengaluru, Karnataka, India; [Shukla, Ashutosh K.] CSIR, Cent Inst Med & Aromat Plants, Biotechnol Div, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP)	Sundaresan, V (corresponding author), CSIR, Cent Inst Med & Aromat Plants, Plant Biol & Systemat, Res Ctr, Bengaluru, Karnataka, India.	vstiridaresari@cimap.res.in	Kumar, Amit/AAE-2381-2022; Mishra, Ph.D., Priyanka/P-9417-2016	Kumar, Amit/0000-0002-8642-7448; Mishra, Ph.D., Priyanka/0000-0002-2725-0232	Council of Scientific and Industrial Research (CSIR), New Delhi, India [BSC-0106, BSC-0203]; CIMAP [CIMAP/PUB/2016/12]	Council of Scientific and Industrial Research (CSIR), New Delhi, India(Council of Scientific & Industrial Research (CSIR) - India); CIMAP	This work was supported by the Council of Scientific and Industrial Research (CSIR), New Delhi, India through the XIIth FYP project BioprosPR (BSC-0106) and ChemBio (BSC-0203). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to Director, CSIR-CIMAP, Lucknow, for his encouragement and providing laboratory facilities for the study. They express their sincere gratitude to Prof. Adrian Slater, School of Allied Health Sciences, De Montfort University, Leicester, U.K., for the thorough editing of the manuscript. The financial support from the Council of Scientific and Industrial Research (CSIR), New Delhi, India through the XIIth FYP project Biopros-PR (BSC0106) and ChemBio (BSC-0203) is also gratefully acknowledged. CIMAP Communication Number: CIMAP/PUB/2016/12.	Alves TLS, 2014, MOL ECOL RESOUR, V14, P324, DOI 10.1111/1755-0998.12182; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1976, WEALTH INDIA, VX; [Anonymous], 1999, AYURV PHARM IND, V2; Aubriot X, 2013, MOL ECOL RESOUR, V13, P57, DOI 10.1111/1755-0998.12028; Austerlitz F, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S10; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Casiraghi M, 2010, BRIEF BIOINFORM, V11, P440, DOI 10.1093/bib/bbq003; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chen J, 2015, MOL ECOL RESOUR, V15, P337, DOI 10.1111/1755-0998.12319; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cock IE, 2015, INFLAMMOPHARMACOLOGY, V23, P203, DOI 10.1007/s10787-015-0246-z; Collins RA, 2013, MOL ECOL RESOUR, V13, P969, DOI 10.1111/1755-0998.12046; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gere J, 2013, ZOOKEYS, P127, DOI 10.3897/zookeys.365.5728; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Hooker JD, 1878, FLORA BRIT INDIA; Hutan PP, 1972, TREE FLORA MALAYA MA; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Krawczyk K, 2014, MOL ECOL RESOUR, V14, P272, DOI 10.1111/1755-0998.12175; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Lamb AFA, 1971, FAST GROWING TIMBER; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Liu J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153008; Liu J, 2015, DIVERS DISTRIB, V21, P188, DOI 10.1111/ddi.12276; Maurin O, 2010, BOT J LINN SOC, V162, P453, DOI 10.1111/j.1095-8339.2010.01027.x; Meier R, 2008, SYST BIOL, V57, P809, DOI 10.1080/10635150802406343; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Mishra P, 2016, PEERJ, V4, DOI 10.7717/peerj.2638; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Mishra P, 2015, APPL BIOCHEM BIOTECH, V176, P1413, DOI 10.1007/s12010-015-1654-7; Nair RV, 2004, CONTROVERSIAL DRUG P; Newmaster S G, 2008, Mol Ecol Resour, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Newmaster SG, 2009, MOL ECOL RESOUR, V9, P172, DOI 10.1111/j.1755-0998.2009.02642.x; Nithaniyal S, 2016, BIOCHEM SYST ECOL, V68, P223, DOI 10.1016/j.bse.2016.08.001; Parkinson CE, 1936, INDIAN FOREST RECORD, V1, P1; Pei NC, 2015, SCI REP-UK, V5, DOI 10.1038/srep15127; Ren BQ, 2010, MOL ECOL RESOUR, V10, P594, DOI 10.1111/j.1755-0998.2009.02815.x; Robba L, 2006, AM J BOT, V93, P1101, DOI 10.3732/ajb.93.8.1101; Robinson EA, 2009, ZOOKEYS, P27, DOI 10.3897/zookeys.16.239; Rogers CB, 1996, P 1 INT IOCD S VICT, P121; Sandionigi A, 2012, PLANT BIOSYST, V146, P805, DOI 10.1080/11263504.2012.740084; Sarwat M, 2006, ELECTRON J BIOTECHN, V9, P86, DOI 10.2225/vol9-issue1-fulltext-3; Sass C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001154; Shi LC, 2011, J SYST EVOL, V49, P261, DOI 10.1111/j.1759-6831.2011.00133.x; Srivastav P. K., 2002, Indian Forester, V128, P289; Srivastava PK, 2003, P NATL A SCI INDIA B, V73, P951; Srivastava PK, 1991, INDIAN SILK, V10, P15; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; van Velzen R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030490; Ved DK, 2008, DEMAND SUPPLY MED PL; Whitlock BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011533; Xiang XG, 2011, MOL ECOL RESOUR, V11, P1012, DOI 10.1111/j.1755-0998.2011.03044.x; Yan LJ, 2015, MOL ECOL RESOUR, V15, P932, DOI 10.1111/1755-0998.12353; Yang JB, 2012, MOL ECOL RESOUR, V12, P267, DOI 10.1111/j.1755-0998.2011.03095.x; Zhang CY, 2012, MOL ECOL RESOUR, V12, P98, DOI 10.1111/j.1755-0998.2011.03076.x; Zheng SH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098061	64	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0182836	10.1371/journal.pone.0182836	http://dx.doi.org/10.1371/journal.pone.0182836			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829803	gold, Green Published, Green Submitted			2022-12-27	WOS:000408085100017
J	Pellegrini, C; Orlandi, A; Costanza, G; Di Stefani, A; Piccioni, A; Di Cesare, A; Chiricozzi, A; Ferlosio, A; Peris, K; Fargnoli, MC				Pellegrini, Cristina; Orlandi, Augusto; Costanza, Gaetana; Di Stefani, Alessandro; Piccioni, Antonella; Di Cesare, Antonella; Chiricozzi, Andrea; Ferlosio, Amedeo; Peris, Kelly; Fargnoli, Maria Concetta			Expression of IL-23/Th17-related cytokines in basal cell carcinoma and in the response to medical treatments	PLOS ONE			English	Article							PHOTODYNAMIC THERAPY; ANTITUMOR IMMUNITY; TH17 CELLS; T-CELLS; IN-VIVO; HEPATOCELLULAR-CARCINOMA; INFLAMMATORY INFILTRATE; MODIFIER IMIQUIMOD; TUMOR PROGRESSION; HELPER-CELLS	Several immune-related markers have been implicated in basal cell carcinoma (BCC) pathogenesis. The BCC inflammatory infiltrate is dominated by Th2 cytokines, suggesting a specific state of immunosuppression. In contrast, regressing BCC are characterized by a Th1 immune response with IFN-gamma promoting a tumor suppressive activity. IL-23/Th17-related cytokines, as interleukin (IL)-17, IL-23 and IL-22, play a significant role in cutaneous inflammatory diseases, but their involvement in skin carcinogenesis is controversial and is poorly investigated in BCC. In this study we investigated the expression of IFN-gamma, IL-17, IL-23 and IL-22 cytokines in BCC at the protein and mRNA level and their modulation during imiquimod (IMQ) treatment or photodynamic therapy (PDT). IFN-gamma, IL-17, IL-23 and IL-22 levels were evaluated by immunohistochemistry and quantitative Real Time PCR in 41 histopathologically-proven BCCs (28 superficial and 13 nodular) from 39 patients. All BCC samples were analyzed at baseline and 19 of 41 also during medical treatment (9 with IMQ 5% cream and 10 with MAL-PDT). Association between cytokines expression and clinicopathological variables was evaluated. Higher levels of IFN-gamma, IL-17, IL-23 and IL-22 were found in BCCs, mainly in the peritumoral infiltrate, compared to normal skin, with the expression being correlated to the severity of the inflammatory infiltrate. IFN-gamma production was higher in superficial BCCs compared to nodular BCCs, while IL-17 was increased in nodular BCCs. A significant correlation was found between IFN-gamma and IL-17 expression with both cytokines expressed by CD4+ and CD8+ T-cells. An increase of all cytokines occurred during the inflammatory phase induced by IMQ and at the early time point of PDT treatment, with significant evidence for IFN-gamma, IL-23, and IL-22. Our results confirm the role of IFN-gamma and support the involvement of IL-23/Th17-related cytokines in BCC pathogenesis and in the inflammatory response during IMQ and MAL-PDT treatments.	[Pellegrini, Cristina; Piccioni, Antonella; Fargnoli, Maria Concetta] Univ LAquila, Biotechnol & Appl Clin Sci, Laquila, Italy; [Orlandi, Augusto; Costanza, Gaetana; Ferlosio, Amedeo] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy; [Di Stefani, Alessandro; Peris, Kelly] Catholic Univ, Inst Dermatol, Rome, Italy; [Di Cesare, Antonella] Univ Florence, Dept Surg & Translat Med, Div Clin Prevent & Oncol Dermatol, Florence, Italy; [Chiricozzi, Andrea] Univ Pisa, Dermatol Dept, Pisa, Italy	University of L'Aquila; University of Rome Tor Vergata; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University of Florence; University of Pisa	Fargnoli, MC (corresponding author), Univ LAquila, Biotechnol & Appl Clin Sci, Laquila, Italy.	mariaconcella.fargnoli@univaq.it	Orlandi, Augusto/AHE-8753-2022; Ferlosio, amedeo/AHE-8783-2022; Pellegrini, Cristina/F-7175-2017; Di Stefani, Alessandro/A-9418-2019; Costanza, Gaetana (Tania)/GXV-4686-2022; costanza, gaetana/J-5171-2018	Pellegrini, Cristina/0000-0003-2168-8097; Di Stefani, Alessandro/0000-0001-8283-2633; costanza, gaetana/0000-0002-1115-4270; Fargnoli, Maria Concetta/0000-0002-7249-2556				Abraham C, 2009, INFLAMM BOWEL DIS, V15, P1090, DOI 10.1002/ibd.20894; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Chiricozzi A, 2012, J BIOL REG HOMEOS AG, V26, P313; Cocco C, 2010, BLOOD, V116, P3887, DOI 10.1182/blood-2009-10-248245; de Sa TR, 2015, FUTURE ONCOL, V11, P3023, DOI 10.2217/fon.15.245; De Giorgi V, 2009, INT J DERMATOL, V48, P312, DOI 10.1111/j.1365-4632.2009.03916.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; Elamin I, 2008, ACTA DERMATOVEN ALP, V17, P55; Fantini F, 2008, ARCH DERMATOL, V144, P186, DOI 10.1001/archdermatol.2007.31; Fargnoli MC, 2015, FUTURE ONCOL, V11, P2991, DOI 10.2217/fon.15.208; Fischer-Stabauer M, 2012, EUR J DERMATOL, V22, P781, DOI 10.1684/ejd.2012.1854; Gaffen SL, 2014, NAT REV IMMUNOL, V14, P585, DOI 10.1038/nri3707; Ganzetti G, 2015, MELANOMA RES, V25, P232, DOI 10.1097/CMR.0000000000000151; Gilliet M, 2004, ARCH DERMATOL, V140, P1490, DOI 10.1001/archderm.140.12.1490; Glaser R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025160; Gollnick SO, 2012, J NATL COMPR CANC NE, V10, pS40; Gollnick SO, 1997, CANCER RES, V57, P3904; Hahn JN, 2011, J CLIN INVEST, V121, P4030, DOI 10.1172/JCI45114; Hanna E, 2016, INT J DERMATOL, V55, P831, DOI 10.1111/ijd.13235; Harper EG, 2009, J INVEST DERMATOL, V129, P2175, DOI 10.1038/jid.2009.65; He DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032126; Heenan PJ, 1996, WHO INT HISTOLOGICAL, V2, P48; Hemdan NYA, 2013, IMMUNOL LETT, V149, P123, DOI 10.1016/j.imlet.2012.11.002; Hinrichs CS, 2009, BLOOD, V114, P596, DOI 10.1182/blood-2009-02-203935; Hu P, 2009, MOL IMMUNOL, V46, P1654, DOI 10.1016/j.molimm.2009.02.025; Ji YQ, 2010, CANCER IMMUNOL IMMUN, V59, P979, DOI 10.1007/s00262-010-0849-6; Jiang RQ, 2011, HEPATOLOGY, V54, P900, DOI 10.1002/hep.24486; Kaiga T, 2007, J IMMUNOL, V178, P7571, DOI 10.4049/jimmunol.178.12.7571; Kaporis HG, 2007, J INVEST DERMATOL, V127, P2391, DOI 10.1038/sj.jid.5700884; KIM J, 1995, J IMMUNOL, V155, P2240; Kirchberger S, 2013, J EXP MED, V210, P917, DOI 10.1084/jem.20122308; Kossard S, 2006, WHO CLASSIFICATION T, P13; Kryczek I, 2009, BLOOD, V114, P1141, DOI 10.1182/blood-2009-03-208249; Langowski JL, 2006, NATURE, V442, P461, DOI 10.1038/nature04808; Lear W, 2007, J CUTAN MED SURG, V11, P19, DOI 10.2310/7750.2007.00011; Li J, 2016, J IMMUNOL RES, DOI DOI 10.1155/2016/9404705; Liu T, 2012, J CLIN IMMUNOL, V32, P1332, DOI 10.1007/s10875-012-9718-8; Morton CA, 2013, J EUR ACAD DERMATOL, V27, P536, DOI 10.1111/jdv.12031; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Muranski P, 2011, IMMUNITY, V35, P972, DOI 10.1016/j.immuni.2011.09.019; Nardinocchi L, 2015, EUR J IMMUNOL, V45, P922, DOI 10.1002/eji.201445052; Papakostas D, 2015, FUTURE ONCOL, V11, P2985, DOI 10.2217/fon.15.192; Passeri D, 2016, J INVEST DERMATOL, V136, P1255, DOI 10.1016/j.jid.2016.01.039; Prignano F, 2009, J CUTAN PATHOL, V36, P409, DOI 10.1111/j.1600-0560.2008.01063.x; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Sa SM, 2007, J IMMUNOL, V178, P2229, DOI 10.4049/jimmunol.178.4.2229; Schon M, 2003, J NATL CANCER I, V95, P1138, DOI 10.1093/jnci/djg016; Sfanos KS, 2008, CLIN CANCER RES, V14, P3254, DOI 10.1158/1078-0432.CCR-07-5164; Tilley C, 2015, MOL CARCINOGEN, V54, P688, DOI 10.1002/mc.22348; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Duijnhoven FH, 2003, IMMUNOBIOLOGY, V207, P105, DOI 10.1078/0171-2985-00221; Verkouteren J.A., 2017, BR J DERMATOL; Wang L, 2010, CANCER RES, V70, P10112, DOI 10.1158/0008-5472.CAN-10-0775; Wen Z, 2014, ANN SURG ONCOL, V21, P125, DOI 10.1245/s10434-013-3322-x; Weyers W, 1999, CANCER-AM CANCER SOC, V86, P288, DOI 10.1002/(SICI)1097-0142(19990715)86:2<288::AID-CNCR13>3.0.CO;2-S; Wolf IH, 2007, AM J DERMATOPATH, V29, P237, DOI 10.1097/01.dad.0000211531.33670.94; Wong DA, 2000, BRIT J DERMATOL, V143, P91, DOI 10.1046/j.1365-2133.2000.03596.x; Wu C, 2009, CLIN EXP IMMUNOL, V158, P199, DOI 10.1111/j.1365-2249.2009.04011.x; Ye J, 2013, AM J PATHOL, V182, P10, DOI 10.1016/j.ajpath.2012.08.041; Yokogawa M, 2013, MOL CARCINOGEN, V52, P760, DOI 10.1002/mc.21901; Zhuang Y, 2012, CANCER IMMUNOL IMMUN, V61, P1965, DOI 10.1007/s00262-012-1241-5	62	21	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183415	10.1371/journal.pone.0183415	http://dx.doi.org/10.1371/journal.pone.0183415			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829805	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100045
J	Suh, B; Shin, DW; Kwon, HM; Yun, JM; Yang, HK; Ahn, E; Lee, H; Park, JH; Cho, B				Suh, Beomseok; Shin, Dong Wook; Kwon, Hyung-Min; Yun, Jae Moon; Yang, Hyung-Kook; Ahn, Eunmi; Lee, Hyejin; Park, Jin Ho; Cho, BeLong			Elevated neutrophil to lymphocyte ratio and ischemic stroke risk in generally healthy adults	PLOS ONE			English	Article							C-REACTIVE PROTEIN; NEUTROPHIL/LYMPHOCYTE RATIO; THROMBOEMBOLIC STROKE; MORTALITY; PREDICT; DISEASE; ATHEROSCLEROSIS; INFLAMMATION	Elevated neutrophil to lymphocyte ratio (NLR) has been reported as a marker for chronic inflammation, associated with poor prognosis in ischemic stroke patients, but there has been no study that investigated its association with ischemic stroke risk. This study was conducted to investigate elevated NLR as an independent risk factor for ischemic stroke incidence. Our retrospective cohort study included 24,708 generally healthy subjects aged 30-75 who received self-referred health screening at Seoul National University Hospital. Data on ischemic stroke incidence was retrieved from national medical claims registry. Median follow-up time was 5.9 years (interquartile range 4.2 years). Adjusted for major cardiovascular risk factors, compared to subjects with NLR<1.5, subjects with 2.5 <= NLR< 3.0, 3.0 <= NLR< 3.5, and NLR >= 3.5 had elevated risk for ischemic stroke incidence with aHR (95% CI) of 1.76 (1.09-2.84), 2.21 (1.21-4.04), and 2.96 (1.57-5.58), respectively. NLR showed significant improvement in discrimination for ischemic stroke incidence compared to traditional cardiovascular risk factors (C-index 0.748 vs. 0.739, P = 0.025). There was significant net improvement in reclassification in Framingham risk for ischemic stroke incidence after addition of NLR, with IDI 0.0035 (P<0.0001), and NRI 6.02% (P = 0.0015). This reclassification for ischemic stroke incidence by NLR was markedly pronounced among subjects with atrial fibrillation with CHA(2)DS(2)-VASc<2 (NRI 42.41%, P = 0.056). Our study suggests elevated NLR to be an independent risk factor for ischemic stroke incidence in generally healthy adults. Future studies are needed to validate our results and further assess how subjects with elevated NLR should be managed within current guidelines.	[Suh, Beomseok; Yun, Jae Moon; Lee, Hyejin; Park, Jin Ho; Cho, BeLong] Seoul Natl Univ Hosp, Dept Family Med, Seoul, South Korea; [Suh, Beomseok; Yun, Jae Moon; Lee, Hyejin; Park, Jin Ho; Cho, BeLong] Seoul Natl Univ Hosp, Hlth Promot Ctr, Seoul, South Korea; [Shin, Dong Wook] Samsung Med Ctr, Dept Family Med, Seoul, South Korea; [Shin, Dong Wook] Samsung Med Ctr, Support Care Ctr, Seoul, South Korea; [Kwon, Hyung-Min] Seoul Metropolitan Govt Seoul Natl Univ Boramae M, Dept Neurol, Seoul, South Korea; [Yang, Hyung-Kook] Natl Canc Ctr, Natl Canc Control Inst, Canc Survivorship Branch, Goyang, South Korea; [Ahn, Eunmi] Natl Canc Ctr, Natl Canc Control Inst, Hosp & Palliat Care Branch, Goyang, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Seoul National University (SNU); Seoul National University Hospital; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Shin, DW (corresponding author), Samsung Med Ctr, Dept Family Med, Seoul, South Korea.; Shin, DW (corresponding author), Samsung Med Ctr, Support Care Ctr, Seoul, South Korea.	dwshin.md@gmail.com	Cho, Belong/GLU-3443-2022; Shin, Dong Wook/J-6721-2016	Cho, Belong/0000-0001-9558-689X; Kwon, Hyung-Min/0000-0002-6101-7127; Shin, Dong Wook/0000-0001-8128-8920				Auer R, 2012, JAMA-J AM MED ASSOC, V307, P1497, DOI 10.1001/jama.2012.434; Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Camm AJ, 2012, EUR HEART J, V33; Curb JD, 2003, CIRCULATION, V107, P2016, DOI 10.1161/01.CIR.0000065228.20100.F7; Ertas G, 2013, J NEUROL SCI, V324, P49, DOI 10.1016/j.jns.2012.09.032; Fuchs TA, 2010, P NATL ACAD SCI USA, V107, P15880, DOI 10.1073/pnas.1005743107; Goff Jr DC, 2013, J AM COLL CARDIOL, V63, P2935, DOI DOI 10.1016/J.JACC.2013.11.005; Guasti L, 2008, EUR HEART J, V29, P1118, DOI 10.1093/eurheartj/ehn138; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hartaigh BO, 2012, ATHEROSCLEROSIS, V224, P161, DOI 10.1016/j.atherosclerosis.2012.04.012; Hijazi Z, 2013, EUR HEART J, V34, P1475, DOI 10.1093/eurheartj/eht024; Horne BD, 2005, J AM COLL CARDIOL, V45, P1638, DOI 10.1016/j.jacc.2005.02.054; Kaptoge S, 2012, NEW ENGL J MED, V367, P1310, DOI 10.1056/NEJMoa1107477; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Khot UN, 2003, JAMA-J AM MED ASSOC, V290, P898, DOI 10.1001/jama.290.7.898; Libby P, 2002, CIRCULATION, V105, P1135, DOI 10.1161/hc0902.104353; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nissen SE, 2005, NEW ENGL J MED, V352, P29, DOI 10.1056/NEJMoa042000; Ridker PM, 1998, CIRCULATION, V98, P731, DOI 10.1161/01.CIR.98.8.731; Shah N, 2014, INT J CARDIOL, V171, P390, DOI 10.1016/j.ijcard.2013.12.019; Tokgoz S, 2014, J STROKE CEREBROVASC, V23, P2163, DOI 10.1016/j.jstrokecerebrovasdis.2014.04.007; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402	22	38	41	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183706	10.1371/journal.pone.0183706	http://dx.doi.org/10.1371/journal.pone.0183706			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829826	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100068
J	Steca, P; Monzani, D; Greco, A; Franzelli, C; Magrin, ME; Miglioretti, M; Sarini, M; Scrignaro, M; Vecchio, L; Fattirolli, F; D'Addario, M				Steca, Patrizia; Monzani, Dario; Greco, Andrea; Franzelli, Cristina; Magrin, Maria Elena; Miglioretti, Massimo; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; Fattirolli, Francesco; D'Addario, Marco			Stability and change of lifestyle profiles in cardiovascular patients after their first acute coronary event	PLOS ONE			English	Article							CARDIAC REHABILITATION; MYOCARDIAL-INFARCTION; RISK-FACTORS; SECONDARY PREVENTION; PHYSICAL-ACTIVITY; DEPRESSION SCALE; HOSPITAL ANXIETY; PATIENTS BELIEFS; HEART-DISEASE; ASSOCIATION	Background Acute coronary syndrome (ACS) is a major cause of morbidity and mortality. Lifestyle and health behavior changes play an important role in the primary and secondary prevention of ACS recurrence. Changes in unhealthy lifestyles after an acute coronary event have been analyzed by considering separate behaviors individually, even though research on the healthy population has demonstrated that unhealthy behaviors tend to co-occur. Purpose The aim of this study was to identify lifestyle profiles of ACS patients and to explore their pathways of change for one year after their first coronary event by adopting a typological approach. Methods Two hundred and twenty-three patients (84% male; mean age = 57.14) completed self-report measures of health-related behaviors at the beginning of cardiac rehabilitation, and six months and twelve months after. At each wave depression, anxiety and heart rate were also evaluated. Cluster analysis was performed to identify lifestyle profiles and to analyze their change over time. Differences in psychological factors and heart rate among clusters were assessed. Results Patients' diet, physical activity, and smoking behavior greatly improved six months after their first coronary event. No further improvements were detected after one year. At each wave specific lifestyle profiles were identified, ranging from more maladaptive to healthier clusters. Patients with multiple unhealthy behaviors experience greater difficulties in maintaining a healthier lifestyle over time. Moreover, the results demonstrated the association between lifestyle profiles at twelve months after the acute coronary event and depression measured six months earlier. Finally, the most maladaptive lifestyle profile had many members with elevated heart rate at twelve months after the cardiac rehabilitation. Conclusions Current findings may have a strong practical impact in the development and implementation of personalized secondary prevention programs targeting lifestyles of ACS patients.	[Steca, Patrizia; Monzani, Dario; Greco, Andrea; Magrin, Maria Elena; Miglioretti, Massimo; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; D'Addario, Marco] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Franzelli, Cristina] Ist Clin Perfezionamento Hosp, Cardiac Rehabil Ctr, Milan, Italy; [Fattirolli, Francesco] Univ Florence, Dept Med & Surg Crit Care, Cardiac Rehabil Unit, Florence, Italy; [Fattirolli, Francesco] Azienda Osped Univ Careggi, Florence, Italy	University of Milano-Bicocca; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi	Monzani, D (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	dario.monzani@unimib.it	Vecchio, Luca/C-1670-2013; Greco, Andrea/I-7266-2016; Monzani, Dario/AAR-2609-2021; D'Addario, Marco/AAY-6426-2021; Monzani, Dario/AAP-4501-2020	Vecchio, Luca/0000-0001-6784-2817; Greco, Andrea/0000-0002-8086-2801; D'ADDARIO, MARCO/0000-0002-7659-885X	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [RBFR08YVUL]	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca"	This work was supported by the Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [grant number RBFR08YVUL]; Principal Investigator: PS, http://futuroinricerca.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abood D, 1994, HEALTH VALUES, V18, P51; Beckie TM, 2010, J CARDIOPULM REHABIL, V30, P147, DOI 10.1097/HCR.0b013e3181d0c2ce; Bergman L., 2002, SLEIPNER A STATISTIC; Bergman L. R., 2003, STUDYING INDIVIDUAL; Bergman LR, 2012, INT J BEHAV DEV, V36, P237, DOI 10.1177/0165025412440947; Berlin I, 2006, ADDICTION, V101, P1814, DOI 10.1111/j.1360-0443.2006.01616.x; Burke V, 1997, PREV MED, V26, P724, DOI 10.1006/pmed.1997.0198; Cooper AF, 2007, HEART, V93, P53, DOI 10.1136/hrt.2005.081299; Cooper AF, 2005, CLIN REHABIL, V19, P87, DOI 10.1191/0269215505cr818oa; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Cuenca-Garcia M, 2013, J NUTR EDUC BEHAV, V45, P549, DOI 10.1016/j.jneb.2013.02.006; de Vries H, 2008, PREV MED, V46, P203, DOI 10.1016/j.ypmed.2007.08.005; Doyle B, 2012, J CLIN NURS, V21, P32, DOI 10.1111/j.1365-2702.2010.03636.x; Facila L, 2012, WORLD J CARDIOL, V4, P15, DOI 10.4330/wjc.v4.i1.15; Farley Robyn L, 2003, Eur J Cardiovasc Nurs, V2, P205; Fine LJ, 2004, AM J PREV MED, V27, P18, DOI 10.1016/j.amepre.2004.04.017; Garcia-Lopez M, 2014, EUR J PREV CARDIOL, V21, P521, DOI 10.1177/2047487312467871; GLASSMAN AH, 1990, JAMA-J AM MED ASSOC, V264, P1546, DOI 10.1001/jama.264.12.1546; Grace SL, 2002, GEN HOSP PSYCHIAT, V24, P127, DOI 10.1016/S0163-8343(02)00179-2; Hayes SN, 2009, WOMENS HEALTH, V5, P709, DOI 10.2217/WHE.09.56; Hu MX, 2016, PREV MED, V94, P12; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Lampropoulos K, 2016, KARDIOL POL, V74, P1154, DOI 10.5603/KP.a2016.0059; Mahoney JL, 2001, INT J BEHAV DEV, V25, P509, DOI 10.1080/01650250042000456; Mayou RA, 2000, PSYCHOSOM MED, V62, P212, DOI 10.1097/00006842-200003000-00011; Morris LJ, 2016, PREV MED, V84, P1, DOI 10.1016/j.ypmed.2015.12.009; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Niaura R, 2001, PSYCHOL ADDICT BEHAV, V15, P13, DOI 10.1037/0893-164X.15.1.13; Palaniappan U, 2001, J NUTR, V131, P1952, DOI 10.1093/jn/131.7.1952; Panagiotakos DB, 2015, MATURITAS, V80, P205, DOI 10.1016/j.maturitas.2014.11.011; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Prochaska JJ, 2011, AM J LIFESTYLE MED, V5, P208, DOI 10.1177/1559827610391883; Schlecht NF, 1999, AM J EPIDEMIOL, V150, P1129, DOI 10.1093/oxfordjournals.aje.a009938; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; SIMOES EJ, 1995, AM J PUBLIC HEALTH, V85, P240, DOI 10.2105/AJPH.85.2.240; Slattery ML, 2002, MED SCI SPORT EXER, V34, P913, DOI 10.1097/00005768-200206000-00002; Sofi F, 2011, ACTA CARDIOL, V66, P791, DOI 10.1080/AC.66.6.2136965; Steca P, 2015, APPL PSYCHOL HEALTH; Topolski T. D., 2006, CTR DIS CONTROL PREV, V3, P1; TRICHOPOULOU A, 1995, BMJ-BRIT MED J, V311, P1457, DOI 10.1136/bmj.311.7018.1457; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Vervueren PL, 2012, ARCH CARDIOVASC DIS, V105, P478, DOI 10.1016/j.acvd.2012.05.008; Vickers KS, 2006, AM J HEALTH BEHAV, V30, P353, DOI 10.5993/AJHB.30.4.2; WHO, 2011, GLOBAL STATUS REPORT; WOODWARD M, 1994, PREV MED, V23, P354, DOI 10.1006/pmed.1994.1049; Yehle KS, 2012, J CARDIOPULM REHABIL, V32, P203, DOI 10.1097/HCR.0b013e31825b4e6a; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zimmermann-Viehoff F, 2010, EUR J CARDIOV PREV R, V17, P509, DOI 10.1097/HJR.0b013e328337b57b	49	22	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183905	10.1371/journal.pone.0183905	http://dx.doi.org/10.1371/journal.pone.0183905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850579	Green Published, gold, Green Submitted			2022-12-27	WOS:000408544200040
J	Belongie, KJ; Ferrannini, E; Johnson, K; Andrade-Gordon, P; Hansen, MK; Petrie, JR				Belongie, Kirstine J.; Ferrannini, Ele; Johnson, Kjell; Andrade-Gordon, Patricia; Hansen, Michael K.; Petrie, John R.			Identification of novel biomarkers to monitor beta-cell function and enable early detection of type 2 diabetes risk	PLOS ONE			English	Article							FACTOR-ALPHA RECEPTOR-2; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; ADIPOSE-TISSUE; MESENCHYMAL TRANSITION; MESSENGER-RNA; SENSITIVITY; EXPRESSION; PROX1; DIFFERENTIATION	A decline in beta-cell function is a prerequisite for the development of type 2 diabetes, yet the level of beta-cell function in individuals at risk of the condition is rarely measured. This is due, in part, to the fact that current methods for assessing beta-cell function are inaccurate, prone to error, labor-intensive, or affected by glucose-lowering therapy. The aim of the current study was to identify novel circulating biomarkers to monitor beta-cell function and to identify individuals at high risk of developing beta-cell dysfunction. In a nested case-control study from the Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) cohort (n = 1157), proteomics and miRNA profiling were performed on fasting plasma samples from 43 individuals who progressed to impaired glucose tolerance (IGT) and 43 controls who maintained normal glucose tolerance (NGT) over three years. Groups were matched at baseline for age, gender, body mass index (BMI), insulin sensitivity (euglycemic clamp) and beta-cell glucose sensitivity (mathematical modeling). Proteomic profiling was performed using the SomaLogic platform (Colorado, USA); miRNA expression was performed using a modified RT-PCR protocol (Regulus Therapeutics, California, USA). Results showed differentially expressed proteins and miRNAs including some with known links to type 2 diabetes, such as adiponectin, but also novel biomarkers and pathways. In cross sectional analysis at year 3, the top differentially expressed biomarkers in people with IGT/reduced beta-cell glucose sensitivity were adiponectin, alpha1-antitrypsin (known to regulate adiponectin levels), endocan, miR-181a, miR-342, and miR-323. At baseline, adiponectin, cathepsin D and NCAM.L1 (proteins expressed by pancreatic beta-cells) were significantly lower in those that progressed to IGT. Many of the novel prognostic biomarker candidates were within the epithelial-mesenchymal transition (EMT) pathway: for example, Noggin, DLL4 and miR-181a. Further validation studies are required in additional clinical cohorts and in patients with type 2 diabetes, but these results identify novel pathways and biomarkers that may have utility in monitoring beta-cell function and/or predicting future decline, allowing more targeted efforts to prevent and intercept type 2 diabetes.	[Belongie, Kirstine J.; Andrade-Gordon, Patricia; Hansen, Michael K.] Janssen Res & Dev, Cardiovasc & Metab Dis Res, Spring House, PA USA; [Ferrannini, Ele] CNR, Inst Clin Physiol, Pisa, Italy; [Johnson, Kjell] Arbor Analyt, Ann Arbor, MI USA; [Petrie, John R.] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland	Johnson & Johnson; Janssen Pharmaceuticals; Consiglio Nazionale delle Ricerche (CNR); Istituto di Fisiologia Clinica (IFC-CNR); University of Glasgow	Petrie, JR (corresponding author), Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland.	john.petrie@glasgow.ac.uk		Petrie, John/0000-0002-4894-9819	Janssen Pharmaceuticals; EU [QLG1-CT-2001-01252]; AstraZeneca (Sweden); Novo Nordisk (Europe); Janssen Research Development; Arbor Analytics	Janssen Pharmaceuticals(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); EU(European Commission); AstraZeneca (Sweden)(AstraZeneca); Novo Nordisk (Europe); Janssen Research Development; Arbor Analytics	This work was funded by an unrestricted grant from Janssen Pharmaceuticals. The Relationship between Insulin Sensitivity and Cardiovascular disease (RISC) study was partly supported by EU Framework V Program Grant QLG1-CT-2001-01252 with additional funding from AstraZeneca (Sweden). RISC is run by the European Group for the study of Insulin Resistance (EGIR) which at the time of this manuscript submission was supported by Novo Nordisk (Europe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Janssen Research & Development (KJB, PAG, MKH) and Arbor Analytics (KJ) provided support in the form of salaries for authors (as per initials) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of each author is articulated in the 'author contributions' section.	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Baldi S, 2013, DIABETES CARE, V36, P4125, DOI 10.2337/dc13-0682; Balta S, 2015, ATHEROSCLEROSIS, V243, P339, DOI 10.1016/j.atherosclerosis.2015.09.030; Caperuto LC, 2008, ENDOCRINOLOGY, V149, P6326, DOI 10.1210/en.2008-0655; Carter S, 2014, ATHEROSCLEROSIS, V237, P645, DOI 10.1016/j.atherosclerosis.2014.09.022; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Collares Cristhianna V A, 2013, BMC Res Notes, V6, P491, DOI 10.1186/1756-0500-6-491; Costa A, 2003, METABOLISM, V52, P1068, DOI 10.1016/S0026-0495(03)00108-2; Curran AM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161350; Efrat S, 2016, DIABETES OBES METAB, V18, P97, DOI 10.1111/dom.12724; Ferrannini E, 2007, DIABETOLOGIA, V50, P2342, DOI 10.1007/s00125-007-0806-x; Ferrannini E, 2011, DIABETOLOGIA, V54, P1507, DOI 10.1007/s00125-011-2112-x; Gohda T, 2012, J AM SOC NEPHROL, V23, P516, DOI 10.1681/ASN.2011060628; Gold L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015004; Green A, 2004, IMPLICATIONS LONG TE, P74; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Gupta A, 2005, J PEDIATR ENDOCR MET, V18, P75; Hamet P, 2016, J HYPERTENS, V34, pE58, DOI 10.1097/01.hjh.0000500001.33810.04; Herder C, 2016, EUR J ENDOCRINOL, V175, P367, DOI 10.1530/EJE-16-0528; Heremans Y, 2002, J CELL BIOL, V159, P303, DOI 10.1083/jcb.200203074; Hills SA, 2004, DIABETOLOGIA, V47, P566, DOI 10.1007/s00125-004-1335-5; Janke J, 2006, HORM METAB RES, V38, P28, DOI 10.1055/s-2006-924973; Jiang YN, 2016, BMJ OPEN DIAB RES CA, V4, DOI 10.1136/bmjdrc-2016-000194; Kahn SE, 2006, NEW ENGL J MED, V355, P2427, DOI 10.1056/NEJMoa066224; Kazenwadel J, 2010, BLOOD, V116, P2395, DOI 10.1182/blood-2009-12-256297; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Kothari AN, 2014, CLIN TRANSLATIONAL M, V3, P1, DOI DOI 10.1186/2001-1326-3-1; Kraus M, 2015, MOL CELL ENDOCRINOL, V414, P177, DOI 10.1016/j.mce.2015.07.026; Krause C, 2011, INT J BIOCHEM CELL B, V43, P478, DOI 10.1016/j.biocel.2011.01.007; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; Latreille M, 2015, J MOL MED, V93, P1159, DOI 10.1007/s00109-015-1296-9; Lecompte S, 2013, DIABETES, V62, P1738, DOI 10.2337/db12-0864; Liao XY, 2013, J CELL SCI, V126, P3848, DOI 10.1242/jcs.123570; Lyssenko V, 2005, DIABETES, V54, P166, DOI 10.2337/diabetes.54.1.166; Maahs DM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013051; Malm HA, 2016, MOL CELL ENDOCRINOL, V424, P23, DOI 10.1016/j.mce.2016.01.010; Manco M, 2010, DIABETES CARE, V33, P2090, DOI 10.2337/dc09-2261; Mansuy-Aubert V, 2013, CELL METAB, V17, P534, DOI 10.1016/j.cmet.2013.03.005; Mari A, 2002, AM J PHYSIOL-ENDOC M, V283, pE1159, DOI 10.1152/ajpendo.00093.2002; Mari A, 2010, DIABETOLOGIA, V53, P749, DOI 10.1007/s00125-009-1647-6; Mari A, 2008, DIABETES OBES METAB, V10, P77, DOI 10.1111/j.1463-1326.2008.00946.x; Mari A, 2001, DIABETES CARE, V24, P539, DOI 10.2337/diacare.24.3.539; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mather KJ, 2008, DIABETES, V57, P980, DOI 10.2337/db07-1419; Mezza T, 2016, J CLIN ENDOCR METAB, V101, P470, DOI 10.1210/jc.2015-2802; Mock K, 2015, ONCOTARGET, V6, P14399, DOI 10.18632/oncotarget.3882; Moly PK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153591; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Niewczas MA, 2012, J AM SOC NEPHROL, V23, P507, DOI 10.1681/ASN.2011060627; Nowak C, 2016, DIABETES, V65, P276, DOI 10.2337/db15-0881; Ohgushi M, 2007, METABOLISM, V56, P571, DOI 10.1016/j.metabol.2006.12.007; Page KA, 2013, CURR DIABETES REP, V13, P252, DOI 10.1007/s11892-013-0363-2; Parray HA, 2015, INT J MOL SCI, V16, P14441, DOI 10.3390/ijms160714441; Paul L, 2016, DIABETES, V65, P687, DOI 10.2337/db15-0713; Polidori D, 2014, DIABETOLOGIA, V57, P891, DOI 10.1007/s00125-014-3196-x; Poy MN, 2009, P NATL ACAD SCI USA, V106, P5813, DOI 10.1073/pnas.0810550106; Rodrigues KF, 2015, DIABETES-METAB RES, V31, P479, DOI 10.1002/dmrr.2639; Sandstrom CS, 2008, DIABETIC MED, V25, P1370, DOI 10.1111/j.1464-5491.2008.02584.x; Shang J, 2015, MOL ENDOCRINOL, V29, P1243, DOI 10.1210/me.2014-1335; Shang XL, 2009, MED HYPOTHESES, V72, P427, DOI 10.1016/j.mehy.2008.10.027; Sharma M, 2011, INT J ENDOCRINOLOGY, V2011; STANTON LW, 1991, MOL ENDOCRINOL, V5, P860, DOI 10.1210/mend-5-6-860; Stern JH, 2016, CELL METAB, V23, P770, DOI 10.1016/j.cmet.2016.04.011; Thamer C, 2006, HORM METAB RES, V38, P178, DOI 10.1055/s-2006-925204; van de Bunt M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055272; Wang Y, 2006, PROTEOMICS, V6, P3862, DOI 10.1002/pmic.200500840; Wei W, 2016, J CELL SCI, V129, P39, DOI 10.1242/jcs.174235; Wellner M, 2003, HORM METAB RES, V35, P217; Westergren HU, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0353-1; Wu ZH, 2016, TUMOR BIOL, V37, P7939, DOI 10.1007/s13277-015-4665-7; Yeh SH, 2016, J DIABETES METAB DIS, V15, DOI 10.1186/s40200-016-0246-6; Zeng LQ, 2015, MOL MED REP, V11, P67, DOI 10.3892/mmr.2014.2723; Zheng YL, 2010, J NEUROL SCI, V299, P101, DOI 10.1016/j.jns.2010.08.067; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	76	32	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182932	10.1371/journal.pone.0182932	http://dx.doi.org/10.1371/journal.pone.0182932			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846711	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000408438600019
J	Blotnick, E; Sol, A; Muhlrad, A				Blotnick, Edna; Sol, Asaf; Muhlrad, Andras			Histones bundle F-actin filaments and affect actin structure	PLOS ONE			English	Article							CYSTIC-FIBROSIS SPUTUM; EXTRACELLULAR HISTONES; ANTIMICROBIAL ACTIVITY; NUCLEAR ACTIN; CROSS-LINKING; HOST-DEFENSE; I COMPLEX; BINDING; PROTEINS; COFILIN	Histones are small polycationic proteins complexed with DNA located in the cell nucleus. Upon apoptosis they are secreted from the cells and react with extracellular polyanionic compounds. Actin which is a polyanionic protein, is also secreted from necrotic cells and interacts with histones. We showed that both histone mixture (histone type III) and the recombinant H2A histone bundles F-actin, increases the viscosity of the F-actin containing solution and polymerizes G-actin. The histone-actin bundles are relatively insensitive to increase of ionic strength, unlike other polycation, histatin, lysozyme, spermine and LL-37 induced F-actin bundles. The histone-actin bundles dissociate completely only in the presence of 300-400 mM NaCl. DNA, which competes with F-actin for histones, disassembles histone induced actin bundles. DNase1, which depolymerizes F- to G-actin, actively unbundles the H2A histone induced but slightly affects the histone mixture induced actin bundles. Cofilin decreases the amount of F-actin sedimented by low speed centrifugation, increases light scattering and viscosity of F-actin-histone mixture containing solutions and forms star like superstructures by copolymerizing G-actin with H2A histone. The results indicate that histones are tightly attached to F-actin by strong electrostatic and hydrophobic forces. Since both histones and F-actin are present in the sputum of patients with cystic fibrosis, therefore, the formation of the stable histone-actin bundles can contribute to the pathology of this disease by increasing the viscosity of the sputum. The actin-histone interaction in the nucleus might affect gene expression.	[Blotnick, Edna] Hebrew Univ Jerusalem, Inst Med Res Israel Canada, Dept Med Neurobiol, Jerusalem, Israel; [Sol, Asaf; Muhlrad, Andras] Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel; [Sol, Asaf] Tufts Univ, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tufts University	Muhlrad, A (corresponding author), Hebrew Univ Jerusalem, Hadassah Sch Dent Med, Inst Dent Sci, Jerusalem, Israel.	andras.muhlrad@mail.huji.ac.il		Sol, Asaf/0000-0002-8731-2490	Hebrew University of Jerusalem	Hebrew University of Jerusalem	This work was supported by Hebrew University of Jerusalem Science Fund (AM).	Allam R, 2014, J MOL MED, V92, P465, DOI 10.1007/s00109-014-1148-z; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bamburg JR, 2016, CYTOSKELETON, V73, P477, DOI 10.1002/cm.21282; Beall B, 2001, BIOCHEMISTRY-US, V40, P14252, DOI 10.1021/bi011806u; Bobkov AA, 2002, J MOL BIOL, V323, P739, DOI 10.1016/S0022-2836(02)01008-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROGAN TD, 1975, THORAX, V30, P72, DOI 10.1136/thx.30.1.72; Bucki R, 2007, EUR RESPIR J, V29, P624, DOI 10.1183/09031936.00080806; Doyle A, 2011, J STRUCT BIOL, V176, P370, DOI 10.1016/j.jsb.2011.09.004; Furukawa R, 1997, INT REV CYTOL, V175, P29, DOI 10.1016/S0074-7696(08)62125-7; GINSBURG I, 1993, INFLAMMATION, V17, P295, DOI 10.1007/BF00918992; Goebel HH, 1997, NEUROMUSCULAR DISORD, V7, P13, DOI 10.1016/S0960-8966(96)00404-X; Grintsevich EE, 2016, NAT CELL BIOL, V18, P876, DOI 10.1038/ncb3390; Gurel PS, 2014, CURR BIOL, V24, P156, DOI 10.1016/j.cub.2013.12.018; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Jay X., 2005, AM J PHYSIOL-LUNG C, V289, pL599; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kanai Y, 2003, MICROBIOL IMMUNOL, V47, P553, DOI 10.1111/j.1348-0421.2003.tb03417.x; Kawasaki H., 2008, Infectious Disorders - Drug Targets, V8, P195; KOUYAMA T, 1981, EUR J BIOCHEM, V114, P33; Lee DY, 2009, J INVEST DERMATOL, V129, P2489, DOI 10.1038/jid.2009.106; MAGRI E, 1978, BIOCHEM BIOPH RES CO, V82, P1207, DOI 10.1016/0006-291X(78)90315-7; Mahaffy RE, 2006, BIOPHYS J, V91, P3519, DOI 10.1529/biophysj.106.080937; Maloney MT, 2007, MOL NEUROBIOL, V35, P21, DOI 10.1007/BF02700622; MANNHERZ HG, 1975, FEBS LETT, V60, P34, DOI 10.1016/0014-5793(75)80412-1; Minamide LS, 2010, J BIOL CHEM, V285, P5450, DOI 10.1074/jbc.M109.063768; Muhlrad A, 2011, BIOPHYS CHEM, V155, P45, DOI 10.1016/j.bpc.2011.02.008; Puius YA, 1998, CURR OPIN CELL BIOL, V10, P23, DOI 10.1016/S0955-0674(98)80083-5; Richards RC, 2001, BIOCHEM BIOPH RES CO, V284, P549, DOI 10.1006/bbrc.2001.5020; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sanders LK, 2007, P NATL ACAD SCI USA, V104, P15994, DOI 10.1073/pnas.0705898104; SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X; Schmoller KM, 2011, J STRUCT BIOL, V173, P350, DOI 10.1016/j.jsb.2010.09.003; Serebryannyy LA, 2016, SCI REP-UK, V6, DOI 10.1038/srep28460; Silvan U, 2016, J STRUCT BIOL, V195, P159, DOI 10.1016/j.jsb.2016.05.008; Sol A, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01248; Sol A, 2015, RSC ADV, V5, P9361, DOI 10.1039/c4ra13007c; Sol A, 2014, J BIOL CHEM, V289, P22926, DOI 10.1074/jbc.M114.579672; Sol A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050078; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Tang JX, 1997, EUR J BIOCHEM, V247, P432, DOI 10.1111/j.1432-1033.1997.00432.x; Tang JX, 1996, J BIOL CHEM, V271, P8556, DOI 10.1074/jbc.271.15.8556; Tang JX, 1997, BIOCHEMISTRY-US, V36, P12600, DOI 10.1021/bi9711386; Varju I, 2015, THROMB HAEMOSTASIS, V113, P1289, DOI 10.1160/TH14-08-0669; VASCONCELLOS CA, 1994, SCIENCE, V263, P969, DOI 10.1126/science.8310295; Virtanen JA, 2017, CURR OPIN CELL BIOL, V46, P33, DOI 10.1016/j.ceb.2016.12.004; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Weiner DJ, 2003, AM J RESP CELL MOL, V28, P738, DOI 10.1165/rcmb.2002-0191OC; WELSH MJ, 1995, SCI AM, V273, P52, DOI 10.1038/scientificamerican1295-52; Williamson WD, 2012, FRONT BIOSCI-LANDMRK, V17, P984, DOI 10.2741/3969; Xu J, 2009, NAT MED, V15, P1318, DOI 10.1038/nm.2053; Xu ZH, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/205054; Yarmola EG, 2001, J BIOL CHEM, V276, P22351, DOI 10.1074/jbc.M101457200	53	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183760	10.1371/journal.pone.0183760	http://dx.doi.org/10.1371/journal.pone.0183760			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846729	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600049
J	Fornaro, L; Vivaldi, C; Lin, D; Xue, H; Falcone, A; Wang, YZ; Crea, F; Bootman, MD				Fornaro, Lorenzo; Vivaldi, Caterina; Lin, Dong; Xue, Hui; Falcone, Alfredo; Wang, Yuzhuo; Crea, Francesco; Bootman, Martin D.			Prognostic relevance of a T-type calcium channels gene signature in solid tumours: A correlation ready for clinical validation	PLOS ONE			English	Article							CA2+ CHANNELS; CELL-GROWTH; CANCER; GLIOBLASTOMA; XENOGRAFTS; INHIBITION; TOOLS; PROLIFERATION; MIBEFRADIL; APOPTOSIS	Background T-type calcium channels (TTCCs) mediate calcium influx across the cell membrane. TTCCs regulate numerous physiological processes including cardiac pacemaking and neuronal activity. In addition, they have been implicated in the proliferation, migration and differentiation of tumour tissues. Although the signalling events downstream of TTCC-mediated calcium influx are not fully elucidated, it is clear that variations in the expression of TTCCs promote tumour formation and hinder response to treatment. Methods We examined the expression of TTCC genes (all three subtypes; CACNA-1G, CACNA-1H and CACNA-1I) and their prognostic value in three major solid tumours (i.e. gastric, lung and ovarian cancers) via a publicly accessible database. Results In gastric cancer, expression of all the CACNA genes was associated with overall survival (OS) among stage I-IV patients (all p<0.05). By combining the three potential biomarkers, a TTCC signature was developed, which retained a significant association with OS both in stage IV and stage I-III patients. In lung and ovarian cancer, association with OS was also significant when all tumour stages were considered, but was partly lost or inconclusive after splitting cases into localized and metastatic subsets. Conclusions Alterations in CACNA gene expression are linked to tumour prognosis. Gastric cancer represents the most promising setting for further evaluation.	[Fornaro, Lorenzo; Vivaldi, Caterina; Falcone, Alfredo] Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy; [Lin, Dong; Xue, Hui; Wang, Yuzhuo] BC Canc Res Ctr, Expt Therapeut, Vancouver, BC, Canada; [Crea, Francesco; Bootman, Martin D.] Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England	University of Pisa; Azienda Ospedaliero Universitaria Pisana; British Columbia Cancer Agency; Open University - UK	Fornaro, L (corresponding author), Azienda Osped Univ Pisana, Unit Med Oncol 2, Pisa, Italy.; Crea, F; Bootman, MD (corresponding author), Open Univ, Sch Life Hlth & Chem Sci, Walton Hall, Milton Keynes, Bucks, England.	lorenzo.fornaro@gmail.com; francesco.crea@open.ac.uk; martin.bootman@open.ac.uk	Bootman, Martin/AAB-3330-2019; Vivaldi, Caterina/AAD-8742-2019	Bootman, Martin/0000-0002-6447-3451; Vivaldi, Caterina/0000-0001-9307-2326; Falcone, Alfredo/0000-0001-5840-2529; Crea, Francesco/0000-0002-4903-2973; Wang, Yuzhuo/0000-0002-9749-8591; Fornaro, Lorenzo/0000-0002-0187-5904				Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Bertolesi GE, 2002, MOL PHARMACOL, V62, P210, DOI 10.1124/mol.62.2.210; Buchanan PJ, 2016, EUR BIOPHYS J BIOPHY, V45, P621, DOI 10.1007/s00249-016-1144-z; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Dong X, 2010, CLIN CANCER RES, V16, P1442, DOI 10.1158/1078-0432.CCR-09-2878; Dziegielewska B, 2014, MOL CANCER RES, V12, P348, DOI 10.1158/1541-7786.MCR-13-0485; Dziegielewska B, 2014, PFLUG ARCH EUR J PHY, V466, P801, DOI 10.1007/s00424-014-1444-z; Fogar P, 1997, ANTICANCER RES, V17, P1227; Gray LS, 2013, EXPERT REV ANTICANC, V13, P589, DOI [10.1586/ERA.13.34, 10.1586/era.13.34]; Heo JH, 2008, BIOORG MED CHEM LETT, V18, P3899, DOI 10.1016/j.bmcl.2008.06.034; Huang WF, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0171-4; Iftinca M C, 2011, J Med Life, V4, P126; Kiryushko D, 2006, MOL BIOL CELL, V17, P2278, DOI 10.1091/mbc.E05-10-0987; Leanza L, 2016, BBA-MOL CELL RES, V1863, P1385, DOI 10.1016/j.bbamcr.2015.11.032; Lester-Coll NH, 2016, NEURO-ONCOLOGY, V18, P51; Li W, 2011, CANCER INVEST, V29, P339, DOI 10.3109/07357907.2011.568565; Lin D, 2014, CANCER RES, V74, P1272, DOI 10.1158/0008-5472.CAN-13-2921-T; Lordick F, 2014, CANCER TREAT REV, V40, P692, DOI 10.1016/j.ctrv.2014.03.002; Lu FM, 2008, CELL CALCIUM, V43, P49, DOI 10.1016/j.ceca.2007.03.006; Mariot P, 2002, J BIOL CHEM, V277, P10824, DOI 10.1074/jbc.M108754200; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; NILIUS B, 1985, NATURE, V316, P443, DOI 10.1038/316443a0; NOWYCKY MC, 1985, NATURE, V316, P440, DOI 10.1038/316440a0; Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029; Press JZ, 2008, GYNECOL ONCOL, V110, P256, DOI 10.1016/j.ygyno.2008.03.011; Santoni G, 2012, BRIT J PHARMACOL, V166, P1244, DOI 10.1111/j.1476-5381.2012.01908.x; Szasz AM, 2016, ONCOTARGET, V7, P49322, DOI 10.18632/oncotarget.10337; Taylor JT, 2008, CANCER LETT, V267, P116, DOI 10.1016/j.canlet.2008.03.032; Valerie NCK, 2013, BIOCHEM PHARMACOL, V85, P888, DOI 10.1016/j.bcp.2012.12.017; Wu C, 2016, INT J ONCOL, P2236, DOI [1016/j.ceca.2007.03.006, DOI 1016/j.ceca.2007.03.006]; Zhang Y, 2014, PFLUG ARCH EUR J PHY, V466, P811, DOI 10.1007/s00424-013-1427-5; Zhang Y, 2012, BRIT J PHARMACOL, V166, P1247, DOI 10.1111/j.1476-5381.2012.01852.x; Zhuang QD, 2017, CAN RESPIR J, V2017, DOI 10.1155/2017/3685261	34	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182818	10.1371/journal.pone.0182818	http://dx.doi.org/10.1371/journal.pone.0182818			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846697	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000408438600016
J	Mayrinck, D; Brito, PM; Meunier, FJ; Alvarado-Ortega, J; Otero, O				Mayrinck, Diogo; Brito, Paulo M.; Meunier, Francois J.; Alvarado-Ortega, Jesus; Otero, Olga			Sorbinicharax verraesi: An unexpected case of a benthic fish outside Acanthomorpha in the Upper Cretaceous of the Tethyan Sea	PLOS ONE			English	Article							PHYLOGENETIC SIGNIFICANCE; BONE	Sorbinicharax verraesi is a marine teleostean fish from the Upper Cretaceous of Nardo (Italy). It was first attributed to the otophysan order Characiformes, which represents potential evidence for the controversial marine origin of the clade. Through a review of all the available material, we demonstrate that this species is not an otophysan since it lacks key structures that would allow for its inclusion in this group. Sorbinicharax has a body shape that recalls ground fishes classically assigned to Acanthomorpha. However, no unambiguous feature allows us to relate it to this clade. In fact, the presence of cellular bony tissue supports its exclusion from Eurypterygii. Since no feature permits the definitive attribution of Sorbinicharax to any teleost group, it remains as Teleostei incertae sedis. We infer that the morphology of Sorbinicharax indicates a benthic ecology. It displays: an anteriorly wide body with enlarged ribs; large pectoral fins, while anal and dorsal fins are reduced; a large head measuring 1/4 of the total body length; and a mouth opening dorsally in a high position. Such morphology was so far undescribed in Nardo. It is surprisingly displayed by a non-eurypterygian teleost fish which means by a fish which does not belong to the clades that diversify since the upper Cretaceous and include the extant families that show ground ecomorphologies.	[Mayrinck, Diogo] Univ Estado Rio de Janeiro, Dept Ensino Ciencias & Biol, Rio De Janeiro, Brazil; [Brito, Paulo M.] Univ Estado Rio de Janeiro, Dept Zool, Rio De Janeiro, Brazil; [Meunier, Francois J.] UPMC, CNRS, IRD,UMR 7208, BOREA,Dept Milieux & Peuplements Aquat,Museum Nat, CP026, Paris, France; [Alvarado-Ortega, Jesus] Univ Nacl Autonoma Mexico, Dept Palaeontol, Mexico City, DF, Mexico; [Otero, Olga] Lab Paleontol Poitiers, UMR 7262, Bat B35 TSA51106, Poitiers, France	Universidade do Estado do Rio de Janeiro; Universidade do Estado do Rio de Janeiro; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Universidad Nacional Autonoma de Mexico; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers	Mayrinck, D (corresponding author), Univ Estado Rio de Janeiro, Dept Ensino Ciencias & Biol, Rio De Janeiro, Brazil.	mdiogobio@yahoo.com.br	Otero, Olga/T-5467-2018	Otero, Olga/0000-0002-8129-2054; Alvarado-Ortega, Jesus/0000-0001-8458-7205; Mayrinck, Diogo/0000-0002-6899-1432				[Anonymous], 2003, B MUS CIV STOR NAT V, V27, P29; BARTRAM A, 1977, J NAT HIST, V11, P361, DOI 10.1080/00222937700770271; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Benton MJ, 2015, PALAEONTOL ELECTRON, V18; Berkovitz BKB, 2017, TEETH OF NON- MAMMALIAN VERTEBRATES, P43, DOI 10.1016/B978-0-12-802850-6.00004-7; Cowman PF, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00394; Davesne D, 2016, FRONT ECOL EVOL, V4; Fink Sara V., 1996, P209, DOI 10.1016/B978-012670950-6/50012-6; FINK SV, 1981, ZOOL J LINN SOC-LOND, V72, P297, DOI 10.1111/j.1096-3642.1981.tb01575.x; FINK SV, 1984, COPEIA, P1033; Friedman M, 2012, PALAEONTOLOGY, V55, P707, DOI 10.1111/j.1475-4983.2012.01165.x; GAYET M, 1986, Bulletin du Museum National d'Histoire Naturelle Section C Sciences de la Terre Paleontologie Geologie Mineralogie, V8, P393; Gayet M., 1985, COMUNICACOES SERVICO, V71, P91; Gayet M, 1981, COMUN SERV GEOL PORT, V67, P173; Goatley CHR, 2009, CORAL REEFS, V28, P449, DOI 10.1007/s00338-009-0477-9; Goatley CHR, 2010, PALEOBIOLOGY, V36, P415, DOI 10.1666/09035.1; JOHNSON GD, 1992, COPEIA, P8; JOHNSON GD, 1993, B MAR SCI, V52, P554; Kolliker A, 1859, P R SOC LONDON, V9, P656; Lobato FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102094; Mayrinck D, 2015, J SYST PALAEONTOL, V13, P397, DOI 10.1080/14772019.2014.893260; Mayrinck D, 2015, CRETACEOUS RES, V56, P66, DOI 10.1016/j.cretres.2015.03.002; MOSS ML, 1965, ACTA ANAT, V60, P262; Muller J., 1846, PHYSIKALISCH MATHEMA, V1846, P117; Murray AM, 2009, PALAEONTOLOGY, V52, P429, DOI 10.1111/j.1475-4983.2009.00851.x; Otero O, 2008, GEOL SOC SPEC PUBL, V295, P155, DOI 10.1144/SP295.10; Otero Olga, 1996, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V202, P313; PARENTI LR, 1986, ZOOL J LINN SOC-LOND, V87, P37, DOI 10.1111/j.1096-3642.1986.tb01329.x; PATTERSON C, 1993, B MAR SCI, V52, P29; ROBERTS CD, 1993, B MAR SCI, V52, P60; Schluter M, 2008, CRETACEOUS RES, V29, P100, DOI 10.1016/j.cretres.2007.04.005; Stiassny Melanie L.J., 1996, P405, DOI 10.1016/B978-012670950-6/50016-3; Taverne Louis, 2003, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V27, P29; Taverne Louis, 2003, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V27, P3; Tyler James C., 2000, Bollettino del Museo Civico di Storia Naturale di Verona Geologia Paleontologia Preistoria, V24, P11; WAINWRIGHT PC, 1991, AM ZOOL, V31, P680; Wainwright Peter C., 2002, P33, DOI 10.1016/B978-012615185-5/50004-9; Wiley E.O., 2010, P123	38	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183879	10.1371/journal.pone.0183879	http://dx.doi.org/10.1371/journal.pone.0183879			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846739	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600054
J	Sauwen, N; Acou, M; Bharath, HN; Sima, DM; Veraart, J; Maes, F; Himmelreich, U; Achten, E; Van Huffel, S				Sauwen, Nicolas; Acou, Marjan; Bharath, Halandur N.; Sima, Diana M.; Veraart, Jelle; Maes, Frederik; Himmelreich, Uwe; Achten, Eric; Van Huffel, Sabine			The successive projection algorithm as an initialization method for brain tumor segmentation using non-negative matrix factorization	PLOS ONE			English	Article							SVD BASED INITIALIZATION	Non-negative matrix factorization (NMF) has become a widely used tool for additive parts-based analysis in a wide range of applications. As NMF is a non-convex problem, the quality of the solution will depend on the initialization of the factor matrices. In this study, the successive projection algorithm (SPA) is proposed as an initialization method for NMF. SPA builds on convex geometry and allocates endmembers based on successive orthogonal subspace projections of the input data. SPA is a fast and reproducible method, and it aligns well with the assumptions made in near-separable NMF analyses. SPA was applied to multi-parametric magnetic resonance imaging (MRI) datasets for brain tumor segmentation using different NMF algorithms. Comparison with common initialization methods shows that SPA achieves similar segmentation quality and it is competitive in terms of convergence rate. Whereas SPA was previously applied as a direct endmember extraction tool, we have shown improved segmentation results when using SPA as an initialization method, as it allows further enhancement of the sources during the NMF iterative procedure.	[Sauwen, Nicolas; Bharath, Halandur N.; Sima, Diana M.; Van Huffel, Sabine] Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium; [Sauwen, Nicolas; Bharath, Halandur N.; Sima, Diana M.; Van Huffel, Sabine] IMEC, Leuven, Belgium; [Acou, Marjan; Achten, Eric] Ghent Univ Hosp, Dept Radiol, Ghent, Belgium; [Sima, Diana M.] Icometrix, R&D Dept, Leuven, Belgium; [Veraart, Jelle] Univ Antwerp, IMinds Vis Lab, Dept Phys, Antwerp, Belgium; [Maes, Frederik] Katholieke Univ Leuven, Dept Elect Engn ESAT, PSI Ctr Proc Speech & Images, Leuven, Belgium; [Himmelreich, Uwe] Katholieke Univ Leuven, Dept Imaging & Pathol, Biomed MRI MoSAIC, Leuven, Belgium	KU Leuven; IMEC; Ghent University; Ghent University Hospital; IMEC; University of Antwerp; KU Leuven; KU Leuven	Van Huffel, S (corresponding author), Katholieke Univ Leuven, Dept Elect Engn ESAT, STADIUS Ctr Dynam Syst Signal Proc & Data Analyt, Leuven, Belgium.; Van Huffel, S (corresponding author), IMEC, Leuven, Belgium.	sabine.vanhuffel@kuleuven.be	Maes, Frederik/I-7572-2013	Maes, Frederik/0000-0003-0027-1479; Himmelreich, Uwe/0000-0002-2060-8895; Sima, Diana M/0000-0002-0118-2905; Veraart, Jelle/0000-0003-0781-0420	Research Foundation Flanders (FWO) [G.0869.12N, IWT IM 135005]; Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program [P7/11]; Belgian Science Policy Office; government agency for Innovation by Science and Technology (IWT) [IM 135005]; European Research Council under the European Union's Seventh Framework Programme [339804, 316679]; European Research Council under the European Union's Seventh Framework Programme (FP7); ERC Advanced Grant: BIOTENSORS [339804]; EU MC ITN TRANSACT [316679]	Research Foundation Flanders (FWO)(FWO); Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program(Belgian Federal Science Policy Office); Belgian Science Policy Office(Belgian Federal Science Policy Office); government agency for Innovation by Science and Technology (IWT)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC)); European Research Council under the European Union's Seventh Framework Programme (FP7); ERC Advanced Grant: BIOTENSORS; EU MC ITN TRANSACT	d NS, DMS and MA received funding from the Research Foundation Flanders (FWO), grant number G.0869.12N. JV received funding from the Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program (P7/11) initiated by the Belgian Science Policy Office. SVH received funding from the government agency for Innovation by Science and Technology (IWT), grant number IM 135005. SVH and HNB received funding from the European Research Council under the European Union's Seventh Framework Programme, grant number 339804. SVH and DMS received funding from the European Research Council under the European Union's Seventh Framework Programme, grant number 316679. Icometrix provided support in the form of salary for author DMS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.; This work has been funded by the following projects: Research Foundation Flanders (FWO), grant number G.0869.12N; IWT IM 135005; Henri Benedictus Fellowship of the Belgian American Educational Foundation; Interuniversity Attraction Poles Program (P7/11) initiated by the Belgian Science Policy Office. European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013), ERC Advanced Grant: BIOTENSORS (no 339804) and the EU MC ITN TRANSACT 2012 (no 316679).	Araujo MCU, 2001, CHEMOMETR INTELL LAB, V57, P65, DOI 10.1016/S0169-7439(01)00119-8; Arora S, 2012, STOC'12: PROCEEDINGS OF THE 2012 ACM SYMPOSIUM ON THEORY OF COMPUTING, P145; Bauer S, 2013, PHYS MED BIOL, V58, pR97, DOI 10.1088/0031-9155/58/13/R97; Boutsidis C, 2008, PATTERN RECOGN, V41, P1350, DOI 10.1016/j.patcog.2007.09.010; Boxerman JL, 2006, AM J NEURORADIOL, V27, P859; Casalino G, 2014, INFORM SCIENCES, V257, P369, DOI 10.1016/j.ins.2013.05.038; Ding C, 2010, IEEE T PATTERN ANAL, V32, P45, DOI 10.1109/TPAMI.2008.277; Gillis N, 2014, SIAM J IMAGING SCI, V7, P1420, DOI 10.1137/130946782; Gillis N, 2014, IEEE T PATTERN ANAL, V36, P698, DOI 10.1109/TPAMI.2013.226; Gillis N, 2012, NEURAL COMPUT, V24, P1085, DOI 10.1162/NECO_a_00256; Heinrich Kevin E, 2008, Comput Intell Neurosci, P276535, DOI 10.1155/2008/276535; Langville A. N., 2006, P 12 ACM SIGKDD INT, P23; Laudadio T, 2013, P ESMRMB 2013 TOUL O, P474; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Li YQ, 2013, NMR BIOMED, V26, P307, DOI 10.1002/nbm.2850; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Maes F, 1997, IEEE T MED IMAGING, V16, P187, DOI 10.1109/42.563664; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Mizutani T., 2015, ARXIV150608387; Niegowski M, 2014, IEEE ENG MED BIO, P4212, DOI 10.1109/EMBC.2014.6944553; Nocedal J, 2006, SPRINGER SER OPER RE, P135; Nock R, 2006, IEEE T PATTERN ANAL, V28, P1223, DOI 10.1109/TPAMI.2006.168; Ortega-Martorell S, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-38; Poot DHJ, 2010, IEEE T MED IMAGING, V29, P819, DOI 10.1109/TMI.2009.2037915; Poullet J-B, 2008, THESIS; Poullet JB, 2007, J MAGN RESON, V186, P293, DOI 10.1016/j.jmr.2007.03.015; Qiao HL, 2015, PATTERN RECOGN LETT, V63, P71, DOI 10.1016/j.patrec.2015.05.019; Rezaei M., 2011, Journal of Applied Sciences, V11, P354, DOI 10.3923/jas.2011.354.359; Rorden C, 2007, J COGNITIVE NEUROSCI, V19, P1081, DOI 10.1162/jocn.2007.19.7.1081; Sauwen N, 2015, NMR BIOMED, V28, P1599, DOI 10.1002/nbm.3413; Sava ARC, 2011, NMR BIOMED, V24, P824, DOI 10.1002/nbm.1628; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Wang YX, 2013, IEEE T KNOWL DATA EN, V25, P1336, DOI 10.1109/TKDE.2012.51; Wild S, 2004, PATTERN RECOGN, V37, P2217, DOI 10.1016/j.patcog.2004.02.013; Yu SH, 2012, SPECTROCHIM ACTA A, V86, P315, DOI 10.1016/j.saa.2011.10.042; Zhang J, 2008, SENSORS-BASEL, V8, P1321, DOI 10.3390/s8021321; Zhao LH, 2008, 2008 7TH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-23, P6826, DOI 10.1109/WCICA.2008.4593968; Zheng ZL, 2007, ENG APPL ARTIF INTEL, V20, P101, DOI 10.1016/j.engappai.2006.03.001	38	8	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180268	10.1371/journal.pone.0180268	http://dx.doi.org/10.1371/journal.pone.0180268			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846686	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600002
J	Fatehi, F; Salort-Campana, E; Le Troter, A; Lareau-Trudel, E; Bydder, M; Foure, A; Guye, M; Bendahan, D; Attarian, S				Fatehi, Farzad; Salort-Campana, Emmanuelle; Le Troter, Arnaud; Lareau-Trudel, Emilie; Bydder, Mark; Foure, Alexandre; Guye, Maxime; Bendahan, David; Attarian, Shahram			Long-term follow-up of MRI changes in thigh muscles of patients with Facioscapulohumeral dystrophy: A quantitative study	PLOS ONE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; DISEASE PROGRESSION; NEUROMUSCULAR DISORDERS; DNA REARRANGEMENTS; PREVALENCE; INVOLVEMENT; POPULATION; BOYS; FSHD; AGE	Facioscapulohumeral muscular dystrophy (FSHD) is one of the most common hereditary muscular disorders. Currently FSHD has no known effective treatment and detailed data on the natural history are lacking. Determination of the efficacy of a given therapeutic approach might be difficult in FSHD given the slow and highly variable disease progression. Magnetic resonance imaging (MRI) has been widely used to qualitatively and quantitatively evaluate in vivo the muscle alterations in various neuromuscular disorders. The main aim of the present study was to investigate longitudinally the time-dependent changes occurring in thigh muscles of FSHD patients using quantitative MRI and to assess the potential relationships with the clinical findings. Thirty-five FSHD1 patients (17 females) were enrolled. Clinical assessment tools including manual muscle testing using medical research council score (MRC), and motor function measure (MFM) were recorded each year for a period ranging from 1 to 2 years. For the MRI measurements, we used a new quantitative index, i.e., the mean pixel intensity (MPI) calculated from the pixel-intensity distribution in T1 weighted images. The corresponding MPI scores were calculated for each thigh, for each compartment and for both thighs totally (MPItotal). The total mean pixel intensity (MPItotal) refers to the sum of each pixel signal intensity divided by the corresponding number of pixels. An increased MPItotal indicates both a raised fat infiltration together with a reduced muscle volume thereby illustrating disease progression. Clinical scores did not change significantly over time whereas MPItotal increased significantly from an initial averaged value of 39.6 to 41.1 with a corresponding rate of 0.62/year. While clinical scores and MPItotal measured at the start of the study were significantly related, no correlation was found between the rate of MPItotal and MRC sum score changes, MFMtotal and MFM subscores. The relative rate of MPItotal change was 2.3% (0.5-4.3)/year and was significantly higher than the corresponding rates measured for MRCS 0% (0-1.7)/year and MFMtotal 0% (0-2.0)/year (p = 0.000). On the basis of these results, we suggested that muscle MRI and more particularly the MPItotal index could be used as a reliable biomarker and outcome measure of disease progression. In slowly progressive myopathies such as FSHD, the MPItotal index might reveal subclinical changes, which could not be evidenced using clinical scales over a short period of time.	[Fatehi, Farzad; Salort-Campana, Emmanuelle; Lareau-Trudel, Emilie; Attarian, Shahram] Univ Aix Marseille, Ctr Reference Malad Neuromusculaires, Marseille, France; [Fatehi, Farzad; Salort-Campana, Emmanuelle; Lareau-Trudel, Emilie; Attarian, Shahram] Univ Aix Marseille, SLA, Ctr Hosp Univ Timone, Marseille, France; [Fatehi, Farzad; Le Troter, Arnaud; Lareau-Trudel, Emilie; Bydder, Mark; Foure, Alexandre; Guye, Maxime; Bendahan, David] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, CNRS, UMR 7339, Marseille, France; [Salort-Campana, Emmanuelle; Attarian, Shahram] Aix Marseille Univ, INSERM, GMGF, Marseille, France; [Salort-Campana, Emmanuelle; Attarian, Shahram] FILNEMUS, Marseille, France; [Fatehi, Farzad] Univ Tehran Med Sci, Shariati Hosp, Iranian Ctr Neurol Res, Tehran, Iran; [Lareau-Trudel, Emilie] Univ Sherbrooke, Div Neurol, Dept Med, Sherbrooke, PQ, Canada	UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Tehran University of Medical Sciences; University of Sherbrooke	Salort-Campana, E (corresponding author), Univ Aix Marseille, Ctr Reference Malad Neuromusculaires, Marseille, France.; Salort-Campana, E (corresponding author), Univ Aix Marseille, SLA, Ctr Hosp Univ Timone, Marseille, France.; Salort-Campana, E (corresponding author), Aix Marseille Univ, INSERM, GMGF, Marseille, France.; Salort-Campana, E (corresponding author), FILNEMUS, Marseille, France.	emmanuelle.salort-campana@ap-hm.fr	Attarian, Shahram/AAE-6214-2021; Fouré, Alexandre/AAI-9587-2020; Fatehi, Farzad/AAM-7430-2020; Bendahan, David/AAU-1420-2020	Fouré, Alexandre/0000-0002-9678-8773; Fatehi, Farzad/0000-0002-6774-7825; le troter, arnaud/0000-0002-7897-9672				Arpan I, 2014, NEUROLOGY, V83, P974, DOI 10.1212/WNL.0000000000000775; Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Berard C, 2005, NEUROMUSCULAR DISORD, V15, P463, DOI 10.1016/j.nmd.2005.03.004; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bonati U, 2015, NEUROMUSCULAR DISORD, V25, P679, DOI 10.1016/j.nmd.2015.05.006; Dahlqvist JR, 2014, NEUROLOGY, V83, P1178, DOI 10.1212/WNL.0000000000000828; Deenen JCW, 2014, NEUROLOGY, V83, P1056, DOI 10.1212/WNL.0000000000000797; Fatehi F, 2016, REV NEUROL-FRANCE, V172, P566, DOI 10.1016/j.neurol.2016.08.002; Fischer D, 2016, CURR OPIN NEUROL, V29, P614, DOI 10.1097/WCO.0000000000000364; Fischmann A, 2012, J NEUROL, V259, P1648, DOI 10.1007/s00415-011-6393-2; Gerevini S, 2016, EUR RADIOL, V26, P693, DOI 10.1007/s00330-015-3890-1; Guizard N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133352; Janssen B, 2016, NEUROLOGY, V86, P1700, DOI 10.1212/WNL.0000000000002640; Janssen BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085416; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Lareau-Trudel E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132717; Le Troter A, 2016, MAGN RESON MATER PHY, V29, P245, DOI 10.1007/s10334-016-0535-6; Leung DG, 2015, MUSCLE NERVE, V52, P512, DOI 10.1002/mus.24569; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Morrow JM, 2016, LANCET NEUROL, V15, P65, DOI 10.1016/S1474-4422(15)00242-2; Morrow JM, 2014, EUR RADIOL, V24, P1610, DOI 10.1007/s00330-014-3145-6; Norwood FLM, 2009, BRAIN, V132, P3175, DOI 10.1093/brain/awp236; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Regula JU, 2016, CLIN NEURORADIOL, V26, P445, DOI 10.1007/s00062-015-0386-y; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Statland J, 2014, NEUROL CLIN, V32, P721, DOI 10.1016/j.ncl.2014.04.003; Statland JM, 2013, NEUROMUSCULAR DISORD, V23, P306, DOI 10.1016/j.nmd.2013.01.008; Tasca G, 2016, ANN NEUROL; Tasca G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100292; Tawil R, 1997, NEUROLOGY, V48, P38, DOI 10.1212/wnl.48.1.38; Theadom A, 2014, NEUROEPIDEMIOLOGY, V43, P259, DOI 10.1159/000369343; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; VANDEUTEKOM JCT, 1993, HUM MOL GENET, V2, P2037; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; WIJMENGA C, 1993, NEUROMUSCULAR DISORD, V3, P487, DOI 10.1016/0960-8966(93)90102-P; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Willcocks RJ, 2014, NEUROMUSCULAR DISORD, V24, P393, DOI 10.1016/j.nmd.2013.12.012; Willis TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070993; Wokke BH, 2013, J MAGN RESON IMAGING, V38, P619, DOI 10.1002/jmri.23998	41	22	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183825	10.1371/journal.pone.0183825	http://dx.doi.org/10.1371/journal.pone.0183825			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841698	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700060
J	Vaananen, T; Vuolteenaho, K; Kautiainen, H; Nieminen, R; Mottonen, T; Hannonen, P; Korpela, M; Kauppi, MJ; Laiho, K; Kaipiainen-Seppanen, O; Luosujarvi, R; Uusitalo, T; Uutela, T; Leirisalo-Repo, M; Moilanen, E				Vaananen, Tuija; Vuolteenaho, Katriina; Kautiainen, Hannu; Nieminen, Riina; Mottonen, Timo; Hannonen, Pekka; Korpela, Markku; Kauppi, Markku J.; Laiho, Kari; Kaipiainen-Seppanen, Oili; Luosujarvi, Riitta; Uusitalo, Tea; Uutela, Toini; Leirisalo-Repo, Marjatta; Moilanen, Eeva		NEO-RACo Study Grp	Glycoprotein YKL-40: A potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab. Evidence from the randomised controlled NEO-RACo trial	PLOS ONE			English	Article							HUMAN CARTILAGE GLYCOPROTEIN-39; SERUM YKL-40; RADIOGRAPHIC PROGRESSION; COMBINATION THERAPY; PERIPHERAL-BLOOD; ACTIVITY SCORES; PLASMA VEGF; FOLLOW-UP; MHC CLASS; INFLAMMATION	Objective YKL-40, a chitinase-like glycoprotein associated with inflammation and tissue remodeling, is produced by joint tissues and recognized as a candidate auto-antigen in rheumatoid arthritis (RA). In the present study, we investigated YKL-40 as a potential biomarker of disease activity in patients with early RA at baseline and during intensive treatment aiming for early remission. Methods Ninety-nine patients with early DMARD-naive RA participated in the NEO-RACo study. For the first four weeks, the patients were treated with the combination of sulphasalazine, methotrexate, hydroxychloroquine and low dose prednisolone (FIN-RACo DMARD combination), and subsequently randomized to receive placebo or infliximab added on the treatment for further 22 weeks. Disease activity was evaluated using the 28-joint disease activity score and plasma YKL-40 concentrations were measured by immunoassay. Results At the baseline, plasma YKL-40 concentration was 57 +/- 37 ( mean +/- SD) ng/ml. YKL-40 was significantly associated with the disease activity score, interleukin-6 and erythrocyte sedimentation rate both at the baseline and during the 26 weeks' treatment. The csDMARD combination decreased YKL-40 levels already during the first four weeks of treatment, and there was no further reduction when the tumour necrosis factor-alpha antagonist infliximab was added on the combination treatment. Conclusions High YKL-40 levels were found to be associated with disease activity in early DMARD-naive RA and during intensive treat-to-target therapy. The present results suggest YKL-40 as a useful biomarker of disease activity in RA to be used to steer treatment towards remission.	[Vaananen, Tuija; Vuolteenaho, Katriina; Nieminen, Riina; Moilanen, Eeva] Univ Tampere, Fac Med & Life Sci, Immunopharmacol Res Grp, Tampere, Finland; [Vaananen, Tuija; Vuolteenaho, Katriina; Nieminen, Riina; Moilanen, Eeva] Tampere Univ Hosp, Tampere, Finland; [Kautiainen, Hannu] Univ Helsinki, Dept Gen Practice, Helsinki, Finland; [Kautiainen, Hannu] Helsinki Univ Hosp, Unit Primary Hlth Care, Helsinki, Finland; [Kautiainen, Hannu] Kuopio Univ Hosp, Unit Primary Hlth Care, Kuopio, Finland; [Kautiainen, Hannu] MedCare Ltd, Aanekoski, Finland; [Mottonen, Timo] Univ Turku, Dept Rheumatol, Turku, Finland; [Mottonen, Timo] Turku Univ Hosp, Turku, Finland; [Hannonen, Pekka] Jyvaskyla Cent Hosp, Dept Med, Jyvaskyla, Finland; [Korpela, Markku] Tampere Univ Hosp, Ctr Rheumat Dis, Dept Internal Med, Tampere, Finland; [Kauppi, Markku J.; Laiho, Kari] Paijat Hame Cent Hosp, Dept Med, Lahti, Finland; [Kauppi, Markku J.] Univ Tampere, Fac Med & Life Sci, Tampere, Finland; [Kaipiainen-Seppanen, Oili] Kuopio Univ Hosp, Dept Med, Kuopio, Finland; [Luosujarvi, Riitta; Leirisalo-Repo, Marjatta] Univ Helsinki, Rheumatol, Helsinki, Finland; [Luosujarvi, Riitta; Leirisalo-Repo, Marjatta] Helsinki Univ Hosp, Helsinki, Finland; [Uusitalo, Tea] Hameenlinna Cent Hosp, Dept Med, Hameenlinna, Finland; [Uutela, Toini] Lapland Cent Hosp, Dept Med, Rovaniemi, Finland	Tampere University; Tampere University; Tampere University Hospital; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Kuopio University Hospital; University of Eastern Finland; University of Turku; University of Turku; Central Finland Central Hospital; Tampere University; Tampere University Hospital; Paijat Hame Central Hospital; Tampere University; Kuopio University Hospital; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital	Vuolteenaho, K (corresponding author), Univ Tampere, Fac Med & Life Sci, Immunopharmacol Res Grp, Tampere, Finland.; Vuolteenaho, K (corresponding author), Tampere Univ Hosp, Tampere, Finland.	katriina.vuolteenaho@uta.fi	Kauppi, Markku/AIC-3929-2022	Mottonen, Timo/0000-0003-1273-4805; Vuolteenaho, Katriina/0000-0003-0017-1291	Competitive Research Funding of Tampere University Hospital; Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	Competitive Research Funding of Tampere University Hospital; Helsinki University Central Hospital Research Funds; Finska Lakaresallskapet	This study was financially supported by the Competitive Research Funding of Tampere University Hospital (KV and EM), the Helsinki University Central Hospital Research Funds (ML-R) and Finska Lakaresallskapet (ML-R). At baseline an unrestricted grant was provided by Schering- Plough Finland, which was used for the purchase of infliximab. Schering-Plough Finland also provided support for investigator meetings. The funders did not have any role in the study design, data collection and analysis, preparation of the manuscript, or decision to publish.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Baeten D, 2000, ARTHRITIS RHEUM, V43, P1233, DOI 10.1002/1529-0131(200006)43:6<1233::AID-ANR6>3.0.CO;2-9; Baeten D, 2004, ARTHRITIS RHEUM-US, V50, P444, DOI 10.1002/art.20012; Bakker MF, 2012, ANN RHEUM DIS, V71, P1692, DOI 10.1136/annrheumdis-2011-200963; Cope AP, 1999, ARTHRITIS RHEUM, V42, P1497, DOI 10.1002/1529-0131(199907)42:7<1497::AID-ANR25>3.0.CO;2-#; den Broeder AA, 2002, ANN RHEUM DIS, V61, P311, DOI 10.1136/ard.61.4.311; Fleischmann R, 2016, ARTHRITIS RHEUMATOL, V68, P2083, DOI 10.1002/art.39714; HAKALA BE, 1993, J BIOL CHEM, V268, P25803; Houseman M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3734; Johansen JS, 1999, RHEUMATOLOGY, V38, P618, DOI 10.1093/rheumatology/38.7.618; JOHANSEN JS, 1993, BRIT J RHEUMATOL, V32, P949; Johansen JS, 2001, SCAND J RHEUMATOL, V30, P297; Kazakova M, 2013, RHEUMATOL INT, V33, P341, DOI 10.1007/s00296-012-2387-3; Kirkpatrick RB, 1997, EXP CELL RES, V237, P46, DOI 10.1006/excr.1997.3764; Knudsen LS, 2006, SCAND J RHEUMATOL, V35, P489, DOI 10.1080/03009740600904300; Knudsen LS, 2008, J RHEUMATOL, V35, P1277; Knudsen LS, 2009, BIOMARK INSIGHTS, V4, P91; Kuusalo L, 2015, SCAND J RHEUMATOL, V44, P449, DOI 10.3109/03009742.2015.1043142; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Leirisalo-Repo M, 2013, ANN RHEUM DIS, V72, P851, DOI 10.1136/annrheumdis-2012-201365; Matsumoto T, 2001, CLIN EXP RHEUMATOL, V19, P655; Mottonen T, 1999, LANCET, V353, P1568, DOI 10.1016/S0140-6736(98)08513-4; Nakano K, 2013, ANN RHEUM DIS, V72, P110, DOI 10.1136/annrheumdis-2012-201526; Nielsen AR, 2011, CYTOKINE, V55, P152, DOI 10.1016/j.cyto.2011.03.014; Nielsen KR, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3391; Pedersen SJ, 2011, ARTHRITIS RHEUM-US, V63, P3789, DOI 10.1002/art.30627; Peltomaa R, 2001, RHEUMATOL INT, V20, P192, DOI 10.1007/s002960100115; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Rantalaiho V, 2014, J RHEUMATOL, V41, P2379, DOI 10.3899/jrheum.140267; Rantalaiho V, 2014, ANN RHEUM DIS, V73, P1954, DOI 10.1136/annrheumdis-2013-203497; Reiss WG, 2016, RHEUMATOL INT, V36, P295, DOI 10.1007/s00296-015-3285-2; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Srivastava SK, 2011, RHEUMATOL INT, V31, P1003, DOI 10.1007/s00296-010-1396-3; Steenbakkers PGA, 2003, J IMMUNOL, V170, P5719, DOI 10.4049/jimmunol.170.11.5719; Tanaka Y, 2014, CLIN EXP IMMUNOL, V177, P419, DOI 10.1111/cei.12349; Tsark EC, 2002, J IMMUNOL, V169, P6625, DOI 10.4049/jimmunol.169.11.6625; Vaananen T, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/215140; van Bilsen JHM, 2004, P NATL ACAD SCI USA, V101, P17180, DOI 10.1073/pnas.0407704101; van Lierop MJC, 2007, ARTHRITIS RHEUM, V56, P2150, DOI 10.1002/art.22651; VANDERHEIJDE DMFM, 1992, ARTHRITIS RHEUM-US, V35, P26; Volck B, 2001, OSTEOARTHR CARTILAGE, V9, P203, DOI 10.1053/joca.2000.0377; Vos K, 2000, ANN RHEUM DIS, V59, P544, DOI 10.1136/ard.59.7.544; Yamaoka K, 2014, ANN RHEUM DIS, V73, P507, DOI 10.1136/annrheumdis-2014-eular.2292	43	25	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183294	10.1371/journal.pone.0183294	http://dx.doi.org/10.1371/journal.pone.0183294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841649	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700022
J	Weckbach, LT; Maurer, U; Schramm, R; Huber, BC; Lackermair, K; Weiss, M; Meiser, B; Hagl, C; Massberg, S; Eifert, S; Grabmaier, U				Weckbach, Ludwig T.; Maurer, Ulrich; Schramm, Rene; Huber, Bruno C.; Lackermair, Korbinian; Weiss, Max; Meiser, Bruno; Hagl, Christian; Massberg, Steffen; Eifert, Sandra; Grabmaier, Ulrich			Lower frequency routine surveillance endomyocardial biopsies after heart transplantation	PLOS ONE			English	Article							INTERNATIONAL SOCIETY; MYCOPHENOLATE-MOFETIL; REJECTION; RECIPIENTS; REGISTRY	In heart transplantation (HTx) patients, routine surveillance endomyocardial biopsies (rsEMB) are recommended for the detection of early cardiac allograft rejection. However, there is no consensus on the optimal frequency of rsEMB. Frequent rsEMB have shown a low diagnostic yield in the new era of potent immunosuppressive regimen. Efficacy and safety of lower frequency rsEMB have not been investigated so far. In this retrospective, single centre, observational study we evaluated 282 patients transplanted between 2004 and 2014. 218 of these patients were investigated by rsEMB and symptom-triggered EMB (stEMB). We evaluated EMB results, complications, risk factors for rejection, survival 1 and 5 years as well as incidence of cardiac allograft vasculopathy (CAV) 3 years after HTx. A mean of 7.1 +/- 2.5 rsEMB were conducted per patient within the first year after HTx identifying 7 patients with asymptomatic and 9 patients with symptomatic acute rejection requiring glucocorticoide pulse therapy. Despite this relatively low frequency of rsEMB, only 6 unscheduled stEMB were required in the first year after HTx leading to 2 additional treatments. In 6 deaths among all 282 patients (2.1%), acute rejection could not be ruled out as a potential underlying cause. Overall survival at 1 year was 78.7% and 5-year survival was 74%. Incidence of CAV was 17% at 3-year follow-up. Morbidity and mortality of lower frequency rsEMB are comparable with data from the International Society for Heart and Lung Transplantation (ISHLT) registry. Consensus is needed on the optimal frequency of EMB.	[Weckbach, Ludwig T.; Huber, Bruno C.; Lackermair, Korbinian; Massberg, Steffen] Ludwig Maximilians Univ Munchen, Dept Med 1, Campus Grosshadern, Munich, Germany; [Maurer, Ulrich; Schramm, Rene; Hagl, Christian; Eifert, Sandra; Grabmaier, Ulrich] Ludwig Maximilians Univ Munchen, Dept Cardiac Surg, Munich, Germany; [Schramm, Rene; Meiser, Bruno; Eifert, Sandra; Grabmaier, Ulrich] Ludwig Maximilians Univ Munchen, Transplantat Ctr, Munich, Germany; [Weiss, Max] Ludwig Maximilians Univ Munchen, Inst Pathol, Munich, Germany; [Massberg, Steffen; Grabmaier, Ulrich] DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; German Centre for Cardiovascular Research	Grabmaier, U (corresponding author), Ludwig Maximilians Univ Munchen, Dept Cardiac Surg, Munich, Germany.; Grabmaier, U (corresponding author), Ludwig Maximilians Univ Munchen, Transplantat Ctr, Munich, Germany.; Grabmaier, U (corresponding author), DZHK German Ctr Cardiovasc Res, Partner Site Munich, Munich, Germany.	ulrich.grabmaier@med.uni-muenchen.de	Massberg, Steffen/AAN-6054-2021	Weckbach, Ludwig T/0000-0002-0981-2246; Huber, Bruno/0000-0002-1032-7686				[Anonymous], CURR OPIN CARDIOL; Chimenti C, 2013, CIRCULATION, V128, P1531, DOI 10.1161/CIRCULATIONAHA.13.001414; Costanzo MR, 2010, J HEART LUNG TRANSPL, V29, P914, DOI 10.1016/j.healun.2010.05.034; Delgado JF, 2006, EXPERT OPIN PHARMACO, V7, P1139, DOI 10.1517/14656566.7.9.1139; Drury JH, 1997, ECHOCARDIOGR-J CARD, V14, P469, DOI 10.1111/j.1540-8175.1997.tb00754.x; Fiorelli AI, 2012, TRANSPL P, V44, P2479, DOI 10.1016/j.transproceed.2012.07.024; Gradek WQ, 2001, J HEART LUNG TRANSPL, V20, P497, DOI 10.1016/S1053-2498(01)00236-4; Hamour IM, 2008, TRANSPLANTATION, V85, P969, DOI 10.1097/TP.0b013e318168d571; JARCHO J, 1994, J HEART LUNG TRANSPL, V13, P583; Kobashigawa J, 1998, TRANSPLANTATION, V66, P507, DOI 10.1097/00007890-199808270-00016; Kobashigawa JA, 2006, AM J TRANSPLANT, V6, P1377, DOI 10.1111/j.1600-6143.2006.01290.x; Lund LH, 2014, J HEART LUNG TRANSPL, V33, P996, DOI 10.1016/j.healun.2014.08.003; Shah KB, 2015, TRANSPLANTATION, V99, pE75, DOI 10.1097/TP.0000000000000615; Stehlik J, 2011, J HEART LUNG TRANSPL, V30, P1078, DOI 10.1016/j.healun.2011.08.003; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Williams MJA, 1996, AM J CARDIOL, V77, P1339, DOI 10.1016/S0002-9149(96)00202-0	16	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182880	10.1371/journal.pone.0182880	http://dx.doi.org/10.1371/journal.pone.0182880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841655	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700013
J	Chiba, R; Akiya, M; Hashimura, M; Oguri, Y; Inukai, M; Hara, A; Saegusa, M				Chiba, Risako; Akiya, Masashi; Hashimura, Miki; Oguri, Yasuko; Inukai, Madoka; Hara, Atsuko; Saegusa, Makoto			ALK signaling cascade confers multiple advantages to glioblastoma cells through neovascularization and cell proliferation	PLOS ONE			English	Article							RECEPTOR TYROSINE KINASE; ANAPLASTIC LYMPHOMA KINASE; CANCER STEM-CELLS; VEGF EXPRESSION; NERVOUS-SYSTEM; UP-REGULATION; HYPOXIA; GENE; NEUROBLASTOMA; TUMORS	Anaplastic lymphoma kinase (ALK), which is a receptor tyrosine kinase, is essentially and transiently expressed in the developing nervous system. Here we examined the functional role of the ALK gene in glioblastomas (GBMs). In clinical samples of GBMs, high ALK expression without gene rearrangements or mutations was frequently observed in perivascular lesions, in contrast to the relatively low expression in the perinecrotic areas, which was positively correlated with N-myc and phosphorylated (p) Stat3 scores and Ki-67 labeling indices. ALK immunoreactivity was also found to be associated with neovascular features including vascular co-option and vascular mimicry. In astrocytoma cell lines, cells stably overexpressing full-length ALK showed an increase in expression of pStat3 and pAkt proteins, as well as hypoxia-inducible factor-1 alpha (HIF-1 alpha) and vascular endothelial growth factor- A (VEGF-A) mRNAs, in contrast to cells with knockdown of endogenous ALK which showed decreased expression of these molecules. Transfection of the constitutively active form of Stat3 induced an increase in HIF-1 alpha promoter activity, and the overexpression of HIF-1 alpha in turn resulted in enhancement of VEGF-A promoter activity. In addition, cells with overexpression or knockdown of ALK also showed a tendency toward increased and decreased proliferation, respectively, through changes in expression of pAkt and pStat3. Finally, ALK promoter was significantly activated by transfection of Sox4 and N-myc, which are known to contribute to neuronal properties. These findings therefore suggest that Nmyc/Sox4-mediated ALK signaling cascades containing Stat3, Akt, HIF-1 alpha, and VEGF-A confer multiple advantages to tumor growth through alterations in neovascularization and cell proliferation in GBMs.	[Chiba, Risako; Akiya, Masashi; Hashimura, Miki; Oguri, Yasuko; Inukai, Madoka; Hara, Atsuko; Saegusa, Makoto] Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa, Japan	Kitasato University	Saegusa, M (corresponding author), Kitasato Univ, Sch Med, Dept Pathol, Minami Ku, Sagamihara, Kanagawa, Japan.	msaegusa@med.kitasato-u.ac.jp						AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BEN-NERIAH Y, 1988, NATURE, V333, P672, DOI 10.1038/333672a0; BERNARDS A, 1990, EMBO J, V9, P2279, DOI 10.1002/j.1460-2075.1990.tb07399.x; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chiarle R, 2008, NAT REV CANCER, V8, P11, DOI 10.1038/nrc2291; Dejean E, 2011, LEUKEMIA, V25, P1882, DOI 10.1038/leu.2011.168; Donnem T, 2013, CANCER MED-US, V2, P427, DOI 10.1002/cam4.105; Hallberg B, 2013, NAT REV CANCER, V13, P685, DOI 10.1038/nrc3580; Hara A, 2016, CANCER MED-US, V5, P3412, DOI 10.1002/cam4.937; Hardee ME, 2012, AM J PATHOL, V181, P1126, DOI 10.1016/j.ajpath.2012.06.030; Hasan MK, 2013, SCI REP-UK, V3, DOI 10.1038/srep03450; Heddleston JM, 2010, BRIT J CANCER, V102, P789, DOI 10.1038/sj.bjc.6605551; Holash J, 1999, SCIENCE, V284, P1994, DOI 10.1126/science.284.5422.1994; Inoue H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0609-8; Inukai M, 2015, HUM PATHOL, V46, P1496, DOI 10.1016/j.humpath.2015.06.008; Iwahara T, 1997, ONCOGENE, V14, P439, DOI 10.1038/sj.onc.1200849; Jogi A, 2002, P NATL ACAD SCI USA, V99, P7021, DOI 10.1073/pnas.102660199; Kamachi Y, 2013, DEVELOPMENT, V140, P4129, DOI 10.1242/dev.091793; Kang J, 2008, ONCOGENE, V27, P3999, DOI 10.1038/onc.2008.15; Kaur B, 2004, J NEURO-ONCOL, V70, P229, DOI 10.1007/s11060-004-2752-5; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kwon MJ, 2012, PATHOL RES PRAC, V57, P682; Lamant L, 2000, AM J PATHOL, V156, P1711, DOI 10.1016/S0002-9440(10)65042-0; Louis, 2016, WHO CLASSIFICATION G; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; MARU Y, 1990, ONCOGENE RES, V5, P199; Marzec M, 2011, ONCOGENE, V30, P1372, DOI 10.1038/onc.2010.505; McDonnell SRP, 2012, ONCOGENE, V31, P3733, DOI 10.1038/onc.2011.542; Medford ARL, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-27; Morris SW, 1997, ONCOGENE, V14, P2175, DOI 10.1038/sj.onc.1201062; Ohgaki H, 2004, CANCER RES, V64, P6892, DOI 10.1158/0008-5472.CAN-04-1337; Parliament MB, 2000, BRIT J CANCER, V82, P635; Reiff T, 2011, DEVELOPMENT, V13, P685; Ricci-Vitiani L, 2010, NATURE, V468, P824, DOI 10.1038/nature09557; Saegusa M, 2012, LAB INVEST, V92, P511, DOI 10.1038/labinvest.2011.196; Soda Y, 2001, P NAT ACAD SCI, V108, P4274; Takeuchi K, 2012, NAT MED, V18, P378, DOI 10.1038/nm.2658; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Williamson SC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13322; Yoshida T, 2013, LAB INVEST, V93, P1184, DOI 10.1038/labinvest.2013.111; Zhang L, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1141087; Zhang L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa1690	43	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183516	10.1371/journal.pone.0183516	http://dx.doi.org/10.1371/journal.pone.0183516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837676	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000076
J	Portbury, SD; Hare, DJ; Finkelstein, DI; Adlard, PA				Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.			Trehalose improves traumatic brain injury-induced cognitive impairment	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; CONTROLLED CORTICAL IMPACT; CELLULAR STRESS RESPONSES; FOOTBALL-LEAGUE PLAYER; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HEAD-INJURY; RAT MODEL; SUBVENTRICULAR ZONE; MEMORY FORMATION	Traumatic brain Injury (TBI) is a significant cause of death and long-term disability for which there are currently no effective pharmacological treatment options. In this study then, we utilized a mouse model of TBI to assess the therapeutic potential of the stable disaccharide trehalose, which is known to protect against oxidative stress, increase levels of chaperone molecules and enhance autophagy. Furthermore, trehalose has demonstrated neuroprotective properties in numerous animal models and has been proposed as a potential treatment for neurodegeneration. As TBI (and associated neurodegenerative disorders) is complicated by a sudden and dramatic change in brain metal concentrations, including iron (Fe) and zinc (Zn), the collective accumulation and translocation of which has been hypothesized to contribute to the pathogenesis of TBI, then we also sought to determine whether trehalose modulated the metal dyshomeostasis associated with TBI. In this study three-monthold C57Bl/6 wildtype mice received a controlled cortical impact TBI, and were subsequently treated for one month with trehalose. During this time animals were assessed on multiple behavioral tasks prior to tissue collection. Results showed an overall significant improvement in the Morris water maze, Y-maze and open field behavioral tests in trehalose-treated mice when compared to controls. These functional benefits occurred in the absence of any change in lesion volume or any significant modulation of biometals, as assessed by laser ablation inductively coupled plasma mass spectrometry. Western blot analysis, however, revealed an upregulation of synaptophysin, doublecortin and brain derived neurotrophic factor protein in trehalose treated mice in the contralateral cortex. These results indicate that trehalose may be efficacious in improving functional outcomes following TBI by a previously undescribed mechanism of action that has relevance to multiple disorders of the central nervous system.	[Portbury, Stuart D.; Hare, Dominic J.; Finkelstein, David I.; Adlard, Paul A.] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia; [Hare, Dominic J.] Univ Technol Sydney, Elemental Bioimaging, Sydney, NSW, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Technology Sydney	Adlard, PA (corresponding author), Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic, Australia.	paul.adlard@florey.edu.au	Finkelstein, David/B-9617-2009; Hare, Dominic/H-2481-2011; Hare, Dominic/AAM-7725-2020	Finkelstein, David/0000-0002-8167-4917; Hare, Dominic/0000-0002-5922-7643; 	Australian Research Council Future Fellowship [FT120100030]; Australian Research Council; Agilent Technologies [LP140100095]	Australian Research Council Future Fellowship(Australian Research Council); Australian Research Council(Australian Research Council); Agilent Technologies	P.A.A. is supported by an Australian Research Council Future Fellowship (FT120100030). D.J.H. is supported by an Australian Research Council Linkage Project with Agilent Technologies (LP140100095).	Adlard PA, 2006, J ALZHEIMERS DIS, V10, P145; Alonso M, 2005, LEARN MEMORY, V12, P504, DOI 10.1101/lm.27305; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Axelson HW, 2013, RESTOR NEUROL NEUROS, V31, P73, DOI 10.3233/RNN-2012-120242; Ayton S, 2015, NEUROTHERAPEUTICS, V12, P109, DOI 10.1007/s13311-014-0312-z; Barnham KJ, 2008, CURR OPIN CHEM BIOL, V12, P222, DOI 10.1016/j.cbpa.2008.02.019; Bayir H, 2006, DEV NEUROSCI-BASEL, V28, P420, DOI 10.1159/000094168; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Beranger F, 2008, BIOCHEM BIOPH RES CO, V374, P44, DOI 10.1016/j.bbrc.2008.06.094; Calabrese EJ, 2016, PHARMACOL RES, V110, P242, DOI 10.1016/j.phrs.2015.12.021; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P753, DOI 10.1016/j.bbadis.2011.11.002; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Carri MT, 2003, BRAIN RES BULL, V61, P365, DOI 10.1016/S0361-9230(03)00179-5; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Chang EH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00332; Chen HL, 2007, AM J EPIDEMIOL, V166, P810, DOI 10.1093/aje/kwm153; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2012, NUTR REV, V70, P410, DOI 10.1111/j.1753-4887.2012.00486.x; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Cope EC, 2010, CURR OPIN CLIN NUTR, V13, P685, DOI 10.1097/MCO.0b013e32833df61a; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Dash PK, 2010, J NEUROSCI RES, V88, P1719, DOI 10.1002/jnr.22336; Doering P, 2007, NEUROSCIENCE, V150, P93, DOI 10.1016/j.neuroscience.2007.09.066; Doering P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010131; Du J, 2013, J PHARM PHARMACOL, V65, P1753, DOI 10.1111/jphp.12108; Echigo R, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-80; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Frederickson CJ, 2004, NEUROSCIENTIST, V10, P18, DOI 10.1177/1073858403255840; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Holler CJ, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0114-3; Ikeda S, 2013, EXCLI J, V12, P641; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kernie SG, 2001, J NEUROSCI RES, V66, P317, DOI 10.1002/jnr.10013; Klevay LM, 2013, MED HYPOTHESES, V81, P995, DOI 10.1016/j.mehy.2013.09.011; Kruger U, 2012, NEUROBIOL AGING, V33, P2291, DOI 10.1016/j.neurobiolaging.2011.11.009; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Levin HS, 2013, J NEUROTRAUM, V30, P610, DOI 10.1089/neu.2012.2394; LINDSAY RM, 1994, TRENDS NEUROSCI, V17, P182, DOI 10.1016/0166-2236(94)90099-X; LINDVALL O, 1994, TRENDS NEUROSCI, V17, P490, DOI 10.1016/0166-2236(94)90139-2; Liu MY, 2013, FOOD CHEM, V136, P485, DOI 10.1016/j.foodchem.2012.09.031; Liu R, 2005, NEUROBIOL DIS, V20, P74, DOI 10.1016/j.nbd.2005.02.003; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Lu LY, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/470676; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Morris DR, 2013, CURR OPIN CLIN NUTR, V16, P708, DOI 10.1097/MCO.0b013e328364f39c; MORTIMER JA, 1991, INT J EPIDEMIOL, V20, pS28, DOI 10.1093/ije/20.Supplement_2.S28; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; Omalu Bennet I, 2010, J Forensic Nurs, V6, P130, DOI 10.1111/j.1939-3938.2010.01078.x; Omalu Bennet I, 2010, J Forensic Nurs, V6, P40, DOI 10.1111/j.1939-3938.2009.01064.x; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Onyszchuk G, 2009, NEUROSCI LETT, V452, P204, DOI 10.1016/j.neulet.2009.01.049; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Portbury SD, 2017, METALLOMICS, V9, P402, DOI 10.1039/c6mt00260a; Portbury SD, 2016, METALLOMICS, V8, P193, DOI 10.1039/c5mt00234f; Portbury SD, 2015, J ALZHEIMERS DIS, V46, P297, DOI 10.3233/JAD-143048; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Richards AB, 2002, FOOD CHEM TOXICOL, V40, P871, DOI 10.1016/S0278-6915(02)00011-X; Ringdal M, 2009, J TRAUMA, V66, P1226, DOI 10.1097/TA.0b013e318181b8e3; Rodriguez-Navarro JA, 2010, NEUROBIOL DIS, V39, P423, DOI 10.1016/j.nbd.2010.05.014; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sadasivan S, 2008, BIOCHEM BIOPH RES CO, V373, P478, DOI 10.1016/j.bbrc.2008.05.031; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Suh SW, 2000, BRAIN RES, V852, P268, DOI 10.1016/S0006-8993(99)02095-8; Tanji K, 2015, BIOCHEM BIOPH RES CO, V465, P746, DOI 10.1016/j.bbrc.2015.08.076; Tokuyama W, 2000, NAT NEUROSCI, V3, P1134, DOI 10.1038/80655; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Van Den Heuvel C, 2007, PROG BRAIN RES, V161, P303, DOI 10.1016/S0079-6123(06)61021-2; Weiner MW, 2013, ALZHEIMERS DEMENT, V9, P445, DOI 10.1016/j.jalz.2013.03.005; Zhang Yan-Bo, 2008, Neurosci Bull, V24, P143, DOI 10.1007/s12264-008-1108-0; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	88	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183683	10.1371/journal.pone.0183683	http://dx.doi.org/10.1371/journal.pone.0183683			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837626	gold, Green Published			2022-12-27	WOS:000408365000102
J	Rode, S; Ohm, H; Zipfel, J; Rumpf, S				Rode, Sandra; Ohm, Henrike; Zipfel, Jaqueline; Rumpf, Sebastian			The spliceosome-associated protein Mfap1 binds to VCP in Drosophila	PLOS ONE			English	Article							MECHANISMS; DENDRITES; NEURONS; SYSTEM	Posttranscriptional regulation of gene expression contributes to many developmental transitions. Previously, we found that the AAA chaperone Valosin-Containing Protein (VCP) regulates ecdysone-dependent dendrite pruning of Drosophila class IV dendritic arborization (c4da) neurons via an effect on RNA metabolism. In a search for RNA binding proteins associated with VCP, we identified the spliceosome-associated protein Mfap1, a component of the tri-snRNP complex. Mfap1 is a nucleolar protein in neurons and its levels are regulated by VCP. Mfap1 binds to VCP and TDP-43, a disease-associated RNA-binding protein. via distinct regions in its N- and C-terminal halfs. Similar to vcp mutations, Mfap1 overexpression causes c4da neuron dendrite pruning defects and mislocalization of TDP-43 in these cells, but genetic analyses show that Mfap1 is not a crucial VCP target during dendrite pruning. Finally, rescue experiments with a lethal mfap1 mutant show that the VCP binding region is not essential for Mfap1 function, but may act to increase its stability or activity.	[Rode, Sandra; Ohm, Henrike; Zipfel, Jaqueline; Rumpf, Sebastian] Univ Munster, Inst Neurobiol, Badestr 9, Munster, Germany	University of Munster	Rumpf, S (corresponding author), Univ Munster, Inst Neurobiol, Badestr 9, Munster, Germany.	sebastian.rumpf@uni-muenster.de	Rumpf, Sebastian/AHC-9393-2022		DFG Cluster of Excellence "Cells in Motion" [EXC1003]	DFG Cluster of Excellence "Cells in Motion"(German Research Foundation (DFG))	This study was supported by the DFG Cluster of Excellence "Cells in Motion" (EXC1003). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen DS, 2008, J BIOL CHEM, V283, P31256, DOI 10.1074/jbc.M803512200; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bischof J, 2013, DEVELOPMENT, V140, P2434, DOI 10.1242/dev.088757; Boeddrich A, 2006, EMBO J, V25, P1547, DOI 10.1038/sj.emboj.7601043; Grueber WB, 2007, DEVELOPMENT, V134, P55, DOI 10.1242/dev.02666; Han C, 2014, NEURON, V81, P544, DOI 10.1016/j.neuron.2013.11.021; Herzmann S, 2017, EMBO J, V36, P1981, DOI 10.15252/embj.201695890; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Kanamori T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7515; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Kuo CT, 2005, P NATL ACAD SCI USA, V102, P15230, DOI 10.1073/pnas.0507393102; Lin M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018068; Liu JL, 2009, MOL BIOL CELL, V20, P1661, DOI 10.1091/mbc.E08-05-0525; Liu JL, 2006, J CELL BIOL, V172, P875, DOI 10.1083/jcb.200511038; Loncle N, 2012, J NEUROSCI, V32, P17086, DOI 10.1523/JNEUROSCI.1391-12.2012; Ma L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002827; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Pesiridis GS, 2009, HUM MOL GENET, V18, pR156, DOI 10.1093/hmg/ddp303; REIMER G, 1987, ARTHRITIS RHEUM, V30, P793, DOI 10.1002/art.1780300709; Rumpf S, 2014, P NATL ACAD SCI USA, V111, P7331, DOI 10.1073/pnas.1406898111; Rumpf S, 2011, DEVELOPMENT, V138, P1153, DOI 10.1242/dev.062703; Schuldiner O, 2015, CELL MOL LIFE SCI, V72, P101, DOI 10.1007/s00018-014-1729-6; Ulrich AKC, 2016, STRUCTURE, V24, P1972, DOI 10.1016/j.str.2016.09.007; Williams DW, 2005, DEVELOPMENT, V132, P3631, DOI 10.1242/dev.01928; Zhang X, 2014, G3-GENES GENOM GENET, V4, P2409, DOI 10.1534/g3.114.013979	25	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183733	10.1371/journal.pone.0183733	http://dx.doi.org/10.1371/journal.pone.0183733			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837687	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000107
J	Rzeznik, M; Triba, MN; Levy, P; Jungo, S; Botosoa, E; Duchemann, B; Le Moyec, L; Bernaudin, JF; Savarin, P; Guez, D				Rzeznik, Matthias; Triba, Mohamed Nawfal; Levy, Pierre; Jungo, Sebastien; Botosoa, Eliot; Duchemann, Boris; Le Moyec, Laurence; Bernaudin, Jean-Francois; Savarin, Philippe; Guez, Dominique			Identification of a discriminative metabolomic fingerprint of potential clinical relevance in saliva of patients with periodontitis using H-1 nuclear magnetic resonance (NMR) spectroscopy	PLOS ONE			English	Article							GINGIVAL CREVICULAR FLUID; METABONOMIC ANALYSIS; CASE DEFINITIONS; OXYGEN-TENSION; DISEASE; BACTERIA; PLAQUE; INFLAMMATION; LACTOBACILLI; POPULATION	Periodontitis is characterized by the loss of the supporting tissues of the teeth in an inflammatory-infectious context. The diagnosis relies on clinical and X-ray examination. Unfortunately, clinical signs of tissue destruction occur late in the disease progression. Therefore, it is mandatory to identify reliable biomarkers to facilitate a better and earlier management of this disease. To this end, saliva represents a promising fluid for identification of biomarkers as metabolomic fingerprints. The present study used high-resolution H-1-nuclear magnetic resonance (NMR) spectroscopy coupled with multivariate statistical analysis to identify the metabolic signature of active periodontitis. The metabolome of stimulated saliva of 26 patients with generalized periodontitis (18 chronic and 8 aggressive) was compared to that of 25 healthy controls. Principal Components Analysis (PCA), performed with clinical variables, indicated that the patient population was homogeneous, demonstrating a strong correlation between the clinical and the radiological variables used to assess the loss of periodontal tissues and criteria of active disease. Orthogonal Projection to Latent Structure (OPLS) analysis showed that patients with periodontitis can be discriminated from controls on the basis of metabolite concentrations in saliva with satisfactory explained variance (R2X = 0.81 and R2Y = 0.61) and predictability (Q2Y = 0.49, CV-AUROC = 0.94). Interestingly, this discrimination was irrespective of the type of generalized periodontitis, i.e. chronic or aggressive. Among the main discriminating metabolites were short chain fatty acids as butyrate, observed in higher concentrations, and lactate, gamma-amino-butyrate, methanol, and threonine observed in lower concentrations in periodontitis. The association of lactate, GABA, and butyrate to generate an aggregated variable reached the best positive predictive value for diagnosis of periodontitis. In conclusion, this pilot study showed that 1H-NMR spectroscopy analysis of saliva could differentiate patients with periodontitis from controls. Therefore, this simple, robust, non-invasive method, may offer a significant help for early diagnosis and follow-up of periodontitis.	[Rzeznik, Matthias; Triba, Mohamed Nawfal; Botosoa, Eliot; Duchemann, Boris; Savarin, Philippe] Paris 13 Univ, Sorbonne Paris Cite, CSPBAT, CNRS,UMR 7244, Bobigny, France; [Rzeznik, Matthias; Jungo, Sebastien; Guez, Dominique] Paris Descartes Univ, Bretonneau Hosp, APHP, Dept Periodontol, Paris, France; [Levy, Pierre] Tenon Hosp, APHP, Dept Publ Hlth, Paris, France; [Levy, Pierre] Sorbonne Univ, INSERM UPMC, UMR S1136, EPAR Team, Paris, France; [Duchemann, Boris; Bernaudin, Jean-Francois] Avicenne Hosp, APHP, Dept Pneumol, Bobigny, France; [Le Moyec, Laurence] Univ Paris Saclay, UBIAE, Univ Evry, Evry, France; [Bernaudin, Jean-Francois] Sorbonne Univ, UPMC Paris 6, Paris, France; [Bernaudin, Jean-Francois] Paris 13 Univ, Sorbonne Paris Cite, EA2363, Bobigny, France; [Botosoa, Eliot] Artois Univ, EA 7394, Inst Charles Violette, Lens, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Bretonneau - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Avicenne - APHP; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Sorbonne Universite	Savarin, P (corresponding author), Paris 13 Univ, Sorbonne Paris Cite, CSPBAT, CNRS,UMR 7244, Bobigny, France.; Guez, D (corresponding author), Paris Descartes Univ, Bretonneau Hosp, APHP, Dept Periodontol, Paris, France.	philippe.savarin@univ-paris13.fr; dominique.guez@parisdescartes.fr		Savarin, Philippe/0000-0003-1451-2376; BOTOSOA, Eliot Patrick/0000-0002-1885-3824; Jungo, Sebastien/0000-0001-7747-7286; Levy, Pierre/0000-0002-2485-3628; BERNAUDIN, Jean-Francois/0000-0002-4893-0106; Duchemann, Boris/0000-0003-0872-2983	Institut Francais de Recherche Odontologique (IFRO)	Institut Francais de Recherche Odontologique (IFRO)	The study has been partly supported by a grant from Institut Francais de Recherche Odontologique (IFRO, 2013). There was no additional external funding received for this study.	Acquier AB, 2016, REDOX REPORT, P1; Aimetti M, 2012, METABOLOMICS, V8, P465, DOI 10.1007/s11306-011-0331-2; AINAMO J, 1975, INT DENT J, V25, P229; Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Amathieu R, 2016, WORLD J GASTROENTERO, V22, P417, DOI 10.3748/wjg.v22.i1.417; Armitage G C, 1999, Ann Periodontol, V4, P1, DOI 10.1902/annals.1999.4.1.1; Barnes VM, 2014, PLOS ONE, V9; Bertram HC, 2009, ANAL CHEM, V81, P9188, DOI 10.1021/ac9020598; Boris S, 2000, MICROBES INFECT, V2, P543, DOI 10.1016/S1286-4579(00)00313-0; Bourgeois D, 2007, J PERIODONTAL RES, V42, P219, DOI 10.1111/j.1600-0765.2006.00936.x; Chang MC, 2013, J PERIODONTAL RES, V48, P66, DOI 10.1111/j.1600-0765.2012.01504.x; CHAVES ES, 1993, J CLIN PERIODONTOL, V20, P139, DOI 10.1111/j.1600-051X.1993.tb00328.x; Costalonga M, 2014, IMMUNOL LETT, V162, P22, DOI 10.1016/j.imlet.2014.08.017; Cuevas-Cordoba B, 2014, OMICS, V18, P87, DOI 10.1089/omi.2013.0064; de Laurentiis G, 2008, EUR RESPIR J, V32, P1175, DOI 10.1183/09031936.00072408; Dieterle F, 2006, ANAL CHEM, V78, P4281, DOI 10.1021/ac051632c; Duchemann B, 2016, SARCOIDOSIS VASC DIF, V33, P10; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Eke P. I., 2015, J PERIODONTOL, V86, P611, DOI DOI 10.1902/J0P.2015.140520; Eke PI, 2016, PERIODONTOL 2000, V72, P76, DOI 10.1111/prd.12145; Eke PI, 2012, J PERIODONTOL, V83, P1449, DOI 10.1902/jop.2012.110664; Estreicher A, 1996, ARCH ORAL BIOL, V41, P733, DOI 10.1016/S0003-9969(96)00076-3; Fayol-Messaoudi D, 2005, APPL ENVIRON MICROB, V71, P6008, DOI 10.1128/AEM.71.10.6008-6013.2005; Giannobile William V, 2012, J Am Dent Assoc, V143, p6S; Grant MM, 2010, J CLIN PERIODONTOL, V37, P1039, DOI 10.1111/j.1600-051X.2010.01622.x; Grootveld M, 2005, BIOCHEM BIOPH RES CO, V329, P1, DOI 10.1016/j.bbrc.2005.01.112; GROSSI SG, 1994, J PERIODONTOL, V65, P260, DOI 10.1902/jop.1994.65.3.260; Gupta Abhaya, 2015, J Oral Biol Craniofac Res, V5, P46, DOI 10.1016/j.jobcr.2015.01.001; Hajishengallis G, 2014, MOL ORAL MICROBIOL, V29, P248, DOI 10.1111/omi.12065; Hanioka T, 2000, J PERIODONTOL, V71, P550, DOI 10.1902/jop.2000.71.4.550; He XS, 2010, MICROB ECOL, V60, P655, DOI 10.1007/s00248-010-9708-4; HUGOSON A, 1982, COMMUNITY DENT ORAL, V10, P187, DOI 10.1111/j.1600-0528.1982.tb00377.x; Humphrey SP, 2001, J PROSTHET DENT, V85, P162, DOI 10.1067/mpr.2001.113778; Jiao Y, 2014, J DENT RES, V93, P539, DOI 10.1177/0022034514528212; Kageyama S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174782; Kambouchner M, 2014, HISTOPATHOLOGY, V65, P549, DOI 10.1111/his.12415; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Koll-Klais P, 2005, ORAL MICROBIOL IMMUN, V20, P354, DOI 10.1111/j.1399-302X.2005.00239.x; Kruk J, 2017, APPL MAGN RESON, V48, P1, DOI 10.1007/s00723-016-0846-9; Kuboniwa M, 2016, J DENT RES, V95, P1381, DOI 10.1177/0022034516661142; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; LANG NP, 1990, J CLIN PERIODONTOL, V17, P714, DOI 10.1111/j.1600-051X.1990.tb01059.x; LANG NP, 1986, J CLIN PERIODONTOL, V13, P590, DOI 10.1111/j.1600-051X.1986.tb00852.x; Lazar V, 2016, CURR PHARM DESIGN, V22, P230, DOI 10.2174/138161282202151221124307; LISTGARTEN MA, 1988, J CLIN PERIODONTOL, V15, P485, DOI 10.1111/j.1600-051X.1988.tb01019.x; Almerich-Silla JM, 2015, DIS MARKERS, V2015, DOI 10.1155/2015/653537; Martin-Cabezas R, 2016, AM HEART J, V180, P98, DOI 10.1016/j.ahj.2016.07.018; Mombelli A, 2003, ORAL DIS, V9, P6, DOI 10.1034/j.1601-0825.9.s1.2.x; Munshi SU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064298; Nam H, 2007, J MICROBIOL, V45, P515; Nibali L, 2015, VIRULENCE, V6, P223, DOI 10.4161/21505594.2014.986407; Niederman R, 1997, CRIT REV ORAL BIOL M, V8, P269, DOI 10.1177/10454411970080030301; Nishihara T, 2000, PERIODONTOL, V36, P14, DOI DOI 10.1111/J.1600-0757.2004.03671.X; OLEARY TJ, 1972, J PERIODONTOL, V43, P38, DOI 10.1902/jop.1972.43.1.38; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Pessi T, 2000, CLIN EXP ALLERGY, V30, P1804, DOI 10.1046/j.1365-2222.2000.00948.x; Pessione E, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00086; Qiqiang L, 2012, J PERIODONTAL RES, V47, P740, DOI 10.1111/j.1600-0765.2012.01489.x; Range H, 2012, J CLIN PERIODONTOL, V39, P799, DOI 10.1111/j.1600-051X.2012.01913.x; Rosa N, 2012, ARCH ORAL BIOL, V57, P853, DOI 10.1016/j.archoralbio.2011.12.010; Santone C, 2014, J PHARMACEUT BIOMED, V88, P441, DOI 10.1016/j.jpba.2013.09.021; Savorani F, 2010, J MAGN RESON, V202, P190, DOI 10.1016/j.jmr.2009.11.012; Scannapieco FA, 2016, PERIODONTOL 2000, V72, P153, DOI 10.1111/prd.12129; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Silwood CJL, 2002, J DENT RES, V81, P422, DOI 10.1177/154405910208100613; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sousa V, 2016, CLIN ORAL IMPLAN RES, V27, P787, DOI 10.1111/clr.12684; Trindade F, 2015, PROTEOM CLIN APPL, V9, P917, DOI 10.1002/prca.201400191; Trindade F, 2014, PROTEOM CLIN APPL, V8, P748, DOI 10.1002/prca.201400028; Tsai C.-Y., 2016, J MICROBIOLOGY IMMUN; Uematsu H, 2003, ARCH ORAL BIOL, V48, P423, DOI 10.1016/S0003-9969(03)00031-1; Wallner-Liebniann S, 2016, J PROTEOME RES, V15, P1787, DOI 10.1021/acs.jproteome.5b01060; YAMADANOSAKA A, 1991, ARCH ORAL BIOL, V36, P697, DOI 10.1016/0003-9969(91)90025-P; YANG RG, 1992, APPL ENVIRON MICROB, V58, P3355, DOI 10.1128/AEM.58.10.3355-3359.1992	76	21	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182767	10.1371/journal.pone.0182767	http://dx.doi.org/10.1371/journal.pone.0182767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837579	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000025
J	Shang, HM; Zhou, HZ; Li, R; Duan, MY; Wu, HX; Lou, YJ				Shang, Hong-Mei; Zhou, Hai-Zhu; Li, Ran; Duan, Meng-Ying; Wu, Hong-Xin; Lou, Yu-Jie			Extraction optimization and influences of drying methods on antioxidant activities of polysaccharide from cup plant (Silphium perfoliatum L.)	PLOS ONE			English	Article							MICROWAVE-ASSISTED EXTRACTION; STRUCTURAL-CHARACTERIZATION; PHYSICOCHEMICAL PROPERTIES; CHEMICAL-COMPOSITION; FRACTIONS; FRUIT	Response surface methodology (RSM) was used to investigate the extraction condition of polysaccharide from cup plant (Silphium perfoliatum L.) (named CPP). Water to raw material ratio (10-30 mL/g), extraction time (40-80 min) and extraction temperature (60-100 degrees C) were set as the 3 independent variables, and their effects on the extraction yield of CPP were measured. In addition, the effects of drying methods including hot air drying (HD), vacuum drying (VD) and freeze drying (FD) on the antioxidant activities of CPP were evaluated. The results showed that the optimal condition to extract CPP was: water to raw material ratio (15 mL/g), extraction time (61 min), and extraction temperature (97 degrees C), a maximum CPP yield of 6.49% was obtained under this condition. CPP drying with FD method showed stronger reducing power (0.943 at 6 mg/mL) and radical scavenging capacities against DPPH radical (75.71% at 1.2 mg/mL) and ABTS radical (98.06 at 1.6 mg/mL) than CPP drying with HD and VD methods. Therefore, freeze drying served as a good method for keeping the antioxidant activities of polysaccharide from cup plant. The polysaccharide from cup plant has potential to use as a natural antioxidant.	[Shang, Hong-Mei; Zhou, Hai-Zhu; Li, Ran; Duan, Meng-Ying; Lou, Yu-Jie] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China; [Shang, Hong-Mei; Zhou, Hai-Zhu; Lou, Yu-Jie] Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun, Jilin, Peoples R China; [Wu, Hong-Xin] CAAS, Grassland Res Inst, Neimenggu, Hohhot, Peoples R China	Jilin Agricultural University; Jilin Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Lou, YJ (corresponding author), Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Jilin, Peoples R China.; Lou, YJ (corresponding author), Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci Jilin Prov, Changchun, Jilin, Peoples R China.	lyjjlau@163.com	Shang, Hongmei/HDL-7105-2022	Shang, Hongmei/0000-0002-0961-491X	China Postdoctoral Science Foundation; National Natural Science Foundation of China [31601972]	China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Project funded by China Postdoctoral Science Foundation and the National Natural Science Foundation of China (No. 31601972). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2007, PHARM BIOL, V6, P494; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chen C, 2015, CARBOHYD POLYM, V130, P122, DOI 10.1016/j.carbpol.2015.05.003; Chen HX, 2008, FOOD CHEM, V106, P559, DOI 10.1016/j.foodchem.2007.06.040; Chen RZ, 2015, IND CROP PROD, V77, P434, DOI 10.1016/j.indcrop.2015.08.006; DODGSON KS, 1962, BIOCHEM J, V84, P106, DOI 10.1042/bj0840106; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Fan LP, 2012, CARBOHYD POLYM, V87, P1849, DOI 10.1016/j.carbpol.2011.10.018; Jing YQ, 2016, INT J BIOL MACROMOL, V91, P188, DOI 10.1016/j.ijbiomac.2016.05.069; Jing YS, 2015, J AGR FOOD CHEM, V63, P3464, DOI 10.1021/jf505915t; Kang MC, 2014, CARBOHYD POLYM, V99, P365, DOI 10.1016/j.carbpol.2013.07.091; Kong LS, 2015, CARBOHYD POLYM, V125, P1, DOI 10.1016/j.carbpol.2015.02.042; Kumar CS, 2016, INT J BIOL MACROMOL, V92, P682, DOI 10.1016/j.ijbiomac.2016.07.062; Li XY, 2016, PROCESS BIOCHEM, V51, P1100, DOI 10.1016/j.procbio.2016.05.006; Liu ZG, 2013, INT J BIOL MACROMOL, V61, P127, DOI 10.1016/j.ijbiomac.2013.06.042; Ma LS, 2013, FOOD RES INT, V50, P633, DOI 10.1016/j.foodres.2011.05.005; Pan SK, 2014, CARBOHYD POLYM, V111, P606, DOI 10.1016/j.carbpol.2014.05.022; Radoslaw K., 2009, FOOD CHEM, V112, P820; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; Rostami H, 2016, CARBOHYD POLYM, V143, P100, DOI 10.1016/j.carbpol.2016.01.075; Wang JQ, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/5692852; Wang W, 2016, INT J BIOL MACROMOL, V82, P979, DOI 10.1016/j.ijbiomac.2015.10.051; Wu CY, 2014, INT J BIOL MACROMOL, V64, P458, DOI 10.1016/j.ijbiomac.2013.12.025; Wu LC, 2006, FOOD CHEM, V95, P319, DOI 10.1016/j.foodchem.2005.01.002; Wu Z, 2015, INT J BIOL MACROMOL, V76, P218, DOI 10.1016/j.ijbiomac.2015.02.043; Xiong SL, 2011, CARBOHYD POLYM, V86, P1273, DOI 10.1016/j.carbpol.2011.06.025; Xu FF, 2016, CARBOHYD POLYM, V151, P364, DOI 10.1016/j.carbpol.2016.05.091; Xu YQ, 2016, FOOD CHEM, V194, P650, DOI 10.1016/j.foodchem.2015.08.061; Yang SF, PLOS ONE; Ying Z, 2011, FOOD CHEM, V127, P1273, DOI 10.1016/j.foodchem.2011.01.083; Zhao QS, 2015, CARBOHYD POLYM, V127, P176, DOI 10.1016/j.carbpol.2015.03.041; Zheng Q, 2016, INT J BIOL MACROMOL, V91, P856, DOI 10.1016/j.ijbiomac.2016.06.042	33	29	29	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183001	10.1371/journal.pone.0183001	http://dx.doi.org/10.1371/journal.pone.0183001			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837625	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000041
J	Mitsuhashi, Y; Furusawa, Y; Aradate, T; Zhao, QL; Moniruzzaman, R; Kanamori, M; Noguchi, K; Kondo, T				Mitsuhashi, Yohei; Furusawa, Yukihiro; Aradate, Tadashi; Zhao, Qing-Li; Moniruzzaman, Rohan; Kanamori, Masahiko; Noguchi, Kyo; Kondo, Takashi			3-O-trans-p-coumaroyl-alphitolic acid, a triterpenoid from Zizyphus jujuba, leads to apoptotic cell death in human leukemia cells through reactive oxygen species production and activation of the unfolded protein response	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; RADIATION-INDUCED APOPTOSIS; OXIDATIVE STRESS; BIOACTIVE CONSTITUENTS; ER STRESS; ENHANCEMENT; MECHANISM; FRUITS; MACROSPHELIDES; IDENTIFICATION	3-O-trans-p-coumaroyl-alphitolic acid (3OTPCA), a triterpenoid isolated from the plant Zizyphus jujuba (ZJ), is known to be cytotoxic to cancer cells; however, the molecular mechanism underlying 3OTPCA-induced cell death remains unknown. Here, we provide novel evidence that 3OTPCA induces apoptotic cell death in human leukemia cells. We found that 3OPTCA induces DNA fragmentation within 24 h after treatment in U937 cells, which was also observed in other leukemia cell lines, including Molt-4 and Jurkat cells. We then investigated other parameters involved in apoptosis, including phosphatidylserine externalization and caspase-3 cleavage in U937 cells treated with 3OTPCA. 3OTPCA caused significant DNA fragmentation, annexin-V binding, and caspase-3 cleavage, indicating that 3OTPCA exerts cytotoxicity through apoptosis induction. RNA-seq analysis revealed that the expression of transcripts associated with the unfolded protein response (UPR), such as spliced XBP-1 and CHOP, were up-regulated by 3OTPCA treatment. 3OTPCA-induced UPR activation may be due to endoplasmic reticulum (ER) stress because both 3OTPCA and thapsigargin, an endoplasmic Ca2+ transport ATPase inhibitor, increased intracellular calcium levels. 3OTPCA down-regulated the expression of Bcl-2, a target of CHOP, and led to the loss of the mitochondrial membrane, indicating that the intrinsic (mitochondrial) apoptotic pathway was triggered by 3OTPCA, likely through UPR activation. Furthermore, we found that 3OTPCA induced superoxide anion generation and, following p38 MAPK phosphorylation, caspase-8 cleavage without affecting Fas expression. It also induced subsequent Bid cleavage, which may enhance the apoptosis triggered by the intrinsic pathway. These findings reveal for the first time that 3OTPCA induces apoptotic cell death through the generation of reactive oxygen species and activation of UPR.	[Mitsuhashi, Yohei; Furusawa, Yukihiro; Zhao, Qing-Li; Kondo, Takashi] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Sugitani, Toyama, Japan; [Furusawa, Yukihiro] Toyama Prefectural Univ, Dept Liberal Arts & Sci, Toyama, Japan; [Aradate, Tadashi] Univ Toyama, Dept Med Biol, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama, Japan; [Moniruzzaman, Rohan] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Oral & Maxillofacial Surg, Sugitani, Toyama, Japan; [Kanamori, Masahiko] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Human Sci 1, Sugitani, Toyama, Japan; [Noguchi, Kyo] Univ Toyama, Dept Radiol, Grad Sch Med & Pharmaceut Sci, Sugitani, Toyama, Japan	University of Toyama; Toyama Prefectural University; University of Toyama; University of Toyama; University of Toyama; University of Toyama	Furusawa, Y (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Sugitani, Toyama, Japan.; Furusawa, Y (corresponding author), Toyama Prefectural Univ, Dept Liberal Arts & Sci, Toyama, Japan.	furusawa@pu-toyama.ac.jp			R&D research promotive foundation of the Hokuriku Industrial Advancement Center	R&D research promotive foundation of the Hokuriku Industrial Advancement Center	This work was supported by the R&D research promotive foundation of the Hokuriku Industrial Advancement Center. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the R&D research promotive foundation of the Hokuriku Industrial Advancement Center.	Aguirre MC, 2006, BIOORGAN MED CHEM, V14, P5673, DOI 10.1016/j.bmc.2006.04.021; Ahmed K, 2007, CHEM-BIOL INTERACT, V170, P86, DOI 10.1016/j.cbi.2007.07.007; Ahmed K, 2012, INT J HYPERTHER, V28, P1, DOI 10.3109/02656736.2011.627408; Ahmed K, 2009, CHEM-BIOL INTERACT, V177, P218, DOI 10.1016/j.cbi.2008.10.030; Bai L, 2016, FOOD FUNCT, V7, P2870, DOI [10.1039/c6fo00613b, 10.1039/C6FO00613B]; Cao SS, 2014, ANTIOXID REDOX SIGN, V21, P396, DOI 10.1089/ars.2014.5851; Choi SH, 2012, J AGR FOOD CHEM, V60, P10245, DOI 10.1021/jf302848u; Cui ZG, 2004, FREE RADICAL RES, V38, P363, DOI 10.1080/1071576042000191754; El Mchichi B, 2007, CELL DEATH DIFFER, V14, P1826, DOI 10.1038/sj.cdd.4402187; Emam H, 2012, CHEM-BIOL INTERACT, V199, P154, DOI 10.1016/j.cbi.2012.07.005; Furusawa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029012; Furusawa Y, 2011, INT J MOL MED, V28, P143, DOI 10.3892/ijmm.2011.702; Furusawa Y, 2010, CANCER LETT, V288, P107, DOI 10.1016/j.canlet.2009.06.029; Furusawa Y, 2009, CELL BIOL INT, V33, P1253, DOI 10.1016/j.cellbi.2009.08.009; Gorman A, 1997, FEBS LETT, V404, P27, DOI 10.1016/S0014-5793(97)00069-0; Goyal R, 2011, J NAT MED-TOKYO, V65, P514, DOI 10.1007/s11418-011-0531-0; Huang X, 2007, AM J CHINESE MED, V35, P517, DOI 10.1142/S0192415X0700503X; Hung CF, 2012, NUTRITION, V28, P98, DOI 10.1016/j.nut.2011.05.009; Lee SM, 2003, PLANTA MED, V69, P1051, DOI 10.1055/s-2003-45155; Li BX, 2016, BOUND VALUE PROBL, DOI 10.1186/s13661-015-0512-4; Li G, 2010, J CELL BIOL, V191, P1113, DOI 10.1083/jcb.201006121; Li XM, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-8; Liu J, 2014, ASIAN PAC J CANCER P, V15, P4519, DOI 10.7314/APJCP.2014.15.11.4519; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Pedruzzi E, 2004, MOL CELL BIOL, V24, P10703, DOI 10.1128/MCB.24.24.10703-10717.2004; Piao JL, 2013, CHEM-BIOL INTERACT, V205, P119, DOI 10.1016/j.cbi.2013.06.011; Plastina P, 2012, J ETHNOPHARMACOL, V140, P325, DOI 10.1016/j.jep.2012.01.022; Sabala Pawel, 1993, Acta Biochimica Polonica, V40, P309; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; SELLINS KS, 1987, J IMMUNOL, V139, P3199; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Tabuchi Y, 2011, INT J MOL MED; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tobiume K, 2001, EMBO REP, V2, P222, DOI 10.1093/embo-reports/kve046; Tumurkhuu G, 2007, FEMS IMMUNOL MED MIC, V49, P304, DOI 10.1111/j.1574-695X.2006.00203.x; YAGI A, 1978, CHEM PHARM BULL, V26, P1798; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshihisa Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047903; Yu DY, 2012, APOPTOSIS, V17, P636, DOI 10.1007/s10495-012-0698-1; Yu DY, 2009, INT J HYPERTHER, V25, P364, DOI 10.1080/02656730902967418; Yu DY, 2009, APOPTOSIS, V14, P655, DOI 10.1007/s10495-009-0329-7; Yu L, 2012, PHYTOMEDICINE, V19, P239, DOI 10.1016/j.phymed.2011.09.071; Zhao QL, 2010, APOPTOSIS, V15, P1270, DOI 10.1007/s10495-010-0522-8; Zhao QL, 2006, FREE RADICAL BIO MED, V40, P1131, DOI 10.1016/j.freeradbiomed.2005.10.064; Zhao SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0078644; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	46	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183712	10.1371/journal.pone.0183712	http://dx.doi.org/10.1371/journal.pone.0183712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832644	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800091
J	Hohn, O; Norley, S; Kucherer, C; Bazarbachi, A; El Hajj, H; Marcus, U; Zimmermann, R; Bannert, N				Hohn, Oliver; Norley, Stephen; Kuecherer, Claudia; Bazarbachi, Ali; El Hajj, Hiba; Marcus, Ulrich; Zimmermann, Ruth; Bannert, Norbert			No significant HTLV seroprevalence in German people who inject drugs	PLOS ONE			English	Article							CELL LYMPHOTROPIC VIRUS; DRIED BLOOD SPOTS; PREGNANT-WOMEN; II INFECTION; HIV; PREVALENCE; USERS; EPIDEMIOLOGY; TYPE-1; TRANSMISSION	Background Although human T-lymphotropic virus (HTLV) is transmitted via the same routes as human immunodeficiency virus (HIV), its worldwide seroprevalence differs drastically because HTLV is transmitted mainly via infected cells rather than free virus. The sharing of needles and other equipment places people who inject drugs (PWID) at particularly high-risk for such blood-borne diseases. Methods To validate the methodology used to process and analyze the dried blood spots (DBS) utilized in the study, dried serum spots (DSS) with dilutions of sera from known HTLV infected individuals were analyzed by ELISA and Western blot. DBS collected between 2011 and 2015 from 2,077 PWID in eight German cities recruited by respondent-driven sampling were tested for HTLV-specific antibodies. Results The validation demonstrated that the use of DSS allowed identification of samples with even low titers of HTLV-specific antibodies, although a confirmatory Western blot with an additional venous blood sample would often be required. Despite numerous HIV and HCV positive individuals being identified within the study population, none tested positive for HTLV. Conclusion While the HIV and HCV prevalences in German PWID are comparable to those in other European countries, the very low prevalence of HTLV reflects the situation in the general population.	[Hohn, Oliver; Norley, Stephen; Kuecherer, Claudia; Bannert, Norbert] Robert Koch Inst, Dept Infect Dis, Div HIV & Other Retroviruses, Berlin, Germany; [Bazarbachi, Ali] Amer Univ Beirut, Dept Cell Biol Anat & Physiol Sci, Dept Internal Med, Beirut, Lebanon; [El Hajj, Hiba] Amer Univ Beirut, Dept Expt Pathol Microbiol & Immunol, Dept Internal Med, Beirut, Lebanon; [Marcus, Ulrich; Zimmermann, Ruth] Robert Koch Inst Berlin, Dept Infect Dis Epidemiol, Div HIV AIDS STI & Bloodborne Infect, Berlin, Germany	Robert Koch Institute; American University of Beirut; American University of Beirut; Robert Koch Institute	Hohn, O (corresponding author), Robert Koch Inst, Dept Infect Dis, Div HIV & Other Retroviruses, Berlin, Germany.	HohnO@rki.de	Marcus, Ulrich/AAF-3085-2020	Marcus, Ulrich/0000-0002-3143-2717; Bazarbachi, Ali/0000-0002-7171-4997; Hohn, Oliver/0000-0002-9064-1607	Robert Koch Institute; German Federal Ministry of Health	Robert Koch Institute; German Federal Ministry of Health	This work was supported by the Robert Koch Institute and the German Federal Ministry of Health. The German Federal Ministry of Health was neither involved in the study design, in the collection, analysis and interpretation of the data, nor in the decision to publish, or preparation of the manuscript.	Abad M, 2011, AIDS RES HUM RETROV, V27, P579, DOI 10.1089/AID.2010.0263; Ades AE, 2000, BRIT MED J, V320, P1497, DOI 10.1136/bmj.320.7248.1497; Araujo A, 2004, ANN NEUROL, V56, P10, DOI 10.1002/ana.20126; Bangham CRM, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.12; Biswas HH, 2009, NEUROLOGY, V73, P781, DOI 10.1212/WNL.0b013e3181b6bba9; Biswas HH, 2010, JAIDS-J ACQ IMM DEF, V54, P290, DOI 10.1097/QAI.0b013e3181cc5481; Boa-Sorte N, 2014, BRAZ J INFECT DIS, V18, P618, DOI 10.1016/j.bjid.2014.05.009; Calattini S, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-30; Calattini S, 2011, VIROLOGY, V410, P48, DOI 10.1016/j.virol.2010.10.025; Das PC, 1996, TRANSFUSION MED, V6, P319, DOI 10.1111/j.1365-3148.1996.tb00090.x; de Castro AC, 2008, REV INST MED TROP SP, V50, P151, DOI 10.1590/S0036-46652008000300004; de la Fuente L, 2006, J CLIN VIROL, V35, P244, DOI 10.1016/j.jcv.2005.06.006; Egan JF, 1999, AIDS RES HUM RETROV, V15, P699, DOI 10.1089/088922299310782; Gessain A, 2015, GEOGRAPHICAL DISTRIB; Gessain A, 2013, VIROLOGY, V435, P187, DOI 10.1016/j.virol.2012.09.035; Gessain A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00388; Hall WW, 1996, J ACQ IMMUN DEF SYND, V13, pS204, DOI 10.1097/00042560-199600001-00031; Hino S, 2011, P JPN ACAD B-PHYS, V87, P152, DOI 10.2183/pjab.87.152; HTLV-I and HTLV-II SEROPREVALENCE IN EUROPE, 1994, JAIDS-J ACQ IMM DEF, V20, pA53; Jogeda EL, 2016, INFECT GENET EVOL, V43, P83, DOI 10.1016/j.meegid.2016.05.022; KALYANARAMAN VS, 1982, SCIENCE, V218, P571, DOI 10.1126/science.6981847; KAPLAN JE, 1990, J ACQ IMMUN DEF SYND, V3, P1096; Laperche S, 2009, VOX SANG, V96, P104, DOI 10.1111/j.1423-0410.2008.01136.x; LINDHARDT BO, 1987, J VIROL METHODS, V18, P73, DOI 10.1016/0166-0934(87)90112-1; Mahieux R, 2011, VIRUSES-BASEL, V3, P1074, DOI 10.3390/v3071074; Malm K, 2012, SCAND J INFECT DIS, V44, P852, DOI 10.3109/00365548.2012.689847; Martin F, 2014, EXPERT REV CLIN IMMU, V10, P1531, DOI 10.1586/1744666X.2014.966690; Murphy EL, 2004, EMERG INFECT DIS, V10, P109, DOI 10.3201/eid1001.020714; Nubling CM, 2001, VOX SANG, V81, P204; PARKER SP, 1995, J CLIN PATHOL, V48, P904, DOI 10.1136/jcp.48.10.904; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; Ribeiro MA, 2010, REV PANAM SALUD PUBL, V27, P330, DOI 10.1590/S1020-49892010000500002; Richard L, 2016, CLIN INFECT DIS, V63, P800, DOI 10.1093/cid/ciw389; Ross RS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-72; Roucoux DF, 2004, AIDS REV, V6, P144; Salemi M, 1999, GENE, V234, P11, DOI 10.1016/S0378-1119(99)00169-9; SCHATZL H, 1994, J MED VIROL, V43, P159, DOI 10.1002/jmv.1890430211; Silva AF, 2005, AIDS RES HUM RETROV, V21, P249, DOI 10.1089/aid.2005.21.249; Slattery JP, 1999, GENOME RES, V9, P525; Solomon SS, 2004, INT J STD AIDS, V15, P658, DOI 10.1258/0956462041944402; Taylor GP, 2005, JAIDS-J ACQ IMM DEF, V38, P104, DOI 10.1097/00126334-200501010-00018; Taylor MB, 1996, EPIDEMIOL INFECT, V117, P343, DOI 10.1017/S0950268800001527; Turci M, 2006, JAIDS-J ACQ IMM DEF, V41, P100, DOI 10.1097/01.qai.0000179426.04166.12; Vallejo A, 2015, J CLIN VIROL, V64, P72, DOI 10.1016/j.jcv.2015.01.010; Watanabe Toshiki, 1997, Leukemia (Basingstoke), V11, P582; Wenz B, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3545-4; Wolfe ND, 2005, P NATL ACAD SCI USA, V102, P7994, DOI 10.1073/pnas.0501734102; Zimmermann R, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-845	48	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183496	10.1371/journal.pone.0183496	http://dx.doi.org/10.1371/journal.pone.0183496			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829831	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100049
J	Rider, SD; Morgan, MS; Arlian, LG				Rider, S. Dean, Jr.; Morgan, Marjorie S.; Arlian, Larry G.			Allergen homologs in the Euroglyphus maynei draft genome	PLOS ONE			English	Article							HOUSE-DUST MITE; DERMATOPHAGOIDES-FARINAE; CROSS-REACTIVITY; MULTIGENE FAMILY; PREVALENCE; MECHANISMS; EXTRACTS	Euroglyphus maynei is a house dust mite commonly found in homes worldwide and is the source of allergens that sensitize and induce allergic reactions in humans. It is the source of species-specific allergens as well as allergens that are cross-reactive with the allergens from house dust mites Dermatophagoides farinae and D. pteronyssinus, and the ectoparasitic scabies mite Sarcoptes scabiei. The genomics, proteomics and molecular biology of E. maynei and its allergens have not been as extensively investigated as those of D. farinae, D. pteronyssinus, and S. scabiei where natural and recombinant allergens from these species have been characterized. Until now, little was known about the genome of E. maynei and it allergens but this information will be important for producing recombinant allergens for diagnostic and therapeutic purposes and for understanding the allergic response mechanism by immune effector cells that mediate the allergic reaction. We sequenced and assembled the 59 Mb E. maynei genome to aid the identification of homologs for known allergenic proteins. The predicted proteome shared orthologs with D. farinae and S. scabiei, and included proteins with homology to more than 30 different groups of allergens. However, the majority of allergen candidates could not be assigned as clear orthologs to known mite allergens. The genomic sequence data, predicted proteome, and allergen homologs identified from E. maynei provide insight into the relationships among astigmatid mites and their allergens, which should allow for the development of improved diagnostics and immunotherapy.	[Rider, S. Dean, Jr.; Morgan, Marjorie S.; Arlian, Larry G.] Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Arlian, LG (corresponding author), Wright State Univ, Dept Biol Sci, Dayton, OH 45435 USA.	larry.arlian@wright.edu			National Institute of Allergy and Infectious Diseases of the National Institutes of Health [R01AI017252]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research reported in this publication was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health under Award Number R01AI017252. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An S, 2013, MOL CELL PROTEOMICS, V12, P1818, DOI 10.1074/mcp.M112.027136; Arlian Larry G, 2002, Curr Allergy Asthma Rep, V2, P401, DOI 10.1007/s11882-002-0074-2; ARLIAN LG, 1993, J ALLERGY CLIN IMMUN, V91, P1051, DOI 10.1016/0091-6749(93)90219-6; Arlian LG, 2003, IMMUNOL ALLERGY CLIN, V23, P443, DOI 10.1016/S0889-8561(03)00005-5; ARLIAN LG, 1992, J ALLERGY CLIN IMMUN, V90, P292, DOI 10.1016/S0091-6749(05)80006-5; Bergstrom FC, 2009, J IMMUNOL, V182, P7809, DOI 10.4049/jimmunol.0804205; Boetzer M, 2011, BIOINFORMATICS, V27, P578, DOI 10.1093/bioinformatics/btq683; Boquete M, 2006, J INVEST ALLERG CLIN, V16, P169; Chan TF, 2015, J ALLERGY CLIN IMMUN, V135, P539, DOI 10.1016/j.jaci.2014.09.031; Chen Nansheng, 2004, Curr Protoc Bioinformatics, VChapter 4, DOI 10.1002/0471250953.bi0410s05; Chikhi R, 2014, BIOINFORMATICS, V30, P31, DOI 10.1093/bioinformatics/btt310; Chikhi R, 2013, ALGORITHM MOL BIOL, V8, DOI 10.1186/1748-7188-8-22; Colloff MJ, 2009, DUST MITES, P1; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Fischer K, 2009, J MOL BIOL, V390, P635, DOI 10.1016/j.jmb.2009.04.082; Garcia-Robaina JC, 1998, J INVEST ALLERG CLIN, V8, P285; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grbic M, 2011, NATURE, V479, P487, DOI 10.1038/nature10640; HILL MR, 1993, CLIN EXP ALLERGY, V23, P110, DOI 10.1111/j.1365-2222.1993.tb00305.x; Holt DC, 2004, J INVEST DERMATOL, V123, P240, DOI 10.1111/j.0022-202X.2004.22716.x; Holt DC, 2003, J INVEST DERMATOL, V121, P1419, DOI 10.1046/j.1523-1747.2003.12621.x; Hoy MA, 2016, GENOME BIOL EVOL, V8, P1762, DOI 10.1093/gbe/evw048; Jeyaprakash A, 2009, EXP APPL ACAROL, V47, P263, DOI 10.1007/s10493-008-9227-x; Kemp SF, 1997, CLIN EXP ALLERGY, V27, P893, DOI 10.1111/j.1365-2222.1997.tb01229.x; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liang Z, 2014, CLONING EXPRES UNPUB; Morgan MS, 2015, INT ARCH ALLERGY IMM, V166, P267, DOI 10.1159/000381854; Morgan MS, 1996, ANN ALLERG ASTHMA IM, V77, P386, DOI 10.1016/S1081-1206(10)63337-6; MUMCUOGLU Y, 1977, ACTA ALLERGOL, V32, P333; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Rider SD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1198-2; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Stanke M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-62; Stanke M., 2011, ORTHOPARAHOMLIST PL; STEWART GA, 1992, EXP APPL ACAROL, V16, P165, DOI 10.1007/BF01201499; Tategaki A, 2000, ACI INTER S, V1, P74; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Thomas WR, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0649-y; Thomas WR, 2015, ALLERGOL INT, V64, P304, DOI 10.1016/j.alit.2015.05.004; Van Zee JP, 2007, INT J PARASITOL, V37, P1297, DOI 10.1016/j.ijpara.2007.05.011; VANHAGEHAMSTEN M, 1989, J ALLERGY CLIN IMMUN, V83, P581, DOI 10.1016/0091-6749(89)90069-9; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3	44	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183535	10.1371/journal.pone.0183535	http://dx.doi.org/10.1371/journal.pone.0183535			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829832	gold, Green Published, Green Submitted			2022-12-27	WOS:000408085100055
J	Berggren, O; Hagberg, N; Alexsson, A; Weber, G; Ronnblom, L; Eloranta, ML				Berggren, Olof; Hagberg, Niklas; Alexsson, Andrei; Weber, Gert; Ronnblom, Lars; Eloranta, Maija-Leena			Plasmacytoid dendritic cells and RNA-containing immune complexes drive expansion of peripheral B cell subsets with an SLE-like phenotype	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTERFERON; ACTIVATION; EXPRESSION; AUTOIMMUNITY; SECRETION; ENHANCE; CD27	Background Hyperactive B cells and a continuous interferon (IFN)-alpha production by plasmacytoid dendritic cells (pDCs) play a key role in systemic lupus erythematosus (SLE). We asked whether the interaction between B cells and pDCs stimulated with RNA-containing immune complexes affects peripheral B cell subsets. Methods B cells and pDCs were isolated from blood of healthy individuals and stimulated with immune complexes consisting of SLE-IgG and U1snRNP (RNA-IC). Expression of cell surface molecules as well as IL-6 and IL-10 production were determined by flow cytometry and immunoassays. Gene expression profiles were determined by a NanoString nCounter expression array. Results We found a remarkable increase of double negative CD27-IgD-B cells, from 7% within fresh CD19+B cells to 37% in the RNA-IC-stimulated co-cultures of B cells and pDCs, comparable to the frequency of double negative B cells in SLE patients. Gene expression analysis of the double negative CD27-IgD -and the CD27 + IgD-memory B cells revealed that twenty-one genes were differentially expressed between the two B cell subsets (>= 2-fold, p< 0.001). The, IL21R, IL4R, CCL4, CCL3, CD83 and the IKAROS Family Zinc Finger 2 (IKZ2) showed higher expression in the double negative CD27-IgD-B cells. Conclusion The interactions between B cells and pDCs together with RNA-containing IC led to an expansion of B cells with similar phenotype as seen in SLE, suggesting that the pDC-B cell crosstalk contributes to the autoimmune feed-forward loop in SLE.	[Berggren, Olof; Hagberg, Niklas; Alexsson, Andrei; Ronnblom, Lars; Eloranta, Maija-Leena] Uppsala Univ, Dept Med Sci, Sci Life Lab, Rheumatol, Uppsala, Sweden; [Weber, Gert] Ernst Moritz Arndt Univ Greifswald, Inst Biochem, Dept Mol Struct Biol, Greifswald, Germany	Uppsala University; Ernst Moritz Arndt Universitat Greifswald	Eloranta, ML (corresponding author), Uppsala Univ, Dept Med Sci, Sci Life Lab, Rheumatol, Uppsala, Sweden.	maija-leena.eloranta@medsci.uu.se	Weber, Gert/I-1800-2013; Eloranta, Maija-Leena/A-8775-2016	Weber, Gert/0000-0003-3624-1060; Eloranta, Maija-Leena/0000-0002-8454-1351	Swedish Rheumatism Association [R-569291, R-653711]; King Gustaf V's 80-years Foundation [FAI-2015-0140]; Agnes och Mac Rudbergs Stiftelse; Swedish Research Council [521-2013-2830]	Swedish Rheumatism Association; King Gustaf V's 80-years Foundation; Agnes och Mac Rudbergs Stiftelse; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was supported by The Swedish Rheumatism Association (https://www.reumatikerforbundet.org), R-569291 (MLE), R-653711 (LR); King Gustaf V's 80-years Foundation, FAI-2015-0140 (MLE) (LR); Agnes och Mac Rudbergs Stiftelse (OB); and The Swedish Research Council 521-2013-2830 (LR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour A, 2016, J ALLERGY CLIN IMMUN; Anolik JH, 2013, LUPUS, V22, P342, DOI 10.1177/0961203312471576; Anolik JH, 2004, ARTHRITIS RHEUM-US, V50, P3580, DOI 10.1002/art.20592; Berggren O, 2012, ARTHRITIS RHEUM-US, V64, P3409, DOI 10.1002/art.34599; Blair PA, 2010, IMMUNITY, V32, P129, DOI 10.1016/j.immuni.2009.11.009; Cederblad B, 1998, J AUTOIMMUN, V11, P465, DOI 10.1006/jaut.1998.0215; CEDERBLAD B, 1991, SCAND J IMMUNOL, V34, P549, DOI 10.1111/j.1365-3083.1991.tb01578.x; Dorner T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3433; Dorner T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2780; Eloranta ML, 2016, J MOL MED, V94, P1103, DOI 10.1007/s00109-016-1421-4; Fitzgerald-Bocarsly P, 2008, CYTOKINE GROWTH F R, V19, P3, DOI 10.1016/j.cytogfr.2007.10.006; Gao N, 2014, ARTHRITIS RHEUMATOL, V66, P2849, DOI 10.1002/art.38742; Georg P, 2012, AUTOIMMUNITY, V45, P579, DOI 10.3109/08916934.2012.719955; Grouard G, 1997, J EXP MED, V185, P1101, DOI 10.1084/jem.185.6.1101; Iwata S, 2016, LUPUS, V25, P850, DOI 10.1177/0961203316643172; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Jego G, 2003, IMMUNITY, V19, P225, DOI 10.1016/S1074-7613(03)00208-5; Kim SJ, 2011, J EXP MED, V208, P2193, DOI 10.1084/jem.20110658; Krzyzak L, 2016, J IMMUNOL, V196, P3581, DOI 10.4049/jimmunol.1502163; Litinskiy MB, 2002, NAT IMMUNOL, V3, P822, DOI 10.1038/ni829; Liu BS, 2014, EUR J IMMUNOL, V44, P2121, DOI 10.1002/eji.201344341; Mauri C, 2010, NAT REV RHEUMATOL, V6, P636, DOI 10.1038/nrrheum.2010.140; Menon M, 2016, IMMUNITY, V44, P683, DOI 10.1016/j.immuni.2016.02.012; Nakou M, 2013, CLIN EXP RHEUMATOL, V31, P172; Richardson C, 2013, J IMMUNOL, V191, P4926, DOI 10.4049/jimmunol.1202263; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Sanz I, 2008, SEMIN IMMUNOL, V20, P67, DOI 10.1016/j.smim.2007.12.006; Sanz I, 2014, SEMIN IMMUNOPATHOL, V36, P365, DOI 10.1007/s00281-014-0430-z; Sawaf M, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/5767106; Silva R, 2011, BLOOD, V117, P5870, DOI 10.1182/blood-2010-09-310318; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tsokos GC, 2016, NAT REV RHEUMATOL, V12, P716, DOI 10.1038/nrrheum.2016.186; Weber G, 2010, EMBO J, V29, P4172, DOI 10.1038/emboj.2010.295; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624	34	14	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183946	10.1371/journal.pone.0183946	http://dx.doi.org/10.1371/journal.pone.0183946			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846748	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600061
J	Chang, JY; Yu, J; Chung, BH; Yang, J; Kim, SJ; Kim, CD; Lee, SH; Lee, JS; Kim, JK; Jung, CW; Oh, CK; Yang, CW				Chang, Ji-Yeun; Yu, Jihyun; Chung, Byung Ha; Yang, Jaeseok; Kim, Sung-Joo; Kim, Chan-Duck; Lee, Sang-Ho; Lee, Jong Soo; Kim, Joong Kyung; Jung, Cheol Woong; Oh, Chang Kwon; Yang, Chul Woo			Immunosuppressant prescription pattern and trend in kidney transplantation: A multicenter study in Korea	PLOS ONE			English	Article							COATED MYCOPHENOLATE SODIUM; RENAL-TRANSPLANTATION; MOFETIL; RECIPIENTS; TACROLIMUS; EFFICACY; SYMPHONY; THERAPY; SAFETY	Background The actual prescription pattern of immunosuppressive agents in kidney transplantation is unclear. Methods We investigated the pattern and trend of immunosuppressive treatment for kidney transplant patients in South Korea. A total of 636 patients at nine transplant centers were enrolled and followed for one year. We reviewed medical records and evaluated induction therapy, as well as the changing pattern and cause of maintenance therapy. Results Most patients (n = 621, 97.6%) received induction therapy often comprising basiliximab (n = 542, 85.2%). The triple therapy including calcineurin inhibitor, mycophenolic acid, and steroids was the major initial maintenance immunosuppression (n = 518, 81.4%), but its proportion decreased by 14% (81.4% to 67.5%) after 1 year. Almost 40% of patients changed immunosuppressive regimen during the 1-year follow-up, most often at an early period (60.2% within the first 4 months). The primary reason for the change was gastrointestinal discomfort (n = 113, 29.8%), followed by infection (112, 29.6%). The most common changing pattern was mycophenolic acid withdrawal (n = 155, 39.1%). Conclusion The initial immunosuppressive regimen is prone to change within the first year of kidney transplantation. Further studies are needed to evaluate the benefits and risks in patients who changed immunosuppressants.	[Chang, Ji-Yeun; Yu, Jihyun; Chung, Byung Ha; Yang, Chul Woo] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea; [Yang, Jaeseok] Seoul Natl Univ Hosp, Transplantat Ctr, Seoul, South Korea; [Kim, Sung-Joo] Sungkyunkwan Univ, Samsung Med Ctr, Sch Med, Dept Surg, Seoul, South Korea; [Kim, Chan-Duck] Kyungpook Natl Univ Hosp, Dept Internal Med, Div Nephrol, Daegu, South Korea; [Lee, Sang-Ho] Kyung Hee Univ Hosp Gangdong, Dept Internal Med, Div Nephrol, Seoul, South Korea; [Lee, Jong Soo] Ulsan Univ Hosp, Dept Internal Med, Div Nephrol, Ulsan, South Korea; [Kim, Joong Kyung] Bong Seng Mem Hosp, Dept Internal Med, Div Nephrol, Busan, South Korea; [Jung, Cheol Woong] Korea Univ, Anam Hosp, Dept Surg, Seoul, South Korea; [Oh, Chang Kwon] Ajou Univ Hosp, Dept Surg, Suwon, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Seoul National University (SNU); Seoul National University Hospital; Sungkyunkwan University (SKKU); Samsung Medical Center; Kyungpook National University; Kyungpook National University Hospital; Kyung Hee University; Kyung Hee University Hospital; University of Ulsan; Ulsan University Hospital; Korea University; Korea University Medicine (KU Medicine); Ajou University; Ajou University Hospital	Yang, CW (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Dept Internal Med,Div Nephrol, Seoul, South Korea.	yangch@catholic.ac.kr	/W-5371-2019	JUNG, CHEOL WOONG/0000-0002-0776-8202; Yang, Jeaseok/0000-0002-5378-7797	Novartis Korea, Ltd.	Novartis Korea, Ltd.	I confirm that this study was funded by Novartis Korea, Ltd. and protocol number was CERL080AKR10 (https//www.novartis.co.kr/). The authors who received the funding were JY, SJK, CDK, SHL, JSL, JKK, CWJ, CKO, CWY. The funder had a role of proposing a multicenter research and making 9 centers participate in the study. The funder did not serve onrelevant legal proceedings. And the funder did not sit on a committee for an organization benefit from publication of the paper. the editorial board of the journal and did not act as an expert witness in relevant legal proceedings. And the funder did not sit on a committee for an organization benefit from publication of the paper.	Ali AA, 2016, SAUDI J KIDNEY DIS T, V27, P341, DOI 10.4103/1319-2442.178559; Axelrod DA, 2016, AM J TRANSPLANT, V16, P2453, DOI 10.1111/ajt.13758; Budde K, 2004, AM J TRANSPLANT, V4, P237, DOI 10.1046/j.1600-6143.2003.00321.x; Cho EK, 2004, J CLIN PHARMACOL, V44, P743, DOI 10.1177/0091270004266634; Ekberg H, 2009, AM J TRANSPLANT, V9, P1876, DOI 10.1111/j.1600-6143.2009.02726.x; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Grinyo JM, 2009, NEPHROL DIAL TRANSPL, V24, P2269, DOI 10.1093/ndt/gfp162; Hart A, 2016, AM J TRANSPLANT, V16, P11, DOI 10.1111/ajt.13666; Hwang HS, 2010, J KOREAN MED SCI, V25, P1759, DOI 10.3346/jkms.2010.25.12.1759; Kasiske BL, 2010, KIDNEY INT, V77, P299, DOI 10.1038/ki.2009.377; Lamb KE, 2011, AM J TRANSPLANT, V11, P450, DOI 10.1111/j.1600-6143.2010.03283.x; Li PM, 2014, TRANSPL INT, V27, P994, DOI 10.1111/tri.12382; Ponticelli C, 2011, TRANSPL P, V43, P2439, DOI 10.1016/j.transproceed.2011.06.025; Saemann MD, 2008, TRANSPL IMMUNOL, V20, P14, DOI 10.1016/j.trim.2008.08.012; Salvadori M, 2004, AM J TRANSPLANT, V4, P231, DOI 10.1046/j.1600-6143.2003.00337.x; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; Suhail SM, 2000, TRANSPLANT P, V32, P1757, DOI 10.1016/S0041-1345(00)01388-9; Tsang WK, 2000, TRANSPLANT P, V32, P1755, DOI 10.1016/S0041-1345(00)01389-0; Webster AC, 2004, TRANSPLANTATION, V77, P166, DOI 10.1097/01.TP.0000109643.32659.C4	19	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183826	10.1371/journal.pone.0183826	http://dx.doi.org/10.1371/journal.pone.0183826			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846737	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600052
J	Kaushik, J; Tandon, S; Gupta, V; Nayyar, J; Singla, SK; Tandon, C				Kaushik, Jyoti; Tandon, Simran; Gupta, Varun; Nayyar, Jasamrit; Singla, Surinder Kumar; Tandon, Chanderdeep			Response surface methodology based extraction of Tribulus terrestris leads to an upsurge of antilithiatic potential by inhibition of calcium oxalate crystallization processes	PLOS ONE			English	Article							DIHYDRATE CRYSTALS; CELLS; MONOHYDRATE; OPTIMIZATION; PROTEIN	Tribulus terrestris has significant antilithiatic efficacy established via both in vitro as well as in vivo studies and is used in numerous anti-urolithiatic herbal formulations viz. Cystone, Uri-flow, Uritone and Neeri. However, to fully utilize its antilithiatic potential, the influence of different extraction parameters on antilithiatic ability of T. terrestris aqueous extract needs elucidation. Thus, the current study was undertaken using statistically optimized extraction conditions for aqueous extract preparation. Response surface methodology was employed to observe the influence of three variables i.e. temperature (degrees C), time (h) and solid: liquid ratio (S: L) on the extraction yield (%) and protein content (mg/g) of T. terrestris aqueous extract. RSM results revealed that the high S: L ratio, low temperature and reduced incubation time were optimal conditions for aqueous extraction. Under such extraction conditions the protein content reached the value of 26.6 +/- 1.22 mg/g and the obtained extraction yield was 27.32 +/- 1.62%. The assessment of antilithiatic activity of 4 selected extracts (AE1-4), revealed enhanced nucleation and aggregation inhibition of calcium oxalate crystals with AE1 and AE2, which in addition significantly altered the size and morphology of calcium oxalate monohydrate (COM) crystals compared to AE3 and AE4. In vitro cell culture based studies on renal epithelial cells (MDCK, NRK-52E and PK 15) proved that the AE1 showed higher cytoprotective potency by increasing cell viability as compared to the oxalate treated group. The free radical scavenging activity of aqueous extract lowered the reactive oxygen specie's induced damage and potentially reduced the signals of programmed cell death due to oxalate injury. In addition, modulation of the COM crystal morphology was enhanced by AE1 as compared to AE2. The FTIR and GC-MS analysis of AE1, showed the presence of biomolecules which could aid in the attenuation of lithiatic process. In the light of these results the utility of the RSM approach to fully optimize the antilithiatic potential of T. terrestris cannot be undermined.	[Kaushik, Jyoti; Tandon, Chanderdeep] Amity Univ, Amity Inst Biotechnol, Noida, India; [Tandon, Simran] Amity Univ, Amity Inst Mol Med & Stem Cell Res, Noida, India; [Gupta, Varun] Jaypee Univ Informat Technol, Dept Biotechnol & Bioinformat, Solan, Himachal Prades, India; [Nayyar, Jasamrit] SD Coll, Dept Chem, Chandigarh, India; [Singla, Surinder Kumar] Panjab Univ, Dept Biochem, Chandigarh, India	Amity University Noida; Amity University Noida; Jaypee University of Information Technology; Goswami Ganesh Dutta S. D. College; Panjab University	Tandon, C (corresponding author), Amity Univ, Amity Inst Biotechnol, Noida, India.	ctandon@amity.edu	Tandon, Chanderdeep/AAF-1124-2020; TANDON, simran/AAF-1158-2020; Kaur, Jasamrit/AAI-1966-2020; Kumar, Varun/AAC-9780-2020	Tandon, Chanderdeep/0000-0003-3720-0455; Kaur, Jasamrit/0000-0002-6068-1245; Tandon, Simran/0000-0002-6937-0216	Department of Biotechnology (DBT) [BT/PR7290/PBD/17/853/2013]; Ministry of Science and Technology, Govt. of India	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Ministry of Science and Technology, Govt. of India	This work was funded by Department of Biotechnology (DBT), Project No. BT/PR7290/PBD/17/853/2013, Ministry of Science and Technology, Govt. of India.; This work was financially supported by the Department of Biotechnology (DBT), Project No. BT/PR7290/PBD/17/853/2013, Ministry of Science and Technology, Govt. of India and carried out at Amity University, Noida, India.	Aggarwal A, 2014, INDIAN J EXP BIOL, V52, P103; Aggarwal A, 2012, PROTEIN PEPTIDE LETT, V19, P812, DOI 10.2174/092986612801619552; Aparna V, 2012, CHEM BIOL DRUG DES, V80, P434, DOI 10.1111/j.1747-0285.2012.01418.x; Barros ME, 2003, UROL RES, V30, P374, DOI 10.1007/s00240-002-0285-y; Bashir S, 2009, J ETHNOPHARMACOL, V122, P106, DOI 10.1016/j.jep.2008.12.004; Basvaraj DR, 2007, EUR ASS UROL, V5, P126; Bele A.A., 2011, IRJP, V2, P56; Box G.E.P., 2005, STAT EXPT; BOX GEP, 1951, J R STAT SOC B, V13, P1, DOI 10.1111/j.2517-6161.1951.tb00067.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Citalingam K, 2015, MOLECULES, V20, P3406, DOI 10.3390/molecules20023406; Coe FL, 2005, J CLIN INVEST, V115, P2598, DOI 10.1172/JCI26662; Conrad J, 2004, FITOTERAPIA, V75, P117, DOI 10.1016/j.fitote.2003.09.001; Indu S., 2014, EUR J BIOT BIOS, V2, P38; Jambrak AR, 2011, J FOOD PROCESSING TE, V2, P2, DOI [10.4172/2157-7110.1000102e, DOI 10.4172/2157-7110.1000102E]; Joshi VS, 2005, J CRYST GROWTH, V275, pE1403, DOI 10.1016/j.jcrysgro.2004.11.240; Khan S., 2000, EFFECTS EXTRACT HERN, P621; Khan Saeed R, 2004, Clin Exp Nephrol, V8, P75; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Kim JH, 2014, PHARMACOGN MAG, V10, P606, DOI 10.4103/0973-1296.139798; Koganti B, 2008, EVALUATION SESBANIA, P300; Kumari V, 2016, 3 BIOTECH, V6, DOI 10.1007/s13205-016-0460-4; Lieske JC, 1996, CALCIFIED TISSUE INT, V58, P195, DOI 10.1007/BF02526887; Lieske JC, 1998, KIDNEY INT, V54, P796, DOI 10.1046/j.1523-1755.1998.00058.x; Liyana-Pathirana CM, 2005, J AGR FOOD CHEM, V53, P2433, DOI 10.1021/jf049320i; Mitra N., 2012, International Journal of Modern Botany, V2, P35, DOI 10.5923/j.ijmb.20120203.01; Mittal A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162600; Nessa F, 2015, EUROPEAN J MED PLANT, V9, P1; Pachana K, 2010, SCIENCEASIA, V36, P165, DOI 10.2306/scienceasia1513-1874.2010.36.165; Prasad K., 2007, PHCOG REV, V1, P175; Price R., 1985, PHYSL PLANT PATHOL, V27, P255, DOI DOI 10.1016/0048-4059(85)90073-6; Raja M., 2011, Der Pharmacia Sinica, V2, P136; Schepers MSJ, 2003, KIDNEY INT, V64, P493, DOI 10.1046/j.1523-1755.2003.00107.x; Sharma D, 2016, EGYPT J BASIC APPL S, P1; Shi H, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-83; Sun XY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.359; Usman H., 2007, RES J BIOSCI, V2, P244; Wang TT, 2010, BJU INT, V106, P1768, DOI 10.1111/j.1464-410X.2010.09258.x; WHO, 2002, ANC REM NEW DIS; Wiessner JH, 2001, KIDNEY INT, V59, P637, DOI 10.1046/j.1523-1755.2001.059002637.x; World Health Organisation (WHO), 2002, MON SEL MED PLANTS; Wu TS, 1999, PHYTOCHEMISTRY, V50, P1411, DOI 10.1016/S0031-9422(97)01086-8; Zhang CY, 2012, MAR DRUGS, V10, P119, DOI 10.3390/md10010119	43	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183218	10.1371/journal.pone.0183218	http://dx.doi.org/10.1371/journal.pone.0183218			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846699	gold, Green Submitted, Green Published			2022-12-27	WOS:000408438600023
J	Wahid, A; Khan, DM; Hussain, I				Wahid, Abdul; Khan, Dost Muhammad; Hussain, Ijaz			Robust Adaptive Lasso method for parameter's estimation and variable selection in high-dimensional sparse models	PLOS ONE			English	Article							LIKELIHOOD; REGRESSION; SHRINKAGE; FACE	High dimensional data are commonly encountered in various scientific fields and pose great challenges to modern statistical analysis. To address this issue different penalized regression procedures have been introduced in the litrature, but these methods cannot cope with the problem of outliers and leverage points in the heavy tailed high dimensional data. For this purppose, a new Robust Adaptive Lasso (RAL) method is proposed which is based on pearson residuals weighting scheme. The weight function determines the compatibility of each observations and downweight it if they are inconsistent with the assumed model. It is observed that RAL estimator can correctly select the covariates with non-zero coefficients and can estimate parameters, simultaneously, not only in the presence of influential observations, but also in the presence of high multicolliearity. We also discuss the model selection oracle property and the asymptotic normality of the RAL. Simulations findings and real data examples also demonstrate the better performance of the proposed penalized regression approach.	[Wahid, Abdul; Khan, Dost Muhammad] Abdul Wali Khan Univ Mardan, Dept Stat, Khyber Pakhtunkhwa, Pakistan; [Hussain, Ijaz] Quiad I Azam Univ Islamabad, Dept Stat, Islamabad, Pakistan		Khan, DM (corresponding author), Abdul Wali Khan Univ Mardan, Dept Stat, Khyber Pakhtunkhwa, Pakistan.	dostmuhammad@awkum.edu.pk	Hussain, Ijaz/AAN-5885-2020; Khan, Dost Muhammad/AAA-7465-2020	Hussain, Ijaz/0000-0002-1586-1503; Khan, Dost Muhammad/0000-0002-3919-8136; Wahid, Ph.D., Abdul/0000-0001-6624-1825				Agostinelli C, 1998, STAT PROBABIL LETT, V37, P341, DOI 10.1016/S0167-7152(97)00136-3; BASU A, 1994, J STAT COMPUT SIM, V50, P173, DOI 10.1080/00949659408811609; BASU A, 1994, STAT PROBABIL LETT, V20, P69, DOI 10.1016/0167-7152(94)90236-4; Belloni A, 2011, ANN STAT, V39, P82, DOI 10.1214/10-AOS827; Biswas A, 2015, STAT, V4, P97, DOI 10.1002/sta4.80; Bradic J, 2011, J R STAT SOC B, V73, P325, DOI 10.1111/j.1467-9868.2010.00764.x; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Fan J., 2014, ARXIV PREPRINT, P1410; Fan JQ, 2010, STAT SINICA, V20, P101; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Friedman J., 2001, SPRINGER SERIES STAT, V1; Fu WJJ, 1998, J COMPUT GRAPH STAT, V7, P397, DOI 10.2307/1390712; Gui J., 2008, BIOMETRICS IJCB 2014, P1; Gui J, 2017, IEEE T NEUR NET LEAR, V28, P1490, DOI 10.1109/TNNLS.2016.2551724; Gui J, 2016, IEEE T CYBERNETICS, V46, P1877, DOI 10.1109/TCYB.2015.2457234; Li YJ, 2008, J COMPUT GRAPH STAT, V17, P163, DOI 10.1198/106186008X289155; Lu CY, 2013, J VIS COMMUN IMAGE R, V24, P111, DOI 10.1016/j.jvcir.2012.05.003; Markatou M, 1998, J AM STAT ASSOC, V93, P740, DOI 10.2307/2670124; McCullagh P., 1989, GENERALIZED LINEAR M, DOI DOI 10.1007/978-1-4899-3242-6; Mi JX, 2013, OPTIK, V124, P6786, DOI 10.1016/j.ijleo.2013.05.099; STAMEY TA, 1989, J UROLOGY, V141, P1076, DOI 10.1016/S0022-5347(17)41175-X; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tutz G, 2009, STAT COMPUT, V19, P239, DOI 10.1007/s11222-008-9088-5; Wang FL, 2012, ADV STRUCT ENG, V15, P693, DOI 10.1260/1369-4332.15.5.693; Wang HS, 2007, J BUS ECON STAT, V25, P347, DOI 10.1198/073500106000000251; Wang HS, 2009, J R STAT SOC B, V71, P671, DOI 10.1111/j.1467-9868.2008.00693.x; Wu YC, 2009, STAT SINICA, V19, P801; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x; Zou H, 2008, ANN STAT, V36, P1108, DOI 10.1214/07-AOS507; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735	32	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183518	10.1371/journal.pone.0183518	http://dx.doi.org/10.1371/journal.pone.0183518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846717	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600031
J	Stefic, K; Chaillon, A; Bouvin-Pley, M; Moreau, A; Braibant, M; Bastides, F; Gras, G; Bernard, L; Barin, F				Stefic, Karl; Chaillon, Antoine; Bouvin-Pley, Melanie; Moreau, Alain; Braibant, Martine; Bastides, Frederic; Gras, Guillaume; Bernard, Louis; Barin, Francis			Probing the compartmentalization of HIV-1 in the central nervous system through its neutralization properties	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CEREBROSPINAL-FLUID; ENV COMPARTMENTALIZATION; GENE FLOW; INFECTION; BRAIN; EVOLUTION; GLYCOPROTEINS; ANTIBODIES; ENVELOPES	Compartmentalization of HIV-1 has been observed in the cerebrospinal fluid (CSF) of patients at different clinical stages. Considering the low permeability of the blood-brain barrier, we wondered if a reduced selective pressure by neutralizing antibodies (NAb) in the central nervous system (CNS) could favor the evolution of NAb-sensitive viruses in this compartment. Single genome amplification (SGA) was used to sequence full-length HIV-1 envelope variants (453 sequences) from paired CSF and blood plasma samples in 9 subjects infected by HIV variants of various clades and suffering from diverse neurologic disorders. Dynamics of viral evolution were evaluated with a bayesian coalescent approach for individuals with longitudinal samples. Pseudotyped viruses expressing envelope glycoproteins variants representative of the quasi-species present in each compartment were generated, and their sensitivity to autologous neutralization, broadly neutralizing antibodies (bNAbs) and entry inhibitors was assessed. Significant compartmentalization of HIV populations between blood and CSF were detected in 5 out of 9 subjects. Some of the previously described genetic determinants for compartmentalization in the CNS were observed regardless of the HIV-1 clade. There was no difference of sensitivity to autologous neutralization between blood-and CSF-variants, even for subjects with compartmentalization, suggesting that selective pressure by autologous NAb is not the main driver of HIV evolution in the CNS. However, we observed major differences of sensitivity to sCD4 or to at least one bNAb targeting either the N160-V1V2 site, the N332-V3 site or the CD4bs, between bloodand CSF-variants in all cases. In particular, HIV-1 variants present in the CSF were more resistant to bNAbs than their blood counterpart in some cases. Considering the possible migration from CSF to blood, the CNS could be a reservoir of bNAb resistant viruses, an observation that should be considered for immunotherapeutic approaches.	[Stefic, Karl; Bouvin-Pley, Melanie; Moreau, Alain; Braibant, Martine; Barin, Francis] Univ Tours, Inserm U966, Tours, France; [Stefic, Karl; Barin, Francis] CHU Bretonneau, Lab Bacteriol Virol, Tours, France; [Chaillon, Antoine] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bastides, Frederic; Gras, Guillaume; Bernard, Louis] CHU Bretonneau, Med Interne & Malad Infect, Tours, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; University of California System; University of California San Diego; CHU Tours	Barin, F (corresponding author), Univ Tours, Inserm U966, Tours, France.; Barin, F (corresponding author), CHU Bretonneau, Lab Bacteriol Virol, Tours, France.	francis.barin@univ-tours.fr	chaillon, antoine/GNH-1623-2022; Stefic, Karl/C-5052-2019; Chaillon, Antoine/GNH-6121-2022	Stefic, Karl/0000-0002-9686-9194; 	Inserm; Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, France	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, France	This work was supported by Inserm and Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche, France. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrildt KT, 2015, J VIROL, V89, P11294, DOI 10.1128/JVI.00946-15; Bar KJ, 2016, NEW ENGL J MED, V375, P2037, DOI 10.1056/NEJMoa1608243; Bednar MM, 2015, CURR HIV-AIDS REP, V12, P262, DOI 10.1007/s11904-015-0265-9; Blackard JT, 2012, CURR HIV RES, V10, P133, DOI 10.2174/157016212799937245; Bouvin-Pley M, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003477; Burton DR, 2015, NAT IMMUNOL, V16, P571, DOI 10.1038/ni.3158; Caskey M, 2017, NAT MED; Chaillon A, 2014, J INFECT DIS, V209, P1642, DOI 10.1093/infdis/jit678; CONNOR RI, 1995, VIROLOGY, V206, P935, DOI 10.1006/viro.1995.1016; Dahm T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8562805; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dunfee RL, 2006, P NATL ACAD SCI USA, V103, P15160, DOI 10.1073/pnas.0605513103; Evering TH, 2014, RETROVIROLOGY, V11, DOI 10.1186/s12977-014-0065-0; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Hudson RR, 2000, GENETICS, V155, P2011; HUDSON RR, 1992, GENETICS, V132, P583; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Klein F, 2013, SCIENCE, V341, P1199, DOI 10.1126/science.1241144; KORBER B, 1992, AIDS RES HUM RETROV, V8, P1549, DOI 10.1089/aid.1992.8.1549; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2013, NAT REV IMMUNOL, V13, P693, DOI 10.1038/nri3516; Lamers SL, 2010, J NEUROVIROL, V16, P230, DOI 10.3109/13550281003735709; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Lynch RM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad5752; Montefiori David C., 2009, V485, P395, DOI 10.1007/978-1-59745-170-3_26; Montefiori DC., 2005, CURR PROTOC IMMUNOL, VChapter 12:12.11.11-12.11.15, DOI [10.1002/0471142735.im1211s64, DOI 10.1002/0471142735.IM1211S64]; Ohagen A, 2003, J VIROL, V77, P12336, DOI 10.1128/JVI.77.22.12336-12345.2003; Oliveira MF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006112; Penn O, 2010, NUCLEIC ACIDS RES, V38, pW23, DOI 10.1093/nar/gkq443; Pilcher CD, 2001, AIDS, V15, P837, DOI 10.1097/00002030-200105040-00004; Pillai SK, 2006, BRAIN, V129, P1872, DOI 10.1093/brain/awl136; Pineda-Pena AC, 2013, INFECT GENET EVOL, V19, P337, DOI 10.1016/j.meegid.2013.04.032; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; POWER C, 1994, J VIROL, V68, P4643, DOI 10.1128/JVI.68.7.4643-4649.1994; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Ritola K, 2005, J VIROL, V79, P10830, DOI 10.1128/JVI.79.16.10830-10834.2005; Salazar-Gonzalez JF, 2008, J VIROL, V82, P3952, DOI 10.1128/JVI.02660-07; Salemi M, 2016, CURR HIV RES, V14, P110, DOI 10.2174/1570162X13666151029102413; Scheid JF, 2016, NATURE, V535, P556, DOI 10.1038/nature18929; Schnell G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002286; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; SIEPEL AC, 1995, AIDS RES HUM RETROV, V11, P1413, DOI 10.1089/aid.1995.11.1413; Simioni S, 2010, AIDS, V24, P1243, DOI 10.1097/QAD.0b013e3283354a7b; SLATKIN M, 1989, GENETICS, V123, P603; Soulie C, 2015, J ANTIMICROB CHEMOTH, V70, P566, DOI 10.1093/jac/dku419; Spudich SS, 2016, CURR OPIN HIV AIDS, V11, P226, DOI 10.1097/COH.0000000000000243; Stam AJ, 2013, AIDS REV, V15, P152; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Sturdevant CB, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004720; Sturdevant CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003094; Tambussi G, 2000, CLIN INFECT DIS, V30, P962, DOI 10.1086/313810; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Valcour V, 2012, J INFECT DIS, V206, P275, DOI 10.1093/infdis/jis326; Vodicka MA, 1997, VIROLOGY, V233, P193, DOI 10.1006/viro.1997.8606; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Zarate S, 2007, J VIROL, V81, P6643, DOI 10.1128/JVI.02268-06; Zayyad Z, 2015, CURR HIV-AIDS REP, V12, P16, DOI 10.1007/s11904-014-0255-3; Zhang M, 2004, GLYCOBIOLOGY, V14, P1229, DOI 10.1093/glycob/cwh106; Zhou TQ, 2010, SCIENCE, V329, P811, DOI 10.1126/science.1192819	64	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0181680	10.1371/journal.pone.0181680	http://dx.doi.org/10.1371/journal.pone.0181680			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841647	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700004
J	Altet, N; Latorre, I; Jimenez-Fuentes, MA; Maldonado, J; Molina, I; Gonzalez-Diaz, Y; Mila, C; Garcia-Garcia, E; Muriel, B; Villar-Hernandez, R; Laabei, M; Gomez, AC; Godoy, P; de Souza-Galvao, ML; Solano, S; Jimenez-Ruiz, CA; Dominguez, J				Altet, Neus; Latorre, Irene; Aangeles Jimenez-Fuentes, Maria; Maldonado, Jose; Molina, Israel; Gonzalez-Diaz, Yoel; Mila, Celia; Garcia-Garcia, Esther; Muriel, Beatriz; Villar-Hernandez, Raquel; Laabei, Maisem; Gomez, Andromeda-Celeste; Godoy, Pere; Luiza de Souza-Galvao, Maria; Solano, Segismundo; Jimenez-Ruiz, Carlos A.; Dominguez, Jose		PII Smoking SEPAR Working Grp	Assessment of the influence of direct tobacco smoke on infection and active TB management	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; TUBERCULOSIS INFECTION; CIGARETTE-SMOKING; INCREASES RISK; CELL RESPONSE; DIAGNOSIS; ASSOCIATION; CONVERSION; EXPOSURE; ALVEOLAR	Background Smoking is a risk factor for tuberculosis (TB) infection and disease progression. Tobacco smoking increases susceptibility to TB in a variety of ways, one of which is due to a reduction of the IFN-gamma response. Consequently, an impaired immune response could affect performance of IFN-gamma Release Assays (IGRAs). Objective In the present study, we assess the impact of direct tobacco smoking on radiological manifestations, sputum conversion and immune response to Mycobacterium tuberculosis, analyzing IFN-gamma secretion by IGRAs. Methods A total of 525 participants were studied: (i) 175 active pulmonary TB patients and (ii) 350 individuals coming from contact tracing studies, 41 of whom were secondary TB cases. Clinical, radiological and microbiological data were collected. T-SPOT. TB and QFN-G-IT were processed according manufacturer's instructions. Results In smoking patients with active TB, QFN-G-IT (34.4%) and T-SPOT. TB (19.5%) had high frequencies of negative results. In addition, by means of an unconditional logistic regression, smoking was a main factor associated with IGRAs' false-negative results (aOR: 3.35; 95% CI: 1.47-7.61; p<0.05). Smoking patients with active TB presented a high probability of having cavitary lesions (aOR: 1.88; 95% CI: 1.02-3.46; p<0.05). Mean culture negativization (months) +/- standard deviation (SD) was higher in smokers than in non-smokers (2.47 +/- 1.3 versus 1.69 +/- 1.4). Latent TB infection (LTBI) was favored in smoking contacts, being a risk factor associated with infection (aOR: 11.57; 95% CI: 5.97-22.41; p<0.00005). The IFN-gamma response was significantly higher in non-smokers than in smokers. Smoking quantity and IFN-gamma response analyzed by IGRAs were dose-dependent related. Conclusions Smoking had a negative effect on radiological manifestations, delaying time of sputum conversion. Our data establish a link between tobacco smoking and TB due to a weakened IFN-gamma response caused by direct tobacco smoke.	[Altet, Neus; Aangeles Jimenez-Fuentes, Maria; Mila, Celia; Luiza de Souza-Galvao, Maria] Hosp Univ Vall dHebron, Unitat TB Vall dHebron Drassanes, Barcelona, Spain; [Altet, Neus; Maldonado, Jose; Molina, Israel; Gonzalez-Diaz, Yoel] Unitat Clinica Tractament Directament Observat TB, Serv Clin, Barcelona, Spain; [Latorre, Irene; Garcia-Garcia, Esther; Muriel, Beatriz; Villar-Hernandez, Raquel; Laabei, Maisem; Gomez, Andromeda-Celeste; Dominguez, Jose] Univ Autonoma Barcelona, Inst Invest Germans Trias & Pujol, CIBER Enfermedades Resp, Badalona, Spain; [Gomez, Andromeda-Celeste] Inst Biotecnol & Biomed, Barcelona, Spain; [Godoy, Pere] Univ Lleida, Dept Salut, Generalitat Cataluna, CIBER Epidemiol & Salud Publ,IRB Lleida, Lleida, Spain; [Solano, Segismundo] Hosp Univ Gregorio Maranon, Madrid, Spain; [Jimenez-Ruiz, Carlos A.] Unidad Tabaquismo Comunidad Autonoma Madrid, Madrid, Spain	Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Universitat de Lleida; General University Gregorio Maranon Hospital	Dominguez, J (corresponding author), Univ Autonoma Barcelona, Inst Invest Germans Trias & Pujol, CIBER Enfermedades Resp, Badalona, Spain.	jadominguez@igtp.cat	Villar Hernández, Raquel/AFN-3894-2022; Gómez, Andromeda/AAI-8082-2020; Villar-Hernández, Raquel/AGD-6666-2022; Laabei, Maisem/AAH-6383-2021; Latorre, Irene/H-8814-2017	Villar Hernández, Raquel/0000-0002-2249-0579; Gómez, Andromeda/0000-0002-0075-6903; Villar-Hernández, Raquel/0000-0002-2249-0579; Laabei, Maisem/0000-0002-8425-3704; Latorre, Irene/0000-0001-8159-2455; Godoy, Pere/0000-0002-2896-7286; Dominguez, Jose/0000-0001-7888-0309; Garcia, Esther/0000-0003-3997-493X; Molina Romero, Israel/0000-0001-6642-7515	Miguel Servet program of the Instituto de Salud Carlos III (Spain); ERS/SEPAR fellowship (LTRF); Instituto de Salud Carlos III [PI 13/01546, PI 16/01912]; ISCIII Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR; Barcelona, Spain)	Miguel Servet program of the Instituto de Salud Carlos III (Spain); ERS/SEPAR fellowship (LTRF); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); ISCIII Subdireccion General de Evaluacion; Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR; Barcelona, Spain)	JD is funded by the Miguel Servet program of the Instituto de Salud Carlos III (Spain). ML was supported by a joint ERS/SEPAR fellowship (LTRF 2015). The research was partially supported by a grant from the Instituto de Salud Carlos III (PI 13/01546 and PI 16/01912), integrated in the Plan Nacional de I+D+I and cofunded by the ISCIII Subdireccion General de Evaluacion and the Fondo Europeo de Desarrollo Regional (FEDER); and a grant from the Sociedad Espanola de Neumologia y Cirugia Toracica (SEPAR; Barcelona, Spain) (Smoking Integrated Research Programme Call) to NA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aabye MG, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-379; Abal AT, 2005, RESP MED, V99, P415, DOI 10.1016/j.rmed.2004.08.016; Aichelburg MC, 2014, INT J TUBERC LUNG D, V18, P709, DOI 10.5588/ijtld.13.0813; Akobeng AK, 2007, ACTA PAEDIATR, V96, P487, DOI 10.1111/j.1651-2227.2006.00179.x; Altet N, 2015, ANN AM THORAC SOC, V12, P680, DOI 10.1513/AnnalsATS.201408-394OC; Altet-Gomez MN, 2005, INT J TUBERC LUNG D, V9, P430; [Anonymous], 2015, WHO REP GLOB TOB EP; Awaisu A, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-2; Chan ED, 2010, AM J RESP CRIT CARE, V182, P990, DOI 10.1164/rccm.201006-0861ED; Chen CM, 2015, PLOS ONE, V10; de Boer RN, 2014, TUBERCULOSIS, V94, P87, DOI 10.1016/j.tube.2013.10.005; DEMARTINO M, 2014, BMC INFECT DIS S1, V14; den Boon S, 2005, THORAX, V60, P555, DOI 10.1136/thx.2004.030924; Diel R, 2011, EUR RESPIR J, V37, P88, DOI 10.1183/09031936.00115110; Domingo-Salvany A., 2000, ATEN PRIM, V25, P350, DOI [10.1016/s0212-6567(00)78518-0, DOI 10.1016/S0212-6567(00)78518-0]; Dominguez J, 2008, CLIN VACCINE IMMUNOL, V15, P168, DOI 10.1128/CVI.00364-07; Feng Y, 2011, INFECT IMMUN, V79, P229, DOI 10.1128/IAI.00709-10; Fiore MC, 2008, RESP CARE, V53, P1217; Huang CC, 2014, INT J TUBERC LUNG D, V18, P1285, DOI 10.5588/ijtld.14.0309; Kherad O, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-217; Lalvani A, 2007, CHEST, V131, P1898, DOI 10.1378/chest.06-2471; Latorre I, 2009, DIAGN MICR INFEC DIS, V65, P236, DOI 10.1016/j.diagmicrobio.2009.07.015; Leung CC, 2003, INT J TUBERC LUNG D, V7, P980; Leung CC, 2015, EUR RESPIR J, V45, P738, DOI 10.1183/09031936.00114214; Lindsay RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093137; Mahishale Vinay, 2015, Chonnam Med J, V51, P86, DOI 10.4068/cmj.2015.51.2.86; Manejo diagnostico y tratamiento del tabaquismo en la practica clinica diaria, 2015, MAN SEPAR PROC; Mazurek Gerald H., 2010, Morbidity and Mortality Weekly Report, V59, P1; Metanat M., 2010, Iranian Journal of Clinical Infectious Diseases, V5, P14; O'Leary SM, 2014, AM J RESP CRIT CARE, V190, P1430, DOI 10.1164/rccm.201407-1385OC; Organization WH, 2016, GLOBAL TUBERCULOSIS; Ruiz-Manzano J, 2008, ARCH BRONCONEUMOL, V44, P551, DOI 10.1016/S1579-2129(08)60102-0; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Shaler CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059185; Shang SB, 2011, J INFECT DIS, V203, P1240, DOI 10.1093/infdis/jir009; Slam K, 2007, INT J TUBERC LUNG D, V11, P1049; Smit RNV, 2010, EUR RESPIR J, V35, P27, DOI 10.1183/09031936.00072909; van Zyl-Smit RN, 2014, THORAX, V69, P363, DOI 10.1136/thoraxjnl-2013-204229; Visser ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029588; World Health Organization, 2006, BMI CLASSIFICATION; World Health Organization, 2014, GUID TUB PAT QUIT SM; World Health Organization International Union Against Tuberculosis and Lung Diseases, 2015, WHOHTMTB2007390; Yen YF, 2014, INT J TUBERC LUNG D, V18, P492, DOI 10.5588/ijtld.13.0694; Zellweger JP, 2015, AM J RESP CRIT CARE, V191, P1176, DOI 10.1164/rccm.201502-0232OC	45	24	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182998	10.1371/journal.pone.0182998	http://dx.doi.org/10.1371/journal.pone.0182998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837570	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000040
J	Au, ED; Fernandez-Godino, R; Kaczynksi, TJ; Sousa, ME; Farkas, MH				Au, Elizabeth D.; Fernandez-Godino, Rosario; Kaczynksi, Tadeusz J.; Sousa, Maria E.; Farkas, Michael H.			Characterization of lincRNA expression in the human retinal pigment epithelium and differentiated induced pluripotent stem cells	PLOS ONE			English	Article							LONG NONCODING RNA; MOLECULAR SIGNATURE; GENE; RPE; MUTATIONS; TRANSCRIPTOME; ANNOTATION; EVOLUTION; PROGRESS; GENCODE	Long intervening non-coding RNAs (lincRNAs) are increasingly being implicated as important factors in many aspects of cellular development, function, and disease, but remain poorly understood. In this study, we examine the human retinal pigment epithelium (RPE) lincRNA transcriptome using RNA-Seq data generated from human fetal RPE (fRPE), RPE derived from human induced pluripotent stem cells (iPS-RPE), and undifferentiated iPS (iPS). In addition, we determine the suitability of iPS-RPE, from a transcriptome standpoint, as a model for use in future studies of lincRNA structure and function. A comparison of gene and isoform expression across the whole transcriptome shows only minimal differences between all sample types, though fRPE and iPS-RPE show higher concordance than either shows with iPS. Notably, RPE signature genes show the highest degree of fRPE to iPSRPE concordance, indicating that iPS-RPE cells provide a suitable model for use in future studies. An analysis of lincRNAs demonstrates high concordance between fRPE and iPS-RPE, but low concordance between either RPE and iPS. While most lincRNAs are expressed at low levels (RPKM < 10), there is a high degree of concordance among replicates within each sample type, suggesting the expression is consistent, even at levels subject to high variability. Finally, we identified and annotated 180 putative novel genes in the fRPE samples, a majority of which are also expressed in the iPS-RPE. Overall, this study represents the first characterization of lincRNA expression in the human RPE, and provides a model for studying the role lincRNAs play in RPE development, function, and disease.	[Au, Elizabeth D.; Kaczynksi, Tadeusz J.; Sousa, Maria E.; Farkas, Michael H.] SUNY Buffalo, Dept Ophthalmol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA; [Fernandez-Godino, Rosario] Harvard Med Sch, Ocular Genom Inst, Dept Ophthalmol, Massachusetts Eye & Ear Infirm, Boston, MA USA; [Kaczynksi, Tadeusz J.; Sousa, Maria E.; Farkas, Michael H.] Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY 14215 USA; [Farkas, Michael H.] SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Harvard University; Harvard Medical School; Massachusetts Eye & Ear Infirmary; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Farkas, MH (corresponding author), SUNY Buffalo, Dept Ophthalmol, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA.; Farkas, MH (corresponding author), Vet Adm Western New York Healthcare Syst, Res Serv, Buffalo, NY 14215 USA.; Farkas, MH (corresponding author), SUNY Buffalo, Dept Biochem, Jacobs Sch Med & Biomed Sci, Buffalo, NY 14226 USA.	mhfarkas@buffalo.edu			Departments of Ophthalmology at the State University of New York at Buffalo; Massachusetts Eye and Ear Infirmary; Research to Prevent Blindness	Departments of Ophthalmology at the State University of New York at Buffalo; Massachusetts Eye and Ear Infirmary; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported by the Departments of Ophthalmology at the State University of New York at Buffalo and Massachusetts Eye and Ear Infirmary to MHF. This work was also supported, in part, by an Unrestricted Grant to the Department of Ophthalmology, University at Buffalo, from Research to Prevent Blindness. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bennis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141597; Caldwell GM, 1999, GENOMICS, V58, P98, DOI 10.1006/geno.1999.5808; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Chiang J, 2015, EXPERT REV MOL DIAGN, V15, P1269, DOI 10.1586/14737159.2015.1081057; Daiger SP, 2013, NA CA2, V5; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; Deniz E, 2017, FUNCT INTEGR GENOMIC, V17, P135, DOI 10.1007/s10142-016-0524-x; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Farkas MH, 2014, AM J PATHOL, V184, P2641, DOI 10.1016/j.ajpath.2014.06.026; Farkas MH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-486; Gal A, 2000, NAT GENET, V26, P270, DOI 10.1038/81555; Gamm DM, 2010, REGEN MED, V5, P315, DOI 10.2217/RME.10.28; Graziotto JJ, 2011, INVEST OPHTH VIS SCI, V52, P190, DOI 10.1167/iovs.10-5194; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu QR, 2010, STEM CELLS, V28, P1981, DOI 10.1002/stem.531; Huang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027288; Iguchi T, 2015, ANTICANCER RES, V35, P1385; Kalloniatis Michael, 2004, Clin Exp Optom, V87, P65; Klassen H, 2016, EXPERT OPIN BIOL TH, V16, P7, DOI 10.1517/14712598.2016.1093110; Le Y-Z, 2015, ASS RES VISION OPHTH, V56, P4274; Levin LA, 2017, OPHTHALMOLOGY; Li F, 2016, INT J MOL SCI, P17; Liao JL, 2010, HUM MOL GENET, V19, P4229, DOI 10.1093/hmg/ddq341; Liu BD, 2015, CANCER CELL, V27, P370, DOI 10.1016/j.ccell.2015.02.004; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035; Mattick JS, 2015, NAT STRUCT MOL BIOL, V22, P5, DOI 10.1038/nsmb.2942; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muniz A, 2014, INVEST OPHTH VIS SCI, V55, P198, DOI 10.1167/iovs.13-11740; Mustafi D, 2013, HUM MOL GENET, V22, P2992, DOI 10.1093/hmg/ddt156; Nashun B, 2015, EMBO J; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Nguyen HV, 2015, J CLIN MED, V4, P567, DOI 10.3390/jcm4040567; Ohsawa R, 2008, BRAIN RES, V1192, P90, DOI 10.1016/j.brainres.2007.04.014; Pan Q, 2005, TRENDS GENET, V21, P73, DOI 10.1016/j.tig.2004.12.004; Peng SM, 2013, STEM CELL TRANSL MED, V2, P534, DOI 10.5966/sctm.2012-0134; Pennesi ME, 2012, MOL ASPECTS MED, V33, P487, DOI 10.1016/j.mam.2012.06.003; Pereira B, 2015, O RNA SEQ READS COUN; Pierce EA, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a017285; Rakoczy EP, 2015, ESSENT OPHTHALMOL, P61, DOI 10.1007/978-3-662-45188-5_5; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Samuel W, 2017, MOL VIS, V23, P60; Schulz HL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-50; Sela N, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-r127; Singh R, 2013, HUM MOL GENET, V22, P593, DOI 10.1093/hmg/dds469; St Laurent G, 2015, TRENDS GENET, V31, P239, DOI 10.1016/j.tig.2015.03.007; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Strunnikova NV, 2010, HUM MOL GENET, V19, P2468, DOI 10.1093/hmg/ddq129; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Tarazona S, 2011, GENOME RES, V21, P2213, DOI 10.1101/gr.124321.111; Tian LF, 2015, GENOMICS, V105, P253, DOI 10.1016/j.ygeno.2015.01.008; Tyner C, 2017, NUCLEIC ACIDS RES, V45, pD626, DOI 10.1093/nar/gkw1134; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Westenskow PD, 2014, ADV EXP MED BIOL, V801, P323, DOI 10.1007/978-1-4614-3209-8_41; Wiley LA, 2015, PROG RETIN EYE RES, V44, P15, DOI 10.1016/j.preteyeres.2014.10.002; Wright LS, 2014, EXP EYE RES, V123, P161, DOI 10.1016/j.exer.2013.12.001; ZHONG H, 2015, SCI REP UK, V5	61	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183939	10.1371/journal.pone.0183939	http://dx.doi.org/10.1371/journal.pone.0183939			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837677	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000137
J	Kim, KH; Kim, DH; Jeong, HJ; Ryu, JS; Kim, YJ; Oh, JY; Kim, MK; Wee, WR				Kim, Kyeong Hwan; Kim, Dong Hyun; Jeong, Hyun Jeong; Ryu, Jin Suk; Kim, Yu Jeong; Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang			Effects of subconjunctival administration of anti-high mobility group box 1 on dry eye in a mouse model of Sjogren's syndrome	PLOS ONE			English	Article							INNATE LYMPHOID-CELLS; HMGB1; PROTEIN; PROMOTES; IL-22; TH17	Purpose Extracellular high mobility group box 1 (HMGB1) acts as a damage associated molecular pattern molecule through the Toll-like receptor to promote autoreactive B cell activation, which may be involved in the pathogenesis of Sjogren's syndrome. The aim of this study was to investigate the effect of subconjunctival administration of anti-HMGB1 on dry eye in a mouse model of Sjogren's syndrome. Methods Ten weeks-old NOD.B10.H2b mice were subconjunctivally injected with 0.02 to 2 mu g of anti-HMGB1 antibodies or PBS twice a week for two consecutive weeks. Tear volume and corneal staining scores were measured and compared between before-and after-treatment. Goblet cell density was counted in PAS stained forniceal conjunctiva and inflammatory foci score (>50 cells/focus) was measured in extraorbital glands. Flow cytometry was performed to evaluate the changes in BrdU(+) cells, IL-17-, IL-10-, or IFN gamma-secreting cells, functional B cells, and IL-22 secreting innate lymphoid cells (ILC3s) in cervical lymph nodes. The level of IL-22 in intraorbital glands was measured by ELISA. Results Injection of 2 mu g or 0.02 mu g anti-HMGB1 attenuated corneal epithelial erosions and increased tear secretion (p< 0.05). Goblet cell density was increased in 0.2 mu g and 2 mu g anti-HMGB1-treated-mice with marginal significance. The inflammatory foci score, and the number of BrdU(+) cells, IL-17-, IL-10-, IFN gamma-secreting cells, and functional B cells did not significantly change following anti-HMGB1 treatment. Surprisingly, the percentage of ILC3s was significantly increased in the draining lymph nodes (p< 0.05), and the expression of IL-22 was significantly increased in the intraorbital glands (p<0.05) after administration of 2 mu g anti-HMGB1. Conclusion This study shows that subconjunctival administration of anti-HMGB1 attenuates clinical manifestations of dry eye. The improvement of dry eye may involve an increase of ILC3s, rather than modulation of B or plasma cells, as shown using a mouse model of Sjogren's syndrome.	[Kim, Kyeong Hwan; Kim, Dong Hyun; Jeong, Hyun Jeong; Ryu, Jin Suk; Kim, Yu Jeong; Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Seoul, South Korea; [Kim, Kyeong Hwan] Haeundae Paik Hosp, Dept Ophthalmol, Busan, South Korea; [Kim, Kyeong Hwan] Inje Univ, Coll Med, Dept Ophthalmol, Busan, South Korea; [Kim, Dong Hyun] Gachon Univ, Gil Med Ctr, Dept Ophthalmol, Incheon, South Korea; [Kim, Yu Jeong; Oh, Joo Youn; Kim, Mee Kum; Wee, Won Ryang] Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Inje University; Gachon University; Seoul National University (SNU)	Kim, MK (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul Artificial Eye Ctr, Lab Ocular Regenerat Med & Immunol, Seoul, South Korea.; Kim, MK (corresponding author), Seoul Natl Univ, Coll Med, Dept Ophthalmol, Seoul, South Korea.	kmk9@snu.ac.kr	Kim, Kyeong Hwan/C-5036-2012	Kim, Kyeong Hwan/0000-0002-7359-663X	Seoul National University Hospital Research Fund [03-2012-0340, 04-2013-0510]	Seoul National University Hospital Research Fund	This work was supported by a grant from the Seoul National University Hospital Research Fund (Project No. 03-2012-0340 and Project No. 04-2013-0510; http://bri.snuh.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosi A, 2015, CURR OPIN RHEUMATOL, V27, P468, DOI 10.1097/BOR.0000000000000195; Annunziato F, 2015, J ALLERGY CLIN IMMUN, V135, P626, DOI 10.1016/j.jaci.2014.11.001; Avalos AM, 2010, AUTOIMMUNITY, V43, P103, DOI 10.3109/08916930903384591; Bertheloot D, 2016, CELL MOL IMMUNOL; Chen YT, 2009, MOL VIS, V15, P563; Delaleu N, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3313; Doyle ME, 2007, AM J PATHOL, V171, P1224, DOI 10.2353/ajpath.2007.070388; Duan LH, 2011, LAB INVEST, V91, P43, DOI 10.1038/labinvest.2010.141; Dupire G, 2012, SCAND J RHEUMATOL, V41, P120, DOI 10.3109/03009742.2011.633099; Eberl G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6566; Ek M, 2006, ARTHRITIS RHEUM, V54, P2289, DOI 10.1002/art.21969; Goto Y, 2014, SCIENCE, V345, P1310, DOI 10.1126/science.1254009; He Z, 2012, SCAND J IMMUNOL, V76, P483, DOI 10.1111/j.1365-3083.2012.02759.x; Hepworth MR, 2015, SCIENCE, V348, P1031, DOI 10.1126/science.aaa4812; Hornung V, 2002, J IMMUNOL, V168, P4531, DOI 10.4049/jimmunol.168.9.4531; Lavoie TN, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/549107; Lee Y, 2013, J IMMUNOL, V190, P5296, DOI 10.4049/jimmunol.1201452; Liu A, 2012, COMP MATH MATH PHYS, V2012, P1, DOI DOI 10.1371/J0URNAL.P0NE.0035379; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Mortha A, 2014, SCIENCE, V343, P1477, DOI 10.1126/science.1249288; Munneke JM, 2014, BLOOD, V124, P812, DOI 10.1182/blood-2013-11-536888; Nguyen C, 2006, MOL IMMUNOL, V43, P1332, DOI 10.1016/j.molimm.2005.09.003; Nikoopour E, 2015, CYTOKINE, V74, P35, DOI 10.1016/j.cyto.2014.09.007; Robinson CP, 1998, ARTHRITIS RHEUM, V41, P150, DOI 10.1002/1529-0131(199801)41:1<150::AID-ART18>3.0.CO;2-T; Sanati G, 2015, EXPERT REV CLIN IMMU, V11, P885, DOI 10.1586/1744666X.2015.1050382; Scardina Giuseppe Alessandro, 2007, Med Oral Patol Oral Cir Bucal, V12, pE565; Sedda S, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/235460; Straino S, 2008, J INVEST DERMATOL, V128, P1545, DOI 10.1038/sj.jid.5701212; Su ZJ, 2011, 2011 24TH INTERNATIONAL VACUUM NANOELECTRONICS CONFERENCE (IVNC), P41; Tang DL, 2011, ANTIOXID REDOX SIGN, V14, P1315, DOI 10.1089/ars.2010.3356; Tsung A, 2014, J INTERN MED, V276, P425, DOI 10.1111/joim.12276; von Burg N, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00416; Wild CA, 2012, INT IMMUNOL, V24, P485, DOI 10.1093/intimm/dxs051; Yanai H, 2009, NATURE, V462, P99, DOI 10.1038/nature08512; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662; Zhang F, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/257930	36	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183678	10.1371/journal.pone.0183678	http://dx.doi.org/10.1371/journal.pone.0183678			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837629	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000099
J	Pan, YQ; Liu, HY; Lau, PY; Luo, F				Pan, Yiqin; Liu, Hongyun; Lau, Puiyi; Luo, Fang			A latent transition analysis of bullying and victimization in Chinese primary school students	PLOS ONE			English	Article							AGGRESSIVE VICTIMS; PREVALENCE; BULLIES; METAANALYSIS; ADOLESCENCE; BEHAVIORS; CHILDREN	Bullying is a social phenomenon that impacts a large number of children and young people, worldwide. This study aimed to longitudinally examine the development of bullying and victimization in Chinese students in grades 4, 5, and 6. We used latent class analysis to empirically identify groups of youth with different bullying and victimization patterns, and then used latent transition analysis to explore the movement of children between these latent classes over time. Results showed that: (1) across the three time points, students could be classified into four classes: bullies, victims, bully-victims, and non-involved children; and (2) students in the non-involved class tended to remain in that class when moving to higher grades, students in the bully and victims classes tended to transition to the non-involved class, while students in the bully-victims class tended to transition to the bullies class. Thus, future intervention should be implemented to prevent bully-victims from bullying behaviors.	[Pan, Yiqin; Liu, Hongyun; Luo, Fang] Beijing Normal Univ, Dept Psychol, Beijing, Peoples R China; [Liu, Hongyun; Luo, Fang] Beijing Adv Innovat Ctr Future Educ, Beijing, Peoples R China; [Lau, Puiyi] Univ Cambridge, Inst Criminol, Cambridge, England	Beijing Normal University; University of Cambridge	Luo, F (corresponding author), Beijing Normal Univ, Dept Psychol, Beijing, Peoples R China.; Luo, F (corresponding author), Beijing Adv Innovat Ctr Future Educ, Beijing, Peoples R China.	luof@bnu.edu.cn	Pan, Yiqin/GSN-3496-2022; HY, Liu/GWV-1865-2022	HY, Liu/0000-0002-3472-9102				Aluede O, 2008, J INSTRUCT PSYCHOL, V35, P151; Barker ED, 2008, J AM ACAD CHILD PSY, V47, P1030, DOI [10.1097/CHI0b013e31817eee98, 10.1097/CHI.ObO13e31817eec98]; Bergeron N, 2005, AGGRESSIVE BEHAV, V31, P116, DOI 10.1002/ab.20049; Chan HC, 2015, AGGRESS VIOLENT BEH, V23, P98, DOI 10.1016/j.avb.2015.05.010; Chan HCO, 2015, J CHILD FAM STUD, V24, P3224, DOI 10.1007/s10826-015-0125-7; Chang L, 2003, CHILD DEV, V74, P535, DOI 10.1111/1467-8624.7402014; Fossati A, 2012, PERSONAL MENT HEALTH, V6, P325, DOI 10.1002/pmh.1201; Gini G, 2014, HEADACHE, V54, P976, DOI 10.1111/head.12344; Gini G, 2013, PEDIATRICS, V132, P720, DOI 10.1542/peds.2013-0614; Ji L.Q., 2003, STUD PSYCHOL BEHAV, V1, P122; Kaltiala-Heino R, 2000, J ADOLESCENCE, V23, P661, DOI 10.1006/jado.2000.0351; Lanza ST, 2007, STRUCT EQU MODELING, V14, P671, DOI 10.1080/10705510701575602; Ministry of Education of the People's Republic of China, 2016, GUID PREV BULL VIOL; Muthen L.K., 2010, MPLUS USERS GUIDE ST; Nylund K.L., 2006, STABILITY INST UNPUB; Nylund K.L., 2007, THESIS; Nylund KL, 2007, STRUCT EQU MODELING, V14, P535, DOI 10.1080/10705510701575396; OLWEUS D, 1979, PSYCHOL BULL, V86, P852, DOI 10.1037/0033-2909.86.4.852; Olweus D, 2001, PEER HARASSMENT IN SCHOOL, P3; Olweus D, 1993, BULLYING SCH WHAT WE, DOI DOI 10.1007/978-1-4757-9116-7_5; Olweus D., 1993, SOCIAL WITHDRAWAL IN, V315, P341; Pellegrini AD, 1999, J EDUC PSYCHOL, V91, P216, DOI 10.1037/0022-0663.91.2.216; Salmivalli C, 2002, AGGRESSIVE BEHAV, V28, P30, DOI 10.1002/ab.90004.abs; Schwartz D, 1997, CHILD DEV, V68, P665, DOI 10.2307/1132117; Schwartz D, 1998, DEV PSYCHOPATHOL, V10, P87, DOI 10.1017/S095457949800131X; SCHWARTZ D, 1993, CHILD DEV, V64, P1755, DOI 10.1111/j.1467-8624.1993.tb04211.x; Shao AH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095290; Solberg ME, 2003, AGGRESSIVE BEHAV, V29, P239, DOI 10.1002/ab.10047; Veenstra R, 2005, DEV PSYCHOL, V41, P672, DOI 10.1037/0012-1649.41.4.672; Williford A, 2014, AGGRESSIVE BEHAV, V40, P24, DOI 10.1002/ab.21503; Wolke D, 2001, BRIT J PSYCHOL, V92, P673, DOI 10.1348/000712601162419; [张文新 Zhang Wenxin], 2002, [心理学报, Acta Psychologica Sinica], V34, P387	32	13	14	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182802	10.1371/journal.pone.0182802	http://dx.doi.org/10.1371/journal.pone.0182802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837571	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000026
J	Cheng, FY; Jeng, MJ; Lin, YC; Wang, SH; Wu, SH; Li, WC; Huang, KF; Chiu, TF				Cheng, Fei-Ying; Jeng, Mei-Jy; Lin, Yin-Chou; Wang, Shih-Hao; Wu, Shih-Hao; Li, Wen-Cheng; Huang, Kuo-Feng; Chiu, Te-Fa			Incidence and severity of acute mountain sickness and associated symptoms in children trekking on Xue Mountain, Taiwan	PLOS ONE			English	Article							HIGH-ALTITUDE; RAPID ASCENT; ADOLESCENTS; PREVALENCE	Background Acute mountain sickness (AMS) occurs in non-acclimatized people after an acute ascent to an altitude of 2,500 m or higher. The aim of this study was to examine the incidence and severity of AMS and associated symptoms in children. Methods The prospective observational study included 197 healthy, non-acclimatized 11 and 12year- old children trekking the round-trip from the trailhead to the summit of Xue Mountain, Taiwan (2,179 m to 3,886 m) over 3 days. AMS was evaluated at Qika Hut (2,460 m) on Day 1, at Sanliujiu Hut on Day 2 (3,100 m), and at the same altitude (3,100 m) after reaching the summit on Day 3. We used the Lake Louise Score (LLS) to diagnose AMS and record daily AMS-associated symptoms. We gave acetazolamide to children with mild to moderate AMS. Dexamethasone was reserved for individuals suffering from severe AMS. Acetaminophen was administrated to children with headache, and metoclopramide for those with nausea or vomiting. Results There were 197 subjects eligible for analysis. The overall incidence of AMS was 40.6%, which was higher in males and in subjects with a higher body mass index (BMI) (p<0.05). The prevalence of AMS on Day 1 was 5.6%, which was significantly lower than that on Day 2 (29.4%) and Day 3 (23.4%). The mean LLS of all subjects was 1.77 +/- 2.08. The overall incidence of severe AMS (LLS >= 5) was 12.5%. The mean LLS of the AMS group (3.02 +/- 2.46) was significantly higher than that of the non-AMS group (0.92 +/- 1.16, p < 0.001). Among the AMS group, the mean LLS was 1.00 +/- 1.55 on Day 1, 4.09 +/- 1.97 on Day 2, and 3.98 +/- 2.42 on Day 3. The most common symptom was sleep disturbance followed by dizziness, and headache. The prevalence of headache was 46.2% on Day 2 at 3,100 m, and 31.3% on Day 3 at the same altitude after climbing the summit (3,886 m). Males experienced significantly more headache and fatigue than females (p < 0.05). The LLS and prevalence of all AMS symptoms were significantly higher in the AMS than the non-AMS group (p < 0.05). Conclusions The AMS incidence among children trekking to Xue Mountain was 40.6%. AMS is common and mostly manifests as mild symptoms. Gender (male) and a higher BMI could be considered two independent risk factors of higher AMS incidence. Sleep disturbance is the most common symptom, and the lower prevalence of headache on Day 3 may be due to the effects of medication and/or acclimatization.	[Cheng, Fei-Ying; Jeng, Mei-Jy] Natl Yang Ming Univ, Sch Med, Inst Emergency & Crit Care Med, Taipei, Taiwan; [Cheng, Fei-Ying] MacKay Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Jeng, Mei-Jy] Taipei Vet Gen Hosp, Dept Pediat, Taipei, Taiwan; [Lin, Yin-Chou] Chang Gung Mem Hosp Taoyuan, Dept Phys Med & Rehabil, Taoyuan, Taiwan; [Wang, Shih-Hao] Chang Gung Mem Hosp Chiayi, Dept Phys Med & Rehabil, Chiayi, Chiayi, Taiwan; [Wang, Shih-Hao] Natl Taiwan Sport Univ, Coll Management, Dept Recreat & Leisure Ind Management, Taoyuan, Taiwan; [Wang, Shih-Hao] Taiwan Wilderness Med Assoc, New Taipei, Taiwan; [Wang, Shih-Hao] Dalin Tzu Chi Hosp, Dept Emergency Med, Chiayi, Taiwan; [Wu, Shih-Hao; Li, Wen-Cheng] Chang Gung Mem Hosp Linkou, Dept Emergency Med, Taoyuan, Taiwan; [Wu, Shih-Hao] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Li, Wen-Cheng] Xiamen Chang Gung Hosp, Dept Hlth Management, Xiamen, Peoples R China; [Huang, Kuo-Feng] Natl Taitung Univ, Dept Phys Educ, Taitung, Taiwan; [Huang, Kuo-Feng] West Garden Hosp, Dept Emergency Med, Taipei, Taiwan; [Chiu, Te-Fa] China Med Univ Hosp, Dept Emergency Med, Taichung, Taiwan; [Chiu, Te-Fa] China Med Univ, Sch Med, Taichung, Taiwan	National Yang Ming Chiao Tung University; Mackay Memorial Hospital; Taipei Veterans General Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Chang Gung Memorial Hospital; Chang Gung University; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wang, SH (corresponding author), Chang Gung Mem Hosp Chiayi, Dept Phys Med & Rehabil, Chiayi, Chiayi, Taiwan.; Wang, SH (corresponding author), Natl Taiwan Sport Univ, Coll Management, Dept Recreat & Leisure Ind Management, Taoyuan, Taiwan.; Wang, SH (corresponding author), Taiwan Wilderness Med Assoc, New Taipei, Taiwan.; Wang, SH (corresponding author), Dalin Tzu Chi Hosp, Dept Emergency Med, Chiayi, Taiwan.	mountainwangsh@gmail.com		Wu, Shih-hao/0000-0001-7625-7193; Lin, Yin-Chou/0000-0002-1058-2329				Bartsch P, 2013, NEW ENGL J MED, V368, P2294, DOI 10.1056/NEJMcp1214870; Bloch J, 2009, PEDIATRICS, V123, P1, DOI 10.1542/peds.2008-0200; CHAN CW, 2016, J TRAVEL MED, V23; Chen HC, 2012, WILD ENVIRON MED, V23, P122, DOI 10.1016/j.wem.2012.03.014; Chiu TF, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-298; Dallimore J, 2009, WILD ENVIRON MED, V20, P221, DOI 10.1580/07-WEME-OR-119R3.1; Gonggalanzi, 2016, ARCH PUBLIC HEALTH, V74, DOI 10.1186/s13690-016-0134-z; HACKETT PH, 1976, LANCET, V2, P1149; HONIGMAN B, 1993, ANN INTERN MED, V118, P587, DOI 10.7326/0003-4819-118-8-199304150-00003; Horiuchi M, 2016, J TRAVEL MED, V23, P1; Imray CH, 2011, BMJ-BRIT MED J, V343, P1; Imray CHE, 2004, WILD ENVIRON MED, V15, P202, DOI 10.1580/1080-6032(2004)15[202:SOAMSI]2.0.CO;2; Kriemler S, 2014, HIGH ALT MED BIOL, V15, P28, DOI 10.1089/ham.2013.1073; Lawrence JS, 2016, WILD ENVIRON MED, V27, P78, DOI 10.1016/j.wem.2015.11.011; MacInnis MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075644; MAGGIORINI M, 1990, BRIT MED J, V301, P853, DOI 10.1136/bmj.301.6756.853; Major SA, 2012, WILD ENVIRON MED, V23, P15, DOI 10.1016/j.wem.2011.12.008; Moraga FA, 2002, WILD ENVIRON MED, V13, P31, DOI 10.1580/1080-6032(2002)013[0031:AMSITW]2.0.CO;2; Moraga FA, 2008, WILD ENVIRON MED, V19, P287, DOI 10.1580/06-WEME-BR-084.1; Murdoch, 1995, J Travel Med, V2, P255, DOI 10.1111/j.1708-8305.1995.tb00671.x; Neumann Karl, 2007, Travel Med Infect Dis, V5, P138, DOI 10.1016/j.tmaid.2006.01.011; Pollard AJ, 2001, HIGH ALT MED BIOL, V2, P389, DOI 10.1089/15270290152608561; Pradhan S, 2009, WILD ENVIRON MED, V20, P359, DOI 10.1580/1080-6032-020.004.0359; Rexhaj E, 2011, PEDIATRICS, V127, pE1445, DOI 10.1542/peds.2010-3756; ROACH RC, 1993, LAKE LOUISE ACUTE MO, P272; Stokes SHM, 2009, ARCH DIS CHILD, V94, P562, DOI 10.1136/adc.2008.151597; THEIS MK, 1993, AM J DIS CHILD, V147, P143, DOI 10.1001/archpedi.1993.02160260033017; Wang SH, 2013, AM J EMERG MED, V31, P1142, DOI 10.1016/j.ajem.2013.03.043; Wang SH, 2010, HIGH ALT MED BIOL, V11, P43, DOI 10.1089/ham.2009.1063; Weng YM, 2013, AM J EMERG MED, V31, P1113, DOI 10.1016/j.ajem.2013.03.028; Yaron M, 2002, WILD ENVIRON MED, V13, P21, DOI 10.1580/1080-6032(2002)013[0021:EODCAI]2.0.CO;2	31	9	9	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183207	10.1371/journal.pone.0183207	http://dx.doi.org/10.1371/journal.pone.0183207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832689	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800052
J	Letsinger, J; Rommel, C; Hirschi, R; Nirula, R; Hawryluk, GWJ				Letsinger, Joshua; Rommel, Casey; Hirschi, Ryan; Nirula, Raminder; Hawryluk, Gregory W. J.			The aggressiveness of neurotrauma practitioners and the influence of the IMPACT prognostic calculator	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; EXTERNAL VALIDATION; OUTCOME PREDICTION; HEAD-INJURY; INTERNATIONAL MISSION; CLINICAL-TRIALS; MODELS; MODERATE; CRASH; MORTALITY	Published guidelines have helped to standardize the care of patients with traumatic brain injury; however, there remains substantial variation in the decision to pursue or withhold aggressive care. The International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) prognostic calculator offers the opportunity to study and decrease variability in physician aggressiveness. The authors wish to understand how IMPACT's prognostic calculations currently influence patient care and to better understand physician aggressiveness. The authors conducted an anonymous international, multidisciplinary survey of practitioners who provide care to patients with traumatic brain injury. Questions were designed to determine current use rates of the IMPACT prognostic calculator and thresholds of age and risk for death or poor outcome that might cause practitioners to consider withholding aggressive care. Correlations between physician aggressiveness, putative predictors of aggressiveness, and demographics were examined. One hundred fifty-four responses were received, half of which were from physicians who were familiar with the IMPACT calculator. The most frequent use of the calculator was to improve communication with patients and their families. On average, respondents indicated that in patients older than 76 years or those with a >85% chance of death or poor outcome it might be reasonable to pursue non-aggressive care. These thresholds were robust and were not influenced by provider or institutional characteristics. This study demonstrates the need to educate physicians about the IMPACT prognostic calculator. The consensus values for age and prognosis identified in our study may be explored in future studies aimed at reducing variability in physician aggressiveness and should not serve as a basis for withdrawing care.	[Letsinger, Joshua; Hawryluk, Gregory W. J.] Univ Utah, Dept Surg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA; [Rommel, Casey] Univ Utah, Sch Med, Dept Biomed Informat, Salt Lake City, UT USA; [Hirschi, Ryan] Univ Utah, Sch Med, Salt Lake City, UT USA; [Nirula, Raminder] Univ Utah, Dept Surg, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Hawryluk, GWJ (corresponding author), Univ Utah, Dept Surg, Clin Neurosci Ctr, Salt Lake City, UT 84112 USA.	gregory.hawryluk@hsc.utah.edu	Rommel, Casey/N-9261-2019	Rommel, Casey/0000-0001-7757-9573; Hawryluk, Gregory/0000-0002-5604-7057	National Institutes of Health, United States National Library of Medicine [T15LM007124]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T35HL007744] Funding Source: NIH RePORTER	National Institutes of Health, United States National Library of Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	CR is funded as a pre-doctoral trainee via the National Institutes of Health, United States National Library of Medicine, Grant Number T15LM007124. CR has received the University of Utah, Richard A. Fay and Carol M. Fay Endowed Graduate Fellowship for the Department of Biomedical Informatics in Honor of Homer R. Warner, M.D., Ph.D. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no other specific funding for this work.	Alvis-Miranda Hernando, 2013, Bull Emerg Trauma, V1, P60; Baltazar GA, 2015, AM SURGEON, V81, pE61; Bazzazi A, 2014, ULUS TRAVMA ACIL CER, V20, P236, DOI 10.5505/tjtes.2014.57089; Brandner S, 2015, J NEUROSURG ANESTH, V27, P26, DOI 10.1097/ANA.0000000000000083; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock R, 1996, Eur J Emerg Med, V3, P109, DOI 10.1097/00063110-199606000-00010; Butler E, 1923, Cal State J Med, V21, P295; Carney N, 2016, NEUROSURGERY; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Castano-Leon AM, 2016, J NEUROTRAUM, V33, P1598, DOI 10.1089/neu.2015.4182; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Gao JX, 2015, INT J CLIN EXP MED, V8, P19881; Gao L, 2015, FRONT BIOSCI-LANDMRK, V20, P763, DOI 10.2741/4335; Greene NH, 2014, ARCH PHYS MED REHAB, V95, P1148, DOI 10.1016/j.apmr.2014.02.020; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Harrison DA, 2013, HEALTH TECHNOL ASSES, V17, P1, DOI 10.3310/hta17230; Hawryluk GWJ, 2016, NEUROSURG CLIN N AM, V27, P375, DOI 10.1016/j.nec.2016.05.002; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V128, P761, DOI 10.1016/B978-0-444-63521-1.00047-9; Iorio-Morin C, 2016, CLIN NEUROL NEUROSUR, V142, P48, DOI 10.1016/j.clineuro.2016.01.021; Kamal VK, 2016, BRAIN INJURY, V30, P393, DOI 10.3109/02699052.2015.1113568; KAUFMANN MA, 1992, RESUSCITATION, V23, P199, DOI 10.1016/0300-9572(92)90003-U; Kawai N, 2013, BRAIN INJURY, V27, P1026, DOI 10.3109/02699052.2013.794963; Kirschen MP, 2015, SEMIN PEDIATR NEUROL, V22, P187, DOI 10.1016/j.spen.2015.05.004; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Liedes H, 2016, STUD HEALTH TECHNOL, V224, P175, DOI 10.3233/978-1-61499-653-8-175; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lingsma HF, 2011, NEUROSURGERY, V68, P601, DOI 10.1227/NEU.0b013e318209333b; Lu J, 2013, J NEUROTRAUM, V30, P1925, DOI 10.1089/neu.2013.2891; Maas Andrew I R, 2015, Handb Clin Neurol, V128, P455, DOI 10.1016/B978-0-444-63521-1.00029-7; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Majdan M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0068-9; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Mikola A, 2015, IEEE ENG MED BIO, P1532, DOI 10.1109/EMBC.2015.7318663; Moore NA, 2013, BRIT J NEUROSURG, V27, P340, DOI 10.3109/02688697.2012.754402; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Olivecrona M, 2012, ACTA NEUROCHIR, V154, P1567, DOI 10.1007/s00701-012-1351-z; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perrin PB, 2015, J HEAD TRAUMA REHAB, V30, P136, DOI 10.1097/HTR.0000000000000026; Pourahmad S, 2016, METHOD INFORM MED, V55, P440, DOI 10.3414/ME15-01-0080; Raj R, 2014, J NEUROTRAUM, V31, P1721, DOI 10.1089/neu.2014.3361; Ramesh VG, 2013, J NEUROSURG, V119, P1351, DOI 10.3171/2013.4.JNS13875; Rizoli S, 2016, BMC EMERG MED, V16, DOI 10.1186/s12873-016-0098-x; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Shafi S, 2014, J NEUROSURG, V120, P773, DOI 10.3171/2013.12.JNS132151; Shaklai S, 2014, BRAIN INJURY, V28, P915, DOI 10.3109/02699052.2013.862739; Sobuwa S, 2014, SAMJ S AFR MED J, V104, P492, DOI [10.7196/SAMJ.7720, 10.7196/samj.7720]; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Sun H, 2016, J NEUROTRAUM, V33, P1535, DOI 10.1089/neu.2015.4164; Talari HR, 2016, WORLD NEUROSURG, V87, P195, DOI 10.1016/j.wneu.2015.11.055; Tasaki O, 2009, J TRAUMA, V66, P304, DOI 10.1097/TA.0b013e31815d9d3f; Turgeon AF, 2013, CRIT CARE MED, V41, P1086, DOI 10.1097/CCM.0b013e318275d046; Whitmore RG, 2012, J NEUROSURG, V116, P1106, DOI 10.3171/2012.1.JNS11962; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032; Yeoman P, 2011, J TRAUMA, V71, P387, DOI 10.1097/TA.0b013e31820ceadd; Zador Z, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158762	59	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183552	10.1371/journal.pone.0183552	http://dx.doi.org/10.1371/journal.pone.0183552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832674	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800063
J	Zhang, J; Zhang, XN; Wang, H; Zhou, HB; Tian, T; Wu, AS				Zhang, Jian; Zhang, Xuena; Wang, Hui; Zhou, Haibin; Tian, Tian; Wu, Anshi			Dexmedetomidine as a neuraxial adjuvant for prevention of perioperative shivering: Meta-analysis of randomized controlled trials	PLOS ONE			English	Article							INTRATHECAL DEXMEDETOMIDINE; SPINAL-ANESTHESIA; TRANSURETHRAL PROSTATECTOMY; HYPERBARIC BUPIVACAINE; PROPHYLACTIC KETAMINE; CLONIDINE; FENTANYL; EFFICACY; MORPHINE; QUALITY	Background Dexmedetomidine, a highly selective alpha 2-adrenoceptor agonist, has been investigated for anti-shivering effects in some trials. This current meta-analysis was conducted to evaluate the effectiveness of dexmedetomidine as a neuraxial adjuvant in preventing perioperative shivering. Methods This systematic review and meta-analysis was registered in PROSPERO [www.crd.york.ac. uk/PROSPERO] with the unique identification number CRD42017055991. The electronic databases PubMed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) were searched to select high-quality randomized controlled trials (RCTs) that evaluated the anti-shivering efficacy for neuraxial application dexmedetomidine as local anesthetic adjuvant. Effects were summarized using pooled risk ratios (RRs), weighed mean differences (MDs), or standardized mean differences (SMDs) and corresponding 95% confidence intervals (Cls) with random effect model. Heterogeneity assessment, sensitivity analysis, and publication bias were performed. The primary outcome was perioperative shivering. Results A total of 1760 patients from 24 studies were included in this meta-analysis. Compared with the placebo, dexmedetomidine reduced the incidence of perioperative shivering (RR: 0.34; 95% Cl: 0.21 to 0.55; P < 0.00001), with a maximum effective dose of 5 mu g via subarachnoid space injection (RR: 0.55; 95% CI: 0.32 to 0.92; P = 0.02), especially in cesarean section (RR: 0.20; 95% CI: 0.09 to 0.45; P = 0.0001). Dexmedetomidine also could improve the characteristics of the block, with an increase only in the incidence of bradycardia (RR: 2.11; 95% CI: 1.23 to 3.60; P = 0.006). No significant difference could be found compared dexmedetomidine with other adjuvants, except morphine. Conclusions This meta-analysis shows that dexmedetomidine as a neuraxial adjuvant had statistically significant efficacy on prevention of perioperative shivering. Moreover, dexmedetomidine could improve the characteristics of the block. However, the potential induction of bradycardia should be taken seriously.	[Zhang, Jian; Zhang, Xuena; Wang, Hui; Wu, Anshi] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Zhou, Haibin] Peking Univ, Dept Anesthesiol, Ji Shui Tan Hosp, Beijing, Peoples R China; [Zhou, Haibin] Peking Univ, Coll Med 4, Beijing, Peoples R China; [Tian, Tian] Capital Med Univ, Beijing Xuanwu Hosp, Dept Anesthesiol, Beijing, Peoples R China	Capital Medical University; Peking University; Peking University; Capital Medical University	Wu, AS (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China.	wuanshi1960@163.com		Wu, Anshi/0000-0003-2353-2184	National Natural Science Foundation of China [8137119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Foundation of China (Grant no. 8137119, recipient: Anshi Wu), URL: http://www nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdallah FW, 2013, BRIT J ANAESTH, V110, P915, DOI 10.1093/bja/aet066; Bagatini Airton, 2002, Rev. Bras. Anestesiol., V52, P606, DOI 10.1590/S0034-70942002000500012; Bajwa Sukhminder Jit Singh, 2012, J Anaesthesiol Clin Pharmacol, V28, P86, DOI 10.4103/0970-9185.92452; Bajwa SJS, 2011, SAUDI J ANAESTH, V5, P365, DOI 10.4103/1658-354X.87264; Bajwa SJS, 2011, INDIAN J ANAESTH, V55, P116, DOI 10.4103/0019-5049.79883; Bozgeyik S, 2014, SAUDI J ANAESTH, V8, P238, DOI 10.4103/1658-354X.130729; Brockwell SE, 2001, STAT MED, V20, P825, DOI 10.1002/sim.650; Das Anjan, 2015, Oman Med J, V30, P257, DOI 10.5001/omj.2015.52; Dinesh CN, 2014, SAUDI J ANAESTH, V8, P202, DOI 10.4103/1658-354X.130719; Fatima N, 2016, JMS J MED SOC, V30, P166; Frank SM, 2000, ANESTHESIOLOGY, V92, P1330, DOI 10.1097/00000542-200005000-00022; Gozdemir M, 2010, J CLIN ANESTH, V22, P184, DOI 10.1016/j.jclinane.2009.06.006; Gupta M, 2014, J CLIN DIAGN RES, V8, P114, DOI 10.7860/JCDR/2014/7883.4023; Gupta M, 2016, PAIN PHYSICIAN, V19, pE411; Gupta R, 2011, INDIAN J ANAESTH, V55, P347, DOI 10.4103/0019-5049.84841; Halder S, 2014, J CLIN DIAGN RES, V8, DOI 10.7860/JCDR/2014/9670.5118; Han Chuanbao, 2014, Zhonghua Yi Xue Za Zhi, V94, P3501; Hanoura SE, 2014, EGYPT J ANAESTH, V30, P353, DOI 10.1016/j.egja.2014.03.004; HARADA Y, 1995, ANESTHESIOLOGY, V83, P344, DOI 10.1097/00000542-199508000-00015; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Hou JB, 2012, NEURAL REGEN RES, V7, P1765, DOI 10.3969/j.issn.1673-5374.2012.23.001; Ioannidis JPA, 2007, BRIT MED J, V335, P914, DOI 10.1136/bmj.39343.408449.80; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Jain D, 2012, SOUTH AFR J ANAESTH, V18, P105, DOI 10.1080/22201173.2012.10872835; Konakci S, 2008, EUR J ANAESTH, V25, P403, DOI 10.1017/S0265021507003079; Kose EA, 2013, J CLIN ANESTH, V25, P275, DOI 10.1016/j.jclinane.2012.11.014; Kranke P, 2004, ANESTH ANALG, V99, P718, DOI 10.1213/01.ANE.0000130589.00098.CD; Kranke P, 2002, ANESTH ANALG, V94, P453, DOI 10.1097/00000539-200202000-00043; Lewis SR, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011107.pub2; Li Z, 2015, DRUG RES, V65, P581, DOI 10.1055/s-0034-1395614; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Liu ZX, 2015, CAN J ANESTH, V62, P816, DOI 10.1007/s12630-015-0368-1; Moawad HE, 2015, EGYPT J ANAESTH, V31, P181, DOI 10.1016/j.egja.2015.01.001; Moher D, 2009, PHYS THER, V89, P873, DOI 10.1093/ptj/89.9.873; Naaz S, 2016, J CLIN DIAGNOSTIC RE, V10; Nethra SS, 2015, INDIAN J ANAESTH, V59, P177, DOI 10.4103/0019-5049.153040; Niu XY, 2013, CNS NEUROSCI THER, V19, P897, DOI 10.1111/cns.12172; Patro SS, 2016, J CLIN DIAGNOSTIC RE, V10; Qi XF, 2016, BIOL PHARM BULL, V39, P1455, DOI 10.1248/bpb.b16-00145; Qi XF, 2016, INT J CLIN PHARM TH, V54, P185, DOI 10.5414/CP202427; Safavi M, 2014, J RES PHARM PRACT, V3, P94, DOI 10.4103/2279-042X.141105; Sagir O, 2007, ACTA ANAESTH SCAND, V51, P44, DOI 10.1111/j.1399-6576.2006.01196.x; Samantaray A, 2015, PAIN PHYSICIAN, V18, P71; Salgado PFS, 2008, REV ASSOC MED BRAS, V54, P110, DOI 10.1590/S0104-42302008000200011; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Schwarzkopf KRG, 2001, ANESTH ANALG, V92, P257; Shaikh SI, 2014, ANAESTH PAIN INTENSI, V18, P180; Shaikh Safiya I, 2016, J Anaesthesiol Clin Pharmacol, V32, P203, DOI 10.4103/0970-9185.182104; Shukla U, 2011, INDIAN J ANAESTH, V55, P242, DOI 10.4103/0019-5049.82666; Sun Y, 2015, DRUG RES, V65, P468, DOI 10.1055/s-0034-1387740; Suresh G, 2016, SRI LANKAN J ANAESTH, V24, P22, DOI 10.4038/slja.v24i1.8111; Talke P, 1997, ANESTHESIOLOGY, V87, P835, DOI 10.1097/00000542-199710000-00017; Tamagaki S, 2010, J PHARM PHARMACOL, V62, P1760, DOI 10.1111/j.2042-7158.2010.01192.x; VIRTANEN R, 1988, EUR J PHARMACOL, V150, P9, DOI 10.1016/0014-2999(88)90744-3; Wu HH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093114; Zhang CS, 2016, J CLIN PHARMACOL, V56, P827, DOI 10.1002/jcph.666	56	11	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183154	10.1371/journal.pone.0183154	http://dx.doi.org/10.1371/journal.pone.0183154			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829798	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100030
J	Ebina, K; Hirao, M; Takagi, K; Ueno, S; Morimoto, T; Matsuoka, H; Kitaguchi, K; Iwahashi, T; Hashimoto, J; Yoshikawa, H				Ebina, Kosuke; Hirao, Makoto; Takagi, Keishi; Ueno, Sachi; Morimoto, Tokimitsu; Matsuoka, Hozo; Kitaguchi, Kazuma; Iwahashi, Toru; Hashimoto, Jun; Yoshikawa, Hideki			Comparison of the effects of forefoot joint-preserving arthroplasty and resection-replacement arthroplasty on walking plantar pressure distribution and patient-based outcomes in patients with rheumatoid arthritis	PLOS ONE			English	Article							FOOT; ANKLE; DEFORMITIES; POSITION; SURGERY	Purpose The purpose of this retrospective study is to clarify the difference in plantar pressure distribution during walking and related patient-based outcomes between forefoot joint-preserving arthroplasty and resection-replacement arthroplasty in patients with rheumatoid arthritis (RA). Methods Four groups of patients were recruited. Group1 included 22 feet of 11 healthy controls (age 48.6 years), Group2 included 36 feet of 28 RA patients with deformed non-operated feet (age 64.8 years, Disease activity score assessing 28 joints with CRP [DAS28-CRP] 2.3), Group3 included 27 feet of 20 RA patients with metatarsal head resection-replacement arthroplasty (age 60.7 years, post-operative duration 5.6 years, DAS28-CRP 2.4), and Group4 included 34 feet of 29 RA patients with metatarsophalangeal (MTP) joint-preserving arthroplasty (age 64.6 years, post-operative duration 3.2 years, DAS28-CRP 2.3). Patients were cross-sectionally examined by F-SCAN II to evaluate walking plantar pressure, and the self-administered foot evaluation questionnaire (SAFE-Q). Twenty joint-preserving arthroplasty feet were longitudinally examined at both pre- and post-operation. Results In the 1st MTP joint, Group4 showed higher pressure distribution (13.7%) than Group2 (8.0%) and Group3 (6.7%) (P<0.001). In the 2nd-3rd MTP joint, Group4 showed lower pressure distribution (9.0%) than Group2 (14.5%) (P<0.001) and Group3 (11.5%) (P<0.05). On longitudinal analysis, Group4 showed increased 1st MTP joint pressure (8.5% vs. 14.7%; P<0.001) and decreased 2nd-3rd MTP joint pressure (15.2% vs. 10.7%; P<0.01) distribution. In the SAFE-Q subscale scores, Group4 showed higher scores than Group3 in pain and pain-related scores (84.1 vs. 71.7; P<0.01) and in shoe-related scores (62.5 vs. 43.1; P< 0.01). Conclusions Joint-preserving arthroplasty resulted in higher 1st MTP joint and lower 2nd-3rd MTP joint pressures than resection-replacement arthroplasty, which were associated with better patient-based outcomes.	[Ebina, Kosuke; Hirao, Makoto; Matsuoka, Hozo; Kitaguchi, Kazuma; Iwahashi, Toru; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan; [Takagi, Keishi; Ueno, Sachi] Osaka Univ, Grad Sch Med, Dept Rehabil, Suita, Osaka, Japan; [Morimoto, Tokimitsu] Suita Municipal Hosp, Dept Orthopaed Surg, Osaka, Japan; [Hashimoto, Jun] Osaka Minami Med Ctr, Natl Hosp Org, Dept Rheumatol, Kawachi Nagano, Osaka, Japan	Osaka University; Osaka University	Ebina, K (corresponding author), Osaka Univ, Grad Sch Med, Dept Orthopaed Surg, Suita, Osaka, Japan.	k-ebina@umin.ac.jp	Ebina, Kosuke/AAH-6171-2019	Ebina, Kosuke/0000-0002-2426-1024				Collins NS, 2016, OSTEOARTHRITIS CARTI; Coughlin MJ, 2000, J BONE JOINT SURG AM, V82A, P322, DOI 10.2106/00004623-200003000-00004; Ebina K, 2016, MOD RHEUMATOL, P1; Farrow SJ, 2005, ARTHRIT RHEUM-ARTHR, V53, P593, DOI 10.1002/art.21327; Hanyu T, 1997, CLIN ORTHOP RELAT R, P131; Hiraiwa M., 2016, MOD RHEUMATOL, P1, DOI 10.1088/0960-1317/25/5/055013; Hirao M, 2017, MOD RHEUMATOL, P1; Jaakkola JI, 2004, FOOT ANKLE INT, V25, P866, DOI 10.1177/107110070402501205; Jeng C, 2008, FOOT ANKLE INT, V29, P959, DOI 10.3113/FAI.2008.0959; Kristen KH, 2002, FOOT ANKLE INT, V23, P221, DOI 10.1177/107110070202300306; Kumar C Senthil, 2007, Foot Ankle Clin, V12, P405; Mann RA, 1996, RHEUM DIS CLIN N AM, V22, P457, DOI 10.1016/S0889-857X(05)70282-9; MICHELSON J, 1994, FOOT ANKLE INT, V15, P608, DOI 10.1177/107110079401501106; Niki H, 2015, MOD RHEUMATOL, V25, P683, DOI 10.3109/14397595.2015.1008672; Niki H, 2013, J ORTHOP SCI, V18, P298, DOI 10.1007/s00776-012-0337-2; Rolfson O, 2016, ACTA ORTHOP, V87, P3, DOI 10.1080/17453674.2016.1181815; Roukis TS, 2010, J FOOT ANKLE SURG, V49, P390, DOI 10.1053/j.jfas.2010.02.023; Roy K J, 1988, Clin Podiatr Med Surg, V5, P491; Schaff P S, 1993, Clin Podiatr Med Surg, V10, P403; Shi Kenrin, 2007, Mod Rheumatol, V17, P110, DOI 10.1007/s10165-006-0551-x; Shirzad K, 2011, J AM ACAD ORTHOP SUR, V19, P505, DOI 10.5435/00124635-201108000-00006; Silvester RN, 2010, J FOOT ANKLE RES, V3, DOI 10.1186/1757-1146-3-24; STOKES IAF, 1979, CLIN ORTHOP RELAT R, P64; Tuna H, 2005, RHEUMATOL INT, V26, P42, DOI 10.1007/s00296-004-0504-7; van der Leeden M, 2006, RHEUMATOLOGY, V45, P465, DOI 10.1093/rheumatology/kei186; Vidmar G, 2009, INT J REHABIL RES, V32, P36, DOI 10.1097/MRR.0b013e328307bdc2; Weijers RE, 2003, FOOT ANKLE INT, V24, P349, DOI 10.1177/107110070302400408; Woodburn J, 1997, BRIT J RHEUMATOL, V36, P932; Woodburn J, 1996, ANN RHEUM DIS, V55, P806, DOI 10.1136/ard.55.11.806	29	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183805	10.1371/journal.pone.0183805	http://dx.doi.org/10.1371/journal.pone.0183805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850582	Green Published, Green Submitted, gold			2022-12-27	WOS:000408544200027
J	Turner, JS; Benet, ZL; Grigorova, I				Turner, Jackson S.; Benet, Zachary L.; Grigorova, Irina			Transiently antigen primed B cells can generate multiple subsets of memory cells	PLOS ONE			English	Article							GERMINAL-CENTERS; CLONAL SELECTION; PLASMA-CELLS; ANTIBODIES; AFFINITY	Memory B cells are long-lived cells that generate a more vigorous response upon recognition of antigen (Ag) and T cell help than naive B cells and ensure maintenance of durable humoral immunity. Functionally distinct subsets of murine memory B cells have been identified based on isotype switching of BCRs and surface expression of the co-stimulatory molecule CD80 and co-inhibitory molecule PD-L2. Memory B cells in a subpopulation with low surface expression of CD80 and PD-L2 are predominantly non-isotype switched and can be efficiently recruited into germinal centers (GCs) in secondary responses. In contrast, a CD80 and PD-L2 positive subset arises predominantly from GCs and can quickly differentiate into antibody-secreting plasma cells (PCs). Here we demonstrate that single transient acquisition of Ag by B cells may be sufficient for their long-term participation in GC responses and for development of various memory B cell subsets including CD80 and PD-L2 positive effector-like memory cells that rapidly differentiate into class-switched PCs during recall responses.	[Turner, Jackson S.; Benet, Zachary L.; Grigorova, Irina] Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Grigorova, I (corresponding author), Univ Michigan, Sch Med, Dept Microbiol & Immunol, Ann Arbor, MI 48109 USA.	igrigor@umich.edu	Grigorova, Irina/AAR-8795-2020	Grigorova, Irina/0000-0002-4963-7403	National Institutes of Health [R01 AI106806]; Herman and Dorothy Miller Award for Innovative Immunology Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106806] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Herman and Dorothy Miller Award for Innovative Immunology Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health grant R01 AI106806 to I.G. and by the Herman and Dorothy Miller Award for Innovative Immunology Research to J.S.T. and Z.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Good-Jacobson KL, 2010, J IMMUNOL, V185, P3117, DOI 10.4049/jimmunol.1001155; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Kaji T, 2012, J EXP MED, V209, P2079, DOI 10.1084/jem.20120127; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; LAVOIE TB, 1992, J IMMUNOL, V148, P503; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Onodera T, 2012, P NATL ACAD SCI USA, V109, P2485, DOI 10.1073/pnas.1115369109; Pape KA, 2011, SCIENCE, V331, P1203, DOI 10.1126/science.1201730; Shinnakasu R, 2016, NAT IMMUNOL, V17, P861, DOI 10.1038/ni.3460; Takahashi Y, 2001, IMMUNITY, V14, P181, DOI 10.1016/S1074-7613(01)00100-5; Taylor JJ, 2012, J EXP MED, V209, P597, DOI 10.1084/jem.20111696; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Turner JS, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15072; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Zuccarino-Catania GV, 2014, NAT IMMUNOL, V15, P631, DOI 10.1038/ni.2914	20	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183877	10.1371/journal.pone.0183877	http://dx.doi.org/10.1371/journal.pone.0183877			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850584	gold, Green Published, Green Submitted			2022-12-27	WOS:000408544200037
J	Barrantes, S; Egea, AJS; Rojas, HAG; Marti, MJ; Compta, Y; Valldeoriola, F; Mezquita, ES; Tolosa, E; Valls-Sole, J				Barrantes, Sergi; Sanchez Egea, Antonio J.; Gonzalez Rojas, Hernan A.; Marti, Maria J.; Compta, Yaroslau; Valldeoriola, Francesc; Simo Mezquita, Ester; Tolosa, Eduard; Valls-Sole, Josep			Differential diagnosis between Parkinson's disease and essential tremor using the smartphone's accelerometer	PLOS ONE			English	Article							PHYSIOLOGICAL TREMOR	Background The differential diagnosis between patients with essential tremor (ET) and those with Parkinson's disease (PD) whose main manifestation is tremor may be difficult unless using complex neuroimaging techniques such as I-123-FP-CIT SPECT. We considered that using smartphone's accelerometer to stablish a diagnostic test based on time-frequency differences between PD an ET could support the clinical diagnosis. Methods The study was carried out in 17 patients with PD, 16 patients with ET, 12 healthy volunteers and 7 patients with tremor of undecided diagnosis (TUD), who were re-evaluated one year after the first visit to reach the definite diagnosis. The smartphone was placed over the hand dorsum to record epochs of 30 s at rest and 30 s during arm stretching. We generated frequency power spectra and calculated receiver operating characteristics curves (ROC) curves of total spectral power, to establish a threshold to separate subjects with and without tremor. In patients with PD and ET, we found that the ROC curve of relative energy was the feature discriminating better between the two groups. This threshold was then used to classify the TUD patients. Results We could correctly classify 49 out of 52 subjects in the category with/without tremor (97.96% sensitivity and 83.3% specificity) and 27 out of 32 patients in the category PD/ET (84.38% discrimination accuracy). Among TUD patients, 2 of 2 PD and 2 of 4 ET were correctly classified, and one patient having PD plus ET was classified as PD. Conclusions Based on the analysis of smartphone accelerometer recordings, we found several kinematic features in the analysis of tremor that distinguished first between healthy subjects and patients and, ultimately, between PD and ET patients. The proposed method can give immediate results for the clinician to gain valuable information for the diagnosis of tremor. This can be useful in environments where more sophisticated diagnostic techniques are unavailable.	[Barrantes, Sergi; Marti, Maria J.; Compta, Yaroslau; Valldeoriola, Francesc; Tolosa, Eduard; Valls-Sole, Josep] UB, Sch Med, Barcelona, Catalonia, Spain; [Sanchez Egea, Antonio J.; Gonzalez Rojas, Hernan A.] Politech Univ Catalonia UPC, Mech Engn Dept EPSEVG, Barcelona, Spain; [Marti, Maria J.; Compta, Yaroslau; Valldeoriola, Francesc] CIBERNED Barcelona, Hosp Clin IDIBAPS, Dept Neurol, Parkinsons Dis & Movement disorder Unit, Catalonia, Spain; [Simo Mezquita, Ester] Politech Univ Catalonia UPC, Math Dept EPSEVG, Barcelona, Spain; [Valls-Sole, Josep] Hosp Clin Barcelona, Dept Neurol, EMG & Motor Control Unit, Barcelona, Spain	University of Barcelona; Universitat Politecnica de Catalunya; CIBERNED; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Universitat Politecnica de Catalunya; University of Barcelona; Hospital Clinic de Barcelona	Valls-Sole, J (corresponding author), UB, Sch Med, Barcelona, Catalonia, Spain.; Valls-Sole, J (corresponding author), Hosp Clin Barcelona, Dept Neurol, EMG & Motor Control Unit, Barcelona, Spain.	jvalls@clinic.cat	Egea, Antonio J. Sánchez/S-4790-2016; Compta, Yaroslau/U-8298-2017	Egea, Antonio J. Sánchez/0000-0001-8085-6869; Compta, Yaroslau/0000-0001-6443-0104; Valls-Sole, Josep/0000-0001-6779-0156; Simo, Ester/0000-0003-4587-7028; Gonzalez Rojas, Hernan Alberto/0000-0001-8911-0115				Antonini A, 2008, MOVEMENT DISORD, V23, P2202, DOI 10.1002/mds.22278; Bain P, 2000, NEUROLOGY, V54, pS7; Brittain JS, 2015, J NEUROSCI, V35, P795, DOI 10.1523/JNEUROSCI.3768-14.2015; Daneault JF, 2013, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00357; Fahn S, 1993, MOVEMENT DISORD, V2, P271; GE Healthcare Inc, 2017, OMNIPAQUE IOH INJ; Halliday DM, 1995, PROG BIOPHYS MOL BIO, V64, P237, DOI 10.1016/S0079-6107(96)00009-0; Helmich RC, 2013, CURR NEUROL NEUROSCI, P13; Hossen A, 2013, BIO-MED MATER ENG, V23, P513, DOI 10.3233/BME-130773; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Marti MJ, 2013, NAT REV NEUROL, V9, P190, DOI 10.1038/nrneurol.2013.47; Joundi RA, 2011, PARKINSONISM RELAT D, V17, P288, DOI 10.1016/j.parkreldis.2011.01.001; Kostikis N, 2015, IEEE J BIOMED HEALTH, V19, P1835, DOI 10.1109/JBHI.2015.2471093; Kostikis N, 2014, IEEE ENG MED BIO, P906, DOI 10.1109/EMBC.2014.6943738; Muthuraman M, 2011, MOVEMENT DISORD, V26, P1548, DOI 10.1002/mds.23672; Raethjen J, 2000, CLIN NEUROPHYSIOL, V111, P1825, DOI 10.1016/S1388-2457(00)00384-9; Raethjen J, 2004, CLIN NEUROPHYSIOL, V115, P2151, DOI 10.1016/j.clinph.2004.04.006; Senova S, 2015, STEREOT FUNCT NEUROS, V93, P94, DOI 10.1159/000369354; Thanawattano C, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0098-1; Tolosa E, 2006, LANCET NEUROL, V5, P75, DOI 10.1016/S1474-4422(05)70285-4; Trenado C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112782; Wile DJ, 2014, J NEUROSCI METH, V230, P1, DOI 10.1016/j.jneumeth.2014.04.021; Woods AM, 2014, PERVASIVE MOB COMPUT, V13, P1, DOI 10.1016/j.pmcj.2013.10.002; Zeuner KE, 2012, CURR OPIN NEUROL, V25, P475, DOI 10.1097/WCO.0b013e3283550c7e	24	44	45	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183843	10.1371/journal.pone.0183843	http://dx.doi.org/10.1371/journal.pone.0183843			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841694	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700062
J	Lera, SC; Sornette, D				Lera, Sandro Claudio; Sornette, Didier			Quantification of the evolution of firm size distributions due to mergers and acquisitions	PLOS ONE			English	Article							COAGULATION EQUATIONS; MODELS; BUSINESS; SIMILARITY; SELECTION; GROWTH; POLICY	The distribution of firm sizes is known to be heavy tailed. In order to account for this stylized fact, previous economic models have focused mainly on growth through investments in a company's own operations (internal growth). Thereby, the impact of mergers and acquisitions (M&A) on the firm size (external growth) is often not taken into consideration, notwithstanding its potential large impact. In this article, we make a first step into accounting for M&A. Specifically, we describe the effect of mergers and acquisitions on the firm size distribution in terms of an integro-differential equation. This equation is subsequently solved both analytically and numerically for various initial conditions, which allows us to account for different observations of previous empirical studies. In particular, it rationalises shortcomings of past work by quantifying that mergers and acquisitions develop a significant influence on the firm size distribution only over time scales much longer than a few decades. This explains why M&A has apparently little impact on the firm size distributions in existing data sets. Our approach is very flexible and can be extended to account for other sources of external growth, thus contributing towards a holistic understanding of the distribution of firm sizes.	[Lera, Sandro Claudio] Swiss Fed Inst Technol, Singapore ETH Ctr, Singapore, Singapore; [Lera, Sandro Claudio; Sornette, Didier] Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland; [Sornette, Didier] Swiss Finance Inst, Geneva, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Geneva	Lera, SC (corresponding author), Swiss Fed Inst Technol, Singapore ETH Ctr, Singapore, Singapore.; Lera, SC (corresponding author), Swiss Fed Inst Technol, Dept Management Technol & Econ, Zurich, Switzerland.	slera@ethz.ch			NRF's Campus for Research Excellence and Technological Enterprise (CREATE) programme	NRF's Campus for Research Excellence and Technological Enterprise (CREATE) programme	We are thankful to M. Takayasu for providing us with information from the Japanese TDB database. The research performed by one of us (SCL), which is reported in this article, was conducted at the Future Resilient Systems at the Singapore-ETH Centre (SEC). The SEC was established as a collaboration between ETH Zurich and the National Research Foundation (NRF) Singapore (FI 370074011) under the auspices of the NRF's Campus for Research Excellence and Technological Enterprise (CREATE) programme.	Aaronovitch S, 1975, BIG BUSINESS THEORET; Aldous DJ, 1999, BERNOULLI, V5, P3, DOI 10.2307/3318611; Axtell R. L., 2008, ECON BULL, V12, P1; Cabral LMB, 2003, AM ECON REV, V93, P1075, DOI 10.1257/000282803769206205; Cefis E, 2009, J EVOL ECON, V19, P1, DOI 10.1007/s00191-008-0105-9; da Costa FP, 2015, CIM SER MATH SCI, V2, P83, DOI 10.1007/978-3-319-16121-1_5; Davis SJ, 1996, SMALL BUS ECON, V8, P297, DOI 10.1007/BF00393278; de Wit G, 2005, INT J IND ORGAN, V23, P423, DOI 10.1016/j.ijindorg.2005.01.012; Embrechts P, 2013, MODELLING EXTREMAL E; Gabaix X, 1999, Q J ECON, V114, P739, DOI 10.1162/003355399556133; Gabaix X, 2015, NATL BUREAU EC RES; Gabaix X, 2011, ECONOMETRICA, V79, P733, DOI 10.3982/ECTA8769; GERTLER M, 1994, Q J ECON, V109, P309, DOI 10.2307/2118465; Gilbrat R., 1931, LIBRAIRIE RECUEIL SI; Grossman GM, 1993, INNOVATION AND GROWT; HANNAH L, 1981, J IND ECON, V29, P305, DOI 10.2307/2098306; Hannah L, 1977, CONCENTRATION MODERN; Harford J, 2005, J FINANC ECON, V77, P529, DOI 10.1016/j.jfineco.2004.05.004; HART PE, 1979, J IND ECON, V27, P211, DOI 10.2307/2098318; HENDRIKS EM, 1983, J STAT PHYS, V31, P519, DOI 10.1007/BF01019497; IJIRI Y, 1974, J POLIT ECON, V82, P315, DOI 10.1086/260194; IJIRI Y, 1971, J POLIT ECON, V79, P314, DOI 10.1086/259745; Kummer C., 2008, STRATEGIC MANAGEMENT, V2, P44; Laskin N, 2003, COMMUN NONLINEAR SCI, V8, P201, DOI 10.1016/S1007-5704(03)00037-6; Lee MH, 2000, ICARUS, V143, P74, DOI 10.1006/icar.1999.6239; Leyvraz F, 2003, PHYS REP, V383, P95, DOI 10.1016/S0370-1573(03)00241-2; Luttmer EGJ, 2007, Q J ECON, V122, P1103, DOI 10.1162/qjec.122.3.1103; Luttmer EGJ, 2011, REV ECON STUD, V78, P1042, DOI 10.1093/restud/rdq028; Malevergne Y, 2013, J ECON DYN CONTROL, V37, P1195, DOI 10.1016/j.jedc.2013.02.004; Malevergne Y., 2009, NAT BUREAU EC RES, V15295, DOI [10.3386/w15295, DOI 10.3386/W15295]; Malevergne Y, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.036111; Menon G, 2004, COMMUN PUR APPL MATH, V57, P1197, DOI 10.1002/cpa.3048; Menon G, 2006, SIAM REV, V48, P745, DOI 10.1137/060662496; Mimouni Z, 2009, PHYSICA A, V388, P1067, DOI 10.1016/j.physa.2008.12.064; MONTROLL EW, 1982, P NATL ACAD SCI USA, V79, P3380, DOI 10.1073/pnas.79.10.3380; Myshkis A. D., 2005, J MATH SC, V129, P4111, DOI DOI 10.1007/S10958-005-0345-2; Niethammer B, 2013, COMMUN MATH PHYS, V318, P505, DOI 10.1007/s00220-012-1553-5; Pagano P, 2003, SCAND J ECON, V105, P255, DOI 10.1111/1467-9442.t01-1-00008; Repin O.N., 2000, QUANTUM ELECTRON, V43, P738, DOI DOI 10.1023/A:1004890226863; Saichev A., 2010, THEORY ZIPFS LAW, P9; Saichev AI, 1997, CHAOS, V7, P753, DOI 10.1063/1.166272; Schenk H., 2005, MULTIDISCIPLINARY EC, P333; Segarra A, 2012, J ECON BEHAV ORGAN, V82, P314, DOI 10.1016/j.jebo.2012.02.012; SINGH A, 1975, ECON J, V85, P497, DOI 10.2307/2230895; Smoluchowski M., 1917, Z PHYS CHEM, V92, P129, DOI [10.1515/zpch-1918-9209, DOI 10.1515/ZPCH-1918-9209]; Smoluchowski M., 1916, Z PHYS, V17, P557; SORNETTE D, 2004, SPRINGER SERIES SYNE, P1; Steindl Josef., 1965, RANDOM PROCESSES GRO; Sutton J, 1997, J ECON LIT, V35, P40; Takayasu M, 2014, J STAT PHYS, V155, P47, DOI 10.1007/s10955-014-0956-4; Wattis JAD, 2006, PHYSICA D, V222, P1, DOI 10.1016/j.physd.2006.07.024; Wyart M, 2003, PHYSICA A, V326, P241, DOI 10.1016/S0378-4371(03)00267-X; Zambrano E, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0789	53	3	3	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183627	10.1371/journal.pone.0183627	http://dx.doi.org/10.1371/journal.pone.0183627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841683	Green Published, gold			2022-12-27	WOS:000408370700044
J	Melville, GW; Siegler, JC; Marshall, PWM				Melville, Geoffrey W.; Siegler, Jason C.; Marshall, Paul W. M.			The effects of d-aspartic acid supplementation in resistance-trained men over a three month training period: A randomised controlled trial	PLOS ONE			English	Article							SPINAL REFLEX EXCITABILITY; HUMAN SKELETAL-MUSCLE; CROSS-SECTIONAL AREA; PODARCIS-S.-SICULA; NEURAL ADAPTATION; GLUTAMATE TRANSPORTER; AROMATASE-ACTIVITY; HOFFMANN REFLEX; AMINO-ACID; H-REFLEX	Context Research on d-aspartic acid (DAA) has demonstrated increases in total testosterone levels in untrained men, however research in resistance-trained men demonstrated no changes, and reductions in testosterone levels. The long-term consequences of DAA in a resistance trained population are currently unknown. Objective To evaluate the effectiveness of DAA to alter basal testosterone levels over 3 months of resistance training in resistance-trained men. Design Randomised, double-blind, placebo controlled trial in healthy resistance-trained men, aged 18-36, had been performing regular resistance training exercise for at least 3 d. w(-1) for the previous 2 years. Randomised participants were 22 men (d-aspartic acid n = 11; placebo n = 11) (age, 23.8 +/- 4.9 y, training age, 3.2 +/- 1.5 y). Intervention D-aspartic acid (6 g. d(-1), DAA) versus equal-weight, visually-matched placebo (PLA). All participants performed 12 weeks of supervised, periodised resistance training (4 d. w(-1)), with a program focusing on all muscle groups. Measures Basal hormones, total testosterone (TT), free testosterone (FT), estradiol (E2), sex-hormone- binding globulin (SHBG) and albumin (ALB); isometric strength; calf muscle crosssectional area (CSA); calf muscle thickness; quadriceps muscle CSA; quadriceps muscle thickness; evoked V-wave and H-reflexes, were assessed at weeks zero (T1), after six weeks (T2) and after 12 weeks (T3). Results No change in basal TT or FT were observed after the intervention. DAA supplementation (n = 10) led to a 16%, 95% CI [-27%, -5%] reduction in E2 from T1-T3 (p< 0.01). The placebo group ( n = 9) demonstrated improvements in spinal responsiveness (gastrocnemius) at the level of the alpha motoneuron. Both groups exhibited increases in isometric strength of the plantar flexors by 17%, 95% CI [7%, 28%] (p< 0.05) as well as similar increases in hypertrophy in the quadriceps and calf muscles. Conclusions The results of this paper indicate that DAA supplementation is ineffective at changing testosterone levels, or positively affecting training outcomes. Reductions in estradiol and the blunting of peripheral excitability appear unrelated to improvements from resistance training.	[Melville, Geoffrey W.; Siegler, Jason C.; Marshall, Paul W. M.] Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia	Western Sydney University	Melville, GW (corresponding author), Western Sydney Univ, Sch Sci & Hlth, Sydney, NSW, Australia.	g.melville@hotmail.com		Siegler, Jason/0000-0003-1346-4982; Melville, Geoffrey/0000-0003-2819-6853				Aagaard P, 2003, EXERC SPORT SCI REV, V31, P61, DOI 10.1097/00003677-200304000-00002; Aagaard P, 2002, J APPL PHYSIOL, V92, P2309, DOI 10.1152/japplphysiol.01185.2001; Adkins DL, 2006, J APPL PHYSIOL, V101, P1776, DOI 10.1152/japplphysiol.00515.2006; Assisi L, 2001, REPRODUCTION, V121, P803, DOI 10.1530/rep.0.1210803; BERG HE, 1993, ACTA PHYSIOL SCAND, V148, P379, DOI 10.1111/j.1748-1716.1993.tb09573.x; Bonifazi M, 2004, BRAIN RES, V1011, P187, DOI 10.1016/j.brainres.2004.03.022; Carroll TJ, 2009, ACTA PHYSIOL, V197, P161, DOI 10.1111/j.1748-1716.2009.01992.x; Carroll TJ, 2002, J PHYSIOL-LONDON, V544, P641, DOI 10.1113/jphysiol.2002.024463; D'Aniello A, 2000, FASEB J, V14, P699, DOI 10.1096/fasebj.14.5.699; D'Aniello A, 2007, BRAIN RES REV, V53, P215, DOI 10.1016/j.brainresrev.2006.08.005; D'Aniello G., 2012, ADV SEX MED, V2, P47, DOI [10.4236/asm.2012.24008, DOI 10.4236/ASM.2012.24008]; D'Aniello S, 2011, FASEB J, V25, P1014, DOI 10.1096/fj.10-168492; DAniello A, 1996, LIFE SCI, V59, P97, DOI 10.1016/0024-3205(96)00266-4; Del Balso C, 2007, J APPL PHYSIOL, V103, P402, DOI 10.1152/japplphysiol.00477.2006; del Olmo MF, 2006, EUR J APPL PHYSIOL, V96, P722, DOI 10.1007/s00421-006-0153-5; Dragert K, 2011, EXP BRAIN RES, V208, P217, DOI 10.1007/s00221-010-2472-3; DUNLOP DS, 1986, BIOCHEM BIOPH RES CO, V141, P27, DOI 10.1016/S0006-291X(86)80329-1; ENGELSEN B, 1986, ACTA NEUROL SCAND, V74, P337; Ferrando AA, 1998, AM J PHYSIOL-ENDOC M, V275, pE864; Gonzalez AM, 2016, SPORTS MED, V46, P671, DOI 10.1007/s40279-015-0450-4; Herbst KL, 2004, CURR OPIN CLIN NUTR, V7, P271, DOI 10.1097/00075197-200405000-00006; INOUE K, 1994, EUR J APPL PHYSIOL O, V69, P88, DOI 10.1007/BF00867933; KANAI Y, 1992, NATURE, V360, P467, DOI 10.1038/360467a0; Koyama H, 2005, LIFE SCI, V76, P2933, DOI 10.1016/j.lfs.2004.10.057; Lagerquist O, 2006, J APPL PHYSIOL, V100, P83, DOI 10.1152/japplphysiol.00533.2005; Lamanna C, 2007, AMINO ACIDS, V32, P45, DOI 10.1007/s00726-006-0351-9; Liu Y, 2003, J APPL PHYSIOL, V94, P2282, DOI 10.1152/japplphysiol.00830.2002; MAUGHAN RJ, 1983, J PHYSIOL-LONDON, V338, P37, DOI 10.1113/jphysiol.1983.sp014658; Melville GW, 2015, J INT SOC SPORT NUTR, V15, DOI 10.1186/s12970-015-0078-7; Nagata Y, 1999, FEBS LETT, V444, P160, DOI 10.1016/S0014-5793(99)00045-9; NEIDLE A, 1990, LIFE SCI, V46, P1517, DOI 10.1016/0024-3205(90)90424-P; Noorkoiv M, 2010, EUR J APPL PHYSIOL, V109, P631, DOI 10.1007/s00421-010-1402-1; Nordlund MM, 2010, J APPL PHYSIOL, V109, P19; Ota N, 2012, AMINO ACIDS, V43, P1873, DOI 10.1007/s00726-012-1364-1; Raucci F, 2005, J ENDOCRINOL, V187, P347, DOI 10.1677/joe.1.06115; SALE DG, 1983, EXP NEUROL, V82, P521, DOI 10.1016/0014-4886(83)90077-8; SCHIEPPATI M, 1987, PROG NEUROBIOL, V28, P345, DOI 10.1016/0301-0082(87)90007-4; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Topo E, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-120; Van Cutsem M, 1998, J PHYSIOL-LONDON, V513, P295, DOI 10.1111/j.1469-7793.1998.295by.x; Vermeulen A, 1999, J CLIN ENDOCR METAB, V84, P3666, DOI 10.1210/jc.84.10.3666; Vila-Cha C, 2012, J APPL PHYSIOL, V112, P54, DOI 10.1152/japplphysiol.00802.2011; West DWD, 2010, INT J BIOCHEM CELL B, V42, P1371, DOI 10.1016/j.biocel.2010.05.012; Willoughby DS, 2013, NUTR RES, V33, P803, DOI 10.1016/j.nutres.2013.07.010; Zehr EP, 2002, EUR J APPL PHYSIOL, V86, P455, DOI 10.1007/s00421-002-0577-5	45	16	16	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182630	10.1371/journal.pone.0182630	http://dx.doi.org/10.1371/journal.pone.0182630			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841667	gold, Green Published			2022-12-27	WOS:000408370700007
J	Vogel, C; Lewis, D; Ntani, G; Cummins, S; Cooper, C; Moon, G; Baird, J				Vogel, Christina; Lewis, Daniel; Ntani, Georgia; Cummins, Steven; Cooper, Cyrus; Moon, Graham; Baird, Janis			The relationship between dietary quality and the local food environment differs according to level of educational attainment: A cross-sectional study	PLOS ONE			English	Article							HEALTH; EXPOSURE; OBESITY; INEQUALITIES; DENSITY; WOMEN; FRUIT; AREA	There is evidence that food outlet access differs according to level of neighbourhood deprivation but little is known about how individual circumstances affect associations between food outlet access and diet. This study explored the relationship between dietary quality and a measure of overall food environment, representing the balance between healthy and unhealthy food outlet access in individualised activity spaces. Furthermore, this study is the first to assess effect modification of level of educational attainment on this relationship. A total of 839 mothers with young children from Hampshire, United Kingdom (UK) completed a cross-sectional survey including a 20-item food frequency questionnaire to measure diet and questions about demographic characteristics and frequently visited locations including home, children's centre, general practitioner, work, main food shop and physical activity location. Dietary information was used to calculate a standardised dietary quality score for each mother. Individualised activity spaces were produced by creating a 1000m buffer around frequently visited locations using ArcGIS. Cross-sectional observational food outlet data were overlaid onto activity spaces to derive an overall food environment score for each mother. These scores represented the balance between healthy and unhealthy food outlets using weightings to characterise the proportion of healthy or unhealthy foods sold in each outlet type. Food outlet access was dominated by the presence of unhealthy food outlets; only 1% of mothers were exposed to a healthy overall food environment in their daily activities. Level of educational attainment moderated the relationship between overall food environment and diet (mid vs low, p = 0.06; high vs low, p = 0.04). Adjusted stratified linear regression analyses showed poorer food environments were associated with better dietary quality among mothers with degrees (beta = -0.02; 95% CI: -0.03, -0.001) and a tendency toward poorer dietary quality among mothers with low educational attainment, however this relationship was not statistically significant (beta = 0.01; 95% CI: -0.01, 0.02). This study showed that unhealthy food outlets, like takeaways and convenience stores, dominated mothers' food outlet access, and provides some empirical evidence to support the concept that individual characteristics, particularly educational attainment, are protective against exposure to unhealthy food environments. Improvements to the imbalance of healthy and unhealthy food outlets through planning restrictions could be important to reduce dietary inequalities.	[Vogel, Christina; Ntani, Georgia; Cooper, Cyrus; Baird, Janis] Univ Southampton, Southampton Gen Hosp, Lifecourse Epidemiol Unit, MRC, Tremona Rd, Southampton, Hants, England; [Lewis, Daniel; Cummins, Steven] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, Dept Social & Environm Hlth Res, 15-17 Tavistock Pl, London, England; [Cooper, Cyrus] Univ Hosp Southampton NHS Fdn Trust, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Cooper, Cyrus] Univ Southampton, Southampton, Hants, England; [Moon, Graham] Univ Southampton, Geog & Environm, Southampton, Hants, England	University of Southampton; University of London; London School of Hygiene & Tropical Medicine; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Southampton	Vogel, C (corresponding author), Univ Southampton, Southampton Gen Hosp, Lifecourse Epidemiol Unit, MRC, Tremona Rd, Southampton, Hants, England.	cv@mrc.soton.ac.uk	Cummins, Steven/C-1230-2009	Cummins, Steven/0000-0002-3957-4357; Lewis, Daniel/0000-0002-2111-4256; Baird, Janis/0000-0002-4039-4361; Cooper, Cyrus/0000-0003-3510-0709; Vogel, Christina/0000-0002-3897-3786	United Kingdom National Institute for Health Research (NIHR) [CV 510981101]; United Kingdom Medical Research Council; NIHR Nutrition Biomedical Research Centre; University of Southampton and the European Union's Seventh Framework Programme; EarlyNutrition [289346]; MRC [MC_U147585819, MC_U147585827, MC_UU_12011/4, G0400491] Funding Source: UKRI; Medical Research Council [MC_U147585824, MC_UU_12011/1, MC_UU_12011/4, U1475000001, G0400491, MC_U147585819, MC_UP_A620_1014, MC_U147585827] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10082, NF-SI-0513-10085, DRF-2011-04-015] Funding Source: researchfish	United Kingdom National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Nutrition Biomedical Research Centre; University of Southampton and the European Union's Seventh Framework Programme; EarlyNutrition; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research and the authors of this paper are supported by the following funding sources: United Kingdom National Institute for Health Research (NIHR) fellowships (CV 510981101 and SC), United Kingdom Medical Research Council, the NIHR Nutrition Biomedical Research Centre (JB CC CV), University of Southampton and the European Union's Seventh Framework Programme (FP7/2007-2013), project EarlyNutrition under grant agreement no. 289346 (JB CC). The views expressed in this publication are those of the authors and not necessarily those of the funding organisations. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Allender S, 2007, OBES REV, V8, P467, DOI 10.1111/j.1467-789X.2007.00394.x; Bader MDM, 2013, HEALTH PLACE, V23, P104, DOI 10.1016/j.healthplace.2013.05.005; Baird J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005290; Ball K, 2006, PUBLIC HEALTH NUTR, V9, P623, DOI 10.1079/PHN2005897; Barker D, 2008, NUTR WOMB BETTER NUT; Barker M, 2011, J HEALTH PSYCHOL, V16, P178, DOI 10.1177/1359105310371397; Barker M, 2009, APPETITE, V52, P631, DOI 10.1016/j.appet.2009.02.011; Black C, 2014, HEALTH PLACE, V27, P229, DOI 10.1016/j.healthplace.2013.09.015; Bloom DE, 2011, GLOBAL EC BURDEN NON; BURGOINE T, 2013, INT J HEALTH GEOGR, V12; Burgoine T, 2016, AM J CLIN NUTR, V103, P1540, DOI 10.3945/ajcn.115.128132; Burgoine T, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1464; CAITLIN EC, 2012, HEALTH PLACE, V18, P1172, DOI DOI 10.1016/J.HEALTHPLACE.2012.05.006; Cetateanu A, 2016, SSM-POPUL HLTH, V2, P196, DOI 10.1016/j.ssmph.2016.04.001; Chaix B, 2012, AM J PREV MED, V43, P440, DOI 10.1016/j.amepre.2012.06.026; Charreire H, 2010, PUBLIC HEALTH NUTR, V13, P1773, DOI 10.1017/S1368980010000753; Christian WJ, 2012, SPAT SPATIO-TEMPORAL, V3, P287, DOI 10.1016/j.sste.2012.09.001; Clarke I. M, 2006, ENVIRON PLANN A, V38, P25; Clary CM, 2015, PREV MED, V71, P83, DOI 10.1016/j.ypmed.2014.11.023; Cobb LK, 2015, OBESITY, V23, P1331, DOI 10.1002/oby.21118; Crozier SR, 2010, EUR J CLIN NUTR, V64, P99, DOI 10.1038/ejcn.2009.114; Cummins S, 2005, J EPIDEMIOL COMMUN H, V59, P207, DOI 10.1136/jech.2003.016147; Cummins S, 2005, HEALTH PLACE, V11, P249, DOI 10.1016/j.healthplace.2004.05.003; Department of Health UK, 2010, OUR HLTH WELLB; E.S.R.I, 2012, ARCGIS; Food Standards Agency, 2010, GUIDANCE FOR FOOD HY; Franco M, 2015, J EPIDEMIOL COMMUN H, V69, P509, DOI 10.1136/jech-2014-203865; Glanz K, 2005, AM J HEALTH PROMOT, V19, P330, DOI 10.4278/0890-1171-19.5.330; Hampshire County Council, 2011, 2010 IND DEPR HAMPSH; Hawkes C, 2008, DEV POLICY REV, V26, P657, DOI 10.1111/j.1467-7679.2008.00428.x; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; Kestens Y, 2010, HEALTH PLACE, V16, P1094, DOI 10.1016/j.healthplace.2010.06.016; Kirkpatrick SI, 2014, AM J PREV MED, V46, P94, DOI 10.1016/j.amepre.2013.08.015; Kwate NOA, 2008, HEALTH PLACE, V14, P32, DOI 10.1016/j.healthplace.2007.04.001; Lake AA, 2010, HEALTH PLACE, V16, P666, DOI 10.1016/j.healthplace.2010.02.004; Larsen K, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-16; Latham P., 2006, NATL EVALUATION SURE; MACINTYRE S, 1993, J SOC POLICY, V22, P213, DOI 10.1017/S0047279400019310; Maguire ER, 2015, HEALTH PLACE, V33, P142, DOI 10.1016/j.healthplace.2015.02.012; MARTEAU TM, 2013, BMJ BRIT MED J, V347; Moudon AV, 2013, PUBLIC HEALTH NUTR, V16, P1238, DOI 10.1017/S1368980013000773; Noble M, 2008, ENGLISH INDICES DEPR; Perchoux C, 2013, HEALTH PLACE, V21, P86, DOI 10.1016/j.healthplace.2013.01.005; Public Health England, 2013, OB ENV REG GROWTH FA; Robinson SM, 2004, EUR J CLIN NUTR, V58, P1174, DOI 10.1038/sj.ejcn.1601946; ROSS CE, 1995, AM SOCIOL REV, V60, P719, DOI 10.2307/2096319; Shareck M., 2015, TOB CONTROL; StataCorp, 2013, STATA STAT SOFTW REL; Thornton LE, 2013, HEALTH PLACE, V24, P80, DOI 10.1016/j.healthplace.2013.08.006; Thornton LE, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.27; US National Institutes of Health, 2011, STRAT PLAN NIH OB RE; Vogel C, 2016, OSTEOPOROSIS INT, V27, P1011, DOI 10.1007/s00198-015-3340-6; Vogel C., 2016, AM J PREV MED	53	23	23	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183700	10.1371/journal.pone.0183700	http://dx.doi.org/10.1371/journal.pone.0183700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841678	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000408370700051
J	Xu, Y; Jiang, Y; Shi, T; Cai, HF; Lan, XY; Zhao, X; Plath, M; Chen, H				Xu, Yao; Jiang, Yu; Shi, Tao; Cai, Hanfang; Lan, Xianyong; Zhao, Xin; Plath, Martin; Chen, Hong			Whole-genome sequencing reveals mutational landscape underlying phenotypic differences between two widespread Chinese cattle breeds	PLOS ONE			English	Article							COPY NUMBER VARIATIONS; STRUCTURAL VARIATION; GENETIC ARCHITECTURE; WIDE ASSOCIATION; CARCASS MERIT; GROWTH TRAITS; SHORT-READ; POLYMORPHISMS; EXPRESSION; EVOLUTION	Whole-genome sequencing provides a powerful tool to obtain more genetic variability that could produce a range of benefits for cattle breeding industry. Nanyang (Bos indicus) and Qinchuan (Bos taurus) are two important Chinese indigenous cattle breeds with distinct phenotypes. To identify the genetic characteristics responsible for variation in phenotypes between the two breeds, in the present study, we for the first time sequenced the genomes of four Nanyang and four Qinchuan cattle with 10 to 12 fold on average of 97.86% and 98.98% coverage of genomes, respectively. Comparison with the Bos_taurus_UMD_3.1 reference assembly yielded 9,010,096 SNPs for Nanyang, and 6,965,062 for Qinchuan cattle, 51% and 29% of which were novel SNPs, respectively. A total of 154,934 and 115,032 small indels (1 to 3 bp) were found in the Nanyang and Qinchuan genomes, respectively. The SNP and indel distribution revealed that Nanyang showed a genetically high diversity as compared to Qinchuan cattle. Furthermore, a total of 2,907 putative cases of copy number variation (CNV) were identified by aligning Nanyang to Qinchuan genome, 783 of which (27%) encompassed the coding regions of 495 functional genes. The gene ontology (GO) analysis revealed that many CNV genes were enriched in the immune system and environment adaptability. Among several CNV genes related to lipid transport and fat metabolism, Lepin receptor gene (LEPR) overlapping with CNV_1815 showed remarkably higher copy number in Qinchuan than Nanyang (log(2) (ratio) = -2.34988; P value = 1.53E-102). Further qPCR and association analysis investigated that the copy number of the LEPR gene presented positive correlations with transcriptional expression and phenotypic traits, suggesting the LEPR CNV may contribute to the higher fat deposition in muscles of Qinchuan cattle. Our findings provide evidence that the distinct phenotypes of Nanyang and Qinchuan breeds may be due to the different genetic variations including SNPs, indels and CNV.	[Xu, Yao; Jiang, Yu; Shi, Tao; Cai, Hanfang; Lan, Xianyong; Zhao, Xin; Plath, Martin; Chen, Hong] Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China; [Xu, Yao] Wuhan Univ Sci & Technol, Inst Biol & Med, Coll Life Sci & Hlth, Wuhan, Hubei, Peoples R China	Northwest A&F University - China; Wuhan University of Science & Technology	Chen, H (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Shaanxi Key Lab Mol Biol Agr, Yangling, Shaanxi, Peoples R China.	chenhong1212@263.net	Zhao, Xin/M-4312-2015; Jiang, Yu/O-5114-2015	Zhao, Xin/0000-0002-1078-7332; Jiang, Yu/0000-0003-4821-3585	National Natural Science Foundation of China [30972080, 31272408, 31600617]; Program of the National Beef Cattle Industrial Technology System [CARS-38]; National 863 Program of China [2013AA102505]; Natural Science Foundation of Jiangsu Province [BK2011206]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of the National Beef Cattle Industrial Technology System; National 863 Program of China(National High Technology Research and Development Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Natural Science Foundation of China (Grant No. 30972080, 31272408, 31600617), the Program of the National Beef Cattle Industrial Technology System (CARS-38), the National 863 Program of China (Grant No. 2013AA102505), and the Natural Science Foundation of Jiangsu Province (BK2011206). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Natural Science Foundation of China (Grant No. 30972080, 31272408, 31600617), the Program of the National Beef Cattle Industrial Technology System (CARS-38), the National 863 Program of China (Grant No. 2013AA102505), and the Natural Science Foundation of Jiangsu Province (BK2011206).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bergen SE, 2012, MOL PSYCHIATR, V17, P880, DOI 10.1038/mp.2012.73; Bickhart DM, 2016, DNA RES, V23, P253, DOI 10.1093/dnares/dsw013; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Blattler A, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0469-0; Boerner V, 2015, J ANIM SCI, V93, P513, DOI 10.2527/jas.2014-8357; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chen WK, 2009, GENOME RES, V19, P500, DOI 10.1101/gr.083741.108; Crispell J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3569-x; Cucco DC, 2009, GENET MOL RES, V8, P291, DOI 10.4238/vol8-4gmr650; Du QZ, 2016, NEW PHYTOL, V209, P1067, DOI 10.1111/nph.13695; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; Eck SH, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r82; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Friedman JM, 2002, NUTR REV, V60, pS1, DOI 10.1301/002966402320634878; Geisler SB, 2007, GENOMICS, V89, P521, DOI 10.1016/j.ygeno.2006.12.004; Hill WG, 2000, LIVEST PROD SCI, V63, P99, DOI 10.1016/S0301-6226(99)00115-3; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Hou YL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-127; Hu ZL, 2007, NUCLEIC ACIDS RES, V35, pD604, DOI 10.1093/nar/gkl946; Islam KK, 2009, ANIM GENET, V40, P766, DOI 10.1111/j.1365-2052.2009.01912.x; Jeon JP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-426; Keel BN, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00207; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Larkin DM, 2012, P NATL ACAD SCI USA, V109, P7693, DOI 10.1073/pnas.1114546109; Lee KT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-519; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu GE, 2008, DEV BIOLOGICALS, V132, P231, DOI 10.1159/000317165; Liu GE, 2010, GENOME RES, V20, P693, DOI 10.1101/gr.105403.110; Liu YJ, 2004, PHYSIOL GENOMICS, V17, P101, DOI 10.1152/physiolgenomics.00213.2003; Mackay TFC, 2001, ANNU REV GENET, V35, P303, DOI 10.1146/annurev.genet.35.102401.090633; Matsuhashi T, 2011, J ANIM SCI, V89, P12, DOI 10.2527/jas.2010-3121; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Medeiros de Oliveira Silva R, 2017, PLOS ONE, V12; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Nkrumah JD, 2005, J ANIM SCI, V83, P20; Ohshima Kazuhiko, 2013, Int J Evol Biol, V2013, P424726, DOI 10.1155/2013/424726; Pannier L, 2010, MEAT SCI, V85, P515, DOI 10.1016/j.meatsci.2010.02.025; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; Rutherford SL, 2000, BIOESSAYS, V22, P1095, DOI 10.1002/1521-1878(200012)22:12&lt;1095::AID-BIES7&gt;3.0.CO;2-A; Scherer SW, 2007, NAT GENET, V39, pS7, DOI 10.1038/ng2093; Singleton AB, 2011, LANCET NEUROL, V10, P942, DOI 10.1016/S1474-4422(11)70196-X; Stafuzza N.B., 2017, PLOS ONE, V12; Stothard P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-559; Traherne JA, 2008, INT J IMMUNOGENET, V35, P179, DOI 10.1111/j.1744-313X.2008.00765.x; Uddin M, 2015, GENET MED, V17, P747, DOI 10.1038/gim.2014.178; Wang JY, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-273; Wright D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000512; Xu LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23161; Xu Y, 2014, GENE, V535, P106, DOI 10.1016/j.gene.2013.11.057; Xu Y, 2013, MAMM GENOME, V24, P508, DOI 10.1007/s00335-013-9483-x; Yang J, 2016, MOL BIOL EVOL, V33, P2576, DOI 10.1093/molbev/msw129; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	60	17	17	5	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183921	10.1371/journal.pone.0183921	http://dx.doi.org/10.1371/journal.pone.0183921			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841720	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700068
J	Beaver, LM; Truong, L; Barton, CL; Chase, TT; Gonnerman, GD; Wong, CP; Tanguay, RL; Ho, E				Beaver, Laura M.; Truong, Lisa; Barton, Carrie L.; Chase, Tyler T.; Gonnerman, Greg D.; Wong, Carmen P.; Tanguay, Robert L.; Ho, Emily			Combinatorial effects of zinc deficiency and arsenic exposure on zebrafish (Danio rerio) development	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA-DAMAGE; IN-VIVO; INTELLECTUAL FUNCTION; EMBRYONIC-DEVELOPMENT; GLUCOSE-HOMEOSTASIS; DRINKING-WATER; RAT; EXPRESSION; PREGNANCY	Zinc deficiency and chronic low level exposures to inorganic arsenic in drinking water are both significant public health concerns that affect millions of people including pregnant women. These two conditions can co-exist in the human population but little is known about their interaction, and in particular, whether zinc deficiency sensitizes individuals to arsenic exposure and toxicity, especially during critical windows of development. To address this, we utilized the Danio rerio (zebrafish) model to test the hypothesis that parental zinc deficiency sensitizes the developing embryo to low-concentration arsenic toxicity, leading to altered developmental outcomes. Adult zebrafish were fed defined zinc deficient and zinc adequate diets and were spawned resulting in zinc adequate and zinc deficient embryos. The embryos were treated with environmentally relevant concentrations of 0, 50, and 500 ppb arsenic. Arsenic exposure significantly reduced the amount of zinc in the developing embryo by similar to 7%. The combination of zinc deficiency and low-level arsenic exposures did not sensitize the developing embryo to increased developmental malformations or mortality. The combination did cause a 40% decline in physical activity of the embryos, and this decline was significantly greater than what was observed with zinc deficiency or arsenic exposure alone. Significant changes in RNA expression of genes that regulate zinc homeostasis, response to oxidative stress and insulin production (including zip1, znt7, nrf2, ogg1, pax4, and insa) were found in zinc deficient, or zinc deficiency and arsenic exposed embryos. Overall, the data suggests that the combination of zinc deficiency and arsenic exposure has harmful effects on the developing embryo and may increase the risk for developing chronic diseases like diabetes.	[Beaver, Laura M.; Chase, Tyler T.; Wong, Carmen P.; Ho, Emily] Oregon State Univ, Biol & Populat Hlth Sci, Corvallis, OR 97331 USA; [Beaver, Laura M.; Wong, Carmen P.; Tanguay, Robert L.; Ho, Emily] Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA; [Truong, Lisa; Barton, Carrie L.; Gonnerman, Greg D.; Tanguay, Robert L.] Oregon State Univ, Dept Environm & Mol Toxicol, Sinnhuber Aquat Res Lab, Corvallis, OR 97331 USA; [Truong, Lisa; Barton, Carrie L.; Gonnerman, Greg D.; Tanguay, Robert L.; Ho, Emily] Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA; [Tanguay, Robert L.; Ho, Emily] Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA; [Ho, Emily] Oregon State Univ, Moore Family Ctr Whole Grain Foods Nutr & Prevent, Corvallis, OR 97331 USA	Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University; Oregon State University	Ho, E (corresponding author), Oregon State Univ, Biol & Populat Hlth Sci, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Linus Pauling Inst, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Environm Hlth Sci Ctr, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Ctr Genome Res & Biocomp, Corvallis, OR 97331 USA.; Ho, E (corresponding author), Oregon State Univ, Moore Family Ctr Whole Grain Foods Nutr & Prevent, Corvallis, OR 97331 USA.	Emily.Ho@oregonstate.edu		Truong, Lisa/0000-0003-1751-4617	National Institute of Environmental Health Sciences [R21-ES023937, R01-ES021100-03S1, P30 ES000210]; Oregon Agricultural Experimental Station	National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Oregon Agricultural Experimental Station	Work conducted in the authors' laboratory is supported by and National Institute of Environmental Health Sciences grants R21-ES023937, R01-ES021100-03S1, P30 ES000210 as well as Oregon Agricultural Experimental Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul KSM, 2015, ENVIRON TOXICOL PHAR, V40, P828, DOI 10.1016/j.etap.2015.09.016; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; [Anonymous], 2014, LANG ENV STAT COMP; Bailey Kathryn, 2014, Reviews on Environmental Health, V29, P9, DOI 10.1515/reveh-2014-0006; Basaki M, 2012, BIOL TRACE ELEM RES, V148, P161, DOI 10.1007/s12011-012-9360-6; Beaver LM, 2017, J NUTR BIOCHEM, V43, P78, DOI 10.1016/j.jnutbio.2017.02.006; Bugel Sean M, 2014, Curr Environ Health Rep, V1, P341; Caulfield LE, 1998, AM J CLIN NUTR, V68, p499S, DOI 10.1093/ajcn/68.2.499S; Caulfield LE, COMP QUANTIFICATION; Chen J, 2016, TOXICOL SCI, V153, P124, DOI 10.1093/toxsci/kfw110; Collombat P, 2009, CELL, V138, P449, DOI 10.1016/j.cell.2009.05.035; Cooper KL, 2013, TOXICOL APPL PHARM, V269, P81, DOI 10.1016/j.taap.2013.03.008; Ding W, 2009, J BIOL CHEM, V284, P6809, DOI 10.1074/jbc.M805566200; Drummond IA, 1998, DEVELOPMENT, V125, P4655; Eide DJ, 2011, METALLOMICS, V3, P1124, DOI 10.1039/c1mt00064k; Ettinger AS, 2009, ENVIRON HEALTH PERSP, V117, P1059, DOI 10.1289/ehp0800533; Farzan SF, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0194-0; Franklin RB, 2003, J INORG BIOCHEM, V96, P435, DOI 10.1016/S0162-0134(03)00249-6; Fung EB, 2015, NUTRIENTS, V7, P4296, DOI 10.3390/nu7064296; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Garg Hemant K., 1993, Indian Journal of Physiology and Pharmacology, V37, P276; Hess SY, 2009, FOOD NUTR BULL, V30, pS60, DOI 10.1177/15648265090301S105; Ho E, 2003, J NUTR, V133, P2543, DOI 10.1093/jn/133.8.2543; Ho E, 2012, COMP BIOCHEM PHYS C, V155, P26, DOI 10.1016/j.cbpc.2011.05.002; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Huestis J, 2016, J INORG BIOCHEM, V163, P45, DOI 10.1016/j.jinorgbio.2016.08.003; JANKOWSKI MA, 1995, TERATOLOGY, V51, P85, DOI 10.1002/tera.1420510207; Jomova K, 2011, J APPL TOXICOL, V31, P95, DOI 10.1002/jat.1649; Jou MY, 2012, PEDIATR RES, V71, P228, DOI 10.1038/pr.2011.44; Jou MY, 2010, J NUTR, V140, P1621, DOI 10.3945/jn.109.119677; Jurowski K, 2014, J BIOL INORG CHEM, V19, P1069, DOI 10.1007/s00775-014-1139-0; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kile ML, 2016, EPIDEMIOLOGY, V27, P173, DOI 10.1097/EDE.0000000000000416; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kimmel RA, 2015, SCI REP-UK, V5, DOI 10.1038/srep14241; Kimmel RA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-75; Kirschke CP, 2003, J BIOL CHEM, V278, P4096, DOI 10.1074/jbc.M207644200; Kloubert V, 2015, FOOD FUNCT, V6, P3195, DOI [10.1039/C5FO00630A, 10.1039/c5fo00630a]; Kurita H, 2013, J NUTR BIOCHEM, V24, P256, DOI 10.1016/j.jnutbio.2012.05.013; Kwok RK, 2006, J HEALTH POPUL NUTR, V24, P190; Li B, 2014, J CELL MOL MED, V18, P895, DOI 10.1111/jcmm.12239; Truong L, 2014, TOXICOL SCI, V137, P212, DOI 10.1093/toxsci/kft235; LIU HJ, 1992, BIOL TRACE ELEM RES, V34, P55, DOI 10.1007/BF02783898; Lopez V, 2008, BIOL TRACE ELEM RES, V122, P238, DOI 10.1007/s12011-007-8079-2; Mandrell D, 2012, JALA-J LAB AUTOM, V17, P66, DOI 10.1177/2211068211432197; MEADOWS N, 1983, ARCH DIS CHILD, V58, P807, DOI 10.1136/adc.58.10.807; Milton AG, 2004, BIOMETALS, V17, P707, DOI 10.1007/s10534-004-1210-3; Morello-Frosch R, 2016, ENVIRON SCI TECHNOL, V50, P12464, DOI 10.1021/acs.est.6b03492; Myers SL, 2010, J EPIDEMIOL COMMUN H, V64, P325, DOI 10.1136/jech.2008.084392; Myers SA, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/173712; Naujokas MF, 2013, ENVIRON HEALTH PERSP, V121, P295, DOI 10.1289/ehp.1205875; Navas-Acien A, 2006, ENVIRON HEALTH PERSP, V114, P641, DOI 10.1289/ehp.8551; Olivares CI, 2016, CHEMOSPHERE, V148, P361, DOI 10.1016/j.chemosphere.2016.01.050; OTEIZA PI, 1990, BIOL TRACE ELEM RES, V24, P13, DOI 10.1007/BF02789137; Padmavathi IJN, 2009, EXP PHYSIOL, V94, P761, DOI 10.1113/expphysiol.2008.045856; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Pan WC, 2013, AM J EPIDEMIOL, V178, P1563, DOI 10.1093/aje/kwt195; Papasani MR, 2006, PHYSIOL GENOMICS, V27, P79, DOI 10.1152/physiolgenomics.00012.2006; Parvez F, 2011, ENVIRON HEALTH PERSP, V119, P1665, DOI 10.1289/ehp.1103548; PETERS JM, 1991, P SOC EXP BIOL MED, V198, P561; Pineda J, 2013, J TRACE ELEM MED BIO, V27, P236, DOI 10.1016/j.jtemb.2012.12.006; Prakash A, 2015, FUND CLIN PHARMACOL, V29, P131, DOI 10.1111/fcp.12110; Quansah R, 2015, ENVIRON HEALTH PERSP, V123, P412, DOI 10.1289/ehp.1307894; Rahman A, 2010, EPIDEMIOLOGY, V21, P797, DOI 10.1097/EDE.0b013e3181f56a0d; Rodrigues EG, 2016, ENVIRON HEALTH-GLOB, V15, DOI 10.1186/s12940-016-0127-y; Romualdo GR, 2016, FOOD CHEM TOXICOL, V96, P280, DOI 10.1016/j.fct.2016.08.020; Sen J, 2008, ARH HIG RADA TOKSIKO, V59, P271, DOI 10.2478/10004-1254-59-2008-1871; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; Song Y, 2009, J NUTR, V139, P1626, DOI 10.3945/jn.109.106369; Stephens WZ, 2016, ISME J, V10, P644, DOI 10.1038/ismej.2015.140; Timme-Laragy AR, 2012, J BIOL CHEM, V287, P4609, DOI 10.1074/jbc.M111.260125; Truong L, 2011, METHODS MOL BIOL, V691, P271, DOI 10.1007/978-1-60761-849-2_16; Tyler Christina R, 2014, Curr Environ Health Rep, V1, P132; United States Institute of Medicine, 2001, PAN MICR DRI DIET RE; URIUHARE JY, 1989, DIABETES, V38, P1282, DOI 10.2337/diabetes.38.10.1282; VAHTER M, 1994, APPL ORGANOMET CHEM, V8, P175, DOI 10.1002/aoc.590080304; Verbanac D, 1997, BIOL TRACE ELEM RES, V57, P91, DOI 10.1007/BF02803873; Wasserman GA, 2004, ENVIRON HEALTH PERSP, V112, P1329, DOI 10.1289/ehp.6964; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Welch AH, 2000, GROUND WATER, V38, P589, DOI 10.1111/j.1745-6584.2000.tb00251.x; Xu H, 2016, TOXICOL SCI, V149, P31, DOI 10.1093/toxsci/kfv211; Zhou XX, 2011, J BIOL CHEM, V286, P22855, DOI 10.1074/jbc.M111.232926	82	22	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183831	10.1371/journal.pone.0183831	http://dx.doi.org/10.1371/journal.pone.0183831			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837703	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000129
J	Boutwell, BB; Nedelec, JL; Winegard, B; Shackelford, T; Beaver, KM; Vaughn, M; Barnes, JC; Wright, JP				Boutwell, Brian B.; Nedelec, Joseph L.; Winegard, Bo; Shackelford, Todd; Beaver, Kevin M.; Vaughn, Michael; Barnes, J. C.; Wright, John P.			The prevalence of discrimination across racial groups in contemporary America: Results from a nationally representative sample of adults	PLOS ONE			English	Article							CHI-SQUARED TESTS; PERCEIVED DISCRIMINATION; HEALTH; NEUROSCIENCE; EXPERIENCES; TABLES; RACE	A large body of social science research is devoted to understanding the causes and correlates of discrimination. Comparatively less effort has been aimed at providing a general prevalence estimate of discrimination using a nationally representative sample. The current study is intended to offer such an estimate using a large sample of American respondents (N = 14,793) while also exploring perceptions regarding why respondents felt they were discriminated against. The results provide a broad estimate of self-reported discrimination experiences D an event that was only reported by about one-quarter of all sample members D across racial and ethnic categories.	[Boutwell, Brian B.; Vaughn, Michael] St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, 3550 Lindell Blvd, St Louis, MO 63103 USA; [Boutwell, Brian B.] St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA; [Nedelec, Joseph L.; Barnes, J. C.; Wright, John P.] Univ Cincinnati, Sch Criminol & Criminal Justice, Cincinnati, OH USA; [Winegard, Bo] Florida State Univ, Dept Psychol, Tallahassee, FL 32306 USA; [Shackelford, Todd] Oakland Univ, Dept Psychol, Rochester, MI 48063 USA; [Beaver, Kevin M.] Florida State Univ, Coll Criminol & Criminal Justice, Tallahassee, FL 32306 USA	Saint Louis University; Saint Louis University; University System of Ohio; University of Cincinnati; State University System of Florida; Florida State University; Oakland University; State University System of Florida; Florida State University	Boutwell, BB (corresponding author), St Louis Univ, Coll Publ Hlth & Social Justice, Sch Social Work, 3550 Lindell Blvd, St Louis, MO 63103 USA.; Boutwell, BB (corresponding author), St Louis Univ, Coll Publ Hlth & Social Justice, Dept Epidemiol, St Louis, MO 63103 USA.	boutwellb@slu.edu	Beaver, Kevin M./B-4631-2013; Shackelford, Todd K./T-6243-2017; Vaughn, Michael/W-2694-2019	Shackelford, Todd K./0000-0001-8101-4292; Barnes, J.C./0000-0001-6932-5397	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD031921] Funding Source: NIH RePORTER; NICHD NIH HHS [P01 HD031921] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bezrukova K, 2012, ACAD MANAG LEARN EDU, V11, P207, DOI 10.5465/amle.2008.0090; Chantala, 2014, GUIDELINES ANAL ADD, P1; Cikara M, 2014, PERSPECT PSYCHOL SCI, V9, P245, DOI 10.1177/1745691614527464; Everett B, 2015, J HEALTH SOC BEHAV, V56, P37, DOI 10.1177/0022146514568349; Everett BG, 2016, POPUL RES POLICY REV, V35, P445, DOI 10.1007/s11113-016-9391-3; Gibbons FX, 2004, J PERS SOC PSYCHOL, V86, P517, DOI 10.1037/0022-3514.86.4.517; Graham J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050092; Harris KM, 2006, TWIN RES HUM GENET, V9, P988, DOI 10.1375/183242706779462787; Jussim L, 2015, CURR DIR PSYCHOL SCI, V24, P490, DOI 10.1177/0963721415605257; Kessler RC, 1999, J HEALTH SOC BEHAV, V40, P208, DOI 10.2307/2676349; Krieger N, 2005, SOC SCI MED, V61, P1576, DOI 10.1016/j.socscimed.2005.03.006; Kubota JT, 2012, NAT NEUROSCI, V15, P940, DOI 10.1038/nn.3136; Kurzban R, 2001, PSYCHOL BULL, V127, P187, DOI 10.1037//0033-2909.127.2.187; Liebkind K, 2000, J COMMUNITY APPL SOC, V10, P1; Molenberghs P, 2013, NEUROSCI BIOBEHAV R, V37, P1530, DOI 10.1016/j.neubiorev.2013.06.002; Monk EP, 2015, AM J SOCIOL, V121, P396, DOI 10.1086/682162; Pang YC, THESIS; Paradies Y, 2006, INT J EPIDEMIOL, V35, P888, DOI 10.1093/ije/dyl056; Pascoe EA, 2009, PSYCHOL BULL, V135, P531, DOI 10.1037/a0016059; RAO JNK, 1981, J AM STAT ASSOC, V76, P221, DOI 10.2307/2287815; RAO JNK, 1984, ANN STAT, V12, P46, DOI 10.1214/aos/1176346391; StataCorp, 2017, STAT BAS REF MAN REL; Sul Lee E., 2005, ANAL COMPLEX SURVEY; Trawalter S, 2008, J EXP SOC PSYCHOL, V44, P1322, DOI 10.1016/j.jesp.2008.03.006; Unnever JD, 2011, CRIMINOL JUST STUD, P1	25	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183356	10.1371/journal.pone.0183356	http://dx.doi.org/10.1371/journal.pone.0183356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837680	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000061
J	Kittikraisak, W; Suntarattiwong, P; Ditsungnoen, D; Pallas, SE; Abimbola, TO; Klungthong, C; Fernandez, S; Srisarang, S; Chotpitayasunondh, T; Dawood, FS; Olsen, SJ; Lindblade, KA				Kittikraisak, Wanitchaya; Suntarattiwong, Piyarat; Ditsungnoen, Darunee; Pallas, Sarah E.; Abimbola, Taiwo O.; Klungthong, Chonticha; Fernandez, Stefan; Srisarang, Suchada; Chotpitayasunondh, Tawee; Dawood, Fatimah S.; Olsen, Sonja J.; Lindblade, Kim A.			Cost-effectiveness of inactivated seasonal influenza vaccination in a cohort of Thai children <= 60 months of age	PLOS ONE			English	Article							QUALITY-OF-LIFE; ECONOMIC-IMPACT; SOUTHERN; VIRUSES; HEALTH	Background Vaccination is the best measure to prevent influenza. We conducted a cost-effectiveness evaluation of trivalent inactivated seasonal influenza vaccination, compared to no vaccination, in children <= 60 months of age participating in a prospective cohort study in Bangkok, Thailand. Methods A static decision tree model was constructed to simulate the population of children in the cohort. Proportions of children with laboratory-confirmed influenza were derived from children followed weekly. The societal perspective and one-year analytic horizon were used for each influenza season; the model was repeated for three influenza seasons (2012-2014). Direct and indirect costs associated with influenza illness were collected and summed. Cost of the trivalent inactivated seasonal influenza vaccine (IIV3) including promotion, administration, and supervision cost was added for children who were vaccinated. Quality-adjusted life years (QALY), derived from literature, were used to quantify health outcomes. The incremental cost-effectiveness ratio (ICER) was calculated as the difference in the expected total costs between the vaccinated and unvaccinated groups divided by the difference in QALYs for both groups. Results Compared to no vaccination, IIV3 vaccination among children <= 60 months in our cohort was not cost-effective in the introductory year (2012 season; 24,450 USD/QALY gained), highly cost-effective in the 2013 season (554 USD/QALY gained), and cost-effective in the 2014 season (16,200 USD/QALY gained). Conclusion The cost-effectiveness of IIV3 vaccination among children participating in the cohort study varied by influenza season, with vaccine cost and proportion of high-risk children demonstrating the greatest influence in sensitivity analyses. Vaccinating children against influenza can be economically favorable depending on the maturity of the program, influenza vaccine performance, and target population.	[Kittikraisak, Wanitchaya; Ditsungnoen, Darunee; Lindblade, Kim A.] US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand; [Suntarattiwong, Piyarat; Srisarang, Suchada; Chotpitayasunondh, Tawee] Minist Publ Hlth, Queen Sirikit Natl Inst Child Hlth, Infect Dis Unit, Bangkok, Thailand; [Pallas, Sarah E.; Abimbola, Taiwo O.] US Ctr Dis Control & Prevent, Global Immunizat Div, Atlanta, GA USA; [Klungthong, Chonticha; Fernandez, Stefan] Armed Forces Res Inst Med Sci, Lab Virol, Bangkok, Thailand; [Dawood, Fatimah S.; Olsen, Sonja J.; Lindblade, Kim A.] US Ctr Dis Control & Prevent, Influenza Div, Atlanta, GA USA	Ministry of Public Health - Thailand; Ministry of Public Health - Thailand; Centers for Disease Control & Prevention - USA; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Centers for Disease Control & Prevention - USA	Kittikraisak, W (corresponding author), US Ctr Dis Control & Prevent Collaborat, Thailand Minist Publ Hlth, Influenza Program, Nonthaburi, Thailand.	glr9@cdc.gov		Pallas, Sarah/0000-0002-9719-6278; Lindblade, Kim/0000-0002-5593-0470	U.S. Centers for Disease Control and Prevention [5U01GH000152]	U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This project was funded by U.S. Centers for Disease Control and Prevention through cooperative agreement 5U01GH000152.	Canaway AG, 2014, INT J OBESITY, V38, P1146, DOI 10.1038/ijo.2013.219; Chit A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133606; Chittaganpitch M, 2012, INFLUENZA OTHER RESP, V6, P276, DOI 10.1111/j.1750-2659.2011.00302.x; Cohen GM, 2000, PEDIATRICS, V106, P973, DOI 10.1542/peds.106.5.973; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Duncan Ian G, 2012, Cost Eff Resour Alloc, V10, P10; Esposito S, 2006, VACCINE, V24, P629, DOI 10.1016/j.vaccine.2005.08.054; Evans DB, 2005, BMJ-BRIT MED J, V331, P1457, DOI 10.1136/bmj.38658.675243.94; Garcia A, 2016, HUM VACC IMMUNOTHER, V12, P2269, DOI 10.1080/21645515.2016.1182275; Haddix AC, 2003, PREVENTION EFFECTIVE; Hall JL, 2005, J PEDIATR-US, V147, P807, DOI 10.1016/j.jpeds.2005.06.031; Hannoun C, 2013, EXPERT REV VACCINES, V12, P1085, DOI 10.1586/14760584.2013.824709; Hibbert CL, 2007, VACCINE, V25, P8010, DOI 10.1016/j.vaccine.2007.09.018; Hirve S, 2015, SEASONAL INFLUENZA V; Johannesson M, 1996, HEALTH POLICY, V36, P231, DOI 10.1016/0168-8510(96)00815-9; Kittikraisak W, 2016, PEDIATR INFECT DIS J, V35, pE318, DOI 10.1097/INF.0000000000001280; Kittikraisak W, 2015, INFLUENZA OTHER RESP, V9, P85, DOI 10.1111/irv.12302; Lee BY, 2015, MED CARE, V53, P218, DOI 10.1097/MLR.0000000000000302; Luce BR, 2001, PEDIATRICS, V108, DOI 10.1542/peds.108.2.e24; Marchetti M, 2007, HUM VACCINES, V3, P14, DOI 10.4161/hv.3.1.3657; Marder E, 2013, MMWR-MORBID MORTAL W, V62, P1; Meeyai A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001829; Meier G, 2015, J MED ECON, V18, P746, DOI 10.3111/13696998.2015.1044456; Owusu JT, 2015, VACCINE, V33, P742, DOI 10.1016/j.vaccine.2014.10.029; Perlroth DJ, 2010, CLIN INFECT DIS, V50, P165, DOI 10.1086/649867; Ropero-Alvarez AM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-361; Saha S, 2014, B WORLD HEALTH ORGAN, V92, P318, DOI 10.2471/BLT.13.124412; Suntarattiwong P, 2016, INFLUENZA INCIDENCE; Tarride JE, 2012, CLINICOECONOMIC OUTC, V4, P287, DOI 10.2147/CEOR.S33444; Van Bellinghen LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098437; World Bank, 2016, GDP PER CAP; World Health Organization, COST EFFECTIVENESS A; World Health Organization, 2012, M STRAT ADV GROUP EX	33	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183391	10.1371/journal.pone.0183391	http://dx.doi.org/10.1371/journal.pone.0183391			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837594	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000063
J	Robinson, JL; Narasimhan, M; Amin, A; Morse, S; Beres, LK; Yeh, PT; Kennedy, CE				Robinson, Jennifer L.; Narasimhan, Manjulaa; Amin, Avni; Morse, Sophie; Beres, Laura K.; Yeh, Ping Teresa; Kennedy, Caitlin Elizabeth			Interventions to address unequal gender and power relations and improve self-efficacy and empowerment for sexual and reproductive health decision-making for women living with HIV: A systematic review	PLOS ONE			English	Review							RISK REDUCTION; CONDOM USE; BEHAVIOR	Background Many women living with HIV experience gendered power inequalities, particularly in their intimate relationships, that prevent them from achieving optimal sexual and reproductive health (SRH) and exercising their rights. We assessed the effectiveness of interventions to improve self-efficacy and empowerment of women living with HIV to make SRH decisions through a systematic review. Methods and findings We included peer-reviewed articles indexed in PubMed, PsycINFO, CINAHL, Embase, and Scopus published through January 3, 2017, presenting multi-arm or pre-post intervention evaluations measuring one of the following outcomes: (1) self-efficacy, empowerment, or measures of SRH decision-making ability, (2) SRH behaviors (e.g., condom use, contraceptive use), or (3) SRH outcomes (e.g., sexually transmitted infections [STIs]). Twenty-one studies evaluating 11 intervention approaches met the inclusion criteria. All were conducted in the United States or sub-Saharan Africa. Two high-quality randomized controlled trials (RCTs) showed significant decreases in incident gonorrhea and chlamydia. Sixteen studies measuring condom use generally found moderate increases associated with the intervention, including in higher-quality RCTs. Findings on contraceptive use, condom self-efficacy, and other empowerment measures (e.g., sexual communication, equitable relationship power) were mixed. Studies were limited by small sample sizes, high loss to follow-up, and high reported baseline condom use. Conclusions While more research is needed, the limited existing evidence suggests that these interventions may help support the SRH and rights of women living with HIV. This review particularly highlights the importance of these interventions for preventing STIs, which present a significant health burden for women living with HIV that is rarely addressed holistically. Empowerment-based interventions should be considered as part of a comprehensive package of STI and other SRH services for women living with HIV.	[Robinson, Jennifer L.; Beres, Laura K.; Yeh, Ping Teresa; Kennedy, Caitlin Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA; [Narasimhan, Manjulaa; Amin, Avni] WHO, Dept Reprod Hlth & Res, Geneva, Switzerland; [Morse, Sophie] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Kennedy, CE (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	caitlinkennedy@jhu.edu	Yeh, Ping Teresa/AAP-9471-2021	Yeh, Ping Teresa/0000-0002-7425-0382; Robinson, Jennifer/0000-0003-4241-5290; Morse, Sophie M./0000-0003-4426-5134; Beres, Laura/0000-0002-4731-7828; Narasimhan, Manjulaa/0000-0003-0598-6887	World Health Organization, Department of Reproductive Health and Research; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH090173] Funding Source: NIH RePORTER	World Health Organization, Department of Reproductive Health and Research(World Health Organization); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the World Health Organization, Department of Reproductive Health and Research. WHO commissioned this review to inform updated WHO guidelines on sexual and reproductive health and rights of women living with HIV. The funder contributed to the study design, data collection, analysis, interpretation, and writing of the review.	Aidala HA, 2002, INVISIBLE EPIDEMIC C; Amin A, 2015, J INT AIDS SOC, V18, P4, DOI 10.7448/IAS.18.6.20302; Atteraya MS, 2014, AIDS EDUC PREV, V26, P1, DOI 10.1521/aeap.2014.26.1.1; Brothers J, 2016, AIDS PATIENT CARE ST, V30, P229, DOI 10.1089/apc.2015.0294; Calvert C, 2013, AIDS, V27, P1631, DOI 10.1097/QAD.0b013e32835fd940; Casey E, 2016, TRAUMA VIOLENCE ABUS; Denison JA, 2008, AIDS BEHAV, V12, P363, DOI 10.1007/s10461-007-9349-x; Dworkin SL, 2013, AIDS BEHAV, V17, P2845, DOI 10.1007/s10461-013-0565-2; Echenique M, 2013, AIDS CARE, V25, P443, DOI 10.1080/09540121.2012.712666; Fogarty LA, 2001, PUBLIC HEALTH REP, V116, P103, DOI 10.1093/phr/116.S1.103; Futterman D, 2010, AIDS CARE, V22, P1093, DOI 10.1080/09540121003600352; Gupta GR, 2000, 13 INT AIDS C JUL 12; Holstad Marcia McDonnell, 2012, Afr J Reprod Health, V16, P14; Holstad MM, 2011, AIDS BEHAV, V15, P885, DOI 10.1007/s10461-010-9865-y; Jewkes RK, 2010, LANCET, V376, P41, DOI 10.1016/S0140-6736(10)60548-X; Jones DL, 2006, AIDS CARE, V18, P629, DOI 10.1080/09540120500415371; Jones DL, 2013, TRANSL BEHAV MED, V3, P416, DOI 10.1007/s13142-013-0213-4; Jones DL, 2007, AM J INFECT DIS, V3, P169, DOI 10.3844/ajidsp.2007.169.176; Jones DL, 2005, J URBAN HEALTH, V82, pIV92, DOI 10.1093/jurban/jti111; Jones DL, 2001, J URBAN HEALTH, V78, P593, DOI 10.1093/jurban/78.4.593; Kalichman SC, 2011, SEX TRANSM INFECT, V87, P183, DOI 10.1136/sti.2010.047514; Klein CH, 2013, AIDS BEHAV, V17, P3013, DOI 10.1007/s10461-013-0479-z; Koester D, 2015, CONCEPT BRIEF 04 GEN; Langen Tabitha T, 2005, Afr Health Sci, V5, P188; Marhefka SL, 2014, TELEMED E-HEALTH, V20, P128, DOI 10.1089/tmj.2013.0072; Moher D., 2015, STATEMENT SYSTEMATIC, V4, DOI [10.1186/2046-4053-4-1, DOI 10.1186/2046-4053-4-12-S2.0-84920780781, DOI 10.14306/RENHYD.20.2.223]; O'Reilly KR, 2017, AIDS BEHAV, V21, P626, DOI 10.1007/s10461-016-1615-3; Organization WH, 2008, ESS PREV CAR INT AD; Organization WH, 2016, CONGUID UANT DRU; Orza L, 2015, J INT AIDS SOC, V18, P65, DOI 10.7448/IAS.18.6.20285; President's Emergency Plan for AIDS Relief (PEPFAR), 2011, GUID PREV SEX TRANSM; Richter L, 2014, AIDS BEHAV, V18, P706, DOI 10.1007/s10461-014-0694-2; Saleh-Onoya D, 2009, AIDS CARE, V21, P817, DOI 10.1080/09540120802537823; Saniquist CC, 2014, CONTRACEPTION, V89, P209, DOI 10.1016/j.contraception.2013.11.003; Senarath U, 2009, ASIA-PAC J PUBLIC HE, V21, P137, DOI 10.1177/1010539509331590; Teti M, 2010, AIDS BEHAV, V14, P567, DOI 10.1007/s10461-009-9562-x; Wechsberg WM, 2010, J PREV INTERV COMMUN, V38, P132, DOI 10.1080/10852351003640799; Weiss SM, 2011, INT J WOMENS HEALTH, V3, P63, DOI 10.2147/IJWH.S5947; Wellings K, 2006, LANCET, V368, P1706, DOI 10.1016/S0140-6736(06)69479-8; WHO, 2014, CONS GUID HIV PREV D; Wingood GM, 2004, JAIDS-J ACQ IMM DEF, V37, pS58, DOI 10.1097/01.qai.0000140603.57478.a9; World Bank, 2016, POV RED EQ EMP OV; World Health Organization, 2017, CONS GUID SEX REPR H; World Health Organization (WHO), GLOB HLTH SECT STRAT; Wyatt GE, 2004, AIDS BEHAV, V8, P453, DOI 10.1007/s10461-004-7329-y	45	30	30	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0180699	10.1371/journal.pone.0180699	http://dx.doi.org/10.1371/journal.pone.0180699			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837562	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000005
J	Thomas, AJ; Pulsipher, A; Davis, BM; Alt, JA				Thomas, Andrew J.; Pulsipher, Abigail; Davis, Brock M.; Alt, Jeremiah A.			LL-37 causes cell death of human nasal epithelial cells, which is inhibited with a synthetic glycosaminoglycan	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE LL-37; NF-KAPPA-B; CHRONIC RHINOSINUSITIS; INFLAMMATORY CASPASES; CATHELICIDIN LL-37; DISEASE SEVERITY; EXPRESSION; PHOSPHATIDYLSERINE; APOPTOSIS; IL-8	LL-37 is an immune peptide that regulates innate and adaptive immune responses in the upper airways. Elevated levels of LL-37 have been linked to cell death and inflammatory diseases, such as chronic rhinosinusitis (CRS). Glycosaminoglycans (GAGs) are polysaccharides that are found on respiratory epithelial cells and serve important roles in mucosal surface repair. Recent findings suggest that a synthetic glycosaminoglycan (GM-0111) can protect against LL-37-induced sinonasal mucosal inflammation and cell death in a murine model of acute RS. Herein, we elucidated the mechanisms by which LL-37 causes sinonasal inflammation and how GM-0111 can prevent these mechanisms. When challenged with LL-37, human nasal epithelial cells (HNEpCs) and mouse macrophages (J774.2) demonstrated increased release of adenosine triphosphate (ATP) and interleukin (IL)-6 and -8, as well as cell death and lysis. These cellular responses were all blocked dose-dependently by pre-treatment with GM-0111. We identified that LL-37-induced cell death is associated with caspase-1 and -8 activation, but not activation of caspase-3/7. These responses were again blocked by GM-0111. Our data suggest that LL-37 causes cellular death of HNEpCs and macrophages through the pro-inflammatory necrotic and/or pyroptotic pathways rather than apoptosis, and that a GM-0111 is capable of inhibiting these pro-inflammatory cellular events.	[Thomas, Andrew J.; Pulsipher, Abigail; Davis, Brock M.; Alt, Jeremiah A.] Univ Utah, Sch Med, Dept Surg,Rhinol Sinus & Skull Base Surg Program, Div Head & Neck Surg, Salt Lake City, UT 84132 USA; [Pulsipher, Abigail; Alt, Jeremiah A.] GlycoMira Therapeut, Salt Lake City, UT 84108 USA	Utah System of Higher Education; University of Utah	Alt, JA (corresponding author), Univ Utah, Sch Med, Dept Surg,Rhinol Sinus & Skull Base Surg Program, Div Head & Neck Surg, Salt Lake City, UT 84132 USA.; Alt, JA (corresponding author), GlycoMira Therapeut, Salt Lake City, UT 84108 USA.	jeremiah.alt@hsc.utah.edu		Thomas, Andrew/0000-0002-5890-1325; Alt, Jeremiah/0000-0003-0560-5028	University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences [KL2TR001065]; National Institute on Allergy and Infectious Diseases (NIAID) [R43 AI126987-01]; University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences [KL2TR001065]; National Institute on Allergy and Infectious Diseases (NIAID) [R43 AI126987-01]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001065] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R43AI126987] Funding Source: NIH RePORTER	University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences; National Institute on Allergy and Infectious Diseases (NIAID); University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences; National Institute on Allergy and Infectious Diseases (NIAID); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grant numbers KL2TR001065 (JAA) and R43 AI126987-01 (AP, JAA) from the University of Utah Program in Personalized Health and the National Center for Advancing Translational Sciences and National Institute on Allergy and Infectious Diseases (NIAID), respectively. The funders had no role in study design, data collection and analysis, and decision to publish or preparation of the manuscript. J.A.A. is a consultant for Spirox (Menlo Park, CA; USA) and Medtronic, Inc. (Jacksonville, FL; USA), which are not affiliated with this investigation. AP and JAA declare financial interest and/or other relationships with GlycoMira Therapeutics, Inc. (Salt Lake City, UT; USA). GlycoMira Therapeutics, Inc. provided support in the form of salary for AP and reagents/supplies, but did not have additional roles in study design, data collection and analysis, and decision to publish or preparation of the manuscript.	Akdis CA, 2013, J ALLERGY CLIN IMMUN, V131, P1479, DOI 10.1016/j.jaci.2013.02.036; Alagarasu K, 2017, PEPTIDES, V92, P23, DOI 10.1016/j.peptides.2017.04.002; Alt JA, 2014, LARYNGOSCOPE; Alt JA, 2015, INT FORUM ALLERGY RH, V5, P1141, DOI 10.1002/alr.21634; Alt JA, 2013, INT FORUM ALLERGY RH, V3, P941, DOI 10.1002/alr.21217; Alt JA, 2013, LARYNGOSCOPE, V123, P2364, DOI 10.1002/lary.24040; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Bachert C, 2001, J ALLERGY CLIN IMMUN, V107, P607, DOI 10.1067/mai.2001.112374; BECKER S, 1991, J IMMUNOL, V147, P4307; Bhattacharyya N, 2007, CURR ALLERGY ASTHM R, V7, P216, DOI 10.1007/s11882-007-0075-2; Brennan MA, 2000, MOL MICROBIOL, V38, P31, DOI 10.1046/j.1365-2958.2000.02103.x; Chen PH, 2004, AM J RHINOL, V18, P381, DOI 10.1177/194589240401800608; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Elenius V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172350; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Gerdin B, 1997, J INTERN MED, V242, P49, DOI 10.1046/j.1365-2796.1997.00173.x; Ghaffar O, 1998, OTOLARYNG HEAD NECK, V118, P504, DOI 10.1016/S0194-5998(98)70209-8; Henriquez KM, 2015, J MED VIROL, V87, P330, DOI 10.1002/jmv.24042; Janicke RU, 1998, J BIOL CHEM, V273, P9357, DOI 10.1074/jbc.273.16.9357; Kahlenberg JM, 2005, J IMMUNOL, V175, P7611, DOI 10.4049/jimmunol.175.11.7611; Kennedy JL, 2013, AM J RHINOL ALLERGY, V27, P367, DOI 10.2500/ajra.2013.27.3906; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Kroemer G, 2009, CELL DEATH DIFFER, V16, P3, DOI 10.1038/cdd.2008.150; Krueger JM, 2008, CURR PHARM DESIGN, V14, P3408, DOI 10.2174/138161208786549281; Krysko O, 2004, APOPTOSIS, V9, P495, DOI 10.1023/B:APPT.0000031452.75162.75; la Sala A, 2003, J LEUKOCYTE BIOL, V73, P339, DOI 10.1189/jlb.0802418; Labbe K, 2008, CELL DEATH DIFFER, V15, P1339, DOI 10.1038/cdd.2008.91; Lamkanfi M, 2010, INT J BIOCHEM CELL B, V42, P21, DOI 10.1016/j.biocel.2009.09.013; Lau YE, 2006, AM J RESP CELL MOL, V34, P399, DOI 10.1165/rcmb.2005-0170OC; Lecoeur H, 2001, CYTOMETRY, V44, P65, DOI 10.1002/1097-0320(20010501)44:1<65::AID-CYTO1083>3.0.CO;2-Q; Lee Stella, 2011, Curr Infect Dis Rep, V13, P159, DOI 10.1007/s11908-011-0166-z; Lee WY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077854; Litvack JR, 2009, AM J RHINOL ALLERGY, V23, P139, DOI 10.2500/ajra.2009.23.3286; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Mader JS, 2009, MOL CANCER RES, V7, P689, DOI 10.1158/1541-7786.MCR-08-0274; Manuele C, 2016, INT J PEDIATR OTORHI, V85, P22, DOI 10.1016/j.ijporl.2016.03.015; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Meltzer Eli O, 2004, J Allergy Clin Immunol, V114, P155, DOI 10.1016/j.jaci.2004.09.029; Miao EA, 2011, IMMUNOL REV, V243, P206, DOI 10.1111/j.1600-065X.2011.01044.x; Min YG, 1999, AM J RHINOL, V13, P339, DOI 10.2500/105065899781367546; Min YG, 2000, J KOREAN MED SCI, V15, P255, DOI 10.3346/jkms.2000.15.3.255; Monie TP, 2015, IMMUNOL REV, V265, P181, DOI 10.1111/imr.12284; Negrini D, 2008, INTENS CARE MED, V34, P610, DOI 10.1007/s00134-007-0962-y; Nell MJ, 2004, FEMS IMMUNOL MED MIC, V42, P225, DOI 10.1016/j.femsim.2004.05.013; Ohkubo Kimihiro, 1998, Rhinology (Utrecht), V36, P156; Ooi EH, 2007, AM J RHINOL, V21, P395, DOI 10.2500/ajr.2007.21.3048; Orlandi RR, 2016, INT FORUM ALLERGY RH, V6, pS3, DOI 10.1002/alr.21694; Peters AT, 2010, J ALLERGY CLIN IMMUN, V125, P397, DOI 10.1016/j.jaci.2009.10.072; Philip NH, 2014, P NATL ACAD SCI USA, V111, P7385, DOI 10.1073/pnas.1403252111; Pulsipher A, 2016, INT FORUM ALLERGY RH; Rhyoo C, 1999, J ALLERGY CLIN IMMUN, V103, P395, DOI 10.1016/S0091-6749(99)70462-8; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496; Rosenfeld RM, 2015, OTOLARYNG HEAD NECK, V152, pS1, DOI 10.1177/0194599815572097; Sejima T, 2012, ALLERGOL INT, V61, P115, DOI 10.2332/allergolint.10-OA-0290; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Siegel RM, 2006, NAT REV IMMUNOL, V6, P308, DOI 10.1038/nri1809; Smith TL, 2010, OTOLARYNG HEAD NECK, V142, P55, DOI 10.1016/j.otohns.2009.10.009; Soler ZM, 2011, LARYNGOSCOPE, V121, P2672, DOI 10.1002/lary.21847; Souza CO, 2012, BBA-GEN SUBJECTS, V1820, P1867, DOI 10.1016/j.bbagen.2012.08.013; Suzuki H, 1996, J ALLERGY CLIN IMMUN, V98, P659, DOI 10.1016/S0091-6749(96)70100-8; Tammi MI, 2002, J BIOL CHEM, V277, P4581, DOI 10.1074/jbc.R100037200; Tan BK, 2013, AM J RESP CRIT CARE, V188, P1275, DOI 10.1164/rccm.201308-1500ED; Thienhaus ML, 2011, RHINOLOGY, V49, P554, DOI [10.4193/Rhino11.072, 10.4193/Rhino10.072]; Torres-Juarez F, 2015, INFECT IMMUN, V83, P4495, DOI 10.1128/IAI.00936-15; Turino GM, 2003, AM J RESP CRIT CARE, V167, P1169, DOI 10.1164/rccm.200205-449PP; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang Q, 2013, INT IMMUNOL, V25, P363, DOI 10.1093/intimm/dxs161; Waring P, 1999, CELL DEATH DIFFER, V6, P624, DOI 10.1038/sj.cdd.4400540; Weng D, 2014, P NATL ACAD SCI USA, V111, P7391, DOI 10.1073/pnas.1403477111; Xie Dan, 2010, Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V24, P337; Zhang XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020500; Zhang YK, 2014, BIOCHEM BIOPH RES CO, V443, P103, DOI 10.1016/j.bbrc.2013.11.074	74	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183542	10.1371/journal.pone.0183542	http://dx.doi.org/10.1371/journal.pone.0183542			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837619	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000077
J	Tsai, TH; Chang, HT; Chen, YJ; Chang, YS				Tsai, Tsai-Hsuan; Chang, Hsien-Tsung; Chen, Yan-Jiun; Chang, Yung-Sheng			Determinants of user acceptance of a specific social platform for older adults: An empirical examination of user interface characteristics and behavioral intention	PLOS ONE			English	Article							HEURISTIC EVALUATION; USABILITY HEURISTICS; TECHNOLOGY; SYSTEM; MODEL; INTERNET; HEALTH; WEB; LONELINESS; NETWORK	The use of the Internet and social applications has many benefits for the elderly, but numerous investigations have shown that the elderly do not perceive online social networks as a friendly social environment. Therefore, TreeIt, a social application specifically designed for the elderly, was developed for this study. In the TreeIt application, seven mechanisms promoting social interaction were designed to allow older adults to use social networking sites (SNSs) to increase social connection, maintain the intensity of social connections and strengthen social experience. This study's main objective was to investigate how user interface design affects older people's intention and attitude related to using SNSs. Fourteen user interface evaluation heuristics proposed by Zhang et al. were adopted as the criteria to assess user interface usability and further grouped into three categories: system support, user interface design and navigation. The technology acceptance model was adopted to assess older people's intention and attitude related to using SNSs. One hundred and one elderly persons were enrolled in this study as subjects, and the results showed that all of the hypotheses proposed in this study were valid: system support and perceived usefulness had a significant effect on behavioral intention; user interface design and perceived ease of use were positively correlated with perceived usefulness; and navigation exerted an influence on perceived ease of use. The results of this study are valuable for the future development of social applications for the elderly.	[Tsai, Tsai-Hsuan; Chen, Yan-Jiun; Chang, Yung-Sheng] Chang Gung Univ, Coll Management, Dept Ind Design, Taoyuan, Taiwan; [Tsai, Tsai-Hsuan] Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan; [Tsai, Tsai-Hsuan] Ming Chi Univ, Dept Visual Commun Design, New Taipei City, Taiwan; [Chang, Hsien-Tsung] Chang Gung Univ, Coll Engn, Dept Comp Sci & Informat Engn, Taoyuan, Taiwan; [Chang, Hsien-Tsung] Chang Gung Mem Hosp, Dept Phys Med & Rehabil, Taoyuan, Taiwan	Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital	Tsai, TH (corresponding author), Chang Gung Univ, Coll Management, Dept Ind Design, Taoyuan, Taiwan.; Tsai, TH (corresponding author), Chang Gung Mem Hosp, Dept Internal Med, Div Cardiol, Taoyuan, Taiwan.; Tsai, TH (corresponding author), Ming Chi Univ, Dept Visual Commun Design, New Taipei City, Taiwan.	ttsai.cgu@gmail.com	Chang, Hsien-Tsung/E-7511-2012	Chang, Hsien-Tsung/0000-0003-4987-5943	Ministry of Science and Technology, Taiwan, ROC [MOST103-2221-E-182-051-MY2, MOST105-2221-E-182 -025 -MY2]; Chang Gung Memorial Hospital	Ministry of Science and Technology, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by the Ministry of Science and Technology, Taiwan, ROC under contract MOST103-2221-E-182-051-MY2, MOST105-2221-E-182 -025 -MY2, and Chang Gung Memorial Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali H., 2013, J INTERNET SOCIAL NE, DOI [10.5171/2013.889433, DOI 10.5171/2013.889433]; Allen M, 2006, J BIOMED INFORM, V39, P412, DOI 10.1016/j.jbi.2005.10.004; Ashraf Anam, 2013, International Journal of Computer and Communication Engineering, V2, P711, DOI 10.7763/IJCCE.2013.V2.280; Atashi A, 2016, APPL CLIN INFORM, V7, P89, DOI 10.4338/ACI-2015-07-RA-0086; Bagozzi R.P., 1988, J ACAD MARKET SCI, V16, P74, DOI [10.1007/BF02723327, DOI 10.1007/BF02723327]; Bedford VH, 1998, FAM RELAT, P369; Bennett DA, 2006, LANCET NEUROL, V5, P406, DOI 10.1016/S1474-4422(06)70417-3; BENTLER PM, 1980, PSYCHOL BULL, V88, P588, DOI 10.1037/0033-2909.107.2.238; Bondevik M, 1998, WESTERN J NURS RES, V20, P325, DOI 10.1177/019394599802000305; BRANSCOMB LM, 1984, IBM SYST J, V23, P224, DOI 10.1147/sj.233.0224; Braun MT, 2013, COMPUT HUM BEHAV, V29, P673, DOI 10.1016/j.chb.2012.12.004; Calisir F, 2004, COMPUT HUM BEHAV, V20, P505, DOI 10.1016/j.chb.2003.10.004; Castilla D, 2013, INT J HUM-COMPUT ST, V71, P350, DOI 10.1016/j.ijhcs.2012.10.017; Cattan M, 2005, AGEING SOC, V25, P41, DOI 10.1017/S0144686X04002594; Chan AJ, 2012, RADIOTHER ONCOL, V102, P142, DOI 10.1016/j.radonc.2011.05.077; Chang SJ, 2014, GERIATR NURS, V35, P137, DOI 10.1016/j.gerinurse.2013.11.005; Cho V, 2009, COMPUT EDUC, V53, P216, DOI 10.1016/j.compedu.2009.01.014; Choi G, 2013, INT J HUM-COMPUT INT, V29, P619, DOI 10.1080/10447318.2012.756333; Choi J, 2010, INT J MED INFORM, V79, P565, DOI 10.1016/j.ijmedinf.2010.05.001; CZAJA SJ, 1993, BEHAV INFORM TECHNOL, V12, P197, DOI 10.1080/01449299308924382; DAVIS FD, 1989, MANAGE SCI, V35, P982, DOI 10.1287/mnsc.35.8.982; De Vogli R, 2007, ARCH INTERN MED, V167, P1951, DOI 10.1001/archinte.167.18.1951; Dillon A, 2000, J AM SOC INFORM SCI, V51, P521, DOI 10.1002/(SICI)1097-4571(2000)51:6<521::AID-ASI4>3.0.CO;2-5; Duggan M, 2015, SOCIAL MEDIA UPDATE; DUNBAR RIM, 1992, J HUM EVOL, V22, P469, DOI 10.1016/0047-2484(92)90081-J; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Francis D, 1991, FRIENDS WORKPLACE GR, P465; Gilbert E., 2012, P 2012 ACM C COMPUTE, P1047, DOI DOI 10.1145/2145204.2145360; Gilbert E, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P211; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Gonzalez M, 2009, ADV ENG SOFTW, V40, P1271, DOI 10.1016/j.advengsoft.2009.01.027; Graham M, 2005, J VISUAL LITERACY, V25, P21, DOI DOI 10.1080/23796529.2005.11674615; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guo XT, 2013, ELECTRON MARK, V23, P49, DOI 10.1007/s12525-012-0112-4; Hair J., 2005, MULTIVAR DATA ANAL; Hair JF., 1979, MULTIVARIATE DATA AN; Hartup WW, 1997, PSYCHOL BULL, V121, P355, DOI 10.1037/0033-2909.121.3.355; Hong W, 2001, J MANAGE INFORM SYST, V18, P97, DOI 10.1080/07421222.2002.11045692; Hu T, 2011, COMMUN ASSOC INF SYS, V29; Hvannberg ET, 2007, INTERACT COMPUT, V19, P225, DOI 10.1016/j.intcom.2006.10.001; Igbaria M, 1995, OMEGA-INT J MANAGE S, V23, P587, DOI 10.1016/0305-0483(95)00035-6; Jaspers MWM, 2009, INT J MED INFORM, V78, P340, DOI 10.1016/j.ijmedinf.2008.10.002; Jeong H, 2011, LIBR COLLECT ACQUIS, V35, P45, DOI 10.1016/j.lcats.2011.03.018; King WR, 2006, INFORM MANAGE-AMSTER, V43, P740, DOI 10.1016/j.im.2006.05.003; Marchionini G, 1998, INFORM PROCESS MANAG, V34, P535, DOI 10.1016/S0306-4573(98)00020-X; McCloskey D. W., 2006, Journal of Organizational and End User Computing, V18, P47, DOI 10.4018/joeuc.2006070103; Nielsen J, 1995, 10 USABILITY HEURIST; Nikov A, 2006, USABILITY EVALUATION; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Oztekin A, 2010, INT J IND ERGONOM, V40, P455, DOI 10.1016/j.ergon.2010.04.001; Oztekin A, 2009, J SYST SOFTWARE, V82, P2038, DOI 10.1016/j.jss.2009.06.047; Pan SY, 2010, COMPUT HUM BEHAV, V26, P1111, DOI 10.1016/j.chb.2010.03.015; Ramayah T, 2006, INFORM DEV, V22, P123, DOI DOI 10.1177/0266666906065575; Rauniar R, 2014, J ENTERP INF MANAG, V27, P6, DOI 10.1108/JEIM-04-2012-0011; Renaud K., 2008, P 2008 ANN RES C S A, DOI [10.1145/1456659.1456684, DOI 10.1145/1456659.1456684]; Schneiderman B, 1998, DESIGNING USER INTER; Scott J., 1995, ACM SIGNS DATABASE, V26, P43, DOI DOI 10.1145/206476.206484; Seeman TE, 1996, ANN EPIDEMIOL, V6, P442, DOI 10.1016/S1047-2797(96)00095-6; Seyal AH, 2002, BEHAV INFORM TECHNOL, V21, P71, DOI 10.1080/01449290210123354; Sharma S, 2005, J BUS RES, V58, P935, DOI 10.1016/j.jbusres.2003.10.007; Smith A., 2013, 72 ONLINE ADULTS ARE; Stevens N, 2001, AGEING SOC, V21, P183, DOI 10.1017/S0144686X01008108; Stone D, 2005, USER INTERFACE DESIG; Tan WS, 2009, INT J IND ERGONOM, V39, P621, DOI 10.1016/j.ergon.2008.02.012; Tang ZH, 2006, TELEMED J E-HEALTH, V12, P24, DOI 10.1089/tmj.2006.12.24; Tsai TH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156680; Venkatesh V, 2000, MANAGE SCI, V46, P186, DOI 10.1287/mnsc.46.2.186.11926; Wilkinson A, 2004, INT J NURS STUD, V41, P411, DOI 10.1016/j.ijnurstu.2003.11.001; Yang SC, 2011, AFR J BUS MANAGE, V5, P9014; Zhang JJ, 2003, J BIOMED INFORM, V36, P23, DOI 10.1016/S1532-0464(03)00060-1; Zickuhr K., 2012, OLDER ADULTS INTERNE	71	16	16	8	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0180102	10.1371/journal.pone.0180102	http://dx.doi.org/10.1371/journal.pone.0180102			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837566	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000003
J	Danobeitia, JS; Ziemelis, M; Ma, XB; Zitur, LJ; Zens, T; Chlebeck, PJ; Van Amersfoort, ES; Fernandez, LA				Danobeitia, Juan S.; Ziemelis, Martynas; Ma, Xiaobo; Zitur, Laura J.; Zens, Tiffany; Chlebeck, Peter J.; Van Amersfoort, Edwin S.; Fernandez, Luis A.			Complement inhibition attenuates acute kidney injury after ischemia-reperfusion and limits progression to renal fibrosis in mice	PLOS ONE			English	Article							C1 INHIBITOR; IMMUNE-RESPONSE; C5A; ACTIVATION; PATHWAY; ANAPHYLATOXINS; MECHANISMS; INNATE; C3A; INFLAMMATION	The complement system is an essential component of innate immunity and plays a major role in the pathogenesis of ischemia-reperfusion injury (IRI). In this study, we investigated the impact of human C1-inhibitor (C1INH) on the early inflammatory response to IRI and the subsequent progression to fibrosis in mice. We evaluated structural damage, renal function, acute inflammatory response, progression to fibrosis and overall survival at 90-days post-injury. Animals receiving C1INH prior to reperfusion had a significant improvement in survival rate along with superior renal function when compared to vehicle (PBS) treated counterparts. Pre-treatment with C1INH also prevented acute IL-6, CXCL1 and MCP-1 upregulation, C5a release, C3b deposition and infiltration by neutrophils and macrophages into renal tissue. This anti-inflammatory effect correlated with a significant reduction in the expression of markers of fibrosis alpha smooth muscle actin, desmin and picrosirius red at 30 and 90 days post-IRI and reduced renal levels of TGF-beta 1 when compared to untreated controls. Our findings indicate that intravenous delivery of C1INH prior to ischemic injury protects kidneys from inflammatory injury and subsequent progression to fibrosis. We conclude that early complement blockade in the context of IRI constitutes an effective strategy in the prevention of fibrosis after ischemic acute kidney injury.	[Danobeitia, Juan S.; Ziemelis, Martynas; Ma, Xiaobo; Zitur, Laura J.; Zens, Tiffany; Chlebeck, Peter J.; Fernandez, Luis A.] Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA; [Van Amersfoort, Edwin S.] Pharming Technol BV, Leiden, Netherlands	University of Wisconsin System; University of Wisconsin Madison	Fernandez, LA (corresponding author), Univ Wisconsin, Dept Surg, Div Transplantat, Madison, WI 53706 USA.	luisf@surgery.wisc.edu	van Amersfoort, Edwin S/J-9944-2018; Danobeitia, Juan/AAC-5327-2020	Danobeitia, Juan/0000-0003-1641-3822; ZITUR, LAURA/0000-0002-1238-2726	NIH [T32AI125231]; Department of Surgery at the University of Wisconsin Madison; Pharming Technologies BV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI125231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Surgery at the University of Wisconsin Madison; Pharming Technologies BV; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by a T32 training grant from the NIH (T32AI125231) and internal funds of the Department of Surgery at the University of Wisconsin Madison. ESVA is employed by Pharming Technologies BV. Pharming Technologies BV provided support in the form of salary for author ESVA and kindly provided the experimental drug used in this study, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section."	Bao LH, 2011, KIDNEY INT, V80, P524, DOI 10.1038/ki.2011.158; Barnett ANR, 2013, CLIN TRANSPLANT, V27, pE216, DOI 10.1111/ctr.12102; Begieneman MPV, 2012, J BURN CARE RES, V33, P544, DOI 10.1097/BCR.0b013e31823bc2fc; Bergamaschini L, 2001, CLIN EXP IMMUNOL, V126, P412, DOI 10.1046/j.1365-2249.2001.01695.x; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Bonventre JV, 2004, KIDNEY INT, V66, P480, DOI 10.1111/j.1523-1755.2004.761_2.x; Boor P, 2007, J AM SOC NEPHROL, V18, P1508, DOI 10.1681/ASN.2006121343; Castellano G, 2010, AM J PATHOL, V176, P1648, DOI 10.2353/ajpath.2010.090276; Curci C, 2014, NEPHROL DIAL TRANSPL, V29, P799, DOI 10.1093/ndt/gft516; Danobeitia JS, 2014, FIBROGENESIS TISSUE, V7, DOI 10.1186/1755-1536-7-16; Danobeitia JS, 2012, J SURG RES, V176, P639, DOI 10.1016/j.jss.2011.10.042; Davis AE, 2010, THROMB HAEMOSTASIS, V104, P886, DOI 10.1160/TH10-01-0073; de Groot H, 2007, TRANSPL P, V39, P481, DOI 10.1016/j.transproceed.2006.12.012; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; de Vries B, 2003, J IMMUNOL, V170, P3883, DOI 10.4049/jimmunol.170.7.3883; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Devarajan P, 2006, J AM SOC NEPHROL, V17, P1503, DOI 10.1681/ASN.2006010017; Diepenhorst GMP, 2009, ANN SURG, V249, P889, DOI 10.1097/SLA.0b013e3181a38f45; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Farrar CA, 2016, IMMUNOBIOLOGY, V221, P1068, DOI 10.1016/j.imbio.2016.05.004; Fu JR, 2006, BIOCHEM BIOPH RES CO, V349, P504, DOI 10.1016/j.bbrc.2006.08.065; Gesuete R, 2009, ANN NEUROL, V66, P332, DOI 10.1002/ana.21740; Guerrot D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S15; Guo RF, 2005, ANNU REV IMMUNOL, V23, P821, DOI 10.1146/annurev.immunol.23.021704.115835; Hajishengallis G, 2010, TRENDS IMMUNOL, V31, P154, DOI 10.1016/j.it.2010.01.002; Jang HR, 2009, CLIN IMMUNOL, V130, P41, DOI 10.1016/j.clim.2008.08.016; Jansen PM, 1998, J IMMUNOL, V160, P475; Jiang HX, 2001, J EXP MED, V194, P1609, DOI 10.1084/jem.194.11.1609; Jordan JE, 2001, CIRCULATION, V104, P1413, DOI 10.1161/hc3601.095578; Kaplan AP, 2014, ADV IMMUNOL, V121, P41, DOI 10.1016/B978-0-12-800100-4.00002-7; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Kisseleva T, 2008, EXP BIOL MED, V233, P109, DOI 10.3181/0707-MR-190; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Lee SB, 2010, KIDNEY INT, V78, pS22, DOI 10.1038/ki.2010.418; Liu D, 2007, J IMMUNOL, V179, P3966, DOI 10.4049/jimmunol.179.6.3966; Lu FX, 2008, AM J PHYSIOL-GASTR L, V295, pG1042, DOI 10.1152/ajpgi.90460.2008; Lu FX, 2013, CARDIOVASC PATHOL, V22, P75, DOI 10.1016/j.carpath.2012.05.003; NURNBERGER W, 1994, INTENS CARE MED, V20, P242, DOI 10.1007/BF01704710; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Peng Qi, 2009, Inflammation & Allergy Drug Targets, V8, P236; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Riedemann NC, 2003, J IMMUNOL, V170, P503, DOI 10.4049/jimmunol.170.1.503; Sangsree S, 2003, AM J PHYSIOL-HEART C, V284, pH1959, DOI 10.1152/ajpheart.00036.2003; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Stahl GL, 2003, AM J PATHOL, V162, P449, DOI 10.1016/S0002-9440(10)63839-4; Thomas ME, 2015, KIDNEY INT, V87, P62, DOI 10.1038/ki.2014.328; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; Veszeli N, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0374-y; Wang PHM, 2006, INT IMMUNOPHARMACOL, V6, P1960, DOI 10.1016/j.intimp.2006.07.031; Zhao HL, 2014, AM J PHYSIOL-RENAL, V306, pF801, DOI 10.1152/ajprenal.00469.2013; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621; Zhou WD, 2012, IMMUNOBIOLOGY, V217, P225, DOI 10.1016/j.imbio.2011.07.016	53	30	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183701	10.1371/journal.pone.0183701	http://dx.doi.org/10.1371/journal.pone.0183701			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832655	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800087
J	De Weggheleire, A; An, S; De Baetselier, I; Soeung, P; Keath, H; So, V; Ros, S; Teav, S; Smekens, B; Buyze, J; Florence, E; van Griensven, J; Thai, S; Francque, S; Lynen, L				De Weggheleire, Anja; An, Sokkab; De Baetselier, Irith; Soeung, Pisith; Keath, Huy; So, Veasna; Ros, Sreyphors; Teav, Syna; Smekens, Bart; Buyze, Jozefien; Florence, Eric; van Griensven, Johan; Thai, Sopheak; Francque, Sven; Lynen, Lutgarde			A cross-sectional study of hepatitis C among people living with HIV in Cambodia: Prevalence, risk factors, and potential for targeted screening	PLOS ONE			English	Article							VIRUS-INFECTION; SPONTANEOUS CLEARANCE; INJECTION PRACTICES; VIRAL-HEPATITIS; NATURAL-HISTORY; BLOOD-DONORS; EPIDEMIOLOGY; COINFECTION; VIREMIA	The epidemiology of hepatitis C in Cambodia is not well-known. We evaluated the prevalence of hepatitis C virus (HCV) and risk factors in the HIV cohort of Sihanouk Hospital Center of Hope in Phnom Penh to strengthen the evidence for suitable HCV testing strategies among people living with HIV (PLWH) in Cambodia. All consenting adult PLWH without a history of HCV treatment were tested for HCV between November 2014 and May 2016 according to the CDC algorithm (HCV antibody II electro-chemiluminescence immunoassay, followed by COBAS (R) AmpliPrep/COBAS (R) TaqMan (R) HCV PCR and INNO-LIA (R) HCV Score immunoblot end-testing). Genotyping was performed using the line probe assay Versant HCV genotype 2.0 (R). The study enrolled a total of 3045 patients (43% males, median age: 42.5 years, <1% high-risk). HCV antibodies were detected in 230 (7.6%; 95% confidence interval [CI] 6.6-8.5). Upon further testing, HCV antibodies were confirmed in 157 (5.2%; 95% CI 4.4-6.0) and active HCV in 106 (3.5%; 95% CI 2.8-4.2). Viremic prevalence peaked among men aged 50-55 years (7.3%) and women aged >55 years (11.2%). Genotype 1b (45%) and 6 (41%) were predominant. Coinfected patients had a higher aspartate-to-platelet ratio index, lower platelets, a lower HBsAg positivity rate and more frequent diabetes. Based on logistic regression, blood transfusion antecedents (adjusted odds ratio 2.9; 95% CI 1.7-4.9), unsafe medical injections (2.0; 1.3-3.2), and partner (3.4; 1.5-7.6) or household member (2.4; 1.3-3.2) with liver disease were independently associated with HCV in women. However, having a tattoo/scarification (1.9; 1.1-3.4) and household member (3.1; 1.3-7.3) with liver disease were associated with HCV in men. Thus, our study found intermediate endemicity of active hepatitis C in a large Cambodian HIV cohort and provides initial arguments for targeted HCV screening (>50 years, partner/household member with liver disease, diabetes, increased aspartate-to-platelet ratio index) as efficient way forward.	[De Weggheleire, Anja; De Baetselier, Irith; Smekens, Bart; Buyze, Jozefien; Florence, Eric; van Griensven, Johan; Lynen, Lutgarde] Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium; [An, Sokkab; Soeung, Pisith; Keath, Huy; So, Veasna; Ros, Sreyphors; Teav, Syna; Thai, Sopheak] Sihanouk Hosp Ctr Hope, Infect Dis, Phnom Penh, Cambodia; [Francque, Sven] Univ Antwerp, Gastroenterol Hepatol, Antwerp, Belgium; [Francque, Sven] Univ Antwerp, Lab Expt Med & Paediat, Antwerp, Belgium	Institute of Tropical Medicine (ITM); University of Antwerp; University of Antwerp	De Weggheleire, A (corresponding author), Inst Trop Med Antwerp, Dept Clin Sci, Antwerp, Belgium.	adeweggheleire@itg.be	Lynen, Lutgarde/AAT-9180-2020; Buyze, Jozefien/B-8550-2014; De Weggheleire, Anja/C-7345-2018; Lynen, Lutgarde/A-1212-2014	Lynen, Lutgarde/0000-0001-7183-4895; Buyze, Jozefien/0000-0001-6780-380X; De Weggheleire, Anja/0000-0001-9377-4766; Lynen, Lutgarde/0000-0001-7183-4895; Florence, Eric/0000-0002-7004-9120	Flemish Government - Department of Economy, Science Innovation; Institute of Tropical Medicine Antwerp; ihanouk Hospital Center of Hope; Belgian Development Cooperation (DGDC)	Flemish Government - Department of Economy, Science Innovation; Institute of Tropical Medicine Antwerp; ihanouk Hospital Center of Hope; Belgian Development Cooperation (DGDC)	This work was supported by a research grant from the Flemish Government - Department of Economy, Science & Innovation and through the framework agreement between the Institute of Tropical Medicine Antwerp, Sihanouk Hospital Center of Hope and the Belgian Development Cooperation (DGDC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkarathamrongsin S, 2011, INTERVIROLOGY, V54, P10, DOI 10.1159/000318884; Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; [Anonymous], BMJ, DOI DOI 10.1136/BMJ.327.7423.1075; [Anonymous], 2017, LANCET GASTROENTEROL, V2, P161; Bes M, 2009, TRANSFUSION, V49, P1296, DOI 10.1111/j.1537-2995.2009.02103.x; Chen M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150512; Chhorvann C, 2014, HIV RELATED RISK BEH; De Monte A, 2016, J CLIN VIROL, V78, P27, DOI 10.1016/j.jcv.2016.02.026; De Weggheleire A, J HEPATOLOGY, V64, pS715; EASL, 2016, REC TREATM HEP C; Filippini P, 2007, J MED VIROL, V79, P1679, DOI 10.1002/jmv.20992; Getchell JP, 2013, MMWR-MORBID MORTAL W, V62, P362; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Goyet S, 2014, AIDS BEHAV, V18, P495, DOI 10.1007/s10461-013-0486-0; Grint D, 2016, HIV MED; Hadlich E, 2007, J GASTROEN HEPATOL, V22, P1506, DOI 10.1111/j.1440-1746.2006.04614.x; Hammerstad SS, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00134; Holding R., 1998, EPIDEMICS DEVASTATIN; IDSA-AASLD, 2016, REC TEST MAN TREAT H; Lerolle N., 2012, Journal of AIDS and Clinical Research, V3, P161; Liaw YF, 2009, LIVER INT, V29, P100, DOI 10.1111/j.1478-3231.2008.01941.x; Makuria AT, 2012, TRANSFUSION, V52, P1940, DOI 10.1111/j.1537-2995.2011.03524.x; Martinello M, 2016, AIDS REV, V18, P69; Murphy J., 2015, COUNTRY LOVE INJECTI; Ol HS, 2009, SE ASIAN J TROP MED, V40, P963; Owens DK, 1997, MED DECIS MAKING, V17, P409, DOI 10.1177/0272989X9701700406; Pepin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099677; Pepin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080948; Platt L, 2016, LANCET INFECT DIS, V16, P797, DOI 10.1016/S1473-3099(15)00485-5; Ranieri R, 2003, CLIN INFECT DIS, V36, P1086, DOI 10.1086/374247; Soeung SC, 2009, AM J TROP MED HYG, V81, P252, DOI 10.4269/ajtmh.2009.81.252; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Stenkvist J, 2014, J HEPATOL, V61, P957, DOI 10.1016/j.jhep.2014.06.014; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thursz M, 2014, NAT REV GASTRO HEPAT, V11, P28, DOI 10.1038/nrgastro.2013.179; van Griensven J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088552; Vong S, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-56; Vun MC, 2016, MMWR-MORBID MORTAL W, V65, P142, DOI 10.15585/mmwr.mm6506a2; World Health Organization, 2017, GUID HEP B C TEST; Yamada H, 2015, HEPATOL RES, V45, P480, DOI 10.1111/hepr.12367; Yu C, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw099	41	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183530	10.1371/journal.pone.0183530	http://dx.doi.org/10.1371/journal.pone.0183530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832660	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800062
J	Forsberg, BR; Melack, JM; Dunne, T; Barthem, RB; Goulding, M; Paiva, RCD; Sorribas, MV; Silva, UL; Weisser, S				Forsberg, Bruce R.; Melack, John M.; Dunne, Thomas; Barthem, Ronaldo B.; Goulding, Michael; Paiva, Rodrigo C. D.; Sorribas, Mino V.; Silva, Urbano L., Jr.; Weisser, Sabine			The potential impact of new Andean dams on Amazon fluvial ecosystems	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; PRIMARY PRODUCTIVITY; FLOODPLAIN FORESTS; METHANE EMISSIONS; TOTAL PHOSPHORUS; RIVER; FISH; MERCURY; WATER; DYNAMICS	Increased energy demand has led to plans for building many new dams in the western Amazon, mostly in the Andean region. Historical data and mechanistic scenarios are used to examine potential impacts above and below six of the largest dams planned for the region, including reductions in downstream sediment and nutrient supplies, changes in downstream flood pulse, changes in upstream and downstream fish yields, reservoir siltation, greenhouse gas emissions and mercury contamination. Together, these six dams are predicted to reduce the supply of sediments, phosphorus and nitrogen from the Andean region by 69, 67 and 57% and to the entire Amazon basin by 64, 51 and 23%, respectively. These large reductions in sediment and nutrient supplies will have major impacts on channel geomorphology, flood-plain fertility and aquatic productivity. These effects will be greatest near the dams and extend to the lowland floodplains. Attenuation of the downstream flood pulse is expected to alter the survival, phenology and growth of floodplain vegetation and reduce fish yields below the dams. Reservoir filling times due to siltation are predicted to vary from 106-6240 years, affecting the storage performance of some dams. Total CO2 equivalent carbon emission from 4 Andean dams was expected to average 10 Tg y(-1) during the first 30 years of operation, resulting in a MegaWatt weighted Carbon Emission Factor of 0.139 tons C MWhr(-1). Mercury contamination in fish and local human populations is expected to increase both above and below the dams creating significant health risks. Reservoir fish yields will compensate some downstream losses, but increased mercury contamination could offset these benefits.	[Forsberg, Bruce R.] Natl Inst Amazon Res, Environm Dynam Dept, Manaus, Amazonas, Brazil; [Melack, John M.; Dunne, Thomas] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA 93106 USA; [Barthem, Ronaldo B.] Emilio Goeldi Museum Para, Belem, Para, Brazil; [Goulding, Michael] Wildlife Conservat Soc, New York, NY USA; [Paiva, Rodrigo C. D.; Sorribas, Mino V.] Univ Fed Rio Grande do Sul, Inst Hydraul Res, Porto Alegre, RS, Brazil; [Silva, Urbano L., Jr.] Chico Mendes Inst Biodivers Conservat, Natl Ctr Res & Conservat Amazon Biodivers, Manaus, Amazonas, Brazil; [Weisser, Sabine] Univ Konstanz, Dept Biol, Constance, Germany	Institute Nacional de Pesquisas da Amazonia; University of California System; University of California Santa Barbara; Museu Paraense Emilio Goeldi; Wildlife Conservation Society; Universidade Federal do Rio Grande do Sul; University of Konstanz	Forsberg, BR (corresponding author), Natl Inst Amazon Res, Environm Dynam Dept, Manaus, Amazonas, Brazil.	brforsberg@gmail.com	Barthem, Ronaldo B/K-1875-2015; forsberg, bruce/AAE-4092-2020	Barthem, Ronaldo B/0000-0002-9919-0478; forsberg, bruce/0000-0001-7606-0585; Paiva, Rodrigo/0000-0003-2918-6681	Science for Nature and People (SNAP) - National Center for Ecological Analysis and Synthesis (NCEAS); Wildlife Conservation Society (WCS); Museu Paraense Emilio Goeldi (MPEG); Institute Nacional de Pesquisas da Amazonia (INPA); David and Lucile Packard Foundation [2013-38757, 2014-39828]; Ward Woods [309519]; The Nature Conservancy (TNC); Gordon and Betty Moore Foundation [500]; John D. and Catherine T. MacArthur Foundation [84377]; Brazilian National Research Council (CNPq) [309636/2011-6]; US Department of Energy [DE-0010620]; NASA; Fulbright fellowship	Science for Nature and People (SNAP) - National Center for Ecological Analysis and Synthesis (NCEAS); Wildlife Conservation Society (WCS); Museu Paraense Emilio Goeldi (MPEG); Institute Nacional de Pesquisas da Amazonia (INPA); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Ward Woods; The Nature Conservancy (TNC); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); John D. and Catherine T. MacArthur Foundation; Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); US Department of Energy(United States Department of Energy (DOE)); NASA(National Aeronautics & Space Administration (NASA)); Fulbright fellowship	The synthetic work for this paper was supported by the Science for Nature and People (SNAP) sponsored by the National Center for Ecological Analysis and Synthesis (NCEAS), the Wildlife Conservation Society (WCS) and the Nature Conservancy (TNC). At WCS we thank Cristian Samper, John Robinson, Julie Kunen, Mariana Varese, Mariana Montoya, Carlos Durigan, Guillermo Estupinan, Micaela Varese, Natalia Piland and Sofia Baca; for SNAP workshop support we thank Charo Lanao; at TNC Craig Groves and Peter Kareiva; at NCEAS Frank Davis and Lee Ann French. We thank D. Kasper, J.R.P. Peleja, E.M. Nakazono, A.P. Souza, J.B. Rocha and D.R. Dietrich for help during the collection and analysis of fish and hair for mercury at Balbina Reservoir and orientation. We also thank the Museu Paraense Emilio Goeldi (MPEG) and the Institute Nacional de Pesquisas da Amazonia (INPA) for their support. For fisheries data we are indebted to the Direccion Regional de la Produccion (DIREPRO), Peru. SNAP funding was provided by the David and Lucile Packard Foundation (Grant # 2013-38757 & #2014-39828), Ward Woods (Grant # 309519), the Wildlife Conservation Society (WCS) and The Nature Conservancy (TNC). Field data reported for the first time was supported by the Gordon and Betty Moore Foundation (Grant 500) and the John D. and Catherine T. MacArthur Foundation (Grant 84377). The Brazilian National Research Council (CNPq) provided a productivity grant to B.R. Forsberg (Grant 309636/2011-6). J.M. Melack received support from the US Department of Energy (Contract No. DE-0010620), NASA and a Fulbright fellowship. From the above institutions, past or present, we thank Avecita Chicchon, Adrian Forsyth, Rosa Lemos da Sa and Enrique Ortiz.	Aalto R, 2006, J GEOL, V114, P85, DOI 10.1086/498101; Abril G, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002457; Abu-Zeid M. A., 1997, International Journal of Water Resources Development, V13, P209, DOI 10.1080/07900629749836; ANA, HIDR HYDR DAT; [Anonymous], 1979, FISHERIES ECOLOGY FL; ARAUJOLIMA CARM, 1986, SCIENCE, V234, P1256, DOI 10.1126/science.234.4781.1256; Armijos E, 2013, J S AM EARTH SCI, V44, P75, DOI 10.1016/j.jsames.2012.09.002; Assahira C, 2017, FOREST ECOL MANAG, V396, P113, DOI 10.1016/j.foreco.2017.04.016; Baby P, 2009, HYDROL PROCESS, V23, P3225, DOI 10.1002/hyp.7391; Barros N, 2011, NAT GEOSCI, V4, P593, DOI 10.1038/ngeo1211; Bastos Wanderley R., 1998, Ciencia e Cultura (Sao Paulo), V50, P255; Belger L, 2006, SCI TOTAL ENVIRON, V367, P451, DOI 10.1016/j.scitotenv.2006.03.033; Bernal C, 2013, J S AM EARTH SCI, V44, P63, DOI 10.1016/j.jsames.2012.11.009; Bodaly RA, 1997, MET IONS BIOL SYST, V34, P259; Bosi M, 2001, INITIAL VIEW METHODO; Brune G. M., 1953, T AM GEOPHYS UNION, V34, P407, DOI DOI 10.1029/TR034I003P00407; Callede J., 2010, REV SCI EAU, V23, P247, DOI [10.7202/044688ar, DOI 10.7202/044688AR]; CARLING PA, 1982, EARTH SURF PROC LAND, V7, P349, DOI 10.1002/esp.3290070407; Castello L, 2015, ROY SOC OPEN SCI, V2, DOI 10.1098/rsos.150299; Castello L, 2016, GLOBAL CHANGE BIOL, V22, P990, DOI 10.1111/gcb.13173; Catarino MF, 2014, B I PESCA SAO PAULO; Chasar LC, 2009, ENVIRON SCI TECHNOL, V43, P2733, DOI 10.1021/es8027567; Connaughton J, 2014, WATER-SUI, V6, P2717, DOI 10.3390/w6092717; Constantine JA, 2014, NAT GEOSCI, V7, P899, DOI [10.1038/NGEO2282, 10.1038/ngeo2282]; Dai ZJ, 2013, J HYDROL, V480, P10, DOI 10.1016/j.jhydrol.2012.12.003; Deemer BR, 2016, BIOSCIENCE, V66, P949, DOI 10.1093/biosci/biw117; Devol AH, 1991, PHOSPHORUS CYCLES TE, V3, P9; Devol AH, 1984, VERHANDLUNGEN INT VE, V22, P1299; de Paiva RCD, 2013, WATER RESOUR RES, V49, P1226, DOI 10.1002/wrcr.20067; DOWNING JA, 1990, CAN J FISH AQUAT SCI, V47, P1929, DOI 10.1139/f90-217; Dunne T, 1998, GEOL SOC AM BULL, V110, P450, DOI 10.1130/0016-7606(1998)110<0450:EOSBTF>2.3.CO;2; ENGLE DL, 1990, LIMNOL OCEANOGR, V35, P483; Farr TG, 2007, REV GEOPHYS, V45, DOI 10.1029/2005RG000183; Fearnside P. M., 2008, OECOLOGIA BRAS, V12, P100, DOI [DOI 10.4257/0EC0.2008.1201.11, DOI 10.4257/OECO.2008.1201.10]; Fearnside PM, 2012, NAT CLIM CHANGE, V2, P382, DOI 10.1038/nclimate1540; Ferreira LV, 2013, AN ACAD BRAS CIENC, V85, P1013, DOI 10.1590/S0001-37652013000300012; Ferreira Leandro Valle, 2007, Pesquisas Botanica, P139; Ferreira LV, 1997, BIODIVERS CONSERV, V6, P1353, DOI 10.1023/A:1018385529531; Ferreira-Ferreira J, 2015, WETL ECOL MANAG, V23, P41, DOI 10.1007/s11273-014-9359-1; Filizola N, 2009, HYDROL PROCESS, V23, P3207, DOI 10.1002/hyp.7394; Finer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035126; FORSBERG BR, 1993, ECOLOGY, V74, P643, DOI 10.2307/1940793; FORSBERG BR, 1988, LIMNOL OCEANOGR, V33, P41, DOI 10.4319/lo.1988.33.1.0041; Forsberg BR, 2017, HYDROBIOLOGIA; Furch K., 1997, CENTRAL AMAZON FLOOD, P47; Galat DL, 2000, HYDROBIOLOGIA, V422, P29, DOI 10.1023/A:1017052319056; Garcia A., 2012, FOLIA AMAZON, V21, P45; Garcia A, 2009, FISH PHYSIOL BIOCHEM, V35, P53, DOI 10.1007/s10695-008-9212-7; GIBBS RJ, 1967, GEOL SOC AM BULL, V78, P1203, DOI 10.1130/0016-7606(1967)78[1203:TGOTAR]2.0.CO;2; Goulding M., 1980, FISHES FOREST EXPLOR; Goulding M, 2000, FLOODS OF FORTUNE; GRACE J, 2016, ECOL STUD-ANAL SYNTH, V227, P79, DOI DOI 10.1007/978-3-662-49902-3_5; Grumbine RE, 2013, SCIENCE, V339, P36, DOI 10.1126/science.1227211; GUYOT JL, 1994, LIMNOL OCEANOGR, V39, P452, DOI 10.4319/lo.1994.39.2.0452; Guyot JL, 1996, IAHS-AISH P, P55; Guyot JL, 1993, HIDROGEOCHIMIE FLEUV; Hall BD, 2005, ECOSYSTEMS, V8, P248, DOI 10.1007/s10021-003-0094-3; HEIMANN D.C, 2011, 20115200 US GEOL SUR; Irion G, 2010, AMAZON FLOODPLAIN FO, P28; Isaac VJ, 2016, FISH RES, V183, P352, DOI 10.1016/j.fishres.2016.06.017; Johnston TA, 1994, CANADIAN J FISHERIES, V48, P1468; JUNK W J, 1989, Canadian Special Publication of Fisheries and Aquatic Sciences, V106, P110; Junk W. J., 1997, CENTRAL AMAZON FLOOD; KALLIOLA R, 1992, NATURWISSENSCHAFTEN, V79, P75, DOI 10.1007/BF01131806; Kasper D, 2014, ENVIRON SCI TECHNOL, V48, P1032, DOI 10.1021/es4042644; Kasper D, 2012, HYDROBIOLOGIA, V694, P87, DOI 10.1007/s10750-012-1133-x; Kemenes A., 2008, CIENCIA HOJE, V41, P20; Kemenes A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029479; Kemenes A, 2016, INLAND WATERS, V6, P295, DOI 10.5268/IW-6.3.980; Kemenes A, 2011, J GEOPHYS RES-BIOGEO, V116, DOI [10.1029/2010JG001465, 10.1029/2010J0001465]; Kern J., 1997, JUNK WJ, P119; Kondolf GM, 1997, ENVIRON MANAGE, V21, P533, DOI 10.1007/s002679900048; Laraque A, 2009, HYDROL PROCESS, V23, P3509, DOI 10.1002/hyp.7463; Latrubesse EM, 2017, NATURE, V546, P363, DOI 10.1038/nature22333; Lees AC, 2016, BIODIVERS CONSERV, V25, P451, DOI 10.1007/s10531-016-1072-3; MALM O, 1989, Ciencia e Cultura (Sao Paulo), V41, P88; Marshall BG, 2016, J FISH BIOL, V89, P220, DOI 10.1111/jfb.12952; MARTINELLI LA, 1993, APPL GEOCHEM, V8, P391, DOI 10.1016/0883-2927(93)90007-4; McClain M. E., 1995, B I FR ETUDES ANDINE, V24, P425; Melack J.M., 2001, BIOGEOCHEMISTRY AMAZ, P235; MELACK JM, 1976, T AM FISH SOC, V105, P575, DOI 10.1577/1548-8659(1976)105<575:PPAFYI>2.0.CO;2; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Melack JM, 2016, ECOL STUD-ANAL SYNTH, V227, P119, DOI 10.1007/978-3-662-49902-3_7; Melack JM, 2009, GEOPHYS MONOGR SER, V186, P525, DOI 10.1029/2008GM000721; MEM, 2008, PORTF GEN TRANSM PRO; Merona AB, 1993, AQUAT LIVING RESOUR, V6, P97; Merona B., 2010, PEIXES PESCA BAIXO R; MERTES LAK, 1995, GEOMORPHOLOGY, V13, P215, DOI 10.1016/0169-555X(95)00038-7; Mertes LAK, 1997, WATER RESOUR RES, V33, P1749, DOI 10.1029/97WR00658; Morris G.L., 1998, RESERVOIR SEDIMENTAT; Myhre G, 2014, CLIMATE CHANGE 2013: THE PHYSICAL SCIENCE BASIS, P659; Nixon SW, 2003, AMBIO, V32, P30, DOI 10.1639/0044-7447(2003)032[0030:RTNAAN]2.0.CO;2; Peres CA, 1997, J TROP ECOL, V13, P381, DOI 10.1017/S0266467400010580; Petermann Peter, 1997, Ecological Studies, V126, P419; Petrere Miguel Jr, 1996, Lakes & Reservoirs Research and Management, V2, P111, DOI 10.1111/j.1440-1770.1996.tb00054.x; Richey JE, 2002, NATURE, V416, P617, DOI 10.1038/416617a; Roddaz M, 2005, TECTONOPHYSICS, V399, P87, DOI 10.1016/j.tecto.2004.12.017; SALO J, 1986, NATURE, V322, P254, DOI 10.1038/322254a0; Santos Geraldo Mendes dos, 1999, Acta Amazonica, V29, P145; Schmidt JC, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005092; Schongart J, 2002, J TROP ECOL, V18, P581, DOI 10.1017/S0266467402002389; Schongart J, 2010, AMAZON FLOOD PLAIN F, P348; SETARO FV, 1984, LIMNOL OCEANOGR, V29, P972, DOI 10.4319/lo.1984.29.5.0972; Silva EA, 2006, ENVIRON BIOL FISH, V77, P63, DOI 10.1007/s10641-006-9055-y; Silva-Forsberg MC, 1999, AMBIO, V28, P519; Sorribas MV, 2016, CLIMATE CHANGE; St Louis VL, 2004, ENVIRON SCI TECHNOL, V38, P1348, DOI 10.1021/es034424f; STALLARD RF, 1983, J GEOPHYS RES-OCEANS, V88, P9671, DOI 10.1029/JC088iC14p09671; Syvitski JPM, 2009, NAT GEOSCI, V2, P681, DOI 10.1038/NGEO629; Trevisan GV, 2007, HYDROBIOLOGIA, V586, P357, DOI 10.1007/s10750-007-0705-7; Vega JS, 2012, 2 CONS STRAT FUND; Weisser CW, 2001, THESIS; WHITE GF, 1988, ENVIRONMENT, V30, P4; Wieland Martin, 2010, International Water Power and Dam Construction, V62, P32; Willacker JJ, 2016, SCI TOTAL ENVIRON, V568, P739, DOI 10.1016/j.scitotenv.2016.03.050; Williams GP, 1984, 1286 US GEOL SURV; Winemiller KO, 2016, SCIENCE, V351, P128, DOI 10.1126/science.aac7082; Wittmann FH, 2010, RILEM PROC, V71, P61; [No title captured]; [No title captured]	120	112	117	3	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182254	10.1371/journal.pone.0182254	http://dx.doi.org/10.1371/journal.pone.0182254			35	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832638	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800018
J	Johnson, LM; Torres, C; Sykes, A; Gibson, DV; Baker, JN				Johnson, Liza-Marie; Torres, Carlos; Sykes, April; Gibson, Deborah V.; Baker, Justin N.			The bereavement experience of adolescents and early young adults with cancer: Peer and parental loss due to death is associated with increased risk of adverse psychological outcomes	PLOS ONE			English	Article							CHILDHOOD-CANCER; GRIEF; SURVIVORS; HEALTH; CARE; EXPOSURE; CHILDREN; YOUTH	Background Adolescents commonly experience loss due to death, and perceived closeness to the deceased can often increase the intensity of bereavement. Adolescents and early young adult (AeYA) oncology patients may recall previous losses or experience new losses, possibly of other children with cancer, while coping with their own increased risk of mortality. The bereavement experiences of AeYA patients are not well described in the literature. Methods and findings This analysis of bereavement sought to describe the prevalence and types of losses, the support following a death, and the impact of loss on AeYAs aged 13-21 years with malignant disease (or a hematologic disorder requiring allogeneic transplant). Participants were receiving active oncologic therapy or had completed therapy within the past 3 years. Participants completed a bereavement questionnaire and inventories on depression, anxiety, and somatization. The cross-sectional study enrolled 153 AeYAs (95% participation), most (88%) of whom had experienced a loss due to death. The most commonly reported losses were of a grandparent (58%) or friend (37%). Peer deaths were predominantly cancer related (66%). Many participants (39%) self-identified a loss as "very significant." As loss significance increased, AeYAs were more likely to report that it had changed their life "a lot/enormously" (P<0.0001), that they were grieving "slowly or never got over it" (P<0.0001), and that they felt a need for more professional help (P = 0.026). Peer loss was associated with increased risk of adverse psychological outcomes (P = 0.029), as was parental loss (P = 0.018). Conclusions Most AeYAs with serious illness experience the grief process as slow or ongoing. Peer or parental loss was associated with increased risk of negative mental health outcomes. Given the high prevalence of peer loss, screening for bereavement problems is warranted in AeYAs with cancer, and further research on grief and bereavement is needed in AeYAs with serious illness.	[Johnson, Liza-Marie; Torres, Carlos; Gibson, Deborah V.; Baker, Justin N.] St Jude Childrens Res Hosp, Div Qual Life & Palliat Care, 332 N Lauderdale St, Memphis, TN 38105 USA; [Torres, Carlos] Univ Memphis, Dept Psychol, Memphis, TN 38152 USA; [Sykes, April] St Jude Childrens Res Hosp, Dept Biostat, 332 N Lauderdale St, Memphis, TN 38105 USA	St Jude Children's Research Hospital; University of Memphis; St Jude Children's Research Hospital	Johnson, LM (corresponding author), St Jude Childrens Res Hosp, Div Qual Life & Palliat Care, 332 N Lauderdale St, Memphis, TN 38105 USA.	Liza.johnson@stjude.org	Torres, Carlos/GRS-7240-2022; Sykes, April/N-4407-2018; Johnson, Liza-Marie/N-8127-2018; Baker, Justin/N-8117-2018	Sykes, April/0000-0002-7667-8155; Johnson, Liza-Marie/0000-0002-7124-979X; Baker, Justin/0000-0002-6584-6483				Ayers T, 2004, DEATH STUD, V28, P491, DOI 10.1080/07481180490461188; Balk D.E., 2009, ADOLESCENT ENCOUNTER; Bleyer A, 2006, CANC EPIDEMIOLOGY OL; Boelen PA, 2015, PSYCHOL TRAUMA-US, V7, P382, DOI 10.1037/tra0000018; BRENT DA, 1992, J AM ACAD CHILD PSY, V31, P629, DOI 10.1097/00004583-199207000-00009; Brown G. W., 1986, DEPRESSION YOUNG PEO, P251; Cupit MC, 2015, WHY GOD SUFFERING CA, P138; Dyregrov A, 1999, SCAND J PSYCHOL, V40, P167, DOI 10.1111/1467-9450.00114; Ens C, 2005, DEATH STUD, V29, P171, DOI 10.1080/07481180590906192; Grenklo TB, 2013, J CLIN ONCOL, V31, P2886, DOI 10.1200/JCO.2012.46.6102; Harrison L, 2001, J ADOLESCENCE, V24, P159, DOI 10.1006/jado.2001.0379; Hinds PS, 2005, J CLIN ONCOL, V23, P9146, DOI 10.1200/JCO.2005.10.538; Hirooka K, 2017, J ADV NURS, V73, P955, DOI 10.1111/jan.13196; Hogan N., 1996, CONTINUING BONDS NEW, P235; Jonas-Simpson C, 2015, DEATH STUD, V39, P242, DOI 10.1080/07481187.2014.991954; Kazak AE, 2010, J CLIN ONCOL, V28, P2002, DOI 10.1200/JCO.2009.25.9564; MacPherson C., 2005, MORTALITY, V10, P113, DOI DOI 10.1080/13576270500102872; Martinson IM, 1991, J ADOLESCENT RES, V6, P54, DOI DOI 10.1177/074355489161005; McNeil J. N., 1991, J ADOLESCENT RES, V6, P132; Michel G, 2010, J CLIN ONCOL, V28, P1740, DOI 10.1200/JCO.2009.23.4534; Neimeyer RA, 2002, AM BEHAV SCI, V46, P235, DOI 10.1177/000276402236676; Nickerson B., 1991, J ADOLESCENT RES, V6, P70, DOI DOI 10.1177/074355489161006; Nitschke R, 2000, MED PEDIATR ONCOL, V34, P268; Noppe LD., 2004, J MENT HLTH COUNS, V26, P146, DOI [10.17744/mehc.26.2.py2tk0kmay1ukc3v, DOI 10.17744/MEHC.26.2.PY2TK0KMAY1UKC3V]; OBRIEN JM, 1991, ADOLESCENCE, V26, P431; Oltjenbruns KA, 1991, J ADOLESC RES, V6, P43; Prasad PK, 2015, J CLIN ONCOL, V33, P2545, DOI 10.1200/JCO.2014.57.7528; Prigerson HG, 2008, BRIT J PSYCHIAT, V193, P435, DOI 10.1192/bjp.bp.108.053157; Reynolds CR., 2004, BEHAV ASSESSMENT SYS, V2, DOI [10.1002/9780470479216.corpsy0114, DOI 10.1002/9780470479216.CORPSY0114]; Rheingold AA, 2004, J LOSS TRAUMA, V9, P1, DOI 10.1080/15325020490255250; Ringler LL, 2000, J ADOLESCENT RES, V15, P209, DOI 10.1177/0743558400152002; Servaty-Seib HL, 2006, OMEGA-J DEATH DYING, V54, P147; Sisk CL, 2004, NAT NEUROSCI, V7, P1040, DOI 10.1038/nn1326; Smith MA, 2014, CANCER-AM CANCER SOC, V120, P2497, DOI 10.1002/cncr.28748; Sood B, 1992, MENTAL HLTH CARE, V2, P17; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Swihart J., 1992, SCHOOL COUNS, V40, P55; Trevino KM, 2011, J ADOLESC YOUNG ADUL, V1, P168, DOI 10.1089/jayao.2011.0024; Warnick AL, 2015, CURR OPIN SUPPORT PA, V9, P58, DOI 10.1097/SPC.0000000000000115	39	9	9	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0181024	10.1371/journal.pone.0181024	http://dx.doi.org/10.1371/journal.pone.0181024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832654	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800002
J	Kenawy, S; Hegazy, R; Hassan, A; El-Shenawy, S; Gomaa, N; Zaki, H; Attia, A				Kenawy, Sara; Hegazy, Rehab; Hassan, Azza; El-Shenawy, Siham; Gomaa, Nawal; Zaki, Hala; Attia, Amina			Involvement of insulin resistance in Dgalactose-induced age-related dementia in rats: Protective role of metformin and saxagliptin	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; AMYLOID-BETA; THERAPEUTIC TARGET; OXIDATIVE STRESS; INFLAMMATION; PROGRESSION; REDUCTIONS; IMPAIRMENT; METABOLISM; EXPRESSION	Age-related dementia is one of the most devastating disorders affecting the elderly. Recently, emerging data suggest that impaired insulin signaling is the major contributor in the development of Alzheimer's dementia (AD), which is the most common type of senile dementia. In the present study, we investigated the potential therapeutic effects of metformin (Met) and saxagliptin (Saxa), as insulin sensitizing agents, in a rat model of brain aging and AD using D-galactose (D-gal, 150 mg/kg/day, s.c. for 90 successive days). Six groups of adult male Wistar rats were used: normal, D-gal, Met (500 mg/kg/day, p.o), and Saxa (1 mg/kg/day, p.o) control groups, as well as D-gal/Met and D-gal/Sax treated groups. Impaired learning and memory function was observed in rats treated with D-gal using Morris water maze test. Biochemical and histopathological findings also revealed some characteristic changes of AD in the brain that include the increased content of acetylcholine, glutamate, and phosphorelated tau, as well as deposition of amyloid plaques and neurofibrillary tangles. Induction of insulin resistance in experimentally aged rats was evidenced by increased blood glycated hemoglobin, brain contents of insulin and receptors for advanced glycated end-products, as well as decreased brain insulin receptor level. Elevation of oxidative stress markers and TNF-alpha brain content was also demonstrated. Met and Saxa, with a preference to Met, restored the normal memory and learning functions in rats, improved D-galinduced state of insulin resistance, oxidative stress and inflammation, and ameliorated the AD biochemical and histopathological alterations in brain tissues. Our findings suggest that D-gal model of aging results in a diminishing of learning and memory function by producing a state of impaired insulin signaling that causes a cascade of deleterious events like oxidative stress, inflammation, and tau hyper-phosphorylation. Reversing of these harmful effects by the use of insulin-sensitizing drugs like Met and Saxa suggests their involvement in alleviation insulin resistance as the underlying pathology of AD and hence their potential use as anti-dementia drugs.	[Kenawy, Sara; Hegazy, Rehab; El-Shenawy, Siham; Gomaa, Nawal] Natl Res Ctr, Med Div, Pharmacol Dept, Giza, Egypt; [Hassan, Azza] Cairo Univ, Fac Vet Med, Pathol Dept, Giza, Egypt; [Zaki, Hala; Attia, Amina] Cairo Univ, Fac Pharm, Pharmacol & Toxicol Dept, Cairo, Egypt	Egyptian Knowledge Bank (EKB); National Research Centre (NRC); Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); Cairo University	Hegazy, R (corresponding author), Natl Res Ctr, Med Div, Pharmacol Dept, Giza, Egypt.	rehab_hegazy@hotmail.com		, Siham/0000-0002-8057-0331; Hegazy, Rehab/0000-0002-2586-2104; Zaki, Hala/0000-0001-9026-4015	National Research Center of Egypt; National Research Centre (Giza, Egypt)	National Research Center of Egypt(National Research Centre (NRC)); National Research Centre (Giza, Egypt)(National Research Centre (NRC))	SK received fund from the National Research Center of Egypt to perform the work in the current manuscript. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported and funded by the National Research Centre (Giza, Egypt).	Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Bevan P, 2001, J CELL SCI, V114, P1429; Bhat RV, 2004, J NEUROCHEM, V89, P1313, DOI 10.1111/j.1471-4159.2004.02422.x; Bhutada P, PROTECTION CHOLINERG; BONAVIDA B, 1991, BIOTHERAPY, V3, P127, DOI 10.1007/BF02172085; Bordji K, 2011, REV NEUROSCIENCE, V22, P285, DOI 10.1515/RNS.2011.029; Bromley-Brits Kelley, 2011, J Vis Exp, DOI 10.3791/2920; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Chen F, 2016, NEUROPHARMACOLOGY, V101, P123, DOI 10.1016/j.neuropharm.2015.07.023; Chen HY, 2016, J ALZHEIMERS DIS, V51, P515, DOI 10.3233/JAD-151089; Chen YX, 2016, CURR TOP MED CHEM, V16, P485, DOI 10.2174/1568026615666150813142423; COCCHETTO DM, 1983, J PHARM SCI-US, V72, P465, DOI 10.1002/jps.2600720503; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Fried LP, 2016, GERONTOLOGIST, V56, pS167, DOI 10.1093/geront/gnw035; Grieb P, 2016, MOL NEUROBIOL, V53, P1741, DOI 10.1007/s12035-015-9132-3; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Huang WJ, 2016, BIOMED REP, V4, P519, DOI 10.3892/br.2016.630; Hunter S, 2013, MOL NEUROBIOL, V48, P556, DOI 10.1007/s12035-013-8445-3; Igel LI, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0568-3; Johnstone M, 1999, J NEUROIMMUNOL, V93, P182, DOI 10.1016/S0165-5728(98)00226-4; Kim Y, 2016, KIDNEY RES CLIN PRAC, V35, P69, DOI 10.1016/j.krcp.2016.02.004; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kosaraju J, SAXAGLIPTIN DIPEPTID; Kosaraju J, 2013, NEUROPHARMACOLOGY, V72, P291, DOI 10.1016/j.neuropharm.2013.04.008; Leszek J, 2016, CNS NEUROL DISORD-DR, V15, P329, DOI 10.2174/1871527315666160202125914; Li HY, 2016, J ETHNOPHARMACOL, V179, P162, DOI 10.1016/j.jep.2015.12.020; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li YN, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/320513; Liu YJ, 2015, J NEUROGENET, V29, P50, DOI 10.3109/01677063.2015.1067203; Maczurek A, 2008, ANN NY ACAD SCI, V1126, P147, DOI 10.1196/annals.1433.026; Manolopoulos KN, 2010, MOL PSYCHIATR, V15, P1046, DOI 10.1038/mp.2010.17; Marin MT, 2011, EUR J PHARMACOL, V660, P363, DOI 10.1016/j.ejphar.2011.03.052; Mcnay EC, 2011, NEUROBIOL LEARN MEM, V96, P432, DOI 10.1016/j.nlm.2011.08.005; Mondragon-Rodriguez S, 2010, EXPERT REV NEUROTHER, V10, P683, DOI 10.1586/ERN.10.27; Muir-Hunter SW, 2016, J NUTR HEALTH AGING, V20, P439, DOI 10.1007/s12603-015-0585-x; Novelle MG, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025932; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; PEREZDELAMORA M, 1989, ANAL BIOCHEM, V180, P248, DOI 10.1016/0003-2697(89)90425-9; Rehman S.U., 2016, MOL NEUROBIOL, DOI [DOI 10.1007/S12035-015-9604-5, 10.1007/s12035-015-9604-5]; Rivera EJ, 2005, J ALZHEIMERS DIS, V8, P247; Salazar JJ, 2016, J DIABETES COMPLICAT, V30, P746, DOI 10.1016/j.jdiacomp.2015.12.017; Snowdon DA, 1997, GERONTOLOGIST, V37, P150, DOI 10.1093/geront/37.2.150; Solini A, 2016, VASC PHARMACOL, V76, P62, DOI 10.1016/j.vph.2015.10.002; Son SM, 2016, J ALZHEIMERS DIS, V51, P1197, DOI 10.3233/JAD-151200; Stefanova NA, 2014, CELL CYCLE, V13, P898, DOI 10.4161/cc.28255; Tarpey MM, 2004, AM J PHYSIOL-REG I, V286, pR431, DOI 10.1152/ajpregu.00361.2003; Tramutola A., 2016, BRAIN RES B; Walker D, 2015, EXPERT OPIN INV DRUG, V24, P393, DOI 10.1517/13543784.2015.1001490; Watson GS, 2006, J NEUROL SCI, V245, P21, DOI 10.1016/j.jns.2005.08.017; WEST MJ, 1994, LANCET, V344, P769, DOI 10.1016/S0140-6736(94)92338-8; Zhang EL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143814	52	41	41	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183565	10.1371/journal.pone.0183565	http://dx.doi.org/10.1371/journal.pone.0183565			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832656	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800064
J	Rafferty, ER; Schurer, JM; Arndt, MB; Choy, RKM; de Hostos, EL; Shoultz, D; Farag, M				Rafferty, Ellen R.; Schurer, Janna M.; Arndt, Michael B.; Choy, Robert K. M.; de Hostos, Eugenio L.; Shoultz, David; Farag, Marwa			Pediatric cryptosporidiosis: An evaluation of health care and societal costs in Peru, Bangladesh and Kenya	PLOS ONE			English	Article							ORAL REHYDRATION THERAPY; CHILDHOOD DIARRHEA; DEVELOPING-COUNTRIES; ROTAVIRUS VACCINATION; SEEKING BEHAVIOR; ECONOMIC BURDEN; CHILDREN; COMMUNITY; DISEASE; MALNUTRITION	Cryptosporidium is a leading cause of pediatric diarrhea in resource-limited settings; yet, few studies report the health care costs or societal impacts of this protozoan parasite. Our study examined direct and indirect costs associated with symptomatic cryptosporidiosis in infants younger than 12 months in Kenya, Peru and Bangladesh. Inputs to the economic burden model, such as disease incidence, population size, health care seeking behaviour, hospital costs, travel costs, were extracted from peer-reviewed literature, government documents, and internationally validated statistical tools for each country. Indirect losses (i.e. caregiver income loss, mortality, and growth faltering) were also estimated. Our findings suggest that direct treatment costs per symptomatic cryptosporidiosis episode were highest in Kenya ($59.01), followed by Peru ($23.32), and Bangladesh ($7.62). The total annual economic impacts for the 0-11 month cohorts were highest in Peru ($41.5M; range $0.88-$599.3M), followed by Kenya ($37.4M; range $1.6-$804.5M) and Bangladesh ($9.6M, range $0.28-$91.5M). For all scenarios, indirect societal costs far outweighed direct treatment costs. These results highlight the critical need for innovative improvements to current prevention, diagnostic and treatment strategies available in resource poor settings, as well as the need for solutions that span multiple disciplines including food and water safety, sanitation and livestock production.	[Rafferty, Ellen R.; Farag, Marwa] Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada; [Schurer, Janna M.] Univ Washington, Ctr Hlth Res 1, Seattle, WA 98195 USA; [Arndt, Michael B.; Choy, Robert K. M.; de Hostos, Eugenio L.; Shoultz, David] PATH, San Francisco, CA USA; [Arndt, Michael B.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Saskatchewan; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Rafferty, ER (corresponding author), Univ Saskatchewan, Sch Publ Hlth, Saskatoon, SK, Canada.; Schurer, JM (corresponding author), Univ Washington, Ctr Hlth Res 1, Seattle, WA 98195 USA.	ersraffe@gmail.com; jschurer@gmail.com		Arndt, Michael/0000-0001-9063-0644; Rafferty, Ellen/0000-0001-9974-8016; Schurer, Janna/0000-0001-6122-5332	Integrated Training Program in Infectious Diseases, Food Safety and Public Policy (ITraP) - Natural Sciences and Engineering Research Council (NSERC); Burroughs Wellcome Fund Collaborative Research Travel Grant; PATH; UK government	Integrated Training Program in Infectious Diseases, Food Safety and Public Policy (ITraP) - Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Burroughs Wellcome Fund Collaborative Research Travel Grant(Burroughs Wellcome Fund); PATH; UK government	Doctoral (ER) and postdoctoral (JMS) stipend support was awarded by the Integrated Training Program in Infectious Diseases, Food Safety and Public Policy (ITraP), which is funded by the Natural Sciences and Engineering Research Council (NSERC). Funding was also provided by the Burroughs Wellcome Fund Collaborative Research Travel Grant. Support for this project was also provided by PATH with funding from the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadi B, 2002, LANCET, V360, P1375, DOI 10.1016/S0140-6736(02)11401-2; Andalon M., 2008, IZA DISCUSSION PAPER, V3390; Barasa EW, 2012, TROP MED INT HEALTH, V17, P958, DOI 10.1111/j.1365-3156.2012.03029.x; Bartelt LA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002125; Bhuiyan MU, 2014, INFLUENZA OTHER RESP, V8, P406, DOI 10.1111/irv.12254; Blum LS, 2011, AM J TROP MED HYG, V85, P1126, DOI 10.4269/ajtmh.2011.11-0171; Cama VA, 2008, EMERG INFECT DIS, V14, P1567, DOI 10.3201/eid1410.071273; Carr R, 2001, WATER QUALITY GUIDEL; Centers for Disease Control and Prevention, 2015, PAR CRYPT; Centers for Disease Control and Prevention, 2015, NIT; Checkley W, 1998, AM J EPIDEMIOL, V148, P497, DOI 10.1093/oxfordjournals.aje.a009675; Checkley W, 2015, LANCET INFECT DIS, V15, P85, DOI 10.1016/S1473-3099(14)70772-8; Chowdhury F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130105; Clark AD, 2009, J INFECT DIS, V200, pS114, DOI 10.1086/605043; Collier SA, 2012, EPIDEMIOL INFECT, V140, P2003, DOI 10.1017/S0950268811002858; Corso PS, 2003, EMERG INFECT DIS, V9, P426, DOI 10.3201/eid0904.020417; Das SK, 2013, AM J TROP MED HYG, V89, P62, DOI 10.4269/ajtmh.13-0107; Edejer T, 2003, WHO GUIDE COST EFFEC; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Guerrant DI, 1999, AM J TROP MED HYG, V61, P707, DOI 10.4269/ajtmh.1999.61.707; Institute for Health Metrics and Evaluation (IHME), 2016, GBD COMP DAT VIS; Institute for Health Metrics and Evaluation (IHME), 2014, HLTH SERV PROV KEN A, P78; Instituto Nacional de Estad A o stica e Informatica-INEI/Peru A, 2013, PER ENC DEM SAL FAM, P529; Kenya National Bureau of Statistics, 2015, EC SURV 2015, P339; Korpe PS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004564; Kotloff KL, 2013, LANCET, V382, P209, DOI 10.1016/S0140-6736(13)60844-2; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Marete I, 2013, East Afr Med J, V90, P222; Mbae C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142055; Moench-Pfanner R, 2016, NUTRIENTS, V8, DOI 10.3390/nu8050292; Molbak K, 1997, AM J CLIN NUTR, V65, P149, DOI 10.1093/ajcn/65.1.149; National Institute of Population Research and Training (NIPORT) Mitra and Associates and ICF International, 2016, BANGL DEM HLTH SURV, P354; Olson CK, 2011, AM J TROP MED HYG, V85, P1134, DOI 10.4269/ajtmh.2011.11-0178; Omore R, 2013, AM J TROP MED HYG, V89, P29, DOI 10.4269/ajtmh.12-0755; Platts-Mills JA, 2015, LANCET GLOB HEALTH, V3, pE564, DOI 10.1016/S2214-109X(15)00151-5; Rheingans R, 2012, CLIN INFECT DIS, V55, pS317, DOI 10.1093/cid/cis763; Rheingans R, 2012, CLIN INFECT DIS, V55, pS327, DOI 10.1093/cid/cis764; Robertson L., 2014, CRYPTOSPORIDIUM FOOD; Shoultz DA, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004242; Sow SO, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004729; Tate JE, 2009, J INFECT DIS, V200, pS76, DOI 10.1086/605058; United Nations Statistics Division, 2016, POP AG SEX URB RUR R; Vera JCA., 2005, REV FAC CIEN EC U NA, V10, P71; Volpicelli K, 2016, MATERN CHILD HLTH J, V20, P2299, DOI 10.1007/s10995-016-2049-2; Winkler J, 2008, HEALTH EDUC RES, V23, P10, DOI 10.1093/her/cyl156; World Bank, 2020, WORLD BANK OPEN DATA; Zwisler Greg, 2013, J Glob Health, V3, P010403, DOI 10.7189/jogh.03.010403	47	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182820	10.1371/journal.pone.0182820	http://dx.doi.org/10.1371/journal.pone.0182820			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832624	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800035
J	Vu, TV; Finkenauer, C; Huizinga, M; Novin, S; Krabbendam, L				Tuong-Van Vu; Finkenauer, Catrin; Huizinga, Mariette; Novin, Sheida; Krabbendam, Lydia			Do individualism and collectivism on three levels (country, individual, and situation) influence theory-of-mind efficiency? A cross-country study	PLOS ONE			English	Article							PERSPECTIVE-TAKING; NEURAL BASIS; SELF; CULTURE; CONSEQUENCES; COGNITION; NETWORKS; EMOTION; ABILITY; EMPATHY	This study investigated whether individualism and collectivism (IC) at country, individual, and situational level influence how quickly and accurately people can infer mental states (i.e. theory of mind, or ToM), indexed by accuracy and reaction time in a ToM task. We hypothesized that collectivism (having an interdependent self and valuing group concerns), compared to individualism (having an independent self and valuing personal concerns), is associated with greater accuracy and speed in recognizing and understanding the thoughts and feelings of others. Students (N = 207) from individualism-representative (the Netherlands) and collectivism- representative (Vietnam) countries (Country IC) answered an individualism-collectivism questionnaire (Individual IC) and were randomly assigned to an individualism-primed, collectivism- primed, or no-prime task (Situational IC) before performing a ToM task. The data showed vast differences between the Dutch and Vietnamese groups that might not be attributable to experimental manipulation. Therefore, we analyzed the data for the groups separately and found that Individual IC did not predict ToM accuracy or reaction time performance. Regarding Situational IC, when primed with individualism, the accuracy performance of Vietnamese participants in affective ToM trials decreased compared to when primed with collectivism and when no prime was used. However, an interesting pattern emerged: Dutch participants were least accurate in affective ToM trials, while Vietnamese participants were quickest in affective ToM trials. Our research also highlights a dilemma faced by cross-cultural researchers who use hard-to-reach populations but face the challenge of disentangling experimental effects from biases that might emerge due to an interaction between cultural differences and experimental settings. We propose suggestions for overcoming such challenges.	[Tuong-Van Vu; Huizinga, Mariette; Krabbendam, Lydia] Vrije Univ Amsterdam, Fac Behav & Movement Sci, Amsterdam, Netherlands; [Finkenauer, Catrin] Univ Utrecht, Dept Interdisciplinary Social Sci, Utrecht, Netherlands; [Novin, Sheida] Univ Utrecht, Dept Social Hlth & Org Psychol, Utrecht, Netherlands	Vrije Universiteit Amsterdam; Utrecht University; Utrecht University	Vu, TV (corresponding author), Vrije Univ Amsterdam, Fac Behav & Movement Sci, Amsterdam, Netherlands.	t.v.vu@vu.nl	Finkenauer, Catrin/N-4867-2019; Krabbendam, Lydia/F-9163-2010	Finkenauer, Catrin/0000-0002-5429-0627; Krabbendam, Lydia/0000-0003-4074-5149; Novin, Sheida/0000-0003-3045-1665; Vu, TuongVan/0000-0001-6700-2439; Huizinga, M./0000-0001-7007-8952	Netherlands Organization for Scientific Research (NWO) [453-11-005]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work received the financial support of the VICI grant from the Netherlands Organization for Scientific Research (NWO, http://www.nwo.nl/) to Lydia Krabbendam [grant number 453-11-005]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DR, 2004, J PERS SOC PSYCHOL, V87, P340, DOI 10.1037/0022-3514.87.3.340; [Anonymous], 2014, CULT BRAIN, DOI DOI 10.1007/S40167-014-0016-6; Apperly IA, 2012, Q J EXP PSYCHOL, V65, P825, DOI 10.1080/17470218.2012.676055; Apperly IA, 2010, Q J EXP PSYCHOL, V63, P1201, DOI 10.1080/17470210903281582; Apperly IA, 2009, DEV PSYCHOL, V45, P190, DOI 10.1037/a0014098; Atkins D, 2016, EMOTION, V16, P587, DOI 10.1037/emo0000162; Balcetis E, 2008, J PERS SOC PSYCHOL, V95, P1252, DOI 10.1037/a0013195; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Birch SAJ, 2004, TRENDS COGN SCI, V8, P255, DOI 10.1016/j.tics.2004.04.011; Bruneau EG, 2012, J EXP SOC PSYCHOL, V48, P855, DOI 10.1016/j.jesp.2012.02.017; Bruneau EG, 2012, NEUROPSYCHOLOGIA, V50, P219, DOI 10.1016/j.neuropsychologia.2011.11.008; Cohen D, 2002, PSYCHOL SCI, V13, P55, DOI 10.1111/1467-9280.00409; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; Declerck CH, 2008, J SOC PSYCHOL, V148, P711, DOI 10.3200/SOCP.148.6.711-726; Duan C., 2008, ASIAN J COUNSELING, V15, P57; Epley N, 2004, J PERS SOC PSYCHOL, V87, P327, DOI 10.1037/0022-3514.87.3.327; Epley N., 2010, HDB SOCIAL PSYCHOL, P498, DOI [10.1002/9780470561119.socpsy001014, DOI 10.1002/9780470561119.SOCPSY001014]; Frith U, 2001, CURR DIR PSYCHOL SCI, V10, P151, DOI 10.1111/1467-8721.00137; Gardner WL, 1999, PSYCHOL SCI, V10, P321, DOI 10.1111/1467-9280.00162; Greenfield PM, 2014, J CROSS CULT PSYCHOL, V45, P37, DOI 10.1177/0022022113513402; Haberstroh S, 2002, J EXP SOC PSYCHOL, V38, P323, DOI 10.1006/jesp.2001.1513; Hong YY, 2000, AM PSYCHOL, V55, P709, DOI 10.1037//0003-066X.55.7.709; Hultsch D.F., 2002, J GERONTOL SERIES B, V57, P101, DOI [10.1093/geronb/57.2.p101, DOI 10.1093/GERONB/57.2.P101, DOI 10.1093/GER0NB/57.2.P101]; Jenkins AC, 2008, P NATL ACAD SCI USA, V105, P4507, DOI 10.1073/pnas.0708785105; Keysar B, 2003, COGNITION, V89, P25, DOI 10.1016/S0010-0277(03)00064-7; Keysers C, 2014, TRENDS COGN SCI, V18, P163, DOI 10.1016/j.tics.2013.12.011; Kinderman P, 1998, BRIT J PSYCHOL, V89, P191, DOI 10.1111/j.2044-8295.1998.tb02680.x; Kitayama SE, 1994, EMOTION CULTURE EMPI; Kuhnen U, 2000, EUR J SOC PSYCHOL, V30, P799; Levine RV, 1999, J CROSS CULT PSYCHOL, V30, P178, DOI 10.1177/0022022199030002003; Luk KKS, 2012, COGNITION, V124, P350, DOI 10.1016/j.cognition.2012.05.016; Marian V, 2004, J MEM LANG, V51, P190, DOI 10.1016/j.jml.2004.04.003; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Matsumoto D, 1996, CULT PSYCHOL, V2, P77, DOI 10.1177/1354067X9621005; Mourey JA, 2015, SOC COGNITION, V33, P308; Nguyen H. D., 2010, NEGOTIATION CONFLICT, V3, P179, DOI [10.1111=j.1750-4716.2010.00057.x, DOI 10.1111/J.1750-4716.2010.00057.X]; OYSERMAN D, 2008, MULTILEVEL ANAL INDI; OYSERMAN D, 1993, J PERS SOC PSYCHOL, V65, P993, DOI 10.1037/0022-3514.65.5.993; Oyserman D, 2002, PSYCHOL BULL, V128, P3, DOI 10.1037/0033-2909.128.1.3; Oyserman D, 2012, HDB MOTIVATION COGNI, P237; Oyserman D, 2008, PSYCHOL BULL, V134, P311, DOI 10.1037/0033-2909.134.2.311; Oyserman D, 2011, EUR REV SOC PSYCHOL, V22, P164, DOI 10.1080/10463283.2011.627187; Oyserman D, 2009, J PERS SOC PSYCHOL, V97, P217, DOI 10.1037/a0015850; PERNER J, 1985, J EXP CHILD PSYCHOL, V39, P437, DOI 10.1016/0022-0965(85)90051-7; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Ross M, 2002, PERS SOC PSYCHOL B, V28, P1040, DOI 10.1177/01461672022811003; Rutherford MD, 2004, BRIT J PSYCHOL, V95, P91, DOI 10.1348/000712604322779488; Schlaffke L, 2015, HUM BRAIN MAPP, V36, P29, DOI 10.1002/hbm.22610; Schneider BA, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00474; Sebastian CL, 2012, SOC COGN AFFECT NEUR, V7, P53, DOI 10.1093/scan/nsr023; SHELDON KM, 1993, PERS SOC PSYCHOL B, V19, P320, DOI 10.1177/0146167293193009; Sheng F, 2012, NEUROIMAGE, V61, P786, DOI 10.1016/j.neuroimage.2012.04.028; Stiller J, 2007, SOC NETWORKS, V29, P93, DOI 10.1016/j.socnet.2006.04.001; Surtees A, 2013, COGNITION, V129, P426, DOI 10.1016/j.cognition.2013.06.008; Taras V, 2014, J CROSS CULT PSYCHOL, V45, P213, DOI 10.1177/0022022113509132; Taras V, 2010, J APPL PSYCHOL, V95, P405, DOI 10.1037/a0018938; Todd AR, 2016, COGNITION, V156, P88, DOI 10.1016/j.cognition.2016.08.004; Triandis H. C., 2012, HDB THEORIES SOCIAL, P498, DOI [10.4135/9781446249222.n51, DOI 10.4135/9781446249222.N51]; TRIANDIS HC, 1989, PSYCHOL REV, V96, P506, DOI 10.1037/0033-295X.96.3.506; Triandis HC, 2001, J PERS, V69, P907, DOI 10.1111/1467-6494.696169; van de Vijver FJK, 2013, AM PSYCHOL, V68, P761, DOI 10.1037/a0033762; Wei MF, 2013, J COUNS PSYCHOL, V60, P625, DOI 10.1037/a0033413; Wu SL, 2007, PSYCHOL SCI, V18, P600, DOI 10.1111/j.1467-9280.2007.01946.x; Ybarra O, 1998, PERS SOC PSYCHOL B, V24, P362, DOI 10.1177/0146167298244003; Young L, 2007, P NATL ACAD SCI USA, V104, P8235, DOI 10.1073/pnas.0701408104; Zhu Y, 2007, NEUROIMAGE, V34, P1310, DOI 10.1016/j.neuroimage.2006.08.047	67	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183011	10.1371/journal.pone.0183011	http://dx.doi.org/10.1371/journal.pone.0183011			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832602	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800042
J	Yuan, Y; Chen, XB; Sun, QB; Huang, TY				Yuan, Ye; Chen, Xuebo; Sun, Qiubai; Huang, Tianyun			Analysis of topological relationships and network properties in the interactions of human beings	PLOS ONE			English	Article							COLLECTIVE BEHAVIOR; FISH SCHOOLS; DYNAMICS; NEURONS; TRANSITION; PARTICLES; DISTANCE; AUTAPSES; DENSITY; RULES	In the animal world, various kinds of collective motions have been found and proven to be efficient ways of carrying out some activities such as searching for food and avoiding predators. Many scholars research the interactions of collective behaviors of human beings according to the rules of collective behaviors of animals. Based on the Lennard-Jones potential function and a self-organization process, our paper proposes a topological communication model to simulate the collective behaviors of human beings. In the results of simulations, we find various types of collective behavior and fission behavior and discover the threshold for the emergence of collective behavior, which is the range five to seven for the number of topology K. According to the analysis of network properties of the model, the indegree of individuals is always equal to the number of topology. In the stable state, the outdegrees of individuals distribute around the value of the number of topology K, except that the out-degree of a single individual is approximately double the out-degrees of the other individuals. In addition, under different initial conditions, some features of different kinds of networks emerge from the model. We also find the leader and herd mentality effects in the characteristics of the behaviors of human beings in our model. Thus, this work could be used to discover how to promote the emergence of beneficial group behaviors and prevent the emergence of harmful behaviors.	[Yuan, Ye] Univ Sci & Technol Liaoning, Sch Elect & Informat Engn, Anshan, Liaoning, Peoples R China; [Chen, Xuebo] Univ Sci & Technol Liaoning, Grad Sch, Anshan, Liaoning, Peoples R China; [Sun, Qiubai] Univ Sci & Technol Liaoning, Sch Business Adm, Anshan, Liaoning, Peoples R China; [Huang, Tianyun] Peking Univ, Ctr Engn Sci & Adv Technol, Beijing, Peoples R China	University of Science & Technology Liaoning; University of Science & Technology Liaoning; University of Science & Technology Liaoning; Peking University	Chen, XB (corresponding author), Univ Sci & Technol Liaoning, Grad Sch, Anshan, Liaoning, Peoples R China.	xuebochen@126.com	Huang, Tian-Yun/AAV-5494-2021	Huang, Tian-Yun/0000-0002-1148-1669; Chen, Xue-Bo/0000-0001-6799-7667				Bajec IL, 2005, J THEOR BIOL, V233, P199, DOI 10.1016/j.jtbi.2004.10.003; Ballerini M, 2008, P NATL ACAD SCI USA, V105, P1232, DOI 10.1073/pnas.0711437105; Camazine S., 2003, SELF ORG BIOL SYSTEM; Couzin ID, 2009, TRENDS COGN SCI, V13, P36, DOI 10.1016/j.tics.2008.10.002; Couzin ID, 2002, J THEOR BIOL, V218, P1, DOI 10.1006/jtbi.2002.3065; Czirok A, 2000, PHYSICA A, V281, P17, DOI 10.1016/S0378-4371(00)00013-3; Dodds PS, 2003, SCIENCE, V301, P827, DOI 10.1126/science.1081058; Ginelli F, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.168103; Haken H., 1981, ERFOLGSGEHEIMNISSE N; Hemelrijk CK, 2008, ETHOLOGY, V114, P245, DOI 10.1111/j.1439-0310.2007.01459.x; Hemelrijk CK, 2005, BEHAV ECOL, V16, P178, DOI 10.1093/beheco/arh149; [黄天云 Huang Tianyun], 2013, [自动化学报, Acta Automatica Sinica], V39, P57; Jones JE, 1924, P ROY SOC LOND MATH; Komareji M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082578; Lukeman R, 2010, P NATL ACAD SCI USA, V107, P12576, DOI 10.1073/pnas.1001763107; Lv M, 2016, NONLINEAR DYNAM, V85, P1479, DOI 10.1007/s11071-016-2773-6; Ma J, 2015, SCI CHINA TECHNOL SC, V58, P2038, DOI 10.1007/s11431-015-5961-6; Moussaid M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078433; Moussaid M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010047; Nickerson R.S., 1998, REV GEN PSYCHOL, V2, P175, DOI [10.1037/1089-2680.2.2.175, DOI 10.1037/1089-2680.2.2.175]; Noelle-Neumann E., 1980, SCHWEIGESPIRALE OFFE; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Olfati-Saber R, 2006, IEEE T AUTOMAT CONTR, V51, P401, DOI 10.1109/TAC.2005.864190; Passos P., 2016, INTERPERSONAL COORDI; Pronin E, 2008, PERS SOC PSYCHOL B, V34, P224, DOI 10.1177/0146167207310023; Qin HX, 2014, SCI CHINA TECHNOL SC, V57, P936, DOI 10.1007/s11431-014-5534-0; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Rio K, 2014, TRANSP RES PROC, V2, P132, DOI 10.1016/j.trpro.2014.09.017; Song XL, 2015, SCI CHINA TECHNOL SC, V58, P1007, DOI 10.1007/s11431-015-5826-z; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Synergetics Haken H., 1977, PHYSICS B, V28, P412; TRAVERS J, 1969, SOCIOMETRY, V32, P425, DOI 10.2307/2786545; VICSEK T, 1995, PHYS REV LETT, V75, P1226, DOI 10.1103/PhysRevLett.75.1226; Vicsek T, 2001, NATURE, V411, P421, DOI 10.1038/35078161; Vicsek T, 2012, PHYS REP, V517, P71, DOI 10.1016/j.physrep.2012.03.004; Vorobeychik Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170780; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Young GF, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002894; Yuan Y, 2017, INT C APPL HUM FACT, P312	39	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183686	10.1371/journal.pone.0183686	http://dx.doi.org/10.1371/journal.pone.0183686			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832629	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800080
J	Braenne, I; Zeng, LY; Willenborg, C; Tragante, V; Kessler, T; Willer, CJ; Laakso, M; Wallentin, L; Franks, PW; Salomaa, V; Dehghan, A; Meitinger, T; Samani, NJ; Asselbergs, FW; Erdmann, J; Schunkert, H				Braenne, Ingrid; Zeng, Lingyao; Willenborg, Christina; Tragante, Vinicius; Kessler, Thorsten; Willer, Cristen J.; Laakso, Markku; Wallentin, Lars; Franks, Paul W.; Salomaa, Veikko; Dehghan, Abbas; Meitinger, Thomas; Samani, Nilesh J.; Asselbergs, Folkert W.; Erdmann, Jeanette; Schunkert, Heribert		CARDIoGRAM Consortium; CARDIoGRAMplusC4D Consortium	Genomic correlates of glatiramer acetate adverse cardiovascular effects lead to a novel locus mediating coronary risk	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; TGF-BETA; MULTIPLE-SCLEROSIS; EXPRESSION; ATHEROSCLEROSIS; ASSOCIATION; MECHANISM; CELLS; ACTIVATION; RECEPTORS	Glatiramer acetate is used therapeutically in multiple sclerosis but also known for adverse effects including elevated coronary artery disease (CAD) risk. The mechanisms underlying the cardiovascular side effects of the medication are unclear. Here, we made use of the chromosomal variation in the genes that are known to be affected by glatiramer treatment. Focusing on genes and gene products reported by drug-gene interaction database to interact with glatiramer acetate we explored a large meta-analysis on CAD genome-wide association studies aiming firstly, to investigate whether variants in these genes also affect cardiovascular risk and secondly, to identify new CAD risk genes. We traced association signals in a 200-kb region around genomic positions of genes interacting with glatiramer in up to 60 801 CAD cases and 123 504 controls. We validated the identified association in additional 21 934 CAD cases and 76 087 controls. We identified three new CAD risk alleles within the TGFB1 region on chromosome 19 that independently affect CAD risk. The lead SNP rs12459996 was genome-wide significantly associated with CAD in the extended meta-analysis (odds ratio 1.09, p = 1.58x10(-12)). The other two SNPs at the locus were not in linkage disequilibrium with the lead SNP and by a conditional analysis showed p-values of 4.05 x 10(-10) and 2.21 x 10(-6). Thus, studying genes reported to interact with glatiramer acetate we identified genetic variants that concordantly with the drug increase the risk of CAD. Of these, TGFB1 displayed signal for association. Indeed, the gene has been associated with CAD previously in both in vivo and in vitro studies. Here we establish genome-wide significant association with CAD in large human samples.	[Braenne, Ingrid; Willenborg, Christina; Erdmann, Jeanette] Univ Lubeck, Inst Cardiogenet, Lubeck, Germany; [Braenne, Ingrid; Erdmann, Jeanette] DZHK German Res Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, Lubeck, Germany; [Braenne, Ingrid; Erdmann, Jeanette] Univ Heart Ctr Lubeck, Lubeck, Germany; [Zeng, Lingyao; Kessler, Thorsten; Schunkert, Heribert] Tech Univ Munich, Deutsch Herzzentrum Munchen, Munich, Germany; [Tragante, Vinicius; Asselbergs, Folkert W.] UMC Utrecht, Div Heart & Lungs, Dept Cardiol, Utrecht, Netherlands; [Willer, Cristen J.] Univ Michigan, Dept Biostat, 1415 Washington Hts, Ann Arbor, MI USA; [Laakso, Markku] Univ Eastern Finland, Internal Med, Inst Clin Med, Kuopio, Finland; [Laakso, Markku] Kuopio Univ Hosp, Kuopio, Finland; [Wallentin, Lars] Uppsala Clin Res Ctr, MTC, Uppsala Sci Pk, Uppsala, Sweden; [Franks, Paul W.] Lund Univ, Skane Univ Hosp Malmo, Genet & Mol Epidemiol Unit, Dept Clin Sci, Malmo, Sweden; [Salomaa, Veikko] THL Natl Inst Hlth & Welf, POB 30,Mannerheimintie 166, Helsinki, Finland; [Dehghan, Abbas] Erasmus MC, Dept Epidemiol, Ca Rotterdam, Netherlands; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, German Res Ctr Environm Hlth, Neuherberg, Germany; [Meitinger, Thomas; Schunkert, Heribert] DZHK German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Inst Human Genet, Munich, Germany; [Samani, Nilesh J.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Samani, Nilesh J.] Glenfield Hosp, NIHR Leicester Cardiovasc Biomed Res Unit, Leicester, Leics, England; [Asselbergs, Folkert W.] Netherlands Heart Inst, Durrer Ctr Cardiovasc Res, Utrecht, Netherlands; [Asselbergs, Folkert W.] UCL, Fac Populat Hlth Sci, Inst Cardiovasc Sci, London, England	University of Lubeck; German Centre for Cardiovascular Research; German Heart Centre Munich; Technical University of Munich; Utrecht University; Utrecht University Medical Center; University of Michigan System; University of Michigan; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Uppsala University; Lund University; Skane University Hospital; Finland National Institute for Health & Welfare; Erasmus University Rotterdam; Erasmus MC; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; German Centre for Cardiovascular Research; Munich Heart Alliance; Technical University of Munich; University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital; University of London; University College London	Erdmann, J (corresponding author), Univ Lubeck, Inst Cardiogenet, Lubeck, Germany.; Erdmann, J (corresponding author), DZHK German Res Ctr Cardiovasc Res, Partner Site Hamburg Lubeck Kiel, Lubeck, Germany.; Erdmann, J (corresponding author), Univ Heart Ctr Lubeck, Lubeck, Germany.	jeanette.erdmann@uni-luebeck.de	Willenborg, Christina/D-2668-2012; Kessler, Thorsten/O-7426-2015; Asselbergs, Folkert W./ABD-6752-2021; Gauguier, Dominique/G-2190-2016; Dehghan, Abbas/ABE-7377-2020; Cazier, Jean-Baptiste/GLR-2949-2022; Kessler, Thorsten/AAI-7292-2021; Franks, Paul/AAA-3300-2020; Palmer, Colin NA/C-7053-2008; Johansson, Åsa/AAG-6799-2021; Erdmann, Jeanette/P-7513-2014; Meitinger, Thomas/O-1318-2015; Müller-Nurasyid, Martina/I-8735-2018; Doney, Alexander/P-7437-2017; McCarthy, Mark/M-3763-2015; Ferrieres, Jean/S-7993-2016	Willenborg, Christina/0000-0001-5217-6882; Asselbergs, Folkert W./0000-0002-1692-8669; Gauguier, Dominique/0000-0001-6156-9530; Cazier, Jean-Baptiste/0000-0001-7581-9051; Kessler, Thorsten/0000-0003-3326-1621; Palmer, Colin NA/0000-0002-6415-6560; Johansson, Åsa/0000-0002-2915-4498; Erdmann, Jeanette/0000-0002-4486-6231; Müller-Nurasyid, Martina/0000-0003-3793-5910; Koenig, Wolfgang/0000-0002-2064-9603; Doney, Alexander/0000-0002-6210-5620; McCarthy, Mark/0000-0002-4393-0510; Goodall, Alison/0000-0002-7883-9645; Ferrieres, Jean/0000-0001-6144-1297; Reilly, Muredach/0000-0002-3035-9386; Wild, Philipp/0000-0003-4413-9752; Stewart, Alexandre/0000-0003-2673-9164; Hopewell, Jemma/0000-0002-3870-8018; Franks, Paul/0000-0002-0520-7604; Voight, Benjamin/0000-0002-6205-9994; Kahonen, Mika/0000-0002-4510-7341; Deloukas, Panos/0000-0001-9251-070X; Ferrario, Marco M/0000-0003-2741-7124	Fondation Leducq (CADgenomics: Understanding CAD Genes) [12CVD02]; German Federal Ministry of Education and Research (BMBF) [01ZX1313A-2014, 01ZX1306A]; European Union Seventh Framework Programme [HEALTH-F2-2013-601456]; DFG as part of the Sonderforschungsbereich [CRC 1123 (B2)]; DZHK; Deutsche Forschungsgemeinschaft (DFG); Netherlands Heart Foundation [2014T001]; UCL Hospitals NIHR Biomedical Research Centre; German Research Foundation (DFG); Technical University of Munich; MRC [MC_UU_12015/1] Funding Source: UKRI	Fondation Leducq (CADgenomics: Understanding CAD Genes)(Leducq Foundation); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union Seventh Framework Programme(European Commission); DFG as part of the Sonderforschungsbereich(German Research Foundation (DFG)); DZHK; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Heart Foundation(Netherlands Heart Foundation); UCL Hospitals NIHR Biomedical Research Centre; German Research Foundation (DFG)(German Research Foundation (DFG)); Technical University of Munich; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by grants from the Fondation Leducq (CADgenomics: Understanding CAD Genes, 12CVD02), the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (e:AtheroSysMed, grant 01ZX1313A-2014 and SysInflame, grant 01ZX1306A), and the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no HEALTH-F2-2013-601456 (CVgenes-at-target). Further grants were received from the DFG as part of the Sonderforschungsbereich CRC 1123 (B2). T.K. was supported by a DZHK Rotation Grant. I.B. was supported by the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence 'Inflammation at Interfaces'. F.W.A. is supported by a Dekker scholarship-Junior Staff Member 2014T001 Netherlands Heart Foundation and UCL Hospitals NIHR Biomedical Research Centre. This work was supported by the German Research Foundation (DFG) and the Technical University of Munich within the funding programme Open Access Publishing.; This work was supported by grants from the Fondation Leducq (CADgenomics: Understanding CAD Genes, 12CVD02), the German Federal Ministry of Education and Research (BMBF) within the framework of the e:Med research and funding concept (e:AtheroSysMed, grant 01ZX1313A-2014 and SysInflame, grant 01ZX1306A), and the European Union Seventh Framework Programme FP7/2007-2013 under grant agreement no HEALTH-F2-2013-601456 (CVgenes-at-target). Further grants were received from the DFG as part of the Sonderforschungsbereich CRC 1123 (B2). T.K. was supported by a DZHK Rotation Grant. I.B. was supported by the Deutsche Forschungsgemeinschaft (DFG) cluster of excellence 'Inflammation at Interfaces'. F.W.A. is supported by a Dekker scholarship-Junior Staff Member 2014T001 - Netherlands Heart Foundation and UCL Hospitals NIHR Biomedical Research Centre.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Aharoni R, 2003, P NATL ACAD SCI USA, V100, P14157, DOI 10.1073/pnas.2336171100; Aharoni R, 2006, J PHARMACOL EXP THER, V318, P68, DOI 10.1124/jpet.106.103192; [Anonymous], 2016, NEW ENGL J MED, V374, P1898; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Arnon R, 2004, P NATL ACAD SCI USA, V101, P14593, DOI 10.1073/pnas.0404887101; Bobik A, 2006, ARTERIOSCL THROM VAS, V26, P1712, DOI 10.1161/01.ATV.0000225287.20034.2c; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Braenne I, 2016, ATHEROSCLEROSIS, V252, pE252, DOI 10.1016/j.atherosclerosis.2016.07.066; Braenne I, 2015, ARTERIOSCL THROM VAS, V35, P2207, DOI 10.1161/ATVBAHA.115.306108; Bujak M, 2007, CARDIOVASC RES, V74, P184, DOI 10.1016/j.cardiores.2006.10.002; Consortium CAD, 2015, NAT GENET; Crosby J, 2014, NEW ENGL J MED, V371, P22, DOI 10.1056/NEJMoa1307095; Deloukas P, 2013, NAT GENET, V45, P25, DOI 10.1038/ng.2480; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Francis DA, 2001, INT J CLIN PRACT, V55, P394; Gordon KJ, 2008, BBA-MOL BASIS DIS, V1782, P197, DOI 10.1016/j.bbadis.2008.01.006; Grainger DJ, 2007, CARDIOVASC RES, V74, P213, DOI 10.1016/j.cardiores.2007.02.022; Grainger DJ, 2004, ARTERIOSCL THROM VAS, V24, P399, DOI 10.1161/01.ATV.0000114567.76772.33; Griffith M, 2013, NAT METHODS, V10, P1209, DOI [10.1038/NMETH.2689, 10.1038/nmeth.2689]; Johnson JA, 2013, PHARMACOL REV, V65, P987, DOI 10.1124/pr.112.007252; KURIHARA H, 1989, BIOCHEM BIOPH RES CO, V159, P1435, DOI 10.1016/0006-291X(89)92270-5; Lalive PH, 2011, CNS DRUGS, V25, P401, DOI 10.2165/11588120-000000000-00000; Lebrin F, 2005, CARDIOVASC RES, V65, P599, DOI 10.1016/j.cardiores.2004.10.036; Leslie R, 2014, BIOINFORMATICS, V30, P185, DOI 10.1093/bioinformatics/btu273; Lev PR, 2007, PLATELETS, V18, P35, DOI 10.1080/09537100600800743; Li QD, 1998, EUR J PHARMACOL, V342, P303, DOI 10.1016/S0014-2999(97)01509-4; Lijnen PJ, 2003, AM J HYPERTENS, V16, P604, DOI 10.1016/S0895-7061(03)00847-1; Mallat Z, 2002, CURR OPIN LIPIDOL, V13, P523, DOI 10.1097/00041433-200210000-00008; Mo JW, 2015, GENET MOL RES, V14, P13835, DOI 10.4238/2015.October.29.3; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; SchiniKerth VB, 1997, CIRCULATION, V96, P3888; Schunkert H, 2015, EUR HEART J, V36, P1566, DOI 10.1093/eurheartj/ehv153; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Stoynev N, 2014, J CARDIOVASC MED, V15, P702, DOI 10.2459/JCM.0b013e32835dbcc8; Tsareva EY, 2012, PHARMACOGENOMICS, V13, P43, DOI [10.2217/PGS.11.136, 10.2217/pgs.11.136]; Wang XL, 1997, CARDIOVASC RES, V34, P404, DOI 10.1016/S0008-6363(97)00033-3; Ward LD, 2012, NUCLEIC ACIDS RES, V40, pD930, DOI 10.1093/nar/gkr917; Ward MR, 2002, ARTERIOSCL THROM VAS, V22, P940, DOI 10.1161/01.ATV.0000019405.84384.9C; Weber MS, 2007, NEUROTHERAPEUTICS, V4, P647, DOI 10.1016/j.nurt.2007.08.002; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Yamamoto K, 2000, CIRCULATION, V102, P1308, DOI 10.1161/01.CIR.102.11.1308; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Zeng LY, 2016, ATHEROSCLEROSIS, V253, P237, DOI 10.1016/j.atherosclerosis.2016.08.029	44	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0182999	10.1371/journal.pone.0182999	http://dx.doi.org/10.1371/journal.pone.0182999			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829817	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100023
J	Pomerantsev, AP; McCall, RM; Chahoud, M; Hepler, NK; Fattah, R; Leppla, SH				Pomerantsev, Andrei P.; McCall, Rita M.; Chahoud, Margaret; Hepler, Nathan K.; Fattah, Rasem; Leppla, Stephen H.			Genome engineering in Bacillus anthracis using tyrosine site-specific recombinases	PLOS ONE			English	Article							PROTECTIVE ANTIGEN GENE; PLASMID PXO1; TOXIN GENE; EXPRESSION; ATXA; MAINTENANCE; PROMOTERS; PROTEINS; CLEAVAGE; CLONING	Tyrosine site-specific recombinases (T-SSR) are polynucleotidyltransferases that catalyze cutting and joining reactions between short specific DNA sequences. We developed three systems for performing genetic modifications in Bacillus anthracis that use T-SSR and their cognate target sequences, namely Escherichia coli bacteriophage P1 Cre-loxP, Saccharomyces cerevisiae Flp-FRT, and a newly discovered IntXO-PSL system from B. anthracis plasmid pXO1. All three tyrosine recombinase systems were used for creation of a B. anthracis sporulation-deficient, plasmid-free strain deleted for ten proteases which had been identified by proteomic analysis as being present in the B. anthracis secretome. This strain was used successfully for production of various recombinant proteins, including several that are candidates for inclusion in improved anthrax vaccines. These genetic tools developed for DNA manipulation in B. anthracis were also used for construction of strains having chromosomal insertions of 1, 2, or 3 adjacent atxA genes. AtxA is a B. anthracis global transcriptional regulator required for the response of B. anthracis virulence factor genes to bicarbonate. We found a positive correlation between the atxA copy number and the expression level of the pagA gene encoding B. anthracis protective antigen, when strains were grown in a carbon dioxide atmosphere. These results demonstrate that the three T-SSR systems described here provide effective tools for B. anthracis genome editing. These T-SSR systems may also be applicable to other prokaryotes and to eukaryotes.	[Pomerantsev, Andrei P.; McCall, Rita M.; Chahoud, Margaret; Hepler, Nathan K.; Fattah, Rasem; Leppla, Stephen H.] NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Leppla, SH (corresponding author), NIAID, Microbial Pathogenesis Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	sleppla@niaid.nih.gov	Hepler, Nathan/AAA-8098-2020	Hepler, Nathan/0000-0001-7833-923X; McCall, Rita/0000-0001-5076-2909	National Institutes of Health Intramural Program [1 ZIA ZI001030-04]; National Institute of Allergy and Infectious Diseases, National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001030] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Intramural Program (1 ZIA ZI001030-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the intramural research program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health. We thank Brian Martin for Nterminal sequencing of proteins and L. Renee Olano for proteomic analysis of secretomes (both at NIAID/NIH Research Technologies Branch) and Sergey Tarasov (Biophysics Resource in the Structural Biophysics Laboratory, NCI/NIH-Frederick) for LC-ESI-MS determination of protein exact masses.	Bertin M, 2010, RES MICROBIOL, V161, P249, DOI 10.1016/j.resmic.2010.03.003; Bongiorni C, 2008, J BACTERIOL, V190, P6483, DOI 10.1128/JB.00766-08; Buchholz F, 2009, CURR OPIN BIOTECH, V20, P383, DOI 10.1016/j.copbio.2009.07.005; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chitlaru T, 2011, MOL MICROBIOL, V81, P1542, DOI 10.1111/j.1365-2958.2011.07790.x; Grindley NDF, 2006, ANNU REV BIOCHEM, V75, P567, DOI 10.1146/annurev.biochem.73.011303.073908; Hoffmaster AR, 1997, INFECT IMMUN, V65, P3091, DOI 10.1128/IAI.65.8.3091-3099.1997; KOEHLER TM, 1994, J BACTERIOL, V176, P586, DOI 10.1128/jb.176.3.586-595.1994; Krishnappa L, 2013, J PROTEOME RES, V12, P4101, DOI 10.1021/pr400433h; Liu SH, 2016, P NATL ACAD SCI USA, V113, pE4079, DOI 10.1073/pnas.1600982113; McKenzie AT, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-229; Moayeri M, 2007, INFECT IMMUN, V75, P5175, DOI 10.1128/IAI.00719-07; Park S, 2000, PROTEIN EXPRES PURIF, V18, P293, DOI 10.1006/prep.2000.1208; Pomerantsev AP, 2016, J BACTERIOL, V198, P1939, DOI 10.1128/JB.01004-15; Pomerantsev AP, 2014, J BACTERIOL, V196, P2921, DOI 10.1128/JB.01747-14; Pomerantsev AP, 2011, PROTEIN EXPRES PURIF, V80, P80, DOI 10.1016/j.pep.2011.05.016; Pomerantsev AP, 2009, J BACTERIOL, V191, P5134, DOI 10.1128/JB.00422-09; Pomerantsev AP, 2006, INFECT IMMUN, V74, P682, DOI 10.1128/IAI.74.1.682-693.2006; Sambrook J., 2001, MOL CLONING LAB MANU, V2001; SINGH Y, 1989, J BIOL CHEM, V264, P19103; UCHIDA I, 1993, J BACTERIOL, V175, P5329, DOI 10.1128/JB.175.17.5329-5338.1993; VODKIN MH, 1983, CELL, V34, P693, DOI 10.1016/0092-8674(83)90402-6; Yen Ting L, 2014, MICROBIOL SPECTR, V2	23	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183346	10.1371/journal.pone.0183346	http://dx.doi.org/10.1371/journal.pone.0183346			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829806	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100040
J	Shukla, SK; Ye, Z; Sandberg, S; Reyes, I; Fritsche, TR; Keifer, M				Shukla, Sanjay K.; Ye, Zhan; Sandberg, Scott; Reyes, Iris; Fritsche, Thomas R.; Keifer, Matthew			The nasal microbiota of dairy farmers is more complex than oral microbiota, reflects occupational exposure, and provides competition for staphylococci	PLOS ONE			English	Article							GUT MICROBIOTA; AUREUS; MICROORGANISMS; ASSOCIATIONS; DIVERSITY; HEALTH	Allergic and autoimmune diseases had been attributed to lack of exposure to biodiversity, an important factor in regulating immune homeostasis in a healthy host. We posit that the microbiome of healthy dairy farmers (DF) will be richer than non-farmers (NF) living in urban settings due to exposure to a greater biodiversity in the dairy environment. However, no studies have investigated the relationships between microbiota of dairy farmers (DF) compared with urban non-farmers (NF). We compared the nasal and oral microbiota of dairy farmers (N_DF, O_DF, respectively) with nasal and oral microbiota of NF in the same geographical area. The N_DF showed high microbial diversity with hundreds of unique genera that reflected environmental/occupational exposures. The nasal and oral microbiomes clustered separately from each other using Principal Coordinate Analysis, and with DF harboring two-fold and 1.5-fold greater exclusive genera in their nose and mouth respectively, than did non-farmers. Additionally, the N_DF group had a lower burden of Staphylococcus spp. suggesting a correlation between higher microbial diversity and competition for colonization by staphylococci. The N_DF samples were negative for the mecA gene, a marker of methicillin-resistance in staphylococci. The lower burden of staphylococci was found to be independent of the abundance of Corynebacterium spp. Exposure to greater biodiversity could enhance microbial competition, thereby reducing colonization with opportunistic pathogens. Future studies will analyze whether exposure to livestock microbiomes offers protection from acute and chronic diseases.	[Shukla, Sanjay K.] Marshfield Clin Fdn Med Res & Educ, Res Inst, Ctr Human Genet, Mol Microbiol Lab, Marshfield, WI 54449 USA; [Ye, Zhan] Marshfield Clin Fdn Med Res & Educ, Res Inst, Biomed Informat Res Ctr, Marshfield, WI USA; [Sandberg, Scott; Reyes, Iris] Marshfield Clin Fdn Med Res & Educ, Res Inst, Natl Farm Med Ctr, Marshfield, WI USA; [Fritsche, Thomas R.] Marshfield Clin Fdn Med Res & Educ, Div Lab Med, Marshfield, WI USA; [Keifer, Matthew] VA Puget Sound, Seattle, WA USA	Marshfield Clinic; Marshfield Clinic; Marshfield Clinic; Marshfield Clinic; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System	Shukla, SK (corresponding author), Marshfield Clin Fdn Med Res & Educ, Res Inst, Ctr Human Genet, Mol Microbiol Lab, Marshfield, WI 54449 USA.	shukla.sanjay@mcrf.mfldclin.edu		Shukla, Sanjay/0000-0001-7267-8572	Marshfield Clinic Research Foundation (MCRF)	Marshfield Clinic Research Foundation (MCRF)	The study was funded by Marshfield Clinic Research Foundation (MCRF) and donations made to MCRF.	Albenberg LG, 2014, GASTROENTEROLOGY, V146, P1564, DOI 10.1053/j.gastro.2014.01.058; Bassis CM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-27; Bogaert D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017035; Bonder MJ, 2016, NAT GENET, V48, P1407, DOI 10.1038/ng.3663; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Campbell SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150502; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Chen J, 2013, SCI REP, V6, P28484; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DOWD SE, 2008, BMC MICROBIOL, V8; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Espinosa-Gongora C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160331; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Frank DN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010598; Gibson MK, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.24, 10.1038/nmicrobiol.2016.24]; Glurich I, 2013, ORAL DIS, V19, P1, DOI 10.1111/j.1601-0825.2012.01921.x; Glurich I, 2016, GENOMICS PERSONALIZE, P35; Hanski I, 2012, P NATL ACAD SCI USA, V109, P8334, DOI 10.1073/pnas.1205624109; Holman DB, 2015, SCI REP-UK, V5, DOI 10.1038/srep15557; John J, 2012, HOSP EPIDEMIOLOGY IN, P385; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Lee SA, 2006, J OCCUP ENVIRON HYG, V3, P118, DOI 10.1080/15459620500524607; Lin Y, 2011, CLIN MED RES, V9, P7, DOI 10.3121/cmr.2010.944; Liu CM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400216; Manichanh C, 2012, NAT REV GASTRO HEPAT, V9, P599, DOI 10.1038/nrgastro.2012.152; McGuinness SL, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1338-0; Naleway Allison L, 2004, Clin Med Res, V2, P5; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Normand AC, 2011, OCCUP ENVIRON MED, V68, P849, DOI 10.1136/oem.2010.061879; Pehrsson EC, 2016, NATURE, V533, P212, DOI 10.1038/nature17672; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rook GAW, 2010, CLIN EXP IMMUNOL, V160, P70, DOI 10.1111/j.1365-2249.2010.04133.x; Schaubeck M, 2016, GUT, V65, P225, DOI 10.1136/gutjnl-2015-309333; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schroeder B, 2016, NAT MED, V22, P1079, DOI 10.1038/nm.4185; Shukla SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145453; Shukla SK, 2015, TRENDS MOL MED, V21, P461, DOI 10.1016/j.molmed.2015.06.002; Shukla SK, 2004, ANTIMICROB AGENTS CH, V48, P3080, DOI 10.1128/AAC.48.8.3080-3085.2004; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uehara Y, 2000, J HOSP INFECT, V44, P127, DOI 10.1053/jhin.1999.0680; van Belkum A, 2009, J INFECT DIS, V199, P1820, DOI 10.1086/599119; Wegienka G, 2015, IMMUNOL ALLERGY CLIN, V35, P1, DOI 10.1016/j.iac.2014.09.002; Wlasiuk G, 2012, CURR OPIN ALLERGY CL, V12, P461, DOI 10.1097/ACI.0b013e328357a3bc; Wos-Oxley ML, 2016, ENVIRON MICROBIOL, V18, P2259, DOI 10.1111/1462-2920.13378; Wos-Oxley ML, 2010, ISME J, V4, P839, DOI 10.1038/ismej.2010.15; Yan ML, 2013, CELL HOST MICROBE, V14, P631, DOI 10.1016/j.chom.2013.11.005; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847	51	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183898	10.1371/journal.pone.0183898	http://dx.doi.org/10.1371/journal.pone.0183898			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850578	Green Published, Green Submitted, gold			2022-12-27	WOS:000408544200038
J	Wood, A; Martin, J; Niedenthal, P				Wood, Adrienne; Martin, Jared; Niedenthal, Paula			Towards a social functional account of laughter: Acoustic features convey reward, affiliation, and dominance	PLOS ONE			English	Article							EMOTION; HUMOR; PERCEPTION; EVOLUTION; GENDER; EXPRESSION; SPEECH; FREQUENCY; SMILES	Recent work has identified the physical features of smiles that accomplish three tasks fundamental to human social living: rewarding behavior, establishing and managing affiliative bonds, and negotiating social status. The current work extends the social functional account to laughter. Participants (N = 762) rated the degree to which reward, affiliation, or dominance (between-subjects) was conveyed by 400 laughter samples acquired from a commercial sound effects website. Inclusion of a fourth rating dimension, spontaneity, allowed us to situate the current approach in the context of existing laughter research, which emphasizes the distinction between spontaneous and volitional laughter. We used 11 acoustic properties extracted from the laugh samples to predict participants' ratings. Actor sex moderated, and sometimes even reversed, the relation between acoustics and participants' judgments. Spontaneous laughter appears to serve the reward function in the current framework, as similar acoustic properties guided perceiver judgments of spontaneity and reward: reduced voicing and increased pitch, increased duration for female actors, and increased pitch slope, center of gravity, first formant, and noisiness for male actors. Affiliation ratings diverged from reward in their sex-dependent relationship to intensity and, for females, reduced pitch range and raised second formant. Dominance displayed the most distinct pattern of acoustic predictors, including increased pitch range, reduced second formant in females, and decreased pitch variability in males. We relate the current findings to existing findings on laughter and human and non-human vocalizations, concluding laughter can signal much more that felt or faked amusement.	[Wood, Adrienne; Martin, Jared; Niedenthal, Paula] Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Wood, A (corresponding author), Univ Wisconsin, Dept Psychol, 1202 W Johnson St, Madison, WI 53706 USA.	adrienne.wood@wisc.edu	Wood, Adrienne/AAQ-2072-2020	Wood, Adrienne/0000-0003-4773-4493; Martin, Jared/0000-0002-2865-3877	National Science Foundation (NSF) Division of Behavioral and Cognitive Sciences in the United States [BCS-1251101]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH018931] Funding Source: NIH RePORTER	National Science Foundation (NSF) Division of Behavioral and Cognitive Sciences in the United States(National Science Foundation (NSF)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant from the National Science Foundation (NSF) Division of Behavioral and Cognitive Sciences in the United States: BCS-1251101, "Behavioral and neural bases of the perception of facial expressions." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apter M.J., 1982, EXPERIENCE MOTIVATIO; Bachorowski JA, 2003, ANN NY ACAD SCI, V1000, P244, DOI 10.1196/annals.1280.012; Bachorowski JA, 2001, J ACOUST SOC AM, V110, P1581, DOI 10.1121/1.1391244; Bachorowski JA, 2001, PSYCHOL SCI, V12, P252, DOI 10.1111/1467-9280.00346; Banziger T, 2005, SPEECH COMMUN, V46, P252, DOI 10.1016/j.specom.2005.02.016; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Barthel H, P 18 INT C PHON SCI; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beddor Patrice Speeter, 1993, V5, P171; Beddot P Specter, 1984, J ACOUST SOC AM S1, V75, pS86; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boersma P., 2015, PRAAT; Borkowska B, 2011, ANIM BEHAV, V82, P55, DOI 10.1016/j.anbehav.2011.03.024; Brescoll VL, 2008, PSYCHOL SCI, V19, P268, DOI 10.1111/j.1467-9280.2008.02079.x; Bryant G, 2014, P NAT ACAD SCI, V113, P4682; Bryant GA, 2014, EVOL HUM BEHAV, V35, P327, DOI 10.1016/j.evolhumbehav.2014.03.003; Calder AJ, 1997, P ROY SOC B-BIOL SCI, V264, P919, DOI 10.1098/rspb.1997.0127; COSER RL, 1960, PSYCHIATR, V23, P81; Drahota A, 2008, SPEECH COMMUN, V50, P278, DOI 10.1016/j.specom.2007.10.001; Eibl-Eibesfeldt I., 1971, ETHOLOGY BIOL BEHAV; Fitch WT, 2006, J ACOUST SOC AM, V120, P2132, DOI 10.1121/1.2258499; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; Fitch WT, 2000, TRENDS COGN SCI, V4, P258, DOI 10.1016/S1364-6613(00)01494-7; Fredrickson BL, 1998, J PERS SOC PSYCHOL, V75, P269, DOI 10.1037/0022-3514.75.1.269; Fridlund AJ, 2002, EMPIRICAL REFLECTION, P45; Fridlund AJ, 2014, HUMAN FACIAL EXPRESS; Gervais M, 2005, Q REV BIOL, V80, P395, DOI 10.1086/498281; Goudbeek M, 2009, INTERSPEECH 2009: 10TH ANNUAL CONFERENCE OF THE INTERNATIONAL SPEECH COMMUNICATION ASSOCIATION 2009, VOLS 1-5, P1551; Gray AW, 2015, HUM NATURE-INT BIOS, V26, P28, DOI 10.1007/s12110-015-9225-8; Gunnery SD, 2016, COGNITION EMOTION, V30, P501, DOI 10.1080/02699931.2015.1018817; Harris CR, 2005, COGNITION EMOTION, V19, P655, DOI 10.1080/02699930441000472; Hodges-Simeon CR, 2010, HUM NATURE-INT BIOS, V21, P406, DOI 10.1007/s12110-010-9101-5; Hugill N, 2011, PERS INDIV DIFFER, V51, P483, DOI 10.1016/j.paid.2011.05.002; Keltner D, 1997, J PERS SOC PSYCHOL, V73, P687, DOI 10.1037/0022-3514.73.4.687; Keltner D, 2006, EVOLUTION SOC PSYCHO, V115, P142; Kipper S, 2001, BEHAVIOUR, V138, P1161, DOI 10.1163/156853901753287181; Kuznetsova A., 2015, R PACKAGE VERSION PA; Lasarcyk E, 2008, P INT SEM SPEECH PRO, V8, P345; Laukka P, 2005, COGNITION EMOTION, V19, P633, DOI 10.1080/02699930441000445; Lavan N, 2016, J NONVERBAL BEHAV, V40, P133, DOI 10.1007/s10919-015-0222-8; Litman L, 2017, BEHAV RES METHODS, V49, P433, DOI 10.3758/s13428-016-0727-z; Martin J, 2016, COMMUNICATION; Martin RA, 2007, PSYCHOLOGY OF HUMOR: AN INTEGRATIVE APPROACH, P1, DOI 10.1016/B978-012372564-6/50020-4; Martin RA, 2003, J RES PERS, V37, P48, DOI 10.1016/S0092-6566(02)00534-2; Martin RA, 1999, HUMOR, V12, P355, DOI 10.1515/humr.1999.12.4.355; Matsumoto D, 2006, J PERS SOC PSYCHOL, V91, P568, DOI 10.1037/0022-3514.91.3.568; McKeown G, 2015, EMOT REV, V7, P30, DOI 10.1177/1754073914544475; Mehu M., 2011, HUM ETHOL B, V26, P10; Mehu M, 2008, BEHAVIOUR, V145, P1747, DOI 10.1163/156853908786279619; Meyer JC, 2000, COMMUN THEOR, V10, P310, DOI 10.1111/j.1468-2885.2000.tb00194.x; Neuhoff CC, 2002, PSYCHOL REP, V91, P1079, DOI 10.2466/PR0.91.7.1079-1080; Niedenthal PM, 2010, BEHAV BRAIN SCI, V33, P417, DOI 10.1017/S0140525X10000865; OHALA JJ, 1983, PHONETICA, V40, P1, DOI 10.1159/000261678; Otovic P, 2014, ETHOLOGY, V120, P1118, DOI 10.1111/eth.12285; Oveis C, 2016, J EXP SOC PSYCHOL, V65, P109, DOI 10.1016/j.jesp.2016.04.005; Panksepp J, 2003, PHYSIOL BEHAV, V79, P533, DOI 10.1016/S0031-9384(03)00159-8; Papousek I, 2011, PERS INDIV DIFFER, V51, P1018, DOI 10.1016/j.paid.2011.08.013; Pisanski K, 2016, TRENDS COGN SCI, V20, P304, DOI 10.1016/j.tics.2016.01.002; Pisanski K, 2014, ANIM BEHAV, V95, P89, DOI 10.1016/j.anbehav.2014.06.011; Provine RR, 2004, CURR DIR PSYCHOL SCI, V13, P215, DOI 10.1111/j.0963-7214.2004.00311.x; PROVINE RR, 1991, ETHOLOGY, V89, P115; PROVINE RR, 1993, ETHOLOGY, V95, P291; Provine RR, 2001, LAUGHTER A SCIENTIFI; Puts DA, 2006, EVOL HUM BEHAV, V27, P283, DOI 10.1016/j.evolhumbehav.2005.11.003; Quene H, 2012, SPEECH COMMUN, V54, P917, DOI 10.1016/j.specom.2012.03.004; R Core Team, 2021, R LANGUAGE ENV STAT; Robson J., 1999, P 14 INT C PHON SCI, P219; Rychlowska M, PSYCHOL SCI IN PRESS; Sander K, 2001, COGNITIVE BRAIN RES, V12, P181, DOI 10.1016/S0926-6410(01)00045-3; Schubert E, 2006, ACTA ACUST UNITED AC, V92, P820; Scott SK, 2014, TRENDS COGN SCI, V18, P618, DOI 10.1016/j.tics.2014.09.002; SMITH JM, 1973, NATURE, V246, P15, DOI 10.1038/246015a0; Smoski MJ, 2003, COGNITION EMOTION, V17, P327, DOI 10.1080/02699930302296; Snowdon CT, 2003, SER AFFECTIVE SCI, P457; Snowdon CT, 2013, EVOLUTION EMOTIONAL, P133, DOI DOI 10.1017/CBO9781107415324.004; Styler W., 2017, USING PRAAT LINGUIST; Szameitat DP, 2011, J VOICE, V25, P32, DOI 10.1016/j.jvoice.2009.06.010; Szameitat DP, 2009, EMOTION, V9, P397, DOI 10.1037/a0015692; ten Bosch L, 2005, SPEECH COMMUN, V47, P80, DOI 10.1016/j.specom.2005.05.009; Tracy JL, 2007, J PERS SOC PSYCHOL, V92, P506, DOI 10.1037/0022-3514.92.3.506; Tracy JL, 2011, EMOT REV, V3, P397, DOI 10.1177/1754073911410747; Van Hooff JA, COMP APPROACH PHYLOG; Vettin J, 2004, J NONVERBAL BEHAV, V28, P93, DOI 10.1023/B:JONB.0000023654.73558.72; Xu Y, 2007, P INT C PHON SCI, P2105	84	39	39	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183811	10.1371/journal.pone.0183811	http://dx.doi.org/10.1371/journal.pone.0183811			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850589	gold, Green Published, Green Submitted			2022-12-27	WOS:000408544200028
J	Muley, A; Odaka, Y; Lewkowich, IP; Vemaraju, S; Yamaguchi, TP; Shawber, C; Dickie, BH; Lang, RA				Muley, Ajit; Odaka, Yoshi; Lewkowich, Ian P.; Vemaraju, Shruti; Yamaguchi, Terry P.; Shawber, Carrie; Dickie, Belinda H.; Lang, Richard A.			Myeloid Wnt ligands are required for normal development of dermal lymphatic vasculature	PLOS ONE			English	Article							GROWTH-FACTOR-C; ENDOTHELIAL-CELL; LYMPHOVENOUS VALVES; VESSELS; MOUSE; MACROPHAGES; DISEASE; LYMPHANGIOGENESIS; SECRETION; PROTEINS	Resident tissue myeloid cells play a role in many aspects of physiology including development of the vascular systems. In the blood vasculature, myeloid cells use VEGFC to promote angiogenesis and can use Wnt ligands to control vascular branching and to promote vascular regression. Here we show that myeloid cells also regulate development of the dermal lymphatic vasculature using Wnt ligands. Using myeloid-specific deletion of the WNT transporter Wntless we show that myeloid Wnt ligands are active at two distinct stages of development of the dermal lymphatics. As lymphatic progenitors are emigrating from the cardinal vein and intersomitic vessels, myeloid Wnt ligands regulate both their numbers and migration distance. Later in lymphatic development, myeloid Wnt ligands regulate proliferation of lymphatic endothelial cells (LEC) and thus control lymphatic vessel caliber. Myeloid-specific deletion of WNT co-receptor Lrp5 or Wnt5a gain-of-function also produce elevated caliber in dermal lymphatic capillaries. These data thus suggest that myeloid cells produce Wnt ligands to regulate lymphatic development and use Wnt pathway co-receptors to regulate the balance of Wnt ligand activity during the macrophage-LEC interaction.	[Muley, Ajit; Shawber, Carrie] Columbia Univ, Med Ctr, Dept OB GYN, New York, NY USA; [Odaka, Yoshi; Vemaraju, Shruti; Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Visual Syst Grp, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA; [Lewkowich, Ian P.] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH 45229 USA; [Yamaguchi, Terry P.] NCI, Canc & Dev Biol Lab, Frederick, MD 21701 USA; [Dickie, Belinda H.] Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Ctr Chronobiol, Cincinnati, OH 45229 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Abrahamson Pediat Eye Inst, Cincinnati, OH 45229 USA; [Lang, Richard A.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; [Lang, Richard A.] Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA	Columbia University; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Harvard University; Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Visual Syst Grp, Div Pediat Ophthalmol, Cincinnati, OH 45229 USA.; Dickie, BH (corresponding author), Boston Childrens Hosp, Dept Surg, Boston, MA 02115 USA.; Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Ctr Chronobiol, Cincinnati, OH 45229 USA.; Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Abrahamson Pediat Eye Inst, Cincinnati, OH 45229 USA.; Lang, RA (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.; Lang, RA (corresponding author), Univ Cincinnati, Coll Med, Dept Ophthalmol, Cincinnati, OH 45267 USA.	Belinda.HsiDickie@childrens.harvard.edu; Richard.Lang@cchmc.org	Odaka, Yoshinobu/AAY-6918-2021	Odaka, Yoshinobu/0000-0003-3966-5475; Lang, Richard/0000-0002-5212-254X	 [R01 EY021636]; NATIONAL CANCER INSTITUTE [ZIABC010345] Funding Source: NIH RePORTER	; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by R01 EY021636. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitalo K, 2005, NATURE, V438, P946, DOI 10.1038/nature04480; Alitalo K, 2011, NAT MED, V17, P1371, DOI 10.1038/nm.2545; Andersson E, 2010, DEV DYNAM, V239, P237, DOI 10.1002/dvdy.22101; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Birner P, 2001, CLIN CANCER RES, V7, P93; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Buttler K, 2013, DEV BIOL, V381, P365, DOI 10.1016/j.ydbio.2013.06.028; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Carpenter AC, 2010, GENESIS, V48, P554, DOI 10.1002/dvg.20651; Cha B, 2016, BMB REP, V49, P403, DOI 10.5483/BMBRep.2016.49.8.112; Cha B, 2016, GENE DEV, V30, P1454, DOI 10.1101/gad.282400.116; Cha KB, 2004, MECH DEVELOP, V121, P183, DOI 10.1016/j.mod.2003.12.002; Ching W, 2006, CELL, V125, P432, DOI 10.1016/j.cell.2006.04.018; Cueni LN, 2006, J INVEST DERMATOL, V126, P2167, DOI 10.1038/sj.jid.5700464; Deng L, 2010, AM J PATHOL, V176, P952, DOI 10.2353/ajpath.2010.090622; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Gale NW, 2002, COLD SPRING HARB SYM, V67, P267, DOI 10.1101/sqb.2002.67.267; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Gordon EJ, 2010, DEVELOPMENT, V137, P3899, DOI 10.1242/dev.050021; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Ito M, 1999, ANAT EMBRYOL, V200, P403, DOI 10.1007/s004290050289; James JM, 2013, DEVELOPMENT, V140, P3903, DOI 10.1242/dev.095026; Jeltsch M, 2014, CIRCULATION; Karkkainen MJ, 2002, SEMIN CELL DEV BIOL, V13, P9, DOI 10.1006/scdb.2001.0286; Karkkainen MJ, 2004, NAT IMMUNOL, V5, P74, DOI 10.1038/ni1013; Klotz L, 2015, NATURE, V522, P62, DOI 10.1038/nature14483; KOCH AE, 1992, CLIN IMMUNOL IMMUNOP, V65, P23, DOI 10.1016/0090-1229(92)90243-H; Kuchler AM, 2006, CURR BIOL, V16, P1244, DOI 10.1016/j.cub.2006.05.026; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Locati M, 2013, ADV IMMUNOL, V120, P163, DOI 10.1016/B978-0-12-417028-5.00006-5; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; Machnik A, 2009, NAT MED, V15, P545, DOI 10.1038/nm.1960; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Martinez-Corral I, 2012, P NATL ACAD SCI USA, V109, P6223, DOI 10.1073/pnas.1115542109; Nicenboim J, 2015, NATURE, V522, P56, DOI 10.1038/nature14425; NUSSE R, 1992, J STEROID BIOCHEM, V43, P9, DOI 10.1016/0960-0760(92)90181-H; Oliver G, 2008, ANN NY ACAD SCI, V1131, P75, DOI 10.1196/annals.1413.006; Oliver G, 2010, DEVELOPMENT, V137, P363, DOI 10.1242/dev.035360; Port F, 2010, TRAFFIC, V11, P1265, DOI 10.1111/j.1600-0854.2010.01076.x; Rao S, 2007, DEVELOPMENT, V134, P4449, DOI 10.1242/dev.012187; Rao S, 2013, NATURE, V494, P243, DOI 10.1038/nature11823; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Semenov MV, 2007, CELL, V131, P1378; Semo J, 2016, DEVELOPMENT, V143, P924, DOI 10.1242/dev.132431; Smith AN, 2005, DEV BIOL, V285, P477, DOI 10.1016/j.ydbio.2005.07.019; SMOLICH BD, 1993, MOL BIOL CELL, V4, P1267, DOI 10.1091/mbc.4.12.1267; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Stefater JA, 2013, BLOOD, V121, P2574, DOI 10.1182/blood-2012-06-434621; Stefater JA, 2011, TRENDS MOL MED, V17, P743, DOI 10.1016/j.molmed.2011.07.009; Stefater JA, 2011, NATURE, V474, P511, DOI 10.1038/nature10085; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tammela T, 2011, NAT CELL BIOL, V13, P1202, DOI 10.1038/ncb2331; Tammela T, 2010, CELL, V140, P460, DOI 10.1016/j.cell.2010.01.045; Tazume H, 2012, ARTERIOSCL THROM VAS, V32, P1400, DOI 10.1161/ATVBAHA.112.247866; Ulvmar MH, 2016, CARDIOVASC RES, V111, P310, DOI 10.1093/cvr/cvw175; Wang YD, 2010, GENE DEV, V24, P2115, DOI 10.1101/gad.1955910; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Yang DH, 2009, CIRC RES, V104, P372, DOI 10.1161/CIRCRESAHA.108.185405; Yang Y, 2012, BLOOD, V120, P2340, DOI 10.1182/blood-2012-05-428607; Yaniv K, 2006, NAT MED, V12, P711, DOI 10.1038/nm1427; Yeo EJ, 2014, CANC RES; Yu HM, 2012, DEVELOPMENT, V139, P4383, DOI 10.1242/dev.083352; Zhong ZD, 2012, J BONE MINER RES, V27, P1849, DOI 10.1002/jbmr.1715	67	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0181549	10.1371/journal.pone.0181549	http://dx.doi.org/10.1371/journal.pone.0181549			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846685	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600006
J	Schaekel, F; May, T; Seiler, J; Hartmann, M; Kreienbrock, L				Schaekel, Franziska; May, Thomas; Seiler, Julia; Hartmann, Maria; Kreienbrock, Lothar			Antibiotic drug usage in pigs in Germany-Are the class profiles changing?	PLOS ONE			English	Article							ANTIMICROBIAL AGENTS; PATTERNS	The development of antimicrobial resistance is triggered by the use of antibiotic drugs. Therefore, the consumption of antibiotics in livestock is monitored, and different measures may be applied if the usage of antibiotic drugs seems inappropriate. Unfortunately, the surveillance of antibiotic consumption is not standardised, and surveillance systems differ. In Germany, the food quality assurance system QS Qualita E t und Sicherheit GmbH (QS) began the documentation of antibiotic drug usage in pigs in 2012 in a private economic based database, and for its members, documentation has been mandatory in all pig age groups since 2014. In this investigation, we calculated the distribution of the antibiotics use per pig age group and half- year, and the percentage of the active substances used from overall treatments within German pig holdings from 1 July, 2013 to 30 June, 2015. In fattening pigs, the median of the treatment frequency is 4.3 in 2013-2 and exhibits a decreasing trend in this time period up to 2.1 in 2015-1. In weaners the median ranged between 11.3 in 2014-2 and 5.8 in 2013-2. The median of sucklers varies between 21.6 and 25.0. In sucklers and weaners, a clear temporal trend is not seen to date. The share of the active substances differs between the age groups. In fattening pigs, mostly tetracyclines and penicillines were used, occurring in approximately 60% of the total treatments. In weaners, amoxicillin and colistin have the highest shares of the treatment frequency, at approximately 60%. The treatment frequencies of macrolides and penicillines have the highest share in sucklers.	[Schaekel, Franziska; Hartmann, Maria; Kreienbrock, Lothar] Univ Vet Med, Dept Biometry Epidemiol & Informat Proc, WHO, Collaborating Ctr Res & Training Hlth Human Anim, Hannover, Germany; [May, Thomas; Seiler, Julia] Qualitat & Sicherheit GmbH, QS, Bonn, Germany	University of Veterinary Medicine Hannover, Foundation; World Health Organization	Schaekel, F (corresponding author), Univ Vet Med, Dept Biometry Epidemiol & Informat Proc, WHO, Collaborating Ctr Res & Training Hlth Human Anim, Hannover, Germany.	franziska.schaekel@tiho-hannover.de						Aarestrup Frank M., 2008, Animal Health Research Reviews, V9, P135, DOI 10.1017/S1466252308001503; [Anonymous], 2015, LEITL SORGF UMG ANT; [Anonymous], 2010, VER DAT INF ARZN DTS; AURES, 2014, RES OST AURES 2013 A; Bos MEH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077525; Callens B, 2012, PREV VET MED, V106, P53, DOI 10.1016/j.prevetmed.2012.03.001; DANMAP, 2016, DANMAP 2015 US ANT A; European Medicines Agency, 2013, EMA2864162012REV1; Hosoi Y, 2013, INT J ANTIMICROB AG, V41, P489, DOI 10.1016/j.ijantimicag.2013.01.002; Huber P.J., 2004, ROBUST STAT; Jensen VF, 2012, J VET PHARMACOL THER, V35, P33, DOI 10.1111/j.1365-2885.2011.01291.x; MARAN, 2015, MARAN MON ANT RES AN; Merle R, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-7; Merle R, 2012, PREV VET MED, V104, P34, DOI 10.1016/j.prevetmed.2011.10.013; Moreno MA, 2012, VET REC, V171, DOI 10.1136/vr.100818; Moreno MA, 2013, VET RECORD OPEN; Murphy D., 2017, EFSA J, V15, pe04666; NORM/NORM-VET -. NORM/NORM-VET, 2015, NORM NORM VET 2015 U; Persoons D, 2012, PREV VET MED, V105, P320, DOI 10.1016/j.prevetmed.2012.02.020; QS Qualitat und Sicherheit GmbH, 2016, GEM STARK PARTN 2016; QS Qualitat und Sicherheit GmbH, 2015, QS ANT BEI SCHWEIN M; QS Qualitat und Sicherheit GmbH, 2015, LEITF ANT SCHWEIN BO; QS Qualitat und Sicherheit GmbH, 2016, QS ANF GES MASSN WIR; SDa Autoriteit Diergeneesmiddelen, 2016, US ANT AGR LIV NETH; Sjolund M, 2016, PREV VET MED, V130, P41, DOI 10.1016/j.prevetmed.2016.06.003; Sjolund M, 2015, PREV VET MED, V121, P257, DOI 10.1016/j.prevetmed.2015.07.005; SVARM, 2015, SWEDRES SVARM 2015 C; Timmerman T, 2006, PREV VET MED, V74, P251, DOI 10.1016/j.prevetmed.2005.10.003; Trauffler M, 2014, BERL MUNCH TIERARZTL, V127, P375, DOI 10.2376/0005-9366-127-375; van der Fels-Klerx HJ, 2011, J ANIM SCI, V89, P1922, DOI 10.2527/jas.2010-3046; van Rennings L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119114; WHO, 2011, WHO CRIT IMP ANT HUM	32	20	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182661	10.1371/journal.pone.0182661	http://dx.doi.org/10.1371/journal.pone.0182661			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841685	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700009
J	Feng, F; Li, XL; Yao, YJ; Liu, M				Feng, Fei; Li, Xianglan; Yao, Yunjun; Liu, Meng			Long-term spatial distributions and trends of the latent heat fluxes over the global cropland ecosystem using multiple satellite-based models	PLOS ONE			English	Article							WATER-VAPOR; EDDY-COVARIANCE; SOLAR-RADIATION; CARBON-DIOXIDE; CLIMATE-CHANGE; EVAPOTRANSPIRATION; FLUXNET; MODIS; VARIABILITY; MAIZE	Estimating cropland latent heat flux (LE) from continental to global scales is vital to modeling crop production and managing water resources. Over the past several decades, numerous LE models were developed, such as the moderate resolution imaging spectroradiometer LE (MOD16) algorithm, revised remote sensing-based Penman-Monteith LE algorithm (RRS), the Priestley-Taylor LE algorithm of the Jet Propulsion Laboratory (PT-JPL) and the modified satellite-based Priestley-Taylor LE algorithm (MS-PT). However, these LE models have not been directly compared over the global cropland ecosystem using various algorithms. In this study, we evaluated the performances of these four LE models using 34 eddy covariance (EC) sites. The results showed that mean annual LE for cropland varied from 33.49 to 58.97 W/m(2) among the four models. The interannual LE slightly increased during 1982-2009 across the global cropland ecosystem. All models had acceptable performances with the coefficient of determination (R-2) ranging from 0.4 to 0.7 and a root mean squared error (RMSE) of approximately 35 W/m(2). MS-PT had good overall performance across the cropland ecosystem with the highest R-2, lowest RMSE and a relatively low bias. The reduced performances of MOD16 and RRS, with R-2 ranging from 0.4 to 0.6 and RMSEs from 30 to 39 W/m(2), might be attributed to empirical parameters in the structure algorithms and calibrated coefficients.	[Feng, Fei; Li, Xianglan] Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Yao, Yunjun; Liu, Meng] Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing, Peoples R China; [Liu, Meng] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China; [Liu, Meng] Univ Chinese Acad Sci, Beijing, Peoples R China	Beijing Normal University; Beijing Normal University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Li, XL (corresponding author), Beijing Normal Univ, Coll Global Change & Earth Syst Sci, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.; Yao, YJ (corresponding author), Beijing Normal Univ, Sch Geog, State Key Lab Remote Sensing Sci, Beijing, Peoples R China.	xlli@bnu.edu.cn; boyyunjun@163.com			High-Tech Research and Development Program of China [2013AA122801]; Natural Science Fund of China [41205104, 41201331]; National Basic Research Program of China [2012CB955302]; Fundamental Research Funds for the Central Universities [2012LYB38]; youth talent support program of College of Global Change and Earth System Science [312231103]; High Resolution Earth Observation Systems of National Science and Technology Major Projects [05-Y30B02-9001-13/15-9]	High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); youth talent support program of College of Global Change and Earth System Science; High Resolution Earth Observation Systems of National Science and Technology Major Projects	This work was partially supported by the High-Tech Research and Development Program of China (Grant 2013AA122801), the Natural Science Fund of China (Grants 41205104 and, 41201331), the National Basic Research Program of China (Grant 2012CB955302), the Fundamental Research Funds for the Central Universities (Grant 2012LYB38), the youth talent support program of College of Global Change and Earth System Science (312231103) and the High Resolution Earth Observation Systems of National Science and Technology Major Projects (Grant 05-Y30B02-9001-13/15-9). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, 56 FAO, P300; Allen RG, 2000, J HYDROL, V229, P27, DOI 10.1016/S0022-1694(99)00194-8; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Behrangi A, 2014, INT J REMOTE SENS, V35, P2170, DOI 10.1080/01431161.2014.889866; Burba GG, 2005, AGR FOREST METEOROL, V135, P190, DOI 10.1016/j.agrformet.2005.11.017; Byun K, 2014, AGR FOREST METEOROL, V197, P169, DOI 10.1016/j.agrformet.2014.07.001; Chen Y, 2014, REMOTE SENS ENVIRON, V140, P279, DOI 10.1016/j.rse.2013.08.045; Churkina G, 1999, GLOBAL CHANGE BIOL, V5, P46, DOI 10.1046/j.1365-2486.1999.00006.x; Cleugh HA, 2007, REMOTE SENS ENVIRON, V106, P285, DOI 10.1016/j.rse.2006.07.007; Ding RS, 2015, HYDROL PROCESS, V29, P239, DOI 10.1002/hyp.10146; Ding RS, 2013, AGR FOREST METEOROL, V168, P140, DOI 10.1016/j.agrformet.2012.08.003; Ershadi A, 2014, AGR FOREST METEOROL, V187, P46, DOI 10.1016/j.agrformet.2013.11.008; Feng F, 2015, REMOTE SENS-BASEL, V7, P16733, DOI 10.3390/rs71215853; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Fung I, 1997, NATURE, V386, P659, DOI 10.1038/386659a0; Gill RA, 2002, NATURE, V417, P279, DOI 10.1038/417279a; Gordon LJ, 2005, P NATL ACAD SCI USA, V102, P7612, DOI 10.1073/pnas.0500208102; Guo Z., 2006, J GEOPHYS RES-ATMOS, V111, pD22, DOI DOI 10.1029/2006JD007845; Kennedy AD, 2011, J CLIMATE, V24, P4541, DOI 10.1175/2011JCLI3978.1; Kustas WP, 2004, REMOTE SENS ENVIRON, V92, P535, DOI 10.1016/j.rse.2004.02.020; Leuning R, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006562; Liu CS, 2013, PROC SPIE, V8869, DOI 10.1117/12.2021713; Liu YL, 2015, J GEOPHYS RES-ATMOS, V120, P2647, DOI 10.1002/2014JD022531; Lucht W, 2002, SCIENCE, V296, P1687, DOI 10.1126/science.1071828; McCabe MF, 2006, REMOTE SENS ENVIRON, V105, P271, DOI 10.1016/j.rse.2006.07.006; Misson Monson RK, 2005, AGR FOR METEOROL, V131, P1; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; MYNENI RB, 1994, REMOTE SENS ENVIRON, V49, P200, DOI 10.1016/0034-4257(94)90016-7; Nemanill R., 1997, INCREASED PLANT GROW; PENMAN HL, 1948, PROC R SOC LON SER-A, V193, P120, DOI 10.1098/rspa.1948.0037; Pereira LS, 1999, J IRRIG DRAIN ENG, V125, P45, DOI 10.1061/(ASCE)0733-9437(1999)125:2(45); Piao SL, 2007, P NATL ACAD SCI USA, V104, P15242, DOI 10.1073/pnas.0707213104; Pinker RT, 2005, SCIENCE, V308, P850, DOI 10.1126/science.1103159; Pipunic RC, 2008, REMOTE SENS ENVIRON, V112, P1295, DOI 10.1016/j.rse.2007.02.038; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rawlins MA, 2006, EARTH INTERACT, V10; Riediger Jan, 2014, Environmental Sciences Europe, V26, DOI 10.1186/s12302-014-0018-1; Sacks WJ, 2011, AGR FOREST METEOROL, V151, P882, DOI 10.1016/j.agrformet.2011.02.010; Schreiber L, 2001, PLANTA, V214, P274, DOI 10.1007/s004250100615; Singh RK, 2016, WATER-SUI, V8, DOI 10.3390/w8010009; Steduto P, 1998, AGR FOREST METEOROL, V89, P215, DOI 10.1016/S0168-1923(97)00082-8; Taylor KE, 2001, J GEOPHYS RES-ATMOS, V106, P7183, DOI 10.1029/2000JD900719; Twine TE, 2000, AGR FOREST METEOROL, V103, P279, DOI 10.1016/S0168-1923(00)00123-4; Valipour M, 2015, ARCH AGRON SOIL SCI, V61, P239, DOI 10.1080/03650340.2014.925107; Vinukollu RK, 2011, REMOTE SENS ENVIRON, V115, P801, DOI 10.1016/j.rse.2010.11.006; Wang KC, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD008351; Wilson K, 2002, AGR FOREST METEOROL, V113, P223, DOI 10.1016/S0168-1923(02)00109-0; Yang FL, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0100031, 10.1371/journal.pone.0076458]; Yao YJ, 2015, ENVIRON MONIT ASSESS, V187, DOI 10.1007/s10661-015-4619-y; Yao YJ, 2014, REMOTE SENS-BASEL, V6, P880, DOI 10.3390/rs6010880; Yao YJ, 2014, J GEOPHYS RES-ATMOS, V119, P4521, DOI 10.1002/2013JD020864; Yao YJ, 2013, AGR FOREST METEOROL, V171, P187, DOI 10.1016/j.agrformet.2012.11.016; Yuan WP, 2010, REMOTE SENS ENVIRON, V114, P1416, DOI 10.1016/j.rse.2010.01.022; Zhang K, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008800; Zhang XY, 2011, AGR WATER MANAGE, V98, P1097, DOI 10.1016/j.agwat.2011.02.003; Zhao L, 2013, J GEOPHYS RES-ATMOS, V118, P9552, DOI 10.1002/jgrd.50697; Zhou LM, 2001, J GEOPHYS RES-ATMOS, V106, P20069, DOI 10.1029/2000JD000115	57	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183771	10.1371/journal.pone.0183771	http://dx.doi.org/10.1371/journal.pone.0183771			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837704	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000118
J	McMahon, CJ; Toomey, JP; Kane, DM				McMahon, Christopher J.; Toomey, Joshua P.; Kane, Deb M.			Insights on correlation dimension from dynamics mapping of three experimental nonlinear laser systems	PLOS ONE			English	Article							SEMICONDUCTOR-LASERS; AUTOMATIC ESTIMATION; FEEDBACK; CHAOS; GENERATION; DISEASE; MODE	Background We have analysed large data sets consisting of tens of thousands of time series from three Type B laser systems: a semiconductor laser in a photonic integrated chip, a semiconductor laser subject to optical feedback from a long free-space-external-cavity, and a solid-state laser subject to optical injection from a master laser. The lasers can deliver either constant, periodic, pulsed, or chaotic outputs when parameters such as the injection current and the level of external perturbation are varied. The systems represent examples of experimental nonlinear systems more generally and cover a broad range of complexity including systematically varying complexity in some regions. Methods In this work we have introduced a new procedure for semi-automatically interrogating experimental laser system output power time series to calculate the correlation dimension (CD) using the commonly adopted Grassberger-Proccacia algorithm. The new CD procedure is called the 'minimum gradient detection algorithm'. A value of minimum gradient is returned for all time series in a data set. In some cases this can be identified as a CD, with uncertainty. Findings Applying the new 'minimum gradient detection algorithm' CD procedure, we obtained robust measurements of the correlation dimension for many of the time series measured from each laser system. By mapping the results across an extended parameter space for operation of each laser system, we were able to confidently identify regions of low CD (CD < 3) and assign these robust values for the correlation dimension. However, in all three laser systems, we were not able to measure the correlation dimension at all parts of the parameter space. Nevertheless, by mapping the staged progress of the algorithm, we were able to broadly classify the dynamical output of the lasers at all parts of their respective parameter spaces. For two of the laser systems this included displaying regions of high-complexity chaos and dynamic noise. These high-complexity regions are differentiated from regions where the time series are dominated by technical noise. This is the first time such differentiation has been achieved using a CD analysis approach. Conclusions More can be known of the CD for a system when it is interrogated in a mapping context, than from calculations using isolated time series. This has been shown for three laser systems and the approach is expected to be useful in other areas of nonlinear science where large data sets are available and need to be semi-automatically analysed to provide real dimensional information about the complex dynamics. The CD/minimum gradient algorithm measure provides additional information that complements other measures of complexity and relative complexity, such as the permutation entropy; and conventional physical measurements.	[Kane, Deb M.] Macquarie Univ, MQ Photon Res Ctr, Sydney, NSW, Australia; Macquarie Univ, Dept Phys & Astron, Sydney, NSW, Australia	Macquarie University; Macquarie University	Kane, DM (corresponding author), Macquarie Univ, MQ Photon Res Ctr, Sydney, NSW, Australia.	deb.kane@mq.edu.au	Kane, Deborah/M-6927-2019; Pisarchik, Alexander N./K-9704-2019	Kane, Deborah/0000-0003-4551-9896; Pisarchik, Alexander N./0000-0003-2471-2507	Science and Industry Endowment Fund [RP 04-174]	Science and Industry Endowment Fund	This research was supported by the Science and Industry Endowment Fund, RP 04-174 (DMK), http://www.sief.org.au/.	ARECCHI FT, 1986, PHYS REV A, V34, P1617, DOI 10.1103/PhysRevA.34.1617; Argyris A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.194101; Argyris J. H., 2015, EXPLORATION DYNAMICA; Bader R., 2013, NONLINEARITIES SYNCH; Bandt C, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.174102; Boon MY, 2008, J VISION, V8, DOI 10.1167/8.1.6; CANNIZZO JK, 1990, ASTROPHYS J, V357, P235, DOI 10.1086/168910; Casaleggio A, 1999, BIOL CYBERN, V81, P279, DOI 10.1007/s004220050562; Chen Ping, 1988, DYNAMIC ECONOMETRIC, P199; Chlouverakis KE, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.066215; CLARK BK, 1995, AM J PHYS, V63, P157, DOI 10.1119/1.17974; Corana A, 2004, CHAOS SOLITON FRACT, V20, P779, DOI 10.1016/j.chaos.2003.08.012; Experimental and numerical intensity time series of an opticallyinjected solid state laser, 2005, OPTICS COMMUNICATION, V254, P282; FRASER AM, 1986, PHYS REV A, V33, P1134, DOI 10.1103/PhysRevA.33.1134; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Hegger R, TISEAN 3 0 1 NONLINE; HEMERY E, 1990, IEEE J QUANTUM ELECT, V26, P633, DOI 10.1109/3.53379; Jeong J, 2001, J CLIN NEUROPHYSIOL, V18, P58, DOI 10.1097/00004691-200101000-00010; Jiang JD, 1999, J SOUND VIB, V223, P529, DOI 10.1006/jsvi.1998.2161; Kane DM, 2014, AIP CONF PROC, V1618, P69, DOI 10.1063/1.4897677; Kane DM, 2014, 2014 OPTOELECTRONICS AND COMMUNICATIONS CONFERENCE AND AUSTRALIAN CONFERENCE ON OPTICAL FIBRE TECHNOLOGY (OECC/ACOFT 2014), P560; Kane DM, 2005, UNLOCKING DYNAMICAL DIVERSITY: OPTICAL FEEDBACK EFFECTS ON SEMICONDUCTOR LASERS, P1, DOI 10.1002/0470856211.ch1; Kane DM, 2014, 2014 C OPTOELECTRONI; Kane DM, 2016, 2016 INTERNATIONAL C; KLISCHE W, 1985, PHYS REV A, V31, P4049, DOI 10.1103/PhysRevA.31.4049; Kotini A, 2002, BRAIN TOPOGR, V15, P107, DOI 10.1023/A:1021420507901; Lan BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150027; LENSTRA D, 1985, IEEE J QUANTUM ELECT, V21, P674, DOI 10.1109/JQE.1985.1072725; Maps of the dynamics of an optically injected solid-state laser, 2005, PHYS REV A, V72; Muller V, 2001, EXP BRAIN RES, V137, P103, DOI 10.1007/s002210000638; Ohtsubo J., 2012, SEMICONDUCTOR LASERS; Sciamanna M, 2015, NAT PHOTONICS, V9, P151, DOI [10.1038/nphoton.2014.326, 10.1038/NPHOTON.2014.326]; SIMPSON TB, 1994, APPL PHYS LETT, V64, P3539, DOI 10.1063/1.111218; Syvridis D, 2009, IEEE J QUANTUM ELECT, V45, P1421, DOI 10.1109/JQE.2009.2027336; Takens F, 1981, DYNAMICAL SYSTEMS TU, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; THEILER J, 1987, PHYS REV A, V36, P4456, DOI 10.1103/PhysRevA.36.4456; TKACH RW, 1986, J LIGHTWAVE TECHNOL, V4, P1655, DOI 10.1109/JLT.1986.1074666; Toomey JP, 2014, OPT EXPRESS, V22, P1713, DOI 10.1364/OE.22.001713; Toomey JP, 2010, OPT EXPRESS, V18, P16955, DOI 10.1364/OE.18.016955; Toomey JP, 2009, OPT EXPRESS, V17, P7592, DOI 10.1364/OE.17.007592; Toomey JP, 2015, OPT EXPRESS, V23, P18754, DOI 10.1364/OE.23.018754; Toomey JP, 2014, 2014 INT SEM LAS C I; Toomey JP, 2016, JOURNAL OF LIGHTWAVE, VPP, P1; Valling S, 2007, OPT COMMUN, V271, P532, DOI 10.1016/j.optcom.2006.10.086	44	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181559	10.1371/journal.pone.0181559	http://dx.doi.org/10.1371/journal.pone.0181559			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837602	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000009
J	Erinjery, JJ; Kumar, S; Kumara, HN; Mohan, K; Dhananjaya, T; Sundararaj, P; Kent, R; Singh, M				Erinjery, Joseph J.; Kumar, Shanthala; Kumara, Honnavalli N.; Mohan, K.; Dhananjaya, Tejeshwar; Sundararaj, P.; Kent, Rafi; Singh, Mewa			Losing its ground: A case study of fast declining populations of a 'least-concern' species, the bonnet macaque (Macaca radiata)	PLOS ONE			English	Article							LION-TAILED MACAQUES; WESTERN-GHATS; HABITAT FRAGMENTATION; LANDSCAPE ECOLOGY; BIRD POPULATIONS; CLIMATE-CHANGE; INDIA; CONSERVATION; BIODIVERSITY; FORESTS	The populations of many species that are widespread and commensal with humans have been drastically declining during the past few decades, but little attention has been paid to their conservation. Here, we report the status of the bonnet macaque, a species that is considered 'least-concern' for conservation. We show that the widely ranging rhesus macaque is expanding its range into the distributional range of the bonnet macaque, a species endemic only to southern India. Bonnet macaques have very low abundance in forests of all types indicating that it is not a typically forest dwelling species. The traditionally preferred habitats of bonnet macaques have been Hindu temples/tourist spots but our data reveal that nearly 50% population of bonnet macaques has disappeared from such previously occupied spots. Another preferred habitat of bonnet macaques has been roadsides with abundant Ficus trees adjoining croplands. We found that between 2003 and 2015, the roadsides have drastically changed where vegetation has been replaced with barren lands and urbanization. Consequently, the populations of bonnet macaques have declined by more than 65% over the past 25 years, and by more than 50% between 2003 and 2015 alone. We, therefore, conclude that this 'least-concern' species is actually facing serious conservation challenges. We also identify a few places such as small hillocks with natural vegetation and a few temples/tourist spots which are likely to remain stable and thus can serve as 'bonnet macaque conservation reserves'. Since the bonnet macaque shares many traits with several other commensal and 'low-risk' species, it can serve as a model for the development of long-term conservation strategies for most such species.	[Erinjery, Joseph J.; Mohan, K.; Dhananjaya, Tejeshwar; Singh, Mewa] Univ Mysore, Biopsychol Lab, Mysuru, India; [Erinjery, Joseph J.; Mohan, K.; Dhananjaya, Tejeshwar; Singh, Mewa] Univ Mysore, Inst Excellence, Mysuru, India; [Erinjery, Joseph J.; Kent, Rafi] Bar Ilan Univ, Dept Geog & Environm, Ramat Gan, Israel; [Kumar, Shanthala; Sundararaj, P.] Bharathiar Univ, Dept Zool, Coimbatore, Tamil Nadu, India; [Kumara, Honnavalli N.] Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India; [Singh, Mewa] Jawaharlal Nehru Ctr Adv Sci Res, Bangalore, Karnataka, India	University of Mysore; University of Mysore; Bar Ilan University; Bharathiar University; Salim Ali Center for Ornithology & Natural History (SACON); Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR)	Kumara, HN (corresponding author), Salim Ali Ctr Ornithol & Nat Hist, Coimbatore, Tamil Nadu, India.	honnavallik@gmail.com	Erinjery, Joseph/J-8443-2019	Erinjery, Joseph/0000-0002-5690-838X; Sundararaj, Palanisamy/0000-0001-9927-5538; Kumara, Honnavalli/0000-0002-7958-6395	J.C. Bose Fellowship of Science and Engineering Research Board, Government of India; Rufford Small Grants	J.C. Bose Fellowship of Science and Engineering Research Board, Government of India; Rufford Small Grants	Partial funding by 1. J.C. Bose Fellowship of Science and Engineering Research Board, Government of India to MS. 2. Rufford Small Grants to SK.	Anderies JM, 2007, J THEOR BIOL, V247, P36, DOI 10.1016/j.jtbi.2007.01.030; [Anonymous], 1993, BOOK INDIAN ANIMALS; [Anonymous], THESIS; Baker PJ, 2007, MAMMAL REV, V37, P297, DOI 10.1111/j.1365-2907.2007.00102.x; Bapureddy G, 2015, CURR SCI INDIA, V108, P118; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; BLEICH VC, 1995, J MAMMAL, V76, P646, DOI 10.2307/1382373; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Carr LW, 2002, APPLYING LANDSCAPE ECOLOGY IN BIOLOGICAL CONSERVATION, P225; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Coffin AW, 2007, J TRANSP GEOGR, V15, P396, DOI 10.1016/j.jtrangeo.2006.11.006; Crick HQ, 2002, BTO RES REP, V290, P1; d'Souza Lancy, 1992, Journal of Ecobiology, V4, P87; De Laet J, 2007, J ORNITHOL, V148, pS275, DOI 10.1007/s10336-007-0154-0; Eudey Ardith A., 2008, Primate Conservation, V23, P129, DOI 10.1896/052.023.0115; Falcucci A, 2007, LANDSCAPE ECOL, V22, P617, DOI 10.1007/s10980-006-9056-4; Fischer J, 2007, GLOBAL ECOL BIOGEOGR, V16, P265, DOI 10.1111/j.1466-8238.2007.00287.x; FOODEN J, 1981, Journal of the Bombay Natural History Society, V78, P463; Fuentes A, 2008, AM J PRIMATOL, V70, P879, DOI 10.1002/ajp.20575; Haila Y, 2002, ECOL APPL, V12, P321, DOI 10.1890/1051-0761(2002)012[0321:ACGOFR]2.0.CO;2; Hamer AJ, 2010, AUSTRAL ECOL, V35, P568, DOI 10.1111/j.1442-9993.2009.02068.x; Hines J. E., 2012, PROGRAM PRESENCE VER; IUCN Red list, 2022, ZOOL, Patent No. [eT158085A760192, 158085760192]; Jannett FJ, 2007, AM MIDL NAT, V158, P168, DOI 10.1674/0003-0031(2007)158[168:NREOMS]2.0.CO;2; Jathanna D, 2003, J ZOOL, V261, P285, DOI 10.1017/S0952836903004278; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; KOYAMA N, 1981, Journal of the Bombay Natural History Society, V78, P240; Kumar M. Ananda, 2002, Journal of the Bombay Natural History Society, V99, P184; Kumar R, 2011, INT J PRIMATOL, V32, P945, DOI 10.1007/s10764-011-9514-y; Kumara HN, 2012, CURR SCI, V103; Kumara HN, 2014, INT J PRIMATOL, V35, P976, DOI 10.1007/s10764-014-9776-2; Kumara HN, 2011, CURR SCI INDIA, V100, P1063; Kumara HN, 2010, PRIMATES, V51, P37, DOI 10.1007/s10329-009-0168-8; Langer MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054443; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Netalkar PS, 2012, PRIMATES KUDRE UNPUB; OXLEY DJ, 1974, J APPL ECOL, V11, P51, DOI 10.2307/2402004; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Ramesh T, 2012, TROP ECOL, V53, P137; REIJNEN R, 1994, J APPL ECOL, V31, P85, DOI 10.2307/2404601; Riley EP, 2007, AM ANTHROPOL, V109, P473, DOI 10.1525/AA.2007.109.3.473; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Saraswat R, 2015, EUR J WILDLIFE RES, V61, P435, DOI 10.1007/s10344-015-0913-9; Sasidharan N., 2002, 246 KFRI; Schilaci MA, 2010, DEV PRIMATOL-PROG PR, P249, DOI 10.1007/978-1-4419-1560-3_14; Sengupta Asmita, 2013, Primate Conservation, V27, P109; Simonds P. E., 1965, P175; SINGH M, 1990, PRIMATES, V31, P589, DOI 10.1007/BF02382542; Singh M, 2004, INT J PRIMATOL, V25, P847, DOI 10.1023/B:IJOP.0000029125.54747.ee; Singh M, 2002, AM J PRIMATOL, V57, P91, DOI 10.1002/ajp.10037; Singh M, 2011, PRIMATES, V52, P149, DOI 10.1007/s10329-011-0234-x; Sodhi NS, 2010, BIOL CONSERV, V143, P2375, DOI 10.1016/j.biocon.2009.12.029; Sol D, 2002, ANIM BEHAV, V63, P495, DOI 10.1006/anbe.2001.1953; Sol D, 2008, AM NAT, V172, pS63, DOI 10.1086/588304; Sorace A, 2002, ORNIS FENNICA, V79, P60; SUGIYAMA Y, 1971, Primates, V12, P247, DOI 10.1007/BF01730414; Thierry Bernard, 2004, Cambridge Studies in Biological and Evolutionary Anthropology, V41, P267; VANAPELDOORN RC, 1992, OIKOS, V65, P265, DOI 10.2307/3545018	58	8	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182140	10.1371/journal.pone.0182140	http://dx.doi.org/10.1371/journal.pone.0182140			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832584	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000408355800013
J	Gupta, N; Vashist, P; Tandon, R; Gupta, SK; Kalaivani, M; Dwivedi, SN				Gupta, Noopur; Vashist, Praveen; Tandon, Radhika; Gupta, Sanjeev K.; Kalaivani, Mani; Dwivedi, S. N.			Use of traditional eye medicine and self-medication in rural India: A population-based study	PLOS ONE			English	Article							CORNEAL DISEASE; ANDHRA-PRADESH; SOUTH-INDIA; SERVICES; PATTERNS; NIGERIA; MALAWI	Objective To determine the type and nature of traditional eye medicine (TEM), their sources and use and practices related to self-medication for ophthalmic diseases in a rural Indian population. Methods A population-based, cross-sectional study was conducted in 25 randomly selected clusters of Rural Gurgaon, Haryana, India as part of CORE (Cornea Opacity Rural Epidemiological) study. In addition to comprehensive ophthalmic examination, health-seeking behavior and use of self-medication and TEM was assessed in the adult population using a semi-structured questionnaire. Physical verification of available ophthalmic medications in the enumerated households was conducted by the study team. Descriptive statistics were computed along with multivariable logistic regression analysis to determine associated factors for use of self-medication and TEM. Results Of the 2160 participants interviewed, 396 (18.2%) reported using ophthalmic medications without consulting an ophthalmologist, mainly for symptoms like watering (37.1%), redness (27.7%), itching (19.2%) and infection (13.6%). On physical verification of available eye drops that were being used without prescription, 26.4% participants were practicing self-medication. Steroid, expired/unlabeled and indigenous eye drops were being used by 151 (26.5%), 120(21.1%) and 75 (13.2%) participants respectively. Additionally, 25.7% (529) participants resorted to home remedies like 'kajal'(61.4%), honey (31.4%), ghee (11.7%) and rose water (9.1%). Conclusion Use of TEM is prevalent in this population. The rampant use of steroid eye drops without prescription along with use of expired or unlabelled eye drops warrants greater emphasis on safe eye care practices in this population. Public awareness and regulatory legislations must be implemented to decrease harmful effects arising due to such practices.	[Gupta, Noopur; Vashist, Praveen; Tandon, Radhika] All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India; [Gupta, Sanjeev K.] All India Inst Med Sci, Ctr Community Med, New Delhi, India; [Kalaivani, Mani; Dwivedi, S. N.] All India Inst Med Sci, Dept Biostat, New Delhi, India	All India Institute of Medical Sciences (AIIMS) New Delhi; Dr. Rajendra Prasad Centre for Ophthalmic Sciences; All India Institute of Medical Sciences (AIIMS) New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Vashist, P (corresponding author), All India Inst Med Sci, Dr Rajendra Prasad Ctr Ophthalm Sci, New Delhi, India.	praveenvashist@yahoo.com	GUPTA, NOOPUR/AAX-5043-2021	GUPTA, NOOPUR/0000-0001-8022-6656; Gupta, Sanjeev/0000-0002-2014-5333				Abasaeed A, 2009, J INFECT DEV COUNTR, V3, P491, DOI 10.3855/jidc.466; Adegbehingbe B O, 2008, Tanzan J Health Res, V10, P240; Bharathi Jayahar M., 2007, Indian Journal of Ophthalmology, V55, P37; Bisika T, 2009, AFR J TRADIT COMPLEM, V6, P23; Carvalho RS, 2009, CLINICS, V64, P735, DOI 10.1590/S1807-59322009000800005; COURTRIGHT P, 1994, BRIT J OPHTHALMOL, V78, P810, DOI 10.1136/bjo.78.11.810; Courtright P, 1996, BRIT J OPHTHALMOL, V80, P694, DOI 10.1136/bjo.80.8.694; Dandona R, 2000, BRIT J OPHTHALMOL, V84, P22, DOI 10.1136/bjo.84.1.22; Editorial, 2001, REV ASSOC MED BRAS, V47, P269; Eze BI, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-40; Fletcher AE, 1999, ARCH OPHTHALMOL-CHIC, V117, P1393, DOI 10.1001/archopht.117.10.1393; Fraunfelder FW, 2004, AM J OPHTHALMOL, V138, P639, DOI 10.1016/j.ajo.2004.04.072; Albarran KF, 2008, PHARM WORLD SCI, V30, P863, DOI 10.1007/s11096-008-9241-4; Gupta N, 2015, BRIT J OPHTHALMOL, V99, P147, DOI 10.1136/bjophthalmol-2014-305945; Gupta Noopur, 2013, Indian J Community Med, V38, P198, DOI 10.4103/0970-0218.120153; Jaya Y, 2014, Cent Afr J Med, V60, P36; Kadri R, 2011, INT J BIOL MED RES, V2, P528; Kara-Jose N, 1985, ARQ BRAS OFTALMOL, V48, P160; Kovai Vilas, 2007, Indian Journal of Ophthalmology, V55, P365; LEWALLEN S, 1995, BRIT J OPHTHALMOL, V79, P343, DOI 10.1136/bjo.79.4.343; Marquez GE, 2012, OPHTHAL EPIDEMIOL, V19, P236, DOI 10.3109/09286586.2012.689076; Marquez GE, 2014, J CLIN EXP OPHTHALMO, V5, P330; Nwosu SNN, 2011, NIGER J CLIN PRACT, V14, P405, DOI 10.4103/1119-3077.91744; Osahon AI., 1995, NIGER J OPHTHALMOL, V3, P51; PRAJNA VN, 1999, INDIAN J OPHTHALMOL, V47, P15; Stanifer JW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122638; Ukponmwan CU, 2010, MIDDLE EAST AFR J OP, V17, P315, DOI 10.4103/0974-9233.71596	27	11	11	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183461	10.1371/journal.pone.0183461	http://dx.doi.org/10.1371/journal.pone.0183461			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829812	gold, Green Submitted, Green Published			2022-12-27	WOS:000408085100046
J	Hu, XL; Li, SS; Zhou, LL; Zhao, MH; Zhu, XQ				Hu, Xiaoli; Li, Saisai; Zhou, Lulu; Zhao, Menghuang; Zhu, Xueqiong			Effect of vitamin E supplementation on uterine cervical neoplasm: A meta-analysis of case-control studies	PLOS ONE			English	Article							INTRAEPITHELIAL NEOPLASIA; HUMAN-PAPILLOMAVIRUS; PROSTATE-CANCER; SERUM MICRONUTRIENTS; LIPID-PEROXIDATION; ALPHA-TOCOPHEROL; RISK-FACTORS; DYSPLASIA; WOMEN; ANTIOXIDANTS	Several epidemiological studies have suggested that vitamin E could reduce the risk of uterine cervical neoplasm. However, controversial data were presented by different reports. Hence, we conducted a meta-analysis to assess the relationship between vitamin E and the risk of cervical neoplasia. We performed a comprehensive search of the PubMed, Embase and Cochrane databases through December 31, 2016. Based on a fixed-effects or randomeffects model, the odds ratio (OR) and 95% confidence intervals (CIs) were calculated to assess the combined risk. Subgroup analyses and meta-regression were done to assess the source of heterogeneity. Subgroup analyses were performed according to survey ways, types of cervical neoplasia, study populations. A protocol was registered with PROSPERO (No. CRD42016036672). In total, 15 case-control studies were included, involving 3741 cases and 6328 controls. Our study suggested that higher category of vitamin E could reduce the cervical neoplasia risk (OR = 0.58, 95% CIs = 0.47-0.72, I-2 = 83%). In subgroup-analysis, both vitamin E intake and blood levels of vitamin E had a significant inverse association with the risk of cervical neoplasm. Additionally, we found the same relationship between vitamin E and cervical neoplasia among different populations and types of cervical neoplasia. Meta-regression showed that none of the including covariates were significantly related to the outcomes. No evidence of publication bias was observed. In conclusion, vitamin E intake and blood vitamin E levels were inversely associated with the risk of cervical neoplasia.	[Zhu, Xueqiong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Peoples R China; Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Zhu, XQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Obstet & Gynecol, Wenzhou, Peoples R China.	zjwzzxq@163.com	zhu, xueqiong/U-1320-2019	Zhu, Xueqiong/0000-0002-8389-928X				Bhuvarahamurthy V, 1996, MOL CELL BIOCHEM, V158, P17; Chen GH, 2015, INT J CLIN EXP MED, V8, P6631; Cho H, 2009, CLIN CHEM LAB MED, V47, P1005, DOI 10.1515/CCLM.2009.221; DAS S, 1994, ACTA ONCOL, V33, P615, DOI 10.3109/02841869409121771; Diao QX, 2016, EUR REV MED PHARMACO, V20, P2710; Ghosh C, 2008, NUTR CANCER, V60, P331, DOI 10.1080/01635580701861769; Goodman MT, 1998, CANCER EPIDEM BIOMAR, V7, P537; GUO LH, 2015, SCI REP UK, V5; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Ho GYF, 1998, INT J CANCER, V78, P594, DOI 10.1002/(SICI)1097-0215(19981123)78:5&lt;594::AID-IJC11&gt;3.0.CO;2-B; Kim J, 2010, NUTR CANCER, V62, P181, DOI 10.1080/01635580903305326; KNEKT P, 1988, INT J EPIDEMIOL, V17, P281, DOI 10.1093/ije/17.2.281; Kontek R, 2014, TOXICOL IN VITRO, V28, P282, DOI 10.1016/j.tiv.2013.11.007; Kress CM, 2015, INT J WOMENS HLTH, V7, P5765; Kwasniewska A, 1997, NUTR CANCER, V28, P248, DOI 10.1080/01635589709514583; Lee GJ, 2005, J KOREAN MED SCI, V20, P267, DOI 10.3346/jkms.2005.20.2.267; Lie AK, 1997, APMIS, V105, P115, DOI 10.1111/j.1699-0463.1997.tb00549.x; Major JM, 2014, J NUTR, V144, P729, DOI 10.3945/jn.113.189928; Munafo MR, 2004, TRENDS GENET, V20, P439, DOI 10.1016/j.tig.2004.06.014; Myung SK, 2011, BJOG-INT J OBSTET GY, V118, P1285, DOI 10.1111/j.1471-0528.2011.03032.x; Nagata C, 1999, BRIT J CANCER, V81, P1234, DOI 10.1038/sj.bjc.6690834; Ni J, 2005, CANCER RES, V65, P9807, DOI 10.1158/0008-5472.CAN-05-1334; Palan PR, 2004, AM J OBSTET GYNECOL, V190, P1407, DOI 10.1016/j.ajog.2004.01.067; Piroozmand A, 2016, JUNDISHAPUR J MICROB, V9, DOI 10.5812/jjm.32728; POTISCHMAN N, 1991, AM J EPIDEMIOL, V134, P1347, DOI 10.1093/oxfordjournals.aje.a116037; Ramamoorthy Venkataraghavan, 2015, Asian Pac J Cancer Prev, V16, P2619; Ricciarelli R, 2002, BIOL CHEM, V383, P457, DOI 10.1515/BC.2002.048; Richard A, 2015, CANCER EPIDEMIOL, V39, P870, DOI 10.1016/j.canep.2015.09.009; Shannon J, 2002, CANCER CAUSE CONTROL, V13, P691, DOI 10.1023/A:1020289618161; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Singh Preeti, 2005, Asian Pac J Cancer Prev, V6, P177; Slattery M L, 1990, Epidemiology, V1, P8, DOI 10.1097/00001648-199001000-00004; Srivastava S., 2009, Indian Journal of Cancer, V46, P297, DOI 10.4103/0019-509X.55549; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Thornton A, 2000, J CLIN EPIDEMIOL, V53, P207, DOI 10.1016/S0895-4356(99)00161-4; Tomita LY, 2011, BRIT J NUTR, V105, P928, DOI 10.1017/S0007114510004447; Tomita LY, 2010, INT J CANCER, V126, P703, DOI 10.1002/ijc.24793; vanPoppel G, 1997, CANCER LETT, V114, P195, DOI 10.1016/S0304-3835(97)04662-4; Weinstein SJ, 2007, CANCER EPIDEM BIOMAR, V16, P1253, DOI 10.1158/1055-9965.EPI-06-1084; Wideroff L, 1998, NUTR CANCER, V30, P130, DOI 10.1080/01635589809514652; Willett W C, 1986, Adv Exp Med Biol, V206, P27; Yeo ASS, 2000, NUTR CANCER, V38, P141, DOI 10.1207/S15327914NC382_1; Zheng NN, 2016, J DRUG TARGET, V24, P663, DOI 10.3109/1061186X.2015.1135335	43	12	12	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183395	10.1371/journal.pone.0183395	http://dx.doi.org/10.1371/journal.pone.0183395			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829815	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100044
J	Helie, S; Shamloo, F; Ell, SW				Helie, Sebastien; Shamloo, Farzin; Ell, Shawn W.			The effect of training methodology on knowledge representation in categorization	PLOS ONE			English	Article							INFORMATION-INTEGRATION; CATEGORY; MODEL; CLASSIFICATION; SYSTEMS; RULES; IDENTIFICATION; ATTENTION; IMPACT	Category representations can be broadly classified as containing within-category information or between-category information. Although such representational differences can have a profound impact on decision-making, relatively little is known about the factors contributing to the development and generalizability of different types of category representations. These issues are addressed by investigating the impact of training methodology and category structures using a traditional empirical approach as well as the novel adaptation of computational modeling techniques from the machine learning literature. Experiment 1 focused on rule-based (RB) category structures thought to promote between-category representations. Participants learned two sets of two categories during training and were subsequently tested on a novel categorization problem using the training categories. Classification training resulted in a bias toward between-category representations whereas concept training resulted in a bias toward within-category representations. Experiment 2 focused on information-integration (II) category structures thought to promote within- category representations. With II structures, there was a bias toward within-category representations regardless of training methodology. Furthermore, in both experiments, computational modeling suggests that only within-category representations could support generalization during the test phase. These data suggest that within-category representations may be dominant and more robust for supporting the reconfiguration of current knowledge to support generalization.	[Helie, Sebastien; Shamloo, Farzin] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA; [Ell, Shawn W.] Univ Maine, Dept Psychol, Orono, ME 04469 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Maine System; University of Maine Orono	Helie, S (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	shelie@purdue.edu			NSF [1349677-BCS, 1349737]	NSF(National Science Foundation (NSF))	The research was supported by NSF grants #1349677-BCS and #1349737 to SH and SWE (respectively). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JR, 1990, ADAPTIVE CHARACTER T; [Anonymous], 1992, INDUCTIVE LOGIC PROG; Ashby F. G., 1992, MULTIDIMENSIONAL MOD; Ashby FG, 2011, J COGNITIVE NEUROSCI, V23, P1549, DOI 10.1162/jocn.2010.21523; Ashby FG, 2001, TRENDS COGN SCI, V5, P204, DOI 10.1016/S1364-6613(00)01624-7; ASHBY FG, 1988, J EXP PSYCHOL LEARN, V14, P33, DOI 10.1037/0278-7393.14.1.33; Ashby FG, 1998, PSYCHOL REV, V105, P442, DOI 10.1037/0033-295X.105.3.442; Ashby FG, 1999, PSYCHON B REV, V6, P363, DOI 10.3758/BF03210826; Ashby FG, 1999, PERCEPT PSYCHOPHYS, V61, P1178, DOI 10.3758/BF03207622; Ashby FG, 1998, MEASUREMENT JUDGMENT; Bishop C. M, 2006, PATTERN RECOGNITION; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Brooks LR, 2007, MEM COGNITION, V35, P1, DOI 10.3758/BF03195937; Busemeyer JR, 2000, J MATH PSYCHOL, V44, P171, DOI 10.1006/jmps.1999.1282; Carvalho PF, 2015, PSYCHON B REV, V22, P281, DOI 10.3758/s13423-014-0676-4; Casale MB, 2008, PERCEPT PSYCHOPHYS, V70, P983, DOI 10.3758/PP.70.6.983; Casale MB, 2012, MEM COGNITION, V40, P434, DOI 10.3758/s13421-011-0154-4; Chin-Parker S, 2002, MEM COGNITION, V30, P353, DOI 10.3758/BF03194936; Ell SW, 2006, PERCEPT PSYCHOPHYS, V68, P1013, DOI 10.3758/BF03193362; Ell SW, 2012, ATTEN PERCEPT PSYCHO, V74, P466, DOI 10.3758/s13414-011-0238-z; Ell SW, 2009, ATTEN PERCEPT PSYCHO, V71, P1263, DOI 10.3758/APP.71.6.1263; Erev I, 1998, PSYCHOL REV, V105, P280, DOI 10.1037/0033-295X.105.2.280; Erickson MA, 1998, J EXP PSYCHOL GEN, V127, P107, DOI 10.1037/0096-3445.127.2.107; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Hammer R, 2009, COGNITION, V112, P105, DOI 10.1016/j.cognition.2009.03.012; Helie S, 2006, TUTOR QUANT METHODS, V2, P1, DOI 10.20982/tqmp.02.1.p001; Helie S, 2015, BRAIN COGNITION, V95, P19, DOI 10.1016/j.bandc.2015.01.009; Helie S, 2012, PSYCHOL RES-PSYCH FO, V76, P292, DOI 10.1007/s00426-011-0348-1; Hoffman AB, 2010, J EXP PSYCHOL GEN, V139, P319, DOI 10.1037/a0019042; Levering KR, 2015, MEM COGNITION, V43, P266, DOI 10.3758/s13421-014-0458-2; Maddox WT, 2005, J EXP PSYCHOL LEARN, V31, P654, DOI 10.1037/0278-7393.31.4.654; MADDOX WT, 1993, PERCEPT PSYCHOPHYS, V53, P49, DOI 10.3758/BF03211715; Maddox WT, 2004, BEHAV PROCESS, V66, P309, DOI 10.1016/j.beproc.2004.03.011; Maddox WT, 2004, PSYCHON B REV, V11, P945, DOI 10.3758/BF03196726; Markman AB, 2003, PSYCHOL BULL, V129, P592, DOI 10.1037/0033-2909.129.4.592; Markman AB, 2002, STEVENS HDB EXPT PSY, V2, P165; MEDIN DL, 1987, COGNITIVE PSYCHOL, V19, P242, DOI 10.1016/0010-0285(87)90012-0; Minda JP, 2004, MEM COGNITION, V32, P1355, DOI 10.3758/BF03206326; NOSOFSKY RM, 1994, PSYCHOL REV, V101, P53, DOI 10.1037/0033-295X.101.1.53; NOSOFSKY RM, 1986, J EXP PSYCHOL GEN, V115, P39, DOI 10.1037/0096-3445.115.1.39; POSNER MI, 1968, J EXP PSYCHOL, V77, P353, DOI 10.1037/h0025953; Pothos EM, 2002, COGNITIVE SCI, V26, P303, DOI 10.1207/s15516709cog2603_6; Reber PJ, 1998, P NATL ACAD SCI USA, V95, P747, DOI 10.1073/pnas.95.2.747; REED SK, 1972, COGNITIVE PSYCHOL, V3, P382, DOI 10.1016/0010-0285(72)90014-X; SHEPARD RN, 1961, PSYCHOL MONOGR, V75, P1, DOI 10.1037/h0093825; Smith JD, 2010, J EXP PSYCHOL-ANIM B, V36, P54, DOI 10.1037/a0015892; Smith JD, 2002, J EXP PSYCHOL LEARN, V28, P800, DOI 10.1037//0278-7393.28.4.800; Thomas RD, 1998, J EXP PSYCHOL LEARN, V24, P119, DOI 10.1037/0278-7393.24.1.119; TREISMAN M, 1984, PSYCHOL REV, V91, P68, DOI 10.1037/0033-295X.91.1.68; Yamauchi T, 1998, J MEM LANG, V39, P124, DOI 10.1006/jmla.1998.2566; Zeithamova D, 2008, J NEUROSCI, V28, P13194, DOI 10.1523/JNEUROSCI.2915-08.2008	51	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183904	10.1371/journal.pone.0183904	http://dx.doi.org/10.1371/journal.pone.0183904			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846732	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600057
J	Buscail, C; Sabate, JM; Bouchoucha, M; Torres, MJ; Alles, B; Hercberg, S; Benamouzig, R; Julia, C				Buscail, Camille; Sabate, Jean-Marc; Bouchoucha, Michel; Torres, Marion J.; Alles, Benjamin; Hercberg, Serge; Benamouzig, Robert; Julia, Chantal			Association between self-reported vegetarian diet and the irritable bowel syndrome in the French NutriNet cohort	PLOS ONE			English	Article							FUNCTIONAL GASTROINTESTINAL DISORDERS; LACTOSE-INTOLERANCE; MULTIPLE IMPUTATION; SEMI-VEGETARIAN; CROHNS-DISEASE; MEAT-EATERS; FOOD; FIBER; PREVALENCE; MANAGEMENT	Background There is growing interest in using diet counselling in the management of patients with irritable bowel syndrome (IBS). Among new emerging diets, vegetarian diets (VD) seem to be experiencing an important popularity, partly because of their alleged health benefits. A recent study performed among a rural Indian population showed that predominant VD could be associated with IBS. Objective This cross-sectional study aimed at assessing the association between the VD and IBS, among a large French cohort, the NutriNet-sante A study. Methods Subjects participating in the NutriNet-Sante A cohort study completed a questionnaire based on Rome III criteria (N = 41,682). Anthropometrics, socio-demographical and lifestyle data, including VD, were collected prior to the completion of Rome III questionnaire via self-administered questionnaires. Association between VD and IBS and its subtypes was investigated through multivariate logistic regression. Results The included subjects were mainly women (78.0%) and the mean age was 49.8 +/- 14.3 years. Among these individuals, 2,264 (5.4%) presented an IBS, and 805 (1.9%) reported a VD. Overall, VD was not associated with IBS or subtypes. A stable VD (i.e. self-declared at least three times) was associated with IBS (aOR 2.60 95% CI [1.37-4.91]), IBS mixed (aOR 2.97 95% CI [1.20-7.36]) and IBS diarrhoea (aOR 2.77 95% CI [1.01-7.59]). Conclusions This study suggests that a long term VD could be associated with IBS. Nevertheless, further studies are needed to confirm these results, and investigate the multiple aspects of the vegetarian diet, possibly related to the IBS.	[Buscail, Camille; Torres, Marion J.; Alles, Benjamin; Hercberg, Serge; Julia, Chantal] Univ Paris 13, Equipe Rech Epidemiol Nutr, Ctr Rech Epidemiol & Biostat CRESS, Inserm 1153,Inra U1125,Cnam,COMUE Sorbonne Paris, Bobigny, France; [Buscail, Camille; Hercberg, Serge; Julia, Chantal] Hop Avicenne, Dept Sante Publ, Bobigny, France; [Sabate, Jean-Marc; Bouchoucha, Michel; Benamouzig, Robert] Hop Avicenne, Serv Hepatogastroenterol, Bobigny, France	heSam Universite; Conservatoire National Arts & Metiers (CNAM); INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Buscail, C (corresponding author), Univ Paris 13, Equipe Rech Epidemiol Nutr, Ctr Rech Epidemiol & Biostat CRESS, Inserm 1153,Inra U1125,Cnam,COMUE Sorbonne Paris, Bobigny, France.; Buscail, C (corresponding author), Hop Avicenne, Dept Sante Publ, Bobigny, France.	c.buscail@eren.smbh.univ-paris13.fr	Alles, Benjamin/F-1006-2017; Serge, Hercberg/F-3038-2017; Buscail, Camille/J-7682-2016; BENAMOUZIG, Robert/W-8067-2019; Chantal, Julia/F-2805-2017	Alles, Benjamin/0000-0002-7970-171X; Serge, Hercberg/0000-0002-3168-1350; Buscail, Camille/0000-0002-6120-6497; Chantal, Julia/0000-0003-2006-5269; BENAMOUZIG, ROBERT/0000-0003-1952-6830; Torres, Marion J/0000-0002-7609-5531	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale; Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Sante publique France Institute; Fondation pour la Recherche Medicale and Paris 13 University	French Ministry of Health; Institut de Veille Sanitaire; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut National de la Recherche Agronomique; Conservatoire National des Arts et Metiers; Sante publique France Institute; Fondation pour la Recherche Medicale and Paris 13 University	The NutriNet-Sante Study is supported by the French Ministry of Health, the Institut de Veille Sanitaire, the Institut National de la Sante et de la Recherche Medicale, the Institut National de la Recherche Agronomique, the Conservatoire National des Arts et Metiers, the Sante publique France Institute and the Fondation pour la Recherche Medicale and Paris 13 University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Study sponsors had no part in study design, collection, analysis, and interpretation of data and the writing of the article and the decision to submit it for publication.	Austin GL, 2009, CLIN GASTROENTEROL H, V7, P706, DOI 10.1016/j.cgh.2009.02.023; Bijkerk CJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3154; Bijkerk CJ, 2004, ALIMENT PHARM THER, V19, P245, DOI 10.1111/j.0269-2813.2004.01862.x; Boettcher E, 2013, AM J GASTROENTEROL, V108, P728, DOI 10.1038/ajg.2013.97; Bommelaer G, 2002, GASTROEN CLIN BIOL, V26, P1118; Brandt LJ, 2002, AM J GASTROENTEROL, V97, pS7; Chiba M, 2010, WORLD J GASTROENTERO, V16, P2484, DOI 10.3748/wjg.v16.i20.2484; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Corazziari E, 2004, BEST PRACT RES CL GA, V18, P613, DOI 10.1016/j.bpg.2004.04.012; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Crowe FL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d4131; Dapoigny M, 2004, EUR J GASTROEN HEPAT, V16, P995, DOI 10.1097/00042737-200410000-00008; Davey GK, 2003, PUBLIC HEALTH NUTR, V6, P259, DOI 10.1079/PHN2002430; Dinu M., 2016, CRIT REV FOOD SCI NU; Drossman DA, 2016, GASTROENTEROLOGY, V150, P1257, DOI 10.1053/j.gastro.2016.03.035; Drossman DA, 2006, GASTROENTEROLOGY, V130, P1377, DOI 10.1053/j.gastro.2006.03.008; Dugum M, 2016, CLEV CLIN J MED, V83, P655, DOI 10.3949/ccjm.83a.14159; El-Salhy M, 2012, INT J MOL MED, V29, P723, DOI 10.3892/ijmm.2012.926; El-Salhy M, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0022-3; Esteve-Saillard M, 2016, OCL OILS FAT CROP LI, V23, DOI 10.1051/ocl/2016015; Eswaran S, 2013, AM J GASTROENTEROL, V108, P718, DOI 10.1038/ajg.2013.63; Eswaran S, 2011, GASTROENTEROL CLIN N, V40, P141, DOI 10.1016/j.gtc.2010.12.012; Farre R, 2013, AM J GASTROENTEROL, V108, P698, DOI 10.1038/ajg.2013.24; Farup PG, 2004, SCAND J GASTROENTERO, V39, P645, DOI 10.1080/00365520410005405; Ferrocino I, 2015, PLOS ONE, V10; Ford AC, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2313; Foundation Rome, 2006, J GASTROINTEST LIVER, V15, P307; Fraser GE, 2009, AM J CLIN NUTR, V90, P248, DOI 10.3945/ajcn.2009.27933; Fraser GE, 1999, AM J CLIN NUTR, V70, p532S, DOI 10.1093/ajcn/70.3.532s; Ghoshal UC, 2016, J GASTROENTEROL HEPA; Gibson PR, 2015, GASTROENTEROLOGY, V148, P1158, DOI 10.1053/j.gastro.2015.02.005; Gibson PR, 2013, SYNDR DIAGN MANAG, P81; Gupta D, 2007, J GASTROEN HEPATOL, V22, P2261, DOI 10.1111/j.1440-1746.2007.04986.x; Hamm LR, 1999, AM J GASTROENTEROL, V94, P1279, DOI 10.1016/S0002-9270(99)00133-1; Hawkins Irana W, 2015, Front Nutr, V2, P21, DOI 10.3389/fnut.2015.00021; Hedenus F, 2014, CLIMATIC CHANGE, V124, P79, DOI 10.1007/s10584-014-1104-5; Heilbronn LK, 2006, JAMA-J AM MED ASSOC, V295, P1539, DOI 10.1001/jama.295.13.1539; Heizer WD, 2009, J AM DIET ASSOC, V109, P1204, DOI 10.1016/j.jada.2009.04.012; Hercberg S., 2012, MAX PORTIONS ALIMENT; Human Research Council, 2014, HRC; Janssen M, 2016, APPETITE, V105, P643, DOI 10.1016/j.appet.2016.06.039; Jorgensen B., 2015, POROI, V11, P1, DOI DOI 10.13008/2151-2957.1220; Key TJ, 2006, P NUTR SOC, V65, P35, DOI 10.1079/PNS2005481; Kwok CS, 2014, INT J CARDIOL, V176, P680, DOI 10.1016/j.ijcard.2014.07.080; Lacy BE, 2013, PHYSICIAN ANSWERS YO; Lassale C, 2016, J ACAD NUTR DIET, V116, P427, DOI 10.1016/j.jand.2015.09.017; Lassale C, 2015, BRIT J NUTR, V113, P953, DOI 10.1017/S0007114515000057; Lee Bo Ra, 2016, Clin Nutr Res, V5, P102, DOI 10.7762/cnr.2016.5.2.102; Leitzmann C., 2014, AM J CLIN NUTR; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lomer MCE, 2008, ALIMENT PHARM THER, V27, P93, DOI 10.1111/j.1365-2036.2007.03557.x; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Lovell RM, 2012, CLIN GASTROENTEROL H, V10, P712, DOI 10.1016/j.cgh.2012.02.029; McEvoy CT, 2012, PUBLIC HEALTH NUTR, V15, P2287, DOI 10.1017/S1368980012000936; Moayyedi P, 2014, AM J GASTROENTEROL, V109, P1367, DOI 10.1038/ajg.2014.195; Monsbakken KW, 2006, EUR J CLIN NUTR, V60, P667, DOI 10.1038/sj.ejcn.1602367; Morcos A, 2009, J DIGEST DIS, V10, P237, DOI 10.1111/j.1751-2980.2009.00392.x; Mullee A, 2017, APPETITE, V114, P299, DOI 10.1016/j.appet.2017.03.052; Nagarajan N, 2015, EUR J GAS TROENTEROL, V1; NAIR P, 1994, DIGEST DIS, V12, P177, DOI 10.1159/000171451; Newport F., US 5 CONS THEMS VEG; Ostgaard H, 2012, MOL MED REP, V5, P1382, DOI 10.3892/mmr.2012.843; Panigrahi MK, 2013, J NEUROGASTROENTEROL, V19, P374, DOI 10.5056/jnm.2013.19.3.374; Parry SD, 2002, EUR J GASTROEN HEPAT, V14, P1225, DOI 10.1097/00042737-200211000-00010; Rao SSC, 2015, ALIMENT PHARM THER, V41, P1256, DOI 10.1111/apt.13167; Reddy KS, 2004, PUBLIC HLTH NUTR, V7; Redman LM, 2011, ANTIOXID REDOX SIGN, V14, P275, DOI 10.1089/ars.2010.3253; RIORDAN AM, 1993, LANCET, V342, P1131, DOI 10.1016/0140-6736(93)92121-9; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sabate J, 2015, PUBLIC HEALTH NUTR, V18, P2067, DOI [10.1017/S1368980014002377, 10.1017/S1368980014003176]; Sabate J, 2014, AM J CLIN NUTR, V100, p476S, DOI 10.3945/ajcn.113.071522; Scarborough P, 2014, CLIMATIC CHANGE, V125, P179, DOI 10.1007/s10584-014-1169-1; Schafer JL, 1998, MULTIVAR BEHAV RES, V33, P545, DOI 10.1207/s15327906mbr3304_5; Scott KP, 2013, PHARMACOL RES, V69, P52, DOI 10.1016/j.phrs.2012.10.020; Shepherd SJ, 2013, AM J GASTROENTEROL, V108, P707, DOI 10.1038/ajg.2013.96; Simren M, 2001, DIGESTION, V63, P108, DOI 10.1159/000051878; Su YS, 2011, J STAT SOFTW, V45, P1; Touvier M, 2011, BRIT J NUTR, V105, P1055, DOI 10.1017/S0007114510004617; Tuck CJ, 2014, EXPERT REV GASTROENT, V8, P819, DOI 10.1586/17474124.2014.917956; Turnbull GK, 2000, NUTRITION, V16, P665, DOI 10.1016/S0899-9007(00)00339-7; VEBU. Vegetarische und vegane Lebensmittel auf Erfolgskurs, 2016, VEG VEG LEB ERF; Wald A, 2008, NUTR CLIN PRACT, V23, P284, DOI 10.1177/0884533608318677; WHO, Q A CARC CONS RED ME; Wu GD, 2016, GUT, V65, P63, DOI 10.1136/gutjnl-2014-308209	85	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183039	10.1371/journal.pone.0183039	http://dx.doi.org/10.1371/journal.pone.0183039			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841661	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700016
J	Islam, N; Miklavcic, SJ; Bradshaw-Hajek, BH; White, LR				Islam, Nazmul; Miklavcic, Stanley J.; Bradshaw-Hajek, Bronwyn H.; White, Lee R.			Convective and diffusive effects on particle transport in asymmetric periodic capillaries	PLOS ONE			English	Article							FLOW; PENETRATION; NUMBERS; CELLS	We present here results of a theoretical investigation of particle transport in longitudinally asymmetric but axially symmetric capillaries, allowing for the influence of both diffusion and convection. In this study we have focused attention primarily on characterizing the influence of tube geometry and applied hydraulic pressure on the magnitude, direction and rate of transport of particles in axi-symmetric, saw-tooth shaped tubes. Three initial value problems are considered. The first involves the evolution of a fixed number of particles initially confined to a central wave-section. The second involves the evolution of the same initial state but including an ongoing production of particles in the central wave-section. The third involves the evolution of particles a fully laden tube. Based on a physical model of convective-diffusive transport, assuming an underlying oscillatory fluid velocity field that is unaffected by the presence of the particles, we find that transport rates and even net transport directions depend critically on the design specifics, such as tube geometry, flow rate, initial particle configuration and whether or not particles are continuously introduced. The second transient scenario is qualitatively independent of the details of how particles are generated. In the third scenario there is no net transport. As the study is fundamental in nature, our findings could engender greater understanding of practical systems.	[Islam, Nazmul; Miklavcic, Stanley J.; Bradshaw-Hajek, Bronwyn H.; White, Lee R.] Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5001, Australia; [Islam, Nazmul] Khulna Univ, Math Discipline Sci Engn & Technol Sch, Khulna, Bangladesh	University of South Australia; Khulna University	Miklavcic, SJ (corresponding author), Univ South Australia, Phen & Bioinformat Res Ctr, Mawson Lakes, SA 5001, Australia.	stan.miklavcic@unisa.edu.au	Hajek, Bronwyn H/H-5513-2011	Hajek, Bronwyn H/0000-0002-7892-4620; Islam, Nazmul/0000-0003-4053-9521; Miklavcic, Stanley/0000-0002-2361-246X	Australian Research Council [DP1096282]; Australian Research Council through its Discovery Grant Scheme [DP1096282]	Australian Research Council(Australian Research Council); Australian Research Council through its Discovery Grant Scheme(Australian Research Council)	LRW gratefully received funding in the form of Discovery Grant #DP1096282 from the Australian Research Council (http://www.arc.gov.au/) for the support of NI. The funders had no role in study, design, data collection and analysis,decision to publish, or preparation of the manuscript.; The authors gratefully acknowledge the support of the Australian Research Council through its Discovery Grant Scheme (DP1096282).	Ahualli S, 2007, J COLLOID INTERF SCI, V309, P342, DOI 10.1016/j.jcis.2007.02.006; Bandopadhyay A, 2016, PHYS FLUIDS, V28, DOI 10.1063/1.4947115; Bradshaw-Hajek BH, 2008, LANGMUIR, V24, P4512, DOI 10.1021/la703777g; Cross SE, 1999, PHARMACEUT RES, V16, P427, DOI 10.1023/A:1018834021066; Dancik Y, 2012, BRIT J CLIN PHARMACO, V73, P564, DOI 10.1111/j.1365-2125.2011.04128.x; DAVIS RH, 1985, ANNU REV FLUID MECH, V17, P91, DOI 10.1146/annurev.fl.17.010185.000515; FEDKIW P, 1977, AICHE J, V23, P255, DOI 10.1002/aic.690230307; GIDDINGS JC, 1993, SCIENCE, V260, P1456, DOI 10.1126/science.8502990; Herringer JW, 2017, AICHE J, V63, P2358, DOI 10.1002/aic.15569; Hewitt GF, 2010, J FLUID MECH, V660, P258, DOI 10.1017/S0022112010002697; Huang LR, 2004, SCIENCE, V304, P987, DOI 10.1126/science.1094567; Islam N, 2015, EUR J MECH B-FLUID, V53, P119, DOI 10.1016/j.euromechflu.2015.04.008; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Jawadzadegan A., 2009, J MECH SCI TECHNOL, V23, P2456; Lee S, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4872035; Levich V.G., 1962, PHYSICOCHEMICAL HYDR; MCNEILL SC, 1992, PHARMACEUT RES, V9, P1422, DOI 10.1023/A:1015854728278; Miragotri S, 2011, INT J PHARMACEUT, V418, P115; MONTEIRORIVIERE NA, 1993, PHARMACEUT RES, V10, P1326, DOI 10.1023/A:1018973814456; MULLER M, 1995, J CONTROL RELEASE, V37, P49, DOI 10.1016/0168-3659(95)00063-E; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pozrikidis C., 1992, BOUNDARY INTEGRAL SI; Tripathi D, 2017, INT J HEAT MASS TRAN, V111, P138, DOI 10.1016/j.ijheatmasstransfer.2017.03.089	23	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183127	10.1371/journal.pone.0183127	http://dx.doi.org/10.1371/journal.pone.0183127			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841658	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000408370700019
J	Micic, D; Gaetano, JN; Rubin, JN; Cohen, RD; Sakuraba, A; Rubin, DT; Pekow, J				Micic, Dejan; Gaetano, John N.; Rubin, Jonah N.; Cohen, Russell D.; Sakuraba, Atsushi; Rubin, David T.; Pekow, Joel			Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease	PLOS ONE			English	Article							POPULATION-BASED COHORT; CROHNS-DISEASE; UNITED-STATES; RISK-FACTORS; CLOSTRIDIUM-DIFFICILE; ULCERATIVE-COLITIS; HEALTH-INSURANCE; HEART-FAILURE; RATES; CARE	Background Management of inpatients with inflammatory bowel disease (IBD) requires increasing resources. We aimed to identify factors associated with hospital readmissions among individuals with IBD. Materials & methods We collected data from the Healthcare Cost and Utilization Project Nationwide Readmissions Database 2013. We identified individuals with index hospitalizations for IBD. Patient-specific factors, comorbidities and hospitalization characteristics were extracted for the index hospitalization. We performed logistic regression modeling to create adjusted odds ratios (ORs) for 30-day hospital readmission. Subgroup analysis was performed based on disease type and performance of surgery. Results We analyzed a total of 55,942 index hospital discharges; 3037 patients (7.0%) were readmitted to the hospital within 30 days. Increasing patient age (> 65: OR: 0.45; 95% CI 0.39-0.53) was associated with a decreased risk of readmission, while a diagnosis of Crohn's disease (OR: 1.09; 95% CI 1.00-1.18) and male sex (OR: 1.16; 95% CI 1.07-1.25) were associated with an increased risk of readmission. The comorbidities of smoking (OR: 1.09; 95% CI 1.00-1.19), anxiety (OR: 1.17; 95% CI 1.01-1.36) and opioid dependence (OR: 1.40; 95% CI 1.06-1.86) were associated with an increased risk of 30-day readmission. Individual hospitalization characteristics and disease complications were significantly associated with readmission. Performance of a surgery during the index admission was associated with a decreased risk of readmission (OR: 0.57; 95% CI 0.33-0.96). Conclusion Analyzing data from a US publicly available all-payer inpatient healthcare database, we identified patient and hospitalization risk factors associated with 30-day readmission. Identifying patients at high risk for readmission may allow for interventions during or after the index hospitalization to decrease this risk.	[Micic, Dejan; Gaetano, John N.; Cohen, Russell D.; Sakuraba, Atsushi; Rubin, David T.; Pekow, Joel] Univ Chicago, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA; [Rubin, Jonah N.] Univ Chicago, Dept Internal Med, Sect Hosp Med, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Micic, D (corresponding author), Univ Chicago, Dept Internal Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA.	dejan.micic@northwestern.edu	Sakuraba, Atsushi/ABD-6796-2020	Sakuraba, Atsushi/0000-0003-2519-6129; Pekow, Joel/0000-0002-4790-8994	National Institutes of Health [T32DK007074, K08DK090152, P30DK42086]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090152, P30DK042086] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grants from the National Institutes of Health [grant number T32DK007074, K08DK090152 (JP), P30DK42086]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allegretti JR, 2015, INFLAMM BOWEL DIS, V21, P2583, DOI 10.1097/MIB.0000000000000537; Ananthakrishnan AN, 2008, GUT, V57, P205, DOI 10.1136/gut.2007.128231; Ananthakrishnan AN, 2008, AM J GASTROENTEROL, V103, P2789, DOI 10.1111/j.1572-0241.2008.02054.x; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Barnes EL, 2017, INFLAMM BOWEL DIS, V23, P875, DOI 10.1097/MIB.0000000000001121; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Bernstein CN, 2006, AM J GASTROENTEROL, V101, P110, DOI 10.1111/j.1572-0241.2006.00330.x; Bewtra M, 2007, CLIN GASTROENTEROL H, V5, P597, DOI 10.1016/j.cgh.2007.01.015; Damle RN, 2016, J SURG RES, V200, P200, DOI 10.1016/j.jss.2015.06.052; Frolkis AD, 2013, GASTROENTEROLOGY, V145, P996, DOI 10.1053/j.gastro.2013.07.041; Hazratjee N, 2013, AM J GASTROENTEROL, V108, P1024, DOI 10.1038/ajg.2012.343; Horton HA, 2014, ANTIMICROB AGENTS CH, V58, P5054, DOI 10.1128/AAC.02606-13; Horwitz L, 2014, J HOSP MED, V9, P743, DOI 10.1002/jhm.2271; Introduction to the HCUP Nationwide Readmissions Database (NRD), 2013, INTR HCUP NAT READM; Jennings JH, 2015, CHEST, V147, P1227, DOI 10.1378/chest.14-1123; Kappelman MD, 2008, GASTROENTEROLOGY, V135, P1907, DOI 10.1053/j.gastro.2008.09.012; Kulaylat AN, 2015, COLORECTAL DIS, V17, P891, DOI 10.1111/codi.12958; Lawrence Kosinski JVB, 2016, PROJECT SONAR REDUCT; Lichtenstein GR, 2005, GASTROENTEROLOGY, V128, P862, DOI 10.1053/j.gastro.2005.01.048; Loop MS, 2016, AM J CARDIOL, V118, P79, DOI 10.1016/j.amjcard.2016.04.015; Nguyen GC, 2008, INFLAMM BOWEL DIS, V14, P1105, DOI 10.1002/ibd.20429; Nguyen GC, 2007, INFLAMM BOWEL DIS, V13, P1408, DOI 10.1002/ibd.20200; Nguyen GC, 2014, CLIN GASTROENTEROL H, V12, P1897, DOI 10.1016/j.cgh.2014.02.042; Oddone EZ, 1996, J GEN INTERN MED, V11, P597, DOI 10.1007/BF02599027; Park KT, 2016, AM J GASTROENTEROL, V111, P15, DOI 10.1038/ajg.2015.207; Poojary P, 2017, INFLAMM BOWEL DIS, V23, P347, DOI 10.1097/MIB.0000000000001041; Rutgeerts P, 2004, GASTROENTEROLOGY, V126, P402, DOI 10.1053/j.gastro.2003.11.014; Silverstein MD, 1999, GASTROENTEROLOGY, V117, P49, DOI 10.1016/S0016-5085(99)70549-4; Singh G, 2016, CHEST, V149, P905, DOI 10.1378/chest.15-0449; Tapper EB, 2016, CLIN GASTROENTEROL H, V14, P1181, DOI 10.1016/j.cgh.2016.04.009; Villani A, 2014, J TELEMED TELECARE, V20, P468, DOI 10.1177/1357633X14555644	31	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182900	10.1371/journal.pone.0182900	http://dx.doi.org/10.1371/journal.pone.0182900			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837634	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000033
J	Nehemia, A; Kochzius, M				Nehemia, Alex; Kochzius, Marc			Reduced genetic diversity and alteration of gene flow in a fiddler crab due to mangrove degradation	PLOS ONE			English	Article							POPULATION-STRUCTURE; LARVAL DISPERSAL; UCA-ANNULIPES; MANAGEMENT; TESTS; RECRUITMENT; OCYPODIDAE; CONTEMPORARY; BOTTLENECKS; VARIABILITY	The fiddler crab Austruca occidentalis is a dominant species in mangrove forests along the East African coast. It enhances soil aeration and, through its engineering activities, makes otherwise-inaccessible food available for other marine organisms. Despite its importance, the habitat of A. occidentalis is threatened by human activities. Clearing the mangroves for salt farming and selective logging of mangroves trees continue to jeopardise mangrove ecosystems in the Western Indian Ocean. This study aims to use partial mitochondrial COI gene sequences and nuclear microsatellites to determine whether salt farming activities in mangroves have a negative impact on the genetic diversity and gene flow of A. occidentalis collected along the Tanzania coast. The level of genetic diversity for both mitochondrial DNA and nuclear microsatellites are relatively lower in samples from salt ponds compared to natural mangrove sites. Analysis of molecular variance (AMOVA) among all populations showed low but significant differentiation (COI: F-st = 0.022, P < 0.05; microsatellites: F-st = 0.022, P < 0.001). A hierarchical AMOVA indicates lower but significant genetic differentiation among populations from salt ponds and natural mangroves sites (COI: F-ct = 0.033, P < 0.05; microsatellites: F-ct = 0.018, P = < 0.01). These results indicate that salt farming has a significant negative impact on the genetic diversity of A. occidentalis. Since higher genetic diversity contributes to a stable population, restoring the cleared habitats might be the most effective measures for the conservation of genetic diversity and hence adaptive potential to environmental change in this species.	[Nehemia, Alex; Kochzius, Marc] VUB, Marine Biol Ecol & Biodivers, Pl Laan 2, Brussels, Belgium; [Nehemia, Alex] Sokoine Univ Agr, Dept Biol Sci, Morogoro, Tanzania	Vrije Universiteit Brussel; Sokoine University of Agriculture	Nehemia, A (corresponding author), VUB, Marine Biol Ecol & Biodivers, Pl Laan 2, Brussels, Belgium.; Nehemia, A (corresponding author), Sokoine Univ Agr, Dept Biol Sci, Morogoro, Tanzania.	alexander_nehemiah@yahoo.co.uk	Kochzius, Marc/AAN-3799-2021	Kochzius, Marc/0000-0001-8953-4719; NEHEMIA, ALEX/0000-0001-5471-7080	CARIBU programme (Erasmus Mundus Action 2) [2013-2618]; Leopold III-Fund [LF/JVG/vm/15.65]; Vrije Universiteit Brussel [NSE-TG-2015-25]	CARIBU programme (Erasmus Mundus Action 2); Leopold III-Fund; Vrije Universiteit Brussel	This study was funded by the CARIBU programme (Erasmus Mundus Action 2) (Grant number 2013-2618), Leopold III-Fund (Grant number: LF/JVG/vm/15.65), and the doctoral school of the Vrije Universiteit Brussel (Grant number: NSE-TG-2015-25). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuodha PAW, 2001, HYDROBIOLOGIA, V458, P255, DOI 10.1023/A:1013130916811; Araujo ES, 2015, ARCH BIOL SCI, V67, P1369, DOI 10.2298/ABS141205115A; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Atkinson SC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151992; Auld JR, 2010, BIOL LETTERS, V6, P222, DOI 10.1098/rsbl.2009.0726; Banks SC, 2013, TRENDS ECOL EVOL, V28, P670, DOI 10.1016/j.tree.2013.08.005; Bartolini F, 2011, MAR ENVIRON RES, V71, P53, DOI 10.1016/j.marenvres.2010.10.002; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Bosire JO, 2014, BIOGEOSCIENCES, V11, P2623, DOI 10.5194/bg-11-2623-2014; Bradic M, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-9; Britto FB, 2011, GENET MOL RES, V10, P4084, DOI 10.4238/2011.November.9.2; Casariego AM, 2004, MAR BIOL, V145, P259, DOI 10.1007/s00227-004-1325-7; Cervini M, 2006, GENET MOL BIOL, V29, P486, DOI 10.1590/S1415-47572006000300015; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Clemens SC, 1996, SCIENCE, V274, P943, DOI 10.1126/science.274.5289.943; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cornuet JM, 1996, GENETICS, V144, P2001; Crook DA, 2015, SCI TOTAL ENVIRON, V534, P52, DOI 10.1016/j.scitotenv.2015.04.034; DiBattista JD, 2008, CONSERV GENET, V9, P141, DOI 10.1007/s10592-007-9317-z; Duke NC, 2007, SCIENCE, V317, P41, DOI 10.1126/science.317.5834.41b; Evans BS, 2004, MAR ECOL PROG SER, V270, P163, DOI 10.3354/meps270163; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FAO, 2007, 153 FAO, P77; Faulks LK, 2011, EVOL APPL, V4, P589, DOI 10.1111/j.1752-4571.2011.00183.x; Fauvelot C, 2009, MAR BIOL, V156, P2313, DOI 10.1007/s00227-009-1259-1; Fratini S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158582; Fu YX, 1997, GENETICS, V147, P915; Garcia-Cisneros A, 2016, SCI REP-UK, V6, DOI 10.1038/srep33269; Geller J, 2013, MOL ECOL RESOUR, V13, P851, DOI 10.1111/1755-0998.12138; Gonzalez EB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163052; Goode MG, 2007, BIOINFORMATICS, V23, P1553, DOI 10.1093/bioinformatics/btm128; Greenbaum G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115203; Haig SM, 1998, ECOLOGY, V79, P413, DOI 10.1890/0012-9658(1998)079[0413:MCTC]2.0.CO;2; Halpern BS, 2004, MAR ECOL PROG SER, V276, P197, DOI 10.3354/meps276197; Hamilton SE, GLOB ECOL BIOGEOGR, V25, P729; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Hothorn T, 2008, J STAT SOFTW, V28, P1; Hui M, 2016, MAR ECOL, V38, P1; Kairo JG, 2001, S AFR J BOT, V67, P383, DOI 10.1016/S0254-6299(15)31153-4; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kinnear M, 2009, J CRUSTACEAN BIOL, V29, P273, DOI 10.1651/08-3049R.1; Kirui KB, 2013, OCEAN COAST MANAGE, V83, P19, DOI 10.1016/j.ocecoaman.2011.12.004; Koch V, 2005, MAR ECOL PROG SER, V291, P177, DOI 10.3354/meps291177; Kochzius M, 2008, MOL ECOL, V17, P3775, DOI 10.1111/j.1365-294X.2008.03803.x; Kristensen E, 2008, AQUAT BOT, V89, P201, DOI 10.1016/j.aquabot.2007.12.005; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; LEGGETT WC, 1994, NETH J SEA RES, V32, P119, DOI 10.1016/0077-7579(94)90036-1; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; LIINGILIE A. S., 2015, MEDITERRANEAN J BIOS, V1, P27; Litulo C, 2004, HYDROBIOLOGIA, V525, P167, DOI 10.1023/B:HYDR.0000038864.38435.6a; Litulo Carlos, 2004, Western Indian Ocean Journal of Marine Science, V3, P87; Mahongo S.B., 2014, J OCEANOGRAPHY MARIN, V5, P1, DOI DOI 10.5897/JOMS2013.0100; Fernandez-Palacios JM, 2016, GLOBAL ECOL BIOGEOGR, V25, P817, DOI 10.1111/geb.12320; Mokhtari M, 2008, ESTUAR COAST SHELF S, V76, P273, DOI 10.1016/j.ecss.2007.07.010; Mokhtari M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117467; Mwandya AW, 2009, ESTUAR COAST SHELF S, V82, P193, DOI 10.1016/j.ecss.2008.12.010; Nagelkerken I, 2008, AQUAT BOT, V89, P155, DOI 10.1016/j.aquabot.2007.12.007; Nehemia A, 2017, J MOLLUS STUD, V83, P1, DOI 10.1093/mollus/eyw040; NEI M, 1975, EVOLUTION, V29, P1, DOI 10.2307/2407137; Otwoma LM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165552; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pini J, 2011, CORAL REEFS, V30, P399, DOI 10.1007/s00338-011-0718-6; Ragionieri L, 2010, ESTUAR COAST SHELF S, V86, P179, DOI 10.1016/j.ecss.2009.11.002; Reznick DN, 1997, SCIENCE, V275, P1934, DOI 10.1126/science.275.5308.1934; Ridgway Tyrone, 2005, Western Indian Ocean Journal of Marine Science, V4, P1; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenberg MS, 2002, BIOL J LINN SOC, V75, P147, DOI 10.1046/j.1095-8312.2002.00012.x; Rumisha C, 2012, MAR POLLUT BULL, V64, P521, DOI 10.1016/j.marpolbul.2011.12.025; SEMESI AK, 1992, HYDROBIOLOGIA, V247, P1, DOI 10.1007/BF00008199; Silva IC, 2010, MAR BIOL, V157, P1113, DOI 10.1007/s00227-010-1393-9; Stockwell CA, 2003, TRENDS ECOL EVOL, V18, P94, DOI 10.1016/S0169-5347(02)00044-7; SWALLOW JC, 1991, J GEOPHYS RES-OCEANS, V96, P22245, DOI 10.1029/91JC01942; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varela ES, 2009, MOL ECOL RESOUR, V9, P1395, DOI 10.1111/j.1755-0998.2009.02674.x; Vasconcelos RP, 2014, ICES J MAR SCI, V71, P638, DOI 10.1093/icesjms/fst136; Walters BB, 2008, AQUAT BOT, V89, P220, DOI 10.1016/j.aquabot.2008.02.009; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Wang Y., 2003, MAR GEOD, V26, P35, DOI [10.1080/01490410390181243, DOI 10.1080/01490410306708, https://doi.org/10.1080/01490410306708]; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wieman AC, 2014, MAR BIOL, V161, P173, DOI 10.1007/s00227-013-2327-0; Wilson GA, 2003, GENETICS, V163, P1177; WOODROFFE CD, 1991, J BIOGEOGR, V18, P479, DOI 10.2307/2845685	88	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182987	10.1371/journal.pone.0182987	http://dx.doi.org/10.1371/journal.pone.0182987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837577	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000039
J	Sanches, PG; op 't Veld, RC; de Graaf, W; Strijkers, GJ; Grull, H				Sanches, Pedro Gomes; op 't Veld, Roel C.; de Graaf, Wolter; Strijkers, Gustav J.; Gruell, Holger			Novel axolotl cardiac function analysis method using magnetic resonance imaging	PLOS ONE			English	Article							SPINAL-CORD REGENERATION; HEART; SALAMANDER; SURVIVAL; BIOLOGY; DISEASE	The salamander axolotl is capable of complete regeneration of amputated heart tissue. However, non-invasive imaging tools for assessing its cardiac function were so far not employed. In this study, cardiac magnetic resonance imaging is introduced as a non-invasive technique to image heart function of axolotls. Three axolotls were imaged with magnetic resonance imaging using a retrospectively gated Fast Low Angle Shot cine sequence. Within one scanning session the axolotl heart was imaged three times in all planes, consecutively. Heart rate, ejection fraction, stroke volume and cardiac output were calculated using three techniques: (1) combined long-axis, (2) short-axis series, and (3) ultrasound (control for heart rate only). All values are presented as mean +/- standard deviation. Heart rate (beats per minute) among different animals was 32.2+/-6.0 (long axis), 30.4+/-5.5 (short axis) and 32.7+/-4.9 (ultrasound) and statistically similar regardless of the imaging method (p > 0.05). Ejection fraction (%) was 59.6+/-10.8 (long axis) and 48.1+/-11.3 (short axis) and it differed significantly (p = 0.019). Stroke volume (mu l/beat) was 133.7+/-33.7 (long axis) and 93.2+/-31.2 (short axis), also differed significantly (p = 0.015). Calculations were consistent among the animals and over three repeated measurements. The heart rate varied depending on depth of anaesthesia. We described a new method for defining and imaging the anatomical planes of the axolotl heart and propose one of our techniques (long axis analysis) may prove useful in defining cardiac function in regenerating axolotl hearts.	[Sanches, Pedro Gomes; op 't Veld, Roel C.; de Graaf, Wolter; Strijkers, Gustav J.; Gruell, Holger] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR Grp, Eindhoven, Netherlands; [op 't Veld, Roel C.] Radboud Univ Nijmegen, Med Ctr, Dept Biomat, Nijmegen, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, Dept Biomed Engn & Phys, Amsterdam, Netherlands; [Gruell, Holger] Univ Hosp Cologne, Dept Radiol, Cologne, Germany	Eindhoven University of Technology; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; University of Cologne	Grull, H (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR Grp, Eindhoven, Netherlands.; Grull, H (corresponding author), Univ Hosp Cologne, Dept Radiol, Cologne, Germany.	holger.gruell@uk-koeln.de	Veld, Roel C op 't/A-4941-2016	Strijkers, Gustav/0000-0001-6700-5058; Grull, Holger/0000-0002-0993-9300	UniversiteitsFonds Eindhoven; Eindhoven University of Technology	UniversiteitsFonds Eindhoven; Eindhoven University of Technology	This study was funded by the UniversiteitsFonds Eindhoven (Health-Anniversary Awards UFe 2011) and the Eindhoven University of Technology (both awarded to HG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakermans AJ, 2015, PROG NUCL MAG RES SP, V88-89, P1, DOI 10.1016/j.pnmrs.2015.03.001; Cano-Martínez Agustina, 2010, Arch. Cardiol. Méx., V80, P79; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Cohn JN, 2000, J AM COLL CARDIOL, V35, P569, DOI 10.1016/S0735-1097(99)00630-0; Davies F, 1941, PHILOS T ROY SOC B, V231, P99, DOI 10.1098/rstb.1941.0005; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; Feder M. E., 1992, ENV PHYSL AMPHIBIANS; Fritsche R, 1997, AM ZOOL, V37, P23; Heijman E, 2007, NMR BIOMED, V20, P439, DOI 10.1002/nbm.1110; HOYT RW, 1984, J EXP ZOOL, V230, P491, DOI 10.1002/jez.1402300318; KRAMER K, 1993, J PHARMACOL TOXICOL, V30, P209, DOI 10.1016/1056-8719(93)90019-B; Kropf N, 2010, J NEUROSURG, V112, P880, DOI 10.3171/2008.10.JNS08222; Lee V.S., 2006, CARDIOVASCULAR MRI P; LINDBLOM D, 1990, J AM COLL CARDIOL, V15, P566, DOI 10.1016/0735-1097(90)90627-2; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; Mchedlishvili L, 2007, DEVELOPMENT, V134, P2083, DOI 10.1242/dev.02852; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakamura R, 2016, DEV GROWTH DIFFER; Nye HLD, 2003, DEV DYNAM, V226, P280, DOI 10.1002/dvdy.10236; Otrock ZK, 2007, BLOOD CELL MOL DIS, V39, P212, DOI 10.1016/j.bcmd.2007.04.001; Phillips A M, 2005, Injury, V36 Suppl 3, pS5, DOI 10.1016/j.injury.2005.07.027; Schnapp E, 2005, DEVELOPMENT, V132, P3243, DOI 10.1242/dev.01906; Shahbaba B., 2012, BIOSTATISTICS R INTR; Steward MM, 2013, CURR TOP MICROBIOL, V367, P163, DOI 10.1007/82_2012_302; Uygur A, 2016, DEV CELL, V36, P362, DOI 10.1016/j.devcel.2016.01.018; van Nierop BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055424	27	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183446	10.1371/journal.pone.0183446	http://dx.doi.org/10.1371/journal.pone.0183446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837595	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000069
J	Pries, LK; Guloksuz, S; Menne-Lothmann, C; Decoster, J; van Winkel, R; Collip, D; Delespaul, P; De Hert, M; Derom, C; Thiery, E; Jacobs, N; Wichers, M; Simons, CJP; Rutten, BPF; van Os, J				Pries, Lotta-Katrin; Guloksuz, Sinan; Menne-Lothmann, Claudia; Decoster, Jeroen; van Winkel, Ruud; Collip, Dina; Delespaul, Philippe; De Hert, Marc; Derom, Catherine; Thiery, Evert; Jacobs, Nele; Wichers, Marieke; Simons, Claudia J. P.; Rutten, Bart P. F.; van Os, Jim			White noise speech illusion and psychosis expression: An experimental investigation of psychosis liability	PLOS ONE			English	Article							AUDITORY-VERBAL HALLUCINATIONS; GENERAL-POPULATION; SCHIZOPHRENIA; ENVIRONMENT; RELIABILITY; PERCEPTION; DISORDER; HEARING	Background An association between white noise speech illusion and psychotic symptoms has been reported in patients and their relatives. This supports the theory that bottom-up and top-down perceptual processes are involved in the mechanisms underlying perceptual abnormalities. However, findings in nonclinical populations have been conflicting. Objectives The aim of this study was to examine the association between white noise speech illusion and subclinical expression of psychotic symptoms in a nonclinical sample. Findings were compared to previous results to investigate potential methodology dependent differences. Methods In a general population adolescent and young adult twin sample (n = 704), the association between white noise speech illusion and subclinical psychotic experiences, using the Structured Interview for Schizotypy-Revised (SIS-R) and the Community Assessment of Psychic Experiences (CAPE), was analyzed using multilevel logistic regression analyses. Results Perception of any white noise speech illusion was not associated with either positive or negative schizotypy in the general population twin sample, using the method by Galdos et al. (2011) (positive: ORadjusted: 0.82, 95% CI: 0.6-1.12, p = 0.217; negative: ORadjusted: 0.75, 95% CI: 0.56-1.02, p = 0.065) and the method by Catalan et al. (2014) (positive: ORadjusted: 1.11, 95% CI: 0.79-1.57, p = 0.557). No association was found between CAPE scores and speech illusion (ORadjusted: 1.25, 95% CI: 0.88-1.79, p = 0.220). For the Catalan et al. (2014) but not the Galdos et al. (2011) method, a negative association was apparent between positive schizotypy and speech illusion with positive or negative affective valence (ORadjusted: 0.44, 95% CI: 0.24-0.81, p = 0.008). Conclusion Contrary to findings in clinical populations, white noise speech illusion may not be associated with psychosis proneness in nonclinical populations.	[Pries, Lotta-Katrin; Guloksuz, Sinan; Menne-Lothmann, Claudia; Decoster, Jeroen; van Winkel, Ruud; Collip, Dina; Delespaul, Philippe; Jacobs, Nele; Wichers, Marieke; Simons, Claudia J. P.; Rutten, Bart P. F.; van Os, Jim] Maastricht Univ, Dept Psychiat & Psychol, Med Ctr, Maastricht, Netherlands; [Guloksuz, Sinan] Yale Sch Med, Dept Psychiat, New Haven, CT USA; [Decoster, Jeroen; van Winkel, Ruud; De Hert, Marc] Katholieke Univ Leuven, Univ Psychiat Ctr, Leuven, Belgium; [Derom, Catherine] Katholieke Univ Leuven, Univ Hosp Leuven, Ctr Human Genet, Leuven, Belgium; [Derom, Catherine] Univ Ghent, Ghent Univ Hosp, Dept Obstet & Gynecol, Ghent, Belgium; [Thiery, Evert] Univ Ghent, Ghent Univ Hosp, Dept Neurol, Ghent, Belgium; [Jacobs, Nele] Open Univ Netherlands, Fac Psychol & Educ Sci, Heerlen, Netherlands; [Wichers, Marieke] Univ Groningen, Univ Med Ctr Groningen, Dept Psychiat, Interdisciplinary Ctr Psychopathol & Emot Regulat, Groningen, Netherlands; [Simons, Claudia J. P.] Inst Mental Hlth Care Eindhoven & De Kempen, GGzE, Eindhoven, Netherlands; [van Os, Jim] Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England	Maastricht University; Yale University; KU Leuven; KU Leuven; University Hospital Leuven; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; Open University Netherlands; University of Groningen; University of London; King's College London	van Os, J (corresponding author), Maastricht Univ, Dept Psychiat & Psychol, Med Ctr, Maastricht, Netherlands.; van Os, J (corresponding author), Kings Coll London, Kings Hlth Partners, Dept Psychosis Studies, Inst Psychiat, London, England.	j.vanos@maastrichtuniversity.nl	Vasconcelos, Ana Carolina Souza de/GXW-3453-2022; Delespaul, Philippe/L-1396-2019; Delespaul, Philippe/E-8982-2011; Wichers, Marieke/N-6667-2014; van Os, Jim/C-2113-2014; van Os, Jim/V-8884-2019; De Hert, Marc/AAH-6090-2021; Guloksuz, Sinan/AAH-1076-2019	Delespaul, Philippe/0000-0001-7420-0898; Delespaul, Philippe/0000-0001-7420-0898; Wichers, Marieke/0000-0001-5024-9064; van Os, Jim/0000-0002-7245-1586; Guloksuz, Sinan/0000-0002-6626-1874; Rutten, Bart/0000-0002-9834-6346; De Hert, Marc/0000-0003-4255-5920	Association for Scientific Research in Multiple Births; European Community's Seventh Framework Program [HEALTH-F2-2009-241909]	Association for Scientific Research in Multiple Births; European Community's Seventh Framework Program	Participants were recruited from the East Flanders Prospective Twin Survey (EFPTS) which is partly supported by the Association for Scientific Research in Multiple Births. Furthermore, the TwinssCan project is part of the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI).; The authors thank Jill Ielegems, Katrien Lyssens, Davinia Verhoeven, and Debora op't Eijnde for data-collection and all twins who volunteered for participation. Furthermore, the authors would like to acknowledge that the East Flanders Prospective Twin Survey (EFPTS) is partly supported by the Association for Scientific Research in Multiple Births and that the TwinssCan project is part of the European Community's Seventh Framework Program under grant agreement No. HEALTH-F2-2009-241909 (Project EU-GEI).	Abbott G, 2013, PSYCHIAT RES, V207, P40, DOI 10.1016/j.psychres.2013.03.005; Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Catalan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102520; Choong C, 2007, Curr Psychiatry Rep, V9, P206, DOI 10.1007/s11920-007-0020-z; Daalman K, 2011, J CLIN PSYCHIAT, V72, P320, DOI 10.4088/JCP.09m05797yel; de Leede-Smith S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00367; Derom C, 2013, TWIN RES HUM GENET, V16, P58, DOI 10.1017/thg.2012.75; Galdos M, 2011, SCHIZOPHRENIA BULL, V37, P1179, DOI 10.1093/schbul/sbq029; Guloksuz S, 2015, PSYCHOL MED, V45, P2389, DOI 10.1017/S0033291715000380; Honig A, 1998, J NERV MENT DIS, V186, P646, DOI 10.1097/00005053-199810000-00009; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x; Kohler CG, 2000, BIOL PSYCHIAT, V48, P127, DOI 10.1016/S0006-3223(00)00847-7; Konings M, 2006, ACTA PSYCHIAT SCAND, V114, P55, DOI 10.1111/j.1600-0447.2005.00741.x; Linscott RJ, 2013, PSYCHOL MED, V43, P1133, DOI 10.1017/S0033291712001626; MARGO A, 1981, BRIT J PSYCHIAT, V139, P122, DOI 10.1192/bjp.139.2.122; Menne-Lothmann C, 2016, ARCH NEUROPSYCHIATRY; Randell J, 2011, J BEHAV THER EXP PSY, V42, P149, DOI 10.1016/j.jbtep.2010.11.002; Rimvall MK, 2016, PSYCHOL MED, V46, P2731, DOI 10.1017/S0033291716001112; Rossell SL, 2005, SCHIZOPHR RES, V78, P95, DOI 10.1016/j.schres.2005.06.002; StataCorp. Release, 2013, REL 13 STAT SOFTW, V13; Stefanis NC, 2002, PSYCHOL MED, V32, P347, DOI 10.1017/S0033291701005141; van Os J, 2009, PSYCHOL MED, V39, P179, DOI 10.1017/S0033291708003814; van Os J, 2017, PSYCHOL MED, V47, P1, DOI 10.1017/S0033291717000915; van Os J, 2008, SCHIZOPHRENIA BULL, V34, P1066, DOI 10.1093/schbul/sbn117; van Os J, 2014, SCHIZOPHRENIA BULL, V40, P729, DOI 10.1093/schbul/sbu069; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vercammen A, 2008, PSYCHOL MED, V38, P1177, DOI 10.1017/S0033291707002437; Vollema MG, 2000, SCHIZOPHRENIA BULL, V26, P619, DOI 10.1093/oxfordjournals.schbul.a033482	28	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183695	10.1371/journal.pone.0183695	http://dx.doi.org/10.1371/journal.pone.0183695			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832672	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800085
J	Varani, S; Ortalli, M; Attard, L; Vanino, E; Gaibani, P; Vocale, C; Rossini, G; Cagarelli, R; Pierro, A; Billi, P; Mastroianni, A; Di Cesare, S; Codeluppi, M; Franceschini, E; Melchionda, F; Gramiccia, M; Scalone, A; Gentilomi, GA; Landini, MP				Varani, Stefania; Ortalli, Margherita; Attard, Luciano; Vanino, Elisa; Gaibani, Paolo; Vocale, Caterina; Rossini, Giada; Cagarelli, Roberto; Pierro, Anna; Billi, Patrizia; Mastroianni, Antonio; Di Cesare, Simona; Codeluppi, Mauro; Franceschini, Erica; Melchionda, Fraia; Gramiccia, Marina; Scalone, Aldo; Gentilomi, Giovanna A.; Landini, Maria P.			Serological and molecular tools to diagnose visceral leishmaniasis: 2-years' experience of a single center in Northern Italy	PLOS ONE			English	Article							RAPID DIAGNOSIS; BONE-MARROW; PCR; SAMPLES; TESTS; BLOOD	The diagnosis of visceral leishmaniasis (VL) remains challenging, due to the limited sensitivity of microscopy, the poor performance of serological methods in immunocompromised patients and the lack of standardization of molecular tests. The aim of this study was to implement a combined diagnostic workflow by integrating serological and molecular tests with standardized clinical criteria. Between July 2013 and June 2015, the proposed workflow was applied to specimens obtained from 94 in-patients with clinical suspicion of VL in the Emilia-Romagna region, Northern Italy. Serological tests and molecular techniques were employed. Twenty-one adult patients (22%) had a confirmed diagnosis of VL by clinical criteria, serology and/or real-time polymerase chain reaction; 4 of these patients were HIV-positive. Molecular tests exhibited higher sensitivity than serological tests for the diagnosis of VL. In our experience, the rK39 immunochromatographic test was insufficiently sensitive for use as a screening test for the diagnosis of VL caused by L. infantum in Italy. However, as molecular tests are yet not standardized, further studies are required to identify an optimal screening test for Mediterranean VL.	[Varani, Stefania; Gaibani, Paolo; Vocale, Caterina; Rossini, Giada] St Orsola Malpighi Univ Hosp, Unit Clin Microbiol, Reg Reference Ctr Microbiol Emergencies CRREM, Bologna, Italy; [Varani, Stefania; Ortalli, Margherita; Landini, Maria P.] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [Attard, Luciano; Vanino, Elisa] Univ Bologna, Dept Med & Surg Sci, Infect Dis Unit, Bologna, Italy; [Cagarelli, Roberto] Publ Hlth Author Emilia Romagna, Bologna, Italy; [Pierro, Anna; Billi, Patrizia] Romagna Hub Lab, Unit Microbiol, Pievesestina, Fc, Italy; [Mastroianni, Antonio; Di Cesare, Simona] GB Morgagni L Pierantoni Hosp, Infect Dis Unit, Forli, Italy; [Codeluppi, Mauro; Franceschini, Erica] Univ Policlin Modena, Infect Dis Unit, Azienda Osped, Modena, Italy; [Melchionda, Fraia] St Orsola Malpighi Univ Hosp, Pediat Hematol & Oncol Unit, Bologna, Italy; [Gramiccia, Marina; Scalone, Aldo] Ist Super Sanita, Infect Dis Dept, Unit Vector Borne Dis & Int Hlth, Rome, Italy; [Gentilomi, Giovanna A.] Univ Bologna, Dept Pharm & Biotechnol, Bologna, Italy; [Landini, Maria P.] Ist Ortoped Rizzoli, Dept Res Innovat & Technol, Ist Ricovero & Cura Carattere Sci, Bologna, Italy	IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; Universita di Modena e Reggio Emilia; Universita di Modena e Reggio Emilia Hospital; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Istituto Superiore di Sanita (ISS); University of Bologna; IRCCS Istituto Ortopedico Rizzoli	Varani, S (corresponding author), St Orsola Malpighi Univ Hosp, Unit Clin Microbiol, Reg Reference Ctr Microbiol Emergencies CRREM, Bologna, Italy.; Varani, S (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	stefania.varani@unibo.it	Varani, Stefania/AAZ-1856-2021; Vocale, Caterina/AAK-9921-2020; Vanino, Elisa/AAC-6431-2022; franceschini, erica/AAC-4025-2022; Pierro, Anna/AAC-7407-2022; Rossini, Giada/K-8815-2016; gaibani, paolo/K-7690-2016	Vocale, Caterina/0000-0001-7470-1713; Pierro, Anna/0000-0001-9873-0367; Rossini, Giada/0000-0002-8917-6680; Vanino, Elisa/0000-0003-3510-1429; gaibani, paolo/0000-0003-3791-8635; Ortalli, Margherita/0000-0001-5447-8817; VARANI, STEFANIA/0000-0003-0862-4937; Franceschini, Erica/0000-0001-6922-5759	Emilia-Romagna Region; University of Bologna	Emilia-Romagna Region(Regione Emilia Romagna); University of Bologna	This work was supported by Lab P3 funds from the Emilia-Romagna Region (to MPL) and by RFO funds (to SV and MPL) from the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; [Anonymous], 2014, BIOMED RES INT, V2014; Antinori S, 2007, CLIN INFECT DIS, V44, P1602, DOI 10.1086/518167; Arce A, 2013, EUROSURVEILLANCE, V18, P5, DOI 10.2807/1560-7917.ES2013.18.30.20546; Bezuneh A, 2014, AM J TROP MED HYG, V91, P1109, DOI [10.4269/ajtmh.14-0759, 10.4269/ajtmh.13-0759]; Bhattacharyya T, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002057; Boelaert M, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009135.pub2; Brandonisio O, 2002, EUR J CLIN MICROBIOL, V21, P461, DOI 10.1007/s10096-002-0739-8; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Cota GF, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001665; Cruz I, 2006, J CLIN MICROBIOL, V44, P2343, DOI 10.1128/JCM.02297-05; Cunningham J, 2012, CLIN INFECT DIS, V55, P1312, DOI 10.1093/cid/cis716; de Godoy Natalia Souza, 2016, J Parasitol Res, V2016, P1084353, DOI 10.1155/2016/1084353; de Paiva-Cavalcanti M, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0021-2; de Ruiter CM, 2014, J CLIN MICROBIOL, V52, P3147, DOI 10.1128/JCM.00372-14; Vilas VJD, 2014, VET REC, V175, P42, DOI 10.1136/vr.g4378; Elfadil A, 2015, PLOS ONE, V10; Gradoni L, 2013, EUROSURVEILLANCE, V18, P2, DOI 10.2807/1560-7917.ES2013.18.30.20539; Gramiccia M, 2013, EUROSURVEILLANCE, V18, P29, DOI 10.2807/1560-7917.ES2013.18.29.20535; Gramiccia M, 2007, ECOL CONT VECTOR-BOR, V1, P75; Lachaud L, 2000, J CLIN MICROBIOL, V38, P236; Lachaud L, 2013, Euro Surveill, V18, P20534, DOI 10.2807/1560-7917.ES2013.18.29.20534; Maia Z, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001484; Maroli M, 2008, TROP MED INT HEALTH, V13, P256, DOI [10.1111/j.1365-3156.2007.01998, 10.1111/j.1365-3156.2007.01998.x]; Mary C, 2004, J CLIN MICROBIOL, V42, P5249, DOI 10.1128/JCM.42.11.5249-5255.2004; Ozerdem D, 2009, PARASITOL RES, V106, P197, DOI 10.1007/s00436-009-1650-3; Pereira MR, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/639310; Santos TR, 2014, ACTA TROP, V140, P137, DOI 10.1016/j.actatropica.2014.08.016; Silva LD, 2006, AM J TROP MED HYG, V75, P739, DOI 10.4269/ajtmh.2006.75.739; Snider H, 2009, NEUROIMMUNOMODULAT, V16, P106, DOI 10.1159/000180265; Solca MD, 2012, VET PARASITOL, V184, P133, DOI 10.1016/j.vetpar.2011.08.026; Travi BL, 2001, AM J TROP MED HYG, V64, P119, DOI 10.4269/ajtmh.2001.64.119; Varani S, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.29.20530; WHO, 2010, REPORT OF A MEETING; Wortmann G, 2001, AM J TROP MED HYG, V65, P583, DOI 10.4269/ajtmh.2001.65.583	35	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183699	10.1371/journal.pone.0183699	http://dx.doi.org/10.1371/journal.pone.0183699			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832646	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800086
J	Zhang, CC; Shao, J; Huang, XN				Zhang, Caicai; Shao, Jing; Huang, Xunan			Deficits of congenital amusia beyond pitch: Evidence from impaired categorical perception of vowels in Cantonese-speaking congenital amusics	PLOS ONE			English	Article							LANGUAGE EXPERIENCE; TONE-DEAFNESS; LEXICAL TONES; MUSIC; BRAIN; IDENTIFICATION; INTONATION; DISCRIMINATION; INDIVIDUALS; MEMORY	Congenital amusia is a lifelong disorder of fine-grained pitch processing in music and speech. However, it remains unclear whether amusia is a pitch-specific deficit, or whether it affects frequency/spectral processing more broadly, such as the perception of formant frequency in vowels, apart from pitch. In this study, in order to illuminate the scope of the deficits, we compared the performance of 15 Cantonese-speaking amusics and 15 matched controls on the categorical perception of sound continua in four stimulus contexts: lexical tone, pure tone, vowel, and voice onset time (VOT). Whereas lexical tone, pure tone and vowel continua rely on frequency/spectral processing, the VOT continuum depends on duration/temporal processing. We found that the amusic participants performed similarly to controls in all stimulus contexts in the identification, in terms of the across-category boundary location and boundary width. However, the amusic participants performed systematically worse than controls in discriminating stimuli in those three contexts that depended on frequency/spectral processing (lexical tone, pure tone and vowel), whereas they performed normally when discriminating duration differences (VOT). These findings suggest that the deficit of amusia is probably not pitch specific, but affects frequency/spectral processing more broadly. Furthermore, there appeared to be differences in the impairment of frequency/spectral discrimination in speech and nonspeech contexts. The amusic participants exhibited less benefit in between-category discriminations than controls in speech contexts (lexical tone and vowel), suggesting reduced categorical perception; on the other hand, they performed inferiorly compared to controls across the board regardless of between-and within-category discriminations in nonspeech contexts (pure tone), suggesting impaired general auditory processing. These differences imply that the frequency/spectral-processing deficit might be manifested differentially in speech and nonspeech contexts in amusics D it is manifested as a deficit of higher-level phonological processing in speech sounds, and as a deficit of lower-level auditory processing in nonspeech sounds.	[Zhang, Caicai; Shao, Jing; Huang, Xunan] Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Hong Kong, Peoples R China; [Zhang, Caicai] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China	Hong Kong Polytechnic University; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhang, CC (corresponding author), Hong Kong Polytech Univ, Dept Chinese & Bilingual Studies, Hong Kong, Hong Kong, Peoples R China.; Zhang, CC (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen, Peoples R China.	caicai.zhang@polyu.edu.hk	; Zhang, Caicai/Q-6914-2018	HUANG, Xunan/0000-0002-1474-4225; SHAO, Jing/0000-0002-2500-2366; Zhang, Caicai/0000-0002-7687-0518	Research Grants Council of Hong Kong(ECS) [25603916]; National Natural Science Foundation of China (NSFC) [11504400]; Hong Kong Polytechnic University [1-ZE4Y]; HK PolyU-PKU Research Centre on Chinese Linguistics [RP2U2]	Research Grants Council of Hong Kong(ECS); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Hong Kong Polytechnic University(Hong Kong Polytechnic University); HK PolyU-PKU Research Centre on Chinese Linguistics	This work was supported by grants from the Research Grants Council of Hong Kong (ECS: 25603916), the National Natural Science Foundation of China (NSFC: 11504400), and the PolyU Start-up Fund for New Recruits at the Hong Kong Polytechnic University (Project account no.: 1-ZE4Y). We thank the HK PolyU-PKU Research Centre on Chinese Linguistics (RP2U2) for supporting the publication of this paper.; This work was supported by grants from the Research Grants Council of Hong Kong (ECS: 25603916), the National Natural Science Foundation of China (NSFC: 11504400), and the PolyU Start-up Fund for New Recruits at the Hong Kong Polytechnic University (Project account no.: 1-ZE4Y). We thank the HK PolyU-PKU Research Centre on Chinese Linguistics (RP2U2) for supporting the publication of this paper. We thank Dr. Si Chen for consultation on statistics, and Mr. Yike Yang for helping with data collection. We thank the anonymous reviewers for constructive comments.	Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; [Anonymous], 2011, FRONT PSYCHOL; Ayotte J, 2002, BRAIN, V125, P238, DOI 10.1093/brain/awf028; Boersma P., 2014, PRAAT DOING PHONETIC; Chao Y. R., 1930, MAITRE PHONETIQUE, V45, P24; Chen JL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00009; Finney D.J., 1971, PROBIT ANAL; Foxton JM, 2004, BRAIN, V127, P801, DOI 10.1093/brain/awh105; Goulet GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036860; Gu F, 2013, NEUROIMAGE, V83, P637, DOI 10.1016/j.neuroimage.2013.02.080; Halle PA, 2004, J PHONETICS, V32, P395, DOI 10.1016/S0095-4470(03)00016-0; Harnad Stevan, 1987, CATEGORICAL PERCEPTI; Huang WT, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00829; Huang X, 2016, P 5 INT S TON ASP LA; Hyde KL, 2003, ANN NY ACAD SCI, V999, P173, DOI 10.1196/annals.1284.023; Hyde KL, 2004, PSYCHOL SCI, V15, P356, DOI 10.1111/j.0956-7976.2004.00683.x; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Hyde KL, 2006, BRAIN, V129, P2562, DOI 10.1093/brain/awl204; Jiang CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041411; Jiang CM, 2012, MEM COGNITION, V40, P1109, DOI 10.3758/s13421-012-0208-2; Jiang CM, 2010, NEUROPSYCHOLOGIA, V48, P2630, DOI 10.1016/j.neuropsychologia.2010.05.009; Johnson Keith, 2015, COURSE PHONETICS; Lehmann A, 2015, EUR J NEUROSCI, V42, P1644, DOI 10.1111/ejn.12931; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Liu F, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01029; Liu F, 2015, NEUROPSYCHOLOGIA, V66, P111, DOI 10.1016/j.neuropsychologia.2014.11.001; Liu F, 2013, ATTEN PERCEPT PSYCHO, V75, P1783, DOI 10.3758/s13414-013-0506-1; Liu F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030374; Liu F, 2010, BRAIN, V133, P1682, DOI 10.1093/brain/awq089; Loui P, 2009, J NEUROSCI, V29, P10215, DOI 10.1523/JNEUROSCI.1701-09.2009; Macmillan NA, 2005, DETECTION THEORY USE; Massaro DW, 1987, SPEECH PERCEPTION EY, P741; Maxwell S. E., 2004, DESIGNING EXPT ANAL; Nguyen S, 2009, ANN NY ACAD SCI, V1169, P490, DOI 10.1111/j.1749-6632.2009.04855.x; Norman-Haignere SV, 2016, J NEUROSCI, V36, P2986, DOI 10.1523/JNEUROSCI.2705-15.2016; Patel AD, 2005, BRAIN COGNITION, V59, P310, DOI 10.1016/j.bandc.2004.10.003; Peng G, 2006, J CHINESE LINGUIST, V34, P134; Peng G, 2010, J PHONETICS, V38, P616, DOI 10.1016/j.wocn.2010.09.003; Peretz I, 2005, ANN NEUROL, V58, P478, DOI 10.1002/ana.20606; Peretz I, 2003, TRENDS COGN SCI, V7, P362, DOI 10.1016/S1364-6613(03)00150-5; Peretz I, 2008, MUSIC PERCEPT, V25, P331, DOI 10.1525/MP.2008.25.4.331; Peretz I, 2007, AM J HUM GENET, V81, P582, DOI 10.1086/521337; Peretz I, 2017, EUR J HUM GENET, V25, P625, DOI 10.1038/ejhg.2017.15; Peretz I, 2009, BRAIN, V132, P1277, DOI 10.1093/brain/awp055; PETERSON GE, 1952, J ACOUST SOC AM, V24, P175, DOI 10.1121/1.1906875; Pfeifer J, 2015, FRONT HUM NEUROSCI, V9, DOI [10.3389/tnhum.2015.00161, 10.3389/fnhum.2015.00161]; Protopapas A, 1997, J ACOUST SOC AM, V101, P2267, DOI 10.1121/1.418247; Repp B., 1984, SPEECH LANGUAGE ADV, V10, P243, DOI [10.1016/B978-0-12-608610-2.50012-1, DOI 10.1016/B978-0-12-608610-2.50012-1]; Schaal NK, 2015, BEHAV BRAIN RES, V294, P141, DOI 10.1016/j.bbr.2015.08.003; Shao J, 2016, P INT SAN FRANC US; Sihvonen AJ, 2016, J NEUROSCI, V36, P8872, DOI 10.1523/JNEUROSCI.0709-16.2016; Smith DRR, 2005, J ACOUST SOC AM, V118, P3177, DOI 10.1121/1.2047107; Thompson WF, 2012, P NATL ACAD SCI USA, V109, P19027, DOI 10.1073/pnas.1210344109; Tseng CY, 2008, 2008 6TH INTERNATIONAL SYMPOSIUM ON CHINESE SPOKEN LANGUAGE PROCESSING, PROCEEDINGS, P45; Vuvan DT, 2015, CORTEX, V69, P186, DOI 10.1016/j.cortex.2015.05.002; Wang B, 2011, J PHONETICS, V39, P595, DOI 10.1016/j.wocn.2011.03.006; Wong PCM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033424; Xi J, 2010, NEUROSCIENCE, V170, P223, DOI 10.1016/j.neuroscience.2010.06.077; Xu YS, 2006, J ACOUST SOC AM, V120, P1063, DOI 10.1121/1.2213572; Zhang CC, 2017, NEUROPSYCHOLOGIA, V97, P18, DOI 10.1016/j.neuropsychologia.2017.01.033	60	26	26	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183151	10.1371/journal.pone.0183151	http://dx.doi.org/10.1371/journal.pone.0183151			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829808	gold, Green Submitted, Green Published			2022-12-27	WOS:000408085100029
J	Eyssel, J; Koehler, A; Dekker, A; Sehner, S; Nieder, TO				Eyssel, Jana; Koehler, Andreas; Dekker, Arne; Sehner, Susanne; Nieder, Timo O.			Needs and concerns of transgender individuals regarding interdisciplinary transgender healthcare: A non-clinical online survey	PLOS ONE			English	Article							PATIENT SATISFACTION; GENDER IDENTITY; CONSUMER INVOLVEMENT; PREVALENCE; DYSPHORIA; SEX; TRANSSEXUALISM; DIVERSITY; COMMUNITY; ONTARIO	This study investigates the needs and concerns transgender (short: trans) individuals have concerning trans healthcare (THC) in interdisciplinary THC centres. Trans individuals' gender does not (fully/constantly) match their sex assigned at birth. To be able to live in their gender role and to prevent or minimise gender dysphoria, they might require a multidisciplinary set of transition related healthcare services. The current shift from the traditionally highly regulated, hierarchical and pathologising approach to THC towards a more patient-centred approach has highlighted the importance of trans patients' satisfaction with treatment processes and results. As the still influential regulations have a negative effect on patient satisfaction, and might also keep trans individuals from seeking transition related treatment, it is crucial to investigate what trans individuals, whether patients or not, need and fear regarding transition related healthcare. Against the backdrop of mixed reactions received from the local trans community regarding the foundation of the Interdisciplinary Transgender Health-care Centre Hamburg (ITHCCH), Germany, this study seeks to determine what trans individuals need with respect to THC in order to guarantee for high quality service provision at the ITHCCH. To this end, an online questionnaire was developed. The researchers employed a participatory approach to questionnaire development by involving a working group consisting of local trans support group representatives and (THC) specialists (N = 4). The sample consisted of N = 415 trans-identified individuals aged between 16 and 76. Most of them were based in Germany. 85.2% (n = 382) reported experience with transition related healthcare and 72.5% (n = 301) had (additional) treatments planned. Analysis revealed a need for communication and feedback opportunities. Furthermore, during the treatment process, addressing individual needs was considered crucial by participants. They agreed moderately with concerns towards THC centres. 96.5% of participants would like high decision-making power concerning treatment-associated decisions. The results demonstrate the importance of patient-centred THC that takes patients' individual needs and realities into consideration and involves patients in decision-making processes.	[Eyssel, Jana; Koehler, Andreas; Dekker, Arne; Nieder, Timo O.] Univ Med Ctr Hamburg Eppendorf, Interdisciplinary Transgender Healthcare Ctr Hamb, Dept Sex Res & Forens Psychiat, Hamburg, Germany; [Sehner, Susanne] Univ Med Ctr Hamburg Eppendorf, Ctr Expt Med, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Nieder, TO (corresponding author), Univ Med Ctr Hamburg Eppendorf, Interdisciplinary Transgender Healthcare Ctr Hamb, Dept Sex Res & Forens Psychiat, Hamburg, Germany.	t.nieder@uke.de	Koehler, Andreas/AAD-2240-2021	Koehler, Andreas/0000-0003-0415-3007; Nieder, Timo/0000-0003-3052-5169	Research Fund of the Faculty of Medicine, University of Hamburg (Forschungsforderungsfonds der Medizinischen Fakultat, Universitat Hamburg);  [NWF-15-08]	Research Fund of the Faculty of Medicine, University of Hamburg (Forschungsforderungsfonds der Medizinischen Fakultat, Universitat Hamburg); 	The research was funded by the Research Fund of the Faculty of Medicine, University of Hamburg (Forschungsforderungsfonds der Medizinischen Fakultat, Universitat Hamburg). The funding was awarded to TN under the grant number NWF-15-08. The grant description can be accessed here: https://www.uke.de/dateien/einrichtungen/medizinische-fakult%C3%A4t/ffm/infoblatt-nachwuchsf-2013-12.pdf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali K, 2006, STROKE, V37, P865, DOI 10.1161/01.STR.0000204053.36966.80; American Psychiatric Association, 2013, SEX CHANG HIST TRANS; [Anonymous], 1992, INT CLASS DIS 10 ICD; Arcelus J, 2015, EUR PSYCHIAT, V30, P807, DOI 10.1016/j.eurpsy.2015.04.005; Barber R, 2011, INT J CONSUM STUD, V35, P609, DOI 10.1111/j.1470-6431.2011.01017.x; Bauer GR, 2014, ANN EMERG MED, V63, P713, DOI 10.1016/j.annemergmed.2013.09.027; Bauer GR, 2009, J ASSOC NURSE AIDS C, V20, P348, DOI 10.1016/j.jana.2009.07.004; Becker S., 1998, INT J TRANSGENDERISM, V2/4; Beresford P., 2002, SOC POLICY SOC, V1, P95, DOI DOI 10.1017/S1474746402000222; Bockting W, 2004, J SEX MARITAL THER, V30, P277, DOI 10.1080/00926230490422467; Bockting WO, 1999, INT J TRANSGENDERISM, P3; Braquet D., 2006, P AM SOC INFORM SCI, V43, P1, DOI [10.1002/meet.14504301282, DOI 10.1002/MEET.14504301282]; Browne K, 2008, TRANS PEOPLE ADDITIO; Coleman T, 2011, CHALLENGING BINARY G; Collin L, 2016, J SEX MED, V13, P613, DOI 10.1016/j.jsxm.2016.02.001; Cruz TM, 2014, SOC SCI MED, V110, P65, DOI 10.1016/j.socscimed.2014.03.032; Davies A, 2013, SEX RELATSH THER, V28, P400, DOI 10.1080/14681994.2013.834321; De Cuypere G, 2007, EUR PSYCHIAT, V22, P137, DOI 10.1016/j.eurpsy.2006.10.002; Deutsch MB, 2012, INT J TRANSGENDERISM, V13, P140, DOI 10.1080/15532739.2011.675233; Dewey JM, 2015, HEALTH EXPECT, V18, P1508, DOI 10.1111/hex.12133; Drescher J, 2012, INT REV PSYCHIATR, V24, P568, DOI 10.3109/09540261.2012.741575; European Union Agency for Fundamental Rights, 2013, EUR UN LESB GAY BIS; European Union Agency for Fundamental Rights, 2014, BEING T EUR UN; Evans C., 1999, EVALUATION SOCIAL WO, P101; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Factor R, 2008, HEALTH SOCIOL REV, V17, P235, DOI 10.5172/hesr.451.17.3.235; Gehrlach C., 2009, PATIENTS EXPERIENCE; Giebel GD, 2008, LANGENBECK ARCH SURG, V393, P513, DOI 10.1007/s00423-008-0310-x; Goddard JC, 2007, BJU INT, V100, P607, DOI 10.1111/j.1464-410X.2007.07017.x; Goetz Katja, 2012, Am J Manag Care, V18, pe55; Grant J.M., 2011, INJUSTICE EVERY TURN; Guldenring A., 2009, PSYCHOTHERAPIE DIALO, V10, P25; Hamm JA, 2014, Z SEXUALFORSCH, V27, P4, DOI 10.1055/s-0034-1366140; Harrison J., 2012, LGBTQ PUBLIC POLICY, V2, P13; IBMCorp, 2012, IBM SPSS STAT WIND V; Ingram BL, 1997, HEALTH CARE MANAGE R, V22, P40, DOI 10.1097/00004010-199707000-00005; Johnson K., 2007, OUT PSYCHOL LESBIAN, P445, DOI DOI 10.1002/9780470713099.CH21; Khoosal D, 2011, SEX RELATSH THER, V26, P72, DOI 10.1080/14681994.2010.534448; Klein J, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-109; Kohler R., 2015, TGEU KEY NOTE SPEECH; Koops L, 2002, BRIT MED J, V325, P415, DOI 10.1136/bmj.325.7361.415; Kuyper L, 2014, ARCH SEX BEHAV, V43, P377, DOI 10.1007/s10508-013-0140-y; Lai MC, 2010, ARCH SEX BEHAV, V39, P1415, DOI 10.1007/s10508-009-9570-y; Lawrence AA, 2003, ARCH SEX BEHAV, V32, P299, DOI 10.1023/A:1024086814364; LINDERPELZ S, 1982, SOC SCI MED, V16, P583, DOI 10.1016/0277-9536(82)90312-4; Liste Weisse, 2016, VERSICHERTENBEFRAGUN; Lombardi E, 2009, J HOMOSEXUAL, V56, P977, DOI 10.1080/00918360903275393; McCormick S, 2004, INT J HEALTH SERV, V34, P625, DOI 10.2190/HPXB-9RK8-ETVM-RVEA; Medizinischer Dienst des Spitzenverbandes Bund der Krankenkassen, 2009, GRUND BEG BEG GESCHL; Meyer zu, 2009, INZIDENZ GESCHLECHTE; Meyerowitz J. J, 2002, SEX CHANGED HIST TRA; Motmans J., 2017, 19 C EUR SOC SEX MED; Motmans Joz, 2010, BEING TRANSGENDER BE; Nationales Aktionsbundnis fur Menschen mit Seltenen Erkrankungen, 2013, NAT PLAN ACT PEOPL R; Nickel S, 2004, PFLEGEMAGAZIN, V5, P9; Nickel S, 2010, HEALTH POLICY, V98, P156, DOI 10.1016/j.healthpol.2010.06.012; Nieder TO, 2014, Z SEXUALFORSCH, V27, P59, DOI 10.1055/s-0034-1366127; Nieder TO, 2011, PSYCHOL SEX, V2, P224, DOI 10.1080/19419899.2010.545955; Nieder TO, 2011, J SEX MED, V8, P783, DOI 10.1111/j.1743-6109.2010.02142.x; Nieder TO, 2015, INT REV, P1; Nieder TO, J SEXUAL MED UNPUB; Parasuraman A, 1988, J RETAILING, V64; Poelchau H-W, 2015, Z SOZIOL ERZIEH SOZI, V3, P320; Radix A, 2015, REF TRANSG HLTH CAR; Radix A, 2014, Z SEXUALFORSCH, V27, P31, DOI 10.1055/s-0034-1366129; Richards C, 2016, INT REV PSYCHIATR, V28, P95, DOI 10.3109/09540261.2015.1106446; Roberts TK, 2014, CLIN BIOCHEM, V47, P983, DOI 10.1016/j.clinbiochem.2014.02.009; Roche R, 2004, EUR J PLAST SURG, V27, P24; Rondahl G., 2009, INT J NURSING ED SCH; Rosemann T, 2007, J EVAL CLIN PRACT, V13, P806, DOI 10.1111/j.1365-2753.2007.00786.x; Scheim AI, 2015, J SEX RES, V52, P1, DOI 10.1080/00224499.2014.893553; Scholl I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107828; Serano JM, 2010, INT J TRANSGENDERISM, V12, P176, DOI 10.1080/15532739.2010.514223; Smith YLS, 2005, PSYCHIAT RES, V137, P151, DOI 10.1016/j.psychres.2005.01.008; StataCorp, 2015, STAT STAT SOFTW REL; TGEU, ILGA EUR CART; Turner D, 2014, J SEX MED, V11, P1914, DOI 10.1111/jsm.12595; Von Unger H., 2014, PARTIZIPATIVE FORSCH; Wilson P, 1999, BRIT J GEN PRACT, V49, P991; Wright MT., 2010, PARTIZIPATIVE QUALIT; Wylie KR, 2009, SEX RELATSH THER, V24, P163, DOI 10.1080/14681990903002730; zerdem O A, 2010, PARTICIPATORY RES ME, P1; Zucker KJ, 2009, INT J TRANSGENDERISM, V11, P8, DOI 10.1080/15532730902799946	83	58	59	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183014	10.1371/journal.pone.0183014	http://dx.doi.org/10.1371/journal.pone.0183014			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846715	Green Submitted, gold, Green Published			2022-12-27	WOS:000408438600021
J	McDaniel, PA; Lown, EA; Malone, RE				McDaniel, Patricia A.; Lown, E. Anne; Malone, Ruth E.			It doesn't seem to make sense for a company that sells cigarettes to help smokers stop using them" : A case study of Philip Morris's involvement in smoking cessation	PLOS ONE			English	Article							TOBACCO INDUSTRY DOCUMENTS; FLORIDA TRUTH CAMPAIGN; PREVENTION PROGRAMS; MEDIA CAMPAIGN; PUBLIC-HEALTH; YOUTH; STRATEGY; ADOLESCENT; INITIATION; CONDUCT	Background In the late 1990s, American tobacco companies began offering limited cessation assistance to smokers by posting links on their company websites to government-sponsored smoking cessation resources. Philip Morris USA (PM) went further, funding youth cessation programs and creating its own online cessation program, QuitAssist. We explore why PM entered the cessation arena, and describe the variety of options considered and how PM-supported cessation programs were evaluated and promoted. Methods We retrieved and analyzed archival PM documents from 1998-2005. We supplemented information from the documents with scholarly articles assessing QuitAssist and archived versions of the PM and QuitAssist websites. Results PM's Youth Smoking Prevention department began funding youth cessation projects and programs soon after its creation in 1998, motivated by the same issue that drove its interest in youth smoking prevention: regulatory threats posed by public and policymaker concern about youth smoking. The department took a similar approach to youth smoking cessation as it did with prevention, rejecting curricula with "anti-industry" themes. In 2002, a "cessation exploration team" examined a variety of rationales for and approaches to company support for adult smoking cessation. Ultimately, PM chose QuitAssist, a limited and less expensive option that nonetheless provided opportunities for engagement with a variety of public health and government officials. Independent research indicates that QuitAssist is not an effective cessation tool. Conclusions While the transformation of ambitious plans into a mundane final product is a recurring theme with PM's corporate responsibility efforts, it would be inappropriate to dismiss PM's smoking cessation endeavors as half-hearted attempts to appear responsible. Such endeavors have the potential to inflict real harm by competing with more effective programs and by helping to maintain a tobacco-favorable policy environment. If PM truly wanted to support cessation, it could drop legal and other challenges to public policies that discourage smoking.	[McDaniel, Patricia A.; Lown, E. Anne; Malone, Ruth E.] Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	McDaniel, PA (corresponding author), Univ Calif San Francisco, Sch Nursing, Dept Social & Behav Sci, San Francisco, CA 94143 USA.	patricia.mcdaniel@ucsf.edu			National Cancer Institute [R01 CA120138]; University of California San Francisco Open Access Publishing Fund; NATIONAL CANCER INSTITUTE [R01CA120138] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of California San Francisco Open Access Publishing Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Cancer Institute, R01 CA120138, REM. University of California San Francisco Open Access Publishing Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpert HR, 2016, TOB CONTROL, V25, P444, DOI 10.1136/tobaccocontrol-2014-051943; Altria, 2015, 2015 REC CHART CONTR; American Cancer Society, 2000, RES GUID YOUTH TOB C; Anderson SJ, 2011, TOB CONTROL, V20, pII8, DOI 10.1136/tc.2010.041921; [Anonymous], 2001, COMMUNICATION; [Anonymous], 2016, TRUTH TOB IND DOC; Apollonio DE, 2010, AM J PUBLIC HEALTH, V100, P1188, DOI 10.2105/AJPH.2009.169573; Arnett JJ, 2000, ADDICT BEHAV, V25, P625, DOI 10.1016/S0306-4603(99)00072-6; Bain and Co, 2003, DEEP DIV; Bain and Company, 2003, PM US CESS EXPL LONG; Bain and Company, 2003, PM US CESS EXPL FOLL; Bain & Co, 2003, PMUSA CESS EXPL CESS; Benner P, 1994, INTERPRETIVE PHENOME; Bero L, 2003, ANNU REV PUBL HEALTH, V24, P267, DOI 10.1146/annurev.publhealth.24.100901.140813; Brandt AM., 2007, CIGARETTE CENTURY RI; Burson-Marsteller, 2000, CESS PROGR; Burson-Marsteller Sada F., 2000, BURSON MARSTELLER SM; Caron, 2017, PROJ CONN; Caron F, 2001, CARON FDN EXCELLENCE; Caron F, 2000, RE GREETINGS; Caron Foundation, 2001, RE PROP; Caron Foundation, 2002, COMMUNICATION; Caron Treatment Centers, 2016, STUD ASS PROGR; Cataldo JK, 2008, J AM GERIATR SOC, V56, P1716, DOI 10.1111/j.1532-5415.2008.01850.x; Center For The Study Of Youth Policy, 2001, YOUTH EMP PROGR YEAR; Center For The Study Of Youth Policy, 1999, LIST PROM PROGR PROG; Chandran G., 2001, RE CESSATION; Community Intervention, 2016, TAP TEG TRAIN HELP T; Culley L., 2003, 3 YEAR OUTLOOK ASCS; Culley L., 2003, PM US CESSATION EXPL; Culley L., 2003, ADULT CESSATION EXEC; Daragan K., 1999, COMMUNICATION; Davies B., 2003, POTENTIAL EXPT PROTO; Desel P., 2000, YOUTH SMOKING CESSAT; Dorfman L, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001241; Duke Center for Child and Family Policy, 2016, QUITASSIST EXT EV PL; Etter JF, 2006, NICOTINE TOB RES, V8, pS27, DOI 10.1080/14622200601039923; Fackler KL, 2001, COMMUNICATION; Farrelly MC, 2002, AM J PUBLIC HEALTH, V92, P901, DOI 10.2105/AJPH.92.6.901; Fernandez H., 2000, YOUTH SMOKING PREVEN; Fernandez H., 2000, FACSIMILE COVER SHEE; Fernandez HL, 2001, PA CONTACT; Fernandez HL, 2001, FW PROJECT EXTENSION; Fernandez HL, 2000, COMMUNICATION; Fernandez HL, 2001, COMMUNICATION; Fernandez HL, 2001, RE PA CONTACT; Fernandez HL, 2000, SMOKENDERS; Fernandez HL, 2001, RE KIDS PEACE; Fooks GJ, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001076; Forster N., 1995, QUALITATIVE METHODS, P147; Fuller S., 2003, PM US CESSATION EXPL; Gilmore AB, 2015, LANCET, V385, P1029, DOI 10.1016/S0140-6736(15)60312-9; Glantz S., 2016, BIG TOBACCO AIMS ITS; Hadel Hopkins L., 2001, COMMUNICATION; Halpern-Felsher BL, 2004, PREV MED, V39, P559, DOI 10.1016/j.ypmed.2004.02.017; Harris JL, 2014, TOB CONTROL, V23, P285, DOI 10.1136/tobaccocontrol-2012-050670; Henningfield JE, 2006, TOB CONTROL, V15, P341, DOI 10.1136/tc.2005.013714; Hicks JJ, 2001, TOB CONTROL, V10, P3, DOI 10.1136/tc.10.1.3; HILL MR, 1993, ARCHIVAL STRATEGIES; Hirschhorn N, 2001, TOB CONTROL, V10, P247, DOI 10.1136/tc.10.3.247; Holsenback GP, 2006, FTC SPECIAL REPORT 2; Hopkins Hadel LL, 2001, FW KIDS PEACE; Hymowitz N., 2001, COMMUNICATION; Karpinski Julie P, 2010, J Pediatr Pharmacol Ther, V15, P249; Krzanowski M., 2000, COMMUNICATION; Landman A, 2002, AM J PUBLIC HEALTH, V92, P917, DOI 10.2105/AJPH.92.6.917; Largo E., 2005, GOOD AFTERNOON; Largo EG, 2004, PM US YOUTH SMOKING; Laugesen M, 2006, TOB CONTROL, V15, P430, DOI 10.1136/tc.2006.016055; Levy C., 2001, YOUTH CESSATION PROG; Levy CJ, 2000, COMMUNICATION; Levy CJ, 2000, RE GREETINGS; Levy CJ, 2001, YOUTH CESSATION; Levy CJ, 2000, RE U PENN; Levy CJ, 2001, RE ELECT VERSION 2 L; Levy CJ, 2000, R NOT TOBACCO; Levy CJ, 2001, COMMUNICATION; Levy CJ, 2000, YOUTH CESSATION PROG; Levy CJ, 1998, COMMUNICATION; Lewis MJ, 2016, TOB CONTROL, V25, P430, DOI 10.1136/tobaccocontrol-2015-052314; Liberman J, 2002, TOB CONTROL, V11, P271, DOI 10.1136/tc.11.3.271; Lieberman PD, 2004, COMMUNICATION; Ling PM, 2004, J GEN INTERN MED, V19, P419, DOI 10.1111/j.1525-1497.2004.30358.x; Lombardo Consulting Group, 2003, PM US AD CESS SUPP I; Lombardo Consulting Group LLC, 2003, CESS CONC TEST PREL; Lorillard, 2015, ADDICTION; MacKenzie R, 2003, TOBACCO IND DOCUMENT; Malone RE, 2000, TOB CONTROL, V9, P334, DOI 10.1136/tc.9.3.334; Malone RE, 2012, TOB CONTROL, V21, P162, DOI 10.1136/tobaccocontrol-2011-050200; Mandel LL, 2006, J ADOLESCENT HEALTH, V39, P868, DOI 10.1016/j.jadohealth.2006.06.010; McDaniel PA, 2012, AM J PUBLIC HEALTH, V102, P1942, DOI 10.2105/AJPH.2011.300619; McDaniel PA, 2012, GLOB PUBLIC HEALTH, V7, P14, DOI 10.1080/17441692.2010.549832; McDaniel PA, 2009, WOMEN HEALTH, V49, P441, DOI 10.1080/03630240903238800; Miller J., 2016, MASSACHUSETTS MAY RA; Moffat BM, 2001, QUAL HEALTH RES, V11, P668, DOI 10.1177/104973201129119361; O'Connell D., 2016, PHILIP MORRIS COULD; Ostern E., 2001, KIDS PEACE; PACKER MJ, 1985, AM PSYCHOL, V40, P1081, DOI 10.1037/0003-066X.40.10.1081; Packer MJ, 1989, ENTERING CIRCLE HERM; Pantani D, 2012, SOC SCI MED, V75, P1387, DOI 10.1016/j.socscimed.2012.02.062; Peeters S, 2016, TOB CONTROL, V25, P108, DOI 10.1136/tobaccocontrol-2014-051919; Petticrew M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160379; Philip Morris, 2004, DUK U MESS FIN 6 16; Philip Morris, 2003, AD CESS EXPL LEARN R; Philip Morris, 1999, US POL LANDSC 1999; Philip Morris, 1998, YOUTH SMOK PREV ISS; Philip Morris, 2005, DRAFT RED HARM ISS T; Philip Morris, 2000, PM US MISS EXPL PROJ; Philip Morris, 2003, AD CESS SUPP IN SCI; Philip Morris, 2002, CESS EXPL; Philip Morris, 2004, PM US CESS SUPP COR; Philip Morris, 1998, CAR LEV APP TALK POI; Philip Morris, 2004, 102504 MG PHIL MORR; Philip Morris, 2007, 2007 YSP CR PROGR; Philip Morris, 2001, YOUTH SMOK PREV CESS; Philip Morris, 2000, 1998 2000 QUANT PERF; Philip Morris, 2000, YOUTH SMOK PREV PROP; Philip Morris, 2004, PM US CESS SUPP IN W; Philip Morris, 2003, CESS SUPP PROGR; Philip Morris, 2003, SUPP AD SMOK WHO HAV; Philip Morris, 2000, SMOK CESS DRAFT MEP; Philip Morris, 2003, POP ASC IN FRAM SCI; Philip Morris, 2000, MISS EXPL PROJ BLUE; Philip Morris, 2003, YOUTH SMOK PREV GRAN; Philip Morris, 2001, DISC PHAS MIDP SRT M; Philip Morris, 2002, PHIL MORR US CESS EX; Philip Morris. Philip Morris USA, 2003, PHIL MORR US SUPP AD; Philip Morris USA, 2005, QUITASSISTTOP 10 REA; Philip Morris USA, 2000, QUITT SMOK; Philip Morris USA, 2005, QUIT ASS; PhilipMorris, 2005, PMUSA QUIT KEY MESS; Pierce JP, 2005, TOB CONTROL, V14, P207, DOI 10.1136/tc.2004.010116; Reynolds RJ, 2005, ADD QUITT; Rosenker D., 2000, RE GREETINGS; Rosenthal K., 2006, CORPORATE RESPONSIBI; Schneider SK, 2016, TOB CONTROL, V25, P355, DOI 10.1136/tobaccocontrol-2014-052207; Schwartz IM, 1998, CHILDREN YOUTH FAMIL; Sebrie EM, 2007, AM J PUBLIC HEALTH, V97, P1357, DOI 10.2105/AJPH.2006.094128; Sly DF, 2001, AM J PUBLIC HEALTH, V91, P233, DOI 10.2105/AJPH.91.2.233; Smith EA, 2008, PUBLIC HEALTH NURS, V25, P554, DOI 10.1111/j.1525-1446.2008.00743.x; Smith KE, 2013, TOB CONTROL, V22, P144, DOI 10.1136/tobaccocontrol-2011-050098; Smith SW, 2006, HEALTH COMMUN, V20, P1, DOI 10.1207/s15327027hc2001_1; Smokenders, 2000, PROP DEV IMPL SCH BA; Szymanczyk M., 2000, COMMUNICATION   1025; Szymanczyk M., 2000, PM USAS 2000 1998 20; Szymanczyk ME, 2005, PM USAS PERFORMANCE; Taylor C, 1985, HUMAN AGENCY LANGUAG, V1, P248; TAYLOR C, 1985, PHILOS PAPERS, V2, P33; Utah Dept of Health, 1997, END END NIC DEP FAC; Vallone DM, 2010, AM J PREV MED, V38, pS312, DOI 10.1016/j.amepre.2009.11.021; van Hasselt M, 2015, ADDICT BEHAV, V45, P104, DOI 10.1016/j.addbeh.2015.01.023; van Manen M., 1990, RES LIVED EXPERIENCE; Wayne GF, 2002, TOB CONTROL, V11, pI32, DOI 10.1136/tc.11.suppl_1.i32; Willard HA, 2004, COMMUNICATION; Yang JS, 2008, TOB CONTROL, V17, P391, DOI 10.1136/tc.2008.026476; Yin R. K., 1994, CASE STUDY RES DESIG	156	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183961	10.1371/journal.pone.0183961	http://dx.doi.org/10.1371/journal.pone.0183961			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846738	gold, Green Published, Green Submitted			2022-12-27	WOS:000408438600062
J	Rao, S; Nandineni, MR				Rao, Soumya; Nandineni, Madhusudan R.			Genome sequencing and comparative genomics reveal a repertoire of putative pathogenicity genes in chilli anthracnose fungus Colletotrichum truncatum	PLOS ONE			English	Article							PROVIDES INSIGHTS; CAUSAL AGENT; PHI-BASE; ANNOTATION; PROTEIN; PEPPER; ALIGNMENT; DATABASE; IDENTIFICATION; TOPOLOGY	Colletotrichum truncatum, a major fungal phytopathogen, causes the anthracnose disease on an economically important spice crop chilli (Capsicum annuum), resulting in huge economic losses in tropical and sub-tropical countries. It follows a subcuticular intramural infection strategy on chilli with a short, asymptomatic, endophytic phase, which contrasts with the intracellular hemibiotrophic lifestyle adopted by most of the Colletotrichum species. However, little is known about the molecular determinants and the mechanism of pathogenicity in this fungus. A high quality whole genome sequence and gene annotation based on transcriptome data of an Indian isolate of C. truncatum from chilli has been obtained. Analysis of the genome sequence revealed a rich repertoire of pathogenicity genes in C. truncatum encoding secreted proteins, effectors, plant cell wall degrading enzymes, secondary metabolism associated proteins, with potential roles in the host-specific infection strategy, placing it next only to the Fusarium species. The size of genome assembly, number of predicted genes and some of the functional categories were similar to other sequenced Colletotrichum species. The comparative genomic analyses with other species and related fungi identified some unique genes and certain highly expanded gene families of CAZymes, proteases and secondary metabolism associated genes in the genome of C. truncatum. The draft genome assembly and functional annotation of potential pathogenicity genes of C. truncatum provide an important genomic resource for understanding the biology and lifestyle of this important phytopathogen and will pave the way for designing efficient disease control regimens.	[Rao, Soumya; Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India; [Rao, Soumya] Manipal Univ, Grad Studies, Manipal, Karnataka, India; [Nandineni, Madhusudan R.] Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE); Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab Genom & Profiling Applicat, Hyderabad, Telangana, India.; Nandineni, MR (corresponding author), Ctr DNA Fingerprinting & Diagnost CDFD, Lab DNA Fingerprinting Serv, Hyderabad, Telangana, India.	nandineni@cdfd.org.in		Nandineni, Madhusudan Reddy/0000-0002-8933-4503; Rao, Soumya/0000-0002-3836-4745	core grants of CDFD; University Grants Commission (UGC), India	core grants of CDFD; University Grants Commission (UGC), India(University Grants Commission, India)	This study was supported by the core grants of CDFD. No additional funding was received for this study. SR was the recipient of Junior and Senior Research Fellowships of the University Grants Commission (UGC), India towards the pursuit of a Ph.D. degree of the Manipal University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Amselem J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002230; Jaramillo VDA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059078; Auyong A.S.M., 2015, J PLANT PATHOL MICRO, V6, P259, DOI [10.4172/2157-7471.1000259, DOI 10.4172/2157-7471.1000259]; Auyong ASM, 2012, J BASIC MICROB, V52, P372, DOI 10.1002/jobm.201100250; Bailey J. A., 1992, Colletotrichum: biology, pathology and control., P88; Baroncelli R., 2014, GENOME ANNOUNC, V2, DOI DOI 10.1128/GENOMEA.00112-14; Baroncelli R, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2917-6; Baroncelli R, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00540-14; Bhadauria V, 2013, EUKARYOT CELL, V12, P2, DOI 10.1128/EC.00192-12; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Brown NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033731; Buiate EAS, 2017, BMC GENOMICS BMC GEN, P1; Campbell Michael S, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0411s48; Cannon PF, 2012, STUD MYCOL, P181, DOI 10.3114/sim0014; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Cresnar B, 2011, BBA-PROTEINS PROTEOM, V1814, P29, DOI 10.1016/j.bbapap.2010.06.020; Crouch J., 2014, GENOMICS PLANT ASS F, P69, DOI DOI 10.1007/978-3-662-44053-7_3; Damm U, 2009, FUNGAL DIVERS, V39, P45; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dean RA, 2005, NATURE, V434, P980, DOI 10.1038/nature03449; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Dong SM, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005704; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eilbeck K, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-67; Feng JX, 2012, BIOINFORMATICS, V28, P2782, DOI 10.1093/bioinformatics/bts515; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Gan P, 2016, GENOME BIOL EVOL, V8, P1467, DOI 10.1093/gbe/evw089; Gan P, 2013, NEW PHYTOL, V197, P1236, DOI 10.1111/nph.12085; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guyon K, 2014, BMC GENOMICS, P15; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Hacquard S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11362; Han JH, 2016, GENOM DATA, V8, P45, DOI 10.1016/j.gdata.2016.03.007; Heard S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130534; Holt C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-491; Horton P, 2007, NUCLEIC ACIDS RES, V35, pW585, DOI 10.1093/nar/gkm259; Jayawardena RS, 2016, MYCOSPHERE, V7, P1192, DOI 10.5943/mycosphere/si/2c/9; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khaldi N, 2010, FUNGAL GENET BIOL, V47, P736, DOI 10.1016/j.fgb.2010.06.003; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim Seungill, 2014, Nat Genet, V46, P270, DOI 10.1038/ng.2877; Kleemann Jochen, 2012, PLoS Pathog, V8, pe1002643, DOI 10.1371/journal.ppat.1002643; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Kombrink A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003769; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kubicek CP, 2014, ANNU REV PHYTOPATHOL, V52, P427, DOI 10.1146/annurev-phyto-102313-045831; Kuck P, 2010, MOL PHYLOGENET EVOL, V56, P1115, DOI 10.1016/j.ympev.2010.04.024; Latunde-Dada AO, 2001, MOL PLANT PATHOL, V2, P187, DOI 10.1046/j.1464-6722.2001.00069.x; Lechner M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-124; Lewis S.E., 2003, GENOME BIOL, V3, P1, DOI [10.1186/gb-2002-3-12-research0082, DOI 10.1186/GB-2002-3-12-RESEARCH0082]; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lo Presti L, 2015, ANNU REV PLANT BIOL, V66, P513, DOI 10.1146/annurev-arplant-043014-114623; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lyu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep15565; Ma LJ, 2010, NATURE, V464, P367, DOI 10.1038/nature08850; MANANDHAR JB, 1995, PLANT DIS, V79, P380, DOI 10.1094/PD-79-0380; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; Medema MH, 2011, NUCLEIC ACIDS RES, V39, pW339, DOI 10.1093/nar/gkr466; Meinken J., 2014, COMPUT MOL BIOL, V4, P1, DOI [10.5376/cmb.2014.04.0007, DOI 10.5376/CMB.2014.04.0007]; Montri P, 2009, PLANT DIS, V93, P17, DOI 10.1094/PDIS-93-1-0017; Nelson David R., 2009, Human Genomics, V4, P59; Nguyen BA, 2009, BMC BIOINFORMATICS, V10, P202, DOI [10.1186/1471-2105-10-202, DOI 10.1186/1471-2105-10-202]; O'Connell RJ, 2012, NAT GENET, V44, P1060, DOI 10.1038/ng.2372; Palmer JM, 2010, CURR OPIN MICROBIOL, V13, P431, DOI 10.1016/j.mib.2010.04.008; Parra G, 2000, GENOME RES, V10, P511, DOI 10.1101/gr.10.4.511; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Perfect SE, 1999, FUNGAL GENET BIOL, V27, P186, DOI 10.1006/fgbi.1999.1143; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Qin C, 2014, P NATL ACAD SCI USA, V111, P5135, DOI 10.1073/pnas.1400975111; Ranathunge NP, 2012, AUSTRALAS PLANT PATH, V41, P463, DOI 10.1007/s13313-012-0156-0; Ranathunge Nalika Priyanwada, 2016, Journal of Plant Protection Research, V56, P157, DOI 10.1515/jppr-2016-0026; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Saier MH, 2006, NUCLEIC ACIDS RES, V34, pD181, DOI 10.1093/nar/gkj001; Saier MH, 2016, NUCLEIC ACIDS RES, V44, pD372, DOI 10.1093/nar/gkv1103; Sanz-Martin JM, 2016, MOL PLANT PATHOL, V17, P1048, DOI 10.1111/mpp.12347; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Selin C, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00600; Shenoy BD, 2007, FUNGAL DIVERS, V27, P197; Shiller J, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00980; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Soderlund C, 2006, GENOME RES, V16, P1159, DOI 10.1101/gr.5396706; Sperschneider J, 2016, NEW PHYTOL, V210, P743, DOI 10.1111/nph.13794; Squissato V, 2015, MED MYCOL CASE REP, V9, P1, DOI 10.1016/j.mmcr.2015.06.001; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stanke M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s11; Takahara H, 2016, NEW PHYTOL, V211, P1323, DOI 10.1111/nph.13994; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Than PP, 2008, PLANT PATHOL, V57, P562, DOI 10.1111/j.1365-3059.2007.01782.x; Than PP, 2008, J ZHEJIANG UNIV-SC B, V9, P764, DOI 10.1631/jzus.B0860007; Todd RB, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-214; Urban M, 2015, NUCLEIC ACIDS RES, V43, pD645, DOI 10.1093/nar/gku1165; Weir BS, 2012, STUD MYCOL, P115, DOI 10.3114/sim0011; Winnenburg R, 2006, NUCLEIC ACIDS RES, V34, pD459, DOI 10.1093/nar/gkj047; Xue MF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002869; Yin YB, 2012, NUCLEIC ACIDS RES, V40, pW445, DOI 10.1093/nar/gks479; Zampounis A, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00821-16; Zhao ZT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-274; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	106	28	28	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183567	10.1371/journal.pone.0183567	http://dx.doi.org/10.1371/journal.pone.0183567			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846714	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600035
J	Wild, HM; Heckemann, RA; Studholme, C; Hammers, A				Wild, Heather M.; Heckemann, Rolf A.; Studholme, Colin; Hammers, Alexander			Gyri of the human parietal lobe: Volumes, spatial extents, automatic labelling, and probabilistic atlases	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; POSITRON EMISSION TOMOGRAPHY; COMPUTERIZED BRAIN ATLAS; LEFT ANGULAR GYRUS; 1ST-EPISODE SCHIZOPHRENIA; CORTICAL GYRIFICATION; INTRACRANIAL VOLUME; STEREOTAXIC SPACE; MRI SEGMENTATION; MYELIN CONTENT	Accurately describing the anatomy of individual brains enables interlaboratory communication of functional and developmental studies and is crucial for possible surgical interventions. The human parietal lobe participates in multimodal sensory integration including language processing and also contains the primary somatosensory area. We describe detailed protocols to subdivide the parietal lobe, analyze morphological and volumetric characteristics, and create probabilistic atlases in MNI152 stereotaxic space. The parietal lobe was manually delineated on 3D T1 MR images of 30 healthy subjects and divided into four regions: supramarginal gyrus (SMG), angular gyrus (AG), superior parietal lobe (supPL) and postcentral gyrus (postCG). There was the expected correlation of male gender with larger brain and intracranial volume. We examined a wide range of anatomical features of the gyri and the sulci separating them. At least a rudimentary primary intermediate sulcus of Jensen (PISJ) separating SMG and AG was identified in nearly all (59/60) hemispheres. Presence of additional gyri in SMG and AG was related to sulcal features and volumetric characteristics. The parietal lobe was slightly (2%) larger on the left, driven by leftward asymmetries of the postCG and SMG. Intersubject variability was highest for SMG and AG, and lowest for postCG. Overall the morphological characteristics tended to be symmetrical, and volumes also tended to covary between hemispheres. This may reflect developmental as well as maturation factors. To assess the accuracy with which the labels can be used to segment newly acquired (unlabelled) T1-weighted brain images, we applied multi-atlas label propagation software (MAPER) in a leave-one-out experiment and compared the resulting automatic labels with the manually prepared ones. The results showed strong agreement (mean Jaccard index 0.69, corresponding to a mean Dice index of 0.82, average mean volume error of 0.6%). Stereotaxic probabilistic atlases of each subregion were obtained. They illustrate the physiological brain torque, with structures in the right hemisphere positioned more anteriorly than in the left, and right/left positional differences of up to 10 mm. They also allow an assessment of sulcal variability, e.g. low variability for parietooccipital fissure and cingulate sulcus. Illustrated protocols, individual label sets, probabilistic atlases, and a maximum-probability atlas which takes into account surrounding structures are available for free download under academic licences.	[Wild, Heather M.; Heckemann, Rolf A.; Hammers, Alexander] Neurodis Fdn, Lyon, France; [Wild, Heather M.] Univ Claude Bernard Lyon 1, Univ Lyon, INSERM, Stem Cell & Brain Res Inst,U1208, Bron, France; [Heckemann, Rolf A.] Univ Gothenburg, Sahlgrenska Univ Hosp, MedTech West, Gothenburg, Sweden; [Studholme, Colin] Univ Washington, Dept Pediat, Div Neonatol, Seattle, WA 98195 USA; [Hammers, Alexander] Kings Coll London, Div Imaging Sci & Biomed Engn, London, England	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Sahlgrenska University Hospital; University of Gothenburg; University of Washington; University of Washington Seattle; University of London; King's College London	Hammers, A (corresponding author), Neurodis Fdn, Lyon, France.; Hammers, A (corresponding author), Kings Coll London, Div Imaging Sci & Biomed Engn, London, England.	alexander.hammers@kcl.ac.uk	Heckemann, Rolf Andreas/H-9022-2019; Hammers, Alexander/D-9982-2015	Heckemann, Rolf Andreas/0000-0003-3582-3683; Hammers, Alexander/0000-0001-9530-4848	AH-Deutsche Forschungsgemeinschaft [DFG HA 3013/1-1]; AH Medical Research Council [G9901497, G108/585]; AH The Neurodis Foundation; AH King's College London; RAH Dunhill Medical Trust [R62/1107]; RAH The Neurodis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD083091] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB017133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055064] Funding Source: NIH RePORTER; MRC [G108/585] Funding Source: UKRI; Medical Research Council [G108/585] Funding Source: researchfish	AH-Deutsche Forschungsgemeinschaft; AH Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AH The Neurodis Foundation; AH King's College London; RAH Dunhill Medical Trust; RAH The Neurodis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors received no specific funding for this work. However, undertaking such research was part of the general brief of other funding during which data for this study was either acquired or analyzed: AH-Deutsche Forschungsgemeinschaft (DFG HA 3013/1-1), AH Medical Research Council (G9901497 to M.J. Koepp, AH Medical Research Council (G108/585 to AH), AH The Neurodis Foundation (salary funding Chair of Excellence in Functional Neuroimaging), AH King's College London (salary funding Professor (Honorary Consultant) of Imaging and Neuroscience), RAH Dunhill Medical Trust (R62/1107), RAH The Neurodis Foundation (salary funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan RL, 2007, NEUROIMAGE, V38, P261, DOI 10.1016/j.neuroimage.2007.06.004; Aljabar P, 2009, NEUROIMAGE, V46, P726, DOI 10.1016/j.neuroimage.2009.02.018; Amiez C, 2014, CEREB CORTEX, V24, P563, DOI 10.1093/cercor/bhs329; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 1997, NEUROIMAGE, V6, P344, DOI 10.1006/nimg.1997.0299; BAJCSY R, 1983, J COMPUT ASSIST TOMO, V7, P618, DOI 10.1097/00004728-198308000-00008; BERGIN PS, 1994, NEUROLOGY, V44, P1770, DOI 10.1212/WNL.44.9.1770-b; BOHM C, 1983, AM J NEURORADIOL, V4, P731; Bonnici HM, 2007, NEUROIMAGE, V35, P648, DOI 10.1016/j.neuroimage.2006.11.031; Brodmann K, 1909, VERGLEICHENDE LOKALI; Brownsett SLE, 2010, CEREB CORTEX, V20, P517, DOI 10.1093/cercor/bhp120; Cappelletti M, 2010, J COGNITIVE NEUROSCI, V22, P331, DOI 10.1162/jocn.2009.21246; Carreiras M, 2010, NEUROIMAGE, V49, P1741, DOI 10.1016/j.neuroimage.2009.09.058; Carter RM, 2012, SCIENCE, V337, P109, DOI 10.1126/science.1219681; Caspers S, 2012, PLOS ONE, P7; Caspers S, 2008, BRAIN STRUCT FUNCT, V212, P481, DOI 10.1007/s00429-008-0195-z; Caspers S, 2006, NEUROIMAGE, V33, P430, DOI 10.1016/j.neuroimage.2006.06.054; Caspers S, 2011, NEUROIMAGE, V58, P362, DOI 10.1016/j.neuroimage.2011.06.027; Cattaneo Z, 2009, NEUROIMAGE, V44, P563, DOI 10.1016/j.neuroimage.2008.09.003; Crespo-Facorro B, 2000, PSYCHIAT RES-NEUROIM, V100, P97, DOI 10.1016/S0925-4927(00)00072-X; Crespo-Facorro B, 2000, PSYCHIAT RES, P100; DANN R, 1989, J COMPUT ASSIST TOMO, V13, P603, DOI 10.1097/00004728-198907000-00009; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Duvernoy H.M., 1999, HUMAN BRAIN SURFACE; EVANS AC, 1988, J CEREBR BLOOD F MET, V8, P513, DOI 10.1038/jcbfm.1988.92; Evans AC, 1991, J CEREB BLOOD FLOW M, P11; Ferro A, 2015, PSYCHIAT RES-NEUROIM, V231, P42, DOI 10.1016/j.pscychresns.2014.10.023; Gautam P, 2015, BEHAV BRAIN RES, V287, P331, DOI 10.1016/j.bbr.2015.03.018; GEE JC, 1993, J COMPUT ASSIST TOMO, V17, P225, DOI 10.1097/00004728-199303000-00011; Glasser MF, 2014, NEUROIMAGE, V93, P165, DOI 10.1016/j.neuroimage.2013.03.060; Glasser MF, 2011, J NEUROSCI, V31, P11597, DOI 10.1523/JNEUROSCI.2180-11.2011; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Greitz T, 1991, J COMPUT ASSIST TOMO, P15; Hammers A, 2002, HUM BRAIN MAPP, V15, P165, DOI 10.1002/hbm.10016; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hammers A, 2007, NEUROIMAGE, V36, P38, DOI 10.1016/j.neuroimage.2007.02.031; Hammers A, 2007, HUM BRAIN MAPP, V28, P34, DOI 10.1002/hbm.20254; Heckemann RA, 2006, NEUROIMAGE, V33, P115, DOI 10.1016/j.neuroimage.2006.05.061; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Herve PY, 2012, NEUROIMAGE, V61, P1255, DOI 10.1016/j.neuroimage.2012.03.073; Hill J, 2010, P NATL ACAD SCI USA, V107, P13135, DOI 10.1073/pnas.1001229107; Horn H, 2009, BRIT J PSYCHIAT, V194, P130, DOI 10.1192/bjp.bp.107.045633; Horwitz B, 1998, P NATL ACAD SCI USA, V95, P8939, DOI 10.1073/pnas.95.15.8939; Huffman Kelly, 2012, Frontiers in Genetics, V3, P212, DOI 10.3389/fgene.2012.00212; Hyatt CJ, 2012, BIOL PSYCHIAT, V72, P207, DOI 10.1016/j.biopsych.2011.11.017; Joseph R., 2000, NEUROPSYCHIATRY NEUR; Jung RE, 2010, HUM BRAIN MAPP, V31, P398, DOI 10.1002/hbm.20874; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kennedy H, 2012, PROG BRAIN RES, V195, P341, DOI 10.1016/B978-0-444-53860-4.00016-7; Lemieux L, 2003, MAGN RESON MED, V49, P872, DOI 10.1002/mrm.10436; Li G, 2014, J NEUROSCI, V34, P4228, DOI 10.1523/JNEUROSCI.3976-13.2014; Liu T, 2012, PLOS ONE, P7; Makropoulos A, 2014, IEEE T MED IMAGING, V33, P1818, DOI 10.1109/TMI.2014.2322280; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Markov NT, 2013, SCIENCE, V342, P578, DOI 10.1126/science.1238406; Molnar Z, 2006, EUR J NEUROSCI, V23, P921, DOI 10.1111/j.1460-9568.2006.04611.x; Nierenberg J, 2005, AM J PSYCHIAT, V162, P1539, DOI 10.1176/appi.ajp.162.8.1539; Ochiai T, 2004, NEUROIMAGE, V22, P706, DOI 10.1016/j.neuroimage.2004.01.023; Ono M, 1990, ATLAS CEREBRAL SULCI; Palaniyappan L, 2012, EUR ARCH PSY CLIN N, V262, P579, DOI 10.1007/s00406-012-0314-y; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Price CJ, 2010, ANN NY ACAD SCI, V1191, P62, DOI 10.1111/j.1749-6632.2010.05444.x; Rizzo G, 1997, NEUROIMAGE, V6, P59, DOI 10.1006/nimg.1997.0277; Roux FE, 2003, J NEUROSURG, V99, P716, DOI 10.3171/jns.2003.99.4.0716; Ruschel M, 2014, CEREB CORTEX, V24, P2436, DOI 10.1093/cercor/bht098; Salamon N, 2005, SURG RADIOL ANAT, V27, P431, DOI 10.1007/s00276-005-0022-7; Schaer M, 2012, JOVE-J VIS EXP, DOI 10.3791/3417; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; SEITZ RJ, 1990, J CEREBR BLOOD F MET, V10, P443, DOI 10.1038/jcbfm.1990.87; Shattuck DW, 2008, NEUROIMAGE, V39, P1064, DOI 10.1016/j.neuroimage.2007.09.031; Shaw P, 2012, BIOL PSYCHIAT, V72, P191, DOI 10.1016/j.biopsych.2012.01.031; Soran B, 2012, IEEE ENG MED BIO, P3219, DOI 10.1109/EMBC.2012.6346650; Stoeckel C, 2009, CORTEX, V45, P1091, DOI 10.1016/j.cortex.2008.12.004; Studholme C., RVIEW; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Sugiura L, 2011, CEREB CORTEX, V21, P2374, DOI 10.1093/cercor/bhr023; Torrey EF, 2007, SCHIZOPHR RES, V97, P215, DOI 10.1016/j.schres.2007.08.023; Tzourio-Mazoyer N, 2015, BRAIN STRUCT FUNCT, V220, P1585, DOI 10.1007/s00429-014-0746-4; Ulmer S., 2010, FMRI; VanEssen DC, 1997, J NEUROSCI, V17, P7079; VONBONIN G, 1951, T AM NEUROL ASSOC, P1; White T, 2003, BIOL PSYCHIAT, V54, P418, DOI 10.1016/S0006-3223(03)00065-9; Wu SS, 2009, CEREB CORTEX, V19, P2930, DOI 10.1093/cercor/bhp063; Xu XM, 2012, NEUROSCI LETT, V526, P33, DOI 10.1016/j.neulet.2012.08.004; Zhang YY, 2001, IEEE T MED IMAGING, V20, P45, DOI 10.1109/42.906424; Zhou SY, 2007, SCHIZOPHR RES, V89, P35, DOI 10.1016/j.schres.2006.08.032	87	13	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180866	10.1371/journal.pone.0180866	http://dx.doi.org/10.1371/journal.pone.0180866			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846692	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600005
J	Du, HF; King, RB; Chi, PL				Du, Hongfei; King, Ronnel B.; Chi, Peilian			Self-esteem and subjective well-being revisited: The roles of personal, relational, and collective self-esteem	PLOS ONE			English	Article							LIFE SATISFACTION; INDIVIDUAL SELF; VALIDATION; NEED; METAANALYSIS; ATTACHMENT; PSYCHOLOGY; HIERARCHY; COGNITION; ANXIETY	Previous studies have shown that self-esteem is an important predictor of subjective wellbeing. However, the majority of research has focused on self-esteem at the individual and the collective level, but has mostly ignored self-esteem at the relational level. According to social identity theory, individuals can maintain and enhance self-esteem through personal traits (personal self-esteem, PSE), relationships with significant others (relational self-esteem, RSE), and relationships with larger groups (collective self-esteem, CSE). The current research investigated whether RSE and CSE can predict subjective well-being beyond PSE among Chinese college students. With four cross-sectional studies and one longitudinal study (N = 847), we found that, when controlling for PSE, RSE was associated with greater life satisfaction, positive affect, meaning in life, happiness, and subjective vitality (Studies 1-5), but CSE was not (Studies 2-5). Implications are discussed.	[Du, Hongfei] Guangzhou Univ, Guangzhou, Guangdong, Peoples R China; [King, Ronnel B.] Educ Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Chi, Peilian] Univ Macau, Macau, Peoples R China	Guangzhou University; Education University of Hong Kong (EdUHK); University of Macau	Du, HF (corresponding author), Guangzhou Univ, Guangzhou, Guangdong, Peoples R China.	dhfpsy@gmail.com	King, Ronnel B/AGZ-0675-2022; Chi, Peilian/W-4177-2019	King, Ronnel B/0000-0003-1723-1748; Chi, Peilian/0000-0002-1839-1113; KING, Ronnel Bornasal/0000-0002-0648-8508	Research Development and Administration Office of University of Macau [MYRG2016-00243-FSS]	Research Development and Administration Office of University of Macau	The current study was supported by a research grant from the Research Development and Administration Office of University of Macau (MYRG2016-00243-FSS) to Dr. Peilian Chi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Bettencourt BA, 1997, PERS SOC PSYCHOL B, V23, P955, DOI 10.1177/0146167297239005; Brewer MB, 2007, PSYCHOL REV, V114, P133, DOI 10.1037/0033-295X.114.1.133; Brewer MB, 1996, J PERS SOC PSYCHOL, V71, P83, DOI 10.1037/0022-3514.71.1.83; Cai HJ, 2009, ASIAN J SOC PSYCHOL, V12, P104, DOI 10.1111/j.1467-839X.2009.01278.x; Cheng C, 2011, J CROSS CULT PSYCHOL, V42, P832, DOI 10.1177/0022022110381117; Crocker J, 2004, PSYCHOL BULL, V130, P392, DOI 10.1037/0033-2909.130.3.392; CROCKER J, 1990, J PERS SOC PSYCHOL, V58, P60, DOI 10.1037/0022-3514.58.1.60; CROCKER J, 1994, PERS SOC PSYCHOL B, V20, P503, DOI 10.1177/0146167294205007; DIENER E, 1995, J PERS SOC PSYCHOL, V68, P653, DOI 10.1037/0022-3514.68.4.653; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Diener E, 2002, PSYCHOL SCI, V13, P81, DOI 10.1111/1467-9280.00415; Diener E, 2015, AM PSYCHOL, V70, P234, DOI 10.1037/a0038899; Du H, 2014, J HLTH PSYCHOL; Du H, 2016, EUROPEAN J PSYCHOL A; Du HF, 2015, PERS INDIV DIFFER, V83, P228, DOI 10.1016/j.paid.2015.04.026; Du HF, 2013, J EXP SOC PSYCHOL, V49, P1002, DOI 10.1016/j.jesp.2013.06.007; Du HF, 2013, PERS INDIV DIFFER, V54, P332, DOI 10.1016/j.paid.2012.09.015; Du HF, 2012, SCAND J PSYCHOL, V53, P258, DOI 10.1111/j.1467-9450.2012.00946.x; Finkel S. E., 1995, CAUSAL ANAL PANEL DA; Gaertner L, 2012, J EXP SOC PSYCHOL, V48, P997, DOI 10.1016/j.jesp.2012.03.009; Greenaway KH, 2015, J PERS SOC PSYCHOL; GREENWALD AG, 1995, PSYCHOL REV, V102, P4, DOI 10.1037/0033-295X.102.1.4; Greenwald Anthony G., 1986, HDB MOTIVATION COGNI, P145; Harter S, 1998, CHILD DEV, V69, P756, DOI 10.2307/1132202; King RB, 2015, CONTEMP EDUC PSYCHOL, V42, P26, DOI 10.1016/j.cedpsych.2015.04.002; Kwan VSY, 1997, J PERS SOC PSYCHOL, V73, P1038, DOI 10.1037/0022-3514.73.5.1038; Leary MR, 2000, ADV EXP SOC PSYCHOL, V32, P1, DOI 10.1016/S0065-2601(00)80003-9; LUHTANEN R, 1992, PERS SOC PSYCHOL B, V18, P302, DOI 10.1177/0146167292183006; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Madigan S, 2013, DEV PSYCHOL, V49, P672, DOI 10.1037/a0028793; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; Nesdale D, 2003, INT J INTERCULT REL, V27, P23, DOI 10.1016/S0147-1767(02)00062-7; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Oishi S, 1999, PERS SOC PSYCHOL B, V25, P980, DOI 10.1177/01461672992511006; Pallini S, 2014, J FAM PSYCHOL, V28, P118, DOI 10.1037/a0035736; Pyszczynski T, 2004, PSYCHOL BULL, V130, P435, DOI 10.1037/0033-2909.130.3.435; Robins RW, 2001, PERS SOC PSYCHOL B, V27, P151, DOI 10.1177/0146167201272002; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Ryan RM, 1997, J PERS, V65, P529, DOI 10.1111/j.1467-6494.1997.tb00326.x; Sedikides C., 2015, INDIVIDUAL SELF RELA, DOI [10.4324/9781315783024, DOI 10.4324/9781315783024]; Sedikides C, 2013, ADV EXP SOC PSYCHOL, V48, P235, DOI 10.1016/B978-0-12-407188-9.00005-3; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Simsek OF, 2013, SOCIAL INDICATORS RE, P1; Sowislo JF, 2013, PSYCHOL BULL, V139, P213, DOI 10.1037/a0028931; Steger MF, 2006, J COUNS PSYCHOL, V53, P80, DOI 10.1037/0022-0167.53.1.80; TAJFEL H, 1982, ANNU REV PSYCHOL, V33, P1, DOI 10.1146/annurev.ps.33.020182.000245; Tajfel H., 2010, SOCIAL IDENTITY INTE, P483; TAYLOR SE, 1988, PSYCHOL BULL, V103, P193, DOI 10.1037/0033-2909.103.2.193; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Zhang LW, 2005, INT J PSYCHOL, V40, P189, DOI 10.1080/00207590444000285	54	72	74	8	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183958	10.1371/journal.pone.0183958	http://dx.doi.org/10.1371/journal.pone.0183958			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841716	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700072
J	Kuck, P; Wilkinson, M; Gross, C; Foster, PG; Wagele, JW				Kueck, Patrick; Wilkinson, Mark; Gross, Christian; Foster, Peter G.; Waegele, Johann W.			Can quartet analyses combining maximum likelihood estimation and Hennigian logic overcome long branch attraction in phylogenomic sequence data?	PLOS ONE			English	Article							SITE RATE VARIATION; RNA-POLYMERASE-II; MISSING DATA; EVOLUTIONARY TREES; COMPOSITIONAL HETEROGENEITY; DATA SETS; INFERENCE; LIFE; PARSIMONY; ACCURACY	Systematic biases such as long branch attraction can mislead commonly relied upon model-based (i.e. maximum likelihood and Bayesian) phylogenetic methods when, as is usually the case with empirical data, there is model misspecification. We present PhyQuart, a new method for evaluating the three possible binary trees for any quartet of taxa. PhyQuart was developed through a process of reciprocal illumination between a priori considerations and the results of extensive simulations. It is based on identification of site-patterns that can be considered to support a particular quartet tree taking into account the Hennigian distinction between apomorphic and plesiomorphic similarity, and employing corrections to the raw observed frequencies of site-patterns that exploit expectations from maximum likelihood estimation. We demonstrate through extensive simulation experiments that, whereas maximum likeilihood estimation performs well in many cases, it can be outperformed by PhyQuart in cases where it fails due to extreme branch length asymmetries producing long-branch attraction artefacts where there is only very minor model misspecification.	[Kueck, Patrick; Waegele, Johann W.] Zool Forsch Museum Alexander Koenig, D-53113 Bonn, Germany; [Kueck, Patrick; Wilkinson, Mark; Gross, Christian; Foster, Peter G.] Nat Hist Museum, London SW7 5BD, England; [Gross, Christian] Delft Univ Technol, NL-2628 CD Delft, Netherlands	Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); Natural History Museum London; Delft University of Technology	Kuck, P (corresponding author), Zool Forsch Museum Alexander Koenig, D-53113 Bonn, Germany.; Kuck, P (corresponding author), Nat Hist Museum, London SW7 5BD, England.	patrick_kueck@web.de		Foster, Peter/0000-0003-0194-9237; Gross, Christian/0000-0002-9482-4259	John Templeton Foundation [43915]; PK's IEF Marie Curie Fellowship	John Templeton Foundation; PK's IEF Marie Curie Fellowship	This work was funded in part by PK's IEF Marie Curie Fellowship and by a grant (43915) from the John Templeton Foundation to MW.	Aguinaldo AMA, 1997, NATURE, V387, P489, DOI 10.1038/387489a0; Anderson FE, 2004, MOL PHYLOGENET EVOL, V33, P440, DOI 10.1016/j.ympev.2004.06.015; Arabi J, 2010, CR BIOL, V333, P438, DOI 10.1016/j.crvi.2010.01.018; Ashkenazy H, 2014, GENOME BIOL EVOL, V6, P3199, DOI 10.1093/gbe/evu252; Bapteste E, 2002, P NATL ACAD SCI USA, V290, P972; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Bininda-Emonds ORP, 2004, PHYLOGENOMIC SUPERTR; Brinkmann H, 2005, SYST BIOL, V54, P743, DOI 10.1080/10635150500234609; Brinkmann H, 2008, J SYST EVOL, V46, P274, DOI 10.3724/SP.J.1002.2008.08038; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Cracraft J., 2004, ASSEMBLING TREE LIFE; Dacks JB, 2002, MOL BIOL EVOL, V19, P830, DOI 10.1093/oxfordjournals.molbev.a004140; Dellaporta SL, 2006, P NATL ACAD SCI USA, V103, P8751, DOI 10.1073/pnas.0602076103; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dress A, 1996, DISCRETE APPL MATH, V71, P95, DOI 10.1016/S0166-218X(96)00059-5; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Dunn KA, 2003, MOL PHYLOGENET EVOL, V27, P259, DOI 10.1016/S1055-7903(02)00442-6; EMBLEY TM, 1993, SYST APPL MICROBIOL, V16, P25; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; Felsenstein J., 2004, INFERRING PHYLOGENIE; Fernandez R, 2015, BIORXIV, P1; Fischer M, 2009, J THEOR BIOL, V256, P247, DOI 10.1016/j.jtbi.2008.09.031; Fletcher W, 2009, MOL BIOL EVOL, V26, P1879, DOI 10.1093/molbev/msp098; Foster PG, 2009, PHILOS T R SOC B, V364, P2197, DOI 10.1098/rstb.2009.0034; Foster PG, 2004, SYST BIOL, V53, P485, DOI 10.1080/10635150490445779; Fuellen G, 2001, BIOINFORMATICS, V17, P1168, DOI 10.1093/bioinformatics/17.12.1168; Gaucher EA, 2005, MOL PHYLOGENET EVOL, V37, P928, DOI 10.1016/j.ympev.2005.03.027; GAUT BS, 1995, MOL BIOL EVOL, V12, P152, DOI 10.1093/oxfordjournals.molbev.a040183; Gee H, 2003, NATURE, V425, P782, DOI 10.1038/425782a; Graybeal A, 1998, SYST BIOL, V47, P9, DOI 10.1080/106351598260996; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Haldane J.B.S., 1927, POSSIBLE WORLDS OTHE; Hartmann S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-95; Harvey P. H., 1996, NEW USES NEW PHYLOGE; HENDY MD, 1989, SYST ZOOL, V38, P297, DOI 10.2307/2992396; HENNIG W, 1965, ANNU REV ENTOMOL, V10, P97, DOI 10.1146/annurev.en.10.010165.000525; Hillis DM, 1996, NATURE, V383, P130, DOI 10.1038/383130a0; Hillis DM, 1998, SYST BIOL, V47, P3, DOI 10.1080/106351598260987; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Hirt RP, 1999, P NATL ACAD SCI USA, V96, P580, DOI 10.1073/pnas.96.2.580; HUELSENBECK JP, 1991, SYST ZOOL, V40, P458, DOI 10.2307/2992240; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Huelsenbeck JP, 1997, SYST BIOL, V46, P69, DOI 10.2307/2413636; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Jeffroy O, 2006, TRENDS GENET, V22, P225, DOI 10.1016/j.tig.2006.02.003; Kocot K. M., 2016, SYST BIOL; Kuck P, 2015, CLADISTICS, V0, P1; Kuck P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036593; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; LAKE JA, 1994, P NATL ACAD SCI USA, V91, P1455, DOI 10.1073/pnas.91.4.1455; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Laumer CE, 2015, CURR BIOL, V25, P2000, DOI 10.1016/j.cub.2015.06.068; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lemmon AR, 2004, SYST BIOL, V53, P265, DOI 10.1080/10635150490423520; Lockhart PJ, 1996, P NATL ACAD SCI USA, V93, P1930, DOI 10.1073/pnas.93.5.1930; LOCKHART PJ, 1994, MOL BIOL EVOL, V11, P605; Meusemann K, 2010, MOL BIOL EVOL, V27, P2451, DOI 10.1093/molbev/msq130; Misof B, 2009, SYST BIOL, V58, P21, DOI 10.1093/sysbio/syp006; Nesnidal MP, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-253; Nesnidal MP, 2010, MOL BIOL EVOL, V27, P2095, DOI 10.1093/molbev/msq097; Nishihara H, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r199; Nosenko T, 2013, MOL PHYLOGENET EVOL, V67, P223, DOI 10.1016/j.ympev.2013.01.010; Ogden TH, 2006, SYST BIOL, V55, P314, DOI 10.1080/10635150500541730; Omilian AR, 2001, MOL BIOL EVOL, V18, P2201, DOI 10.1093/oxfordjournals.molbev.a003767; Philippe H, 2005, ANNU REV ECOL EVOL S, V36, P541, DOI 10.1146/annurev.ecolsys.35.112202.130205; Philippe H, 2000, P ROY SOC B-BIOL SCI, V267, P1213, DOI 10.1098/rspb.2000.1130; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Pick KS, 2010, MOL BIOL EVOL, V27, P1983, DOI 10.1093/molbev/msq089; Pisani D, 2004, SYST BIOL, V53, P978, DOI 10.1080/10635150490888877; PISANI D, 2009, TIMETREE LIFE; Podsiadlowski L, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-284; Poe S, 2003, SYST BIOL, V52, P423, DOI 10.1080/10635150390197046; Poe S, 1998, MOL BIOL EVOL, V15, P1086, DOI 10.1093/oxfordjournals.molbev.a026008; Pol D, 2001, CLADISTICS, V17, P266, DOI 10.1111/j.1096-0031.2001.tb00123.x; Pollock DD, 2002, SYST BIOL, V51, P664, DOI 10.1080/10635150290102357; Privman E, 2012, MOL BIOL EVOL, V29, P1, DOI 10.1093/molbev/msr177; Rannala B, 1998, SYST BIOL, V47, P702, DOI 10.1080/106351598260680; Rosenberg MS, 2003, MOL BIOL EVOL, V20, P610, DOI 10.1093/molbev/msg067; Rota-Stabelli O, 2011, P ROY SOC B-BIOL SCI, V278, P298, DOI 10.1098/rspb.2010.0590; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Sanderson MJ, 2000, MOL BIOL EVOL, V17, P782, DOI 10.1093/oxfordjournals.molbev.a026357; Sela I, 2015, NUCLEIC ACIDS RES, V43, pW7, DOI 10.1093/nar/gkv318; Sharma PP, 2014, MOL BIOL EVOL, P1; Simmons MP, 2012, CLADISTICS, V28, P208, DOI 10.1111/j.1096-0031.2011.00375.x; Simmons MP, 2012, MOL PHYLOGENET EVOL, V62, P472, DOI 10.1016/j.ympev.2011.10.017; Simmons MP, 2011, MOL PHYLOGENET EVOL, V61, P177, DOI 10.1016/j.ympev.2011.06.003; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Snir S, 2012, MOL PHYLOGENET EVOL, V62, P1, DOI 10.1016/j.ympev.2011.06.021; Soltis PS, 2001, TAXON, V50, P663, DOI 10.2307/1223700; Struck TH, 2014, MOL BIOL EVOL, V31, P1833, DOI 10.1093/molbev/msu143; Sullivan J, 2001, SYST BIOL, V50, P723, DOI 10.1080/106351501753328848; SULLIVAN J, 1995, MOL BIOL EVOL, V12, P988; Sullivan Jack, 1997, Journal of Mammalian Evolution, V4, P77, DOI 10.1023/A:1027314112438; Susko E, 2005, J MOL EVOL, V61, P351, DOI 10.1007/s00239-004-0352-9; Susko E, 2015, SYST BIOL, V64, P243, DOI 10.1093/sysbio/syu099; Swofford D.L., 1996, PHYLOGENETIC INFEREN; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Telford MJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0479; Wagele JW, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-147; Whelan NV, 2015, P NATL ACAD SCI USA, V112, P5773, DOI 10.1073/pnas.1503453112; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; Wilkinson M, 1998, SYST BIOL, V47, P673, DOI 10.1080/106351598260662; Wilkinson M, 2006, SYSTEMATIC ASS SPECI; Wilkinson M, 2007, TRENDS ECOL EVOL, V22, P114, DOI 10.1016/j.tree.2007.01.002; Williams TA, 2012, P ROY SOC B-BIOL SCI, V279, P4870, DOI 10.1098/rspb.2012.1795; Wong KM, 2008, SCIENCE, V319, P473, DOI 10.1126/science.1151532; YANG ZH, 1994, MOL BIOL EVOL, V11, P316; Yang ZH, 1996, TRENDS ECOL EVOL, V11, P367, DOI 10.1016/0169-5347(96)10041-0; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	113	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183393	10.1371/journal.pone.0183393	http://dx.doi.org/10.1371/journal.pone.0183393			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841676	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700029
J	Pui, M; Nicol, AM; Brauer, M; Palad, F; Carlsten, C				Pui, Mandy; Nicol, Anne-Marie; Brauer, Michael; Palad, Farshad; Carlsten, Christopher			A qualitative study of the knowledge, attitudes, and behaviors of people exposed to diesel exhaust at the workplace in British Columbia, Canada	PLOS ONE			English	Article							AIR-POLLUTION; PARTICULATE MATTER; WORKERS	Purpose To identify exposure-related knowledge, attitudes and behaviors of individuals occupationally exposed to diesel exhaust (DE); to reveal strengths, knowledge gaps and misperceptions therein. Methods A Mental Models approach was used to gather information about current scientific understanding of DE exposure hazards and the ways in which exposure can be reduced. Thirty individuals in British Columbia who were regularly exposed to occupational DE were interviewed. The audio was recorded and transcribed. Data was grouped together and examined to draw out themes around DE awareness, hazard assessment and risk reduction behaviors. These themes were then compared and contrasted with existing grey and research literature in order to reveal strengths, gaps and misperceptions regarding DE exposure. Results Study participants were aware and concerned about their exposure to DE but had incomplete and sometimes incorrect understanding of exposure pathways, health effects, and effective strategies to reduce their exposures. The perceived likelihood of exposure to DE was significantly greater compared to that of other work hazards (p<0.01), whereas the difference for their perceived severity of consequences was not significant. There was no universally perceived main source of information regarding DE, and participants generally distrusted sources of information based on their past experience with the source. Most of the actions that were taken to address DE exposure fell into the area of administrative controls such as being aware of sources of DE and avoiding these sources. Conclusions This study of the knowledge, attitude, and behavior of those occupationally exposed to DE found, most notably, that more education and training and the creation of a health effects inventory regarding DE exposure were desired.	[Pui, Mandy; Brauer, Michael; Carlsten, Christopher] Univ British Columbia, Dept Med, Vancouver, BC, Canada; [Nicol, Anne-Marie; Palad, Farshad] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Brauer, Michael; Carlsten, Christopher] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada	University of British Columbia; Simon Fraser University; University of British Columbia	Pui, M; Carlsten, C (corresponding author), Univ British Columbia, Dept Med, Vancouver, BC, Canada.; Carlsten, C (corresponding author), Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada.	dieselworkers@gmail.com; carlsten@mail.ubc.ca	Brauer, Michael/Y-2810-2019	Brauer, Michael/0000-0002-9103-9343				Alfaro-Moreno E, 2007, CURR OPIN PULM MED, V13, P98, DOI 10.1097/MCP.0b013e328013f47e; Baccarelli A, 2007, J THROMB HAEMOST, V5, P252, DOI 10.1111/j.1538-7836.2007.02300.x; Baranowski T, 2003, OBESITY RES, V11; Brook RD, 2010, OCCUP ENV MED; Brook RD, 2008, CLIN SCI, V115, P175, DOI 10.1042/CS20070444; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Bull ER D S, 2014, BMJ OPEN, V4; Calderon-Garciduenas L, 2008, BRAIN COGNITION, V68, P117, DOI 10.1016/j.bandc.2008.04.008; Calderon-Garciduenas L, 2008, TOXICOL PATHOL, V36, P289, DOI 10.1177/0192623307313011; Canada H, 2013, FUELS AIR POLLUTION; Canada S., EMPLOYMENT IND SEX C; CAREX, 2014, PROF EST BURN; Carlsten C, 2007, THROMB RES; CCOHS, 2012, HLTH SAF REP, V10; CCOHS, 2008, OH S LEG CAN BAS RES; Centre CP, 2012, REDUCING EXPOSURES O; Chen JC, 2009, NEUROTOXICOLOGY, V30, P231, DOI 10.1016/j.neuro.2008.12.011; CupeBC, HLTH SAF MATT BRIT; Demers P., 2007, CARCINOGEN SURVEILLA; Freire C, 2010, J EPIDEMIOL COMMUN H, V64, P223, DOI 10.1136/jech.2008.084574; GAMBLE J, 1987, ENVIRON RES, V44, P6, DOI 10.1016/S0013-9351(87)80082-8; Gupta A, 2006, AM J IND MED, V49, P423, DOI 10.1002/ajim.20312; Kim J, 2014, OCCUP ENV MED S1, V71; McCreanor J, 2007, NEW ENGL J MED, V357, P2348, DOI 10.1056/NEJMoa071535; Miller KA, 2007, NEW ENGL J MED, V356, P447, DOI 10.1056/NEJMoa054409; Miller PG, 2015, AM J DRUG ALCOHOL AB, V41, P16, DOI 10.3109/00952990.2014.966199; Morgan M. G., 2002, RISK COMMUNICATION M; Nicol AM HA, 2008, EUR SAF REL C VAL SP; NIOSH, MIN TOP DIES EXH 201; NTP, 12 REP CARC DIES EXH; Organization WH, 2008, AD COMM SOC MOB TB C, P116; OSHA, 2015, SAF HAZ; OSHA Occupational Safety and Health Administration, 2013, HAZ AL DIES EXH DIES; Sadhra S, 2002, OCCUP ENVIRON MED, V59, P689, DOI 10.1136/oem.59.10.689; Santos MS, 2007, CHEST, V131, P1768, DOI 10.1378/chest.06-2487; Society CC, 2015, LUNG CANC STAT CAN; STEENLAND K, 1992, AM J IND MED, V21, P887, DOI 10.1002/ajim.4700210612; Strauss A., 1998, BASICS QUALITATIVE R; Wood M, 2012, RISK ANAL, V32, P1349, DOI 10.1111/j.1539-6924.2012.01832.x; WorkSafeBC, WORKSAFEBC 2012 STAT; WorkSafeBC, 2010, OHS REG GUID 5; Zaksek M, 2004, RISK ANAL, V24, P1503, DOI 10.1111/j.0272-4332.2004.00545.x	42	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182890	10.1371/journal.pone.0182890	http://dx.doi.org/10.1371/journal.pone.0182890			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841707	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700014
J	Chen, YF; Ding, JP; Yan, HJ; Lu, J; Ding, P; Chen, GH; Li, JJ; Huan, XP; Yang, HT; Tang, WM; Fu, GF				Chen, Yuan-Fang; Ding, Jian-Ping; Yan, Hong-Jing; Lu, Jing; Ding, Ping; Chen, Guo-Hong; Li, Jian-Jun; Huan, Xi-Ping; Yang, Hai-Tao; Tang, Wei-Ming; Fu, Geng-Feng			The current status of syphilis prevention and control in Jiangsu province, China: A cross-sectional study	PLOS ONE			English	Article							MULTILEVEL; EPIDEMIC	Objective To analyze the midterm evaluation data from the National Syphilis Prevention and Control Plan (2010-2020) and evaluate the current status of syphilis prevention and control in Jiangsu province, China. Methods We collected data via (1) field surveys conducted in 2015 and (2) data recorded in existing syphilis surveillance systems. We conducted descriptive statistical analysis to evaluate the current landscape of syphilis control initiatives and their potential effect in syphilis control. Results The incidence of all cases of syphilis decreased from 2010 (32.3 per 100,000) to 2015 (30.1 per 100,000), with an annual growth of -1.17% (x(trend)(2) = -7.52, P<0.001) in Jiangsu province. The incidence of primary and secondary syphilis and congenital syphilis both decreased significantly from 2010 to 2015. The average awareness rate of syphilis knowledge among professional personnel was 95.4% (3781/3963). Rural residents had the lowest awareness rate (83.5%, 1875/2245) and commercial sex workers had the highest awareness rate (92.1%, 7804/8474) in 2015. Only 47.8% (33908/70894) of patients received provider-initiated syphilis counseling and testing (PISTC) services in sexually transmitted disease (STD) clinics, but 94.5% (87927/93020) of all syphilis patients received free testing for syphilis. Overall, 97.2% (9378/9648) of syphilis reported cases of syphilis at medical institutions were confirmed to be accurate, and 92.2% (5850/6345) of patients diagnosed with syphilis at medical institutions received treatment with penicillin. Conclusion The syphilis incidence rate in Jiangsu has decreased in recent years, but remains at a high level. It is essential to promote PISTC services to improve knowledge of syphilis and rates of testing and treatment in Jiangsu province.	[Chen, Yuan-Fang; Ding, Jian-Ping; Yan, Hong-Jing; Lu, Jing; Ding, Ping; Chen, Guo-Hong; Li, Jian-Jun; Huan, Xi-Ping; Fu, Geng-Feng] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Yang, Hai-Tao] Jiangsu Inst Parasit Dis, Wuxi, Peoples R China; [Tang, Wei-Ming] Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China	Jiangsu Provincial Center for Disease Control & Prevention	Fu, GF (corresponding author), Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China.; Tang, WM (corresponding author), Univ N Carolina, Project China, Guangzhou, Guangdong, Peoples R China.	weimingtangscience@gmail.com; fugf@jscdc.cn						Azeredo CM, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011571; Centers for Disease Control and Prevention, 2006, MMWR Recomm Rep, V55, P1; Champredon D, 2016, EPIDEMIOL INFECT, V144, P3244, DOI 10.1017/S0950268816001643; Chen XS, 2013, CHINESE MED J-PEKING, V126, P2774, DOI 10.3760/cma.j.issn.0366-6999.20123559; China Ministry of Health, 2010, NOT MIN HLTH ISS NAT; Chivriga V., 2016, SUBSIDIZING AGR REPU, P37; Fu GF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118863; Han Y., 2013, CHINESE J HUMAN SEXU, V22, P37; Hongcheng S, 2016, CHIN J AIDS STD, V22, P32, DOI DOI 10.13419/J.CNKI.AIDS.2016.01.11; Hu Yu-Feng, 2010, Zhonghua Liu Xing Bing Xue Za Zhi, V31, P876; Huang SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121814; Ma P, 2012, JIANGSU J PREVENTIVE, V23, P34; Patton ME, 2014, MMWR-MORBID MORTAL W, V63, P402; Qin JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102203; Song X, 2017, CHINA RURAL HLTH, P59; Sun YP, 2016, MED INFORM, V29, P285; Tang WM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085985; Taylor MM, 2016, B WORLD HEALTH ORGAN, V94, P559, DOI 10.2471/BLT.16.173310; Tucker JD, 2011, CURR OPIN INFECT DIS, V24, P50, DOI 10.1097/QCO.0b013e32834204bf; Wang Jian, 2016, Chinese Journal of Dermatology, V49, P364; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; Wong NS, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-016-4004-y; World Health Organisation, 2021, SEXUALLY TRANSMITTED; Wu XB, 2012, SEX TRANSM INFECT, V88, P325, DOI 10.1136/sextrans-2011-050397; Xia JH, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0760-0; Xu JG, 2013, INT J LAB MED, V34, P3182; Yang HT, 2014, CLIN INFECT DIS, V58, P1753, DOI 10.1093/cid/ciu175; Zhang JX, 2011, J THERM SCI, V20, P1, DOI 10.1007/s11630-011-0426-0; Zhang WY, 2016, J DERMATOLOGY VENERE, V38, P1002; Zhao Y, 2007, MODERN PREVENTIVE ME, V34, P1956; [邹亚明 Zou Yaming], 2016, [中山大学学报. 医学科学版, Journal of Sun Yat-sen University. Medical Sciences], V37, P142; 樊尚荣(编译), 2015, [中国全科医学, Chinese General Practice], V18, P3260	32	4	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183409	10.1371/journal.pone.0183409	http://dx.doi.org/10.1371/journal.pone.0183409			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837587	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000064
J	Kainuma, S; Miyagawa, S; Fukushima, S; Tsuchimochi, H; Sonobe, T; Fujii, Y; Pearson, JT; Saito, A; Harada, A; Toda, K; Shirai, M; Sawa, Y				Kainuma, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Tsuchimochi, Hirotsugu; Sonobe, Takashi; Fujii, Yutaka; Pearson, James T.; Saito, Atsuhiro; Harada, Akima; Toda, Koichi; Shirai, Mikiyasu; Sawa, Yoshiki			Influence of coronary architecture on the variability in myocardial infarction induced by coronary ligation in rats	PLOS ONE			English	Article							CELL-SHEET TECHNIQUE; HEART-FAILURE; ISCHEMIC CARDIOMYOPATHY; ARTERY LIGATION; THERAPY; MODEL; LOCATION; MOUSE; MICE; SIZE	It has been shown that the size of myocardial infarction in rats created by coronary ligation technique is not uniform, varying from 4% to 65%. We hypothesized that infarct size variability induced by coronary artery ligation might be caused by coronary artery branching pattern. Coronary artery angiography was performed in 50 normal Lewis rats and in chronic myocardial infarction models in which coronary artery was ligated immediately below the left atrial appendage or 2mm distal to the left atrial appendage (n = 25 for each), followed by histological analysis. Unlike the human, the rats had a single major septal artery arising from the proximal part of the left coronary artery (n = 30) or right coronary artery (n = 20). There were three branching patterns of left circumflex artery (LCX): 33 (66%) had LCX branching peripherally from a long left main coronary artery (LMCA), while the remainder 17 (34%) had the LCX branching from the proximal part of the septal artery or a short LMCA. The rats with distal coronary ligation presented myocardial infarction localized to an anterior territory irrespective of LCX branching pattern. In the rats with proximal coronary ligation, 64% (n = 16) had broad myocardial infarction involving the anterior and lateral territories, while the remainder (36%, n = 9) had myocardial infarction localized to an anterior territory with the intact LCX arising proximally from a short LMCA. The interventricular septum was spared from infarction in all rats because of its anatomical location. Infarct size variations were caused not only by ligation site but also by varying LCX branching patterns. There are potential risks to create different sizes of myocardial infarction, particularly when targeting a broad range of myocardial infarction. The territory of the septal artery always appears to be spared from myocardial infarction induced by the coronary ligation technique.	[Kainuma, Satoshi; Miyagawa, Shigeru; Fukushima, Satsuki; Saito, Atsuhiro; Harada, Akima; Toda, Koichi; Sawa, Yoshiki] Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan; [Tsuchimochi, Hirotsugu; Sonobe, Takashi; Fujii, Yutaka; Pearson, James T.; Shirai, Mikiyasu] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Cardiac Physiol, Suita, Osaka, Japan; [Pearson, James T.] Monash Univ, Dept Physiol, Clayton, Vic, Australia	Osaka University; National Cerebral & Cardiovascular Center - Japan; Monash University	Sawa, Y (corresponding author), Osaka Univ, Grad Sch Med, Dept Cardiovasc Surg, Suita, Osaka, Japan.	sawa-p@surg1.med.osaka-u.ac.jp	Sonobe, Takashi/Q-6600-2016; Tsuchimochi, Hirotsugu/D-8224-2011; Fukushima, Satsuki/ABE-6582-2020; Pearson, James/B-4631-2012	Sonobe, Takashi/0000-0003-3589-0405; Tsuchimochi, Hirotsugu/0000-0001-7591-2520; Fukushima, Satsuki/0000-0002-9481-8860; Pearson, James/0000-0002-3318-5406; Miyagawa, Shigeru/0000-0003-0015-6569	Ministry of Health, Labour and Welfare of Japan; JSPS KAKENHI [26670616]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labour and Welfare of Japan. The work was supported by JSPS KAKENHI Grant (26670616): https://kaken.nii.ac.jp/ja/grant/KAKENHI-PROJECT-26670616/.	Ahn D, 2004, AM J PHYSIOL-HEART C, V286, pH1201, DOI 10.1152/ajpheart.00862.2003; Bayat H, 2002, BASIC RES CARDIOL, V97, P206, DOI 10.1007/s003950200013; Gao E, 2010, CIRC RES, V107, P1445, DOI 10.1161/CIRCRESAHA.110.223925; GELTMAN EM, 1979, CIRCULATION, V60, P805, DOI 10.1161/01.CIR.60.4.805; Imanishi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069302; JOHNS TNP, 1954, ANN SURG, V140, P675, DOI 10.1097/00000658-195411000-00006; Kainuma S, 2015, MOL THER, V23, P374, DOI 10.1038/mt.2014.225; Klocke R, 2007, CARDIOVASC RES, V74, P29, DOI 10.1016/j.cardiores.2006.11.026; Kumar D, 2005, CORONARY ARTERY DIS, V16, P41, DOI 10.1097/00019501-200502000-00008; Liu YH, 1997, AM J PHYSIOL-HEART C, V272, pH722, DOI 10.1152/ajpheart.1997.272.2.H722; MACLEAN D, 1978, J CLIN INVEST, V61, P541, DOI 10.1172/JCI108965; Matsuda T, 2014, CIRC J, V78, P222, DOI 10.1253/circj.CJ-13-0534; Narita T, 2013, INT J CARDIOL, V168, P261, DOI 10.1016/j.ijcard.2012.09.081; Narita T, 2013, MOL THER, V21, P860, DOI 10.1038/mt.2013.9; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; POMBO JF, 1971, CIRCULATION, V43, P480, DOI 10.1161/01.CIR.43.4.480; Shudo Y, 2011, TRANSPLANTATION, V92, pE34, DOI 10.1097/TP.0b013e31822d875c; Tano N, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002815; Tanol N, 2014, MOL THER, V22, P1864, DOI 10.1038/mt.2014.110; Uchinaka A, 2010, CELL TRANSPLANT, V19, P573; Uchinaka A, 2014, TISSUE ENG PT A, V20, P3073, DOI [10.1089/ten.tea.2013.0763, 10.1089/ten.TEA.2013.0763]; WILSON RB, 1970, ARCH PATHOL, V89, P457	22	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183323	10.1371/journal.pone.0183323	http://dx.doi.org/10.1371/journal.pone.0183323			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837679	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000059
J	Li, J; Zhong, R; Palva, ET				Li, Jing; Zhong, Rusen; Palva, E. Tapio			WRKY70 and its homolog WRKY54 negatively modulate the cell wall-associated defenses to necrotrophic pathogens in Arabidopsis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; OXIDATIVE CROSS-LINKING; TRANSCRIPTION FACTOR; SIGNALING PATHWAYS; SALICYLIC-ACID; DISEASE RESISTANCE; BOTRYTIS-CINEREA; PLANT; STRESS; SUPPRESSION	Previous studies have identified the Arabidopsis thaliana transcription factor WRKY70 as a node of convergence for salicylic acid (SA) and jasmonic acid (JA)-mediated defense signal pathways and, together with its closest homolog WRKY54, as a negative regulator of SA biosynthesis. Here, we demonstrate that WRKY70 together with WRKY54 negatively affect the response of Arabidopsis to the necrotrophic pathogens Pectobacterium carotovorum and Botrytis cinerea, but not to the hemibiotroph Pseudomonas syringae pv tomato (Pst) DC3000, as revealed by mutants studies. Unstressed wrky54wrky70 double mutants exhibited increased levels of SA, accumulation of hydrogen peroxide (H2O2) and up-regulated expression of both SA and JA/ethylene (ET) responsive defense related genes. Additionally, protein cross-linking in cell wall was promoted by endogenous SA, suggesting involvement of wall-associated defenses against necrotrophs. This response to necrotrophs was compromised by introducing the sid2-1 allele impairing SA biosynthesis and leading to reduction of H2O2 content and of defense gene expression. The data suggest that the elevated SA level in the wrky54wrky70 double mutant results in moderate accumulation of H2O2, in promoting cell wall fortification and consequently enhanced resistance to necrotrophs but is not sufficient to trigger hypersensitive reaction (HR)-like cell death and resistance to biotrophs/hemibiotrophs like Pst DC3000.	[Li, Jing; Zhong, Rusen] Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan, Hubei, Peoples R China; [Palva, E. Tapio] Univ Helsinki, Dept Biosci, Viikki Bioctr, Div Genet, Helsinki, Finland	Wuhan University of Technology; University of Helsinki	Li, J (corresponding author), Wuhan Univ Technol, Sch Chem Chem Engn & Life Sci, Wuhan, Hubei, Peoples R China.	celery_wh@126.com			Academy of Finland Center of Excellence programme; Academy of Finland [257644]; European Research Area in Plant Genomics [ERAPGFP/06.023a]; Fundamental Research Funds for the Central Universities [WUT:2017IVA115, 2017IB006]	Academy of Finland Center of Excellence programme(Academy of Finland); Academy of Finland(Academy of Finland); European Research Area in Plant Genomics; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	The work was supported by the Academy of Finland Center of Excellence programme, the project of Academy of Finland (257644) and the European Research Area in Plant Genomics (ERAPGFP/06.023a) and the Fundamental Research Funds for the Central Universities (WUT:2017IVA115 and 2017IB006) to JL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Antico Christopher J, 2012, [Frontiers in Biology, 生物学前沿], V7, P48; Asselbergh B, 2007, PLANT PHYSIOL, V144, P1863, DOI 10.1104/pp.107.099226; Besseau S, 2012, J EXP BOT, V63, P2667, DOI 10.1093/jxb/err450; Bolwell GP, 2009, SIGNAL COMMUN PLANTS, P113, DOI 10.1007/978-3-642-00390-5_7; Bostock RM, 2005, ANNU REV PHYTOPATHOL, V43, P545, DOI 10.1146/annurev.phyto.41.052002.095505; BRISSON LF, 1994, PLANT CELL, V6, P1703, DOI 10.1105/tpc.6.12.1703; Brown I, 1998, PLANT J, V15, P333, DOI 10.1046/j.1365-313X.1998.00215.x; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Coego A, 2005, PLANT CELL, V17, P2123, DOI 10.1105/tpc.105.032375; Cui J, 2005, P NATL ACAD SCI USA, V102, P1791, DOI 10.1073/pnas.0409450102; Daudi A, 2012, PLANT CELL, V24, P275, DOI 10.1105/tpc.111.093039; Davidsson PR, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00191; Dong XN, 2004, CURR OPIN PLANT BIOL, V7, P547, DOI 10.1016/j.pbi.2004.07.005; Draper J, 1997, TRENDS PLANT SCI, V2, P162, DOI 10.1016/S1360-1385(97)01030-3; Ellinger D, 2013, PLANT PHYSIOL, V161, P1433, DOI 10.1104/pp.112.211011; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Glazebrook J, 2005, ANNU REV PHYTOPATHOL, V43, P205, DOI 10.1146/annurev.phyto.43.040204.135923; Govrin EM, 2000, CURR BIOL, V10, P751, DOI 10.1016/S0960-9822(00)00560-1; He P, 2007, CELL MICROBIOL, V9, P1385, DOI 10.1111/j.1462-5822.2007.00944.x; Hwang BH, 2012, PLANT CELL TISS ORG, V103; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; Koornneef A, 2008, PLANT PHYSIOL, V147, P1358, DOI 10.1104/pp.108.121392; Koornneef A, 2008, PLANT PHYSIOL, V146, P839, DOI 10.1104/pp.107.112029; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kunkel BN, 2002, CURR OPIN PLANT BIOL, V5, P325, DOI 10.1016/S1369-5266(02)00275-3; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; LEVINE A, 1994, CELL, V79, P583, DOI 10.1016/0092-8674(94)90544-4; Li J, 2004, PLANT CELL, V16, P319, DOI 10.1105/tpc.016980; Li J, 2006, PLANT J, V46, P477, DOI 10.1111/j.1365-313X.2006.02712.x; Li J, 2013, NEW PHYTOL, V200, P455, DOI 10.1111/nph.12378; Lindeberg M, 2012, TRENDS MICROBIOL, V20, P199, DOI 10.1016/j.tim.2012.01.003; Luna E, 2011, MOL PLANT MICROBE IN, V24, P183, DOI 10.1094/MPMI-07-10-0149; Mengiste T, 2003, PLANT CELL, V15, P2551, DOI 10.1105/tpc.014167; Mengiste T, 2012, ANNU REV PHYTOPATHOL, V50, P267, DOI 10.1146/annurev-phyto-081211-172955; Mur LAJ, 2006, PLANT PHYSIOL, V140, P249, DOI 10.1104/pp.105.072348; Nomura K, 2005, CURR OPIN PLANT BIOL, V8, P361, DOI 10.1016/j.pbi.2005.05.005; PALVA TK, 1994, MOL PLANT MICROBE IN, V7, P356, DOI 10.1094/MPMI-7-0356; Pieterse CM, 2004, CURR OPIN PLANT BIOL, V7, P456, DOI 10.1016/j.pbi.2004.05.006; Rizhsky L, 2004, J BIOL CHEM, V279, P11736, DOI 10.1074/jbc.M313350200; Robert-Seilaniantz A, 2007, CURR OPIN PLANT BIOL, V10, P372, DOI 10.1016/j.pbi.2007.06.003; Shetty NP, 2008, EUR J PLANT PATHOL, V121, P267, DOI 10.1007/s10658-008-9302-5; Shirasu K, 1997, PLANT CELL, V9, P261, DOI 10.1105/tpc.9.2.261; Survila M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01945; Temme N, 2009, MOL PLANT MICROBE IN, V22, P987, DOI 10.1094/MPMI-22-8-0987; Thomma BPHJ, 1998, P NATL ACAD SCI USA, V95, P15107, DOI 10.1073/pnas.95.25.15107; Toth IK, 2005, CURR OPIN PLANT BIOL, V8, P424, DOI 10.1016/j.pbi.2005.04.001; Truman W, 2007, P NATL ACAD SCI USA, V104, P1075, DOI 10.1073/pnas.0605423104; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Vidal S, 1997, PLANT J, V11, P115, DOI 10.1046/j.1365-313X.1997.11010115.x; vonTiedemann A, 1997, PHYSIOL MOL PLANT P, V50, P151; Wang D, 2006, PLOS PATHOG, V2, P1042, DOI 10.1371/journal.ppat.0020123; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	55	46	47	3	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183731	10.1371/journal.pone.0183731	http://dx.doi.org/10.1371/journal.pone.0183731			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837631	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000106
J	Muenks, AG; Stiers, KM; Beamer, LJ				Muenks, Andrew G.; Stiers, Kyle M.; Beamer, Lesa J.			Sequence-structure relationships, expression profiles, and disease-associated mutations in the paralogs of phosphoglucomutase 1	PLOS ONE			English	Article							ACETYLGLUCOSAMINE-PHOSPHATE MUTASE; D-PHOSPHOHEXOMUTASE SUPERFAMILY; PGM3; DEFICIENCY; PROTEIN; MUSCLE; IDENTIFICATION; DEFECTS; GENE; PHOSPHOPENTOMUTASE	The key metabolic enzyme phosphoglucomutase 1 (PGM1) controls glucose homeostasis in most human cells. Four proteins related to PGM1, known as PGM2, PGM2L1, PGM3 and PGM5, and referred to herein as paralogs, are encoded in the human genome. Although all members of the same enzyme superfamily, these proteins have distinct substrate preferences and different functional roles. The recent association of PGM1 and PGM3 with inherited enzyme deficiencies prompts us to revisit sequence-structure and other relationships among the PGM1 paralogs, which are understudied despite their importance in human biology. Using currently available sequence, structure, and expression data, we investigated evolutionary relationships, tissue-specific expression profiles, and the amino acid preferences of key active site motifs. Phylogenetic analyses indicate both ancient and more recent divergence between the different enzyme sub-groups comprising the human paralogs. Tissue-specific protein and RNA expression profiles show widely varying patterns for each paralog, providing insight into function and disease pathology. Multiple sequence alignments confirm high conservation of key active site regions, but also reveal differences related to substrate specificity. In addition, we find that sequence variants of PGM2, PGM2L1, and PGM5 verified in the human population affect residues associated with disease-related mutants in PGM1 or PGM3. This suggests that inherited diseases related to dysfunction of these paralogs will likely occur in humans.	[Muenks, Andrew G.; Stiers, Kyle M.; Beamer, Lesa J.] Univ Missouri, Dept Biochem, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia	Beamer, LJ (corresponding author), Univ Missouri, Dept Biochem, Columbia, MO 65211 USA.	beamerl@missouri.edu		Stiers, Kyle/0000-0001-5542-022X; Beamer, Lesa/0000-0001-5689-200X	National Institutes of Health [T32 GM008396-26]; American Heart Society [17PRE33400210]; Patton Trust of the Kansas City Area Life Sciences Research Foundation; National Science Foundation [MCB-1409898]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008396] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1409898] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Society; Patton Trust of the Kansas City Area Life Sciences Research Foundation; National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	KMS was supported by National Institutes of Health training grant T32 GM008396-26 and a predoctoral fellowship 17PRE33400210 from the American Heart Society. This work was supported by grants to LJB from the Patton Trust of the Kansas City Area Life Sciences Research Foundation and the National Science Foundation (MCB-1409898). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei I, 2001, CURRENT PROTOCOLS HU; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arimura T, 2009, CARDIOVASC RES, V83, P80, DOI 10.1093/cvr/cvp119; Barreteau H, 2008, FEMS MICROBIOL REV, V32, P168, DOI 10.1111/j.1574-6976.2008.00104.x; Beamer L.J., 2015, J INHERIT METAB DIS, V38; BELKIN AM, 1994, J CELL SCI, V107, P159; BELKIN AM, 1994, J CELL SCI, V107, P1993; BELKIN AM, 1995, J BIOL CHEM, V270, P6328, DOI 10.1074/jbc.270.11.6328; Charif D, 2007, THE SEQINR PACKAGE; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Gaudet P, 2011, BRIEF BIOINFORM, V12, P449, DOI 10.1093/bib/bbr042; Gururaj A, 2004, ONCOGENE, V23, P8118, DOI 10.1038/sj.onc.1207969; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lee Y, 2014, J BIOL CHEM, V289, P32010, DOI 10.1074/jbc.M114.597914; Li CY, 2000, GENE, V242, P97, DOI 10.1016/S0378-1119(99)00543-0; LOWRY OH, 1969, J BIOL CHEM, V244, P910; Lundin KE, 2015, CLIN IMMUNOL, V161, P366, DOI 10.1016/j.clim.2015.10.002; Maliekal P, 2007, J BIOL CHEM, V282, P31844, DOI 10.1074/jbc.M706818200; MCALPINE PJ, 1970, ANN HUM GENET, V34, P169, DOI 10.1111/j.1469-1809.1970.tb00230.x; Mehra-Chaudhary R, 2011, PROTEINS, V79, P1215, DOI 10.1002/prot.22957; Mio T, 2000, BBA-GENE STRUCT EXPR, V1492, P369, DOI 10.1016/S0167-4781(00)00120-2; Moiseeva E., 2004, EUROPEAN J BIOCH, V235, P103; Molt S, 2014, J CELL SCI, V127, P3578, DOI 10.1242/jcs.152157; Nishitani Y, 2006, J BIOL CHEM, V281, P19740, DOI 10.1074/jbc.M600801200; Pacheco-Cuellar G, 2017, J BONE MINE IN PRESS; Pang H, 2002, ANN HUM GENET, V66, P139, DOI 10.1017/S0003480002001033; Perez B, 2013, J INHERIT METAB DIS, V36, P535, DOI 10.1007/s10545-012-9525-7; PUTT W, 1993, BIOCHEM J, V296, P417, DOI 10.1042/bj2960417; QUICK CB, 1974, EUR J BIOCHEM, V42, P511, DOI 10.1111/j.1432-1033.1974.tb03366.x; Regni C, 2004, STRUCTURE, V12, P55, DOI 10.1016/j.str.2003.11.015; ROBERT X, 2014, NUCLEIC ACIDS RES, V42, P320, DOI DOI 10.1093/NAR/GKU316; Sassi A, 2014, J ALLERGY CLIN IMMUN, V133, P1410, DOI 10.1016/j.jaci.2014.02.025; Shackelford GS, 2004, PROTEIN SCI, V13, P2130, DOI 10.1110/ps.04801104; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Stiers KM, 2017, ADV PROTEIN CHEM STR, P265; Stiers KM, 2017, FEBS J, V284, P937, DOI 10.1111/febs.14025; Stiers KM, 2016, J MOL BIOL, V428, P1493, DOI 10.1016/j.jmb.2016.02.032; Stojkovic T, 2009, NEW ENGL J MED, V361, P425, DOI 10.1056/NEJMc0901158; Stray-Pedersen A, 2014, AM J HUM GENET, V95, P96, DOI 10.1016/j.ajhg.2014.05.007; Tegtmeyer LC, 2014, NEW ENGL J MED, V370, P533, DOI 10.1056/NEJMoa1206605; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Wilhelm M, 2014, NATURE, V509, P582, DOI 10.1038/nature13319; Willems AP, 2016, BBA-GEN SUBJECTS, V1860, P1640, DOI 10.1016/j.bbagen.2015.12.017; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 2014, J ALLERGY CLIN IMMUN, V133, P1400, DOI 10.1016/j.jaci.2014.02.013	48	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183563	10.1371/journal.pone.0183563	http://dx.doi.org/10.1371/journal.pone.0183563			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837627	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000082
J	Aguilera, O; Luz, Z; Carrillo-Briceno, JD; Kocsis, L; Vennemann, TW; de Toledo, PM; Nogueira, A; Amorim, KB; Moraes-Santos, H; Polck, MR; Ruivo, MD; Linhares, AP; Monteiro-Neto, C				Aguilera, Orangel; Luz, Zoneibe; Carrillo-Briceno, Jorge D.; Kocsis, Laszlo; Vennemann, Torsten W.; de Toledo, Peter Mann; Nogueira, Afonso; Amorim, Kamilla Borges; Moraes-Santos, Heloisa; Polck, Marcia Reis; Ruivo, Maria de Lourdes; Linhares, Ana Paula; Monteiro-Neto, Cassiano			Neogene sharks and rays from the Brazilian 'Blue Amazon'	PLOS ONE			English	Article							SPOTTED EAGLE RAY; MOVEMENT PATTERNS; EARLY MIOCENE; POPULATION-STRUCTURE; FISH ASSEMBLAGE; SEA-LEVEL; ISOTOPIC COMPOSITION; CARCHARHINUS-LEUCAS; STRONTIUM ISOTOPES; RHINOPTERA-BONASUS	The lower Miocene Pirabas Formation in the North of Brazil was deposited under influence of the proto-Amazon River and is characterized by large changes in the ecological niches from the early Miocene onwards. To evaluate these ecological changes, the elasmobranch fauna of the fully marine, carbonate-rich beds was investigated. A diverse fauna with 24 taxa of sharks and rays was identified with the dominant groups being carcharhiniforms and myliobatiforms. This faunal composition is similar to other early Miocene assemblages from the proto-Carribbean bioprovince. However, the Pirabas Formation has unique features compared to the other localities; being the only Neogene fossil fish assemblage described from the Atlantic coast of Tropical Americas. Phosphate oxygen isotope composition of elasmobranch teeth served as proxies for paleotemperatures and paleoecology. The data are compatible with a predominantly tropical marine setting with recognized inshore and offshore habitats with some probable depth preferences (e.g., Aetomylaeus groups). Paleohabitat of taxa particularly found in the Neogene of the Americas (+Carcharhinus ackermannii, +Aetomylaeus cubensis) are estimated to have been principally coastal and shallow waters. Larger variation among the few analyzed modern selachians reflects a larger range for the isotopic composition of recent seawater compared to the early Miocene. This probably links to an increased influence of the Amazon River in the coastal regions during the Holocene.	[Aguilera, Orangel; Monteiro-Neto, Cassiano] Univ Fed Fluminense, Inst Biol, Dept Biol Marinha, Rio De Janeiro, Brazil; [Aguilera, Orangel; Luz, Zoneibe; Nogueira, Afonso] Univ Fed Para, Inst Geociencias, Belem, Para, Brazil; [Carrillo-Briceno, Jorge D.] Univ Zurich, Palaeontol Inst & Museum, Zurich, Canton Of Zuric, Switzerland; [Kocsis, Laszlo] Univ Brunei Darussalam, Fac Sci, Geol Grp, Jalan Tungku, Gadong, Brunei; [Luz, Zoneibe; Vennemann, Torsten W.] Univ Lausanne, Inst Dynam Surface Terrestre, Lausanne, Vaud, Switzerland; [de Toledo, Peter Mann] Inst Nacl Pesquisas Espaciais, Sao Paulo, Brazil; [Amorim, Kamilla Borges] Univ Sao Paulo, Inst Astron Geofis & Ciencias Atmosfer, Sao Paulo, Brazil; [Moraes-Santos, Heloisa; Ruivo, Maria de Lourdes; Linhares, Ana Paula] Museu Paraense Emilio Goeldi, Coordenacao Ciencias Terra & Ecol, Belem, Para, Brazil; [Polck, Marcia Reis] Dept Nacl Prod Mineral, Rio De Janeiro, RJ, Brazil	Universidade Federal Fluminense; Universidade Federal do Para; University of Zurich; University Brunei Darussalam; University of Lausanne; Instituto Nacional de Pesquisas Espaciais (INPE); Universidade de Sao Paulo; Museu Paraense Emilio Goeldi	Luz, Z (corresponding author), Univ Fed Para, Inst Geociencias, Belem, Para, Brazil.; Luz, Z (corresponding author), Univ Lausanne, Inst Dynam Surface Terrestre, Lausanne, Vaud, Switzerland.	zoneibe.luz@gmail.com	Aguilera, Orangel/D-5055-2013; Toledo, Peter M/P-3618-2015	Toledo, Peter M/0000-0003-4265-2624; Borges Amorim, Kamilla/0000-0002-5031-402X; Luz, Zoneibe/0000-0002-8920-7694; NOGUEIRA, AFONSO/0000-0002-5225-9255; Aguilera, Orangel/0000-0003-4418-8351; Kocsis, Laszlo/0000-0003-4613-1850	National Counsel of Technological and Scientific Development (CNPq); Museum Paraense Emilio Goeldi (MPEG); Departamento Nacional de Producao Mineral (DNPM); Universidade Federal Fluminense (UFF); Universidade Federal do Para (UFPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [ICAAF 111/2014]; Instituto Nacional de Ciencia e Tecnologia (INCT) in Brazil; Palaeontological Institute and Museum at the University of Zurich; University of Lausanne	National Counsel of Technological and Scientific Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Museum Paraense Emilio Goeldi (MPEG); Departamento Nacional de Producao Mineral (DNPM); Universidade Federal Fluminense (UFF); Universidade Federal do Para (UFPA); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Instituto Nacional de Ciencia e Tecnologia (INCT) in Brazil; Palaeontological Institute and Museum at the University of Zurich; University of Lausanne	This research was supported by the National Counsel of Technological and Scientific Development (CNPq) (http//www.cnpq.br, to O.A.), the Museum Paraense Emilio Goeldi (MPEG) (http://www.museu-goeldi.br/, to O.A., H.M-S, M.L. R., A.P.L.), the Departamento Nacional de Producao Mineral (DNPM) (http://www.dnpm.gov.br/, to M.R.P), the Universidade Federal Fluminense (UFF) (http://www.uff.br/, to O.A., C.M.-N.), the Universidade Federal do Para (UFPA) (http://www.portal.ufpa.br,to O.A., A.N., K.B.A.), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) (http://www.capes.gov.br/, to Z.L.), Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (http://ww.fapespa.pa.gov.br/, ICAAF 111/2014, to A.N.), Instituto Nacional de Ciencia e Tecnologia (INCT) (http://inct.cnpq.br/home/, to P.T., Z.L.) in Brazil and the Palaeontological Institute and Museum at the University of Zurich (http://www.pim.uzh.ch, to J.C-B.) as well as the University of Lausanne for the financial support of the isotopic analyses.	Agassiz L., 1835, NEUES JB MINERALOGIE, V1835, P290; Aguilera O, 2001, J PALEONTOL, V75, P732, DOI 10.1666/0022-3360(2001)075<0732:AECUFA>2.0.CO;2; Aguilera O. A., 2016, PALAEO ICHTHYOLOGICA, V14, P7; Aguilera OA, 2010, PECES FOSILES CARIBE; Aguilera O, 2014, J S AM EARTH SCI, V56, P422, DOI 10.1016/j.jsames.2014.09.021; Aguilera Orangel, 2013, Swiss Journal of Palaeontology, V132, P99, DOI 10.1007/s13358-013-0051-5; Aguilera Orangel A., 2010, P129; Aguilera Orangel Antonio, 2013, Swiss Journal of Palaeontology, V132, P45, DOI 10.1007/s13358-013-0052-4; Aguilera Socorro Orangel, 2012, Boletim do Museu Paraense Emilio Goeldi Ciencias Naturais, V7, P29; Aguilera Socorro Orangel Antonio, 2011, Swiss Journal of Palaeontology, V130, P217, DOI 10.1007/s13358-011-0020-9; Cabrera DA, 2012, AMEGHINIANA, V49, P126, DOI 10.5710/AMGH.v49i1(469); Alvan A., 2006, 13 C PER GEOL LIM 17, P595; Bezerra ISAA, 2015, BRAZ J GEOL, V45, P63, DOI 10.1590/2317-4889201530124; Ameghino Florentino, 1906, Anales del Museo Nacional Buenos Aires Ser 3, V8, P1; Amiot R, 2008, PALAEOGEOGR PALAEOCL, V264, P85, DOI 10.1016/j.palaeo.2008.04.001; Andrianavalona TH, 2015, PLOS BIOL, V10, P1; [Anonymous], 1999, LEIPZIGER GEOWISSENS, P9; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Antunes M. T, 1970, Revta Fac. Cienc. Univ. Lisb. (Cienc. nat.), V16, P119; Antunes MT, 1964, NEOCRETA CICO CENOZO; Antunes MT, 1970, REV FAC CIENCIAS LIS, V16, P1; Apolin J., 2004, PUBLICACION ESPECIAL, V6, P401; Argyriou T, 2015, J AFR EARTH SCI, V102, P86, DOI 10.1016/j.jafrearsci.2014.11.008; Arratia Gloria, 1996, Muenchner Geowissenschaftliche Abhandlungen Reihe A Geologie und Palaeontologie, V30, P9; Barker A. S., 2006, IUCN RED LIST THREAT; BARRICK RE, 1993, PALEOCEANOGRAPHY, V8, P845, DOI 10.1029/93PA01412; Bassin C., 2000, EOS T AGU, V81, pF897, DOI DOI 10.1007/S00015-005-1168-3; Bassos-Hull K, 2014, ENVIRON BIOL FISH, V97, P1039, DOI 10.1007/s10641-014-0294-z; Billups K, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000567; Blainville H, 1816, B SOC PHILOMATHIQUE, V8, P121; Blake C.C., 1862, GEOLOGIST, V5, P316; Boessenecker Robert W., 2011, PalArch's Journal of Vertebrate Palaeontology, V8, P1; Bohme M, 2003, PALAEOGEOGR PALAEOCL, V195, P389, DOI 10.1016/S0031-0182(03)00367-5; Bonaparte C.L., 1838, NOUVELLES ANN SCI NA, V2, P195; Bor T, 2012, MIOCENE CHONDRICHTHY, P21; Buchmann F, 1997, NOTAS TE CNICAS, V10, P7; Cadenat J., 1963, Bull Inst franY Afr noire, V25A, P526; Campos D.A., 1984, LEXICO ESTRATIGRAFIC; Cappetta H., 2012, HDB PALEOICHTHYOLOGY; Cappetta H., 1970, SELACIENS MIOCENE RE; Carlson JK, 2014, AQUAT CONSERV, V24, P104, DOI 10.1002/aqc.2382; Carlson JK, 2010, J FISH BIOL, V77, P661, DOI 10.1111/j.1095-8649.2010.02707.x; Carr BJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145396; Carrillo-Briceno JD, 2016, PALAEONTOL ELECTRON, V19, P1; Carrillo-Briceno JD, 2016, AMEGHINIANA, V53, P77, DOI 10.5710/AMGH.26.10.2015.2931; Carrillo-Briceno JD, 2015, J S AM EARTH SCI, V60, P56, DOI 10.1016/j.jsames.2015.02.001; Carrillo-Briceno JD, 2014, J S AM EARTH SCI, V51, P76, DOI 10.1016/j.jsames.2014.01.001; Carrillo-Briceno JD, 2013, REV CHIL HIST NAT, V86, P191, DOI 10.4067/S0716-078X2013000200008; CASE G R, 1980, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V171, P75; CASIER E, 1958, MEMOIRES SUISSES PAL, V74, P1, DOI DOI 10.1111/J.1463-6395.2011.00502.X; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Cicimurri David J., 2014, PalArch's Journal of Vertebrate Palaeontology, V11, P1; Coates AG, 2004, GEOL SOC AM BULL, V116, P1327, DOI 10.1130/B25275.1; Coates AG, 2003, GEOL SOC AM BULL, V115, P271, DOI 10.1130/0016-7606(2003)115<0271:ENHOTC>2.0.CO;2; Coates AG, 2013, B MAR SCI, V89, P801, DOI 10.5343/bms.2012.1076; Collins AB, 2007, J FISH BIOL, V71, P1159, DOI 10.1111/j.1095-8649.2007.01590.x; Collins AB, 2008, ESTUAR COAST, V31, P1174, DOI 10.1007/s12237-008-9100-5; COMPAGNO L.J.V., 1998, FAO SPECIES IDENTI 1, V3, P1410; COMPAGNO L.J.V., 1999, FAO SPECIES IDENTIFI, P1467; Compagno L.J.V., 2005, SHARKS WORLD; COMPAGNO LJV, 1977, AM ZOOL, V17, P303; Compagno LJV, 1973, ZOOL J LINN SOC S1, P15; Cope E. D., 1867, P ACAD NAT SCI PHILA, V19, P138; Costa S., 2009, B MUS PARA EMILIO GO, V4, P221; Costa SARF, 2011, THESIS U FEDERAL PAR; Cuvier G., 1829, REGNE ANIMAL DISTRIB; DACULSI G, 1980, ARCH ORAL BIOL, V25, P145, DOI 10.1016/0003-9969(80)90013-8; Dartevelle E., 1943, ANN MUSEE CONGO BE A, V2, P1; Dera G, 2009, EARTH PLANET SC LETT, V286, P198, DOI 10.1016/j.epsl.2009.06.027; Dewar H, 2008, MAR BIOL, V155, P121, DOI 10.1007/s00227-008-0988-x; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier ML, 2008, MAR ECOL PROG SER, V370, P221, DOI 10.3354/meps07628; Donovan Stephen K., 2001, Bulletin of the Mizunami Fossil Museum, V28, P211; Ebert D. A., 2003, SHARKS RAYS CHIMAERA; Ebert DA, 2013, FAO SPECIES CATA LOG; Ebert DA, 2013, SHARK WORLD; Enault S, 2015, ZOOL J LINN SOC-LOND, V174, P549, DOI 10.1111/zoj.12244; Enault S, 2013, ZOOL J LINN SOC-LOND, V169, P144, DOI 10.1111/zoj.12059; Feldheim KA, 2014, MOL ECOL, V23, P110, DOI 10.1111/mec.12583; Figueiredo J, 2009, GEOLOGY, V37, P619, DOI 10.1130/G25567A.1; Fischer J, 2014, HIST BIOL, V26, P710, DOI 10.1080/08912963.2013.838953; Fischer J, 2013, CHEM GEOL, V342, P44, DOI 10.1016/j.chemgeo.2013.01.022; Fischer J, 2012, PALAEOGEOGR PALAEOCL, V353, P60, DOI 10.1016/j.palaeo.2012.07.002; Froese R., 2016, WORLD WIDE WEB ELECT; Garman S., 1913, Memoirs of the Museum of Comparative Zoology at Harvard College Cambridge, V36; Garman Samuel, 1908, Bulletin of the Museum of Comparative Zoology at Harvard College, V51; Geoffroy Saint-Hilare E., 1817, EMPEREUR NAPOLE GRAN, V1, P18; Gill, 1872, ARRANGEMENT FAMILIES; Gill T.N., 1862, P ACAD NAT SCI PHILA, V14, P329; Gillette D.D., 1984, Journal of Vertebrate Paleontology, V4, P172; Glikman LS., 1964, SHARKS PALEOGENE THE; Goes A.M., 1990, B MUSEU PARAENSE CT, V2, P3; Gonzalez-Barba G., 2000, 17 S GEOL LAT RES EX, V18, P1; Gorini C, 2014, TERRA NOVA, V26, P179, DOI 10.1111/ter.12083; Gray J., 1834, ILLUSTRATIONS INDIAN; Gregory-Wodzicki KM, 2000, GEOL SOC AM BULL, V112, P1091, DOI 10.1130/0016-7606(2000)112<1091:UHOTCA>2.0.CO;2; Halfar J, 2005, GEOLOGY, V33, P481, DOI 10.1130/G21462.1; HAQ BU, 1987, SCIENCE, V235, P1156, DOI 10.1126/science.235.4793.1156; Hasse K, 1879, MORPHOLOGISCHE PALAO, V1; HERMAN J, 1991, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Biologie, V61, P73; Heupel MR, 2010, MAR FRESHWATER RES, V61, P1, DOI 10.1071/MF09019; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Horton B.K., 2010, GSAT, V20, P4, DOI [10.1130/GSATG76A.1, DOI 10.1130/GSATG76A.1]; HULBERT RC, 2001, FOSSIL VERTEBRATES F; Iturralde-Vinent M., 1996, Journal of the Geological Society of Jamaica, V31, P7; Iturralde-Vinent M, 1998, REV SOC MEXICANA PAL, V8, P135; Iturralde-Vinent MA, 1999, B AM MUS NAT HIST, P1; Jackson JBC, 2013, B MAR SCI, V89, P779, DOI 10.5343/bms.2012.1096; Jordan D.S., 1896, B US NAT MUS, V47, P1, DOI [10.5962/bhl.title.39714, DOI 10.5962/BHL.TITLE.46755]; Jordan DS, 1888, P ACAD NAT SCI PHILA, V39, P387; Jorgensen SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047819; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Karr JD, 2002, OCEANOL ACTA, V25, P71, DOI 10.1016/S0399-1784(02)01183-0; Kindlimann R., 1990, B LIMA, V69, P91; Kocsis L, 2009, PALAEOGEOGR PALAEOCL, V271, P117, DOI 10.1016/j.palaeo.2008.10.003; Kocsis L, 2015, ENVIRON BIOL FISH, V98, P1609, DOI 10.1007/s10641-015-0386-4; Kocsis L, 2014, PALAEOGEOGR PALAEOCL, V394, P74, DOI 10.1016/j.palaeo.2013.11.002; Kocsis L, 2011, CHIMIA, V65, P787, DOI 10.2533/chimia.2011.787; KOLODNY Y, 1983, EARTH PLANET SC LETT, V64, P398, DOI 10.1016/0012-821X(83)90100-0; Kominz MA, 2008, BASIN RES, V20, P211, DOI 10.1111/j.1365-2117.2008.00354.x; Kruckow T., 1990, Courier Forschungsinstitut Senckenberg, V119, P1; Kyne PM, 2003, AETOMYLAEUS NICHOFII; Landau B, 2008, PALAEOGEOGR PALAEOCL, V257, P445, DOI 10.1016/j.palaeo.2007.10.019; Laurito C. A, 1999, SELACEOS FOSILES LOC; Laurito Cesar A., 2008, Revista Geologica de America Central, V39, P65; Lecuyer C, 1996, PALAEOGEOGR PALAEOCL, V126, P61, DOI 10.1016/S0031-0182(96)00070-3; LECUYER C, 1993, PALAEOGEOGR PALAEOCL, V105, P235, DOI 10.1016/0031-0182(93)90085-W; Lecuyer C, 2013, CHEM GEOL, V347, P217, DOI 10.1016/j.chemgeo.2013.03.008; Leite F.P.R., 2004, NOGENO AMAZO NIA ORI, P55; Lessa R, 1999, MAR FRESHWATER RES, V50, P383, DOI 10.1071/MF98127; Lessa Rosangela, 1997, Cybium, V21, P123; Leuzinger L, 2015, BIOGEOSCIENCES, V12, P6945, DOI 10.5194/bg-12-6945-2015; Long Douglas J., 1993, Tertiary Research, V14, P117; LONGINEL.A, 1973, EARTH PLANET SC LETT, V20, P337, DOI 10.1016/0012-821X(73)90007-1; LONGINELLI A, 1973, EARTH PLANET SC LETT, V19, P373, DOI 10.1016/0012-821X(73)90088-5; Lowe Christopher G., 2006, Atoll Research Bulletin, P281; Lucuyer C., 2004, HDB STABLE ISOTOPE A, P482, DOI [DOI 10.1016/B978-044451114-0/50024-7, 10.1016/B978-044451114-0/50024-7]; Cione AL, 2011, BIOL J LINN SOC, V103, P423, DOI 10.1111/j.1095-8312.2011.01685.x; Marsili S, 2007, RIV ITAL PALEONTOL S, V113, P79, DOI 10.13130/2039-4942/6360; Matsubara K., 1936, Dobutsugaku Zasshi Tokyo, V48, P380; Maury C. J., 1925, MONOGRAFIA SERVICO G, V4; MOLLER IJ, 1975, ARCH ORAL BIOL, V20, P797, DOI 10.1016/0003-9969(75)90056-4; Montes C, 2015, SCIENCE, V348, P226, DOI 10.1126/science.aaa2815; Moura RL, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501252; Muller George Friedrich, 1760, KONIGLICH PREUSSISCH; Muller J, 1839, SYSTEMATISCHE BESCHR; NISHDA K, 1990, Memoirs of the Faculty of Fisheries Hokkaido University, V37, P1; O'Dea A, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600883; Pellegrini M, 2008, PALAEOGEOGR PALAEOCL, V266, P119, DOI 10.1016/j.palaeo.2008.03.017; Pimiento C, 2013, J PALEONTOL, V87, P755, DOI 10.1666/12-117; Pimiento C, 2013, J S AM EARTH SCI, V42, P159, DOI 10.1016/j.jsames.2012.11.005; Pindell J., 2009, GEOLOGY EVOLUTION RE; Pindell J. L., 1995, AAPG MEMOIR, V62, P101; Poey F., 1876, ANALES SOC ESPANOLA, V5, P373; Portell RW, 2008, CARIBB J SCI, V44, P279; Posner A. S., 1984, Phosphate Minerals, P330; Puceat E, 2003, PALEOCEANOGRAPHY, V18, DOI 10.1029/2002PA000823; Puceat E, 2007, GEOLOGY, V35, P107, DOI 10.1130/G23103A.1; Purdy RW, 2001, SM C PALEOB, V90, P71; Ranzani C, 1839, DISS PRIMA NOVI COMM, V4, P65; Reinecke Thomas, 2011, Palaeontos, V20, P1; Reis MAF., 2005, ANUARIO I GEOCIENC, V28, P31; Nogueira ACR, 2013, J S AM EARTH SCI, V46, P89, DOI 10.1016/j.jsames.2013.05.004; Rossetti D.F., 2004, NE OGENO AMAZO NIA O, P13; Rossetti DD, 2001, J S AM EARTH SCI, V14, P77; Rossetti DF, 2015, SEDIMENT GEOL, V330, P1, DOI 10.1016/j.sedgeo.2015.10.001; Rossetti DF, 2013, EARTH-SCI REV, V123, P87, DOI 10.1016/j.earscirev.2013.04.005; Ruppell W, 1837, FISCHE ROTHEN MEERES; Santos R, 1971, B MUSEU PARAENSE EMI, V16, P1; Santos R, 1960, MONOGRAFIA DIVISAO G; Schwarzhans Werner, 2013, Palaeo Ichthyologica, V13, P83; Sellas AB, 2015, J HERED, V106, P266, DOI 10.1093/jhered/esv011; Shephard GE, 2010, NAT GEOSCI, V3, P870, DOI [10.1038/ngeo1017, 10.1038/NGEO1017]; Skinner H.C.W, 2003, TREATISE GEOCHEMISTR, V8, P117; Soares Junior A.V., 2011, GEOCIE NCIAS UNESP, V30, P669; Suarez M, 2003, 10 C GEOL CHIL; Suarez M., 2006, CAINOZOIC RES, V4, P3; Underwood C. J., 2004, CAINOZOIC RES, V3, P157; Underwood CJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122553; Vennemann TW, 2001, GEOCHIM COSMOCHIM AC, V65, P1583, DOI 10.1016/S0016-7037(00)00629-3; Voigt M., 2011, FIELD GUIDE SHARKS G; White C, 1887, CONTRIBUICAO PALEONT; White W. T., 2006, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2006.RLTS.T60120A12307534.en; White WT, 2014, ZOOTAXA, V3860, P149, DOI 10.11646/zootaxa.3860.2.3; Whitley G. P., 1929, Australian Zoologist, V5, P353; Whitley G. P., 1940, FISHES AUSTR 1; Woodward A, 1889, RITISH MUSEUM NATURA; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P2245, DOI 10.1016/j.gca.2003.11.009; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	190	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182740	10.1371/journal.pone.0182740	http://dx.doi.org/10.1371/journal.pone.0182740			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832664	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000408355800031
J	Chen, Q; Wu, H; Tao, J; Liu, CL; Deng, ZY; Liu, Y; Chen, GQ; Liu, BY; Xu, CS				Chen, Qiang; Wu, Hui; Tao, Jia; Liu, Chenglong; Deng, Zeyu; Liu, Yang; Chen, Guoqiao; Liu, Baoyun; Xu, Changshui			Effect of naringin on gp120-induced injury mediated by P2X(7) receptors in rat primary cultured microglia	PLOS ONE			English	Article							AIDS DEMENTIA COMPLEX; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; GP120; ATP; HIV; ACTIVATION; MODULATION; EXPRESSION; IL-1-BETA	Human immunodeficiency virus type-1 (HIV-1) envelope glycoprotein 120 has been shown to activate microglia, causing release of inflammatory and toxic factors. The P2X(7) receptor, primarily expressed on microglia, is closely associated with inflammation. Naringin, a plant bioflavonoid, has anti-inflammatory and anti-oxidative properties. We hypothesized that P2X(7) receptor mediated gp120-induced injury in primary cultured microglia, and that naringin would have a protective effect. We showed that HIV-1 gp120 peptide (V3 loop, fragment 308-331) appeared to induce apoptosis of primary cultured microglia. However, there was a decrease of microglia apoptosis in gp120+naringin group compared with gp120 group. Using qPCR, Western blot, and immunofluorescence, we showed that gp120 stimulated expression of P2X(7) mRNA and receptor protein, and this stimulation was inhibited by naringin. Treatment with gp120 increased concentrations of eATP, TNF alpha and IL-1 beta, and these effects were inhibited by naringin. Taken together, these results suggested that gp120 contributed to microglial cell injury and neurotoxic activity by up-regulating expression of P2X(7), in a naringin-protective manner.	[Chen, Qiang; Liu, Chenglong; Deng, Zeyu; Xu, Changshui] Nanchang Univ, Basic Med Coll, Dept Physiol, Nanchang, Jiangxi, Peoples R China; [Wu, Hui; Tao, Jia] Nanchang Univ, Clin Med Coll 2, Nanchang, Jiangxi, Peoples R China; [Liu, Yang; Chen, Guoqiao; Liu, Baoyun] Nanchang Univ, Clin Med Coll 1, Nanchang, Jiangxi, Peoples R China	Nanchang University; Nanchang University; Nanchang University	Xu, CS (corresponding author), Nanchang Univ, Basic Med Coll, Dept Physiol, Nanchang, Jiangxi, Peoples R China.	xuchangshui@ncu.edu.cn		Tao, Jia/0000-0002-1388-4410; Xu, Changshui/0000-0002-3928-3605; Liu, Chenglong/0000-0001-8235-8513	National Natural Science Foundation of China [81260187]; Cultivating Foundation of Young Scientists of Jiangxi Province [20153BCB23033]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Cultivating Foundation of Young Scientists of Jiangxi Province	This work was supported by a grant (No. 81260187) from the National Natural Science Foundation of China (URL: http://www.nsfc.gov.cn/), a grant (No. 20153BCB23033) from the Cultivating Foundation of Young Scientists (Star of Jinggang) of Jiangxi Province (URL: http://www.jxstc.gov.cn/); all grants were received by Changshui Xu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett R, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271813; Brabers NACH, 2006, EUR J CLIN INVEST, V36, P447, DOI 10.1111/j.1365-2362.2006.01657.x; Burm SM, 2016, GLIA, V64, P2231, DOI 10.1002/glia.23059; Chen NC, 2017, GLIA, V65, P431, DOI 10.1002/glia.23081; Chen Q., 2016, GENET MOL RES, V15; Chen Q, 2016, INFLAMMATION, V39, P1814, DOI 10.1007/s10753-016-0417-0; Chtourou Y, 2015, CHEM-BIOL INTERACT, V239, P76, DOI 10.1016/j.cbi.2015.06.036; Cui QJ, 2014, NEUROCHEM RES, V39, P1254, DOI 10.1007/s11064-014-1306-2; Di Virgilio F, 2016, BIOMED J, V39, P326, DOI 10.1016/j.bj.2016.08.006; Emileh A, 2014, BIOCHEMISTRY-US, V53, P3403, DOI 10.1021/bi500136f; Fang KM, 2009, J NEUROCHEM, V111, P1225, DOI 10.1111/j.1471-4159.2009.06409.x; Feng JF, 2015, PURINERG SIGNAL, V11, P361, DOI 10.1007/s11302-015-9458-3; Ferrari D, 1997, NEUROPHARMACOLOGY, V36, P1295, DOI 10.1016/S0028-3908(97)00137-8; Garden GA, 2002, GLIA, V40, P240, DOI 10.1002/glia.10155; Gopinath K, 2016, CAN J PHYSIOL PHARM, V94, P65, DOI 10.1139/cjpp-2015-0035; Guo LY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070565; Hao F, 2013, NEUROCHEM RES, V38, P1002, DOI 10.1007/s11064-013-1010-7; High KP, 2012, JAIDS-J ACQ IMM DEF, V60, pS1, DOI 10.1097/QAI.0b013e31825a3668; Jin JJ, 2012, AM J TRANSL RES, V4, P302; Kesby JP, 2015, EUR NEUROPSYCHOPHARM, V25, P141, DOI 10.1016/j.euroneuro.2014.07.014; Kim HD, 2016, J NUTR BIOCHEM, V28, P140, DOI 10.1016/j.jnutbio.2015.10.013; Li WS, 2014, CURR PHARM BIOTECHNO, V15, P1173, DOI 10.2174/1389201015666141111114442; Lioi AB, 2015, J IMMUNOL, V195, P4438, DOI 10.4049/jimmunol.1401319; Lisi L, 2012, J NEUROCHEM, V120, P106, DOI 10.1111/j.1471-4159.2011.07549.x; Liu B, 2001, J NEUROCHEM, V77, P182, DOI 10.1046/j.1471-4159.2001.t01-1-00216.x; Louboutin JP, 2014, ANTIOXIDANTS-BASEL, V3, P770, DOI 10.3390/antiox3040770; Lynch RM, 2015, J VIROL, V89, P4201, DOI 10.1128/JVI.03608-14; Monif M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0621-8; Monif M, 2009, J NEUROSCI, V29, P3781, DOI 10.1523/JNEUROSCI.5512-08.2009; Navia BA, 2005, NEUROTOX RES, V8, P3, DOI 10.1007/BF03033817; Potucek YD, 2006, NEUROCHEM INT, V49, P204, DOI 10.1016/j.neuint.2006.04.005; Qin SS, 2016, BRAIN RES BULL, V124, P164, DOI 10.1016/j.brainresbull.2016.04.020; Suzuki T, 2004, J NEUROSCI, V24, P1, DOI 10.1523/JNEUROSCI.3792-03.2004; Valdez AN, 2016, NEUROBIOL STRESS, V4, P44, DOI 10.1016/j.ynstr.2016.02.005; Walsh JG, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-35; Xu CS, 2011, GLIA, V59, P997, DOI 10.1002/glia.21171; Yan YF, 2011, CHINESE MED J-PEKING, V124, P4217, DOI 10.3760/cma.j.issn.0366-6999.2011.24.018; Yiangou Y, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-12	38	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183688	10.1371/journal.pone.0183688	http://dx.doi.org/10.1371/journal.pone.0183688			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832643	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800081
J	Hung, CY; Wu, WT; Chang, KV; Wang, TG; Han, DS				Hung, Chen-Yu; Wu, Wei-Ting; Chang, Ke-Vin; Wang, Tyng-Guey; Han, Der-Sheng			Predicting the length of hospital stay of post-acute care patients in Taiwan using the Chinese version of the continuity assessment record and evaluation item set	PLOS ONE			English	Article							INDWELLING URINARY CATHETERS; OF-STAY; ACUTE STROKE; DISCHARGE DESTINATION; ISCHEMIC-STROKE; POSTACUTE CARE; REHABILITATION; EXPERIENCE; ADMISSION; DURATION	Background The Chinese version of the Continuity Assessment Record and Evaluation (CARE-C) item set was developed to facilitate the assessment of post-acute care (PAC) patients in Taiwan. Considering that the length of hospital stay (LOS) has a significant effect on the total healthcare cost, determining whether the CARE-C scores could predict the LOS of PAC patients is of great interest to the PAC providers. Methods This prospective trial included PAC patients with stroke or central nervous system injuries. The demographic data and CARE-C scores were collected after admission and before discharge. A multivariable stepwise linear regression model was used to identify the predictors of the LOS using age, sex, tube placement status, CARE-C component scores at admission, and score differences between admission and discharge as independent variables. Results This study included 178 patients (66 women and 112 men), with a mean age of 61.9 +/- 15.6 years. Indwelling urinary catheter placement status at admission (beta = 0.241, p = 0.002) was a positive predictor of the LOS, whereas age (beta = -0.189, p = 0.010), core transfer subscale score at admission (beta = -0.176, p = 0.020), and difference in continence subscale score (beta = -0.203, p = 0.008) were negative predictors of the LOS. The model explained 14% of the total variance. Conclusions Indwelling urinary catheter placement status at admission, age, core transfer subscale score at admission, and difference in the CARE-C continence subscale score were identified as predictors of the LOS. The explanatory power of these predictors might be limited due to the regulations of Taiwan's National Health Insurance.	[Hung, Chen-Yu; Wu, Wei-Ting; Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, BeiHu Branch, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chang, Ke-Vin; Han, Der-Sheng] Natl Taiwan Univ Hosp, BeiHu Branch, Community & Geriatr Med Res Ctr, Taipei, Taiwan; [Chang, Ke-Vin; Wang, Tyng-Guey; Han, Der-Sheng] Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan; [Chang, Ke-Vin; Wang, Tyng-Guey; Han, Der-Sheng] Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan	National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Han, DS (corresponding author), Natl Taiwan Univ Hosp, BeiHu Branch, Dept Phys Med & Rehabil, Taipei, Taiwan.; Han, DS (corresponding author), Natl Taiwan Univ Hosp, BeiHu Branch, Community & Geriatr Med Res Ctr, Taipei, Taiwan.; Han, DS (corresponding author), Natl Taiwan Univ Hosp, Dept Phys Med & Rehabil, Taipei, Taiwan.; Han, DS (corresponding author), Natl Taiwan Univ, Coll Med, Dept Phys Med & Rehabil, Taipei, Taiwan.	dshan1121@yahoo.com.tw		HAN, DER-SHENG/0000-0001-7642-8060; WANG, TYNG-GUEY/0000-0003-3298-4916	Taiwanese Society of Physical Medicine and Rehabilitation; Bureau of National Health Insurance [F1030033722]	Taiwanese Society of Physical Medicine and Rehabilitation; Bureau of National Health Insurance	This study was sponsored by the Taiwanese Society of Physical Medicine and Rehabilitation, and the Bureau of National Health Insurance grant No. F1030033722. The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atalay A, 2009, INT J REHABIL RES, V32, P48, DOI 10.1097/MRR.0b013e32830d3689; Beckers V, 2012, ACTA NEUROL BELG, V112, P19, DOI 10.1007/s13760-012-0026-0; Bettger JAP, 2007, ARCH PHYS MED REHAB, V88, P1526, DOI 10.1016/j.apmr.2007.06.768; Bogousslavsky J, 1996, ARCH NEUROL-CHICAGO, V53, P265, DOI 10.1001/archneur.1996.00550030077025; Bohannon R W, 1994, J Stroke Cerebrovasc Dis, V4, P235, DOI 10.1016/S1052-3057(10)80097-7; Chang KC, 2002, STROKE, V33, P2670, DOI 10.1161/01.STR.0000034396.68980.39; Chang KV, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001828; Cowey E, 2012, CLIN REHABIL, V26, P470, DOI 10.1177/0269215511426160; DeJong G, 2014, ARCH PHYS MED REHAB, V95, P218, DOI 10.1016/j.apmr.2013.10.014; Deutsch A, 2012, CONTINUITY ASSESSMEN; Elwood D, 2009, PM&R, V1, P147, DOI 10.1016/j.pmrj.2008.10.010; Gage B., 2012, DEV TESTING CONTINUI; GALSKI T, 1993, STROKE, V24, P1794, DOI 10.1161/01.STR.24.12.1794; Holloway RG, 1996, NEUROLOGY, V46, P854; Holroyd-Leduc JM, 2007, J AM GERIATR SOC, V55, P227, DOI 10.1111/j.1532-5415.2007.01064.x; Hsieh CY, 2014, INT J STROKE, V9, pE3, DOI 10.1111/ijs.12232; Huang YC, 2013, J STROKE CEREBROVASC, V22, pE152, DOI 10.1016/j.jstrokecerebrovasdis.2012.10.014; Jorgensen HS, 1997, STROKE, V28, P1138, DOI 10.1161/01.STR.28.6.1138; Lin CL, 2009, J FORMOS MED ASSOC, V108, P653, DOI 10.1016/S0929-6646(09)60386-7; Saint S, 2000, AM J MED, V109, P476, DOI 10.1016/S0002-9343(00)00531-3; SHAH S, 1990, STROKE, V21, P241, DOI 10.1161/01.STR.21.2.241; Shieh G, 2014, BEHAV RES METHODS, V46, P808, DOI 10.3758/s13428-013-0415-1; Taiwo W, 2016, DISABIL REHABIL, P1; Tan WS, 2009, ARCH PHYS MED REHAB, V90, P1202, DOI 10.1016/j.apmr.2009.01.027; Wee JYM, 2005, AM J PHYS MED REHAB, V84, P604, DOI 10.1097/01.phm.0000171005.08744.ab; Wen CP, 2008, ANN INTERN MED, V148, P258, DOI 10.7326/0003-4819-148-4-200802190-00004; Wu CH, 2013, NEUROUROL URODYNAM, V32, P480, DOI 10.1002/nau.22317; Yeh HJ, 2017, ARCH PHYS MED REHAB, V98, P707, DOI 10.1016/j.apmr.2016.08.468	28	6	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183612	10.1371/journal.pone.0183612	http://dx.doi.org/10.1371/journal.pone.0183612			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832680	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800070
J	Kamal, N; Ganguly, J; Saile, E; Klee, SR; Hoffmaster, A; Carlson, RW; Forsberg, LS; Kannenberg, EL; Quinn, CP				Kamal, Nazia; Ganguly, Jhuma; Saile, Elke; Klee, Silke R.; Hoffmaster, Alex; Carlson, Russell W.; Forsberg, Lennart S.; Kannenberg, Elmar L.; Quinn, Conrad P.			Structural and immunochemical relatedness suggests a conserved pathogenicity motif for secondary cell wall polysaccharides in Bacillus anthracis and infection-associated Bacillus cereus	PLOS ONE			English	Article							O-ANTIGENIC POLYSACCHARIDE; N-ACETYLQUINOVOSAMINE; UNITED-STATES; IDENTIFICATION; STRAINS; SPECTROSCOPY; BACTERIA; ANTIBODY; UNIQUE; COMMON	Bacillus anthracis (Ba) and human infection-associated Bacillus cereus (Bc) strains Bc G9241 and Bc 03BB87 have secondary cell wall polysaccharides (SCWPs) comprising an aminoglycosyl trisaccharide repeat: -> 4)-beta-D-ManpNAc-(1 -> 4)-beta-D-GlcpNAc-(1 -> 6)-alpha-DGlcpNAc-( 1 ->,substituted at GlcNAc residues with both alpha-and beta-Galp. In Bc G9241 and Bc 03BB87, an additional alpha-Galp is attached to O-3 of ManNAc. Using NMR spectroscopy, mass spectrometry and immunochemical methods, we compared these structures to SCWPs from Bc biovar anthracis strains isolated from great apes displaying "anthrax-like" symptoms in Cameroon (Bc CA) and Co A te d'Ivoire (Bc CI). The SCWPs of Bc CA/CI contained the identical HexNAc trisaccharide backbone and Gal modifications found in Ba, together with the alpha-Gal-(1 -> 3) substitution observed previously at ManNAc residues only in Bc G9241/03BB87. Interestingly, the great ape derived strains displayed a unique alpha-Gal( 1 -> 3)-alpha-Gal-(1 -> 3) disaccharide substitution at some ManNAc residues, a modification not found in any previously examined Ba or Bc strain. Immuno-analysis with specific polyclonal anti-Ba SCWP antiserum demonstrated a reactivity hierarchy: high reactivity with SCWPs from Ba 7702 and Ba Sterne 34F2, and Bc G9241 and Bc 03BB87; intermediate reactivity with SCWPs from Bc CI/CA; and low reactivity with the SCWPs from structurally distinct Ba CDC684 (a unique strain producing an SCWP lacking all Gal substitutions) and non-infection- associated Bc ATCC10987 and Bc 14579 SCWPs. Ba-specific monoclonal antibody EAII-6G6-2-3 demonstrated a 10-20 fold reduced reactivity to Bc G9241 and Bc 03BB87 SCWPs compared to Ba 7702/34F2, and low/undetectable reactivity to SCWPs from Bc CI, Bc CA, Ba CDC684, and non-infection-associated Bc strains. Our data indicate that the HexNAc motif is conserved among infection-associated Ba and Bc isolates (regardless of human or great ape origin), and that the number, positions and structures of Gal substitutions confer unique antigenic properties. The conservation of this structural motif could open a new diagnostic route in detection of pathogenic Bc strains.	[Kamal, Nazia; Saile, Elke; Hoffmaster, Alex; Quinn, Conrad P.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Ganguly, Jhuma; Carlson, Russell W.; Forsberg, Lennart S.; Kannenberg, Elmar L.] Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA; [Ganguly, Jhuma] Indian Inst Engn Sci & Technol, Sibpur, W Bengal, India; [Klee, Silke R.; Kannenberg, Elmar L.] Robert Koch Inst, Ctr Biol Threats & Special Pathogens, Berlin, Germany	Centers for Disease Control & Prevention - USA; University System of Georgia; University of Georgia; Indian Institute of Engineering Science Technology Shibpur (IIEST); Robert Koch Institute	Forsberg, LS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, 220 Riverbend Rd, Athens, GA 30602 USA.	sforsb@ccrc.uga.edu	Ganguly, Jhuma/AAY-2927-2020	Ganguly, Jhuma/0000-0001-5119-6144; Quinn, Conrad/0000-0002-1576-8157	National Institutes of Health [R21 AI076753]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health award R21 AI076753 to RWC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonation KS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004923; ASH C, 1991, INT J SYST BACTERIOL, V41, P343, DOI 10.1099/00207713-41-3-343; BAX A, 1985, J MAGN RESON, V65, P355, DOI 10.1016/0022-2364(85)90018-6; BROWN WC, 1973, APPL MICROBIOL, V25, P295, DOI 10.1128/AEM.25.2.295-300.1973; Candela T, 2011, J BIOL CHEM, V286, P31250, DOI 10.1074/jbc.M111.249821; Carbohydrate Builder: Woods Group, 2005, GLYCAM WEB; CATALDI A, 1990, MOL MICROBIOL, V4, P1111, DOI 10.1111/j.1365-2958.1990.tb00685.x; Choudhury B, 2006, J BIOL CHEM, V281, P27932, DOI 10.1074/jbc.M605768200; CIUCANU I, 1984, CARBOHYD RES, V131, P209, DOI 10.1016/0008-6215(84)85242-8; Courtney B, 2013, J LAW MED ETHICS, V41, P22, DOI 10.1111/jlme.12033; DAVIS AL, 1991, J MAGN RESON, V94, P637, DOI 10.1016/0022-2364(91)90154-L; De BK, 2002, EMERG INFECT DIS, V8, P1060, DOI 10.3201/eid0810.020392; EZZELL JW, 1990, J CLIN MICROBIOL, V28, P223, DOI 10.1128/JCM.28.2.223-231.1990; Forsberg LS, 2008, J BIOL CHEM, V283, P16037, DOI 10.1074/jbc.M709615200; Forsberg LS, 2012, GLYCOBIOLOGY, V22, P1103, DOI 10.1093/glycob/cws080; Forsberg LS, 2011, GLYCOBIOLOGY, V21, P934, DOI 10.1093/glycob/cwr026; Forsberg LS, 2003, J BIOL CHEM, V278, P51347, DOI 10.1074/jbc.M309016200; Fournier B, 2005, CLIN MICROBIOL REV, V18, P521, DOI 10.1128/CMR.18.3.521-540.2005; GERWIG GJ, 1979, CARBOHYD RES, V77, P1, DOI 10.1016/S0008-6215(00)83788-X; Gevorkian G, 2005, BIOCHEM J, V387, P411, DOI 10.1042/BJ20041139; Goossens PL, 2009, MOL ASPECTS MED, V30, P467, DOI 10.1016/j.mam.2009.07.005; Helgason E, 2000, APPL ENVIRON MICROB, V66, P2627, DOI 10.1128/AEM.66.6.2627-2630.2000; HENDERSON I, 1994, INT J SYST BACTERIOL, V44, P99, DOI 10.1099/00207713-44-1-99; Hoffmaster AR, 2006, J CLIN MICROBIOL, V44, P3352, DOI 10.1128/JCM.00561-06; Hoffmaster AR, 2004, P NATL ACAD SCI USA, V101, P8449, DOI 10.1073/pnas.0402414101; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; Jernigan JA, 2001, EMERG INFECT DIS, V7, P933, DOI 10.3201/eid0706.010604; Keim P, 2001, J CLIN MICROBIOL, V39, P4566, DOI 10.1128/JCM.39.12.4566-4567.2001; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Klee SR, 2006, J BACTERIOL, V188, P5333, DOI 10.1128/JB.00303-06; Klee SR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010986; Lawrence TFW, 1916, J BACTERIOL, V1, P277; Leoff C, 2008, J BIOL CHEM, V283, P29812, DOI 10.1074/jbc.M803234200; Leoff C, 2008, J BACTERIOL, V190, P112, DOI 10.1128/JB.01292-07; Leoff C, 2009, GLYCOBIOLOGY, V19, P665, DOI 10.1093/glycob/cwp036; Li H, 2008, J IMMUNOL METHODS, V333, P89, DOI 10.1016/j.jim.2008.01.007; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; Niederweis M, 2010, TRENDS MICROBIOL, V18, P109, DOI 10.1016/j.tim.2009.12.005; Oppenheimer SB, 2008, ACTA HISTOCHEM, V110, P6, DOI 10.1016/j.acthis.2007.08.003; Petersen BO, 2006, CARBOHYD RES, V341, P550, DOI 10.1016/j.carres.2005.11.020; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Rasko DA, 2005, FEMS MICROBIOL REV, V29, P303, DOI 10.1016/j.femsre.2004.12.005; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Russell PK, 2012, BIOSECUR BIOTERROR, V10, P66, DOI 10.1089/bsp.2012.0305; Sterne M., 1937, OND J VET SCI AN IND, V9, P16; Verdaguer V, 2007, EXPERT REV MOL DIAGN, V7, P21, DOI 10.1586/14737159.7.1.21; Verez-Bencomo V, 2004, SCIENCE, V305, P522, DOI 10.1126/science.1095209; Weintraub A, 2003, CARBOHYD RES, V338, P2539, DOI 10.1016/j.carres.2003.07.008; Wilson JW, 2002, POSTGRAD MED J, V78, P216, DOI 10.1136/pmj.78.918.216; YORK WS, 1986, METHOD ENZYMOL, V118, P3; Zanetta JP, 1999, GLYCOBIOLOGY, V9, P255, DOI 10.1093/glycob/9.3.255	51	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183115	10.1371/journal.pone.0183115	http://dx.doi.org/10.1371/journal.pone.0183115			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832613	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800047
J	Lin, YH; Liao, XN; Fan, LL; Qu, YJ; Cheng, DY; Shi, YH				Lin, Yi-Hua; Liao, Xi-Ning; Fan, Li-Li; Qu, Yue-Jin; Cheng, De-Yun; Shi, Yong-Hong			Long-term treatment with budesonide/formoterol attenuates circulating CRP levels in chronic obstructive pulmonary disease patients of group D	PLOS ONE			English	Article							C-REACTIVE PROTEIN; METERED-DOSE INHALER; INFLAMMATORY BIOMARKERS; SYSTEMIC INFLAMMATION; COPD; FLUTICASONE; BUDESONIDE; MORTALITY; EFFICACY; COMORBIDITIES	Background The systemic inflammation is associated with clinical outcome and mortality in chronic obstructive pulmonary disease (COPD) patients. To investigate the effects of tiotropium (Tio) and/or budesonide/formoterol (Bud/Form) on systemic inflammation biomarkers in stable COPD patients of group D, a randomized, open-label clinical trial was conducted. Methods Eligible participants (n = 324) were randomized and received either Tio 18ug once daily (group I), Bud/Form 160/4.5ug twice daily (group II), Bud/Form 320/9ug twice daily (group III), or Tio 18ug once daily with Bud/Form 160/4.5ug twice daily (group IV) for 6 months. Systemic inflammation biomarkers were measured before randomization and during the treatment, including C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-8 (IL-8), serum amyloid A (SAA), tumor necrosis factor-a (TNF-alpha), fibrinogen (Fib), and white blood cell (WBC). Results After 6-month treatment, CRP levels in group II, group III and group IV changed by a median (interquartile range) of -1.25 (-3.29, 1.18) mg/L, -1.13 (-2.55, 0.77) mg/L, and -1.56 (-4.64, 0.22) mg/L respectively, all of which with statistical differences compared with group I. In addition, there were no treatment differences in terms of IL-8, SAA, TNF-alpha, Fib and WBC levels. Conclusions A long-term treatment with Bud/Form alone or together with Tio can attenuate circulating CRP levels in COPD patients of group D, compared with Tio alone.	[Lin, Yi-Hua; Qu, Yue-Jin; Shi, Yong-Hong] Xiamen Univ, Affiliated Hosp 1, Dept Resp Med, Xiamen, Fujian, Peoples R China; [Lin, Yi-Hua; Liao, Xi-Ning; Fan, Li-Li; Cheng, De-Yun] Sichuan Univ, West China Hosp, Dept Resp Med, Chengdu, Sichuan, Peoples R China	Xiamen University; Sichuan University	Shi, YH (corresponding author), Xiamen Univ, Affiliated Hosp 1, Dept Resp Med, Xiamen, Fujian, Peoples R China.	shiyonghong_XMU@163.com		Lin, Yihua/0000-0002-9354-7704				Agusti AGN, 2003, EUR RESPIR J, V21, P347, DOI 10.1183/09031936.03.00405703; Anderson R, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/105420; Bestall JC, 1999, THORAX, V54, P581, DOI 10.1136/thx.54.7.581; Cavailles A, 2013, EUR RESPIR REV, V22, P454, DOI 10.1183/09059180.00008612; Cazzola M, 2007, PULM PHARMACOL THER, V20, P556, DOI 10.1016/j.pupt.2006.06.001; Dahl M, 2007, AM J RESP CRIT CARE, V175, P250, DOI 10.1164/rccm.200605-713OC; de Torres JP, 2006, EUR RESPIR J, V27, P902, DOI 10.1183/09031936.06.00109605; Decramer M, 2013, LANCET RESP MED, V1, P73, DOI 10.1016/S2213-2600(12)70060-7; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; Garcia-Rio F, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-63; Global Initiative for Chronic Obstructive Lung Disease, 2013, GLOBAL STRATEGY DIAG; Gold Executive Committee, 2011, GLOB STRAT DIAGN MAN; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Jones PW, 2009, EUR RESPIR J, V34, P648, DOI 10.1183/09031936.00102509; Kochanek K, 2011, NATL VITAL STAT REP, V54, P1; Liang BM, 2012, ENDOCRINE, V42, P190, DOI 10.1007/s12020-011-9583-x; Lin YH, 2016, PAK J MED SCI, V32, P1453, DOI 10.12669/pjms.326.10905; McGarvey LP, 2007, THORAX, V62, P411, DOI 10.1136/thx.2006.072348; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Pradhan AD, 2002, JAMA-J AM MED ASSOC, V288, P980, DOI 10.1001/jama.288.8.980; Putcha N, 2013, COPD, V10, P324, DOI 10.3109/15412555.2012.744963; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Reid MB, 2001, RESP RES, V2, P269, DOI 10.1186/rr67; Rennard SI, 2009, DRUGS, V69, P549, DOI 10.2165/00003495-200969050-00004; Sin DD, 2004, AM J RESP CRIT CARE, V170, P760, DOI 10.1164/rccm.200404-543OC; Sin DD, 2008, AM J RESP CRIT CARE, V177, P1207, DOI 10.1164/rccm.200709-1356OC; Stork S, 2006, AM J MED, V119, P519, DOI 10.1016/j.amjmed.2005.10.062; Tang YJ, 2010, CHINESE MED J-PEKING, V123, P1652, DOI 10.3760/cma.j.issn.0366-6999.2010.13.007; Tashkin DP, 2008, DRUGS, V68, P1975, DOI 10.2165/00003495-200868140-00004; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Thomsen M, 2012, AM J RESP CRIT CARE, V186, P982, DOI 10.1164/rccm.201206-1113OC; Vestbo J, 2014, AM J RESP CRIT CARE, V189, P1022, DOI 10.1164/rccm.201311-2006PP; von Scheele I, 2010, INHAL TOXICOL, V22, P493, DOI 10.3109/08958370903521216; Wang XQ, 2013, J INFLAMM RES, V6, P109, DOI 10.2147/JIR.S43736; Zhong NS, 2012, CURR MED RES OPIN, V28, P257, DOI 10.1185/03007995.2011.636420	37	4	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183300	10.1371/journal.pone.0183300	http://dx.doi.org/10.1371/journal.pone.0183300			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832630	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800055
J	Nazario-Yepiz, NO; Loustalot-Laclette, MR; Carpinteyro-Ponce, J; Abreu-Goodger, C; Markow, TA				Nazario-Yepiz, Nestor O.; Ramirez Loustalot-Laclette, Mariana; Carpinteyro-Ponce, Javier; Abreu-Goodger, Cei; Ann Markow, Therese			Transcriptional responses of ecologically diverse Drosophila species to larval diets differing in relative sugar and protein ratios	PLOS ONE			English	Article							CACTOPHILIC DROSOPHILA; FAT-BODY; OBESITY; MELANOGASTER; METABOLISM; INSULIN; CARNITINE; GENE; BIOSYNTHESIS; MOJAVENSIS	We utilized three ecologically diverse Drosophila species to explore the influence of ecological adaptation on transcriptomic responses to isocaloric diets differing in their relative proportions of protein to sugar. Drosophila melanogaster, a cosmopolitan species that breeds in decaying fruit, exemplifies individuals long exposed to a Western diet higher in sugar, while the natural diet of the cactophilic D. mojavensis, is much lower in carbohydrates. Drosophila arizonae, the sister species of D. mojavensis, is largely cactophilic, but also utilizes rotting fruits that are higher in sugars than cacti. We exposed third instar larvae for 24 hours to diets either (1) high in protein relative to sugar, (2) diets with equal amounts of protein and sugar, and (3) diets low in protein but high in sugar. As we predicted, based upon earlier interspecific studies of development and metabolism, the most extreme differences in gene expression under different dietary conditions were found in D. mojavensis followed by D. arizonae. No differential expression among diets was observed for D. melanogaster, a species that survives well under all three conditions, with little impact on its metabolism. We suggest that these three species together provide a model to examine individual and population differences in vulnerability to lifestyle-associated health problems such as metabolic syndrome and diabetes.	[Nazario-Yepiz, Nestor O.; Ramirez Loustalot-Laclette, Mariana; Carpinteyro-Ponce, Javier; Abreu-Goodger, Cei; Ann Markow, Therese] Lab Nacl Genom Biodiversidad, Guanajuato, Mexico; [Carpinteyro-Ponce, Javier] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Ann Markow, Therese] Univ Calif San Diego, Dept Cell & Mol Biol, La Jolla, CA 92093 USA	University System of Maryland; University of Maryland College Park; University of California System; University of California San Diego	Markow, TA (corresponding author), Lab Nacl Genom Biodiversidad, Guanajuato, Mexico.; Markow, TA (corresponding author), Univ Calif San Diego, Dept Cell & Mol Biol, La Jolla, CA 92093 USA.	tmarkow@ucsd.edu	Abreu-Goodger, Cei/A-1268-2010	Abreu-Goodger, Cei/0000-0001-8302-9893; Nazario-Yepiz, Nestor Octavio/0000-0002-3511-0109	CONACyT [180385]; National Science Foundation [1351502]; LANGEBIO-CINVESTAV; CONACyT	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF)); LANGEBIO-CINVESTAV; CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT grant 180385 and National Science Foundation grant 1351502 to TAM, a CONACyT graduate fellowship to JCP and funds from LANGEBIO-CINVESTAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTONIEWSKI C, 1994, MOL CELL BIOL, V14, P4465, DOI 10.1128/MCB.14.7.4465; BATTERHAM P, 1983, DEV BIOL, V96, P346, DOI 10.1016/0012-1606(83)90172-0; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; CANDY DJ, 1961, BIOCHEM J, V78, P531, DOI 10.1042/bj0780531; Chien S, 2002, NUCLEIC ACIDS RES, V30, P149, DOI 10.1093/nar/30.1.149; Choquet H, 2011, CURR GENOMICS, V12, P169, DOI 10.2174/138920211795677895; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; De Panis DN, 2016, MOL ECOL, V25, P4534, DOI 10.1111/mec.13785; Deusing DJ, 2015, BIOCHEM BIOPH RES CO, V460, P747, DOI 10.1016/j.bbrc.2015.03.101; Fiamoncini J, 2013, OBESITY, V21, P1200, DOI 10.1002/oby.20132; FRERIKSEN A, 1991, J BIOL CHEM, V266, P21399; Gabrisko M, 2011, J MOL EVOL, V72, P104, DOI 10.1007/s00239-010-9406-3; GEER BW, 1984, GENET RES, V43, P307, DOI 10.1017/S0016672300026094; Goff LA, 2013, R PACKAG VERSION 2 1; Halme A, 2010, CURR BIOL, V20, P458, DOI 10.1016/j.cub.2010.01.038; Jiang ZH, 2005, OBES RES, V13, P1898, DOI 10.1038/oby.2005.233; Kuhnlein RP, 2012, J LIPID RES, V53, P1430, DOI 10.1194/jlr.R024299; Lee C, 1980, J BIOL CHEM, V255, P4673; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Matzkin LM, 2011, J NUTR, V141, P1127, DOI 10.3945/jn.111.138438; Matzkin LM, 2009, J INSECT PHYSIOL, V55, P1145, DOI 10.1016/j.jinsphys.2009.08.008; Matzkin LM, 2009, GENETICS, V182, P1279, DOI 10.1534/genetics.109.104927; Mirth CK, 2014, P NATL ACAD SCI USA, V111, P7018, DOI 10.1073/pnas.1313058111; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Nazario-Yepiz NO, 2016, J NUTRITIONAL BIOL, V1, P101; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nelson D.L., 2008, LEHNINGER PRINCIPLES, V5, P527; Padmanabha D, 2014, TRENDS ENDOCRIN MET, V25, P518, DOI 10.1016/j.tem.2014.03.011; Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Ringseis R, 2012, EUR J NUTR, V51, P1, DOI 10.1007/s00394-011-0284-2; Sanchez-Flores A, 2016, G3-GENES GENOM GENET, V6, P3097, DOI 10.1534/g3.116.033779; Sellers JA, 2003, J BIOL CHEM, V278, P20367, DOI 10.1074/jbc.M300271200; Strijbis K, 2010, IUBMB LIFE, V62, P357, DOI 10.1002/iub.323; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trinh I, 2013, PHYSIOLOGY, V28, P117, DOI 10.1152/physiol.00025.2012; Zera AJ, 2011, J EXP BIOL, V214, P179, DOI 10.1242/jeb.046912; Zhou XF, 2008, GENETICS, V178, P273, DOI 10.1534/genetics.107.080754; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	41	11	11	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183007	10.1371/journal.pone.0183007	http://dx.doi.org/10.1371/journal.pone.0183007			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832647	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800041
J	El-Hendawy, S; Al-Suhaibani, N; Hassan, W; Tahir, M; Schmidhalter, U				El-Hendawy, Salah; Al-Suhaibani, Nasser; Hassan, Wael; Tahir, Mohammad; Schmidhalter, Urs			Hyperspectral reflectance sensing to assess the growth and photosynthetic properties of wheat cultivars exposed to different irrigation rates in an irrigated arid region	PLOS ONE			English	Article							SPECTRAL VEGETATION INDEXES; WATER-USE EFFICIENCY; LEAF GAS-EXCHANGE; CANOPY TEMPERATURE; DROUGHT STRESS; CAPACITY; CHLOROPHYLL; PLANTS; TRAITS; YIELD	Simultaneous indirect assessment of multiple and diverse plant parameters in an exact and expeditious manner is becoming imperative in irrigated arid regions, with a view toward creating drought-tolerant genotypes or for the management of precision irrigation. This study aimed to evaluate whether spectral reflectance indices (SRIs) in three parts of the electromagnetic spectrum ((visible-infrared (VIS), near-infrared (NIR)), and shortwave-infrared (SWIR)) could be used to track changes in morphophysiological parameters of wheat cultivars exposed to 1.00, 0.75, and 0.50 of the estimated evapotranspiration (ETc). Significant differences were found in the parameters of growth and photosynthetic efficiency, and canopy spectral reflectance among the three cultivars subjected to different irrigation rates. All parameters were highly and significantly correlated with each other particularly under the 0.50 ETc treatment. The VIS/VIS- and NIR/VIS-based indices were sufficient and suitable for assessing the growth and photosynthetic properties of wheat cultivars similar to those indices based on NIR/NIR, SWIR/NIR, or SWIR/SWIR. Almost all tested SRIs proved to assess growth and photosynthetic parameters, including transpiration rate, more efficiently when regressions were analyzed for each water irrigation rate individually. This study, the type of which has rarely been conducted in irrigated arid regions, indicates that spectral reflectance data can be used as a rapid and non-destructive alternative method for assessment of the growth and photosynthetic efficiency of wheat under a range of water irrigation rates.	[El-Hendawy, Salah; Al-Suhaibani, Nasser; Tahir, Mohammad] King Saud Univ, Coll Food & Agr Sci, Dept Plant Prod, Riyadh, Saudi Arabia; [El-Hendawy, Salah] Suez Canal Univ, Fac Agr, Dept Agron, Ismailia, Egypt; [Hassan, Wael] Suez Canal Univ, Fac Agr, Dept Agr Bot, Ismailia, Egypt; [Hassan, Wael] Shaqra Univ, Quwayiyah Coll Sci & Humanities, Dept Biol, Shaqra, Saudi Arabia; [Schmidhalter, Urs] Tech Univ Munich, Dept Plant Sci, Chair Plant Nutr, Freising Weihenstephan, Germany	King Saud University; Egyptian Knowledge Bank (EKB); Suez Canal University; Egyptian Knowledge Bank (EKB); Suez Canal University; Shaqra University; Technical University of Munich	El-Hendawy, S (corresponding author), King Saud Univ, Coll Food & Agr Sci, Dept Plant Prod, Riyadh, Saudi Arabia.; El-Hendawy, S (corresponding author), Suez Canal Univ, Fac Agr, Dept Agron, Ismailia, Egypt.	shendawy@yahoo.com	Schmidhalter, Urs/C-5477-2012; Hassan, Wael M./T-5513-2018; El-Hendawy, Salah/ABB-5234-2020; Schmidhalter, Urs/AAO-9132-2021; alsuhaibani, Nasser A./AAN-3871-2020; Hassan, Wael M./I-9908-2017; Schmidhalter, Urs/CAE-9356-2022	Schmidhalter, Urs/0000-0003-4106-7124; Hassan, Wael M./0000-0002-5471-9606; El-Hendawy, Salah/0000-0002-8104-3410; Schmidhalter, Urs/0000-0003-4106-7124; 	King Saud University [RG-1435-032]; King Saud University	King Saud University(King Saud University); King Saud University(King Saud University)	The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at the King Saud University for funding this Research Group No. (RG-1435-032).; The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at the King Saud University for supporting this work.	Ahmed I, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058204, 10.1371/journal.pone.0077869]; Allen R.G., 1998, FAO IRRIGATION DRAIN, DOI DOI 10.1016/J.EJA.2010.12.001; Aparicio N, 2002, CROP SCI, V42, P1547, DOI 10.2135/cropsci2002.1547; Araus JL, 2002, ANN BOT-LONDON, V89, P925, DOI 10.1093/aob/mcf049; Ashinie Bogale, 2011, Journal of Biodiversity and Environmental Sciences (JBES), V1, P22; Babar MA, 2006, CROP SCI, V46, P1046, DOI 10.2135/cropsci2005.0211; Balzarolo M, 2015, BIOGEOSCIENCES, V12, P3089, DOI 10.5194/bg-12-3089-2015; Bayat B, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8070557; Becker E, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00379; Ceccato P, 2001, REMOTE SENS ENVIRON, V77, P22, DOI 10.1016/S0034-4257(01)00191-2; Chavez RO, 2013, INT J APPL EARTH OBS, V21, P53, DOI 10.1016/j.jag.2012.08.013; El-Hendawy S, 2015, TURK J AGRIC FOR, V39, P572, DOI 10.3906/tar-1406-164; El-Hendawy SE, 2017, AGR WATER MANAGE, V182, P1, DOI 10.1016/j.agwat.2016.12.003; El-Hendawy SK, 2015, PAK J BOT, V47, P2093; El-Hendawy SE, 2017, J AGRON CROP SCI, P1; Elsayed S, 2011, FUNCT PLANT BIOL, V38, P523, DOI 10.1071/FP11021; Elshafei A. A., 2013, Australian Journal of Crop Science, V7, P887; Fang YJ, 2015, CELL MOL LIFE SCI, V72, P673, DOI 10.1007/s00018-014-1767-0; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Farooq M, 2014, CRIT REV PLANT SCI, V33, P331, DOI 10.1080/07352689.2014.875291; Fereres E, 2007, J EXP BOT, V58, P147, DOI 10.1093/jxb/erl165; Fiorani F, 2012, CURR OPIN BIOTECH, V23, P227, DOI 10.1016/j.copbio.2011.12.010; Garbulsky MF, 2011, REMOTE SENS ENVIRON, V115, P281, DOI 10.1016/j.rse.2010.08.023; Garriga M, 2014, J INTEGR PLANT BIOL, V56, P505, DOI 10.1111/jipb.12193; Ghobadi M, 2013, IND CROP PROD, V50, P29, DOI 10.1016/j.indcrop.2013.07.009; Gutierrez M, 2010, J EXP BOT, V61, P3291, DOI 10.1093/jxb/erq156; Hackl H, 2013, FUNCT PLANT BIOL, V40, P409, DOI 10.1071/FP12208; Hameed A, 2011, PLANT PHYSIOL BIOCH, V49, P178, DOI 10.1016/j.plaphy.2010.11.009; Hu YC, 2017, FUNCT PLANT BIOL, V44, P134, DOI [10.1071/FP16217, 10.1071/fp16217]; Huang N, 2012, AGR FOREST METEOROL, V160, P80, DOI 10.1016/j.agrformet.2012.03.005; Hura T, 2007, ACTA PHYSIOL PLANT, V29, P103, DOI 10.1007/s11738-006-0013-2; Inoue Y, 2008, REMOTE SENS ENVIRON, V112, P156, DOI 10.1016/j.rse.2007.04.011; Klute A., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P687; Leufen G, 2013, ACTA PHYSIOL PLANT, V35, P1763, DOI 10.1007/s11738-012-1213-6; Li YP, 2017, CROP J, V5, P231, DOI 10.1016/j.cj.2017.01.001; Lin C, 2015, BIOGEOSCIENCES, V12, P49, DOI 10.5194/bg-12-49-2015; Lobos GA, 2014, J INTEGR PLANT BIOL, V56, P470, DOI 10.1111/jipb.12114; Marino G, 2014, ENVIRON EXP BOT, V99, P43, DOI 10.1016/j.envexpbot.2013.10.008; Martin D, 1990, MANAGEMENT FARM IRRI; Medrano H, 2012, AGR WATER MANAGE, V114, P4, DOI 10.1016/j.agwat.2012.06.025; Middleton EM, 2012, HYPERSPECTRAL REMOTE SENSING OF VEGETATION, P265; Muller B, 2011, J EXP BOT, V62, P1715, DOI 10.1093/jxb/erq438; Muttiah R., 2002, FORM LAB SPECTROSCOP; Niinemets U, 2010, FOREST ECOL MANAG, V260, P1623, DOI 10.1016/j.foreco.2010.07.054; Ollinger SV, 2011, NEW PHYTOL, V189, P375, DOI 10.1111/j.1469-8137.2010.03536.x; Pask AJD, 2013, CROP SCI, V53, P2090, DOI 10.2135/cropsci2013.01.0011; Penuelas J, 1997, CROP SCI, V37, P198, DOI 10.2135/cropsci1997.0011183X003700010033x; Pereira J. S., 1993, P237; Pinheiro C, 2011, J EXP BOT, V62, P869, DOI 10.1093/jxb/erq340; Prieto JA, 2012, PLANT CELL ENVIRON, V35, P1313, DOI 10.1111/j.1365-3040.2012.02491.x; Rabas AR, 2003, ANN BOT-LONDON, V92, P529, DOI 10.1093/aob/mcg171; Ranjan R, 2015, P NATL ACAD SCI IN B; Rapaport T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088930; Rollins JA, 2013, J EXP BOT, V64, P3201, DOI 10.1093/jxb/ert158; Rud R, 2011, REMOTE SENS LETT, V2, P289, DOI 10.1080/01431161.2010.520343; Schaefer MT, 2016, REMOTE SENS-BASEL, V8, DOI 10.3390/rs8020109; Schmid I, 2016, J AGRON CROP SCI, V202, P81, DOI 10.1111/jac.12127; Serrano L, 2010, AGR ECOSYST ENVIRON, V139, P490, DOI 10.1016/j.agee.2010.09.007; Sun P, 2008, INT J REMOTE SENS, V29, P1725, DOI 10.1080/01431160701373754; Sun PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105165; Taghvaeian S, 2014, AGR WATER MANAGE, V144, P69, DOI 10.1016/j.agwat.2014.06.003; Thanyapraneedkul J, 2012, REMOTE SENS-BASEL, V4, P3689, DOI 10.3390/rs4123689; Wang LL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031021; Wang Q, 2016, IFOREST, V9, P30, DOI 10.3832/ifor1634-008; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108592; Zygielbaum AI, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038906	66	22	23	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183262	10.1371/journal.pone.0183262	http://dx.doi.org/10.1371/journal.pone.0183262			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829809	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100033
J	Giordano, BV; Kaur, S; Hunter, FF				Giordano, Bryan V.; Kaur, Sukhdeep; Hunter, Fiona F.			West Nile virus in Ontario, Canada: A twelve-year analysis of human case prevalence, mosquito surveillance, and climate data	PLOS ONE			English	Article							CULEX-PIPIENS; BRIDGE VECTOR; UNITED-STATES; DIPTERA-CULICIDAE; SOUTHERN ONTARIO; INFECTION RATES; NEW-YORK; AMPLIFICATION; HEMISPHERE; DISEASE	West Nile Virus (WNV) first arrived in Ontario, Canada in 2001 and has since spread throughout most of the province, causing disease in humans. The provincial government established a province-wide surveillance program to monitor WNV transmission throughout the 36 regional health units. Here we have acquired records of WNV human and mosquito surveillance from 2002 to 2013 to describe seasonal and geographic trends in WNV activity in southern Ontario. Additionally, we obtained climate data from seven municipalities to investigate how temperature and precipitation affect WNV transmission dynamics. We identified a strong quadratic relationship between the number of confirmed human cases and positive Culex mosquito pools recorded at the end of each year (R-2 = 0.9783, p < 0.001). Using Spearman rank correlation tests, we identified that the minimum infection rate of Culex pipiens/restuans pools are the strongest predictor of human cases at a 1 week lag period. We also identified positive correlations between minimum infection rates, temperature, vector abundance, and cumulative precipitation. Global Moran's I index indicates strong positive autocorrelation and clustering of positive Culex pool counts in southern Ontario. Local indicators of spatial association tests revealed a total of 44 high-high and 1 high-low trap locations (n = 680). In the current work we have identified when and where hot spots of WNV activity have occurred in southern Ontario. The municipalities surrounding the western shore of the Lake Ontario and Windsor-Essex County have the largest records of positive mosquitoes and human cases. We identified that positive mosquitoes are a strong indicator of human cases to follow in the coming weeks. An epidemic action threshold of cumulative positive Culex pools was established, allowing Ontario public health officials to predict an epidemic at epidemiological week 34 (rho = 0.90, p < 0.001). These data have the potential to contribute to more efficient larvicide programs and awareness campaigns for the public.	[Giordano, Bryan V.; Hunter, Fiona F.] Brock Univ, Ctr Biotechnol, St Catharines, ON, Canada; [Giordano, Bryan V.; Hunter, Fiona F.] Brock Univ, Ctr Vector Borne Dis, St Catharines, ON, Canada; [Kaur, Sukhdeep; Hunter, Fiona F.] Entomogen Inc, St Catharines, ON, Canada; [Hunter, Fiona F.] Brock Univ, Dept Biol Sci, St Catharines, ON, Canada	Brock University; Brock University; Brock University	Hunter, FF (corresponding author), Brock Univ, Ctr Biotechnol, St Catharines, ON, Canada.; Hunter, FF (corresponding author), Brock Univ, Ctr Vector Borne Dis, St Catharines, ON, Canada.; Hunter, FF (corresponding author), Entomogen Inc, St Catharines, ON, Canada.; Hunter, FF (corresponding author), Brock Univ, Dept Biol Sci, St Catharines, ON, Canada.	fhunter@brocku.ca			Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-03802, PGSD2-489191-2016]; President of Entomogen Inc.; entomological consulting company	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); President of Entomogen Inc.; entomological consulting company	This work was supported by the Natural Sciences and Engineering Research Council of Canada RGPIN-2015-03802 to FFH; Natural Sciences and Engineering Research Council of Canada PGSD2-489191-2016 to BVG and FFH is President of Entomogen Inc., an entomological consulting company. Much of the original entomological data were collected through her company although the current manuscript is based on Dr. Hunter's role as Supervisor to Bryan Giordano at Brock University. SK is an Entomogen employee who worked on many of the statistical analyses in the paper. Entomogen Inc. provided support in the form of salaries for author [SK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andreadis TG, 2004, VECTOR-BORNE ZOONOT, V4, P360, DOI 10.1089/vbz.2004.4.360; Andreadis TG, 2001, EMERG INFECT DIS, V7, P670; Apperson CS, 2004, VECTOR-BORNE ZOONOT, V4, P71, DOI 10.1089/153036604773083013; Artsob H, 2009, ZOONOSES PUBLIC HLTH, V56, P357, DOI 10.1111/j.1863-2378.2008.01207.x; Artsob H, 2006, ROY SOC CH, V1, P18; Beroll H., 2007, POPUL HEALTH METR, V5, P1; CHIANG CL, 1962, AM J HYG, V75, P377, DOI 10.1093/oxfordjournals.aje.a120259; Chun Y., 2013, SPATIAL STAT GEOSTAT; Drebot Michael A, 2003, Can J Infect Dis, V14, P105; Giordano BV, 2015, J AM MOSQUITO CONTR, V31, P101, DOI 10.2987/14-6456R.1; Government of Canada, 2017, HIST CLIM DAT; Gubler DJ, 2000, VIRAL IMMUNOL, V13, P469, DOI 10.1089/vim.2000.13.469; Gujral IB, 2007, EMERG INFECT DIS, V13, P419, DOI 10.3201/eid1303.060941; Hamer GL, 2008, J MED ENTOMOL, V45, P125, DOI 10.1603/0022-2585(2008)45[125:CPDCAB]2.0.CO;2; Hamer GL, 2009, AM J TROP MED HYG, V80, P268, DOI 10.4269/ajtmh.2009.80.268; Hunter FF, 2015, J MED ENTOMOL, V52, P509, DOI 10.1093/jme/tjv018; Johnson BJ, 2013, J MED ENTOMOL, V50, P195, DOI 10.1603/ME12035; Kilpatrick AM, 2006, PLOS BIOL, V4, P606, DOI 10.1371/journal.pbio.0040082; Kilpatrick AM, 2005, EMERG INFECT DIS, V11, P425, DOI 10.3201/eid1103.040364; Komar N, 2003, EMERG INFECT DIS, V9, P311, DOI 10.3201/eid0903.020628; Krivoruchko K., 2012, ARCUSER; Kulasekera VL, 2001, EMERG INFECT DIS, V7, P722, DOI 10.3201/eid0704.010421; Lanciotti RS, 1999, SCIENCE, V286, P2333, DOI 10.1126/science.286.5448.2333; Lee J, 2001, STAT ANAL ARCVIEW GI; Loeb M, 2005, EMERG INFECT DIS, V11, P1433; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2016, VECT BORN DIS 2015 S; Ontario Agency for Health Protection and Promotion (Public Health Ontario), 2013, GUID PUBL HLTH UN CO; Pardo-Iguzquiza E, 2005, MATH GEOL, V37, P477, DOI 10.1007/s11004-005-6665-4; Paz S, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2013.0561; Petersen LR, 2002, ANN INTERN MED, V137, P173, DOI 10.7326/0003-4819-137-3-200208060-00009; Public Health Agency of Canada, 2016, SURV W NIL VIR; Public Health Agency of Canada (PHAC), 2016, W NIL VIR OTH MOSQ B; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Russell C. R., 2007, THESIS; Russell C, 2012, CAN ENTOMOL, V144, P667, DOI 10.4039/tce.2012.65; SMITHBURN K. C, 1940, AMER JOUR TROP MED, V20, P471; Statistics Canada, 2016, CHANG LANDSC CAN MET; Statistics Canada, 2011, DAT PROD 2011 CENS; Statistics Canada, 2015, HLTH REG BOUND FIL H; Statistics Canada, 2017, CENS PROGR PREV CENS; Thielman Aynsley C., 2007, Canadian Journal of Arthropod Identification, V4, P1; Turell MJ, 2005, J MED ENTOMOL, V42, P57, DOI 10.1603/0022-2585(2005)042[0057:AUOTPO]2.0.CO;2; Turell MJ, 2001, J MED ENTOMOL, V38, P130, DOI 10.1603/0022-2585-38.2.130; Valiakos G, 2013, INTECH; Wang JF, 2011, J MED ENTOMOL, V48, P468, DOI 10.1603/ME10117; Wood DM, 1979, MOSQUITOES CANADA 6; Zheng H, 2014, CCDR, P40	48	25	25	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183568	10.1371/journal.pone.0183568	http://dx.doi.org/10.1371/journal.pone.0183568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829827	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100058
J	Adekunbi, DA; Li, XF; Li, SY; Adegoke, OA; Iranloye, BO; Morakinyo, AO; Lightman, SL; Taylor, PD; Poston, L; O'Byrne, KT				Adekunbi, Daniel A.; Li, Xiao Feng; Li, Shengyun; Adegoke, Olufeyi A.; Iranloye, Bolanle O.; Morakinyo, Ayodele O.; Lightman, Stafford L.; Taylor, Paul D.; Poston, Lucilla; O'Byrne, Kevin T.			Role of amygdala kisspeptin in pubertal timing in female rats	PLOS ONE			English	Article							HYPOTHALAMIC KISS1 EXPRESSION; LUTEINIZING-HORMONE SURGE; MESSENGER-RNA EXPRESSION; MEDIAL AMYGDALA; GENE-EXPRESSION; ARCUATE NUCLEUS; REPRODUCTIVE FUNCTION; SEXUAL-BEHAVIOR; NEURONS; BRAIN	To investigate the mechanism by which maternal obesity disrupts reproductive function in offspring, we examined Kiss1 expression in the hypothalamic arcuate (ARC) and anteroventral periventricular (AVPV) nuclei, and posterodorsal medial amygdala (MePD) of pre-pubertal and young adult offspring. Sprague-Dawley rats were fed either a standard or energy-dense diet for six weeks prior to mating and throughout pregnancy and lactation. Male and female offspring were weaned onto normal diet on postnatal day (pnd) 21. Brains were collected on pnd 30 or 100 for qRT-PCR to determine Kiss1 mRNA levels. Maternal obesity increased Kiss1 mRNA expression in the MePD of pre-pubertal male and female offspring, whereas Kiss1 expression was not affected in the ARC or AVPV at this age. Maternal obesity reduced Kiss1 expression in all three brain regions of 3 month old female offspring, but only in MePD of males. The role of MePD kisspeptin on puberty, estrous cyclicity and pre-ovulatory LH surges was assessed directly in a separate group of post-weanling and young adult female rats exposed to a normal diet throughout their life course. Bilateral intra-MePD cannulae connected to osmotic mini-pumps for delivery of kisspeptin receptor antagonist (Peptide 234 for 14 days) were chronically implanted on pnd 21 or 100. Antagonism of MePD kisspeptin delayed puberty onset, disrupted estrous cyclicity and reduced the incidence of LH surges. These data show that the MePD plays a key role in pubertal timing and ovulation and that maternal obesity may act via amygdala kisspeptin signaling to influence reproductive function in the offspring.	[Adekunbi, Daniel A.; Li, Xiao Feng; Li, Shengyun; Taylor, Paul D.; Poston, Lucilla; O'Byrne, Kevin T.] Kings Coll London, Fac Life Sci & Med, Div Womens Hlth, London, England; [Adekunbi, Daniel A.; Adegoke, Olufeyi A.; Iranloye, Bolanle O.; Morakinyo, Ayodele O.] Univ Lagos, Dept Physiol, Coll Med, Lagos, Nigeria; [Lightman, Stafford L.] Univ Bristol, Henry Wellcome Lab Integrat Neurosci & Endocrinol, Bristol, Avon, England	University of London; King's College London; University of Lagos; University of Bristol	O'Byrne, KT (corresponding author), Kings Coll London, Fac Life Sci & Med, Div Womens Hlth, London, England.	kevin.obyrne@kcl.ac.uk	Adekunbi, Daniel/HII-7074-2022; li, xiaofeng/GXF-9442-2022	Iranloye, Bolanle/0000-0001-7498-0193; Lightman, Stafford/0000-0002-8546-9646; O'Byrne, Kevin/0000-0002-2548-4182; Morakinyo, Femi/0000-0002-1577-2412; Adekunbi, Daniel/0000-0001-5456-3392; Taylor, Paul David/0000-0002-4740-4307; Poston, Lucilla/0000-0003-1100-2821	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J002232/1]; Medical Research Council (MRC) [MR/N022637/1]; BBSRC [BB/J002232/1] Funding Source: UKRI; MRC [MR/N022637/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J002232/1] Funding Source: researchfish; Medical Research Council [MR/N022637/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (http://www.bbsrc.sc.uk/) Grant# BB/J002232/1 to Kevin O'Byrne, Stafford Lightman, Lucilla Poston and the Medical Research Council (MRC) (https://www.mrc.ac.uki/) Grant # MR/N022637/1 to Kevin O'Byrne, Stafford Lightman. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers-Wolthers CHJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179156; Ambrosetti V, 2016, ENDOCRINE, V53, P258, DOI 10.1007/s12020-016-0858-0; Bouret SG, 2004, J NEUROSCI, V24, P2797, DOI 10.1523/JNEUROSCI.5369-03.2004; Cadiz-Moretti B, 2016, BRAIN STRUCT FUNCT, V221, P1033, DOI 10.1007/s00429-014-0954-y; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; Cheong Y, 2014, FERTIL STERIL, V102, P899, DOI 10.1016/j.fertnstert.2014.06.015; Clarkson J, 2009, J NEUROENDOCRINOL, V21, P673, DOI 10.1111/j.1365-2826.2009.01892.x; Clarkson J, 2006, ENDOCRINOLOGY, V147, P5817, DOI 10.1210/en.2006-0787; Colledge WH, 2009, TRENDS ENDOCRIN MET, V20, P115, DOI 10.1016/j.tem.2008.10.005; Comninos AN, 2017, J CLIN INVEST, V127, P709, DOI 10.1172/JCI89519; Comninos AN, 2016, BRAIN STRUCT FUNCT, V221, P2035, DOI 10.1007/s00429-015-1024-9; Connor KL, 2012, J PHYSIOL-LONDON, V590, P2167, DOI 10.1113/jphysiol.2011.223305; Cooke BM, 2011, J NEUROENDOCRINOL, V23, P65, DOI 10.1111/j.1365-2826.2010.02075.x; Cooke BM, 2006, NEUROSCIENCE, V138, P997, DOI 10.1016/j.neuroscience.2005.06.018; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Deardorff J, 2013, MATERN CHILD HLTH J, V17, P1391, DOI 10.1007/s10995-012-1139-z; Donato Jose Jr, 2011, Front Endocrinol (Lausanne), V2, P57, DOI 10.3389/fendo.2011.00057; Donato J, 2011, J CLIN INVEST, V121, P355, DOI 10.1172/JCI45106; Donato J, 2010, PHYSIOL BEHAV, V99, P67, DOI 10.1016/j.physbeh.2009.10.012; Franssen D, 2016, ENDOCRINOLOGY, V157, P1740, DOI 10.1210/en.2015-1937; Grachev P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044344; Gresham R, 2016, NEUROSCI LETT, V627, P13, DOI 10.1016/j.neulet.2016.05.042; HilakiviClarke L, 1997, P NATL ACAD SCI USA, V94, P9372, DOI 10.1073/pnas.94.17.9372; Hounsgaard ML, 2014, ANDROLOGY-US, V2, P198, DOI 10.1111/j.2047-2927.2013.00171.x; Hu MH, 2015, ENDOCRINOLOGY, V156, P2619, DOI 10.1210/en.2014-1655; Iwasa T, 2010, J PHYSIOL-LONDON, V588, P821, DOI 10.1113/jphysiol.2009.183558; Jacobs S, 2014, PHYSIOL BEHAV, V129, P280, DOI 10.1016/j.physbeh.2014.03.003; Kim J, 2011, ENDOCRINOLOGY, V152, P2020, DOI 10.1210/en.2010-1498; King BM, 2006, AM J PHYSIOL-REG I, V291, pR1201, DOI 10.1152/ajpregu.00199.2006; Kinoshita M, 2005, ENDOCRINOLOGY, V146, P4431, DOI 10.1210/en.2005-0195; Kirk SL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005870; Knox AMI, 2009, J NEUROENDOCRINOL, V21, P683, DOI 10.1111/j.1365-2826.2009.01885.x; Kubo A, 2016, AM J EPIDEMIOL, V184, P7, DOI 10.1093/aje/kww006; Kumar D, 2014, J NEUROSCI, V34, P3756, DOI 10.1523/JNEUROSCI.5123-13.2014; Kurian JR, 2012, ENDOCRINOLOGY, V153, P3331, DOI 10.1210/en.2012-1221; Li XF, 2015, ENDOCRINOLOGY, V156, P3725, DOI 10.1210/en.2015-1366; Li XF, 2010, J PHYSL, V588, p821 ; Li XF, 2012, ENDOCRINOLOGY, V153, P4422, DOI 10.1210/en.2012-1223; Li XF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008334; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Neal-Perry G, 2009, ENDOCRINOLOGY, V150, P3699, DOI 10.1210/en.2008-1667; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; PALKOVITS M, 1973, BRAIN RES, V59, P449, DOI 10.1016/0006-8993(73)90290-4; Pardo-Bellver C, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00033; Pineda R, 2010, ENDOCRINOLOGY, V151, P722, DOI 10.1210/en.2009-0803; Pineda R, 2016, NEUROENDOCRINOLOGY; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Poston L, 2016, LANCET DIABETES ENDO, V4, P1025, DOI 10.1016/S2213-8587(16)30217-0; Rodriguez-Gonzalez GL, 2015, INT J OBESITY, V39, P549, DOI 10.1038/ijo.2014.209; Ruth KS, 2016, SCI REP-UK, V6, DOI 10.1038/srep24710; Santos M, 2015, AM J PHYSIOL-REG I, V308, pR219, DOI 10.1152/ajpregu.00398.2014; Shahab M, 2005, P NATL ACAD SCI USA, V102, P2129, DOI 10.1073/pnas.0409822102; SIMERLY RB, 1990, J COMP NEUROL, V294, P76, DOI 10.1002/cne.902940107; Sloboda DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006744; Smith JT, 2006, J NEUROSCI, V26, P6687, DOI 10.1523/JNEUROSCI.1618-06.2006; Smith JT, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097758; Smith JT, 2009, PEPTIDES, V30, P94, DOI 10.1016/j.peptides.2008.08.013; Smith JT, 2005, ENDOCRINOLOGY, V146, P3686, DOI 10.1210/en.2005-0488; Stephens SBZ, 2016, ENDOCRINOLOGY, V157, P4021, DOI 10.1210/en.2016-1431; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Takumi K, 2015, NEUROSCI RES, V100, P21, DOI 10.1016/j.neures.2015.06.004; Takumi K, 2011, J MOL NEUROSCI, V43, P138, DOI 10.1007/s12031-010-9430-1; Vida B, 2010, J NEUROENDOCRINOL, V22, P1032, DOI 10.1111/j.1365-2826.2010.02045.x; Zhang C, 2009, ENDOCRINOLOGY, V150, P2388, DOI 10.1210/en.2008-1313	64	22	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183596	10.1371/journal.pone.0183596	http://dx.doi.org/10.1371/journal.pone.0183596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846730	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600040
J	Marchant, A; Le Coupanec, A; Joly, C; Perthame, E; Sertour, N; Garnier, M; Godard, V; Ferquel, E; Choumet, V				Marchant, Axelle; Le Coupanec, Alain; Joly, Claire; Perthame, Emeline; Sertour, Natacha; Garnier, Martine; Godard, Vincent; Ferquel, Elisabeth; Choumet, Valerie			Infection of Ixodes ricinus by Borrelia burgdorferi sensu lato in peri-urban forests of France	PLOS ONE			English	Article							MULTILOCUS SEQUENCE-ANALYSIS; FRAGMENT-LENGTH-POLYMORPHISM; TAMIAS-SIBIRICUS-BARBERI; LYME-DISEASE SPIROCHETE; INTERGENIC SPACER; MOLECULAR CHARACTERIZATION; DEER DENSITY; SP-NOV.; TICKS; HOST	Lyme borreliosis is the most common tick-borne disease in the northern hemisphere. In Europe, it is transmitted by Ixodes ticks that carry bacteria belonging to the Borrelia burgdorferi sensu lato complex. The objective of this work was to explore eco-epidemiological factors of Lyme borreliosis in peri-urban forests of France (Se A nart, Notre-Dame and Rambouillet). We investigated whether the introduction of Tamias sibiricus in Se A nart could alter the density of infected ticks. Moreover, the density and tick infection were investigated according to the tree species found in various patches of Se A nart forest. For this purpose, ticks were sampled during 3 years. In the Se A nart forest, the density of nymph and adult ticks showed no significant difference between 2008, 2009 and 2011. The nymph density varied significantly as a function of the month of collection. Regarding the nymphs, a higher rate of infection and infected density were found in 2009. Plots with chipmunks (C) presented a lower density of both nymphs and adult ticks than plots without chipmunks (NC) did. A higher rate of infection of nymphs with Borrelia was seen in C plots. The prevalence of the various species of Borrelia was also found to vary between C and NC plots with the year of the collect. The presence of chestnut trees positively influenced the density of both nymphs and adults. The infected nymph density showed a significant difference depending on the peri-urban forest studied, Se A nart being higher than Rambouillet. The prevalence of Borrelia species also differed between the various forests studied. Concerning the putative role that Tamias sibiricus may play in the transmission of Borrelia, our results suggest that its presence is correlated with a higher rate of infection of questing ticks by Borrelia genospecies and if its population increases, it could play a significant role in the risk of transmission of Lyme borreliosis.	[Marchant, Axelle; Le Coupanec, Alain; Joly, Claire; Sertour, Natacha; Garnier, Martine; Ferquel, Elisabeth; Choumet, Valerie] Inst Pasteur, Ctr Natl Reference Borrelia, Paris, France; [Perthame, Emeline] Inst Pasteur, Bioinformat & Biostat Hub C3BI, USR IP CNRS Bioinformat & Biostat 3756, Paris, France; [Godard, Vincent] Univ Paris 08, CNRS, UMR7533, LADYSS, St Denis, France; [Ferquel, Elisabeth; Choumet, Valerie] Inst Pasteur, Unite Environm & Risques Infect, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-VIII; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Choumet, V (corresponding author), Inst Pasteur, Ctr Natl Reference Borrelia, Paris, France.; Choumet, V (corresponding author), Inst Pasteur, Unite Environm & Risques Infect, Paris, France.	vchoumet@pasteur.fr		Choumet, Valerie/0000-0003-4714-1006	Institut National de Veille Sanitaire (INVS); Ilede-France Region under a Partnerships for Citizens for Research and Innovation [PICRI] contract	Institut National de Veille Sanitaire (INVS); Ilede-France Region under a Partnerships for Citizens for Research and Innovation [PICRI] contract	This work was supported by Institut National de Veille Sanitaire (INVS) and by the Ilede-France Region under a Partnerships for Citizens for Research and Innovation [PICRI] contract and a call for projects validated by the Scientific Council of the Maison des Sciences de l'Homme Paris Nord.	Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Beytout J, 2007, VECTOR-BORNE ZOONOT, V7, P507, DOI 10.1089/vbz.2006.0633; Bonnet S, 2015, TICKS TICK-BORNE DIS, V6, P393, DOI 10.1016/j.ttbdis.2015.03.008; Cagnacci F, 2012, INT J PARASITOL, V42, P365, DOI 10.1016/j.ijpara.2012.02.012; Casjens SR, 2011, J BACTERIOL, V193, P6995, DOI 10.1128/JB.05951-11; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Ceballos LA, 2014, EXP APPL ACAROL, V64, P121, DOI 10.1007/s10493-014-9794-y; Chao LL, 2010, J MED MICROBIOL, V59, P254, DOI 10.1099/jmm.0.016626-0; Chao LL, 2002, AM J TROP MED HYG, V67, P504, DOI 10.4269/ajtmh.2002.67.504; Chapuis JL, 2005, REV ECOL-TERRE VIE, V60, P239; Chu Chen-yi, 2006, Zhonghua Liu Xing Bing Xue Za Zhi, V27, P681; Classens, 1988, FRANCE DORIGINES GIB, V5, P359; Collares-Pereira M, 2004, J CLIN MICROBIOL, V42, P1316, DOI 10.1128/JCM.42.3.1316-1318.2004; Comstedt P, 2006, EMERG INFECT DIS, V12, P1087; CRAINE NG, 1995, FOLIA PARASIT, V42, P73; De Sousa R, 2012, APPL ENVIRON MICROB, V78, P3767, DOI 10.1128/AEM.07945-11; Derdakova M, 2003, APPL ENVIRON MICROB, V69, P509, DOI 10.1128/AEM.69.1.509-516.2003; Diuk-Wasser MA, 2006, J MED ENTOMOL, V43, P166, DOI 10.1603/0022-2585(2006)043[0166:SPOHIS]2.0.CO;2; Dubska L, 2009, APPL ENVIRON MICROB, V75, P596, DOI 10.1128/AEM.01674-08; Ferquel E, 2006, APPL ENVIRON MICROB, V72, P3074, DOI 10.1128/AEM.72.4.3074-3078.2006; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; FISH D, 1990, J WILDLIFE DIS, V26, P339, DOI 10.7589/0090-3558-26.3.339; Gassner F, 2011, VECTOR-BORNE ZOONOT, V11, P523, DOI 10.1089/vbz.2010.0026; Gomez-Diaz E, 2011, ENVIRON MICROBIOL, V13, P2453, DOI 10.1111/j.1462-2920.2011.02515.x; Guner ES, 2003, J MED MICROBIOL, V52, P807, DOI 10.1099/jmm.0.05205-0; Halperin JJ, 2016, J NEUROL; Hanincova K, 2006, EMERG INFECT DIS, V12, P604; Hanincova K, 2003, PARASITOLOGY, V126, P11, DOI 10.1017/S0031182002002548; Hanincova K, 2003, APPL ENVIRON MICROB, V69, P2825, DOI 10.1128/AEM.69.5.2825-2830.2003; Jacquot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088581; Jouda F, 2004, VECTOR-BORNE ZOONOT, V4, P23, DOI 10.1089/153036604773082960; Kiewra D, 2017, TICKS TICK-BORNE DIS, V8, P362, DOI 10.1016/j.ttbdis.2016.12.011; Kjelland V, 2010, ACTA VET SCAND, V52, DOI 10.1186/1751-0147-52-59; Kurtenbach K, 2002, TRENDS MICROBIOL, V10, P74, DOI 10.1016/S0966-842X(01)02298-3; Kurtenbach K, 1998, APPL ENVIRON MICROB, V64, P1169; Kurtenbach K, 1998, INFECT IMMUN, V66, P1248, DOI 10.1128/IAI.66.3.1248-1251.1998; KURTENBACH K, 1994, INFECT IMMUN, V62, P5344, DOI 10.1128/IAI.62.12.5344-5352.1994; Kurtenbach K, 2006, NAT REV MICROBIOL, V4, P660, DOI 10.1038/nrmicro1475; LeFleche A, 1997, INT J SYST BACTERIOL, V47, P921; LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100; MARCONI RT, 1992, J CLIN MICROBIOL, V30, P628, DOI 10.1128/JCM.30.3.628-632.1992; Maresca B, LA FRE A QUENTATION; Margos G, 2009, APPL ENVIRON MICROB, V75, P5410, DOI 10.1128/AEM.00116-09; Marsot M, 2012, INT J PARASITOL, V42, P781, DOI 10.1016/j.ijpara.2012.05.010; Marsot M, 2011, APPL ENVIRON MICROB, V77, P5716, DOI 10.1128/AEM.01846-10; Marsot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055377; Masuzawa T, 2005, INT J MED MICROBIOL, V294, P455, DOI 10.1016/j.ijmm.2004.09.008; McCabe GJ, 2004, VECTOR-BORNE ZOONOT, V4, P143, DOI 10.1089/1530366041210765; OLSEN B, 1995, APPL ENVIRON MICROB, V61, P3082; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Perret JL, 2004, J MED ENTOMOL, V41, P361, DOI 10.1603/0022-2585-41.3.361; Pichon B, 2006, VECTOR-BORNE ZOONOT, V6, P382, DOI 10.1089/vbz.2006.6.382; Piesman J, 2004, PARASITOLOGY, V129, pS191, DOI 10.1017/S0031182003004694; Pisanu B, 2014, TICKS TICK-BORNE DIS, V5, P1, DOI 10.1016/j.ttbdis.2013.07.007; POSTIC C, 1994, AM J PHYSIOL, V266, pE548, DOI 10.1152/ajpendo.1994.266.4.E548; POSTIC D, 1994, INT J SYST BACTERIOL, V44, P743, DOI 10.1099/00207713-44-4-743; Postic D, 1999, J CLIN MICROBIOL, V37, P3010, DOI 10.1128/JCM.37.9.3010-3012.1999; Postic D, 2007, INT J MED MICROBIOL, V297, P263, DOI 10.1016/j.ijmm.2007.01.006; Poupon MA, 2006, APPL ENVIRON MICROB, V72, P976, DOI 10.1128/AEM.72.1.976-979.2006; Reye AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054476; Richter D, 2006, INT J SYST EVOL MICR, V56, P873, DOI 10.1099/ijs.0.64050-0; Richter D, 2004, APPL ENVIRON MICROB, V70, P6414, DOI 10.1128/AEM.70.11.6414-6419.2004; Richter D, 2012, VECTOR-BORNE ZOONOT, V12, P21, DOI 10.1089/vbz.2011.0668; Rijpkema Sjoerd G. T., 1997, Clin Microbiol Infect, V3, P109; Rudenko N, 2011, TICKS TICK-BORNE DIS, V2, P123, DOI 10.1016/j.ttbdis.2011.04.002; Stanek G, 2011, CLIN MICROBIOL INFEC, V17, P487, DOI 10.1111/j.1469-0691.2011.03492.x; Tagliapietra V, 2011, VET PARASITOL, V183, P114, DOI 10.1016/j.vetpar.2011.07.022; Ullmann AJ, 2003, J PARASITOL, V89, P1256, DOI 10.1645/Ge-3081RN; Vandenesch A, 2014, Euro Surveill, V19, DOI 10.2807/1560-7917.ES2014.19.34.20883; Vassallo M, 2000, EXP APPL ACAROL, V24, P941, DOI 10.1023/A:1010669003887; Vennestrom J, 2008, PARASITOL INT, V57, P32, DOI 10.1016/j.parint.2007.07.004; Vor T, 2010, EXP APPL ACAROL, V51, P405, DOI 10.1007/s10493-010-9337-0; Vourc'h G, 2016, TICKS TICK-BORNE DIS, V7, P644, DOI 10.1016/j.ttbdis.2016.02.008; Vourc'h G, 2007, VECTOR-BORNE ZOONOT, V7, P637, DOI 10.1089/vbz.2007.0111; Wang GQ, 1999, CLIN MICROBIOL REV, V12, P633, DOI 10.1128/CMR.12.4.633; Wilhelmsson P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081433; Wilhelmsson P, 2010, J CLIN MICROBIOL, V48, P4169, DOI 10.1128/JCM.01061-10; Zhang F, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-157	78	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183543	10.1371/journal.pone.0183543	http://dx.doi.org/10.1371/journal.pone.0183543			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846709	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600033
J	Oh, H; Custead, R; Wang, YY; Barlow, S				Oh, Hyuntaek; Custead, Rebecca; Wang, Yingying; Barlow, Steven			Neural encoding of saltatory pneumotactile velocity in human glabrous hand	PLOS ONE			English	Article							PRIMARY SOMATOSENSORY CORTEX; MEDIAN NERVE-STIMULATION; POSTERIOR PARIETAL CORTEX; MOVING TACTILE STIMULI; FUNCTIONAL MRI; HAIRY SKIN; DIRECTIONAL SENSITIVITY; CYTOARCHITECTONIC MAPS; MOTOR CORTEX; FMRI	Neurons in the somatosensory cortex are exquisitely sensitive to mechanical stimulation of the skin surface. The location, velocity, direction, and adaptation of tactile stimuli on the skin's surface are discriminable features of somatosensory processing, however the representation and processing of dynamic tactile arrays in the human somatosensory cortex are poorly understood. The principal aim of this study was to map the relation between dynamic saltatory pneumatic stimuli at discrete traverse velocities on the glabrous hand and the resultant pattern of evoked BOLD response in the human brain. Moreover, we hypothesized that the hand representation in contralateral Brodmann Area (BA) 3b would show a significant dependence on stimulus velocity. Saltatory pneumatic pulses (60 ms duration, 9.5 ms rise/fall) were repetitively sequenced through a 7-channel TAC-Cell array at traverse velocities of 5, 25, and 65 cm/s on the glabrous hand initiated at the tips of D2 (index finger) and D3 (middle finger) and sequenced towards the D1 (thumb). The resulting hemodynamic response was sampled during 3 functional MRI scans (BOLD) in 20 neurotypical right-handed adults at 3T. Results from each subject were inserted to the one-way ANOVA within-subjects and one sample t-test to evaluate the group main effect of all three velocities stimuli and each of three different velocities, respectively. The stimulus evoked BOLD response revealed a dynamic representation of saltatory pneumotactile stimulus velocity in a network consisting of the contralateral primary hand somatosensory cortex (BA3b), associated primary motor cortex (BA4), posterior insula, and ipsilateral deep cerebellum. The spatial extent of this network was greatest at the 5 and 25 cm/s pneumotactile stimulus velocities.	[Oh, Hyuntaek; Barlow, Steven] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA; [Custead, Rebecca; Wang, Yingying; Barlow, Steven] Univ Nebraska, Dept Special Educ & Commun Disorders, Lincoln, NE USA; [Oh, Hyuntaek; Custead, Rebecca; Wang, Yingying; Barlow, Steven] Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA; [Oh, Hyuntaek] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; University of Nebraska System; University of Nebraska Lincoln; Baylor College of Medicine	Oh, H (corresponding author), Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68588 USA.; Oh, H (corresponding author), Univ Nebraska, Ctr Brain Biol & Behav, Lincoln, NE 68588 USA.; Oh, H (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	hyuntaek.oh@huskers.unl.edu	Wang, Yingying/I-2705-2018	Wang, Yingying/0000-0001-6502-1388	Barkley Trust Foundation (SM Barlow - PI)	Barkley Trust Foundation (SM Barlow - PI)	This work was supported by the internal grant from Barkley Trust Foundation (SM Barlow - PI). There was no additional external funding received for this study.	Ackerley R, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00051; Backes WH, 2000, CLIN NEUROPHYSIOL, V111, P1738, DOI 10.1016/S1388-2457(00)00420-X; Bertolasi L, 1998, J PHYSIOL-LONDON, V511, P947, DOI 10.1111/j.1469-7793.1998.947bg.x; Besle J, 2013, J NEUROPHYSIOL, V109, P2293, DOI 10.1152/jn.00499.2012; Blakemore SJ, 1999, NEUROIMAGE, V10, P448, DOI 10.1006/nimg.1999.0478; Blakemore SJ, 2003, EXP BRAIN RES, V153, P239, DOI 10.1007/s00221-003-1597-z; Blakemore SJ, 2001, NEUROREPORT, V12, P1879, DOI 10.1097/00001756-200107030-00023; Bornhovd K, 2002, BRAIN, V125, P1326, DOI 10.1093/brain/awf137; Brodoehl S, 2013, BEHAV BRAIN RES, V238, P259, DOI 10.1016/j.bbr.2012.10.038; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Bursztyn LLCD, 2006, CURR BIOL, V16, P2440, DOI 10.1016/j.cub.2006.10.051; Caspers S, 2013, CEREB CORTEX, V23, P615, DOI 10.1093/cercor/bhs048; Chen TL, 2008, NEUROIMAGE, V40, P1765, DOI 10.1016/j.neuroimage.2008.01.020; Custead R, 2015, BRAIN RES, V1622, P81, DOI 10.1016/j.brainres.2015.06.025; Dallmann CJ, 2015, J NEUROPHYSIOL, V114, P3131, DOI 10.1152/jn.00621.2015; Dean J, 2006, CLIN PHYSIOL FUNCT I, V26, P314, DOI 10.1111/j.1475-097X.2006.00689.x; DREYER DA, 1978, SENS PROCESS, V2, P71; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eickhoff SB, 2007, NEUROIMAGE, V36, P511, DOI 10.1016/j.neuroimage.2007.03.060; Eickhoff SB, 2006, NEUROIMAGE, V32, P570, DOI 10.1016/j.neuroimage.2006.04.204; ESSICK GK, 1995, J NEUROSCI, V15, P848; ESSICK GK, 1988, SOMATOSENS MOT RES, V6, P21, DOI 10.3109/08990228809144639; Ferretti A, 2007, HUM BRAIN MAPP, V28, P645, DOI 10.1002/hbm.20292; FOX PT, 1985, P NATL ACAD SCI USA, V82, P7462, DOI 10.1073/pnas.82.21.7462; Franklin C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134518; FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007; Friston KJ, 2005, NEUROIMAGE, V24, P244, DOI 10.1016/j.neuroimage.2004.08.055; Gazzola V, 2009, CEREB CORTEX, V19, P1239, DOI 10.1093/cercor/bhn181; Gleeson BT, 2010, IEEE T HAPTICS, V3, P177, DOI [10.1109/TOH.2010.20, 10.1109/ToH.2010.20]; Hagen MC, 2002, EUR J NEUROSCI, V16, P957, DOI 10.1046/j.1460-9568.2002.02139.x; Huang RS, 2007, NEUROIMAGE, V34, P1060, DOI 10.1016/j.neuroimage.2006.10.024; Iggo A., 2012, SOMATOSENSORY SYSTEM, V2; Johansson RS, 2009, NAT REV NEUROSCI, V10, P345, DOI 10.1038/nrn2621; Kampe KKW, 2000, HUM BRAIN MAPP, V9, P106, DOI 10.1002/(SICI)1097-0193(200002)9:2<106::AID-HBM5>3.0.CO;2-Y; Karkhanis AN, 2014, J PHYSIOL-LONDON, V592, P3625, DOI 10.1113/jphysiol.2014.270942; KEYSON DV, 1995, PERCEPT PSYCHOPHYS, V57, P738, DOI 10.3758/BF03213278; Kim SG, 1997, MAGNET RESON MED, V37, P631, DOI 10.1002/mrm.1910370427; Ktiada R, 2003, NEUROREPORT, V14, P719, DOI 10.1097/01.wnr.0000065508.53896.aa; LEE CJ, 1992, CEREB CORTEX, V2, P81, DOI 10.1093/cercor/2.2.81; Lin YY, 2003, CAN J NEUROL SCI, V30, P31, DOI 10.1017/S0317167100002407; Loken LS, 2011, BRAIN RES, V1417, P9, DOI 10.1016/j.brainres.2011.08.011; Martuzzi R, 2014, HUM BRAIN MAPP, V35, P213, DOI 10.1002/hbm.22172; McGlone F, 2012, EUR J NEUROSCI, V35, P1782, DOI 10.1111/j.1460-9568.2012.08092.x; McGlone F, 2014, NEURON, V82, P737, DOI 10.1016/j.neuron.2014.05.001; McGlone F, 2010, NEUROSCI BIOBEHAV R, V34, P148, DOI 10.1016/j.neubiorev.2009.08.004; Mitsuo K, 2003, PROG BRAIN RES, V142, P171; Morrison I, 2011, J NEUROSCI, V31, P9554, DOI 10.1523/JNEUROSCI.0397-11.2011; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; OLAUSSON H, 1993, J PHYSIOL-LONDON, V464, P545, DOI 10.1113/jphysiol.1993.sp019650; Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896; Papadelis C, 2011, NEUROIMAGE, V54, P60, DOI 10.1016/j.neuroimage.2010.07.054; Pei YC, 2014, J NEUROPHYSIOL, V112, P3023, DOI 10.1152/jn.00391.2014; Popescu EA, 2013, HUM BRAIN MAPP, V34, P1415, DOI 10.1002/hbm.21519; Ridding MC, 2000, EXP BRAIN RES, V131, P135, DOI 10.1007/s002219900269; Rozzi S, 2006, CEREB CORTEX, V16, P1389, DOI 10.1093/cercor/bhj076; Sanchez-Panchuelo RM, 2012, J NEUROSCI, V32, P15815, DOI 10.1523/JNEUROSCI.2501-12.2012; Schweisfurth M. A., 2014, FRONTIERS HUMAN NEUR, V8; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Tommerdahl M, 2006, J NEUROSCI, V26, P5970, DOI 10.1523/JNEUROSCI.5270-05.2006; Tseng YW, 2007, J NEUROPHYSIOL, V98, P54, DOI 10.1152/jn.00266.2007; Venkatesan L, 2010, BRAIN RES, V1348, P63, DOI 10.1016/j.brainres.2010.06.015; VERRILLO RT, 1986, J ACOUST SOC AM, V80, P528, DOI 10.1121/1.394047; Weibull A, 2008, MAGN RESON IMAGING, V26, P1342, DOI 10.1016/j.mri.2008.04.007; WHITSEL BL, 1978, FED PROC, V37, P2223; WHITSEL BL, 1986, SOMATOSENS MOT RES, V3, P185, DOI 10.3109/07367228609144583; Wienbruch C, 2006, NEUROSCI LETT, V398, P183, DOI 10.1016/j.neulet.2006.01.025; Xing J, 2000, J COGNITIVE NEUROSCI, V12, P601, DOI 10.1162/089892900562363	67	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183532	10.1371/journal.pone.0183532	http://dx.doi.org/10.1371/journal.pone.0183532			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841675	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700039
J	Brenes-Soto, A; Dierenfeld, ES; Janssens, GPJ				Brenes-Soto, Andrea; Dierenfeld, Ellen S.; Janssens, Geert P. J.			Colouration in amphibians as a reflection of nutritional status: The case of tree frogs in Costa Rica	PLOS ONE			English	Article							NUPTIAL COLORATION; BODY CONDITION; REPRODUCTIVE SUCCESS; DIETARY CAROTENOIDS; SIZE; HEMATOLOGY; SIGNALS; PLASMA; VALUES; TRANSFORMATIONS	Colouration has been considered a cue for mating success in many species; ornaments in males often are related to carotenoid mobilization towards feathers and/or skin and can signal general health and nutrition status. However, there are several factors that can also link with status, such as physiological blood parameters and body condition, but there is not substantial evidence which supports the existence of these relationships and interactions in anurans. This study evaluated how body score and blood values interact with colouration in free-range Agalychnis callidryas and Agalychnis annae males. We found significant associations between body condition and plasmatic proteins and haematocrit, as well as between body condition and colour values from the chromaticity diagram. We also demonstrated that there is a significant relation between the glucose and plasmatic protein values that were reflected in the ventral colours of the animals, and haematocrit inversely affected most of those colour values. Significant differences were found between species as well as between populations of A. callidryas, suggesting that despite colour variation, there are also biochemical differences within animals from the same species located in different regions. These data provide information on underlying factors for colouration of male tree frogs in nature, provide insights about the dynamics of several nutrients in the amphibian model and how this could affect the reproductive output of the animals.	[Brenes-Soto, Andrea; Janssens, Geert P. J.] Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium; [Brenes-Soto, Andrea] Univ Costa Rica, Dept Anim Sci, San Jose, Costa Rica; [Dierenfeld, Ellen S.] Ellen S Dierenfeld LLC, St Louis, MO USA	Ghent University; Universidad Costa Rica	Brenes-Soto, A (corresponding author), Univ Ghent, Fac Vet Med, Anim Nutr Lab, Merelbeke, Belgium.; Brenes-Soto, A (corresponding author), Univ Costa Rica, Dept Anim Sci, San Jose, Costa Rica.	andrea.brenessoto@ugent.be	Janssens, Geert/C-2264-2008		Research Department, University of Costa Rica [739- B2-076]; Ellen S. Dierenfeld, LLC; University of Costa Rica	Research Department, University of Costa Rica; Ellen S. Dierenfeld, LLC; University of Costa Rica	The work was supported by Research Department, University of Costa Rica, Project No. 739- B2-076, www.vinv.ucr.ac.cr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Ellen S. Dierenfeld is affiliated to Ellen S. Dierenfeld, LLC. Ellen S. Dierenfeld, LLC. provided support in the form of salary for author ESD, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the "author contributions" section.; The authors would like to thank Yolanda Matamoros, from Simon Bolivar Zoo, Santiago Parra from San Isidro de Dota and the staff from El Zota Biological Station for the access to the collection sites. We would also like to thank Jesenia Vasquez Vargas, research assistant, Jose Hernandez and Randall Arguedas for the technical assistance and the University of Costa Rica for the financial support in the development of the study.	Aiello S.E., 2012, MERK VET MANUAL; Alonso-Alvarez C, 2004, AM NAT, V164, P651, DOI 10.1086/424971; Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; Andersson Malte, 1994; [Anonymous], 2012, BOL CIENT NUS HIS NA, V1, P233; [Anonymous], 2020, BIOL AMPHIBIANS, V28, P32; Bancila RI, 2010, AMPHIBIA-REPTILIA, V31, P558, DOI 10.1163/017353710X518405; Bell BD, 2004, BIOL CONSERV, V120, P189, DOI 10.1016/j.biocon.2004.02.011; Berg J. M., 2008, BIOQUIMICA; Blount JD, 2004, ARCH BIOCHEM BIOPHYS, V430, P10, DOI 10.1016/j.abb.2004.03.039; Bray RE, 2001, PROCEEDINGS OF THE AZA NUTRITION ADVISORY GROUP FOURTH CONFERENCE ON ZOO AND WILDLIFE NUTRITION, P25; Brenes-Soto A, 2014, ZOO BIOL, V33, P544, DOI 10.1002/zoo.21175; Briggs VS, 2008, ETHOLOGY, V114, P489, DOI 10.1111/j.1439-0310.2008.01490.x; BROWDER LW, 1968, J HERED, V59, P163, DOI 10.1093/oxfordjournals.jhered.a107674; Zenklusen MCC, 2011, REV BIOL TROP, V59, P17; Cathers T, 1997, J ZOO WILDLIFE MED, V28, P171; Chang SH, 1974, J KOREAN CHEM SOC, V18, P289; Chelonians Flanagan J., 2015, ZOO WILD ANIMAL MED, P27; Coppo J, 2004, FACENA, V20, P73; Coppo JA, 2005, REV BIOL TROP, V53, P545; COPPO JA, 2001, FISIOLOGIA COMPARADA; COSTANZO JP, 1993, J EXP BIOL, V181, P245; CZECZUGA B, 1980, COMP BIOCHEM PHYS B, V65, P623, DOI 10.1016/0305-0491(80)90170-4; Das MK, 2014, ISRN, V2014, P1, DOI DOI 10.1093/imrn/rns215; Davis AK, 2008, HERPETOL J, V18, P83; Dickinson VM, 2002, J WILDLIFE DIS, V38, P143, DOI 10.7589/0090-3558-38.1.143; Duellman WE, 2001, HYLID FROGS MIDDLE A; Dugas MB, 2013, ZOO BIOL, V32, P655, DOI 10.1002/zoo.21102; ENDLER JA, 1992, AM NAT, V139, pS125, DOI 10.1086/285308; Fioranelli S, 2005, COM CIENT TECNOL, V003, P1; FROST SK, 1984, J MORPHOL, V179, P229, DOI 10.1002/jmor.1051790303; GATTEN RE, 1969, COMP BIOCHEM PHYSIOL, V30, P1019, DOI 10.1016/0010-406X(69)91039-1; Gomez D, 2010, BEHAVIOUR, V147, P1753, DOI 10.1163/000579510X534227; GROSS J, 1966, BIOCHEM J, V101, P747, DOI 10.1042/bj1010747; Gul C, 2011, ACTA HERPETOL, V6, P137; Hadfield CA, 2006, J EXOT PET MED, V15, P255, DOI 10.1053/j.jepm.2006.09.004; Hettyey A, 2009, AMPHIBIA-REPTILIA, V30, P37, DOI 10.1163/156853809787392784; Hill GE, 2000, J AVIAN BIOL, V31, P559, DOI 10.1034/j.1600-048X.2000.310415.x; Hill GE, 1999, AM NAT, V154, P589, DOI 10.1086/303264; Hill GE, 2014, INTEGR COMP BIOL, V54, P645, DOI 10.1093/icb/icu029; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; IGA T, 1975, J EXP ZOOL, V192, P331, DOI 10.1002/jez.1401920306; Jacobs L, 2016, BIOL J LINN SOC; Jain NC, 1993, ESSENTIALS VET HEMAT; Johnson JD, 2013, BIOCHIMIE, V95, P436, DOI 10.1016/j.biochi.2012.10.021; Kaneko JJ, 2008, CLINICAL BIOCHEMISTRY OF DOMESTIC ANIMALS, 6TH EDITION, P1; Kelber A, 2006, J EXP BIOL, V209, P781, DOI 10.1242/jeb.02060; Kelleher SR, 2017, ANIM BEHAV, V129, P161, DOI 10.1016/j.anbehav.2017.05.013; Khachik F, 2002, INVEST OPHTH VIS SCI, V43, P3383; KING RB, 1993, J EXP ZOOL, V267, P40, DOI 10.1002/jez.1402670107; KISTLER A, 1980, INT J BIOCHEM, V12, P395, DOI 10.1016/0020-711X(80)90119-6; KRINSKY NI, 1994, PURE APPL CHEM, V66, P1003, DOI 10.1351/pac199466051003; LEENDERS T., 2001, GUIDE AMPHIBIANS REP; Lutz T., 2009, ENCICLOPEDIA NUTR CL; Mader DR, 1996, REPTILE MED SURG; Matias-Ferrer N, 2015, HERPETOL J, V25, P169; McDonald P., 2010, ANIM NUTR; McGraw KJ, 2004, PHYSIOL BIOCHEM ZOOL, V77, P484, DOI 10.1086/383506; McGraw KJ, 2002, COMP BIOCHEM PHYS B, V131, P261, DOI 10.1016/S1096-4959(01)00500-0; Merton D., 2012, SMALL ANIMAL CLIN PH; MORTON RA, 1949, BIOCHEM J, V45, P612, DOI 10.1042/bj0450612; Murray R. K., 2012, HARPERS ILLUSTRATED; Newman SH, 1997, COLON WATERBIRD, V20, P492, DOI 10.2307/1521600; Ogilvy V, 2012, ANIM CONSERV, V15, P480, DOI 10.1111/j.1469-1795.2012.00536.x; OLSSON M, 1994, ANIM BEHAV, V48, P607, DOI 10.1006/anbe.1994.1280; Olvera-Novoa MA, 2007, AQUACULTURE, V266, P191, DOI 10.1016/j.aquaculture.2007.02.013; PACKARD GC, 1976, AM MIDL NAT, V96, P482, DOI 10.2307/2424090; Patrick L, 2009, REV BIOL TROP, V57, P313; Pinto F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073234; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; READING CJ, 1995, OECOLOGIA, V102, P453, DOI 10.1007/BF00341357; Ready M, 2010, LEAF LIT, V3, P14; Reppert A, 2011, PROC NUT ADV G, P40; Robertson J. S., 2008, THESIS; Robertson JM, 2009, MOL ECOL, V18, P1375, DOI 10.1111/j.1365-294X.2009.04126.x; Sarna T, 2006, PIGMENTARY SYSTEM PH, P311; Savage J.M., 2002, AMPHIBIANS REPTILES; SCHIEDT K, 1985, PURE APPL CHEM, V57, P685, DOI 10.1351/pac198557050685; Sefc KM, 2014, COMP BIOCHEM PHYS A, V173, P42, DOI 10.1016/j.cbpa.2014.03.006; Shirakata Yoshinori, 2006, Chugokugakuen Journal, V5, P17; SINGH K, 1978, ANAT ANZEIGER, V143, P161; Smith H, 2006, EUROP SOC EVOL BIOL, V20, P310; Somsueb P, 2001, AQUAC RES, V32, P33, DOI 10.1046/j.1355-557x.2001.00033.x; Stegen JC, 2004, CAN J ZOOL, V82, P889, DOI 10.1139/Z04-068; Stuart S. N., 2008, THREATENED AMPHIBIAN; SUGA T, 1988, J NAT PROD, V51, P713, DOI 10.1021/np50058a008; Sztatecsny M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1587, DOI 10.1007/s00265-012-1412-6; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x; Zhu B, 2016, PLOS ONE, V11, P1; Zoran DL, 2002, J AM VET MED ASSOC, V221, P1559, DOI 10.2460/javma.2002.221.1559; IUCN RED LIST THREAT	91	11	11	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182020	10.1371/journal.pone.0182020	http://dx.doi.org/10.1371/journal.pone.0182020			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837604	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000014
J	Kuravi, SJ; Yates, CM; Foster, M; Harrison, P; Hazeldine, J; Hampson, P; Watson, C; Belli, A; Midwinter, M; Nash, GB				Kuravi, Sahithi J.; Yates, Clara M.; Foster, Mark; Harrison, Paul; Hazeldine, Jon; Hampson, Peter; Watson, Chris; Belli, Antonio; Midwinter, Mark; Nash, Gerard B.			Changes in the pattern of plasma extracellular vesicles after severe trauma	PLOS ONE			English	Article							CELL-DERIVED MICROPARTICLES; PROCOAGULANT MICROPARTICLES; CIRCULATING MICROPARTICLES; PLATELET MICROPARTICLES; ORGAN DYSFUNCTION; GLYCOPROTEIN IB; FLOW-CYTOMETRY; MICROVESICLES; BLOOD; STANDARDIZATION	Background Extracellular vesicles (EV) released into the circulation after traumatic injury may influence complications. We thus evaluated the numbers of EV in plasma over 28 days after trauma and evaluated their pro-coagulant and inflammatory effects. Methods and findings 37 patients suffering trauma with an injury severity score > 15 were studied along with 24 healthy controls. Plasma samples were isolated by double centrifugation (2000g 20min; 13000g 2min) from blood collected from within an hour up to 28 days after injury. Plasma EV were counted and sized using nanoparticle tracking analysis (NTA); counts and cellular origins were also determined by flow cytometry (FC) using cell-specific markers. Functional effects were tested in a procoagulant phospholipid assay and in flow-based, leukocyte adhesion assay after endothelial cells (EC) were treated with EV. We found that EV concentrations measured by NTA were significantly increased in trauma patients compared to healthy controls, and remained elevated over days. In addition, or FC showed that patients with trauma had higher numbers of EV derived from platelets (CD41+), leukocytes (CD45+) and endothelial EC (CD144+). The increases were evident throughout the 28-day follow-up. However, the FC count represented <1% of the count detected by NTA, and only 1-2% of EV identified using NTA had a diameter > 400nm. The procoagulant phospholipid activity assay showed that patient plasma accelerated coagulation on day 1 and day 3 after trauma, with coagulation times correlated with EV counts. Furthermore, treatment of EC for 24 hours with plasma containing EV tended to increase the recruitment of peripheral flowing blood mononuclear cells. Conclusions EV counted by FC represent a small sub-population of the total load detected by NTA. Both methods however indicate a significant increase in plasma EV after severe traumatic injury that have pro-coagulant and pro-inflammatory effects that may influence outcomes.	[Kuravi, Sahithi J.; Yates, Clara M.; Nash, Gerard B.] Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Kuravi, Sahithi J.; Yates, Clara M.; Foster, Mark; Hazeldine, Jon; Belli, Antonio; Midwinter, Mark; Nash, Gerard B.] Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England; [Harrison, Paul; Hazeldine, Jon; Hampson, Peter; Belli, Antonio] Univ Birmingham, Coll Med & Dent Sci, Inst Inflammat & Ageing, Birmingham, W Midlands, England; [Watson, Chris] Queen Elizabeth Hosp, Dept Haematol, Birmingham, W Midlands, England; [Midwinter, Mark] Univ Queensland, Fac Med, Rural Clin Sch Bundaberg, Bundaberg, Qld, Australia	University of Birmingham; University of Birmingham; University of Birmingham; University of Birmingham; University of Queensland	Nash, GB (corresponding author), Univ Birmingham, Inst Cardiovasc Sci, Coll Med & Dent Sci, Birmingham, W Midlands, England.; Nash, GB (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, NIHR Surg Reconstruct & Microbiol Res Ctr, Birmingham, W Midlands, England.	g.nash@bham.ac.uk	Nash, Gerard B/E-4182-2010; Harrison, Paul/AAN-1916-2021; Belli, Antonio/I-3799-2015; Hazeldine, Jon/T-5725-2019	Nash, Gerard B/0000-0002-5935-2831; Harrison, Paul/0000-0003-4610-8909; Belli, Antonio/0000-0002-3211-9933; 	National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC) [RRAK 12708]; University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Royal Centre for Defence Medicine; Scar Free Foundation	National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC); University Hospitals Birmingham NHS Foundation Trust; University of Birmingham; Royal Centre for Defence Medicine; Scar Free Foundation	SK, CY, JH, AB were funded by the National Institute for Health Research Surgical Reconstruction and Microbiology Research Centre (NIHR SRMRC, grant number RRAK 12708), a partnership between University Hospitals Birmingham NHS Foundation Trust, the University of Birmingham and the Royal Centre for Defence Medicine. PH was funded by Scar Free Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed SR, 2011, J IMMUNOL, V187, P1432, DOI 10.4049/jimmunol.1100299; Al-Nedawi K, 2009, CELL CYCLE, V8, P2014, DOI 10.4161/cc.8.13.8988; ANDERSON BO, 1990, J TRAUMA, V30, pS44; Ayers L, 2011, THROMB RES, V127, P370, DOI 10.1016/j.thromres.2010.12.014; Barry OP, 1998, J CLIN INVEST, V102, P136, DOI 10.1172/JCI2592; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; BODE AP, 1994, TRANSFUSION, V34, P690, DOI 10.1046/j.1537-2995.1994.34894353465.x; Bone RC, 1996, ANN INTERN MED, V125, P680, DOI 10.7326/0003-4819-125-8-199610150-00009; BUTTRUM SM, 1993, BLOOD, V82, P1165; Chandler WL, 2011, J THROMB HAEMOST, V9, P1216, DOI 10.1111/j.1538-7836.2011.04283.x; CIPOLLE MD, 1993, CRIT CARE CLIN, V9, P261, DOI 10.1016/S0749-0704(18)30196-9; COOKE BM, 1993, MICROVASC RES, V45, P33, DOI 10.1006/mvre.1993.1004; Curry N, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25625; Demetriades D, 2004, J AM COLL SURGEONS, V198, P20, DOI 10.1016/j.jamcollsurg.2003.09.003; Dragovic RA, 2011, NANOMED-NANOTECHNOL, V7, P780, DOI 10.1016/j.nano.2011.04.003; Flaumenhaft R, 2010, SEMIN THROMB HEMOST, V36, P881, DOI 10.1055/s-0030-1267042; Flaumenhaft R, 2009, BLOOD, V113, P1112, DOI 10.1182/blood-2008-06-163832; Fujimi S, 2003, J TRAUMA, V54, P114, DOI 10.1097/00005373-200301000-00014; Gardiner C, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.19671; Gardiner EE, 2014, TRANSFUS MED REV, V28, P56, DOI 10.1016/j.tmrv.2014.03.001; Giannoudis PV, 1998, BRIT J SURG, V85, P986; Giannoudis PV, 2004, J BONE JOINT SURG BR, V86B, P313, DOI 10.1302/0301-620X.86B3.15035; Giannoudis PV, 1998, ACTA ORTHOP SCAND, V69, P184, DOI 10.3109/17453679809117625; Hazeldine J, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002338; HOLME PA, 1994, THROMB HAEMOSTASIS, V72, P666; Jy W, 2004, J THROMB HAEMOST, V2, P1842, DOI 10.1111/j.1538-7836.2004.00936.x; Key NS, 2010, THROMB RES, V125, pS42, DOI 10.1016/j.thromres.2010.01.035; Lacroix R, 2013, J THROMB HAEMOST, V11, P1190, DOI 10.1111/jth.12207; Lacroix R, 2012, J THROMB HAEMOST, V10, P437, DOI 10.1111/j.1538-7836.2011.04610.x; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Leroyer AS, 2008, J INTERN MED, V263, P528, DOI 10.1111/j.1365-2796.2008.01957.x; Matijevic N, 2014, THROMB RES, V134, P652, DOI 10.1016/j.thromres.2014.07.023; Matijevic N, 2011, THROMB RES, V128, P35, DOI 10.1016/j.thromres.2011.02.011; Mause SF, 2005, ARTERIOSCL THROM VAS, V25, P1512, DOI 10.1161/01.ATV.0000170133.43608.37; Mesri C, 1998, J IMMUNOL, V161, P4382; Morel N, 2008, J TRAUMA, V64, P698, DOI 10.1097/TA.0b013e31816493ad; Morel O, 2005, THROMB J, V3, DOI 10.1186/1477-9560-3-15; Morel O, 2005, REV MED INTERNE, V26, P791, DOI 10.1016/j.revmed.2005.03.015; Morel O, 2008, PLATELETS, V19, P9, DOI 10.1080/09537100701817232; MURPHY S, 1969, NEW ENGL J MED, V280, P1094, DOI 10.1056/NEJM196905152802004; Ogura H, 2001, J TRAUMA, V50, P801, DOI 10.1097/00005373-200105000-00005; Padilla Foster M., 2016, THESIS; Park MS, 2012, SURGERY, V151, P831, DOI 10.1016/j.surg.2011.12.022; Rose S, 1996, ZBL CHIR, V121, P896; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; Sinauridze EI, 2007, THROMB HAEMOSTASIS, V97, P425, DOI 10.1160/TH06-06-0313; van der Pol E, 2014, J THROMB HAEMOST, V12, P1182, DOI 10.1111/jth.12602; Van der Pol E, 2012, J THROMB HAEMOST, V10, P919, DOI 10.1111/j.1538-7836.2012.04683.x; van der Pol E, 2010, J THROMB HAEMOST, V8, P2596, DOI 10.1111/j.1538-7836.2010.04074.x; WINOKUR R, 1995, BLOOD, V85, P1796, DOI 10.1182/blood.V85.7.1796.bloodjournal8571796; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	51	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183640	10.1371/journal.pone.0183640	http://dx.doi.org/10.1371/journal.pone.0183640			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837705	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000093
J	Long, MC; Krause, E				Long, Mark C.; Krause, Eleanor			Altruism by age and social proximity	PLOS ONE			English	Article							RISK EXPERIMENTAL-EVIDENCE; ECONOMICS; ENVIRONMENTS; UNCERTAINTY; RECIPROCITY; EVOLUTION; AVERSE; HEALTH; LIFE; SEX	This study evaluates the extent to which an individual's stated altruistic sentiments can be influenced by context-most importantly, by the age and social proximity of the other person and by the nature of what is being sacrificed. We measure willingness to sacrifice own health for another person's health and willingness to sacrifice own wealth for another person's wealth. To evaluate these sentiments, two surveys were administered to representative samples of Americans which contained hypothetical scenarios with context randomly assigned; the first survey posed a dictator game question and the second survey was designed to elicit marginal rates of substitution between own and other's health/wealth. As expected, we find less altruism towards those who are more socially distant (e.g., strangers relative to family). We find individuals are more health altruistic towards young children and more wealth altruistic towards adults, and health altruism tends to be lowest for survey respondents near retirement age. We find no relationship between levels of altruism and the distance between the respondent's state of birth and state of current residence. These findings improve society's understanding of situational altruism and kinship and reciprocity as motivations for altruism, and they have practical implications concerning the economic valuation of human lives used to guide public policy-making.	[Long, Mark C.; Krause, Eleanor] Univ Washington, Evans Sch Publ Policy & Governance, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Long, MC (corresponding author), Univ Washington, Evans Sch Publ Policy & Governance, Seattle, WA 98195 USA.	marklong@uw.edu			National Science Foundation [1457913]; University of Washington Research Royalty Fund Award; Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant [R24 HD042828]	National Science Foundation(National Science Foundation (NSF)); University of Washington Research Royalty Fund Award; Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant	This work was supported by the National Science Foundation - Award 1457913 (ML), https://www.nsf.gov/; University of Washington Innovation Award (ML), http://www.washington.edu/research/topics/innovation-awards; University of Washington Research Royalty Fund Award (ML), https://www.washington.edu/research/or/?page=rrf; and Eunice Kennedy Shriver National Institute of Child Health and Human Development research infrastructure grant - R24 HD042828 (ML), https://www.nih.gov/about-nih/what-we-do/nih-almanac/eunice-kennedy-shriver-national-institute-child-health-human-development-nichd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson H, 2009, ACCIDENT ANAL PREV, V41, P286, DOI 10.1016/j.aap.2008.11.009; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Angelini V, 2013, REV ECON HOUSEHOLD, V11, P393, DOI 10.1007/s11150-012-9170-9; Arias E., 2006, NATL VITAL STAT REPO, V58; ARROW KJ, 1963, AM ECON REV, V53, P941; Axelrod R., 1984, EVOLUTION COOPERATIO, DOI DOI 10.2307/3323905; BECKER GS, 1976, J ECON LIT, V14, P817; Ben-Ner A, 2011, PERS INDIV DIFFER, V51, P216, DOI 10.1016/j.paid.2010.04.024; Brady KL, 2008, NAT RESOUR J, V48, P541; Brock JM, 2013, AM ECON REV, V103, P415, DOI 10.1257/aer.103.1.415; Buurman M, 2012, J ECON BEHAV ORGAN, V83, P279, DOI 10.1016/j.jebo.2012.06.003; Carlsson F, 2005, ECONOMICA, V72, P375, DOI 10.1111/j.0013-0427.2005.00421.x; Cowell FA, 2001, EUR ECON REV, V45, P941, DOI 10.1016/S0014-2921(01)00121-0; Curry O, 2013, BRIT J PSYCHOL, V104, P283, DOI 10.1111/j.2044-8295.2012.02119.x; Curry O, 2011, BIOL LETTERS, V7, P651, DOI 10.1098/rsbl.2010.1202; Eckel CC, 1998, ECON J, V108, P726, DOI 10.1111/1468-0297.00311; Engel C, 2011, EXP ECON, V14, P583, DOI 10.1007/s10683-011-9283-7; Falk A, 2006, GAME ECON BEHAV, V54, P293, DOI 10.1016/j.geb.2005.03.001; Fehr E, 2009, J EUR ECON ASSOC, V7, P235, DOI 10.1162/JEEA.2009.7.2-3.235; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; GfK, 2013, DESIGN SUMMARY; HAMILTON WD, 1964, J THEOR BIOL, V7, P17, DOI 10.1016/0022-5193(64)90039-6; Hayashi F, 1996, ECONOMETRICA, V64, P261, DOI 10.2307/2171783; Hurley J, 2013, J HEALTH ECON, V32, P671, DOI 10.1016/j.jhealeco.2013.03.005; Jacobsson F, 2007, ECON J, V117, P761, DOI 10.1111/j.1468-0297.2007.02049.x; Johannesson M, 1997, J RISK UNCERTAINTY, V15, P221, DOI 10.1023/A:1007705309543; JONESLEE MW, 1992, ECON J, V102, P80, DOI 10.2307/2234853; Krawczyk M, 2016, AM ECON REV, V106, P836, DOI 10.1257/aer.20130779; Krawczyk M, 2010, EXP ECON, V13, P500, DOI 10.1007/s10683-010-9253-5; Krupnick A, 2002, J RISK UNCERTAINTY, V24, P161, DOI 10.1023/A:1014020027011; Lennon MC, 2003, 1 NAT CTR CHILDR POV; LOWE R, 1973, PSYCHOL REP, V33, P567, DOI 10.2466/pr0.1973.33.2.567; Macrae CN, 1998, SOC COGNITION, V16, P400, DOI 10.1521/soco.1998.16.4.400; McFadden D., 1973, FRONTIERS ECONOMETRI, P105, DOI DOI 10.1108/EB028592; Nelson LD, 2005, J EXP SOC PSYCHOL, V41, P423, DOI 10.1016/j.jesp.2004.08.003; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Rawls J., 1971, THEORY JUSTICE; ROTTON J, 1977, PSYCHOL REP, V40, P102, DOI 10.2466/pr0.1977.40.1.102; SANBONMATSU LISA, 2011, MOVING OPPORTUNITY F; Schwartz S. H., 1977, ADV EXP SOC PSYCHOL, V10, P221, DOI [10.1016/s0065-2601(08)60358-5, 10.1016/S0065-2601(08) 60358-5, DOI 10.1016/S0065-2601(08)60358-5]; Simpson B, 2008, SOC PSYCHOL QUART, V71, P37, DOI 10.1177/019027250807100106; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; U.S. Census Bureau, 2011, MOV RAT REACH REC LO; Yamada K, 2006, APPL ECON, V38, P1839, DOI 10.1080/00036840600825746	45	9	9	5	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0180411	10.1371/journal.pone.0180411	http://dx.doi.org/10.1371/journal.pone.0180411			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837557	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000004
J	Makhanova, N; Morgan, AP; Kayashima, Y; Makhanov, A; Hiller, S; Zhilicheva, S; Xu, LQ; de Villena, FPM; Maeda, N				Makhanova, Natalia; Morgan, Andrew P.; Kayashima, Yukako; Makhanov, Andrei; Hiller, Sylvia; Zhilicheva, Svetlana; Xu, Longquan; de Villena, Fernando Pardo-Manuel; Maeda, Nobuyo			Genetic architecture of atherosclerosis dissected by QTL analyses in three F2 intercrosses of apolipoprotein E-null mice on C57BL6/J, DBA/2J and 129S6/SvEvTac backgrounds	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; IDENTIFICATION; ASSOCIATION; LESIONS; CROSS	Quantitative trait locus (QTL) analyses of intercross populations between widely used mouse inbred strains provide a powerful approach for uncovering genetic factors that influence susceptibility to atherosclerosis. Epistatic interactions are common in complex phenotypes and depend on genetic backgrounds. To dissect genetic architecture of atherosclerosis, we analyzed F2 progeny from a cross between apolipoprotein E-null mice on DBA/2J (DBA-apoE) and C57BL/6J (B6-apoE) genetic backgrounds and compared the results with those from two previous F2 crosses of apolipoprotein E-null mice on 129S6/SvEvTac (129-apoE) and DBA-apoE backgrounds, and B6-apoE and 129-apoE backgrounds. In these round-robin crosses, in which each parental strain was crossed with two others, large-effect QTLs are expected to be detectable at least in two crosses. On the other hand, observation of QTLs in one cross only may indicate epistasis and/or absence of statistical power. For atherosclerosis at the aortic arch, Aath4 on chromosome (Chr)2:66 cM follows the first pattern, with significant QTL peaks in (DBAx129)F2 and (B6xDBA)F2 mice but not in (B6x129)F2 mice. We conclude that genetic variants unique to DBA/2J at Aath4 confer susceptibility to atherosclerosis at the aortic arch. A similar pattern was observed for Aath5 on chr10:35 cM, verifying that the variants unique to DBA/2J at this locus protect against arch plaque development. However, multiple loci, including Aath1 (Chr1:49 cM), and Aath2 (Chr1:70 cM) follow the second type of pattern, showing significant peaks in only one of the three crosses (B6-apoE x 129-apoE). As for atherosclerosis at aortic root, the majority of QTLs, including Ath29 (Chr9:33 cM), Ath44 (Chr1:68 cM) and Ath45 (Chr2:83 cM), was also inconsistent, being significant in only one of the three crosses. Only the QTL on Chr7:37 cM was consistently suggestive in two of the three crosses. Thus QTL analysis of round-robin crosses revealed the genetic architecture of atherosclerosis.	[Makhanova, Natalia; Kayashima, Yukako; Hiller, Sylvia; Zhilicheva, Svetlana; Xu, Longquan; Maeda, Nobuyo] Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA; [Morgan, Andrew P.; de Villena, Fernando Pardo-Manuel] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC USA; [Morgan, Andrew P.; de Villena, Fernando Pardo-Manuel] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC USA; [Makhanov, Andrei] Georgia Inst Technol, Coll Comp, Atlanta, GA 30332 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University System of Georgia; Georgia Institute of Technology	Maeda, N (corresponding author), Univ North Carolina Chapel Hill, Dept Pathol & Lab Med, Chapel Hill, NC 27599 USA.	nobuyo@med.unc.edu			National Institutes of Health (NIH) [HL042630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL042630] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008719] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by a National Institutes of Health (NIH) grant HL042630 (PI: N. Maeda). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; Beavis W. D., 1994, P 49 ANN CORN SORGH, P250; Beavis WD, 1998, MOL DISSECTION COMPL, P145, DOI DOI 10.1093/MP/SSR111; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Broman K., 2009, A GUIDE TO QTL MAPPI; Choi Y, 2015, BIOINFORMATICS, V31, P2745, DOI 10.1093/bioinformatics/btv195; Colinayo VV, 2003, MAMM GENOME, V14, P464, DOI 10.1007/s00335-002-2187-2; Ganesh SK, 2013, HUM MOL GENET, V22, P1663, DOI 10.1093/hmg/dds555; Irvin MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024052; Kayashima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117478; Kayashima Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088274; Kenney-Hunt JP, 2008, GENETICS, V178, P2275, DOI 10.1534/genetics.107.084434; Kenney-Hunt JP, 2006, MAMM GENOME, V17, P526, DOI 10.1007/s00335-005-0160-6; Kessler T, 2016, EMBO MOL MED, V8, P688, DOI 10.15252/emmm.201506174; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Lalani SR, 2013, HUM MOL GENET, V22, P4339, DOI 10.1093/hmg/ddt283; Maeda N, 2007, ATHEROSCLEROSIS, V195, P75, DOI 10.1016/j.atherosclerosis.2006.12.006; Mann MRW, 1999, HUM MOL GENET, V8, P1867, DOI 10.1093/hmg/8.10.1867; Morgan AP, 2016, GENETICS, V204, P267, DOI 10.1534/genetics.116.191007; PIEDRAHITA JA, 1992, P NATL ACAD SCI USA, V89, P4471, DOI 10.1073/pnas.89.10.4471; Sen S, 2007, MAMM GENOME, V18, P87, DOI 10.1007/s00335-006-0090-y; STEWARTPHILLIPS JL, 1989, CLIN INVEST MED, V12, P121; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Tomita H, 2010, CIRC RES, V106, P1052, DOI 10.1161/CIRCRESAHA.109.207175; Treusch S, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004913; Wang JR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S3-S13; Wang SS, 2007, ARTERIOSCL THROM VAS, V27, P2671, DOI 10.1161/ATVBAHA.107.148106; Wang SS, 2007, CIRC RES, V101, pE11, DOI 10.1161/CIRCRESAHA.107.152975; Wang XS, 2005, AM J HUM GENET, V77, P1, DOI 10.1086/431656; WARNICK GR, 1985, CLIN CHEM, V31, P217; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	31	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182882	10.1371/journal.pone.0182882	http://dx.doi.org/10.1371/journal.pone.0182882			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837567	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000031
J	Deng, XL; Wang, Y; Xiao, GS				Deng, Xiu-Ling; Wang, Yan; Xiao, Guo-Sheng			Effects of equol on multiple K+ channels stably expressed in HEK 293 cells	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ISOFLAVONE METABOLITE EQUOL; CARDIAC POTASSIUM CHANNELS; TRANSIENT OUTWARD CURRENT; PIG VENTRICULAR MYOCYTES; FACTOR RECEPTOR KINASE; HUMAN ATRIAL MYOCYTES; ANTIOXIDANT ACTIVITY; TYROSINE KINASE; SOY ISOFLAVONES	The present study investigated the effects of equol on cardiovascular K+ channel currents. The cardiovascular K+ channel currents were determined in HEK 293 cells stably expressing cloned differential cardiovascular K+ channels with conventional whole-cell patch voltage-clamp technique. We found that equol inhibited hKv1.5 (IC50: 15.3 mu M), hKv4.3 (IC50: 29.2 mu M and 11.9 mu M for hKv4.3 peak current and charge area, respectively), I-Ks (IC50: 24.7 mu M) and I-hERG (IC50: 31.6 and 56.5 mu M for I-hERG.tail and I-hERG.step, respectively), but not hKir2.1 current, in a concentration-dependent manner. Interestingly, equol increased BKCa current with an EC50 of 0.1 mu M. It had no significant effect on guinea pig ventricular action potentials at concentrations of <= 3 mu M. These results demonstrate that equol inhibits several cardiac K+ currents at relatively high concentrations, whereas it increases BKCa current at very low concentrations, suggesting that equol is a safe drug candidate for treating patients with cerebral vascular disorders.	[Deng, Xiu-Ling] Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Xian, Shaanxi, Peoples R China; [Wang, Yan; Xiao, Guo-Sheng] Xiamen Univ, Xiamen Cardiovasc Hosp, Xiamen, Fujian, Peoples R China	Xi'an Jiaotong University; Xiamen University	Deng, XL (corresponding author), Xi An Jiao Tong Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Sch Basic Med Sci, Xian, Shaanxi, Peoples R China.; Xiao, GS (corresponding author), Xiamen Univ, Xiamen Cardiovasc Hosp, Xiamen, Fujian, Peoples R China.	dengxl@mail.xjtu.edu.cn; xgs71@163.com			National Nature Science Foundation of China [81570214, 81370191]; Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China; Key Cardiovascular Laboratory Fund from Department of Xiamen Science and Technology, Xiamen, China [3502Z20150050]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China; Key Cardiovascular Laboratory Fund from Department of Xiamen Science and Technology, Xiamen, China	This work was supported in part by grants (No.81570214, No.81370191) from National Nature Science Foundation of China, a Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China and a Key Cardiovascular Laboratory Fund (3502Z20150050) from Department of Xiamen Science and Technology, Xiamen, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by grants (No.81570214, No.81370191) from National Nature Science Foundation of China, a Collaborative Grant for Study on Prevention and Control of Major Chronic Non-infectious Diseases of the 13th Five-Year National Research Plan from Ministry of Science and Technology, China and a Key Cardiovascular Laboratory Fund (3502Z20150050) from Department of Xiamen Science and Technology, Xiamen, China.	Amberg GC, 2003, AM J PHYSIOL-CELL PH, V284, pC583, DOI 10.1152/ajpcell.00301.2002; Atkinson C, 2005, EXP BIOL MED, V230, P155, DOI 10.1177/153537020523000302; Blair RM, 2003, J NUTR, V133, P2262, DOI 10.1093/jn/133.7.2262; Choi EJ, 2014, MOL MED REP, V9, P328, DOI 10.3892/mmr.2013.1752; CLARK RB, 1995, BRIT J PHARMACOL, V115, P335, DOI 10.1111/j.1476-5381.1995.tb15882.x; Dixon JE, 1996, CIRC RES, V79, P659, DOI 10.1161/01.RES.79.4.659; Dong MQ, 2010, BBA-BIOMEMBRANES, V1798, P995, DOI 10.1016/j.bbamem.2010.01.010; Farkas AS, 2010, DRUGS, V70, P573, DOI 10.2165/11535230-000000000-00000; Feng JL, 1997, CIRC RES, V80, P572, DOI 10.1161/01.RES.80.4.572; Giudicessi JR, 2011, HEART RHYTHM, V8, P1024, DOI 10.1016/j.hrthm.2011.02.021; Guo KP, 2010, BRIT J NUTR, V104, P118, DOI 10.1017/S0007114510000279; Hazim S, 2016, AM J CLIN NUTR, V103, P694, DOI 10.3945/ajcn.115.125690; Hedlund TE, 2003, PROSTATE, V54, P68, DOI 10.1002/pros.10137; Jackman KA, 2007, CURR MED CHEM, V14, P2824, DOI 10.2174/092986707782360178; Jackman KA, 2007, BRAIN RES, V1141, P99, DOI 10.1016/j.brainres.2007.01.007; Kim HJ, 2011, AM J PHYSIOL-CELL PH, V300, pC567, DOI 10.1152/ajpcell.00031.2010; Ko EA, 2009, VASC PHARMACOL, V50, P51, DOI 10.1016/j.vph.2008.09.004; Legette LL, 2014, J AGR FOOD CHEM, V62, P1294, DOI 10.1021/jf400097m; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 2002, J MOL CELL CARDIOL, V34, P1185, DOI 10.1006/jmcc.2002.2053; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 2008, CIRCULATION, V117, P2449, DOI 10.1161/CIRCULATIONAHA.108.769554; Li GR, 2010, ADV PHARMACOL, V59, P93, DOI 10.1016/S1054-3589(10)59004-5; Li GR, 2009, CARDIOVASC RES, V81, P286, DOI 10.1093/cvr/cvn322; Liew R, 2003, J PHARMACOL EXP THER, V304, P985, DOI 10.1124/jpet.102.042986; Liu H, 2007, J MOL CELL CARDIOL, V42, P760, DOI 10.1016/j.yjmcc.2006.10.013; Magee PJ, 2014, EUR J NUTR, V53, P345, DOI 10.1007/s00394-013-0520-z; Magee PJ, 2011, P NUTR SOC, V70, P10, DOI 10.1017/S0029665110003940; Mahmoud AM, 2014, J STEROID BIOCHEM, V140, P116, DOI 10.1016/j.jsbmb.2013.12.010; Ohkura Y, 2015, J CARDIOVASC PHARM, V65, P500, DOI 10.1097/FJC.0000000000000220; OYAMA Y, 1992, JPN J PHARMACOL, V58, P185, DOI 10.1254/jjp.58.185; Peretz A, 1999, J PHYSIOL-LONDON, V519, P373, DOI 10.1111/j.1469-7793.1999.0373m.x; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Rowlands DJ, 2011, HYPERTENSION, V57, P833, DOI 10.1161/HYPERTENSIONAHA.110.162198; Rufer CE, 2006, J AGR FOOD CHEM, V54, P2926, DOI 10.1021/jf053112o; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Setchell KDR, 2005, AM J CLIN NUTR, V81, P1072; Setchell KDR, 2006, J NUTR, V136, P2188, DOI 10.1093/jn/136.8.2188; Setchell KDR, 2010, J NUTR, V140, p1363S, DOI 10.3945/jn.109.119784; Turner R, 2004, FREE RADICAL RES, V38, P209, DOI 10.1080/10715760310001641854; Veerman CC, 2013, CIRC-ARRHYTHMIA ELEC, V6, P1002, DOI 10.1161/CIRCEP.113.000239; Wu HJ, 2011, J MOL CELL CARDIOL, V51, P966, DOI 10.1016/j.yjmcc.2011.08.022; Wu W, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059749, 10.1371/journal.pone.0059016]; Yang L, 2015, ANESTHESIOLOGY, V122, P571, DOI 10.1097/ALN.0000000000000495; Yu W, 2016, PHARMACOL RES, V107, P186, DOI 10.1016/j.phrs.2016.03.015; Yu W, 2014, CURR NEUROVASC RES, V11, P367, DOI 10.2174/1567202611666140908094517; Yuan JP, 2007, MOL NUTR FOOD RES, V51, P765, DOI 10.1002/mnfr.200600262; Zhang DY, 2008, CELL SIGNAL, V20, P1815, DOI 10.1016/j.cellsig.2008.06.006; Zhang DY, 2011, BBA-BIOMEMBRANES, V1808, P1993, DOI 10.1016/j.bbamem.2011.04.015; Zhang HT, 2010, EUR J PHARMACOL, V630, P100, DOI 10.1016/j.ejphar.2009.12.032; Zhang YH, 2012, CARDIOVASC RES, V93, P424, DOI 10.1093/cvr/cvr347	52	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183708	10.1371/journal.pone.0183708	http://dx.doi.org/10.1371/journal.pone.0183708			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832658	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800089
J	Roy, G; Zhang, S; Li, L; Higham, E; Wu, H; Marelli, M; Bowen, MA				Roy, Gargi; Zhang, Shu; Li, Lina; Higham, Eileen; Wu, Herren; Marelli, Marcello; Bowen, Michael A.			Development of a fluorescent reporter system for monitoring ER stress in Chinese hamster ovary cells and its application for therapeutic protein production	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; TRANSCRIPTION FACTOR XBP-1; B-CELLS; SECRETORY CAPACITY; QUALITY-CONTROL; MESSENGER-RNA; CHO-CELLS; DIFFERENTIATION; ATF6; IRE1	Mammalian cell expression systems have become a workhorse for the production of biotherapeutic proteins. As such, there is an ever increasing demand for higher productivity from these expression platforms to reduce manufacturing costs. While great advances have been made in the optimization of culture conditions and cell line selection to improve productivity, protein mis-folding remains a common limitation to high levels of production of therapeutic proteins. Accumulation of mis- and unfolded protein in the endoplasmic reticulum (ER) causes ER stress and initiates the unfolded protein response (UPR) that results in an activation of protein folding machinery, translation attenuation in an effort to proper folding of the newly synthesized peptides or may even lead to apoptosis if the correct folding is not restored. As a result, UPR associated apoptosis often results in lower protein expression. To better understand the molecular mechanisms in these pathways, we developed a reporter construct that detects Inositol-requiring enzyme 1 (IRE1)-alpha mediated splicing of X-box binding protein 1 (XBP1) to monitor the course of UPR activation in cell lines expressing monoclonal antibodies. Using this reporter we observed a clear activation of UPR in cells treated with known ER stress causing pharmacological agents, such as Tunicamycin (Tm) and Thapsigargin (Tg), as well as in stable IgG expressing cells during fed-batch cultures. Furthermore, we developed a stress metric that we term as ER stress index (ERSI) to gauge basal ER stress in cells which we used as a predictive tool for isolation of high IgG expressing cell lines. This reporter system, with its ability to monitor the stress involved in recombinant protein expression, has utility to assist in devising engineering strategies for improved production of biotherapeutic drugs.	[Roy, Gargi; Zhang, Shu; Wu, Herren; Marelli, Marcello; Bowen, Michael A.] MedImmune LLC, Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Li, Lina; Higham, Eileen] MedImmune LLC, Cell Culture & Fermentat Sci, Gaithersburg, MD USA; [Zhang, Shu] Gilead Sci, Biol Dev, San Diego, CA USA; [Higham, Eileen] Juno Therapeut, Proc Dev, Seattle, WA USA; [Bowen, Michael A.] Juno Therapeut, Analyt Dev, Seattle, WA USA	AstraZeneca; Medimmune; AstraZeneca; Medimmune; Gilead Sciences	Roy, G; Bowen, MA (corresponding author), MedImmune LLC, Antibody Discovery & Prot Engn, Gaithersburg, MD USA.; Bowen, MA (corresponding author), Juno Therapeut, Analyt Dev, Seattle, WA USA.	royg@medimmune.com; m.bowen@miami.edu		Marelli, Marcello/0000-0001-7095-8263	Medlmmune LLC	Medlmmune LLC	This study received funding from Medlmmune LLC. Medlmmune provided support in the form of salaries for authors [GR, SZ, LL, EH, HW, MM, MAB], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Becker E, 2008, J BIOTECHNOL, V135, P217, DOI 10.1016/j.jbiotec.2008.03.008; Cain K, 2013, BIOTECHNOL PROGR, V29, P697, DOI 10.1002/btpr.1693; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Cudna RE, 2003, BIOTECHNOL BIOENG, V81, P56, DOI 10.1002/bit.10445; Du ZM, 2013, BIOTECHNOL BIOENG, V110, P2184, DOI 10.1002/bit.24877; DuRose JB, 2006, MOL BIOL CELL, V17, P3095, DOI 10.1091/mbc.E06-01-0055; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Evans K, 2015, BIOTECHNOL PROGR, V31, P1172, DOI 10.1002/btpr.2145; Forman MS, 2003, TRENDS NEUROSCI, V26, P407, DOI 10.1016/S0166-2236(03)00197-8; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Gunn KE, 2003, FASEB J, V17, pC209; HAMMOND C, 1994, P NATL ACAD SCI USA, V91, P913, DOI 10.1073/pnas.91.3.913; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kober L, 2012, BIOTECHNOL BIOENG, V109, P2599, DOI 10.1002/bit.24527; Ku SCY, 2010, BIOTECHNOL PROGR, V26, P517, DOI 10.1002/btpr.322; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LYTTON J, 1991, J BIOL CHEM, V266, P17067; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Paschen W, 2001, J NEUROCHEM, V79, P719, DOI 10.1046/j.1471-4159.2001.00623.x; Prashad K, 2015, CYTOTECHNOLOGY, V67, P237, DOI 10.1007/s10616-013-9678-8; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Tigges M, 2006, METAB ENG, V8, P264, DOI 10.1016/j.ymben.2006.01.006; Tirosh B, 2005, J EXP MED, V202, P505, DOI 10.1084/jem.20050575; van Anken E, 2003, IMMUNITY, V18, P243, DOI 10.1016/S1074-7613(03)00024-4; van Huizen R, 2003, J BIOL CHEM, V278, P15558, DOI 10.1074/jbc.M212074200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang XZ, 1998, EMBO J, V17, P5708, DOI 10.1093/emboj/17.19.5708; Wurm FM, 2004, NAT BIOTECHNOL, V22, P1393, DOI 10.1038/nbt1026; Ye J, 2000, MOL CELL, V6, P1355, DOI 10.1016/S1097-2765(00)00133-7; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000; Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848	37	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183694	10.1371/journal.pone.0183694	http://dx.doi.org/10.1371/journal.pone.0183694			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832690	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800084
J	Sletta, KY; Tveitaras, MK; Lu, N; Engelsen, AST; Reed, RK; Garmann-Johnsen, A; Stuhr, L				Sletta, Kristine Yttersian; Tveitaras, Maria K.; Lu, Ning; Engelsen, Agnete S. T.; Reed, Rolf K.; Garmann-Johnsen, Annette; Stuhr, Linda			Oxygen-dependent regulation of tumor growth and metastasis in human breast cancer xenografts	PLOS ONE			English	Article							HYPERBARIC-OXYGEN; MESENCHYMAL TRANSITION; GENE-EXPRESSION; PROSTATE-CANCER; N-CADHERIN; LUNG; CELLS; HYPEROXIA; PATTERNS; OUTCOMES	Background Tumor hypoxia is relevant for tumor growth, metabolism, resistance to chemotherapy and metastasis. We have previously shown that hyperoxia, using hyperbaric oxygen treatment (HBOT), attenuates tumor growth and shifts the phenotype from mesenchymal to epithelial (MET) in the DMBA-induced mammary tumor model. This study describes the effect of HBOT on tumor growth, angiogenesis, chemotherapy efficacy and metastasis in a triple negative MDA-MB-231 breast cancer model, and evaluates tumor growth using a triple positive BT-474 breast cancer model. Materials and methods 5 x 10(5) cancer cells were injected s.c. in the groin area of NOD/SCID female mice. The BT474 group was supplied with Progesterone and Estradiol pellets 2-days prior to tumor cell injection. Mice were divided into controls (1 bar, pO(2) = 0.2 bar) or HBOT (2.5 bar, pO(2) = 2.5 bar, 90 min, every third day until termination of the experiments). Treatment effects were determined by assessment of tumor growth, proliferation (Ki67-staining), angiogenesis (CD31-staining), metastasis (immunostaining), EMT markers (western blot), stromal components collagen type I, Itgb1 and FSP1 (immunostaining) and chemotherapeutic efficacy (5FU). Results HBOT significantly suppressed tumor growth in both the triple positive and negative tumors, and both MDA-MB-231 and BT-474 showed a decrease in proliferation after HBOT. No differences were found in angiogenesis or 5FU efficacy between HBOT and controls. Nevertheless, HBOT significantly reduced both numbers and total area of the metastastatic lesions, as well as reduced expression of N-cadherin, Axl and collagen type I measured in the MDA-MB-231 model. No change in stromal Itgb1 and FSP1 was found in either tumor model. Conclusion Despite the fact that behavior and prognosis of the triple positive and negative subtypes of cancer are different, the HBOT had a similar suppressive effect on tumor growth, indicating that they share a common oxygen dependent anti-tumor mechanism. Furthermore, HBOT significantly reduced the number and area of metastatic lesions in the triple negative model as well as a significant reduction in the EMT markers N-cadherin, Axl and density of collagen type I.	[Sletta, Kristine Yttersian; Tveitaras, Maria K.; Lu, Ning; Engelsen, Agnete S. T.; Reed, Rolf K.; Stuhr, Linda] Univ Bergen, Dept Biomed, Bergen, Norway; [Tveitaras, Maria K.; Engelsen, Agnete S. T.; Reed, Rolf K.; Stuhr, Linda] Univ Bergen, Ctr Canc Biomarkers CCBIO, Bergen, Norway; [Tveitaras, Maria K.] Haukeland Hosp, Matrix Biol, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital	Stuhr, L (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.; Stuhr, L (corresponding author), Univ Bergen, Ctr Canc Biomarkers CCBIO, Bergen, Norway.	linda.stuhr@uib.no	Engelsen, Agnete Svendsen Tenfjord/AAB-6652-2020; Reed, Rolf K./B-9422-2017	Engelsen, Agnete Svendsen Tenfjord/0000-0003-0375-3406; Reed, Rolf K./0000-0002-2633-6595	Research Council of Norway through its Centre of Excellence funding scheme [223250]; Norwegian Cancer Society, Helse Vest RHF	Research Council of Norway through its Centre of Excellence funding scheme; Norwegian Cancer Society, Helse Vest RHF	This work was partly supported by the Research Council of Norway through its Centre of Excellence funding scheme, project number 223250. The study was also supported by the Norwegian Cancer Society, Helse Vest RHF.	ALAGOZ T, 1995, CANCER, V75, P2313, DOI 10.1002/1097-0142(19950501)75:9<2313::AID-CNCR2820750921>3.0.CO;2-6; Chen J, 2010, BRIT J CANCER, V102, P351, DOI 10.1038/sj.bjc.6605486; Conklin MW, 2012, CELL ADHES MIGR, V6, P249, DOI 10.4161/cam.20567; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Derycke LDM, 2004, INT J DEV BIOL, V48, P463, DOI 10.1387/ijdb.041793ld; Ferreira BI, 2017, MEDCHEMCOMM, V8, P53, DOI 10.1039/c6md00394j; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Gill AL, 2004, QJM-INT J MED, V97, P385, DOI 10.1093/qjmed/hch074; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Granowitz EV, 2005, ANTICANCER RES, V25, P3833; Haroon ATMY, 2007, UNDERSEA HYPERBAR M, V34, P83; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kalns J, 1998, ANTICANCER RES, V18, P363; Kluft O., 1965, HYPERBARIC OXYGEN EX; Lash GE, 2002, GROWTH FACTORS, V20, P189, DOI 10.1080/0897719021000069560; Li MC, 2016, ONCOL REP, V36, P521, DOI 10.3892/or.2016.4766; LINDENSCHMIDT RC, 1986, CARCINOGENESIS, V7, P1581, DOI 10.1093/carcin/7.9.1581; Liu ZJ, 2015, J ZHEJIANG UNIV-SC B, V16, P32, DOI 10.1631/jzus.B1400221; Luo WR, 2012, HISTOPATHOLOGY, V61, P237, DOI 10.1111/j.1365-2559.2012.04212.x; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; MESTROVIC J, 1990, CLIN EXP METASTAS, V8, P113, DOI 10.1007/BF00117784; Miller KD, 2016, CA-CANCER J CLIN, V66, P271, DOI 10.3322/caac.21349; Mimeault M, 2013, J CELL MOL MED, V17, P30, DOI 10.1111/jcmm.12004; Moen I, 2011, DRUG THERAPY STUDIES, P10; Moen I, 2012, TARGET ONCOL, V7, P233, DOI 10.1007/s11523-012-0233-x; Moen I, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-21; Moen I, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-446; Moen I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006381; Nerenberg Paul S., 2007, Cancer Genomics & Proteomics, V4, P319; Ohguri T, 2009, INT J HYPERTHER, V25, P160, DOI 10.1080/02656730802610357; Park SJ, 2016, ONCOL LETT, V11, P1895, DOI 10.3892/ol.2016.4115; Petre PM, 2003, J THORAC CARDIOV SUR, V125, P85, DOI 10.1067/mtc.2003.90; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Raa A, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-23; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 2015, CLIN SCI, V129, P1037, DOI 10.1042/CS20150451; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stepien K, 2016, MED ONCOL, V33, DOI 10.1007/s12032-016-0814-0; Stuhr LEB, 2004, CANCER LETT, V210, P35, DOI 10.1016/j.canlet.2004.02.012; Stuhr LEB, 2007, J NEURO-ONCOL, V85, P191, DOI 10.1007/s11060-007-9407-2; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Wang Z, CURR DRUG TARGETS, V11, P745; Wu XY, 2015, ONCOTARGET, V6, P29143, DOI 10.18632/oncotarget.5020	43	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183254	10.1371/journal.pone.0183254	http://dx.doi.org/10.1371/journal.pone.0183254			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832662	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800053
J	Jovelet, C; Madic, J; Remon, J; Honore, A; Girard, R; Rouleau, E; Andre, B; Besse, B; Droniou, M; Lacroix, L				Jovelet, Cecile; Madic, Jordan; Remon, Jordi; Honore, Aurelie; Girard, Romain; Rouleau, Etienne; Andre, Barbara; Besse, Benjamin; Droniou, Magali; Lacroix, Ludovic			Crystal digital droplet PCR for detection and quantification of circulating EGFR sensitizing and resistance mutations in advanced non-small cell lung cancer	PLOS ONE			English	Article							TUMOR-DNA; PLASMA	Over the past years, targeted therapies using tyrosine kinase inhibitors (TKI) have led to an increase in progression-free survival and response rate for a subgroup of non-small cell lung cancer (NSCLC) patients harbouring specific gene abnormalities compared with chemotherapy. However long-lasting tumor regression is rarely achieved, due to the development of resistant tumoral subclones, which requires alternative therapeutic approaches. Molecular profile at progressive disease is a challenge for making adaptive treatment decisions. The aim of this study was to monitor EGFR-mutant tumors over time based on the quantity of mutant DNA circulating in plasma (ctDNA), comparing two different methods, Crystal (TM) Digital (TM) PCR and Massive Parallel Sequencing (MPS). In plasma circulating cell free DNA (cfDNA) of 61 advanced NSCLC patients we found an overall correlation of 78% between mutated allelic fraction measured by Crystal Digital PCR and MPS. 7 additional samples with sensitizing mutations and 4 additional samples with the resistance mutation were detected with Crystal Digital PCR, but not with MPS. Monitoring levels of both mutation types over time showed a correlation between levels and trends of mutated ctDNA detected and clinical assessment of disease for the 6 patients tested. In conclusion, Crystal Digital PCR exhibited good performance for monitoring mutational status in plasma cfDNA, and also appeared as better suited to the detection of known mutations than MPS in terms of features such as time to results.	[Jovelet, Cecile; Honore, Aurelie; Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, CNRS UMS3655, INSERM US23, AMMICA,Plateforme Genom BMO, Villejuif, France; [Jovelet, Cecile; Honore, Aurelie; Rouleau, Etienne; Lacroix, Ludovic] Gustave Roussy, CNRS UMS3655, INSERM US23, AMMICA,Ctr Ressources Biol, Villejuif, France; [Madic, Jordan; Andre, Barbara; Droniou, Magali] Stilla Technol, 1 Mail Prof Georges Mathe, Villejuif, France; [Remon, Jordi; Besse, Benjamin] Inst Gustave Roussy, Dept Med Oncol, Villejuif, France; [Remon, Jordi; Besse, Benjamin] Univ Paris Sud, Fac Med, Le Kremlin Bicetre, France; [Girard, Romain] Ecole Polytech, Route Saclay, Palaiseau, France; [Rouleau, Etienne; Lacroix, Ludovic] Inst Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; UDICE-French Research Universities; Universite Paris Saclay; Institut Polytechnique de Paris; UNICANCER; Gustave Roussy	Lacroix, L (corresponding author), Gustave Roussy, CNRS UMS3655, INSERM US23, AMMICA,Plateforme Genom BMO, Villejuif, France.; Lacroix, L (corresponding author), Gustave Roussy, CNRS UMS3655, INSERM US23, AMMICA,Ctr Ressources Biol, Villejuif, France.; Lacroix, L (corresponding author), Inst Gustave Roussy, Dept Biol & Pathol Med, Villejuif, France.	ludovic.lacroix@gustaveroussy.fr	Besse, Benjamin/V-1523-2019	Besse, Benjamin/0000-0001-5090-8189; Jovelet, Cecile/0000-0001-7299-3409	Stilla Technologies	Stilla Technologies	Stilla Technologies funded the travel grant for CJ to attend and present at an international Meeting. This commercial affiliation does not alter our adherence to PLOS ONE policies on sharing data and materials.	Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Barlesi F, 2016, LANCET, V387, P1415, DOI 10.1016/S0140-6736(16)00004-0; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Heitzer E, 2015, CLIN CHEM, V61, P112, DOI 10.1373/clinchem.2014.222679; Hudecova I, 2015, CLIN BIOCHEM, V48, P948, DOI 10.1016/j.clinbiochem.2015.03.015; Jovelet C, 2016, CLIN CANCER RES, V22, P2960, DOI 10.1158/1078-0432.CCR-15-2470; Leighl NB, 2014, J CLIN ONCOL, V32, P3673, DOI 10.1200/JCO.2014.57.3055; Lemoine A, 2016, INNOV THERAPEUTIQUES, V2, P225; Lianos GD, 2015, FUTURE ONCOL, V11, P545, DOI 10.2217/fon.14.250; Madic J, 2016, Biomol Detect Quantif, V10, P34; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Qiu MT, 2015, CANCER EPIDEM BIOMAR, V24, P206, DOI 10.1158/1055-9965.EPI-14-0895; Reguart N, 2015, FUTURE ONCOL, V11, P1245, DOI 10.2217/fon.15.15; Remon J, 2017, ANN ONCOL OFF  0118; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Taly V, 2013, CLIN CHEM, V59, P1722, DOI 10.1373/clinchem.2013.206359; Watanabe M, 2015, CLIN CANCER RES, V21, P3552, DOI 10.1158/1078-0432.CCR-14-2151; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zonta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159094	25	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183319	10.1371/journal.pone.0183319	http://dx.doi.org/10.1371/journal.pone.0183319			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829811	gold, Green Published, Green Submitted			2022-12-27	WOS:000408085100038
J	Lee, EP; Hsia, SH; Hsiao, HF; Chen, MC; Lin, JJ; Chan, OW; Lin, CY; Yang, MC; Liao, SL; Lai, SH				Lee, En-Pei; Hsia, Shao-Hsuan; Hsiao, Hsiu-Feng; Chen, Min-Chi; Lin, Jainn-Jim; Chan, Oi-Wa; Lin, Chia-Ying; Yang, Mei-Chin; Liao, Sui-Ling; Lai, Shen-Hao			Evaluation of diaphragmatic function in mechanically ventilated children: An ultrasound study	PLOS ONE			English	Article							CRITICALLY-ILL PATIENTS; PEDIATRIC INTENSIVE-CARE; RISK-FACTORS; EXTUBATION; DYSFUNCTION; THICKNESS; ATROPHY; FIBERS	Background The recovery of diaphragmatic function is vital for successful extubation from mechanical ventilation. Recent studies have detected diaphragm atrophy in ventilated adults by using ultrasound, but no similar report has been conducted in children. In the current study, we hypothesized that mechanically ventilated children may also develop diaphragm atrophy and diaphragmatic dysfunction. Materials and methods Children who were admitted to the pediatric intensive care unit and were newly intubated for mechanical ventilation were enrolled into this prospective case-control study. Diaphragm ultrasound assessments were performed daily to evaluate diaphragmatic function in the enrolled children until their discharge from the pediatric intensive care unit. Diaphragm thickness and the diaphragmatic thickening fraction (DTF) were measured through these assessments. Results A total of 31 patients were enrolled, and overall, 1389 ultrasound assessments were performed. Immediately after intubation, the initial diaphragm thickness and DTF were measured to be 1.94 +/- 0.44 mm and 25.85% +/- 3.29%, respectively. In the first 24 hours of mechanical ventilation, diaphragm thickness and the DTF decreased substantially and decreased gradually thereafter. After extubation, the DTF was significantly different between the successful and failed extubation groups (P < 0.001), and a DTF value of <17% was associated with extubation failure. Conclusions Diaphragm ultrasound is a noninvasive method for measuring diaphragmatic function in mechanically ventilated children. In this study, significant diaphragm atrophy and a decreased DTF were observed within 24 hours of mechanical ventilation. The recovery of diaphragm thickness and the DTF may be a potential predictor of successful extubation from mechanical ventilation.	[Lee, En-Pei; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Chan, Oi-Wa; Lin, Chia-Ying] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Pediat Crit Care Med, Taoyuan, Taiwan; [Lee, En-Pei; Hsia, Shao-Hsuan; Lin, Jainn-Jim; Chan, Oi-Wa; Lin, Chia-Ying; Liao, Sui-Ling; Lai, Shen-Hao] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Hsiao, Hsiu-Feng; Yang, Mei-Chin] Chang Gung Mem Hosp Linkou, Dept Resp Therapy, Taoyuan, Taiwan; [Chen, Min-Chi] Chang Gung Mem Hosp, Dept Hematol & Oncol, Chiayi, Taiwan; [Chen, Min-Chi] Chang Gung Univ, Coll Med, Dept Publ Hlth, Taoyuan, Taiwan; [Chen, Min-Chi] Chang Gung Univ, Coll Med, Biostat Consulting Ctr, Taoyuan, Taiwan; [Lin, Jainn-Jim] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Pediat Neurol, Taoyuan, Taiwan; [Liao, Sui-Ling] Chang Gung Mem Hosp Keelung, Dept Pediat, Keelung, Taiwan; [Lai, Shen-Hao] Chang Gung Mem Hosp Linkou, Dept Pediat, Div Pediat Pulmonol, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lai, SH (corresponding author), Chang Gung Univ, Coll Med, Taoyuan, Taiwan.; Lai, SH (corresponding author), Chang Gung Mem Hosp Linkou, Dept Pediat, Div Pediat Pulmonol, Taoyuan, Taiwan.	kpm104@adm.cgmh.org.tw			Chang Gung Memorial Hospital [CMRPG3E1211, CMRPG3E1212, CMRPG3E1213, CMRPG3E1211-3]; Ministry of Health and Ware, Taiwan [KMRPB3F032]; Ministry of Health and Ware [KMRPB3F032]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); Ministry of Health and Ware, Taiwan; Ministry of Health and Ware	This work was supported by Chang Gung Memorial Hospital (CMRPG3E1211, CMRPG3E1212, and CMRPG3E1213) and the Ministry of Health and Ware, Taiwan (KMRPB3F032). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to the financial support of the Ministry of Health and Ware (KMRPB3F032) and Chang Gung Memorial Hospital (CMRPG3E1211-3).	Baldwin CE, 2011, RESPIROLOGY, V16, P1136, DOI 10.1111/j.1440-1843.2011.02005.x; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Cholette J, 2009, CRIT CARE MED, V37, pA434, DOI 10.1097/CCM.0b013e3181b6e760; Cohn D, 1997, J APPL PHYSIOL, V83, P291, DOI 10.1152/jappl.1997.83.1.291; Demoule A, 2013, AM J RESP CRIT CARE, V188, P213, DOI 10.1164/rccm.201209-1668OC; DiNino E, 2014, THORAX, V69, P423, DOI 10.1136/thoraxjnl-2013-204111; Farias JA, 2004, INTENS CARE MED, V30, P918, DOI 10.1007/s00134-004-2225-5; Ferrari G, 2014, CRIT ULTRASOUND J, V6, DOI 10.1186/2036-7902-6-8; Fontela Patricia S, 2005, Pediatr Crit Care Med, V6, P166, DOI 10.1097/01.PCC.0000154922.65189.48; Goligher EC, 2015, INTENS CARE MED, V41, P642, DOI 10.1007/s00134-015-3687-3; Grosu HB, 2012, CHEST, V142, P1455, DOI 10.1378/chest.11-1638; Khemani RG, 2007, PEDIAT CRIT CARE M S, V8, pA39, DOI [DOI 10.1001/JAMA.293.4.470, 10.1001/jama.293.4.470]; KRAMER MS, 1981, CLIN PHARMACOL THER, V29, P111, DOI 10.1038/clpt.1981.18; Kurachek SC, 2003, CRIT CARE MED, V31, P2657, DOI 10.1097/01.CCM.0000094228.90557.85; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Matamis D, 2013, INTENS CARE MED, V39, P801, DOI 10.1007/s00134-013-2823-1; McCool FD, 1997, AM J RESP CRIT CARE, V155, P1329, DOI 10.1164/ajrccm.155.4.9105075; Newth CJL, 2009, PEDIATR CRIT CARE ME, V10, P1, DOI 10.1097/PCC.0b013e318193724d; Polla B, 2004, THORAX, V59, P808, DOI 10.1136/thx.2003.009894; Powers SK, 2013, AM J PHYSIOL-REG I, V305, pR464, DOI 10.1152/ajpregu.00231.2013; Randolph AG, 2002, JAMA-J AM MED ASSOC, V288, P2561, DOI 10.1001/jama.288.20.2561; Umbrello M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0894-9; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; Vivier E, 2012, INTENS CARE MED, V38, P796, DOI 10.1007/s00134-012-2547-7; Zambon M, 2013, ANN UPDATE INTENSIVE, V2013, P427; Zambon M, 2016, CRIT CARE MED, V44, P1347, DOI 10.1097/CCM.0000000000001657; Zambon M, 2013, INTENS CARE MED, V39, P986, DOI 10.1007/s00134-013-2882-3	28	26	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183560	10.1371/journal.pone.0183560	http://dx.doi.org/10.1371/journal.pone.0183560			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829819	Green Submitted, gold, Green Published			2022-12-27	WOS:000408085100057
J	Neuser, J; Galuppo, P; Fraccarollo, D; Willig, J; Kempf, T; Berliner, D; Bauersachs, J; Widder, JD				Neuser, Jonas; Galuppo, Paolo; Fraccarollo, Daniela; Willig, Jens; Kempf, Tibor; Berliner, Dominik; Bauersachs, Johann; Widder, Julian Daniel			Intermediate CD14(++)CD16(+) monocytes decline after transcatheter aortic valve replacement and correlate with functional capacity and left ventricular systolic function	PLOS ONE			English	Article							EXERCISE CAPACITY; 1-YEAR OUTCOMES; RISK SCORES; SUBSETS; IMPLANTATION; RECEPTORS; STENOSIS; CELLS	Background Transcatheter aortic valve replacement (TAVR) is the method of choice for patients with severe aortic valve stenosis, who are ineligible or at high risk for surgery. Though TAVR leads to a significant reduction in mortality, a notable amount of patients are re-hospitalized early after TAVR. Parameters or biomarkers predicting outcome are therefore needed to identify patients who benefit most. Specific monocyte subsets have been associated with cardiovascular diseases and were shown to possess prognostic value. Methods Peripheral blood was drawn before and after transfemoral TAVR with the self-expanding CoreValve, Boston Lotus or the balloon-expanding Edwards Sapien prosthesis. Classical (CD14(++)CD16(-)), intermediate (CD14(++)CD16(+)) and non-classical (CD14(+)CD16(++)) monocyte subsets were determined by flow cytometry. Transthoracic echocardiography was performed before, early after as well as 3 months after the TAVR procedure. Results No significant differences in the absolute monocyte counts were found after TAVR. A significant decline in the intermediate monocyte population was though observed early after TAVR (pre 4.01 +/-.38%, post 2.803 +/- 0.34%, p <= 0.05). Creatinine levels stayed stable after TAVR procedure and intermediate monocytes were associated with worse renal function. Monocyte decline was not related to changes in CRP-, noradrenaline, cortisol or aldosterone-levels. The amount of intermediate monocytes correlated with worse cardiac function and predicted the possibility to reach an improvement in NYHA functional class at 3 months after TAVR. Conclusions A significant decline of intermediate monocytes occurs shortly after TAVR. High levels of intermediate monocytes were associated with worse cardiac function and predicted poor functional capacity, hinting at a possible prognostic value.	[Neuser, Jonas; Galuppo, Paolo; Fraccarollo, Daniela; Willig, Jens; Kempf, Tibor; Berliner, Dominik; Bauersachs, Johann; Widder, Julian Daniel] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany	Hannover Medical School	Widder, JD (corresponding author), Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany.	widder.julian@mh-hannover.de	Kempf, Tibor/ABA-3167-2021	Kempf, Tibor/0000-0001-6901-8442; Berliner, Dominik/0000-0002-5710-3540				Abdel-Wahab M, 2015, J AM COLL CARDIOL, V66, P791, DOI 10.1016/j.jacc.2015.06.026; Adams DH, 2014, NEW ENGL J MED, V370, P1790, DOI 10.1056/NEJMoa1400590; BAIN RJI, 1990, EUR J APPL PHYSIOL O, V61, P112, DOI 10.1007/BF00236703; Berg KE, 2012, CIRC-CARDIOVASC GENE, V5, P122, DOI 10.1161/CIRCGENETICS.111.960385; Cockburn J, 2017, J CARDIOVASC SURG, V58, P467, DOI 10.23736/S0021-9509.16.09339-3; Deeb GM, 2016, J AM COLL CARDIOL, V67, P2565, DOI 10.1016/j.jacc.2016.03.506; DRACUP K, 1992, J HEART LUNG TRANSPL, V11, P273; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Fingerle-Rowson G, 1998, INFLAMMATION, V22, P367, DOI 10.1023/A:1022316815196; FRANCIOSA JA, 1981, AM J CARDIOL, V47, P33, DOI 10.1016/0002-9149(81)90286-1; Galante A, 2001, J AM COLL CARDIOL, V38, P1078, DOI 10.1016/S0735-1097(01)01484-X; Guirao X, 1997, AM J PHYSIOL-ENDOC M, V273, pE1203, DOI 10.1152/ajpendo.1997.273.6.E1203; Heine GH, 2012, NAT REV NEPHROL, V8, P362, DOI 10.1038/nrneph.2012.41; Koskinas KC, 2015, AM J CARDIOL, V116, P1560, DOI 10.1016/j.amjcard.2015.08.016; Krau NC, 2015, EUR J HEART FAIL, V17, P945, DOI 10.1002/ejhf.318; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Li CY, 2003, ANESTH ANALG, V96, P518, DOI 10.1097/00000539-200302000-00040; Liu BY, 2015, J IMMUNOL, V194, P5150, DOI 10.4049/jimmunol.1402409; Lund O, 1997, EUR HEART J, V18, P1977; Mack MJ, 2015, LANCET, V385, P2477, DOI 10.1016/S0140-6736(15)60308-7; Marino F, 2013, AMINO ACIDS, V45, P55, DOI 10.1007/s00726-011-1186-6; Mizuno K, 2005, IMMUNOL LETT, V101, P168, DOI 10.1016/j.imlet.2005.05.008; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; RATGE D, 1988, CLIN EXP PHARMACOL P, V15, P43, DOI 10.1111/j.1440-1681.1988.tb01007.x; Reardon MJ, 2015, J AM COLL CARDIOL, V66, P113, DOI 10.1016/j.jacc.2015.05.017; Rickard AJ, 2009, HYPERTENSION, V54, P537, DOI 10.1161/HYPERTENSIONAHA.109.131110; Rogacev KS, 2012, J AM COLL CARDIOL, V60, P1512, DOI 10.1016/j.jacc.2012.07.019; Rogacev KS, 2011, EUR HEART J, V32, P84, DOI 10.1093/eurheartj/ehq371; Scanzano A, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00171; SCHOPF RE, 1983, J IMMUNOPHARMACOL, V5, P203, DOI 10.3109/08923978309039106; Shimoni S, 2016, J GERIATR CARDIOL, V13, P81, DOI 10.11909/j.issn.1671-5411.2016.01.015; Sinning JM, 2015, AM HEART J, V170, P821, DOI 10.1016/j.ahj.2015.07.003; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Stansfield BK, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0040-3; Suzuki A, 2017, EUROPACE, V19, P40, DOI 10.1093/europace/euv422; Tamburino C, 2015, J AM COLL CARDIOL, V66, P804, DOI 10.1016/j.jacc.2015.06.013; Thaler B, 2016, SCI REP-UK, V6, DOI 10.1038/srep30162; Vahanian A, 2012, EUR HEART J, V33, P2451, DOI 10.1093/eurheartj/ehs109; VANDENBROEK SAJ, 1992, AM J CARDIOL, V70, P359, DOI 10.1016/0002-9149(92)90619-A; Zahn R, 2013, AM J CARDIOL, V112, P272, DOI 10.1016/j.amjcard.2013.03.024; Zawada AM, 2016, EPIGENETICS-US, V11, P259, DOI 10.1080/15592294.2016.1158363; Ziegler-Heitbrock L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00423; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	43	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183670	10.1371/journal.pone.0183670	http://dx.doi.org/10.1371/journal.pone.0183670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829829	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100065
J	Yemelin, A; Brauchler, A; Jacob, S; Laufer, J; Heck, L; Foster, AJ; Antelo, L; Andresen, K; Thines, E				Yemelin, Alexander; Brauchler, Annamaria; Jacob, Stefan; Laufer, Julian; Heck, Larissa; Foster, Andrew J.; Antelo, Luis; Andresen, Karsten; Thines, Eckhard			Identification of factors involved in dimorphism and pathogenicity of Zymoseptoria tritici	PLOS ONE			English	Article							TUMEFACIENS-MEDIATED TRANSFORMATION; MYCOSPHAERELLA-GRAMINICOLA; SEPTORIA-TRITICI; FUNCTIONAL-CHARACTERIZATION; INSERTIONAL MUTAGENESIS; SEQUENCE ANALYSIS; STRESS RESPONSES; PROTEIN-KINASE; G-ALPHA; GENE	A forward genetics approach was applied in order to investigate the molecular basis of morphological transition in the wheat pathogenic fungus Zymoseptoria tritici. Z. tritici is a dimorphic plant pathogen displaying environmentally regulated morphogenetic transition between yeast-like and hyphal growth. Considering the infection mode of Z. tritici, the switching to hyphal growth is essential for pathogenicity allowing the fungus the host invasion through natural openings like stomata. We exploited a previously developed Agrobacterium tumefaciens-mediated transformation (ATMT) to generate a mutant library by insertional mutagenesis including more than 10,000 random mutants. To identify genes involved in dimorphic switch, a plate-based screening system was established. With this approach eleven dimorphic switch deficient random mutants were recovered, ten of which exhibited a yeast-like mode of growth and one mutant predominantly growing filamentously, producing high amount of mycelium under different incubation conditions. Using genome walking approach previously established, the T-DNA integration sites were recovered and the disrupted genomic loci of corresponding mutants were identified and validated within reverse genetics approach. As prove of concept, two of the random mutants obtained were selected for further investigation using targeted gene inactivation. Both genes deduced were found to encode known factors, previously characterized in other fungi: Ssk1p being constituent of HOG pathway and Ade5,7p involved in de novo purine biosynthesis. The targeted mutant strains defective in these genes exhibit a drastically impaired virulence within infection assays on whole wheat plants. Moreover exploiting further physiological assays the predicted function for both gene products could be confirmed in concordance with conserved biological role of homologous proteins previously described in other fungal organisms.	[Yemelin, Alexander; Jacob, Stefan; Laufer, Julian; Heck, Larissa; Foster, Andrew J.; Thines, Eckhard] IBWF gGmbH, Inst Biotechnol & Drug Res, Kaiserslautern, Germany; [Brauchler, Annamaria; Antelo, Luis; Andresen, Karsten; Thines, Eckhard] Johannes Gutenberg Univ Mainz, Inst Mol Physiol Microbiol & Wine Res, Mainz, Germany	Johannes Gutenberg University of Mainz	Yemelin, A (corresponding author), IBWF gGmbH, Inst Biotechnol & Drug Res, Kaiserslautern, Germany.	yemelin@ibwf.de	Jacob, Stefan/AAR-4833-2020; Jacob, Stefan/X-9782-2018	Jacob, Stefan/0000-0003-2966-4110	Stiftung Rheinland-Pfalz fur Innovation	Stiftung Rheinland-Pfalz fur Innovation	This work was supported by a grant from the "Stiftung Rheinland-Pfalz fur Innovation". The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIBA A, 1989, J BIOL CHEM, V264, P21239; Arraiano LS, 2009, PLANT PATHOL, V58, P910, DOI 10.1111/j.1365-3059.2009.02118.x; Arraiano LS, 2001, THEOR APPL GENET, V103, P758, DOI 10.1007/s001220100668; Bahn YS, 2006, MOL BIOL CELL, V17, P3122, DOI 10.1091/mbc.E06-02-0113; Bayles RA, 1991, RES NOTE VARIETAL RE, V4; Betts MF, 2007, FUNGAL GENET BIOL, V44, P1035, DOI 10.1016/j.fgb.2007.05.001; Boyce KJ, 2015, FEMS MICROBIOL REV, V39, P797, DOI 10.1093/femsre/fuv035; Brown WJ, 2003, TRAFFIC, V4, P214, DOI 10.1034/j.1600-0854.2003.00078.x; CARROLL AM, 1994, FUNGAL GENET NEWSLET, V41, P22, DOI DOI 10.4148/1941-4765.1367; Cereghino GPL, 2001, GENE, V263, P159, DOI 10.1016/S0378-1119(00)00576-X; Chauhan N, 2003, EUKARYOT CELL, V2, P1018, DOI 10.1128/EC.2.5.1018-1024.2003; Choi J, 2007, MOL MICROBIOL, V66, P371, DOI 10.1111/j.1365-2958.2007.05918.x; Choi YE, 2011, MOL PLANT MICROBE IN, V24, P469, DOI 10.1094/MPMI-04-10-0090; Cools HJ, 2008, PEST MANAG SCI, V64, P681, DOI 10.1002/ps.1568; Covert SF, 2001, MYCOL RES, V105, P259, DOI 10.1017/S0953756201003872; Dantas AD, 2015, BIOMOLECULES, V5, P142, DOI 10.3390/biom5010142; de Groot MJA, 1998, NAT BIOTECHNOL, V16, P839, DOI 10.1038/nbt0998-839; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; Eyal Z., 1987, SEPTORIA DIS WHEAT C; Fitzgerald AM, 2003, MYCOL RES, V107, P803, DOI 10.1017/S0953756203008086; Fraaije BA, 2005, PHYTOPATHOLOGY, V95, P933, DOI 10.1094/PHYTO-95-0933; Gauthier Greg, 2008, Microbe Wash DC, V3, P416; Gauthier GM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004608; Hardwick NV, 2001, PLANT PATHOL, V50, P453, DOI 10.1046/j.1365-3059.2001.00596.x; Hayes LE, 2013, PLANT DIS, V97, P1511, DOI 10.1094/PDIS-05-13-0486-PDN; Jacob S, 2015, FUNGAL BIOL-UK, V119, P580, DOI 10.1016/j.funbio.2015.03.003; Jezewski S, 2007, MICROBIOL-SGM, V153, P2351, DOI 10.1099/mic.0.2006/004028-0; Jiang LH, 2010, FEMS YEAST RES, V10, P199, DOI 10.1111/j.1567-1364.2009.00600.x; Jin FH, 2004, FEMS MICROBIOL LETT, V239, P79, DOI 10.1016/j.femsle.2004.08.025; Jones E. W., 1982, MOL BIOL YEAST SACCH, P181; Jorgensen LN, 2014, J INTEGR AGR, V13, P265, DOI 10.1016/S2095-3119(13)60646-2; Jorgensen LN, 1999, SEPTORIA ON CEREALS: A STUDY OF PATHOSYSTEMS, P251; Kaye SB, 1998, BRIT J CANCER, V78, P1, DOI 10.1038/bjc.1998.747; Kema GHJ, 1996, PHYTOPATHOLOGY, V86, P777, DOI 10.1094/Phyto-86-777; Kim JE, 2007, CURR GENET, V51, P99, DOI 10.1007/s00294-006-0110-1; Kojima K, 2004, MOL MICROBIOL, V53, P1785, DOI 10.1111/j.1365-2958.2004.04244.x; Kramer B, 2009, FUNGAL GENET BIOL, V46, P667, DOI 10.1016/j.fgb.2009.06.001; Krishnamurthy S, 2004, MICROBIOL-SGM, V150, P1991, DOI 10.1099/mic.0.27029-0; Leclerque A, 2004, CURR GENET, V45, P111, DOI 10.1007/s00294-003-0468-2; Leroux P, 2011, PEST MANAG SCI, V67, P44, DOI 10.1002/ps.2028; Levdikov VM, 1998, STRUCTURE, V6, P363, DOI 10.1016/S0969-2126(98)00038-0; Nguyen LN, 2011, CELL CYCLE, V10, DOI 10.4161/cc.10.18.16932; Madrid M, 2004, J BIOL CHEM, V279, P41594, DOI 10.1074/jbc.M405509200; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; Marshall R, 2011, PLANT PHYSIOL, V156, P756, DOI 10.1104/pp.111.176347; MCKENZIE R, 1987, CURR GENET, V12, P591, DOI 10.1007/BF00368061; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P389, DOI 10.1094/MPMI-19-0389; Mehrabi R, 2006, MOL PLANT MICROBE IN, V19, P1262, DOI 10.1094/MPMI-19-1262; Mehrabi R, 2009, EUKARYOT CELL, V8, P1001, DOI 10.1128/EC.00258-08; Meng Y, 2007, FUNGAL GENET BIOL, V44, P1050, DOI 10.1016/j.fgb.2007.04.002; Michielse CB, 2005, CURR GENET, V48, P1, DOI 10.1007/s00294-005-0578-0; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Munch S, 2011, MOL PLANT PATHOL, V12, P43, DOI 10.1111/j.1364-3703.2010.00651.x; Nowikovsky K, 2004, J BIOL CHEM, V279, P30307, DOI 10.1074/jbc.M403607200; Orton ES, 2011, MOL PLANT PATHOL, V12, P413, DOI 10.1111/j.1364-3703.2010.00688.x; Ponomarenko A., 2011, PLANT HLTH INSTR; Rho HS, 2001, MOL CELLS, V12, P407; Rodriguez-Gabriel MA, 2003, EMBO J, V22, P6256, DOI 10.1093/emboj/cdg597; Rudd JJ, 2015, FUNGAL GENET BIOL, V79, P24, DOI 10.1016/j.fgb.2015.04.005; Saito H, 2004, J BIOCHEM, V136, P267, DOI 10.1093/jb/mvh135; Sambrook J., 2001, MOL CLONING LAB MANU; Sanna ML, 2012, FUNGAL BIOL-UK, V116, P769, DOI 10.1016/j.funbio.2012.04.008; Stammler G., 2011, Bulletin OEPP, V41, P149, DOI 10.1111/j.1365-2338.2011.02454.x; Steinberg G, 2015, FUNGAL GENET BIOL, V79, P17, DOI 10.1016/j.fgb.2015.04.002; STOTZ A, 1990, GENE, V95, P91, DOI 10.1016/0378-1119(90)90418-Q; Torriani SFF, 2009, PEST MANAG SCI, V65, P155, DOI 10.1002/ps.1662; Valentin-Berrios S, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-100; van den Berg F, 2013, PHYTOPATHOLOGY, V103, P1209, DOI 10.1094/PHYTO-03-13-0061-R; Yu PL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149153; Zhang Y, 2002, APPL ENVIRON MICROB, V68, P532, DOI 10.1128/AEM.68.2.532-538.2002; Zhang Z, 2000, GENE, V253, P145, DOI 10.1016/S0378-1119(00)00289-4	71	13	13	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183065	10.1371/journal.pone.0183065	http://dx.doi.org/10.1371/journal.pone.0183065			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829795	gold, Green Published, Green Submitted			2022-12-27	WOS:000408085100026
J	Wang, MZ; Kong, J; Meng, XH; Luan, S; Luo, K; Sui, J; Chen, BL; Cao, JW; Shi, XL				Wang, Mingzhu; Kong, Jie; Meng, Xianhong; Luan, Sheng; Luo, Kun; Sui, Juan; Chen, Baolong; Cao, Jiawang; Shi, Xiaoli			Evaluation of genetic parameters for growth and cold tolerance traits in Fenneropenaeus chinensis juveniles	PLOS ONE			English	Article							OREOCHROMIS-NILOTICUS; NILE TILAPIA; BODY-WEIGHT; PRAWN	In this study, genetic parameters were obtained for growth and cold tolerance of 99 Fenneropenaeus chinensis juvenile families by means of indoor artificial cooling (starting from 14 degrees C, 2 degrees C/d). A linear mixed model was fitted to estimate variance components using the ASReml software package. Heritabilities estimated for body weight (BW) and body length (BL) of F. chinensis juveniles were 0.078 +/- 0.124 and 0.131 +/- 0.133, respectively. The estimates of heritability were low in magnitude for both traits. The differences between the heritabilities estimated for the two growth traits were not significant with each other, and the heritabilities were not significantly different from zero (P>0.05). The phenotypic and genetic correlation coefficients between BW and BL were as high as 0.9408 +/- 0.0040 and 0.9562 +/- 0.0551, respectively, and both were significantly different from zero (P < 0.01). The heritabilities of temperature at death (TAD) and cooling degree hours (CDH) were 0.265 +/- 0.091 and 0.077 +/- 0.058, respectively. The heritability estimates for TAD was moderate and significantly different from zero (P < 0.01). The correlation analysis indicated that the phenotypic correlation coefficient between TAD and CDH was - 0.5470 +/- 0.0174, and the genetic correlation coefficient was - 0.6707 +/- 0.3635. In the analysis of growth traits and cold tolerance traits, the values of phenotypic correlation coefficient were floating between - 0.1055 and 0.1098, both were significantly different from zero (P < 0.05), while the genetic correlation had a larger range (0.0526 similar to 0.9914), and all were not significantly different from zero (P > 0.05). In this study, there was a low correlation between growth and cold tolerance traits, indicating that growth traits and cold tolerance traits should be considered collectively in the breeding program of shrimp.	[Wang, Mingzhu; Kong, Jie; Meng, Xianhong; Luan, Sheng; Luo, Kun; Sui, Juan; Chen, Baolong; Cao, Jiawang; Shi, Xiaoli] Chinese Acad Fishery Sci, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China; [Wang, Mingzhu; Kong, Jie; Meng, Xianhong; Luan, Sheng; Luo, Kun; Sui, Juan; Chen, Baolong; Cao, Jiawang; Shi, Xiaoli] Qingdao Natl Lab & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China; [Wang, Mingzhu; Meng, Xianhong] Shanghai Ocean Univ, Shanghai, Peoples R China	Chinese Academy of Fishery Sciences; Yellow Sea Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University	Meng, XH (corresponding author), Chinese Acad Fishery Sci, Key Lab Sustainable Utilizat Marine Fisheries Res, Minist Agr, Yellow Sea Fisheries Res Inst, Qingdao, Peoples R China.; Meng, XH (corresponding author), Qingdao Natl Lab & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China.; Meng, XH (corresponding author), Shanghai Ocean Univ, Shanghai, Peoples R China.	mengxianhong@ysfri.ac.cn			Central Public-interest Scientific Institution Basal Research Fund, CAFS [2016HY-ZD04]; National Natural Science Foundation of China [41676148]; Key R&D Program of Shandong province [2016ZDJS06A07]; Taishan Scholar Program for Seed Industry	Central Public-interest Scientific Institution Basal Research Fund, CAFS; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key R&D Program of Shandong province; Taishan Scholar Program for Seed Industry	This project was financially supported by the Central Public-interest Scientific Institution Basal Research Fund, CAFS (no. 2016HY-ZD04), National Natural Science Foundation of China (no. 41676148), Key R&D Program of Shandong province (2016ZDJS06A07), and The Taishan Scholar Program for Seed Industry.	Charo-Karisa H, 2005, AQUACULTURE, V249, P115, DOI 10.1016/j.aquaculture.2005.04.029; Cnaani A, 2000, AQUACULT INT, V8, P289, DOI 10.1023/A:1009299109614; He YuYing, 2011, Agricultural Science & Technology - Hunan, V12, P613; Huang Fu-You, 2008, Zhongguo Haiyang Daxue Xuebao, V38, P269; Jiang X, 2013, J FISHERY SCI CHINA, P544; Kong Jie, 2012, Journal of Fisheries of China, V36, P1854; LI J, 2015, BOUND VALUE PRO 0110; Li Jian, 2005, Journal of Fisheries of China, V29, P1; Li WJ, 2016, ACTA OCEANOL SIN, V35, P12, DOI 10.1007/s13131-016-0845-6; Li WJ, 2015, AQUACULTURE, V441, P8, DOI 10.1016/j.aquaculture.2015.02.013; Liu BaoSuo, 2011, Journal of Fisheries of China, V35, P1601; Liu RY, 2004, 4 SESS ABSTR WORLD C, P1; Lu Qi-xi, 2011, Guangxi Shifan Daxue Xuebao Ziran Kexue Ban, V29, P104; Moore SS, 1999, AQUACULTURE, V173, P19, DOI 10.1016/S0044-8486(98)00461-X; Nguyen NH, 2007, AQUACULTURE, V272, pS38, DOI 10.1016/j.aquaculture.2007.08.013; Perry GML, 2005, AQUACULTURE, V250, P120, DOI 10.1016/j.aquaculture.2005.04.042; [田永胜 TIAN Yongsheng], 2008, [海洋水产研究, Marine Fisheries Research], V29, P1; Wang QY., 2013, PRINCIPLES PRACTICES, P42; Zhang TS, 2011, ACTA OCEANOL SIN, V30, P78, DOI 10.1007/s13131-011-0093-8	19	4	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183801	10.1371/journal.pone.0183801	http://dx.doi.org/10.1371/journal.pone.0183801			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850577	Green Published, Green Submitted, gold			2022-12-27	WOS:000408544200026
J	Li, JK; Cui, GW; Hu, GF; Wang, MJ; Zhang, P; Qin, LG; Shang, C; Zhang, HL; Zhu, XC; Qu, MN				Li, Jikai; Cui, Guowen; Hu, Guofu; Wang, Mingjun; Zhang, Pan; Qin, Ligang; Shang, Chen; Zhang, Hailing; Zhu, Xiaocen; Qu, Mingnan			Proteome dynamics and physiological responses to short-term salt stress in Leymus chinensis leaves	PLOS ONE			English	Article							CHLOROPHYLL BIOSYNTHESIS; TRANSGENIC EXPRESSION; ARABIDOPSIS-THALIANA; POSIDONIA-OCEANICA; SALINITY; TOLERANCE; DROUGHT; GENE; GROWTH; PHOTOSYNTHESIS	Salt stress is becoming an increasing threat to global agriculture. In this study, physiological and proteomics analysis were performed using a salt-tolerant grass species, Leymus chinensis (L. chinensis). The aim of this study is to understand the potential mechanism of salt tolerance in L. chinensis that used for crop molecular breeding. A series of short-term (<48 h) NaCl treatments (0 similar to 700 mM) were conducted. Physiological data indicated that the root and leaves growth were inhibited, chlorophyll contents decreased, while hydraulic conductivity, proline, sugar and sucrose were accumulated under salt stress. For proteomic analysis, we obtained 274 differentially expressed proteins in response to NaCl treatments. GO analysis revealed that 44 out of 274 proteins are involved in the biosynthesis of amino acids and carbon metabolism. Our findings suggested that L. chinensis copes with salt stress by stimulating the activities of POD, SOD and CAT enzymes, speeding up the reactions of later steps of citrate cycle, and synthesis of proline and sugar. In agreement with our physiological data, proteomic analysis also showed that salt stress depress the expression of photosystem relevant proteins, Calvin cycle, and chloroplast biosynthesis.	[Li, Jikai; Cui, Guowen; Hu, Guofu; Wang, Mingjun; Zhang, Pan; Qin, Ligang] Northeast Agr Univ, Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China; [Li, Jikai; Shang, Chen; Zhang, Hailing] Heilongjiang Acad Agr Sci, Inst Grass Res, Harbin, Heilongjiang, Peoples R China; [Zhu, Xiaocen; Qu, Mingnan] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Plant Physiol & Ecol, Shanghai, Peoples R China	Northeast Agricultural University - China; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS; Heilongjiang Academy of Agricultural Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Cui, GW (corresponding author), Northeast Agr Univ, Anim Sci & Technol, Harbin, Heilongjiang, Peoples R China.	cgw603@163.com			Ministry of Science and Technology [2016YFC0500607]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	National key research and development project(2016YFC0500607) funded by Ministry of Science and Technology(http://www.most.gov.cn): Rapid recovery and efficient utilization techniques of degraded meadow in cold regions of black soil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by National key research and development project, Ministry of Science and Technology (2016YFC0500607),"Rapid recovery and efficient utilization techniques of degraded meadow in cold regions of black soil".	Abdul Qados A.M.S., 2011, J SAUDI SOC AGR SCI, V10, P7, DOI [10.1016/j.jssas.2010.06.002, DOI 10.1016/J.JSSAS.2010.06.002]; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Carillo P, 2011, ABIOTIC STRESS IN PLANTS - MECHANISMS AND ADAPTATIONS, P21; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng TL, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00030; Clayton WD, 1986, GRASSES OF THE WORLD; Ellouzi H, 2014, PLANTA, V240, P1299, DOI 10.1007/s00425-014-2154-7; Elmore JM, 2011, MOL PLANT, V4, P416, DOI 10.1093/mp/ssq083; Ghosh D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00006; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Hakim AK, 2012, MOL CELLULAR PROTEOM, V11; Harb A, 2010, PLANT PHYSIOL, V154, P1254, DOI 10.1104/pp.110.161752; HIRASAWA T, 1991, JPN J CROP SCI, V60, P174, DOI 10.1626/jcs.60.174; ILAG LL, 1994, PLANT CELL, V6, P265, DOI 10.1105/tpc.6.2.265; Jia H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144808; Jin H, 2006, PLANT SCI, V175, P784; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Koch MS, 2007, AQUAT BOT, V86, P14, DOI 10.1016/j.aquabot.2006.08.003; Liu A, 2016, ECOTOXICOLOGY; Liu ZJ, 2017, J PLANT PHYSIOL, V211, P90, DOI 10.1016/j.jplph.2016.12.014; Luo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138974; Lv DW, 2014, J PROTEOME RES, V13, P2381, DOI 10.1021/pr401184v; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Marin-Guirao L, 2011, ESTUAR COAST SHELF S, V92, P286, DOI 10.1016/j.ecss.2011.01.003; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Mittler R, 2004, TRENDS PLANT SCI, V9, P490, DOI 10.1016/j.tplants.2004.08.009; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Nagata N, 2005, PLANT CELL, V17, P233, DOI 10.1105/tpc.104.027276; Ouyang B, 2007, J EXP BOT, V58, P507, DOI 10.1093/jxb/erl258; Pang Cai-Hong, 2008, V69, P231, DOI 10.1007/978-3-540-72954-9_9; Peng XJ, 2011, PLANT CELL REP, V30, P1493, DOI 10.1007/s00299-011-1058-2; Piro A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00464; PREMACHANDRA GS, 1992, J EXP BOT, V43, P1569, DOI 10.1093/jxb/43.12.1569; Qureshi MI, 2013, PHYTOCHEMISTRY, V95, P215, DOI 10.1016/j.phytochem.2013.06.026; Rai S, 2014, J PROTEOMICS, V98, P254, DOI 10.1016/j.jprot.2013.12.020; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Sanchez-Romera B, 2014, PLANT CELL ENVIRON, V37, P995, DOI 10.1111/pce.12214; Sandoval-Gil JM, 2012, ESTUAR COAST SHELF S, V115, P260, DOI 10.1016/j.ecss.2012.09.008; Sandoval-Gil JM, 2014, MAR ENVIRON RES, V95, P39, DOI 10.1016/j.marenvres.2013.12.011; Shi HT, 2013, J PROTEOME RES, V12, P4951, DOI 10.1021/pr400479k; Shi HT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053422; Sobhanian H, 2010, J PROTEOME RES, V9, P2882, DOI 10.1021/pr900974k; Sun YP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053632; Tang X, 2014, CRIT REV BIOTECHNOL, P16; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; Wang LK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096765; Wang SH, 2014, PLANT CELL, V26, P4875, DOI 10.1105/tpc.114.133116; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Wohlbach DJ, 2008, PLANT CELL, V20, P1101, DOI 10.1105/tpc.107.055871; Yu JJ, 2011, J PROTEOME RES, V10, P3852, DOI 10.1021/pr101102p; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zheng LY, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00678	54	15	18	6	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							0183615	10.1371/journal.pone.0183615	http://dx.doi.org/10.1371/journal.pone.0183615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846722	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600041
J	Narres, M; Kvitkina, T; Claessen, H; Droste, S; Schuster, B; Morbach, S; Rumenapf, G; Van Acker, K; Icks, A				Narres, Maria; Kvitkina, Tatjana; Claessen, Heiner; Droste, Sigrid; Schuster, Bjoern; Morbach, Stephan; Ruemenapf, Gerhard; Van Acker, Kristien; Icks, Andrea			Incidence of lower extremity amputations in the diabetic compared with the non-diabetic population: A systematic review	PLOS ONE			English	Review							LOWER-LIMB AMPUTATIONS; PERIPHERAL ARTERIAL-DISEASE; MAJOR AMPUTATION; REGIONAL-VARIATION; VASCULAR-DISEASE; GERMAN CITY; FOOT CARE; INDIVIDUALS; PREVALENCE; MELLITUS	Lower extremity amputation (LEA) in patients with diabetes results in high mortality, reduced quality of life, and increased medical costs. Exact data on incidences of LEA in diabetic and non-diabetic patients are important for improvements in preventative diabetic foot care, avoidance of fatal outcomes, as well as a solid basis for health policy and the economy. However, published data are conflicting, underlining the necessity for the present systematic review of population-based studies on incidence, relative risks and changes of amputation rates over time. It was conducted according to the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. Nineteen out of 1582 studies retrieved were included in the analysis. The incidence of LEA in the diabetic population ranged from 78 to 704 per 100,000 person-years and the relative risks between diabetic and non-diabetic patients varied between 7.4 and 41.3. Study designs, statistical methods, definitions of major and minor amputations, as well as the methods to identify patients with diabetes differed greatly, explaining in part these considerable differences. Some studies found a decrease in incidence of LEA as well as relative risks over time. This obvious lack of evidence should be overcome by new studies using a standardized design with comparable methods and definitions.	[Narres, Maria; Kvitkina, Tatjana; Claessen, Heiner; Icks, Andrea] German Diabet Ctr, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany; [Narres, Maria; Kvitkina, Tatjana; Droste, Sigrid; Schuster, Bjoern; Morbach, Stephan; Icks, Andrea] Heinrich Heine Univ Dusseldorf, Fac Med, Ctr Hlth & Soc, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany; [Narres, Maria; Kvitkina, Tatjana; Claessen, Heiner; Icks, Andrea] German Ctr Diabet Res DZD, Munich, Germany; [Morbach, Stephan] Virgin Mary Hosp Soest, Dept Diabetol & Angiol, Munich, Germany; [Ruemenapf, Gerhard] Deaconess Fdn Hosp, Upper Rhine Vasc Ctr Speyer Mannheim, Clin Vasc Surg, Speyer, Germany; [Van Acker, Kristien] Ctr Sante Fagnes, Chimay, Belgium	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Narres, M (corresponding author), German Diabet Ctr, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany.; Narres, M (corresponding author), Heinrich Heine Univ Dusseldorf, Fac Med, Ctr Hlth & Soc, Inst Hlth Serv Res & Hlth Econ, Dusseldorf, Germany.; Narres, M (corresponding author), German Ctr Diabet Res DZD, Munich, Germany.	Maria.Narres@ddz.uni-duesseldorf.de			Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG) [ZMV I 5-2515VCK005]; German Federal Ministry of Education and Research (BMBF); German Diabetes Foundation [370/04/15]	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); German Diabetes Foundation	This work is supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW), the German Federal Ministry of Health (BMG) funding code ZMV I 5-2515VCK005 and in part by a grant from the German Federal Ministry of Education and Research (BMBF) to the German Center for Diabetes Research (DZD e.V.) as well as by the German Diabetes Foundation: grant no. 370/04/15. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott CA, 2010, DIABETES CARE, V33, P1325, DOI 10.2337/dc09-2067; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; [Anonymous], 1990, Diabet Med, V7, P360; Atlas ID, 2016, IDF DIABETES ATLAS; BAYO J, 1993, MED CLIN-BARCELONA, V101, P609; Calle-Pascual AL, 2001, DIABETES CARE, V24, P1686, DOI 10.2337/diacare.24.9.1686; Canavan RJ, 2008, DIABETES CARE, V31, P459, DOI 10.2337/dc07-1159; Cochrane Consumers and Communication Review Group, 2011, GUID REV AUTH ASS ST; Collins TC, 2002, MED CARE, V40, P106; Almaraz MC, 2012, DIABETES RES CLIN PR, V95, P399, DOI 10.1016/j.diabres.2011.10.035; Dillingham TR, 2002, ARCH PHYS MED REHAB, V83, P1252, DOI 10.1053/apmr.2002.34805; Ephraim PL, 2003, ARCH PHYS MED REHAB, V84, P747, DOI 10.1016/S0003-9993(03)04932-8; Fosse S, 2009, DIABETIC MED, V26, P391, DOI 10.1111/j.1464-5491.2009.02698.x; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; GUJRAL JS, 1993, DIABETIC MED, V10, P271, DOI 10.1111/j.1464-5491.1993.tb00057.x; Harris CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042493; Hinchliffe RJ, 2012, DIABETES-METAB RES, V28, P179, DOI 10.1002/dmrr.2249; Hoffmann F, 2013, J DIABETES COMPLICAT, V27, P467, DOI 10.1016/j.jdiacomp.2013.05.001; Hoffstad O, 2015, DIABETES CARE, V38, P1852, DOI 10.2337/dc15-0536; Holman N, 2012, DIABETOLOGIA, V55, P1919, DOI 10.1007/s00125-012-2468-6; Icks A, 2009, EXP CLIN ENDOCR DIAB, V117, P500, DOI 10.1055/s-0029-1225333; Icks A, 2011, DIABETES CARE, V34, P1350, DOI 10.2337/dc10-2341; Ikonen TS, 2010, DIABETES CARE, V33, P2598, DOI 10.2337/dc10-0462; Jeffcoate WJ, 2005, ACTA CHIR BELG, V105, P140, DOI 10.1080/00015458.2005.11679687; Kusnik-Joinville O, 2008, DIABETES METAB, V34, P266, DOI 10.1016/j.diabet.2008.01.005; Kvitkina T, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0064-9; LARSSON J, 1995, ACTA ORTHOP SCAND, V66, P181, DOI 10.3109/17453679508995520; LARSSON J, 1995, DIABETIC MED, V12, P770, DOI 10.1111/j.1464-5491.1995.tb02078.x; Lavery LA, 1996, DIABETES CARE, V19, P48, DOI 10.2337/diacare.19.1.48; Lombardo FL, 2014, LOWER EXTREMITY AMPU, V9; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Morris AD, 1998, DIABETES CARE, V21, P738, DOI 10.2337/diacare.21.5.738; Moxey PW, 2011, DIABETIC MED, V28, P1144, DOI 10.1111/j.1464-5491.2011.03279.x; O'Connor JW, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0083188, 10.1371/journal.pone.0080504]; Peek ME, 2011, CLIN ORTHOP RELAT R, V469, P1951, DOI 10.1007/s11999-010-1735-4; Pernot HFM, 1997, CLIN REHABIL, V11, P93, DOI 10.1177/026921559701100202; Price P, 2004, CLIN INFECT DIS, V39, pS129, DOI 10.1086/383274; Rasmussen BSB, 2016, DIABETOLOGIA, V59, P121, DOI 10.1007/s00125-015-3781-7; SAMANTA A, 1987, DIABETES RES CLIN PR, V4, P1, DOI 10.1016/S0168-8227(87)80026-8; Schaper NC, 2012, DIABETES-METAB RES, V28, P218, DOI 10.1002/dmrr.2255; Schipf S, 2012, DIABETIC MED, V29, pE88, DOI 10.1111/j.1464-5491.2012.03578.x; Scottish Intercollegiate Guidelines Network (SIGN), METH CHECKL 1 SYST R; Sebastianski M, 2014, HEART, V100, P100, DOI 10.1136/heartjnl-2013-303605; Shamliyan T, 2013, AM J PUBLIC HLTH RES, V1, P183; Shaw J, 2012, NAT REV ENDOCRINOL, V8, P386, DOI 10.1038/nrendo.2012.78; Siegel EG, 2011, DIABETOLOGE, V7, P496, DOI 10.1007/s11428-011-0751-7; SIJTONEN OI, 1993, DIABETES CARE, V16, P16, DOI 10.2337/diacare.16.1.16; Tamayo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113154; Thorud JC, 2016, J FOOT ANKLE SURG, V55, P591, DOI 10.1053/j.jfas.2016.01.012; Trautner C, 2001, DIABETES CARE, V24, P855, DOI 10.2337/diacare.24.5.855; Trautner C, 2007, DIABETES CARE, V30, P2633, DOI 10.2337/dc07-0876; Tukiainen E, 2006, ANN SURG, V244, P949, DOI 10.1097/01.sla.0000247985.45541.e8; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Unwin N, 2000, BRIT J SURG, V87, P328, DOI 10.1046/j.1365-2168.2000.01344.x; Vamos EP, 2010, DIABETES CARE, V33, P2592, DOI 10.2337/dc10-0989; van Houtum WH, 1997, DIABETES RES CLIN PR, V38, P177, DOI 10.1016/S0168-8227(97)00105-8; Van Houtum WH, 2008, DIABETES-METAB RES, V24, pS14, DOI 10.1002/dmrr.826; vanHoutum WH, 1996, J INTERN MED, V240, P227, DOI 10.1046/j.1365-2796.1996.42868000.x; vanHoutum WH, 1996, DIABETES RES CLIN PR, V31, P125, DOI 10.1016/0168-8227(96)01199-0; vanHoutum WH, 1996, J DIABETES COMPLICAT, V10, P325, DOI 10.1016/1056-8727(95)00088-7; Wrobel JS, 2001, DIABETES CARE, V24, P860, DOI 10.2337/diacare.24.5.860; Zayed H, 2009, INT J CLIN PRACT, V63, P855, DOI 10.1111/j.1742-1241.2007.01608.x	62	119	121	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182081	10.1371/journal.pone.0182081	http://dx.doi.org/10.1371/journal.pone.0182081			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846690	Green Published, gold			2022-12-27	WOS:000408438600008
J	Walabyeki, J; Adamson, J; Buckley, HL; Sinclair, H; Atkin, K; Graham, H; Whitaker, K; Wardle, J; Macleod, U				Walabyeki, Julie; Adamson, Joy; Buckley, Hannah L.; Sinclair, Helena; Atkin, Karl; Graham, Hilary; Whitaker, Katriina; Wardle, Jane; Macleod, Una			Experience of, awareness of and help-seeking for potential cancer symptoms in smokers and non-smokers: A cross-sectional study	PLOS ONE			English	Article							LUNG-CANCER; RISK-FACTORS; PUBLIC AWARENESS; SMOKING; DELAY; DIAGNOSIS; AUSTRALIA; KNOWLEDGE; BEHAVIOR; IMPACT	Background Presenting to primary care with potential cancer symptoms is contingent on one's ability to recognize potentially serious symptoms. We investigated differences between smokers and non-smokers in symptoms experienced, awareness and consulting of potential respiratory, head and neck cancer symptoms. Methods Smokers and non-smokers aged over 50 from Yorkshire general practice lists were sent a postal questionnaire asking about symptoms, consulting and awareness of cancer symptoms. Data were analysed using STATA14. Results Response rate after one reminder was 30.5% (1205/3954). Smoking status was associated with experience of cough (p<0.001), breathlessness (p = 0.002) and tiredness (p = 0.004) with smokers (25.8% of population) more likely than never-smokers (53.6% of population) to experience all three symptoms (cough OR = 2.56; 95% CI[1.75-3.75], breathlessness OR = 2.39; 95%CI[1.43-4.00], tiredness OR = 1.57; 95% CI[1.12-2.19]). Smoking status was associated with awareness of breathlessness as a potential cancer symptom (p = 0.035) and consulting for cough (p = 0.011) with smokers less likely to consult than never-smokers (OR = 0.37; 95%CI[0.17-0.80]). Conclusion Our findings suggest that current smokers are more likely to experience cough, breathlessness and tiredness, but are less likely to consult for cough than never-smokers. To increase cancer awareness and promote consulting among smokers, innovative interventions improving symptom recognition and empowering smokers to seek help are required.	[Walabyeki, Julie; Sinclair, Helena; Macleod, Una] Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England; [Adamson, Joy] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Buckley, Hannah L.; Atkin, Karl; Graham, Hilary] Univ York, Dept Hlth Sci, York, N Yorkshire, England; [Whitaker, Katriina] Univ Surrey, Sch Hlth Sci, Guildford, Surrey, England; [Wardle, Jane] UCL, Hlth Behav Res Ctr, London, England; [Buckley, Hannah L.] Univ Leeds, Leeds Inst Clin Trials Res, Leeds, W Yorkshire, England	University of Hull; University of York - UK; Newcastle University - UK; University of York - UK; University of Surrey; University of London; University College London; University of Leeds	Walabyeki, J (corresponding author), Univ Hull, Hull York Med Sch, Kingston Upon Hull, N Humberside, England.	Julie.Walabyeki@hyms.ac.uk	Whitaker, Katriina/AAA-6593-2020	Whitaker, Katriina/0000-0002-0947-1840; Adamson, Joy/0000-0002-9860-0850	National Awareness and Early Diagnosis Initiative (NAEDI); CRUK [C1294/A13905]; NIHR CRN; Cancer Research UK (CRUK); Cancer Research UK [13905] Funding Source: researchfish	National Awareness and Early Diagnosis Initiative (NAEDI); CRUK(Cancer Research UK); NIHR CRN; Cancer Research UK (CRUK)(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The work was supported by the National Awareness and Early Diagnosis Initiative (NAEDI)-Project Award, CRUK; Ref: C1294/A13905. The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank the study participants, pilot study volunteers; participating practices; Dr Trish Green and Ms Claire Ward, who helped with the questionnaire packs preparation; HYMS IT team; Dr Judith Dyson for her contribution and our collaborators, Dr Gill Greenwood (Consultant in Oral Medicine and special care dentistry), Professor Nick Stafford (ENT surgery, University of Hull) and Dr Gavin Anderson (Department of Respiratory Medicine, Hull and East Yorkshire Hospitals. We acknowledge the support of the NIHR CRN and our funders, National Awareness and Early Diagnosis Initiative (NAEDI)-Project Award, Cancer Research UK (CRUK).	Blakely T, 2013, CANCER CAUSE CONTROL, V24, P1243, DOI 10.1007/s10552-013-0204-2; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Coleman MP, 2011, LANCET, V377, P127, DOI 10.1016/S0140-6736(10)62231-3; Crane M, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3051-8; Cromme SK, 2016, BRIT J GEN PRACT, V66, pE474, DOI 10.3399/bjgp16X685621; de Almeida AA, 2014, J BRAS PNEUMOL, V40, P286, DOI 10.1590/S1806-37132014000300012; Department of Health (DoH), 2007, CANC REF STRAT; Elliott AM, 2012, BMC FAMILY PRACTICE, V13, P1; Forbes LJL, 2014, BRIT J CANCER, V111, P581, DOI 10.1038/bjc.2014.304; Ford AC, 2006, THORAX, V61, P975, DOI 10.1136/thx.2006.060087; Friedemann Smith C, 2016, SMOKERS ARE LESS NON; Hamilton W, 2005, THORAX, V60, P1059, DOI 10.1136/thx.2005.045880; Health and Social Care Information Centre (HSCIC), 2015, STAT SMOK, P1; Hoseini M, 2016, ENVIRON SCI POLLUT R, V23, P25065, DOI 10.1007/s11356-016-7619-8; Ironmonger L, 2015, Br J Cancer, V112, P207, DOI 10.1038/bjc.2014.596; Kotz D, 2012, ADDICTION, V107, P995, DOI 10.1111/j.1360-0443.2011.03739.x; Lee YCA, 2013, INT J CANCER, V133, P2688, DOI 10.1002/ijc.28288; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Macleod U, 2009, BRIT J CANCER, V101, pS92, DOI 10.1038/sj.bjc.6605398; McLachlan S, 2015, FAM PRACT, V32, P568, DOI 10.1093/fampra/cmv048; Moffat J, 2015, BRIT J CANCER, V112, pS14, DOI 10.1038/bjc.2015.31; Office of National Statistics (ONS), 2016, STAT B, P1; ONS, 2013, CANC REG STAT, V2015, P1; Osborne J., 2011, DEALING MISSING INCO, P105; PHE, 2016, RESP S AW BE CLEAR C; Public Health England (PHE), 2016, LOC TOB CONTR PROF E; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Richards MA, 2009, BRIT J CANCER, V101, pS125, DOI 10.1038/sj.bjc.6605402; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; Simon AE, 2012, THORAX, V67, P426, DOI 10.1136/thoraxjnl-2011-200898; Smith LK, 2005, LANCET, V366, P825, DOI 10.1016/S0140-6736(05)67030-4; Smith SM, 2009, THORAX, V64, P523, DOI 10.1136/thx.2008.096560; Stubbings S, 2009, BRIT J CANCER, V101, pS13, DOI 10.1038/sj.bjc.6605385; The National Institute for Health and Care Excellence (NICE), 2015, NICE GUID, VNG12, P1; Tynan Michael A., 2012, Morbidity and Mortality Weekly Report, V61, P565; Vander Weg MW, 2012, NICOTINE TOB RES, V14, P123, DOI 10.1093/ntr/ntr141; Wagland R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165677; Walter FM, 2015, BRIT J CANCER, V112, pS6, DOI 10.1038/bjc.2015.30; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Whitaker KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114028	40	9	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183647	10.1371/journal.pone.0183647	http://dx.doi.org/10.1371/journal.pone.0183647			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846706	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600043
J	Zangooei, MH; Habibi, J				Zangooei, Mohammad Hossein; Habibi, Jafar			Hybrid multiscale modeling and prediction of cancer cell behavior	PLOS ONE			English	Article							AGENT-BASED MODEL; TUMOR-GROWTH; AUTOMATON MODEL; SOLID TUMOR; MULTICELLULAR PATTERNS; MATHEMATICAL-MODEL; HETEROGENEITY; ANGIOGENESIS; PHENOTYPES; CONTINUUM	Background Understanding cancer development crossing several spatial-temporal scales is of great practical significance to better understand and treat cancers. It is difficult to tackle this challenge with pure biological means. Moreover, hybrid modeling techniques have been proposed that combine the advantages of the continuum and the discrete methods to model multiscale problems. Methods In light of these problems, we have proposed a new hybrid vascular model to facilitate the multiscale modeling and simulation of cancer development with respect to the agent-based, cellular automata and machine learning methods. The purpose of this simulation is to create a dataset that can be used for prediction of cell phenotypes. By using a proposed Q-learning based on SVR-NSGA-II method, the cells have the capability to predict their phenotypes autonomously that is, to act on its own without external direction in response to situations it encounters. Results Computational simulations of the model were performed in order to analyze its performance. The most striking feature of our results is that each cell can select its phenotype at each time step according to its condition. We provide evidence that the prediction of cell phenotypes is reliable. Conclusion Our proposed model, which we term a hybrid multiscale modeling of cancer cell behavior, has the potential to combine the best features of both continuum and discrete models. The in silico results indicate that the 3D model can represent key features of cancer growth, angiogenesis, and its related micro-environment and show that the findings are in good agreement with biological tumor behavior. To the best of our knowledge, this paper is the first hybrid vascular multiscale modeling of cancer cell behavior that has the capability to predict cell phenotypes individually by a self-generated dataset.	[Zangooei, Mohammad Hossein; Habibi, Jafar] Sharif Univ Technol, Dept Comp Engn, Tehran, Iran	Sharif University of Technology	Habibi, J (corresponding author), Sharif Univ Technol, Dept Comp Engn, Tehran, Iran.	jhabibi@sharif.edu	Zangooei, Mohammad Hossein/AAD-9441-2021; Zangooei, Mohammad Hossein/AAJ-6094-2020	Zangooei, Mohammad Hossein/0000-0002-1471-3584				Alarcon T, 2003, J THEOR BIOL, V225, P257, DOI 10.1016/S0022-5193(03)00244-3; Alemani D, 2012, J IMMUNOL METHODS, V376, P55, DOI 10.1016/j.jim.2011.11.009; Anderson AR, 2014, CANCER RES, V66, P1366; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2007, SINGLE CELL BASED MO, P3; AndersonAR ChaplainMA, 2000, J THEORETICAL MED, V2, P129, DOI DOI 10.1080/10273660008833042; Athale C, 2005, J THEOR BIOL, V233, P469, DOI 10.1016/j.jtbi.2004.10.019; Brown JM, 2007, METHOD ENZYMOL, V435, P297, DOI 10.1016/S0076-6879(07)35015-5; Butler J, 2014, SIMULATING CANC GROW, P67; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Cai Y, 2011, J THEOR BIOL, V279, P90, DOI 10.1016/j.jtbi.2011.02.017; Chaplain MAJ, 2000, J NEURO-ONCOL, V50, P37, DOI 10.1023/A:1006446020377; Chapuis A., 2015, COMPUTATIONAL BIOMEC, P25; Chen L, 2012, FRONT ARCHIT RES, V1, P166, DOI 10.1016/j.foar.2012.03.003; Cristini V., 2010, MULTISCALE MODELING; de Pillis LG, 2005, CANCER RES, V65, P7950, DOI 10.1158/0008-5472.CAN-05-0564; Deacon N, 2014, COMPUTATIONAL BIOMEC, P27; Deisboeck TS, 2011, ANNU REV BIOMED ENG, V13, P127, DOI 10.1146/annurev-bioeng-071910-124729; DEMICHELI R, 1980, EUR J CANCER, V16, P1603, DOI 10.1016/0014-2964(80)90034-1; Edgar LT, 2013, COMPUT METHOD BIOMEC, V16, P790, DOI 10.1080/10255842.2012.662678; Freedman HI, 2009, NONLINEAR ANAL-REAL, V10, P2709, DOI 10.1016/j.nonrwa.2008.08.001; Gerlee P, 2007, J THEOR BIOL, V246, P583, DOI 10.1016/j.jtbi.2007.01.027; Gerlee P, 2013, CANCER RES, V73, P2407, DOI 10.1158/0008-5472.CAN-12-4355; Ghaffari A, 2014, J APPL MATH, DOI 10.1155/2014/363109; Hatzikirou H, 2010, COMPUT MATH APPL, V59, P2326, DOI 10.1016/j.camwa.2009.08.041; Jinghua W, 2014, J HEAT TRANSFER AM S, V136, P71101; Kholodenko BN, 1999, J BIOL CHEM, V274, P30169, DOI 10.1074/jbc.274.42.30169; KUZNETSOV VA, 1994, B MATH BIOL, V56, P295, DOI 10.1007/BF02460644; LAIRD AK, 1964, BRIT J CANCER, V18, P490, DOI 10.1038/bjc.1964.55; Lejon A, 2015, VARIANCE REDUCED SIM; Lollini Pier-Luigi, 2008, P363, DOI 10.1007/978-0-8176-4713-1_14; Macal CM, 2007, PROCEEDINGS OF THE 2007 WINTER SIMULATION CONFERENCE, VOLS 1-5, P83; Macklin P, 2012, J THEOR BIOL, V301, P122, DOI 10.1016/j.jtbi.2012.02.002; Mallet DG, 2006, J THEOR BIOL, V239, P334, DOI 10.1016/j.jtbi.2005.08.002; Mansury Y, 2006, J THEOR BIOL, V238, P146, DOI 10.1016/j.jtbi.2005.05.027; Olsen MM, 2013, PROCEDIA COMPUT SCI, V18, P1016, DOI 10.1016/j.procs.2013.05.267; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; Owen MR, 2011, CANCER RES, V71, P2826, DOI 10.1158/0008-5472.CAN-10-2834; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; Perfahl H, 2013, BIOANALYSIS-ADV MAT, V2, P29, DOI 10.1007/978-1-4614-4376-6_3; Perry SW, 2002, J NEUROVIROL, V8, P611, DOI 10.1080/13550280290101021; Piccolo E, 2002, ONCOGENE, V21, P6520, DOI 10.1038/sj.onc.1205821; Poleszczuk Jan, 2014, Appl Math (Irvine), V5, P144; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; QI AS, 1993, J THEOR BIOL, V161, P1, DOI 10.1006/jtbi.1993.1035; Rangamani P, 2007, BIOTECHNOL BIOENG, V97, P1216, DOI 10.1002/bit.21307; Reis EA, 2009, PHYSICA A, V388, P1303, DOI 10.1016/j.physa.2008.11.038; Rejniak KA, 2011, WIRES SYST BIOL MED, V3, P115, DOI 10.1002/wsbm.102; Schaller G, 2006, PHILOS T R SOC A, V364, P1443, DOI 10.1098/rsta.2006.1780; Shay JW, 2011, SEMIN CANCER BIOL, V21, P349, DOI 10.1016/j.semcancer.2011.10.001; Sherratt JA, 2001, J MATH BIOL, V43, P291, DOI 10.1007/s002850100088; Shrestha SMB, 2013, INT J NUMER METH BIO, V29, P542, DOI 10.1002/cnm.2539; Song JF, 2008, OPT EXPRESS, V16, P15304, DOI 10.1364/OE.16.015304; Sun XQ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-218; Trappey CV, 2008, ADV ENG INFORM, V22, P421, DOI 10.1016/j.aei.2008.05.007; Wang J, 2013, THEOR BIOL MED MODEL, V10, DOI 10.1186/1742-4682-10-41; Wang ZH, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-50; Wang ZH, 2009, BIOINFORMATICS, V25, P2389, DOI 10.1093/bioinformatics/btp416; WODARZ D, 2009, PLOS ONE, V4; Wolfram S, 1994, CELLULAR AUTOMATA CO; Zangooei MH, 2014, NEUROCOMPUTING, V136, P14, DOI 10.1016/j.neucom.2014.01.042; Zhang L, 2009, MATH COMPUT MODEL, V49, P307, DOI 10.1016/j.mcm.2008.05.011; Zhang L, 2007, J THEOR BIOL, V244, P96, DOI 10.1016/j.jtbi.2006.06.034; Zhang L, 2011, THEOR BIOL MED MODEL, V8, DOI 10.1186/1742-4682-8-46; Zhang L, 2009, MATH COMPUT SIMULAT, V79, P2021, DOI 10.1016/j.matcom.2008.09.007	65	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183810	10.1371/journal.pone.0183810	http://dx.doi.org/10.1371/journal.pone.0183810			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846712	Green Submitted, Green Published, gold			2022-12-27	WOS:000408438600051
J	Cho, SH; An, HJ; Kim, KA; Ko, JJ; Kim, JH; Kim, YR; Ahn, EH; Rah, H; Lee, WS; Kim, NK				Cho, Sung Hwan; An, Hui Jeong; Kim, Kyung Ah; Ko, Jung Jae; Kim, Ji Hyang; Kim, Young Ran; Ahn, Eun Hee; Rah, HyungChul; Lee, Woo Sik; Kim, Nam Keun			Single nucleotide polymorphisms at miR-146a/196a2 and their primary ovarian insufficiency-related target gene regulation in granulosa cells	PLOS ONE			English	Article							MIR-499A-GREATER-THAN-G POLYMORPHISMS; MICRORNAS; FAILURE; ASSOCIATION; EXPRESSION; CANCER; FOXO3; RISK; MICE; MIR-196A2T-GREATER-THAN-C	MicroRNAs post-transcriptionally regulate gene expression in animals and plants. The aim of this study was to identify new target genes for microRNA polymorphisms (miR-146aC>G and miR-196a2T>C) in primary ovarian insufficiency (POI). We cloned and transfected miR146aC>G and miR-196a2T>C into human granulosa cells and used microarrays and qPCR-arrays to examine the changes in the messenger RNA expression profile. We show miR146aC>G and miR-196a2T>C change the mRNA expression patterns in granulosa cell. In each case, mRNAs were up or down-regulated after treatments with miR-146a C or G and miR-196a2 T or C. We found that miR-146a led to a significantly altered regulation of the mRNA levels of FOXO3, FOXL2 and CCND2 compared to controls. We also found that the polymorphisms of miR-146a led to a significantly altered regulation of CCND2 and FOXO3. Our results suggest that miR-146aC>G and miR-196a2T>C can regulate the levels of many of their target transcripts. In addition, specific target genes of miR-146aC>G polymorphisms may be involved in granulosa cell regulation.	[Cho, Sung Hwan; An, Hui Jeong; Kim, Kyung Ah; Ko, Jung Jae; Kim, Nam Keun] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea; [Kim, Ji Hyang; Kim, Young Ran; Ahn, Eun Hee] CHA Univ, Dept Obstet & Gynecol, Sch Med, Seongnam, South Korea; [Rah, HyungChul] Chungbuk Natl Univ, Healthcare Bigdata Linkage Platform Team, Cheongju, Chungbuk, South Korea; [Lee, Woo Sik] CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Sch Med, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Chungbuk National University; Pochon Cha University	Kim, NK (corresponding author), CHA Univ, Dept Biomed Sci, Coll Life Sci, Seongnam, South Korea.; Lee, WS (corresponding author), CHA Univ, Fertil Ctr, CHA Gangnam Med Ctr, Sch Med, Seoul, South Korea.	wooslee@cha.ac.kr; nkkim@cha.ac.kr		Kim, Nam Keun/0000-0003-0541-3528	Korea Healthcare technology RD Project [HI15C1972010015]; Ministry for Health, Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea [2009-0093821, 2014R1A2A2A01003994, 2015R1D1A1A09057432]; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology [2013R1A1A2009661]	Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea; Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science, and Technology	This study was partly supported by a grant of the Korea Healthcare technology R&D Project (HI15C1972010015), Ministry for Health, Welfare & Family Affairs, Republic of Korea and by Basic Science Research Program through National Research Foundation of Korea Grants funded by the Korean Government (2009-0093821, 2014R1A2A2A01003994 and 2015R1D1A1A09057432), Republic of Korea and Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology (grant 2013R1A1A2009661).	Abd El Naby WS, 2013, ZYGOTE, V21, P31, DOI 10.1017/S0967199411000566; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Baley J, 2012, J OVARIAN RES, V5, DOI 10.1186/1757-2215-5-8; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Castrillon DH, 2003, SCIENCE, V301, P215, DOI 10.1126/science.1086336; Chen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060317; Chen X, 2015, MOL MED REP, V12, P5155, DOI 10.3892/mmr.2015.4036; Cho SH, 2016, EUR J OBSTET GYN R B, V202, P14, DOI 10.1016/j.ejogrb.2016.04.009; Choi DH, 2011, HUM REPROD, V26, P1171, DOI 10.1093/humrep/der066; COULAM CB, 1986, OBSTET GYNECOL, V67, P604; de los Santos MJ, 2000, BIOL REPROD, V63, P1811, DOI 10.1095/biolreprod63.6.1811; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eberhard N, 2009, ANDROLOGY MALE REPRO, P193; Elsarraj HS, 2012, J MAMMARY GLAND BIOL, V17, P79, DOI 10.1007/s10911-012-9240-x; Gallardo TD, 2008, HUM REPROD, V23, P216, DOI 10.1093/humrep/dem255; Han Y, 2013, BIOL REPROD, V57, P1; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu ZB, 2008, J CLIN INVEST, V118, P2600, DOI 10.1172/JCI34934; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Imbar T, 2014, FERTIL STERIL, V101, P1524, DOI 10.1016/j.fertnstert.2014.04.024; Jazdzewski K, 2008, P NATL ACAD SCI USA, V105, P7269, DOI 10.1073/pnas.0802682105; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jeon YJ, 2012, GENE, V494, P168, DOI 10.1016/j.gene.2011.12.026; John GB, 2007, REPRODUCTION, V133, P855, DOI 10.1530/REP-06-0051; Kodaman PH, 2010, SEMIN REPROD MED, V28, P360, DOI 10.1055/s-0030-1262895; Kuo FT, 2012, REPRODUCTION, V144, P485, DOI 10.1530/REP-11-0259; Liu ZL, 2013, MOL ENDOCRINOL, V27, P238, DOI 10.1210/me.2012-1296; Medeiros LA, 2011, P NATL ACAD SCI USA, V108, P14163, DOI 10.1073/pnas.1111241108; Nelson LM, 2009, NEW ENGL J MED, V360, P606, DOI 10.1056/NEJMcp0808697; Nishi Y, 2001, ENDOCRINOLOGY, V142, P437, DOI 10.1210/en.142.1.437; Oktay K, 2010, J CLIN ONCOL, V28, P240, DOI 10.1200/JCO.2009.24.2057; Pan Q, 2007, MOL HUM REPROD, V13, P797, DOI 10.1093/molehr/gam063; Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865; Qin YY, 2007, AM J HUM GENET, V81, P576, DOI 10.1086/519496; Rah H, 2013, REPROD SCI, V20, P60, DOI 10.1177/1933719112450341; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Reynaud K, 2000, MOL CELL ENDOCRINOL, V163, P101, DOI 10.1016/S0303-7207(99)00246-4; Santamaria X, 2014, FERTIL STERIL, V101, P1545, DOI 10.1016/j.fertnstert.2014.04.044; Sha Min, 2013, Cancer Cell Int, V13, P50, DOI 10.1186/1475-2867-13-50; Simpson JL, 2008, ANN NY ACAD SCI, V1135, P146, DOI 10.1196/annals.1429.019; Song Feng-Ju, 2011, Chin J Cancer, V30, P381; Suzuki Y, 2010, AM J PHYSIOL-HEART C, V299, pH1077, DOI 10.1152/ajpheart.00212.2010; Teague EMCO, 2010, HUM REPROD UPDATE, V16, P142, DOI 10.1093/humupd/dmp034; Toloubeydokhti T, 2008, SEMIN REPROD MED, V26, P469, DOI 10.1055/s-0028-1096127; Tripurani SK, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-25; Virant-Klun I, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/3984937; Wang BB, 2010, REPROD BIOMED ONLINE, V20, P499, DOI 10.1016/j.rbmo.2010.01.008; Watkins WJ, 2006, FERTIL STERIL, V86, P1518, DOI 10.1016/j.fertnstert.2006.03.054; Welt CK, 2008, CLIN ENDOCRINOL, V68, P499, DOI 10.1111/j.1365-2265.2007.03073.x; Xiaobing L, 2011, PLOS GENET, V7; Yang XK, 2012, REPRODUCTION, V144, P235, DOI 10.1530/REP-11-0371; Zhou Y., 2011, CHIN J BIRTH HLTH HE, V19, P20	53	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183479	10.1371/journal.pone.0183479	http://dx.doi.org/10.1371/journal.pone.0183479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841705	Green Submitted, gold, Green Published			2022-12-27	WOS:000408370700036
J	Fu, XW; Feng, HQ; Liu, ZF; Wu, KM				Fu, Xiaowei; Feng, Hongqiang; Liu, Zhongfang; Wu, Kongming			Trans-regional migration of the beet armyworm, Spodoptera exigua (Lepidoptera: Noctuidae), in North-East Asia	PLOS ONE			English	Article							HELICOVERPA-ARMIGERA LEPIDOPTERA; CNAPHALOCROCIS-MEDINALIS LEPIDOPTERA; NILAPARVATA-LUGENS HOMOPTERA; AUTUMN MIGRATION; BOHAI SEA; SEASONAL MIGRATION; RETURN MIGRATION; INSECT MIGRATION; PIED PIPER; RADAR	The beet armyworm, Spodoptera exigua (Hubner) (Lepidoptera: Noctuidae), is a serious polyphagous insect pest worldwide. This species is known as a long-distance migrant, and previous studies on its migration have been mostly carried out in regions where it can over-winter. However, what pattern of seasonal migration this species exhibits in regions where it cannot overwinter (i.e., the 'summer breeding region') remains unknown. Here, we present data from 14-years of monitoring on a small remote island located in the center of the Bohai Strait, in northern China, by means of searchlight trapping and ovarian dissection. We found that the population size of this overseas migration varied significantly among years, with very large migrations in 2005, 2007, 2009, and 2014 that resulted in annual total catches of more than ten thousand individuals. In addition, nightly catches exhibited a significant inter-month variability, with the vast majority of S. exigua moths being trapped in August and September, (81.1 +/- 3.6%), making S. exigua one of the most frequently encountered species in that period. The mean time from the earliest trap capture to the latest capture within a given year was 113 +/- 22 d (range 57 d [2003] to 138 d [2008]). The sex ratio (females: males) was significantly less than 1:1 in each month, but the proportion of females showed an upward trend from June to October. The majority of trapped females in summer were mated (94.4 +/- 10.7% in June, 80.0 +/- 6.4% in July) and sexually mature (88.9 +/- 11.1% in June, 61.8 +/- 12.3% in July), suggesting the onset of mating and/or sexual maturation does not terminate the migration behavior in this species. These findings provide a good starting point for study of the trans-regional migration of S. exigua across different climate zones.	[Fu, Xiaowei; Wu, Kongming] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China; [Feng, Hongqiang] Henan Acad Agr Sci, Inst Plant Protect, Zhengzhou, Henan, Peoples R China; [Liu, Zhongfang] Shanxi Acad Agr Sci, Inst Plant Protect, Taiyuan, Shanxi, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Henan Academy of Agricultural Sciences; Shanxi Agricultural University	Wu, KM (corresponding author), Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing, Peoples R China.	wukongming@caas.cn		Feng, Hongqiang/0000-0002-1171-248X	National Natural Sciences Foundation of China [31601630]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the National Natural Sciences Foundation of China (grant number: 31601630).; We would like to thank Chao Li, Jianglong Guo, Xiao Wu, Hong Chang, Limei He and Shengyuan Zhao from the Institute of Plant Protection, Chinese Academy of Agricultural Sciences and Long Cao, Lei Yang, Kangle Fan, Doudou Wang and Lili Song from the College of Plant Protection, Henan Agricultural University, for their contributions in searchlight trapping and ovarian dissections. English editing was done by Van Driesche Scientific Editing. This research was supported by the National Natural Sciences Foundation of China (grant number: 31601630).	Aarvik L., 1981, Fauna Norvegica Series B, V28, P90; Ahmad M, 2010, CROP PROT, V29, P1428, DOI 10.1016/j.cropro.2010.07.025; ALI A, 1992, ENVIRON ENTOMOL, V21, P780, DOI 10.1093/ee/21.4.780; [Anonymous], DPS DATA PROCESSING; Berzitis EA, 2014, GLOBAL CHANGE BIOL, V20, P2778, DOI 10.1111/gcb.12557; Carde RT, 2008, CURR BIOL, V18, pR472, DOI 10.1016/j.cub.2008.04.018; Chapman JW, 2012, P NATL ACAD SCI USA, V109, P14924, DOI 10.1073/pnas.1207255109; Chapman JW, 2011, ANNU REV ENTOMOL, V56, P337, DOI 10.1146/annurev-ento-120709-144820; Chapman JW, 2010, SCIENCE, V327, P682, DOI 10.1126/science.1182990; Dingle H., 2014, MIGRATION BIOL LIFE, P352; Dingle H, 2007, BIOSCIENCE, V57, P113, DOI 10.1641/B570206; DRAKE VA, 1988, ANNU REV ENTOMOL, V33, P183, DOI 10.1146/annurev.en.33.010188.001151; Ehler LE, 2004, BIOCONTROL, V49, P121, DOI 10.1023/B:BICO.0000017364.20596.38; FARROW RA, 1987, AUST J ZOOL, V35, P1, DOI 10.1071/ZO9870001; Feng HQ, 2005, B ENTOMOL RES, V95, P361, DOI 10.1079/BER2005367; Feng HQ, 2008, ENVIRON ENTOMOL, V37, P774, DOI 10.1603/0046-225X(2008)37[774:AMOMSL]2.0.CO;2; Feng HQ, 2007, AGR FOREST ENTOMOL, V9, P103, DOI 10.1111/j.1461-9563.2007.00326.x; Feng HQ, 2006, ECOL ENTOMOL, V31, P511, DOI 10.1111/j.1365-2311.2006.00813.x; Feng HQ, 2009, J ECON ENTOMOL, V102, P95, DOI 10.1603/029.102.0114; Feng HQ, 2004, J ECON ENTOMOL, V97, P1874, DOI 10.1603/0022-0493-97.6.1874; Feng HQ, 2004, ENVIRON ENTOMOL, V33, P1253, DOI 10.1603/0046-225X-33.5.1253; Feng HQ, 2003, B ENTOMOL RES, V93, P115, DOI 10.1079/BER2002221; Chaves LF, 2010, J MED ENTOMOL, V47, P291, DOI 10.1603/ME09250; FRENCH RA, 1969, J ANIM ECOL, V38, P199, DOI 10.2307/2746; Fu XW, 2014, B ENTOMOL RES, V104, P601, DOI 10.1017/S0007485314000376; Fu XW, 2015, J ECON ENTOMOL, V108, P525, DOI 10.1093/jee/tov019; Fu XW, 2014, CROP PROT, V64, P143, DOI 10.1016/j.cropro.2014.06.021; Fu XW, 2014, J ECON ENTOMOL, V107, P1399, DOI 10.1603/EC13380; GILMORE E. C., 1958, AGRON JOUR, V50, P611; Guo JL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131639; Han LZ, 2009, J APPL ENTOMOL, V133, P262, DOI 10.1111/j.1439-0418.2008.01353.x; Hu CX, 2015, CLIMATIC CHANGE, V132, P337, DOI 10.1007/s10584-015-1427-x; Jiang XF., 2010, J CHANGJIANG VEG, V18, P36; Johnson C.G., 1969, MIGRATION DISPERSAL; JOHNSON CG, 1963, NATURE, V198, P423, DOI 10.1038/198423a0; Karimi-Malati A, 2014, J ASIA-PAC ENTOMOL, V17, P349, DOI 10.1016/j.aspen.2014.03.002; Karimi-Malati A, 2014, ENVIRON ENTOMOL, V43, P795, DOI 10.1603/EN11272; Kim Y, 2000, ENVIRON ENTOMOL, V29, P868, DOI 10.1603/0046-225X-29.5.868; KIMURA S, 1991, ANN REPORT SOC PLANT, V42, P148; Kwon Min, 2006, Journal of Asia-Pacific Entomology, V9, P361, DOI 10.1016/S1226-8615(08)60315-5; Long Y, 2012, ENVIRON ENTOMOL, V41, P1231, DOI 10.1603/EN12143; MCNEIL JN, 1987, INSECT SCI APPL, V8, P591, DOI 10.1017/S1742758400022657; Mehrkhou F, 2012, ENVIRON ENTOMOL, V41, P326, DOI 10.1603/EN10255; Mikkola K, 2003, ENTOMOL FENNICA, V14, P15; Pan Lei, 2014, Chinese Journal of Applied Entomology, V51, P974, DOI 10.7679/j.issn.2095-1353.2014.117; RILEY JR, 1994, B ENTOMOL RES, V84, P389, DOI 10.1017/S0007485300032521; RILEY JR, 1995, B ENTOMOL RES, V85, P397, DOI 10.1017/S0007485300036130; Roff DA, 2007, BIOSCIENCE, V57, P155, DOI 10.1641/B570210; Saeed S, 2010, J PEST SCI, V83, P165, DOI 10.1007/s10340-009-0283-8; *SAS I INC, 2001, JMP START STAT; Serafim Jr. M., 2003, Braz. J. Biol., V63, P349, DOI 10.1590/S1519-69842003000200020; Shi BK, 2014, J INTEGR AGR, V13, P1520, DOI 10.1016/S2095-3119(14)60804-2; Showers WB, 1997, ANNU REV ENTOMOL, V42, P393, DOI 10.1146/annurev.ento.42.1.393; STINNER RE, 1983, ANNU REV ENTOMOL, V28, P319, DOI 10.1146/annurev.en.28.010183.001535; Su JY, 2014, CROP PROT, V61, P58, DOI 10.1016/j.cropro.2014.03.013; Tang QY, 2013, INSECT SCI, V20, P254, DOI 10.1111/j.1744-7917.2012.01519.x; TAYLOR RAJ, 1986, J ANIM ECOL, V55, P1103, DOI 10.2307/4436; WADA T, 1988, ENTOMOL EXP APPL, V46, P141, DOI 10.1007/BF00190844; Wang Xianhui, 2003, Acta Phytophylacica Sinica, V30, P261; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; WILLIAMS CB, 1957, ANNU REV ENTOMOL, V2, P163, DOI 10.1146/annurev.en.02.010157.001115; Wu Kong-Ming, 2002, Acta Ecologica Sinica, V22, P1075; Wu X, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132904; Yan NS, 2001, CHINESE TOBACCO SCI, V2, P25; Yin JianLi, 2010, Plant Diseases and Pests, V1, P52; Zanuncio JC, 1998, FOREST ECOL MANAG, V108, P85, DOI 10.1016/S0378-1127(98)00215-1; Zhai Bao-Ping, 1993, Acta Ecologica Sinica, V13, P356; Zhang AY, 2001, J HEZE TEACHERS COLL, V23, P23; Zhang B., 2008, CHINESE AGR SCI B, V24, P427; Zhang Xiao-Ming, 2015, Chinese Journal of Applied Entomology, V52, P237, DOI 10.7679/j.issn.2095-1353.2015.025; Zhao XY, 2016, B ENTOMOL RES, V106, P740, DOI 10.1017/S000748531600047X; Zheng XL, 2011, J ENTOMOL RES SOC, V13, P39; Zhou C, 2011, PHYTOPARASITICA, V39, P315, DOI 10.1007/s12600-011-0157-5; Ziter C, 2012, GLOBAL CHANGE BIOL, V18, P2771, DOI 10.1111/j.1365-2486.2012.02748.x	74	14	18	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183582	10.1371/journal.pone.0183582	http://dx.doi.org/10.1371/journal.pone.0183582			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841696	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700043
J	Huang, FQ; Spangler, JR; Huang, AY				Huang, Faqing; Spangler, Joseph Rankin; Huang, Allen Yang			In vivo cloning of up to 16 kb plasmids in E-coli is as simple as PCR	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; DNA-MOLECULES; PRODUCTS; CONSTRUCTION; YEAST; EFFICIENT; VECTORS; VITRO	The precise assembly of defined DNA sequences into plasmids is an essential task in bioscience research. While a number of molecular cloning techniques have been developed, many methods require specialized expensive reagents or laborious experimental procedure. Not surprisingly, conventional cloning techniques based on restriction digestion and ligation are still commonly used in routine DNA cloning. Here, we describe a simple, fast, and economical cloning method based on RecA-and RecET-independent in vivo recombination of DNA fragments with overlapping ends using E. coli. All DNA fragments were prepared by a 2-consecutive PCR procedure with Q5 DNA polymerase and used directly for transformation resulting in 95% cloning accuracy and zero background from parental template plasmids. Quantitative relationships were established between cloning efficiency and three factors -the length of overlapping nucleotides, the number of DNA fragments, and the size of target plasmids -which can provide general guidance for selecting in vivo cloning parameters. The method may be used to accurately assemble up to 5 DNA fragments with 25 nt overlapping ends into relatively small plasmids, and 3 DNA fragments into plasmids up to 16 kb in size. The whole cloning procedure may be completed within 2 days by a researcher with little training in cloning. The combination of high accuracy and zero background eliminates the need for screening a large number of colonies. The method requires no enzymes other than Q5 DNA polymerase, has no sequence restriction, is highly reliable, and represents one of the simplest, fastest, and cheapest cloning techniques available. Our method is particularly suitable for common cloning tasks in the lab where the primary goal is to quickly generate a plasmid with a pre-defined sequence at low costs.	[Huang, Faqing; Spangler, Joseph Rankin] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Huang, Allen Yang] Oak Grove High Sch, Hattiesburg, MS USA	University of Southern Mississippi	Huang, FQ (corresponding author), Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	Faqing.Huang@usm.edu		Spangler, Joseph/0000-0002-0673-1459	University of Southern Mississippi; National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER	University of Southern Mississippi; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was funded by a Development Fund from the University of Southern Mississippi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Ballard lab and the Cullen lab for providing pIk [36] and pk-Dcr [37] for use as the templates for the construction of pIkB, pDcEG, and pDSADE. We would like to acknowledge the Mississippi INBRE program supported by the National Institutes of Health for using its facilities.	Annaluru N, 2014, SCIENCE, V344, P55, DOI 10.1126/science.1249252; ASLANIDIS C, 1990, NUCLEIC ACIDS RES, V18, P6069, DOI 10.1093/nar/18.20.6069; Benoit RM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153158; Brand LA, 2005, J BIOL CHEM, V280, P20185, DOI 10.1074/jbc.C500044200; Bryksin AV, 2010, BIOTECHNIQUES, V48, P463, DOI 10.2144/000113418; BUBECK P, 1993, NUCLEIC ACIDS RES, V21, P3601, DOI 10.1093/nar/21.15.3601; Cao PG, 2014, PLASMID, V76, P40, DOI 10.1016/j.plasmid.2014.09.002; Chen GJ, 2000, BIOTECHNIQUES, V28, P498, DOI 10.2144/00283st08; COHEN SN, 1973, P NATL ACAD SCI USA, V70, P3240, DOI 10.1073/pnas.70.11.3240; Coleman Tricia M, 2005, RNA Biol, V2, P129, DOI 10.4161/rna.2.4.2285; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Dutra BE, 2007, P NATL ACAD SCI USA, V104, P216, DOI 10.1073/pnas.0608293104; GANCHI PA, 1992, MOL BIOL CELL, V3, P1339, DOI 10.1091/mbc.3.12.1339; Garcia-Nafria J, 2016, SCI REP-UK, V6, DOI 10.1038/srep27459; Geu-Flores F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm106; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Jacobus AP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119221; Joska TM, 2014, J MICROBIOL METH, V100, P46, DOI 10.1016/j.mimet.2013.11.013; Kelwick Richard, 2014, Front Bioeng Biotechnol, V2, P60, DOI 10.3389/fbioe.2014.00060; Kennedy EM, 2015, P NATL ACAD SCI USA, V112, pE6945, DOI 10.1073/pnas.1513421112; Kostylev M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137466; Lee DF, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw436; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; LOBBAN PE, 1973, J MOL BIOL, V78, P453, DOI 10.1016/0022-2836(73)90468-3; Lovett ST, 2002, GENETICS, V160, P851; MA H, 1987, GENE, V58, P201, DOI 10.1016/0378-1119(87)90376-3; Muyrers J P, 2000, Genet Eng (N Y), V22, P77; Oldenburg KR, 1997, NUCLEIC ACIDS RES, V25, P451, DOI 10.1093/nar/25.2.451; OLINER JD, 1993, NUCLEIC ACIDS RES, V21, P5192, DOI 10.1093/nar/21.22.5192; Shao Zengyi, 2014, Curr Protoc Chem Biol, V6, P65, DOI 10.1002/9780470559277.ch130191; Strauss E, 2002, J BIOL CHEM, V277, P48205, DOI 10.1074/jbc.M204560200; Trehan A, 2016, SCI REP-UK, V6, DOI 10.1038/srep19121; van Leeuwen J, 2015, COLD SPRING HARB PRO, V2015; Walhout AJM, 2000, METHOD ENZYMOL, V328, P575, DOI 10.1016/S0076-6879(00)28419-X; WATT VM, 1985, P NATL ACAD SCI USA, V82, P4768, DOI 10.1073/pnas.82.14.4768; Zhang YM, 2000, NAT BIOTECHNOL, V18, P1314, DOI 10.1038/82449; Zhang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gkr1288; Zhu BG, 2007, BIOTECHNIQUES, V43, P356, DOI 10.2144/000112536	40	19	20	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183974	10.1371/journal.pone.0183974	http://dx.doi.org/10.1371/journal.pone.0183974			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837659	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000138
J	Mahabadi, AA; Balcer, B; Dykun, I; Forsting, M; Schlosser, T; Heusch, G; Rassaf, T				Mahabadi, Amir Abbas; Balcer, Bastian; Dykun, Iryna; Forsting, Michael; Schlosser, Thomas; Heusch, Gerd; Rassaf, Tienush			Cardiac computed tomography-derived epicardial fat volume and attenuation independently distinguish patients with and without myocardial infarction	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; VISCERAL ABDOMINAL FAT; ADIPOSE-TISSUE VOLUME; HEINZ NIXDORF RECALL; PERICARDIAL FAT; CORONARY-ARTERY; PLASMA-PROTEIN; ASSOCIATION; CT; ADIPONECTIN	Background and objective Epicardial adipose tissue (EAT) volume is associated with coronary plaque burden and adverse events. We aimed to determine, whether CT-derived EAT attenuation in addition to EAT volume distinguishes patients with and without myocardial infarction. Methods and results In 94 patients with confirmed or suspected coronary artery disease (aged 66.9+/-14.7years, 61%male) undergoing cardiac CT imaging as part of clinical workup, EAT volume was retrospectively quantified from non-contrast cardiac CT by delineation of the pericardium in axial images. Mean attenuation of all pixels from EAT volume was calculated. Patients with type-I myocardial infarction (n = 28) had higher EAT volume (132.9 +/- 111.9ml vs. 109.7 +/- 94.6ml, p = 0.07) and CT-attenuation (-86.8 +/- 5.8HU vs. -89.0 +/- 3.7HU, p = 0.03) than patients without type-I myocardial infarction, while EAT volume and attenuation were only modestly inversely correlated (r = -0.24, p = 0.02). EAT volume increased per standard deviation of age (18.2 [6.2-30.2] ml, p = 0.003), BMI (29.3 [18.4-40.2] ml, p<0.0001), and with presence of diabetes (44.5 [16.7-72.3] ml, p = 0.0002), while attenuation was higher in patients with lipid-lowering therapy (2.34 [0.08-4.61] HU, p = 0.04). In a model containing volume and attenuation, both measures of EAT were independently associated with the occurrence of type-I myocardial infarction (OR [95% CI]: 1.79 [1.10-2.94], p = 0.02 for volume, 2.04 [1.18-3.53], p = 0.01 for attenuation). Effect sizes remained stable for EAT attenuation after adjustment for risk factors (1.44 [0.77-2.68], p = 0.26 for volume; 1.93 [1.11-3.39], p = 0.02 for attenuation). Conclusion CT-derived EAT attenuation, in addition to volume, distinguishes patients with vs. without myocardial infarction and is increased in patients with lipid-lowering therapy. Our results suggest that assessment of EAT attenuation could render complementary information to EAT volume regarding coronary risk burden.	[Mahabadi, Amir Abbas; Balcer, Bastian; Dykun, Iryna; Rassaf, Tienush] Univ Clin Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, Essen, Germany; [Forsting, Michael; Schlosser, Thomas] Univ Clin Essen, Dept Diagnost & Intervent Radiol & Neuroradiol, Essen, Germany; [Heusch, Gerd] Univ Clin Essen, Inst Pathophysiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen; University of Duisburg Essen	Mahabadi, AA (corresponding author), Univ Clin Essen, West German Heart & Vasc Ctr Essen, Dept Cardiol & Vasc Med, Essen, Germany.	amir-abbas.mahabadi@uk-essen.de	Heusch, Gerd/ABE-6675-2020; Mahabadi, Amir/ABE-6057-2020					Arita Y, 2002, CIRCULATION, V105, P2893, DOI 10.1161/01.CIR.0000018622.84402.FF; Baba S, 2010, J NUCL MED, V51, P246, DOI 10.2967/jnumed.109.068775; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Greif M, 2009, ARTERIOSCL THROM VAS, V29, P781, DOI 10.1161/ATVBAHA.108.180653; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Hell MM, 2016, J CARDIOVASC COMPUT, V10, P141, DOI 10.1016/j.jcct.2016.01.009; Hell MM, 2016, J CARDIOVASC COMPUT, V10, P52, DOI 10.1016/j.jcct.2015.07.011; Jain SH, 2009, DIABETES CARE, V32, P903, DOI 10.2337/dc08-1733; Jungen C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14155; Jungen C, 2016, AM J CASE REP, V17, P280, DOI 10.12659/AJCR.897412; Konishi M, 2010, ATHEROSCLEROSIS, V213, P649, DOI 10.1016/j.atherosclerosis.2010.10.007; Laine P, 1999, CIRCULATION, V99, P361, DOI 10.1161/01.CIR.99.3.361; Mahabadi AA, 2016, JACC IN PRESS; Mahabadi AA, 2014, JACC-CARDIOVASC IMAG, V7, P909, DOI 10.1016/j.jcmg.2014.07.002; Mahabadi AA, 2014, EUR HEART J-CARD IMG, V15, P863, DOI 10.1093/ehjci/jeu006; Mahabadi AA, 2013, J AM COLL CARDIOL, V61, P1388, DOI 10.1016/j.jacc.2012.11.062; Mahabadi AA, 2010, ATHEROSCLEROSIS, V211, P195, DOI 10.1016/j.atherosclerosis.2010.02.013; Mahabadi AA, 2009, EUR HEART J, V30, P850, DOI 10.1093/eurheartj/ehn573; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; Moebus S, 2009, DIABETOLOGIA, V52, P81, DOI 10.1007/s00125-008-1173-y; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Pou KM, 2007, CIRCULATION, V116, P1234, DOI 10.1161/CIRCULATIONAHA.107.710509; Roffi M, 2016, EUR HEART J, V37, P267, DOI 10.1093/eurheartj/ehv320; Rosito GA, 2008, CIRCULATION, V117, P605, DOI 10.1161/CIRCULATIONAHA.107.743062; Schlett CL, 2012, ATHEROSCLEROSIS, V222, P129, DOI 10.1016/j.atherosclerosis.2012.02.029; Torriani M, 2015, OBES SURG, V25, P381, DOI 10.1007/s11695-014-1485-6	27	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183514	10.1371/journal.pone.0183514	http://dx.doi.org/10.1371/journal.pone.0183514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837682	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000075
J	Potkin, SG; Loze, JY; Forray, C; Baker, RA; Sapin, C; Peters-Strickland, T; Beillat, M; Nylander, AG; Hertel, P; Schmidt, SN; Ettrup, A; Eramo, A; Hansen, K; Naber, D				Potkin, Steven G.; Loze, Jean-Yves; Forray, Carlos; Baker, Ross A.; Sapin, Christophe; Peters-Strickland, Timothy; Beillat, Maud; Nylander, Anna-Greta; Hertel, Peter; Schmidt, Simon Nitschky; Ettrup, Anders; Eramo, Anna; Hansen, Karina; Naber, Dieter			Relationship between response to aripiprazole once-monthly and paliperidone palmitate on work readiness and functioning in schizophrenia: A post-hoc analysis of the QUALIFY study	PLOS ONE			English	Article							LIFE SCALE	Schizophrenia is a chronic disease with negative impact on patients' employment status and quality of life. This post-hoc analysis uses data from the QUALIFY study to elucidate the relationship between work readiness and health-related quality of life and functioning. QUALIFY was a 28-week, randomized study (NCT01795547) comparing the treatment effectiveness of aripiprazole once-monthly 400 mg and paliperidone palmitate once-monthly using the Heinrichs-Carpenter Quality-of-Life Scale as the primary endpoint. Also, patients' capacity to work and work readiness (Yes/No) was assessed with the Work Readiness Questionnaire. We categorized patients, irrespective of treatment, by work readiness at baseline and week 28: No to Yes (n = 41), Yes to Yes (n = 49), or No at week 28 (n = 118). Quality-of-Life Scale total, domains, and item scores were assessed with a mixed model of repeated measures. Patients who shifted from No to Yes in work readiness showed robust improvements on Quality-of-Life Scale total scores, significantly greater than patients not ready to work at week 28 (least squares mean difference: 11.6+/-2.6, p<0.0001). Scores on Quality-of-Life Scale instrumental role domain and items therein-occupational role, work functioning, work levels, work satisfaction-significantly improved in patients shifting from No to Yes in work readiness (vs patients No at Week 28). Quality-of-Life Scale total scores also significantly predicted work readiness at week 28. Overall, these results highlight a strong association between improvements in health-related quality of life and work readiness, and suggest that increasing patients' capacity to work is an achievable and meaningful goal in the treatment of impaired functioning in schizophrenia.	[Potkin, Steven G.] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Loze, Jean-Yves] Otsuka Pharmaceut Europe Ltd, Wexham, England; [Forray, Carlos] Lundbeck LLC, Paramus, NJ USA; [Baker, Ross A.; Peters-Strickland, Timothy] Otsuka Pharmaceut Dev & Commercializat Inc, Princeton, NJ USA; [Sapin, Christophe; Beillat, Maud; Hansen, Karina] Lundbeck SAS, Issy Les Moulineaux, France; [Nylander, Anna-Greta; Hertel, Peter; Schmidt, Simon Nitschky; Ettrup, Anders] H Lundbeck & Co AS, Valby, Denmark; [Eramo, Anna] Lundbeck LLC, Deerfield, IL USA; [Naber, Dieter] Univ Med Ctr Hamburg Eppendorf, Dept Psychiat & Psychotherapy, Hamburg, Germany	University of California System; University of California Irvine; Otsuka Pharmaceutical; Lundbeck Corporation; Lundbeck Corporation - France; Lundbeck Corporation; University of Hamburg; University Medical Center Hamburg-Eppendorf	Potkin, SG (corresponding author), Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA.	sgpotkin@uci.edu		Ettrup, Anders/0000-0002-8926-3012	H. Lundbeck A/S; Otsuka Pharmaceutical Development & Commercialization, Inc.	H. Lundbeck A/S; Otsuka Pharmaceutical Development & Commercialization, Inc.(Otsuka Pharmaceutical)	This work was supported by H. Lundbeck A/S and Otsuka Pharmaceutical Development & Commercialization, Inc. Authors Forray C, Sapin C, Beillat M, Nylander AG, Hertel P, Schmidt SN, Ettrup A, Eramo A, and Hansen K are employed by H. Lundbeck A/S; authors Baker RA and Peters Strickland T are employed by Otsuka Pharmaceutical Development & Commercialization, Inc.; and author Loze JY is employed by Otsuka Pharmaceutical Europe Ltd. The specific roles of these authors are articulated in the 'author contributions' section. The funders provided support in the form of salaries for these authors, and were involved in the study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Bilker WB, 2003, NEUROPSYCHOPHARMACOL, V28, P773, DOI 10.1038/sj.npp.1300093; Emsley R, 2013, SCHIZOPHR RES, V148, P117, DOI 10.1016/j.schres.2013.05.016; Falissard B, 2016, INT J METH PSYCH RES, V25, P101, DOI 10.1002/mpr.1483; Fiszdon JM, 2008, SCHIZOPHR RES, V105, P105, DOI 10.1016/j.schres.2008.06.010; Guy W., 1976, CDEU ASSESSMENT MANU; Hasan A, 2013, WORLD J BIOL PSYCHIA, V14, P2, DOI 10.3109/15622975.2012.739708; HEINRICHS DW, 1984, SCHIZOPHRENIA BULL, V10, P388, DOI 10.1093/schbul/10.3.388; Karagianis J, 2009, INT J CLIN PRACT, V63, P1578, DOI 10.1111/j.1742-1241.2009.02191.x; Karow A, 2014, DIALOGUES CLIN NEURO, V16, P185; Kuhnigk O, 2012, J PSYCHIATR PRACT, V18, P321, DOI 10.1097/01.pra.0000419816.75752.65; LEIDY NK, 1994, NURS RES, V43, P196; Leucht S, 2006, NEUROPSYCHOPHARMACOL, V31, P2318, DOI 10.1038/sj.npp.1301147; Lewis SW, 2006, SCHIZOPHRENIA BULL, V32, P715, DOI 10.1093/schbul/sbj067; Naber D, 2015, SCHIZOPHR RES, V168, P498, DOI 10.1016/j.schres.2015.07.007; Potkin SG, 2016, INT J NEURO IN PRESS; Potkin SG, 2016, CNS SPECTRUMS, V21, P199, DOI 10.1017/S1092852914000352; Thornicroft G, 2004, SCHIZOPHR RES, V69, P125, DOI 10.1016/S0920-9964(03)00191-9	17	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183475	10.1371/journal.pone.0183475	http://dx.doi.org/10.1371/journal.pone.0183475			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837593	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000070
J	Yang, T; Kersigo, J; Wu, S; Fritzsch, B; Bassuk, AG				Yang, Tian; Kersigo, Jennifer; Wu, Shu; Fritzsch, Bernd; Bassuk, Alexander G.			Prickle1 regulates neurite outgrowth of apical spiral ganglion neurons but not hair cell polarity in the murine cochlea	PLOS ONE			English	Article							NEURAL-TUBE DEFECTS; LIM DOMAIN PROTEIN; PLANAR POLARITY; INNER-EAR; GENE-EXPRESSION; MOUSE PRICKLE1; PCP PATHWAY; MICE; VANGL2; IDENTIFICATION	In the mammalian organ of Corti (OC), the stereocilia on the apical surface of hair cells (HCs) are uniformly organized in a neural to abneural axis (or medial-laterally). This organization is regulated by planar cell polarity (PCP) signaling. Mutations of PCP genes, such as Vangl2, Dvl1/2, Celsr1, and Fzd3/6, affect the formation of HC orientation to varying degrees. Prickle1 is a PCP signaling gene that belongs to the prickle / espinas / testin family. Prickle1 protein is shown to be asymmetrically localized in the HCs of the OC, and this asymmetric localization is associated with loss of PCP in Smurf mutants, implying that Prickle1 is involved in HC PCP development in the OC. A follow-up study found no PCP polarity defects after loss of Prickle1 (Prickle1(-/-)) in the cochlea. We show here strong Prickle1 mRNA expression in the spiral ganglion by in situ hybridization and beta-Gal staining, and weak expression in the OC by beta-Gal staining. Consistent with this limited expression in the OC, cochlear HC PCP is unaffected in either Prickle1(C251X/C251X) mice or Prickle1(f/f); Pax2-cre conditional null mice. Meanwhile, type II afferents of apical spiral ganglion neurons (SGN) innervating outer hair cells (OHC) have unusual neurite growth. In addition, afferents from the apex show unusual collaterals in the cochlear nuclei that overlap with basal turn afferents. Our findings argue against the role of Prickle1 in regulating hair cell polarity in the cochlea. Instead, Prickle1 regulates the polarity-related growth of distal and central processes of apical SGNs.	[Yang, Tian; Kersigo, Jennifer; Fritzsch, Bernd] Univ Iowa, Dept Biol, Iowa City, IA 52242 USA; [Wu, Shu; Bassuk, Alexander G.] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Yang, T; Fritzsch, B (corresponding author), Univ Iowa, Dept Biol, Iowa City, IA 52242 USA.; Bassuk, AG (corresponding author), Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA.	tian-yang@uiowa.edu; bernd-fritzsch@uiowa.edu; alexander-bassuk@uiowa.edu		Bassuk, Alexander/0000-0002-4067-2157; Fritzsch, Bernd/0000-0002-4882-8398	NIH [R01 DC005590, P30 DC 010362, NS064159-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the NIH: R01 DC005590 and P30 DC 010362 to BF, NS064159-01A1 to AGB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Appler JM, 2013, J NEUROSCI, V33, P3679, DOI 10.1523/JNEUROSCI.4703-12.2013; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Bekman E, 2002, MECH DEVELOP, V119, pS77, DOI 10.1016/S0925-4773(03)00095-9; Cai TT, 2015, J NEUROSCI, V35, P5870, DOI 10.1523/JNEUROSCI.5083-14.2015; Copley CO, 2013, J NEUROSCI, V33, P14001, DOI 10.1523/JNEUROSCI.1307-13.2013; Curtin JA, 2003, CURR BIOL, V13, P1129, DOI 10.1016/S0960-9822(03)00374-9; Dabdoub A., 2016, PRIMARY AUDITORY NEU; Duncan JS, 2017, DEV BIOL, V423, P126, DOI 10.1016/j.ydbio.2017.01.020; Duncan JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062046; Elkon R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9549; Elliott KL, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00025; Etheridge SL, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000259; Fantetti KN, 2011, HEARING RES, V278, P86, DOI 10.1016/j.heares.2011.04.005; Feng J, 2016, CEREB CORTEX, V26, P3323, DOI 10.1093/cercor/bhw132; Fritzsch B, 2015, CELL TISSUE RES, P368; Fritzsch B, 2016, METHODS MOL BIOL, V1427, P243, DOI 10.1007/978-1-4939-3615-1_14; Fritzsch B, 2016, SPRINGER HANDB AUDIT, V52, P49, DOI 10.1007/978-1-4939-3031-9_3; Fritzsch B, 2013, EVOL DEV, V15, P63, DOI 10.1111/ede.12015; Fritzsch B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009377; Giese AP, 2012, DEVELOPMENT, V139, P3775, DOI 10.1242/dev.074229; Goodrich LV, 2016, SPRINGER HANDB AUDIT, V52, P11, DOI 10.1007/978-1-4939-3031-9_2; Hudspeth AJ, 2014, NAT REV NEUROSCI, V15, P600, DOI 10.1038/nrn3786; Jahan I, 2015, BIOESSAYS, V37, P1016, DOI 10.1002/bies.201500044; Jahan I, 2015, DEVELOPMENT, V142, P2810, DOI 10.1242/dev.123091; Jones C, 2008, NAT GENET, V40, P69, DOI 10.1038/ng.2007.54; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Katoh M, 2003, INT J MOL MED, V11, P249; Koundakjian EJ, 2007, J NEUROSCI, V27, P14078, DOI 10.1523/JNEUROSCI.3765-07.2007; Liu CQ, 2014, BIOL OPEN, V3, P861, DOI 10.1242/bio.20148375; Liu CQ, 2013, HUM MOL GENET, V22, P2234, DOI 10.1093/hmg/ddt075; Liu HZ, 2014, J NEUROSCI, V34, P11085, DOI 10.1523/JNEUROSCI.1690-14.2014; Lu CC, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004823; Lu XW, 2016, WIRES DEV BIOL, V5, P85, DOI 10.1002/wdev.202; Mao YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094580; Mapp OM, 2011, DEVELOPMENT, V138, P2121, DOI 10.1242/dev.060442; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Muniak MA, 2016, SPRINGER HANDB AUDIT, V52, P157, DOI 10.1007/978-1-4939-3031-9_6; Muniak MA, 2013, J COMP NEUROL, V521, P1510, DOI 10.1002/cne.23238; Narimatsu M, 2009, CELL, V137, P295, DOI 10.1016/j.cell.2009.02.025; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Okpodu S, 2012, INVEST OPHTHALMOL, V53, P3961; Okuda H, 2007, FEBS LETT, V581, P4754, DOI 10.1016/j.febslet.2007.08.075; Paemka L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080737; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ren DD, 2013, DEV DYNAMICS; Rudnicki A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-484; Scheffer DI, 2015, J NEUROSCI, V35, P6366, DOI 10.1523/JNEUROSCI.5126-14.2015; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Shimojo M, 2006, J NEUROCHEM, V96, P1130, DOI 10.1111/j.1471-4159.2005.03608.x; Shimojo M, 2003, MOL CELL BIOL, V23, P9025, DOI 10.1128/MCB.23.24.9025-9031.2003; Sienknecht UJ, 2008, J COMP NEUROL, V510, P378, DOI 10.1002/cne.21791; Tao H, 2011, AM J HUM GENET, V88, P138, DOI 10.1016/j.ajhg.2010.12.012; Tao H, 2009, P NATL ACAD SCI USA, V106, P14426, DOI 10.1073/pnas.0901332106; Tarchini B, 2016, DEVELOPMENT, V143, P3926, DOI 10.1242/dev.139089; Teufel A, 2005, INT J MOL MED, V15, P513; Tonniges J, 2010, J MICROSC-OXFORD, V239, P117, DOI 10.1111/j.1365-2818.2009.03363.x; Torban E, 2004, J BIOL CHEM, V279, P52703, DOI 10.1074/jbc.M408675200; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Wang JB, 2006, DEVELOPMENT, V133, P1767, DOI 10.1242/dev.02347; Wang JB, 2005, NAT GENET, V37, P980, DOI 10.1038/ng1622; Wang W, 2016, NATURE COMMUNICATION, V7; Wang YH, 2006, J NEUROSCI, V26, P2147, DOI 10.1523/JNEUROSCI.4698-05.2005; Yang T, 2013, MOL GENETICS GENOMIC; Yang T, 2014, CELL TISSUE RES, V357, P549, DOI 10.1007/s00441-014-1925-6; Yang T, 2013, DEV DYNAM, V242, P1293, DOI 10.1002/dvdy.24025; Yin HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031988; Zheng Q, 2007, BIOL CELL, V99, P489, DOI 10.1042/BC20060126; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	70	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183773	10.1371/journal.pone.0183773	http://dx.doi.org/10.1371/journal.pone.0183773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837644	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000119
J	Christiansen, H; Brandt, S; Walter, V; Wabitsch, M; Rothenbacher, D; Brenner, H; Schimmelmann, BG; Hirsch, O				Christiansen, Hanna; Brandt, Stephanie; Walter, Viola; Wabitsch, Martin; Rothenbacher, Dietrich; Brenner, Hermann; Schimmelmann, Benno G.; Hirsch, Oliver			Prediction of BMI at age 11 in a longitudinal sample of the Ulm Birth Cohort Study	PLOS ONE			English	Article							RESTRAINED EATING BEHAVIOR; BODY-MASS INDEX; CHILDHOOD OBESITY; OVERWEIGHT; CHILDREN; WEIGHT; RISK; PREADOLESCENCE; ADOLESCENCE; PREVALENCE	Obesity is one of the greatest public health challenges in the world with childhood prevalence rates between 20-26% and numerous associated health risks. The aim of the current study was to analyze the 11-year follow-up data of the Ulm Birth Cohort Study (UBCS), to identify whether abnormal eating behavior patterns, especially restrained eating, predict body mass index (BMI) at 11 years of age and to explore other factors known to be longitudinally associated with it. Of the original UBCS, n = 422 children (similar to 40% of the original sample) and their parents participated in the 11-year follow-up. BMI at age 8 and 11 as well as information on restrained eating, psychological problems, depressive symptoms, lifestyle, and IQ at age 8 were assessed. Partial Least Squares Structural Equation Modeling (PLS-SEM) was used to predict children's BMI scores at age 11. PLS-SEM explained 68% of the variance of BMI at age 11, with BMI at age 8 being the most important predictor. Restrained eating, via BMI at age 8 as well as parental BMI, had further weak associations with BMI at age 11; no other predictor was statistically significant. Since established overweight at age 8 already predicts BMI scores at age 11 longitudinally, obesity interventions should be implemented in early childhood.	[Christiansen, Hanna] Philipps Univ, Dept Clin Child & Adolescent Psychol & Psychother, Marburg, Germany; [Brandt, Stephanie; Wabitsch, Martin] Univ Med Ctr Ulm, Div Pediat Endocrinol & Diabet, Dept Pediat & Adolescent Med, Ulm, Germany; [Walter, Viola; Brenner, Hermann] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Rothenbacher, Dietrich] Ulm Univ, Inst Epidemiol & Med Biometry, Ulm, Germany; [Schimmelmann, Benno G.] Univ Bern, Univ Hosp Child & Adolescent Psychiat, Bern, Switzerland; [Schimmelmann, Benno G.] Univ Hosp Hamburg Eppendorf, Dept Child & Adolescent Psychiat, Hamburg, Germany; [Hirsch, Oliver] FOM Univ Appl Sci, Siegen, Germany	Philipps University Marburg; Ulm University; Helmholtz Association; German Cancer Research Center (DKFZ); Ulm University; University of Bern; University Hospital of Bern; University of Hamburg; University Medical Center Hamburg-Eppendorf	Hirsch, O (corresponding author), FOM Univ Appl Sci, Siegen, Germany.	christih@staff.uni-marburg.de; oliver.hirsch@fom-net.de	Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Hirsch, Oliver/H-2876-2019	Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Walter, Viola/0000-0001-6780-8846; Rothenbacher, Dietrich/0000-0002-3563-2791; Hirsch, Oliver/0000-0003-4496-2554	German Research Foundation [BR 1704/3-1, BR 1704/3-2, BR 1704/3-3]; Kompetenznetz Adipositas - Federal Ministry of Education and Research [FKZ 01GI0840]	German Research Foundation(German Research Foundation (DFG)); Kompetenznetz Adipositas - Federal Ministry of Education and Research	This work was supported by grants of the German Research Foundation (BR 1704/3-1, BR 1704/3-2, BR 1704/3-3) and of the Kompetenznetz Adipositas (Competence Network Obesity) funded by the Federal Ministry of Education and Research (FKZ 01GI0840). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach TM, 1991, INTEGRATIVE GUIDE FO; Allen G., 2011, EARLY INTERVENTION N; American Psychiatric Association, 2013, DSM 5 DIAGN CLASS DI, V5th, DOI [DOI 10.1176/APPI.BOOKS.9780890425596.X00DIAGNOSTICCLASSIFICATION, DOI 10.1176/APPI.BOOKS.9780890425596.DSM05]; Braet C, 1997, BEHAV RES THER, V35, P863, DOI 10.1016/S0005-7967(97)00045-4; Braet C, 2008, J HEALTH PSYCHOL, V13, P733, DOI 10.1177/1359105308093850; Brandt S, 2015, ATHEROSCLEROSIS, V240, P174, DOI 10.1016/j.atherosclerosis.2015.02.045; BROPHY S, 2009, BMC PUBLIC HEALTH, V9; Carnell S, 2013, PHYSIOL BEHAV, V121, P79, DOI 10.1016/j.physbeh.2013.02.015; Cohen J.E., 1988, STAT POWER ANAL BEHA; Court, 2001, COLOURED PROGR MATRI; DOPFNER M, 1994, Z KINDER JUG-PSYCH, V22, P189; Doyle AC, 2007, OBESITY, V15, P145, DOI 10.1038/oby.2007.515; Dubois L, 2006, INT J OBESITY, V30, P610, DOI 10.1038/sj.ijo.0803141; Field AE, 2003, PEDIATRICS, V112, P900, DOI 10.1542/peds.112.4.900; Flores G, 2013, INT J OBESITY, V37, P31, DOI 10.1038/ijo.2012.168; Forrester-Knauss C, 2012, APPETITE, V59, P921, DOI 10.1016/j.appet.2012.08.026; Funk MB, 2015, BUNDESGESUNDHEITSBLA, V58, P1110, DOI 10.1007/s00103-015-2220-8; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Grohskopf L, 2011, AM J TRANSPLANT, V11, P2250, DOI 10.1111/j.1600-6143.2011.03793.x; Hair J. F., 2014, PRIMER PARTIAL LEAST, DOI DOI 10.1177/1077558702059003004; Hair JF, 2011, J MARKET THEORY PRAC, V19, P139, DOI 10.2753/MTP1069-6679190202; Hankey M, 2017, J PEDIAT PSYCHOL; Hirsch O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105303; Hoffmann SW, 2012, OBESITY, V20, P2151, DOI 10.1038/oby.2012.172; Incledon E, 2011, INT J PEDIATR OBES, V6, pE1, DOI 10.3109/17477166.2010.549491; Keane E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043503; Knussmann R., 1996, VERGLEICHENDE BIOL M; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Long JM, 2012, J SPEC PEDIATR NURS, V17, P41, DOI 10.1111/j.1744-6155.2011.00309.x; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Munkholm A, 2016, J ADOLESCENT HEALTH, V58, P533, DOI 10.1016/j.jadohealth.2016.01.006; Munkholm A, 2016, APPETITE, V101, P46, DOI 10.1016/j.appet.2016.02.020; Neimeijer RAM, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00525; Nunally J. C., 1994, PSYCHOMETRIC THEORY; Olstad DL, 2009, APPL PHYSIOL NUTR ME, V34, P551, DOI 10.1139/H09-016; Power C, 2000, P NUTR SOC, V59, P267, DOI 10.1017/S002966510000029X; Rifas-Shiman SL, 2012, OBESITY, V20, P1261, DOI 10.1038/oby.2011.350; Rooney BL, 2011, MATERN CHILD HLTH J, V15, P1166, DOI 10.1007/s10995-010-0689-1; Sarstedt M, 2010, J APPL STAT, V37, P1299, DOI 10.1080/02664760903030213; Schacht M, 2006, J CLIN PSYCHOL, V62, P1259, DOI 10.1002/jclp.20300; Skinner AC, 2013, PUBLIC HEALTH REP, V128, P46, DOI 10.1177/003335491312800107; Snoek HM, 2007, SCAND J PSYCHOL, V48, P23, DOI 10.1111/j.1467-9450.2006.00568.x; Snoek HM, 2013, APPETITE, V67, P81, DOI 10.1016/j.appet.2013.03.014; Stiensmeier-Pelster JB-KM., 2014, DEPRESSIONSINVENTAR; van Strien T, 2008, INT J EAT DISORDER, V41, P72, DOI 10.1002/eat.20424; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Weyermann M, 2009, AM J GASTROENTEROL, V104, P182, DOI 10.1038/ajg.2008.61; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301; Wijnhoven TMA, 2013, PEDIATR OBES, V8, P79, DOI 10.1111/j.2047-6310.2012.00090.x	49	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182338	10.1371/journal.pone.0182338	http://dx.doi.org/10.1371/journal.pone.0182338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832593	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800021
J	Jadot, I; Colombaro, V; Martin, B; Habsch, I; Botton, O; Nortier, J; Decleves, AE; Caron, N				Jadot, Ines; Colombaro, Vanessa; Martin, Blanche; Habsch, Isabelle; Botton, Olivia; Nortier, Joelle; Decleves, Anne-Emilie; Caron, Nathalie			Restored nitric oxide bioavailability reduces the severity of acute-to-chronic transition in a mouse model of aristolochic acid nephropathy	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; L-ARGININE SUPPLEMENTATION; INTERSTITIAL FIBROSIS; RENAL-FAILURE; CYCLOSPORINE; INFLAMMATION; PROGRESSION; MECHANISM; DISEASE; NEPHROTOXICITY	Aristolochic Acid (AA) nephropathy (AAN) is a progressive tubulointerstitial nephritis characterized by an early phase of acute kidney injury (AKI) leading to chronic kidney disease (CKD). The reduced nitric oxide (NO) bioavailability reported in AAN might contribute to renal function impairment and progression of the disease. We previously demonstrated that L-arginine (L-Arg) supplementation is protective in AA-induced AKI. Since the severity of AKI may be considered a strong predictor of progression to CKD, the present study aims to assess the potential benefit of L-Arg supplementation during the transition from the acute phase to the chronic phase of AAN. C57BL/6J male mice were randomly subjected to daily i.p. injections of vehicle or AA for 4 days. To determine whether renal AA-induced injuries were linked to reduced NO production, L-Arg was added to drinking water from 7 days before starting i.p. injections, until the end of the protocol. Mice were euthanized 5, 10 and 20 days after vehicle or AA administration. AA-treated mice displayed marked renal injury and reduced NO bioavailability, while histopathological features of AAN were reproduced, including interstitial cell infiltration and tubulointerstitial fibrosis. L-Arg treatment restored renal NO bioavailability and reduced the severity of AA-induced injury, inflammation and fibrosis. We concluded that reduced renal NO bioavailability contributes to the processes underlying AAN. Furthermore, L-Arg shows nephroprotective effects by decreasing the severity of acute-to-chronic transition in experimental AAN and might represent a potential therapeutic tool in the future.	[Jadot, Ines; Colombaro, Vanessa; Martin, Blanche; Habsch, Isabelle; Botton, Olivia; Caron, Nathalie] Univ Namur UNamur, NARILIS Namur Res Inst Life Sci, Mol Physiol Res Unit URPhyM, Namur, Belgium; [Nortier, Joelle] ULB, Nephrol Dept, Erasme Acad Hosp, Brussels, Belgium; [Nortier, Joelle] ULB, Lab Expt Nephrol, Fac Med, Brussels, Belgium; [Decleves, Anne-Emilie] Univ Mons UMONS, Res Inst Hlth Sci & Technol, Fac Med & Pharm, Lab Mol Biol, Mons, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Mons	Jadot, I (corresponding author), Univ Namur UNamur, NARILIS Namur Res Inst Life Sci, Mol Physiol Res Unit URPhyM, Namur, Belgium.	ines.jadot@unamur.be		Nortier, Joelle/0000-0003-3609-8217				Alfieri C, 2015, NEPHROL DIAL TRANSPL, P1; Amirshahrokhi K, 2015, INFLAMMATION, V38, P476, DOI 10.1007/s10753-014-9953-7; Basile DP, 2007, KIDNEY INT, V72, P151, DOI 10.1038/sj.ki.5002312; Baudoux TER, 2012, KIDNEY INT, V82, P1105, DOI 10.1038/ki.2012.264; Baylis C, 2008, AM J PHYSIOL-RENAL, V294, pF1, DOI 10.1152/ajprenal.00424.2007; Can C, 2000, EUR J PHARMACOL, V390, P327, DOI 10.1016/S0014-2999(00)00025-X; Cao Q, 2015, PHYSIOLOGY, V30, P183, DOI 10.1152/physiol.00046.2014; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Debelle FD, 2002, J AM SOC NEPHROL, V13, P431, DOI 10.1681/ASN.V132431; Debelle FD, 2008, KIDNEY INT, V74, P158, DOI 10.1038/ki.2008.129; Decleves AE, 2006, INT J MOL MED, V18, P83; Decleves AE, 2016, EXP PHYSIOL, V101, P193, DOI 10.1113/EP085333; DEPIERREUX M, 1994, AM J KIDNEY DIS, V24, P172, DOI 10.1016/S0272-6386(12)80178-8; Ferenbach D.A., 2015, MECH MALADAPTISMS MA, V11, P264, DOI DOI 10.1038/NRNEPH.2015.3; Ferenbach DA, 2016, CURR OPIN NEPHROL HY, V25, P194, DOI 10.1097/MNH.0000000000000218; Gewin L, 2016, EXP PHYSIOL, V101, P33, DOI 10.1113/EP085545; Gokmen MR, 2013, ANN INTERN MED; Guerrot D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S15; Heung M, 2012, CURR OPIN NEPHROL HY, V21, P628, DOI 10.1097/MNH.0b013e3283588f24; Huang TC, 2014, LIFE SCI, V114, P4, DOI 10.1016/j.lfs.2014.07.034; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2002, IARC Monogr Eval Carcinog Risks Hum, V82, P1; Jadot I, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020297; Klahr S, 2004, SEMIN NEPHROL, V24, P389, DOI 10.1016/j.semnephrol.2004.04.010; Kurus M, 2005, INT UROL NEPHROL, V37, P587, DOI 10.1007/s11255-004-0011-5; Lebeau C, 2005, NEPHROL DIAL TRANSPL, V20, P2321, DOI 10.1093/ndt/gfi042; Li X, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/582902; Li YC, 2012, BIOCHEM BIOPH RES CO, V423, P832, DOI 10.1016/j.bbrc.2012.06.049; Mansour M, 2002, PHARMACOL RES, V45, P441, DOI 10.1006/phrs.2002.0968; Mihout F, 2011, J PATHOL, V223, P37, DOI 10.1002/path.2769; Mount PF, 2006, ACTA PHYSIOL, V187, P433, DOI 10.1111/j.1748-1716.2006.01582.x; Nortier JL, 2000, NEW ENGL J MED, V342, P1686, DOI 10.1056/NEJM200006083422301; Peters H, 2000, KIDNEY INT, V57, P992, DOI 10.1046/j.1523-1755.2000.00927.x; Pozdzik AA, 2008, KIDNEY INT, V73, P595, DOI 10.1038/sj.ki.5002714; Pozdzik AA, 2008, NEPHROL DIAL TRANSPL, V23, P2480, DOI 10.1093/ndt/gfn140; Pozdzik AA, 2010, HISTOPATHOLOGY, V56, P449, DOI 10.1111/j.1365-2559.2010.03509.x; Qi XM, 2007, TOXICOL APPL PHARM, V222, P105, DOI 10.1016/j.taap.2007.03.029; REYES AA, 1994, KIDNEY INT, V45, P1346, DOI 10.1038/ki.1994.176; Saleh S, 2005, BASIC CLIN PHARMACOL, V97, P91, DOI 10.1111/j.1742-7843.2005.pto_114.x; Schneider R, 2003, KIDNEY INT, V64, P216, DOI 10.1046/j.1523-1755.2003.00063.x; Shihab FS, 2000, KIDNEY INT, V58, P1174, DOI 10.1046/j.1523-1755.2000.00273.x; Stiborova A M, 2016, ARCH TOXICOL; Sun D, 2006, AM J NEPHROL, V26, P363, DOI 10.1159/000094778; Sun D, 2012, LIFE SCI, V90, P900, DOI 10.1016/j.lfs.2012.04.018; VANHERWEGHEM JL, 1993, LANCET, V341, P387, DOI 10.1016/0140-6736(93)92984-2; Venkatachalam MA, 2010, AM J PHYSIOL-RENAL, V298, pF1078, DOI 10.1152/ajprenal.00017.2010; Wen YJ, 2008, TRANSL RES, V152, P38, DOI 10.1016/j.trsl.2008.05.002; Yang L, 2007, NEPHROL DIAL TRANSPL, V22, P445, DOI 10.1093/ndt/gfl556; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009; Zuk A, 2016, ANNU REV MED, V67, P293, DOI 10.1146/annurev-med-050214-013407	49	13	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183604	10.1371/journal.pone.0183604	http://dx.doi.org/10.1371/journal.pone.0183604			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832640	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800069
J	Pellino, G; Simillis, C; Qiu, SY; Rasheed, S; Mills, S; Warren, O; Kontovounisios, C; Tekkis, PP				Pellino, Gianluca; Simillis, Constantinos; Qiu, Shengyang; Rasheed, Shahnawaz; Mills, Sarah; Warren, Oliver; Kontovounisios, Christos; Tekkis, Paris P.			Social media and colorectal cancer: A systematic review of available resources	PLOS ONE			English	Review							COMMUNITY; SURGERY	Aim Social media (SM) can provide information and medical knowledge to patients. Our aim was to review the literature and web-based content on SM that is used by Colorectal Cancer (CRC) patients, as well as surgeons' interaction with SM. Method Studies published between 2006 and 2016 were assessed. We also assessed the impact of several hashtags on Twitter with a freeware (Symplur). Results Nine studies were included assessing Twitter (78%), Forums/Cancer-survivor networks (33%), and Facebook (22%). Aims included use of SM by CRC patients (67%), cancer-specific usage of SM with different types of cancer (44%), content credibility (33%), and influence in CRC awareness (33%). Prevention was the most common information that CRC patients looked for, followed by treatment side-effects. Only 2% of CRC SM users are doctors. SM use by colorectal consultants was suboptimal. Only 38% of surgeons had a LinkedIn account (most with less than 50 connections), and 3% used Twitter. A steep increase of tweets was observed for searched Hashtags over time, which was more marked for #ColonCancer (+67% vs+38%, #Coloncancer vs #RectalCancer). Participants engaged with colon cancer increased by 85%, whereas rectal cancer ones increased by 29%. The hashtag '#RectalCancer' was mostly tweeted by colorectal surgeons. The official twitter account of American Society of Colorectal Surgeons (@ fascrs_updates) was the most active account. Conclusion CRC patients and relatives are increasingly engaging with SM. CRC surgeons' participation is poor, but we confirm a trend toward a greater involvement. Most SM lack of authoritative validation and the quality of shared content still is largely anecdotic and not scientifically evidenced-based. However, SM may offer several advantages over conventional information sharing sources for CRC patients and surgeons, and create connections with mutual enrichment.	[Pellino, Gianluca; Simillis, Constantinos; Qiu, Shengyang; Rasheed, Shahnawaz; Kontovounisios, Christos; Tekkis, Paris P.] Royal Marsden Hosp, Dept Colorectal Surg, London, England; [Rasheed, Shahnawaz; Mills, Sarah; Warren, Oliver; Kontovounisios, Christos; Tekkis, Paris P.] Chelsea & Westminster Hosp, Dept Colorectal Surg, London, England; [Rasheed, Shahnawaz; Kontovounisios, Christos; Tekkis, Paris P.] Imperial Coll, Dept Surg & Canc, London, England	Royal Marsden NHS Foundation Trust; Imperial College London; Imperial College London	Kontovounisios, C (corresponding author), Chelsea & Westminster Hosp, Dept Colorectal Surg, London, England.; Kontovounisios, C (corresponding author), Imperial Coll, Dept Surg & Canc, London, England.	c.kontovounisios@imperial.ac.uk	Similis, Constantinos/V-1581-2019; Kontovounisios, Christos/ABC-9225-2020; Mills, Sarah/AAT-4553-2021	Pellino, Gianluca/0000-0002-8322-6421; Simillis, Constantinos/0000-0001-8864-4350; KONTOVOUNISIOS, CHRISTOS/0000-0002-1828-1395; Warren, Oliver/0000-0001-8948-7473				AmericanMedicalAssociation A, 2016, PROF US SOC MED 2011; [Anonymous], 2012, MCKINSEY GLOB I; Arezzo A, 2016, COLORECTAL DIS, V18, P214, DOI 10.1111/codi.13260; Atallah S, 2016, TECH COLOPROCTOL, V20, P71, DOI 10.1007/s10151-015-1403-5; Awan A., 2016, LINKEDINS 400 MILLIO; Beusterien K, 2013, ECANCERMEDICALSCIENC, V7, DOI 10.3332/ecancer.2013.361; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Constine J., 2016, BILLION USERS CRUSHE; Crannell W Christian, 2016, J Surg Res, V206, P536, DOI 10.1016/j.jss.2016.06.050; Cutrona SL, 2013, JMIR RES PROTOC, V2, DOI 10.2196/resprot.2886; De la Torre-Diez I, 2012, TELEMED E-HEALTH, V18, P404, DOI 10.1089/tmj.2011.0227; Dreier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107575; Flight IH, 2012, JMIR RES PROTOC, V1, DOI 10.2196/resprot.2135; GeneralMedicalCouncil G, 2016, US SOC MED 2013; Hawkes AL, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-560; Informatics IIfH, 2016, PAT AD MHEALTH US EV; Italian Comm EuroSurg Collaborativ, 2016, TECH COLOPROCTOL, V20, P423, DOI 10.1007/s10151-016-1427-5; Kailas A, 2010, IEEE PULSE, V1, P57, DOI 10.1109/MPUL.2010.937244; Lee KC, 2016, ANN COLOPROCTOL, V32, P184, DOI 10.3393/ac.2016.32.5.184; Lee T.M, 2010, HEALTHCARE HASHTAGS; Logghe HJ, 2016, TECH COLOPROCTOL, V20, P805, DOI 10.1007/s10151-016-1542-3; McDonald JJ, 2015, COLORECTAL DIS, V17, P165, DOI 10.1111/codi.12780; McKendrick DRA, 2012, J MED INTERNET RES, V14, P197, DOI 10.2196/jmir.2144; McLuhan M., 1994, UNDERSTANDING MEDIA; O'Neill S, 2012, COLORECTAL DIS, V14, pe530, DOI 10.1111/j.1463-1318.2012.03088.x; Ogedegbe G, 2005, J NATL MED ASSOC, V97, P162; Oremus Will, 2016, WHO CONTROLS YOUR FA; PARK S, 2016, MEDICINE, V95, DOI DOI 10.1097/MD; Pellino G, 2017, TECH COLOPROCTOL, V21, P251, DOI 10.1007/s10151-017-1601-4; Portier Kenneth, 2013, Journal of the National Cancer Institute Monographs, P195, DOI 10.1093/jncimonographs/lgt025; Project PRGA, 2012, PROJECT PRGA SOCIAL; Smith SA, 2015, JACOBS J FOOD NUTR, V2; TNEJo Medicine, 2016, ABOUT NEJM; Tsuya A, 2014, J MED INTERNET RES, V16, P110, DOI 10.2196/jmir.3298; Vohra RS, 2015, JAMA SURG, V150, P192, DOI 10.1001/jamasurg.2014.1324; Wexner SD, 2017, COLORECTAL DIS, V19, P105, DOI 10.1111/codi.13572; Wong RK, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-677; Xu Songhua, 2016, JMIR Public Health Surveill, V2, pe17, DOI 10.2196/publichealth.5205	38	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183031	10.1371/journal.pone.0183031	http://dx.doi.org/10.1371/journal.pone.0183031			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832603	gold, Green Submitted, Green Published			2022-12-27	WOS:000408355800044
J	Balmer, P; Bauer, A; Pujar, S; McGarvey, KM; Welle, M; Galichet, A; Muller, EJ; Pruitt, KD; Leeb, T; Jagannathan, V				Balmer, Pierre; Bauer, Anina; Pujar, Shashikant; McGarvey, Kelly M.; Welle, Monika; Galichet, Arnaud; Mueller, Eliane J.; Pruitt, Kim D.; Leeb, Tosso; Jagannathan, Vidhya			A curated catalog of canine and equine keratin genes	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; DIFFERENTIATION; SEQUENCE	Keratins represent a large protein family with essential structural and functional roles in epithelial cells of skin, hair follicles, and other organs. During evolution the genes encoding keratins have undergone multiple rounds of duplication and humans have two clusters with a total of 55 functional keratin genes in their genomes. Due to the high similarity between different keratin paralogs and species-specific differences in gene content, the currently available keratin gene annotation in species with draft genome assemblies such as dog and horse is still imperfect. We compared the National Center for Biotechnology Information (NCBI) (dog annotation release 103, horse annotation release 101) and Ensembl (release 87) gene predictions for the canine and equine keratin gene clusters to RNA-seq data that were generated from adult skin of five dogs and two horses and from adult hair follicle tissue of one dog. Taking into consideration the knowledge on the conserved exon/intron structure of keratin genes, we annotated 61 putatively functional keratin genes in both the dog and horse, respectively. Subsequently, curators in the RefSeq group at NCBI reviewed their annotation of keratin genes in the dog and horse genomes (Annotation Release 104 and Annotation Release 102, respectively) and updated annotation and gene nomenclature of several keratin genes. The updates are now available in the NCBI Gene database (https://www.ncbi.nlm.nih.gov/gene).	[Balmer, Pierre] Univ Bern, Vetsuisse Fac, Div Clin Dermatol, Dept Clin Vet Med, Bern, Switzerland; [Balmer, Pierre; Bauer, Anina; Welle, Monika; Galichet, Arnaud; Mueller, Eliane J.; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland; [Bauer, Anina; Leeb, Tosso; Jagannathan, Vidhya] Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland; [Pujar, Shashikant; Pruitt, Kim D.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Welle, Monika; Mueller, Eliane J.] Univ Bern, Inst Anim Pathol, Vetsuisse Fac, Bern, Switzerland; [Galichet, Arnaud; Mueller, Eliane J.] Univ Bern, Dept Clin Res Mol Dermatol & Stem Cell Res, Bern, Switzerland; [Mueller, Eliane J.] Bern Univ Hosp, Inselspital, Dermatol Clin, Bern, Switzerland	University of Bern; University of Bern; University of Bern; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Bern; University of Bern; University of Bern; University Hospital of Bern	Jagannathan, V (corresponding author), Univ Bern, Vetsuisse Fac, Dermfocus, Bern, Switzerland.; Jagannathan, V (corresponding author), Univ Bern, Inst Genet, Vetsuisse Fac, Bern, Switzerland.	vidhya.jagannathan@vetsuisse.unibe.ch	Leeb, Tosso/G-3187-2014; Jagannathan, Vidhya/P-1055-2019; Welle, Monika Maria/ABF-6113-2021	Leeb, Tosso/0000-0003-0553-4880; Jagannathan, Vidhya/0000-0002-8155-0041; Pujar, Shashikant/0000-0001-7132-5513; Pruitt, Kim/0000-0001-7950-1374; Bauer, Anina/0000-0002-6765-4012	Swiss National Science Foundation [CRSI13_160738 / 1]; Intramural Research Program of the NIH, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Intramural Research Program of the NIH, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This study was funded by a grant from the Swiss National Science Foundation (CRSI13_160738 / 1). Work carried out by NCBI authors was funded by the Intramural Research Program of the NIH, National Library of Medicine.	Avci P, 2013, EXPERT OPIN DRUG DIS, V8, P331, DOI 10.1517/17460441.2013.761202; Bray DJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132706; Carter RA, 2010, J ANIM SCI, V88, P3843, DOI 10.2527/jas.2010-2964; Coleman SJ, 2010, ANIM GENET, V41, P121, DOI 10.1111/j.1365-2052.2010.02118.x; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; FUCHS E, 1980, CELL, V19, P1033, DOI 10.1016/0092-8674(80)90094-X; Gu LH, 2007, CURR OPIN CELL BIOL, V19, P13, DOI 10.1016/j.ceb.2006.12.007; Hesse M, 2004, EUR J CELL BIOL, V83, P19, DOI 10.1078/0171-9335-00354; Hoeppner MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091172; Homberg M, 2014, INT REV CEL MOL BIO, V311, P265, DOI 10.1016/B978-0-12-800179-0.00007-6; Hutton E, 1998, J CELL BIOL, V143, P487, DOI 10.1083/jcb.143.2.487; Knobel M, 2015, CELL TISSUE RES, V360, P583, DOI 10.1007/s00441-014-2105-4; KUGA T, 2016, SCI REP UK, V6; Lemke JR, 2014, DERMATOLOGY, V229, P55, DOI 10.1159/000362200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Loschke F, 2015, CURR OPIN CELL BIOL, V32, P56, DOI 10.1016/j.ceb.2014.12.006; Moll R, 2008, HISTOCHEM CELL BIOL, V129, P705, DOI 10.1007/s00418-008-0435-6; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oshima RG, 2007, EXP CELL RES, V313, P1981, DOI 10.1016/j.yexcr.2007.04.007; Pan XO, 2013, CURR OPIN CELL BIOL, V25, P47, DOI 10.1016/j.ceb.2012.10.018; Paramio JM, 1999, MOL CELL BIOL, V19, P3086; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; REIS A, 1994, NAT GENET, V6, P174, DOI 10.1038/ng0294-174; Schweizer J, 2007, EXP CELL RES, V313, P2010, DOI 10.1016/j.yexcr.2007.02.032; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Vaidya MM, 2007, J BIOSCIENCES, V32, P629, DOI 10.1007/s12038-007-0062-8; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; Wang FR, 2016, METHOD ENZYMOL, V568, P303, DOI 10.1016/bs.mie.2015.09.032	30	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0180359	10.1371/journal.pone.0180359	http://dx.doi.org/10.1371/journal.pone.0180359			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846680	Green Submitted, gold, Green Published			2022-12-27	WOS:000408438600003
J	Ganie, SA; Pani, DR; Mondal, TK				Ganie, Showkat Ahmad; Pani, Dipti Ranjan; Mondal, Tapan Kumar			Genome-wide analysis of DUF221 domaincontaining gene family in Oryza species and identification of its salinity stress-responsive members in rice	PLOS ONE			English	Article							SATIVA L.; EXPRESSION ANALYSIS; ABIOTIC STRESS; ABSCISIC-ACID; DEHYDRATION STRESS; ARABIDOPSIS; DROUGHT; SALT; DUPLICATION; MICRORNAS	DUF221 domain-containing genes (DDP genes) play important roles in developmental biology, hormone signalling transduction, and responses to abiotic stress. Therefore to understand their structural and evolutionary relationship, we did a genome-wide analysis of this important gene family in rice. Further, through comparative genomics, DDP genes from Oryza sativa subsp. (indica), nine different wild species of rice and Arabidopsis were also identified. We also found an expansion of the DDP gene families in rice and Arabidopsis which is due to the segmental duplication events in some of the gene family members. In general, a highly purifying selection was found acting on all the deduced paralogous and orthologous DDP gene pairs. The data from microarray and subsequent qRT-PCR analysis revealed that although several OsDDPs were differentially regulated under salinity stress, yet OsDDP6 was upregulated at all the developmental stages in salt tolerant rice genotype, FL478. Interestingly, OsDDP6 was found to be involved in proline metabolism pathway as indicated by protein network analysis. The diverse gene structures, varied transmembrane topologies and the differential expression patterns implied the functional diversity in DDP genes. Therefore, the comprehensive evolutionary analysis of DDP genes from different Oryza species and Arabidopsis performed in this study will provide the basis for further functional validation studies vis-a-vis DDP genes of rice and other plant species.	[Ganie, Showkat Ahmad; Mondal, Tapan Kumar] ICAR Natl Bur Plant Genet Resources, Div Genom Resources, Pusa Campus, New Delhi, India; [Pani, Dipti Ranjan] NBPGR Base Ctr, ICAR Natl Rice Res Inst Campus, Cuttack, Orissa, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources	Mondal, TK (corresponding author), ICAR Natl Bur Plant Genet Resources, Div Genom Resources, Pusa Campus, New Delhi, India.	mondaltk@rediffmail.com	Ganie, Showkat/M-1659-2019	Ganie, Showkat/0000-0002-8654-9840; MONDAL, TAPAN/0000-0001-6702-2990	Department of Biotechnology, Govt. of India, New Delhi	Department of Biotechnology, Govt. of India, New Delhi(Department of Biotechnology (DBT) India)	The authors are grateful to Dr K. V. Bhat, Head, Division of Genomic Resources and Director, NBPGR, New Delhi for providing the facility. SAG is grateful to Department of Biotechnology, Govt. of India, New Delhi for providing the fellowship.	Abe H, 2003, PLANT CELL, V15, P63, DOI 10.1105/tpc.006130; Aneja M, 1999, PLANT GROWTH REGUL, V27, P149, DOI 10.1023/A:1006153502897; Arora R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-242; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Blanc G, 2004, PLANT CELL, V16, P1667, DOI 10.1105/tpc.021345; Brunner JD, 2014, NATURE, V516, P207, DOI 10.1038/nature13984; Buchanan-Wollaston V, 2007, ANN BOT, V101, P197, DOI [DOI 10.1093/AOB/MCM286, 10.1093/aob/mcm286]; Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615; Chen F, 2006, DNA RES, V13, P53, DOI 10.1093/dnares/dsl001; Chen JF, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2596; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dai Xinbin, 2011, Nucleic Acids Res, V39, pW155, DOI 10.1093/nar/gkr319; Dat J, 2000, CELL MOL LIFE SCI, V57, P779, DOI 10.1007/s000180050041; DeFalco TA, 2010, BIOCHEM J, V425, P27, DOI 10.1042/BJ20091147; Deng PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137990; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fang YJ, 2008, MOL GENET GENOMICS, V280, P547, DOI 10.1007/s00438-008-0386-6; Fawcett JA, 2009, P NATL ACAD SCI USA, V106, P5737, DOI 10.1073/pnas.0900906106; Fernandez-Aguado M, 2013, APPL MICROBIOL BIOT, V97, P795, DOI 10.1007/s00253-012-4256-0; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Ganie SA, 2016, PHYSIOL MOL BIOL PLA, V22, P107, DOI 10.1007/s12298-016-0342-6; Ganie SA, 2016, FUNCT INTEGR GENOMIC, V16, P1, DOI 10.1007/s10142-015-0460-1; Ganie SA, 2015, MOL BREEDING, V35, DOI 10.1007/s11032-015-0207-7; Ganie SA, 2014, PLANT SYST EVOL, V300, P1741, DOI 10.1007/s00606-014-0999-7; Goodacre NF, 2014, MBIO, V5, DOI 10.1128/mBio.00744-13; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Gu ZM, 2008, GENE, V415, P1, DOI 10.1016/j.gene.2008.02.011; Gu ZL, 2002, TRENDS GENET, V18, P609, DOI 10.1016/S0168-9525(02)02837-8; Guo L, 2006, CELL RES, V16, P277, DOI 10.1038/sj.cr.7310035; Hauser R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002815; Hashimoto Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062589; Higo K, 1999, NUCLEIC ACIDS RES, V27, P297, DOI 10.1093/nar/27.1.297; Hou CC, 2014, CELL RES, V24, P632, DOI 10.1038/cr.2014.14; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Jain M, 2007, PLANT PHYSIOL, V143, P1467, DOI 10.1104/pp.106.091900; Jaiswal P, 2006, NUCLEIC ACIDS RES, V34, pD717, DOI 10.1093/nar/gkj154; Jami SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047801; Jamsheer KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134328; Jia L, 2004, PLANT PHYSIOL, V134, P575, DOI 10.1104/pp.103.027201; Katiyar A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-544; Kawahara Y, 2013, RICE, V6, DOI 10.1186/1939-8433-6-4; Kobayashi Y, 2004, PLANT CELL, V16, P1163, DOI 10.1105/tpc.019943; Kolkman JA, 2001, NAT BIOTECHNOL, V19, P423, DOI 10.1038/88084; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kumar G, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-107; Kushwaha HR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-200; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Lee TH, 2013, NUCLEIC ACIDS RES, V41, pD1152, DOI 10.1093/nar/gks1104; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Li YS, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0653-8; Lijavetzky D, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-17; Liu LP, 2013, MICROB PATHOGENESIS, V64, P6, DOI 10.1016/j.micpath.2013.06.001; Liu QP, 2012, FUNCT INTEGR GENOMIC, V12, P649, DOI 10.1007/s10142-012-0282-3; Liu SP, 2010, J PLANT BIOL, V53, P444, DOI 10.1007/s12374-010-9135-6; Luo YC, 2006, FEBS LETT, V580, P5111, DOI 10.1016/j.febslet.2006.08.046; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; McAinsh MR, 2009, NEW PHYTOL, V181, P275, DOI 10.1111/j.1469-8137.2008.02682.x; Molla KA, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0498-1; Mondal TK, 2014, PLANT MOL BIOL REP, V32, P605, DOI 10.1007/s11105-013-0664-2; Mondal TK, 2014, GENE, V535, P204, DOI 10.1016/j.gene.2013.11.033; Munne-Bosch S, 2004, FUNCT PLANT BIOL, V31, P203, DOI 10.1071/FP03236; Mustafiz A, 2011, FUNCT INTEGR GENOMIC, V11, P293, DOI 10.1007/s10142-010-0203-2; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Pani DR, 2013, J INDIAN SOC COASTAL, V31, p11 ; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Prince VE, 2002, NAT REV GENET, V3, P827, DOI 10.1038/nrg928; Rai A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032658; Rajendran K, 2009, PLANT CELL ENVIRON, V32, P237, DOI 10.1111/j.1365-3040.2008.01916.x; Ramamoorthy R, 2008, PLANT CELL PHYSIOL, V49, P865, DOI 10.1093/pcp/pcn061; Ray S, 2007, MOL GENET GENOMICS, V278, P493, DOI 10.1007/s00438-007-0267-4; Reddy ASN, 2013, PLANT CELL, V25, P3657, DOI 10.1105/tpc.113.117523; Reddy ASN, 2011, PLANT CELL, V23, P2010, DOI 10.1105/tpc.111.084988; Rengasamy P, 2010, FUNCT PLANT BIOL, V37, P613, DOI 10.1071/FP09249; Rohila JS, 2007, J INTEGR PLANT BIOL, V49, P751, DOI 10.1111/j.1744-7909.2007.00501.x; Ruan SL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-34; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shaik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049331; Sharma M, 2014, DNA RES, V21, P267, DOI 10.1093/dnares/dst056; Sharoni AM, 2012, MOL GENET GENOMICS, V287, P1, DOI 10.1007/s00438-011-0659-3; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; Simpson SD, 2003, PLANT J, V33, P259, DOI 10.1046/j.1365-313X.2003.01624.x; Singh AK, 2015, RICE, V8, DOI 10.1186/s12284-015-0054-5; Soni P, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24738; SUNKAR R, 2008, BMC PLANT BIOL, V8; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Szarzynska B, 2009, NUCLEIC ACIDS RES, V37, P3083, DOI 10.1093/nar/gkp189; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tripathi AK, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0414-8; Trivellini A, 2011, J EXP BOT, V62, P5437, DOI 10.1093/jxb/err218; URAO T, 1993, PLANT CELL, V5, P1529, DOI 10.1105/tpc.5.11.1529; Vij S, 2006, MOL GENET GENOMICS, V276, P565, DOI 10.1007/s00438-006-0165-1; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wagner A, 2002, GENOME BIOL, V3; Wang XY, 2005, NEW PHYTOL, V165, P937, DOI 10.1111/j.1469-8137.2004.01293.x; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; Wu S, 2010, ONCOGENE, V29, P2302, DOI 10.1038/onc.2010.34; Xing Wang, 2013, Australian Journal of Crop Science, V7, P289; Ye HY, 2009, PLANT MOL BIOL, V71, P291, DOI 10.1007/s11103-009-9524-8; YI QM, 1995, HEREDITAS, V122, P135, DOI 10.1111/j.1601-5223.1995.00135.x; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Yuan F, 2014, NATURE, V514, P367, DOI 10.1038/nature13593; Yue R, 2015, PLOS ONE, V10, DOI DOI 10.1371/JOURNAL.PONE.0118751	109	23	28	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182469	10.1371/journal.pone.0182469	http://dx.doi.org/10.1371/journal.pone.0182469			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846681	gold, Green Submitted, Green Published			2022-12-27	WOS:000408438600010
J	Kwak, YK; Lee, SW; Kay, CS; Park, HH				Kwak, Yoo-Kang; Lee, Sea-Won; Kay, Chul Seung; Park, Hee Hyun			Intensity-modulated radiotherapy reduces gastrointestinal toxicity in pelvic radiation therapy with moderate dose	PLOS ONE			English	Article							CERVICAL-CANCER; CLINICAL-OUTCOMES; CONCURRENT CHEMOTHERAPY; RADICAL SURGERY; CARCINOMA; WOMEN; IRRADIATION; IMPACT; CISPLATIN; UTERUS	This retrospective study was performed to evaluate and compare gastrointestinal (GI) toxicities caused by conventional radiotherapy (cRT) and intensity modulated radiotherapy (IMRT) in 136 cancer patients treated with pelvic radiotherapy (RT) with moderate radiation dose in a single institution. A matched-pair analysis of the two groups was performed; each group included 68 patients. Conventional RT was delivered using the four-field box technique and IMRT was delivered with helical tomotherapy. The median daily dose was 1.8 Gy and the median total dose was 50.4 Gy (range 25.2-56 Gy). Primary end point was GI toxicity during and after RT. Secondary end point was factors that affect toxicity. Patients treated with IMRT had lower incidence of grade >= 2 acute GI toxicity compared to the patients treated with cRT (p = 0.003). The difference remained significant in multivariate analysis (p = 0.01). The incidence of chronic GI toxicity was not statistically different between the two groups, but the cRT group had higher incidence of grade 3 chronic GI toxicity. Based on our results, IMRT can reduce GI toxicity compared to cRT in the treatment of pelvic radiotherapy even with moderate radiation dose and this will enhance patients' quality of life and treatment compliance.	[Kwak, Yoo-Kang; Lee, Sea-Won] Catholic Univ Korea, Seoul St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Kay, Chul Seung; Park, Hee Hyun] Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea	Kay, CS (corresponding author), Catholic Univ Korea, Incheon St Marys Hosp, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	k41645@chol.com		Kwak, Yoo-Kang/0000-0002-7615-7819				Barker CL, 2009, BRIT J CANCER, V100, P1558, DOI 10.1038/sj.bjc.6605050; Barraclough LH, 2012, RADIOTHER ONCOL, V103, P327, DOI 10.1016/j.radonc.2012.04.018; Brixey CJ, 2002, INT J RADIAT ONCOL, V54, P1388, DOI 10.1016/S0360-3016(02)03801-4; Buchali A, 1999, RADIOTHER ONCOL, V52, P29, DOI 10.1016/S0167-8140(99)00068-7; Chan P, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-13; Chen MF, 2007, INT J RADIAT ONCOL, V67, P1438, DOI 10.1016/j.ijrobp.2006.11.005; Denham JW, 1999, RADIOTHER ONCOL, V51, P43, DOI 10.1016/S0167-8140(99)00027-4; Du XL, 2012, GYNECOL ONCOL, V125, P151, DOI 10.1016/j.ygyno.2011.12.432; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Gandhi AK, 2013, INT J RADIAT ONCOL, V87, P542, DOI 10.1016/j.ijrobp.2013.06.2059; Gilbert A, 2015, INT J RADIAT ONCOL, V92, P555, DOI 10.1016/j.ijrobp.2015.02.021; Huh SJ, 2004, RADIOTHER ONCOL, V71, P73, DOI 10.1016/j.radonc.2004.01.005; Kidd EA, 2010, INT J RADIAT ONCOL, V77, P1085, DOI 10.1016/j.ijrobp.2009.06.041; Krol R, 2014, INT J COLORECTAL DIS, V29, P273, DOI 10.1007/s00384-013-1784-8; Landoni F, 1997, LANCET, V350, P535, DOI 10.1016/S0140-6736(97)02250-2; Lengele B, 2009, RADIOTHER ONCOL, V92, P22, DOI 10.1016/j.radonc.2008.11.007; Lukka H, 2002, CLIN ONCOL-UK, V14, P203, DOI 10.1053/clon.2002.0076; Mell LK, 2008, INT J RADIAT ONCOL, V71, P1504, DOI 10.1016/j.ijrobp.2008.04.046; Mundt AJ, 2002, INT J RADIAT ONCOL, V52, P1330, DOI 10.1016/S0360-3016(01)02785-7; Mundt AJ, 2001, GYNECOL ONCOL, V82, P456, DOI 10.1006/gyno.2001.6250; Peters WA, 2000, J CLIN ONCOL, V18, P1606, DOI 10.1200/JCO.2000.18.8.1606; Ray A, 2013, ASIA-PAC J CLIN ONCO, V9, P280, DOI 10.1111/ajco.12049; Roeske JC, 2003, RADIOTHER ONCOL, V69, P201, DOI 10.1016/j.radonc.2003.05.001; Roeske JC, 2000, INT J RADIAT ONCOL, V48, P1613, DOI 10.1016/S0360-3016(00)00771-9; Taylor A, 2007, CLIN ONCOL-UK, V19, P542, DOI 10.1016/j.clon.2007.05.002; van de Bunt L, 2008, RADIOTHER ONCOL, V88, P233, DOI 10.1016/j.radonc.2007.12.017; YEOH E, 1993, AM J MED, V95, P397, DOI 10.1016/0002-9343(93)90309-D; Yeoh EEK, 2004, AM J GASTROENTEROL, V99, P361, DOI 10.1111/j.1572-0241.2004.04037.x; Yeoh EEK, 2000, INT J RADIAT ONCOL, V47, P915, DOI 10.1016/S0360-3016(00)00487-9; Yeoh EK, 2012, INT J RADIAT ONCOL, V84, pE593, DOI 10.1016/j.ijrobp.2012.06.032	31	16	20	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183339	10.1371/journal.pone.0183339	http://dx.doi.org/10.1371/journal.pone.0183339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846718	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600025
J	Kalu, AW; Telele, NF; Gebreselasie, S; Fekade, D; Abdurahman, S; Marrone, G; Sonnerborg, A				Kalu, Amare Worku; Telele, Nigus Fikrie; Gebreselasie, Solomon; Fekade, Daniel; Abdurahman, Samir; Marrone, Gaetano; Sonnerborg, Anders			Prediction of coreceptor usage by five bioinformatics tools in a large Ethiopian HIV-1 subtype C cohort	PLOS ONE			English	Article							CD4 CELL COUNT; ANTIRETROVIRAL THERAPY; GENOTYPIC ALGORITHMS; PHENOTYPIC ASSAYS; TROPISM; IMPACT; EPIDEMIOLOGY; PROGRESSION; RECOVERY; CCR5	Background Genotypic tropism testing (GTT) has been developed largely on HIV-1 subtype B. Although a few reports have analysed the utility of GTT in other subtypes, more studies using HIV-1 subtype C (HIV-1C) are needed, considering the huge contribution of HIV-1C to the global epidemic. Methods Plasma was obtained from 420 treatment-naive HIV-1C infected Ethiopians recruited 2009 - 2011. The V3 region was sequenced and the coreceptor usage was predicted by five tools: Geno2Pheno clinical- and clonal-models, PhenoSeq-C, C-PSSM and Raymond's algorithm. The impact of baseline tropism on antiretroviral treatment (ART) outcome was evaluated. Results Of 352 patients with successful baseline V3 sequences, the proportion of predicted R5 virus varied between the methods by 12.5% (78.1%-90.6%). However, only 58.2% of the predictions were concordant and only 1.7% were predicted to be X4-tropic across the five methods. Compared pairwise, the highest concordance was between C-PSSM and Geno2Pheno clonal (86.4%). In bivariate intention to treat (ITT) analysis, R5 infected patients achieved treatment success more frequently than X4 infected at month six as predicted by Geno2Pheno clinical (77.8% vs 58.7%, P = 0.004) and at month 12 by C-PSSM (61.9% vs 46.6%, P = 0.038). However, in the multivariable analysis adjusted for age, gender, baseline CD4 and viral load, only tropism as predicted by C-PSSM showed an impact on month 12 (P = 0.04, OR 2.47, 95% CI 1.06-5.79). Conclusion Each of the bioinformatics models predicted R5 tropism with comparable frequency but there was a large discordance between the methods. Baseline tropism had an impact on outcome of first line ART at month 12 in multivariable ITT analysis but only based on prediction by C-PSSM which thus possibly could be used for predicting outcome of ART in HIV-1C infected Ethiopians.	[Kalu, Amare Worku; Telele, Nigus Fikrie; Sonnerborg, Anders] Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden; [Kalu, Amare Worku; Telele, Nigus Fikrie; Gebreselasie, Solomon] Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia; [Fekade, Daniel] Addis Ababa Univ, Dept Internal Med, Addis Ababa, Ethiopia; [Abdurahman, Samir] Publ Hlth Agcy Sweden, Solna, Sweden; [Marrone, Gaetano; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Unit Infect Dis, Stockholm, Sweden	Karolinska Institutet; Addis Ababa University; Addis Ababa University; Public Health Agency of Sweden; Karolinska Institutet	Kalu, AW (corresponding author), Karolinska Inst, Div Clin Microbiol, Dept Lab Med, Stockholm, Sweden.; Kalu, AW (corresponding author), Addis Ababa Univ, Dept Microbiol Immunol & Parasitol, Addis Ababa, Ethiopia.	Amare.worku.kalu@ki.se	Sönnerborg, Anders/W-2011-2019; Kalu, Amare/O-5143-2018	Sönnerborg, Anders/0000-0001-8928-3374; Kalu, Amare/0000-0003-3950-6992	Swedish Research Council; Swedish Institutet; EDCTP; EuResist consortium; CDC Cooperative Agreement [5U2GPS00085 8]; European and Developing Clinical Trial Partnership; Swedish Civil Contingencies Agency; Swedish Institute	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Institutet; EDCTP; EuResist consortium; CDC Cooperative Agreement(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); European and Developing Clinical Trial Partnership; Swedish Civil Contingencies Agency; Swedish Institute	Samples and data were collected by the Advanced Clinical Monitoring of Antiretroviral Treatment in Ethiopia, funded by CDC Cooperative Agreement 5U2GPS00085 8. Part of this work has been supported by the European and Developing Clinical Trial Partnership, the Swedish Research Council, the Swedish Civil Contingencies Agency and the Swedish Institute.; We acknowledge Addis Ababa University (AAU) College of Health Sciences, particularly Dr Ahmed Raja (CED) and Dr Dawit Wondimagegn; the ACM steering committee, particularly Dr Achamyeleh Alebachew. We also acknowledge support from the Swedish Research Council, the Swedish Institutet, the EDCTP and the EuResist consortium.	Abbate I, 2011, CLIN MICROBIOL INFEC, V17, P725, DOI 10.1111/j.1469-0691.2010.03350.x; Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Bader J, 2017, CLIN INFECT DIS, V64, P295, DOI 10.1093/cid/ciw737; Braun P, 2007, EUR J MED RES, V12, P463; Brumme ZL, 2004, AIDS, V18, pF1, DOI 10.1097/00002030-200403050-00001; Cashin K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08543; Ceresola ER, 2015, J ANTIMICROB CHEMOTH, V70, P1391, DOI 10.1093/jac/dku573; Cilliers T, 2003, J VIROL, V77, P4449, DOI 10.1128/JVI.77.7.4449-4456.2003; Crous S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-203; Dauwe K, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1217-0; DELWART EL, 1995, PCR METH APPL, V4, pS202; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Garrido C, 2008, J CLIN MICROBIOL, V46, P887, DOI 10.1128/JCM.01611-07; Gijsbers EF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076255; Goodenow MM, 2006, J LEUKOCYTE BIOL, V80, P965, DOI 10.1189/jlb.0306148; Gupta S, 2015, INTERVIROLOGY, V58, P1, DOI 10.1159/000369017; Hoffmann C, 2007, EUR J MED RES, V12, P385; Jensen MA, 2006, J VIROL, V80, P4698, DOI 10.1128/JVI.80.10.4698-4704.2006; JOHANSSON B, 1995, AIDS RES HUM RETROV, V11, P761, DOI 10.1089/aid.1995.11.761; Kalu AW, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2163-1; Lanca AM, 2012, MEM I OSWALDO CRUZ, V107, P96, DOI 10.1590/S0074-02762012000100014; Lengauer T, 2007, NAT BIOTECHNOL, V25, P1407, DOI 10.1038/nbt1371; Neogi U, 2014, PLOS ONE, V9; Neogi U, 2014, AIDS, V28, P2319, DOI 10.1097/QAD.0000000000000419; Neogi U, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-24; Neogi Ujjwal, 2009, AIDS Res Ther, V6, P28, DOI 10.1186/1742-6405-6-28; Prosperi MCF, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-56; Ray N, 2006, CURR TOP MICROBIOL, V303, P97, DOI 10.1007/978-3-540-33397-5_5; Raymond S, 2016, JAIDS-J ACQ IMM DEF, V72, P376, DOI 10.1097/QAI.0000000000000984; Raymond S, 2010, JAIDS-J ACQ IMM DEF, V53, P167, DOI 10.1097/QAI.0b013e3181c8413b; Resistance UKCGoHD, 2014, AIDS, V28, P773; Riemenschneider M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24883; Sallam M, 2017, INFECT GENET EVOL, V49, P157, DOI 10.1016/j.meegid.2017.01.004; Sechet M, 2015, INTERVIROLOGY, V58, P155, DOI 10.1159/000398798; Seclen E, 2011, J CLIN MICROBIOL, V49, P3380, DOI 10.1128/JCM.00908-11; Seclen E, 2011, J INFECT DIS, V204, P139, DOI 10.1093/infdis/jir218; Skrabal K, 2007, J CLIN MICROBIOL, V45, P279, DOI 10.1128/JCM.01118-06; Teklu AM, 2017, ETHIOP J HEALTH SCI, V27, P3, DOI [10.4314/ejhs.v27i1.2S, 10.4314/ejhs.v27i1.2s]; Trabaud MA, 2012, J MED VIROL, V84, P402, DOI 10.1002/jmv.23209; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Weiser B, 2008, AIDS, V22, P469, DOI 10.1097/QAD.0b013e3282f4196c	41	3	3	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0182384	10.1371/journal.pone.0182384	http://dx.doi.org/10.1371/journal.pone.0182384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841646	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700006
J	Dimitriadis, Z; Scholtz, W; Ensminger, SM; Piper, C; Bitter, T; Wiemer, M; Vlachojannis, M; Borgermann, J; Faber, L; Horstkotte, D; Gummert, J; Scholtz, S				Dimitriadis, Zisis; Scholtz, Werner; Ensminger, Stephan M.; Piper, Cornelia; Bitter, Thomas; Wiemer, Marcus; Vlachojannis, Marios; Boergermann, Jochen; Faber, Lothar; Horstkotte, Dieter; Gummert, Jan; Scholtz, Smita			Impact of sheath diameter of different sheath types on vascular complications and mortality in transfemoral TAVI approaches using the Proglide closure device	PLOS ONE			English	Article							AORTIC-VALVE IMPLANTATION; END-POINT DEFINITIONS; ACCESS SITE CLOSURE; ANEURYSM REPAIR; TRANSCATHETER; REPLACEMENT; MULTICENTER; STENOSIS; REGISTRY; OUTCOMES	Objective Evaluation of the impact of the sheath diameter on vascular complications and mortality in transfemoral aortic valve implantation. Method Between 2012 and 2014, 183 patients underwent the procedure using a sheath diameter of 18-24 F. This collective was divided into two groups: group 1, with a sheath diameter of 18F (G1, n = 94), consisted of patients with 18F Medtronic Sentrant and 18 F Direct Flow sheaths, and group 2 with a sheath diameter of 19-24 F (G2, n = 89) consisted of patients with Edwards expandable e-sheath and Solopath sheaths. Perclose-Proglide (R) was used as a closure device in all patients. Results G1 had significantly more female patients (64.9% vs. 46.1% in G2, p = 0.01) and the average BMI was lower (26 +/- 4.5% vs. 27.4 +/- 4.7%, p = 0.03). There was no significant difference in the incidence of major and minor vascular complications (G1: 12.8% vs. G2: 12.4%, p = 0.9). 30-day mortality was similar in both groups (G1: 6.4 +/- 2.5% [95% CI: 0.88-0.98], G2: 3.7 +/- 1.9% [95% CI: 0.92-0.99]. The Kaplan Meier analysis of survival revealed no significant differences either. Conclusion The difference in sheath diameter had no effect on either incidence or severity of vascular complications. There was no impact on mortality either.	[Dimitriadis, Zisis; Scholtz, Werner; Piper, Cornelia; Bitter, Thomas; Vlachojannis, Marios; Faber, Lothar; Horstkotte, Dieter; Scholtz, Smita] Ruhr Univ Bochum, Clin Cardiol, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany; [Ensminger, Stephan M.; Boergermann, Jochen; Gummert, Jan] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany; [Wiemer, Marcus] Ruhr Univ Bochum, Johannes Wesling Klinikum Minden, Dept Cardiol & Crit Care Med, Minden, Germany	Ruhr University Bochum; Ruhr University Bochum; Ruhr University Bochum	Dimitriadis, Z (corresponding author), Ruhr Univ Bochum, Clin Cardiol, Herz & Diabet Zentrum NRW, Bad Oeynhausen, Germany.	akleemeyer@hdz-nrw.de	Ensminger, Stephan Prof. Dr./AAQ-2141-2021; Faber, Lothar/AAJ-1135-2020	Ensminger, Stephan Prof. Dr./0000-0002-9508-3261; 				Abdel-Wahab M, 2015, TRENDS CARDIOVAS MED, V25, P154, DOI 10.1016/j.tcm.2014.10.001; Agarwal S, 2015, HEART, V101, P169, DOI 10.1136/heartjnl-2014-306254; Barbanti M, 2013, EUROINTERVENTION, V9, P929, DOI 10.4244/EIJV9I8A156; Barbash IM, 2015, EUR HEART J, V36, P3370, DOI 10.1093/eurheartj/ehv417; Borz B, 2014, CATHETER CARDIO INTE, V83, pE227, DOI 10.1002/ccd.25390; Cribier A, 2002, CIRCULATION, V106, P3006, DOI 10.1161/01.CIR.0000047200.36165.B8; Eisenack M, 2009, J ENDOVASC THER, V16, P708, DOI 10.1583/08-2622.1; Eltchaninoff H, 2012, ARCH CARDIOVASC DIS, V105, P132, DOI 10.1016/j.acvd.2012.02.002; Eltchaninoff H, 2011, EUR HEART J, V32, P191, DOI 10.1093/eurheartj/ehq261; Etezadi V, 2011, J VASC INTERV RADIOL, V22, P142, DOI 10.1016/j.jvir.2010.10.008; Genereux P, 2012, J AM COLL CARDIOL, V60, P1043, DOI 10.1016/j.jacc.2012.07.003; Greason KL, 2013, J CARDIAC SURG, V28, P348, DOI 10.1111/jocs.12140; Griese DP, 2013, CATHETER CARDIO INTE, V82, pE734, DOI 10.1002/ccd.25053; Hayashida K, 2012, JACC-CARDIOVASC INTE, V5, P207, DOI 10.1016/j.jcin.2011.09.020; Hayashida K, 2011, JACC-CARDIOVASC INTE, V4, P851, DOI 10.1016/j.jcin.2011.03.019; Howell M, 2002, CATHETER CARDIO INTE, V55, P281, DOI 10.1002/ccd.10072; Kappetein AP, 2012, J AM COLL CARDIOL, V60, P1438, DOI [10.1016/j.jacc.2012.09.001, 10.1093/ejcts/ezs533]; Kodali S, 2016, EUR HEART J; Krishnaswamy A, 2014, CATHETER CARDIO INTE, V84, P844, DOI 10.1002/ccd.25488; Lefevre T, 2011, EUR HEART J, V32, P148, DOI 10.1093/eurheartj/ehq427; Leon MB, 2011, J AM COLL CARDIOL, V57, P253, DOI 10.1016/j.jacc.2010.12.005; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Manoharan G, 2015, JACC-CARDIOVASC INTE, V8, P1359, DOI 10.1016/j.jcin.2015.05.015; Masson JB, 2009, JACC-CARDIOVASC INTE, V2, P811, DOI 10.1016/j.jcin.2009.07.005; McCabe JM, 2016, AM J CARDIOL; Nelson PR, 2014, J VASC SURG, V59, P1181, DOI 10.1016/j.jvs.2013.10.101; Ramlawi Basel, 2012, Methodist Debakey Cardiovasc J, V8, P22; Rodes-Cabau J, 2010, J AM COLL CARDIOL, V55, P1080, DOI 10.1016/j.jacc.2009.12.014; Sari C, 2015, PERFUSION-UK, V30, P666, DOI 10.1177/0267659115578002; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Steinberger JD, 2015, TECH VASC INTERV RAD, V18, P93, DOI 10.1053/j.tvir.2015.04.007; Tchetche D, 2010, EUROINTERVENTION, V5, P659, DOI 10.4244/EIJV5I6A109; Thomas M, 2011, CIRCULATION, V124, P425, DOI 10.1161/CIRCULATIONAHA.110.001545; Van Mieghem NM, 2014, EUROINTERVENTION, V9, P1317, DOI 10.4244/EIJV9I11A222; Van Mieghem NM, 2010, EUROINTERVENTION, V5, P673, DOI 10.4244/EIJV5I6A111; Walther T, 2015, J AM COLL CARDIOL, V65, P2173, DOI 10.1016/j.jacc.2015.03.034; Webb J, 2011, EUR HEART J, V32, P140, DOI 10.1093/eurheartj/ehq453; Zahn R, 2011, EUR HEART J, V32, P198, DOI 10.1093/eurheartj/ehq339	38	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183658	10.1371/journal.pone.0183658	http://dx.doi.org/10.1371/journal.pone.0183658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837613	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000095
J	Donchenko, EK; Pechnikova, EV; Mishyna, MY; Manukhova, TI; Sokolova, OS; Nikitin, NA; Atabekov, JG; Karpova, OV				Donchenko, Ekaterina K.; Pechnikova, Evgeniya V.; Mishyna, Maryia Yu.; Manukhova, Tatiana I.; Sokolova, Olga S.; Nikitin, Nikolai A.; Atabekov, Joseph G.; Karpova, Olga V.			Structure and properties of virions and virus-like particles derived from the coat protein of Alternanthera mosaic virus	PLOS ONE			English	Article							ELECTRON-MICROSCOPY; POTEXVIRUS; IDENTIFICATION; PORTULACA; BINDING; PHLOX	Plant viruses and their virus-like particles (VLPs) have a lot of advantages for biotechnological applications including complete safety for humans. Alternanthera mosaic virus (AltMV) is a potentially promising object for design of novel materials. The 3D structures of AltMV virions and its VLPs were obtained by single particle EM at similar to 13 angstrom resolution. The comparison of the reconstructions and a trypsin treatment revealed that AltMV CPs possesses a different fold in the presence (virions) and absence of viral RNA (VLPs). For the first time, the structure of morphologically similar virions and virus-like particles based on the coat protein of a helical filamentous plant virus is shown to be different. Despite this, both AltMV virions and VLPs are stable in a wide range of conditions. To provide a large amount of AltMV for biotechnology usage the isolation procedure was modified.	[Donchenko, Ekaterina K.; Manukhova, Tatiana I.; Sokolova, Olga S.; Nikitin, Nikolai A.; Atabekov, Joseph G.; Karpova, Olga V.] Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia; [Pechnikova, Evgeniya V.] Russian Acad Sci, Lab Electron Microscopy, VA Shoubnikov Inst Crystallog, Moscow, Russia; [Pechnikova, Evgeniya V.] Kurchatov Inst, Nano Bio Informat Cognit Sociohumanist NBICS Sci, Natl Res Ctr, Moscow, Russia; [Mishyna, Maryia Yu.] Tel Hai Coll, Dept Food Sci, Upper Galilee, Israel; [Pechnikova, Evgeniya V.] Thermo Fisher Sci, Mat & Struct Anal, Eindhoven, Netherlands	Lomonosov Moscow State University; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS; National Research Centre - Kurchatov Institute; Tel Hai Academy College; Thermo Fisher Scientific	Donchenko, EK (corresponding author), Lomonosov Moscow State Univ, Fac Biol, Moscow, Russia.	donchenko@mail.bio.msu.ru	Sokolova, Olga S/G-7794-2016; Karpova, Olga V/H-2475-2013; Maryia, Mishyna/A-9409-2016; Nikitin, Nikolai/D-6520-2013; Manukhova, Tatiana/AAS-3685-2021; Sokolova, Olga/AAM-8289-2020; Donchenko (Petrova), Ekaterina/D-7561-2012	Karpova, Olga V/0000-0002-0605-9033; Nikitin, Nikolai/0000-0001-9626-2336; Manukhova, Tatiana/0000-0001-9498-1257; Sokolova, Olga/0000-0003-4678-232X; Mishyna, Maryia/0000-0001-9079-8156; Donchenko (Petrova), Ekaterina/0000-0002-5872-3928	Russian Science Foundation [14-24-00007]; Russian Foundation for Basic Research [16-34-00658_mol_a]; 'Thermo Fisher Scientific'; Russian Science Foundation [17-24-00002] Funding Source: Russian Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); 'Thermo Fisher Scientific'; Russian Science Foundation(Russian Science Foundation (RSF))	This work (study design, data collection and analysis) was funded by the Russian Science Foundation (Grant No. 14-24-00007) to JGA. www.rscf.ru. Building the 3D reconstructions was funded by Russian Foundation for Basic Research (Grant No. 16-34-00658_mol_a to EP). www.rfbr.ru. Currently one of the authors (Pechnikova E.V.) is employed by a commercial company 'Thermo Fisher Scientific'. The presented cryo-EM results were obtained in V.A. Shoubnikov Institute of Crystallography RAS and National Research Centre 'Kurchatov Institute', where Pechnikova E.V. was employed at that time. 'Thermo Fisher Scientific' provided support in the form of salary for author [Pechnikova E.V.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Agirrezabala X, 2015, ELIFE, V4, DOI 10.7554/eLife.11795; Baker CA, 2006, PLANT DIS, V90, P833, DOI 10.1094/PD-90-0833C; BANCROFT JB, 1979, VIROLOGY, V98, P121, DOI 10.1016/0042-6822(79)90531-2; Brunt A. A., 1997, PLANT VIRUSES ONLINE; Ciuffo M, 2004, PLANT PATHOL, V53, P515, DOI 10.1111/j.1365-3059.2004.01040.x; Clare DK, 2015, STRUCTURE, V23, P1815, DOI 10.1016/j.str.2015.06.028; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; DiMaio F, 2015, NAT STRUCT MOL BIOL, V22, P642, DOI 10.1038/nsmb.3054; Duarte L. M. L., 2008, Revista Brasileira de Horticultura Ornamental, V14, P59; ERICKSON JW, 1976, VIROLOGY, V72, P514, DOI 10.1016/0042-6822(76)90180-X; ERICKSON JW, 1978, VIROLOGY, V90, P36, DOI 10.1016/0042-6822(78)90330-6; Geering ADW, 1999, ARCH VIROL, V144, P577, DOI 10.1007/s007050050526; Gleba Y, 2007, CURR OPIN BIOTECH, V18, P134, DOI 10.1016/j.copbio.2007.03.002; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Hammond J, 2006, ARCH VIROL, V151, P477, DOI 10.1007/s00705-005-0646-2; Hammond J, 2006, ACTA HORTIC, P71, DOI 10.17660/ActaHortic.2006.722.8; Ivanov PA, 2011, VIRUS GENES, V42, P268, DOI 10.1007/s11262-010-0556-6; Iwabuchi N, 2016, GENOME ANNOUNC, V5; Karpova OV, 2006, MOL BIOL+, V40, P703; Lebel ME, 2017, J IMMUNOL, V198, P292, DOI 10.4049/jimmunol.1601271; Lebel ME, 2016, NANO LETT, V16, P1826, DOI 10.1021/acs.nanolett.5b04877; Lockhart BE, 2008, PLANT DIS, V92, P1473, DOI 10.1094/PDIS-92-10-1473B; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; Mukhamedzhanova Anna A, 2011, Open Virol J, V5, P136, DOI 10.2174/1874357901105010136; Nikitin N. A., 2016, Moscow University Biological Sciences Bulletin, V71, P128, DOI 10.3103/S0096392516030081; Nikitin N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142415; Rodionova NP, 2003, J MOL BIOL, V333, P565, DOI 10.1016/j.jmb.2003.08.058; Savard C, 2012, VACCINE, V30, P2535, DOI 10.1016/j.vaccine.2012.01.085; Savard C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021522; Semenyuk PI, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1522, DOI 10.1134/S0006297916120130; Smith KM., 1972, TXB PLANT VIRUS DIS, V3; Steele JFC, 2017, WIRES NANOMED NANOBI, V9, DOI 10.1002/wnan.1447; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Tang J, 2010, AUSTRALAS PLANT DIS, V5, P25, DOI 10.1071/DN10010; Tremblay MH, 2006, FEBS J, V273, P14, DOI 10.1111/j.1742-4658.2005.05033.x; Trifonova E. A., 2015, MOSC U BIOL SCI B, V70, P194, DOI [10.3103/S0096392515040094, DOI 10.3103/S0096392515040094]; Trifonova EA, 2017, ANTIVIR RES, V144, P27, DOI 10.1016/j.antiviral.2017.05.006; Yang SQ, 2012, J MOL BIOL, V422, P263, DOI 10.1016/j.jmb.2012.05.032	38	11	12	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183824	10.1371/journal.pone.0183824	http://dx.doi.org/10.1371/journal.pone.0183824			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837650	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000128
J	Dong, HD; Lv, Y; Sreevatsan, S; Zhao, DM; Zhou, XM				Dong, Haodi; Lv, Yue; Sreevatsan, Srinand; Zhao, Deming; Zhou, Xiangmei			Differences in pathogenicity of three animal isolates of Mycobacterium species in a mouse model	PLOS ONE			English	Article							IL-1-BETA PRODUCTION; TUBERCULOSIS; BOVIS; VIRULENCE; MPB83; MPB70; STRAINS; CATTLE; PARATUBERCULOSIS; INFLAMMASOME	Animal mycobacterioses are among the most important zoonoses worldwide. These are generally caused by either Mycobacterium tuberculosis (MTB), M. bovis (MBO) or M. avium (MAV). To test the hypothesis that different species of pathogenic mycobacteria isolated from varied anatomic locations or animal species differ in virulence and pathogenicity, we performed experiments with three mycobacteria strains (NTSE-3(MTB), NTSE-4(MBO) and NTSE-5 (MAV)) obtained from animal species. Spoligotyping analysis was used to confirm both MTB and MBO strains while the MAV strain was confirmed by 16s rDNA sequencing. BALB/c mice were intranasally infected with the three strains at low and high CFU doses to evaluate variations in pathogenicity. Clinical and pathological parameters were assessed. Infected mice were euthanized at 80 days post-inoculation (dpi). Measures of lung and body weights indicated that the MBO infected group had higher mortality, more weight loss, higher bacterial burden and more severe lesions in lungs than the other two groups. Cytokine profiles showed higher levels of TNF-alpha for MBO versus MTB, while MAV had the highest amounts of IFN-beta in vitro and in vivo. In vitro levels of other cytokines such as IL-1 beta, IL-10, IL-12, IL-17, and IFN-beta showed that Th1 cells had the strongest response in MBO infected mice and that Th2 cells were inhibited. We found that the level of virulence among the three isolates decreased in the following order MBO> MTB> MAV.	[Dong, Haodi; Lv, Yue; Zhao, Deming; Zhou, Xiangmei] China Agr Univ, Minist Agr, Key Lab Anim Epidemiol, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Dong, Haodi; Lv, Yue; Zhao, Deming; Zhou, Xiangmei] China Agr Univ, Coll Vet Med, Beijing, Peoples R China; [Sreevatsan, Srinand] Univ Minnesota, Coll Vet Med, Vet Populat Med Dept, St Paul, MN 55108 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University; University of Minnesota System; University of Minnesota Twin Cities	Zhou, XM (corresponding author), China Agr Univ, Minist Agr, Key Lab Anim Epidemiol, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Zhou, XM (corresponding author), China Agr Univ, Coll Vet Med, Beijing, Peoples R China.	zhouxm@cau.edu.cn	Sreevatsan, Srinand/V-6808-2019	Sreevatsan, Srinand/0000-0002-5162-2403	National Science & Technology Pillar Program [2015BAI09B01]; National Natural Science Foundation of China [31572487]; MoSTRCUK international cooperation project [2013DFG32500]; State Key Lab of Agrobiotechnology Project [2012SKLAB0614]; CAU Foreign Experts Major Projects [2012z018]; High-end Foreign Experts Recruitment Program [GDT20161100071]	National Science & Technology Pillar Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MoSTRCUK international cooperation project; State Key Lab of Agrobiotechnology Project; CAU Foreign Experts Major Projects; High-end Foreign Experts Recruitment Program	This work was supported by National Science & Technology Pillar Program during the Twelfth Five-year Plan Period (No. 2015BAI09B01), National Natural Science Foundation of China (Project No. 31572487), the MoSTRCUK international cooperation project (Project No. 2013DFG32500), Funding of State Key Lab of Agrobiotechnology (Project No. 2012SKLAB0614), 2016 CAU Foreign Experts Major Projects (Project No: 2012z018) High-end Foreign Experts Recruitment Program (Project No: GDT20161100071).	Ameni G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076891; [Anonymous], 1896, T ASSOC AM PHYSICIAN, V11, P75; Appelberg R, 2006, IMMUNOL RES, V35, P179, DOI 10.1385/IR:35:3:179; Asensio JG, 2006, J BIOL CHEM, V281, P1313, DOI 10.1074/jbc.C500388200; Cervantes-Villagrana AR, 2013, VACCINE, V31, P676, DOI 10.1016/j.vaccine.2012.11.042; CHATTERJEE D, 1989, INFECT IMMUN, V57, P322, DOI 10.1128/IAI.57.2.322-330.1989; Cheng CC, 2014, ANN CLIN MICROB ANTI, V13, DOI 10.1186/1476-0711-13-1; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Di Paolo NC, 2015, IMMUNITY, V43, P1125, DOI 10.1016/j.immuni.2015.11.016; DUNN PL, 1995, INFECT IMMUN, V63, P3428, DOI 10.1128/IAI.63.9.3428-3437.1995; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gonzalo-Asensio J, 2014, P NATL ACAD SCI USA, V111, P11491, DOI 10.1073/pnas.1406693111; HARBOE M, 1995, SCAND J IMMUNOL, V42, P46, DOI 10.1111/j.1365-3083.1995.tb03624.x; Henry T, 2007, J EXP MED, V204, P987, DOI 10.1084/jem.20062665; JARNAGIN JL, 1983, AM J VET RES, V44, P1920; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; Koch R, 1901, Br Med J, V2, P189; Kolb J, 2014, INT J MED MICROBIOL, V304, P941, DOI 10.1016/j.ijmm.2014.06.001; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Logan KE, 2008, TUBERCULOSIS, V88, P437, DOI 10.1016/j.tube.2008.05.005; Marassi CD, 2011, ACTA TROP, V118, P101, DOI 10.1016/j.actatropica.2011.02.015; McNab FW, 2014, J IMMUNOL, V193, P3600, DOI 10.4049/jimmunol.1401088; Medina E, 2006, TUBERCULOSIS, V86, P20, DOI 10.1016/j.tube.2005.04.003; Michel AL, 2010, VET MICROBIOL, V140, P371, DOI 10.1016/j.vetmic.2009.08.029; Novikov A, 2011, J IMMUNOL, V187, P2540, DOI 10.4049/jimmunol.1100926; Ocepek M, 2005, J CLIN MICROBIOL, V43, P3555, DOI 10.1128/JCM.43.7.3555-3557.2005; Olsen A, 2016, MBIO, V7, DOI 10.1128/mBio.01023-15; Pena OM, 2011, J IMMUNOL, V186, P7243, DOI 10.4049/jimmunol.1001952; Pruvot M, 2014, PREV VET MED, V117, P95, DOI 10.1016/j.prevetmed.2014.09.003; Raviglione M, 2016, INFECT DIS REP, V8, P33, DOI 10.4081/idr.2016.6570; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rivas-Santiago B, 2015, IMMUNOTHERAPY-UK, V7, P207, DOI [10.2217/IMT.14.119, 10.2217/imt.14.119]; Said-Salim B, 2006, MOL MICROBIOL, V62, P1251, DOI 10.1111/j.1365-2958.2006.05455.x; Shah S, 2013, J IMMUNOL, V191, P3514, DOI 10.4049/jimmunol.1301331; Singh VK, 2014, TUBERCULOSIS, V94, P252, DOI 10.1016/j.tube.2014.02.001; Srivastava K, 2008, INDIAN J MED RES, V128, P26; Verdugo C, 2014, PREV VET MED, V117, P436, DOI 10.1016/j.prevetmed.2014.09.009; Wedlock DN, 2003, TUBERCULOSIS, V83, P339, DOI 10.1016/S1472-9792(03)00055-6; Whelan AO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008527; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zarden CFO, 2013, TROP ANIM HEALTH PRO, V45, P1203, DOI 10.1007/s11250-012-0347-2; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	42	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183666	10.1371/journal.pone.0183666	http://dx.doi.org/10.1371/journal.pone.0183666			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837698	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000097
J	Garcia-Canadilla, P; Rodriguez, JF; Palazzi, MJ; Gonzalez-Tendero, A; Schonleitner, P; Balicevic, V; Loncaric, S; Luiken, JJFP; Ceresa, M; Camara, O; Antoons, G; Crispi, F; Gratacos, E; Bijnens, B				Garcia-Canadilla, Patricia; Rodriguez, Jose F.; Palazzi, Maria J.; Gonzalez-Tendero, Anna; Schonleitner, Patrick; Balicevic, Vedrana; Loncaric, Sven; Luiken, Joost J. F. P.; Ceresa, Mario; Camara, Oscar; Antoons, Gudrun; Crispi, Fatima; Gratacos, Eduard; Bijnens, Bart			A two dimensional electromechanical model of a cardiomyocyte to assess intra-cellular regional mechanical heterogeneities	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; CARDIAC MYOCYTES; SARCOPLASMIC-RETICULUM; SARCOMERE DYNAMICS; LEFT-VENTRICLE; HEART-FAILURE; FAILING HEART; CONTRACTION; MUSCLE; CA2+	Experimental studies on isolated cardiomyocytes from different animal species and human hearts have demonstrated that there are regional differences in the Ca2+ release, Ca2+ decay and sarcomere deformation. Local deformation heterogeneities can occur due to a combination of factors: regional/local differences in Ca2+ release and/or re-uptake, intra-cellular material properties, sarcomere proteins and distribution of the intracellular organelles. To investigate the possible causes of these heterogeneities, we developed a two-dimensional finite-element electromechanical model of a cardiomyocyte that takes into account the experimentally measured local deformation and cytosolic [Ca2+] to locally define the different variables of the constitutive equations describing the electro/mechanical behaviour of the cell. Then, the model was individualised to three different rat cardiac cells. The local [Ca2+] transients were used to define the [Ca2+]-dependent activation functions. The cell-specific local Young's moduli were estimated by solving an inverse problem, minimizing the error between the measured and simulated local deformations along the longitudinal axis of the cell. We found that heterogeneities in the deformation during contraction were determined mainly by the local elasticity rather than the local amount of Ca2+, while in the relaxation phase deformation was mainly influenced by Ca2+ re-uptake. Our electromechanical model was able to successfully estimate the local elasticity along the longitudinal direction in three different cells. In conclusion, our proposed model seems to be a good approximation to assess the heterogeneous intracellular mechanical properties to help in the understanding of the underlying mechanisms of cardiomyocyte dysfunction.	[Garcia-Canadilla, Patricia; Palazzi, Maria J.; Ceresa, Mario; Camara, Oscar; Bijnens, Bart] Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain; [Rodriguez, Jose F.] Politecn Milan, LaBS, Chem Mat & Chem Engn Dept Giulio Natta, Milan, Italy; [Gonzalez-Tendero, Anna; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, BCNatal Barcelona Ctr Maternal Fetal & Neonatal M, Hosp Clin, Barcelona, Spain; [Gonzalez-Tendero, Anna; Crispi, Fatima; Gratacos, Eduard] Univ Barcelona, Hosp St Joan de Deu, Fetal I D Fetal Med Res Ctr, IDIBAPS, Barcelona, Spain; [Schonleitner, Patrick; Antoons, Gudrun] Maastricht Univ, Dept Physiol, Maastricht, Netherlands; [Balicevic, Vedrana] Univ Zagreb, Fac Elect Engn & Comp, Zagreb, Croatia; [Loncaric, Sven; Luiken, Joost J. F. P.] Maastricht Univ, Mol Genet, Maastricht, Netherlands; [Crispi, Fatima; Gratacos, Eduard] Ctr Biomed Res Rare Dis CIBER ER, Madrid, Spain; [Bijnens, Bart] ICREA, Barcelona, Spain	Pompeu Fabra University; Polytechnic University of Milan; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Maastricht University; University of Zagreb; Maastricht University; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; ICREA	Garcia-Canadilla, P (corresponding author), Univ Pompeu Fabra, Dept Informat & Commun Technol, Barcelona, Spain.	patricia.garciac@upf.edu	Antoons, Gudrun/R-1220-2018; Ceresa, Mario/ABH-3523-2020; Garcia-Canadilla, Patricia/D-8085-2014; Camara, Oscar/I-4710-2015; Bijnens, Bart/AAE-7186-2021; Ceresa, Mario/ABH-2480-2020; Loncaric, Sven/ABE-5634-2021; Gratacos, Eduard/AAR-4939-2020; Matas, Jose F Rodriguez/H-4589-2011; Bijnens, Bart H/C-2955-2008	Antoons, Gudrun/0000-0002-5846-0363; Ceresa, Mario/0000-0002-2410-0212; Garcia-Canadilla, Patricia/0000-0002-0223-1617; Camara, Oscar/0000-0002-5125-6132; Bijnens, Bart/0000-0003-3130-6937; Ceresa, Mario/0000-0002-2410-0212; Gratacos, Eduard/0000-0002-7405-7224; Matas, Jose F Rodriguez/0000-0001-7612-266X; Bijnens, Bart H/0000-0003-3130-6937; Palazzi, Maria J./0000-0002-4894-4110; Loncaric, Sven/0000-0002-4857-5351	Ministerio de Economia y Competitividad [SAF2012-37196, TIN2014-52923-R]; Instituto de Salud Carlos III [PI11/01709, PI14/00226]; EU [611823]; Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "la Caixa (Barcelona, Spain); Fundacio Mutua Madrilena; Fundacio Agrupacio Mutua (Spain); AGAUR SGR (Barcelona, Spain) [928]; Programa de Ayudas Predoctorales de Formacion en investigacion en Salud from the Instituto Carlos III, Spain [FI12/00362]	Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); EU(European Commission); Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "la Caixa (Barcelona, Spain)(La Caixa Foundation); Fundacio Mutua Madrilena; Fundacio Agrupacio Mutua (Spain); AGAUR SGR (Barcelona, Spain); Programa de Ayudas Predoctorales de Formacion en investigacion en Salud from the Instituto Carlos III, Spain	This study was partly supported by grants from Ministerio de Economia y Competitividad (ref. SAF2012-37196, TIN2014-52923-R); the Instituto de Salud Carlos III (ref. PI11/01709, PI14/00226) integrado en el Plan Nacional de I+D+I y cofinanciado por el ISCIII-Subdireccion General de Evaluacion y el Fondo Europeo de Desarrollo Regional (FEDER) Otra manera de hacer Europa; the EU FP7 for research, technological development and demonstration under grant agreement VP2HF (no 611823); The Cerebra Foundation for the Brain Injured Child (Carmarthen, Wales, UK); Obra Social "la Caixa (Barcelona, Spain); Fundacio Mutua Madrilena; Fundacio Agrupacio Mutua (Spain) and AGAUR 2014 SGR grant no 928 (Barcelona, Spain). P.G.C. was supported by the Programa de Ayudas Predoctorales de Formacion en investigacion en Salud (FI12/00362) from the Instituto Carlos III, Spain. P.G.C wants to acknowledge to Boehringer Ingelhiem Fonds for the travel grant to do her research stay at LaBS group in Politecnico di Milano.	Adeniran I, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00166; BACKX PH, 1995, J GEN PHYSIOL, V105, P1, DOI 10.1085/jgp.105.1.1; Balocco S., 2008, P 11 INT C MED IM CO, V11, P131; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Biesmans L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025100; BRADY AJ, 1991, PHYSIOL REV, V71, P413, DOI 10.1152/physrev.1991.71.2.413; Cimrman R, 2003, SIMULATIONS BIOMED, P544; Cimrman R., 2013, P 6 EUR C PYTH SCI E, P65; Cimrman R, 2003, COMPUT FLUID SOLID M, P2524; Constantino J, 2013, AM J PHYSIOL-HEART C, V305, pH1265, DOI 10.1152/ajpheart.00426.2013; Constantino J, 2012, PROG BIOPHYS MOL BIO, V110, P372, DOI 10.1016/j.pbiomolbio.2012.07.009; Edman K A, 1980, Eur Heart J, VSuppl A, P49; EDMAN KAP, 1982, J PHYSIOL-LONDON, V329, P1; Favino M, 2016, EUROPACE, V305, P622; Geuzaine C, 2009, INT J NUMER METH ENG, V79, P1309, DOI 10.1002/nme.2579; Gonzalez-Tendero A, 2013, AM J PHYSIOL-HEART C, V305, pH1752, DOI 10.1152/ajpheart.00514.2013; Hatano A, 2011, BIOPHYS J, V101, P2601, DOI 10.1016/j.bpj.2011.10.020; Heinzel FR, 2002, CIRC RES, V91, P1023, DOI 10.1161/01.RES.0000045940.67060.DD; Hofmann UG, 1997, J STRUCT BIOL, V119, P84, DOI 10.1006/jsbi.1997.3868; Hohendanner F, 2013, CIRC RES, V113, P527, DOI 10.1161/CIRCRESAHA.113.300895; Hunter William C., 2000, Cardiology Clinics, V18, P443, DOI 10.1016/S0733-8651(05)70155-7; Keldermann RH, 2010, AM J PHYSIOL-HEART C, V299, pH134, DOI 10.1152/ajpheart.00862.2009; Kerckhoffs RCP, 2005, AM J PHYSIOL-HEART C, V289, pH1889, DOI 10.1152/ajpheart.00340.2005; Kerckhoffs RCP, 2003, ANN BIOMED ENG, V31, P536, DOI 10.1114/1.1566447; Kuznetsova TG, 2007, MICRON, V38, P824, DOI 10.1016/j.micron.2007.06.011; Lieber SC, 2004, AM J PHYSIOL-HEART C, V287, pH645, DOI 10.1152/ajpheart.00564.2003; Marchesseau S, 2013, MED IMAGE ANAL, V17, P816, DOI 10.1016/j.media.2013.04.012; Mathur AB, 2001, J BIOMECH, V34, P1545, DOI 10.1016/S0021-9290(01)00149-X; Negroni JA, 1996, J MOL CELL CARDIOL, V28, P915, DOI 10.1006/jmcc.1996.0086; Ohashi T, 2002, BIO-MED MATER ENG, V12, P319; Pustoc'h A, 2005, ACTA BIOTHEOR, V53, P277, DOI 10.1007/s10441-005-4880-5; Ruiz-Baier R, 2013, MATH MED BIOL, P1; Sacherer M, 2012, BRIT J PHARMACOL, V167, P493, DOI 10.1111/j.1476-5381.2012.01995.x; Sermesant M, 2006, MED IMAGE ANAL, V10, P642, DOI 10.1016/j.media.2006.04.002; Sermesant M, 2012, MED IMAGE ANAL, V16, P201, DOI 10.1016/j.media.2011.07.003; SHROFF SG, 1995, AM J PHYSIOL-CELL PH, V269, pC286, DOI 10.1152/ajpcell.1995.269.1.C286; Song LS, 2006, P NATL ACAD SCI USA, V103, P4305, DOI 10.1073/pnas.0509324103; Sugiura S, 2006, NAT PROTOC, V1, P1453, DOI 10.1038/nprot.2006.241; Torre I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113067; Tracqui P, 2008, J THEOR BIOL, V255, P92, DOI 10.1016/j.jtbi.2008.07.036; Tracqui P, 2009, PHILOS T R SOC A, V367, P4887, DOI 10.1098/rsta.2009.0149; Walker CA, 1999, J THORAC CARDIOV SUR, V118, P375, DOI 10.1016/S0022-5223(99)70233-3; Weiwad WKK, 2000, J MOL CELL CARDIOL, V32, P247, DOI 10.1006/jmcc.1999.1069	43	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182915	10.1371/journal.pone.0182915	http://dx.doi.org/10.1371/journal.pone.0182915			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837585	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000034
J	Guimaraes-e-Silva, AS; Silva, SD; da Silva, RCR; Pinheiro, VCS; Rebelo, JMM; Melo, MN				Guimaraes-e-Silva, Antonia Suely; Silva, Soraia de Oliveira; Ribeiro da Silva, Rosa Cristina; Soares Pinheiro, Valeria Cristina; Macario Rebelo, Jose Manuel; Melo, Maria Norma			Leishmania infection and blood food sources of phlebotomines in an area of Brazil endemic for visceral and tegumentary leishmaniasis	PLOS ONE			English	Article							DIPTERA PSYCHODIDAE PHLEBOTOMINAE; SAND FLIES; CUTANEOUS LEISHMANIASIS; VIANNIA LAINSONI; NATURAL INFECTION; MIXED INFECTION; EQUUS-CABALLUS; MARANHAO STATE; AMAZON REGION; MINAS-GERAIS	The aims of the study were to determine the blood feeding preferences of sandflies and to identify species of Leishmania that infected phlebotomines in Caxias, Maranhao, Brazil, an area that is highly endemic for leishmaniasis. Sandflies were captured in light traps located in the peridomiciliary environments of randomly selected houses in urban and rural settings between 1800 and 0600 hours on new moon days between March 2013 and February 2015. DNA extracts from 982 engorged female sandflies were submitted to fragment length polymorphism analysis to identify infecting species of Leishmania, and blood sources were identified for 778 of these specimens. Infection by Leishmania infantum was detected in Lutzomyia longipalpis, Lu. whitmani and Lu. termitophila; L. infantum/L. braziliensis in Lu. longipalpis, Lu. whitmani and Lu. trinidadensis; L. shawi in Lu. longipalpis; L. mexicana in Lu. longipalpis; L. braziliensis in Lu. longipalpis and Lu. whitmani; L. guyanensis in Lu. longipalpis and Lu. termitophila; L. amazonensis in Lu. longipalpis and L. lainsoni or L. naiffi in Lu. longipalpis, while Lu. longipalpis and Lu. trinidadensis were infected with unidentified Leishmania sp. Blood sources were identified in 573 individual phlebotomines and the preferred hosts were, in decreasing order, chicken, dog, rodent and human with lower preferences for pig, horse, opossum and cattle. Lu. longipalpis and Lu. whitmani performed mixed feeding on man, dog and rodent, while Lu. longipalpis was the most opportunistic species, feeding on the blood of all hosts surveyed, but preferably on dog/chicken, dog/rodent and rodent/chicken. Our findings reveal the concomitant circulation of Leishmania species that cause visceral leishmaniasis and tegumentary leishmaniasis in the study area, and explain the occurrence of autochthonous human cases of both clinical forms of leishmaniasis in Caxias, Maranhao. The results support our hypothesis that, in the municipality of Caxias, transmission of Leishmania occurs in close proximity to humans.	[Guimaraes-e-Silva, Antonia Suely; Ribeiro da Silva, Rosa Cristina; Soares Pinheiro, Valeria Cristina] Univ Estadual Maranhao, Lab Entomol Med LABEM, Ctr Estudos Super Caxias, Caxias, Maranhao, Brazil; [Silva, Soraia de Oliveira; Melo, Maria Norma] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Biol Leishmania, Dept Parasitol, Belo Horizonte, MG, Brazil; [Macario Rebelo, Jose Manuel] Univ Fed Maranhao, Lab Entomol & Vetores, Dept Biol, Sao Luis, Maranhao, Brazil	Universidade Estadual do Maranhao; Universidade Federal de Minas Gerais; Universidade Federal do Maranhao	Melo, MN (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Biol Leishmania, Dept Parasitol, Belo Horizonte, MG, Brazil.	melo@icb.ufmg.br	Silva, Rosa/AGH-4018-2022; Pinheiro, Valeria Cristina Soares/W-8389-2019	Ribeiro da Silva, Rosa Cristina/0000-0002-7184-0408	Conselho de Desenvolvimento Cientifico e Tecnologico; Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao	Conselho de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao(Fundacao de Amparo a Pesquisa e Desenvolvimento Cientifico do Maranhao (FAPEMA))	This work is supported by Conselho de Desenvolvimento Cientifico e Tecnologico, MNM; Fundacao de Amparo a Pesquisa e ao Desenvolvimento Cientifico e Tecnologico do Maranhao, JMMR.	AGUILAR C M, 1984, Memorias do Instituto Oswaldo Cruz, V79, P181, DOI 10.1590/S0074-02761984000200005; Alexander B, 2002, EMERG INFECT DIS, V8, P1480, DOI 10.3201/eid0812.010485; de Souza AAA, 2016, PARASITE, V23, DOI 10.1051/parasite/2016022; Felipe IMA, 2011, MEM I OSWALDO CRUZ, V106, P207, DOI 10.1590/S0074-02762011000200015; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; Andrade JD, 2009, NEOTROP ENTOMOL, V38, P688, DOI 10.1590/S1519-566X2009000500022; [Anonymous], 2015, GLOB HLTH OBS IND ES; AZEVEDO ACR, 1990, MEM I OSWALDO CRUZ, V85, P251, DOI 10.1590/S0074-02761990000200021; Barata RA, 2005, REV SOC BRAS MED TRO, V38, P421, DOI 10.1590/S0037-86822005000500012; Barbosa David Soeiro, 2010, Ciencia Animal Brasileira, V11, P653, DOI 10.5216/cab.v11i3.5933; Bastrenta B, 2002, ACTA TROP, V83, P249, DOI 10.1016/S0001-706X(02)00129-8; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; BIAGI F, 1972, T ROY SOC TROP MED H, V66, P943, DOI 10.1016/0035-9203(72)90132-0; Brandao SP, 2003, T ROY SOC TROP MED H, V97, P291, DOI 10.1016/S0035-9203(03)90146-5; BRAZIL R P, 1987, Memorias do Instituto Oswaldo Cruz, V82, P145, DOI 10.1590/S0074-02761987000100025; BRAZIL RP, 1991, MEM I OSWALDO CRUZ, V86, P497, DOI 10.1590/S0074-02761991000400029; Brilhante AF, 2015, J VENOM ANIM TOXINS, V21, DOI 10.1186/s40409-015-0041-8; Cabrera MAA, 2003, REV I MED TROPICAL, V25, P79; Carvalho GML, 2008, VECTOR-BORNE ZOONOT, V8, P407, DOI 10.1089/vbz.2007.0180; Casanova C, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002443; Costa J M, 1992, Rev Soc Bras Med Trop, V25, P115, DOI 10.1590/S0037-86821992000200005; CRONIN T M, 1987, Paleontological Society Memoir, P1; Sales KGD, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0840-3; Dantas-Torres F, 2007, VET PARASITOL, V149, P139, DOI 10.1016/j.vetpar.2007.07.007; de Carvalho MR, 2010, ACTA TROP, V116, P108, DOI 10.1016/j.actatropica.2010.03.009; Dos Santos SO, 1998, MED VET ENTOMOL, V12, P315, DOI 10.1046/j.1365-2915.1998.00104.x; El Tai NO, 2000, T ROY SOC TROP MED H, V94, P575, DOI 10.1016/S0035-9203(00)90093-2; Figueredo LA, 2012, REV BRAS PARASITOL V, V21, P418, DOI 10.1590/S1984-29612012005000010; Filho SP, 2006, VET PARASITOL, V140, P54; Galati Eunice Aparecida Bianchi, 2003, Revista de Patologia Tropical, V32, P235; Gil LHS, 2003, MEM I OSWALDO CRUZ, V98, P751, DOI 10.1590/S0074-02762003000600007; Governo do Estado do Atlas do, GOV EST MAR ATL MAR; Haouas N, 2007, AM J TROP MED HYG, V77, P1054, DOI 10.4269/ajtmh.2007.77.1054; Instituto Brasileiro de Geografia e Estat o A stica (IBGE), CENS DEM; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Lainson R., 2010, TOPLEY WILSONS MICRO, DOI 10.1002/9780470688618; Lainson R, 2005, TOPLEY WILSONS MICRO, V5, P313; Lainson Ralph, 2010, Revista Pan-Amazonica de Saude, V1, P13; Lana RS, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/385493; Lins RMMA, 2002, INSECT MOL BIOL, V11, P117, DOI 10.1046/j.1365-2583.2002.00315.x; LUCAS CM, 1994, AM J TROP MED HYG, V51, P533, DOI 10.4269/ajtmh.1994.51.533; Madeira Maria de Fátima, 2003, Rev. Soc. Bras. Med. Trop., V36, P551, DOI 10.1590/S0037-86822003000500002; Madeira MF, 2006, T ROY SOC TROP MED H, V100, P442, DOI 10.1016/j.trstmh.2005.07.011; Marco JD, 2001, MEM I OSWALDO CRUZ, V96, P649, DOI 10.1590/S0074-02762001000500009; Marcondes M., 2013, Brazilian Journal of Veterinary Research and Animal Science, V50, P341, DOI 10.11606/issn.2318-3659.v50i5p341-352; Savani ESMM, 2009, VET PARASITOL, V160, P18, DOI 10.1016/j.vetpar.2008.10.090; MAYRINK W, 1979, ANN TROP MED PARASIT, V73, P123, DOI 10.1080/00034983.1979.11687239; Michalsky Érika Monteiro, 2011, Rev. Soc. Bras. Med. Trop., V44, P58, DOI 10.1590/S0037-86822011000100014; Ministerio da Saude do Brasil, 2007, MAN VIG LEISHM TEG A; Missawa Nanci Akemi, 2011, Rev. Soc. Bras. Med. Trop., V44, P76, DOI 10.1590/S0037-86822011000100017; Oliveira-Pereira YN, 2008, CAD SAUDE PUBLICA, V24, P2183, DOI 10.1590/S0102-311X2008000900024; Paiva BR, THESIS; Quaresma PF, 2012, MEM I OSWALDO CRUZ, V107, P480, DOI 10.1590/S0074-02762012000400007; Rangel EF, 2009, MEM I OSWALDO CRUZ, V104, P937, DOI 10.1590/S0074-02762009000700001; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Soares VYR, 2014, MEM I OSWALDO CRUZ, V109, P379, DOI 10.1590/0074-0276130405; Salomon OD, 2010, ACTA TROP, V113, P84, DOI 10.1016/j.actatropica.2009.08.024; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SANTOS FR, 1993, HUM GENET, V90, P655; Saraiva L, 2010, MEM I OSWALDO CRUZ, V105, P1033, DOI 10.1590/S0074-02762010000800013; Scarpassa VM, 2015, OVERVIEW TROPICAL DI; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2; Shaw JJ, 2002, WORLD CL PARASITES, V4, P11; Shaw JJ, 1999, MEMOIRS ENTOMOLOGY; Silva LB, 2015, REV PATOL TROP, V44, P181; Silveira F.T., 1989, Revista da Sociedade Brasileira de Medicina Tropical, V22, P125, DOI 10.1590/S0037-86821989000300003; SILVEIRA FT, 1984, REV INST MED TROP SP, V26, P272, DOI 10.1590/S0036-46651984000500008; SILVEIRA FT, 1991, MEM I OSWALDO CRUZ, V86, P127, DOI 10.1590/S0074-02761991000100021; SILVEIRA FT, 1991, REV I MED TROP, V33, P18, DOI 10.1590/S0036-46651991000100004; Nasciment MDSB, 2013, REV SOC BRAS MED TRO, V46, P555, DOI 10.1590/0037-8682-0150-2013; Soares IR, 2013, VET PARASITOL, V197, P665, DOI 10.1016/j.vetpar.2013.06.014; Soares Maria Regiane Araujo, 2010, Cad Saude Publica, V26, P2409, DOI 10.1590/S0102-311X2010001200019; Steuber S, 2005, PARASITOL RES, V97, P247, DOI 10.1007/s00436-005-1410-y; Tanure A, 2015, REV INST MED TROP SP, V57, P321, DOI 10.1590/S0036-46652015000400008; Tolezano JE, 2007, VET PARASITOL, V149, P280, DOI 10.1016/j.vetpar.2007.07.008; YOSHIDA ELA, 1990, MEM I OSWALDO CRUZ, V85, P133, DOI 10.1590/S0074-02761990000100026; Young David G., 1994, Memoirs of the American Entomological Institute (Gainesville), V54, P1	77	25	25	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0179052	10.1371/journal.pone.0179052	http://dx.doi.org/10.1371/journal.pone.0179052			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837565	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000002
J	Hallengren, M; Astrand, P; Eksborg, S; Barle, H; Frostell, C				Hallengren, Mikael; Astrand, Per; Eksborg, Staffan; Barle, Hans; Frostell, Claes			Septic shock and the use of norepinephrine in an intermediate care unit: Mortality and adverse events	PLOS ONE			English	Article							GOAL-DIRECTED RESUSCITATION; SEVERE SEPSIS; HOSPITAL MORTALITY; DETERMINANTS; MANAGEMENT; THERAPY; ACCESS	Background Septic shock is associated with high mortality. Aged and multimorbid patients are not always eligible for intensive care units. Norepinephrine is an accepted treatment for hypotension in septic shock. It is unknown whether norepinephrine has a place in treatment outside an intensive care unit and when given peripherally. Objectives To describe mortality, Acute Physiology And Chronic Health Evaluation (APACHE-II), time to mean arterial pressure >65 mmHg, and adverse events in patients with septic shock receiving norepinephrine peripherally in an intermediate care unit. Methods From a retrospective chart review of 91 patients with septic shock treated with norepinephrine for hypotension, ward mortality, 30-, 60- and 90-day mortality, standardized mortality ratio (SMR) and adverse events (necrosis and arrhythmia) were analysed. Administration route via peripheral venous catheter or central venous catheter was registered. Results Median age was 81 (43-96) years and median APACHE-II score was 26 (12-42). Observed ward mortality was 27.5% (SMR 0.443, 95% CI: 0.287-0.654), and 30-day and 90-day mortality were 47.2% and 58.2%, respectively. Conclusions Elderly patients with septic shock treated with norepinephrine displayed a better survival in the ward and at 30 days than expected. Our retrospective study did not indicate frequent complications when administering norepinephrine via a peripheral venous catheter.	[Hallengren, Mikael; Barle, Hans; Frostell, Claes] Karolinska Inst, Danderyd Hosp, Div Anaesthesia & Intens Care, Dept Clin Sci, Stockholm, Sweden; [Astrand, Per] Karolinska Inst, Danderyd Hosp, Dept Clin Sci, Div Internal Med, Stockholm, Sweden; [Eksborg, Staffan] Karolinska Inst, Astrid Lindgren Childrens Hosp, Karolinska Univ Hosp Solna, Dept Womens & Childrens Hlth,Childhood Canc Res U, Stockholm, Sweden; [Frostell, Claes] Claes Frostell Res & Consulting AB, Stockholm, Sweden	Danderyds Hospital; Karolinska Institutet; Danderyds Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Hallengren, M (corresponding author), Karolinska Inst, Danderyd Hosp, Div Anaesthesia & Intens Care, Dept Clin Sci, Stockholm, Sweden.	mikael.hallengren@sll.se		Hallengren, Mikael/0000-0002-1481-8511; Eksborg, Staffan/0000-0001-7326-9471	Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute; Claes Frostell Research Consulting AB; Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute; Claes Frostell Research Consulting AB	Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute(Karolinska Institutet); Claes Frostell Research Consulting AB; Claes Frostell Research and Consulting AB; Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS); Karolinska Institute(Karolinska Institutet); Claes Frostell Research Consulting AB	This study was funded in part by Claes Frostell Research and Consulting AB - (1) Fee for IRB, (2) Fee for English proofreading, (3) The publication fee in case of acceptance in PLOS ONE. Data Collection was in part supported by the following educational funds to MH as part of his medical studies. The educational funds were paid as a bench fee from Karolinska Institute to Karolinska Institute Danderyds Hospital (KIDS) for expenses when accepting and supervising a master thesis at the institution. There is no grant name, number or URL, however we have a certificate from Karolinska Institute explaining the bench fee. It is uploaded as a separate file named S2 File. This will hopefully explain in full extent the bench fee from Karolinska Institute and further questions can be answered by contact information in the certificate. No additional funding was received for this study. Claes Frostell is the owner of Claes Frostell Research & Consulting AB. Claes Frostell Research & Consulting AB provided support in the form of part time salary for author CF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; [Anonymous], 2012, KIDNEY INT SUPPL, V2, P1, DOI [10.1038/kisup.2012.1, DOI 10.1038/KISUP.2012.1]; Bai XW, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0532-y; Cecconi M, 2014, MINERVA ANESTESIOL, V80, P701; Dalegrave Daniele, 2012, Rev. bras. ter. intensiva, V24, P362, DOI 10.1590/S0103-507X2012000400012; Dellinger RP, 2013, INTENS CARE MED, V41, P580, DOI [DOI 10.1007/s00134-012-2769-8, 10.1007/s00134-012-2769-8]; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hodzic Samir, 2014, Med Arch, V68, P300, DOI 10.5455/medarh.2014.68.300-303; Kato R, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0085-5; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kumar R, 2011, INDIAN PEDIATR, V48, P277, DOI 10.1007/s13312-011-0055-4; Labelle A, 2012, CRIT CARE MED, V40, P2016, DOI 10.1097/CCM.0b013e318250aa72; Lampin ME, 2012, ACTA PAEDIATR, V101, pe426, DOI 10.1111/j.1651-2227.2012.02725.x; LIDDELL FDK, 1984, J EPIDEMIOL COMMUN H, V38, P85, DOI 10.1136/jech.38.1.85; Loubani OM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.01.014; Marik P, 2016, BRIT J ANAESTH, V116, P339, DOI 10.1093/bja/aev349; McEvoy C, 2013, CURR INFECT DIS REP, V15, P400, DOI 10.1007/s11908-013-0361-1; Morimatsu H, 2004, RESUSCITATION, V62, P249, DOI 10.1016/j.resuscitation.2004.03.016; Mouncey PR, 2015, NEW ENGL J MED, V372, P1301, DOI 10.1056/NEJMoa1500896; Omar S, 2011, ANAESTH INTENS CARE, V39, P449, DOI 10.1177/0310057X1103900316; Pavon A, 2013, CRIT CARE MED, V41, P2600, DOI 10.1097/CCM.0b013e31829a6e89; Peake SL, 2014, NEW ENGL J MED, V371, P1496, DOI 10.1056/NEJMoa1404380; Rai SS, 2010, CRIT CARE RESUSC, V12, P177; Ricard JD, 2013, CRIT CARE MED, V41, P2108, DOI 10.1097/CCM.0b013e31828a42c5; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Rogers G, 2000, INT J SPORTS MED, V21, P90; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Turner DA, 2010, PEDIATR EMERG CARE, V26, P563, DOI 10.1097/PEC.0b013e3181ea71e1; Yealy DM, 2014, NEW ENGL J MED, V370, P1683, DOI 10.1056/NEJMoa1401602	29	16	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183073	10.1371/journal.pone.0183073	http://dx.doi.org/10.1371/journal.pone.0183073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837628	Green Published, gold			2022-12-27	WOS:000408365000046
J	Li, J				Li, Jin			Assessing the accuracy of predictive models for numerical data: Not r nor r(2), why not? Then what?	PLOS ONE			English	Article							ABSOLUTE ERROR MAE; REFINED INDEX; PERFORMANCE; RMSE	Assessing the accuracy of predictive models is critical because predictive models have been increasingly used across various disciplines and predictive accuracy determines the quality of resultant predictions. Pearson product-moment correlation coefficient (r) and the coefficient of determination (r(2)) are among the most widely used measures for assessing predictive models for numerical data, although they are argued to be biased, insufficient and misleading. In this study, geometrical graphs were used to illustrate what were used in the calculation of r and r(2) and simulations were used to demonstrate the behaviour of r and r(2) and to compare three accuracy measures under various scenarios. Relevant confusions about r and r(2), has been clarified. The calculation of r and r(2) is not based on the differences between the predicted and observed values. The existing error measures suffer various limitations and are unable to tell the accuracy. Variance explained by predictive models based on cross-validation (VEcv) is free of these limitations and is a reliable accuracy measure. Legates and McCabe's efficiency (E-1) is also an alternative accuracy measure. The r and r(2) do not measure the accuracy and are incorrect accuracy measures. The existing error measures suffer limitations. VEcv and E-1 are recommended for assessing the accuracy. The applications of these accuracy measures would encourage accuracy-improved predictive models to be developed to generate predictions for evidence-informed decision-making.	[Li, Jin] Geosci Australia, Natl Earth & Marine Observat, Environm Geosci Div, Canberra, ACT, Australia	Geoscience Australia	Li, J (corresponding author), Geosci Australia, Natl Earth & Marine Observat, Environm Geosci Div, Canberra, ACT, Australia.	Jin.Li@ga.gov.au		Li, Jin/0000-0001-9339-3349	Geoscience Australia	Geoscience Australia	This study was supported by Geoscience Australia. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auguie B, 2017, GRIDEXTRA MISCELLANE; Bennett ND, 2013, ENVIRON MODELL SOFTW, V40, P1, DOI 10.1016/j.envsoft.2012.09.011; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; Crawley M.J., 2007, R BOOK; Crawley MJ, 2003, STAT COMPUTING INTRO; Draper N.R., 1998, APPL REGRESSION ANAL, P79; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; GREENWOOD DJ, 1985, PLANT SOIL, V85, P185, DOI 10.1007/BF02139623; Gupta HV, 2009, J HYDROL, V377, P80, DOI 10.1016/j.jhydrol.2009.08.003; He YF, 2010, SCI TOTAL ENVIRON, V408, P4211, DOI 10.1016/j.scitotenv.2010.04.052; Karl JW, 2010, RANGELAND ECOL MANAG, V63, P335, DOI 10.2111/REM-D-09-00074.1; Kessler E, 1994, ATMOS RES, V34, P217, DOI 10.1016/0169-8095(94)90093-0; Kohavi R, 1995, STUDY CROSS VALIDATI, P1137; Krause P., 2005, ADV GEOSCI, V5, P89, DOI [10.5194/adgeo-5-89-2005, DOI 10.5194/ADGEO-5-89-2005, DOI 10.5194/ADGE0-5-89-2005]; Kuhn M., 2013, APPL PREDICTIVE MODE, DOI 10.1007/978-1-4614-6849-3; KVALSETH TO, 1985, AM STAT, V39, P279, DOI 10.2307/2683704; Legates DR, 2013, INT J CLIMATOL, V33, P1053, DOI 10.1002/joc.3487; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Legates DR, 1997, GEOPHYS RES LETT, V24, P2319, DOI 10.1029/97GL02207; Li J, 2013, 20TH INTERNATIONAL CONGRESS ON MODELLING AND SIMULATION (MODSIM2013), P394; Li J., 2008, REV SPATIAL INTERPOL; Li J, 2013, DATA MINING APPL R, P299; Li J, 2013, P 11 AUSTR DAT MIN C, V146; Li J, 2017, ENVIRON MODELL SOFTW, V97, P112, DOI 10.1016/j.envsoft.2017.07.016; Li J, 2016, ENVIRON MODELL SOFTW, V80, P1, DOI 10.1016/j.envsoft.2016.02.004; Li J, 2011, ECOL INFORM, V6, P228, DOI 10.1016/j.ecoinf.2010.12.003; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; MCCUEN RH, 1975, WATER RESOUR RES, V11, P1021, DOI 10.1029/WR011i006p01021; MURPHY AH, 1989, MON WEATHER REV, V117, P572, DOI 10.1175/1520-0493(1989)117<0572:SSACCI>2.0.CO;2; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Schemper M, 2003, STAT MED, V22, P2299, DOI 10.1002/sim.1486; Schloeder CA, 2001, SOIL SCI SOC AM J, V65, P470, DOI 10.2136/sssaj2001.652470x; Singh V, 2011, ENVIRON MODELL SOFTW, V26, P778, DOI 10.1016/j.envsoft.2010.11.014; Vicente-Serrano SM, 2003, CLIMATE RES, V24, P161, DOI 10.3354/cr024161; Weglarczyk S, 1998, J HYDROL, V206, P98, DOI 10.1016/S0022-1694(98)00094-8; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Willmott CJ, 2005, CLIMATE RES, V30, P79, DOI 10.3354/cr030079; Willmott CJ, 2006, INT J GEOGR INF SCI, V20, P89, DOI 10.1080/13658810500286976; Willmott CJ, 2015, ENVIRON MODELL SOFTW, V73, P167, DOI 10.1016/j.envsoft.2015.08.012; Willmott CJ, 2012, INT J CLIMATOL, V32, P2088, DOI 10.1002/joc.2419; Willmott CJ, 2009, ATMOS ENVIRON, V43, P749, DOI 10.1016/j.atmosenv.2008.10.005	41	57	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183250	10.1371/journal.pone.0183250	http://dx.doi.org/10.1371/journal.pone.0183250			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837692	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000053
J	Li, Z; Tang, Y; Tang, N; Feng, Q; Zhong, H; Liu, YM; Wang, LM; He, F				Li, Zhen; Tang, Yan; Tang, Na; Feng, Qian; Zhong, Hua; Liu, Yong-min; Wang, La-mei; He, Fang			High anti-human cytomegalovirus antibody levels are associated with the progression of essential hypertension and target organ damage in Han Chinese population	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; BLOOD-PRESSURE; OXIDATIVE STRESS; INFECTION; RISK; ATHEROSCLEROSIS; MECHANISMS; MORTALITY; ETIOLOGY; DISEASE	Human cytomegalovirus (CMV) infection is associated with hypertension and has been linked with the pathogenesis of increased arterial blood pressure (BP). Currently, whether CMV infection is associated with the progression of hypertension and hypertensive target organ damage (TOD) remains to be identified. We aimed to examine the relationship between CMV infection and the progression of hypertension and hypertensive TOD, which could provide clues on the possible mediating mechanisms, in the Han Chinese population. A total of 372 patients with hypertension and 191 healthy controls (Han participants from Xinjiang, China) were included in the study. Enzyme-linked immunosorbent assay (ELISA) and qPCR were used to detect CMV infection. C-reactive protein (CRP), tumor necrosis factor-alpha (TNF-alpha), and interleukin-6 (IL-6) titers were also analyzed using an ELISA kit. Moreover, cardiovascular disease markers were evaluated by echocardiography, carotid ultrasonography, and tomographic scans. Essential hypertension (EH) patients exhibited a marked increase in CMV IgG antibody, CRP, TNF-alpha, and IL-6 levels. Higher grade of hypertension and hypertensive TOD had higher CMV IgG antibody and CRP levels. The CMV IgG antibody titers were positively correlated with arterial BP, greater grade of hypertension and hypertensive TOD, and CRP and IL-6 levels. The higher quartile of CMV IgG titer and CRP level were associated with the incidence of hypertension and the progression of hypertension and hypertensive TOD. In the Han Chinese population, high CMV IgG titers are associated with the progression of hypertension and hypertensive TOD. CMV IgG titer >4.25 U could be an independent predictor of hypertension and progression of hypertension, while that >4.85 U could be an independent risk factor for hypertensive TOD. The underlying mechanism may be largely mediated by chronic inflammation.	[Li, Zhen; Tang, Na; Feng, Qian; Zhong, Hua; Liu, Yong-min; He, Fang] Shihezi Univ, Coll Med, Dept Pathophysiol, Key Lab Educ Minist Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China; [Li, Zhen] Shihezi Univ, Coll Med, Affiliated Hosp 1, Dept Emergency & Crit Care Med, Shihezi, Peoples R China; [Tang, Yan] Shihezi Univ, Coll Med, Affiliated Hosp 1, Dept Geriatr, Shihezi, Peoples R China; [Wang, La-mei] Shihezi Univ, Coll Med, Ctr Med Funct Expt, Shihezi, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University	He, F (corresponding author), Shihezi Univ, Coll Med, Dept Pathophysiol, Key Lab Educ Minist Xinjiang Endem & Ethn Dis, Shihezi, Peoples R China.	fangf2002shz@126.com	Liu, Yong/GWQ-6163-2022		National Natural Science Foundation of China [U1403123]; Ministry of Major Science & Technology of Shihezi University [gxjs2013-zdgg04, gxjs2013-zdgg04-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Major Science & Technology of Shihezi University	This project was supported by the Joint Funds of the National Natural Science Foundation of China (No.U1403123) and the Ministry of Major Science & Technology of Shihezi University (No. gxjs2013-zdgg04, No.gxjs2013-zdgg04-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2006, J AM GERIATR SOC, V54, P1046, DOI 10.1111/j.1532-5415.2006.00796.x; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; Chen YM, 2014, J MICROBIOL IMMUNOL, V47, P345, DOI 10.1016/j.jmii.2013.01.011; Cheng J, 2009, PLOS PATHOG, V5, P4713; Chobanian AV, 1996, ARCH INTERN MED, V156, P1952, DOI 10.1001/archinte.156.17.1952; Choudhary A, 2015, INDIAN J MED MICR S2, V33, P135; COSENTINO F, 1994, HYPERTENSION, V23, P229, DOI 10.1161/01.HYP.23.2.229; Delitala AP, 2015, NUTR METAB CARDIOVAS, V25, P1104, DOI 10.1016/j.numecd.2015.09.001; Dolan A, 2004, J GEN VIROL, V85, P1301, DOI 10.1099/vir.0.79888-0; Dumortier J, 2008, J VIROL, V82, P6524, DOI 10.1128/JVI.00502-08; Ehret GB, 2016, NATURE GENETICS, V48; Martinez-Rodriguez JE, 2013, ARTERIOSCL THROM VAS, V33, P2653, DOI 10.1161/ATVBAHA.113.302163; Gandhi MK, 2003, BLOOD REV, V17, P259, DOI 10.1016/S0268-960X(03)00028-6; Gaytant MA, 2002, OBSTET GYNECOL SURV, V57, P245, DOI 10.1097/00006254-200204000-00024; Gomez-Hernandez A, 2016, INT J ENDOCRINOL, V2016, DOI 10.1155/2016/1216783; Gu Dong-feng, 2003, Zhonghua Yufang Yixue Zazhi, V37, P84; Guetta E, 1997, CIRC RES, V81, P8, DOI 10.1161/01.RES.81.1.8; Haarala A, 2012, CLIN EXP IMMUNOL, V167, P309, DOI 10.1111/j.1365-2249.2011.04513.x; Huang LC, 2016, J ATHEROSCLEROSIS TH; Huang ZR, 2012, CNS NEUROSCI THER, V18, P457, DOI 10.1111/j.1755-5949.2012.00326.x; Hui J, 2016, WIEN KLIN WOCHENSCHR, V128, P586, DOI 10.1007/s00508-016-0977-x; IKEDA U, 1991, AM J PHYSIOL, V260, pH1713, DOI 10.1152/ajpheart.1991.260.5.H1713; Jeong SH, 2016, GLOBAL AUTEUR: THE POLITICS OF AUTHORSHIP IN 21ST CENTURY CINEMA, P1; Jeong SJ, 2015, CLIN CHIM ACTA, V445, P65, DOI 10.1016/j.cca.2015.03.015; Kunes J, 2009, PHYSIOL RES, V58, pS33, DOI 10.33549/physiolres.931913; Labarrere CA, 2004, AM J MED, V117, P499, DOI 10.1016/j.amjmed.2004.03.039; Landmesser U, 2002, HYPERTENSION, V40, P511, DOI 10.1161/01.HYP.0000032100.23772.98; Lee SY, 2011, INT J NANOMED, V6, P179, DOI 10.2147/IJN.S12760; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Lin WR, 2002, NEUROBIOL DIS, V9, P82, DOI 10.1006/nbdi.2001.0465; Lloyd-Jones D, 2009, CIRCULATION, V119, P480, DOI 10.1161/CIRCULATIONAHA.108.191259; Mancia G, 2013, BLOOD PRESSURE, V25, P1751; MCVOY MA, 1989, J INFECT DIS, V160, P1, DOI 10.1093/infdis/160.1.1; Mehta SK, 2000, J INFECT DIS, V182, P1761, DOI 10.1086/317624; Muhlestein JB, 2000, CIRCULATION, V102, P20; Mundkur LA, 2012, HEART, V98, P982, DOI 10.1136/heartjnl-2012-301850; Patel R, 2006, J VASC SURG, V43, P364, DOI 10.1016/j.jvs.2005.10.032; Pierdomenico SD, 2009, AM J HYPERTENS, V22, P842, DOI 10.1038/ajh.2009.103; Popovic M, 2012, J THROMB THROMBOLYS, V33, P160, DOI 10.1007/s11239-011-0662-x; Priviero FBM, 2009, AM J HYPERTENS, V22, P493, DOI 10.1038/ajh.2009.18; Prosch S, 2001, J BIOL CHEM, V276, P40712, DOI 10.1074/jbc.M009815200; Roberts ET, 2010, AM J EPIDEMIOL, V172, P363, DOI 10.1093/aje/kwq177; Rust P, 2016, IMPACT SALT INTAKE P; Sachetelli S, 2006, KIDNEY INT, V69, P1016, DOI 10.1038/sj.ki.5000210; Savva GM, 2013, AGING CELL, V12, P381, DOI 10.1111/acel.12059; Shamran HA, 2015, BIOMED RES INT, V2015, P1; Simanek AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016103; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Tang N, 2014, MED SCI MONITOR, V20, P2508, DOI 10.12659/MSM.892861; van der Meer IM, 2002, STROKE, V33, P2750, DOI 10.1161/01.STR.0000044168.00485.02; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Wall NA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055686; Wang GC, 2010, AM J EPIDEMIOL, V171, P1144, DOI 10.1093/aje/kwq062; WANG H., 2015, EURASIP J WIREL COMM, V2015, P1, DOI DOI 10.1016/J.TPLANTS.2015.04.003; Yaiw KC, 2013, HERPESVIRIDAE, V4, P1; Young W, 2000, CIRC RES, V86, P906, DOI 10.1161/01.RES.86.8.906; Zhang J, 2015, MED SCI MONITOR, V21, P4102, DOI 10.12659/MSM.896071; Zhang MM, 2011, MED HYPOTHESES, V76, P682, DOI 10.1016/j.mehy.2011.01.032; Zheng L, 2016, CIRCULATION J OFFICI	60	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181440	10.1371/journal.pone.0181440	http://dx.doi.org/10.1371/journal.pone.0181440			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837559	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000007
J	Richards, KH; Schanze, N; Monk, R; Rijntjes, E; Rathmann, D; Kohrle, J				Richards, Keith H.; Schanze, Nancy; Monk, Ray; Rijntjes, Eddy; Rathmann, Daniel; Koehrle, Josef			A validated LC-MS/MS method for cellular thyroid hormone metabolism: Uptake and turnover of mono-iodinated thyroid hormone metabolites by PCCL3 thyrocytes	PLOS ONE			English	Article							TANDEM MASS-SPECTROMETRY; 3-IODOTHYRONAMINE; 3,5-DIIODOTHYRONINE; HYPOTHYROIDISM; INACTIVATION; IMMUNOASSAY; THYRONINE; PATHWAYS; HUMANS; CELLS	Tyrosine and phenolic ring de-iodination of thyroid hormones (TH) is crucial for regulating their physiological activity. Furthermore, reactions such as de-carboxylation to thyronamines (TAM) and de-amination to thyroacetic acids (TAc) produce TH metabolites (THM) with distinct biological properties. This needs to be considered when studying effects of TH and THM. The accurate and precise quantitative analysis of TH and THM in cell culture supernatants and cell lysates are key procedures required for studying the in vitro metabolism of TH. We report here the development of a liquid-liquid extraction/isotope dilution-liquid chromatography-electrospray tandem mass spectrometry (LC-MS/MS) method for the quantification of 9 thyronines (TN) and 6 TAM in human hepatocellular carcinoma Hep G2 cell lysate extracts. In addition, we adapted the method to quantify TH, TAM and TAc, in cell lysates of FBS-depleted rat thyroid epithelium PCCL3 cells. The methods for both cell lines were validated by rigorous assessment of linearity, limits of quantification and detection (LLOQ and LLOD respectively), intra-and inter-day accuracy, precision, process efficiency (PE), matrix effect (ME) and relative recovery (RE). Calibration curves covering 11 concentrations (based on 400 mu l of lysate) were linear in the range 0.016-50 nM and 0.010-50 nM for Hep G2 and PCCL3 cells respectively. The lower limits of quantification were in the range 0.031 to 1 nM. We applied the PCCL3 version of the LC-MS/MS method to the analysis of lysed cell extracts from PCCL3 cells that had been incubated with 3-iodo-L-thyronine (T1), 3-iodothyronamine (3-T(1)AM) and 3-iodothyroacetic acid (3-T1Ac). Over the course of 30 minutes incubation 3-T1AM was de-iodinated to 4-[4-(2-aminoethylphenoxy)]phenol (thyronamine, T(0)AM) and de-aminated to 3-T1Ac respectively, whilst T1 underwent de-iodination to T-0. This data indicates avid metabolism of these mono-iodinated compounds and the utility of LC-MS/MS to quantify such cellular metabolism.	[Richards, Keith H.; Schanze, Nancy; Monk, Ray; Rijntjes, Eddy; Koehrle, Josef] Charite Univ Med Berlin, Inst Expt Endokrinol, Augustenburger Pl 1, Berlin, Germany; [Rathmann, Daniel] Chromicent GmbH, Johann Hittorf Str 8, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Kohrle, J (corresponding author), Charite Univ Med Berlin, Inst Expt Endokrinol, Augustenburger Pl 1, Berlin, Germany.	josef.koehrle@charite.de	Köhrle, Josef/AAH-6438-2020	Köhrle, Josef/0000-0002-9187-9078; Rijntjes, Eddy/0000-0001-8870-8545; Schanze, Nancy/0000-0002-4012-103X	Deutsche Forschungsgemeinschaft DFG [K0922-16/1-2, K0922-17/1-2, SPP1629]; Charite thesis scholarship	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG)); Charite thesis scholarship	This work was supported by the Deutsche Forschungsgemeinschaft DFG (K0922-16/1-2 to J.K. and K0922-17/1-2 to J.K) in the framework of the DFG funded Priority Programme SPP1629 THYROIDTRANSACT and a Charite thesis scholarship (to N.S.). The company Chromicent GmbH played no part in any capacity in the project	Agretti P, 2011, J MOL ENDOCRINOL, V47, P23, DOI 10.1530/JME-10-0168; Braulke LJ, 2008, J COMP PHYSIOL B, V178, P167, DOI 10.1007/s00360-007-0208-x; Buhrman DL, 1996, J AM SOC MASS SPECTR, V7, P1099, DOI 10.1016/S1044-0305(96)00072-4; Commissione Europea, 2001, GOV EUR LIBR BIANC 2, P1; Dentice M, 2011, J ENDOCRINOL, V209, P273, DOI 10.1530/JOE-11-0002; FUSCO A, 1987, MOL CELL BIOL, V7, P3365, DOI 10.1128/MCB.7.9.3365; Fusco A, 1985, EPITHELIAL TRANSFORM; Ghelardoni S, 2014, J ENDOCRINOL, V221, P101, DOI 10.1530/JOE-13-0311; Hoefig CS, 2011, J CLIN ENDOCR METAB, V96, P1864, DOI 10.1210/jc.2010-2680; Johannes J, 2016, MOL ENDOCRINOL, V30, P796, DOI 10.1210/me.2016-1037; Jonas W, 2015, ENDOCRINOLOGY, V156, P389, DOI 10.1210/en.2014-1604; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; Lehmphul I, 2014, THYROID, V24, P1350, DOI 10.1089/thy.2013.0688; Matuszewski BK, 2003, ANAL CHEM, V75, P3019, DOI 10.1021/ac020361s; Padron AS, 2014, J ENDOCRINOL, V221, P415, DOI 10.1530/JOE-13-0502; PILO A, 1990, AM J PHYSIOL, V258, pE715, DOI 10.1152/ajpendo.1990.258.4.E715; PITTMAN CS, 1972, J CLIN INVEST, V51, P1759, DOI 10.1172/JCI106977; RAMSDEN DB, 1984, BIOMED MASS SPECTROM, V11, P193, DOI 10.1002/bms.1200110411; Rathmann D, 2015, EUR THYROID J, V4, P51, DOI 10.1159/000430840; Richards K, 2017, MOL CELLULA IN PRESS; Scanlan TS, 2004, NAT MED, V10, P638, DOI 10.1038/nm1051; Schanze N, 2017, THYROID, V27, P11, DOI 10.1089/thy.2016.0182; Visser TJ, 1996, ACTA MED AUST, V23, P10; Vogeser M, 2010, CLIN CHEM, V56, P1234, DOI 10.1373/clinchem.2009.138602; WILLETTS P, 1979, J CLIN ENDOCR METAB, V49, P658, DOI 10.1210/jcem-49-4-658; Wu SY, 2005, THYROID, V15, P943, DOI 10.1089/thy.2005.15.943	26	12	12	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183482	10.1371/journal.pone.0183482	http://dx.doi.org/10.1371/journal.pone.0183482			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837607	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000072
J	Van Kampen, JM; Kay, DG				Van Kampen, Jackalina M.; Kay, Denis G.			Progranulin gene delivery reduces plaque burden and synaptic atrophy in a mouse model of Alzheimer's disease	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3; AMYLOID-BETA DEPOSITION; A-BETA; GROWTH-FACTOR; NEUROTROPHIC FACTOR; NEURITE OUTGROWTH; OXIDATIVE STRESS; DOWN-REGULATION; HOST-DEFENSE; NEPRILYSIN	Progranulin (PGRN) is a multifunctional protein that is widely expressed throughout the brain, where it has been shown to act as a critical regulator of CNS inflammation and also functions as an autocrine neuronal growth factor, important for long-term neuronal survival. PGRN has been shown to activate cell signaling pathways regulating excitoxicity, oxidative stress, and synaptogenesis, as well as amyloidogenesis. Together, these critical roles in the CNS suggest that PGRN has the potential to be an important therapeutic target for the treatment of various neurodegenerative disorders, particularly Alzheimer's disease (AD). AD is the leading cause of dementia and is marked by the appearance of extracellular plaques consisting of aggregates of amyloid-beta (A beta), as well as neuroinflammation, oxidative stress, neuronal loss and synaptic atrophy. The ability of PGRN to target multiple key features of AD pathophysiology suggests that enhancing its expression may benefit this disease. Here, we describe the application of PGRN gene transfer using in vivo delivery of lentiviral expression vectors in a transgenic mouse model of AD. Viral vector delivery of the PGRN gene effectively enhanced PGRN expression in the hippocampus of Tg2576 mice. This elevated PGRN expression significantly reduced amyloid plaque burden in these mice, accompanied by reductions in markers of inflammation and synaptic atrophy. The overexpression of PGRN was also found to increase activity of neprilysin, a key amyloid beta degrading enzyme. PGRN regulation of neprilysin activity could play a major role in the observed alterations in plaque burden. Thus, PGRN may be an effective therapeutic target for the treatment of AD.	[Van Kampen, Jackalina M.; Kay, Denis G.] Neurodyn Inc, Charlottetown, PE, Canada; [Van Kampen, Jackalina M.] Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE, Canada; [Van Kampen, Jackalina M.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Kay, Denis G.] Univ Prince Edward Isl, Dept Pathol & Microbiol, Charlottetown, PE, Canada	University of Prince Edward Island; Mayo Clinic; University of Prince Edward Island	Van Kampen, JM (corresponding author), Neurodyn Inc, Charlottetown, PE, Canada.; Van Kampen, JM (corresponding author), Univ Prince Edward Isl, Dept Biomed Sci, Charlottetown, PE, Canada.; Van Kampen, JM (corresponding author), Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.	jvankampen@neurodyn.ca		Van Kampen, Jackalina/0000-0002-8351-4757	Atlantic Canada Opportunities Agency	Atlantic Canada Opportunities Agency	This work was supported by Atlantic Canada Opportunities Agency (http://www.acoa-apeca.gc.ca/Eng/Pages/Home.aspx) (DK). The funding organizations, Atlantic Canada Opportunities Agency and Neurodyn Inc., did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries and research materials.	Ahmed Z, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-7; Ahmed Z, 2010, AM J PATHOL, V177, P311, DOI 10.2353/ajpath.2010.090915; Akiyama H, 2001, BRAIN RES, V902, P277, DOI 10.1016/S0006-8993(01)02390-3; Apelt J, 2003, NEUROSCI LETT, V339, P183, DOI 10.1016/S0304-3940(03)00030-2; Avrahami L, 2013, J BIOL CHEM, V288, P1295, DOI 10.1074/jbc.M112.409250; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Barua NU, 2012, J ALZHEIMERS DIS, V32, P43, DOI 10.3233/JAD-2012-120658; Benzing WC, 1999, NEUROBIOL AGING, V20, P581, DOI 10.1016/S0197-4580(99)00065-2; Brouwers N, 2008, NEUROLOGY, V71, P656, DOI 10.1212/01.wnl.0000319688.89790.7a; Cerpa W, 2009, DRUG NEWS PERSPECT, V22, P579, DOI [10.1358/dnp.2009.10.1436817, 10.1358/dnp.2009.22.10.1443391]; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cote M, 2015, NEUROBIOL DIS, V82, P99, DOI 10.1016/j.nbd.2015.05.017; Cruts Marc, 2006, Current Alzheimer Research, V3, P485, DOI 10.2174/156720506779025251; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Devos D, 2013, NEUROBIOL DIS, V50, P42, DOI 10.1016/j.nbd.2012.09.007; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; El-Amouri SS, 2008, AM J PATHOL, V172, P1342, DOI 10.2353/ajpath.2008.070620; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Garzon DJ, 2007, J NEUROSCI, V27, P2628, DOI 10.1523/JNEUROSCI.5053-06.2007; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Guo A, 2010, BRAIN RES; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; He ZH, 2002, CANCER RES, V62, P5590; Heneka MT, 2010, J NEURAL TRANSM, V117, P919, DOI 10.1007/s00702-010-0438-z; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Hynd MR, 2004, NEUROCHEM INT, V45, P583, DOI 10.1016/j.neuint.2004.03.007; Inestrosa NC, 2010, NAT REV NEUROSCI, V11, P77, DOI 10.1038/nrn2755; Irwin D, 2009, J NEUROL SCI, V276, P9, DOI 10.1016/j.jns.2008.08.024; Iwata N, 2001, SCIENCE, V292, P1550, DOI 10.1126/science.1059946; Jacobsen JS, 2006, P NATL ACAD SCI USA, V103, P5161, DOI 10.1073/pnas.0600948103; Jin FY, 1997, CELL, V88, P417, DOI 10.1016/S0092-8674(00)81880-2; Kang KA, 2010, INT J MOL SCI, V11, P4348, DOI 10.3390/ijms11114348; Kawarabayashi T, 2001, J NEUROSCI, V21, P372, DOI 10.1523/JNEUROSCI.21-02-00372.2001; Kelley BJ, 2010, ARCH NEUROL-CHICAGO, V67, P171, DOI 10.1001/archneurol.2010.113; Kimura R, 2009, NEUROSCIENCE, V162, P1212, DOI 10.1016/j.neuroscience.2009.05.025; Kleinberger G, 2010, J NEUROCHEM, V115, P735, DOI 10.1111/j.1471-4159.2010.06961.x; Knowles RB, 1998, J NEUROPATH EXP NEUR, V57, P1122, DOI 10.1097/00005072-199812000-00003; Long ZM, 2015, CNS NEUROSCI THER, V21, P887, DOI 10.1111/cns.12445; Malaspina A, 2001, J NEUROCHEM, V77, P132, DOI 10.1046/j.1471-4159.2001.t01-1-00231.x; Maqbool M, 2016, EUR J MED CHEM, V107, P63, DOI 10.1016/j.ejmech.2015.10.018; Marr RA, 2003, J NEUROSCI, V23, P1992; Marr RA, 2004, J MOL NEUROSCI, V22, P5, DOI 10.1385/JMN:22:1-2:5; Martens LH, 2012, J CLIN INVEST; Marzo A, 2016, CURR BIOL, V26, P2551, DOI 10.1016/j.cub.2016.07.024; McGeer PL, 2006, J ALZHEIMERS DIS, V9, P271; McGeer PL, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P271; McGeer PL, 2001, NEUROBIOL AGING, V22, P799, DOI 10.1016/S0197-4580(01)00289-5; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Mogi M, 1996, NEUROSCI LETT, V211, P13, DOI 10.1016/0304-3940(96)12706-3; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Nedachi T, 2011, NEUROSCIENCE, V185, P106, DOI 10.1016/j.neuroscience.2011.04.037; Niehrs C, 2012, EMBO J, V31, P2705, DOI 10.1038/emboj.2012.124; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Ohmi K, 2003, P NATL ACAD SCI USA, V100, P1902, DOI 10.1073/pnas.252784899; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Pereson S, 2009, J PATHOL, V219, P173, DOI 10.1002/path.2580; Petkau TL, 2012, NEUROBIOL DIS, V45, P711, DOI 10.1016/j.nbd.2011.10.016; Petoukhov E, 2013, J CELL SCI, V126, P5412, DOI 10.1242/jcs.132076; Phiel CJ, 2003, NATURE, V423, P435, DOI 10.1038/nature01640; Qian YS, 2015, EUR J PHARMACOL, V764, P298, DOI 10.1016/j.ejphar.2015.07.028; Qin R, 2011, TOXICOL LETT, V202, P1, DOI 10.1016/j.toxlet.2011.01.001; Revuelta GJ, 2008, AM J ALZHEIMERS DIS, V23, P488, DOI 10.1177/1533317508321910; Rosa E, 2015, NEUROBIOL AGING, V36, P2406, DOI 10.1016/j.neurobiolaging.2015.04.014; Rosen EY, 2011, NEURON, V71, P1030, DOI 10.1016/j.neuron.2011.07.021; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Schwab C, 2010, BBA-MOL BASIS DIS, V1802, P889, DOI 10.1016/j.bbadis.2009.10.013; Seira O, 2014, MOL NEUROBIOL, V49, P931, DOI 10.1007/s12035-013-8571-y; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sereno L, 2009, NEUROBIOL DIS, V35, P359, DOI 10.1016/j.nbd.2009.05.025; Shirotani K, 2001, J BIOL CHEM, V276, P21895, DOI 10.1074/jbc.M008511200; Shruster A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040843; Spencer B, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-109; Takeuchi A, 2000, AM J PATHOL, V157, P331, DOI 10.1016/S0002-9440(10)64544-0; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tao J, 2012, BRAIN RES, V1436, P130, DOI 10.1016/j.brainres.2011.11.063; Tapia L, 2011, J NEUROSCI, V31, P11126, DOI 10.1523/JNEUROSCI.6244-10.2011; Van Kampen JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097032; Wang XH, 2009, STEM CELLS, V27, P3021, DOI 10.1002/stem.230; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yang YZ, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-14; Yao YM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-21; Yasojima K, 2001, BRAIN RES, V919, P115, DOI 10.1016/S0006-8993(01)03008-6; Yi H, 2012, NEUROREPORT, V23, P189, DOI 10.1097/WNR.0b013e32834fab06; Yin FF, 2010, FASEB J, V24, P4639, DOI 10.1096/fj.10-161471; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zanocco-Marani T, 1999, CANCER RES, V59, P5331; Zhang YR, 2016, J STAT MECH-THEORY E, P1, DOI 10.1088/1742-5468/2016/11/113207; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	91	24	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182896	10.1371/journal.pone.0182896	http://dx.doi.org/10.1371/journal.pone.0182896			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837568	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000032
J	Dock, J; Ramirez, CM; Hultin, L; Hausner, MA; Hultin, P; Elliott, J; Yang, OO; Anton, PA; Jamieson, BD; Effros, RB				Dock, Jeffrey; Ramirez, Christina M.; Hultin, Lance; Hausner, Mary Ann; Hultin, Patricia; Elliott, Julie; Yang, Otto O.; Anton, Peter A.; Jamieson, Beth D.; Effros, Rita B.			Distinct aging profiles of CD8(+)T cells in blood versus gastrointestinal mucosal compartments	PLOS ONE			English	Article							CD28(-) T-CELLS; REPLICATIVE SENESCENCE; CYTOMEGALOVIRUS-SEROPOSITIVITY; IMMUNE-RESPONSES; IN-VIVO; AGE; INFECTION; HIV; EXPRESSION; SUBSETS	A hallmark of human immunosenescence is the accumulation of late-differentiated memory CD8(+) T cells with features of replicative senescence, such as inability to proliferate, absence of CD28 expression, shortened telomeres, loss of telomerase activity, enhanced activation, and increased secretion of inflammatory cytokines. Importantly, oligoclonal expansions of these cells are associated with increased morbidity and mortality risk in elderly humans. Currently, most information on the adaptive immune system is derived from studies using peripheral blood, which contains approximately only 2% of total body lymphocytes. However, most lymphocytes reside in tissues. It is not clear how representative blood changes are of the total immune status. This is especially relevant with regard to the human gastrointestinal tract (GALT), a major reservoir of total body lymphocytes (approximately 60%) and an anatomical region of high antigenic exposure. To assess how peripheral blood T cells relate to those in other locations, we compare CD8(+) T cells from peripheral blood and the GALT, specifically rectosigmoid colon, in young/middle age, healthy donors, focusing on phenotypic and functional alterations previously linked to senescence in peripheral blood. Overall, our results indicate that gut CD8(+) T cells show profiles suggestive of greater differentiation and activation than those in peripheral blood. Specifically, compared to blood from the same individual, the gut contains significantly greater proportions of CD8(+) T cells that are CD45RA(-) (memory), CD28(-), CD45RA(-) CD28(+) (early memory), CD45RA(-)CD28(-)(late memory), CD25(-), HLA-DR+ CD38(+) (activated) and Ki-67(+) (proliferating); ex vivo CD3(+) telomerase activity levels are greater in the gut as well. However, gut CD8(+) T cells may not necessarily be more senescent, since they expressed significantly lower levels of CD57 and PD-1 on CD45RO(+) memory cells, and had in vitro proliferative dynamics similar to that of blood cells. Compartment-specific age-effects in this cohort were evident as well. Blood cells showed a significant increase with age in proportion of HLA-DR(+)38(+), Ki-67(+) and CD25(+)CD8(+)T cells; and an increase in total CD3(+) ex-vivo telomerase activity that approached significance. By contrast, the only age-effect seen in the gut was a significant increase in CD45RA(-) (memory) and concurrent decrease in CD45RA(+)CD28(+)(naive) CD8(+) T cells. Overall, these results indicate dynamics of peripheral blood immune senescence may not hold true in the gut mucosa, underscoring the importance for further study of this immunologically important tissue in evaluating the human immune system, especially in the context of chronic disease and aging.	[Dock, Jeffrey; Effros, Rita B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Ramirez, Christina M.] Univ Calif Los Angeles, Dept Biostat, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Hultin, Lance; Hausner, Mary Ann; Jamieson, Beth D.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90095 USA; [Hultin, Lance; Hausner, Mary Ann; Hultin, Patricia; Elliott, Julie; Yang, Otto O.; Anton, Peter A.; Jamieson, Beth D.; Effros, Rita B.] UCLA, AIDS Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Hultin, Patricia] Univ Calif Los Angeles, Dept Epidemiol, Fielding Sch Publ Hlth, Los Angeles, CA USA; [Elliott, Julie; Anton, Peter A.] Univ Calif Los Angeles, David Geffen Sch Med, Div Digest Dis, Dept Med, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Div Infect Dis, Dept Med, Los Angeles, CA 90095 USA; [Yang, Otto O.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Yang, Otto O.] AIDS Healthcare Fdn, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Effros, RB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA.; Effros, RB (corresponding author), UCLA, AIDS Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA.	reffros@mednet.ucla.edu	Ramirez, Christina/AAT-5088-2021	Ramirez, Christina/0000-0002-8435-0416	NIH [AG032422, CM 6042, AI28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; Mucosal Immunology Core grant [5P30 AI028697]; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); Mucosal Immunology Core grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH AG032422 to RBE. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and the Center for AIDS Research Flow Cytometry Core Facility that is supported by NIH awards CM 6042 and AI28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. Someexperiments utilized subjects recruited by the Mucosal Immunology Core grant (5P30 AI028697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by NIH AG032422 to RBE. Flow cytometry was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and the Center for AIDS Research Flow Cytometry Core Facility that is supported by NIH awards CA16042 and AI28697, and by the JCCC, the UCLA AIDS Institute, and the David Geffen School of Medicine at UCLA. Some experiments utilized subjects recruited by the UCLA CFAR Mucosal Immunology Core Laboratory (MICL) grant (5P30 AI028697).	Aksoy P, 2006, BIOCHEM BIOPH RES CO, V349, P353, DOI 10.1016/j.bbrc.2006.08.066; Almanzar G, 2005, J VIROL, V79, P3675, DOI 10.1128/JVI.79.6.3675-3683.2005; Appay V, 2008, CYTOM PART A, V73A, P975, DOI 10.1002/cyto.a.20643; Appay V, 2007, EXP GERONTOL, V42, P432, DOI 10.1016/j.exger.2006.12.003; Bandres E, 2000, CLIN IMMUNOL, V96, P230, DOI 10.1006/clim.2000.4894; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Bodnar AG, 1996, EXP CELL RES, V228, P58, DOI 10.1006/excr.1996.0299; Brenchley JM, 2003, BLOOD, V101, P2711, DOI 10.1182/blood-2002-07-2103; Chidrawar S, 2009, CLIN EXP IMMUNOL, V155, P423, DOI 10.1111/j.1365-2249.2008.03785.x; Chistiakov DA, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00781; Chou JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064702; Czesnikiewicz-Guzik M, 2008, CLIN IMMUNOL, V127, P107, DOI 10.1016/j.clim.2007.12.002; Dandekar S, 2010, CURR OPIN HIV AIDS, V5, P173, DOI 10.1097/COH.0b013e328335eda3; DANIELS CK, 1993, EXP GERONTOL, V28, P549, DOI 10.1016/0531-5565(93)90043-D; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2011, ANNU REV MED, V62, P141, DOI 10.1146/annurev-med-042909-093756; Di Benedetto S, 2015, BIOGERONTOLOGY, V16, P631, DOI 10.1007/s10522-015-9563-2; Dock J, 2017, J IMMUNOL METHODS, V445, P77, DOI 10.1016/j.jim.2017.03.014; Dock JN, 2011, AGING DIS, V2, P382; EFFROS RB, 1994, EXP GERONTOL, V29, P601, DOI 10.1016/0531-5565(94)90073-6; Effros RB, 2005, IMMUNOL REV, V205, P147, DOI 10.1111/j.0105-2896.2005.00259.x; Effros RB, 2004, EXP GERONTOL, V39, P517, DOI 10.1016/j.exger.2003.09.024; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fagnoni FF, 1996, IMMUNOLOGY, V88, P501, DOI 10.1046/j.1365-2567.1996.d01-689.x; Fayad R, 2004, J IMMUNOL, V173, P2692, DOI 10.4049/jimmunol.173.4.2692; Focosi D, 2010, J LEUKOCYTE BIOL, V87, P107, DOI 10.1189/jlb.0809566; Fujihashi K, 2004, MECH AGEING DEV, V125, P889, DOI 10.1016/j.mad.2004.05.009; Fujihashi K, 2000, VACCINE, V18, P1675, DOI 10.1016/S0264-410X(99)00505-8; Graham LS, 2009, CLIN IMMUNOL, V133, P265, DOI 10.1016/j.clim.2009.07.011; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; GUYGRAND D, 1991, J EXP MED, V173, P471, DOI 10.1084/jem.173.2.471; Hadrup SR, 2006, J IMMUNOL, V176, P2645, DOI 10.4049/jimmunol.176.4.2645; Hakim FT, 2007, TISSUE ANTIGENS, V70, P179, DOI 10.1111/j.1399-0039.2007.00891.x; Haynes L, 2002, SPRINGER SEMIN IMMUN, V24, P53, DOI 10.1007/s00281-001-0095-2; Herndler-Brandstetter D, 2005, J IMMUNOL, V175, P1566, DOI 10.4049/jimmunol.175.3.1566; Izcue A, 2009, ANNU REV IMMUNOL, V27, P313, DOI 10.1146/annurev.immunol.021908.132657; Jones SC, 2008, J IMMUNOL, V180, P4465, DOI 10.4049/jimmunol.180.7.4465; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Kok A, 2015, MUCOSAL IMMUNOL, V8, P127, DOI 10.1038/mi.2014.50; Koga T, 2000, J IMMUNOL, V165, P5352, DOI 10.4049/jimmunol.165.9.5352; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; LATTHE M, 1994, EUR J IMMUNOL, V24, P1703, DOI 10.1002/eji.1830240737; Lazuardi L, 2005, IMMUNOLOGY, V114, P37, DOI 10.1111/j.1365-2567.2004.02006.x; Li-Weber M, 2002, CELL DEATH DIFFER, V9, P101, DOI 10.1038/sj.cdd.4400984; Lin Y, 2016, IMMUN AGEING, V13, DOI 10.1186/s12979-016-0079-7; Looney RJ, 1999, CLIN IMMUNOL, V90, P213, DOI 10.1006/clim.1998.4638; Merino J, 1998, CLIN EXP IMMUNOL, V112, P48; Mowat AM, 1997, IMMUNOL REV, V156, P145, DOI 10.1111/j.1600-065X.1997.tb00966.x; Mudd JC, 2016, J INFECT DIS, V214, pS58, DOI 10.1093/infdis/jiw258; Ostan R, 2008, NEUROIMMUNOMODULAT, V15, P224, DOI 10.1159/000156466; Pandiyan P, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00228; Papagno L, 2004, PLOS BIOL, V2, P173, DOI 10.1371/journal.pbio.0020020; Parish ST, 2009, J IMMUNOL, V182, P4237, DOI 10.4049/jimmunol.0803449; Pawelec G, 2010, J COMP PATHOL, V141, pS39, DOI 10.1016/j.jcpa.2009.09.005; Pawelec G, 2009, REV MED VIROL, V19, P47, DOI 10.1002/rmv.598; Poles MA, 2001, J VIROL, V75, P8390, DOI 10.1128/JVI.75.18.8390-8399.2001; Posnett DN, 1999, INT IMMUNOL, P11; Qin OY, 2004, EXP GERONTOL, V39, P607, DOI 10.1016/j.exger.2003.11.016; Sabbaj S, 2005, J IMMUNOL, V174, P2951, DOI 10.4049/jimmunol.174.5.2951; Saurwein-Teissl M, 2002, J IMMUNOL, V168, P5893, DOI 10.4049/jimmunol.168.11.5893; SCHIEFERDECKER HL, 1992, J IMMUNOL, V149, P2816; Schirmer M, 2002, ARTHRITIS RES, V4, P71, DOI 10.1186/ar386; Schmidt D, 1996, J CLIN INVEST, V97, P2027, DOI 10.1172/JCI118638; Schmucker DL, 1996, DIGEST DIS SCI, V41, P1183, DOI 10.1007/BF02088236; Schwaiger S, 2003, J IMMUNOL, V170, P613, DOI 10.4049/jimmunol.170.1.613; Shacklett Barbara L, 2010, Curr Infect Dis Rep, V12, P19, DOI 10.1007/s11908-009-0072-9; Shacklett BL, 2003, J IMMUNOL METHODS, V279, P17, DOI 10.1016/S0022-1759(03)00255-2; Staras SAS, 2006, CLIN INFECT DIS, V43, P1143, DOI 10.1086/508173; Strindhall J, 2013, AGE, V35, P985, DOI 10.1007/s11357-012-9400-3; Strioga M, 2011, IMMUNOLOGY, V134, P17, DOI 10.1111/j.1365-2567.2011.03470.x; Sun ZP, 2008, J CLIN IMMUNOL, V28, P464, DOI 10.1007/s10875-008-9213-4; Swain S, 2005, SEMIN IMMUNOL, V17, P370, DOI 10.1016/j.smim.2005.05.007; Tarazona R, 2000, MECH AGEING DEV, V121, P77; TAYLOR LD, 1992, IMMUNOLOGY, V75, P614; Valenzuela HF, 2002, CLIN IMMUNOL, P105; Vulcano M, 2008, CURR DRUG TARGETS, V9, P404, DOI 10.2174/138945008784221143; WALFORD RL, 1964, GERONTOLOGIST, V4, P195, DOI 10.1093/geront/4.4.195; WAYNE SJ, 1990, J GERONTOL, V45, pM45, DOI 10.1093/geronj/45.2.M45; Weinberger B, 2007, HUM IMMUNOL, V68, P86, DOI 10.1016/j.humimm.2006.10.019; Weng NP, 2009, TRENDS IMMUNOL, V30, P306, DOI 10.1016/j.it.2009.03.013; Wertheimer AM, 2014, J IMMUNOL, V192, P2143, DOI 10.4049/jimmunol.1301721; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Yang OO, 2005, JAIDS-J ACQ IMM DEF, V39, P507	83	17	18	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182498	10.1371/journal.pone.0182498	http://dx.doi.org/10.1371/journal.pone.0182498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832609	Green Published, gold			2022-12-27	WOS:000408355800025
J	Acuna-Marrero, D; Smith, ANH; Hammerschlag, N; Hearn, A; Anderson, MJ; Calich, H; Pawley, MDM; Fischer, C; Salinas-de-Leon, P				Acuna-Marrero, David; Smith, Adam N. H.; Hammerschlag, Neil; Hearn, Alex; Anderson, Marti J.; Calich, Hannah; Pawley, Matthew D. M.; Fischer, Chris; Salinas-de-Leon, Pelayo			Residency and movement patterns of an apex predatory shark (Galeocerdo cuvier) at the Galapagos Marine Reserve	PLOS ONE			English	Article							STATE-SPACE MODELS; CARCHARODON-CARCHARIAS; ANIMAL MOVEMENT; TIGER SHARK; SATELLITE TELEMETRY; FORAGING BEHAVIOR; HAWAIIAN WATERS; PROTECTED AREA; SOUTH-AFRICA; SEAL ISLAND	The potential effectiveness of marine protected areas (MPAs) as a conservation tool for large sharks has been questioned due to the limited spatial extent of most MPAs in contrast to the complex life history and high mobility of many sharks. Here we evaluated the movement dynamics of a highly migratory apex predatory shark (tiger shark Galeocerdo cuvier) at the Galapagos Marine Reserve (GMR). Using data from satellite tracking passive acoustic telemetry, and stereo baited remote underwater video, we estimated residency, activity spaces, site fidelity, distributional abundances and migration patterns from the GMR and in relation to nesting beaches of green sea turtles (Chelonia mydas), a seasonally abundant and predictable prey source for large tiger sharks. Tiger sharks exhibited a high degree of philopatry, with 93% of the total satellite-tracked time across all individuals occurring within the GMR. Large sharks (> 200 cm TL) concentrated their movements in front of the two most important green sea turtle-nesting beaches in the GMR, visiting them on a daily basis during nocturnal hours. In contrast, small sharks (< 200 cm TL) rarely visited turtle-nesting areas and displayed diurnal presence at a third location where only immature sharks were found. Small and some large individuals remained in the three study areas even outside of the turtle-nesting season. Only two sharks were satellite-tracked outside of the GMR, and following long-distance migrations, both individuals returned to turtle-nesting beaches at the subsequent turtle-nesting season. The spatial patterns of residency and site fidelity of tiger sharks suggest that the presence of a predictable source of prey and suitable habitats might reduce the spatial extent of this large shark that is highly migratory in other parts of its range. This highly philopatric behaviour enhances the potential effectiveness of the GMR for their protection.	[Acuna-Marrero, David; Salinas-de-Leon, Pelayo] Charles Darwin Res Stn, Puerto Ayora, Islas Galapagos, Ecuador; [Acuna-Marrero, David; Smith, Adam N. H.; Pawley, Matthew D. M.] Massey Univ, Inst Nat & Math Sci, Albany Campus, Auckland, New Zealand; [Hammerschlag, Neil; Calich, Hannah] Univ Miami, Rosenstiel Sch Marine & Atmospher Sci, 4600 Rickenbacker Causeway, Miami, FL 33149 USA; [Hammerschlag, Neil] Univ Miami, Abess Ctr Ecosyst Sci & Policy, Miami, FL USA; [Hearn, Alex] Univ San Francisco Quito, Quito, Ecuador; [Anderson, Marti J.] Massey Univ, New Zealand Inst Adv Study, Auckland, New Zealand; [Fischer, Chris] OCEARCH, Park City, UT USA	Massey University; University of Miami; University of Miami; Massey University	Acuna-Marrero, D (corresponding author), Charles Darwin Res Stn, Puerto Ayora, Islas Galapagos, Ecuador.; Acuna-Marrero, D (corresponding author), Massey Univ, Inst Nat & Math Sci, Albany Campus, Auckland, New Zealand.	d.acuna-marrero@massey.ac.nz	Anderson, Marti J./AAQ-9038-2021; Hearn, Alex/AAK-6461-2020	Anderson, Marti J./0000-0002-4018-4049; Calich, Hannah/0000-0001-7541-9584; Smith, Adam/0000-0003-0059-6206	IWC Schaffhausen; Charles Darwin Research Station; Lindblad Expeditions/National Geographic Funds; OCEARCH	IWC Schaffhausen; Charles Darwin Research Station; Lindblad Expeditions/National Geographic Funds; OCEARCH	IWC Schaffhausen (http://www.iwc.com/en/) en/) provided financial support for the acquisition of satellite and acoustic tags/receivers and for covering logistic costs of conducting tagging field work. This fund was granted to the Charles Darwin Research Station. Lindblad Expeditions/National Geographic Funds (https //www.expeditions.com) provided financial support for the acquisition of SBRUVs equipment and for covering logistic costs to conduct SBRUVs field work. This fund was granted to the Charles Darwin Research Station. OCEARCH (www.ocearch.org) provided financial support for the acquisition of satellite and acoustic tags and provided its research boat to conduct tagging field work. This fund was granted to AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Marrero D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115946; Afonso AS, 2012, J FISH BIOL, V81, P2080, DOI 10.1111/j.1095-8649.2012.03455.x; [Anonymous], 1963, ANIMAL SPECIES EVOLU; Banks SJ., 2002, RESERVA MARINA GAL P, P22; Beebe W, 1924, GALAPAGOS WORLDS ENG; Beyer H. L, 2012, GEOSPATIAL MODELLING; Bond ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032983; Cappo M, 2004, J EXP MAR BIOL ECOL, V302, P123, DOI 10.1016/j.jembe.2003.10.006; Chapman DD, 2015, ANNU REV MAR SCI, V7, P547, DOI 10.1146/annurev-marine-010814-015730; Compagno L.J.V., 2005, SHARKS WORLD; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Escalle L, 2015, J FISH BIOL, V87, P323, DOI 10.1111/jfb.12724; Ferreira LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116916; Fitzpatrick R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051927; Graham F, 2016, DIVERS DISTRIB, V22, P534, DOI 10.1111/ddi.12425; Hammerschlag N, 2011, J EXP MAR BIOL ECOL, V398, P1, DOI 10.1016/j.jembe.2010.12.012; Hammerschlag N, 2016, BEHAV ECOL SOCIOBIOL, P1; Hammerschlag N, 2006, ENVIRON BIOL FISH, V76, P341, DOI 10.1007/s10641-006-9038-z; Hammerschlag N, 2015, ECOLOGY, V96, P2117, DOI 10.1890/14-2113.1; Hammerschlag N, 2012, FUNCT ECOL, V26, P567, DOI 10.1111/j.1365-2435.2012.01973.x; Hearn A, 2010, MAR BIOL, V157, P1899, DOI 10.1007/s00227-010-1460-2; Hearn AR, 2014, SOC ECOL INTERACT GA, P23, DOI 10.1007/978-3-319-02769-2_2; Heithaus MR, 2007, MAR BIOL, V151, P1455, DOI 10.1007/s00227-006-0583-y; Heithaus MR, 2002, MAR BIOL, V140, P237, DOI 10.1007/s00227-001-0711-7; Heupel MR, 2014, MAR ECOL PROG SER, V496, P47, DOI 10.3354/meps10529; Heylings P., 2002, RESERVA MARINA GAL P, P10; Holland KN, 1999, MAR BIOL, V134, P665, DOI 10.1007/s002270050582; Hueter R. E., 2005, Journal of Northwest Atlantic Fishery Science, V35, P239; Jonsen ID, 2013, DEEP-SEA RES PT II, V88-89, P34, DOI 10.1016/j.dsr2.2012.07.008; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Klimley AP, 2001, MAR BIOL, V138, P617, DOI 10.1007/s002270000489; Lea JSE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11202; Lowe CG, 1996, ENVIRON BIOL FISH, V47, P203, DOI 10.1007/BF00005044; Lucifora LO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019356; Martin RA, 2009, J ZOOL, V279, P111, DOI 10.1111/j.1469-7998.2009.00586.x; Martin RA, 2005, J MAR BIOL ASSOC UK, V85, P1121, DOI 10.1017/S002531540501218X; Meyer CG, 2007, MAR ECOL PROG SER, V333, P13, DOI 10.3354/meps333013; Meyer CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084799; Meyer CG, 2010, MAR BIOL, V157, P1857, DOI 10.1007/s00227-010-1457-x; Meyer CG, 2009, MAR ECOL PROG SER, V381, P223, DOI 10.3354/meps07951; Mora C, 2006, SCIENCE NEW YORK WAS, P1750; Norse EA, 2010, B MAR SCI, V86, P179; Papastamatiou YP, 2009, ECOLOGY, V90, P996, DOI 10.1890/08-0491.1; Parra M, 2015, EVALUACION INCIDENCI, P95; Patterson TA, 2008, TRENDS ECOL EVOL, V23, P87, DOI 10.1016/j.tree.2007.10.009; Penaherrera C, 2012, REV BIOL TROP, V60, P735; de Leon PS, 2016, PEERJ, V4, DOI 10.7717/peerj.1911; Santana-Garcon J, 2014, METHODS ECOL EVOL, V5, P824, DOI 10.1111/2041-210X.12216; Seminoff Jeffrey A., 2008, Endangered Species Research, V4, P57, DOI 10.3354/esr00066; Silverman B. W., 1986, DENSITY ESTIMATION S, V26; Simpfendorfer CA, 2011, MAR FRESHWATER RES, V62, P518, DOI 10.1071/MF11086; Simpfendorfer CA, 2001, ENVIRON BIOL FISH, V61, P37, DOI 10.1023/A:1011021710183; Snell HM, 1996, J BIOGEOGR, V23, P619, DOI 10.1111/j.1365-2699.1996.tb00022.x; Speed CW, 2010, MAR ECOL PROG SER, V408, P275, DOI 10.3354/meps08581; Springer S, 1967, SHARKS SKATES RAYS, P149, DOI DOI 10.1111/J.1095-8649.2012.03244.X; Watson DL, 2005, MAR BIOL, V148, P415, DOI 10.1007/s00227-005-0090-6; Werry JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083249; White ER, 2015, CONSERV BIOL, V29, P1186, DOI 10.1111/cobi.12478; White TD, 2017, BIOL CONSERV, V207, P64, DOI 10.1016/j.biocon.2017.01.009; Whitney NM, 2007, MAR BIOL, V151, P63, DOI 10.1007/s00227-006-0476-0; WITHERINGTON BE, 1992, HERPETOLOGICA, V48, P31; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034; Zarate P, 2002, RESERVA MARINA GALAP, P373; Zarate P., 2002, RESERVA MARINA GALAP, P305; Zarate P, 2009, INFORM FINAL ACTIVID; Zarate P, 2013, AQUAT BIOL, V19, P217, DOI 10.3354/ab00534	68	28	29	5	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183669	10.1371/journal.pone.0183669	http://dx.doi.org/10.1371/journal.pone.0183669			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829820	Green Published, Green Submitted, gold			2022-12-27	WOS:000408085100064
J	Benedetti, Y; Morelli, F				Benedetti, Yanina; Morelli, Federico			Spatial mismatch analysis among hotspots of alien plant species, road and railway networks in Germany and Austria	PLOS ONE			English	Article							BIOTIC INTERACTIONS; FOREST ROADS; LAND-USE; INVASIONS; LANDSCAPE; RESPONSES; PATTERNS; SCALES; BIODIVERSITY; MANAGEMENT	Road and railway networks are pervasive elements of all environments, which have expanded intensively over the last century in all European countries. These transportation infrastructures have major impacts on the surrounding landscape, representing a threat to biodiversity. Roadsides and railways may function as corridors for dispersal of alien species in fragmented landscapes. However, only few studies have explored the spread of invasive species in relationship to transport network at large spatial scales. We performed a spatial mismatch analysis, based on a spatially explicit correlation test, to investigate whether alien plant species hotspots in Germany and Austria correspond to areas of high density of roads and railways. We tested this independently of the effects of dominant environments in each spatial unit, in order to focus just on the correlation between occurrence of alien species and density of linear transportation infrastructures. We found a significant spatial association between alien plant species hotspots distribution and roads and railways density in both countries. As expected, anthropogenic landscapes, such as urban areas, harbored more alien plant species, followed by water bodies. However, our findings suggested that the distribution of neobiota is strongest correlated to road/railways density than to land use composition. This study provides new evidence, from a transnational scale, that alien plants can use roadsides and rail networks as colonization corridors. Furthermore, our approach contributes to the understanding on alien plant species distribution at large spatial scale by the combination with spatial modeling procedures.	[Benedetti, Yanina; Morelli, Federico] Czech Univ Life Sci Prague, Dept Appl Geoinformat & Spatial Planning, Fac Environm Sci, Prague, Czech Republic	Czech University of Life Sciences Prague	Benedetti, Y (corresponding author), Czech Univ Life Sci Prague, Dept Appl Geoinformat & Spatial Planning, Fac Environm Sci, Prague, Czech Republic.	ybenedetti73@gmail.com	Benedetti, Yanina/B-8815-2016; Morelli, Federico/P-1094-2018	Benedetti, Yanina/0000-0003-1600-2310; Morelli, Federico/0000-0003-1099-1357				[Anonymous], 2013, J LANDSC ECOL, V6; Bacaro G, 2015, COMMUNITY ECOL, V16, P223, DOI 10.1556/168.2015.16.2.10; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bernes C, 2016, ENVIRON EVID, V5, DOI 10.1186/s13750-016-0055-x; Blackburn TM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001850; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; BOSSARD M, 2000, CORINE LAND COVER TE; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Central Intelligence Agency, 2013, WORLD FACTB 2013 14; Chytry M, 2009, DIVERS DISTRIB, V15, P98, DOI 10.1111/j.1472-4642.2008.00515.x; Claridge Kevin, 2002, Biological Invasions, V4, P339, DOI 10.1023/A:1023671006342; Dostalek J, 2016, PLANT BIOSYST, V150, P442, DOI 10.1080/11263504.2014.986244; EEA, 1994, COR LAND COV REP 2; EEA, 2012, ACT POT FUT AL PLANT; ESRI, 2011, ARCGIS DESKT REL 10; Fernandez-Murillo MP, 2015, WEED RES, V55, P565, DOI 10.1111/wre.12174; Fletcher CS, 2013, ECOL APPL, V23, P1881, DOI 10.1890/12-2059.1; Flory SL, 2009, BIOL CONSERV, V142, P2531, DOI 10.1016/j.biocon.2009.05.024; Forman RTT, 1998, ANNU REV ECOL SYST, V29, P207, DOI 10.1146/annurev.ecolsys.29.1.207; Forman RTT, 2003, ROAD ECOLOGY SCI SOL; Fortin MJ, 2002, ECOSCIENCE, V9, P213, DOI 10.1080/11956860.2002.11682707; Graham MH, 2003, ECOLOGY, V84, P2809, DOI 10.1890/02-3114; Grimm NB, 2008, FRONT ECOL ENVIRON, V6, P264, DOI 10.1890/070147; Haugo RD, 2013, FOREST ECOL MANAG, V289, P175, DOI 10.1016/j.foreco.2012.10.019; Hosmer D.W., 2005, APPL LOGISTIC REGRES; Ibanez I, 2009, J APPL ECOL, V46, P1219, DOI 10.1111/j.1365-2664.2009.01736.x; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; Joly M, 2011, ENVIRON MANAGE, V48, P514, DOI 10.1007/s00267-011-9711-7; Kissling WD, 2008, GLOBAL ECOL BIOGEOGR, V17, P59, DOI 10.1111/j.1466-8238.2007.00334.x; Kleinbauer I, 2010, BIOL CONSERV, V143, P382, DOI 10.1016/j.biocon.2009.10.024; Kociolek AV, 2011, CONSERV BIOL, V25, P241, DOI 10.1111/j.1523-1739.2010.01635.x; Kosaka Y, 2010, MT RES DEV, V30, P252, DOI 10.1659/MRD-JOURNAL-D-10-00036.1; Legendre P., 2012, NUMERICAL ECOLOGY, V3rd ed.; Lembrechts JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089664; Lu ZJ, 2006, WEED SCI, V54, P1068, DOI 10.1614/WS-06-040R1.1; Manly B.F.J., 2006, RANDOMIZATION BOOTST, V3rd, DOI DOI 10.1201/9781315273075; MANTEL N, 1967, CANCER RES, V27, P209; Meunier G, 2012, INVAS PLANT SCI MANA, V5, P92, DOI 10.1614/IPSM-D-11-00049.1; Mitchell CE, 2006, ECOL LETT, V9, P726, DOI 10.1111/j.1461-0248.2006.00908.x; Morelli F, 2013, ECOL INDIC, V34, P372, DOI 10.1016/j.ecolind.2013.05.021; Mortensen DA, 2009, INVAS PLANT SCI MANA, V2, P191, DOI 10.1614/IPSM-08-125.1; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nakazawa, 2017, FMSB FUNCTIONS MED S; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Oduor AMO, 2013, NEW PHYTOL, V200, P986, DOI 10.1111/nph.12429; OECD, 2013, ED GLANC 2013 OECD I, DOI 10.1787/9789264185715-sum-is; Okimura T, 2016, BIODIVERS CONSERV, V25, P995, DOI 10.1007/s10531-016-1103-0; Oksanen J, 2016, VEGAN COMMUNITY ECOL, V3-4, P291; Ozaslan C., 2016, Agriculture and Forestry, V62, P285; Paiaro V, 2011, AUSTRAL ECOL, V36, P176, DOI 10.1111/j.1442-9993.2010.02134.x; Pauchard A, 2004, CONSERV BIOL, V18, P238, DOI 10.1111/j.1523-1739.2004.00300.x; Penone C, 2012, BIOL CONSERV, V148, P126, DOI 10.1016/j.biocon.2012.01.041; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Pysek P, 2005, ECOSCIENCE, V12, P302, DOI 10.2980/i1195-6860-12-3-302.1; Pysek P, 2010, BIOINVASIONS AND GLOBALIZATION: ECOLOGY, ECONOMICS, MANAGEMENT, AND POLICY, P66; R Core Team, 2017, R LANG ENV STAT COMP; Rowland M, 2013, TECHNICAL GUIDE MONI, V403; Rutkovska Santa, 2013, Estonian Journal of Ecology, V62, P212, DOI 10.3176/eco.2013.3.03; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanderson EW, 2002, BIOSCIENCE, V52, P891, DOI 10.1641/0006-3568(2002)052[0891:THFATL]2.0.CO;2; Seebens H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14435; Seiler A, 2001, INTRODUTORY RES ESSA, V9, P1; Silverman BW, 1986, MONOGRAPHS CHAPMAN H; Skurski TC, 2014, INVAS PLANT SCI MANA, V7, P432, DOI 10.1614/IPSM-D-13-00099.1; Souza L, 2011, FUNCT ECOL, V25, P1106, DOI 10.1111/j.1365-2435.2011.01857.x; Spellerberg IF, 1998, GLOBAL ECOL BIOGEOGR, V7, P317, DOI 10.1046/j.1466-822x.1998.00308.x; Stajerova K, 2017, LANDSC ECOL; Steyn C, 2017, J VEG SCI, V28, P337, DOI 10.1111/jvs.12477; Stotz GC, 2017, J VEG SCI, V28, P325, DOI 10.1111/jvs.12499; Taramarcaz P, 2005, SWISS MED WKLY, V135, P538; Theoharides KA, 2007, NEW PHYTOL, V176, P256, DOI 10.1111/j.1469-8137.2007.02207.x; Triola M. F, 2010, ELEMENTARY STAT; Trombulak SC, 2000, CONSERV BIOL, V14, P18, DOI 10.1046/j.1523-1739.2000.99084.x; Turbelin AJ, 2017, GLOBAL ECOL BIOGEOGR, V26, P78, DOI 10.1111/geb.12517; Venables WN., 2002, MODERN APPL STAT S, V4; Watkins RZ, 2003, CONSERV BIOL, V17, P411, DOI 10.1046/j.1523-1739.2003.01285.x; Wisdom MJ, 2005, T N AM WILDL NAT RES, P145	77	19	23	7	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183691	10.1371/journal.pone.0183691	http://dx.doi.org/10.1371/journal.pone.0183691			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829818	Green Submitted, gold, Green Published			2022-12-27	WOS:000408085100066
J	Cheon, KS; Kim, KA; Yoo, KO				Cheon, Kyeong-Sik; Kim, Kyung-Ah; Yoo, Ki-Oug			The complete chloroplast genome sequences of three Adenophora species and comparative analysis with Campanuloid species (Campanulaceae)	PLOS ONE			English	Article							TRACHELIUM-CAERULEUM; ENDEMIC GENUS; REARRANGEMENTS; ALIGNMENT	We report the complete chloroplast genomes of three Adenophora species, and analyzed these compared them to five published Campanuloid plastomes. The total genome length of Adenophora divaricata, Adenophora erecta, and Adenophora stricta ranged from 159,759 to 176,331 bp. Among the eight Campanuloid species, many inversions were found to be only in the LSC region. IR contraction was also identified in the plastid genome of Adenophora stricta. Phylogenetic analyses based on 76 protein coding genes showed that Campanuloids are monophyletic, and are composed of two major groups: Campanula s. str. and Rapunculus. When we compared each homologous locus among the four Adenophora species, ten regions showed high nucleotide divergence value (>0.03). Among these, nine loci, excepting ycf3-rpoB, are considered to be useful molecular markers for phylogenetic studies and will be helpful to resolve phylogenetic relationships of Adenophora.	[Cheon, Kyeong-Sik; Kim, Kyung-Ah; Yoo, Ki-Oug] Kangwon Natl Univ, Dept Biol Sci, Chunchon, Gangwon, South Korea	Kangwon National University	Yoo, KO (corresponding author), Kangwon Natl Univ, Dept Biol Sci, Chunchon, Gangwon, South Korea.	yooko@kangwon.ac.kr	Yoo, Ki-Oug/ABI-6073-2020		Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2016R1D1A3B03931131]; Kangwon National University	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Kangwon National University	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2016R1D1A3B03931131), and Kangwon National University.	Baranov AI, 1963, Q J TAIWAN MUSEUM, V16, P143; Chang CC, 2006, MOL BIOL EVOL, V23, P279, DOI 10.1093/molbev/msj029; Cheon KS, 2016, MITOCHONDRIAL DNA A, V27, P2169, DOI 10.3109/19401736.2014.982610; Cheon KS, 2016, MITOCHONDRIAL DNA A, V27, P1629, DOI 10.3109/19401736.2014.958702; Cheon KS, 2013, J SYST EVOL, V51, P704, DOI 10.1111/jse.12039; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cosner ME, 1997, CURR GENET, V31, P419, DOI 10.1007/s002940050225; Crowl AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094199; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Eddie WMM, 2003, ANN MO BOT GARD, V90, P554, DOI 10.2307/3298542; Fedorov AA., 1957, FLORA USSR, V24, P246; Fischer FEL, 1823, MEMORIES SOC IMPERIA, V6, P165; Fu CX., 1986, NATURAL SCI J HARBIN, V2, P41; Haberle RC, 2008, J MOL EVOL, V66, P350, DOI 10.1007/s00239-008-9086-4; Haberle RC, 2009, TAXON, V58, P715, DOI 10.1002/tax.583003; Hong DY., 1983, FLORA REIPUBLICAE PO, V73, P92; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kim K., 2016, THESIS; Kim KA, 2016, MITOCHONDRIAL DNA A, V27, P2963, DOI [10.3109/19401736.2015.1063121, 10.3109/19401736.2015.1060461]; KIM Kyung-Ah, 2012, [Korean Journal of plant Taxonomy, 식물분류학회지], V42, P282; KIM Kyung-Ah, 2011, [Korean Journal of plant Taxonomy, 식물분류학회지], V41, P119; Kim Young-Dong, 1999, Journal of Plant Biology, V42, P168; Kim YK, 2009, MOL CELLS, V27, P365, DOI 10.1007/s10059-009-0047-6; Kolakovskii A. A., 1994, Botanicheskii Zhurnal (St. Petersburg), V79, P109; Korshinsky S., MEMORIES ACAD IMPERI, V42, P1; Lee JK, 1989, THESIS; Lee S, 1997, J PLANT RES, V110, P77, DOI 10.1007/BF02506845; LEE S, 1986, Korean Journal of Plant Taxonomy, V16, P25; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lohse M, 2007, CURR GENET, V52, P267, DOI 10.1007/s00294-007-0161-y; Nakai T, 1909, BOT MAG TOKYO, V23, P185; Nakai T, 1911, J COLL SCI IMP U TOK, V31, P64; Okazaki J., 1993, FLORA JAPAN, V3a, P406; Park KR, 2000, RES I BASIC SCI KYUN, V14, P171; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schonland S., 1889, NATURL PFLANZ, VIV, P40; SHETLER SG, 1986, ANN MO BOT GARD, V73, P653, DOI 10.2307/2399199; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Takhtajan A., 1997, DIVERSITY CLASSIFICA, P405; Tu P, 1996, Zhongguo Zhong Yao Za Zhi, V21, P581; Tu P, 1997, Zhongguo Zhong Yao Za Zhi, V22, P67; WAKASUGI T, 1994, P NATL ACAD SCI USA, V91, P9794, DOI 10.1073/pnas.91.21.9794; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yoo K. O., 1995, THESIS; Yoo KO, 2016, MITOCHONDRIAL DNA B, V1, P184, DOI 10.1080/23802359.2016.1149791; Yoo KO, 1996, HORTIC ENVIRON BIOTE, V37, P324; Yoo KO, 1995, KOREAN J PLANT RESOU, V8, P223; Yoo KO, 1995, KOREAN J PLANT RESOU, V8, P303; 屠鹏飞, 1998, 西北植物学报, V18, P613	52	14	14	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183652	10.1371/journal.pone.0183652	http://dx.doi.org/10.1371/journal.pone.0183652			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829825	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100063
J	Li, Q; Yang, WS; Wang, XC; Cao, D; Zhu, D; Lv, FJ; Liu, Y; Yuan, L; Zhang, G; Xiong, X; Li, R; Hu, YX; Qin, XY; Xie, P				Li, Qi; Yang, Wen-Song; Wang, Xing-Chen; Cao, Du; Zhu, Dan; Lv, Fa-Jin; Liu, Yang; Yuan, Liang; Zhang, Gang; Xiong, Xin; Li, Rui; Hu, Yun-Xin; Qin, Xin-Yue; Xie, Peng			Blend sign predicts poor outcome in patients with intracerebral hemorrhage	PLOS ONE			English	Article							ULTRAEARLY HEMATOMA GROWTH; COMPUTED-TOMOGRAPHY; CONTRAST EXTRAVASATION; BLOOD-PRESSURE; SPOT SIGN; EXPANSION; MORTALITY; ENLARGEMENT; PROGNOSIS	Introduction Blend sign has been recently described as a novel imaging marker that predicts hematoma expansion. The purpose of our study was to investigate the prognostic value of CT blend sign in patients with ICH. Objectives and methods Patients with intracerebral hemorrhage who underwent baseline CT scan within 6 hours were included. The presence of blend sign on admission nonenhanced CT was independently assessed by two readers. The functional outcome was assessed by using the modified Rankin Scale (mRS) at 90 days. Results Blend sign was identified in 40 of 238 (16.8%) patients on admission CT scan. The proportion of patients with a poor functional outcome was significantly higher in patients with blend sign than those without blend sign (75.0% versus 47.5%, P = 0.001). The multivariate logistic regression analysis demonstrated that age, intraventricular hemorrhage, admission GCS score, baseline hematoma volume and presence of blend sign on baseline CT independently predict poor functional outcome at 90 days. The CT blend sign independently predicts poor outcome in patients with ICH (odds ratio 3.61, 95% confidence interval [1.47-8.89]; p = 0.005). Conclusions Early identification of blend sign is useful in prognostic stratification and may serve as a potential therapeutic target for prospective interventional studies.	[Li, Qi; Wang, Xing-Chen; Cao, Du; Zhu, Dan; Zhang, Gang; Xiong, Xin; Li, Rui; Qin, Xin-Yue; Xie, Peng] Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China; [Yang, Wen-Song] Chongqing Med Univ, Yongchuan Hosp, Dept Neurol, Chongqing, Peoples R China; [Lv, Fa-Jin; Liu, Yang] Chongqing Med Univ, Affiliated Hosp 1, Dept Radiol, Chongqing, Peoples R China; [Yuan, Liang] Chongqing Med Univ, Univ Town Hosp, Dept Radiol, Chongqing, Peoples R China; [Hu, Yun-Xin] Chongqing Jiulongpo Peoples Hosp, Dept Neurol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Li, Q; Xie, P (corresponding author), Chongqing Med Univ, Dept Neurol, Affiliated Hosp 1, Chongqing, Peoples R China.	qili_md@yahoo.com; peng_xie@yahoo.com	Demchuk, Andrew M/E-1103-2012; Li, Qi/ABE-4182-2021	Demchuk, Andrew M/0000-0002-4930-7789; Li, Qi/0000-0002-9144-148X	National Natural Science Foundation of China [81200899]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (grant no. 81200899). Recipient: Qi Li.	An SJ, 2017, J STROKE, V19, P3, DOI 10.5853/jos.2016.00864; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Blacquiere D, 2015, STROKE, V46, P3111, DOI 10.1161/STROKEAHA.115.010566; Boulouis G, 2017, STROKE, V48, P1120, DOI 10.1161/STROKEAHA.116.015062; Boulouis G, 2016, STROKE, V47, P2511, DOI 10.1161/STROKEAHA.116.014425; Boulouis G, 2016, JAMA NEUROL, V73, P961, DOI 10.1001/jamaneurol.2016.1218; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; Brouwers HB, 2015, STROKE, V46, P2498, DOI 10.1161/STROKEAHA.115.009659; Brouwers HB, 2014, JAMA NEUROL, V71, P158, DOI 10.1001/jamaneurol.2013.5433; Brouwers HB, 2013, CEREBROVASC DIS, V35, P195, DOI 10.1159/000346599; Davis SM, 2006, NEUROLOGY, V66, P1175, DOI 10.1212/01.wnl.0000208408.98482.99; Delcourt C, 2012, NEUROLOGY, V79, P314, DOI 10.1212/WNL.0b013e318260cbba; Du FZ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115777; FUJII Y, 1994, J NEUROSURG, V80, P51, DOI 10.3171/jns.1994.80.1.0051; Goldstein JN, 2007, NEUROLOGY, V68, P889, DOI 10.1212/01.wnl.0000257087.22852.21; Hansen BM, 2013, J NEUROL NEUROSUR PS, V84, P1150, DOI 10.1136/jnnp-2013-305200; Kazui S, 1996, STROKE, V27, P1783, DOI 10.1161/01.STR.27.10.1783; Koch S, 2016, NEUROLOGY, V87, P786, DOI 10.1212/WNL.0000000000002962; Li Q, 2016, STROKE, V47, P1777, DOI 10.1161/STROKEAHA.116.013186; Li Q, 2015, STROKE, V46, P2119, DOI 10.1161/STROKEAHA.115.009185; Mayer SA, 2005, NEW ENGL J MED, V352, P777, DOI 10.1056/NEJMoa042991; NEW PFJ, 1976, RADIOLOGY, V121, P635, DOI 10.1148/121.3.635; Poon MTC, 2014, J NEUROL NEUROSUR PS, V85, P660, DOI 10.1136/jnnp-2013-306476; Purrucker JC, 2016, JAMA NEUROL, V73, P169, DOI 10.1001/jamaneurol.2015.3682; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Rodriguez-Luna D, 2011, NEUROLOGY, V77, P1599, DOI 10.1212/WNL.0b013e3182343387; Rodriguez-Luna D, 2016, NEUROLOGY, V87, P357, DOI 10.1212/WNL.0000000000002897; Sato S, 2014, NEUROLOGY, V83, P2232, DOI 10.1212/WNL.0000000000001076; Sporns PB, 2017, STROKE, V48, P131, DOI 10.1161/STROKEAHA.116.014068; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Zheng J, 2017, MED SCI MONITOR, V23, P2250, DOI 10.12659/MSM.901583; Zia E, 2009, STROKE, V40, P3567, DOI 10.1161/STROKEAHA.109.556324	32	26	28	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183082	10.1371/journal.pone.0183082	http://dx.doi.org/10.1371/journal.pone.0183082			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829797	Green Submitted, Green Published, gold			2022-12-27	WOS:000408085100027
J	Fernando, MR; Jiang, C; Krzyzanowski, GD; Ryan, WL				Fernando, M. Rohan; Jiang, Chao; Krzyzanowski, Gary D.; Ryan, Wayne L.			New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes	PLOS ONE			English	Article							VESICLES	Cell-free DNA (cfDNA) in blood is used as a source of genetic material for noninvasive prenatal and cancer diagnostic assays in clinical practice. Recently we have started a project for new biomarker discovery with a view to developing new noninvasive diagnostic assays. While reviewing literature, it was found that exosomes may be a rich source of biomarkers, because exosomes play an important role in human health and disease. While characterizing exosomes found in human blood plasma, we observed the presence of cfDNA in plasma exosomes. Plasma was obtained from blood drawn into K3EDTA tubes. Exosomes were isolated from cell-free plasma using a commercially available kit. Sizing and enumeration of exosomes were done using electron microscopy and NanoSight particle counter. NanoSight and confocal microscopy was used to demonstrate the association between dsDNA and exosomes. DNA extracted from plasma and exosomes was measured by a fluorometric method and a droplet digital PCR (ddPCR) method. Size of extracellular vesicles isolated from plasma was heterogeneous and showed a mean value of 92.6 nm and a mode 39.7 nm. A large proportion of extracellular vesicles isolated from plasma were identified as exosomes using a fluorescence probe specific for exosomes and three protein markers, Hsp70, CD9 and CD63, that are commonly used to identify exosome fraction. Fluorescence dye that stain dsDNA showed the association between exosomes and dsDNA. Plasma cfDNA concentration analysis showed more than 93% of amplifiable cfDNA in plasma is located in plasma exosomes. Storage of a blood sample showed significant increases in exosome count and exosome DNA concentration. This study provide evidence that a large proportion of plasma cfDNA is localized in exosomes. Exosome release from cells is a metabolic energy dependent process, thus suggesting active release of cfDNA from cells as a source of cfDNA in plasma.	[Fernando, M. Rohan; Jiang, Chao; Krzyzanowski, Gary D.] Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, Omaha, NE 68182 USA; [Fernando, M. Rohan; Krzyzanowski, Gary D.; Ryan, Wayne L.] CFGenome, Dept Res & Dev, Omaha, NE 68130 USA	University of Nebraska System; University of Nebraska Medical Center	Fernando, MR (corresponding author), Univ Nebraska, Med Ctr, Dept Obstet & Gynecol, Omaha, NE 68182 USA.; Fernando, MR (corresponding author), CFGenome, Dept Res & Dev, Omaha, NE 68130 USA.	mrohan.fernando@unmc.edu			University of Nebraska Foundation	University of Nebraska Foundation	The authors did not get any specific funding for this project. The project was funded by the general funds provided to the laboratory by the University of Nebraska Foundation. Dr. W. L. Ryan is Professor Emeritus, University of Nebraska Medical Center, who has been associated with the department for more than 40 years. As one of the collaborators, WLR was involved in designing the experiments and writing the manuscript. During the time this project was done (September 2014 to March 2016), MRF, CJ and GDK were full-time employees of the University of Nebraska Medical Center. In August 2016, WLR, MRF and GDK started CFGenome, a startup company located in Omaha NE. MRF is the CEO of CFGenome and GDK is an employee. MRF has applied for 2 patents which are unrelated to this project.	Anitei M, 2010, MOL MEMBR BIOL, V27, P443, DOI 10.3109/09687688.2010.522601; Arbabi A, 2016, BIOINFORMATICS, V32, P1662, DOI 10.1093/bioinformatics/btw178; Ashley N, 2005, EXP CELL RES, V303, P432, DOI 10.1016/j.yexcr.2004.10.013; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Fan HC, 2010, CLIN CHEM, V56, P1279, DOI 10.1373/clinchem.2010.144188; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hahn S, 2010, CLIN CHEM, V56, P1210, DOI 10.1373/clinchem.2010.149609; Hindson BJ, 2011, ANAL CHEM, V83, P8604, DOI 10.1021/ac202028g; Huang XY, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-319; Jiang PY, 2016, TRENDS GENET, V32, P360, DOI 10.1016/j.tig.2016.03.009; Kalra H, 2013, PROTEOMICS, V13, P3354, DOI 10.1002/pmic.201300282; Menck K, 2017, JOVE-J VIS EXP, DOI 10.3791/55057; Norton SE, 2013, J CLIN LAB ANAL, V27, P305, DOI 10.1002/jcla.21603; Orlando KA, 2006, EXP CELL RES, V312, P5, DOI 10.1016/j.yexcr.2005.09.012; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Thierry AR, 2016, CANCER METAST REV, V35, P347, DOI 10.1007/s10555-016-9629-x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Yu SCY, 2014, P NATL ACAD SCI USA, V111, P8583, DOI 10.1073/pnas.1406103111	21	153	156	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0183915	10.1371/journal.pone.0183915	http://dx.doi.org/10.1371/journal.pone.0183915			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850588	Green Submitted, Green Published, gold			2022-12-27	WOS:000408544200041
J	Noh, JW; Kim, J; Yang, Y; Park, J; Cheon, J; Kwon, YD				Noh, Jin-Won; Kim, Jinseok; Yang, Youngmi; Park, Jumin; Cheon, Jooyoung; Kwon, Young Dae			Body mass index and self-rated health in East Asian countries: Comparison among South Korea, China, Japan, and Taiwan	PLOS ONE			English	Article							PERCEIVED WEIGHT STATUS; SOCIOECONOMIC-STATUS; UNIVERSITY-STUDENTS; LIFE SATISFACTION; OLDER-ADULTS; ASSOCIATION; ADOLESCENTS; PERCEPTION; OBESITY; BEHAVIOR	There have been conflicting findings regarding the relationship between body mass index (BMI) and self-rated health (SRH) worldwide. The purpose of this study was to examine the association between BMI and SRH by comparing its relationship in four East Asian countries: South Korea, China, Japan, and Taiwan. Using data from the East Asian Social Survey, the relationship between weight status and SRH status was investigated and compared between four countries, China, Japan, South Korea, and Taiwan. An ordinal logit regression model was estimated for each country, and the results were compared. We found that the relationship between weight status and SRH status differed across the four countries. In China, people who were overweight reported better SRH scores than those of normal weight, whereas in Japan, obese and severely obese people reported poor scores. In contrast, South Koreans who were underweight, obese, or severely obese reported poor ratings of health status than those of normal weight. In Taiwan, however, no differences in respondents' weight status were found across SRH scores. There were notable differences in the relationship between BMI and SRH status in four East Asian countries. Individual countries should consider these relationships when designing and implementing obesity intervention programs.	[Noh, Jin-Won] Eulji Univ, Dept Healthcare Management, Seongnam, South Korea; [Noh, Jin-Won] Univ Groningen, Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kim, Jinseok; Yang, Youngmi] Seoul Womens Univ, Dept Social Welf, Seoul, South Korea; [Park, Jumin] Natl Inst Hlth Clin Ctr, Bethesda, MD USA; [Cheon, Jooyoung] Sungshin Univ, Dept Nursing Sci, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea; [Kwon, Young Dae] Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea	Eulji University; University of Groningen; Seoul Women's University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Sungshin Women's University; Catholic University of Korea; Catholic University of Korea	Kwon, YD (corresponding author), Catholic Univ Korea, Coll Med, Dept Humanities & Social Med, Seoul, South Korea.; Kwon, YD (corresponding author), Catholic Univ Korea, Catholic Inst Healthcare Management, Seoul, South Korea.	snukyd1@naver.com	Kwon, Young Dae/T-1591-2017	Kwon, Young Dae/0000-0002-8781-6832; Cheon, Jooyoung/0000-0001-9622-0937; Noh, Jin-Won/0000-0001-5172-4023				Albrecht SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072983; Allen CD, 2016, J ADOLESCENT HEALTH, V58, P47, DOI 10.1016/j.jadohealth.2015.09.006; Assari S., 2017, INT J EPIDE IN PRESS; Assari S, 2015, INT J PREVENTIVE MED, V6, DOI 10.4103/2008-7802.164413; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-36; Assari S, 2014, J DIABETES METAB DIS, V13, DOI 10.1186/2251-6581-13-3; Brewis AA, 2017, AM J HUM BIOL, V29, DOI 10.1002/ajhb.22972; Brewis AA, 2011, CURR ANTHROPOL, V52, P269, DOI 10.1086/659309; Bryant AN, 2014, AM J GERIAT PSYCHIAT, V22, P653, DOI 10.1016/j.jagp.2013.08.006; Centers for Disease Control and Prevention (CDC), 2016, AD OB FACTS; Centers for Disease Control Prevention, 2000, MEAS HLTH DAYS POP A; Chan YY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2080-z; Chisuwa-Hayami N, 2017, HEALTH PROMOT PERSPE, V7, P80, DOI 10.15171/hpp.2017.15; Dinsa GD, 2012, OBES REV, V13, P1067, DOI 10.1111/j.1467-789X.2012.01017.x; Herman KM, 2013, QUAL LIFE RES, V22, P2693, DOI 10.1007/s11136-013-0394-9; Heshmat R, 2015, QUAL LIFE RES, V24, P263, DOI 10.1007/s11136-014-0757-x; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Imai K, 2008, OBESITY, V16, P402, DOI 10.1038/oby.2007.70; Inoue M, 2007, J OCCUP HEALTH, V49, P376, DOI 10.1539/joh.49.376; International Monetary Fund, 2016, WORLD EC OUTL APR 20; ISAPS, 2015, INT SURV AESTH COSM; Joh HK, 2013, OBESITY FACTS, V6, P17, DOI 10.1159/000346805; Kim G, 2014, AM J GERIAT PSYCHIAT, V22, P661, DOI 10.1016/j.jagp.2012.08.011; Lee Hwi-Won, 2015, J Prev Med Public Health, V48, P287, DOI 10.3961/jpmph.15.048; Lim HJ, 2013, OBESITY, V21, P2596, DOI 10.1002/oby.20361; Lim WY, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-184; Mee Lee Young, 2013, [Korean Journal of community Nutrition, 대한지역사회영양학회지], V18, P25; Molarius A, 2007, EUR J PUBLIC HEALTH, V17, P125, DOI 10.1093/eurpub/ckl070; Mota J, 2012, J PHYS ACT HEALTH, V9, P378, DOI 10.1123/jpah.9.3.378; Ohara K, 2014, EAT WEIGHT DISORD-ST, V19, P461, DOI 10.1007/s40519-014-0130-7; Park JH, 2013, PUBLIC HEALTH, V127, P834, DOI 10.1016/j.puhe.2012.12.012; Pike KM, 2014, CURR OPIN PSYCHIATR, V27, P436, DOI 10.1097/YCO.0000000000000100; Pu C, 2010, ASIA PAC J CLIN NUTR, V19, P180; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491; Swami V, 2012, AESTHET SURG J, V32, P220, DOI 10.1177/1090820X11431577; Tang K, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4249-0; United Nations, 2015, STESASERA390 UN; United Nations, 2015, GAPIII CONT CERT SCH; Wang A, 2015, PREV CHRONIC DIS, V12, DOI 10.5888/pcd12.150070; World Bank, 2016, GDP PER CAP PPP CURR; World Health Organization, 2018, OB OV FACT SHEET 311; Wu SQ, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-320, 10.1186/1471-2458-13-636]; Zhang L, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3864-5; Zhang Yan Bing, 2005, COMMUNICATION RES RE, V22, P2	44	16	16	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183881	10.1371/journal.pone.0183881	http://dx.doi.org/10.1371/journal.pone.0183881			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846742	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600055
J	Bodson, J; Wilson, A; Warner, EL; Kepka, D				Bodson, Julia; Wilson, Andrew; Warner, Echo L.; Kepka, Deanna			Religion and HPV vaccine-related awareness, knowledge, and receipt among insured women aged 18-26 in Utah	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINATION; YOUNG-ADULT WOMEN; UNITED-STATES; PARENTS; CANCER; ADOLESCENTS; STUDENTS	Introduction We investigate the associations between religious practice and human papillomavirus (HPV) vaccine-related awareness, knowledge, and receipt among young women in Utah. Methods We surveyed 326 insured women aged 18-26 by mail. Fisher's Exact Tests and multivariable logistic regression models were used to evaluate the relations between religious practice and HPV vaccine-related outcomes. Data collection occurred January-December 2013; analyses were conducted June-September 2015. Results Multivariable analyses reveal that when controlling for age, educational attainment, and marital status, participants who practiced an organized religion were significantly less likely to have heard of HPV (aOR = 0.25, p = 0.0123), to have heard of the HPV vaccine (aOR = 0.41, p = 0.0368), to know how HPV is spread (aOR = 0.45, p = 0.0074), to have received a provider recommendation for the HPV vaccine (aOR = 0.36, p = 0.0332), and to have received at least one (aOR = 0.50, p = 0.0073) or all three (aOR = 0.47, p = 0.0026) doses of the HPV vaccine. Bivariate analyses produce parallel results. Conclusions Results indicate that religious young women in Utah are not only under-vaccinated, but are also under-informed about HPV and the HPV vaccine. These results suggest that suboptimal vaccine coverage among religious young women may present a serious health risk for the community. Strategies for educational interventions targeted to this population are discussed.	[Bodson, Julia; Warner, Echo L.; Kepka, Deanna] Huntsman Canc Inst, Canc Control & Populat Sci, Salt Lake City, UT 84103 USA; [Wilson, Andrew] Univ Utah, Dept Family & Prevent Med, Salt Lake City, UT USA; [Warner, Echo L.; Kepka, Deanna] Univ Utah, Coll Nursing, Salt Lake City, UT 84112 USA	Huntsman Cancer Institute; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Bodson, J (corresponding author), Huntsman Canc Inst, Canc Control & Populat Sci, Salt Lake City, UT 84103 USA.	Julia.Bodson@hci.utah.edu	Warner, Echo/K-4068-2018	Warner, Echo/0000-0002-7844-3309; Wilson, Andrew/0000-0003-3679-9232	Huntsman Cancer Institute; Huntsman Cancer Foundation	Huntsman Cancer Institute; Huntsman Cancer Foundation	This project was supported in part by Huntsman Cancer Institute and Huntsman Cancer Foundation. The funding source had no involvement in study design; in the collection, analysis, and interpretation of the data; in the writing of the report; or in the decision to submit the article for publication.	Chen D., 2015, DESERET NEWS; Constantine NA, 2007, J ADOLESCENT HEALTH, V40, P108, DOI 10.1016/j.jadohealth.2006.10.007; Davidson L., 2012, SALT LAKE TRIBUNE; Dillman DA, 2009, E COMMUNICATION; Finer LB, 2013, PEDIATRICS, V131, P886, DOI 10.1542/peds.2012-3495; Gehrke R, 2016, MORMON CHURCH OPPOSI; Gerend MA, 2011, WOMEN HEALTH, V51, P25, DOI 10.1080/03630242.2011.540744; Hariri S, 2011, J INFECT DIS, V204, P566, DOI 10.1093/infdis/jir341; Healthy People 2020, 2010, PICS OBJECTIVES IMM; Krakow MM, 2015, WOMEN HEALTH ISS, V25, P105, DOI 10.1016/j.whi.2014.11.006; Lefkowitz ES, 2014, WOMEN HEALTH, V54, P487, DOI 10.1080/03630242.2014.903552; Litton AG, 2011, J PEDIATR ADOL GYNEC, V24, P166, DOI 10.1016/j.jpag.2011.01.004; Manhart LE, 2011, VACCINE, V29, P5238, DOI 10.1016/j.vaccine.2011.05.024; Markowitz Lauri E., 2007, Morbidity and Mortality Weekly Report, V56, P1; Poulson RL, 1998, J AM COLL HEALTH, V46, P227, DOI 10.1080/07448489809600227; Rambout L, 2014, PREV MED, V58, P22, DOI 10.1016/j.ypmed.2013.10.009; Ratanasiripong NT, 2012, J AM COLL HEALTH, V60, P461, DOI 10.1080/07448481.2012.684365; Reagan-Steiner S, 2016, MMWR-MORBID MORTAL W, V65, P850, DOI 10.15585/mmwr.mm6533a4; Reynolds D., 2014, J CHRIST NURS, V31, P172; Rimer B. K., 2014, ACCELERATING HPV VAC; Sadigh G, 2012, HUM VACC IMMUNOTHER, V8, DOI 10.4161/hv.18456; Shelton RC, 2013, J RELIG HEALTH, V52, P1120, DOI 10.1007/s10943-011-9553-x; Thomas TL, 2013, J ADOLESCENT HEALTH, V52, pS60, DOI 10.1016/j.jadohealth.2012.08.011; Thomas TL, 2012, J NURS SCHOLARSHIP, V44, P358, DOI 10.1111/j.1547-5069.2012.01479.x; Thompson VLS, 2012, J HEALTH CARE POOR U, V23, P290, DOI 10.1353/hpu.2012.0007; Williams WW, 2012, MMWR-MORBID MORTAL W, V2014, P95; Wilson AR, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0323-5; Zimet GD, 2008, ANNU REV MED, V59, P223, DOI 10.1146/annurev.med.59.092806.131644	28	23	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183725	10.1371/journal.pone.0183725	http://dx.doi.org/10.1371/journal.pone.0183725			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841681	Green Published, Green Submitted, gold			2022-12-27	WOS:000408370700054
J	Kilbride, P; Lamb, S; Gibbons, S; Bundy, J; Erro, E; Selden, C; Fuller, B; Morris, J				Kilbride, Peter; Lamb, Stephen; Gibbons, Stephanie; Bundy, James; Erro, Eloy; Selden, Clare; Fuller, Barry; Morris, John			Cryopreservation and re-culture of a 2.3 litre biomass for use in a bioartificial liver device	PLOS ONE			English	Article							HUMAN HEPATOCYTES; CHAIN DELIVERY; STEM-CELLS; SPHEROIDS; ALGINATE; SCALE; TRANSPLANTATION; VITRIFICATION; TEMPERATURES; STRATEGY	For large and complex tissue engineered constructs to be available on demand, long term storage using methods, such as cryopreservation, are essential. This study optimised parameters such as excess media concentration and warming rates and used the findings to enable the successful cryopreservation of 2.3 litres of alginate encapsulated liver cell spheroids. This volume of biomass is typical of those required for successful treatment of Acute Liver Failure using our Bioartificial Liver Device. Adding a buffer of medium above the biomass, as well as slow (0.6 E C/min) warming rates was found to give the best results, so long as the warming through the equilibrium melting temperature was rapid. After 72 h post thaw-culture, viable cell number, glucose consumption, lactate production, and alpha-fetoprotein production had recovered to pre-freeze values in the 2.3 litre biomass (1.00 +/- 0.05, 1.19 +/- 0.10, 1.23 +/- 0.18, 2.03 +/- 0.04 per ml biomass of the pre-cryopreservation values respectively). It was also shown that further improvements in warming rates of the biomass could reduce recovery time to < 48 h. This is the first example of a biomass of this volume being successfully cryopreserved in a single cassette and re-cultured. It demonstrates that a bioartificial liver device can be cryopreserved, and has wider applications to scale-up large volume cryopreservation.	[Kilbride, Peter; Lamb, Stephen; Morris, John] Gen Elect Healthcare, Asymptote, Cambridge, England; [Kilbride, Peter; Gibbons, Stephanie; Bundy, James; Erro, Eloy; Selden, Clare] UCL, Inst Liver & Digest Hlth, Royal Free Hosp Campus, London, England; [Fuller, Barry] UCL, Dept Surg, Royal Free Hosp Campus, London, England	General Electric; University of London; University College London; University of London; University College London	Kilbride, P (corresponding author), Gen Elect Healthcare, Asymptote, Cambridge, England.; Kilbride, P (corresponding author), UCL, Inst Liver & Digest Hlth, Royal Free Hosp Campus, London, England.	peter.kilbride.11@ucl.ac.uk		Selden, Angela/0000-0003-2648-443X; Erro Barbarin, Eloy/0000-0002-3558-4216	Medical Research Council (UK) Industrial Case Studentship [9203]; Asymptote Ltd.; Innovate UK [101103]; Liver Group Charity; Wellcome Trust	Medical Research Council (UK) Industrial Case Studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Asymptote Ltd.; Innovate UK(UK Research & Innovation (UKRI)Innovate UK); Liver Group Charity; Wellcome Trust(Wellcome TrustEuropean Commission)	Peter Kilbride was funded through a Medical Research Council (UK) Industrial Case Studentship 9203. Funding for this work was provided by Asymptote Ltd. and Innovate UK (101103). Stephanie Gibbons was funded by the Liver Group Charity, and James Bundy & Eloy Erro were funded by the Wellcome Trust. The funder provided support in the form of salaries for authors [MRC - PK, Wellcome - JB, CS and EE, Liver Group Charity - SG, Asymptote - JM], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ABLETT S, 1992, J CHEM SOC FARADAY T, V88, P789, DOI 10.1039/ft9928800789; AKHTAR T, 1979, CRYOBIOLOGY, V16, P424, DOI 10.1016/0011-2240(79)90055-5; Alexandre E, 2002, CRYOBIOLOGY, V44, P103, DOI 10.1016/S0011-2240(02)00011-1; [Anonymous], CRYOBIOLOGY; Baust JM, 2000, IN VITRO CELL DEV-AN, V36, P262; Baust JM, 2009, BIOPRESERV BIOBANK, V7, P3, DOI 10.1089/bio.2009.0701.jmb; Bernal W, 2013, NEW ENGL J MED, V369, P2525, DOI 10.1056/NEJMra1208937; Borel Rinkes IH, 1992, CELL TRANSPLANT, V1, P281; Brockbank KGN, 2006, ADV BIOPRESERVATION, P157; Campbell BK, 2014, HUM REPROD, V29, P1749, DOI 10.1093/humrep/deu144; Coward SM, 2005, ARTIF ORGANS, V29, P152, DOI 10.1111/j.1525-1594.2005.29026.x; Day JG, 2007, CRYOPRESERVATION FRE, Vxi; Erro E, 2013, BIORESEARCH OPEN ACC, V2, P1, DOI 10.1089/biores.2012.0286; Evans S, 2000, CRYOBIOLOGY, V40, P126, DOI 10.1006/cryo.2000.2232; Fahy GM, 2006, REJUV RES, V9, P279, DOI 10.1089/rej.2006.9.279; Fahy GM, 2009, ORGANOGENESIS, V5, P167, DOI 10.4161/org.5.3.9974; Guibert EE, 2011, TRANSFUS MED HEMOTH, V38, P125, DOI 10.1159/000327033; Khush KK, 2015, AM J TRANSPLANT, V15, P642, DOI 10.1111/ajt.13055; Kilbride P, 2016, CRYOBIOLOGY; Kilbride P, 2016, BIORESEARCH OPEN ACC, V5, P146, DOI 10.1089/biores.2016.0017; Kilbride P, 2014, CRYOBIOLOGY, V69, P367, DOI 10.1016/j.cryobiol.2014.09.003; KORBER C, 1988, Q REV BIOPHYS, V21, P229, DOI 10.1017/S0033583500004303; Lee WM, 2012, SEMIN RESP CRIT CARE, V33, P36, DOI 10.1055/s-0032-1301733; Li Y, 2012, BIORESEARCH OPEN ACC, V1, P205, DOI 10.1089/biores.2012.0224; Malpique R, 2010, TISSUE ENG PART C-ME, V16, P965, DOI 10.1089/ten.TEC.2009.0660; Marasco SF, 2011, J HEART LUNG TRANSPL, V30, P414, DOI 10.1016/j.healun.2010.10.002; Massie IR, 2012, DEV OPTIMISED CRYOPR; Massie I, 2014, TISSUE ENG PART C-ME, V20, P693, DOI [10.1089/ten.tec.2013.0571, 10.1089/ten.TEC.2013.0571]; Massie I, 2011, TISSUE ENG PART C-ME, V17, P765, DOI [10.1089/ten.tec.2010.0394, 10.1089/ten.TEC.2010.0394]; Massie I, 2013, TISSUE ENG PART C-ME, V19, P189, DOI [10.1089/ten.tec.2012.0307, 10.1089/ten.TEC.2012.0307]; Mazur P, 1970, CIBA FDN S FROZ CELL; MCGANN LE, 1981, CRYOBIOLOGY, V18, P469, DOI 10.1016/0011-2240(81)90205-4; Meryman HT, 1966, CRYOBIOLOGY, Vxiv; Milenkovic M, 2011, J ASSIST REPROD GEN, V28, P7, DOI 10.1007/s10815-010-9477-5; Morris GJ, 2013, CRYOBIOLOGY, V66, P85, DOI 10.1016/j.cryobiol.2012.11.007; MUNN CS, 1986, RADIOLOGY, V159, P731, DOI 10.1148/radiology.159.3.3517957; Nyberg SL, 2014, PATHOBIOLOGY OF HUMAN DISEASE: A DYNAMIC ENCYCLOPEDIA OF DISEASE MECHANISMS, P1800, DOI 10.1016/B978-0-12-386456-7.04205-2; Petrowsky H, 2015, TRANSPLANTATION LIVE, P582, DOI DOI 10.1016/B978-1-4557-0268-8.00044-0; RAPATZ G., 1960, BIODYNAMICA, V8, P195; Rasmussen D, 1968, PHASE DIAGRAM SYSTEM; RUGGERA PS, 1990, CRYOBIOLOGY, V27, P465, DOI 10.1016/0011-2240(90)90035-3; Santos-Sousa CA, 2015, INT J MORPHOL, V33, P1293, DOI 10.4067/S0717-95022015000400017; Selden C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082312; Serra M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023212; Sputtek A, 2011, CYTOTHERAPY, V13, P481, DOI 10.3109/14653249.2010.529891; Stephenne X, 2010, WORLD J GASTROENTERO, V16, P1, DOI 10.3748/wjg.v16.i1.1; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Wang T, 2014, CRYOBIOLOGY, V68, P234, DOI 10.1016/j.cryobiol.2014.02.002; Wusteman M, 2004, CRYOBIOLOGY, V48, P179, DOI 10.1016/j.cryobiol.2004.01.002	49	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183385	10.1371/journal.pone.0183385	http://dx.doi.org/10.1371/journal.pone.0183385			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841674	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700028
J	Kraaijenbrink, C; Vegter, RJK; Hensen, AHR; Wagner, H; van der Woude, LHV				Kraaijenbrink, Cassandra; Vegter, Riemer J. K.; Hensen, Alexander H. R.; Wagner, Heiko; van der Woude, Lucas H. V.			Different cadences and resistances in sub-maximal synchronous handcycling in able-bodied men: Effects on efficiency and force application	PLOS ONE			English	Article							SPONTANEOUSLY CHOSEN CRANK; WHEELCHAIR; REHABILITATION; PROPULSION; CAPACITY; ARM	Background With the introduction of an add-on handcycle, a crank system that can be placed in front of a wheelchair, handcycling was made widely available for daily life. With it, people go into town more easily, e.g. to do groceries; meet up with friends, etc. They have more independency and can be socially active. Our aim is to explore some settings of the handcycle, so that it can be optimally used as a transportation device. Therefore, the effects of cadence and added resistance on gross mechanical efficiency and force application during sub-maximal synchronous handcycling were investigated. We hypothesized that a cadence of 52 rpm with a higher resistance (35 W) would lead to a higher gross mechanical efficiency and a more tangential force application than a higher cadence of 70 rpm and no extra resistance (15 W). Methods Twelve able-bodied men rode in an instrumented add-on handcycle on a motorized level treadmill at 1.94 m/s. They performed three sessions of three four-minute blocks of steady state exercise. Gear (70, 60 and 52 rpm) was changed in-between the blocks and resistance (rolling resistance +0 W, +10 W, +20 W) was changed across sessions, both in a counterbalanced order. 3D force production, oxygen uptake and heart rate were measured continuously. Gross mechanical efficiency (ME) and fraction of effective force (FEF) were calculated as main outcomes. The effects of cadence and resistance were analyzed using a repeated measures ANOVA (P<0.05) with Bonferroni-corrected post-hoc pairwise comparisons. Results With a decrease in cadence a slight increase in ME (70 rpm: 5.5 (0.2)%, 60 rpm: 5.7 (0.2)%, 52 rpm: 5.8 (0.2)%, P = 0.008, eta(2)(p) = 0.38), while an increase in FEF (70 rpm: 58.0 (3.2)%, 60 rpm: 66.0 (2.8)%, 52 rpm: 71.3 (2.3)%, P<0.001,eta(2)(p) = 0.79) is seen simultaneously. Also with an increase in resistance an increase in ME (+0 W: 4.0 (0.2)%, +10 W: 6.0 (0.3)%, +20 W: 7.0 (0.2)%, P<0.001,eta(2)(p) = 0.92) and FEF (+0 W: 59.0 (2.9)%, +10 W: 66.1 (3.4)%, +20 W: 70.2 (2.4)%, P<0.001,eta(2)(p) = 0.56) was found. Interpretation A cadence of 52 rpm against a higher resistance of about 35 W leads to a more optimal direction of forces and is more mechanically efficient than propelling at a higher cadence or lower resistance. Therefore, changing gears on a handcycle is important, and it is advised to keep the linear hand velocity relatively low for locomotion purposes.	[Kraaijenbrink, Cassandra; Vegter, Riemer J. K.; Hensen, Alexander H. R.; van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands; [Kraaijenbrink, Cassandra; Wagner, Heiko] Univ Munster, Dept Movement Sci, Inst Sport Sci, Munster, North Rhine Wes, Germany; [van der Woude, Lucas H. V.] Univ Groningen, Univ Med Ctr Groningen, Ctr Rehabil, Groningen, Netherlands	University of Groningen; University of Munster; University of Groningen	Kraaijenbrink, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Ctr Human Movement Sci, Groningen, Netherlands.; Kraaijenbrink, C (corresponding author), Univ Munster, Dept Movement Sci, Inst Sport Sci, Munster, North Rhine Wes, Germany.	kraaijen@uni-muenster.de	van der Woude, Lucas H/E-7986-2018; JK, Vegter Riemer/N-3385-2013; Wagner, Heiko/D-9677-2013	van der Woude, Lucas H/0000-0002-8472-334X; JK, Vegter Riemer/0000-0002-4294-6086; Wagner, Heiko/0000-0002-5470-5044; Kraaijenbrink, Cassandra/0000-0003-3763-7278				Arnet U, 2012, PROPULSION STYLE MEC, P88; Arnet U, 2013, J APPL BIOMECH, V29, P687, DOI 10.1123/jab.29.6.687; Bergman BC, 1999, J APPL PHYSIOL, V87, pU33; Bertucci W, 2005, J BIOMECH, V38, P1003, DOI 10.1016/j.jbiomech.2004.05.037; BORG G, 1970, Scandinavian Journal of Rehabilitation Medicine, V2, P92; Dallmeijer AJ, 2004, INT J SPORTS MED, V25, P622, DOI 10.1055/s-2004-817879; Dallmeijer AJ, 2004, SPINAL CORD, V42, P91, DOI 10.1038/sj.sc.3101566; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Foss O, 2004, EUR J APPL PHYSIOL, V92, P443, DOI 10.1007/s00421-004-1175-5; GARBY L, 1987, ACTA PHYSIOL SCAND, V129, P443, DOI 10.1111/j.1365-201X.1987.tb10613.x; Groen WG, 2010, DISABIL REHABIL, V32, P2165, DOI 10.3109/09638288.2010.505677; Hansen EA, 2002, J BIOMECH, V35, P277, DOI 10.1016/S0021-9290(01)00182-8; Hettinga F J, 2010, Phys Med Rehabil Clin N Am, V21, P127, DOI 10.1016/j.pmr.2009.07.010; Marais G, 2002, INT J SPORTS MED, V23, P120, DOI 10.1055/s-2002-20131; Marais G, 2002, ERGONOMICS, V45, P631, DOI 10.1080/00140130210151821; Mascher D, RESP EXCHANGE RATIO; POWERS SK, 1984, J APPL PHYSIOL, V56, P495, DOI 10.1152/jappl.1984.56.2.495; Romkes J, 1999, BIOMEDICAL ASPECTS M, V5; Rossato M, 2008, INT J SPORTS MED, V29, P746, DOI 10.1055/s-2008-1038375; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Valent L, 2010, DISABIL REHABIL, V32, P2191, DOI 10.3109/09638288.2010.509461; Valent LJ, 2008, ARCH PHYS MED REHAB, V89, P1016, DOI 10.1016/j.apmr.2007.10.034; Valent LJM, 2009, PHYS THER, V89, P1051, DOI 10.2522/ptj.20080340; van der Woude LHV, 2000, J MED ENG TECHNOL, V24, P242, DOI 10.1080/030919000300037168; van der Woude LHV, 2001, AM J PHYS MED REHAB, V80, P765, DOI 10.1097/00002060-200110000-00012; van Drongelen S, 2011, MED ENG PHYS, V33, P1167, DOI 10.1016/j.medengphy.2011.04.018; VANDERWOUDE LHV, 1986, ERGONOMICS, V29, P1561, DOI 10.1080/00140138608967269; VEEGER D, 1989, Journal of Rehabilitation Research and Development, V26, P37; VEEGER HEJ, 1992, MED SCI SPORT EXER, V24, P100; Vercruyssen F, 2010, J SCI MED SPORT, V13, P225, DOI 10.1016/j.jsams.2008.12.631; Verellen J, 2004, MED SCI SPORT EXER, V36, P1826, DOI 10.1249/01.MSS.0000142367.04918.5A	31	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183502	10.1371/journal.pone.0183502	http://dx.doi.org/10.1371/journal.pone.0183502			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7EP	28841704	Green Submitted, gold, Green Published			2022-12-27	WOS:000408370700037
J	Meena, C; Rungta, PD; Sinha, S				Meena, Chandrakala; Rungta, Pranay Deep; Sinha, Sudeshna			Threshold-activated transport stabilizes chaotic populations to steady states	PLOS ONE			English	Article							ADAPTIVE DYNAMICS; CARDIAC CHAOS; NETWORKS; PROMOTES; SYSTEMS; LATTICE; RATES; MAPS	We explore Random Scale-Free networks of populations, modelled by chaotic Ricker maps, connected by transport that is triggered when population density in a patch is in excess of a critical threshold level. Our central result is that threshold-activated dispersal leads to stable fixed populations, for a wide range of threshold levels. Further, suppression of chaos is facilitated when the threshold-activated migration is more rapid than the intrinsic population dynamics of a patch. Additionally, networks with large number of nodes open to the environment, readily yield stable steady states. Lastly we demonstrate that in networks with very few open nodes, the degree and betweeness centrality of the node open to the environment has a pronounced influence on control. All qualitative trends are corroborated by quantitative measures, reflecting the efficiency of control, and the width of the steady state window.	[Meena, Chandrakala; Rungta, Pranay Deep; Sinha, Sudeshna] Indian Inst Sci Educ & Res Mohali, Dept Phys Sci, Sas Nagar, Punjab, India	Indian Institute of Science Education & Research (IISER) - Mohali	Sinha, S (corresponding author), Indian Inst Sci Educ & Res Mohali, Dept Phys Sci, Sas Nagar, Punjab, India.	sudeshna@iisermohali.ac.in		Meena, Chandrakala/0000-0003-4340-5561; Sinha, Sudeshna/0000-0002-1364-5276	DST INSPIRE Fellowship; J.C. Bose National Fellowship [SB/S2/JCB-013/2015]	DST INSPIRE Fellowship; J.C. Bose National Fellowship	CM acknowledges financial support from DST INSPIRE Fellowship, and SS acknowledges support from the J.C. Bose National Fellowship (SB/S2/JCB-013/2015). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CM acknowledges financial support from DST INSPIRE Fellowship, and SS acknowledges support from the J.C. Bose National Fellowship (SB/S2/JCB-013/2015).	BAK P, 1987, PHYS REV LETT, V59, P381, DOI 10.1103/PhysRevLett.59.381; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Britton N.F., 2003, ESSENTIAL MATH BIOL; BROWN JH, 1977, ECOLOGY, V58, P445, DOI 10.2307/1935620; Cazelles B, 2001, P ROY SOC B-BIOL SCI, V268, P2595, DOI 10.1098/rspb.2001.1843; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Cornelius SP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2939; Daido H, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.104101; Dey S, 2006, SCIENCE, V312, P434, DOI 10.1126/science.1125317; GARFINKEL A, 1992, SCIENCE, V257, P1230, DOI 10.1126/science.1519060; GLASS L, 1994, INT J BIFURCAT CHAOS, V4, P1061, DOI 10.1142/S0218127494000770; Hall K, 1997, PHYS REV LETT, V78, P4518, DOI 10.1103/PhysRevLett.78.4518; Hanski I, 1998, NATURE, V396, P41, DOI 10.1038/23876; He GG, 2007, IEEE IJCNN, P350, DOI 10.1109/IJCNN.2007.4370981; HUBERMAN BA, 1990, IEEE T CIRCUITS SYST, V37, P547, DOI 10.1109/31.52759; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Mondal A, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.026215; Morie T., 2011, 2011 European Conference on Circuit Theory and Design (ECCTD 2011), P126, DOI 10.1109/ECCTD.2011.6043293; Murali K, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.016210; OTT E, 1990, PHYS REV LETT, V64, P2837, DOI 10.1103/PhysRevLett.64.2837; Reichenbach T, 2007, NATURE, V448, P1046, DOI 10.1038/nature06095; Scheffer M, 1997, ECOLOGY, V78, P272; Sinha S, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066209; SINHA S, 1995, INT J MOD PHYS B, V9, P875, DOI 10.1142/S0217979295000355; Sinha S, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.036212; SINHA S, 1994, PHYS REV E, V49, P4832, DOI 10.1103/PhysRevE.49.4832; SINHA S, 1993, PHYS REV LETT, V71, P2010, DOI 10.1103/PhysRevLett.71.2010; Sinha S, 1998, PHYS REV E, V58, pR5221, DOI 10.1103/PhysRevE.58.R5221; SINHA S, 1995, PHYS LETT A, V199, P365, DOI 10.1016/0375-9601(95)00075-E; SINHA S, 1990, PHYSICA D, V43, P118, DOI 10.1016/0167-2789(90)90020-P; Tanaka G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00232; Taylor CM, 2011, BIOL LETT; Wang XF, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.056113	34	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183251	10.1371/journal.pone.0183251	http://dx.doi.org/10.1371/journal.pone.0183251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841660	Green Submitted, gold, Green Published			2022-12-27	WOS:000408370700021
J	Zhai, Q; Xue, GX; Li, M				Zhai, Qing; Xue, Guo-xi; Li, Meng			DNA barcoding-based sexual association of Sovia lucasii and S. lii (Lepidoptera: Hesperiidae), with description of a new subspecies	PLOS ONE			English	Article							BUTTERFLIES; DIMORPHISM	Both sexes of two sympatric and sexually dimorphic species, Sovia lucasii (Mabille, 1876) and S. lii Xue, 2015, are associated based on DNA barcoding using the COI (mitochondrial cytochrome coxidase I) gene. The females are thus identified for the first time, and their wing patterns and genitalia are described and illustrated for the convenience of morphological identification hereafter. A new subspecies, S. lucasii minor ssp. nov., from the northeastern and eastern parts of the Sichuan Basin of China, is reported. External and genital differences between the new taxon and the nominate subspecies, which is distributed in western Sichuan and newly discovered in northwestern Guangxi, are illustrated and discussed.	[Zhai, Qing] Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China; [Xue, Guo-xi; Li, Meng] Zhengzhou Univ Light Ind, Sch Food & Bioengn, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Zhengzhou University of Light Industry	Zhai, Q (corresponding author), Henan Agr Univ, Coll Plant Protect, Zhengzhou, Henan, Peoples R China.	zhaiqingjn@163.com			National Natural Science Foundation of China [41401067, 31401810]; China Postdoctoral Science Foundation [2016M602935XB]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	Funding provided by National Natural Science Foundation of China, No. 41401067 (GX), URL: https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; National Natural Science Foundation of China, No. 31401810 (ML), URL: https://isisn.nsfc.gov.cn/egrantindex/funcindex/prjsearch-list; and Project Funded by China Postdoctoral Science Foundation, No. 2016M602935XB (QZ), URL: http://jj. chinapostdoctor.org.cn/V1/Program3/Info_Show2.aspx?InfoID=bf5f0be7-56e6-41e2-b07d-a-6dca6e23f3a &InfoCategoryID=2&Show=0&rnd=2e6b1dba-fc97-4e49-8187-da0e67b602dc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns John M., 2007, Journal of the Lepidopterists' Society, V61, P138; Burns JM, 2008, P NATL ACAD SCI USA, V105, P6350, DOI 10.1073/pnas.0712181105; Editing committee of geomorphic atlas of the People's Republic of China, 2009, GEOM ATL PEOPL REP C; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Laguerre Michel, 2016, Journal of Insect Biodiversity, V4, DOI [10.12976/jib/2016.4.21, 10.12976/jib/2016.4.11]; Li WC, 2016, SYST BIODIVERS, V14, P303, DOI 10.1080/14772000.2016.1140246; Lukhtanov VA, 2016, SYST BIODIVERS, V14, P599, DOI 10.1080/14772000.2016.1203371; Moraes SD, 2017, SYST BIODIVERS, V15, P259, DOI 10.1080/14772000.2016.1250835; Przybylowicz L, 2015, ZOOL J LINN SOC-LOND, V173, P22, DOI 10.1111/zoj.12198; Rand DB, 2000, MOL PHYLOGENET EVOL, V17, P85, DOI 10.1006/mpev.2000.0820; Shirozu T., 1960, BUTTERFLIES FORMOSA, P481; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Corley MFV, 2017, ZOOTAXA, V4221, P594, DOI 10.11646/zootaxa.4221.5.7; Xue GX, 2015, ZOOTAXA, V3985, P583, DOI 10.11646/zootaxa.3985.4.7; Xue GX, 2016, ENTOMOL FENNICA, V27, P70, DOI 10.33338/ef.59125	17	9	10	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183847	10.1371/journal.pone.0183847	http://dx.doi.org/10.1371/journal.pone.0183847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841714	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700063
J	Barykina, NV; Subach, OM; Piatkevich, KD; Jung, EE; Malyshev, AY; Smirnov, IV; Bogorodskiy, AO; Borshchevskiy, VI; Varizhuk, AM; Pozmogova, GE; Boyden, ES; Anokhin, KV; Enikolopov, GN; Subach, FV				Barykina, Natalia V.; Subach, Oksana M.; Piatkevich, Kiryl D.; Jung, Erica E.; Malyshev, Aleksey Y.; Smirnov, Ivan V.; Bogorodskiy, Andrey O.; Borshchevskiy, Valentin I.; Varizhuk, Anna M.; Pozmogova, Galina E.; Boyden, Edward S.; Anokhin, Konstantin V.; Enikolopov, Grigori N.; Subach, Fedor V.			Green fluorescent genetically encoded calcium indicator based on calmodulin/M13-peptide from fungi	PLOS ONE			English	Article							CA2+ INDICATORS; PROTEINS; ZEBRAFISH; TRANSGENESIS; CALMODULIN; NEURONS; MECHANISM; SENSORS; DESIGN	Currently available genetically encoded calcium indicators (GECIs) utilize calmodulins (CaMs) or troponin C from metazoa such as mammals, birds, and teleosts, as calcium-binding domains. The amino acid sequences of the metazoan calcium-binding domains are highly conserved, which may limit the range of the GECI key parameters and cause undesired interactions with the intracellular environment in mammalian cells. Here we have used fungi, evolutionary distinct organisms, to derive CaM and its binding partner domains and design new GECI with improved properties. We applied iterative rounds of molecular evolution to develop FGCaMP, a novel green calcium indicator. It includes the circularly permuted version of the enhanced green fluorescent protein (EGFP) sandwiched between the fungal CaM and a fragment of CaM-dependent kinase. FGCaMP is an excitation-ratiometric indicator that has a positive and an inverted fluorescence response to calcium ions when excited at 488 and 405 nm, respectively. Compared with the GCaMP6s indicator in vitro, FGCaMP has a similar brightness at 488 nm excitation, 7-fold higher brightness at 405 nm excitation, and 1.3-fold faster calcium ion dissociation kinetics. Using site-directed mutagenesis, we generated variants of FGCaMP with improved binding affinity to calcium ions and increased the magnitude of FGCaMP fluorescence response to low calcium ion concentrations. Using FGCaMP, we have successfully visualized calcium transients in cultured mammalian cells. In contrast to the limited mobility of GCaMP6s and G-GECO1.2 indicators, FGCaMP exhibits practically 100% molecular mobility at physiological concentrations of calcium ion in mammalian cells, as determined by photobleaching experiments with fluorescence recovery. We have successfully monitored the calcium dynamics during spontaneous activity of neuronal cultures using FGCaMP and utilized whole-cell patch clamp recordings to further characterize its behavior in neurons. Finally, we used FGCaMP in vivo to perform structural and functional imaging of zebrafish using wide-field, confocal, and light-sheet microscopy.	[Barykina, Natalia V.; Subach, Oksana M.; Bogorodskiy, Andrey O.; Borshchevskiy, Valentin I.; Enikolopov, Grigori N.; Subach, Fedor V.] Moscow Inst Phys & Technol, Moscow, Russia; [Barykina, Natalia V.; Anokhin, Konstantin V.] PK Anokhin Inst Normal Physiol RAMS, Moscow, Russia; [Subach, Oksana M.; Anokhin, Konstantin V.] Natl Res Ctr Kurchatov Inst, Moscow, Russia; [Piatkevich, Kiryl D.; Jung, Erica E.; Boyden, Edward S.] MIT, Media Lab, Cambridge, MA 02139 USA; [Malyshev, Aleksey Y.; Smirnov, Ivan V.] RAS, Inst Higher Nervous Act & Neurophysiol, Moscow, Russia; [Smirnov, Ivan V.] NI Pirogov Russian Natl Res Med Univ, Medicobiol Fac, Moscow, Russia; [Varizhuk, Anna M.; Pozmogova, Galina E.] Fed Med Biol Agcy, Fed Res & Clin Ctr Phys Chem Med, Moscow, Russia; [Varizhuk, Anna M.] RAS, Engelhardt Inst Mol Biol, Moscow, Russia; [Boyden, Edward S.] MIT, McGovern Inst Brain Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Anokhin, Konstantin V.] Lomonosov Moscow State Univ, Moscow, Russia; [Enikolopov, Grigori N.] SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA; [Enikolopov, Grigori N.] SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA	Moscow Institute of Physics & Technology; Russian Academy of Medical Sciences; Anokhin Institute of Normal Physiology; National Research Centre - Kurchatov Institute; Massachusetts Institute of Technology (MIT); Institute of Higher Nervous Activity & Neurophysiology of RAS; Russian Academy of Sciences; Pirogov Russian National Research Medical University; Lopukhin Federal Research & Clinical Center of Physical-Chemical Medicine of Federal Medical Biological Agency; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS; Massachusetts Institute of Technology (MIT); Lomonosov Moscow State University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Enikolopov, GN; Subach, FV (corresponding author), Moscow Inst Phys & Technol, Moscow, Russia.; Enikolopov, GN (corresponding author), SUNY Stony Brook, Dept Anesthesiol, Stony Brook, NY 11794 USA.; Enikolopov, GN (corresponding author), SUNY Stony Brook, Ctr Dev Genet, Stony Brook, NY 11794 USA.	Grigori.Enikolopov@stonybrookmedicine.edu; subach.fv@mipt.ru	Anokhin, Konstantin V./K-7983-2014; Subach, Fedor/AAA-5320-2021; Enikolopov, Grigori/P-5731-2019; Bogorodskiy, Andrey/R-7690-2016; Borshchevskiy, Valentin I./F-2287-2014; Galina, Pozmogova/S-6204-2017; Varizhuk, Anna/Y-7558-2019; Смирнов, Иван/AAO-2062-2020; Malyshev, Aleksey/R-8471-2018	Anokhin, Konstantin V./0000-0003-4437-6002; Subach, Fedor/0000-0003-2720-7821; Enikolopov, Grigori/0000-0001-8178-8917; Bogorodskiy, Andrey/0000-0002-7589-7823; Borshchevskiy, Valentin I./0000-0003-4398-9712; Galina, Pozmogova/0000-0001-9458-4972; Varizhuk, Anna/0000-0001-9359-8651; Смирнов, Иван/0000-0002-6192-7008; Malyshev, Aleksey/0000-0002-4633-7691; Barykina, Natalia/0000-0001-5835-8388	RSF [16-15-10323, 16-15-00291, 18-44-04015, 14-25-00013, 16-15-00294]; RFBR [15-04-03383, 17-29-01037]; HHMI-Simons Faculty Scholars Program, NIH [2R01DA029639]; NIH [1DP1NS087724, 1R01GM104948]; Russian Ministry of Education and Science [11.G34.31.0071]; National Institute of Aging [R01AG040209]; New York State Stem Cell Science (NYSTEM) [C029569]; Russian Science Foundation [17-15-00058, 17-25-00005, 16-15-00291] Funding Source: Russian Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [DP1NS087724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA029639] Funding Source: NIH RePORTER	RSF(Russian Science Foundation (RSF)); RFBR(Russian Foundation for Basic Research (RFBR)); HHMI-Simons Faculty Scholars Program, NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); New York State Stem Cell Science (NYSTEM); Russian Science Foundation(Russian Science Foundation (RSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by RSF grant No 16-15-10323 to F.V.S. (developing the FGCaMP indicator), RFBR grant No 15-04-03383 to F.V.S. (rAAVs isolation), by RSF grant No 16-15-00291 to A.Y.M. (experiments with patch clamp), by RSF grant No18-44-04015 to V.I.B. (FRAP experiments), by RSF grant No14-25-00013 to G.E. P. (stop-flow studies), HHMI-Simons Faculty Scholars Program, NIH grants 2R01DA029639, NIH Director's Pioneer Award 1DP1NS087724, and 1R01GM104948, and the IET Harvey Prize to E.S. B. (in vivo imaging in zebrafish), by RSF grant No. 14-15-00685 to K.V.A. (isolation and imaging of neuronal cultures) and by grants from RSF (grant No 16-15-00294), RFBR (grant No 17-29-01037), the Russian Ministry of Education and Science (grant 11.G34.31.0071), the National Institute of Aging (R01AG040209), and New York State Stem Cell Science (NYSTEM) (C029569) to G.N.E.	Akerboom J, 2009, J BIOL CHEM, V284, P6455, DOI 10.1074/jbc.M807657200; [Anonymous], 2008, NATURE METHODS, V6, P1; Baird GS, 1999, P NATL ACAD SCI USA, V96, P11241, DOI 10.1073/pnas.96.20.11241; Barykina NV, 2016, SCI REP-UK, V6, DOI 10.1038/srep34447; BROCARD JB, 1993, NEURON, V11, P751, DOI 10.1016/0896-6273(93)90084-5; Chen TW, 2013, NATURE, V499, P295, DOI 10.1038/nature12354; Fisher S, 2006, NAT PROTOC, V1, P1297, DOI 10.1038/nprot.2006.230; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; Hasan MT, 2004, PLOS BIOL, V2, P763, DOI 10.1371/journal.pbio.0020163; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Horikawa K, 2010, NAT METHODS, V7, P729, DOI 10.1038/nmeth.1488; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Jurado LA, 1999, PHYSIOL REV, V79, P661, DOI 10.1152/physrev.1999.79.3.661; Kimura Y, 2008, DEVELOPMENT, V135, P3001, DOI 10.1242/dev.024802; Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343; Miyawaki A, 1997, NATURE, V388, P882, DOI 10.1038/42264; Nagai T, 2001, P NATL ACAD SCI USA, V98, P3197, DOI 10.1073/pnas.051636098; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Ohkura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051286; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Panier T, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00065; PORUMB T, 1994, PROTEIN ENG, V7, P109, DOI 10.1093/protein/7.1.109; Renaud O, 2011, NAT PROTOC, V6, P1897, DOI 10.1038/nprot.2011.408; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Subach FV, 2009, NAT METHODS, V6, P153, DOI [10.1038/nmeth.1298, 10.1038/NMETH.1298]; Subach OM, 2008, CHEM BIOL, V15, P1116, DOI 10.1016/j.chembiol.2008.08.006; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Subedi A, 2014, METHODS, V66, P433, DOI 10.1016/j.ymeth.2013.06.012; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Wang Q, 2008, STRUCTURE, V16, P1817, DOI 10.1016/j.str.2008.10.008; Zhao YX, 2014, INTEGR BIOL-UK, V6, P714, DOI 10.1039/c4ib00039k; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592; Zou J, 2007, BIOCHEMISTRY-US, V46, P12275, DOI 10.1021/bi7007307	35	16	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183757	10.1371/journal.pone.0183757	http://dx.doi.org/10.1371/journal.pone.0183757			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837632	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000112
J	Kang, HR; Lee, SN; Cho, YJ; Jeon, JS; Noh, H; Han, DC; Park, S; Kwon, SH				Kang, Hye Ran; Lee, Si Nae; Cho, Yun Ju; Jeon, Jin Seok; Noh, Hyunjin; Han, Dong Cheol; Park, Suyeon; Kwon, Soon Hyo			A decrease in serum creatinine after ICU admission is associated with increased mortality	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; AUGMENTED RENAL CLEARANCE; CRITICALLY-ILL PATIENTS; LONG-TERM SURVIVAL; INTENSIVE-CARE-UNIT; PROSPECTIVE COHORT; PROGNOSIS; OUTCOMES; IMPACT	Background The elevation of serum creatinine (SCr), acute kidney injury (AKI), is associated with an increase of mortality in critically ill patients. However, it is uncertain whether a decrease in SCr in the intensive care unit (ICU) has an effect on outcomes. Methods In a retrospective study, we enrolled 486 patients who had been admitted to an urban tertiary center ICU between Jan 2014 and Dec 2014. The effect of changes in SCr after ICU admission on 90 day mortality was analyzed. Patients were classified into 3 groups based on change in SCr after ICU admission: a stable SCr group (Delta SCr < 0.3mg/dL during ICU stay), a decreased SCr group (Delta SCr >= -0.3 mg/dL during ICU stay) and an increased SCr group with criteria based on the KDIGO AKI criteria. Results In total, 486 patients were identified. SCr decreased in 123 (25.3%) patients after ICU admission. AKI developed in 125 (24.4%) patients. The overall 90-day mortality rate was 29.0%. In a Kaplan-Meyer analysis, the mortality of the AKI group was higher than that of other groups (p<0.0001). Patients with a decrease in SCr had a higher mortality rate than those with stable SCr (p<0.0001). A Cox analysis showed that both a decrease in SCR (HR, 3.56; 95% CI, 1.59-7.97; p = 0.002) and an increase in SCr (AKI stage 1, HR, 9.35; 95% CI, 4.18-20.9; p<0.0001; AKI stage 2, HR, 11.82; 95% CI, 3.85-36.28; p<0.0001; AKI stage 3, HR, 17.41; 95% CI, 5.50-55.04; p<0.0001) were independent risk factors for death compared to stable SCr. Conclusion Not only an increase in SCr, but also a decrease in SCr was associated with mortality in critically ill patients.	[Kang, Hye Ran; Lee, Si Nae; Cho, Yun Ju; Jeon, Jin Seok; Noh, Hyunjin; Han, Dong Cheol; Kwon, Soon Hyo] Soonchunhyang Univ Hosp, Div Nephrol, Seoul, South Korea; [Jeon, Jin Seok; Noh, Hyunjin; Han, Dong Cheol; Kwon, Soon Hyo] Soonchunhyang Univ Hosp, Hyonam Kidney Lab, Seoul, South Korea; [Park, Suyeon] Soonchunhyang Univ Hosp, Dept Biostat, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University Hospital; Soonchunhyang University; Soonchunhyang University Hospital; Soonchunhyang University; Soonchunhyang University Hospital	Kwon, SH (corresponding author), Soonchunhyang Univ Hosp, Div Nephrol, Seoul, South Korea.; Kwon, SH (corresponding author), Soonchunhyang Univ Hosp, Hyonam Kidney Lab, Seoul, South Korea.	ksoonhyo@schmc.ac.kr		Kwon, Soon Hyo/0000-0002-4114-4196	Soonchunhayng University	Soonchunhayng University	SHK received grant from Soonchunhayng University.	Baptista JP, 2012, INT J ANTIMICROB AG, V39, P420, DOI 10.1016/j.ijantimicag.2011.12.011; Baptista JP, 2011, CRIT CARE, V15, DOI 10.1186/cc10262; Claus BOM, 2013, J CRIT CARE, V28, P695, DOI 10.1016/j.jcrc.2013.03.003; Cruz DN, 2007, CRIT CARE, V11, DOI 10.1186/cc5965; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Group KAKIW, 2012, KDIGO CLIN PRACT GUI, P131; Hasper D, 2009, CRIT CARE, V13, DOI 10.1186/cc8144; Hoste EAJ, 2006, CRIT CARE, V10, DOI 10.1186/cc4915; Kwon SH, 2011, J CRIT CARE, V26, P566, DOI 10.1016/j.jcrc.2011.01.004; Lassnigg A, 2004, J AM SOC NEPHROL, V15, P1597, DOI 10.1097/01.ASN.0000130340.93930.DD; Linder A, 2014, AM J RESP CRIT CARE, V189, P1075, DOI 10.1164/rccm.201311-2097OC; Liu KD, 2011, CRIT CARE MED, V39, P2665, DOI 10.1097/CCM.0b013e318228234b; Loef BG, 2005, J AM SOC NEPHROL, V16, P195, DOI 10.1681/ASN.2003100875; Masewu A, 2016, BMC NEPHROL, V17, DOI 10.1186/s12882-016-0333-4; Mehta RH, 2010, AM J CARDIOL, V106, P1728, DOI 10.1016/j.amjcard.2010.07.045; Nisula S, 2013, INTENS CARE MED, V39, P420, DOI 10.1007/s00134-012-2796-5; Ou SM, 2016, J CACHEXIA SARCOPENI, V7, P144, DOI 10.1002/jcsm.12053; Prowle JR, 2014, CLIN J AM SOC NEPHRO, V9, P1015, DOI 10.2215/CJN.11141113; Shacham Y, 2015, CLIN CARDIOL, V38, P274, DOI 10.1002/clc.22384; Soliman IW, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1416-0; Srisawat N, 2015, AM J NEPHROL, V41, P81, DOI 10.1159/000371748; Tian JM, 2009, AM J KIDNEY DIS, V53, P974, DOI 10.1053/j.ajkd.2009.02.007; Troger U, 2012, INT J ANTIMICROB AG, V40, P370, DOI 10.1016/j.ijantimicag.2012.05.010; Udy AA, 2014, CRIT CARE MED, V42, P520, DOI 10.1097/CCM.0000000000000029; Udy AA, 2012, CHEST, V142, P30, DOI 10.1378/chest.11-1671; Vincent JL, 2010, CRIT CARE, V14, DOI 10.1186/cc8204; Yoo J, 2015, KOREAN J INTERN MED, V30, P205, DOI 10.3904/kjim.2015.30.2.205	27	7	7	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183156	10.1371/journal.pone.0183156	http://dx.doi.org/10.1371/journal.pone.0183156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837589	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000048
J	Park, SH; Lee, SI; Kim, SA; Christensen, K; Ricke, SC				Park, Si Hong; Lee, Sang In; Kim, Sun Ae; Christensen, Karen; Ricke, Steven C.			Comparison of antibiotic supplementation versus a yeast-based prebiotic on the cecal microbiome of commercial broilers	PLOS ONE			English	Article							GROWTH-PERFORMANCE; FED DIETS; COLONIZATION; POPULATIONS; PARAMETERS; BACTERIA; ECOLOGY; MANNANOLIGOSACCHARIDE; METABOLISM; RESPONSES	Prebiotics are defined as fermentable food ingredients that selectively stimulate beneficial bacteria in the lower gastrointestinal tract of the host. The purpose of this study was to assess growth performance of broilers and the cecal microbial populations of an antibiotic, BMD50, supplemented birds compared to broiler chickens fed the prebiotic, Biolex (R) MB40. Weight response data including feed conversion ratios (FCR), carcasses without giblets (WOG), wing, skin, white meat were collected during processing. Extracted DNA from cecal contents was utilized for microbiome analysis via an Illumina Miseq. In conclusion, white meat yield of Biolex (R) MB40 supplemented group exhibited significant improvement compared to both negative control (NC) and BMD50 supplemented groups. In addition, antibiotic significantly decreased level of Lactobacillus in 2 wk compared to other groups. A significantly higher percentage of Campylobacter was observed from the 4 wk old birds treated with antibiotic BMD50 compared to the NC and prebiotic group. Retention of broiler performance and improvement of white meat yield suggest that the prebiotic MB40 appears to be a potential alternative to replace the antibiotic growth promoter.	[Park, Si Hong; Lee, Sang In; Kim, Sun Ae; Ricke, Steven C.] Univ Arkansas, Dept Food Sci, Ctr Food Safety, Fayetteville, AR 72703 USA; [Christensen, Karen] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA; [Park, Si Hong] Oregon State Univ, Dept Food Sci & Technol, Corvallis, OR 97331 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville; Oregon State University	Ricke, SC (corresponding author), Univ Arkansas, Dept Food Sci, Ctr Food Safety, Fayetteville, AR 72703 USA.	sricke@uark.edu		Ricke, Steven/0000-0002-3584-9915	Leiber GmbH	Leiber GmbH	This study was funded by Leiber GmbH. The funder had no role in study design, data collection and analysis, or preparation of the manuscript, but they reviewed the manuscript and agreed to publish.	Ashayerizadeh A, 2009, Pak J Biol Sci, V12, P52, DOI 10.3923/pjbs.2009.52.57; Backhed F, 2014, ISME J, V8, P2216; Baffoni L, 2012, INT J FOOD MICROBIOL, V157, P156, DOI 10.1016/j.ijfoodmicro.2012.04.024; BARNES E. M., 1958, British Veterinary Journal, V114, P333; Baurhoo B, 2009, POULTRY SCI, V88, P2262, DOI 10.3382/ps.2008-00562; Biggs P, 2007, POULTRY SCI, V86, P2327, DOI 10.3382/ps.2007-00427; BOUHNIK Y, 1994, GASTROENTEROLOGY, V106, pA598; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cean A, 2015, FOODBORNE PATHOG DIS, V12, P122, DOI 10.1089/fpd.2014.1849; Cetin N, 2005, J VET MED A, V52, P263, DOI 10.1111/j.1439-0442.2005.00736.x; Chakravorty S, 2007, J MICROBIOL METH, V69, P330, DOI 10.1016/j.mimet.2007.02.005; Dewulf EM, 2013, GUT, V62, P1112, DOI 10.1136/gutjnl-2012-303304; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Dozier WA, 2014, J APPL POULTRY RES, V23, P494, DOI 10.3382/japr.2014-00967; ELLIOTT SD, 1959, J GEN MICROBIOL, V20, P426, DOI 10.1099/00221287-20-2-426; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; FULLER R, 1989, J APPL BACTERIOL, V66, P365; Ganan M, 2013, ZOONOSES PUBLIC HLTH, V60, P141, DOI 10.1111/j.1863-2378.2012.01510.x; Gibson GR, 2000, J NUTR, V130, p391S, DOI 10.1093/jn/130.2.391S; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Gorbach SL, 2001, NEW ENGL J MED, V345, P1202, DOI 10.1056/NEJM200110183451610; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Heinken A, 2014, J BACTERIOL, V196, P3289, DOI 10.1128/JB.01780-14; Hidaka H., 1986, Bifidobacteria and Microflora, V5, P37; Hooge D. M., 2004, International Journal of Poultry Science, V3, P163; Hutkins RW, 2016, CURR OPIN BIOTECH, V37, P1, DOI 10.1016/j.copbio.2015.09.001; Ignacio E. D., 1995, Poultry Science, V74, P196; Jin LZ, 1998, POULTRY SCI, V77, P1259, DOI 10.1093/ps/77.9.1259; Kaakoush NO, 2014, GUT PATHOG, P6; Kleessen B, 2001, BRIT J NUTR, V86, P291, DOI 10.1079/BJN2001403; Kozich JJ, 2013, APPL ENVIRON MICROB, V79, P5112, DOI 10.1128/AEM.01043-13; Kudoh K, 1999, J NUTR SCI VITAMINOL, V45, P173, DOI 10.3177/jnsv.45.173; Le Bihan-Duval E, 1998, BRIT POULTRY SCI, V39, P346, DOI 10.1080/00071669888881; Lee PR., 2003, PERSPECT BIOL MED, V46, P603; Lee SI, 2016, POULTRY SCI, V95, P144, DOI 10.3382/ps/pev322; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lubritz DL, 1997, J APPL POULTRY RES, V6, P253, DOI 10.1093/japr/6.3.253; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Midilli M, 2008, S AFR J ANIM SCI, V38, P21; Miquel S, 2014, GUT MICROBES, V5, P146, DOI 10.4161/gmic.27651; Morales-Lopez R, 2009, POULTRY SCI, V88, P601, DOI 10.3382/ps.2008-00298; Newman K., 1994, P ALLT 10 ANN S, V167, P174; OFEK I, 1977, NATURE, V265, P623, DOI 10.1038/265623a0; OYOFO BA, 1989, POULTRY SCI, V68, P1351, DOI 10.3382/ps.0681351; OYOFO BA, 1989, POULTRY SCI, V68, P1357, DOI 10.3382/ps.0681357; Park SH, 2017, POULTRY SCI, V96, P2400, DOI 10.3382/ps/pex014; Park S. H., 2014, J PROB HLTH, V2, P2; Pelicano ERL, 2004, Rev. Bras. Cienc. Avic., V6, P177, DOI 10.1590/S1516-635X2004000300008; Pelícia K, 2004, Rev. Bras. Cienc. Avic., V6, P99, DOI 10.1590/S1516-635X2004000200005; Ramirez-Farias C, 2009, BRIT J NUTR, V101, P541, DOI 10.1017/S0007114508019880; Ricke SC, 2003, POULTRY SCI, V82, P632, DOI 10.1093/ps/82.4.632; Robinson CK, 2016, ANN EPIDEMIOL, V26, P311, DOI 10.1016/j.annepidem.2016.04.005; Rolfe RD, 2000, J NUTR, V130, p396S, DOI 10.1093/jn/130.2.396S; Rosen GD, 2007, BRIT POULTRY SCI, V48, P21, DOI 10.1080/00071660601050755; Shane S. M., 2001, SCI TECHNOLOGY FEED, P65; Soergel DAW, 2012, ISME J, V6, P1440, DOI 10.1038/ismej.2011.208; Spring P, 2000, POULTRY SCI, V79, P205, DOI 10.1093/ps/79.2.205; STARR MP, 1951, AM J PUBLIC HEALTH, V41, P1375; Stevens L, 1991, GENETICS EVOLUTION D; Takahashi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105592; Tareb R, 2013, J MED MICROBIOL, V62, P637, DOI 10.1099/jmm.0.049965-0; Torres-Rodriguez A, 2007, INT J POULT SCI, V6, P154; Tzortzis G, 2005, J NUTR, V135, P1726, DOI 10.1093/jn/135.7.1726; Waldroup P. W., 2003, International Journal of Poultry Science, V2, P44; Yu ZT, 2004, APPL ENVIRON MICROB, V70, P4800, DOI 10.1128/AEM.70.8.4800-4806.2004	66	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182805	10.1371/journal.pone.0182805	http://dx.doi.org/10.1371/journal.pone.0182805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837669	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000027
J	Sumi, M; Sato, S; Nakamura, T				Sumi, Misa; Sato, Shuntaro; Nakamura, Takashi			Extranodal spread of primary and secondary metastatic nodes: The dominant risk factor of survival in patients with head and neck squamous cell carcinoma	PLOS ONE			English	Article							EXTRACAPSULAR SPREAD; PROGNOSTIC-FACTOR; CANCER; CLASSIFICATION; PROPOSAL; HYPOXIA; EXTENT	Extranodal spread (ENS) in patients with head and neck squamous cell carcinoma (HNSCC) can greatly influence the prognostic outcomes. However, the relative risks of ENS in the primary (1st) and secondary (2nd) metastatic nodes (mets) are not well documented. We retrospectively analyzed the hazard ratios (HRs) of ENS in the 1st and 2nd mets from 516 HNSCC patients who had undergone primary tumor excision. The impact of clinically and/or histologically confirmed ENS-positive mets on prognosis in terms of cancer-specific survival was analyzed. Cox proportional hazard regression analysis indicated that ENS-positive 1st met (adjusted HR = 3.15; 95% CI, 1.40-7.56; p = 0.006) and ENS-positive 2nd met (adjusted HR = 4.03; 95% CI, 1.41-16.96; p = 0.007) significantly and independently predicted poor prognosis; however, other variables including primary site, met size or numbers, and met location in the contralateral side of the primary lesion, did not. Cumulative incidence function and Cox analyses indicated that differences in ENS profiles of 1st and 2nd mets stratified HNSCC patients with varying risks of poor outcome; HRs relative to patients with ENS-positive 1st met (-)/ENS-positive 2nd met (-) were 4.02 (95% CI, 1.78-8.24; p = 0.002), 8.29 (95% CI, 4.58-14.76; p < 0.001), and 25.80 (95% CI, 10.15-57.69; p < 0.001) for patients with ENS-positive 1st met (+)/ENS-positive 2nd met (-), ENS-positive 1st met (-)/ENS-positive 2nd met (+), and ENS-positive 1st met (+)/ENS-positive 2nd met (+) patients, respectively. Kaplan-Meier analysis indicated that the 2nd met that appeared in the neck side with a history of 1st met and neck dissection had a higher risk of ENS than the 2nd met in the neck side without the history (p = 0.003). These results suggested that ENS is a dominant prognostic predictor of HNSCC patients, with double-positive ENS in the 1st and 2nd mets predicting the most devastating outcome.	[Sumi, Misa; Nakamura, Takashi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan; [Sato, Shuntaro] Nagasaki Univ Hosp, Clin Res Ctr, Nagasaki, Japan	Nagasaki University; Nagasaki University	Nakamura, T (corresponding author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Radiol & Canc Biol, Nagasaki, Japan.	taku@nagasaki-u.ac.jp	Sato, Shuntaro/AAN-8048-2020	Sato, Shuntaro/0000-0002-6055-3649	Grants-in-Aid for Scientific Research [15K11078] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Ahn TS, 2015, ANN SURG ONCOL, V22, P3745, DOI 10.1245/s10434-014-4359-1; Amin MB, 2017, AJCC CANC STAGING MA; Amit M, 2013, ANN SURG ONCOL, V20, P3575, DOI 10.1245/s10434-013-3044-0; Anniko M, 2010, EUR MAN MED, P1, DOI 10.1007/978-3-540-68940-9; Chang J, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3461; Cochran AJ, 2006, NAT REV IMMUNOL, V6, P659, DOI 10.1038/nri1919; Cox TR, 2015, NATURE, V522, P106, DOI 10.1038/nature14492; de Juan J, 2013, JAMA OTOLARYNGOL, V139, P483, DOI 10.1001/jamaoto.2013.2666; Greenberg JS, 2003, CANCER, V97, P1464, DOI 10.1002/cncr.11202; Katayama I, 2012, EUR J RADIOL, V81, P3326, DOI 10.1016/j.ejrad.2012.06.018; King AD, 2004, EUR J RADIOL, V52, P264, DOI 10.1016/j.ejrad.2004.03.004; Langendijk JA, 2005, CANCER-AM CANCER SOC, V104, P1408, DOI 10.1002/cncr.21340; LEEMANS CR, 1994, CANCER-AM CANCER SOC, V73, P187, DOI 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J; Luchini C, 2016, SURG ONCOL, V25, P60, DOI 10.1016/j.suronc.2015.09.005; Pereira ER, 2015, SEMIN CELL DEV BIOL, V38, P98, DOI 10.1016/j.semcdb.2015.01.008; Puri Sajeev K, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P119, DOI 10.1097/00020840-200304000-00010; Shingaki S, 2003, AM J SURG, V185, P278, DOI 10.1016/S0002-9610(02)01378-8; Silva SD, 2014, CLIN EXP METASTAS, V31, P307, DOI 10.1007/s10585-013-9629-y; Sinha P, 2012, CANCER-AM CANCER SOC, V118, P3519, DOI 10.1002/cncr.26671; Sumi M, 2011, J MAGN RESON IMAGING, V33, P830, DOI 10.1002/jmri.22454; Van den Eynden GG, 2007, HISTOPATHOLOGY, V51, P440, DOI 10.1111/j.1365-2559.2007.02761.x; Vaupel P, 2014, ADV EXP MED BIOL, V812, P19, DOI 10.1007/978-1-4939-0620-8_3; Wreesmann VB, 2016, HEAD NECK-J SCI SPEC, V38, pE1192, DOI 10.1002/hed.24190; Xing Y, 2016, CANCER-AM CANCER SOC, V122, P534, DOI 10.1002/cncr.29780	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183611	10.1371/journal.pone.0183611	http://dx.doi.org/10.1371/journal.pone.0183611			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837620	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000087
J	Uneno, Y; Taneishi, K; Kanai, M; Okamoto, K; Yamamoto, Y; Yoshioka, A; Hiramoto, S; Nozaki, A; Nishikawa, Y; Yamaguchi, D; Tomono, T; Nakatsui, M; Baba, M; Morita, T; Matsumoto, S; Kuroda, T; Okuno, Y; Muto, M				Uneno, Yu; Taneishi, Kei; Kanai, Masashi; Okamoto, Kazuya; Yamamoto, Yosuke; Yoshioka, Akira; Hiramoto, Shuji; Nozaki, Akira; Nishikawa, Yoshitaka; Yamaguchi, Daisuke; Tomono, Teruko; Nakatsui, Masahiko; Baba, Mika; Morita, Tatsuya; Matsumoto, Shigemi; Kuroda, Tomohiro; Okuno, Yasushi; Muto, Manabu			Development and validation of a set of six adaptable prognosis prediction (SAP) models based on time-series real-world big data analysis for patients with cancer receiving chemotherapy: A multicenter case crossover study	PLOS ONE			English	Article							SURVIVAL PREDICTION; SCORE; SYSTEM; INDEX	Background We aimed to develop an adaptable prognosis prediction model that could be applied at any time point during the treatment course for patients with cancer receiving chemotherapy, by applying time-series real-world big data. Methods Between April 2004 and September 2014, 4,997 patients with cancer who had received systemic chemotherapy were registered in a prospective cohort database at the Kyoto University Hospital. Of these, 2,693 patients with a death record were eligible for inclusion and divided into training (n = 1,341) and test (n = 1,352) cohorts. In total, 3,471,521 laboratory data at 115,738 time points, representing 40 laboratory items [e.g., white blood cell counts and albumin (Alb) levels] that were monitored for 1 year before the death event were applied for constructing prognosis prediction models. All possible prediction models comprising three different items from 40 laboratory items (C-40(3) = 9,880) were generated in the training cohort, and the model selection was performed in the test cohort. The fitness of the selected models was externally validated in the validation cohort from three independent settings. Results A prognosis prediction model utilizing Alb, lactate dehydrogenase, and neutrophils was selected based on a strong ability to predict death events within 1-6 months and a set of six prediction models corresponding to 1,2, 3, 4, 5, and 6 months was developed. The area under the curve (AUC) ranged from 0.852 for the 1 month model to 0.713 for the 6 month model. External validation supported the performance of these models. Conclusion By applying time-series real-world big data, we successfully developed a set of six adaptable prognosis prediction models for patients with cancer receiving chemotherapy.	[Uneno, Yu; Kanai, Masashi; Nishikawa, Yoshitaka; Matsumoto, Shigemi; Muto, Manabu] Kyoto Univ Hosp, Dept Clin Oncol, Kyoto, Japan; [Taneishi, Kei; Okuno, Yasushi] RIKEN Adv Inst Computat Sci, Kobe, Hyogo, Japan; [Okamoto, Kazuya; Kuroda, Tomohiro] Kyoto Univ Hosp, Div Informat Technol & Adm Planning, Kyoto, Japan; [Yamamoto, Yosuke] Kyoto Univ, Grad Sch Med, Sch Publ Hlth, Dept Healthcare Epidemiol, Kyoto, Japan; [Yamamoto, Yosuke] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Kyoto, Japan; [Yoshioka, Akira] Mitsubishi Kyoto Hosp, Dept Palliat Care, Kyoto, Japan; [Hiramoto, Shuji] Mitsubishi Kyoto Hosp, Dept Clin Oncol, Kyoto, Japan; [Nozaki, Akira] Kyoto Min Iren Chuo Hosp, Dept Med Oncol, Kyoto, Japan; [Yamaguchi, Daisuke] Natl Canc Ctr Hosp East, Dept Gastrointestinal Oncol, Kashiwa, Chiba, Japan; [Tomono, Teruko] Kyoto Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Kyoto, Japan; [Nakatsui, Masahiko; Okuno, Yasushi] Kyoto Univ, Grad Sch Med, Dept Clin Syst Oncoinformat, Kyoto, Japan; [Baba, Mika] Suita Tokushukai Hosp, Dept Palliat Med, Suita, Osaka, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Palliat & Support Care Div, Hamamatsu, Shizuoka, Japan	Kyoto University; RIKEN; Kyoto University; Kyoto University; Kyoto University; National Cancer Center - Japan; Kyoto University; Kyoto University	Okuno, Y (corresponding author), RIKEN Adv Inst Computat Sci, Kobe, Hyogo, Japan.; Okuno, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Clin Syst Oncoinformat, Kyoto, Japan.	okuno.yasushi.4c@kyoto-u.ac.jp	Taneishi, Kei/C-6013-2016; Kuroda, Tomohiro/F-7041-2010; YAMAMOTO, Yosuke/HCH-0666-2022; Nishikawa, Yoshitaka/GLV-3579-2022	Taneishi, Kei/0000-0001-8475-5870; Kuroda, Tomohiro/0000-0003-1472-7203; Nishikawa, Yoshitaka/0000-0003-3313-1990	Chugai Pharmaceutical Co., Ltd; Mitsui Knowledge Industry Co., Ltd; Taiho Pharmaceutical Co., Ltd.; FOCUS Establishing Supercomputing Center of Excellence	Chugai Pharmaceutical Co., Ltd; Mitsui Knowledge Industry Co., Ltd; Taiho Pharmaceutical Co., Ltd.; FOCUS Establishing Supercomputing Center of Excellence	The study was supported by research grants from Chugai Pharmaceutical Co., Ltd, Mitsui Knowledge Industry Co., Ltd, and Taiho Pharmaceutical Co., Ltd. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the FOCUS Establishing Supercomputing Center of Excellence. We thank Dr. Akiko Tamon, Dr. Masatoshi Hamanaka, and Dr. J.B. Brown for their help in the conception and design of the study and data collection. We also appreciate the Japan ProVal Study Group (Prognostic scores Validation Study Group), the participating study sites and site investigators, Satoshi Inoue, M.D. (Seirei Hospice, Seirei Mikatahara General Hospital), Masayuki Ikenaga, M.D. (Hospice Children's Hospice Hospital, Yodogawa Christian Hospital), Yoshihisa Matsumoto, M.D., Ph.D. (Department of Palliative Medicine, National Cancer Center Hospital East), Mika Baba, M.D. (Saito Yukoukai Hospital Department of palliative care), Ryuichi Sekine, M.D. (Department of Pain and Palliative Care, Kameda Medical Center), Takashi Yamaguchi, M.D., Ph.D. (Department of Palliative Medicine, Kobe University Graduate School of Medicine), Takeshi Hirohashi, M.D. (Department of Palliative Care, Mitui Memorial Hospital), Tsukasa Tajima, M.D. (Department of Palliative Medicine, Tohoku University Hospital), Ryohei Tatara, M.D. (Osaka City General Hospital, Department of Palliative Medicine), Hiroaki Watanabe, M.D. (Komaki City Hospital), Hiroyuki Otani, M.D. (Department of Palliative Care Team, and Palliative and Supportive Care, National Kyushu Cancer Center), Chizuko Takigawa, M.D. (Department of Palliative Care, KKR Sapporo Medical Center), Yoshinobu Matsuda, M.D. (Department of Psychosomatic Medicine, National Hospital), Hiroka Nagaoka, M.D. (University of Tsukuba, Department of Medical Social Service Center for Palliative), Masanori Mori,M.D. (Seirei Hamamatsu General Hospital), Yo Tei, M.D. (SeireiHospice, Seirei Mikatahara General Hospital), Shuji Hiramoto, M.D. (Department of Oncology, Mitsubishi Kyoto Hospital), Akihiko Suga, M.D. (Department of Palliative Medicine Shizuoka Saiseikai General Hospital), Takayuki Hisanaga, M.D. (Tsukuba Medical Center Foundation), Tatsuhiko Ishihara, M.D. (Okayama Saiseikai General Hospital, Palliative Care Department), Tomoyuki Iwashita, M.D. (Matsue City Hospital), Keisuke Kaneishi, M.D., Ph. D. (Department of Palliative Care Unit, JCHO Tokyo Shinjuku Medical Center), Shohei Kawagoe, M.D. (Aozora clinic), Toshiyuki Kuriyama,M.D., Ph.D. (Department of Palliative Medicine, Wakayama Medical University Hospital Oncology Center,), Takashi Maeda, M.D. (Department of Palliative Care, Tokyo Metropolitan Cancer and Infectious Disease Center Komagome Hospital), Ichiro Mori, M.D. (Gratia Hospital Hospice), Nobuhisa Nakajima, M. D., Ph.D. (Department of Palliative Medicine, Graduate School of Medicine, Tohoku University), Tomohiro Nishi, M.D. (Kawasaki Comprehensive Care Center, Kawasaki Municipal Ida Hospital), Hiroki Sakurai, M.D. (Department of Palliative Care, St. Luke's International Hospital, Tokyo), Satofumi Shimoyama,M.D., Ph.D. (Department of Palliative care, Aichi Cancer Center Hospital), Takuya Shinjo, M.D. (Shinjo Clinic, Kobe), Hiroto Shirayama, M.D. (Iryouhoujinn Takumikai Osaka Kita Homecare Clinic), Takeshi Yamada, M.D., Ph.D. (Department of Gastrointestinal and Hepato-Biliary-Pancreatic Surgery, Nippon Medical School), Shigeki Ono, M.D. (Division of Palliative Medicine, Shizuoka Cancer Center Hospital), Taketoshi Ozawa, M.D., Ph.D. (Megumi Zaitaku Clinic), Ryo Yamamoto, M.D. (Saku Central Hospital Advanced Care Center, Department of Palliative Medicine), Naoki Yamamoto,M.D., Ph.D. (Shinsei Hospital, Department of Primary Care Service), Hideki Shishido, M.D. (Shishido Internal Medicine Clinic), Mie Shimizu, M.D.; (Saiseikai Matsusaka General Hospital), Masanori Kawahara, M.D., Ph.D. (Soshukai Okabe Clinic), Shigeru Aoki, M.D. (Sakanoue Family Clinic), Akira Demizu, M.D. (Demizu Clinic), Masahiro Goshima, M.D., Ph.D. (Homecare-Clinic Kobe), Keiji Goto, M.D. (Himawari Zaitaku Clinic), Yasuaki Gyoda,M.D., Ph.D. (Kanamecyo Home Care clinic), Jun Hamano, M.D. (Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba), Kotaro Hashimoto, M.D. (Fukushima Home Palliative Care Clinic), Sen Otomo, M.D. (Shonan International Village Clinic), Masako Sekimoto, M.D. (Sekimoto Clinic), Takemi Shibata,M.D. (Kanwakeakurini kku Eniwa), Yuka Sugimoto, M.D. (Sugimoto Homecare Clinic), Mikako Matsunaga, M.D. (Senri Pain Clinic), Yukihiko Takeda, M.D. (Hidamari Clinic), Takeshi Sasara,M.D. (Yuuaikai Nanbu Hospital), and Jun Nagayama, M.D. (Peace Clinic Nakai).	Baba M, 2015, EUR J CANCER, V51, P1618, DOI 10.1016/j.ejca.2015.04.025; Barbot AC, 2008, J CLIN ONCOL, V26, P2538, DOI 10.1200/JCO.2007.14.9518; Chawla NV, 2002, J ARTIF INTELL RES, V16, P321, DOI 10.1613/jair.953; EIDINGER RN, 1984, CANCER, V53, P2736, DOI 10.1002/1097-0142(19840615)53:12<2736::AID-CNCR2820531233>3.0.CO;2-W; Enzinger AC, 2015, J CLIN ONCOL, V33, P3809, DOI 10.1200/JCO.2015.61.9239; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Gwilliam B, 2011, BRIT MED J, V343, DOI 10.1136/bmj.d4920; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Matsumoto S, 2007, J CLIN ONCOL, V25; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Penel N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006483; Pirovano M, 1999, J PAIN SYMPTOM MANAG, V17, P231, DOI 10.1016/S0885-3924(98)00145-6; Redelmeier DA, 1997, J CLIN EPIDEMIOL, V50, P1281, DOI 10.1016/S0895-4356(97)00196-0; Scarpi E, 2011, ONCOLOGIST, V16, P1793, DOI 10.1634/theoncologist.2011-0130; Suh SY, 2007, EUR J CANCER, V43, P1051, DOI 10.1016/j.ejca.2007.01.031; TEMPLETON AJ, 2014, JNCI J NATL CANCER I, V106; Vigano A, 2000, ARCH INTERN MED, V160, P861, DOI 10.1001/archinte.160.6.861; Weeks JC, 2012, NEW ENGL J MED, V367, P1616, DOI 10.1056/NEJMoa1204410; Weeks JC, 1998, JAMA-J AM MED ASSOC, V279, P1709, DOI 10.1001/jama.279.21.1709	19	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183291	10.1371/journal.pone.0183291	http://dx.doi.org/10.1371/journal.pone.0183291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837592	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000057
J	Weissmueller, NT; Marsay, L; Schiffter, HA; Carlisle, RC; Rollier, CS; Prud'homme, RK; Pollard, AJ				Weissmueller, Nikolas T.; Marsay, Leanne; Schiffter, Heiko A.; Carlisle, Robert C.; Rollier, Christine S.; Prud'homme, Robert K.; Pollard, Andrew J.			Alternative vaccine administration by powder injection: Needle-free dermal delivery of the glycoconjugate meningococcal group Y vaccine	PLOS ONE			English	Article							CAPSULAR POLYSACCHARIDE; BALLISTIC DELIVERY; ANTIBODY-RESPONSES; INFLUENZA VACCINE; PARTICLE-SIZE; HUMAN SKIN; IMMUNOGENICITY; IMMUNIZATION; MICROPARTICLES; FORMULATION	Powder-injectors use gas propulsion to deposit lyophilised drug or vaccine particles in the epidermal and sub epidermal layers of the skin. We prepared dry-powder (T-g = 45.2 +/- 0.5 degrees C) microparticles (58.1 mu m) of a MenY-CRM197 glyconjugate vaccine (0.5% wt.) for intradermal needle-free powder injection (NFPI). SFD used ultrasound atomisation of the liquid vaccine-containing excipient feed, followed by lyophilisation above the glass transition temperature (T-g' = -29.9 +/- 0.3 degrees C). This resulted in robust particles (density similar to 0.53 +/-0.09 g/cm(3)) with a narrow volume size distribution (mean diameter 58.1 mu m, and span = 1.2), and an impact parameter (rho vr similar to 11.5 kg/m.s) sufficient to breach the Stratum corneum (sc). The trehalose, manitol, dextran (10 kDa), dextran (150 kDa) formulation, or TMDD (3:3:3:1), protected the MenY-CRM197 glyconjugate during SFD with minimal loss, no detectable chemical degradation or physical aggregation. In a capsular group Y Neisseria meningitidis serum bactericidal assay (SBA) with human serum complement, the needle free vaccine, which contained no alum adjuvant, induced functional protective antibody responses in vivo of similar magnitude to the conventional vaccine injected by hypodermic needle and syringe and containing alum adjuvant. These results demonstrate that needle-free vaccination is both technically and immunologically valid, and could be considered for vaccines in development.	[Weissmueller, Nikolas T.; Marsay, Leanne; Rollier, Christine S.; Pollard, Andrew J.] Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, Oxfordshire, England; [Weissmueller, Nikolas T.; Marsay, Leanne; Rollier, Christine S.; Pollard, Andrew J.] NIHR Oxford Biomed Res Inst, Oxford, Oxfordshire, England; [Weissmueller, Nikolas T.; Prud'homme, Robert K.] Princeton Univ, Dept Biol & Chem Engn, Princeton, NJ 08544 USA; [Weissmueller, Nikolas T.; Schiffter, Heiko A.; Carlisle, Robert C.] BUBBL, Inst Biomed Engn, Oxford, Oxfordshire, England; [Schiffter, Heiko A.] Univ Appl Sci, Dept Appl Nat Sci, Cologne, North Rhine Wes, Germany	University of Oxford; Princeton University; University of Oxford	Weissmueller, NT (corresponding author), Univ Oxford, Oxford Vaccine Grp, Dept Paediat, Oxford, Oxfordshire, England.; Weissmueller, NT (corresponding author), NIHR Oxford Biomed Res Inst, Oxford, Oxfordshire, England.; Weissmueller, NT (corresponding author), Princeton Univ, Dept Biol & Chem Engn, Princeton, NJ 08544 USA.; Weissmueller, NT (corresponding author), BUBBL, Inst Biomed Engn, Oxford, Oxfordshire, England.	ntw@princeton.edu		Weissmueller, Nikolas/0000-0003-4589-9286; Schiffter-Weinle, Heiko Alexander/0000-0003-0407-3242	Oxford Martin School, University of Oxford	Oxford Martin School, University of Oxford	This work was supported by the Oxford Martin School, University of Oxford. URL: http://www.oxfordmartin.ox.ac.uk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora A, 2008, INT J PHARMACEUT, V364, P227, DOI 10.1016/j.ijpharm.2008.08.032; Bal SM, 2010, J CONTROL RELEASE, V148, P266, DOI 10.1016/j.jconrel.2010.09.018; Berti F, 2004, BIOPHYS J, V86, P3, DOI 10.1016/S0006-3495(04)74078-3; Blanchard-Rohner G, 2011, EXPERT REV VACCINES, V10, P673, DOI 10.1586/erv.11.14; Borrow R, 2006, VACCINE, V24, P5093, DOI 10.1016/j.vaccine.2006.03.091; Borrow R, 2000, FEMS IMMUNOL MED MIC, V28, P79, DOI 10.1111/j.1574-695X.2000.tb01460.x; Broker M, 2016, HUM VACC IMMUNOTHER, V12, P1808, DOI 10.1080/21645515.2016.1153206; Burkoth TL, 1999, CRIT REV THER DRUG, V16, P331, DOI 10.1615/CritRevTherDrugCarrierSyst.v16.i4.10; Chen Dexiang, 2002, Expert Rev Vaccines, V1, P265, DOI 10.1586/14760584.1.3.265; Chen DX, 2004, VIRUS RES, V103, P147, DOI 10.1016/j.virusres.2004.02.027; Chen DX, 2003, VACCINE, V21, P2830, DOI 10.1016/S0264-410X(03)00175-0; Chen DX, 2000, NAT MED, V6, P1187, DOI 10.1038/80538; Chiu SS, 2009, VACCINE, V27, P4834, DOI 10.1016/j.vaccine.2009.05.066; Costantino HR, 2002, J PHARM SCI-US, V91, P388, DOI 10.1002/jps.10059; Costantino HR, 2000, PHARMACEUT RES, V17, P1374, DOI 10.1023/A:1007570030368; De Gregorio E, 2014, NAT REV IMMUNOL, V14, P505, DOI 10.1038/nri3694; Dean HJ, 2004, VACCINE, V23, P681, DOI 10.1016/j.vaccine.2004.06.041; Dean HJ, 2003, COMP IMMUNOL MICROB, V26, P373, DOI 10.1016/S0147-9571(03)00021-3; GHEESLING LL, 1994, J CLIN MICROBIOL, V32, P1475, DOI 10.1128/JCM.32.6.1475-1482.1994; Granoff DM, 1998, CLIN DIAGN LAB IMMUN, V5, P479, DOI 10.1128/CDLI.5.4.479-485.1998; Hancock BC, 1997, J PHARM SCI, V86, P1, DOI 10.1021/js9601896; Ho MM, 2000, VACCINE, V19, P716, DOI 10.1016/S0264-410X(00)00261-9; Jafri RZ, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-17; Johnson KA, 1997, ADV DRUG DELIVER REV, V26, P3, DOI 10.1016/S0169-409X(97)00506-1; Karande P, 2004, NAT BIOTECHNOL, V22, P192, DOI 10.1038/nbt928; Kelly DF, 2004, IMMUNOLOGY, V113, P163, DOI 10.1111/j.1365-2567.2004.01971.x; Kendall M, 2004, J BIOMECH, V37, P1733, DOI 10.1016/j.jbiomech.2004.01.032; Kendall M, 2004, J INVEST DERMATOL, V122, P739, DOI 10.1111/j.0022-202X.2004.22320.x; Kendall MAF, 2002, SHOCK WAVES, V12, P23, DOI 10.1007/s001930200126; Kupper TS, 2004, NAT REV IMMUNOL, V4, P211, DOI 10.1038/nri1310; LEVI G, 1995, FOOD RES INT, V28, P145, DOI 10.1016/0963-9969(95)90798-F; Levine MM, 2003, NAT MED, V9, P99, DOI 10.1038/nm0103-99; Lieberman JM, 1996, JAMA-J AM MED ASSOC, V275, P1499, DOI 10.1001/jama.275.19.1499; Liu Y, 2007, MED ENG PHYS, V29, P390, DOI 10.1016/j.medengphy.2006.05.015; Maa YF, 2004, J PHARM SCI-US, V93, P1912, DOI 10.1002/jps.20104; Maa YF, 2003, PHARMACEUT RES, V20, P969, DOI 10.1023/A:1024493719236; Maa YF, 1998, J PHARM SCI, V87, P152, DOI 10.1021/js970308x; Maury M, 2005, EUR J PHARM BIOPHARM, V59, P565, DOI 10.1016/j.ejpb.2004.10.002; McIntosh EDG, 2015, VACCINE, V33, P4414, DOI 10.1016/j.vaccine.2015.07.019; Mitragotri S, 2005, NAT REV IMMUNOL, V5, P905, DOI 10.1038/nri1728; Moginger U, 2016, SCI REP-UK, V6, DOI 10.1038/srep20488; Mvundura M, 2015, VACCINE, V33, P2697, DOI 10.1016/j.vaccine.2015.03.084; Nail Steven L, 2002, Pharm Biotechnol, V14, P281; Ogura M, 2008, ADV DRUG DELIVER REV, V60, P1218, DOI 10.1016/j.addr.2008.03.006; Perrett KP, 2009, PEDIATR INFECT DIS J, V28, P186, DOI 10.1097/INF.0b013e31818e037d; Pollard AJ, 2009, NAT REV IMMUNOL, V9, P212, DOI 10.1038/nri2494; Ratanji KD, 2014, J IMMUNOTOXICOL, V11, P99, DOI 10.3109/1547691X.2013.821564; Rochelle C, 2007, J PHARM SCI-US, V96, P2296, DOI 10.1002/jps.20861; Rubinstein LJ, 1998, INFECT IMMUN, V66, P5450, DOI 10.1128/IAI.66.11.5450-5456.1998; Schiffter H., 2007, EUR PHARM REV, V3, P67; Schiffter H, 2010, J R SOC INTERFACE, V7, pS483, DOI 10.1098/rsif.2010.0114.focus; Snape MD, 2008, JAMA-J AM MED ASSOC, V299, P173, DOI 10.1001/jama.2007.29-c; Sonner C, 2002, J PHARM SCI-US, V91, P2122, DOI 10.1002/jps.10204; Tang XL, 2004, PHARM RES-DORDR, V21, P191, DOI 10.1023/B:PHAM.0000016234.73023.75; WAHL M, 1987, SCAND J INFECT DIS, V19, P617, DOI 10.3109/00365548709117195; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3; Weissmueller NT, 2015, CLIN VACCINE IMMUNOL, V22, P586, DOI 10.1128/CVI.00121-15; Weissmueller NT, 2013, EXPERT REV VACCINES, V12, P687, DOI [10.1586/ERV.13.48, 10.1586/erv.13.48]; Wilburn SQ, 2004, INT J OCCUP ENV HEAL, V10, P451, DOI 10.1179/oeh.2004.10.4.451; World Health Organization, 2004, SAF INJ GLOB FACTS F; Zhang L, 2015, EXPERT REV VACCINES, V14, P1509, DOI 10.1586/14760584.2015.1081067	62	5	5	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183427	10.1371/journal.pone.0183427	http://dx.doi.org/10.1371/journal.pone.0183427			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837693	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000065
J	Hosokawa, Y; Masaki, N; Takei, S; Horikawa, M; Matsushita, S; Sugiyama, E; Ogura, H; Shiiya, N; Setou, M				Hosokawa, Yuko; Masaki, Noritaka; Takei, Shiro; Horikawa, Makoto; Matsushita, Shoko; Sugiyama, Eiji; Ogura, Hiroyuki; Shiiya, Norihiko; Setou, Mitsutoshi			Recurrent triple-negative breast cancer (TNBC) tissues contain a higher amount of phosphatidylcholine (32:1) than non-recurrent TNBC tissues	PLOS ONE			English	Article							MASS-SPECTROMETRY; PROGRESSION; SURVIVAL	Triple-negative breast cancer (TNBC) is one of the breast cancer subtype that displays a high risk of early recurrence and short overall survival. Improvement of the prognosis of patients with TNBC requires identifying a predictive factor of recurrence, which would make it possible to provide beneficial personalized treatment. However, no clinically reliable predictive factor is currently known. In this study, we investigated the predictive factor of recurrence in TNBC using matrix-assisted laser desorption/ionization-imaging mass spectrometry for lipid profiling of breast cancer specimens obtained from three and six patients with recurrent and non-recurrent TNBC, respectively. The signal for phosphatidylcholine (PC) (32:1) at m/z 732.5 was significantly higher in the recurrence group compared to the non-recurrence group (P = 0.024). PC (32:1) was more abundant in the cancer epithelial area than it was in the surrounding stroma, suggesting that abnormal lipid metabolism was associated with malignant transformation. Our results indicate PC (32:1) as a candidate predictive factor of TNBC recurrence. A future prospective study investigating whether personalized therapy based on PC (32:1) intensity improves the prognosis of patients with TNBC is recommended.	[Hosokawa, Yuko; Ogura, Hiroyuki; Shiiya, Norihiko] Hamamatsu Univ, Sch Med, Dept Surg 1, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Hosokawa, Yuko; Masaki, Noritaka; Takei, Shiro; Horikawa, Makoto; Matsushita, Shoko; Sugiyama, Eiji; Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Int Mass Imaging Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Hosokawa, Yuko; Masaki, Noritaka; Takei, Shiro; Horikawa, Makoto; Matsushita, Shoko; Sugiyama, Eiji; Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Dept Cellular & Mol Anat, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Preeminent Med Photon Educ & Res Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan; [Setou, Mitsutoshi] Univ Hong Kong, Dept Anat, 6-F,William MW Mong Block,Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Setou, Mitsutoshi] RIKEN, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo, Japan	Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; Hamamatsu University School of Medicine; University of Hong Kong; RIKEN	Setou, M (corresponding author), Hamamatsu Univ, Sch Med, Int Mass Imaging Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Hamamatsu Univ, Sch Med, Dept Cellular & Mol Anat, Higashi Ku, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Preeminent Med Photon Educ & Res Ctr, Higashi Ku, Hamamatsu, Shizuoka, Japan.; Setou, M (corresponding author), Univ Hong Kong, Dept Anat, 6-F,William MW Mong Block,Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.; Setou, M (corresponding author), RIKEN, Ctr Mol Imaging Sci, Chuo Ku, Kobe, Hyogo, Japan.	setou@hama-med.ac.jp	Horikawa, Makoto/GSE-0110-2022	Horikawa, Makoto/0000-0002-5094-7070	MEXT/JSPS KAKENHI [JP15H05898B1]; Imaging Platform Grant [967]; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED [921910520]; MEXT/JSPS KAKENHI [JP15H05898B1]; Imaging Platform Grant [967]; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED [921910520]; Grants-in-Aid for Scientific Research [15H05898, 15H05897] Funding Source: KAKEN	MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Imaging Platform Grant; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); MEXT/JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Imaging Platform Grant; Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by MEXT/JSPS KAKENHI Grant Number JP15H05898B1, Imaging Platform Grant Number 967, and Advanced Research and Development Programs for Medical Innovation (CREST) from Japan Agency for Medical Research and Development, AMED Grant Number 921910520 to M. Setou. The funders had no role in study design, data collection, analysis, and preparation of the manuscript.	Abalsamo L, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3151; Abdelzaher E, 2015, TUMOR BIOL, V36, P5473, DOI 10.1007/s13277-015-3214-8; Abramson VG, 2014, CURR BREAST CANCER R, V6, P154, DOI 10.1007/s12609-014-0152-1; Baumann J, 2013, BBA-MOL CELL BIOL L, V1831, P1509, DOI 10.1016/j.bbalip.2013.03.011; Berry KAZ, 2011, CHEM REV, V111, P6491, DOI 10.1021/cr200280p; Delvolve AM, 2011, ANAL METHODS-UK, V3, P1729, DOI 10.1039/c1ay05107e; Fleisher B, 2016, BREAST CANCER-TARGET, V8, P183, DOI 10.2147/BCTT.S114659; Goto-Inoue N, 2011, BBA-MOL CELL BIOL L, V1811, P961, DOI 10.1016/j.bbalip.2011.03.004; He MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep11298; Hilvo M, 2011, CANCER RES, V71, P3236, DOI 10.1158/0008-5472.CAN-10-3894; Holder AM, 2013, BREAST CANCER RES TR, V137, P319, DOI 10.1007/s10549-012-2354-4; Hsu FF, 2003, J AM SOC MASS SPECTR, V14, P352, DOI 10.1016/S1044-0305(03)00064-3; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Iorio E, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00205; Kang HS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-465; Kim H. Y., 2016, ONCOTARGET; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Mao XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep21043; Moessinger C, 2014, BMC CELL BIOL, V15, DOI 10.1186/s12860-014-0043-3; Morita Y, 2013, J HEPATOL, V59, P292, DOI 10.1016/j.jhep.2013.02.030; Peck B, 2016, CANCER METAB, V4, DOI 10.1186/s40170-016-0146-8; Peltier S, 2008, INT J MOL MED, V22, P559, DOI 10.3892/ijmm_00000056; Ridgway ND, 2013, CRIT REV BIOCHEM MOL, V48, P20, DOI 10.3109/10409238.2012.735643; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wahba HA, 2015, CANCER BIOL MED, V12, P106, DOI 10.7497/j.issn.2095-3941.2015.0030; Waki ML, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026721	26	24	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183724	10.1371/journal.pone.0183724	http://dx.doi.org/10.1371/journal.pone.0183724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832678	Green Submitted, gold, Green Published			2022-12-27	WOS:000408355800095
J	Lattin, CR; Stabile, FA; Carson, RE				Lattin, Christine R.; Stabile, Frank A.; Carson, Richard E.			Estradiol modulates neural response to conspecific and heterospecific song in female house sparrows: An in vivo positron emission tomography study	PLOS ONE			English	Article							AUDITORY-EVOKED RESPONSES; PASSER-DOMESTICUS; ACOUSTIC COMMUNICATION; GENOMIC RESPONSES; ZEBRA FINCH; FOREBRAIN; BRAIN; SELECTIVITY; SONGBIRDS; ESTROGENS	Although there is growing evidence that estradiol modulates female perception of male sexual signals, relatively little research has focused on female auditory processing. We used in vivo F-18-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) imaging to examine the neuronal effects of estradiol and conspecific song in female house sparrows (Passer domesticus). We assessed brain glucose metabolism, a measure of neuronal activity, in females with empty implants, estradiol implants, and empty implants similar to 1 month after estradiol implant removal. Females were exposed to conspecific or heterospecific songs immediately prior to imaging. The activity of brain regions involved in auditory perception did not differ between females with empty implants exposed to conspecific vs. heterospecific song, but neuronal activity was significantly reduced in females with estradiol implants exposed to heterospecific song. Furthermore, our within-individual design revealed that changes in brain activity due to high estradiol were actually greater several weeks after peak hormone exposure. Overall, this study demonstrates that PET imaging is a powerful tool for assessing large-scale changes in brain activity in living songbirds, and suggests that after breeding is done, specific environmental and physiological cues are necessary for estradiol-stimulated females to lose the selectivity they display in neural response to conspecific song.	[Lattin, Christine R.; Carson, Richard E.] Yale Univ, Yale Positron Emiss Tomog Ctr, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA; [Stabile, Frank A.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT USA	Yale University; Yale University	Lattin, CR (corresponding author), Yale Univ, Yale Positron Emiss Tomog Ctr, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA.	christine.lattin@yale.edu	Carson, Richard E/H-3250-2011; Lattin, Christine/E-5662-2013	Carson, Richard E/0000-0002-9338-7966; Lattin, Christine/0000-0003-4030-4212	Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation; American Ornithologists' Union; American Philosophical Society; National Institutes of Health [1S100D010322-01]	Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation(Howard Hughes Medical Institute); American Ornithologists' Union; American Philosophical Society; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was funded by the Howard Hughes Medical Institute Fellowship of the Life Sciences Research Foundation (http://www.lsrf.org/); American Ornithologists' Union (http://www.americanornithology.org/); American Philosophical Society (https://www.amphilsoc.org/) to CRL; and the National Institutes of Health grant 1S100D010322-01 (https://www.nih.gov/) to REC.	Adams MC, 2010, AM J ROENTGENOL, V195, P310, DOI 10.2214/AJR.10.4923; Anderson TR., 2006, BIOL UBIQUITOUS HOUS; Arch VS, 2009, HEARING RES, V252, P15, DOI 10.1016/j.heares.2009.01.001; Caras ML, 2012, J NEUROSCI, V32, P17597, DOI 10.1523/JNEUROSCI.3938-12.2012; Caras ML, 2010, J COMP PHYSIOL A, V196, P581, DOI 10.1007/s00359-010-0545-1; Carney JPJ, 2006, MED PHYS, V33, P976, DOI 10.1118/1.2174132; Chao A, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00057; Chatziioannou AF, 2002, EUR J NUCL MED, V29, P98, DOI 10.1007/s00259-001-0683-3; Cornil CA, 2012, FRONT NEUROENDOCRIN, V33, P425, DOI 10.1016/j.yfrne.2012.08.003; Cross DJ, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1046; Cudeck R, 1996, MULTIVAR BEHAV RES, V31, P371, DOI 10.1207/s15327906mbr3103_6; Das RG, 2007, LAB ANIM-UK, V41, P312, DOI 10.1258/002367707781282802; De Groof G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00196; De Groof G, 2009, J NEUROSCI, V29, P13557, DOI 10.1523/JNEUROSCI.1788-09.2009; Espino GG, 2003, NEUROSCIENCE, V122, P521, DOI 10.1016/S0306-4522(03)00549-9; GAHR M, 1993, J COMP NEUROL, V327, P112, DOI 10.1002/cne.903270109; Grace JA, 2003, J NEUROPHYSIOL, V89, P472, DOI 10.1152/jn.00088.2002; HEGNER RE, 1986, HORM BEHAV, V20, P313, DOI 10.1016/0018-506X(86)90040-1; Henry KS, 2009, J EXP BIOL, V212, P3817, DOI 10.1242/jeb.033035; Lattin CR, 2017, HORM BEHAV, V89, P121, DOI 10.1016/j.yhbeh.2016.12.016; Lieske CL, 2002, J AVIAN MED SURG, V16, P277, DOI 10.1647/1082-6742(2002)016[0277:EOHBGM]2.0.CO;2; Lucas JR, 2007, J COMP PHYSIOL A, V193, P201, DOI 10.1007/s00359-006-0180-z; Lucas JR, 2002, J COMP PHYSIOL A, V188, P981, DOI 10.1007/s00359-002-0359-x; MacDougall-Shackleton SA, 1998, NEUROREPORT, V9, P3047, DOI 10.1097/00001756-199809140-00024; Maney DL, 2006, EUR J NEUROSCI, V23, P1523, DOI 10.1111/j.1460-9568.2006.04673.x; Maney DL, 2008, J COMP NEUROL, V511, P173, DOI 10.1002/cne.21830; Marzluff JM, 2012, P NATL ACAD SCI USA, V109, P15912, DOI 10.1073/pnas.1206109109; Mauvais-Jarvis F, 2013, ENDOCR REV, V34, P309, DOI 10.1210/er.2012-1055; MOLLER AP, 1988, BEHAV ECOL SOCIOBIOL, V22, P373; Noirot IC, 2009, HEARING RES, V252, P49, DOI 10.1016/j.heares.2009.04.012; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Sanford SE, 2010, DEV NEUROBIOL, V70, P73, DOI 10.1002/dneu.20757; Schiffer WK, 2007, J NUCL MED, V48, P277; Shi J, 1997, EXP BRAIN RES, V117, P200, DOI 10.1007/s002210050216; Sisneros JA, 2009, INTEGR ZOOL, V4, P33, DOI 10.1111/j.1749-4877.2008.00133.x; Sockman KW, 2007, J ORNITHOL, V148, pS225, DOI 10.1007/s10336-007-0151-3; Theunissen FE, 2006, CURR OPIN NEUROBIOL, V16, P400, DOI 10.1016/j.conb.2006.07.003; Van der Linden A, 2009, TRENDS NEUROSCI, V32, P257, DOI 10.1016/j.tins.2009.01.005; Vellema M, 2011, NEUROIMAGE, V57, P352, DOI 10.1016/j.neuroimage.2011.04.033; Visser EP, 2009, J NUCL MED, V50, P139, DOI 10.2967/jnumed.108.055152; Vriens D, 2009, NUCL MED COMMUN, V30, P550, DOI 10.1097/MNM.0b013e32832bdc80; Wong KP, 2011, J NUCL MED, V52, P800, DOI 10.2967/jnumed.110.085092	42	14	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182875	10.1371/journal.pone.0182875	http://dx.doi.org/10.1371/journal.pone.0182875			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832614	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800037
J	Wang, SH; Wang, KL; Yang, WK; Lee, TH; Lo, WY; Lee, JD				Wang, Shih-Ho; Wang, Kuan-Lin; Yang, Wen-Kai; Lee, Tsung-Han; Lo, Wan-Yu; Lee, Jane-Dar			Expression and potential roles of sodium-potassium ATPase and E-cadherin in human gastric adenocarcinoma	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NA+/K+-ATPASE; CELL-ADHESION; NA,K-ATPASE; CANCER; SUPPRESSION; JUNCTIONS; SUBUNIT; PATHWAY; PUMP	Background Gastric adenocarcinoma originates from an abnormal epithelium. The aim of this study was to investigate the expression of sodium-potassium ATPase (NKA), a transmembrane protein located in the epithelium for Na+ and K+ transportation, and E-cadherin, which are both crucial for the epithelium and adherens junction, as potential gastric cancer biomarkers. Methods 45 patients diagnosed with gastric adenocarcinoma were recruited. Immunohistochemistry and immunofluorescence were conducted to for localization of NKA alpha 1-, beta 1-isoform, and E-cadherin. NKA enzyme activity was determined by NADH-linked methods and immunoblotting of NKA alpha 1-, beta 1-isoform, and E-cadherin were performed to evaluate protein expression. Results Immunostaining revealed that NKA was co-localized with E-cadherin in the glands of the gastric epithelium. Both NKA activity and alpha 1-isoform protein expression were reduced in the study group (P < 0.05), indicating impaired NKA functions. In the adherens junctions, the NKA beta 1-isoform and E-cadherin were significantly reduced in the study groups (P < 0.05), indicating the adhesion force between cells may have been weakened. Conclusions A significant decrease in NKA function (protein and activity) and E-cadherin in tumor lesions appear promising biomarker for gastric adenocarcinoma. Therefore, developing screening methods for detecting NKA function may be beneficial for the early diagnosis of gastric cancer. In our knowledge, this study was the first to investigate the NKA and E-cadherin expression in the relation of gastric adenocarcinoma in human patients.	[Wang, Shih-Ho] Kaohsiung Chang Gung Mem Hosp, Dept Surg, Div Gen Surg, Kaohsiung, Taiwan; [Wang, Shih-Ho] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Wang, Shih-Ho] Cheng Shiu Univ, Ctr Gen Educ, Kaohsiung, Taiwan; [Wang, Kuan-Lin; Yang, Wen-Kai; Lee, Tsung-Han] Natl Chung Hsing Univ, Dept Life Sci, Taichung, Taiwan; [Yang, Wen-Kai; Lo, Wan-Yu] Hungkuang Univ, Bachelor Degree Program Anim Healthcare, Taichung, Taiwan; [Lo, Wan-Yu] Hungkuang Univ, Dept Biotechnol, Taichung, Taiwan; [Lee, Jane-Dar] Feng Yuan Hosp, Dept Urol, Minist Hlth & Welf, Taichung, Taiwan; [Lee, Jane-Dar] Cent Taiwan Univ Sci & Technol, Taichung, Taiwan; [Lee, Jane-Dar] Taichung Armed Forces Gen Hosp, Dept Surg, Taichung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Cheng Shiu University; National Chung Hsing University; Hungkuang University; Hungkuang University; Central Taiwan University Science & Technology	Lee, JD (corresponding author), Feng Yuan Hosp, Dept Urol, Minist Hlth & Welf, Taichung, Taiwan.; Lee, JD (corresponding author), Cent Taiwan Univ Sci & Technol, Taichung, Taiwan.; Lee, JD (corresponding author), Taichung Armed Forces Gen Hosp, Dept Surg, Taichung, Taiwan.	jane.dar@yahoo.com.tw		Lee, Tsung-Han/0000-0002-3542-4335				Barwe SP, 2005, MOL BIOL CELL, V16, P1082, DOI 10.1091/mbc.E04-05-0427; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Gofuku J, 1998, BRIT J CANCER, V78, P1095, DOI 10.1038/bjc.1998.634; Harris TJC, 2010, NAT REV MOL CELL BIO, V11, P502, DOI 10.1038/nrm2927; Huang L, 2015, AM J TRANSL RES, V7, P2141; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Koksoy AA, 2002, J ANKARA MED SCH, V24, P73; Lee JD, 2016, J KOREAN MED SCI, V31, P280, DOI 10.3346/jkms.2016.31.2.280; Lee JD, 2012, ANN VASC SURG, V26, P1100, DOI 10.1016/j.avsg.2011.12.014; Lee SJ, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0430-1; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Litan A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00086; Liu X, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/637308; Mijatovic T, 2012, PHARM PAT ANAL, V1, P91, DOI [10.4155/PPA.12.3, 10.4155/ppa.12.3]; Mobasheri A, 2003, CANCER CELL INT, V3, P1; Muscella A, 2002, J ENDOCRINOL, V173, P315, DOI 10.1677/joe.0.1730315; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P3717, DOI 10.1091/mbc.12.12.3717; Rajasekaran SA, 2005, SEMIN NEPHROL, V25, P328, DOI 10.1016/j.semnephrol.2005.03.008; Rajasekaran SA, 2010, MOL CANCER THER, V9, P1515, DOI 10.1158/1535-7163.MCT-09-0832; Scheiner-Bobis G, 2002, EUR J BIOCHEM, V269, P2424, DOI 10.1046/j.1432-1033.2002.02909.x; Vagin O, 2007, J BIOENERG BIOMEMBR, V39, P367, DOI 10.1007/s10863-007-9103-0; Vagin O, 2012, AM J PHYSIOL-CELL PH, V302, pC1271, DOI 10.1152/ajpcell.00456.2011; Wang SH, 2011, WORLD J GASTROENTERO, V17, P4675, DOI 10.3748/wjg.v17.i42.4675	25	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183692	10.1371/journal.pone.0183692	http://dx.doi.org/10.1371/journal.pone.0183692			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832634	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800083
J	Zahawi, RA; Oviedo-Brenes, F; Peterson, CJ				Zahawi, Rakan A.; Oviedo-Brenes, Federico; Peterson, Chris J.			A degradation debt? Large-scale shifts in community composition and loss of biomass in a tropical forest fragment after 40 years of isolation	PLOS ONE			English	Article							ATLANTIC FOREST; TREE RECRUITMENT; LIANA ABUNDANCE; RAIN; DIVERSITY; DENSITY; BIODIVERSITY; MORTALITY; DYNAMICS; CLIMATE	Habitat loss and fragmentation are among the biggest threats to tropical biodiversity and associated ecosystem services. We examined forest dynamics in a mid-elevation 365-ha fragment in southern Costa Rica. The fragment was isolated in the mid-1970s and belongs to the Las Cruces Biological Station. A 2.25-ha permanent plot was established in the center of the old-growth forest (>400 m to nearest edge boundary) and all plants >5 cm DBH were censused, mapped, and identified to species in two surveys taken similar to 5-6 years apart (>3,000 stems/survey). Although the reserve maintains high species richness (>200 spp.), with many rare species represented by only one individual, we document a strong shift in composition with a two-fold increase in the number of soft-wooded pioneer individuals. The dominant late-successional understory tree species, Chrysochlamys glauca (Clusiaceae), and most species in the Lauraceae, declined dramatically. Turnover was high: 22.9% of stems in the first survey were lost, and 27.8% of stems in the second survey represented new recruits. Mean tree diameter decreased significantly and there was a 10% decrease in overall biomass. Such alteration has been documented previously but only in smaller fragments or within similar to 100 m of an edge boundary. Further penetration into this fragment was perhaps driven by a progressive invasion of disturbance-adapted species into the fragment's core over time; the loss of once-dominant late successional species could be a contributing factor. The pattern found is of particular concern given that such fragments represent a substantial portion of today's remaining tropical habitat; further studies in similar-sized fragments that have been isolated for similar prolonged periods are called for.	[Zahawi, Rakan A.; Oviedo-Brenes, Federico] Org Trop Studies, Las Cruces Biol Stn, San Vito De Coto Brus, Puntarenas, Costa Rica; [Peterson, Chris J.] Univ Georgia, Dept Plant Biol, Athens, GA USA; [Zahawi, Rakan A.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA	University System of Georgia; University of Georgia; University of California System; University of California Santa Cruz	Zahawi, RA (corresponding author), Org Trop Studies, Las Cruces Biol Stn, San Vito De Coto Brus, Puntarenas, Costa Rica.; Zahawi, RA (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	rzahawi@ucsc.edu	Zahawi, Rakan/N-1028-2014	Zahawi, Rakan/0000-0002-5678-2967	University of Georgia; Organization for Tropical Studies	University of Georgia; Organization for Tropical Studies	The authors received no specific funding for this work; general research funds from both CJP (University of Georgia) and RAZ (Organization for Tropical Studies) were used to cover expenses incurred.	Anderson PK, 2004, TRENDS ECOL EVOL, V19, P535, DOI 10.1016/j.tree.2004.07.021; Augspurger CK, 2007, BIOTROPICA, V39, P702, DOI 10.1111/j.1744-7429.2007.00326.x; Banks-Leite C, 2014, SCIENCE, V345, P1041, DOI 10.1126/science.1255768; Borgella R, 2005, ECOL APPL, V15, P1062, DOI 10.1890/04-0352; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chazdon RL, 2005, ECOLOGY, V86, P1808, DOI 10.1890/04-0572; Clark DA, 2001, ECOLOGY, V82, P1460, DOI 10.1890/0012-9658(2001)082[1460:GTTCTH]2.0.CO;2; CLARK DA, 1992, ECOL MONOGR, V62, P315, DOI 10.2307/2937114; Colwell R.K., 2016, ESTIMATES STAT ESTIM; Comita LS, 2010, SCIENCE, V329, P330, DOI 10.1126/science.1190772; Condit R., 1998, Tropical forest census plots: methods and results from Barro Colorado Island, Panama and a comparison with other plots.; CONDIT R, 1995, ECOL MONOGR, V65, P419, DOI 10.2307/2963497; Corlett RT, 2014, GLOBAL FOREST FRAGMENTATION, P69, DOI 10.1079/9781780642031.0069; Daily GC, 2001, ECOL APPL, V11, P1, DOI 10.1890/1051-0761(2001)011[0001:CBUOHD]2.0.CO;2; Dirzo R, 2007, BIOTROPICA, V39, P355, DOI 10.1111/j.1744-7429.2007.00274.x; Dosch JJ, 2007, J TROP ECOL, V23, P151, DOI 10.1017/S0266467406003853; ESTRADA A, 1993, VEGETATIO, V108, P245; Evans JP, 2014, BIOL INVASIONS, V16, P1581, DOI 10.1007/s10530-013-0592-y; Ewers RM, 2017, ECOGRAPHY, V40, P26, DOI 10.1111/ecog.02585; Feeley KJ, 2007, ECOL LETT, V10, P461, DOI 10.1111/j.1461-0248.2007.01033.x; Ferraz SFB, 2014, LANDSCAPE ECOL, V29, P187, DOI 10.1007/s10980-014-9988-z; Fraedrich SW, 2015, FOREST PATHOL, V45, P60, DOI 10.1111/efp.12124; Galetti M, 2013, SCIENCE, V340, P1086, DOI 10.1126/science.1233774; Gallery RE, 2010, J ECOL, V98, P147, DOI 10.1111/j.1365-2745.2009.01589.x; Gascon C, 2000, SCIENCE, V288, P1356, DOI 10.1126/science.288.5470.1356; Gilbert GS, 2010, J VEG SCI, V21, P388, DOI 10.1111/j.1654-1103.2009.01151.x; GILBERT GS, 1994, OECOLOGIA, V98, P100, DOI 10.1007/BF00326095; Haddad NM, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500052; Harms KE, 2000, NATURE, V404, P493, DOI 10.1038/35006630; Harms KE, 2001, J ECOL, V89, P947, DOI 10.1111/j.1365-2745.2001.00615.x; Holdridge L. R., 1971, Forest environments in tropical life zones: a pilot study.; Hubbell SP, 2004, TROPICAL FOREST DIVERSITY AND DYNAMISM: FINDINGS FROM A LARGE-SCALE PLOT NETWORK, P8; Hubbell Stephen P., 2001, V32, pi; Ingwell LL, 2010, J ECOL, V98, P879, DOI 10.1111/j.1365-2745.2010.01676.x; JANZEN DH, 1983, OIKOS, V41, P402, DOI 10.2307/3544100; Susan GWL, 2009, J VEG SCI, V20, P323, DOI 10.1111/j.1654-1103.2009.01044.x; Laurance WF, 1997, SCIENCE, V278, P1117, DOI 10.1126/science.278.5340.1117; Laurance WF, 2004, NATURE, V428, P171, DOI 10.1038/nature02383; Laurance WF, 2002, CONSERV BIOL, V16, P605, DOI 10.1046/j.1523-1739.2002.01025.x; Laurance WF, 2000, NATURE, V404, P836, DOI 10.1038/35009032; Laurance WF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001017; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Laurance William F, 2006, Ecology, V87, P469, DOI 10.1890/05-0064; Laurance WF, 2015, ANN MO BOT GARD, V100, P159, DOI 10.3417/2011087; Laurance WF, 2014, ECOLOGY, V95, P1604, DOI 10.1890/13-1571.1; Laurance WF, 2011, BIOL CONSERV, V144, P56, DOI 10.1016/j.biocon.2010.09.021; LCBS, PART LIST TREES REG; LCBS, BIRD CHECKL CRUC BIO; Mendenhall CD, 2014, NATURE, V509, P213, DOI 10.1038/nature13139; Mendenhall CD, 2011, P NATL ACAD SCI USA, V108, P16313, DOI 10.1073/pnas.1111687108; Mesquita RCG, 1999, BIOL CONSERV, V91, P129, DOI 10.1016/S0006-3207(99)00086-5; Metzger JP, 2009, BIOL CONSERV, V142, P1166, DOI 10.1016/j.biocon.2009.01.033; Nepstad DC, 2007, ECOLOGY, V88, P2259, DOI 10.1890/06-1046.1; Oliveira MA, 2008, FOREST ECOL MANAG, V256, P1910, DOI 10.1016/j.foreco.2008.07.014; Oliveira MA, 2004, ORYX, V38, P389, DOI 10.1017/S0030605304000754; Pacheco J, 2006, REV BIOL TROP, V54, P219; Phillips OL, 2004, PHILOS T R SOC B, V359, P381, DOI 10.1098/rstb.2003.1438; Reid JL, 2012, BIOTROPICA, V44, P350, DOI 10.1111/j.1744-7429.2011.00814.x; Santo-Silva EE, 2016, PLANT ECOL, V217, P1129, DOI 10.1007/s11258-016-0638-1; Santos BA, 2008, BIOL CONSERV, V141, P249, DOI 10.1016/j.biocon.2007.09.018; Santos BA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012625; Scariot A, 1999, J ECOL, V87, P66, DOI 10.1046/j.1365-2745.1999.00332.x; Schnitzer SA, 2006, BIOTROPICA, V38, P581, DOI 10.1111/j.1744-7429.2006.00187.x; Schnitzer SA, 2011, ECOL LETT, V14, P397, DOI 10.1111/j.1461-0248.2011.01590.x; SNOW DW, 1981, BIOTROPICA, V13, P1, DOI 10.2307/2387865; Tabarelli M, 2010, CONSERV BIOL, V24, P1654, DOI 10.1111/j.1523-1739.2010.01529.x; Terborgh J, 2008, ECOLOGY, V89, P1757, DOI 10.1890/07-0479.1; Thompson S, 2010, J ECOL, V98, P1434, DOI 10.1111/j.1365-2745.2010.01726.x; Zahawi RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143554	70	7	8	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183133	10.1371/journal.pone.0183133	http://dx.doi.org/10.1371/journal.pone.0183133			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832611	Green Published, Green Submitted, gold			2022-12-27	WOS:000408355800048
J	Zarai, Y; Margaliot, M; Tuller, T				Zarai, Yoram; Margaliot, Michael; Tuller, Tamir			A deterministic mathematical model for bidirectional excluded flow with Langmuir kinetics	PLOS ONE			English	Article							TRANSLATION ELONGATION; PROTEIN-SYNTHESIS; EXCLUSION PROCESS; RIBOSOME RESCUE; GENE-EXPRESSION; QUALITY-CONTROL; 5' END; CONTRACTION; MOTORS; TRANSCRIPTION	In many important cellular processes, including mRNA translation, gene transcription, phosphotransfer, and intracellular transport, biological "particles" move along some kind of "tracks". The motion of these particles can be modeled as a one-dimensional movement along an ordered sequence of sites. The biological particles (e.g., ribosomes or RNAPs) have volume and cannot surpass one another. In some cases, there is a preferred direction of movement along the track, but in general the movement may be bidirectional, and furthermore the particles may attach or detach from various regions along the tracks. We derive a new deterministic mathematical model for such transport phenomena that may be interpreted as a dynamic mean-field approximation of an important model from mechanical statistics called the asymmetric simple exclusion process (ASEP) with Langmuir kinetics. Using tools from the theory of monotone dynamical systems and contraction theory we show that the model admits a unique steady-state, and that every solution converges to this steady-state. Furthermore, we show that the model entrains (or phase locks) to periodic excitations in any of its forward, backward, attachment, or detachment rates. We demonstrate an application of this phenomenological transport model for analyzing ribosome drop off in mRNA translation.	[Zarai, Yoram; Tuller, Tamir] Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel; [Margaliot, Michael] Tel Aviv Univ, Sch Elect Engn, IL-69978 Tel Aviv, Israel; [Margaliot, Michael; Tuller, Tamir] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University	Tuller, T (corresponding author), Tel Aviv Univ, Dept Biomed Engn, IL-69978 Tel Aviv, Israel.	tamirtul@post.tau.ac.il		Tuller, Tamir/0000-0003-4194-7068	Israeli Ministry of Science, Technology, and Space; Binational Science Foundation; Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israel Science Foundation; Israeli Ministry of Science and Technology; US-Israel Binational Science Foundation	Israeli Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); Binational Science Foundation(US-Israel Binational Science Foundation); Edmond J. Safra Center for Bioinformatics at Tel Aviv University; Israel Science Foundation(Israel Science Foundation); Israeli Ministry of Science and Technology(Ministry of Science, Technology and Space (MOST), Israel); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	MM and TT are partially supported by research grants from the Israeli Ministry of Science, Technology, and Space, and the Binational Science Foundation. YZ is partially supported by a fellowship from the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The research of MM is also supported by a research grant from the Israel Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the anonymous referee for comments that greatly helped in improving this paper. The research of YZ is partially supported by the Edmond J. Safra Center for Bioinformatics at Tel Aviv University. The research of MM and TT is partially supported by research grants from the Israeli Ministry of Science and Technology, and the US-Israel Binational Science Foundation. The research of MM is also supported by a research grant from the Israel Science Foundation.	Alberts B, 2008, MOL BIOL CELL; Algar RJR, 2014, IEEE DECIS CONTR P, P5437, DOI 10.1109/CDC.2014.7040239; Aminzare Z, 2014, IEEE DECIS CONTR P, P3835, DOI 10.1109/CDC.2014.7039986; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Arcak M, 2011, AUTOMATICA, V47, P1219, DOI 10.1016/j.automatica.2011.01.010; Blythe RA, 2007, J PHYS A-MATH THEOR, V40, pR333, DOI 10.1088/1751-8113/40/46/R01; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; Chu D, 2014, EMBO J, V33, P21, DOI 10.1002/embj.201385651; Churchman LS, 2011, NATURE, V469, P368, DOI 10.1038/nature09652; Csikasz-Nagy A, 2011, J R SOC INTERFACE, V8, P480, DOI 10.1098/rsif.2010.0336; Dana A, 2015, G3-GENES GENOM GENET, V5, P73, DOI 10.1534/g3.114.015099; DESOER CA, 1972, IEEE T CIRCUITS SYST, VCT19, P480, DOI 10.1109/TCT.1972.1083507; Dixit R, 2008, SCIENCE, V319, P1086, DOI 10.1126/science.1152993; Edri S, 2014, IEEE T BIOMED CIRC S, V8, P54, DOI 10.1109/TBCAS.2013.2290063; Evans MR, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026117; Ezaki T, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/18/185002; Fisher ME, 1999, P NATL ACAD SCI USA, V96, P6597, DOI 10.1073/pnas.96.12.6597; Garcia-Meseguer MJ, 2003, B MATH BIOL, V65, P279, DOI 10.1016/S0092-8240(02)00096-4; Gilchrist MA, 2006, J THEOR BIOL, V239, P417, DOI 10.1016/j.jtbi.2005.08.007; Heldt FS, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2015.0107; Hooper SD, 2000, NUCLEIC ACIDS RES, V28, P3517, DOI 10.1093/nar/28.18.3517; JACQUEZ JA, 1993, SIAM REV, V35, P43, DOI 10.1137/1035003; JORGENSEN F, 1990, J MOL BIOL, V215, P511, DOI 10.1016/S0022-2836(05)80164-0; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Keiler KC, 2015, NAT REV MICROBIOL, V13, P285, DOI 10.1038/nrmicro3438; Kerner BS, 2013, EPL-EUROPHYS LETT, V102, DOI 10.1209/0295-5075/102/28010; Klumpp S, 2003, J STAT PHYS, V113, P233, DOI 10.1023/A:1025778922620; Klumpp S, 2009, RNA BIOL, V6, P392, DOI 10.4161/rna.6.4.8952; KURLAND CG, 1992, ANNU REV GENET, V26, P29, DOI 10.1146/annurev.ge.26.120192.000333; KURLAND CG, 1993, STARVATION BACTERIA, P225; Leduc C, 2012, P NATL ACAD SCI USA, V109, P6100, DOI 10.1073/pnas.1107281109; Lipowsky R, 2005, PHYSICA A, V352, P53, DOI 10.1016/j.physa.2004.12.034; Lipowsky R, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.108101; Lohmiller W, 1998, AUTOMATICA, V34, P683, DOI 10.1016/S0005-1098(98)00019-3; MARGALIOT M, 2012, EEE ACM T COMPUT BI, V9, P1724, DOI DOI 10.1109/TCBB.2012.120; Margaliot M, 2016, AUTOMATICA, V67, P178, DOI 10.1016/j.automatica.2016.01.018; Margaliot M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096039; Margaliot M, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0267; Margaliot M, 2012, IEEE ACM T COMPUT BI, V9, P1545, DOI 10.1109/TCBB.2012.88; Mierczynski J., 1991, C MATH, V62, P43, DOI DOI 10.4064/CM-62-1-43-47); Nudler E, 2012, CELL, V149, P1438, DOI 10.1016/j.cell.2012.06.003; Parmeggiani A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046101; Parmeggiani A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.086601; Poker G, 2015, SCI REP-UK, V5, DOI 10.1038/srep12795; Poker G, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0713; Raveh A, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2015.1062; Raveh A, 2015, IEEE ACM T COMPUT BI, V12, P1429, DOI 10.1109/TCBB.2015.2418782; Reuveni S, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002127; Russo G, 2013, IEEE T AUTOMAT CONTR, V58, P1328, DOI 10.1109/TAC.2012.2223355; Russo G, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000739; SANDBERG IW, 1978, IEEE T CIRCUITS SYST, V25, P273, DOI 10.1109/TCS.1978.1084473; Schadschneider A, 2011, STOCHASTIC TRANSPORT IN COMPLEX SYSTEMS: FROM MOLECULES TO VEHICLES, P1; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shaw LB, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.021910; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; SMILLIE J, 1984, SIAM J MATH ANAL, V15, P530, DOI 10.1137/0515040; Smith HL, 1995, PROVIDENCE RI AM MAT, V41; Subramaniam AR, 2014, CELL, V159, P1200, DOI 10.1016/j.cell.2014.10.043; Telley IA, 2009, BIOPHYS J, V96, P3341, DOI 10.1016/j.bpj.2009.01.015; Tuller T, 2015, NUCLEIC ACIDS RES, V43, P13, DOI 10.1093/nar/gku1313; Willmann RD, 2002, PHYSICA A, V316, P430, DOI 10.1016/S0378-4371(02)01217-7; Yonath A, 2012, MACROMOLECULAR CRYST, P195, DOI DOI 10.1007/978-94-007-2530-0_18; Zafrir Z, 2016, DNA RES, V23, P377, DOI 10.1093/dnares/dsw019; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zarai Y, 2017, IEEE ACM T COMPUTATI; Zarai Y, 2017, SCI REP, V7; Zarai Y, 2017, OPTIMAL TRANSLATION; Zarai Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166481; Zarai Y, 2013, IEEE ACM T COMPUT BI, V10, P1322, DOI 10.1109/TCBB.2013.120; Zhang G, 2010, NUCLEIC ACIDS RES, V38, P4778, DOI 10.1093/nar/gkq196; Zia RKP, 2011, J STAT PHYS, V144, P405, DOI 10.1007/s10955-011-0183-1; Zupanic A, 2014, RNA, V20, P1507, DOI 10.1261/rna.045286.114	76	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182178	10.1371/journal.pone.0182178	http://dx.doi.org/10.1371/journal.pone.0182178			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832591	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800016
J	Korza, G; Abini-Agbomson, S; Setlow, B; Shen, A; Setlow, P				Korza, George; Abini-Agbomson, Stephen; Setlow, Barbara; Shen, Aimee; Setlow, Peter			Levels of L-malate and other low molecular weight metabolites in spores of Bacillus species and Clostridium difficile	PLOS ONE			English	Article							BACTERIAL SPORULATION; MEGATERIUM SPORES; DIPICOLINIC ACID; AMINO-ACIDS; MOTHER CELL; GERMINATION; BETA-POLY(L-MALATE); FORESPORE; SUBTILIS	Dormant spores of Bacillus species lack ATP and NADH and contain notable levels of only a few other common low mol wt energy reserves, including 3-phosphoglyceric acid (3PGA), and glutamic acid. Recently, Bacillus subtilis spores were reported to contain similar to 30 mu mol of L-malate/g dry wt, which also could serve as an energy reserve. In present work, L-malate levels were determined in the core of dormant spores of B. subtilis, Bacillus cereus, Bacillus megaterium and Clostridium difficile, using both an enzymatic assay and C-13-NMR on extracts prepared by several different methods. These assays found that levels of L-malate in B. cereus and B. megaterium spores were <= 0.5 mu mol/g dry wt, and <= 1 mu mol/g dry wt in B. subtilis spores, and levels of L-lactate and pyruvate in B. megaterium and B. subtilis spores were < 0.5 mu mol/g dry wt. Levels of L-malate in C. difficile spores were <= 1 mu mol/g dry wt, while levels of 3PGA were similar to 7 mu mol/g; the latter value was determined by P-31-NMR, and is in between the 3PGA levels in B. megaterium and B. subtilis spores determined previously. C-13-NMR analysis of spore extracts further showed that B. megaterium, B. subtilis and C. difficile contained significant levels of carbonate/bicarbonate in the spore core. Low mol wt carbon-containing small molecules present at > 3 mu mol/g dry spores are: i) dipicolinic acid, carbonate/bicarbonate and 3PGA in B. megaterium, B. subtilis and C. difficile; ii) glutamate in B. megaterium and B. subtilis; iii) arginine in B. subtilis; and iv) at least one unidentified compound in all three species.	[Korza, George; Abini-Agbomson, Stephen; Setlow, Barbara; Setlow, Peter] UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA; [Shen, Aimee] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA	Tufts University	Setlow, P (corresponding author), UConn Hlth, Dept Mol Biol & Biophys, Farmington, CT 06030 USA.	setlow@nso2.uchc.edu		Abini-Agbomson, Stephen/0000-0003-0148-6498; Shen, Aimee/0000-0002-9786-5742	Short Term Innovative Research (STIR) from Army Research Office [W91NF-16-1-0024]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108684] Funding Source: NIH RePORTER	Short Term Innovative Research (STIR) from Army Research Office; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a Short Term Innovative Research (STIR) award to PS from the Army Research Office (www.arl.army.mil), and a research grant (W91NF-16-1-0024 to PS, also from the Army Research Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagyan I, 1998, GENE, V212, P179, DOI 10.1016/S0378-1119(98)00172-3; BERGERE JL, 1975, ANN INST PASTEUR MIC, VA126, P421; Camp AH, 2009, GENE DEV, V23, P1014, DOI 10.1101/gad.1781709; Clements MO, 1968, J BACTERIOL, V180, P1787; Doan T, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000566; FISCHER H, 1989, BIOCHEMISTRY-US, V28, P5219, DOI 10.1021/bi00438a045; Ghosh S, 2015, J BACTERIOL, V197, P992, DOI 10.1128/JB.02520-14; HAUSENBAUER JM, 1977, J BACTERIOL, V129, P1148, DOI 10.1128/JB.129.2.1148-1150.1977; HODSON PH, 1965, J BACTERIOL, V90, P1503, DOI 10.1128/JB.90.5.1503-.1965; Loshon CA, 2006, J BACTERIOL, V188, P3153, DOI 10.1128/JB.188.8.3153-3158.2006; LOSHON CA, 1993, CAN J MICROBIOL, V39, P259, DOI 10.1139/m93-036; Magge A, 2008, J BACTERIOL, V190, P4798, DOI 10.1128/JB.00477-08; Meisner J, 2008, P NATL ACAD SCI USA, V105, P15100, DOI 10.1073/pnas.0806301105; NELSON DL, 1970, J BIOL CHEM, V245, P1137; NELSON DL, 1970, J BIOL CHEM, V245, P1128; Nelson DL, 1969, SPORES 4, P59; Nicholson WL., 1990, MOL BIOL METHODS BAC, P391, DOI DOI 10.1111/J.1751-1097.1991.TB02087.X; Paidhungat M, 2000, J BACTERIOL, V182, P5505, DOI 10.1128/JB.182.19.5505-5512.2000; Paidhungat M., 2002, BACILLUS SUBTILIS IT, P537, DOI DOI 10.1128/9781555817992.CH37; PELEG Y, 1990, APPL ENVIRON MICROB, V56, P2777, DOI 10.1128/AEM.56.9.2777-2783.1990; PERRY JJ, 1956, J BACTERIOL, V72, P295, DOI 10.1128/JB.72.3.295-300.1956; Pinchai N, 2006, FEBS J, V273, P1046, DOI 10.1111/j.1742-4658.2006.05131.x; Schmidt A, 1996, EUR J CELL BIOL, V70, P373; SCOTT IR, 1978, BIOCHEM J, V174, P627, DOI 10.1042/bj1740627; Setlow B, 1996, J BACTERIOL, V178, P3486, DOI 10.1128/jb.178.12.3486-3495.1996; SETLOW B, 1977, J BACTERIOL, V132, P744, DOI 10.1128/JB.132.2.744-746.1977; SETLOW P, 1970, J BIOL CHEM, V245, P3637; Setlow P, 2013, J APPL MICROBIOL, V115, P1251, DOI 10.1111/jam.12343; SETLOW P, 1994, J APPL BACTERIOL, V76, pS49, DOI 10.1111/j.1365-2672.1994.tb04357.x; SETLOW P, 1975, J BIOL CHEM, V250, P623; SETLOW P, 1970, J BIOL CHEM, V245, P3645; Setlow P, 2012, FOOD MICROBIOLOGY FU, V4th, P45; Sinai L, 2015, MOL CELL, V57, P695, DOI 10.1016/j.molcel.2014.12.019; SINGH RP, 1977, J BACTERIOL, V130, P1130, DOI 10.1128/JB.130.3.1130-1138.1977; SZULMAJSTER JEKISIEL, 1965, P162; Wang SW, 2015, J BACTERIOL, V197, P2361, DOI 10.1128/JB.00200-15; Willibald B, 1999, EUR J BIOCHEM, V265, P1085, DOI 10.1046/j.1432-1327.1999.00834.x	37	5	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							e0182656	10.1371/journal.pone.0182656	http://dx.doi.org/10.1371/journal.pone.0182656			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE9SU	28850573	Green Published, gold, Green Submitted			2022-12-27	WOS:000408544200005
J	Ribeiro, PPC; Silva, DMD; de Assis, CF; Correia, RTP; Damasceno, KSFDC				Cabral Ribeiro, Penha Patricia; de Lima e Silva, Denise Maria; de Assis, Cristiane Fernandes; Pinto Correia, Roberta Targino; da Silva Chaves Damasceno, Karla Suzanne Florentino			Bioactive properties of faveleira (Cnidoscolus quercifolius) seeds, oil and press cake obtained during oilseed processing	PLOS ONE			English	Article							IN-VITRO ANTIOXIDANT; PHENOLIC-COMPOUNDS; ANTIMICROBIAL ACTIVITIES; FATTY-ACIDS; L.; CAPACITY; EXTRACTS; QUALITY; FLAX; IDENTIFICATION	To the best of our knowledge, this is the first report in the literature concerning the bioactive properties of faveleira products. This work focuses on the physicochemical evaluation of faveleira oil, as well as it investigates the bioactive properties of faveleira seeds, faveleira oil and the press cake obtained during the oilseed processing. The seeds were cold pressed and the following tests were performed: physicochemical characteristics (acidity, peroxide values, moisture and volatile matter, density and viscosity) and fatty acid profile of faveleira oil; total phenolic and flavonoid content of faveleira seed and press cake; antibacterial activity of seed, oil and press cake; and antioxidant activity (DPPH radical scavenging activity, reducing power assay, total antioxidant capacity, superoxide radical scavenging assay and oxygen radical absorbance capacity) of seed, oil and press cake. Our work demonstrated that the faveleira seed oil has low acidity (0.78 +/- 0.03% oleic acid) and peroxide value (1.13 +/- 0.12 mEq/1000g), associated with the relevant concentration of linoleic acid (53.56%). It was observed that important phenolics (398.89 +/- 6.34 mg EAG/100 g), especially flavonoids (29.81 +/- 0.71 mg RE/g) remain in the press cake, which indicates that the by-product of the faveleira oilseed production constitutes a rich residual source of bioactive compounds. No bacterial growth inhibition was detected, but all samples including faveleira seeds, press cake, oil and its fractions have potent antioxidant activities, mainly the press cake, with oxygen radical absorbance capacity of 28.39 +/- 4.36 mu M TE/g. Our results also show that faveleira oil has potential to be used as edible oil and the press cake should be used to contain the most antioxidants from seed.	[Cabral Ribeiro, Penha Patricia; de Lima e Silva, Denise Maria; da Silva Chaves Damasceno, Karla Suzanne Florentino] Univ Fed Rio Grande do Norte, Dept Nutr, Natal, Rio Grande Do N, Brazil; [de Assis, Cristiane Fernandes] Univ Fed Rio Grande do Norte, Sch Pharm, Natal, Rio Grande Do N, Brazil; [Pinto Correia, Roberta Targino] Univ Fed Rio Grande do Norte, Dept Chem Engn, Natal, Rio Grande Do N, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte	Ribeiro, PPC (corresponding author), Univ Fed Rio Grande do Norte, Dept Nutr, Natal, Rio Grande Do N, Brazil.	penhapatriciar@hotmail.com	Assis, Cristiane Fernandes de/AAY-9213-2021; Hoskin, Roberta/W-2785-2019	Assis, Cristiane Fernandes de/0000-0001-7595-5395; Hoskin, Roberta/0000-0003-0900-4983; Florentino da Silva Chaves Damasceno, Karla Suzanne/0000-0001-6884-1023; Cabral Ribeiro, Penha Patricia/0000-0002-4867-5248				Abu Bakar MF, 2009, FOOD CHEM, V113, P479, DOI 10.1016/j.foodchem.2008.07.081; Alves CQ, 2010, QUIM NOVA, V33, P2202, DOI 10.1590/S0100-40422010001000033; [Anonymous], 1994, FATS OILS HUM NUTR; AOCS, 2014, OFFICIAL METHODS REC; AOCS, 2003, OFFICIAL METHODS REC; Arranz S, 2008, EUR FOOD RES TECHNOL, V227, P425, DOI 10.1007/s00217-007-0737-2; Basu S, 2012, INDIAN J BIOCHEM BIO, V49, P115; Belhadj F, 2016, FOOD CHEM, V204, P29, DOI 10.1016/j.foodchem.2016.02.111; Chirinos R, 2013, FOOD CHEM, V141, P1732, DOI 10.1016/j.foodchem.2013.04.078; Christodouleas DC, 2015, FOOD ANAL METHOD, V8, P1294, DOI 10.1007/s12161-014-0005-6; Condelli N, 2015, FOOD CHEM, V177, P233, DOI 10.1016/j.foodchem.2015.01.001; Dasgupta N, 2004, FOOD CHEM, V88, P219, DOI 10.1016/j.foodchem.2004.01.036; Dorni C, 2017, FATTY ACID PROFILE E; Ferronatto Regina, 2007, Rev. bras. farmacogn., V17, P224, DOI 10.1590/S0102-695X2007000200016; Fujita A, 2013, FOOD RES INT, V54, P495, DOI 10.1016/j.foodres.2013.07.025; Ganske F., 2006, ORAC ASSAY FLUORSTAR; Gao F, 2016, J FOOD COMPOS ANAL, V45, P26, DOI 10.1016/j.jfca.2015.09.004; Candela CG, 2011, NUTR HOSP, V26, P323, DOI [10.1590/S0212-16112011000200013, 10.3305/nh.2011.26.2.5117]; Hartman L., 1973, Laboratory Practice, V22 [7] 475-476, P494; Islam T, 2016, LWT-FOOD SCI TECHNOL, V72, P423, DOI 10.1016/j.lwt.2016.05.005; Karaman S, 2015, J AGR FOOD CHEM, V63, P2305, DOI 10.1021/jf504390t; Kim J, 2010, FOOD CHEM, V118, P398, DOI 10.1016/j.foodchem.2009.05.011; Kumaran A, 2007, LWT-FOOD SCI TECHNOL, V40, P344, DOI 10.1016/j.lwt.2005.09.011; de Medeiros EJL, 2013, J THERM ANAL CALORIM, V112, P1515, DOI 10.1007/s10973-012-2653-3; Li X, 2014, J FOOD NUTR RES, V2, P244; Lopez-Huertas E, 2010, PHARMACOL RES, V61, P200, DOI 10.1016/j.phrs.2009.10.007; Paredes PF, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/7930563; Makni M, 2008, FOOD CHEM TOXICOL, V46, P3714, DOI 10.1016/j.fct.2008.09.057; Marques FG, 2015, REV BRAS FARMACOGN, V25, P522, DOI 10.1016/j.bjp.2015.07.019; Matthaus B, 2002, J AGR FOOD CHEM, V50, P3444, DOI 10.1021/jf011440s; Medeiros E, 2014, MOLECULES, V19, P992, DOI 10.3390/molecules19010992; Mohamed AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060269; National Committee for Clinical Laboratory Standards, 2009, PERF STAND ANT DISK; Nobrega EM, 2014, J FOOD PROCESS PRES, P1; Ribeiro SAO, 2016, LWT-FOOD SCI TECHNOL, V65, P464, DOI 10.1016/j.lwt.2015.08.053; Ogbunugafor H. A., 2011, Pakistan Journal of Nutrition, V10, P409; Onivogui G, 2016, ASIAN PAC J TROP BIO, V6, P20, DOI 10.1016/j.apjtb.2015.09.023; Sobrinho TJSP, 2011, AFR J PHARM PHARMACO, V5, P2310, DOI 10.5897/AJPP11.608; Perez-Jimenez J, 2006, FOOD RES INT, V39, P791, DOI 10.1016/j.foodres.2006.02.003; do Prado ACP, 2013, IND CROP PROD, V45, P64, DOI 10.1016/j.indcrop.2012.11.042; Raj CA, 2012, CHIN J NAT MEDICINES, V10, P263, DOI 10.3724/SP.J.1009.2012.00263; Roleira FMF, 2015, FOOD CHEM, V183, P235, DOI 10.1016/j.foodchem.2015.03.039; Santos JCO, 2005, J THERM ANAL CALORIM, V79, P271, DOI 10.1007/s10973-005-0048-4; Santoso H, 2014, PROCEDIA CHEM, V9, P248, DOI 10.1016/j.proche.2014.05.030; Saravanan S, 2014, FOOD SCI HUM WELL, V3, P56, DOI DOI 10.1016/J.FSHW.2014.05.001; Schmidt S, 2005, CZECH J FOOD SCI, V23, P93, DOI 10.17221/3377-CJFS; Shahidi F, 2015, J FUNCT FOODS, V18, P757, DOI 10.1016/j.jff.2015.01.047; Silva SI, 2014, BIOMASS BIOENERG, V69, P124, DOI 10.1016/j.biombioe.2014.07.010; Slatnar A, 2014, FOOD RES INT, V64, P783, DOI 10.1016/j.foodres.2014.08.009; Souza BB, 2012, AGROPECUARIA CIENTIF, V8, P1; Tabart J, 2009, FOOD CHEM, V113, P1226, DOI 10.1016/j.foodchem.2008.08.013; Teh SS, 2015, FOOD CHEM, V187, P460, DOI 10.1016/j.foodchem.2015.04.043; Teh SS, 2013, J FOOD COMPOS ANAL, V30, P26, DOI 10.1016/j.jfca.2013.01.004; Thanonkaew A, 2012, LWT-FOOD SCI TECHNOL, V48, P231, DOI 10.1016/j.lwt.2012.03.018; Wang J, 2008, INT J BIOL MACROMOL, V42, P127, DOI 10.1016/j.ijbiomac.2007.10.003; Yang J, 2009, LWT-FOOD SCI TECHNOL, V42, P1, DOI 10.1016/j.lwt.2008.07.007	56	14	16	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0183935	10.1371/journal.pone.0183935	http://dx.doi.org/10.1371/journal.pone.0183935			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846740	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600058
J	Caparros-Gonzalez, RA; Romero-Gonzalez, B; Strivens-Vilchez, H; Gonzalez-Perez, R; Martinez-Augustin, O; Peralta-Ramirez, MI				Caparros-Gonzalez, Rafael A.; Romero-Gonzalez, Borja; Strivens-Vilchez, Helen; Gonzalez-Perez, Raquel; Martinez-Augustin, Olga; Isabel Peralta-Ramirez, Maria			Hair cortisol levels, psychological stress and psychopathological symptoms as predictors of postpartum depression	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; POSTNATAL DEPRESSION; SPANISH VERSION; PREGNANCY; RISK; ANXIETY; SCALE; DYSREGULATION; VALIDATION; DISTRESS	Postpartum depression affects a huge number of women and has detrimental consequences. Knowing the factors associated with postpartum depression during pregnancy can help its prevention. Although there is evidence surrounding behavioral or psychological predictors of postpartum depression, there is a lack of evidence of biological forecasters. The aim of this study was to analyze the sociodemographic, obstetric, and psychological variables along with hair cortisol levels during the first, second, and third trimesters of pregnancy that could predict postpartum depression symptoms. A sample of 44 pregnant women was assessed during 3 trimesters of pregnancy and the postpartum period using psychological questionnaires and hair cortisol levels. Participants were divided into 2 groups: a group with postpartum depression symptoms and a group with no postpartum depression symptoms. Results showed significant positive differences between groups in the first trimester regarding the Somatization subscale of the SCL-90-R (p<.05). In the second trimester, significant differences were found in the Somatization, Depression, Anxiety, and GSI subscales (p<.05). In the third trimester significant differences between both groups were found regarding pregnancy-specific stress. We found significant positive differences between groups regarding hair cortisol levels in the first and the third trimester. Hair cortisol levels could predict 21.7% of the variance of postpartum depression symptoms. In conclusion, our study provided evidence that psychopathological symptoms, pregnancy-specific stress, and hair cortisol levels can predict postpartum depression symptoms at different time-points during pregnancy. These findings can be applied in future studies and improve maternal care in clinical settings.	[Caparros-Gonzalez, Rafael A.; Romero-Gonzalez, Borja; Isabel Peralta-Ramirez, Maria] Univ Granada, Fac Psychol, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain; [Caparros-Gonzalez, Rafael A.] Hosp Poniente, Dept Gynecol & Obstet, El Ejido, Spain; [Strivens-Vilchez, Helen] Gongora Primary Hlth Ctr, Midwifery Dept, Granada, Spain; [Gonzalez-Perez, Raquel] Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Dept Pharmacol, CIBERehd,Sch Pharm, Granada, Spain; [Martinez-Augustin, Olga] Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Dept Biochem & Mol Biol 2, CIBERehd,Sch Pharm, Granada, Spain	University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada	Caparros-Gonzalez, RA; Romero-Gonzalez, B (corresponding author), Univ Granada, Fac Psychol, Brain Mind & Behav Res Ctr CIMCYC, Granada, Spain.; Caparros-Gonzalez, RA (corresponding author), Hosp Poniente, Dept Gynecol & Obstet, El Ejido, Spain.; Gonzalez-Perez, R (corresponding author), Univ Granada, Inst Invest Biosanitaria Ibs GRANADA, Dept Pharmacol, CIBERehd,Sch Pharm, Granada, Spain.	rcg477@correo.ugr.es; borjaps@correo.ugr.es; raquel.gonzalez@ciberehd.or	Peralta, Maria Isabel MI/I-3920-2015; Caparros-Gonzalez, Rafael A./P-1519-2015; Romero-Gonzalez, Borja/ABF-5918-2020; Augustin, Olga Martínez/K-6720-2014; Romero-Gonzalez, Borja/X-7551-2018	Peralta, Maria Isabel MI/0000-0001-8201-8906; Caparros-Gonzalez, Rafael A./0000-0002-0565-1123; Romero-Gonzalez, Borja/0000-0002-6350-1836; Augustin, Olga Martínez/0000-0001-8291-3468; Romero-Gonzalez, Borja/0000-0002-6350-1836	Spanish Ministry of Science and Innovation [PSI2015-63494-P]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study is a part of a Doctoral Thesis and was supported by the I+D Project "PSI2015-63494-P" of the Spanish Ministry of Science and Innovation. URL of the funder's website: http://panwww.idi.mineco.gob.es/portal/site/MICINNI/menuitem.00d7c011ca2a3753222b7d1001432ea0/?vgnextoid=33881f4368aef110VgnVCM1000001034e20aRCRD. The funder's role was providing funding for data collection and analysis, and preparation of the manuscript.	Abell JG, 2016, PSYCHONEUROENDOCRINO, V73, P148, DOI 10.1016/j.psyneuen.2016.07.214; Alderdice F, 2013, J REPROD INFANT PSYC, V31, P431, DOI 10.1080/02646838.2013.835039; Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; Andalusian Ministry of Health, 2010, PREGNANCY HEALTH DOC; Andy Field, 2009, DISCOVERING STAT USI; Becker M, 2016, CURR PSYCHIAT REP, V18, DOI 10.1007/s11920-016-0664-7; Bergink V, 2011, J PSYCHOSOM RES, V70, P385, DOI 10.1016/j.jpsychores.2010.07.008; Bergman K, 2010, BIOL PSYCHIAT, V67, P1026, DOI 10.1016/j.biopsych.2010.01.002; BOYCE P, 1993, AUST NZ J PSYCHIAT, V27, P472, DOI 10.3109/00048679309075805; Braig S, 2016, PAEDIATR PERINAT EP, V30, P97, DOI 10.1111/ppe.12255; Caparros-Caparros B, 2007, INT J CLIN HLTH PSYC, V7, P781; Caparros-Gonzalez RA, 2015, J REPROD INFANT PSYC, V33, pE36; Chen Z, 2013, J CHROMATOGR B, V929, P187, DOI 10.1016/j.jchromb.2013.04.026; Clout D, 2015, J AFFECT DISORDERS, V188, P60, DOI 10.1016/j.jad.2015.08.054; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; D'Anna-Hernandez KL, 2011, PHYSIOL BEHAV, V104, P348, DOI 10.1016/j.physbeh.2011.02.041; de Rezende MG, 2016, J AFFECT DISORDERS, V193, P249, DOI 10.1016/j.jad.2015.12.065; Derogatis L. R., 1975, SCL 90 R ADM SCORING; Diego MA, 2004, PSYCHIATRY, V67, P63, DOI 10.1521/psyc.67.1.63.31251; Duthie L, 2013, NEUROENDOCRINOLOGY, V98, P106, DOI 10.1159/000354702; Fan FL, 2009, INT J GYNECOL OBSTET, V105, P46, DOI 10.1016/j.ijgo.2008.12.001; Figueiredo B, 2009, ARCH WOMEN MENT HLTH, V12, P143, DOI 10.1007/s00737-009-0059-4; Garcia-Esteve L, 2003, J AFFECT DISORDERS, V75, P71, DOI 10.1016/S0165-0327(02)00020-4; Glynn LM, 2013, NEUROPEPTIDES, V47, P363, DOI 10.1016/j.npep.2013.10.007; HARRIS B, 1989, BRIT J PSYCHIAT, V154, P813, DOI 10.1192/bjp.154.6.813; Iliadis SI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135471; Institutional Review Board (IRB). Office for Human Research Protection, 2016, INF CONS ASS CAP CON; Jolley SN, 2007, BIOL RES NURS, V8, P210, DOI 10.1177/1099800406294598; Katon W, 2014, J WOMENS HEALTH, V23, P753, DOI 10.1089/jwh.2014.4824; Leigh B, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-24; Lobel M., 2016, ENCY MENTAL HLTH, V3, P318, DOI [DOI 10.1016/B978-0-12-397045-9.00164-6, 10.1016/B978-0-12-397045-9.00164-6]; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; Maroto-Navarro G, 2005, INT J CLIN HLTH PSYC, V5, P305, DOI DOI 10.1016/J.JAD.2010.01.069; Mastorakos G, 2003, ANN NY ACAD SCI, V997, P136, DOI 10.1196/annals.1290.016; Meyer J, 2014, JOVE-J VIS EXP, DOI 10.3791/50882; Milgrom J, 2008, J AFFECT DISORDERS, V108, P147, DOI 10.1016/j.jad.2007.10.014; Milgrom J, 2011, J AFFECT DISORDERS, V130, P385, DOI 10.1016/j.jad.2010.10.045; National Institute for Health and Care Excelence, 2016, ANT POSTN MENT HLTH; Nierop A, 2006, PSYCHOSOM MED, V68, P931, DOI 10.1097/01.psy.0000244385.93141.3b; O'Hara MW, 2013, ANNU REV CLIN PSYCHO, V9, P379, DOI 10.1146/annurev-clinpsy-050212-185612; Ramirez FP, 2013, J TRANSCULT NURS, V24, P348, DOI 10.1177/1043659613493328; Perez-Ramirez F, 2016, J REPROD INFANT PSYC; Puente C, 2016, HEALTH CARE WOMEN IN, V37, P97; Putnam K, 2015, LANCET PSYCHIAT, V2, P59, DOI 10.1016/S2215-0366(14)00055-8; Remor E, 2006, SPAN J PSYCHOL, V9, P86, DOI 10.1017/S1138741600006004; Reuland DS, 2009, ANN FAM MED, V7, P455, DOI 10.1370/afm.981; Robertson E, 2004, GEN HOSP PSYCHIAT, V26, P289, DOI 10.1016/j.genhosppsych.2004.02.006; Russell E, 2015, THER DRUG MONIT, V37, P71, DOI 10.1097/FTD.0000000000000148; Saligheh M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00597; Sandman C.A., 2016, FETAL DEV, P229, DOI [10.1007/978-3-319-22023-9_13, DOI 10.1007/978-3-319-22023-9_13]; Sauve B, 2007, CLIN INVEST MED, V30, pE183, DOI 10.25011/cim.v30i5.2894; Schetter CD, 2012, CURR OPIN PSYCHIATR, V25, P141, DOI 10.1097/YCO.0b013e3283503680; Scheyer K, 2016, ARCH WOMEN MENT HLTH, V19, P317, DOI 10.1007/s00737-015-0563-7; Senturk MB, 2016, J MATERN-FETAL NEO M, P1; Seth S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0915-y; Sockol LE, 2013, CLIN PSYCHOL REV, V33, P1205, DOI 10.1016/j.cpr.2013.10.004; Stalder T, 2012, BRAIN BEHAV IMMUN, V26, P1019, DOI 10.1016/j.bbi.2012.02.002; Suhitharan T, 2016, NEUROPSYCH DIS TREAT, V12, P1333, DOI 10.2147/NDT.S105918; Turkcapar AF, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0532-1; Vanston CM, 2005, NEUROREPORT, V16, P779, DOI 10.1097/00001756-200505120-00024; Vliegen N, 2014, HARVARD REV PSYCHIAT, V22, P1, DOI 10.1097/HRP.0000000000000013; Wikenius E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161804; Wosu AC, 2013, ANN EPIDEMIOL, V23, P797, DOI 10.1016/j.annepidem.2013.09.006; Yali AM, 1999, J PSYCHOSOM OBST GYN, V20, P39, DOI 10.3109/01674829909075575; Yim IS, 2015, ANNU REV CLIN PSYCHO, V11, P99, DOI 10.1146/annurev-clinpsy-101414-020426	66	79	80	2	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182817	10.1371/journal.pone.0182817	http://dx.doi.org/10.1371/journal.pone.0182817			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE8EO	28846691	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600015
J	DeMatteo, KE; Rinas, MA; Zurano, JP; Selleski, N; Schneider, RG; Arguelles, CF				DeMatteo, Karen E.; Rinas, Miguel A.; Pablo Zurano, Juan; Selleski, Nicole; Schneider, Rosio G.; Arguelles, Carina F.			Using niche-modelling and species-specific cost analyses to determine a multispecies corridor in a fragmented landscape	PLOS ONE			English	Article							JAGUARS PANTHERA-ONCA; PUMAS PUMA-CONCOLOR; ATLANTIC FOREST; DETECTION DOGS; CONSERVATION; CONNECTIVITY; SELECTION; PREDICTION; DISTRIBUTIONS; POPULATIONS	Misiones, Argentina, contains the largest remaining tract of Upper Parana A Atlantic Forest ecoregion; however, similar to 50% of native forest is unprotected and located in a mosaic of plantations, agriculture, and pastures. Existing protected areas are becoming increasingly isolated due to ongoing habitat modification. These factors, combined with lower than expected regional carnivore densities, emphasize the need to understand the effect of fragmentation on animal movement and connectivity between protected areas. Using detection dogs and genetic analyses of scat, we collected data on jaguars (Panthera onca), pumas (Puma concolor), ocelots (Leopardus pardalis), oncillas (Leopardus tigrinus), and bush dogs (Speothos venaticus) across habitats that varied in vegetation, disturbance, human proximity, and protective status. With MaxEnt we evaluated habitat use, habitat suitability, and potential species richness for the five carnivores across northern-central Misiones, Argentina. Through a multifaceted cost analysis that included unique requirements of each carnivore and varying degrees of overlap among them, we determined the optimal location for primary/secondary corridors that would link the northern-central zones of the Green Corridor in Misiones and identified areas within these corridors needing priority management. A secondary analysis, comparing these multispecies corridors with the jaguar's unique requirements, demonstrated that this multispecies approach balanced the preferences of all five species and effectively captured areas required by this highly restricted and endangered carnivore. We emphasize the potential importance of expanding beyond a single umbrella or focal species when developing biological corridors that aim to capture the varied ecological requirementsof coexisting species and ecological processes across the landscape. Detection dogs and genetic analyses of scat allow data on multiple species to be collected efficiently across multiple habitat types independent of the degree of legal protection. These data used with multi-focal GIS analyses balance the varying degree of overlap and unique properties among them allowing for comprehensive conservation strategies to be developed relatively rapidly. Our comprehensive approach serves as a model to other regions faced with habitat loss and lack of data. The five carnivores focused on in our study have wide ranges, so the results from this study can be expanded and combined with surrounding countries, with analyses at the species or community level.	[DeMatteo, Karen E.] Washington Univ, Dept Biol & Environm Studies, St Louis, MO 63130 USA; [DeMatteo, Karen E.] St Louis Zoo, WildCare Inst, St Louis, MO 63110 USA; [DeMatteo, Karen E.] Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA; [Rinas, Miguel A.] Minist Ecol & Recursos Nat Renovables, Posadas, Misiones, Argentina; [Pablo Zurano, Juan; Selleski, Nicole; Schneider, Rosio G.; Arguelles, Carina F.] Univ Nacl Misiones UNaM, Fac Ciencias Exactas Quim & Nat, Dept Genet, Posadas, Misiones, Argentina; [Arguelles, Carina F.] UNaM CONICET, GIGA, IBS Nodo Posadas, Posadas, Misiones, Argentina; [Pablo Zurano, Juan] Univ Fed Paraiba, Programa Posgrad Ciencias Bio, Joao Pessoa, Paraiba, Brazil; [Selleski, Nicole] Univ Brasilia, Fac Ciencias Saude, Campus Darcy Ribeiro, Brasilia, DF, Brazil; [Schneider, Rosio G.] IBS Nodo Posadas, Lab Genet Evolut, Posadas, Misiones, Argentina	Washington University (WUSTL); University of Missouri System; University of Missouri Columbia; Universidade Federal da Paraiba; Universidade de Brasilia	DeMatteo, KE (corresponding author), Washington Univ, Dept Biol & Environm Studies, St Louis, MO 63130 USA.; DeMatteo, KE (corresponding author), St Louis Zoo, WildCare Inst, St Louis, MO 63110 USA.; DeMatteo, KE (corresponding author), Univ Missouri, Div Biol Sci, Columbia, MO 65211 USA.	kdematteo@aol.com	Zurano, Juan Pablo Pablo/I-5294-2016	Zurano, Juan Pablo Pablo/0000-0003-4201-4366; Schneider, Rosio Gabriela/0000-0001-9245-6512	Conservation, Food, & Health Foundation; National Geographic Society Conservation Trust; Palm Beach Zoo Conservation Fund; University of Missouri-St. Louis; Zoological Gardens of Chester North of England Zoological Society Conservation and Research Fund; Jaguar Conservation Fund Woodland Park Zoo; Phoenix Zoo Conservation & Science Program; Fresno Chaffee Zoo Wildlife Conservation Fund; Kickstarter Fund; Paris Zoo; Riverbanks Conservation Support Fund	Conservation, Food, & Health Foundation; National Geographic Society Conservation Trust(National Geographic Society); Palm Beach Zoo Conservation Fund; University of Missouri-St. Louis; Zoological Gardens of Chester North of England Zoological Society Conservation and Research Fund; Jaguar Conservation Fund Woodland Park Zoo; Phoenix Zoo Conservation & Science Program; Fresno Chaffee Zoo Wildlife Conservation Fund; Kickstarter Fund; Paris Zoo; Riverbanks Conservation Support Fund	Funding was provided by the Conservation, Food, & Health Foundation, National Geographic Society Conservation Trust, the Palm Beach Zoo Conservation Fund, a University of Missouri-St. Louis Research Award, the Zoological Gardens of Chester North of England Zoological Society Conservation and Research Fund, the Jaguar Conservation Fund Woodland Park Zoo, Phoenix Zoo Conservation & Science Program, Fresno Chaffee Zoo Wildlife Conservation Fund, Kickstarter Fund, Paris Zoo, and Riverbanks Conservation Support Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], AICHI BIODIVERSITY T; Beier P, 2008, CONSERV BIOL, V22, P836, DOI 10.1111/j.1523-1739.2008.00942.x; Beier P, 2009, ECOL APPL, V19, P2067, DOI 10.1890/08-1898.1; Bissonette JA, 2008, BIOL CONSERV, V141, P482, DOI 10.1016/j.biocon.2007.10.019; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Brodie JF, 2015, CONSERV BIOL, V29, P122, DOI 10.1111/cobi.12337; Brost BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048965; Bruner AG, 2004, BIOSCIENCE, V54, P1119, DOI 10.1641/0006-3568(2004)054[1119:FCASOM]2.0.CO;2; de Azevedo FCC, 2007, BIOL CONSERV, V137, P391, DOI 10.1016/j.biocon.2007.02.022; Chetkiewicz CLB, 2009, J APPL ECOL, V46, P1036, DOI 10.1111/j.1365-2664.2009.01686.x; Clevenger AP, 2005, BIOL CONSERV, V121, P453, DOI 10.1016/j.biocon.2004.04.025; Cullen Junior L., 2005, Natureza & Conservacao, V3, P43; Cushman SA, 2009, CONSERV BIOL, V23, P368, DOI 10.1111/j.1523-1739.2008.01111.x; De Angelo C, 2013, BIOL CONSERV, V159, P422, DOI 10.1016/j.biocon.2012.12.021; De Angelo C, 2011, DIVERS DISTRIB, V17, P422, DOI 10.1111/j.1472-4642.2011.00746.x; de la Sancha NU, 2014, DIVERS DISTRIB, V20, P1058, DOI 10.1111/ddi.12210; DeMatteo KE, 2014, WILDLIFE SOC B, V38, P862, DOI 10.1002/wsb.474; DeMatteo KE, 2014, INTEGR ZOOL, V9, P623, DOI 10.1111/1749-4877.12113; Dematteo KE, 2009, J WILDLIFE MANAGE, V73, P1436, DOI 10.2193/2008-545; Di Bitetti MS, 2010, ACTA OECOL, V36, P403, DOI 10.1016/j.actao.2010.04.001; Di Bitetti MS, 2013, JORNADAS PROYECTOS I, V2013, P1; Dilkina B, 2017, CONSERV BIOL, V31, P192, DOI 10.1111/cobi.12814; Dixon JD, 2006, CONSERV BIOL, V20, P155, DOI 10.1111/j.1523-1739.2005.00292.x; Duan RY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112764; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Farrell LE, 2000, MOL ECOL, V9, P1583, DOI 10.1046/j.1365-294x.2000.01037.x; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fuller T, 2006, BIOL CONSERV, V133, P131, DOI 10.1016/j.biocon.2006.04.040; Gilbert-Norton L, 2010, CONSERV BIOL, V24, P660, DOI 10.1111/j.1523-1739.2010.01450.x; Goulart FVB, 2009, MAMM BIOL, V74, P182, DOI 10.1016/j.mambio.2009.02.006; Haag T, 2010, MOL ECOL, V19, P4906, DOI 10.1111/j.1365-294X.2010.04856.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; Izquierdo AE, 2008, ECOL SOC, V13; Izquierdo AE, 2012, FORESTS, V3, P764, DOI 10.3390/f3030764; Kolowski JM, 2008, BIOL CONSERV, V141, P1119, DOI 10.1016/j.biocon.2008.02.011; Krosby M, 2015, LANDSCAPE ECOL, V30, P2121, DOI 10.1007/s10980-015-0235-z; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; Lima ED, 2012, WILDLIFE RES, V39, P512, DOI 10.1071/WR11176; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Long RA, 2009, J WILDLIFE MANAGE, V73, P294, DOI 10.2193/2008-052; Mcrae BH, 2007, P NATL ACAD SCI USA, V104, P19885, DOI 10.1073/pnas.0706568104; Miotto RA, 2007, BIOTROPICA, V39, P647, DOI 10.1111/j.1744-7429.2007.00315.x; Nikolakaki P, 2004, LANDSCAPE URBAN PLAN, V68, P77, DOI 10.1016/S0169-2046(03)00167-1; Oliveira T.G., 2010, BIOL CONSERVATION WI, P559; Parks SA, 2013, CONSERV BIOL, V27, P145, DOI 10.1111/j.1523-1739.2012.01929.x; Paviolo A, 2008, ORYX, V42, P554, DOI 10.1017/S0030605308000641; Paviolo A, 2009, J MAMMAL, V90, P926, DOI 10.1644/08-MAMM-A-128.1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2008, ECOL APPL, V18, P1200, DOI 10.1890/07-0507.1; Rabinowitz A, 2010, BIOL CONSERV, V143, P939, DOI 10.1016/j.biocon.2010.01.002; Ray N, 2002, BIODIVERS CONSERV, V11, P2143, DOI 10.1023/A:1021390527698; Rayfield B, 2010, LANDSCAPE ECOL, V25, P519, DOI 10.1007/s10980-009-9436-7; Santini L, 2016, DIVERS DISTRIB, V22, P199, DOI 10.1111/ddi.12390; Sawyer SC, 2011, J APPL ECOL, V48, P668, DOI 10.1111/j.1365-2664.2011.01970.x; Schiaffino K, 2011, PLAN ACCIO N CONSERV; Schmidt-Soltau K, 2007, WORLD DEV, V35, P2182, DOI 10.1016/j.worlddev.2007.02.008; Simberloff D, 1998, BIOL CONSERV, V83, P247, DOI 10.1016/S0006-3207(97)00081-5; Skov F, 1997, ECOGRAPHY, V20, P347, DOI 10.1111/j.1600-0587.1997.tb00379.x; Sunquist M, 2002, WILD CATS WORLD, P252; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Trisurat Y, 2012, J NAT CONSERV, V20, P264, DOI 10.1016/j.jnc.2012.05.002; Vynne C, 2010, THESIS; Vynne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028939	67	15	15	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183648	10.1371/journal.pone.0183648	http://dx.doi.org/10.1371/journal.pone.0183648			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841692	gold, Green Published, Green Submitted			2022-12-27	WOS:000408370700047
J	Sciezynska, A; Ruszkowska, E; Szulborski, K; Rydz, K; Wierzbowska, J; Kosinska, J; Rekas, M; Ploski, R; Szaflik, JP; Oldak, M				Sciezynska, Aneta; Ruszkowska, Ewelina; Szulborski, Kamil; Rydz, Katarzyna; Wierzbowska, Joanna; Kosinska, Joanna; Rekas, Marek; Ploski, Rafal; Szaflik, Jacek Pawel; Oldak, Monika			Processing of OPA1 with a novel N-terminal mutation in patients with autosomal dominant optic atrophy: Escape from nonsense-mediated decay	PLOS ONE			English	Article							MESSENGER-RNA DECAY; TRANSCRIPTS; GENE; PENETRANCE; NEUROPATHY; EXPRESSION; FAMILIES; DISEASE; CODONS	Autosomal Dominant Optic Atrophy (ADOA) is the most common dominantly inherited optic neuropathy. In the majority of patients it is caused by OPA1 mutations and those predicted to introduce a premature termination codon (PTC) are frequently detected. Transcripts containing PTC may be degraded by nonsense-mediated mRNA decay (NMD), however very little is known about an effect of OPA1 mutations on NMD activation. Here, using a combination of linkage analysis and DNA sequencing, we have identified a novel c. 91C>T OPA1 mutation with a putative premature stop codon (Q31*), which segregated with ADOA in two Polish families. At the mRNA level we found no changes in the amount of OPA1 transcript among mutation carriers vs. non-carriers. Specific allele quantification revealed a considerable level of the OPA1 mutant transcript. Our study identifies a novel pathogenic OPA1 mutation and shows that it is located in the transcript region not prone for NMD activation. The data emphasizes the importance of analyzing how mutated genes are being processed in the cell. This gives an insight into the molecular mechanism of a genetic disease and promotes development of innovative therapeutic approaches.	[Sciezynska, Aneta; Ruszkowska, Ewelina; Rydz, Katarzyna; Oldak, Monika] Med Univ Warsaw, Dept Histol & Embryol, Warsaw, Poland; [Szulborski, Kamil; Szaflik, Jacek Pawel] Med Univ Warsaw, Dept Ophthalmol, Warsaw, Poland; [Wierzbowska, Joanna; Rekas, Marek] Mil Inst Med, Dept Ophthalmol, Warsaw, Poland; [Kosinska, Joanna; Ploski, Rafal] Med Univ Warsaw, Dept Med Genet, Warsaw, Poland	Medical University of Warsaw; Medical University of Warsaw; Military Institute of Aviation Medicine; Medical University of Warsaw	Oldak, M (corresponding author), Med Univ Warsaw, Dept Histol & Embryol, Warsaw, Poland.	monika.oldak@wum.edu.pl	Ścieżyńska, Aneta/AAA-3378-2022	Kosinska, Joanna/0000-0003-3767-6584; Oldak, Monika/0000-0002-4216-9141; Machnicka, Katarzyna/0000-0003-2357-6742; Rekas, Marek/0000-0003-0429-6649; Ploski, Rafal/0000-0001-6286-5526; Sciezynska, Aneta/0000-0003-0438-2678; Wierzbowska, Joanna/0000-0002-6993-7518	Narodowe Centrum Nauki (National Science Center of Poland, NCN) [N N402 591540 (5915/B/P01/2011/40)]	Narodowe Centrum Nauki (National Science Center of Poland, NCN)	The work was supported by Narodowe Centrum Nauki (National Science Center of Poland, NCN) grant no. N N402 591540 (5915/B/P01/2011/40)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amati-Bonneau P, 2005, ANN NEUROL, V58, P958, DOI 10.1002/ana.20681; Barbosa C, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003529; Cohen L, 2016, GENET RES, V98, DOI 10.1017/S0016672316000070; Cohn AC, 2007, AM J OPHTHALMOL, V143, P656, DOI 10.1016/j.ajo.2006.12.038; Ferre M, 2009, HUM MUTAT, V30, pE692, DOI 10.1002/humu.21025; Fuhrmann N, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-25; Harries LW, 2004, DIABETES, V53, P500, DOI 10.2337/diabetes.53.2.500; Keeling KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060478; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Nguyen LS, 2014, NEUROSCI BIOBEHAV R, V46, P175, DOI 10.1016/j.neubiorev.2013.10.016; Lenaers G, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-46; Li Y, 2008, MOL VIS, V14, P2451; Miller JN, 2014, MUTAT RES-REV MUTAT, V762, P52, DOI 10.1016/j.mrrev.2014.05.001; Neu-Yilik G, 2008, ADV GENET, V62, P185, DOI 10.1016/S0065-2660(08)00604-4; Nyiko T, 2009, PLANT MOL BIOL, V71, P367, DOI 10.1007/s11103-009-9528-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ranieri M, 2012, J NEUROL SCI, V315, P146, DOI 10.1016/j.jns.2011.12.002; Rodningen OK, 1999, HUM MUTAT, V13, P186, DOI 10.1002/(SICI)1098-1004(1999)13:3<186::AID-HUMU2>3.0.CO;2-K; Schimpf S, 2008, HUM MUTAT, V29, P106, DOI 10.1002/humu.20607; Schrijver I, 2002, AM J HUM GENET, V71, P223, DOI 10.1086/341581; Silva AL, 2006, RNA, V12, P2160, DOI 10.1261/rna.201406; Skidd PM, 2013, SEMIN OPHTHALMOL, V28, P422, DOI 10.3109/08820538.2013.825296; Toomes C, 2001, HUM MOL GENET, V10, P1369, DOI 10.1093/hmg/10.13.1369; Yu-Wai-Man P, 2010, BRAIN, V133, P771, DOI 10.1093/brain/awq007	24	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183866	10.1371/journal.pone.0183866	http://dx.doi.org/10.1371/journal.pone.0183866			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841713	Green Published, gold, Green Submitted			2022-12-27	WOS:000408370700065
J	An, XY; Sendra, VG; Liadi, I; Ramesh, B; Romain, G; Haymaker, C; Martinez-Paniagua, M; Lu, YB; Radvanyi, LG; Roysam, B; Varadarajan, N				An, Xingyue; Sendra, Victor G.; Liadi, Ivan; Ramesh, Balakrishnan; Romain, Gabrielle; Haymaker, Cara; Martinez-Paniagua, Melisa; Lu, Yanbin; Radvanyi, Laszlo G.; Roysam, Badrinath; Varadarajan, Navin			Single-cell profiling of dynamic cytokine secretion and the phenotype of immune cells	PLOS ONE			English	Article							CD8(+) T-CELLS; NK CELLS; INTERFERON-GAMMA; TUMOR-CELLS; IFN-GAMMA; ACTIVATION; DIFFERENTIATION; HETEROGENEITY; INHIBITION; RESISTANCE	Natural killer (NK) cells are a highly heterogeneous population of innate lymphocytes that constitute our first line of defense against several types of tumors and microbial infections. Understanding the heterogeneity of these lymphocytes requires the ability to integrate their underlying phenotype with dynamic functional behaviors. We have developed and validated a single-cell methodology that integrates cellular phenotyping and dynamic cytokine secretion based on nanowell arrays and bead-based molecular biosensors. We demonstrate the robust passivation of the polydimethylsiloxane (PDMS)-based nanowells arrays with polyethylene glycol (PEG) and validated our assay by comparison to enzyme-linked immunospot (ELISPOT) assays. We used numerical simulations to optimize the molecular density of antibodies on the surface of the beads as a function of the capture efficiency of cytokines within an open-well system. Analysis of hundreds of individual human peripheral blood NK cells profiled ex vivo revealed that CD56(dim)CD16(+) NK cells are immediate secretors of interferon gamma (IFN-gamma) upon activation by phorbol 12-myristate 13-acetate (PMA) and iono-mycin (< 3 h), and that there was no evidence of cooperation between NK cells leading to either synergistic activation or faster IFN-gamma secretion. Furthermore, we observed that both the amount and rate of IFN-gamma secretion from individual NK cells were donor-dependent. Collectively, these results establish our methodology as an investigational tool for combining phenotyping and real-time protein secretion of individual cells in a high-throughput manner.	[An, Xingyue; Sendra, Victor G.; Liadi, Ivan; Ramesh, Balakrishnan; Romain, Gabrielle; Martinez-Paniagua, Melisa; Varadarajan, Navin] Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA; [Haymaker, Cara; Radvanyi, Laszlo G.] Univ Texas MD Anderson Canc Ctr, Dept Melanoma Med Oncol, Houston, TX 77030 USA; [Lu, Yanbin; Roysam, Badrinath] Univ Houston, Dept Elect & Comp Engn, Houston, TX USA	University of Houston System; University of Houston; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Varadarajan, N (corresponding author), Univ Houston, Dept Chem & Biomol Engn, Houston, TX 77204 USA.	nvaradar@central.uh.edu		Haymaker, Cara/0000-0002-1317-9287; An, Xingyue/0000-0001-9912-0683	NIH [R01CA174385]; CPRIT [RP130570]; MRA Award [509800]; Welch Foundation [E1774]; Owens Foundation, CDMRP [CA160591]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; MRA Award; Welch Foundation(The Welch Foundation); Owens Foundation, CDMRP	This publication was supported by the NIH (R01CA174385), CPRIT (RP130570); MRA Award (509800); Welch Foundation (E1774), Owens Foundation, CDMRP (CA160591). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Becker PSA, 2016, CANCER IMMUNOL IMMUN, V65, P477, DOI 10.1007/s00262-016-1792-y; Beziat V, 2011, J IMMUNOL, V186, P6753, DOI 10.4049/jimmunol.1100330; Breart B, 2008, J CLIN INVEST, V118, P1390, DOI 10.1172/JCI34388; Cao J, 2015, CLIN PROTEOM, V12, DOI 10.1186/s12014-015-9101-x; Chen Y, 2009, J IMMUNOL METHODS, V340, P65, DOI 10.1016/j.jim.2008.09.024; Chokkalingam V, 2013, LAB CHIP, V13, P4740, DOI 10.1039/c3lc50945a; De Maria A, 2011, P NATL ACAD SCI USA, V108, P728, DOI 10.1073/pnas.1012356108; Dundua A, 2016, MACROMOL RAPID COMM, V37, P2030, DOI 10.1002/marc.201600473; Ekins RP, 1998, CLIN CHEM, V44, P2015; Elshal MF, 2006, METHODS, V38, P317, DOI 10.1016/j.ymeth.2005.11.010; Gao JJ, 2016, CELL, V167, P397, DOI 10.1016/j.cell.2016.08.069; Gerbitz A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034552; Han Q, 2012, P NATL ACAD SCI USA, V109, P1607, DOI 10.1073/pnas.1117194109; Han Q, 2010, LAB CHIP, V10, P1391, DOI 10.1039/b926849a; Haymaker CL, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1014246; Heyes CD, 2007, MOL BIOSYST, V3, P419, DOI 10.1039/b700055n; Konry T, 2013, SCI REP-UK, V3, DOI 10.1038/srep03179; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Liadi I, 2015, CANCER IMMUNOL RES, V3, P473, DOI 10.1158/2326-6066.CIR-14-0195; Liadi I, 2013, JOVE-J VIS EXP, DOI 10.3791/50058; Liu YP, 2016, BIOMICROFLUIDICS, V10, DOI 10.1063/1.4946870; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; Lu Y, 2015, P NATL ACAD SCI USA, V112, pE607, DOI 10.1073/pnas.1416756112; Ma C, 2011, NAT MED, V17, P738, DOI 10.1038/nm.2375; Marie R, 2006, LANGMUIR, V22, P10103, DOI 10.1021/la060198m; Martinon F, 2009, HUM GENE THER, V20, P1291, DOI 10.1089/hum.2009.044; Mempel TR, 2010, METHODS MOL BIOL, V616, P181, DOI 10.1007/978-1-60761-461-6_12; Nie S, 2014, LAB CHIP, V14, P1087, DOI 10.1039/c3lc51303c; Poli A, 2009, IMMUNOLOGY, V126, P458, DOI 10.1111/j.1365-2567.2008.03027.x; Qin ZH, 2003, CANCER RES, V63, P4095; Reefman E, 2010, J IMMUNOL, V184, P4852, DOI 10.4049/jimmunol.0803954; Rezvani K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00578; Romain G, 2014, BLOOD, V124, P3241, DOI 10.1182/blood-2014-04-569061; Romee R, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf2341; Sakamoto N, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0632-8; Schneider F, 2009, SENSOR ACTUAT A-PHYS, V151, P95, DOI 10.1016/j.sna.2009.01.026; SOMANCHI SS, 2011, JOVE-J VIS EXP, V48, P2540, DOI DOI 10.3791/2540; Son KJ, 2016, ANALYST, V141, P679, DOI 10.1039/c5an01648g; Torres AJ, 2014, ANAL CHEM, V86, P11562, DOI 10.1021/ac4030297; Varadarajan N, 2012, P NATL ACAD SCI USA, V109, P3885, DOI 10.1073/pnas.1111205109; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Wong I, 2009, MICROFLUID NANOFLUID, V7, P291, DOI 10.1007/s10404-009-0443-4; Yu XL, 2015, LANGMUIR, V31, P5891, DOI 10.1021/acs.langmuir.5b01085; Zaidi MR, 2011, CLIN CANCER RES, V17, P6118, DOI 10.1158/1078-0432.CCR-11-0482; Zaretsky I, 2012, LAB CHIP, V12, P5007, DOI 10.1039/c2lc40808b; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	46	26	26	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0181904	10.1371/journal.pone.0181904	http://dx.doi.org/10.1371/journal.pone.0181904			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837583	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000013
J	Brunquell, J; Snyder, A; Cheng, F; Westerheide, SD				Brunquell, Jessica; Snyder, Alana; Cheng, Feng; Westerheide, Sandy D.			HSF-1 is a regulator of miRNA expression in Caenorhabditis elegans	PLOS ONE			English	Article							HEAT-SHOCK FACTOR-1; OXIDATIVE STRESS; GENE-EXPRESSION; C. ELEGANS; LIFE-SPAN; LONGEVITY; MICRORNA; INHIBITION; RESPONSES; DAF-16	The ability of an organism to sense and adapt to environmental stressors is essential for proteome maintenance and survival. The highly conserved heat shock response is a survival mechanism employed by all organisms, including the nematode Caenorhabditis elegans, upon exposure to environmental extremes. Transcriptional control of the metazoan heat shock response is mediated by the heat shock transcription factor HSF-1. In addition to regulating global stress-responsive genes to promote stress-resistance and survival, HSF-1 has recently been shown to regulate stress-independent functions in controlling development, metabolism, and longevity. However, the indirect role of HSF-1 in coordinating stress-dependent and -independent processes through post-transcriptional regulation is largely unknown. MicroRNAs (miRNAs) have emerged as a class of post-transcriptional regulators that control gene expression through translational repression or mRNA degradation. To determine the role of HSF-1 in regulating miRNA expression, we have performed high-throughput small RNA-sequencing in C. elegans grown in the presence and absence of hsf-1 RNAi followed by treatment with or without heat shock. This has allowed us to uncover the miRNAs regulated by HSF-1 via heat-dependent and -independent mechanisms. Integrated miRNA/mRNA target-prediction analyses suggest HSF-1 as a post-transcriptional regulator of development, metabolism, and longevity through regulating miRNA expression. This provides new insight into the possible mechanism by which HSF-1 controls these processes. We have also uncovered oxidative stress response factors and insulin-like signaling factors as a common link between processes affected by HSF-1-regulated miRNAs in stress-dependent and -independent mechanisms, respectively. This may provide a role for miRNAs in regulating cross-talk between various stress responses. Our work therefore uncovers an interesting potential role for HSF-1 in post-transcriptionally controlling gene expression in C. elegans, and suggests a mechanism for cross-talk between stress responses.	[Brunquell, Jessica; Snyder, Alana; Westerheide, Sandy D.] Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA; [Cheng, Feng] Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA; [Cheng, Feng] Univ S Florida, Coll Publ Hlth, Dept Biostat, Tampa, FL 33620 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; State University System of Florida; University of South Florida	Westerheide, SD (corresponding author), Univ S Florida, Coll Arts & Sci, Dept Cell Biol Microbiol & Mol Biol, Tampa, FL 33620 USA.; Cheng, F (corresponding author), Univ S Florida, Coll Pharm, Dept Pharmaceut Sci, Tampa, FL 33620 USA.; Cheng, F (corresponding author), Univ S Florida, Coll Publ Hlth, Dept Biostat, Tampa, FL 33620 USA.	fcheng1@health.usf.edu; swesterheide@usf.edu	Cheng, Feng/A-9760-2009	Cheng, Feng/0000-0003-3619-8090; Westerheide, Sandy/0000-0003-4683-9648	Department of Cell Biology, Microbiology, and Molecular Biology at the University of South Florida; NIH Office of Research Infrastructure Programs [P40 OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	Department of Cell Biology, Microbiology, and Molecular Biology at the University of South Florida; NIH Office of Research Infrastructure Programs; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a departmental start-up grant from the Department of Cell Biology, Microbiology, and Molecular Biology at the University of South Florida to Sandy D. Westerheide.; We would like to thank Dr. R.I. Morimoto for providing the phsp-70(C12C8.1)::GFP strain and the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440), for providing the phsp-16.2(Y46H3A.3)::GFP and N2 strains.	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Adachi M, 2009, PLOS ONE, V4, pA57, DOI 10.1371/journal.pone.0007719; Ahmed R, 2013, GENOME BIOL EVOL, V5, P1246, DOI 10.1093/gbe/evt086; Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Baird NA, 2014, SCIENCE, V346, P360, DOI 10.1126/science.1253168; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRENNER S, 1974, GENETICS, V77, P71; Brunquell J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2837-5; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Chiang WC, 2012, CELL, V148, P322, DOI 10.1016/j.cell.2011.12.019; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crombie TA, 2016, J EXP BIOL, V219, P2201, DOI 10.1242/jeb.135327; Dai SY, 2015, EMBO J, V34, P275, DOI 10.15252/embj.201489062; de Lencastre A, 2010, CURR BIOL, V20, P2159, DOI 10.1016/j.cub.2010.11.015; Douglas PM, 2015, CELL REP, V12, P1196, DOI 10.1016/j.celrep.2015.07.026; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Ferguson AA, 2010, MOL CELL BIOL, V30, P2651, DOI 10.1128/MCB.01340-09; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Friedlander MR, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-4-r57; Goh GYS, 2014, AGING CELL, V13, P70, DOI 10.1111/acel.12154; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247; Hsu AL, 2003, SCIENCE, V300, P1142, DOI 10.1126/science.1083701; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jan CH, 2011, NATURE, V469, P97, DOI 10.1038/nature09616; Kagias K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-222; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Li M, 2005, DEV CELL, V9, P415, DOI 10.1016/j.devcel.2005.08.002; Link CD, 1999, CELL STRESS CHAPERON, V4, P235, DOI 10.1379/1466-1268(1999)004<0235:DOOSRI>2.3.CO;2; Liu N, 2012, NATURE, V482, P519, DOI 10.1038/nature10810; Lucanic M, 2013, AGING-US, V5, P394, DOI 10.18632/aging.100564; Miska EA, 2007, PLOS GENET, V3, P2395, DOI 10.1371/journal.pgen.0030215; Morley JF, 2004, MOL BIOL CELL, V15, P657, DOI 10.1091/mbc.E03-07-0532; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nehammer C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08866; Oliveros J.C., 2007, INTERACTIVE TOOL COM; PARSELL DA, 1993, ANNU REV GENET, V27, P437, DOI 10.1146/annurev.ge.27.120193.002253; Raynes R, 2012, J BIOL CHEM, V287, P29045, DOI 10.1074/jbc.M112.353714; Seo K, 2013, AGING CELL, V12, P1073, DOI 10.1111/acel.12140; Smith-Vikos T, 2014, CURR BIOL, V24, P2238, DOI 10.1016/j.cub.2014.08.013; Spiro Z, 2012, ANTIOXID REDOX SIGN, V17, P890, DOI 10.1089/ars.2011.4161; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Vihervaara A, 2014, J CELL SCI, V127, P261, DOI 10.1242/jcs.132605; Volovik Y, 2014, CELL REP, V9, P2192, DOI 10.1016/j.celrep.2014.11.028; Westerheide SD, 2005, J BIOL CHEM, V280, P33097, DOI 10.1074/jbc.R500010200; Young JC, 2004, NAT REV MOL CELL BIO, V5, P781, DOI 10.1038/nrm1492	48	9	10	4	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183445	10.1371/journal.pone.0183445	http://dx.doi.org/10.1371/journal.pone.0183445			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837599	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000068
J	Markus, B; Szabo, K; Pfliegler, WP; Petrenyi, K; Boros, E; Pocsi, I; Tozser, J; Csosz, E; Dombradi, V				Markus, Bernadett; Szabo, Krisztina; Pfliegler, Walter P.; Petrenyi, Katalin; Boros, Eniko; Pocsi, Istvan; Tozser, Jozsef; Csosz, Eva; Dombradi, Viktor			Proteomic analysis of protein phosphatase Z1 from Candida albicans	PLOS ONE			English	Article							CELL-WALL INTEGRITY; ELONGATION-FACTOR 2; SACCHAROMYCES-CEREVISIAE; SALT TOLERANCE; IN-VIVO; YEAST; TRANSLATION; BIOFILMS; GENE; PPZ1	Protein phosphatase Z is a "novel type" fungus specific serine/threonine protein phosphatase. Previously our research group identified the CaPPZ1 gene in the opportunistic pathogen Candida albicans and reported that the gene deletion had several important physiological consequences. In order to reveal the protein targets and the associated mechanisms behind the functions of the phosphatase a proteomic method was adopted for the comparison of the cappz1 deletion mutant and the genetically matching QMY23 control strain. Proteins extracted from the control and deletion mutant strains were separated by two-dimensional gel electrophoresis and the protein spots were stained with RuBPS and Pro-Q Diamond in order to visualize the total proteome and the phosphoproteome, respectively. The alterations in spot intensities were determined by densitometry and were analysed with the Delta2D (Decodon) software. Spots showing significantly different intensities between the mutant and control strains were excised from the gels and were digested with trypsin. The resulting peptides were identified by LC-MS/MS mass spectrometry. As many as 15 protein spots were found that exhibited significant changes in their intensity upon the deletion of the phosphatase and 20 phosphoproteins were identified in which the level of phosphorylation was modified significantly in the mutant. In agreement with previous findings we found that the affected proteins function in protein synthesis, oxidative stress response, regulation of morphology and metabolism. Among these proteins we identified two potential CaPpz1 substrates (Eft2 and Rpp0) that may regulate the elongation step of translation. RT-qPCR experiments revealed that the expression of the genes coding for the affected proteins was not altered significantly. Thus, the absence of CaPpz1 exerted its effects via protein synthesis/degradation and phosphorylation/dephosphorylation. In addition, our proteomics data strongly suggested a role for CaPpz1 in biofilm formation, was confirmed experimentally. Thus our unbiased proteomic approach lead to the discovery of a novel function for this phosphatase in C. albicans.	[Markus, Bernadett; Tozser, Jozsef; Csosz, Eva] Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Prote Core Facil, Debrecen, Hungary; [Szabo, Krisztina; Petrenyi, Katalin; Dombradi, Viktor] Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary; [Pfliegler, Walter P.; Boros, Eniko; Pocsi, Istvan] Univ Debrecen, Fac Sci & Technol, Dept Biotechnol & Microbiol, Debrecen, Hungary	University of Debrecen; University of Debrecen; University of Debrecen	Csosz, E (corresponding author), Univ Debrecen, Dept Biochem & Mol Biol, Fac Med, Prote Core Facil, Debrecen, Hungary.; Dombradi, V (corresponding author), Univ Debrecen, Dept Med Chem, Fac Med, Debrecen, Hungary.	cseva@med.unideb.hu; dombradi@med.unideb.hu	Tozser, Jozsef/A-7840-2008; Pfliegler, Walter P./D-1114-2018	Tozser, Jozsef/0000-0003-0274-0056; Pfliegler, Walter P./0000-0001-6723-4416; Csosz, Eva/0000-0003-4373-2175; Szabo, Krisztina/0000-0002-8461-9294	National Research, Development and Innovation Office [NKFIH K108989]	National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	This work was supported by the National Research, Development and Innovation Office NKFIH K108989 grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Thanks are due to Dr Alexander Johnson (University of California, San Francisco, USA) for the QMY23 control strain. The authors are indebted for the expert technical assistance of Ms Andrea Farkas Tankane (University of Debrecen, Debrecen, Hungary). This work was supported by the National Research, Development and Innovation Office-NKFIH K108989 grant.	Adam C, 2012, MICROBIOL-SGM, V158, P1258, DOI 10.1099/mic.0.057075-0; [Anonymous], 1995, J BIOL CHEM, V270, P13036; Arino J, 2002, EUR J BIOCHEM, V269, P1072, DOI 10.1046/j.0014-2956.2002.02753.x; Balcells L, 1997, EUR J BIOCHEM, V250, P476, DOI 10.1111/j.1432-1033.1997.0476a.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Casado C, 2012, FUNGAL GENET BIOL, V49, P708; Chen E, 2016, AM SOC MICROBIOLOGY, V7; Clotet J, 1999, MOL CELL BIOL, V19, P2408; Cohen PTW, 1997, TRENDS BIOCHEM SCI, V22, P245, DOI 10.1016/S0968-0004(97)01060-8; Daniels KJ, 2013, EUKARYOT CELL, V12, P1389, DOI 10.1128/EC.00127-13; de Nadal E, 2001, J BIOL CHEM, V276, P14829, DOI 10.1074/jbc.M010824200; Dominguez JM, 1998, ANTIMICROB AGENTS CH, V42, P2279, DOI 10.1128/AAC.42.9.2279; Garcia-Gimeno MA, 2003, J BIOL CHEM, V278, P47744, DOI 10.1074/jbc.M306157200; Gauci Victoria J, 2011, J Chem Biol, V4, P3, DOI 10.1007/s12154-010-0043-5; Jin Y, 2003, J CLIN MICROBIOL, V41, P2961, DOI 10.1128/JCM.41.7.2961-2967.2003; Karkowska-Kuleta J, 2014, MOL ORAL MICROBIOL, V29, P270, DOI 10.1111/omi.12078; Kovacs L, 2010, J BASIC MICROB, V50, pS74, DOI 10.1002/jobm.200900434; LEE KS, 1993, MOL CELL BIOL, V13, P5843, DOI 10.1128/MCB.13.9.5843; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Hernaez ML, 2010, J PROTEOMICS, V73, P1404, DOI 10.1016/j.jprot.2010.02.008; Martinez JP, 2016, FEMS YEAST RES, V16; Mendoza A, 1999, GENE, V229, P183, DOI 10.1016/S0378-1119(99)00024-4; Merchan S, 2004, EUKARYOT CELL, V3, P100, DOI 10.1128/EC.3.1.100-107.2004; Minhas A, 2012, J BIOL CHEM, V287, P7301, DOI 10.1074/jbc.M111.299438; Mironova L J, 2007, GENES CELLS, V12, P435; Mitrovich QM, 2007, GENOME RES, V17, P492, DOI 10.1101/gr.6111907; Muszkieta L, 2014, CELL MICROBIOL, V16, P1784, DOI 10.1111/cmi.12326; Nagy G, 2014, APPL MICROBIOL BIOT, V98, P5185, DOI 10.1007/s00253-014-5696-5; Nobile CJ, 2015, ANNU REV MICROBIOL, V69, P71, DOI 10.1146/annurev-micro-091014-104330; Nobile CJ, 2012, CELL, V148, P126, DOI 10.1016/j.cell.2011.10.048; Noble SM, 2010, NAT GENET, V42, P590, DOI 10.1038/ng.605; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Perez A, 2006, FEMS YEAST RES, V6, P1074, DOI 10.1111/j.1567-1364.2006.00131.x; Petrenyi K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160965; POSAS F, 1995, FEBS LETT, V368, P39, DOI 10.1016/0014-5793(95)00593-X; Rabilloud T, 2001, PROTEOMICS, V1, P699, DOI 10.1002/1615-9861(200104)1:5<699::AID-PROT699>3.3.CO;2-3; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rodriguez-Gabriel MA, 1998, BIOCHEMISTRY-US, V37, P16620, DOI 10.1021/bi981396i; Serrano R J, 2002, EMBO J, V21, P920; Szklarczyk D, 2017, NUCLEIC ACIDS RES, V45, pD362, DOI 10.1093/nar/gkw937; Szoor B, 1998, BBA-PROTEIN STRUCT M, V1388, P260, DOI 10.1016/S0167-4838(98)00201-5; Tsui C, 2016, PATHOG DIS, V74, DOI 10.1093/femspd/ftw018; Vialas V, 2012, PROTEOMICS, V12, P2331, DOI 10.1002/pmic.201100588	43	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183176	10.1371/journal.pone.0183176	http://dx.doi.org/10.1371/journal.pone.0183176			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837603	gold, Green Accepted, Green Published			2022-12-27	WOS:000408365000050
J	Moore, RC; Paolillo, EW; Heaton, A; Fazeli, PL; Jeste, DV; Moore, DJ				Moore, Raeanne C.; Paolillo, Emily W.; Heaton, Anne; Fazeli, Pariya L.; Jeste, Dilip V.; Moore, David J.			Clinical utility of the UCSD Performance-Based Skills Assessment D Brief (UPSA-B) in adults living with HIV: Associations with neuropsychological impairment and patient-reported everyday functioning difficulties	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS-INFECTION; ANTIRETROVIRAL THERAPY; IMPACT; SCHIZOPHRENIA; DEPENDENCE; CAPACITY; SPECIFICITY; SENSITIVITY; DYSFUNCTION; VALIDATION	Objective Requiring only 10-15 minutes to complete, the UCSD Performance-Based Skills Assessment (UPSA-B) has high clinical utility as a brief measure of functional capacity. This study aimed to validate the UPSA-B in adults living with HIV/AIDS (HIV+), and identify whether the UPSA-B can be used as an indicator of functional dependence in this population. Method One hundred and three HIV+ adults and 91 HIV-adults completed a comprehensive neuropsychological and neuromedical battery, including a self-report measure of functional status (IADL Dependence vs. IADL Independence), an objective measure of functional capacity (UPSA-B), and a self-report measure of mood states including a subscale related to cognitive difficulties (Profile of Mood States [POMS]-Confusion/Bewilderment subscale). Results HIV+ participants had significantly lower UPSA-B scores than their HIV-counterparts (p = 0.02), although this fell to a trend (p = 0.08) when including covariates. Among the HIV+ group, higher UPSA-B scores were related to better neuropsychological ability, but unrelated to self-reported functional independence. Conversely, UPSA-B scores were unrelated to participant-reported cognitive difficulties on the POMS Confusion/Bewilderment subscale. An ROC curve was generated to determine the optimal UPSA-B value for discriminating between normal neuropsychological functioning versus neuropsychological impairment, with results indicating an optimal cutoff of 79. The UPSA-B identified HIV+ persons with cognitive impairment with 70.9% accuracy. Conclusions The UPSA-B was able to differentiate neuropsychological impairment from no impairment among HIV+ participants and holds promise as a clinical screening tool in this population. However, indicators of functional disability among adults living with HIV is still not well understood and is likely multifactorial in nature. These data highlight the complex interplay between objective functional capacity, neurocognitive ability, subjective cognitive symptoms, and functional dependence.	[Moore, Raeanne C.; Heaton, Anne; Jeste, Dilip V.; Moore, David J.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Moore, Raeanne C.] VA San Diego Healthcare Syst, San Diego, CA 92161 USA; [Paolillo, Emily W.] Univ Calif San Diego, San Diego State Univ, San Diego Joint Doctoral Program Clin Psychol, San Diego, CA 92103 USA; [Fazeli, Pariya L.] Univ Alabama Birmingham, UAB Sch Nursing, Birmingham, AL USA; [Jeste, Dilip V.] Univ Calif San Diego, Stein Inst Res Aging, San Diego, CA 92103 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; California State University System; San Diego State University; University of California System; University of California San Diego; University of Alabama System; University of Alabama Birmingham; University of California System; University of California San Diego	Moore, RC (corresponding author), Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA.; Moore, RC (corresponding author), VA San Diego Healthcare Syst, San Diego, CA 92161 USA.	r6moore@ucsd.edu	Moore, Raeanne/ABC-6648-2020	Fazeli, Pariya/0000-0001-6629-0010	National Institute of Mental Health [R01 MH099987, P30MH062512, K23 MH107260, R00 AG048762, T32 AA013525]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH107260, P30MH062512] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R00AG048762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [T32AA013525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA031098] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by the National Institute of Mental Health (grant number R01 MH099987, P30MH062512, K23 MH107260 (salary support to RCM), R00 AG048762 (salary support to PLF), T32 AA013525 (stipend support to EWP)). The views expressed in this article are those of the authors and do not reflect the official policy or position of the Department of the Navy, Department of Defense, National Institutes of Health, nor the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antinori A, 2007, NEUROLOGY, V69, P1789, DOI 10.1212/01.WNL.0000287431.88658.8b; Bangsberg David R, 2007, Curr HIV/AIDS Rep, V4, P65, DOI 10.1007/s11904-007-0010-0; Blackstone K, 2012, CLIN NEUROPSYCHOL, V26, P894, DOI 10.1080/13854046.2012.694479; Blackstone K, 2013, J ADDICT MED, V7, P255, DOI 10.1097/ADM.0b013e318293653d; Bowie CR, 2006, AM J PSYCHIAT, V163, P418, DOI 10.1176/appi.ajp.163.3.418; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; Cattie JE, 2012, J CLIN EXP NEUROPSYC, V34, P906, DOI 10.1080/13803395.2012.692772; Doyle KL, 2013, J NEUROVIROL, V19, P565, DOI 10.1007/s13365-013-0218-2; Fluss R, 2005, BIOMETRICAL J, V47, P458, DOI 10.1002/bimj.200410135; Garcia-Portilla MP, 2013, SCHIZOPHR RES, V150, P421, DOI 10.1016/j.schres.2013.07.049; Gorman AA, 2009, NEUROPSYCHOL REV, V19, P186, DOI 10.1007/s11065-009-9095-0; Heaton RK, 2010, NEUROLOGY, V75, P2087, DOI 10.1212/WNL.0b013e318200d727; Heaton RK, 2004, J INT NEUROPSYCH SOC, V10, P317, DOI 10.1017/S1355617704102130; HEATON RK, 1994, PSYCHOSOM MED, V56, P8, DOI 10.1097/00006842-199401000-00001; Henry BL, 2010, ADDICT BEHAV, V35, P593, DOI 10.1016/j.addbeh.2010.01.013; Hutchinson AB, 2006, JAIDS-J ACQ IMM DEF, V43, P451, DOI 10.1097/01.qai.0000243090.32866.4e; Kamat R, 2012, ARCH CLIN NEUROPSYCH, V27, P520, DOI 10.1093/arclin/acs055; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Loong TW, 2003, BMJ-BRIT MED J, V327, P716, DOI 10.1136/bmj.327.7417.716; Marcotte TD, 1999, J INT NEUROPSYCH SOC, V5, P579, DOI 10.1017/S1355617799577011; Mausbach BT, 2008, J PSYCHIATR RES, V42, P320, DOI 10.1016/j.jpsychires.2006.12.008; Mausbach BT, 2007, SCHIZOPHRENIA BULL, V33, P1364, DOI 10.1093/schbul/sbm014; Mausbach BT, 2011, SCHIZOPHR RES, V132, P165, DOI 10.1016/j.schres.2011.07.022; Mausbach BT, 2010, BIPOLAR DISORD, V12, P45, DOI 10.1111/j.1399-5618.2009.00787.x; Mausbach BT, 2009, SCHIZOPHRENIA BULL, V35, P307, DOI 10.1093/schbul/sbn152; McNair D., 1981, MANUAL PROFILE MOOD; Moore RC, 2015, SCHIZOPHR RES, V169, P121, DOI 10.1016/j.schres.2015.09.017; Moore RC, 2015, SCHIZOPHR RES, V164, P187, DOI 10.1016/j.schres.2015.02.014; Moore RC, 2013, SCHIZOPHR RES, V144, P87, DOI 10.1016/j.schres.2012.12.028; Moore RC, 2016, AM J GERIAT PSYCHIAT, V25, P829; Morgan EE, 2014, PSYCHIAT RES, V220, P527, DOI 10.1016/j.psychres.2014.07.008; Olsson AK, 2012, PSYCHIAT RES, V197, P290, DOI 10.1016/j.psychres.2011.11.002; Patterson TL, 2001, SCHIZOPHRENIA BULL, V27, P235, DOI 10.1093/oxfordjournals.schbul.a006870; Sadek JR, 2007, J CLIN EXP NEUROPSYC, V29, P266, DOI 10.1080/13803390600659384; Scott JC, 2011, NEUROPSYCHOLOGY, V25, P511, DOI 10.1037/a0022491; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Sumiyoshi Chika, 2014, Schizophr Res Cogn, V1, P137, DOI 10.1016/j.scog.2014.08.002; Thames AD, 2011, J CLIN EXP NEUROPSYC, V33, P200, DOI 10.1080/13803395.2010.499357; Thames AD, 2011, CLIN NEUROPSYCHOL, V25, P224, DOI 10.1080/13854046.2010.539577; Thurlow J, 2009, J INT AIDS SOC, V12, DOI 10.1186/1758-2652-12-18; Woods SP, 2008, NEUROPSYCHOLOGY, V22, P110, DOI 10.1037/0894-4105.22.1.110; Zlatar ZZ, 2014, J GERIATR PSYCH NEUR, V27, P181, DOI 10.1177/0891988714524628	42	22	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183614	10.1371/journal.pone.0183614	http://dx.doi.org/10.1371/journal.pone.0183614			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837678	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000088
J	Smit, NW; ten Sande, JN; Parvizi, M; van Amersfoorth, SCM; Plantinga, JA; van Spreuwel-Goossens, CAFM; van Dongen, EMWM; van Dessel, PFHM; Kluijtmans, SGJM; Meijborg, VMF; de Bakker, JMT; Harmsen, MC; Coronel, R				Smit, Nicoline W.; ten Sande, Judith N.; Parvizi, Mojtaba; van Amersfoorth, Shirley C. M.; Plantinga, Josee A.; van Spreuwel-Goossens, Carolien A. F. M.; van Dongen, Elisabeth M. W. M.; van Dessel, Pascal F. H. M.; Kluijtmans, Sebastianus G. J. M.; Meijborg, Veronique M. F.; de Bakker, Jacques M. T.; Harmsen, Martin C.; Coronel, Ruben			Recombinant human collagen-based microspheres mitigate cardiac conduction slowing induced by adipose tissue-derived stromal cells	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; RANDOMIZED PHASE-1 TRIAL; HEART; CARDIOMYOCYTES; REPAIR; TRANSPLANTATION; REGENERATION; RETENTION	Background Stem cell therapy to improve cardiac function after myocardial infarction is hampered by poor cell retention, while it may also increase the risk of arrhythmias by providing an arrhythmogenic substrate. We previously showed that porcine adipose tissue-derived-stromal cells (pASC) induce conduction slowing through paracrine actions, whereas rat ASC (rASC) and human ASC (hASC) induce conduction slowing by direct coupling. We postulate that biomaterial microspheres mitigate the conduction slowing influence of pASC by interacting with paracrine signaling. Aim To investigate the modulation of ASC-loaded recombinant human collagen-based microspheres, on the electrophysiological behavior of neonatal rat ventricular myocytes (NRVM). Method Unipolar extracellular electrograms, derived from microelectrode arrays (8x8 electrodes) containing NRVM, co-cultured with ASC or ASC loaded microspheres, were used to determine conduction velocity (CV) and conduction heterogeneity. Conditioned medium (Cme) of (co)cultures was used to assess paracrine mechanisms. Results Microspheres did not affect CV in control (NRVM) monolayers. In co-cultures of NRVM and rASC, hASC or pASC, CV was lower than in controls (14.4+/-1.0, 13.0+/-0.6 and 9.0+/-1.0 vs. 19.5+/-0.5 cm/s respectively, p<0.001). Microspheres loaded with either rASC or hASC still induced conduction slowing compared to controls (13.5+/-0.4 and 12.6+/-0.5 cm/s respectively, p<0.001). However, pASC loaded microspheres increased CV of NRVM compared to pASC and NRMV co-cultures (16.3+/-1.3 cm/s, p<0.001) and did not differ from controls (p = NS). Cme of pASC reduced CV in control monolayers of NRVM (10.3+/-1.1 cm/s, p<0.001), similar to Cme derived from pASC-loaded microspheres (11.1+/-1.7 cm/s, p = 1.0). The presence of microspheres in monolayers of NRVM abolished the CV slowing influence of Cme pASC (15.9+/-1.0 cm/s, p = NS vs. control). Conclusion The application of recombinant human collagen-based microspheres mitigates indirect paracrine conduction slowing through interference with a secondary autocrine myocardial factor.	[Smit, Nicoline W.; ten Sande, Judith N.; van Amersfoorth, Shirley C. M.; van Dessel, Pascal F. H. M.; Meijborg, Veronique M. F.; de Bakker, Jacques M. T.; Coronel, Ruben] Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Clin & Expt Cardiol, Ctr Heart, Amsterdam, Netherlands; [Smit, Nicoline W.; ten Sande, Judith N.; Meijborg, Veronique M. F.] Holland Heart House, Netherlands Heart Inst, Utrecht, Netherlands; [Parvizi, Mojtaba; Plantinga, Josee A.; Harmsen, Martin C.] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands; [van Spreuwel-Goossens, Carolien A. F. M.; van Dongen, Elisabeth M. W. M.; Kluijtmans, Sebastianus G. J. M.] Fujifilm Mfg Europe BV, Tilburg, Netherlands; [Coronel, Ruben] Fdn Univ Bordeaux, Inst Rythmol & Modelisat Cardiaque LIRYC, Bordeaux, France	University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Fujifilm Corporation; CHU Bordeaux	Smit, NW (corresponding author), Univ Amsterdam, Acad Med Ctr Amsterdam, Dept Clin & Expt Cardiol, Ctr Heart, Amsterdam, Netherlands.; Smit, NW (corresponding author), Holland Heart House, Netherlands Heart Inst, Utrecht, Netherlands.	n.w.smit@amc.uva.nl	Coronel, Ruben/AAZ-8948-2020; Parvizi, Mojtaba/Q-1543-2019; Harmsen, Martin/R-4579-2019; Harmsen, Martin C/F-3197-2016	Coronel, Ruben/0000-0001-9433-6119; Harmsen, Martin/0000-0002-7128-2741; Harmsen, Martin C/0000-0002-7128-2741; Meijborg, Veronique/0000-0002-2358-0170	ICARUS of the BioMedical Materials program [P5.01]; LeDucq (SHAPEHEART network)	ICARUS of the BioMedical Materials program; LeDucq (SHAPEHEART network)	The financial contributions of ICARUS of the BioMedical Materials program (project-P5.01) and the LeDucq (SHAPEHEART network) are gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askar SFA, 2013, CIRC-ARRHYTHMIA ELEC, V6, P380, DOI 10.1161/CIRCEP.111.000215; Bagno LL, 2015, CELL TRANSPLANT; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Cartledge JE, 2015, CARDIOVASC RES, V105, P260, DOI 10.1093/cvr/cvu264; Chang MG, 2006, CIRCULATION, V113, P1832, DOI 10.1161/CIRCULATIONAHA.105.593038; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P673, DOI 10.1161/CIRCINTERVENTIONS.114.001580; DEBAKKER JMT, 1993, CIRCULATION, V88, P915, DOI 10.1161/01.CIR.88.3.915; Hamdi H, 2014, CELL TRANSPLANT, V23, P87, DOI 10.3727/096368912X658836; Hasan A, 2016, MACROMOL BIOSCI, V16, P958, DOI 10.1002/mabi.201500396; Heubach JF, 2004, J PHYSIOL-LONDON, V554, P659, DOI 10.1113/jphysiol.2003.055806; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Kakkar R, 2010, CIRC RES, V106, P47, DOI 10.1161/CIRCRESAHA.109.207456; KLEBER AG, 1986, CIRCULATION, V73, P189, DOI 10.1161/01.CIR.73.1.189; LAMMERS WJEP, 1990, AM J PHYSIOL, V259, pH1254, DOI 10.1152/ajpheart.1990.259.4.H1254; Lan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173814; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; MARUYAMA T, 1991, AM J PHYSL, V261, P66880; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Mumcuoglu D dML, 2016, DEV INJECTABLE BMP 2, P1; Oedayrajsingh-Varma MJ, 2006, CYTOTHERAPY, V8, P166, DOI 10.1080/14653240600621125; Panda NC, 2014, J INTERV CARD ELECTR, V41, P117, DOI 10.1007/s10840-014-9940-9; Parvizi M, 2016, BIOTECHNOL J, V11, P932, DOI 10.1002/biot.201500519; Parvizi M, 2016, J BIOMED MATER RES A, V104, P503, DOI 10.1002/jbm.a.35588; Pedrotty DM, 2009, CARDIOVASC RES, V83, P688, DOI 10.1093/cvr/cvp164; Potse M, 2002, COMPUT METH PROG BIO, V69, P225, DOI 10.1016/S0169-2607(02)00014-7; Price MJ, 2006, INT J CARDIOL, V111, P231, DOI 10.1016/j.ijcard.2005.07.036; Przybyt E, 2013, CURR STEM CELL RES T, V8, P270, DOI 10.2174/1574888X11308040002; Roche ET, 2014, BIOMATERIALS, V35, P6850, DOI 10.1016/j.biomaterials.2014.04.114; SHEETS MF, 1988, CIRC RES, V63, P386, DOI 10.1161/01.RES.63.2.386; Sundelacruz S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003737; Takahashi M, 2006, AM J PHYSIOL-HEART C, V291, pH886, DOI 10.1152/ajpheart.00142.2006; Ten Sande JN, 2016, STEM CELLS TRANSL ME; Tirziu D, 2010, CIRCULATION, V122, P928, DOI 10.1161/CIRCULATIONAHA.108.847731; Tuin A, 2010, TISSUE ENG PT A, V16, P1811, DOI [10.1089/ten.tea.2009.0592, 10.1089/ten.TEA.2009.0592]; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Weeke-Klimp A, 2010, J MOL CELL CARDIOL, V49, P606, DOI 10.1016/j.yjmcc.2010.07.007; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zhang M, 2001, J MOL CELL CARDIOL, V33, P907, DOI 10.1006/jmcc.2001.1367	39	7	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183481	10.1371/journal.pone.0183481	http://dx.doi.org/10.1371/journal.pone.0183481			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837600	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000071
J	Sorensen, G; Nagler, EM; Pawar, P; Gupta, PC; Pednekar, MS; Wagner, GR				Sorensen, Glorian; Nagler, Eve M.; Pawar, Pratibha; Gupta, Prakash C.; Pednekar, Mangesh S.; Wagner, Gregory R.			Lost in translation: The challenge of adapting integrated approaches for worker health and safety for low- and middle-income countries	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; SOCIAL IMPACT BONDS; BEHAVIOR-CHANGE; OCCUPATIONAL-HEALTH; WORKPLACE-HEALTH; MANUFACTURING WORKSITES; INDUSTRIAL-POPULATION; CANCER PREVENTION; CHRONIC DISEASE; GLOBAL HEALTH	Objectives To describe the process of adapting an intervention integrating occupational safety and health (OSH) and health promotion for manufacturing worksites in India and the challenges faced in implementing it; and explore how globalization trends may influence the implementation of these integrated approaches in India and other low- and middle-income countries (LMICs). Methods This study D conducted in 22 manufacturing worksites in Mumbai, India D adapted and implemented an evidence-based intervention tested in the U.S. that integrated OSH and tobacco control. The systematic adaptation process included formative research and pilot testing, to ensure that the tested intervention was tailored to the local setting. We used qualitative methods and process evaluation to assess the extent to which this intervention was implemented, and to explore barriers to implementation. Results While participating worksites agreed to implement this intervention, not all components of the adapted intervention were implemented fully in the 10 worksites assigned to the intervention condition. We found that the OSH infrastructure in India focused predominantly on regulatory compliance, medical screening (secondary prevention) and the treatment of injuries. We observed generally low levels of leadership support and commitment to OSH, evidenced by minimal management participation in the intervention, reluctance to discuss OSH issues with the study team or workers, and little receptivity to recommendations resulting from the industrial hygienist's reports. Conclusion India presents one example of a LMIC with a rising burden of non-communicable diseases and intensified exposures to both physical and organizational hazards on the job. Our experiences highlight the importance of national and global trends that shape workers' experiences on the job and their related health outcomes. Beyond a singular focus on prevention of non-communicable diseases, coordinated national and international efforts are needed to address worker health outcomes in the context of the conditions of work that clearly shape them.	[Sorensen, Glorian; Nagler, Eve M.] Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA; [Sorensen, Glorian; Nagler, Eve M.; Gupta, Prakash C.; Pednekar, Mangesh S.; Wagner, Gregory R.] Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA; [Pawar, Pratibha; Gupta, Prakash C.; Pednekar, Mangesh S.] Sekhsaria Inst Publ Hlth, Healis, Navi Mumbai, India	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health	Sorensen, G (corresponding author), Dana Farber Canc Inst, Ctr Community Based Res, Boston, MA 02115 USA.; Sorensen, G (corresponding author), Harvard TH Chan Sch Publ Hlth, Boston, MA 02115 USA.	Glorian_Sorensen@dfci.harvard.edu	Wagner, Gregory R/B-1014-2009	Sorensen, Glorian/0000-0001-6625-7931; Pednekar, Mangesh/0000-0001-6266-5356	National Institutes of Health, National Cancer Institute [R01 CA140304, K05 CA10866]	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the National Institutes of Health, National Cancer Institute (http://www.cancer.gov/), grant number R01 CA140304 and K05 CA10866 to GS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotram R. V., 2005, Indian Journal of Occupational and Environmental Medicine, V9, P10; Ahuja R., 2007, HLTH WORKPLACE CORPO; Anger WK, 2015, J OCCUP HEALTH PSYCH, V20, P226, DOI 10.1037/a0038340; Baggs J, 2003, AM J IND MED, V43, P483, DOI 10.1002/ajim.10209; Baker EL., 2011, OCCUPATIONAL ENV HLT, P428; Benach J, 2007, FINAL REPORT WHO COM; Bertera R L, 1993, Am J Health Promot, V7, P365; BERTERA RL, 1990, AM J PUBLIC HEALTH, V80, P1101, DOI 10.2105/AJPH.80.9.1101; Bloom DE, 2014, EC NONCOMMUNICABLE D; Bloom DE, 2011, GLOBAL EC BURDEN NON; Brecker N, 2010, OCCUP MED-OXFORD, V60, P577, DOI 10.1093/occmed/kqq104; Buck Consultants, 2009, WORK WELL GLOB SURV; Bureau of Indian Standards, 14489 IS; Burton J., 2010, WHO HLTH WORKPLACE F; Cherniack M, 2013, J OCCUP ENVIRON MED, V55, pS38, DOI 10.1097/JOM.0000000000000044; Cordeira LS, 2015, HLTH ED RES; Council N. R., 2001, MUSC DIS WORKPL LOW; Council on Foreign Relations, 2014, EM CRIS NONC DIS; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Department of Health and Human Services, DHHS NIOSH PUBL; DEVEREUX RB, 1991, J HYPERTENS, V9, pS34; Elliot DL, 2007, J OCCUP ENVIRON MED, V49, P204, DOI 10.1097/JOM.0b013e3180329a8d; Etheredge LM, 2007, HEALTH AFFAIR, V26, pW107, DOI 10.1377/hlthaff.26.2.w107; Farmer P, 2010, LANCET, V376, P1186, DOI 10.1016/S0140-6736(10)61152-X; Feltner C, 2016, ANN INTERN MED, V165, P262, DOI 10.7326/M16-0626; Fitzgerald JL, 2013, AUST HEALTH REV, V37, P199, DOI 10.1071/AH12238; Fustukian S., 2002, HLTH POLICY GLOBALIS, P208; Ghodasara NB, 1992, INDIAN J ENV PROTECT, V12, P50; Glasgow RE, 2011, TRANSL BEHAV MED, V1, P201, DOI 10.1007/s13142-011-0047-x; Glass RI, 2013, JAMA-J AM MED ASSOC, V310, P903, DOI 10.1001/jama.2013.276558; Goetzel RZ, 2001, J OCCUP ENVIRON MED, V43, P10, DOI 10.1097/00043764-200101000-00003; Goetzel RZ, 2012, NIOSH 2012 RES COMPE; Grotto I, 2008, CURR OPIN CARDIOL, V23, P335, DOI 10.1097/HCO.0b013e3283021c70; Guazzi M, 2014, PROG CARDIOVASC DIS, V56, P508, DOI 10.1016/j.pcad.2013.11.003; Guidotti Tee L., 2011, GLOBAL OCCUPATIONAL; Gupta PC, 2014, INDIAN J CANCER, V51, P67, DOI 10.4103/0019-509X.147476; Hakim D., 2015, NY TIMES; Harrington JM, 1999, ANN OCCUP HYG, V43, P1; Hlobil H, 2007, EUR SPINE J, V16, P919, DOI 10.1007/s00586-006-0283-9; Hogstedt C, 2007, GLOBALIZATION HLTH, P138, DOI DOI 10.1093/ACPROF:OSO/9780195172997.003.0008; Howard J., 2015, NIOSH E NEWS     APR; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Hunt MK, 2005, HEALTH EDUC BEHAV, V32, P10, DOI 10.1177/1090198104264216; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS STUD; Institute of Medicine, 2005, INT EMPL HLTH MOD PR; International Institute for Population Sciences, 2010, GLOB AD TOB SURV GAT; International Labour Office, 2009, WORK IMPR SMALL ENT; International Labour Office, LIST ILO CONV REC; International Labour Office (ILO), 2001, ILO OSH 2001 GUID OC; International Labour Organization [ILO], 2016, INT LAB C 105 SESS; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Kawakami T, 2015, WORK IMPROVEMENT NEI; Kessler R, 2011, AM J PREV MED, V40, P637, DOI 10.1016/j.amepre.2011.02.023; Kondracki NL, 2002, J NUTR EDUC BEHAV, V34, P224, DOI 10.1016/S1499-4046(06)60097-3; LaMontagne AD, 2005, AM J IND MED, V48, P282, DOI 10.1002/ajim.20218; LaMontagne AD, 2004, OCCUP ENVIRON MED, V61, P651, DOI 10.1136/oem.2003.011718; LaMontagne AD, 2014, UNDERSTANDING HLTH D; Leigh J, 1999, EPIDEMIOLOGY, V10, P626, DOI 10.1097/00001648-199909000-00032; Lobb R, 2013, ANNU REV PUBL HEALTH, V34, P235, DOI 10.1146/annurev-publhealth-031912-114444; Loeppke RR, 2015, J OCCUP ENVIRON MED, V57, P585, DOI 10.1097/JOM.0000000000000467; Lucchini RG, 2015, ANN GLOB HEALTH, V81, P463, DOI 10.1016/j.aogh.2015.08.024; Maes S, 1998, AM J PUBLIC HEALTH, V88, P1037, DOI 10.2105/AJPH.88.7.1037; McKleroy VS, 2006, AIDS EDUC PREV, V18, P59, DOI 10.1521/aeap.2006.18.supp.59; McLellan D, 2011, SAFEWELL PRACTICE GU; McMichael C, 2005, J PUBLIC HEALTH-UK, V27, P215, DOI 10.1093/pubmed/fdi024; Mendel P, 2008, ADM POLICY MENT HLTH, V35, P21, DOI 10.1007/s10488-007-0144-9; Mendes R, 2011, GLOBAL OCCUPATIONAL; Merllie A D, 2004, LABOUR MARKET TRENDS; Miles M.B., 2019, QUALITATIVE DATA ANA, Vfourth; Morse J. M., 1995, QUALITATIVE RES METH; Nagler EM, 2013, HEALTH EDUC RES, V28, P113, DOI 10.1093/her/cys060; [Occupational Safety and Health Administration Labor Do], 2015, LAB DO; Okechukwu CA, 2009, CANCER CAUSE CONTROL, V20, P887, DOI 10.1007/s10552-009-9324-0; Oldenburg B, 2011, TRANSL BEHAV MED, V1, P252, DOI 10.1007/s13142-011-0051-1; Olson R, 2009, J OCCUP ENVIRON MED, V51, P1233, DOI 10.1097/JOM.0b013e3181c1dc7a; Pingle S, 2012, IND HEALTH, V50, P167, DOI 10.2486/indhealth.MS1366; Prabhakaran D, 2009, J AM COLL CARDIOL, V53, P1718, DOI 10.1016/j.jacc.2008.12.062; Pronk NP, 2013, J OCCUP ENVIRON MED, V55, pS30, DOI 10.1097/JOM.0000000000000031; Pronk NP, 2012, PREV CHRONIC DIS, V9, pE154, DOI DOI 10.5888/PCD9110323]; Punnett L, 2013, J OCCUP ENVIRON MED, V55, pS19, DOI 10.1097/JOM.0000000000000040; Quinlan M, 2001, INT J HEALTH SERV, V31, P507, DOI 10.2190/22BK-9XC0-AK7L-M6QH; Rantanen J, 2011, GLOBAL OCCUPATIONAL; Reddy KS, 2006, B WORLD HEALTH ORGAN, V84, P461, DOI 10.2471/BLT.05.027037; Reddy KS, REPORT TOBACCO CONTR; Robertson MM, 2013, APPL ERGON, V44, P73, DOI 10.1016/j.apergo.2012.05.001; Safe Work Australia, WORKPL HLTH SAF BUS; Saiyed HN, 2004, IND HEALTH, V42, P141, DOI 10.2486/indhealth.42.141; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Schill AL, 2013, J OCCUP ENVIRON MED, V55, pS8, DOI 10.1097/JOM.0000000000000037; Schnall PL, 2016, INT J HEALTH SERV, V46, P656, DOI 10.1177/0020731416664687; Schulte P, 2010, SCAND J WORK ENV HEA, V36, P422, DOI 10.5271/sjweh.3076; Sharma DC, 1998, LANCET, V352, P1204, DOI 10.1016/S0140-6736(05)60546-6; Shaw William S, 2006, Work, V26, P107; Shaw WS, 2003, J OCCUP REHABIL, V13, P129, DOI 10.1023/A:1024997000505; Siegrist J, 2004, SOC SCI MED, V58, P1463, DOI 10.1016/S0277-9536(03)00349-6; Silverstein M, 2008, AM J PUBLIC HEALTH, V98, P416, DOI 10.2105/AJPH.2007.117382; Sinha DN, 2014, INDIAN J CANCER, V51, P73, DOI 10.4103/0019-509X.147477; Sorensen G, 1998, AM J PUBLIC HEALTH, V88, P1685, DOI 10.2105/AJPH.88.11.1685; Sorensen G, 2002, CANCER CAUSE CONTROL, V13, P493, DOI 10.1023/A:1016385001695; Sorensen G, 2003, PREV MED, V37, P188, DOI 10.1016/S0091-7435(03)00111-7; Sorensen G, 2005, AM J PUBLIC HEALTH, V95, P1389, DOI 10.2105/AJPH.2004.038745; Sorensen G, 2004, STEPS HEALTHIER US W; Sorensen G, 2016, TOB CONTROL; Sorensen G, 2007, CANCER CAUSE CONTROL, V18, P51, DOI 10.1007/s10552-006-0076-9; Sorensen G, 2016, PREV MED, V91, P188, DOI 10.1016/j.ypmed.2016.08.005; Sorensen G, 2013, J OCCUP ENVIRON MED, V55, pS12, DOI 10.1097/JOM.0000000000000032; Sorensen G, 2011, AM J PUBLIC HEALTH, V101, pS196, DOI 10.2105/AJPH.2010.300075; Sorensen G, 2009, TOWARD THE ELIMINATION OF CANCER DISPARITIES: CLINICAL AND PUBLIC HEALTH PERSPECTIVES, P83, DOI 10.1007/978-0-387-89443-0_4; Stewart B.W., 2003, WORLD CANC REPORT; Takala J, 1999, EPIDEMIOLOGY, V10, P640, DOI 10.1097/00001648-199909000-00034; Taylor DW, 2010, BURDEN NONCOMMUNICAB; Thakur Jarnail Singh, 2012, Indian J Occup Environ Med, V16, P108, DOI 10.4103/0019-5278.111750; Trupin E, 2014, JAMA PEDIATR, V168, P985, DOI 10.1001/jamapediatrics.2014.1157; Tsutsumi A, 2009, J OCCUP ENVIRON MED, V51, P554, DOI 10.1097/JOM.0b013e3181a24d28; United Nations, 2015, GLOB IMP; US Congress Office of Technology Assessment, 1995, PUBL OTA ENV; Vahtera J, 1999, J EPIDEMIOL COMMUN H, V53, P399, DOI 10.1136/jech.53.7.399; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; *WHO, 2007, EMPL COND HLTH IN FI; Wingood GM, 2008, JAIDS-J ACQ IMM DEF, V47, pS40, DOI 10.1097/QAI.0b013e3181605df1; World Economic Forum, WORKPL WELLN IND; World Economic Forum, 2009, IND INN WORKPL WELLN; World Health Organization, 1997, TOB HLTH GLOB STAT C; World Health Organization, 2011, EXECUTIVE SUMMARY; World Health Organization, 1995, REC 2 M WHO COLL CTR	125	9	9	3	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182607	10.1371/journal.pone.0182607	http://dx.doi.org/10.1371/journal.pone.0182607			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837688	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000022
J	Watanabe, T; Shibasaki, M; Maruyama, F; Sekizaki, T; Nakagawa, I				Watanabe, Takayasu; Shibasaki, Masaki; Maruyama, Fumito; Sekizaki, Tsutomu; Nakagawa, Ichiro			Investigation of potential targets of Porphyromonas CRISPRs among the genomes of Porphyromonas species	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; HORIZONTAL TRANSFER; GENE-TRANSFER; CAS SYSTEMS; SMALL RNA; SP NOV.; CD-HIT; GINGIVALIS; SEQUENCE; BACTERIA	The oral bacterial species Porphyromonas gingivalis, a periodontal pathogen, has plastic genomes that may be driven by homologous recombination with exogenous deoxyribonucleic acid (DNA) that is incorporated by natural transformation and conjugation. However, bacteriophages and plasmids, both of which are main resources of exogenous DNA, do not exist in the known P. gingivalis genomes. This could be associated with an adaptive immunity system conferred by clustered regularly interspaced short palindromic repeat (CRISPR) and CRISPR-associated (cas) genes in P. gingivalis as well as innate immune systems such as a restriction-modification system. In a previous study, few immune targets were predicted for P. gingivalis CRISPR/Cas. In this paper, we analyzed 51 P. gingivalis genomes, which were newly sequenced, and publicly available genomes of 13 P. gingivalis and 46 other Porphyromonas species. We detected 6 CRISPR/Cas types (classified by sequence similarity of repeat) in P. gingivalis and 12 other types in the remaining species. The Porphyromonas CRISPR spacers with potential targets in the genus Porphyromonas were approximately 23 times more abundant than those with potential targets in other genus taxa (1,720/6,896 spacers vs. 74/6,896 spacers). Porphyromonas CRISPR/Cas may be involved in genome plasticity by exhibiting selective interference against intra-and interspecies nucleic acids.	[Watanabe, Takayasu; Sekizaki, Tsutomu] Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Lab Food Borne Pathogen Microbiol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan; [Shibasaki, Masaki] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Oral Implantol & Regenerat Dent Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo, Japan; [Maruyama, Fumito; Nakagawa, Ichiro] Kyoto Univ, Grad Sch Med, Dept Microbiol, Sakyo Ku, Yoshida Konoe Cho, Kyoto, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Kyoto University	Watanabe, T (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Res Ctr Food Safety, Lab Food Borne Pathogen Microbiol,Bunkyo Ku, 1-1-1 Yayoi, Tokyo, Japan.	atakawat@mail.ecc.u-tokyo.ac.jp	Maruyama, Fumito/AAK-5928-2020; Sekizaki, Tsutomu/AAB-1816-2021	Maruyama, Fumito/0000-0003-2347-616X; Sekizaki, Tsutomu/0000-0002-8899-2504; Watanabe, Takayasu/0000-0001-5487-8191	Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant [JP12J05796, JP14J02840, JP26861544, JP16K08015]	Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant	This work was supported by the Japan Society for the Promotion of Science (Tokyo, Japan) KAKENHI Grant Numbers JP12J05796, JP14J02840, JP26861544, and JP16K08015 (to TW). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aklujkar M, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-230; Alkhnbashi OS, 2014, BIOINFORMATICS, V30, pI489, DOI 10.1093/bioinformatics/btu459; Aronesty E., 2013, OPEN BIOINFORM J, V7, P1, DOI 10.2174/1875036201307010001; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Baltrus DA, 2009, GENOME DYNAM, V6, P75, DOI 10.1159/000235764; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Bland C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-209; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Burmistrz M, 2015, J BACTERIOL, V197, P2631, DOI 10.1128/JB.00261-15; Cady KC, 2011, J BACTERIOL, V193, P3433, DOI 10.1128/JB.01411-10; Chakraborty S, 2010, MOL PHYLOGENET EVOL, V56, P878, DOI 10.1016/j.ympev.2010.05.020; COYKENDALL AL, 1980, INT J SYST BACTERIOL, V30, P559, DOI 10.1099/00207713-30-3-559; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Cugini C, 2013, J ORAL MICROBIOL, V5, DOI 10.3402/jom.v5i0.19804; Darmon E, 2014, MICROBIOL MOL BIOL R, V78, P1, DOI 10.1128/MMBR.00035-13; Dewhirst FE, 2010, J BACTERIOL, V192, P5002, DOI 10.1128/JB.00542-10; Didelot X, 2010, TRENDS MICROBIOL, V18, P315, DOI 10.1016/j.tim.2010.04.002; Dziarski R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146162; Eggerth AH, 1933, J BACTERIOL, V25, P389, DOI 10.1128/JB.25.4.389-413.1933; ENERSEN M, 2011, J ORAL MICROBIOL, P3; Fournier D, 2001, INT J SYST EVOL MICR, V51, P1179, DOI 10.1099/00207713-51-3-1179; Foxman EF, 2011, NAT REV MICROBIOL, V9, P254, DOI 10.1038/nrmicro2541; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goessweiner-Mohr N, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.PLAS-0004-2013; Hanage WP, 2006, J THEOR BIOL, V239, P210, DOI 10.1016/j.jtbi.2005.08.035; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Jorth P, 2012, MBIO, V3, DOI 10.1128/mBio.00309-12; Karginov FV, 2010, MOL CELL, V37, P7, DOI 10.1016/j.molcel.2009.12.033; Koehler A, 2003, MICROBIOL-SGM, V149, P2407, DOI 10.1099/mic.0.26267-0; Kong Y, 2013, GENOME BIOL EVOL, V5, P1611, DOI 10.1093/gbe/evt116; Lamont RJ, 1998, MICROBIOL MOL BIOL R, V62, P1244, DOI 10.1128/MMBR.62.4.1244-1263.1998; Lange SJ, 2013, NUCLEIC ACIDS RES, V41, P8034, DOI 10.1093/nar/gkt606; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; McLean JS, 2013, GENOME RES, V23, P867, DOI 10.1101/gr.150433.112; Mell JC, 2014, J BACTERIOL, V196, P1471, DOI 10.1128/JB.01293-13; Naito M, 2008, DNA RES, V15, P215, DOI 10.1093/dnares/dsn013; Naito M, 2011, MICROBIOL-SGM, V157, P2022, DOI 10.1099/mic.0.047803-0; Nelson KE, 2003, J BACTERIOL, V185, P5591, DOI 10.1128/JB.185.18.5591-5601.2003; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ogier JC, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-568; Ohyama A, 2006, J COMPUT AIDED CHEM, V7, P102, DOI 10.2751/jcac.7.102; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Phillips P, 2014, FEMS MICROBIOL LETT, V351, P202, DOI 10.1111/1574-6968.12320; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Sakamoto M, 2006, INT J SYST EVOL MICR, V56, P1599, DOI 10.1099/ijs.0.64192-0; Salmond GPC, 2015, NAT REV MICROBIOL, V13, P777, DOI 10.1038/nrmicro3564; SALYERS AA, 1995, MICROBIOL REV, V59, P579, DOI 10.1128/MMBR.59.4.579-590.1995; Samson JE, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.PLAS-0034-2014; Schoen C, 2009, VACCINE, V27, pB103, DOI 10.1016/j.vaccine.2009.04.064; Serbanescu MA, 2015, J BACTERIOL, V197, P749, DOI 10.1128/JB.02333-14; SMITH JM, 1993, P NATL ACAD SCI USA, V90, P4384, DOI 10.1073/pnas.90.10.4384; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sorek R, 2013, ANNU REV BIOCHEM, V82, P237, DOI 10.1146/annurev-biochem-072911-172315; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Suominen I, 2003, INT J SYST EVOL MICR, V53, P1369, DOI 10.1099/ijs.0.02277-0; Tribble GD, 2007, J BACTERIOL, V189, P6382, DOI 10.1128/JB.00460-07; Tribble GD, 2013, FUTURE MICROBIOL, V8, P607, DOI [10.2217/FMB.13.30, 10.2217/fmb.13.30]; Tribble GD, 2012, MBIO, V3, DOI 10.1128/mBio.00231-11; Vasu K, 2013, MICROBIOL MOL BIOL R, V77, P53, DOI 10.1128/MMBR.00044-12; Vos M, 2009, TRENDS MICROBIOL, V17, P226, DOI 10.1016/j.tim.2009.03.001; Watanabe T, 2013, GENOME BIOL EVOL, V5, P1099, DOI 10.1093/gbe/evt075; Watanabe T, 2011, J BACTERIOL, V193, P4259, DOI 10.1128/JB.05269-11; WYSS C, 1992, J CLIN MICROBIOL, V30, P2225, DOI 10.1128/JCM.30.9.2225-2229.1992; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zou SM, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0177-y	68	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183752	10.1371/journal.pone.0183752	http://dx.doi.org/10.1371/journal.pone.0183752			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837670	Green Submitted, gold, Green Published			2022-12-27	WOS:000408365000110
J	Almasud, AA; Giles, KH; Miklavcic, JJ; Martins, KJB; Baracos, VE; Putman, CT; Guan, LL; Mazurak, VC				Almasud, Alaa A.; Giles, Kaitlin H.; Miklavcic, John J.; Martins, Karen J. B.; Baracos, Vickie E.; Putman, Charles T.; Guan, Leluo L.; Mazurak, Vera C.			Fish oil mitigates myosteatosis and improves chemotherapy efficacy in a preclinical model of colon cancer	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; SKELETAL-MUSCLE DEPLETION; TRANSCRIPTION FACTORS; PROGNOSTIC-FACTOR; RATS BEARING; PPAR-GAMMA; MASS; SUPPLEMENTATION; PROGRESSION; EXPRESSION	Background This study aimed to assess whether feeding a diet containing fish oil was efficacious in reducing tumor-and subsequent chemotherapy-associated myosteatosis, and improving tumor response to treatment. Methods Female Fischer 344 rats were fed either a control diet for the entire study (control), or switched to a diet containing fish oil (2.0 g/100 g of diet) one week prior to tumor implantation (long term fish oil) or at the start of chemotherapy (adjuvant fish oil). Chemotherapy (irinotecan plus 5-fluorouracil) was initiated 2 weeks after tumor implantation (cycle-1) and 1 week thereafter (cycle-2). Reference animals received no tumor or treatment and only consumed the control diet. All skeletal muscle measures were conducted in the gastrocnemius. To assess myosteatosis, lipids were assessed histologically by Oil Red O staining and total triglyceride content was quantified by gas chromatography. Expression of adipogenic transcription factors were assessed at the mRNA level by real-time RT-PCR. Results Feeding a diet containing fish oil significantly reduced tumor-and subsequent chemotherapy-associated increases in skeletal muscle neutral lipid (p<0.001) and total triglyceride content (p<0.03), and expression of adipogenic transcription factors (p<0.01) compared with control diet fed animals. The adjuvant fish oil diet was as effective as the long term fish oil diet in mitigating chemotherapy-associated skeletal muscle fat content, and in reducing tumor volume during chemotherapy compared with control fed animals (p<0.01). Conclusion Long term and adjuvant fish oil diets are equally efficacious in reducing chemotherapy-associated myosteatosis that may be occurring by reducing expression of transcription factors involved in adipogenesis/lipogenesis, and improving tumor-response to chemotherapy in a neoplastic model.	[Almasud, Alaa A.; Giles, Kaitlin H.; Miklavcic, John J.; Martins, Karen J. B.; Mazurak, Vera C.] Univ Alberta, Dept Agr Food & Nutrit Sci, Alberta Inst Human Nutr, Edmonton, AB, Canada; [Baracos, Vickie E.] Univ Alberta, Dept Oncol, Palliat Care Med, Edmonton, AB, Canada; [Putman, Charles T.] Univ Alberta, Fac Med & Dent, Neurosci & Mental Hlth Inst, Exercise Biochem Lab,Fac Phys Educ & Recreat, Edmonton, AB, Canada; [Guan, Leluo L.] Univ Alberta, Dept Agr Food & Nutr Sci, Funct Genom & Microbiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta; University of Alberta	Mazurak, VC (corresponding author), Univ Alberta, Dept Agr Food & Nutrit Sci, Alberta Inst Human Nutr, Edmonton, AB, Canada.	vera.mazurak@ualberta.ca	; Mazurak, Vera/J-5136-2014	Almasud, Alaa/0000-0003-0758-9818; Miklavcic, John/0000-0001-7676-1939; Mazurak, Vera/0000-0002-7724-6354	Canadian Institutes of Health Research [259704]; Ministry of Highly Educated of Saudi Arabia Scholarship; Saudi Arabian Cultural Bureau; University of Alberta	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ministry of Highly Educated of Saudi Arabia Scholarship; Saudi Arabian Cultural Bureau; University of Alberta(University of Alberta)	This study was funded by the Canadian Institutes of Health Research (259704). Alaa Almasud was funded by the Ministry of Highly Educated of Saudi Arabia Scholarship, Saudi Arabian Cultural Bureau. Kaitlin Giles was funded by the Queen Elizabeth II scholarship from the University of Alberta.; Financial funding support for this research was supported by a grant from the Canadian Institutes of Health Research (Operating grant 259704). The authors of this manuscript would like to thank Yanhong Chen and Rebecca Kong from Dr. Guan's Lab for technical assistance. Abha Dunichand-Hoedl is also acknowledged for her expertise in assisting with the animal experiments.	An L, 2012, BIOCHEM BIOPH RES CO, V428, P405, DOI 10.1016/j.bbrc.2012.10.068; Antoun S, 2013, CANCER-AM CANCER SOC, V119, P3377, DOI 10.1002/cncr.28218; Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Baracos VE, 2004, NUTR RES REV, V17, P177, DOI 10.1079/NRR200488; Blauwhoff-Buskermolen S, 2016, J CLIN ONCOL, V34, P1339, DOI 10.1200/JCO.2015.63.6043; Bougnoux P, 2009, BRIT J CANCER, V101, P1978, DOI 10.1038/sj.bjc.6605441; Brey CW, 2009, INT J BIOL SCI, V5, P622; Chircop M, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00304; Conklin Kenneth A, 2002, Altern Med Rev, V7, P4; Ewaschuk JB, 2014, APPL PHYSIOL NUTR ME, V39, P654, DOI 10.1139/apnm-2013-0423; FOLCH J, 1957, J BIOL CHEM, V226, P497; Grounds MD, 2014, AM J PATHOL, V184, P1668, DOI 10.1016/j.ajpath.2014.02.005; Hajjaji N, 2013, CANCER TREAT REV, V39, P473, DOI 10.1016/j.ctrv.2012.07.001; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Hu SM, 2012, MOL ENDOCRINOL, V26, P977, DOI 10.1210/me.2011-1253; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Lee SJ, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/327167; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Liu MH, 2014, SCI REP-UK, V4, DOI 10.1038/srep05538; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marchildon F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145583; Martin L, 2013, J CLIN ONCOL, V31, P1539, DOI 10.1200/JCO.2012.45.2722; Miyamoto Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129742; Morland S. L., 2016, Journal of Nutrition & Intermediary Metabolism, V5, P107, DOI 10.1016/j.jnim.2016.05.001; Moro C, 2008, AM J PHYSIOL-ENDOC M, V294, pE203, DOI 10.1152/ajpendo.00624.2007; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P3774, DOI 10.1002/cncr.25933; Murphy RA, 2011, CANCER-AM CANCER SOC, V117, P1775, DOI 10.1002/cncr.25709; Murphy RA, 2010, J NUTR, V140, P1602, DOI 10.3945/jn.110.123521; Piotrowska M, 2012, ACTA PHYSL, V205, P145; Pratt VC, 2002, BRIT J CANCER, V87, P1370, DOI 10.1038/sj.bjc.6600659; Rollins KE, 2016, CLIN NUTR, V35, P1103, DOI 10.1016/j.clnu.2015.08.005; Sabel MS, 2011, ANN SURG ONCOL, V18, P3579, DOI 10.1245/s10434-011-1976-9; Sekiya M, 2008, BIOCHEM BIOPH RES CO, V375, P602, DOI 10.1016/j.bbrc.2008.08.068; Stephens NA, 2011, J CACHEXIA SARCOPENI, V2, P111, DOI 10.1007/s13539-011-0030-x; Todorcevic M, 2016, J CLIN MED, V5, DOI 10.3390/jcm5010003; Xue HY, 2007, CLIN CANCER RES, V13, P7146, DOI 10.1158/1078-0432.CCR-07-0823; Xue HY, 2009, BRIT J NUTR, V102, P434, DOI 10.1017/S0007114508199482	37	21	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183576	10.1371/journal.pone.0183576	http://dx.doi.org/10.1371/journal.pone.0183576			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832677	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800066
J	Huang, ZJ; Lu, Q; Wang, J; Chen, X; Mao, XY; He, ZL				Huang, Zhujian; Lu, Qin; Wang, Jun; Chen, Xian; Mao, Xiaoyun; He, Zhenli			Inhibition of the bioavailability of heavy metals in sewage sludge biochar by adding two stabilizers	PLOS ONE			English	Article							SOILS; SPECIATION; HYPERACCUMULATOR; REMEDIATION; PYROLYSIS; PB	Agricultural application of sewage sludge (SS) after carbonization is a plausible way for disposal. Despite its benefits of improving soil fertility and C sequestration, heavy metals contained in sewage sludge biochars (SSB) are still a concern. In this study, two types of heavy metal stabilizers were chosen: fulvic acid (FA) and phosphogypsum (with CaSO4, CS, as the main component). The two stabilizers were incorporated into SS prior to 350 degrees C carbonization for 1 h at the rates of 1%, 2%, or 4%. The obtained SSBs were then analyzed by Fourier transform infrared spectroscopy (FTIR) and X-ray photoelectron spectroscopy (XPS). Total and available concentrations of four heavy metals, i.e., Zn, Pb, Cd, and Ni, in the SSBs were determined. In addition, a series of pot soil culture experiments was conducted to investigate the effects of stabilizers incorporation into SSB on heavy metal bioavailability and the uptake by plants (corn as an indicator) and plant biomass yield, with SS and SSB (no stabilizers) as controls. The results showed that incorporation of both FA and CS increased functional groups such as carboxyl, phenol, hydroxyl, amine and quinine groups in the SSBs. The percentage of heavy metals in sulfuric and oxidizable state and residual state of SSBs were significantly increased after carbonization, and hence the mobility of the heavy metals in SSBs was decreased. The introduction of the stabilizers (i.e., FA or CS) significantly lowered the total and available concentrations of Zn, Pb, Cd, and Ni. The reduction in available heavy metal concentration increased with incorporation rate of the stabilizers from 1% to 4%. In the treatments with FA or CS incorporated SSB, less heavy metals were taken up by plants and more plant biomass yields were obtained. The mitigating effects were more pronounced at higher rates of FA or CS stabilizer. These findings provide a way to lower bioavailability of heavy metals in SS or SSB for land application or horticulture as a peat substitute.	[Huang, Zhujian; Lu, Qin; Wang, Jun; Chen, Xian; Mao, Xiaoyun] South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China; [Huang, Zhujian] Guangdong Prov Key Lab Environm Pollut Control &, Guangzhou, Guangdong, Peoples R China; [He, Zhenli] Univ Florida, Inst Food & Agr Sci, Indian River Res & Educ Ctr, Ft Pierce, FL USA	South China Agricultural University; State University System of Florida; University of Florida	Mao, XY (corresponding author), South China Agr Univ, Coll Nat Resources & Environm, Guangzhou, Guangdong, Peoples R China.	xymao@scau.edu.cn	He, Zhenli/A-4773-2008		Natural Science Foundation of China [51509093]; Science and Technology Project of Guangdong Province [20166020242005, 20156020215012, 2014A050503065, 2017A020216025]; Science and Technology Project of Guangzhou City [201508030039, 201504282153571]; Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology [2016K0014]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Project of Guangdong Province; Science and Technology Project of Guangzhou City; Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology	This work was supported by the grants (51509093) from Natural Science Foundation of China, the grants (20166020242005, 20156020215012, 2014A050503065 and 2017A020216025) from the Science and Technology Project of Guangdong Province, the grants (201508030039 and 201504282153571) from the Science and Technology Project of Guangzhou City and the grant (2016K0014) from the Research Fund Program of Guangdong Provincial Key Laboratory of Environmental Pollution Control and Remediation Technology.	Angelova V, 2004, J PLANT NUTR, V27, P757, DOI 10.1081/PLN-120030609; Hossain MK, 2010, CHEMOSPHERE, V78, P1167, DOI 10.1016/j.chemosphere.2010.01.009; Huang ZJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159802; Huang ZJ, 2016, APPL SURF SCI, V370, P209, DOI 10.1016/j.apsusc.2016.02.126; Koppolu L, 2003, BIOMASS BIOENERG, V24, P69, DOI 10.1016/S0961-9534(02)00074-0; Luo F, 2014, ENVIRON SCI POLLUT R, V21, P8707, DOI 10.1007/s11356-014-2797-8; Ma LQ, 1999, WATER AIR SOIL POLL, V110, P1, DOI 10.1023/A:1005025708044; Macias F, 2017, PROCED EARTH PLAN SC, V17, P666, DOI 10.1016/j.proeps.2016.12.178; Mahmoud E, 2015, LAND DEGRAD DEV, V26, P819, DOI 10.1002/ldr.2288; Mendez A, 2017, BIOL AGRIC HORTIC, V33, P40, DOI 10.1080/01448765.2016.1185645; Mendez A, 2012, CHEMOSPHERE, V89, P1354, DOI 10.1016/j.chemosphere.2012.05.092; Rijkenberg MJA, 2010, SCI TOTAL ENVIRON, V408, P1212, DOI 10.1016/j.scitotenv.2009.11.053; Shin W, 2016, J SOIL SEDIMENT, V16, P726, DOI 10.1007/s11368-015-1279-z; Sun Y, 2014, INT J PHYTOREMEDIAT, V16, P496, DOI 10.1080/15226514.2013.798617; Sun YB, 2016, FRONT ENV SCI ENG, V10, P85, DOI 10.1007/s11783-014-0689-2; Szolnoki Z, 2013, WATER AIR SOIL POLL, V224, DOI 10.1007/s11270-013-1737-4; Tang WW, 2014, SCI TOTAL ENVIRON, V468, P1014, DOI 10.1016/j.scitotenv.2013.09.044; Umoren I. U., 2007, Environmentalist, V27, P241, DOI 10.1007/s10669-007-9001-3; Walter I, 2006, ENVIRON POLLUT, V139, P507, DOI 10.1016/j.envpol.2005.05.020; Wang Jun, 2015, Journal of South China Agricultural University, V36, P54; Xu DB, 2012, PEDOSPHERE, V22, P815, DOI 10.1016/S1002-0160(12)60067-8; Xue T, 2013, PEDOSPHERE, V23, P265, DOI 10.1016/S1002-0160(13)60015-6; Yin HB, 2016, CHEM ENG J, V285, P112, DOI 10.1016/j.cej.2015.09.108; Zanini S, 2005, SURF COAT TECH, V200, P953, DOI 10.1016/j.surfcoat.2005.01.093; Zhang SQ, 2017, CHEMOSPHERE, V166, P334, DOI 10.1016/j.chemosphere.2016.09.095	25	25	25	9	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183617	10.1371/journal.pone.0183617	http://dx.doi.org/10.1371/journal.pone.0183617			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832651	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800072
J	Sheng, L; Li, ZH				Sheng, Lei; Li, Zhaohui			Adjuvant treatment with monosialoganglioside may improve neurological outcomes in neonatal hypoxic-ischemic encephalopathy: A meta-analysis of randomized controlled trials	PLOS ONE			English	Article							ASPHYXIA; GANGLIOSIDE; BRAIN	Background Ganglioside has a neuroprotective role in neonatal hypoxic-ischemic encephalopathy (HIE). This study aimed to evaluate the neurological outcomes of monosialoganglioside as adjuvant treatment for neonatal HIE by conducting a meta-analysis. Methods A comprehensive literature search was made in the Pubmed, EMBASE, Cochrane Library, Wanfang, CNKI, VIP databases through October 2016. Randomized controlled trials comparing monosialoganglioside with the usual treatment for newborns having HIE deemed eligible. Weighted mean difference (WMD) and risk ratio (RR) with 95% confidence interval (CI) were calculated for continuous and dichotomous data, respectively. Results Ten trials consisting of 787 neonates were included. Adjuvant treatment with monosialoganglioside significantly reduced major neurodevelopmental disabilities (RR = 0.35; 95% CI = 0.21-0.57), cerebral palsy (RR = 0.32; 95% CI = 0.12-0.87), mental retardation (RR = 0.31; 95% CI = 0.11-0.88) as well as improved the mental (WMD = 14.95; 95% CI = 7.44-22.46) and psychomotive (WMD = 13.40; 95% CI = 6.69-20.11) development index during the follow-up. Also, monosialoganglioside significantly improved Neonatal Behavioral Neurological Assessment scores (WMD = 2.91; 95% CI = 2.05-3.78) compared with the usual treatment. However, adverse effects associated with monosialoganglioside were poorly reported in the included trials. Conclusion Adjuvant treatment with monosialoganglioside had beneficial effects in improving neurological outcomes in neonatal HIE. However, these findings should be interpreted with caution because of methodological flaws in the included trials. Furthermore, safety of monosialoganglioside use should also be further evaluated.	[Sheng, Lei; Li, Zhaohui] First Peoples Hosp Jining, Dept Pediat, Jining, Shandong, Peoples R China		Li, ZH (corresponding author), First Peoples Hosp Jining, Dept Pediat, Jining, Shandong, Peoples R China.	lizhaohuijn@163.com						Ballough GPH, 1998, MOL CHEM NEUROPATHOL, V34, P1, DOI 10.1007/BF02815133; BAO XL, 1991, CHINESE MED J-PEKING, V104, P742; Davidson JO, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00198; de Haan M, 2006, DEVELOPMENTAL SCI, V9, P350, DOI 10.1111/j.1467-7687.2006.00499.x; FERRARI G, 1995, J BIOL CHEM, V270, P3074, DOI 10.1074/jbc.270.7.3074; Gorria M, 2006, BIOCHEM PHARMACOL, V72, P1343, DOI 10.1016/j.bcp.2006.07.014; Jiang L.-L., 2014, SHOCK VIB, V2014, P8, DOI [10.1155/2014/418178, DOI 10.1155/2014/418178]; Kurinczuk JJ, 2010, EARLY HUM DEV, V86, P329, DOI 10.1016/j.earlhumdev.2010.05.010; Lai MC, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/609813; Lau J, 2006, BMJ-BRIT MED J, V333, P597, DOI 10.1136/bmj.333.7568.597; Li P, 2015, CLIN MED ENG, V22, P251; Lu YD, 2008, J APPL CLIN PEDIAR, V23, P150; Lucki NC, 2012, ANNU REV PHYSIOL, V74, P131, DOI 10.1146/annurev-physiol-020911-153321; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Palmano K, 2015, NUTRIENTS, V7, P3891, DOI 10.3390/nu7053891; Ramirez MR, 2003, NEUROSCI RES, V46, P339, DOI 10.1016/S0168-0102(03)00100-7; SARNAT HB, 1976, ARCH NEUROL-CHICAGO, V33, P696, DOI 10.1001/archneur.1976.00500100030012; Shi WH, 2013, CHIN J NERV DIS, V16, P79; Sun YF, 2009, CHIN PRAC MED, V4, P134; THORNBERG E, 1995, ACTA PAEDIATR, V84, P927, DOI 10.1111/j.1651-2227.1995.tb13794.x; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; Xiang JJ, 2005, J CLIN RES, V22, P812; Xie XY, 2016, CHIN PHARM, V27, P1067; Yang X., 2016, J GUANGXI U CHIN MED, V19, P66; Yildiz EP, 2016, EXPERT REV NEUROTHER, P1; Yin FM, 2010, MOD J INTEGR TRADIT, V19, P1739; Zeng L., 2009, CHIN J NERV DIS, V12, P84; Zhang B, 2010, MED J COMMUN, V24, P697; Zhang JJ, 2013, CHIN PHARMACEU, V22, P146; Zhang ZY, 2009, CONT MED, V15, P10; 蔡清, 2009, [中国实用儿科杂志, Chinese Journal of Practical Pediatrics], V24, P968	31	12	15	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183490	10.1371/journal.pone.0183490	http://dx.doi.org/10.1371/journal.pone.0183490			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832625	gold, Green Published, Green Submitted			2022-12-27	WOS:000408355800061
J	Cai, T; McPherson, B; Li, CW; Yang, F				Cai, Ting; McPherson, Bradley; Li, Caiwei; Yang, Feng			Tone perception in Mandarin-speaking school age children with otitis media with effusion	PLOS ONE			English	Article							HEARING-IMPAIRED LISTENERS; SPEECH-PERCEPTION; COCHLEAR IMPLANTS; NOISE; CHINESE; IDENTIFICATION; RECOGNITION; CUES; INTELLIGIBILITY; ACQUISITION	Objectives The present study explored tone perception ability in school age Mandarin-speaking children with otitis media with effusion (OME) in noisy listening environments. The study investigated the interaction effects of noise, tone type, age, and hearing status on monaural tone perception, and assessed the application of a hierarchical clustering algorithm for profiling hearing impairment in children with OME. Methods Forty-one children with normal hearing and normal middle ear status and 84 children with OME with or without hearing loss participated in this study. The children with OME were further divided into two subgroups based on their severity and pattern of hearing loss using a hierarchical clustering algorithm. Monaural tone recognition was measured using a picture-identification test format incorporating six sets of monosyllabic words conveying four lexical tones under speech spectrum noise, with the signal-to-noise ratio (SNR) conditions ranging from -9 to -21 dB. Results Linear correlation indicated tone recognition thresholds of children with OME were significantly correlated with age and pure tone hearing thresholds at every frequency tested. Children with hearing thresholds less affected by OME performed similarly to their peers with normal hearing. Tone recognition thresholds of children with auditory status more affected by OME were significantly inferior to those of children with normal hearing or with minor hearing loss. Younger children demonstrated poorer tone recognition performance than older children with OME. A mixed design repeated-measure ANCOVA showed significant main effects of listening condition, hearing status, and tone type on tone recognition. Contrast comparisons revealed that tone recognition scores were significantly better under -12 dB SNR than under -15 dB SNR conditions and tone recognition scores were significantly worse under -18 dB SNR than those obtained under -15 dB SNR conditions. Tone 1 was the easiest tone to identify and Tone 3 was the most difficult tone to identify for all participants, when considering -12, -15, and -18 dB SNR as within-subject variables. The interaction effect between hearing status and tone type indicated that children with greater levels of OME-related hearing loss had more impaired tone perception of Tone 1 and Tone 2 compared to their peers with lesser levels of OME-related hearing loss. However, tone perception of Tone 3 and Tone 4 remained similar among all three groups. Tone 2 and Tone 3 were the most perceptually difficult tones for children with or without OME-related hearing loss in all listening conditions. Conclusions The hierarchical clustering algorithm demonstrated usefulness in risk stratification for tone perception deficiency in children with OME- related hearing loss. There was marked impairment in tone perception in noise for children with greater levels of OME- related hearing loss. Monaural lexical tone perception in younger children was more vulnerable to noise and OME- related hearing loss than that in older children.	[Cai, Ting; McPherson, Bradley] Univ Hong Kong, Fac Educ, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China; [Li, Caiwei] Shenzhen Childrens Hosp, Dept Otorhinolaryngol, Shenzhen, Peoples R China; [Yang, Feng] Shenzhen Childrens Hosp, Dept Speech Therapy, Shenzhen, Peoples R China	University of Hong Kong	Cai, T (corresponding author), Univ Hong Kong, Fac Educ, Div Speech & Hearing Sci, Hong Kong, Hong Kong, Peoples R China.	caiting13579@gmail.com; hkufrank@163.com			Small Project Fund from the University of Hong Kong [201309176026]; Faculty of Education Research Fund from the University of Hong Kong; Shenzhen Municipal Science and Technology Innovation Committee [JCYJ20140416141331555]	Small Project Fund from the University of Hong Kong; Faculty of Education Research Fund from the University of Hong Kong; Shenzhen Municipal Science and Technology Innovation Committee	This research was supported in part by the Small Project Fund (No. 201309176026, recipient: BM) and Faculty of Education Research Fund (recipient: TC) from the University of Hong Kong. This study was also supported by funding from the Shenzhen Municipal Science and Technology Innovation Committee (No. JCYJ20140416141331555, recipient: FY).; The authors thank the children and families for their kind participation. The authors also are grateful to the medical team in the Shenzhen Children's Hospital, whose support was essential to the completion of this study. This research was supported in part by the Small Project Fund (No. 201309176026) and Faculty of Education Research Fund from the University of Hong Kong. This study was also supported by funding from Shenzhen Municipal Science and Technology Innovation Committee (No. JCYJ20140416141331555).	ABRAMSON AS, 1978, LANG SPEECH, V21, P319, DOI 10.1177/002383097802100406; American National Standard Institute, 2008, S3111999 ANSI; American National Standards Institute, 2007, S3391987 ANSI; [Anonymous], 2011, FRONT PSYCHOL; Cai T, 2017, DISABIL REH IN PRESS, P1; Cai T, 2017, INT J AUDIOL, V56, P65, DOI 10.1080/14992027.2016.1250960; Mondelli MFCG, 2016, BRAZ J OTORHINOLAR, V82, P427, DOI 10.1016/j.bjorl.2015.08.019; CARHART R, 1959, J SPEECH HEAR DISORD, V24, P330, DOI 10.1044/jshd.2404.330; Chan KMK, 2015, NOISE HEALTH, V17, P48, DOI 10.4103/1463-1741.149580; Chen F, 2014, J SPEECH LANG HEAR R, V57, P338, DOI 10.1044/1092-4388(2013/12-0324); Crandell CC, 2000, LANG SPEECH HEAR SER, V31, P362, DOI 10.1044/0161-1461.3104.362; Fu Q-J, 2000, ASIA PAC J SPEECH LA, V5, P45, DOI DOI 10.1179/136132800807547582; Fu QJ, 1998, J ACOUST SOC AM, V104, P505, DOI 10.1121/1.423251; GANDOUR JT, 1978, LANG SPEECH, V21, P1, DOI 10.1177/002383097802100101; Gardner RM, 1997, PERCEPT MOTOR SKILL, V84, P587, DOI 10.2466/pms.1997.84.2.587; Hicks CB, 2002, J SPEECH LANG HEAR R, V45, P573, DOI 10.1044/1092-4388(2002/046); Howard CS, 2010, INT J AUDIOL, V49, P928, DOI 10.3109/14992027.2010.520036; Howie J. M., 1976, ACOUSTICAL STUDIES M; Hua Z, 2000, J CHILD LANG, V27, P3, DOI 10.1017/S030500099900402X; Hughson W., 1944, T SECT OPHTHALMOL AM, V48, P1; International Organization for Standardization, 2004, 3891 ISO; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; Johansen H., 1948, ACTA OTO-LARYNGOL, V36, P65; Kong YY, 2006, J ACOUST SOC AM, V120, P2830, DOI 10.1121/1.2346009; Krenmayr A, 2011, INT J AUDIOL, V50, P155, DOI 10.3109/14992027.2010.530613; Lee C.Y., 2013, SPEECH LANG HEARING, V16, P46, DOI [10.1179/2050571X12Z.0000000003, DOI 10.1179/2050571X12Z.0000000003]; LI CN, 1977, J CHILD LANG, V4, P185, DOI 10.1017/S0305000900001598; Li J, 2008, ZHONG GUO TING LI YA, P22; Liang Z., 1963, ACTA PHYS SINICA, V26, P85; Lieu JEC, 2004, ARCH OTOLARYNGOL, V130, P524, DOI 10.1001/archotol.130.5.524; Liu TC, 2000, AUDIOLOGY, V39, P106; Mao Y., 2016, P IEEE 83 VEH TECHN, P1, DOI DOI 10.1080/14992027.2016.1219073; McFadden B, 2008, LANG SPEECH HEAR SER, V39, P342, DOI 10.1044/0161-1461(2008/032); NABELEK AK, 1974, J SPEECH HEAR RES, V17, P724, DOI 10.1044/jshr.1704.724; Nissen SL, 2005, INT J AUDIOL, V44, P379, DOI 10.1080/14992020500147615; Patel AD, 2010, P SPEECH PROSODY; Peng SC, 2004, EAR HEARING, V25, P251, DOI 10.1097/01.AUD.0000130797.73809.40; Pett M. A., 2016, NONPARAMETRIC STAT H; Rosenfeld RM, 2016, OTOLARYNG HEAD NECK, V154, pS1, DOI 10.1177/0194599815623467; Sato H, 2008, J ACOUST SOC AM, V123, P2064, DOI 10.1121/1.2839283; SHAH N, 1991, J ROY SOC MED, V84, P581; So, 2000, PUTONGHUA SEGMENTAL; STAGRAY JR, 1992, J SPEECH HEAR RES, V35, P1406, DOI 10.1044/jshr.3506.1406; Wang JJ, 2013, J ACOUST SOC AM, V134, pEL91, DOI 10.1121/1.4811159; Wang S, 2013, ACTA OTO-LARYNGOL, V133, P47, DOI 10.3109/00016489.2012.705438; WHALEN DH, 1992, PHONETICA, V49, P25, DOI 10.1159/000261901; Winiger AM, 2016, AM J AUDIOL, V25, P232, DOI 10.1044/2016_AJA-15-0060; Wong PS, 2005, J SPEECH LANG HEAR R, V48, P1065, DOI 10.1044/1092-4388(2005/074); Xu GQ, 2013, NEUROPSYCHOLOGIA, V51, P550, DOI 10.1016/j.neuropsychologia.2012.12.006; Xu L, 2003, J ACOUST SOC AM, V114, P3024, DOI 10.1121/1.1623786; Yip M., 2002, TONE; Yuen KCP, 2014, J SPEECH LANG HEAR R, V57, P2005, DOI 10.1044/2014_JSLHR-H-13-0060; Yuen Kevin C P, 2009, Cochlear Implants Int, V10 Suppl 1, P138, DOI 10.1179/cim.2009.10.Supplement-1.138; Zhang JX, 2008, FOLIA PHONIATR LOGO, V60, P179, DOI 10.1159/000128276; Zheng Y, 2009, EAR HEARING, V30, P600, DOI 10.1097/AUD.0b013e3181b4aba8; Zhou N, 2013, OTOL NEUROTOL, V34, P499, DOI 10.1097/MAO.0b013e318287ca86; Zhu S., 2015, INFLUENCE TONE CONSO; Zhu Shufeng, 2015, Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi, V50, P651; Zhu SF, 2014, INT J PEDIATR OTORHI, V78, P2292, DOI 10.1016/j.ijporl.2014.10.036; Zhu SF, 2014, INT J PEDIATR OTORHI, V78, P2174, DOI 10.1016/j.ijporl.2014.10.004	60	1	1	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183394	10.1371/journal.pone.0183394	http://dx.doi.org/10.1371/journal.pone.0183394			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829840	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100043
J	Valderrama-Zurian, JC; Aguilar-Moya, R; Cepeda-Benito, A; Melero-Fuentes, D; Navarro-Moreno, MA; Gandia-Balaguer, A; Aleixandre-Benavent, R				Valderrama-Zurian, Juan-Carlos; Aguilar-Moya, Remedios; Cepeda-Benito, Antonio; Melero-Fuentes, David; Navarro-Moreno, Maria-Angeles; Gandia-Balaguer, Asuncion; Aleixandre-Benavent, Rafael			Productivity trends and collaboration patterns: A diachronic study in the eating disorders field	PLOS ONE			English	Article							CO-AUTHORSHIP NETWORKS; BULIMIA-NERVOSA; COAUTHORSHIP; PUBLICATIONS; SCIENCE; WEB; PERFORMANCE; JOURNALS; CHINA	Objective The present study seeks to extend previous bibliometric studies on eating disorders (EDs) by including a time-dependent analysis of the growth and evolution of multi-author collaborations and their correlation with ED publication trends from 1980 to 2014 ( 35 years). Methods Using standardized practices, we searched Web of Science (WoS) Core Collection (WoSCC) ( indexes: Science Citation Index-Expanded [SCIE], & Social Science Citation Index [SSCI]) and Scopus (areas: Health Sciences, Life Sciences, & Social Sciences and Humanities) to identify a large sample of articles related to EDs. We then submitted our sample of articles to bibliometric and graph theory analyses to identify co-authorship and social network patterns. Results We present a large number of detailed findings, including a clear pattern of scientific growth measured as number of publications per five-year period or quinquennium (Q), a tremendous increase in the number of authors attracted by the ED subject, and a very high and steady growth in collaborative work. Conclusions We inferred that the noted publication growth was likely driven by the noted increase in the number of new authors per Q. Social network analyses suggested that collaborations within ED follow patters of interaction that are similar to well established and recognized disciplines, as indicated by the presence of a "giant cluster", high cluster density, and the replication of the "small world " phenomenon -the principle that we are all linked by short chains of acquaintances.	[Valderrama-Zurian, Juan-Carlos; Melero-Fuentes, David] Univ Catolica Valencia San Vicente Martir, Inst Documentac & Tecnol Informac, Valencia, Spain; [Aguilar-Moya, Remedios] Univ Catolica Valencia San Vicente Martir, Dept Ciencias Educ, Godella, Spain; [Cepeda-Benito, Antonio] Univ Vermont, Dept Psychol Sci, Burlington, VT USA; [Navarro-Moreno, Maria-Angeles] Univ Catolica Valencia San Vicente Martir, Dept Ciencias Expt & Matemat, Valencia, Spain; [Gandia-Balaguer, Asuncion] Univ Catolica Valencia San Vicente Martir, Dept Ciencias Aplicadas Actividad Fis & Gest, Valencia, Spain; [Aleixandre-Benavent, Rafael] Univ Politecn Valencia, CSIC, INGENIO, Valencia, Spain; [Aleixandre-Benavent, Rafael] Univ Valencia, CSIC, UISYS, Valencia, Spain	Universidad Catolica de Valencia San Vicente Martir; Universidad Catolica de Valencia San Vicente Martir; University of Vermont; Universidad Catolica de Valencia San Vicente Martir; Universidad Catolica de Valencia San Vicente Martir; Consejo Superior de Investigaciones Cientificas (CSIC); Universitat Politecnica de Valencia; Consejo Superior de Investigaciones Cientificas (CSIC); University of Valencia	Melero-Fuentes, D (corresponding author), Univ Catolica Valencia San Vicente Martir, Inst Documentac & Tecnol Informac, Valencia, Spain.	david.melero@ucv.es	Benito, Antonio Cepeda/D-2066-2013; Aleixandre-Benavent, Rafael/G-1011-2015; Navarro, M Ángeles/B-4202-2018; Valderrama-Zurian, Juan Carlos/E-1201-2018	Aleixandre-Benavent, Rafael/0000-0002-6678-8844; Valderrama-Zurian, Juan Carlos/0000-0001-5787-6853; Cepeda-Benito, Antonio/0000-0001-9101-9951	Universidad Catolica de Valencia "San Vicente Martir"; Spanish Government assistance through Government Delegation for the National Drugs Plan of the Ministry of Health, Social Services and Equality [2016/028]; National R+D+I [CS02012-39632-C02-01, CS02015-65594-C2-2-R]; Networks of Excellence Call of the Ministry of Economy and Competitiveness [CS02015-71867-REDT]	Universidad Catolica de Valencia "San Vicente Martir"; Spanish Government assistance through Government Delegation for the National Drugs Plan of the Ministry of Health, Social Services and Equality; National R+D+I; Networks of Excellence Call of the Ministry of Economy and Competitiveness	This work was performed with a subsidy from Universidad Catolica de Valencia "San Vicente Martir" to resarch group INDOTEI: Evaluacion de la Ciencia, for the years 2016-2017. This work is benefited from Spanish Government assistance through Government Delegation for the National Drugs Plan of the Ministry of Health, Social Services and Equality (project 2016/028); and National R+D+I (projects: CS02012-39632-C02-01 and CS02015-65594-C2-2-R) and 2015-Networks of Excellence Call (project CS02015-71867-REDT) of the Ministry of Economy and Competitiveness.	Agudelo D, 2003, PSICOTHEMA, V15, P507; Aguinaga M, 2000, An Sist Sanit Navar, V23, P279; Aleixandre-Benavent R, 2011, REV PATOLOGIA RESPIR, V14, P1; American Psychiatric Association, 1980, DIAGNOSTIC STAT MANU, V3rd; American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU; Baker Timothy B, 2003, Nicotine Tob Res, V5 Suppl 1, pS89; Barabasi AL, 2002, PHYSICA A, V311, P590, DOI 10.1016/S0378-4371(02)00736-7; Bartol T, 2014, SCIENTOMETRICS, V98, P1491, DOI 10.1007/s11192-013-1148-8; Bordons M, 2002, REV ESP CARDIOL, V55, P900, DOI 10.1016/S0300-8932(02)76728-6; Bordons M, 2000, ASIST MON SER, P197; Bordons M, 2015, J INFORMETR, V9, P135, DOI 10.1016/j.joi.2014.12.001; Chan HF, 2016, SCIENTOMETRICS, V106, P509, DOI 10.1007/s11192-015-1796-y; Clinton D, 2010, EUR EAT DISORD REV, V18, P1, DOI 10.1002/erv.986; El Ghoch M, 2013, NUTRIENTS, V5, P5140, DOI 10.3390/nu5125140; Fatt CK, 2010, SCIENTOMETRICS, V85, P849, DOI 10.1007/s11192-010-0254-0; Gonzalez-Alcaide G, 2015, PLOS ONE, V10; Gonzalez-Alcaide G, 2008, FERTIL STERIL, V90, P941, DOI 10.1016/j.fertnstert.2007.07.1378; Gonzalez-Alcaide G, 2013, J CRIM JUSTICE EDUC, V24, P15, DOI 10.1080/10511253.2012.664153; Guardiola-Wanden-Berghe R, 2013, SCIENTOMETRICS, V94, P305, DOI 10.1007/s11192-012-0866-7; Jacomy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098679; Jones AW, 2007, FORENSIC SCI INT, V165, P115, DOI 10.1016/j.forsciint.2006.05.013; Kawamura M, 2000, J Oral Sci, V42, P75; Klein JT, 1996, LIBR TRENDS, V45, P134; Kretschmer H, 2004, SCIENTOMETRICS, V60, P409, DOI 10.1023/B:SCIE.0000034383.86665.22; Kumar S, 2015, ASLIB J INFORM MANAG, V67, P55, DOI 10.1108/AJIM-09-2014-0116; Lambiotte R, 2009, J INFORMETR, V3, P180, DOI 10.1016/j.joi.2009.03.007; LANCELOT C, 1991, INT J EAT DISORDER, V10, P57, DOI 10.1002/1098-108X(199101)10:1&lt;57::AID-EAT2260100107&gt;3.0.CO;2-T; Lawani S.M., 1980, QUALITY COLLABORATIO; Leydesdorff L, 2012, PROF INFORM, V21, P43, DOI 10.3145/epi.2012.ene.06; Lopez-Illescas C, 2008, J INFORMETR, V2, P304, DOI 10.1016/j.joi.2008.08.001; Lopez-Munoz F, 2003, DEPRESS ANXIETY, V18, P95, DOI 10.1002/da.10121; McClelland J, 2013, EUR EAT DISORD REV, V21, P436, DOI 10.1002/erv.2256; Miller MN, 2001, PSYCHIATRY, V64, P93, DOI 10.1521/psyc.64.2.93.18621; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Pike KM, 2015, J EAT DISORD, V3, DOI 10.1186/s40337-015-0070-2; Pino-Diaz J, 2011, REV ESP DOC CIENT, V34, P301, DOI 10.3989/redc.2011.3.804; PRICE D, 1976, INT FORUM INFORM DOC, V1, P17; Prince R., 1983, TRANSCULT PSYCHIAT R, V20, P299, DOI [10.1177/136346158302000419, DOI 10.1177/136346158302000419]; Qian Jie, 2013, Shanghai Arch Psychiatry, V25, P212, DOI 10.3969/j.issn.1002-0829.2013.04.003; Rodriguez de Fonseca F., 2006, MANUAL INTRO INVESTI, P9; Soh N, 2012, INT J EAT DISORDER, V45, P990, DOI 10.1002/eat.22036; Soh NLW, 2013, J EAT DISORD, V1, DOI 10.1186/2050-2974-1-4; SPITZER RL, 1991, INT J EAT DISORDER, V10, P627, DOI 10.1002/1098-108X(199111)10:6<627::AID-EAT2260100602>3.0.CO;2-4; Theander SS, 2002, EUR EAT DISORD REV, V10, P386, DOI 10.1002/erv.495; Theander SS, 2004, EUROPEAN EATING DISO, V12, P4; Valderrama-Zurian JC, 2015, J INFORMETR, V9, P570, DOI 10.1016/j.joi.2015.05.002; Van Raan AFJ, 1999, EVALUATING SCI EXCEL, V40, P30; Warren CS, 2005, INT J EAT DISORDER, V37, P241, DOI 10.1002/eat.20102; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wonderlich SA, 2005, PSYCHOL MED, V35, P649, DOI 10.1017/S0033291704004234; Wonderlich SA, 2014, FOCUS, V12, P489; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099; Yan EJ, 2010, SCIENTOMETRICS, V83, P115, DOI 10.1007/s11192-009-0027-9; Yin LC, 2006, INFORM PROCESS MANAG, V42, P1599, DOI 10.1016/j.ipm.2006.03.021	55	8	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 29	2017	12	8							0182760	10.1371/journal.pone.0182760	http://dx.doi.org/10.1371/journal.pone.0182760			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE9SU	28850569	Green Submitted, Green Published, gold			2022-12-27	WOS:000408544200006
J	Chaudhary, JK; Rath, PC				Chaudhary, Jitendra Kumar; Rath, Pramod C.			Microgrooved-surface topography enhances cellular division and proliferation of mouse bone marrow-derived mesenchymal stem cells	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; STROMAL CELLS; NEURONAL DIFFERENTIATION; SIGNALING PATHWAY; DISEASE; CULTURE; PROGENITORS; EXPRESSION; COLONIES; PROTOCOL	Mesenchymal stem cells' (MSCs) fate is largely determined by the various topographical features and a range of extracellular matrix (ECM) components present in their niches. Apart from maintaining structural stability, they regulate cell morphology, division, proliferation, migration and differentiation among others. Traditional MSC cultures, which are mainly based on two-dimensional smooth surfaces of culture dishes and plates, do not provide topographical cues similar to in vivo three-dimensional niches, impacting various cellular processes. Therefore, we culture the mouse bone marrow-derived MSCs on microgrooved bearing surface, partially mimicking in vivo reticulated niche, to study its effect on morphology, pluripotency factor-associated stemness, cell division and rate of proliferation. Following culture, morphological features, and MSC-specific marker gene expression, such as CD29, CD44, Sca-1 along with HSC (Haematopoietic stem cell)-specific markers like CD34, CD45, CD11b were evaluated by microscopy and immunophenotyping, respectively. HSC is another type of bone marrow stem cell population, which concertedly interacts with MSC during various functions, including haematopoiesis. In addition, mesenchymal stem cells were further analyzed for gene expression of pluripotency-associated transcription factors such as Oct3/4, Sox-2, Nanog and Myc, as well as differentiated into adipocytes, osteocytes and chondrocytes. Our results show that microgrooved surface-cultured mesenchymal stem cells (MMSCs) expressed higher levels of expected cell surface and pluripotencyassociated markers and proliferated more rapidly (2-3xfold) with higher percentage of cells in S/G2-M-phase, consequently giving rise to higher cell yield compared to standard culture flask-grown cells (MSCs), taken as control. Furthermore, both MSCs and MMSCs showed considerable accumulation of intracellular lipid-droplets, higher alkaline phosphatase activity and secretion of extracellular matrix that are characteristics of adipogenesis, osteogenesis and chondrogenesis, respectively.	[Chaudhary, Jitendra Kumar; Rath, Pramod C.] Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi, India	Jawaharlal Nehru University, New Delhi	Rath, PC (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Mol Biol Lab, New Delhi, India.	pcrath@mail.jnu.ac.in	RATH, PRAMOD/AAP-5565-2020	CHAUDHARY, JITENDRA/0000-0001-8499-9656	School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC); DRS; Department of Science and Technology (DST) FIST & PURSE, Government of India; University Grants Commission (UGC) Research Network Resource Centre (RNRC)	School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC); DRS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Science and Technology (DST) FIST & PURSE, Government of India; University Grants Commission (UGC) Research Network Resource Centre (RNRC)	This work was supported by the School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC) and DRS as well as the Department of Science and Technology (DST) FIST & PURSE, Government of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to acknowledge the Central Instrumentation Facility (CIF), SLS and Advanced Instrumentation Research Facility (AIRF), JNU, New Delhi, and ICMR-JRF/SRF to J.K.C. The financial support to the School of Life Sciences, J.N.U. from the University Grants Commission (UGC) Research Network Resource Centre (RNRC) and DRS as well as the Department of Science and Technology (DST) FIST & PURSE, Government of India are gratefully acknowledged.	Anjos-Afonso F., 2008, CURR PROTOC STEM CEL, V7, p2B. 3.1; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Bao J, 2016, INT J MOL MED, V38, P457, DOI 10.3892/ijmm.2016.2638; Binrui C, 2016, ACCOUNTS CHEM RES, V49, P1111; Bouffi C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014247; Chaudhary JK, 2017, J CELL SCI THERAPY, V8, P261, DOI DOI 10.4172/2157-7013.1000261; Chen DD, 2017, J NEUROSCI RES, V95, P907, DOI 10.1002/jnr.23879; Colter DC, 2000, P NATL ACAD SCI USA, V97, P3213, DOI 10.1073/pnas.070034097; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Czapla J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158745; Freund D, 2006, STEM CELLS DEV, V15, P815, DOI 10.1089/scd.2006.15.815; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Gattazzo F, 2014, BBA-GEN SUBJECTS, V1840, P2506, DOI 10.1016/j.bbagen.2014.01.010; Gerlach JC, 2012, STEM CELLS DEV, V21, P3258, DOI 10.1089/scd.2012.0296; GOSHIMA J, 1991, CLIN ORTHOP RELAT R, V262, P298; Greco SJ, 2007, STEM CELLS, V25, P3143, DOI 10.1634/stemcells.2007-0351; Jones S, 2007, J IMMUNOL, V179, P2824, DOI 10.4049/jimmunol.179.5.2824; Li LR, 2016, SCI REP-UK, V6, DOI 10.1038/srep37894; Liu Y, 2017, COLLOID SURFACE B, V154, P1, DOI 10.1016/j.colsurfb.2017.02.035; Matsubara T, 2004, BIOCHEM BIOPH RES CO, V313, P503, DOI 10.1016/j.bbrc.2003.11.143; Mishra RR, 2012, MOL BIOL REP, V39, P7389, DOI 10.1007/s11033-012-1571-6; Mishra RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028433; Munneke JM, 2016, TRANSPLANTATION, V100, P2309, DOI 10.1097/TP.0000000000001029; Nadri N, 2007, IN VITRO CELL DEV, V43, P276; Oh SH, 2015, CELL TRANSPLANT, V24, P1097, DOI 10.3727/096368914X679237; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prat M, 2017, METHODS MOL BIOL, V1553, P169, DOI 10.1007/978-1-4939-6756-8_13; Rakian R, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0235-6; Ranzoni AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep39656; Reichert D, 2015, SCI REP-UK, V5, DOI 10.1038/srep15680; Rodrigues M., 2010, CURR STEM CELL RES T, V1, P32, DOI DOI 10.1186/SCRT32; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Trivanovic D, 2015, LIFE SCI, V141, P61, DOI 10.1016/j.lfs.2015.09.019; Tsai CC, 2012, MOL CELL, V47, P169, DOI 10.1016/j.molcel.2012.06.020; Wang SJ, 2016, STEM CELLS DEV, V25, P1195, DOI 10.1089/scd.2016.0055; Watt FM, 2013, NAT REV MOL CELL BIO, V14, P467, DOI 10.1038/nrm3620; Yan YH, 2016, LIFE SCI, V166, P131, DOI 10.1016/j.lfs.2016.10.004; Zhou YX, 2016, STEM CELL REV REP, V12, P560, DOI 10.1007/s12015-016-9671-7; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	41	14	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182128	10.1371/journal.pone.0182128	http://dx.doi.org/10.1371/journal.pone.0182128			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846679	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600009
J	Harikrishnan, H; Singh, KKB; Ismail, A				Harikrishnan, Hemavathy; Singh, Kirnpal Kaur Banga; Ismail, Asma			Outer membrane proteins analysis of Shigella sonnei and evaluation of their antigenicity in Shigella infected individuals	PLOS ONE			English	Article							DYSENTERIAE TYPE-1; ANTIBODY-RESPONSES; IMMUNE-RESPONSE; ACUTE DIARRHEA; FLEXNERI 2A; SERUM	Bacillary dysentery caused by infection with Shigella spp. remains as serious and common health problem throughout the world. It is a highly multi drug resistant organism and rarely identified from the patient at the early stage of infection. S. sonnei is the most frequently isolated species causing shigellosis in industrialized countries. The antigenicity of outer membrane protein of this pathogen expressed during human infection has not been identified to date. We have studied the antigenic outer membrane proteins expressed by S. sonnei, with the aim of identifying presence of specific IgA and IgG in human serum against the candidate protein biomarkers. Three antigenic OMPs sized 33.3, 43.8 and 100.3 kDa were uniquely recognized by IgA and IgG from patients with S. sonnei infection, and did not cross-react with sera from patients with other types of infection. The antigenic proteome data generated in this study are a first for OMPs of S. sonnei, and they provide important insights of human immune responses. Furthermore, numerous prime candidate proteins were identified which will aid the development of new diagnostic tools for the detection of S. sonnei.	[Harikrishnan, Hemavathy; Singh, Kirnpal Kaur Banga] Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Hlth Campus, Kelantan, Malaysia; [Ismail, Asma] Univ Sains Malaysia, Off Vice Chancellor, George Town, Malaysia; [Ismail, Asma] Univ Sains Malaysia, Inst Res Mol Med INFORMM, Kelantan, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Universiti Sains Malaysia	Singh, KKB (corresponding author), Univ Sains Malaysia, Sch Med Sci, Dept Med Microbiol & Parasitol, Hlth Campus, Kelantan, Malaysia.	kiren@usm.my	Singh, Kirnpal Kaur Banga/A-5761-2010; Singh, Kirnpal Kaur Banga/ABC-5192-2020; HARIKRISHNAN, HEMAVATHY/AAK-7007-2020; Banga Singh, Kirnpal Kaur/ABC-5195-2020	Singh, Kirnpal Kaur Banga/0000-0002-9958-5760; Singh, Kirnpal Kaur Banga/0000-0002-9958-5760; Banga Singh, Kirnpal Kaur/0000-0002-9958-5760	Research University Cluster [1001/PSKBP/8630012]; Institute for Postgraduate Studies, Universiti Sains Malaysia	Research University Cluster; Institute for Postgraduate Studies, Universiti Sains Malaysia(Universiti Sains Malaysia)	This research was supported by a Research University Cluster Grant (1001/PSKBP/8630012) titled "Molecular approaches to fundamental studies on biomarkers and development of sustainable rapid nanobiodiagnostics to enteric diseases for low resource settings" (2011-2013) to KK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by a Research University Cluster Grant (1001/PSKBP/8630012) titled "Molecular approaches to fundamental studies on biomarkers and development of sustainable rapid nanobiodiagnostics to enteric diseases for low resource settings" (2011-2013). We gratefully acknowledge the Institute for Postgraduate Studies, Universiti Sains Malaysia, for providing the fellowship assistance and the Department of Medical Microbiology and Parasitology, School of Medical Sciences, Universiti Sains Malaysia, for providing facilities and specimens.	Arya D, 1977, Indian J Pathol Microbiol, V20, P15; Ashkenazi Shai, 2004, Semin Pediatr Infect Dis, V15, P246, DOI 10.1053/j.spid.2004.07.005; Biswas T, 2000, FEMS IMMUNOL MED MIC, V29, P129; Faruque SM, 2002, APPL ENVIRON MICROB, V68, P3908, DOI 10.1128/AEM.68.8.3908-3913.2002; Harikrishnan H, 2013, GUT PATHOG, V5, DOI 10.1186/1757-4749-5-38; Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593; Islam AHMS, 2011, DIAGN MICR INFEC DIS, V69, P38, DOI 10.1016/j.diagmicrobio.2010.09.008; ISLAM D, 1995, INFECT IMMUN, V63, P2054, DOI 10.1128/IAI.63.5.2054-2061.1995; ISMAIL A, 1991, BIOCHEM BIOPH RES CO, V181, P301, DOI 10.1016/S0006-291X(05)81417-2; KANTELE AM, 1988, J INFECT DIS, V158, P1011, DOI 10.1093/infdis/158.5.1011; LI A, 1994, SCAND J INFECT DIS, V26, P435, DOI 10.3109/00365549409008617; Liston A, 2016, TRENDS IMMUNOL, V37, P637, DOI 10.1016/j.it.2016.08.002; Livio S, 2014, CLIN INFECT DIS, V59, P933, DOI 10.1093/cid/ciu468; LORY S, 1985, CURR TOP MICROBIOL, V118, P53; MoezArdalan K, 2003, J HEALTH POPUL NUTR, V21, P96; Mukhopadhaya A, 2003, VACCINE, V21, P3043, DOI 10.1016/S0264-410X(03)00111-7; Niyogi SK, 2005, J MICROBIOL, V43, P133; OBERHELMAN RA, 1991, INFECT IMMUN, V59, P2341, DOI 10.1128/IAI.59.7.2341-2350.1991; Ojha SC, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/412370; Ozuah P O, 1998, Pediatr Rev, V19, P100, DOI 10.1542/pir.19-3-100; Pore D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022663; Raqib R, 2003, INFECT IMMUN, V71, P2684, DOI 10.1128/IAI.71.5.2684-2692.2003; Rasolofo-Razanamparany V, 2001, INFECT IMMUN, V69, P5230, DOI 10.1128/IAI.69.9.5230-5234.2001; Robin G, 1997, J INFECT DIS, V175, P1128, DOI 10.1086/516452; ROY S, 1994, MICROBIOS, V79, P55; Sansonetti P, 1996, RES IMMUNOL, V147, P595, DOI 10.1016/S0923-2494(97)85227-3; Sansonetti PJ, 2001, AM J PHYSIOL-GASTR L, V280, pG319, DOI 10.1152/ajpgi.2001.280.3.G319; Turner SA, 2003, ANTIMICROB AGENTS CH, V47, P727, DOI 10.1128/AAC.47.2.727-734.2003; Warren BR, 2006, CRIT REV FOOD SCI, V46, P551, DOI 10.1080/10408390500295458	29	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0182878	10.1371/journal.pone.0182878	http://dx.doi.org/10.1371/journal.pone.0182878			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846684	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000408438600018
J	Lutter, M; Bahl, E; Hannah, C; Hofammann, D; Acevedo, S; Cui, HX; McAdams, CJ; Michaelson, JJ				Lutter, Michael; Bahl, Ethan; Hannah, Claire; Hofammann, Dabney; Acevedo, Summer; Cui, Huxing; McAdams, Carrie J.; Michaelson, Jacob J.			Novel and ultra-rare damaging variants in neuropeptide signaling are associated with disordered eating behaviors	PLOS ONE			English	Article							DIET-INDUCED OBESITY; MESOLIMBIC DOPAMINE SYSTEM; GLUCAGON-LIKE PEPTIDE-1; ANOREXIA-NERVOSA; TNF-ALPHA; GENETIC-VARIANTS; BULIMIA-NERVOSA; FOOD-INTAKE; MICE; NEUROTENSIN	Objective Eating disorders develop through a combination of genetic vulnerability and environmental stress, however the genetic basis of this risk is unknown. Methods To understand the genetic basis of this risk, we performed whole exome sequencing on 93 unrelated individuals with eating disorders (38 restricted-eating and 55 binge-eating) to identify novel damaging variants. Candidate genes with an excessive burden of predicted damaging variants were then prioritized based upon an unbiased, data-driven bioinformatic analysis. One top candidate pathway was empirically tested for therapeutic potential in a mouse model of binge-like eating. Results An excessive burden of novel damaging variants was identified in 186 genes in the restricted-eating group and 245 genes in the binge-eating group. This list is significantly enriched (OR = 4.6, p<0.0001) for genes involved in neuropeptide/ neurotrophic pathways implicated in appetite regulation, including neurotensin-, glucagon-like peptide 1-and BDNF-signaling. Administration of the glucagon-like peptide 1 receptor agonist exendin-4 significantly reduced food intake in a mouse model of 'binge-like' eating. Conclusions These findings implicate ultra-rare and novel damaging variants in neuropeptide/neurotropic factor signaling pathways in the development of eating disorder behaviors and identify glucagon-like peptide 1-receptor agonists as a potential treatment for binge eating.	[Lutter, Michael] Eating Recovery Ctr Dallas, Plano, TX USA; [Bahl, Ethan; Hannah, Claire; Hofammann, Dabney; Michaelson, Jacob J.] Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA; [Acevedo, Summer; McAdams, Carrie J.] Univ Texas Southwestern Med Ctr Dallas, Dept Psychiat, Dallas, TX USA; [Cui, Huxing] Univ Iowa, Dept Pharmacol, Carver Coll Med, Iowa City, IA 52242 USA	University of Iowa; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Iowa	Michaelson, JJ (corresponding author), Univ Iowa, Dept Psychiat, Carver Coll Med, Iowa City, IA 52242 USA.	jacob-michaelson@uiowa.edu	McAdams, Carrie J./M-6822-2017	McAdams, Carrie J./0000-0002-4768-6703; Cui, Huxing/0000-0002-8627-8534; Michaelson, Jacob/0000-0001-9713-0992	Klarman Family Foundation Grants Program in Eating Disorder Research; University of Iowa Foundation, Department of Psychiatry; NIMH grants [MH093684, MH105527]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008629] Funding Source: NIH RePORTER	Klarman Family Foundation Grants Program in Eating Disorder Research; University of Iowa Foundation, Department of Psychiatry; NIMH grants; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by funding from the Klarman Family Foundation Grants Program in Eating Disorder Research (ML), University of Iowa Foundation, Department of Psychiatry (ML), and NIMH grants MH093684 (CJM), and MH105527 (JJM).	ALLEN GV, 1995, NEUROSCIENCE, V69, P533, DOI 10.1016/0306-4522(95)00261-G; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Avena NM, 2012, NEUROPHARMACOLOGY, V63, P87, DOI 10.1016/j.neuropharm.2011.11.010; Bannerman E, 2001, CLIN NUTR, V20, P399, DOI 10.1054/clnu.2001.0463; Bataille D, 2014, DIABETES RES CLIN PR, V106, P1, DOI 10.1016/j.diabres.2014.06.010; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boraska V., 2014, MOL PSYCHIAT; BrainSpan, 2014, BRAINSPAN ATL DEV HU; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Bulik CM, 2006, ARCH GEN PSYCHIAT, V63, P305, DOI 10.1001/archpsyc.63.3.305; Cao XH, 2014, J CLIN INVEST, V124, P4351, DOI 10.1172/JCI74726; Cochet-Bissuel M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00132; Cui HX, 2013, J CLIN INVEST, V123, P4706, DOI 10.1172/JCI71400; Czyzyk TA, 2012, FASEB J, V26, P3483, DOI 10.1096/fj.12-208041; Czyzyk TA, 2010, OBESITY, V18, P1710, DOI 10.1038/oby.2010.46; Dalvi PS, 2012, ENDOCRINOLOGY, V153, P2208, DOI 10.1210/en.2011-1795; Dossat AM, 2015, INT J EAT DISORDER, V48, P199, DOI 10.1002/eat.22264; Dubern B, 2008, PEDIATR RES, V63, P211, DOI 10.1203/PDR.0b013e31815ed62b; Eddy KT, 2008, AM J PSYCHIAT, V165, P245, DOI 10.1176/appi.ajp.2007.07060951; Egecioglu E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069010; Fichter MM, 2007, INT J EAT DISORDER, V40, pS61, DOI 10.1002/eat.20443; Foster DJ, 2016, NEURON, V91, P1244, DOI 10.1016/j.neuron.2016.08.017; Friry C, 2002, BIOCHEM BIOPH RES CO, V290, P1161, DOI 10.1006/bbrc.2001.6308; Gu GB, 2013, J COMP NEUROL, V521, P2235, DOI 10.1002/cne.23282; Huo LH, 2008, ENDOCRINOLOGY, V149, P492, DOI 10.1210/en.2007-0633; Ishiguro H, 2010, SYNAPSE, V64, P92, DOI 10.1002/syn.20714; Khalil RB, 2011, EAT WEIGHT DISORD-ST, V16, pE300; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Leinninger GM, 2011, CELL METAB, V14, P313, DOI 10.1016/j.cmet.2011.06.016; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li J, 2016, NATURE, V533, P411, DOI 10.1038/nature17662; Liao GY, 2013, MOL METAB, V2, P491, DOI 10.1016/j.molmet.2013.08.002; Lu BX, 2009, NATURE, V457, P741, DOI 10.1038/nature07579; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marcora SM, 2006, AM J CLIN NUTR, V84, P1463, DOI 10.1093/ajcn/84.6.1463; Mason BL, 2013, TRK B SIGNALING IN D; Mendez IA, 2015, NEUROPSYCHOPHARMACOL, V40, P2103, DOI 10.1038/npp.2015.67; Milos G, 2005, BRIT J PSYCHIAT, V187, P573, DOI 10.1192/bjp.187.6.573; Naessen S, 2011, AM J CLIN NUTR, V94, P967, DOI 10.3945/ajcn.111.014837; NHLBI, 2014, EX VAR SERV; Opland D, 2013, MOL METAB, V2, P423, DOI 10.1016/j.molmet.2013.07.008; Patel HJ, 2017, LIFE SCI, V170, P56, DOI 10.1016/j.lfs.2016.11.033; Pinheiro AP, 2010, AM J MED GENET B, V153B, P1070, DOI 10.1002/ajmg.b.31082; R Core Team, 2013, R LANG ENV STAT COMP; Ribases M, 2005, MOL PSYCHIATR, V10, P851, DOI 10.1038/sj.mp.4001670; Rimmer A, 2014, NAT GENET, V46, P912, DOI 10.1038/ng.3036; Robert SA, 2015, OBES RES CLIN PRACT, V9, P301, DOI 10.1016/j.orcp.2015.03.005; Santis S, 2009, N-S ARCH PHARMACOL, V379, P181, DOI 10.1007/s00210-008-0346-z; Shin JH, 2015, P NATL ACAD SCI USA, V112, P8124, DOI 10.1073/pnas.1508846112; Sodersten P, 2016, NEUROSCI BIOBEHAV R, V60, P26, DOI 10.1016/j.neubiorev.2015.11.003; Solmi M, 2015, PSYCHONEUROENDOCRINO, V51, P237, DOI 10.1016/j.psyneuen.2014.09.031; Solmi M, 2013, INT J EAT DISORDER, V46, P639, DOI 10.1002/eat.22153; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Wang K, 2010, NUCLEIC ACIDS RES, V38, pe164, DOI DOI 10.1093/nar/gkq603; Xue B, 2017, NEUROPHARMACOLOGY, V112, P57, DOI 10.1016/j.neuropharm.2016.04.005; Zeeland AASV, 2014, MOL PSYCHIATR, V19, P724, DOI 10.1038/mp.2013.91; Zhang H. Y., 2016, ADDICT BIOL	59	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0181556	10.1371/journal.pone.0181556	http://dx.doi.org/10.1371/journal.pone.0181556			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846695	Green Published, Green Submitted, gold			2022-12-27	WOS:000408438600007
J	Li, MZ; Chen, K; Liu, FT; Su, FX; Li, SR; Zhu, LL				Li, Mingzhu; Chen, Kai; Liu, Fengtao; Su, Fengxi; Li, Shunrong; Zhu, Liling			Nipple sparing mastectomy in breast cancer patients and long-term survival outcomes: An analysis of the SEER database	PLOS ONE			English	Article							CONSERVING SURGERY; FOLLOW-UP; SUBCUTANEOUS MASTECTOMY; ONCOLOGICAL SAFETY; RECONSTRUCTION; EXPERIENCE; INVOLVEMENT; POPULATION; RECURRENCE; MANAGEMENT	Purpose To determine the prevalence of nipple-sparing mastectomy (NSM) and its long-term survival outcomes in breast cancer patients. Method We used the Surveillance, Epidemiology, and End Results database and identified 2,440 breast cancer patients who received NSM during 1998-2013. We used chi-square and binary logistic regression to identify factors associated with the use of radiotherapy after NSM. We used Kaplan-Meier analysis to estimate cancer-specific survival (CSS) and overall survival (OS). We used the log-rank test and Cox regression to identify factors associated with CSS and OS. Results The median age of the population was 50 years. There were 725 (29.7%), 1064 (43.6%) and 651 (26.7%) patients who had Tis, T1 and T2-3 disease and 1943 (79.6%), 401 (16.4%) and 96 (3.9%) patients who had N0, N1 and N2-3 disease, respectively. The rates of RT use were 61.4%, 39.6% and 10.9% in patients with N2-3 disease, N1 or T3/N0 disease and Tis/ T1-2N0 disease, respectively. Elderly age, African American race, and higher T-stage and N-stage were associated with receiving radiotherapy. For patients diagnosed between 1998-2010 (N = 763), the median follow-up was 69 months. The 5-and 10-yr CSS were 96.9% and 94.9%, respectively. The 5- and 10-yr OS were 94.1% and 88.0%, respectively. Ethnicity, T-stage and N-stage were factors independently associated with CSS, and age and T-stage were factors independently associated with OS. Conclusions The use of NSM has increased, and it is oncologically safe for breast cancer patients.	[Li, Mingzhu] Fujian Med Univ, Quanzhou Hosp 1, Quanzhou, Fujian, Peoples R China; [Chen, Kai; Liu, Fengtao; Su, Fengxi; Li, Shunrong; Zhu, Liling] Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Chen, Kai; Liu, Fengtao; Su, Fengxi; Li, Shunrong; Zhu, Liling] Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China; [Zhu, Liling] Yale Univ, Dept Biostat, Yale Sch Publ Hlth, New Haven, CT 06520 USA	Fujian Medical University; Sun Yat Sen University; Sun Yat Sen University; Yale University	Li, SR; Zhu, LL (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China.; Li, SR; Zhu, LL (corresponding author), Sun Yat Sen Univ, Breast Tumor Ctr, Sun Yat Sen Mem Hosp, Guangzhou, Guangdong, Peoples R China.; Zhu, LL (corresponding author), Yale Univ, Dept Biostat, Yale Sch Publ Hlth, New Haven, CT 06520 USA.	lishr@mail.sysu.edu.cn; liling.zhu@yale.edu			National Natural Science Foundation of China [81402201/81372817]; National Natural Science Foundation of Guangdong Province [2014A030310070]; Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology [[2013]163]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology	The authors have no conflicts of interest or financial disclosures. This study was supported by the National Natural Science Foundation of China (grant# 81402201/81372817), National Natural Science Foundation of Guangdong Province (grant# 2014A030310070), and grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology.; The authors have no conflicts of interest or financial disclosures. This study was supported by the National Natural Science Foundation of China (Grant# 81402201/81372817), National Natural Science Foundation of Guangdong Province (Grant# 2014A030310070), and Grant [2013]163 from Key Laboratory of Malignant Tumor Molecular Mechanism and Translational Medicine of Guangzhou Bureau of Science and Information Technology.	Adam H, 2014, EJSO-EUR J SURG ONC, V40, P1209, DOI 10.1016/j.ejso.2014.07.037; Agarwal S, 2015, ANN SURG ONCOL, V22, P46, DOI 10.1245/s10434-014-3932-y; Agarwal S, 2014, AM J SURG, V208, P93, DOI 10.1016/j.amjsurg.2013.09.030; Alperovich M, 2016, BREAST J, V22, P18, DOI 10.1111/tbj.12517; Amara D, 2015, ANN SURG ONCOL, V22, P3803, DOI 10.1245/s10434-015-4646-5; Benediktsson KP, 2008, EJSO-EUR J SURG ONC, V34, P143, DOI 10.1016/j.ejso.2007.06.010; Caruso F, 2006, EJSO-EUR J SURG ONC, V32, P937, DOI 10.1016/j.ejso.2006.05.013; Chen K, 2015, ONCOTARGET, V6, P40127, DOI 10.18632/oncotarget.5394; De La Cruz L, 2015, ANN SURG ONCOL, V22, P3241, DOI 10.1245/s10434-015-4739-1; Eisenberg REK, 2014, BREAST J, V20, P15, DOI 10.1111/tbj.12199; Frasier LL, 2016, JAMA ONCOL, V2, P95, DOI 10.1001/jamaoncol.2015.3717; Gerber B, 2009, ANN SURG, V249, P461, DOI 10.1097/SLA.0b013e31819a044f; Jagsi R, 2012, CANCER-AM CANCER SOC, V118, P333, DOI 10.1002/cncr.26295; Jensen JA, 2011, ANN SURG ONCOL, V18, P1665, DOI 10.1245/s10434-010-1475-4; MACMILLAN RD, 1994, BRIT J SURG, V81, P56, DOI 10.1002/bjs.1800810119; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moo TA, 2016, ANN SURG ONCOL, V23, P3221, DOI 10.1245/s10434-016-5366-1; Munhoz AM, 2013, BREAST CANCER RES TR, V140, P545, DOI 10.1007/s10549-013-2634-7; NCCN, 2016, VERSION I, P1; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Petit JY, 2009, BREAST CANCER RES TR, V117, P333, DOI 10.1007/s10549-008-0304-y; Poruk KE, 2015, AM J SURG, V209, P212, DOI 10.1016/j.amjsurg.2014.04.001; Sakurai T, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0481-3; Shi AP, 2012, BREAST CARE, V7, P131, DOI 10.1159/000337640; Tang R, 2016, J AM COLL SURGEONS, V222, P1149, DOI 10.1016/j.jamcollsurg.2016.02.016; van Maaren MC, 2016, LANCET ONCOL, V17, P1158, DOI 10.1016/S1470-2045(16)30067-5; Voltura AM, 2008, ANN SURG ONCOL, V15, P3396, DOI 10.1245/s10434-008-0102-0	27	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183448	10.1371/journal.pone.0183448	http://dx.doi.org/10.1371/journal.pone.0183448			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841691	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700033
J	Yuan, XL; Bai, J; Li, LH; Kurban, A; De Maeyer, P				Yuan, Xiuliang; Bai, Jie; Li, Longhui; Kurban, Alishir; De Maeyer, Philippe			The dominant role of climate change in determining changes in evapotranspiration in Xinjiang, China from 2001 to 2012	PLOS ONE			English	Article							GLOBAL TERRESTRIAL EVAPOTRANSPIRATION; POPULUS-EUPHRATICA OLIV.; HYDRAULIC REDISTRIBUTION; CENTRAL-ASIA; WATER CYCLE; SOIL-WATER; TEMPERATURE; ENERGY; INTENSIFICATION; TRANSPIRATION	The Xinjiang Uyghur Autonomous Region of China has experienced significant land cover and climate change since the beginning of the 21 st century. However, a reasonable simulation of evapotranspiration (ET) and its response to environmental factors are still unclear. For this study, to simulate ET and its response to climate and land cover change in Xinjiang, China from 2001 to 2012, we used the Common Land Model (CoLM) by adding irrigation effects for cropland and modifying root distributions and the root water uptake process for shrubland. Our results indicate that mean annual ET from 2001 to 2012 was 131.22 (+/- 21.78) mm/year and demonstrated no significant trend (p = 0.12). The model simulation also indicates that climate change was capable of explaining 99% of inter-annual ET variability; land cover change only explained 1%. Land cover change caused by the expansion of croplands increased annual ET by 1.11 mm while climate change, mainly resulting from both decreased temperature and precipitation, reduced ET by 21.90 mm. Our results imply that climate change plays a dominant role in determining changes in ET, and also highlight the need for appropriate land-use strategies for managing water sources in dryland ecosystems within Xinjiang.	[Yuan, Xiuliang; Bai, Jie; Li, Longhui; Kurban, Alishir] Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China; [Yuan, Xiuliang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Yuan, Xiuliang; De Maeyer, Philippe] Univ Ghent, Dept Geog, Ghent, Belgium; [Yuan, Xiuliang; Li, Longhui; Kurban, Alishir; De Maeyer, Philippe] Sinobelgian Joint Lab Geoinformat, Urumqi, Peoples R China; [Yuan, Xiuliang; Li, Longhui; Kurban, Alishir; De Maeyer, Philippe] Sinobelgian Joint Lab Geoinformat, Ghent, Belgium	Chinese Academy of Sciences; Xinjiang Institute of Ecology & Geography, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Ghent University	Yuan, XL (corresponding author), Chinese Acad Sci, Xinjiang Inst Ecol & Geog, State Key Lab Desert & Oasis Ecol, Urumqi, Peoples R China.; Yuan, XL (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; Yuan, XL (corresponding author), Univ Ghent, Dept Geog, Ghent, Belgium.; Yuan, XL (corresponding author), Sinobelgian Joint Lab Geoinformat, Urumqi, Peoples R China.; Yuan, XL (corresponding author), Sinobelgian Joint Lab Geoinformat, Ghent, Belgium.	yuanxiuliang12@mails.ucas.ac.cn	Li, Longhui/I-5797-2018; De Maeyer, Philippe/N-7152-2019; De Maeyer, Philippe A.M./F-2985-2011; Kurban, Alishir/AGK-9193-2022	Li, Longhui/0000-0001-9983-6681; De Maeyer, Philippe/0000-0001-8902-3855; De Maeyer, Philippe A.M./0000-0001-8902-3855; Kurban, Alishir/0000-0001-9387-8127	National Natural Science Foundation of China [U1403382]; Key Laboratory Project of Xinjiang Uyghur Autonomous Region, China [2016D03004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Project of Xinjiang Uyghur Autonomous Region, China	This research was supported by the National Natural Science Foundation of China (grant no. U1403382) and Key Laboratory Project of Xinjiang Uyghur Autonomous Region, China (2016D03004).	Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Brooks JR, 2002, TREE PHYSIOL, V22, P1107, DOI 10.1093/treephys/22.15-16.1107; Chen X, 2013, CURR OPIN ENV SUST, V5, P116, DOI 10.1016/j.cosust.2012.12.005; Chen YN, 2015, ENVIRON RES, V139, P11, DOI 10.1016/j.envres.2014.12.029; Dai YJ, 2004, J CLIMATE, V17, P2281, DOI 10.1175/1520-0442(2004)017&lt;2281:ATMFCT&gt;2.0.CO;2; Dai YJ, 2003, B AM METEOROL SOC, V84, P1013, DOI 10.1175/BAMS-84-8-1013; Durack PJ, 2012, SCIENCE, V336, P455, DOI 10.1126/science.1212222; Hao XM, 2013, ECOHYDROLOGY, V6, P974, DOI 10.1002/eco.1338; Hao XM, 2010, J ARID ENVIRON, V74, P905, DOI 10.1016/j.jaridenv.2010.01.005; Hu ZY, 2016, J GEOPHYS RES-ATMOS, V121, P5648, DOI 10.1002/2016JD024781; Hu ZY, 2014, J CLIMATE, V27, P1143, DOI 10.1175/JCLI-D-13-00064.1; Huntington TG, 2006, J HYDROL, V319, P83, DOI 10.1016/j.jhydrol.2005.07.003; Jia BQ, 2004, J ARID ENVIRON, V56, P11, DOI 10.1016/S0140-1963(03)00002-8; Jing CQ, 2014, HYDROL PROCESS, V28, P5436, DOI 10.1002/hyp.10047; Jung M, 2010, NATURE, V467, P951, DOI 10.1038/nature09396; Lee JE, 2005, P NATL ACAD SCI USA, V102, P17576, DOI 10.1073/pnas.0508785102; Li CF, 2013, ECOL MODEL, V267, P148, DOI 10.1016/j.ecolmodel.2013.06.007; Li L, 2013, J HYDROL, V502, P145, DOI 10.1016/j.jhydrol.2013.08.026; Li LH, 2012, J GEOPHYS RES-BIOGEO, V117, DOI 10.1029/2012JG002038; Lioubimtseva E, 2009, J ARID ENVIRON, V73, P963, DOI 10.1016/j.jaridenv.2009.04.022; [刘波 LIU Bo], 2008, [地理学报, Acta Geographica Sinica], V63, P1131; Liu M, 2008, J AM WATER RESOUR AS, V44; Liu ML, 2012, J HYDROL, V426, P39, DOI 10.1016/j.jhydrol.2012.01.009; Luo GP, 2008, J ENVIRON MANAGE, V88, P775, DOI 10.1016/j.jenvman.2007.04.003; Luo GP, 2010, J GEOGR SCI, V20, P510, DOI 10.1007/s11442-010-0510-5; Mu QZ, 2011, REMOTE SENS ENVIRON, V115, P1781, DOI 10.1016/j.rse.2011.02.019; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; Pan SF, 2015, EARTHS FUTURE, V3, P15, DOI 10.1002/2014EF000263; Qian TT, 2006, J HYDROMETEOROL, V7, P953, DOI 10.1175/JHM540.1; Ryel RJ, 2002, OECOLOGIA, V130, P173, DOI 10.1007/s004420100794; Schenk HJ, 2002, ECOL MONOGR, V72, P311, DOI 10.1890/0012-9615(2002)072[0311:TGBOR]2.0.CO;2; Sheffield J, 2006, J CLIMATE, V19, P3088, DOI 10.1175/JCLI3790.1; Shi Y. F., 2003, CHIN QUAT SCI, V23, P152, DOI DOI 10.3321/j.issn:1001-7410.2003.02.005; SHUKLA J, 1982, SCIENCE, V215, P1498, DOI 10.1126/science.215.4539.1498; Tao H, 2011, J HYDROL, V400, P1, DOI 10.1016/j.jhydrol.2011.01.016; Trenberth KE, 2009, B AM METEOROL SOC, V90, P311, DOI 10.1175/2008BAMS2634.1; Xu H, 2007, PLANT CELL ENVIRON, V30, P399, DOI 10.1111/j.1365-3040.2006.001626.x; Yang QC, 2015, ECOHYDROLOGY, V8, P714, DOI 10.1002/eco.1538; Yuan XL, 2015, REMOTE SENS-BASEL, V7, P10164, DOI 10.3390/rs70810164; Yuan XL, 2015, REMOTE SENS LETT, V6, P69, DOI 10.1080/2150704X.2014.1002944; Zhang K, 2015, SCI REP-UK, V5, DOI 10.1038/srep15956; Zheng Z, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000413	42	7	9	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 25	2017	12	8							e0183071	10.1371/journal.pone.0183071	http://dx.doi.org/10.1371/journal.pone.0183071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7EP	28841645	Green Submitted, Green Published, gold			2022-12-27	WOS:000408370700017
J	Drouillard, M; Torres, R; Mamelle, E; De Seta, D; Sterkers, O; Ferrary, E; Nguyen, Y				Drouillard, Mylene; Torres, Renato; Mamelle, Elisabeth; De Seta, Daniele; Sterkers, Olivier; Ferrary, Evelyne; Yann Nguyen			Influence of electrode array stiffness and diameter on hearing in cochlear implanted guinea pig	PLOS ONE			English	Article							RESIDUAL HEARING; INSERTION TRAUMA; MODEL; HISTOPATHOLOGY; INTRACOCHLEAR; PRESERVATION; FIBROSIS	During cochlear implantation, electrode array translocation and trauma should be avoided to preserve residual hearing. The aim of our study was to evaluate the effect of physical parameters of the array on residual hearing and cochlear structures during insertion. Three array prototypes with different stiffnesses or external diameters were implanted in normal hearing guinea pigs via a motorized insertion tool carried on a robot-based arm, and insertion forces were recorded. Array prototypes 0.4 and 0.4R had 0.4 mm external diameter and prototype 0.3 had 0.3 mm external diameter. The axial stiffness was set to 1 for the 0.4 prototype and the stiffnesses of the 0.4R and 0.3 prototypes were calculated from this as 6.8 and 0.8 (relative units), respectively. Hearing was assessed preoperatively by the auditory brainstem response (ABR), and then at day 7 and day 30 post-implantation. A study of the macroscopic anatomy was performed on cochleae harvested at day 30 to examine the scala location of the array. At day 7, guinea pigs implanted with the 0.4R array had significantly poorer hearing results than those implanted with the 0.3 array (26 +/- 17.7, 44 +/- 23.4, 33 +/- 20.5 dB, n = 7, vs 5 +/- 8.7, 1 +/- 11.6, 12 +/- 11.5 dB, n = 6, mean +/- SEM, respectively, at 8, 16 and 24 kHz, p< 0.01) or those implanted with the 0.4 array (44 +/- 23.4 dB, n = 7, vs 28 +/- 21.7 dB, n = 7, at 16 kHz, p< 0.05). Hearing remained stable from day 7 to day 30. The maximal peak of insertion force was higher with the 0.4R array than with the 0.3 array (56 +/- 23.8 mN, n = 7, vs 26 +/- 8.7 mN, n = 6). Observation of the cochleae showed that an incorrectly positioned electrode array or fibrosis were associated with hearing loss >= 40 dB (at 16 kHz). An optimal position in the scala tympani with a flexible and thin array and prevention of fibrosis should be the primary objectives to preserve hearing during cochlear implantation.	[Drouillard, Mylene; Torres, Renato; Mamelle, Elisabeth; De Seta, Daniele; Sterkers, Olivier; Ferrary, Evelyne; Yann Nguyen] Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, INSERM, Unite Rehabil Chirurg Miniinvas & Robotisee Audit, Paris, France; [Drouillard, Mylene; Torres, Renato; Mamelle, Elisabeth; De Seta, Daniele; Sterkers, Olivier; Ferrary, Evelyne; Yann Nguyen] GHU Pitie Salpetriere, AP HP, Serv ORL, Otol Implants Auditifs & Chirurg Base Crane, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Nguyen, Y (corresponding author), Univ Pierre & Marie Curie Paris 6, Sorbonne Univ, INSERM, Unite Rehabil Chirurg Miniinvas & Robotisee Audit, Paris, France.; Nguyen, Y (corresponding author), GHU Pitie Salpetriere, AP HP, Serv ORL, Otol Implants Auditifs & Chirurg Base Crane, Paris, France.	yann.nguyen@inserm.fr	Nguyen, Yann/AAX-5740-2020; Torres, Renato/AAU-5149-2020	Torres, Renato/0000-0001-6701-6793; Ferrary, Evelyne/0000-0003-0066-8556; Nguyen, Yann/0000-0003-4635-0658	Agence Regionale pour la Sante ile de France	Agence Regionale pour la Sante ile de France	Mylene Drouillard was funded by grant from Agence Regionale pour la Sante ile de France.	[Anonymous], 2014, BIOMED RES INT, DOI DOI 10.1155/2014/532570; Choi CH, 2005, HEARING RES, V205, P193, DOI 10.1016/j.heares.2005.03.018; Clark G M, 1995, Ann Otol Rhinol Laryngol Suppl, V166, P40; Eshraghi AA, 2006, ANAT REC PART A, V288A, P473, DOI 10.1002/ar.a.20305; Eshraghi AA, 2015, ACTA OTO-LARYNGOL, V135, P328, DOI 10.3109/00016489.2015.1012276; Giordano P, 2014, OTOL NEUROTOL, V35, P1440, DOI 10.1097/MAO.0000000000000440; Jia H, 2016, NEUROSCIENCE, V316, P261, DOI 10.1016/j.neuroscience.2015.12.031; Kamakura T, 2016, HEARING RES, V339, P132, DOI 10.1016/j.heares.2016.06.015; Mamelle E, 2017, EUR ARCH OTO-RHINO-L, V274, P729, DOI 10.1007/s00405-016-4331-8; Miroir M, 2012, OTOL NEUROTOL, V33, P1092, DOI 10.1097/MAO.0b013e31825f24de; Nadol JB, 2001, ANN OTO RHINOL LARYN, V110, P883, DOI 10.1177/000348940111000914; Nguyen S, 2016, AURIS NASUS LARYNX, V43, P485, DOI 10.1016/j.anl.2016.02.014; O'Leary SJ, 2013, HEARING RES, V298, P27, DOI 10.1016/j.heares.2013.01.012; OLEARY MJ, 1991, ANN OTO RHINOL LARYN, V100, P695, DOI 10.1177/000348949110000901; Reiss LAJ, 2015, HEARING RES, V327, P163, DOI 10.1016/j.heares.2015.06.007; Roland Peter S, 2006, Adv Otorhinolaryngol, V64, P11, DOI 10.1159/000094642; Ryu KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136617; Schurzig D, 2012, IEEE-ASME T MECH, V17, P381, DOI 10.1109/TMECH.2011.2106795; Torres R, 2017, EUR ARCH OTO-RHINO-L, V274, P715, DOI 10.1007/s00405-016-4329-2; Wade SA, 2014, IEEE T BIO-MED ENG, V61, P1177, DOI 10.1109/TBME.2013.2296566; Wanna GB, 2015, OTOL NEUROTOL, V36, P1343, DOI 10.1097/MAO.0000000000000829; Wilk M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147552; Wright CG, 2013, OTOL NEUROTOL, V34, P402, DOI 10.1097/MAO.0b013e318278509a; Nguyen Y, 2013, ACTA OTO-LARYNGOL, V133, P116, DOI 10.3109/00016489.2012.723824	24	17	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183674	10.1371/journal.pone.0183674	http://dx.doi.org/10.1371/journal.pone.0183674			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837630	gold, Green Published, Green Submitted			2022-12-27	WOS:000408365000098
J	Kesherwani, V; Shahshahan, HR; Mishra, PK				Kesherwani, Varun; Shahshahan, Hamid R.; Mishra, Paras K.			Cardiac transcriptome profiling of diabetic Akita mice using microarray and next generation sequencing	PLOS ONE			English	Article							LONG NONCODING RNA; DIFFERENTIAL EXPRESSION; CARDIOVASCULAR-DISEASE; LIPOPROTEIN-LIPASE; ISCHEMIC-STROKE; SKELETAL-MUSCLE; HEART-FAILURE; MOUSE MODEL; MICRORNAS; GENE	Although diabetes mellitus (DM) causes cardiomyopathy and exacerbates heart failure, the underlying molecular mechanisms for diabetic cardiomyopathy/heart failure are poorly understood. Insulin2 mutant (Ins2(+/-)) Akita is a mouse model of T1DM, which manifests cardiac dysfunction. However, molecular changes at cardiac transcriptome level that lead to cardiomyopathy remain unclear. To understand the molecular changes in the heart of diabetic Akita mice, we profiled cardiac transcriptome of Ins2(+/-) Akita and Ins2(+/+) control mice using next generation sequencing (NGS) and microarray, and determined the implications of differentially expressed genes on various heart failure signaling pathways using Ingenuity pathway (IPA) analysis. First, we validated hyperglycemia, increased cardiac fibrosis, and cardiac dysfunction in twelve-week male diabetic Akita. Then, we analyzed the transcriptome levels in the heart. NGS analyses on Akita heart revealed 137 differentially expressed transcripts, where Bone Morphogenic Protein-10 (BMP10) was the most upregulated and hairy and enhancer of split-related (HELT) was the most downregulated gene. Moreover, twelve long non-coding RNAs (lncRNAs) were upregulated. The microarray analyses on Akita heart showed 351 differentially expressed transcripts, where vomeronasal-1 receptor-180 (Vmn1r180) was the most upregulated and WD Repeat Domain 83 Opposite Strand (WDR83OS) was the most downregulated gene. Further, miR-101c and H19 lncRNA were upregulated but Neat1 lncRNA was downregulated in Akita heart. Eleven common genes were upregulated in Akita heart in both NGS and microarray analyses. IPA analyses revealed the role of these differentially expressed genes in key signaling pathways involved in diabetic cardiomyopathy. Our results provide a platform to initiate focused future studies by targeting these genes and/or non-coding RNAs, which are differentially expressed in Akita hearts and are involved in diabetic cardiomyopathy.	[Kesherwani, Varun; Shahshahan, Hamid R.; Mishra, Paras K.] Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA; [Mishra, Paras K.] Univ Nebraska Med Ctr, Dept Anesthesiol, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Mishra, PK (corresponding author), Univ Nebraska Med Ctr, Dept Cellular & Integrat Physiol, Omaha, NE 68198 USA.; Mishra, PK (corresponding author), Univ Nebraska Med Ctr, Dept Anesthesiol, Omaha, NE 68198 USA.	paraskumar.mishra@unmc.edu	Mishra, Paras Kumar/ABG-3882-2020	Mishra, Paras Kumar/0000-0002-7810-9239	NIH [HL-113281, HL-116205]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113281, R01HL116205] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work is supported in part by NIH grants HL-113281 and HL-116205 to Paras K. Mishra. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DR, 2014, MOL GENET METAB, V113, P161, DOI 10.1016/j.ymgme.2014.04.001; Aledo R, 2001, HUM GENET, V109, P19, DOI 10.1007/s004390100554; Archer K, 2015, INT J MOL SCI, V16, P23651, DOI 10.3390/ijms161023651; Armstrong DWJ, 2013, REGUL PEPTIDES, V186, P108, DOI 10.1016/j.regpep.2013.08.006; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basu R, 2009, AM J PHYSIOL-HEART C, V297, pH2096, DOI 10.1152/ajpheart.00452.2009; Bera TK, 2000, MOL CELL BIOL, V20, P2902, DOI 10.1128/MCB.20.8.2902-2906.2000; Bugger H, 2008, DIABETES, V57, P2924, DOI 10.2337/db08-0079; Burke MA, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86898; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Caroli A, 2013, J CARDIOL, V61, P315, DOI 10.1016/j.jjcc.2013.01.012; Chao Yung-Mei, 2016, Shengli Xuebao, V68, P557, DOI 10.13294/j.aps.2016.0064; Chavali V, 2014, CELL BIOCHEM BIOPHYS, V68, P25, DOI 10.1007/s12013-013-9679-4; Chavali V, 2013, DIABET METAB SYND OB, V6, P151, DOI 10.2147/DMSO.S30968; Chen SL, 2014, J CELL MOL MED, V18, P415, DOI 10.1111/jcmm.12218; Cohen-Solal A, 2008, J CARD FAIL, V14, P615, DOI 10.1016/j.cardfail.2008.04.001; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Dijk W, 2016, J LIPID RES, V57, P1670, DOI 10.1194/jlr.M067363; Dlamini Z, 2015, EXP MOL PATHOL, V98, P574, DOI 10.1016/j.yexmp.2015.03.022; Feng BA, 2010, DIABETES-METAB RES, V26, P40, DOI 10.1002/dmrr.1054; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Garin I, 2010, P NATL ACAD SCI USA, V107, P3105, DOI 10.1073/pnas.0910533107; Ge M, 2009, AM J CHINESE MED, V37, P1059, DOI 10.1142/S0192415X09007491; Gidlof O, 2014, SCAND CARDIOVASC J, V48, P328, DOI 10.3109/14017431.2014.983965; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Hemmeryckx B, 2014, EUR J PHARMACOL, V723, P175, DOI 10.1016/j.ejphar.2013.12.036; Iaconetti C, 2013, INT J MOL SCI, V14, P19987, DOI 10.3390/ijms141019987; Jiao YH, 2015, FUND CLIN PHARMACOL, V29, P260, DOI 10.1111/fcp.12111; Jun JI, 2011, NAT REV DRUG DISCOV, V10, P945, DOI 10.1038/nrd3599; Kaasboll OJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149000; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Kumar M, 2012, PROTEIN CELL, V3, P726, DOI 10.1007/s13238-012-2055-0; Kumarswamy R, 2013, CIRC RES, V113, P676, DOI 10.1161/CIRCRESAHA.113.300226; Leask A, 2006, J CELL SCI, V119, P4803, DOI 10.1242/jcs.03270; Lewis A, 2016, J CACHEXIA SARCOPENI, V7, P330, DOI 10.1002/jcsm.12078; Li TT, 2016, CELL PHYSIOL BIOCHEM, V38, P670, DOI 10.1159/000438659; Li X, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027465; Li XM, 2016, ADV ENG SOFTW, V93, P1, DOI 10.1016/j.advengsoft.2015.11.003; Liu LT, 2016, CARDIOVASC RES, V111, P56, DOI 10.1093/cvr/cvw078; Liu Y, 2012, CLIN EXP HYPERTENS, V34, P504, DOI 10.3109/10641963.2012.681719; Ma LB, 2013, REGUL PEPTIDES, V181, P9, DOI 10.1016/j.regpep.2012.12.003; Mathew V, 2004, CIRCULATION, V109, P476, DOI 10.1161/01.CIR.0000109693.64957.20; Matkovich SJ, 2010, CIRC RES, V106, P166, DOI 10.1161/CIRCRESAHA.109.202176; Mellor KM, 2014, AM J PHYSIOL-HEART C, V306, pH1240, DOI 10.1152/ajpheart.00059.2014; Melman YF, 2014, CIRC-HEART FAIL, V7, P203, DOI 10.1161/CIRCHEARTFAILURE.113.000266; Mishra PK, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-49; Mishra PK, 2012, CAN J PHYSIOL PHARM, V90, P353, DOI [10.1139/y11-131, 10.1139/Y11-131]; Mishra PK, 2010, BIOCHEM BIOPH RES CO, V401, P175, DOI 10.1016/j.bbrc.2010.09.006; Mishra PK, 2009, J CELL MOL MED, V13, P778, DOI 10.1111/j.1582-4934.2009.00744.x; Miyazaki M, 2003, J BIOL CHEM, V278, P33904, DOI 10.1074/jbc.M304724200; Moon SS, 2012, DIABETES RES CLIN PR, V95, P230, DOI 10.1016/j.diabres.2011.09.035; Nandi SS, 2016, DIABETES, V65, P3075, DOI 10.2337/db16-0023; Ottosen S, 2015, ANTIMICROB AGENTS CH, V59, P599, DOI 10.1128/AAC.04220-14; Patel TP, 2016, HEART FAIL REV, V21, P11, DOI 10.1007/s10741-015-9515-6; Pereira NL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085708; Prathipati P, 2016, FRONT PHYSIOL, V7, DOI [10.3389/fphys.7016.00093, 10.3389/fphys.2016.00093]; Puthanveetil P, 2015, CRIT REV CL LAB SCI, V52, P138, DOI 10.3109/10408363.2014.997931; Quiat D, 2013, J CLIN INVEST, V123, P11, DOI 10.1172/JCI62876; Rees SD, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-83; Ren ZQ, 2014, GENET MOL RES, V13, P2949, DOI 10.4238/2014.April.16.3; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Ruan XB, 2016, J CELL BIOCHEM, V117, P1061, DOI 10.1002/jcb.25427; Rubattu S, 2013, EUR J INTERN MED, V24, P80, DOI 10.1016/j.ejim.2012.09.002; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Servais EL, 2012, CLIN CANCER RES, V18, P2478, DOI 10.1158/1078-0432.CCR-11-2614; Smart-Halajko MC, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-89; Stitziel NO, 2016, NEW ENGL J MED, V375, P2306, DOI 10.1056/NEJMc1607380; Tao H, 2015, EXPERT OPIN THER TAR, V19, P707, DOI 10.1517/14728222.2014.1001740; Theisen MJ, 2004, P NATL ACAD SCI USA, V101, P16442, DOI 10.1073/pnas.0405809101; Tsintzas K, 2007, J CLIN ENDOCR METAB, V92, P3967, DOI 10.1210/jc.2007-1104; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Visser M, 2017, HEART RHYTHM, V14, P1035, DOI 10.1016/j.hrthm.2017.01.010; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wilson KD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002609; Xia ZM, 2010, MATH PROBL ENG, V2010, DOI 10.1155/2010/962435; Xu J, 2016, DATABASE, V2016, P1, DOI DOI 10.3390/PHARMACEUTICS8010008; Yang KC, 2014, CIRCULATION, V129, P1009, DOI 10.1161/CIRCULATIONAHA.113.003863; Yoshioka M, 1997, DIABETES, V46, P887, DOI 10.2337/diabetes.46.5.887; Yu XX, 2005, P NATL ACAD SCI USA, V102, P1767, DOI 10.1073/pnas.0409564102; Zeng CW, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-693; Zhu JH, 2016, SCI REP-UK, V6, DOI 10.1038/srep28400	83	31	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182828	10.1371/journal.pone.0182828	http://dx.doi.org/10.1371/journal.pone.0182828			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837672	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000030
J	Kulp, JL; Cloudsdale, IS; Kulp, JL; Guarnieri, F				Kulp, John L., III; Cloudsdale, Ian S.; Kulp, John L., Jr.; Guarnieri, Frank			Hot-spot identification on a broad class of proteins and RNA suggest unifying principles of molecular recognition	PLOS ONE			English	Article							PANCREATIC TRYPSIN-INHIBITOR; FRAGMENT-BASED APPROACH; ENSEMBLE MONTE-CARLO; BINDING-SITES; HIV-1 PROTEASE; CRYSTAL-STRUCTURES; X-RAY; DRUG DISCOVERY; LEAD DISCOVERY; LENNARD-JONES	Chemically diverse fragments tend to collectively bind at localized sites on proteins, which is a cornerstone of fragment-based techniques. A central question is how general are these strategies for predicting a wide variety of molecular interactions such as small molecule-protein, protein-protein and protein-nucleic acid for both experimental and computational methods. To address this issue, we recently proposed three governing principles, (1) accurate prediction of fragment-macromolecule binding free energy, (2) accurate prediction of water-macromolecule binding free energy, and (3) locating sites on a macromolecule that have high affinity for a diversity of fragments and low affinity for water. To test the generality of these concepts we used the computational technique of Simulated Annealing of Chemical Potential to design one small fragment to break the RecA-RecA protein-protein interaction and three fragments that inhibit peptide-deformylase via water-mediated multi-body interactions. Experiments confirm the predictions that 6-hydroxydopamine potently inhibits RecA and that PDF inhibition quantitatively tracks the water-mediated binding predictions. Additionally, the principles correctly predict the essential bound waters in HIV Protease, the surprisingly extensive binding site of elastase, the pinpoint location of electron transfer in dihydrofolate reductase, the HIV TAT-TAR protein-RNA interactions, and the MDM2-MDM4 differential binding to p53. The experimental confirmations of highly non-obvious predictions combined with the precise characterization of a broad range of known phenomena lend strong support to the generality of fragment-based methods for characterizing molecular recognition.	[Kulp, John L., III; Cloudsdale, Ian S.; Kulp, John L., Jr.] Conifer Point Pharmaceut, Doylestown, PA USA; [Kulp, John L., III] Baruch S Blumberg Inst, Dept Chem, Doylestown, PA USA; [Guarnieri, Frank] PAKA Pulm Pharmaceut, Acton, MA 01720 USA		Guarnieri, F (corresponding author), PAKA Pulm Pharmaceut, Acton, MA 01720 USA.	frankguarnieri@yahoo.com		Kulp, John/0000-0003-2586-9207	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health [R43GM109549]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM109549] Funding Source: NIH RePORTER	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Dr. Guarnieri is an employee of PAKA Pulmonary Pharmaceuticals and affiliated with Virginia Commonwealth University. Dr. Kulp III is an employee of Conifer Point Pharmaceuticals and an employee of the nonprofit, The Baruch S. Blumberg Institute. Dr. Kulp JR and Dr. Cloudsdale are employees of Conifer Point Pharmaceuticals. PAKA provided support in the form of salary for Dr. Guarnieri, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Conifer Point provided salary support for Dr. Kulp III and Dr. Kulp JR and these individuals had a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Specific roles are articulated in the 'authors contributions' section. Part of the research reported in this publication was supported by National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health under award number R43GM109549.	ADAMS DJ, 1975, MOL PHYS, V29, P307, DOI 10.1080/00268977500100221; Aktories K, 2011, NAT REV MICROBIOL, V9, P487, DOI 10.1038/nrmicro2592; ALBER T, 1976, NATURE, V263, P297, DOI 10.1038/263297a0; Allen KN, 1996, J PHYS CHEM-US, V100, P2605, DOI 10.1021/jp952516o; Amano M, 2013, ANTIMICROB AGENTS CH, V57, P2036, DOI 10.1128/AAC.02189-12; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; BERNDT KD, 1992, J MOL BIOL, V227, P757, DOI 10.1016/0022-2836(92)90222-6; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bohnuud T, 2012, NUCLEIC ACIDS RES, V40, P7644, DOI 10.1093/nar/gks519; Boularot A, 2007, J MED CHEM, V50, P10, DOI 10.1021/jm060910c; Bradbury MW, 2011, J MOL BIOL, V412, P412, DOI 10.1016/j.jmb.2011.07.034; Buhrman G, 2011, J MOL BIOL, V413, P773, DOI 10.1016/j.jmb.2011.09.011; CHEN ZG, 1994, J BIOL CHEM, V269, P26344; Cheng YK, 1998, NATURE, V392, P696, DOI 10.1038/33653; Chessari G, 2009, DRUG DISCOV TODAY, V14, P668, DOI 10.1016/j.drudis.2009.04.007; Chilingaryan Z, 2012, INT J MOL SCI, V13, P12857, DOI 10.3390/ijms131012857; Chuang GY, 2009, BIOPHYS J, V97, P2846, DOI 10.1016/j.bpj.2009.09.004; Corey R, 2014, ANTIMICROB AGENTS CH, V58, P6518, DOI 10.1128/AAC.03360-14; Cui PX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07453; Czapinska H, 2000, J MOL BIOL, V295, P1237, DOI 10.1006/jmbi.1999.3445; Czarna A, 2009, CELL CYCLE, V8, P1176, DOI 10.4161/cc.8.8.8185; DANISHEFSKY AT, 1993, PROTEIN SCI, V2, P577; Davidson A, 2011, NUCLEIC ACIDS RES, V39, P248, DOI 10.1093/nar/gkq713; Davies TG, 2016, J MED CHEM, V59, P3991, DOI 10.1021/acs.jmedchem.6b00228; De Zutter JK, 2001, STRUCTURE, V9, P47, DOI 10.1016/S0969-2126(00)00552-9; Dennis S, 2002, P NATL ACAD SCI USA, V99, P4290, DOI 10.1073/pnas.062398499; DORSEY BD, 1994, J MED CHEM, V37, P3443, DOI 10.1021/jm00047a001; Eakin AE, 2012, ANTIMICROB AGENTS CH, V56, P1240, DOI 10.1128/AAC.05485-11; Edink E, 2011, J AM CHEM SOC, V133, P5363, DOI 10.1021/ja110571r; Egger J, 2013, J AM CHEM SOC, V135, P9820, DOI 10.1021/ja4029582; Erlanson DA, 2016, NAT REV DRUG DISCOV, V15, P605, DOI 10.1038/nrd.2016.109; Feki A, 2004, CRIT REV ONCOL HEMAT, V52, P103, DOI 10.1016/j.critrevonc.2004.07.002; Gable JE, 2016, CHEMMEDCHEM, V11, P862, DOI 10.1002/cmdc.201500526; Golden MS, 2013, J AM CHEM SOC, V135, P6242, DOI 10.1021/ja400914z; GOODFORD PJ, 1985, J MED CHEM, V28, P849, DOI 10.1021/jm00145a002; Grasberger BL, 2005, J MED CHEM, V48, P909, DOI 10.1021/jm049137g; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Guarnieri F, 1996, J AM CHEM SOC, V118, P8493, DOI 10.1021/ja961482a; Guarnieri F., 2012, DICHOTOMY UNDERSTAND, P4; Guarnieri F., 2015, DESIGNING ORALLY AVA, V1289, P211; Guarnieri F, 2004, U.S. Patent, Patent No. 6735530; Guarnieri Frank, 2015, Methods Mol Biol, V1289, P185, DOI 10.1007/978-1-4939-2486-8_14; Guarnieri F, 2010, P NATL ACAD SCI USA, V107, P10661, DOI 10.1073/pnas.1001349107; Hall DH, 2011, J AM CHEM SOC, V133, P20668, DOI 10.1021/ja207914y; Hao GF, 2012, J AM CHEM SOC, V134, P11168, DOI 10.1021/ja3001908; Hay DA, 2014, J AM CHEM SOC, V136, P9308, DOI 10.1021/ja412434f; HOUSSET D, 1991, J MOL BIOL, V220, P757, DOI 10.1016/0022-2836(91)90115-M; Hu BL, 2006, J BIOL CHEM, V281, P33030, DOI 10.1074/jbc.C600147200; HUGHES DL, 1982, J MOL BIOL, V162, P645, DOI 10.1016/0022-2836(82)90393-X; Huguet F, 2012, CHEMMEDCHEM, V7, P1020, DOI 10.1002/cmdc.201200076; Indiani C, 2013, P NATL ACAD SCI USA, V110, P5410, DOI 10.1073/pnas.1303301110; Joseph TL, 2010, CELL CYCLE, V9, P1167, DOI 10.4161/cc.9.6.11067; Katada T, 2012, BIOL PHARM BULL, V35, P2103, DOI 10.1248/bpb.b212024; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kozakov D, 2011, P NATL ACAD SCI USA, V108, P13528, DOI 10.1073/pnas.1101835108; Kulp JL, 2012, J COMPUT AID MOL DES, V26, P583, DOI 10.1007/s10822-012-9546-1; Kulp JL, 2011, J AM CHEM SOC, V133, P10740, DOI 10.1021/ja203929x; Kumar M, 2002, BIOCHEM BIOPH RES CO, V294, P395, DOI 10.1016/S0006-291X(02)00482-5; Lax A, 2012, CURR TOP MICROBIOL, V361, P131, DOI 10.1007/82_2012_236; Lee AM, 2007, ANAL BIOCHEM, V367, P247, DOI 10.1016/j.ab.2007.04.021; Li C, 2010, J MOL BIOL, V398, P200, DOI 10.1016/j.jmb.2010.03.005; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Liu FL, 2006, J MOL BIOL, V358, P1191, DOI 10.1016/j.jmb.2006.02.076; Liu LK, 2014, J MED CHEM, V57, P2714, DOI 10.1021/jm5000276; Liu ZG, 2013, BIOCHEM BIOPH RES CO, V430, P1022, DOI 10.1016/j.bbrc.2012.12.045; Marcellino D, 2010, J NEURAL TRANSM, V117, P681, DOI 10.1007/s00702-010-0400-0; Mashalidis EH, 2013, NAT PROTOC, V8, P2309, DOI 10.1038/nprot.2013.130; Massari S, 2013, CURR PHARM DESIGN, V19, P1860, DOI 10.2174/1381612811319100010; Massova I, 1999, J AM CHEM SOC, V121, P8133, DOI 10.1021/ja990935j; MATTOS C, 1994, NAT STRUCT BIOL, V1, P55, DOI 10.1038/nsb0194-55; Mattos C, 2006, J MOL BIOL, V357, P1471, DOI 10.1016/j.jmb.2006.01.039; Mattos C, 1996, NAT BIOTECHNOL, V14, P595, DOI 10.1038/nbt0596-595; Mehler EL, 1999, BIOPHYS J, V77, P3, DOI 10.1016/S0006-3495(99)76868-2; MEYER EF, 1986, J MOL BIOL, V189, P533, DOI 10.1016/0022-2836(86)90322-0; MEZEI M, 1987, MOL PHYS, V61, P565, DOI 10.1080/00268978700101321; Mikuni J, 2010, ANAL BIOCHEM, V402, P26, DOI 10.1016/j.ab.2010.03.019; Miller RM, 2013, J AM CHEM SOC, V135, P5298, DOI 10.1021/ja401221b; MIRANKER A, 1991, PROTEINS, V11, P29, DOI 10.1002/prot.340110104; Moffett K, 2011, BIOORG MED CHEM LETT, V21, P7155, DOI 10.1016/j.bmcl.2011.09.078; Moore WR, 2005, CURR OPIN DRUG DISC, V8, P355; Mousseau Guillaume, 2012, Biology (Basel), V1, P668, DOI 10.3390/biology1030668; Mullard A, 2012, NAT REV DRUG DISCOV, V11, P172, DOI 10.1038/nrd3680; Murray K, 2007, PEPTIDE SCI, V88, P657; NAVIA MA, 1989, P NATL ACAD SCI USA, V86, P7, DOI 10.1073/pnas.86.1.7; Peterson EJR, 2012, ASSAY DRUG DEV TECHN, V10, P260, DOI 10.1089/adt.2011.0409; Pierce J A, 1969, Trans Assoc Am Physicians, V82, P87; Popowicz GM, 2011, ANGEW CHEM INT EDIT, V50, P2680, DOI 10.1002/anie.201003863; Prashar V, 2010, BIOCHEM BIOPH RES CO, V396, P1018, DOI 10.1016/j.bbrc.2010.05.049; Qin LY, 2014, J AM CHEM SOC, V136, P18023, DOI 10.1021/ja509223m; Raman EP, 2015, J AM CHEM SOC, V137, P2608, DOI 10.1021/ja512054f; Raman EP, 2013, J CHEM INF MODEL, V53, P3384, DOI 10.1021/ci4005628; Randhawa H, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-321; Roca AI, 1997, PROG NUCLEIC ACID RE, V56, P129, DOI 10.1016/S0079-6603(08)61005-3; Rojas A, 2013, CELL SIGNAL, V25, P609, DOI 10.1016/j.cellsig.2012.11.022; Rouhana J, 2013, J MED CHEM, V56, P8497, DOI 10.1021/jm4009357; Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P586, DOI 10.1021/bi962337c; Scott DE, 2013, CHEMBIOCHEM, V14, P332, DOI 10.1002/cbic.201200521; Sexton Jonathan Z, 2010, Curr Chem Genomics, V4, P34, DOI 10.2174/1875397301004010034; Sheth A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.112; Shuker SB, 1996, SCIENCE, V274, P1531, DOI 10.1126/science.274.5292.1531; Siegert P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003385; Silvestre HL, 2013, P NATL ACAD SCI USA, V110, P12984, DOI 10.1073/pnas.1304045110; Singleton SF, 2007, TETRAHEDRON, V63, P3553, DOI 10.1016/j.tet.2006.10.092; Steffens LS, 2010, RES MICROBIOL, V161, P346, DOI 10.1016/j.resmic.2010.04.003; TURINO GM, 1969, SCIENCE, V165, P709, DOI 10.1126/science.165.3894.709; Vallee M, 2014, SCIENCE, V343, P94, DOI 10.1126/science.1243985; Van Molle I, 2012, CHEM BIOL, V19, P1300, DOI 10.1016/j.chembiol.2012.08.015; Waaijers S, 2013, J PROTEOME RES, V12, P3181, DOI 10.1021/pr400047p; Wang ZM, 1998, BBA-PROTEIN STRUCT M, V1384, P335, DOI 10.1016/S0167-4838(98)00027-2; Wellendorph P, 2009, MOL PHARMACOL, V76, P453, DOI 10.1124/mol.109.055244; Wernick NLB, 2010, TOXINS, V2, P310, DOI 10.3390/toxins2030310; Wigle TJ, 2007, BIOORG MED CHEM LETT, V17, P3249, DOI 10.1016/j.bmcl.2007.04.013; Wigle TJ, 2009, J BIOMOL SCREEN, V14, P1092, DOI 10.1177/1087057109342126; Wilcken R, 2012, J AM CHEM SOC, V134, P6810, DOI 10.1021/ja301056a; Winter A, 2016, MOL CANCER THER, V15, P3, DOI 10.1158/1535-7163.MCT-15-0446; Winter A, 2012, Q REV BIOPHYS, V45, P383, DOI 10.1017/S0033583512000108; WLODAWER A, 1984, J MOL BIOL, V180, P301, DOI 10.1016/S0022-2836(84)80006-6; WLODAWER A, 1987, J MOL BIOL, V193, P145, DOI 10.1016/0022-2836(87)90633-4; WLODAWER A, 1987, J MOL BIOL, V198, P469, DOI 10.1016/0022-2836(87)90294-4; Yedidi RS, 2012, BIOCHEM BIOPH RES CO, V421, P413, DOI 10.1016/j.bbrc.2012.03.096; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005	121	3	3	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183327	10.1371/journal.pone.0183327	http://dx.doi.org/10.1371/journal.pone.0183327			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837642	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000060
J	Purcell, KM; Craig, JK; Nance, JM; Smith, MD; Bennear, LS				Purcell, Kevin M.; Craig, J. Kevin; Nance, James M.; Smith, Martin D.; Bennear, Lori S.			Fleet behavior is responsive to a large-scale environmental disturbance: Hypoxia effects on the spatial dynamics of the northern Gulf of Mexico shrimp fishery	PLOS ONE			English	Article							GENERALIZED ADDITIVE-MODELS; SOUTHEASTERN UNITED-STATES; BROWN SHRIMP; FARFANTEPENAEUS-AZTECUS; MANAGEMENT IMPLICATIONS; ELECTRONIC LOGBOOK; CONTINENTAL-SHELF; MENHADEN FISHERY; DISSOLVED-OXYGEN; FISHING EFFORT	The northwestern Gulf of Mexico shelf experiences one of the largest seasonal hypoxic zones in the western hemisphere. Hypoxia (dissolved oxygen, DO <= 2.0 mg.L-1) is most severe from May to August during the height of the Gulf shrimp fishery, but its effects on the fishery are not well known. Prior studies indicate that hypoxia alters the spatial dynamics of shrimp and other species through habitat loss and aggregation in nearby oxygenated refuge habitats. We hypothesized that hypoxia-induced changes in the distribution of shrimp also alter the spatial dynamics of the Gulf shrimp fleet. We integrated data on the geographic distribution of shrimp tows and bottom DO to evaluate the effects of hypoxia on spatial patterns in shrimping effort. Our analyses indicate that shrimping effort declines in low DO waters on both the Texas and Louisiana shelf, but that considerable effort still occurs in low DO waters off Louisiana, likely because riverine nutrients fuel both benthic production and low bottom DO in the same general regions. The response of the shrimp fleet to hypoxia on the Louisiana shelf was complex with shifts in effort inshore, offshore, westward, and eastward of the hypoxic zone, as well as to an oxygenated area between two hypoxia regimes associated with the Mississippi and the Atchafalaya River outflows. In contrast, effort on the Texas shelf mostly shifted offshore in response to low DO but also shifted inshore in some years. Spatial patterns in total shrimping effort were driven primarily by the number of shrimp tows, consistent with aggregation of the fleet outside of hypoxic waters, though tow duration also declined in low DO waters. Overall, our results demonstrate that hypoxia alters the spatial dynamics of the Gulf shrimp fishery with potential consequences for harvest interactions and the economic condition of the fishery.	[Purcell, Kevin M.; Craig, J. Kevin] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA; [Nance, James M.] Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Galveston Lab, Galveston, TX USA; [Smith, Martin D.; Bennear, Lori S.] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Purcell, Kevin M.] Harrisburg Univ Sci & Technol, Harrisburg, PA USA	National Oceanic Atmospheric Admin (NOAA) - USA; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA; Duke University	Craig, JK (corresponding author), Natl Marine Fisheries Serv, Southeast Fisheries Sci Ctr, Beaufort Lab, Beaufort, NC 28516 USA.	kevin.craig@noaa.gov		Craig, Joseph/0000-0002-0148-4989	National Oceanic and Atmospheric administration (NOM) Center [NA09NOS4780186]	National Oceanic and Atmospheric administration (NOM) Center	Financial support for this project was provided by the National Oceanic and Atmospheric administration (NOM) Center for Sponsored Coastal Ocean Research under award # NA09NOS4780186. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed herein are those of the authors and do not necessarily reflect the view of NOAA or any of its sub-agencies.	[Anonymous], 2009, CONT SHELF RES, V29, P1464; ArreguinSanchez F, 1996, REV FISH BIOL FISHER, V6, P221; Bacheler NM, 2010, FISH OCEANOGR, V19, P107, DOI 10.1111/j.1365-2419.2009.00531.x; Bartolino V, 2012, MAR ECOL PROG SER, V444, P251, DOI 10.3354/meps09434; Bianchi TS, 2010, SCI TOTAL ENVIRON, V408, P1471, DOI 10.1016/j.scitotenv.2009.11.047; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Chesney EJ, 2000, ECOL APPL, V10, P350; Ciannelli L, 2012, P ROY SOC B-BIOL SCI, V279, P3635, DOI 10.1098/rspb.2012.0849; Condrey R, 2005, CLIMATE CHANGE FISHE, P89; Craig JK, 2010, FISH OCEANOGR, V19, P301, DOI 10.1111/j.1365-2419.2010.00545.x; Craig JK, 2013, ESTUAR COAST, V36, P268, DOI 10.1007/s12237-012-9577-9; Craig JK, 2012, MAR ECOL PROG SER, V445, P75, DOI 10.3354/meps09437; Craig JK, 2005, CAN J FISH AQUAT SCI, V62, P1295, DOI 10.1139/F05-036; Craig JK, 2005, MAR ECOL PROG SER, V294, P79, DOI 10.3354/meps294079; Davies TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114037; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; DiMarco SF, 2012, AQUAT GEOCHEM, V18, P159, DOI 10.1007/s10498-011-9156-x; DiMarco SF, 2010, J MARINE SYST, V80, P25, DOI 10.1016/j.jmarsys.2009.08.005; Drexler M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064458; Eales James, 1986, MAR RESOUR ECON, V2, P331, DOI [10.1086/mre.2.4.42628909, DOI 10.1086/MRE.2.4.42628909]; ELDRIDGE PJ, 1988, MAR FISH REV, V50, P29; Froehlich HE, 2014, ESTUAR COAST, V37, P449, DOI 10.1007/s12237-013-9676-2; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gallaway BJ, 2003, N AM J FISH MANAGE, V23, P787, DOI 10.1577/M02-105; Gallaway BJ, 2003, N AM J FISH MANAGE, V23, P581, DOI 10.1577/1548-8675(2003)023<0581:DOASEL>2.0.CO;2; Gezelius SS, 2007, HUM ECOL, V35, P587, DOI 10.1007/s10745-006-9096-z; Gillis DM, 2006, CAN J FISH AQUAT SCI, V63, P254, DOI 10.1139/F05-211; Gillis DM, 2001, ICES J MAR SCI, V58, P61, DOI 10.1006/jmsc.2000.0990; Greene RM, 2009, ECOL APPL, V19, P1161, DOI 10.1890/08-0035.1; Gruss A, 2014, FISH RES, V159, P11, DOI 10.1016/j.fishres.2014.05.005; Gunter G., 1963, J MISS ACAD SCI, V9, P286; HARPER DE, 1991, GEOL SOC SPEC PUBL, P49, DOI 10.1144/GSL.SP.1991.058.01.04; HASTIE T, 1993, J ROY STAT SOC B MET, V55, P757; Haynie AC, 2010, J ENVIRON ECON MANAG, V59, P165, DOI 10.1016/j.jeem.2009.11.001; Hazen EL, 2009, MAR ECOL PROG SER, V375, P195, DOI 10.3354/meps07791; Hetland RD, 2008, J MARINE SYST, V70, P49, DOI 10.1016/j.jmarsys.2007.03.002; Holland DS, 2000, LAND ECON, V76, P133, DOI 10.2307/3147262; Huang L, 2014, AM ECON REV, V104, P4071, DOI 10.1257/aer.104.12.4071; Huang L, 2012, MAR RESOUR ECON, V27, P3, DOI 10.5950/0738-1360-27.1.3; Huang L, 2010, MAR COAST FISH, V2, P232, DOI 10.1577/C09-048.1; Iverson K, 2009, J MAR ED, V25; Langseth BJ, 2016, FISH RES, V181, P186, DOI 10.1016/j.fishres.2016.04.013; Langseth BJ, 2014, MAR COAST FISH, V6, P223, DOI 10.1080/19425120.2014.949017; Ludsin SA, 2009, J EXP MAR BIOL ECOL, V381, pS121, DOI 10.1016/j.jembe.2009.07.016; Michael PE, 2015, FISH OCEANOGR, V24, P478, DOI 10.1111/fog.12123; Murawski SA, 2005, ICES J MAR SCI, V62, P1150, DOI 10.1016/j.icesjms.2005.04.005; Nance James M., 1994, North American Journal of Fisheries Management, V14, P522, DOI 10.1577/1548-8675(1994)014<0522:FOITER>2.3.CO;2; Nance JM, 1993, NMFSSEFSC337; Obenour DR, 1985, ENV SCI TECHNOL, V47; PATELLA F, 1975, MAR FISH REV, V37, P22; Poos JJ, 2010, ICES J MAR SCI, V67, P155, DOI 10.1093/icesjms/fsp219; Prince ED, 2010, FISH OCEANOGR, V19, P448, DOI 10.1111/j.1365-2419.2010.00556.x; Rabalais NN, 2007, ECOL APPL, V17, pS129, DOI 10.1890/06-0644.1; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Rabalais NN, 2002, BIOSCIENCE, V52, P129, DOI 10.1641/0006-3568(2002)052[0129:BSIPGO]2.0.CO;2; Rester J. K., 2011, SEAMAP ENV BIOL ATLA; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Smith MD, 2014, MAR RESOUR ECON, V29, P111, DOI 10.1086/676826; Smith MD, 2010, B MAR SCI, V86, P461; Smith MD, 2006, CAN J FISH AQUAT SCI, V63, P153, DOI 10.1139/F05-205; Smith MD, 2005, J ENVIRON ECON MANAG, V50, P319, DOI 10.1016/j.jeem.2005.04.001; Smith MD, 2017, P NATL ACAD SCI; Soykan CU, 2014, ECOL APPL, V24, P71, DOI 10.1890/12-0826.1; Stramma L, 2012, NAT CLIM CHANGE, V2, P33, DOI 10.1038/NCLIMATE1304; Sun J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159626; Switzer TS, 2009, J EXP MAR BIOL ECOL, V381, pS51, DOI 10.1016/j.jembe.2009.07.011; Sys K, 2016, ICES J MAR SCI, V73, P1485, DOI 10.1093/icesjms/fsw008; Thronson A, 2008, ESTUAR COAST, V31, P802, DOI 10.1007/s12237-008-9056-5; Turner RE, 2008, ENVIRON SCI TECHNOL, V42, P2323, DOI 10.1021/es071617k; Tyler RM, 2007, MAR ECOL PROG SER, V333, P257, DOI 10.3354/meps333257; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Wang XLL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053381; Wannamaker CM, 2000, J EXP MAR BIOL ECOL, V249, P145, DOI 10.1016/S0022-0981(00)00160-X; Wilen JE, 2002, B MAR SCI, V70, P553; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Zhang HY, 2009, J EXP MAR BIOL ECOL, V381, pS80, DOI 10.1016/j.jembe.2009.07.014; Zimmerman RJ, 2000, CONCEPTS AND CONTROVERSIES IN TIDAL MARSH ECOLOGY, P293	78	15	15	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183032	10.1371/journal.pone.0183032	http://dx.doi.org/10.1371/journal.pone.0183032			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE7CK	28837674	Green Published, gold			2022-12-27	WOS:000408365000043
J	Rosager, AM; Sorensen, MD; Dahlrot, RH; Hansen, S; Schonberg, DL; Rich, JN; Lathia, JD; Kristensen, BW				Rosager, Ann Mari; Sorensen, Mia D.; Dahlrot, Rikke H.; Hansen, Steinbjorn; Schonberg, David L.; Rich, Jeremy N.; Lathia, Justin D.; Kristensen, Bjarne W.			Transferrin receptor-1 and ferritin heavy and light chains in astrocytic brain tumors: Expression and prognostic value	PLOS ONE			English	Article							IRON-METABOLISM; ADJUVANT TEMOZOLOMIDE; BREAST-CANCER; GLIOBLASTOMA; GLIOMA; MARKER; CELLS; RADIOTHERAPY; HOMEOSTASIS; CONCOMITANT	Astrocytic brain tumors are the most frequent primary brain tumors. Treatment with radio- and chemotherapy has increased survival making prognostic biomarkers increasingly important. The aim of the present study was to investigate the expression and prognostic value of transferrin receptor-1 (TfR1) as well as ferritin heavy (FTH) and light (FTL) chain in astrocytic brain tumors. A cohort of 111 astrocytic brain tumors (grade II-IV) was stained immunohistochemically with antibodies against TfR1, FTH, and FTL and scored semi-quantitatively. Double-immunofluorescence stainings were established to determine the phenotype of cells expressing these markers. We found that TfR1, FTH, and FTL were expressed by tumor cells in all grades. TfR1 increased with grade (p<0.001), but was not associated with prognosis in the individual grades. FTH and FTL were expressed by tumor cells and cells with microglial/macrophage morphology. Neither FTH nor FTL increased with malignancy grade, but low FTH expression by both tumor cells (p = 0.03) and microglia/macrophages (p = 0.01) correlated with shorter survival in patients anaplastic astrocytoma. FTL-positive microglia/macrophages were frequent in glioblastomas, and high FTL levels correlated with shorter survival in the whole cohort (p = 0.01) and in patients with anaplastic astrocytoma (p = 0.02). Double-immunofluorescence showed that TfR1, FTH, and FTL were co-expressed to a limited extent with the stem cell-related marker CD133. FTH and FTL were also co-expressed by IBA-1-positive microglia/macrophages. In conclusion, TfR1 was highly expressed in glioblastomas and associated with shorter survival in the whole cohort, but not in the individual malignancy grades. Low levels of FTH-positive tumor cells and microglia/macrophages were associated with poor survival in anaplastic astrocytomas, while high amounts of FTL-positive microglia/macrophages had a negative prognostic value. The results suggest that regulation of the iron metabolism in astrocytic brain tumors is complex involving both autocrine and paracrine signaling.	[Rosager, Ann Mari; Sorensen, Mia D.; Kristensen, Bjarne W.] Odense Univ Hosp, Dept Pathol, Odense, Denmark; [Rosager, Ann Mari; Sorensen, Mia D.; Hansen, Steinbjorn; Kristensen, Bjarne W.] Univ Southern Denmark, Dept Clin Res, Odense, Denmark; [Dahlrot, Rikke H.; Hansen, Steinbjorn] Odense Univ Hosp, Dept Oncol, Odense, Denmark; [Schonberg, David L.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44106 USA; [Lathia, Justin D.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sorensen, MD (corresponding author), Odense Univ Hosp, Dept Pathol, Odense, Denmark.; Sorensen, MD (corresponding author), Univ Southern Denmark, Dept Clin Res, Odense, Denmark.	mia.soerensen@rsyd.dk	Kristensen, Bjarne Winther/AAX-5491-2020; Lathia, Justin/AHB-8296-2022; Rich, Jeremy/AAM-1445-2021; Kristensen, Bjarne Winther/A-6690-2012	Kristensen, Bjarne Winther/0000-0002-6352-0826; Kristensen, Bjarne Winther/0000-0002-6352-0826; Rosager, Ann Mari/0000-0003-2353-7612; Hansen, Steinbjorn/0000-0001-5651-6493; Dahlrot, Rikke/0000-0003-1538-4361	Odense University Hospital Research Funds; University of Southern Denmark; Agnete Lovgren's legat; Familien Hede Nielsen's Foundation; Meta and Hakon Bagger's Foundation; Else and Mogens Wendell-Wedellsborg Foundation	Odense University Hospital Research Funds; University of Southern Denmark; Agnete Lovgren's legat; Familien Hede Nielsen's Foundation; Meta and Hakon Bagger's Foundation; Else and Mogens Wendell-Wedellsborg Foundation	This work was supported by the Odense University Hospital Research Funds, University of Southern Denmark, Agnete Lovgren's legat, Familien Hede Nielsen's Foundation, Meta and Hakon Bagger's Foundation, and Else and Mogens Wendell-Wedellsborg Foundation.	Arai H, 2012, BRAIN TUMOR PATHOL, V29, P160, DOI 10.1007/s10014-012-0081-5; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bradshaw A, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00021; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Christensen K, 2008, J NEURO-ONCOL, V90, P157, DOI 10.1007/s11060-008-9648-8; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Connor JR, 2001, PEDIATR NEUROL, V25, P118, DOI 10.1016/S0887-8994(01)00303-4; CONNOR JR, 1992, J NEUROSCI RES, V31, P75, DOI 10.1002/jnr.490310111; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Dahlrot RH, 2014, INT J CLIN EXP PATHO, V7, P3739; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Debinski W, 2008, DRUG DEVELOP RES, V69, P407, DOI 10.1002/ddr.20272; Emerit J, 2001, BIOMED PHARMACOTHER, V55, P333, DOI 10.1016/S0753-3322(01)00068-3; Eyler CE, 2011, CELL, V146, P53, DOI 10.1016/j.cell.2011.06.006; Flavahan WA, 2013, NAT NEUROSCI, V16, P1373, DOI 10.1038/nn.3510; Gautam P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046153; Hjelmeland AB, 2011, CELL DEATH DIFFER, V18, P829, DOI 10.1038/cdd.2010.150; Huang JY, 2013, FASEB J, V27, P2845, DOI 10.1096/fj.12-216929; KANEKO Y, 1989, ACTA NEUROPATHOL, V79, P129, DOI 10.1007/BF00294369; Kell DB, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-2; Kim JS, 2011, J VET SCI, V12, P1, DOI 10.4142/jvs.2011.12.1.1; Kolenda J, 2011, J NEURO-ONCOL, V103, P43, DOI 10.1007/s11060-010-0357-8; KONDO K, 1990, CHEST, V97, P1367, DOI 10.1378/chest.97.6.1367; Laske DW, 1997, NAT MED, V3, P1362, DOI 10.1038/nm1297-1362; Lathia JD, 2014, CELL REP, V6, P117, DOI 10.1016/j.celrep.2013.11.043; Lathia JD, 2012, ANN NEUROL, V72, P766, DOI 10.1002/ana.23674; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu HD, 2013, NEUROL SCI, V34, P1173, DOI 10.1007/s10072-012-1214-7; Liu NQ, 2014, MOL CELL PROTEOMICS, V13, P1814, DOI 10.1074/mcp.M113.037176; PANACCIO M, 1987, IMMUNOL CELL BIOL, V65, P461, DOI 10.1038/icb.1987.55; Peyssonnaux C, 2007, J CLIN INVEST, V117, P1926, DOI 10.1172/JCI31370; Prutki M, 2006, CANCER LETT, V238, P188, DOI 10.1016/j.canlet.2005.07.001; Rouault Tracey A, 2006, Semin Pediatr Neurol, V13, P142, DOI 10.1016/j.spen.2006.08.002; Schonberg D. L., 2013, MOL ASPECTS MED; Schonberg DL, 2015, CANCER CELL, V28, P441, DOI 10.1016/j.ccell.2015.09.002; SHINDELMAN JE, 1981, INT J CANCER, V27, P329, DOI 10.1002/ijc.2910270311; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; The WHO, 2020, CLASSIFICATION TUMOU; Torti Suzy V., 2013, Critical Reviews in Oncogenesis, V18, P435; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Tortorella S, 2014, J MEMBRANE BIOL, V247, P291, DOI 10.1007/s00232-014-9637-0; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Weaver M, 2003, J NEURO-ONCOL, V65, P3, DOI 10.1023/A:1026246500788; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Wu TF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149361; Ye XZ, 2012, J IMMUNOL, V189, P444, DOI 10.4049/jimmunol.1103248; Zhang X, 2006, GLIA, V54, P795, DOI 10.1002/glia.20416	49	32	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0182954	10.1371/journal.pone.0182954	http://dx.doi.org/10.1371/journal.pone.0182954			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837569	gold, Green Submitted, Green Published			2022-12-27	WOS:000408365000036
J	Surdziel, E; Clay, I; Nigsch, F; Thiemeyer, A; Allard, C; Hoffman, G; Reece-Hoyes, JS; Phadke, T; Gambert, R; Keller, CG; Ludwig, MG; Baumgarten, B; Frederiksen, M; Schubeler, D; Seuwen, K; Bouwmeester, T; Fodor, BD				Surdziel, Ewa; Clay, Ieuan; Nigsch, Florian; Thiemeyer, Anke; Allard, Cyril; Hoffman, Gregory; Reece-Hoyes, John S.; Phadke, Tanushree; Gambert, Romain; Keller, Caroline Gubser; Ludwig, Marie-Gabrielle; Baumgarten, Birgit; Frederiksen, Mathias; Schubeler, Dirk; Seuwen, Klaus; Bouwmeester, Tewis; Fodor, Barna D.			Multidimensional pooled shRNA screens in human THP-1 cells identify candidate modulators of macrophage polarization	PLOS ONE			English	Article							INNATE IMMUNE-RESPONSES; NF-KAPPA-B; GENE-EXPRESSION; ACTIVATED MACROPHAGES; EPIGENETIC REGULATION; HELMINTH INFECTION; DENDRITIC CELLS; IMAGE-ANALYSIS; CANCER-CELLS; O-GLCNAC	Macrophages are key cell types of the innate immune system regulating host defense, inflammation, tissue homeostasis and cancer. Within this functional spectrum diverse and often opposing phenotypes are displayed which are dictated by environmental clues and depend on highly plastic transcriptional programs. Among these the 'classical' (M1) and 'alternative' (M2) macrophage polarization phenotypes are the best characterized. Understanding macrophage polarization in humans may reveal novel therapeutic intervention possibilities for chronic inflammation, wound healing and cancer. Systematic loss of function screening in human primary macrophages is limited due to lack of robust gene delivery methods and limited sample availability. To overcome these hurdles we developed cell-autonomous assays using the THP-1 cell line allowing genetic screens for human macrophage phenotypes. We screened 648 chromatin and signaling regulators with a pooled shRNA library for M1 and M2 polarization modulators. Validation experiments confirmed the primary screening results and identified OGT (O-linked N-acetylglucosamine (GlcNAc) transferase) as a novel mediator of M2 polarization in human macrophages. Our approach offers a possible avenue to utilize comprehensive genetic tools to identify novel candidate genes regulating macrophage polarization in humans.	[Surdziel, Ewa; Clay, Ieuan; Nigsch, Florian; Thiemeyer, Anke; Allard, Cyril; Gambert, Romain; Keller, Caroline Gubser; Ludwig, Marie-Gabrielle; Baumgarten, Birgit; Frederiksen, Mathias; Seuwen, Klaus; Bouwmeester, Tewis; Fodor, Barna D.] Novartis Inst Biomed Res, Basel, Switzerland; [Hoffman, Gregory; Reece-Hoyes, John S.; Phadke, Tanushree] Novartis Inst Biomed Res, Cambridge, MA USA; [Schubeler, Dirk] Friedrich Miescher Inst BioMed Res, Basel, Switzerland	Novartis; Novartis; Friedrich Miescher Institute for Biomedical Research	Fodor, BD (corresponding author), Novartis Inst Biomed Res, Basel, Switzerland.	barna.fodor@novartis.com	Nigsch, Florian/ABB-9306-2021	Nigsch, Florian/0000-0002-2919-8749; Clay, Ieuan/0000-0001-9722-8834; Reece-Hoyes, John/0000-0001-5251-5813; Fodor, Barna/0000-0003-1653-4376; Gubser Keller, Caroline/0000-0001-9459-6076	Novartis	Novartis(Novartis)	Novartis provided support in the form of salaries for authors ES, IC, FN, AT, CA, GH, JSRH, TP, RG, CGK, MGL, BB, MF, KS, TB and BDF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Belkina AC, 2013, J IMMUNOL, V190, P3670, DOI 10.4049/jimmunol.1202838; Beyer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045466; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Chanput W, 2014, INT IMMUNOPHARMACOL, V23, P37, DOI 10.1016/j.intimp.2014.08.002; Chen XF, 2012, P NATL ACAD SCI USA, V109, pE2865, DOI 10.1073/pnas.1121131109; Courtine E, 2012, INNATE IMMUN-LONDON, V18, P753, DOI 10.1177/1753425912440296; Courtine E, 2011, INFECT IMMUN, V79, P1848, DOI 10.1128/IAI.00021-11; Daigneault M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008668; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Estoppey D, 2017, SCI REP-UK, V7, DOI 10.1038/srep42728; Fullard N, 2012, INT J BIOCHEM CELL B, V44, P851, DOI 10.1016/j.biocel.2012.02.017; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hoffman GR, 2014, P NATL ACAD SCI USA, V111, P3128, DOI 10.1073/pnas.1316793111; Hwang SY, 2013, AM J PHYSIOL-CELL PH, V305, pC601, DOI 10.1152/ajpcell.00042.2013; Ishii M, 2009, BLOOD, V114, P3244, DOI 10.1182/blood-2009-04-217620; Italiani P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087680; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Li AQ, 2016, ONCOTARGET, V7, P37966, DOI 10.18632/oncotarget.9274; LI Q, 2016, SCI REP UK, V6; Li X, 2017, J EXP MED, V214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Marek L, 2013, J MED CHEM, V56, P427, DOI 10.1021/jm301254q; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mestas J, 2004, J IMMUNOL, V172, P2731, DOI 10.4049/jimmunol.172.5.2731; Mounir Z, 2016, ELIFE, V5, DOI 10.7554/eLife.13964; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Murray PJ, 2011, J LEUKOCYTE BIOL, V89, P557, DOI 10.1189/jlb.0710409; Mylonas KJ, 2009, J IMMUNOL, V182, P3084, DOI 10.4049/jimmunol.0803463; Nicodeme E, 2010, NATURE, V468, P1119, DOI 10.1038/nature09589; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Parnas O, 2015, CELL, V162, P675, DOI 10.1016/j.cell.2015.06.059; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; Poralla L, 2015, J CELL MOL MED, V19, P2162, DOI 10.1111/jcmm.12595; Roger T, 2011, BLOOD, V117, P1205, DOI 10.1182/blood-2010-05-284711; Rotival M, 2015, MOL CELL PROTEOMICS, V14, P484, DOI 10.1074/mcp.M114.043836; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Spiller KL, 2016, EXP CELL RES, V347, P1, DOI 10.1016/j.yexcr.2015.10.017; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Su WC, 2013, P NATL ACAD SCI USA, V110, P17516, DOI 10.1073/pnas.1312374110; Sun J, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.7; Troegeler A, 2014, IMMUNOL CELL BIOL, V92, P699, DOI 10.1038/icb.2014.39; Vangamudi B, 2015, CANCER RES, V75, P3865, DOI 10.1158/0008-5472.CAN-14-3798; Zhou HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031752	59	21	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183679	10.1371/journal.pone.0183679	http://dx.doi.org/10.1371/journal.pone.0183679			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837623	Green Published, gold, Green Submitted			2022-12-27	WOS:000408365000100
J	Zhang, WY; He, ZB; Guan, W; Ma, R				Zhang, Wenyi; He, Zhengbing; Guan, Wei; Ma, Rui			Selfish routing equilibrium in stochastic traffic network: A probability-dominant description	PLOS ONE			English	Article							MODEL	This paper suggests a probability-dominant user equilibrium (PdUE) model to describe the selfish routing equilibrium in a stochastic traffic network. At PdUE, travel demands are only assigned to the most dominant routes in the same origin-destination pair. A probability-dominant rerouting dynamic model is proposed to explain the behavioral mechanism of PdUE. To facilitate applications, the logit formula of PdUE is developed, of which a well-designed route set is not indispensable and the equivalent varitional inequality formation is simple. Two routing strategies, i.e., the probability-dominant strategy (PDS) and the dominant probability strategy (DPS), are discussed through a hypothetical experiment. It is found that, whether out of insurance or striving for perfection, PDS is a better choice than DPS. For more general cases, the conducted numerical tests lead to the same conclusion. These imply that PdUE (rather than the conventional stochastic user equilibrium) is a desirable selfish routing equilibrium for a stochastic network, given that the probability distributions of travel time are available to travelers.	[Zhang, Wenyi; He, Zhengbing; Guan, Wei] Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China; [Ma, Rui] Univ Calif Davis, Dept Civil & Environm Engn, Davis, CA 95616 USA	Beijing Jiaotong University; University of California System; University of California Davis	He, ZB (corresponding author), Beijing Jiaotong Univ, MOE Key Lab Urban Transportat Complex Syst Theory, Beijing, Peoples R China.	he.zb@hotmail.com	He, Zhengbing/H-8046-2013	He, Zhengbing/0000-0001-5716-3853; Zhang, Wenyi/0000-0002-4752-9994	National Natural Science Foundation of China [71601015, 71621001, 71501009]; Fundamental Research Funds for the Central Universities [2016RC049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is supported by the National Natural Science Foundation of China under Grant Nos. 71601015 to WZ, 71621001 to WG, and 71501009 ZH; and Fundamental Research Funds for the Central Universities under Grant No. 2016RC049 to WZ.	Akamatsu T, 1996, TRANSPORT RES B-METH, V30, P369, DOI 10.1016/0191-2615(96)00003-3; Bell MGH, 1995, TRANSPORT RES B-METH, V29, P287, DOI 10.1016/0191-2615(95)00005-X; Ben-Akiva ME., 1985, DISCRETE CHOICE ANAL; Castillo E, 2008, TRANSPORT RES B-METH, V42, P373, DOI 10.1016/j.trb.2007.08.002; Chen A, 2010, TRANSPORT RES B-METH, V44, P493, DOI 10.1016/j.trb.2009.11.003; Daganzo C. F., 1977, Transportation Science, V11, P253, DOI 10.1287/trsc.11.3.253; DIAL RB, 1971, TRANSPORT RES, V5, P83, DOI 10.1016/0041-1647(71)90012-8; Fosgerau M, 2009, TRANSPORT RES B-METH, V43, P494, DOI 10.1016/j.trb.2008.10.004; HALL RW, 1983, TRANSPORT RES B-METH, V17, P275, DOI 10.1016/0191-2615(83)90046-2; HUANG HJ, 1995, J OPER RES SOC, V46, P977, DOI 10.1038/sj/jors/0460805; Kitthamkesom S, 2013, TRANSPORT RES B-METH, V57, P378, DOI 10.1016/j.trb.2013.06.001; Levy H, 2006, STUD RISK UNCERTAIN, V12, P1, DOI 10.1007/0-387-29311-6; Lo HK, 2006, TRANSPORT RES B-METH, V40, P792, DOI 10.1016/j.trb.2005.10.003; Ma XY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117294; Ma XL, 2017, J TRANSP GEOGR, V58, P135, DOI 10.1016/j.jtrangeo.2016.12.001; Ma XL, 2015, TRANSPORT RES C-EMER, V54, P187, DOI 10.1016/j.trc.2015.03.014; McFadden D., 1974, SPATIAL INTERACTION, P75; Nagurney A., 1993, NETWORK EC VARIATION; Nie Y, 2011, TRANSPORT RES B-METH, V45, P1641, DOI 10.1016/j.trb.2011.06.001; Prashker JN, 2004, TRANSPORT REV, V24, P437, DOI 10.1080/0144164042000181707; Prato CG, 2009, J CHOICE MODEL, V2, P65; Train KE, 2009, DISCRETE CHOICE METHODS WITH SIMULATION, 2ND EDITION, P1, DOI 10.1017/CBO9780511805271; Wardrop JG, 1952, P I CIVIL ENG, P325, DOI [10.1680/ipeds.1952.11362, DOI 10.1680/IPEDS.1952.11259]; Zhang WY, 2015, NETW SPAT ECON, V15, P1075, DOI 10.1007/s11067-014-9281-3; Zhang WY, 2013, J CENT SOUTH UNIV, V20, P3770, DOI 10.1007/s11771-013-1906-z; Zhang WY, 2013, DISCRETE DYN NAT SOC, V2013, DOI 10.1155/2013/162128	26	2	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183135	10.1371/journal.pone.0183135	http://dx.doi.org/10.1371/journal.pone.0183135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE2ZB	28829834	gold, Green Published, Green Submitted			2022-12-27	WOS:000408085100028
J	Huang, WY; Hsin, IL; Chen, DR; Chang, CC; Kor, CT; Chen, TY; Wu, HM				Huang, Wan-Yu; Hsin, I-Lun; Chen, Dar-Ren; Chang, Chia-Chu; Kor, Chew-Teng; Chen, Ting-Yu; Wu, Hung-Ming			Circulating interleukin-8 and tumor necrosis factor-alpha are associated with hot flashes in healthy postmenopausal women	PLOS ONE			English	Article							VASOMOTOR SYMPTOMS; GENE-EXPRESSION; NEUROKININ-B; MENOPAUSE; INFLAMMATION; INVOLVEMENT; SECRETION; SEROTONIN; ESTROGENS; NEURONS	Introduction Hot flashes have been postulated to be linked to systemic inflammation. This study aimed to investigate the relationship between hot flashes, pro-inflammatory factors, and leukocytes in healthy, non-obese postmenopausal women. Participants and design In this cross-sectional study, a total of 202 women aged 45-60 years were stratified into one of four groups according to their hot-flash status: never experienced hot flashes (Group N), mild hot flashes (Group m), moderate hot flashes (Group M), and severe hot flashes (Group S). Variables measured in this study included clinical parameters, hot flash experience, leukocytes, and fasting plasma levels of nine circulating cytokines/chemokines measured by using multiplex assays. Multiple linear regression analysis was used to evaluate the associations of hot flashes with these pro-inflammatory factors. Settings The study was performed in a hospital medical center. Results The mean values of leukocyte number were not different between these four groups. The hot flash status had a positive tendency toward increased levels of circulating IL-6 (P-trend = 0.049), IL-8 (P-trend < 0.001), TNF-alpha (P-trend = 0.008), and MIP1 beta (P-trend = 0.04). Multivariate linear regression analysis revealed that hot-flash severity was significantly associated with IL-8 (P-trend < 0.001) and TNF alpha (P-trend = 0.007) among these nine cytokines/chemokines after adjustment for age, menopausal duration, BMI and FSH.Multivariate analysis further revealed that severe hot flashes were strongly associated with a higher IL-8 (% difference, 37.19%; 95% confidence interval, 14.98,63.69; P < 0.001) and TNF alpha ( 51.27%; 6.64,114.57; P < 0.05). Conclusion The present study provides evidence that hot flashes are associated with circulating IL-8 and TNF-alpha in healthy postmenopausal women. It suggests that hot flashes might be related to low-grade systemic inflammation.	[Huang, Wan-Yu] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan, Taiwan; [Hsin, I-Lun; Chen, Ting-Yu; Wu, Hung-Ming] Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan; [Chen, Dar-Ren] Changhua Christian Hosp, Comprehens Breast Canc Ctr, Changhua, Taiwan; [Chang, Chia-Chu] Changhua Christian Hosp, Dept Nephrol, Changhua, Taiwan; [Kor, Chew-Teng] Changhua Christian Hosp, Internal Med Res Ctr, Div Stat, Changhua, Taiwan; [Wu, Hung-Ming] Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan; [Wu, Hung-Ming] China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan	National Cheng Kung University; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; Changhua Christian Hospital; China Medical University Taiwan	Wu, HM (corresponding author), Changhua Christian Hosp, Inflammat Res & Drug Dev Ctr, Changhua, Taiwan.; Wu, HM (corresponding author), Changhua Christian Hosp, Dept Neurol, Changhua, Taiwan.; Wu, HM (corresponding author), China Med Univ, Grad Inst Acupuncture Sci, Taichung, Taiwan.	18288@cch.org.tw	Chen, Ting-Yu/AAD-8375-2021	Hsin, I-Lun/0000-0003-4711-3582	Ministry of Science and Technology, Taiwan [MOST 105-2314-6-371-004]; Changhua Christian Hospital Research Foundation, Changhua City, Taiwan [105-CCH-PRJ-006]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Changhua Christian Hospital Research Foundation, Changhua City, Taiwan	This study was funded by grant MOST 105-2314-6-371-004 from the Ministry of Science and Technology, Taiwan, and by grants 105-CCH-PRJ-006 from the Changhua Christian Hospital Research Foundation, Changhua City, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 2002, CIRC RES, V91, P1142, DOI 10.1161/01.RES.0000046018.23605.3E; Apostolakis S, 2009, CARDIOVASC RES, V84, P353, DOI 10.1093/cvr/cvp241; Avis NE, 2015, JAMA INTERN MED, V175, P531, DOI 10.1001/jamainternmed.2014.8063; Bechlioulis A, 2010, J CLIN ENDOCR METAB, V95, P1199, DOI 10.1210/jc.2009-2262; Berendsen HHG, 2000, MATURITAS, V36, P155, DOI 10.1016/S0378-5122(00)00151-1; Chakrabarti S, 2008, IUBMB LIFE, V60, P376, DOI 10.1002/iub.48; Chedraui P, 2011, GYNECOL ENDOCRINOL, V27, P685, DOI 10.3109/09513590.2010.521270; De Miguel C, 2015, CURR HYPERTENS REP, V17, DOI 10.1007/s11906-014-0507-z; Domingueti CP, 2016, J DIABETES COMPLICAT, V30, P738, DOI 10.1016/j.jdiacomp.2015.12.018; Figueroa-Vega N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120990; Freedman RR, 1999, AM J OBSTET GYNECOL, V181, P66, DOI 10.1016/S0002-9378(99)70437-0; FUJISHIMA S, 1993, J CELL PHYSIOL, V154, P478, DOI 10.1002/jcp.1041540305; Goncalves RB, 2011, INFLAMM RES, V60, P409, DOI 10.1007/s00011-011-0308-7; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Huang WY, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176430; JILKA RL, 1992, SCIENCE, V257, P88, DOI 10.1126/science.1621100; Karaoulanis SE, 2012, ANN GEN PSYCHIATR, V11, DOI 10.1186/1744-859X-11-9; Kobashi C, 2009, J INFLAMM-LOND, V6, DOI 10.1186/1476-9255-6-25; KRONENBERG F, 1987, CAN J PHYSIOL PHARM, V65, P1312, DOI 10.1139/y87-208; Lewis JE, 2005, MATURITAS, V50, P209, DOI 10.1016/j.maturitas.2004.06.015; Malutan A, 2013, ACTA ENDOCRINOL-BUCH, V9, P133, DOI 10.4183/aeb.2013.133; McLarnon JG, 2016, J ALZHEIMERS DIS PAR, V6, P5; Muka T, 2016, JAMA CARDIOL, V1, P767, DOI 10.1001/jamacardio.2016.2415; Noguchi M, 2008, ENDOCRINOLOGY, V149, P2899, DOI 10.1210/en.2007-1521; Ohayon MM, 2006, ARCH INTERN MED, V166, P1262, DOI 10.1001/archinte.166.12.1262; Orleans RJ, 2014, NEW ENGL J MED, V370, P1777, DOI 10.1056/NEJMp1402080; PACIFICI R, 1989, P NATL ACAD SCI USA, V86, P2398, DOI 10.1073/pnas.86.7.2398; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; Prague JK, 2017, LANCET, V389, P1809, DOI 10.1016/S0140-6736(17)30823-1; Rance NE, 2013, FRONT NEUROENDOCRIN, V34, P211, DOI 10.1016/j.yfrne.2013.07.003; RANCE NE, 1991, ENDOCRINOLOGY, V128, P2239, DOI 10.1210/endo-128-5-2239; Salmi P, 1998, PHARMACOL TOXICOL, V82, P122, DOI 10.1111/j.1600-0773.1998.tb01410.x; SHEARD MH, 1967, NATURE, V216, P495, DOI 10.1038/216495a0; Sloan JA, 2001, J CLIN ONCOL, V19, P4280, DOI 10.1200/JCO.2001.19.23.4280; Soules MR, 2001, J WOMEN HEALTH GEN-B, V10, P843, DOI 10.1089/152460901753285732; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Szmuilowicz ED, 2011, MENOPAUSE, V18, P603, DOI 10.1097/gme.0b013e3182014849; Thurston RC, 2008, CIRCULATION, V118, P1234, DOI 10.1161/CIRCULATIONAHA.108.776823; Thurston RC, 2011, OBSTET GYN CLIN N AM, V38, P489, DOI 10.1016/j.ogc.2011.05.006; Thurston RC, 2012, J CLIN ENDOCR METAB, V97, P3487, DOI 10.1210/jc.2012-1410; Thurston RC, 2012, OBSTET GYNECOL, V119, P753, DOI 10.1097/AOG.0b013e31824a09ec; Thurston RC, 2011, MENOPAUSE, V18, P1044, DOI 10.1097/gme.0b013e31821f5d39; Thurston RC, 2011, MENOPAUSE, V18, P352, DOI 10.1097/gme.0b013e3181fa27fd; Vlahopoulos S, 1999, BLOOD, V94, P1878, DOI 10.1182/blood.V94.6.1878; Willerson JT, 2004, CIRCULATION, V109, P2, DOI 10.1161/01.CIR.0000129535.04194.38; Yasui T, 2006, J CLIN ENDOCR METAB, V91, P4805, DOI 10.1210/jc.2006-1100	48	17	18	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 28	2017	12	8							e0184011	10.1371/journal.pone.0184011	http://dx.doi.org/10.1371/journal.pone.0184011			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE8EO	28846735	Green Published, gold, Green Submitted			2022-12-27	WOS:000408438600065
J	Chiacchio, T; Delogu, G; Vanini, V; Cuzzi, G; De Maio, F; Pinnetti, C; Sampaolesi, A; Antinori, A; Goletti, D				Chiacchio, Teresa; Delogu, Giovanni; Vanini, Valentina; Cuzzi, Gilda; De Maio, Flavio; Pinnetti, Carmela; Sampaolesi, Alessandro; Antinori, Andrea; Goletti, Delia			Immune characterization of the HBHA-specific response in Mycobacterium tuberculosisinfected patients with or without HIV infection	PLOS ONE			English	Article							HEPARIN-BINDING HEMAGGLUTININ; T-CELL RESPONSES; EFFECTOR MEMORY PHENOTYPE; ACTIVE TUBERCULOSIS; PROTECTIVE IMMUNITY; INTERFERON-GAMMA; IFN-GAMMA; INDIVIDUALS; LYMPHOCYTES; ANTIGEN	RD1-based Interferon-. Release Assays (IGRAs) cannot distinguish latent from active tuberculosis (TB) disease. Conversely, a positive response to heparin-binding haemagglutinin (HBHA)-based IGRAs, among TB-infected subjects, correlates with Mycobacterium tuberculosis (Mtb) containment and low risk of TB progression. The aim of this study was to characterize HBHA-immune responses in HIV-infected and uninfected subjects with active TB or latent TB infection (LTBI). Methods 49 subjects were prospectively enrolled: 22 HIV-uninfected (13 TB, 9 LTBI) and 27 HIVinfected (12 HIV-TB, 15 HIV-LTBI). Whole blood and peripheral blood mononuclear cells were stimulated with HBHA and RD1 antigens. Interferon (IFN). release was evaluated by ELISA whereas cytokine profile [IFN gamma, tumor necrosis (TNF) alpha, interleukin (IL) 2] and phenotype (CD45RA, CCR7) by flow cytometry. Results Among LTBI individuals, HBHA stimulation induced IFN. release in all the HIV-uninfected, while, only 4/ 15 HIV-infected responded. Within the active TB, only 5/ 13 HIV-uninfected and 1/ 12 HIV-TB patients responded. Interestingly, by cytometry we showed that CD4 (+) T-cells response to HBHA was significantly impaired in the HIV-infected subjects with TB or LTBI compared to the HIV-uninfected subjects. The phenotype of HBHA-specific CD4 T-cells showed a predominantly central memory (CM) and effector memory (EM) phenotype without differences among the groups. Differently, HBHA-specific CD8 (+) T-cells, showed mainly a CM and naive phenotype in LTBI group while TB, HIV-LTBI and HIV-TB groups were characterized by EM or terminally differentiated phenotypes. Interestingly, differently than whatobserved for RD1, the cytokine profile of HBHA-specific T-cells evaluated by cytometry showed that the CD4 (+) T-cells were mostly monofunctional. Conversely, CD8-specific Tcells were mostly monofunctional for both HBHA and RD1 stimulations. Conclusions These results characterize the impact of HIV infection in CD4- and CD8-specific response to HBHA in both LTBI and TB patients. HIV infection impairs the CD4 response to HBHA and likely this may lead to an impairment of TB control.	[Chiacchio, Teresa; Vanini, Valentina; Cuzzi, Gilda; Goletti, Delia] L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy; [Delogu, Giovanni; De Maio, Flavio] Univ Cattolica Sacro Cuore, Fdn Policlin Univ Gemelli, Inst Microbiol, Rome, Italy; [Pinnetti, Carmela; Sampaolesi, Alessandro; Antinori, Andrea] L Spallanzani Natl Inst Infect Dis INMI, Dept Clin & Clin Res, IRCCS, Rome, Italy	IRCCS Lazzaro Spallanzani; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Lazzaro Spallanzani	Goletti, D (corresponding author), L Spallanzani Natl Inst Infect Dis INMI, Dept Epidemiol & Preclin Res, Translat Res Unit, Rome, Italy.	delia.goletti@inmi.it	De Maio, Flavio/AAL-7355-2021; goletti, delia/AAM-6577-2020; Antinori, Andrea/K-7125-2016; De Maio, Flavio/J-9452-2018; De Maio, Flavio/AAD-1076-2022	De Maio, Flavio/0000-0002-4744-9820; Antinori, Andrea/0000-0003-2121-4684; De Maio, Flavio/0000-0002-4744-9820; Goletti, Delia/0000-0001-8360-4376	Italian Ministry of Health [RF-2011-02349395, 97/RF-2011-02348713, 54/GR-2011-02350886]; European Union: EC IDEA [FP7-HEALTH-2009-241642]; EC HORIZON TBVAC [643381]	Italian Ministry of Health(Ministry of Health, Italy); European Union: EC IDEA; EC HORIZON TBVAC	This work was supported by the Italian Ministry of Health: RF-2011-02349395, 97/RF-2011-02348713, 54/GR-2011-02350886 (http:// www.salute.gov.it/imgs/C_17_pagineAree_3878_ listaFile_itemName_23_jile.pdf) and the European Union: EC FP7 IDEA (FP7-HEALTH-2009-241642) http://cordis.europa.eu/project/rcn/94020_it.html; EC HORIZON2020 TBVAC2020 (contract no. 643381) http://www.tbvi.eu/for-partners/tbvac2020/tbvac2020-project-description/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belay M, 2016, J INFECTION, V72, P189, DOI 10.1016/j.jinf.2015.09.040; Beveridge NER, 2008, TUBERCULOSIS, V88, P631, DOI 10.1016/j.tube.2008.06.005; Caccamo N, 2010, EUR J IMMUNOL, V40, P2211, DOI 10.1002/eji.201040455; Chiacchio T, 2014, J INFECTION, V69, P533, DOI 10.1016/j.jinf.2014.06.009; Corbiere V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043285; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Delogu G, 2016, SCAND J IMMUNOL, V84, P344, DOI 10.1111/sji.12493; Delogu G, 2004, FEMS MICROBIOL LETT, V239, P33, DOI 10.1016/j.femsle.2004.08.015; Delogu G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018315; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Getahun H, 2015, EUR RESPIR J, V46, P1563, DOI 10.1183/13993003.01245-2015; Goletti D, 2014, J RHEUMATOL, V91, P24, DOI DOI 10.3899/jrheum.140099; Goletti D, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-11; Goletti D, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-5; Goletti D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012577; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Houben RMGJ, 2011, INT J TUBERC LUNG D, V15, P24; Launois P, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/640309; Lewinsohn DA, 2003, AM J RESP CRIT CARE, V168, P1346, DOI 10.1164/rccm.200306-837OC; Mack U, 2009, EUR RESPIR J, V33, P956, DOI 10.1183/09031936.00120908; Mascart F, 2015, EXPERT REV VACCINES, V14, P1573, DOI 10.1586/14760584.2015.1102638; Masungi C, 2002, J INFECT DIS, V185, P513, DOI 10.1086/338833; Nusbaum RJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21522; Parra M, 2004, INFECT IMMUN, V72, P6799, DOI 10.1128/IAI.72.12.6799-6805.2004; Petruccioli E, 2017, TUBERCULOSIS, V106, P38, DOI 10.1016/j.tube.2017.06.002; Petruccioli E, 2016, EUR RESPIR J, V48, P1751, DOI 10.1183/13993003.01012-2016; Petruccioli E, 2016, J INFECTION, V73, P588, DOI 10.1016/j.jinf.2016.09.008; Petruccioli E, 2013, J INFECTION, V66, P475, DOI 10.1016/j.jinf.2013.02.004; Podlekareva DN, 2016, LANCET HIV, V3, pE120, DOI 10.1016/S2352-3018(15)00252-0; Pokrovskiy V, 2014, J INT AIDS SOC, V17, P10, DOI 10.7448/IAS.17.4.19502; Pollock KM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146905; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Ronacher K, 2015, IMMUNOL REV, V264, P121, DOI 10.1111/imr.12257; Sester M, 2011, EUR RESPIR J, V37, P100, DOI 10.1183/09031936.00114810; Sester M, 2014, AM J RESP CRIT CARE, V190, P1168, DOI 10.1164/rccm.201405-0967OC; Smits K, 2015, J CLIN CELL IMMUNOL, V6, P341; Stenger S, 1998, SCIENCE, V282, P121, DOI 10.1126/science.282.5386.121; Stylianou E, 2014, EUR J IMMUNOL, V44, P440, DOI 10.1002/eji.201343887; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; Temmerman S, 2004, NAT MED, V10, P935, DOI 10.1038/nm1090; Temmerman ST, 2005, J INFECT DIS, V192, P226, DOI 10.1086/430930; Vanini V, 2012, J INFECTION, V65, P49, DOI 10.1016/j.jinf.2012.03.017; Vincenti D, 2007, CLIN EXP IMMUNOL, V150, P91, DOI 10.1111/j.1365-2249.2007.03462.x; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; World Health Organisation (WHO), 2016, GLOB TUB REP 2016; Wyndham-Thomas C, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0796-0; Wyndham-Thomas C, 2014, CLIN VACCINE IMMUNOL, V21, P321, DOI 10.1128/CVI.00651-13; Zanetti S, 2005, CLIN DIAGN LAB IMMUN, V12, P1135, DOI 10.1128/CDLI.12.9.1135-1138.2005	50	22	22	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183846	10.1371/journal.pone.0183846	http://dx.doi.org/10.1371/journal.pone.0183846			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837654	Green Submitted, Green Published, gold			2022-12-27	WOS:000408365000131
J	Thomas, E; Valdivia, J; Caicedo, CA; Quaedvlieg, J; Wadt, LHO; Corvera, R				Thomas, Evert; Valdivia, Jheyson; Alcazar Caicedo, Carolina; Quaedvlieg, Julia; Wadt, Lucia Helena O.; Corvera, Ronald			NTFP harvesters as citizen scientists: Validating traditional and crowdsourced knowledge on seed production of Brazil nut trees in the Peruvian Amazon	PLOS ONE			English	Article							BERTHOLLETIA-EXCELSA; POPULATION; FRUIT; PATTERNS; DENSITY; QUALITY; GROWTH; SET	Understanding the factors that underlie the production of non-timber forest products (NTFPs), as well as regularly monitoring production levels, are key to allow sustainability assessments of NTFP extractive economies. Brazil nut (Bertholletia excelsa, Lecythidaceae) seed harvesting from natural forests is one of the cornerstone NTFP economies in Amazonia. In the Peruvian Amazon it is organized in a concession system. Drawing on seed production estimates of > 135,000 individual Brazil nut trees from > 400 concessions and ethno-ecological interviews with > 80 concession holders, here we aimed to (i) assess the accuracy of seed production estimates by Brazil nut seed harvesters, and (ii) validate their traditional ecological knowledge (TEK) about the variables that influence Brazil nut production. We compared productivity estimates with actual field measurements carried out in the study area and found a positive correlation between them. Furthermore, we compared the relationships between seed production and a number of phenotypic, phytosanitary and environmental variables described in literature with those obtained for the seed production estimates and found high consistency between them, justifying the use of the dataset for validating TEK and innovative hypothesis testing. As expected, nearly all TEK on Brazil nut productivity was corroborated by our data. This is reassuring as Brazil nut concession holders, and NTFP harvesters at large, rely on their knowledge to guide the management of the trees upon which their extractive economies are based. Our findings suggest that productivity estimates of Brazil nut trees and possibly other NTFP-producing species could replace or complement actual measurements, which are very expensive and labour intensive, at least in areas where harvesters have a tradition of collecting NTFPs from the same trees over multiple years or decades. Productivity estimates might even be sourced from harvesters through registers on an annual basis, thus allowing a more cost-efficient and robust monitoring of productivity levels.	[Thomas, Evert] Biovers Int, Lima, Peru; [Valdivia, Jheyson] Univ Nacl Amazon Madre de Dios, Puerto Maldonado, Peru; [Alcazar Caicedo, Carolina] Biovers Int, Cali, Colombia; [Wadt, Lucia Helena O.] Embrapa Rondonia, Porto Velho, RO, Brazil; [Corvera, Ronald] Inst Invest Amazonia Peruana, Puerto Maldonado, Peru	Alliance; Bioversity International; Universidad Nacional Amazonica De Madre De Dios; Alliance; Bioversity International; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Thomas, E (corresponding author), Biovers Int, Lima, Peru.	evert.thomas@gmail.com	Wadt, Lucia HO/M-1703-2013	Valdivia Gomez, Jheyson Jerzel/0000-0002-2989-5747; Quaedvlieg, Julia/0000-0003-4412-6759; Wadt, Lucia/0000-0002-5018-7550	CGIAR Fund Donors through CGIAR Research Program on Forests Trees and Agroforestry	CGIAR Fund Donors through CGIAR Research Program on Forests Trees and Agroforestry(CGIAR)	This research was supported by CGIAR Fund Donors, through the CGIAR Research Program on Forests Trees and Agroforestry.	Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Auguie B, 2017, GRIDEXTRA MISCELLANE; Bjornstad ON, 2016, NCF SPATIAL NONPARAM, V1-7; Clay JW, 1993, COMMUNICATION; Forrester G, 2015, J NAT CONSERV, V24, P1, DOI 10.1016/j.jnc.2015.01.002; Guariguata MR, 2009, FOREST ECOL MANAG, V258, P788, DOI 10.1016/j.foreco.2009.05.022; Hirao AS, 2010, ANN BOT-LONDON, V105, P637, DOI 10.1093/aob/mcq018; ICSU, 2002, SER SCI SUST DEV, V4; Jones FA, 2008, P ROY SOC B-BIOL SCI, V275, P2759, DOI 10.1098/rspb.2008.0894; Kainer KA, 2006, J TROP ECOL, V22, P147, DOI 10.1017/S0266467405002981; Kainer KA, 2007, FOREST ECOL MANAG, V250, P244, DOI 10.1016/j.foreco.2007.05.024; Kainer KA, 2014, J APPL ECOL, V51, P655, DOI 10.1111/1365-2664.12231; Katori Takuro, 2015, Journal of Ecology and Environment, V38, P39, DOI 10.5141/ecoenv.2015.004; Kelling S, 2015, AMBIO, V44, pS601, DOI 10.1007/s13280-015-0710-4; Kremen C, 2011, CONSERV BIOL, V25, P607, DOI 10.1111/j.1523-1739.2011.01657.x; Layne JN, 2004, AM J BOT, V91, P1378, DOI 10.3732/ajb.91.9.1378; LEVIN DA, 1981, ANN MO BOT GARD, V68, P233, DOI 10.2307/2398797; Malinga D., 2015, SCHOLARS ACAD J BIOS, V3, P173; Meisel J.E., 2014, ORCHIDS TROPICAL AM; Mori S. A., 1990, Advances in Economic Botany, V8, P130; Motta Maues M., 2002, POLLINATING BEES THE, P245; Muller CH, 1981, CASTANHA DO BRASIL E; NELSON B W, 1985, Acta Amazonica, V15, P225; OMALLEY DM, 1988, THEOR APPL GENET, V76, P929, DOI 10.1007/BF00273683; Peres CA, 2003, SCIENCE, V302, P2112, DOI 10.1126/science.1091698; POWELL AH, 1987, BIOTROPICA, V19, P176, DOI 10.2307/2388742; Quaedvlieg J, 2014, J RURAL STUD, V33, P41, DOI 10.1016/j.jrurstud.2013.10.004; Quesada CA, 2010, BIOGEOSCIENCES, V7, P1515, DOI 10.5194/bg-7-1515-2010; Rockwell CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135464; Schongart J, 2015, BIOTROPICA, V47, P550, DOI 10.1111/btp.12243; Scoles R, 2015, HUM ECOL; SILANDER JA, 1978, BIOTROPICA, V10, P292, DOI 10.2307/2387681; Solda MP, 2003, IMPACT CERTIFICATION; Steinke J, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0441-y; Thomas E., 2014, Boletim do Museu Paraense Emilio Goeldi, Ciencias Naturais, V9, P267; Thomas E, 2015, J BIOGEOGR, V42, P1367, DOI 10.1111/jbi.12540; Thomas E, 2010, AGROFOREST SYST, V80, P131, DOI 10.1007/s10457-010-9315-x; Tonini H., 2008, Floresta, V38, P445; Van Etten J, 2019, EXP AGR, V55, P275, DOI 10.1017/S0014479716000739; Venables WN., 2002, MODERN APPL STAT S, V4, DOI 10.1007/978-0-387-21706-2; Wadt LHO, 2005, FOREST ECOL MANAG, V211, P371, DOI 10.1016/j.foreco.2005.02.061; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; Zuidema PA, 2002, J TROP ECOL, V18, P1, DOI 10.1017/S0266467402002018; Zuidema PA, 2003, ECOLOGIA MANEJO ARBO	44	16	17	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 24	2017	12	8							e0183743	10.1371/journal.pone.0183743	http://dx.doi.org/10.1371/journal.pone.0183743			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE7CK	28837638	Green Published, Green Submitted, gold			2022-12-27	WOS:000408365000109
J	Biscaglia, S; Tonet, E; Pavasini, R; Serenelli, M; Bugani, G; Cimaglia, P; Gallo, F; Spitaleri, G; Del Franco, A; Aquila, G; Dalla Sega, FV; Tebaldi, M; Tumscitz, C; Ferrari, R; Campo, G				Biscaglia, Simone; Tonet, Elisabetta; Pavasini, Rita; Serenelli, Matteo; Bugani, Giulia; Cimaglia, Paolo; Gallo, Francesco; Spitaleri, Giosafat; Del Franco, Annamaria; Aquila, Giorgio; Dalla Sega, Francesco Vieceli; Tebaldi, Matteo; Tumscitz, Carlo; Ferrari, Roberto; Campo, Gianluca			A counseling program on nuisance bleeding improves quality of life in patients on dual antiplatelet therapy: A randomized controlled trial	PLOS ONE			English	Article							IMPACT; TICAGRELOR; CLOPIDOGREL; PRASUGREL; EVENTS; EQ-5D	Background Nuisance bleeding is a major determinant of quality of life and drug discontinuation in patients on dual antiplatelet therapy (DAPT). However, no randomized trial has been focused on the impact of nuisance bleeding on quality of life. Methods BATMAN is an investigator-driven, randomized, controlled, single-center, open trial (NCT02554006). Four hundred and forty-eight consecutive patients with indication to at least 6 months of DAPT were randomized to: i) multimodal counseling program focused on nuisance bleedings (interventional arm); ii) usual discharge process (control arm). The primary endpoint was the one-month health-related quality of life assessed by the EuroQol-5 Dimension (EQ-5D) visual analog scale (VAS) score. Secondary endpoints were EQ-5D at 1 and 6 months, EQ-5D VAS at 6 months, DAPT withdrawal, need of information regarding DAPT and/or nuisance bleedings, 6-month ischemic and bleeding adverse events. Results The EQ5D-VAS was significantly higher in the interventional arm compared to the control arm at 1 and 6 months (81[74-88] vs. 73[64-80], p < 0.001 at 1 month; 82[76-88] vs. 74 [65-81], p < 0.001 at 6 months). Patients in the interventional arm had also significantly lower pain/discomfort and anxiety/depression at the EQ-5D both at 1 and 6 months. Patients in the control arm withdrew DAPT significantly more (7 (3%) vs. 1 (0.4%), p = 0.03) and looked for information regarding DAPT and/or about nuisance bleeding more frequently than those in the interventional arm (178 (79%) vs. 19 (8%), p < 0.001). Conclusions The systematic utilization of a multimodal counseling program improved quality of life and reduced the DAPT withdrawal rate in patients on DAPT.	[Biscaglia, Simone; Tonet, Elisabetta; Pavasini, Rita; Serenelli, Matteo; Bugani, Giulia; Cimaglia, Paolo; Gallo, Francesco; Spitaleri, Giosafat; Del Franco, Annamaria; Tebaldi, Matteo; Tumscitz, Carlo; Ferrari, Roberto; Campo, Gianluca] Azienda Osped Univ S Anna, Cardiovasc Sect, Med Sci Dept, Ferrara, Italy; [Aquila, Giorgio] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Dalla Sega, Francesco Vieceli] Univ Ferrara, Dept Med Sci, Ferrara, Italy; [Ferrari, Roberto; Campo, Gianluca] Univ Ferrara, Ferrara, Italy; [Ferrari, Roberto; Campo, Gianluca] ES Hlth Sci Fdn, Maria Cecilia Hosp, GVM Care& Res, Cotignola, Italy; [Ferrari, Roberto; Campo, Gianluca] Univ Ferrara, Lab Technol Adv Therapies LTTA, Ferrara, Italy	University of Ferrara; Arcispedale Sant'Anna; University of Ferrara; University of Ferrara; University of Ferrara; Maria Cecilia Hospital; University of Ferrara	Biscaglia, S (corresponding author), Azienda Osped Univ S Anna, Cardiovasc Sect, Med Sci Dept, Ferrara, Italy.	bscsmn@unife.it	Bugani, Giulia/AAB-5075-2022; Spitaleri, Giosafat/K-4319-2018; Vieceli Dalla Sega, Francesco/GQZ-1869-2022; Aquila, Giorgio/X-4412-2019; Pavasini, Rita/K-7544-2018; Biscaglia, Simone/AAH-8727-2021; FERRARI, ROBERTO/ABD-5169-2020; Tonet, Elisabetta/AAC-2220-2022	Spitaleri, Giosafat/0000-0002-0214-9082; Aquila, Giorgio/0000-0002-3936-8895; Pavasini, Rita/0000-0002-1763-9711; Biscaglia, Simone/0000-0001-6074-2370; Tonet, Elisabetta/0000-0003-0257-1272; Vieceli Dalla Sega, Francesco/0000-0003-3445-3983; Cimaglia, Paolo/0000-0002-3326-7663; Campo, Gianluca/0000-0002-5150-188X; Ferrari, Roberto/0000-0003-2046-9175; Del Franco, Annamaria/0000-0003-1405-9436				Alexopoulos D, 2014, THROMB HAEMOSTASIS, V112, P551, DOI 10.1160/TH14-02-0119; Amin AP, 2016, J AM COLL CARDIOL, V67, P59, DOI 10.1016/j.jacc.2015.10.034; Amin AP, 2013, J AM COLL CARDIOL, V61, P2130, DOI 10.1016/j.jacc.2013.02.044; Armero S, 2011, AM J CARDIOL, V108, P1710, DOI 10.1016/j.amjcard.2011.07.038; Ben-Dor I, 2010, AM HEART J, V159, P871, DOI 10.1016/j.ahj.2010.01.016; Biscaglia S, 2016, PLATELETS, V27, P484, DOI 10.3109/09537104.2015.1119815; Bonaca MP, 2016, JAMA CARDIOL, V1, P425, DOI 10.1001/jamacardio.2016.1017; Bonaca MP, 2015, NEW ENGL J MED, V372, P1791, DOI 10.1056/NEJMoa1500857; Campo G, 2014, J AM COLL CARDIOL, V63, P506, DOI 10.1016/j.jacc.2013.09.043; Decker Carole, 2008, Patient Prefer Adherence, V2, P167; Ellis JJ, 2005, CURR MED RES OPIN, V21, P1209, DOI 10.1185/030079905X56349; Garavalia L, 2011, EUR J CARDIOVASC NUR, V10, P50, DOI 10.1016/j.ejcnurse.2010.04.002; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; MEHRAN R, 2011, CIRCULATION, V123, P2736, DOI [10.1161/CIRCULATIONAHA.110.009449, DOI 10.1161/CIRCULATI0NAHA.110.009449]; Mehran R, 2013, LANCET, V382, P1714, DOI 10.1016/S0140-6736(13)61720-1; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Roy P, 2008, AM J CARDIOL, V102, P1614, DOI 10.1016/j.amjcard.2008.07.063; Verheye S, 2015, NEW ENGL J MED, V372, P519, DOI 10.1056/NEJMoa1402556; Windecker S, 2014, EUR HEART J, V35, P2541, DOI [10.1093/ejcts/ezu366, 10.1093/eurheartj/ehu278, 10.5603/KP.2014.0224]	19	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0182124	10.1371/journal.pone.0182124	http://dx.doi.org/10.1371/journal.pone.0182124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832589	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800012
J	Husmann, C; Frank, M; Schmidt, B; Jockel, KH; Antel, J; Reissner, V; Libuda, L; Hebebrand, J; Focker, M				Husmann, Christiane; Frank, Mirjam; Schmidt, Boerge; Joeckel, Karl-Heinz; Antel, Jochen; Reissner, Volker; Libuda, Lars; Hebebrand, Johannes; Foecker, Manuel			Low 25( OH)-vitamin D concentrations are associated with emotional and behavioral problems in German children and adolescents	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; HEALTH INTERVIEW; REPRESENTATIVE SAMPLE; DEPRESSIVE SYMPTOMS; D SUPPLEMENTATION; 25-HYDROXYVITAMIN D; HIGH PREVALENCE; METAANALYSIS; OVERWEIGHT; CHILDHOOD	Background Evidence has accumulated for the association between low vitamin D serum concentrations and mental health disorders in both children and adults. We performed a cross-sectional analysis in a population-based sample of children and adolescents to detect associations between 25(OH)-vitamin D serum [25(OH) D] concentrations and scores of the five Strengths and Difficulties Questionnaire (SDQ) subscales and the total difficulties score in different age groups (age >= 3-<12 years and >= 12-<18 years). Methods 9068 participants of the population-based, nation-wide German Health Interview and Examination Survey for Children and Adolescents (KIGGS) with information on mental health status assessed by the SDQ and 25(OH) D levels were included in the analysis. For statistical analysis we used linear regression models stratified by gender based on different adjustment sets. For the younger subsample the analysis was additionally adjusted for the frequency of playing outside. We compared the associations based on parent-and self-ratings of the SDQ for children and adolescents aged >= 12-< 18 years. Results We found inverse associations between 25(OH) D concentrations and the subscales emotional problems, peer relationship problems and the total difficulties score in both genders after adjustment for potential confounders. The strongest associations were observed in the older subsample for parent-ratings in boys and self-ratings in girls. In the younger subsample the associations were less strong and no longer evident after adjustment for potential confounders such as migration background, socioeconomic status and frequency of playing outside. Conclusion Based on the large-scale cross-sectional study in a German population-based sample of children and adolescents we detected inverse associations between 25( OH) D concentrations and both parent-and self-rated SDQ scores of the total difficulties scale and different subscales with the strongest association in the subsample aged >= 12-<18 years for both genders. Migration background and socioeconomic status were detected as relevant confounders. Further studies-particularly in countries with comparatively low mean 25(OH) D concentrations-in childhood and adolescence are warranted. Longitudinal studies are also necessary to infer direction of effects. Finally, RCTs in children and adolescents are required to determine whether Vitamin D is beneficial for mental health.	[Husmann, Christiane; Antel, Jochen; Reissner, Volker; Libuda, Lars; Hebebrand, Johannes; Foecker, Manuel] Univ Duisburg Essen, Univ Hosp Essen, Dept Child & Adolescent Psychiat, Essen, Germany; [Frank, Mirjam; Schmidt, Boerge; Joeckel, Karl-Heinz] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany	University of Duisburg Essen; University of Duisburg Essen	Focker, M (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Child & Adolescent Psychiat, Essen, Germany.	manuel.foecker@uni-due.de	Libuda, Lars/AAF-2747-2019; Föcker, Manuel/CAF-0365-2022		Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia	Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia	The work is funded by the Ministry of Innovation, Science and Research of the State of North Rhine-Westphalia. J H and K-H J received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvold DS, 2009, ENDOCR PRACT, V15, P203, DOI 10.4158/EP.15.3.203; Azzam H.M.E., 2015, MIDDLE E CURR PSYCHI, V22, P9, DOI DOI 10.1097/01.XME.0000457269.05570.78; Bener A, 2014, J PEDIATR NEUROSCI, V9, P227, DOI 10.4103/1817-1745.147574; Bener Abdulbari, 2013, Glob J Health Sci, V6, P47, DOI 10.5539/gjhs.v6n2p47; Bergmann KE, 2015, MONATSSCHR KINDERH, V163, P1020, DOI 10.1007/s00112-015-3390-z; Bergmann KE, 2015, MONATSSCHR KINDERH, V163, P1012, DOI 10.1007/s00112-015-3389-5; Bettge S, 2008, EUR CHILD ADOLES PSY, V17, P71, DOI 10.1007/s00787-008-1008-x; Binkley N, 2013, J CLIN DENSITOM, V16, P402, DOI 10.1016/j.jocd.2013.08.006; Cashman KD, 2016, AM J CLIN NUTR, V103, P1033, DOI 10.3945/ajcn.115.120873; Eyles DW, 2013, FRONT NEUROENDOCRIN, V34, P47, DOI 10.1016/j.yfrne.2012.07.001; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Fares JE, 2003, BONE, V33, P242, DOI 10.1016/S8756-3282(03)00160-1; Feng J., 2016, NUTR NEUROSCI; Fernell E, 2015, MOL AUTISM, V6, DOI 10.1186/2040-2392-6-3; Finger JD, 2014, INT J BEHAV NUTR PHY, V11, DOI 10.1186/1479-5868-11-43; Focker M, 2017, EUROPEAN CHILD ADOLE; Gloth F M 3rd, 1999, J Nutr Health Aging, V3, P5; Goksugur SB, 2014, PEDIATR INT, V56, P515, DOI 10.1111/ped.12286; Gong ZL, 2014, NEUROREPORT, V25, P23, DOI 10.1097/WNR.0000000000000034; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Gowda U, 2015, NUTRITION, V31, P421, DOI 10.1016/j.nut.2014.06.017; Hintzpeter B, 2008, J NUTR, V138, P1482, DOI 10.1093/jn/138.8.1482; Holling H, 2008, EUR CHILD ADOLES PSY, V17, P34, DOI 10.1007/s00787-008-1004-1; Hogberg G, 2012, ACTA PAEDIATR, V101, P779, DOI 10.1111/j.1651-2227.2012.02655.x; Holick MF, 2007, J BONE MINER RES, V22, pV28, DOI 10.1359/JBMR.07S211; Institute of Medicine FaNB, 2010, DIETARY REFERENCE IN; Jorde R, 2008, J INTERN MED, V264, P599, DOI 10.1111/j.1365-2796.2008.02008.x; Kamal M, 2014, ADHD-ATTEND DEFICIT, V6, P73, DOI 10.1007/s12402-014-0130-5; Khoraminya N, 2013, AUST NZ J PSYCHIAT, V47, P271, DOI 10.1177/0004867412465022; Krause L, 2014, GESUNDHEITSWESEN, V76, P377, DOI 10.1055/s-0033-1355370; Kromeyer-Hauschild K, 2001, MONATSSCHR KINDERH, V149, P807, DOI 10.1007/s001120170107; Krug S, 2012, BUNDESGESUNDHEITSBLA, V55, P111, DOI 10.1007/s00103-011-1391-1; Lampert T, 2014, BUNDESGESUNDHEITSBLA, V57, P762, DOI 10.1007/s00103-014-1974-8; Lansdowne ATG, 1998, PSYCHOPHARMACOLOGY, V135, P319, DOI 10.1007/s002130050517; Li GW, 2014, J CLIN ENDOCR METAB, V99, P757, DOI 10.1210/jc.2013-3450; Milaneschi Y, 2014, MOL PSYCHIATR, V19, P444, DOI 10.1038/mp.2013.36; Parker GB, 2017, J AFFECT DISORDERS, V208, P56, DOI 10.1016/j.jad.2016.08.082; Pike JW, 2010, J STEROID BIOCHEM, V121, P130, DOI 10.1016/j.jsbmb.2010.02.036; Rubin KH, 2002, CHILD DEV, V73, P483, DOI 10.1111/1467-8624.00419; Saad K, 2015, NUTR NEUROSCI; Schafer TK, 2016, QUAL LIFE RES, V25, P3077, DOI 10.1007/s11136-016-1334-2; Schenk L, 2007, BUNDESGESUNDHEITSBLA, V50, P590, DOI 10.1007/s00103-007-0220-z; Shaffer JA, 2014, PSYCHOSOM MED, V76, P190, DOI 10.1097/PSY.0000000000000044; Spedding S, 2014, NUTRIENTS, V6, P1501, DOI 10.3390/nu6041501; Tanner JM, 1962, GROWTH ADOLESCENCE, V2nd; Thierfelder W, 2007, BUNDESGESUNDHEITSBLA, V50, P757, DOI 10.1007/s00103-007-0238-2; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041575; Tolppanen AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040097; Tolppanen AM, 2012, J CHILD PSYCHOL PSYC, V53, P757, DOI 10.1111/j.1469-7610.2011.02518.x; Tolppanen AM, 2012, J CLIN ENDOCR METAB, V97, P1202, DOI 10.1210/jc.2011-2516; Verduijn J, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.137; VERHULST FC, 1992, J CHILD PSYCHOL PSYC, V33, P1011, DOI 10.1111/j.1469-7610.1992.tb00922.x; Vieth R, 2004, J STEROID BIOCHEM, V89-90, P571, DOI 10.1016/j.jsbmb.2004.03.037; Vieth R, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-8; Zhang M, 2011, NUTRITION, V27, P530, DOI 10.1016/j.nut.2010.05.016; Zhu DM, 2015, PSYCHIAT RES, V228, P565, DOI 10.1016/j.psychres.2015.05.051	56	13	16	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183091	10.1371/journal.pone.0183091	http://dx.doi.org/10.1371/journal.pone.0183091			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832616	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800046
J	Litchfield, CA; Quinton, G; Tindle, H; Chiera, B; Kikillus, KH; Roetman, P				Litchfield, Carla A.; Quinton, Gillian; Tindle, Hayley; Chiera, Belinda; Kikillus, K. Heidy; Roetman, Philip			The 'Feline Five': An exploration of personality in pet cats (Felis catus)	PLOS ONE			English	Article							TIGERS PANTHERA-TIGRIS; DOMESTIC CATS; INDIVIDUAL-DIFFERENCES; ANIMAL PERSONALITY; SILVESTRIS-CATUS; SOCIAL-BEHAVIOR; RHESUS MACAQUES; OWNERS; HOME; PATTERNS	The idea of animals possessing personalities was once dismissed by the scientific community, but has since gained traction with evidence for potential application to improve captive animal management and welfare. Although domestic cats are popular companion animals, research has tended to overlook the value of personality assessment for management and care of pet cats. The aim of this study was to investigate personality in a large sample of pet cats with a view to understanding practical implications for pet cats in the home. Personality of 2,802 pet cats, from South Australia and New Zealand, was rated by their owners utilising a survey measuring 52 personality traits. Five reliable personality factors were found using principal axis factor analysis: Neuroticism, Extraversion, Dominance, Impulsiveness and Agreeableness. Implications for the 'Feline Five' are discussed in relation to their potential application to improving the management and welfare of pet cats. Highly Impulsive cats for example, may be reacting to something stressful in their environment, whereas cats with low Agreeableness scores, showing irritability may indicate underlying pain or illness. Thus, the need for a systematic and holistic approach to personality that includes both the individual pet cat and its environment is recommended, and opens the door to future interdisciplinary intervention.	[Litchfield, Carla A.; Quinton, Gillian] Univ South Australia, Ctr Social Change, Sch Psychol Social Work & Social Policy, Adelaide, SA, Australia; [Tindle, Hayley; Roetman, Philip] Univ South Australia, Sch Nat & Built Environm, Discovery Circle, Adelaide, SA, Australia; [Chiera, Belinda] Univ South Australia, Sch Informat Technol & Math Sci, Adelaide, SA, Australia; [Kikillus, K. Heidy] Victoria Univ Wellington, Ctr Biodivers & Restorat Ecol, Wellington, New Zealand	University of South Australia; University of South Australia; University of South Australia; Victoria University Wellington	Litchfield, CA (corresponding author), Univ South Australia, Ctr Social Change, Sch Psychol Social Work & Social Policy, Adelaide, SA, Australia.	Carla.Litchfield@unisa.edu.au	Litchfield, Carla/AAX-6988-2020	Litchfield, Carla/0000-0002-1167-1374; Chiera, Belinda/0000-0001-9274-0943	South Australian Dog and Cat Management Board; University of South Australia's Discovery Circle Initiative; Adelaide and Mt Lofty Ranges Natural Resources Management Board; Department of Environment, Water and Natural Resources; City of Marion; City of Salisbury; Dog and Cat Management Board; University of South Australia; City of Marion; City of Mitcham; Adelaide and Mount Lofty Ranges Natural Resources Management Board; Department of Environment, Water and Natural Resources; Wellington City Council, Victoria University of Wellington; World Wildlife Fund	South Australian Dog and Cat Management Board; University of South Australia's Discovery Circle Initiative; Adelaide and Mt Lofty Ranges Natural Resources Management Board; Department of Environment, Water and Natural Resources; City of Marion; City of Salisbury; Dog and Cat Management Board; University of South Australia; City of Marion; City of Mitcham; Adelaide and Mount Lofty Ranges Natural Resources Management Board; Department of Environment, Water and Natural Resources; Wellington City Council, Victoria University of Wellington; World Wildlife Fund	The project (PR) received funding from the South Australian Dog and Cat Management Board (http://www.dogandcatboard.com.au/). The project (PR) was also funded by the University of South Australia's Discovery Circle Initiative (http.//www.discoverycircle.org.au) which receives external funding from the Adelaide and Mt Lofty Ranges Natural Resources Management Board; Department of Environment, Water and Natural Resources; City of Marion; and City of Salisbury.; We are grateful to the cat owners for their participation in this study. The Cat Tracker project commenced in North Carolina, led by staff from the North Carolina Museum of Natural Sciences and the North Carolina State University, where it was primarily focussed on the tracking of pet cats (http://cats.yourwildlife.org/). We duplicated the cat tracking project in South Australia and New Zealand and added the social and cat personality research. We thank Karina Burgess for help with the early survey design. Supporting organisations in South Australia were: Dog and Cat Management Board; University of South Australia; City of Marion; City of Salisbury; City of Mitcham; Adelaide and Mount Lofty Ranges Natural Resources Management Board; and the Department of Environment, Water and Natural Resources. Supporting organisations in New Zealand were: Wellington City Council, Victoria University of Wellington; and World Wildlife Fund. We are grateful to the Academic Editor and two anonymous reviewers for their time, thoroughness and useful comments.	Arahori M, 2016, J VET BEHAV, V11, P109, DOI 10.1016/j.jveb.2015.07.039; ASPCA (American Society for the Prevention of Cruelty to Animals), SHELT INT SURR PET S; Barratt DG, 1997, WILDLIFE RES, V24, P263, DOI 10.1071/WR96020; Barry KJ, 1999, APPL ANIM BEHAV SCI, V64, P193, DOI 10.1016/S0168-1591(99)00030-1; BARTLETT MS, 1954, J ROY STAT SOC B, V16, P296; Bell AM, 2007, ECOL LETT, V10, P828, DOI 10.1111/j.1461-0248.2007.01081.x; Bernstein PL, 2014, DOMESTIC CAT: THE BIOLOGY OF ITS BEHAVIOUR, 3RD EDITION, P71; Bernstein PL, 1996, ANTHROZOOS, V9, P25, DOI 10.2752/089279396787001572; Bradshaw JWS, 2016, J VET BEHAV, V11, P113, DOI 10.1016/j.jveb.2015.09.004; Bradshaw JWS, 1996, APPL ANIM BEHAV SCI, V47, P61, DOI 10.1016/0168-1591(95)01011-4; Capitanio JP, 1999, AM J PRIMATOL, V47, P299, DOI 10.1002/(SICI)1098-2345(1999)47:4<299::AID-AJP3>3.0.CO;2-P; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Costa P.T., 1992, PERS INDIVID DIF, V13, P653, DOI [10.1016/0191-8869(92)90236-I, DOI 10.1016/0191-8869(92)90236-I]; David M, 2016, ETHOLOGY, V122, P1, DOI 10.1111/eth.12445; De Rouck M, 2005, ANIM WELFARE, V14, P229; DeVellis R., 2017, SCALE DEV THEORY APP, V4; DiStefano C., 2009, PRACT ASSESS RES EVA, V14, P1, DOI DOI 10.10/1531-7714; Durr R, 1997, J COMP PSYCHOL, V111, P412, DOI 10.1037/0735-7036.111.4.412; Ellis SLH, 2013, J FELINE MED SURG, V15, P219, DOI 10.1177/1098612X13477537; Faure E, 2009, ANTHROZOOS, V22, P221, DOI 10.2752/175303709X457577; FEAVER J, 1986, ANIM BEHAV, V34, P1016, DOI 10.1016/S0003-3472(86)80160-9; Feuerstein N, 2008, APPL ANIM BEHAV SCI, V113, P150, DOI 10.1016/j.applanim.2007.10.010; Field A., 2013, DISCOVERING STAT USI; Freeman HD, 2010, AM J PRIMATOL, V72, P653, DOI 10.1002/ajp.20833; Gartner MC, 2015, PERS INDIV DIFFER, V75, P102, DOI 10.1016/j.paid.2014.10.042; Gartner MC, 2014, J COMP PSYCHOL, V128, P414, DOI 10.1037/a0037104; Gartner MC, 2013, APPL ANIM BEHAV SCI, V147, P261, DOI 10.1016/j.applanim.2012.11.002; Gartner MC, 2013, APPL ANIM BEHAV SCI, V144, P1, DOI 10.1016/j.applanim.2012.11.010; Gartner MC, 2012, ZOO BIOL, V31, P151, DOI 10.1002/zoo.20385; Gazzano A, 2015, J VET BEHAV, V10, P535, DOI 10.1016/j.jveb.2015.07.042; Gosling SD, 1999, CURR DIR PSYCHOL SCI, V8, P69, DOI 10.1111/1467-8721.00017; Gosling SD, 1998, ANTHROZOOS, V11, P148, DOI 10.2752/089279398787000661; Gosling SD, 2001, PSYCHOL BULL, V127, P45, DOI 10.1037//0033-2909.127.1.45; Hellyer P, 2007, J FELINE MED SURG, V9, P466, DOI 10.1016/j.jfms.2007.09.001; Horback KM, 2013, APPL ANIM BEHAV SCI, V149, P55, DOI 10.1016/j.applanim.2013.09.009; Hosey G., 2013, ZOO ANIMALS BEHAV MA, V2nd ed.; Iki T, 2011, APPL ANIM BEHAV SCI, V132, P71, DOI 10.1016/j.applanim.2011.03.008; John O.P., 1999, HDB PERSONALITY THEO, VVolume 2, P102; Johnson-Bennett P., 2011, THINK LIKE A CAT; KAISER HF, 1974, PSYCHOMETRIKA, V39, P31, DOI 10.1007/BF02291575; Koski SE, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00070; Kotrschal K, 2014, DOMESTIC CAT: THE BIOLOGY OF ITS BEHAVIOUR, 3RD EDITION, P113; Landsberg G, 2010, J FELINE MED SURG, V12, P837, DOI 10.1016/j.jfms.2010.09.004; Lindell EM, 1997, APPL ANIM BEHAV SCI, V55, P153, DOI 10.1016/S0168-1591(97)00032-4; Locurto C, 2007, COMP COGN BEHAV REV, V2, P67; Lower SE, 2001, ANIM BEHAV, V61, P231, DOI 10.1006/anbe.2000.1545; MCCUNE S, 1995, APPL ANIM BEHAV SCI, V45, P109, DOI 10.1016/0168-1591(95)00603-P; Mertens C., 1991, Anthrozoos, V4, P214, DOI 10.2752/089279391787057062; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Molsher R, 2005, WILDLIFE RES, V32, P587, DOI 10.1071/WR04093; Natoli E, 2005, NEUROSCI BIOBEHAV R, V29, P151, DOI 10.1016/j.neubiorev.2004.06.011; Pallant J., 2010, SPSS SURVIVAL MANUAL, DOI DOI 10.1108/jacpr.2011.55003baa.002; Phillips C, 2007, APPL ANIM BEHAV SCI, V106, P244, DOI 10.1016/j.applanim.2007.01.007; Plowman A, 2013, BIAZA HDB ZOO AQUARI, P134; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V31, P119, DOI 10.1016/0168-1591(91)90159-U; Powell DM, 2011, PRIMATOL MONOGR, P185, DOI 10.1007/978-4-431-53892-9_8; Razal CB, 2016, ANIM BEHAV COG, V3, P22, DOI [10.12966/abc.02.02.2016, DOI 10.12966/ABC.02.02.2016]; REISNER IR, 1994, PHYSIOL BEHAV, V55, P1119, DOI 10.1016/0031-9384(94)90396-4; Rochlitz I, 2005, APPL ANIM BEHAV SCI, V93, P97, DOI 10.1016/j.applanim.2005.01.002; ROCKWELL RC, 1975, SOCIOL METHOD RES, V3, P308, DOI 10.1177/004912417500300304; RSPCA (Royal Society for the Prevention of Cruelty to Animals), 2014, AUSTR NAT STAT 2014; Sax LJ, 2003, RES HIGH EDUC, V44, P409, DOI 10.1023/A:1024232915870; Siegford JM, 2003, ANTHROZOOS, V16, P332, DOI 10.2752/089279303786991982; Tabachnick B. G., 2001, USING MULTIVARIATE S; TURNER DC, 1986, ANIM BEHAV, V34, P1890, DOI 10.1016/S0003-3472(86)80275-5; vandenBos R, 1996, J ETHOL, V14, P123, DOI 10.1007/BF02348869; Vazire S., 2007, HDB RES METHODS PERS, P190; Watkins M.W., 2000, MONTE CARLO PCA PARA; Watters JV, 2012, ZOO BIOL, V31, P1, DOI 10.1002/zoo.20379; Wedl M, 2011, BEHAV PROCESS, V86, P58, DOI 10.1016/j.beproc.2010.09.001; Weiss A, 2006, J PERS SOC PSYCHOL, V90, P501, DOI 10.1037/0022-3514.90.3.501; Weiss A, 2009, AM J PRIMATOL, V71, P283, DOI 10.1002/ajp.20649; Weiss A, 2011, J COMP PSYCHOL, V125, P72, DOI 10.1037/a0021187; Wielebnowski NC, 2002, ZOO BIOL, V21, P77, DOI 10.1002/zoo.10005; Wielebnowski NC, 1999, ZOO BIOL, V18, P335, DOI 10.1002/(SICI)1098-2361(1999)18:4<335::AID-ZOO8>3.0.CO;2-X; Zeigler-Hill V, 2010, APPL ANIM BEHAV SCI, V124, P104, DOI 10.1016/j.applanim.2010.02.012	76	27	28	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183455	10.1371/journal.pone.0183455	http://dx.doi.org/10.1371/journal.pone.0183455			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832622	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000408355800059
J	Palmer-Young, EC; Alison, H; Alexander, JK; Donnelly, D; Jonathan, A; Connon, SJ; Weston, I; Kimberly, S; Irwin, RE; Adler, LS				Palmer-Young, Evan C.; Hogeboom, Alison; Kaye, Alexander J.; Donnelly, Dash; Andicoechea, Jonathan; Connon, Sara June; Weston, Ian; Skyrm, Kimberly; Irwin, Rebecca E.; Adler, Lynn S.			Context-dependent medicinal effects of anabasine and infection-dependent toxicity in bumble bees	PLOS ONE			English	Article							BOMBUS-TERRESTRIS; CRITHIDIA-BOMBI; SECONDARY METABOLITES; INTESTINAL PATHOGEN; COMBINED PESTICIDE; NECTAR-NICOTINE; PARASITE; HOST; HONEYBEES; INSECT	Background Floral phytochemicals are ubiquitous in nature, and can function both as antimicrobials and as insecticides. Although many phytochemicals act as toxins and deterrents to consumers, the same chemicals may counteract disease and be preferred by infected individuals. The roles of nectar and pollen phytochemicals in pollinator ecology and conservation are complex, with evidence for both toxicity and medicinal effects against parasites. However, it remains unclear how consistent the effects of phytochemicals are across different parasite lineages and environmental conditions, and whether pollinators actively self-medicate with these compounds when infected. Approach Here, we test effects of the nectar alkaloid anabasine, found in Nicotiana, on infection intensity, dietary preference, and survival and performance of bumble bees (Bombus impatiens). We examined variation in the effects of anabasine on infection with different lineages of the intestinal parasite Crithidia under pollen-fed and pollen-starved conditions. Results We found that anabasine did not reduce infection intensity in individual bees infected with any of four Crithidia lineages that were tested in parallel, nor did anabasine reduce infection intensity in microcolonies of queenless workers. In addition, neither anabasine nor its isomer, nicotine, was preferred by infected bees in choice experiments, and infected bees consumed less anabasine than did uninfected bees under no-choice conditions. Furthermore, anabasine exacerbated the negative effects of infection on bee survival and microcolony performance. Anabasine reduced infection in only one experiment, in which bees were deprived of pollen and post-pupal contact with nestmates. In this experiment, anabasine had antiparasitic effects in bees from only two of four colonies, and infected bees exhibited reduced-rather than increased-phytochemical consumption relative to uninfected bees. Conclusions Variation in the effect of anabasine on infection suggests potential modulation of tritrophic interactions by both host genotype and environmental variables. Overall, our results demonstrate that Bombus impatiens prefer diets without nicotine and anabasine, and suggest that the medicinal effects and toxicity of anabasine may be context dependent. Future research should identify the specific environmental and genotypic factors that determine whether nectar phytochemicals have medicinal or deleterious effects on pollinators.	[Palmer-Young, Evan C.] Univ Massachusetts, Organism & Evolutionary Biol, Amherst, MA 01003 USA; [Palmer-Young, Evan C.; Hogeboom, Alison; Connon, Sara June; Weston, Ian; Skyrm, Kimberly; Adler, Lynn S.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Kaye, Alexander J.; Donnelly, Dash; Andicoechea, Jonathan; Irwin, Rebecca E.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA; [Connon, Sara June; Irwin, Rebecca E.] North Carolina State Univ, Dept Appl Ecol, Raleigh, NC 27695 USA; [Hogeboom, Alison] Colorado State Univ, Dept Bioagr & Pest Sci, Ft Collins, CO 80523 USA; [Kaye, Alexander J.] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Andicoechea, Jonathan] Univ Minnesota, STEM Educ Ctr, St Paul, MN 55108 USA; [Skyrm, Kimberly] Massachusetts Dept Agr Resources, Apiary Program, Amherst, MA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; Dartmouth College; University of North Carolina; North Carolina State University; Colorado State University; Tufts University; University of Minnesota System; University of Minnesota Twin Cities	Palmer-Young, EC (corresponding author), Univ Massachusetts, Organism & Evolutionary Biol, Amherst, MA 01003 USA.; Palmer-Young, EC (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	ecp52@cornell.edu	Palmer-Young, Evan/AFL-1225-2022	Palmer-Young, Evan/0000-0002-9258-2073	National Science Foundation (NSF) [NSFDEB-1258096]; NSF GRFP [DGE-0907995]; NSF DDIG [NSFDEB-1501907]; Cooperative State Research, Education, and Extension Service (CSREES) [USDA-AFRI 2013-02536]; National Institute of Food and Agriculture Predoctoral Fellowship [USDA-AFRI-2016-67011-24698]; Garden Club of America Centennial Pollinator Fellowship (ECPY); National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA); Division Of Environmental Biology [1638866] Funding Source: National Science Foundation	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); NSF DDIG(National Science Foundation (NSF)); Cooperative State Research, Education, and Extension Service (CSREES)(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); National Institute of Food and Agriculture Predoctoral Fellowship; Garden Club of America Centennial Pollinator Fellowship (ECPY); National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was funded by the National Science Foundation (NSF: nsf.gov) under NSFDEB-1258096 (to LSA and RED), NSF GRFP (DGE-0907995 to ECPY), and NSF DDIG (NSFDEB-1501907 to ECPY and LSA); by the National Research Initiative (NRI) Arthropod and Nematode Biology and Management Program of the United States Department of Agriculture (USDA: usda.gov) Cooperative State Research, Education, and Extension Service (CSREES) Grant USDA-AFRI 2013-02536 (to LSA and RED; by a National Institute of Food and Agriculture Predoctoral Fellowship (USDA-AFRI-2016-67011-24698 to EPY), and by the Garden Club of America (www.gcamerica.org) Centennial Pollinator Fellowship (ECPY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Adler LS, 2012, ECOL LETT, V15, P1140, DOI 10.1111/j.1461-0248.2012.01838.x; Adler LS, 2012, OECOLOGIA, V168, P1033, DOI 10.1007/s00442-011-2153-3; Alaux C, 2010, ENVIRON MICROBIOL, V12, P774, DOI 10.1111/j.1462-2920.2009.02123.x; Anthony WE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142496; Archer CR, 2014, FUNCT ECOL, V28, P913, DOI 10.1111/1365-2435.12226; Arnold SEJ, 2014, J CHEM ECOL, V40, P878, DOI 10.1007/s10886-014-0467-4; BAKER HG, 1977, APIDOLOGIE, V8, P349, DOI 10.1051/apido:19770405; Baracchi David, 2015, F1000Res, V4, P73, DOI 10.12688/f1000research.6262.2; Barribeau SM, 2014, P NATL ACAD SCI USA, V111, P3496, DOI 10.1073/pnas.1318628111; Barribeau SM, 2013, INFECT GENET EVOL, V20, P249, DOI 10.1016/j.meegid.2013.09.014; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Biller OM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144668; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; BREER H, 1987, J INSECT PHYSIOL, V33, P771, DOI 10.1016/0022-1910(87)90025-4; Brown MJF, 2003, J ANIM ECOL, V72, P994, DOI 10.1046/j.1365-2656.2003.00770.x; Brunner FS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0128; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Ceja-Navarro JA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8618; Cisarovsky G, 2014, ENTOMOL EXP APPL, V152, P209, DOI 10.1111/eea.12218; Conroy TJ, 2016, ENVIRON ENTOMOL, V45, P1212, DOI 10.1093/ee/nvw099; Costa C, 2010, APIDOLOGIE, V41, P141, DOI 10.1051/apido/2009070; de Roode JC, 2013, SCIENCE, V340, P150, DOI 10.1126/science.1235824; Detzel Andreas, 1993, Chemoecology, V4, P8, DOI 10.1007/BF01245891; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Dobson HEM, 2000, PLANT SYST EVOL, V222, P63, DOI 10.1007/BF00984096; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; du Rand EE, 2015, SCI REP-UK, V5, DOI 10.1038/srep11779; DURRER S, 1994, P ROY SOC B-BIOL SCI, V258, P299, DOI 10.1098/rspb.1994.0176; Fauser-Misslin A, 2014, J APPL ECOL, V51, P450, DOI 10.1111/1365-2664.12188; Fox J., 2018, R COMPANION APPL REG, VThird; Gegear RJ, 2005, ANIM BEHAV, V70, P209, DOI 10.1016/j.anbehav.2004.09.025; Gherman BI, 2014, BEHAV ECOL SOCIOBIOL, V68, P1777, DOI 10.1007/s00265-014-1786-8; Gill RJ, 2012, NATURE, V491, P105, DOI 10.1038/nature11585; Gillespie S, 2010, ECOL ENTOMOL, V35, P737, DOI 10.1111/j.1365-2311.2010.01234.x; Goldberg F, 1999, J PHYSIOL-LONDON, V514, P759, DOI 10.1111/j.1469-7793.1999.759ad.x; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Graystock P, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1371; Hartmann T, 1996, ENTOMOL EXP APPL, V80, P177, DOI 10.1007/BF00194753; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Heinrich B., 2004, BUMBLEBEE EC; Huang M, 2012, NEW PHYTOL, V193, P997, DOI 10.1111/j.1469-8137.2011.04001.x; Hurst V, 2014, J COMP PHYSIOL A, V200, P881, DOI 10.1007/s00359-014-0932-0; Imhoof B, 1999, INSECT SOC, V46, P233, DOI 10.1007/s000400050139; Irwin RE, 2004, ECOLOGY, V85, P1503, DOI 10.1890/03-0390; Junker RR, 2013, J CHEM ECOL, V39, P810, DOI 10.1007/s10886-013-0325-9; Karban R, 1997, ECOLOGY, V78, P603, DOI 10.1890/0012-9658(1997)078[0603:TPAHPC]2.0.CO;2; Kassambara A., 2016, SURVMINER DRAWING SU; Kessler D, 2008, SCIENCE, V321, P1200, DOI 10.1126/science.1160072; Kessler D, 2012, PLANT J, V71, P529, DOI 10.1111/j.1365-313X.2012.05008.x; Kessler SC, 2015, NATURE, V521, P74, DOI 10.1038/nature14414; Koch H, 2011, P NATL ACAD SCI USA, V108, P19288, DOI 10.1073/pnas.1110474108; Kohler A, 2012, J INSECT PHYSIOL, V58, P918, DOI 10.1016/j.jinsphys.2012.04.007; Kohler A, 2012, J INSECT PHYSIOL, V58, P286, DOI 10.1016/j.jinsphys.2011.12.002; Kwong WK, 2016, NAT REV MICROBIOL, V14, P374, DOI 10.1038/nrmicro.2016.43; Lefevre T, 2012, J ANIM ECOL, V81, P70, DOI 10.1111/j.1365-2656.2011.01901.x; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; LIPA JJ, 1988, ACTA PROTOZOOL, V27, P287; Logan A, 2005, PARASITOLOGY, V130, P637, DOI 10.1017/S0031182005007304; Manson JS, 2010, OECOLOGIA, V162, P81, DOI 10.1007/s00442-009-1431-9; Manson JS, 2009, ECOL ENTOMOL, V34, P421, DOI 10.1111/j.1365-2311.2009.01100.x; Marxer M, 2016, EVOL BIOL, P1; Oddoze C, 1998, J CHROMATOGR B, V708, P95, DOI 10.1016/S0378-4347(97)00632-4; Otterstatter MC, 2006, PARASITOLOGY, V133, P749, DOI 10.1017/S003118200600120X; Otterstatter MC, 2007, OECOLOGIA, V154, P411, DOI 10.1007/s00442-007-0834-8; Palmer-Young EC, 2016, SCI REP-UK, V6, DOI 10.1038/srep37087; R Core Team, 2021, R LANGUAGE ENV STAT; Richardson CH, 1936, J ECON ENTOMOL, V29, P850, DOI 10.1093/jee/29.5.850; Richardson LL, 2016, ECOLOGY, V97, P325, DOI 10.1890/15-0263.1; Richardson LL, 2015, P R SOC LOND B, V282; Rosenkranz V, 2008, MOLECULES, V13, P2462, DOI 10.3390/molecules13102462; Roulston TH, 2011, ANNU REV ENTOMOL, V56, P293, DOI 10.1146/annurev-ento-120709-144802; Sadd BM, 2013, PARASITE IMMUNOL, V35, P339, DOI 10.1111/pim.12043; Sadd BM, 2011, EVOLUTION, V65, P2995, DOI 10.1111/j.1558-5646.2011.01345.x; Sattelle DB, 2005, BIOESSAYS, V27, P366, DOI 10.1002/bies.20207; Schiestl FP, 1999, P ENTOMOL SOC WASH, V101, P880; Schmid-Hempel R, 1998, FUNCT ECOL, V12, P22, DOI 10.1046/j.1365-2435.1998.00153.x; Schmid-Hempel R, 2014, J ANIM ECOL, V83, P823, DOI 10.1111/1365-2656.12185; Schmid-Hempel R, 2011, INFECT GENET EVOL, V11, P564, DOI 10.1016/j.meegid.2011.01.002; Schmid-Hempel R, 2010, J EUKARYOT MICROBIOL, V57, P337, DOI 10.1111/j.1550-7408.2010.00480.x; Schwarz RS, 2015, J EUKARYOT MICROBIOL, V62, P567, DOI 10.1111/jeu.12209; SHYKOFF JA, 1991, APIDOLOGIE, V22, P117, DOI 10.1051/apido:19910204; Singaravelan N, 2006, J CHEM ECOL, V32, P49, DOI 10.1007/s10886-006-9350-2; Singaravelan N, 2005, J CHEM ECOL, V31, P2791, DOI 10.1007/s10886-005-8394-z; Singer MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004796; SOLOWAY SB, 1976, ENVIRON HEALTH PERSP, V14, P109, DOI 10.2307/3428368; Tadmor-Melamed H, 2004, FUNCT ECOL, V18, P844, DOI 10.1111/j.0269-8463.2004.00929.x; Thany SH, 2003, INSECT MOL BIOL, V12, P255, DOI 10.1046/j.1365-2583.2003.00409.x; Therneau T.M., 2015, R PACKAGE COXME MIXE; Thomson JD, 2015, ARTHROPOD-PLANT INTE, V9, P1, DOI 10.1007/s11829-014-9350-z; Thorburn L., 2015, F1000RESEARCH, V4, P880, DOI DOI 10.12688/F1000RESEARCH.6870.2; Tognazzo M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049137; Tomizawa M, 2003, ANNU REV ENTOMOL, V48, P339, DOI 10.1146/annurev.ento.48.091801.112731; Tseng M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106401; Tyler Elizabeth R, 2006, BMC Physiol, V6, P6, DOI 10.1186/1472-6793-6-6; Ujvary I., 1999, NICOTINOID INSECTICI, P29, DOI [10.1007/978-4-431-67933-2_2, DOI 10.1007/978-4-431-67933-2_2]; Vannette RL, 2016, ECOLOGY, V97, P1410, DOI 10.1890/15-0858.1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilke CO, 2016, CRAN REP; Wink M, 2002, CHEMOECOLOGY, V12, P29, DOI 10.1007/s00049-002-8324-2; Wongsrichanalai C, 2002, LANCET INFECT DIS, V2, P209, DOI 10.1016/S1473-3099(02)00239-6; World Health Organization, 2001, INT CLASS FUNCT DIS; Yamamoto Izuru, 1999, NICOTINOID INSECTICI, P3, DOI DOI 10.1007/978-4-431-67933-2_1; Yothers MA, 1940, J ECON ENTOMOL, V33, P800, DOI 10.1093/jee/33.5.800	105	9	9	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183729	10.1371/journal.pone.0183729	http://dx.doi.org/10.1371/journal.pone.0183729			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE6YW	28832668	Green Published, gold, Green Submitted			2022-12-27	WOS:000408355800096
J	Tsai, YC; Chen, HM; Hsiao, SM; Chen, CS; Lin, MY; Chiu, YW; Hwang, SJ; Kuo, MC				Tsai, Yi-Chun; Chen, Hui-Mei; Hsiao, Shih-Ming; Chen, Cheng-Sheng; Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan			Association of physical activity with cardiovascular and renal outcomes and quality of life in chronic kidney disease	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; OLDER-ADULTS; HANDGRIP STRENGTH; CKD; PERFORMANCE; PREDICTOR; HEMODIALYSIS; DISABILITY; SURVIVAL; EXERCISE	Patients with chronic kidney disease (CKD) are more readily prone to have impaired physical activity than the general population. The aim of this study is to examine the relationship between physical activity and adverse clinical outcomes and quality of life (QOL) in CKD. One hundred and sixty-one patients with CKD stages 1-5 was enrolled from February 2013 to September 2013 and followed up until June 2016. Physical activity was measured using high handgrip strength, 30-second chair stand, and 2-minute step. The QOL was assessed using the Taiwan version of the World Health Organization Quality of Life-BREF. Clinical outcomes included commencing dialysis, major adverse cardiovascular events (MACEs), and first hospitalization. Of all participants, 1 kgf increase in handgrip strength was significantly associated with 0.13 score increase in total scores of QOL and 0.05 score increase in physical domain of QOL in adjusted analysis. One time increase in 30-second chair stand was significantly correlated with 0.14 score increase in psychological domain of QOL. Over a mean follow-up period of 29.1-11.2 months, 37 (23.0%) reached commencing dialysis, 11 (6.8%) had MACEs, and 50(31.1%) had first hospitalization. High handgrip strength (hazard ratio (HR): 0.89, 95% CI: 0.84-0.96) and high 2-minute step (HR: 0.04, 95% CI: 0.01-0.95) were significantly associated with decreased risk for commencing dialysis in multivariate analysis. Thirty-second chair-stand was negatively associated with MACEs (HR: 0.65, 95% CI: 0.47-0.89) and first hospitalization (HR: 0.84, 95% CI: 0.74-0.95). In conclusion, physical activity is a potential predictor of QOL and adverse clinical outcomes in patients with CKD.	[Tsai, Yi-Chun] Kaohsiung Med Univ Hosp, Div Gen Med, Dept Internal Med, Kaohsiung, Taiwan; [Tsai, Yi-Chun; Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Hui-Mei; Chen, Cheng-Sheng] Kaohsiung Med Univ, Grad Med, Kaohsiung, Taiwan; [Chen, Hui-Mei] Kaohsiung Med Univ, Dept Occupat Therapy, Coll Hlth Sci, Kaohsiung, Taiwan; [Hsiao, Shih-Ming] Kaohsiung Med Univ Hosp, Dept Nursing, Kaohsiung, Taiwan; [Chen, Cheng-Sheng] Kaohsiung Med Univ Hosp, Dept Psychiat, Kaohsiung, Taiwan; [Lin, Ming-Yen; Chiu, Yi-Wen; Hwang, Shang-Jyh; Kuo, Mei-Chuan] Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University	Kuo, MC (corresponding author), Kaohsiung Med Univ Hosp, Div Nephrol, Dept Internal Med, Kaohsiung, Taiwan.; Kuo, MC (corresponding author), Kaohsiung Med Univ, Fac Renal Care, Kaohsiung, Taiwan.	mechku@cc.kmu.edu.tw	Lin, Ming Yen/A-8637-2010	Lin, Ming Yen/0000-0002-8194-4833; Chen, Hui-Mei/0000-0002-3712-5144	Kaohsiung Medical University Hospital [KMUH-98-P18]	Kaohsiung Medical University Hospital	This research was supported by a grant from the Kaohsiung Medical University Hospital (KMUH-98-P18). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beddhu S, 2009, CLIN J AM SOC NEPHRO, V4, P1901, DOI 10.2215/CJN.01970309; Bharakhada N, 2012, AM J KIDNEY DIS, V60, P583, DOI 10.1053/j.ajkd.2012.04.024; Carrero JJ, 2010, SEMIN DIALYSIS, V23, P498, DOI 10.1111/j.1525-139X.2010.00784.x; Centers for Disease Control and Prevention (CDC), NAT HLTH NUTR EX SUR; Chang KV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117167; Chang YT, 2011, NEPHROL DIAL TRANSPL, V26, P3588, DOI 10.1093/ndt/gfr013; Chen IR, 2014, CLIN J AM SOC NEPHRO, V9, P1183, DOI 10.2215/CJN.09810913; Garg AX, 2001, KIDNEY INT, V60, P1867, DOI 10.1046/j.1523-1755.2001.00001.x; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; Haider S, 2016, QUAL LIFE RES, V25, P3129, DOI 10.1007/s11136-016-1349-8; Hiraki K, 2013, CLIN EXP NEPHROL, V17, P225, DOI 10.1007/s10157-012-0681-8; Hsiao SM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165400; Johansen KL, 2012, AM J KIDNEY DIS, V59, P126, DOI 10.1053/j.ajkd.2011.10.008; Johansen KL, 2000, KIDNEY INT, V57, P2564, DOI 10.1046/j.1523-1755.2000.00116.x; Jones CJ, 1999, RES Q EXERCISE SPORT, V70, P113, DOI 10.1080/02701367.1999.10608028; Kasapis C, 2005, J AM COLL CARDIOL, V45, P1563, DOI 10.1016/j.jacc.2004.12.077; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Lopes AA, 2014, CLIN J AM SOC NEPHRO, V9, P1702, DOI 10.2215/CJN.12371213; Metter EJ, 2002, J GERONTOL A-BIOL, V57, pB359, DOI 10.1093/gerona/57.10.B359; Newman AB, 2006, JAMA-J AM MED ASSOC, V295, P2018, DOI 10.1001/jama.295.17.2018; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Pedrosa R, 2009, BRAZ J PHYS THER, V13, P252, DOI 10.1590/S1413-35552009005000030; Ro YS, 2017, RESUSCITATION, V115, P44, DOI 10.1016/j.resuscitation.2017.03.041; Roshanravan B, 2013, J AM SOC NEPHROL, V24, P822, DOI 10.1681/ASN.2012070702; Slee AD, 2012, NUTR METAB, V9, DOI 10.1186/1743-7075-9-36; Stump CS, 2011, CARDIORENAL MED, V1, P164, DOI 10.1159/000329929; Yao G, 2002, J FORMOS MED ASSOC, V101, P342	27	34	37	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 23	2017	12	8							e0183642	10.1371/journal.pone.0183642	http://dx.doi.org/10.1371/journal.pone.0183642			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FE6YW	28832653	Green Submitted, Green Published, gold			2022-12-27	WOS:000408355800075
J	Xu, XY; Xu, XL; Zhou, YP; Zeng, SH; Kong, WW				Xu, Xiaoyong; Xu, Xiaoling; Zhou, Yipeng; Zeng, Shaohua; Kong, Weiwen			Identification of protoplast-isolation responsive microRNAs in Citrus reticulata Blanco by high-throughput sequencing	PLOS ONE			English	Article							SMALL RNA; ENZYMATIC ISOLATION; OXIDATIVE STRESS; PLANT MICRORNAS; FLOWERING TIME; EXPRESSION; GENES; ARABIDOPSIS; GENERATION; REGENERATION	Protoplast isolation is a stress-inducing process, during which a variety of physiological and molecular alterations take place. Such stress response affects the expression of totipotency of cultured protoplasts. MicroRNAs (miRNAs) play important roles in plant growth, development and stress responses. However, the underlying mechanism of miRNAs involved in the protoplast totipotency remains unclear. In this study, high-throughput sequencing technology was used to sequence two populations of small RNA from calli and callus-derived protoplasts in Citrus reticulata Blanco. A total of 67 known miRNAs from 35 families and 277 novel miRNAs were identified. Among these miRNAs, 18 known miRNAs and 64 novel miRNAs were identified by differentially expressed miRNAs (DEMs) analysis. The expression patterns of the eight DEMs were verified by qRT-PCR. Target prediction showed most targets of the miRNAs were transcription factors. The expression levels of half targets showed a negative correlation to those of the miRNAs. Furthermore, the physiological analysis showed high levels of antioxidant activities in isolated protoplasts. In short, our results indicated that miRNAs may play important roles in protoplast-isolation response.	[Xu, Xiaoyong; Xu, Xiaoling; Zhou, Yipeng; Kong, Weiwen] Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China; [Xu, Xiaoyong; Kong, Weiwen] Yangzhou Univ, Joint Int Res Lab Agr & Agri Product Safety, Minist Educ, Yangzhou, Jiangsu, Peoples R China; [Zeng, Shaohua] Chinese Acad Sci, Guangdong Prov Key Lab Appl Bot South China Botan, Guangzhou, Guangdong, Peoples R China	Yangzhou University; Yangzhou University; Chinese Academy of Sciences	Xu, XY; Kong, WW (corresponding author), Yangzhou Univ, Sch Hort & Plant Protect, Yangzhou, Jiangsu, Peoples R China.; Xu, XY; Kong, WW (corresponding author), Yangzhou Univ, Joint Int Res Lab Agr & Agri Product Safety, Minist Educ, Yangzhou, Jiangsu, Peoples R China.	xyxu@yzu.edu.cn; wwkong@yzu.edu.cn		Kong, Weiwen/0000-0002-5372-7110; Xu, Xiaoyong/0000-0003-0771-595X	National Natural Science Foundation of China [31372025]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (31372025). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott AL, 2011, CURR BIOL, V21, pR668, DOI 10.1016/j.cub.2011.07.027; Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Axtell MJ, 2008, TRENDS PLANT SCI, V13, P343, DOI 10.1016/j.tplants.2008.03.009; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Butt AD, 1997, J PLANT PHYSIOL, V150, P729, DOI 10.1016/S0176-1617(97)80290-8; Chen CJ, 2011, RNA BIOL, V8, P538, DOI 10.4161/rna.8.3.15199; Chupeau MC, 2013, PLANT CELL, V25, P2444, DOI 10.1105/tpc.113.109538; Curaba J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-6; Davey MR, 2005, BIOTECHNOL ADV, V23, P131, DOI 10.1016/j.biotechadv.2004.09.008; deMarco A, 1996, PLANT PHYSIOL, V110, P137, DOI 10.1104/pp.110.1.137; Ding Q, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0267-6; Eeckhaut T, 2013, PLANTA, V238, P991, DOI 10.1007/s00425-013-1936-7; Fan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125833; Fang YN, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2882-0; Fang YN, 2014, TREE GENET GENOMES, V10, P1567, DOI 10.1007/s11295-014-0780-7; Fu HJ, 2006, MOL BIOTECHNOL, V32, P197, DOI 10.1385/MB:32:3:197; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Gou JY, 2011, PLANT CELL, V23, P1512, DOI 10.1105/tpc.111.084525; Guo Rongfang, 2015, Front Plant Sci, V6, P1212, DOI 10.3389/fpls.2015.01212; Hsieh LC, 2009, PLANT PHYSIOL, V151, P2120, DOI 10.1104/pp.109.147280; Huijser P, 2011, DEVELOPMENT, V138, P4117, DOI 10.1242/dev.063511; ISHII S, 1987, IN VITRO CELL DEV B, V23, P653; Jia XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep11093; Jover-Gil S, 2005, INT J DEV BIOL, V49, P733, DOI 10.1387/ijdb.052015sj; Karlova R, 2013, J EXP BOT, V64, P1863, DOI 10.1093/jxb/ert049; Khan GA, 2011, PLANT MOL BIOL, V77, P47, DOI 10.1007/s11103-011-9793-x; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lelandais-Briere C, 2009, PLANT CELL, V21, P2780, DOI 10.1105/tpc.109.068130; Li C, 2016, J CELL PHYSIOL, V231, P303, DOI 10.1002/jcp.25125; Liu HW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129002; Liu MY, 2017, PLANT CELL TISS ORG, V130, P103, DOI 10.1007/s11240-017-1207-6; Liu YL, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-695; Lu YB, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0642-y; Ma CL, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00201; Mallory AC, 2006, NAT GENET, V38, pS31, DOI 10.1038/ng1791; Meyers BC, 2008, PLANT CELL, V20, P3186, DOI 10.1105/tpc.108.064311; Ondrej V, 2009, MOL CELLS, V27, P443, DOI 10.1007/s10059-009-0057-4; Ondrej V, 2009, PLANT CELL TISS ORG, V96, P229, DOI 10.1007/s11240-008-9479-5; Papadakis AK, 1999, PLANT PHYSIOL, V121, P197, DOI 10.1104/pp.121.1.197; Papadakis AK, 2002, PLANT PHYSIOL BIOCH, V40, P549, DOI 10.1016/S0981-9428(02)01423-7; Permar V, 2014, PHYSIOL MOL PLANT P, V88, P77, DOI 10.1016/j.pmpp.2014.09.004; Sattar S, 2016, PLANT CELL ENVIRON, V39, P1216, DOI 10.1111/pce.12645; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Sharma R, 2011, PLANT MOL BIOL, V77, P391, DOI 10.1007/s11103-011-9819-4; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Shriram V, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00817; SIMINIS CI, 1994, PLANT PHYSIOL, V105, P1375, DOI 10.1104/pp.105.4.1375; Song CNA, 2010, BMC GENOMICS, V11, DOI [10.1186/1471-2164-11-431, 10.1186/1471-2164-11-261]; Song CN, 2009, PLANTA, V230, P671, DOI 10.1007/s00425-009-0971-x; Sorin C, 2014, NEW PHYTOL, V202, P1197, DOI 10.1111/nph.12735; Spanudakis E, 2014, J EXP BOT, V65, P365, DOI 10.1093/jxb/ert453; Sternes PR, 2015, PLANT MOL BIOL REP, V33, P931, DOI 10.1007/s11105-014-0787-0; Sunkar R, 2005, PLANT CELL, V17, P1397, DOI 10.1105/tpc.105.031682; Tan F, 2011, J PROTEOME RES, V10, P551, DOI 10.1021/pr100748e; Tewari RK, 2012, PLANTA, V235, P99, DOI 10.1007/s00425-011-1495-8; Thiebaut F, 2012, PLANT CELL ENVIRON, V35, P502, DOI 10.1111/j.1365-3040.2011.02430.x; Wang L, 2010, MOL PLANT, V3, P794, DOI 10.1093/mp/ssq042; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu JX, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01416; Wu XM, 2015, PLANT BIOTECHNOL J, V13, P383, DOI 10.1111/pbi.12317; Xiao LH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035961; Xie M, 2015, CURR GENOMICS, V16, P23, DOI 10.2174/1389202915666141128002211; Xie RJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep42094; Xu L, 2013, J EXP BOT, V64, P4271, DOI 10.1093/jxb/ert240; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Xu XY, 2013, PLANT CELL TISS ORG, V114, P161, DOI 10.1007/s11240-013-0312-4; Yang XZ, 2011, GENOMICS, V98, P40, DOI 10.1016/j.ygeno.2011.03.011; Yang XY, 2008, J EXP BOT, V59, P3661, DOI 10.1093/jxb/ern214; Yang XY, 2013, J EXP BOT, V64, P1521, DOI 10.1093/jxb/ert013; Zhang BH, 2015, J EXP BOT, V66, P1749, DOI 10.1093/jxb/erv013; Zhang BH, 2015, J CELL PHYSIOL, V230, P1, DOI 10.1002/jcp.24685; Zhao J, 2001, J BIOL CHEM, V276, P22772, DOI 10.1074/jbc.M101756200; Zhao WC, 2015, J EXP BOT, V66, P4653, DOI 10.1093/jxb/erv238; Zhou M, 2013, PLANT PHYSIOL, V161, P1375, DOI 10.1104/pp.112.208702; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	77	2	3	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183524	10.1371/journal.pone.0183524	http://dx.doi.org/10.1371/journal.pone.0183524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829800	gold, Green Submitted, Green Published			2022-12-27	WOS:000408085100052
J	Li, YP; Xu, HY; Su, SS; Ye, JR; Chen, JJ; Jin, XR; Lin, Q; Zhang, DQ; Ye, CE; Chen, CS				Li, Yuping; Xu, Hanyan; Su, Shanshan; Ye, Junru; Chen, Junjie; Jin, Xuru; Lin, Quan; Zhang, Dongqing; Ye, Caier; Chen, Chengshui			Clinical validation of a highly sensitive assay to detect EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma	PLOS ONE			English	Article							FACTOR RECEPTOR MUTATION; TUMOR-TISSUE; PERIPHERAL-BLOOD; CANCER-PATIENTS; DIAGNOSTIC-ACCURACY; GEFITINIB; RESISTANCE; PREDICTOR; SAMPLES; NSCLC	Background Circulating tumor DNA (ctDNA) is a promising biomarker for noninvasive epidermal growth factor receptor (EGFR) mutations detection in lung cancer patients, but the existing methods have limitations in sensitivity or in availability. In this study, we evaluated the performance of a novel assay called ADx-SuperARMS in detecting EGFR mutations in plasma cell-free DNA from patients with advanced lung adenocarcinoma. Methods A total of 109 patients with metastatic advanced adenocarcinoma were recruited who provided both blood samples and matched tumor tissue samples. EGFR mutation status in plasma samples were tested with ADx-SuperARMS EGFR assay and tumor tissue samples were tested with ADx- ARMS EGFR assay. The clinical sensitivity, specificity, positive prediction value (PPV), and negative prediction value (NPV) of ADx-SuperARMS EGFR assay were calculated by using EGFR mutation status in tumor tissue as standard reference. A receiver operating characteristic (ROC) analysis was implemented and an area under the curve (AUC) was calculated to evaluate sensitivity and specificity of exon 19 deletion (E19Del) and L858R mutation detection. The objective response rate (ORR) were calculated according to the EGFR mutation status determined by ADx-superARMS as well. Results 0.2% analytical sensitivity and 100% specificity of the ADx-SuperARMS EGFR assays for EGFR E19Del, L858R, and T790M mutants were confirmed by using a series of diluted cell line DNA. In the clinical study, EGFR mutations were detected in 45.9% (50/109) of the plasma samples and in 56.9% (62/109) of the matched tumor tissue samples. The sensitivity, specificity, PPV and NPV of the ADx-SuperARMS EGFR assay for plasma EGFR mutation detection were 82.0% (50/61), 100% (48/48), 100% (50/50), and 81.4% (48/59), respectively. In ROC analysis, ADx-SuperARMS achieved sensitivity and specificity of 88% and 99% in E19Dels as well as sensitivity and specificity of 89% and 100% in L858R, respectively. Among the 35 patients who were plasma EGFR mutation positive and treated with first generation of EGFR-tyrosine kinase inhibitors (TKIs), 23 (65.7%) achieved partial response, 11 (31.4%) sustained disease, and 1 (2.9%) progressive disease. The ORR and disease control rate (DCR) were 65.7% and 97.1%, respectively. Conclusions ADx-SuperARMS EGFR assay is likely to be a highly sensitive and specific method to non-invasively detect plasma EGFR mutations of patients with advanced lung adenocarcinoma. The EGFR mutations detected by ADx-SuperARMS EGFR assay could predict the efficacy of the treatment with first generation of EGFR-TKIs. Hence, EGFR blood testing with ADx-SuperARMS could address the unmet clinical needs.	[Li, Yuping; Xu, Hanyan; Su, Shanshan; Ye, Junru; Chen, Junjie; Jin, Xuru; Lin, Quan; Zhang, Dongqing; Chen, Chengshui] Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Zhejiang, Peoples R China; [Ye, Caier] Wenzhou Med Univ, Affiliated Hosp 1, Dept Radiol, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University	Chen, CS (corresponding author), Wenzhou Med Univ, Affiliated Hosp 1, Dept Pulm & Crit Care Med, Wenzhou, Zhejiang, Peoples R China.	wzchencs1@163.com	yu, yanbo/GZM-8474-2022; li, yu/HGL-9518-2022; LI, Yue/GRS-8071-2022; Li, yu/HHZ-5236-2022		Natural Science Foundation of Zhejiang Province [LY15H010007]; Wenzhou Municipal Science and Technology Bureau [ZH2017001]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Wenzhou Municipal Science and Technology Bureau	This study was funded by grants from the Natural Science Foundation of Zhejiang Province[LY15H010007 to Yuping Li] and the Wenzhou Municipal Science and Technology Bureau(CN)[ZH2017001 to Yuping Li].	Bai H, 2009, J CLIN ONCOL, V27, P2653, DOI 10.1200/JCO.2008.17.3930; Diaz LA, 2014, J CLIN ONCOL, V32, P579, DOI 10.1200/JCO.2012.45.2011; Douillard JY, 2014, J THORAC ONCOL, V9, P1345, DOI 10.1097/JTO.0000000000000263; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Ellison G, 2013, J CLIN PATHOL, V66, P79, DOI 10.1136/jclinpath-2012-201194; Errico Alessia, 2014, Nat Rev Clin Oncol, V11, P684, DOI 10.1038/nrclinonc.2014.186; Esposito A, 2014, CANCER TREAT REV, V40, P648, DOI 10.1016/j.ctrv.2013.10.003; Ettinger DS, 2016, J NATL COMPR CANC NE, V14, P255, DOI 10.6004/jnccn.2016.0031; Gettinger S, 2011, CLIN CHEST MED, V32, P839, DOI 10.1016/j.ccm.2011.08.017; Hasegawa T, 2015, INTERNAL MED, V54, P1977, DOI 10.2169/internalmedicine.54.4394; Hong QY, 2015, CANCER-AM CANCER SOC, V121, P3080, DOI 10.1002/cncr.29584; Kawamura T, 2016, CANCER SCI, V107, P1001, DOI 10.1111/cas.12963; Khozin S, 2017, CLIN CANCER RES, V23, P2131, DOI 10.1158/1078-0432.CCR-16-1773; Kimura H, 2007, BRIT J CANCER, V97, P778, DOI 10.1038/sj.bjc.6603949; Lababede O, 2011, CHEST, V139, P183, DOI 10.1378/chest.10-1099; Li XF, 2014, TRANSL ONCOL, V7, P341, DOI 10.1016/j.tranon.2014.04.006; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Liu XQ, 2013, J CLIN PATHOL, V66, P1065, DOI 10.1136/jclinpath-2013-201728; Lowes LE, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091505; Luo J, 2014, SCI REP-UK, V4, DOI 10.1038/srep06269; Ma ML, 2016, GENE, V591, P58, DOI 10.1016/j.gene.2016.06.053; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; McGuire S, 2014, ADV NUTR, V5, P456, DOI 10.3945/an.114.006171; Minguet J, 2016, INT J CANCER, V138, P2549, DOI 10.1002/ijc.29915; Mok T, 2015, CLIN CANCER RES, V21, P3196, DOI 10.1158/1078-0432.CCR-14-2594; Mok Tony S, 2017, N Engl J Med, V376, P629, DOI 10.1056/NEJMoa1612674; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Newman AM, 2016, NAT BIOTECHNOL, V34, P547, DOI 10.1038/nbt.3520; Newman AM, 2014, NAT MED, V20, P552, DOI 10.1038/nm.3519; Nurwidya Fariz, 2016, Chonnam Med J, V52, P151, DOI 10.4068/cmj.2016.52.3.151; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Oxnard GR, 2014, CLIN CANCER RES, V20, P1698, DOI 10.1158/1078-0432.CCR-13-2482; Perez-Barrios C, 2016, TRANSL LUNG CANCER R, V5, P665, DOI 10.21037/tlcr.2016.12.03; QIAGEN, 2014, THER EGFR PLASM RGQ; Qian X, 2016, ONCOTARGET, V7, P29154, DOI 10.18632/oncotarget.8684; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Shi YK, 2013, LANCET ONCOL, V14, P953, DOI 10.1016/S1470-2045(13)70355-3; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sorensen BS, 2014, CANCER-AM CANCER SOC, V120, P3896, DOI 10.1002/cncr.28964; Soria JC, 2015, LANCET ONCOL, V16, P897, DOI 10.1016/S1470-2045(15)00006-6; Uchida J, 2015, CLIN CHEM, V61, P1191, DOI 10.1373/clinchem.2015.241414; US Food & Drug Administration, 2016, PREM APPR P150044 CO; Wang Z, 2014, PR GR LAK SYMP VLSI, P9, DOI 10.1145/2591513.2591519; Weber B, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-294; Wei WE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168795; Wu YL, 2013, LUNG CANCER, V81, P280, DOI 10.1016/j.lungcan.2013.03.004; Xu F, 2012, ONCOTARGETS THER, V5, P439, DOI 10.2147/OTT.S37289; Ye X, 2013, J THORAC ONCOL, V8, P1118, DOI 10.1097/JTO.0b013e31829f691f; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Zhang H, 2013, J MOL DIAGN, V15, P819, DOI 10.1016/j.jmoldx.2013.06.006; Zhou YC, 2017, ONCOTARGET, V8, P15023, DOI 10.18632/oncotarget.14706; Zhu GS, 2015, J MOL DIAGN, V17, P265, DOI 10.1016/j.jmoldx.2015.01.004	53	43	53	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 22	2017	12	8							e0183331	10.1371/journal.pone.0183331	http://dx.doi.org/10.1371/journal.pone.0183331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FE2ZB	28829813	Green Published, gold, Green Submitted			2022-12-27	WOS:000408085100039
J	Li, YY; Jia, XY; Liu, BZ; Qi, YM; Zhang, XB; Ji, R; Yu, YB; Zuo, XL; Li, YQ				Li, Yueyue; Jia, Xinyong; Liu, Baozhen; Qi, Yanmei; Zhang, Xiubin; Ji, Rui; Yu, Yanbo; Zuo, Xiuli; Li, Yanqing			Randomized controlled trial: Standard versus supplemental bowel preparation in patients with Bristol stool form 1 and 2	PLOS ONE			English	Article							DOSE POLYETHYLENE-GLYCOL; COLONOSCOPY PREPARATION; AFTERNOON COLONOSCOPY; MAGNESIUM CITRATE; QUALITY; IMPACT; SCALE; BISACODYL; EFFICACY; 4-LITER	Background Bristol stool form 1 and 2 is an important predictor of inadequate bowel preparation. Aim To evaluate the efficacy of supplemental preparation in bowel cleansing quality among patients with Bristol stool form 1 and 2, as well as the feasibility of tailored bowel preparation guided by Bristol stool form scale. Methods Patients with Bristol stool form 1 and 2 from 3 Chinese tertiary hospitals randomly received either 2 L PEG-ELP (group A) or 10 mg bisacodyl plus 2 L PEG-ELP (group B); patients with Bristol stool form 3 to 7 received 2 L PEG-ELP (group C) for bowel preparation. The primary endpoint is the rate of adequate bowel reparation for the whole colon. The adequate bowel preparation rate for separate colon segments, the polyp detection rate (PDR), tolerability, acceptability, sleeping quality and compliance were evaluated as secondary endpoints. Results 700 patients were randomized. In per-protocol analysis, patients in group B attained significantly higher successful preparation rate than group A (88.7% vs. 61.2%, p<0.001) and similar with group C (88.7% vs. 85.0%, p = 0.316). The PDR in group B was significantly higher than group A (43.2% vs. 25.7%, p<0.001). Acceptability was much higher in group B and C. Conclusions 10 mg bisacodyl plus 2 L PEG-ELP can significantly improve both bowel preparation quality and PDR in patients with Bristol stool form 1 and 2. Bristol stool form scale may be an easy and efficient guide for tailored bowel preparation before colonoscopy.	[Li, Yueyue; Ji, Rui; Yu, Yanbo; Zuo, Xiuli; Li, Yanqing] Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Dept Gastroenterol, Jinan, Peoples R China; [Jia, Xinyong; Zhang, Xiubin] Shandong Univ, Qianfoshan Hosp, Dept Endoscopy, Jinan, Peoples R China; [Liu, Baozhen; Qi, Yanmei] Binzhou Peoples Hosp, Dept Gastroenterol, Binzhou, Peoples R China	Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University	Li, YQ (corresponding author), Shandong Univ, Qilu Hosp, Lab Translat Gastroenterol, Dept Gastroenterol, Jinan, Peoples R China.	liyanqing@sdu.edu.cn	yu, yanbo/GZM-8474-2022; li, yu/HGL-9518-2022; LI, Yue/GRS-8071-2022; Li, yu/HHZ-5236-2022		National Natural Science Foundation of China [81330012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study is supported by National Natural Science Foundation of China (Grant No. 81330012), www.nsfc.gov.cn/publish/portal1/. The author YQL received this funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brahmania M, 2014, GASTROINTEST ENDOSC, V79, P408, DOI 10.1016/j.gie.2013.08.035; Calderwood AH, 2010, GASTROINTEST ENDOSC, V72, P686, DOI 10.1016/j.gie.2010.06.068; Chokshi RV, 2012, GASTROINTEST ENDOSC, V75, P1197, DOI 10.1016/j.gie.2012.01.005; Chung YW, 2009, J CLIN GASTROENTEROL, V43, P448, DOI 10.1097/MCG.0b013e3181662442; Connor A, 2012, GUT, V61, P1525, DOI 10.1136/gutjnl-2011-300861; Enestvedt BK, 2012, CLIN GASTROENTEROL H, V10, P1225, DOI 10.1016/j.cgh.2012.08.029; Froehlich F, 2005, GASTROINTEST ENDOSC, V61, P378, DOI 10.1016/S0016-5107(04)02776-2; Gavin DR, 2013, GUT, V62, P242, DOI 10.1136/gutjnl-2011-301848; Harewood GC, 2003, GASTROINTEST ENDOSC, V58, P76, DOI 10.1067/mge.2003.294; Hassan C, 2012, CLIN GASTROENTEROL H, V10, P501, DOI 10.1016/j.cgh.2011.12.037; HEATON KW, 1991, GUT, V32, P73, DOI 10.1136/gut.32.1.73; Lai EJ, 2009, GASTROINTEST ENDOSC, V69, P620, DOI 10.1016/j.gie.2008.05.057; Lebwohl B, 2010, DIGEST DIS SCI, V55, P2014, DOI 10.1007/s10620-009-1079-7; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; Liu XD, 2014, GUT, V63, P125, DOI 10.1136/gutjnl-2012-304292; Longcroft-Wheaton G, 2012, J CLIN GASTROENTEROL, V46, P57, DOI 10.1097/MCG.0b013e318233a986; Malhotra A, 2016, COLORECTAL DIS, V18, P200, DOI 10.1111/codi.13084; Manabe N, 2009, ALIMENT PHARM THER, V30, P930, DOI 10.1111/j.1365-2036.2009.04118.x; Manes G, 2014, ENDOSCOPY, V46, P662, DOI 10.1055/s-0034-1365800; Martinez AP, 2012, REV LAT-AM ENFERM, V20, P583, DOI 10.1590/S0104-11692012000300021; Matro R, 2010, AM J GASTROENTEROL, V105, P1954, DOI 10.1038/ajg.2010.160; Ness RM, 2001, AM J GASTROENTEROL, V96, P1797, DOI 10.1016/S0002-9270(01)02437-6; ODONNELL LJD, 1990, BMJ-BRIT MED J, V300, P439, DOI 10.1136/bmj.300.6722.439; Parente F, 2015, DIGEST LIVER DIS, V47, P857, DOI 10.1016/j.dld.2015.06.008; Repici A, 2012, ALIMENT PHARM THER, V36, P717, DOI 10.1111/apt.12026; Rex DK, 2002, AM J GASTROENTEROL, V97, P1696; Rex DK, 2014, CLIN GASTROENTEROL H, V12, P458, DOI 10.1016/j.cgh.2013.11.003; Saltzman JR, 2015, GASTROINTEST ENDOSC, V81, P781, DOI 10.1016/j.gie.2014.09.048; Senore C, 2011, J MED SCREEN, V18, P128, DOI 10.1258/jms.2011.010135; Sharma VK, 1998, GASTROINTEST ENDOSC, V47, P167, DOI 10.1016/S0016-5107(98)70351-7; Tae JW, 2012, GASTROINTEST ENDOSC, V76, P804, DOI 10.1016/j.gie.2012.05.026	31	43	53	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 27	2017	12	2							e0171563	10.1371/journal.pone.0171563	http://dx.doi.org/10.1371/journal.pone.0171563			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EN3UW	28829813	Green Published, gold, Green Submitted			2022-12-27	WOS:000395934400007
